PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McKenzie, JA; Buettmann, E; Abraham, AC; Gardner, MJ; Silva, MJ; Killian, ML				McKenzie, Jennifer A.; Buettmann, Evan; Abraham, Adam C.; Gardner, Michael J.; Silva, Matthew J.; Killian, Megan L.			Loss of scleraxis in mice leads to geometric and structural changes in cortical bone, as well as asymmetry in fracture healing	FASEB JOURNAL			English	Article						skeletal repair; callus; development; transcription factors; tendon	REFERENCE-POINT INDENTATION; MORPHOGENETIC PROTEIN-2; TISSUE DIFFERENTIATION; ADULT MICE; MODEL; LIMB; EXPRESSION; PROGENITORS; OSTEOTOMY; TENDONS	Scleraxis (Scx) is a known regulator of tendon development, and recent work has identified the role of Scx in bone modeling. However, the role of Scx in fracture healing has not yet been explored. This study was conducted to identify the role of Scx in cortical bone development and fracture healing. Scx green fluorescent protein-labeled (ScxGFP) reporter and Scx-knockout (Scx-mutant) mice were used to assess bone morphometry and the effects of fracture healing on Scx localization and gene expression, as well as callus healing response. Botulinum toxin (BTX) was used to investigate muscle unloading effects on callus shape. Scx-mutant long bones had structural and mechanical defects. Scx gene expression was elevated and bmp4 was decreased at 24 h after fracture. ScxGFP + cells were localized throughout the healing callus after fracture. Scx-mutant mice demonstrated disrupted callus healing and asymmetry. Asymmetry of Scx-mutant callus was not due to muscle unloading. Wild-type littermates (age matched) served as controls. This is the first study to explore the role of Scx in cortical bone mechanics and fracture healing. Deletion of Scx during development led to altered long bone properties and callus healing. This study also demonstrated that Scx may play a role in the periosteal response during fracture healing.-McKenzie, J. A., Buettmann, E., Abraham, A. C., Gardner, M. J., Silva, M. J., Killian, M. L. Loss of scleraxis in mice leads to geometric and structural changes in cortical bone, as well as asymmetry in fracture healing.	[McKenzie, Jennifer A.; Buettmann, Evan; Abraham, Adam C.; Silva, Matthew J.; Killian, Megan L.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Gardner, Michael J.] Stanford Univ, Dept Orthoped Surg, Redwood City, CA USA; [Killian, Megan L.] Univ Delaware, Dept Biomed Engn, 5 Innovat Way,Suite 200, Newark, DE 19716 USA	Washington University (WUSTL); Stanford University; University of Delaware	Killian, ML (corresponding author), Univ Delaware, Dept Biomed Engn, 5 Innovat Way,Suite 200, Newark, DE 19716 USA.	killianm@udel.edu	Killian, Megan L./K-2442-2015; Buettmann, Evan/Q-2411-2019	Killian, Megan L./0000-0001-6868-5550; Buettmann, Evan/0000-0001-8439-477X; Silva, Matthew/0000-0001-7375-4522; Abraham, Adam/0000-0003-2131-5178	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS [F32 AR064652, R21 AR066798]; Washington University Musculoskeletal Research Center Grant [NIH-P30 AR057235]; Orthopaedic Research and Education Foundation; Children's Discovery Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR066798, R01AR050211, F32AR064652, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB018266] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; Washington University Musculoskeletal Research Center Grant; Orthopaedic Research and Education Foundation; Children's Discovery Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Grants F32 AR064652 (to M.L.K.), and R21 AR066798 (to M.J.S. and M.J.G.); Washington University Musculoskeletal Research Center Grant NIH-P30 AR057235; the Orthopaedic Research and Education Foundation, and the Children's Discovery Institute (Postdoctoral Fellowship to M.L.K.). The authors thank Daniel Leib and Crystal Idleburg (Musculoskeletal Research Center) for microCT and histology assistance. The authors declare no conflicts of interest.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abraham AC, 2016, BONE, V87, P37, DOI 10.1016/j.bone.2016.03.013; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010; Epari DR, 2010, P I MECH ENG H, V224, P1543, DOI 10.1243/09544119JEIM808; Eyal S, 2015, DEVELOPMENT, V142, P1831, DOI 10.1242/dev.121970; Fischer C, 2016, INJURY, V47, P342, DOI 10.1016/j.injury.2015.11.007; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Gardner MJ, 2011, J ORTHOP SCI, V16, P298, DOI 10.1007/s00776-011-0051-5; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Guimaraes JM, 2013, J ORTHOP RES, V31, P1971, DOI 10.1002/jor.22455; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Holguin N., 2016, J BONE MINER RES; Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Killian ML, 2016, FASEB J, V30, P301, DOI 10.1096/fj.14-258236; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2; LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; McBride-Gagyi SH, 2015, BONE, V81, P533, DOI 10.1016/j.bone.2015.09.003; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Porter SM, 2016, J ORTHOP RES, V34, P1224, DOI 10.1002/jor.23146; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Ritchie RO, 2006, STRAIN, V42, P225, DOI 10.1111/j.1475-1305.2006.00282.x; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294; Rot C, 2014, DEV CELL, V31, P159, DOI 10.1016/j.devcel.2014.08.026; Scammell BE, 1996, J BONE MINER RES, V11, P737; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015; Seeherman HJ, 2010, J BONE JOINT SURG AM, V92A, P411, DOI 10.2106/JBJS.H.01732; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Tsuji K, 2008, J BONE JOINT SURG AM, V90A, P14, DOI 10.2106/JBJS.G.01109; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Zelzer E, 2014, BIRTH DEFECTS RES C, V102, P101, DOI 10.1002/bdrc.21056; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	52	13	13	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					882	+		10.1096/fj.201600969R	http://dx.doi.org/10.1096/fj.201600969R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27864378	Green Published			2022-12-26	WOS:000395671200005
J	Slim, KE; Vauzour, D; Tejera, N; Voshol, PJ; Cassidy, A; Minihane, AM				Slim, Kenna E.; Vauzour, David; Tejera, Noemi; Voshol, Peter J.; Cassidy, Aedin; Minihane, Anne Marie			The effect of dietary fish oil on weight gain and insulin sensitivity is dependent on APOE genotype in humanized targeted replacement mice	FASEB JOURNAL			English	Article						diabetes; glucose; Glut4; IL-10; IPGTT	CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E POLYMORPHISM; ENDOPLASMIC-RETICULUM STRESS; POLYUNSATURATED FATTY-ACIDS; ADIPOSE-TISSUE; E GENE; GLUCOSE-TRANSPORTER; METABOLIC SYNDROME; BODY-COMPOSITION; SKELETAL-MUSCLE	We investigated the independent and interactive impact of the common APOE genotype and marine n-3 polyunsaturated fatty acids (PUFAs) on the development of obesity and associated cardiometabolic dysfunction in a murine model. Human APOE3 and APOE4 targeted replacement mice were fed either a control high-fat diet (HFD) or an HFD supplemented with 3% n-3 PUFAs from fish oil (HFD + FO) for 8 wk. We established the impact of intervention on food intake, body weight, and visceral adipose tissue (VAT) mass; plasma, lipids (cholesterol and triglycerides), liver enzymes, and adipokines; glucose and insulin during an intraperitoneal glucose tolerance test; and Glut4 and ApoE expression in VAT. HFD feeding induced more weight gain and higher plasma lipids in APOE3 compared to APOE4 mice (P < 0.05), along with a 2-fold higher insulin and impaired glucose tolerance. Supplementing APOE3, but not APOE4, animals with dietary n-3 PUFAs decreased body-weight gain, plasma lipids, and insulin (P < 0.05) and improved glucose tolerance, which was associated with increased VAT Glut4 mRNA levels (P< 0.05). Our findings demonstrate that an APOE3 genotype predisposes mice to develop obesity and its metabolic complications, which was attenuated by n-3 PUFA supplementation.	[Slim, Kenna E.; Vauzour, David; Tejera, Noemi; Cassidy, Aedin; Minihane, Anne Marie] Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich NR4 7UQ, Norfolk, England; [Voshol, Peter J.] Louis Bolk Inst, Dept Nutr & Hlth, Driebergen, Netherlands; [Voshol, Peter J.] Univ Cambridge, Inst Metab Sci, Cambridge, England	University of East Anglia; University of Cambridge	Minihane, AM (corresponding author), Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich NR4 7UQ, Norfolk, England.	a.minihane@uea.ac.uk	Vauzour, Dr David/C-2245-2008	Vauzour, Dr David/0000-0001-5952-8756; Tejera, Noemi/0000-0001-8100-6022	University of East Anglia Faculty of Medicine and Health Sciences Graduate School studentship; Biotechnology and Biological Sciences Research Council Institute Strategic Program grant [BB/J004545/1]	University of East Anglia Faculty of Medicine and Health Sciences Graduate School studentship; Biotechnology and Biological Sciences Research Council Institute Strategic Program grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by a University of East Anglia Faculty of Medicine and Health Sciences Graduate School studentship and a Biotechnology and Biological Sciences Research Council Institute Strategic Program grant (BB/ J004545/1).	Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bender N, 2014, OBES REV, V15, P657, DOI 10.1111/obr.12189; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Carvalho-Wells AL, 2012, AM J CLIN NUTR, V96, P1447, DOI 10.3945/ajcn.112.043240; Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549; Chouinard-Watkins R, 2013, BRIT J NUTR, V110, P1751, DOI 10.1017/S0007114513001268; Chouinard-Watkins R, 2015, AM J CLIN NUTR, V102, P505, DOI 10.3945/ajcn.114.103507; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Conway V, 2014, PROSTAG LEUKOTR ESS, V91, P261, DOI 10.1016/j.plefa.2014.09.007; Dose J, 2016, FREE RADICAL BIO MED, V96, P264, DOI 10.1016/j.freeradbiomed.2016.04.031; Ellis JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026679; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Golubic R, 2013, INT J OBESITY, V37, P404, DOI 10.1038/ijo.2012.58; Harris WS, 2008, CURR ATHEROSCLER REP, V10, P503, DOI 10.1007/s11883-008-0078-z; Hofmann SM, 2008, DIABETES, V57, P5, DOI 10.2337/db07-0403; HORWITZ W, 1980, METHODS ANAL; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huang ZH, 2015, J LIPID RES, V56, P215, DOI 10.1194/jlr.M050567; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; Kolaczynski JW, 1996, DIABETES, V45, P699, DOI 10.2337/diabetes.45.5.699; Kolovou GD, 2009, IN VIVO, V23, P33; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marques-Vidal P, 2003, OBES RES, V11, P1200, DOI 10.1038/oby.2003.165; Matualatupauw JC, 2016, MOL NUTR FOOD RES, V60, P1649, DOI 10.1002/mnfr.201500941; Minihane AM, 2007, P NUTR SOC, V66, P183, DOI 10.1017/S0029665107005435; NEUFER PD, 1993, J BIOL CHEM, V268, P13824; Oh JY, 2001, CLIN GENET, V60, P132, DOI 10.1034/j.1399-0004.2001.600207.x; Ouyang QF, 2015, MOL MED REP, V12, P2589, DOI 10.3892/mmr.2015.3774; Puglisi MJ, 2011, J NUTR BIOCHEM, V22, P101, DOI 10.1016/j.jnutbio.2010.07.003; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; Slim K, 2014, CURR CARDIOVASC RISK, V8, DOI 10.1007/s12170-014-0411-8; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Vauzour D, 2015, J NUTR BIOCHEM, V26, P211, DOI 10.1016/j.jnutbio.2014.09.005; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Yue L, 2009, J BIOL CHEM, V284, P10453, DOI 10.1074/jbc.M808482200; ZECHNER R, 1991, J BIOL CHEM, V266, P10583	56	10	11	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					989	997		10.1096/fj.201600921RR	http://dx.doi.org/10.1096/fj.201600921RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895108	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000395671200015
J	Esser, L; Zhou, F; Pluchino, KM; Shiloach, J; Ma, JC; Tang, W; Gutierrez, C; Zhang, A; Shukla, S; Madigan, JP; Zhou, TQ; Kwong, PD; Ambudkar, SV; Gottesman, MM; Xia, D				Esser, Lothar; Zhou, Fei; Pluchino, Kristen M.; Shiloach, Joseph; Ma, Jichun; Tang, Wai-kwan; Gutierrez, Camilo; Zhang, Alex; Shukla, Suneet; Madigan, James P.; Zhou, Tongqing; Kwong, Peter D.; Ambudkar, Suresh V.; Gottesman, Michael M.; Xia, Di			Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; DRUG-BINDING; CRYSTAL-STRUCTURE; CATALYTIC CYCLE; NUCLEOTIDE; RESISTANCE; SITES; FLEXIBILITY; HYDROLYSIS; STATE	P-glycoprotein (P-gp) is a polyspecific ATP-dependent transporter linked to multidrug resistance in cancer; it plays important roles in determining the pharmacokinetics of many drugs. Understanding the structural basis of P-gp, substrate polyspecificity has been hampered by its intrinsic flexibility, which is facilitated by a 75-residue linker that connects the two halves of P-gp. Here we constructed a mutant murine P-gp with a shortened linker to facilitate structural determination. Despite dramatic reduction in rhodamine 123 and calcein-AM transport, the linker-shortened mutant P-gp possesses basal ATPase activity and binds ATP only in its N-terminal nucleotide-binding domain. Nine independently determined structures of wild type, the linker mutant, and a methylated P-gp at up to 3.3 angstrom resolution display significant movements of individual transmembrane domain helices, which correlated with the opening and closing motion of the two halves of P-gp. The open-and-close motion alters the surface topology of P-gp within the drug-binding pocket, providing a mechanistic explanation for the polyspecificity of P-gp in substrate interactions.	[Esser, Lothar; Zhou, Fei; Pluchino, Kristen M.; Ma, Jichun; Tang, Wai-kwan; Gutierrez, Camilo; Zhang, Alex; Shukla, Suneet; Madigan, James P.; Ambudkar, Suresh V.; Gottesman, Michael M.; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37,Rm 2122C,37 Convent Dr, Bethesda, MD 20892 USA; [Shiloach, Joseph] NIDDK, Biotechnol Unit, NIH, Bethesda, MD 20892 USA; [Zhou, Tongqing; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Xia, D (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37,Rm 2122C,37 Convent Dr, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Zhou, Tongqing/A-6880-2010; Ambudkar, Suresh V/L-1317-2016	Zhou, Tongqing/0000-0002-3935-4637; 	Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005598, ZIABC010319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500] Funding Source: NIH RePORTER	Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hrycyna CA, 1998, BIOCHEMISTRY-US, V37, P13660, DOI 10.1021/bi9808823; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kapoor K, 2013, J BIOL CHEM, V288, P32622, DOI 10.1074/jbc.M113.498980; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2014, J BIOL CHEM, V289, P8484, DOI 10.1074/jbc.M114.552075; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Ohnuma S, 2011, BIOCHEMISTRY-US, V50, P3724, DOI 10.1021/bi200073f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pluchino KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136396; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	61	111	114	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					446	461		10.1074/jbc.M116.755884	http://dx.doi.org/10.1074/jbc.M116.755884			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27864369	Green Published, hybrid			2022-12-26	WOS:000392316100004
J	Zhang, YX; Li, Q; Youn, JY; Cai, H				Zhang, Yixuan; Li, Qiang; Youn, Ji Youn; Cai, Hua			Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATION; MICE; OVEREXPRESSION; EXPRESSION; PLATELETS; APOPTOSIS; INVASION; MODEL; NOTCH	The VEGF/VEGFR2/Akt/eNOS/NO pathway is essential to VEGF-induced angiogenesis. We have previously discovered a novel role of calpain in mediating VEGF-induced PI3K/AMPK/Akt/eNOS activation through Ezrin. Here, we sought to identify possible feedback regulation of VEGFR2 by calpain via its substrate protein phosphotyrosine phosphatase 1B (PTP1B), and the relevance of this pathway to VEGF-induced angiogenesis, especially in diabetic wound healing. Overexpression of PTP1B inhibited VEGF-induced VEGFR2 and Akt phosphorylation in bovine aortic endothelial cells, while PTP1B siRNA increased both, implicating negative regulation of VEGFR2 by PTP1B. Calpain inhibitor ALLN induced VEGFR2 activation, which can be completely blocked by PTP1B overexpression. Calpain activation induced by overexpression or Ca/A23187 resulted in PTP1B cleavage, which can be blocked by ALLN. Moreover, calpain activation inhibited VEGF-induced VEGFR2 phosphorylation, which can be restored by PTP1B siRNA. These data implicate calpain/PTP1B negative feedback regulation of VEGFR2, in addition to the primary signaling pathway of VEGF/VEGFR2/calpain/PI3K/AMPK/Akt/eNOS. Wenext examined a potential role of PTP1B in VEGF-induced angiogenesis. Endothelial cells transfected with PTP1B siRNA showed faster wound closure in response to VEGF. Aortic discs isolated from PTP1B siRNA-transfected mice also had augmented endothelial outgrowth. Importantly, PTP1B inhibition and/or calpain overexpression significantly accelerated wound healing in STZ-induced diabetic mice. In conclusion, our data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; [Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Cardiol,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Mol Med,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med & Cardiol, Dept Anesthesiol,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.; Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med & Cardiol, Dept Med,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu		Zhang, Yixuan/0000-0001-7317-7235	National Heart, Lung and Blood Institute (NHLBI), National Institute of Health [HL077440, HL088975, HL108701, HL119968]; American Heart Association [12EIA8990025]; AHA Postdoctoral Fellowship Award [14POST20380995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088975, R01HL077440, R01HL119968, R01HL108701] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI), National Institute of Health; American Heart Association(American Heart Association); AHA Postdoctoral Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute (NHLBI), National Institute of Health Grants HL077440 (to H. C.), HL088975 (to H. C.), HL108701 (to H. C., D. G. H.), HL119968 (to H. C.), an American Heart Association Established Investigator Award (EIA) 12EIA8990025 (to H. C.), and an AHA Postdoctoral Fellowship Award 14POST20380995 (to Y. X. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Besnier M, 2014, FASEB J, V28, P3351, DOI 10.1096/fj.13-245753; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Go Ronald S, 2003, Methods Mol Med, V85, P59; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Herre DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126866; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Liu C, 2014, HYPERTENSION, V63, P353, DOI 10.1161/HYPERTENSIONAHA.113.02361; Ma H, 2009, J OCUL PHARMACOL TH, V25, P409, DOI 10.1089/jop.2009.0030; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Suryawan A, 2003, AM J PHYSIOL-ENDOC M, V284, pE47, DOI 10.1152/ajpendo.00210.2002; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tie L, 2009, AM J PHYSIOL-ENDOC M, V296, pE1423, DOI 10.1152/ajpendo.00150.2009; Wang H, 2008, DIABETES, V57, P540, DOI 10.2337/db07-0967; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6; Youn JY, 2012, CLIN SCI, V123, P509, DOI 10.1042/CS20110407; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; Zheng Y, 2007, ARTERIOSCL THROM VAS, V27, P503, DOI 10.1161/01.ATV.0000256459.06671.3c	37	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					407	416		10.1074/jbc.M116.766832	http://dx.doi.org/10.1074/jbc.M116.766832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27872190	Green Published, hybrid			2022-12-26	WOS:000392316100001
J	Alluri, H; Grimsley, M; Shaji, CA; Varghese, KP; Zhang, SYL; Peddaboina, C; Robinson, B; Beeram, MR; Huang, JH; Tharakan, B				Alluri, Himakarnika; Grimsley, Marcene; Shaji, Chinchusha Anasooya; Varghese, Kevin Paul; Zhang, Shenyuan L.; Peddaboina, Chander; Robinson, Bobby; Beeram, Madhava R.; Huang, Jason H.; Tharakan, Binu			Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; INJURY; PERMEABILITY; MATRIX-METALLOPROTEINASE-9; CLEAVAGE; EDEMA; DYSFUNCTION; MODULATION; INDUCTION	Blood-brain barrier (BBB) breakdown and the associated microvascular hyperpermeability followed by brain edema are hallmark features of several brain pathologies, including traumatic brain injuries (TBI). Recent studies indicate that pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) that is upregulated following traumatic injuries also promotes BBB dysfunction and hyperpermeability, but the underlying mechanisms are not clearly known. The objective of this study was to determine the role of calpains in mediating BBB dysfunction and hyperpermeability and to test the effect of calpain inhibition on theBBBfollowing traumatic insults to the brain. In these studies, rat brain microvascular endothelial cell monolayers exposed to calpain inhibitors (calpain inhibitor III and calpastatin) or transfected with calpain-1 siRNA demonstrated attenuation of IL-1 beta-induced monolayer hyperpermeability. Calpain inhibition led to protection against IL-1 beta-induced loss of zonula occludens-1 (ZO-1) at the tight junctions and alterations in F-actin cytoskeletal assembly. IL-1 beta treatment had no effect on ZO-1 gene (tjp1) or protein expression. Calpain inhibition via calpain inhibitor III and calpastatin decreased IL-1 beta-induced calpain activity significantly (p < 0.05). IL-1 beta had no detectable effect on intracellular calcium mobilization or endothelial cell viability. Furthermore, calpain inhibition preserved BBB integrity/permeability in a mouse controlled cortical impact model of TBI when studied using Evans blue assay and intravital microscopy. These studies demonstrate that calpain-1 acts as a mediator of IL-1 beta-induced loss of BBB integrity and permeability by altering tight junction integrity, promoting the displacement of ZO-1, and disorganization of cytoskeletal assembly. IL-1 beta-mediated alterations in permeability are neither due to the changes in ZO-1 expression nor cell viability. Calpain inhibition has beneficial effects against TBI-induced BBB hyperpermeability.	[Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Peddaboina, Chander; Robinson, Bobby; Tharakan, Binu] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA; [Huang, Jason H.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Neurosurg,Coll Med, Temple, TX 76504 USA; [Beeram, Madhava R.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Pediat,Coll Med, Temple, TX 76504 USA; [Grimsley, Marcene] Texas Biosci Inst, Temple, TX 76502 USA; [Varghese, Kevin Paul] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhang, Shenyuan L.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tharakan, B (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	btharakan@medicine.tamhsc.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Baylor Scott and White Health Academic Operations Research funds	Baylor Scott and White Health Academic Operations Research funds	This work was supported by Baylor Scott and White Health Academic Operations Research funds (to B. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alluri H, 2014, MICROCIRCULATION, V21, P187, DOI 10.1111/micc.12110; Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Chakraborti S, 2012, INDIAN J BIOCHEM BIO, V49, P316; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Fei B, 2013, BBA-MOL CELL RES, V1833, P2153, DOI 10.1016/j.bbamcr.2013.05.010; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Jeong SY, 2013, P NATL ACAD SCI USA, V110, pE4007, DOI 10.1073/pnas.1316852110; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kotecki M, 2010, MICROVASC RES, V80, P339, DOI 10.1016/j.mvr.2010.07.012; Loot AE, 2013, J CARDIOVASC PHARM, V61, P528, DOI 10.1097/FJC.0b013e31828d0fa3; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; Prangsaengtong O, 2012, HUM CELL, V25, P36, DOI 10.1007/s13577-012-0042-7; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2015, MOL NEUROBIOL, V52, P1054, DOI 10.1007/s12035-015-9255-6; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Toba S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01224; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Yuan S. Y., 2010, C SERIES INTEGRATED, P39; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492	49	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26958	26969		10.1074/jbc.M116.735365	http://dx.doi.org/10.1074/jbc.M116.735365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875293	hybrid, Green Published			2022-12-26	WOS:000391576300002
J	Jones, JM; Sweet, J; Brzezinski, MA; McNair, HM; Passow, U				Jones, Jonathan M.; Sweet, Julia; Brzezinski, Mark A.; McNair, Heather M.; Passow, Uta			Evaluating Carbonate System Algorithms in a Nearshore System: Does Total Alkalinity Matter?	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INORGANIC CARBON; PH; SEAWATER; VARIABILITY; CO2; IMPACTS; DISSOCIATION; SATURATION; WATERS	Ocean acidification is a threat to many marine organisms, especially those that use calcium carbonate to form their shells and skeletons. The ability to accurately measure the carbonate system is the first step in characterizing the drivers behind this threat. Due to logistical realities, regular carbonate system sampling is not possible in many nearshore ocean habitats, particularly in remote, difficult-to-access locations. The ability to autonomously measure the carbonate system in situ relieves many of the logistical challenges; however, it is not always possible to measure the two required carbonate parameters autonomously. Observed relationships between sea surface salinity and total alkalinity can frequently provide a second carbonate parameter thus allowing for the calculation of the entire carbonate system. Here, we assessed the rigor of estimating total alkalinity from salinity at a depth <15 m by routinely sampling water from a pier in southern California for several carbonate system parameters. Carbonate system parameters based on measured values were compared with those based on estimated TA values. Total alkalinity was not predictable from salinity or from a combination of salinity and temperature at this site. However, dissolved inorganic carbon and the calcium carbonate saturation state of these nearshore surface waters could both be estimated within on average 5% of measured values using measured pH and salinity-derived or regionally averaged total alkalinity. Thus we find that the autonomous measurement of pH and salinity can be used to monitor trends in coastal changes in DIC and saturation state and be a useful method for high-frequency, long-term monitoring of ocean acidification.	[Jones, Jonathan M.; Sweet, Julia; Brzezinski, Mark A.; Passow, Uta] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Jones, Jonathan M.] Cabrillo Natl Monument, San Diego, CA USA; [Jones, Jonathan M.; Brzezinski, Mark A.; McNair, Heather M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Jones, JM (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.; Jones, JM (corresponding author), Cabrillo Natl Monument, San Diego, CA USA.; Jones, JM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	jonathan_jones@nps.gov		Sweet, Julia/0000-0002-0013-0759	State Water Resources Control Board, California; National Science Foundation (NSF) [OCE-1041038]; University of California's multi-campus research program; University of California; Santa Barbara Coastal Fund of Associated Students; Santa Barbara Coastal Long Term Ecological Research program (SBC LTER) [OCE-0620276]; Gretchen Hofmann; Ocean Acidification Network; Directorate For Geosciences [1232779] Funding Source: National Science Foundation	State Water Resources Control Board, California; National Science Foundation (NSF)(National Science Foundation (NSF)); University of California's multi-campus research program; University of California(University of California System); Santa Barbara Coastal Fund of Associated Students; Santa Barbara Coastal Long Term Ecological Research program (SBC LTER); Gretchen Hofmann; Ocean Acidification Network; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The project was conducted in collaboration with the Surface Water Ambient Monitoring Program (SWAMP) from the State Water Resources Control Board, California, which funded a portion of carbonate system analyses. The majority of the 2-year program was funded by the National Science Foundation (NSF) grant OCE-1041038. Work by JMJ was additionally supported by the University of California's multi-campus research program, Ocean Acidification: A Training and Research Consortium, (http:// oceanacdification.msi.ucsb.edu) and the University of California, Santa Barbara Coastal Fund of Associated Students (https://coastalfund.as. ucsb.edu). CTD data and data management were supported by the Santa Barbara Coastal Long Term Ecological Research program (SBC LTER; NSF grant OCE-0620276). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; During the first year, the determination of carbonate system parameters was conducted in collaboration with the Surface Water Ambient Monitoring Program (SWAMP) from the State Water Resources Control Board. We thank the Dickson laboratory for the careful and speedy determination of carbonate system parameters during this time, and their helpful comments as we were building our capacity to measure the carbonate system. CTD data and data management were provided by the Santa Barbara Coastal LTER. We thank Libe Washburn, Janice Jones, Chris Gotschalk, Tom Philippi, David Salazar, and Eduardo Romero for their technical and logistical assistance. We thank Gretchen Hofmann and the Ocean Acidification Network for logistical and financial support (http://oceanacidification.msi.ucsb.edu)).	Abril G, 2015, BIOGEOSCIENCES, V12, P67, DOI 10.5194/bg-12-67-2015; Alin SR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007511; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Benhelal E, 2013, J CLEAN PROD, V51, P142, DOI 10.1016/j.jclepro.2012.10.049; Bockmon EE, 2015, MAR CHEM, V171, P36, DOI 10.1016/j.marchem.2015.02.002; Brzezinski MA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007397; Cross JN, 2013, MAR CHEM, V154, P100, DOI 10.1016/j.marchem.2013.05.012; Cullison Gray SE, 2011, MAR CHEM, V125, P82; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Hofmann G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09638; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Huang WJ, 2012, LIMNOL OCEANOGR-METH, V10, P711, DOI 10.4319/lom.2012.10.711; Jiang ZP, 2014, GLOBAL BIOGEOCHEM CY, V28, P729, DOI 10.1002/2013GB004678; Kapsenberg L, 2016, LIMNOL OCEANOGR, V61, P953, DOI 10.1002/lno.10264; Kim H-C, 2006, CONTRIBUTION PHYTOPL; Kim HC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040271; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Liu XW, 2011, ENVIRON SCI TECHNOL, V45, P4862, DOI 10.1021/es200665d; Martz TR, 2015, OCEANOGRAPHY, V28, P40, DOI 10.5670/oceanog.2015.30; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; McLaughlin K, 2015, OCEANOGRAPHY, V28, P160, DOI 10.5670/oceanog.2015.39; Mehrbach C, 1973, MEASUREMENT OF THE A; Millero FJ, 1998, MAR CHEM, V60, P111, DOI 10.1016/S0304-4203(97)00084-4; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; Parsons T., 2013, MANUAL CHEM BIOL MET, DOI DOI 10.1016/B978-0-08-030287-4.50011-6; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Takahashi T, 2014, MAR CHEM, V164, P95, DOI 10.1016/j.marchem.2014.06.004; Takeshita Y, 2015, BIOGEOSCIENCES, V12, P5853, DOI 10.5194/bg-12-5853-2015; Uppstrom LR, 1974, DEEP SEA RES OCEANOG; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053396; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yang B, 2015, MAR CHEM, V176, P199, DOI 10.1016/j.marchem.2015.09.008; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	42	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165191	10.1371/journal.pone.0165191	http://dx.doi.org/10.1371/journal.pone.0165191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893739	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400005
J	Kalyani, M; Hasselfeld, K; Janik, JM; Callahan, P; Shi, HF				Kalyani, Manu; Hasselfeld, Kathryn; Janik, James M.; Callahan, Phyllis; Shi, Haifei			Effects of High-Fat Diet on Stress Response in Male and Female Wildtype and Prolactin Knockout Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GENE-EXPRESSION; BRAIN PROLACTIN; BASAL ACTIVITY; MESSENGER-RNA; RECEPTOR GENE; LEPTIN; MOUSE; RAT; CORTICOSTERONE	Prolactin (PRL) is well characterized for its roles in initiation and maintenance of lactation, and it also suppresses stress-induced responses. Feeding a high-fat diet (HFD) disrupts activity of the hypothalamic-pituitary-adrenal (HPA) axis. Whether PRL regulates HPA axis activation under HFD feeding is not clear. Male and female wildtype (WT) and PRL knockout (KO) mice were fed either a standard low-fat diet (LFD) or HFD for 12 weeks. Circulating corticosterone (CORT) levels were measured before, during, and after mice were subjected to an acute restraint stress or remained in their home cages as no stress controls. HFD feeding increased leptin levels, but the increase was lower in KO than in WT mice. All stressed female groups and only LFD-fed stressed males had elevated CORT levels compared to their no stress same-sex counterparts regardless of genotype. These results indicated that HFD consumption blunted the HPA axis response to acute stress in males but not females. Additionally, basal hypothalamic CRH content was lower in HFD than LFD males, but was similar among female groups. Furthermore, although basal CORT levels were similar among KO and WT groups, CORT levels were higher in KO mice than their WT counterparts during stress, suggesting that loss of PRL led to greater HPA axis activation. Basal PRL receptor mRNA levels in the choroid plexus were higher in HFD than LFD same-sex counterparts, suggesting activation of central PRL's action by HFD feeding in both males and females. Current results confirmed PRL's roles in suppression of the stress-induced HPA axis activation. Although HFD feeding activated central PRL's action in both sexes, only the male HPA axis was dampened by HFD feeding.	[Kalyani, Manu; Hasselfeld, Kathryn; Janik, James M.; Callahan, Phyllis; Shi, Haifei] Miami Univ, Dept Biol Physiol & Neurosci, Oxford, OH 45056 USA; [Janik, James M.; Callahan, Phyllis; Shi, Haifei] Miami Univ, Cell Mol & Struct Biol, Oxford, OH 45056 USA	Miami University; Miami University	Kalyani, M; Shi, HF (corresponding author), Miami Univ, Dept Biol Physiol & Neurosci, Oxford, OH 45056 USA.; Shi, HF (corresponding author), Miami Univ, Cell Mol & Struct Biol, Oxford, OH 45056 USA.	kalyanm@miamioh.edu; shih@miamioh.edu		Shi, Haifei/0000-0002-9523-7742	National Institutes of Health [DK046479, DK090823]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD046479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health DK046479 (JJ and PC) and DK090823 (HS), https://www.niddk.nih.gov/Pages/defaultaspx.; We are thankful for support from Miami University Senate Committee on Faculty Research (HS).	Auvinen HE, 2011, HORM METAB RES, V43, P899, DOI 10.1055/s-0031-1291305; Auvinen HE, 2012, J ENDOCRINOL, V214, P191, DOI 10.1530/JOE-12-0056; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Brandebourg TD, 2007, BIOCHEM BIOPH RES CO, V357, P408, DOI 10.1016/j.bbrc.2007.03.168; Clark KA, 2006, AM J PHYSIOL-REG I, V290, pR306, DOI 10.1152/ajpregu.00350.2005; Clark KA, 2008, BRAIN RES, V1195, P89, DOI 10.1016/j.brainres.2007.12.009; DEMAREST KT, 1985, NEUROENDOCRINOLOGY, V41, P504, DOI 10.1159/000124227; Fernandez-Guasti A, 2012, HORM METAB RES, V44, P607, DOI 10.1055/s-0032-1312592; Ferrini M, 1999, NEUROENDOCRINOLOGY, V69, P129, DOI 10.1159/000054411; Fleenor D, 2005, ENDOCRINOLOGY, V146, P103, DOI 10.1210/en.2004-0744; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Fujikawa T, 2005, ENDOCRINOLOGY, V146, P3471, DOI 10.1210/en.2004-1528; Fujikawa T, 2004, ENDOCRINOLOGY, V145, P2006, DOI 10.1210/en.2003-1446; FUJIKAWA T, 1995, ENDOCRINOLOGY, V136, P5608, DOI 10.1210/en.136.12.5608; GARTHWAITE TL, 1980, ENDOCRINOLOGY, V107, P671, DOI 10.1210/endo-107-3-671; GonzalezParra S, 1996, J NEUROENDOCRINOL, V8, P211, DOI 10.1046/j.1365-2826.1996.04526.x; HANDA RJ, 1994, PHYSIOL BEHAV, V55, P117, DOI 10.1016/0031-9384(94)90018-3; Handa RJ, 2014, FRONT NEUROENDOCRIN, V35, P197, DOI 10.1016/j.yfrne.2013.11.001; Heiman ML, 1997, ENDOCRINOLOGY, V138, P3859, DOI 10.1210/en.138.9.3859; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hler KD, 1974, ENDOCRINOLOGY, V94, P1003, DOI 10.1210/endo-94-4-1003; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Hsu HT, 2006, J CLIN ENDOCR METAB, V91, P2761, DOI 10.1210/jc.2005-2383; KITAY JI, 1963, ENDOCRINOLOGY, V73, P253, DOI 10.1210/endo-73-2-253; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kruse M, 1998, ENDOCR RES, V24, P587, DOI 10.3109/07435809809032650; LaPensee CR, 2006, ENDOCRINOLOGY, V147, P4638, DOI 10.1210/en.2006-0487; Ling C, 2001, ENDOCRINOLOGY, V142, P4880, DOI 10.1210/en.142.11.4880; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; MANGURIAN LP, 1992, ENDOCRINOLOGY, V131, P698, DOI 10.1210/en.131.2.698; Miller WJS, 2004, J NEUROSCI, V24, P10628, DOI 10.1523/JNEUROSCI.5540-03.2004; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Pecoraro N, 2006, PHYSIOL BEHAV, V89, P598, DOI 10.1016/j.physbeh.2006.07.019; Pi XJ, 2003, NEUROENDOCRINOLOGY, V77, P187, DOI 10.1159/000069510; Pi XJ, 2002, MOL BRAIN RES, V103, P130, DOI 10.1016/S0169-328X(02)00194-8; Seale JV, 2004, J NEUROENDOCRINOL, V16, P989, DOI 10.1111/j.1365-2826.2004.01258.x; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Torner L, 2004, EUR J NEUROSCI, V19, P1601, DOI 10.1111/j.1460-9568.2004.03264.x; Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vachon P, 2001, CONTEMP TOP LAB ANIM, V40, P22; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166416	10.1371/journal.pone.0166416	http://dx.doi.org/10.1371/journal.pone.0166416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893788	gold, Green Submitted, Green Published			2022-12-26	WOS:000389472400025
J	Reichert, K; do Carmo, HRP; Torina, AG; de Carvalho, DD; Sposito, AC; Vilarinho, KAD; Silveira, LDM; de Oliveira, PPM; Petrucci, O				Reichert, Karla; Pereira do Carmo, Helison Rafael; Torina, Anali Galluce; de Carvalho, Daniela Diogenes; Sposito, Andrei Carvalho; de Souza Vilarinho, Karlos Alexandre; Silveira-Filho, Lindemberg da Mota; Martins de Oliveira, Pedro Paulo; Petrucci, Orlando			Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism	PLOS ONE			English	Article							NF-KAPPA-B; MATRIX-METALLOPROTEINASE INHIBITION; HEART-FAILURE; MATRICELLULAR PROTEINS; EXTRACELLULAR-MATRIX; CARDIAC-HYPERTROPHY; RAT MODEL; IN-VITRO; ACTIVATION; EXPRESSION	Purpose Therapeutic strategies that modulate ventricular remodeling can be useful after acute myocardial infarction (MI). In particular, statins may exert effects on molecular pathways involved in collagen metabolism. The aim of this study was to determine whether treatment with atorvastatin for 4 weeks would lead to changes in collagen metabolism and ventricular remodeling in a rat model of MI. Methods Male Wistar rats were used in this study. MI was induced in rats by ligation of the left anterior descending coronary artery (LAD). Animals were randomized into three groups, according to treatment: sham surgery without LAD ligation (sham group, n = 14), LAD ligation followed by 10mg atorvastatin/kg/day for 4 weeks (atorvastatin group, n = 24), or LAD ligation followed by saline solution for 4 weeks (control group, n = 27). After 4 weeks, hemodynamic characteristics were obtained by a pressure-volume catheter. Hearts were removed, and the left ventricles were subjected to histologic analysis of the extents of fibrosis and collagen deposition, as well as the myocyte cross-sectional area. Expression levels of mediators involved in collagen metabolism and inflammation were also assessed. Results End-diastolic volume, fibrotic content, and myocyte cross-sectional area were significantly reduced in the atorvastatin compared to the control group. Atorvastatin modulated expression levels of proteins related to collagen metabolism, including MMP1, TIMP1, COL I, PCPE, and SPARC, in remote infarct regions. Atorvastatin had anti-inflammatory effects, as indicated by lower expression levels of TLR4, IL-1, and NF-kB p50. Conclusion Treatment with atorvastatin for 4 weeks was able to attenuate ventricular dysfunction, fibrosis, and left ventricular hypertrophy after MI in rats, perhaps in part through effects on collagen metabolism and inflammation. Atorvastatin may be useful for limiting ventricular remodeling after myocardial ischemic events.	[Reichert, Karla; Pereira do Carmo, Helison Rafael; Torina, Anali Galluce; de Carvalho, Daniela Diogenes; Petrucci, Orlando] State Univ Campinas UNICAMP, Lab Myocardial Ischemia Reperfus, Fac Med Sci, Campinas, SP, Brazil; [de Souza Vilarinho, Karlos Alexandre; Silveira-Filho, Lindemberg da Mota; Martins de Oliveira, Pedro Paulo; Petrucci, Orlando] State Univ Campinas UNICAMP, Dept Surg, Discipline Cardiac Surg, Fac Med Sci, Campinas, SP, Brazil; [Sposito, Andrei Carvalho] State Univ Campinas UNICAMP, Dept Internal Med, Fac Med Sci, Campinas, SP, Brazil; [Petrucci, Orlando] Washington Univ, Sch Med, Dept Surg, Sect Pediat Cardiothorac Surg, St Louis, MO 63110 USA	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Washington University (WUSTL)	Petrucci, O (corresponding author), State Univ Campinas UNICAMP, Lab Myocardial Ischemia Reperfus, Fac Med Sci, Campinas, SP, Brazil.	orlandopetrucci@mac.com	de Carvalho, Daniela/G-9453-2019; Sposito, Andrei C/G-4116-2013; Carvalho, Daniela/L-1944-2013	Sposito, Andrei C/0000-0001-7127-2052; Carvalho, Daniela/0000-0002-2479-949X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/10661-4, 2012/09494-3, 2012/09130-1, 2011/14550-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [http://www.fapesp.br/] (Grant Numbers: 2013/10661-4, Grant Numbers: 2012/09494-3, Grant Numbers: 2012/09130-1, Grant Numbers: 2011/14550-7).	Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; An Z, 2013, CHINESE MED J-PEKING, V126, P2149, DOI 10.3760/cma.j.issn.0366-6999.20123223; Anzai T, 2013, CIRC J, V77, P580, DOI 10.1253/circj.CJ-13-0013; Apple KA, 2006, J CARDIOVASC PHARM, V47, P228, DOI 10.1097/01.fjc.0000200989.23987.b8; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Briasoulis A, 2012, CURR TOP MED CHEM, V12, P1214, DOI 10.2174/1568026611208011214; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Cokkinos DV, 2011, HEART FAIL REV, V16, P1, DOI 10.1007/s10741-010-9192-4; de Jong S, 2012, NETH HEART J, V20, P44, DOI 10.1007/s12471-011-0226-x; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Faria TD, 2011, ARCH MED RES, V42, P274, DOI 10.1016/j.arcmed.2011.06.002; Feng Y, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/170352; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Garjani A, 2011, EUR J PHARMACOL, V666, P135, DOI 10.1016/j.ejphar.2011.04.061; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Gosse P, 2005, J HYPERTENS, V23, pS27, DOI 10.1097/01.hjh.0000165625.79933.9a; Han L, 2013, EXP THER MED, V6, P721, DOI 10.3892/etm.2013.1208; Hayashidani S, 2002, CIRCULATION, V105, P868, DOI 10.1161/hc0702.104164; Kaludercic N, 2008, CARDIOVASC THER, V26, P24, DOI 10.1111/j.1527-3466.2007.00034.x; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kukacka Jiri, 2005, Biomedical Papers (Olomouc), V149, P225; Lepper PM, 2012, CIRC-CARDIOVASC INTE, V5, P146, DOI 10.1161/CIRCINTERVENTIONS.112.968495; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Mandosi E, 2010, J ATHEROSCLER THROMB, V17, P539, DOI 10.5551/jat.2956; Martin J, 2005, CLIN EXP PHARMACOL P, V32, P697, DOI 10.1111/j.1440-1681.2005.04256.x; McCurdy S, 2010, J MOL CELL CARDIOL, V48, P544, DOI 10.1016/j.yjmcc.2009.06.018; Minicucci MF, 2010, ARQ BRAS CARDIOL, V95, P635, DOI 10.1590/S0066-782X2010005000130; Moore L, 2012, HEART FAIL REV, V17, P693, DOI 10.1007/s10741-011-9266-y; Nishioka T, 2010, AM J PHYSIOL-HEART C, V298, pH1072, DOI 10.1152/ajpheart.00255.2009; Nwogu JI, 2001, CIRCULATION, V104, P2216, DOI 10.1161/hc4301.097193; Okamoto H, 2012, CARDIOVASC THER, V30, pe198, DOI 10.1111/j.1755-5922.2011.00276.x; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Planavila A, 2005, BBA-MOL CELL BIOL L, V1687, P76, DOI 10.1016/j.bbalip.2004.11.004; Roehl AB, 2013, ANESTHESIOLOGY, V118, P1385, DOI 10.1097/ALN.0b013e31828744c0; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Song XJ, 2011, INT J MED SCI, V8, P564, DOI 10.7150/ijms.8.564; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Spinale Francis G, 2009, Curr Treat Options Cardiovasc Med, V11, P339; Stefanon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064986; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tan J, 2012, YONSEI MED J, V53, P501, DOI 10.3349/ymj.2012.53.3.501; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025320; Torina AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121842; Tousoulis D, 2012, CURR TOP MED CHEM, V12, P1181, DOI 10.2174/1568026611208011181; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; van der Meij E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053882; Vanhoutte D, 2010, J MOL CELL CARDIOL, V48, P445, DOI 10.1016/j.yjmcc.2009.09.013; Yang J, 2011, MOL BIOL REP, V38, P3037, DOI 10.1007/s11033-010-9970-z; Yang J, 2010, MOL CELL BIOCHEM, V345, P189, DOI 10.1007/s11010-010-0572-9; Ye P, 2006, J PHARM PHARM SCI, V9, P365; Yeung AC, 2002, CIRCULATION, V105, P2937, DOI 10.1161/01.CIR.0000023397.12047.03; Zimmerman SD, 2000, AM J PHYSIOL-HEART C, V278, pH194, DOI 10.1152/ajpheart.2000.278.1.H194; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013; Zou C, 2013, TEX HEART I J, V40, P140	66	30	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166845	10.1371/journal.pone.0166845	http://dx.doi.org/10.1371/journal.pone.0166845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880844	Green Published, gold			2022-12-26	WOS:000388889500038
J	de Winter, NJ; Snoeck, C; Claeys, P				de Winter, Niels J.; Snoeck, Christophe; Claeys, Philippe			Seasonal Cyclicity in Trace Elements and Stable Isotopes of Modern Horse Enamel	PLOS ONE			English	Article							BIOAPATITE CARBONATE PRETREATMENTS; TRIDACNA-GIGAS BIVALVES; MAMMALIAN TOOTH ENAMEL; OXYGEN-ISOTOPE; FOSSIL BONE; NEOLITHIC SHEEP; DIAGENESIS; RATIOS; TEETH; FRACTIONATION	The study of stable isotopes in fossil bioapatite has yielded useful results and has shown that bioapatites are able to faithfully record paleo-environmental and paleo-climatic parameters from archeological to geological timescales. In an effort to establish new proxies for the study of bioapatites, intra-tooth records of enamel carbonate stable isotope ratios from a modern horse are compared with trace element profiles measured using laboratory micro X Ray Fluorescence scanning. Using known patterns of tooth eruption and the relationship between stable oxygen isotopes and local temperature seasonality, an age model is constructed that links records from six cheek upper right teeth from the second premolar to the third molar. When plotted on this age model, the trace element ratios from horse tooth enamel show a seasonal pattern with a small shift in phase compared to stable oxygen isotope ratios. While stable oxygen and carbon isotopes in tooth enamel are forced respectively by the state of the hydrological cycle and the animal's diet, we argue that the seasonal signal in trace elements reflects seasonal changes in dust intake and diet of the animal. The latter explanation is in agreement with seasonal changes observed in carbon isotopes of the same teeth. This external forcing of trace element composition in mammal tooth enamel implies that trace element ratios may be used as proxies for seasonal changes in paleo-environment and paleo-diet.	[de Winter, Niels J.; Snoeck, Christophe; Claeys, Philippe] Vrije Univ Brussel, Dept Analyt Environm & Geochem, Pleinlaan 2, B-1050 Brussels, Belgium	Vrije Universiteit Brussel	de Winter, NJ (corresponding author), Vrije Univ Brussel, Dept Analyt Environm & Geochem, Pleinlaan 2, B-1050 Brussels, Belgium.	nidewint@vub.ac.be	Snoeck, Christophe/V-9679-2019; (VUB), VRIJE UNIVERSITEIT BRUSSEL/B-4895-2008	Snoeck, Christophe/0000-0003-3770-4055; (VUB), VRIJE UNIVERSITEIT BRUSSEL/0000-0002-4585-7687; de Winter, Niels/0000-0002-1453-5407	IWT [IWT600]; Belgian Science Policy Office, Cold Case project; Hercules Foundation [HERC9, HERC1309]; Belgian Science Policy Office through the Cold Case project; IWT Flanders PhD fellowship	IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy Office, Cold Case project; Hercules Foundation; Belgian Science Policy Office through the Cold Case project; IWT Flanders PhD fellowship	This work was supported by IWT, IWT600, PhD fellowship, NJW; Belgian Science Policy Office, Cold Case project, post-doctoral fellowship, CS; Hercules Foundation, HERC9, funded isotope lab; and Hercules Foundation, HERC1309, funded XRF lab.; The authors wish to thank three anonymous reviewers and the editors for their comments and suggestions that helped to improve this paper. This work is supported in part by Belgian Science Policy Office through the Cold Case project. NJW is financed by IWT Flanders PhD fellowship. PC thanks the Hercules foundation Flanders for upgrade of the stable isotope laboratory (grant HERC9) and acquisition of XRF instrumentation (grant HERC1309). The authors wish to thank Prof. Paul Simoens from Ghent University's veterinary science department for help with specimen acquisition, and for his great contribution to the discussion of the diet of the horse. The authors thank Prof. Geert Janssens and Prof Richard Ducatelle of the veterinary department of the University of Ghent for offering their expertise on diet and environment of draft horses and Kevin De Bondt for his expertise on isotopic signatures of Belgian rain and surface waters. Thanks go to David Verstraeten for help with stable isotope measurements, to Christina Makarona for help with the mu XRF measurements and to Quinten Dierckens for his assistance with the sampling.	Phung AT, 2013, TALANTA, V115, P6, DOI 10.1016/j.talanta.2013.04.019; [Anonymous], [No title captured]; [Anonymous], 1982, BAR BRIT SERIES; Balasse M, 2006, J ZOOL, V270, P170, DOI 10.1111/j.1469-7998.2006.00104.x; Balasse M, 2005, J ZOOL, V266, P283, DOI 10.1017/S0952836905006916; Balasse M, 2003, INT J OSTEOARCHAEOL, V13, P3, DOI 10.1002/oa.656; Balasse M, 2003, J ARCHAEOL SCI, V30, P205, DOI 10.1006/jasc.2002.0833; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; Balasse M, 1999, J ARCHAEOL SCI, V26, P593, DOI 10.1006/jasc.1998.0376; Bendrey R, 2015, ARCHAEOMETRY, V57, P1104, DOI 10.1111/arcm.12151; Blaise E, 2011, J ARCHAEOL SCI, V38, P3085, DOI 10.1016/j.jas.2011.07.007; Bocherens H, 1999, J ARCHAEOL SCI, V26, P599, DOI 10.1006/jasc.1998.0377; Bocherens H., 2015, QUAT INT; Bouguer P, 1729, ESSAI OPTIQUE GRADAT; Bryant JD, 1996, GEOLOGY, V24, P477, DOI 10.1130/0091-7613(1996)024<0477:OICOHT>2.3.CO;2; Bryant JD, 1996, PALAEOGEOGR PALAEOCL, V126, P75, DOI 10.1016/S0031-0182(96)00071-5; BURKE A, 1995, J ARCHAEOL SCI, V22, P479, DOI 10.1006/jasc.1995.0047; Burton J.H., 2002, BIOGEOCHEMICAL APPRO, P159, DOI 10.1007/0-306-47194-9_8; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Chenery C, 2010, J ARCHAEOL SCI, V37, P150, DOI 10.1016/j.jas.2009.09.025; Curzon M., 1983, CRC HDB EXPT ASPECTS, P123; D'Ambrosia AR, 2014, PALAEOGEOGR PALAEOCL, V414, P310, DOI 10.1016/j.palaeo.2014.09.014; DANSGAARD W, 1964, TELLUS, V16, P436; Teruel JD, 2015, ARCH ORAL BIOL, V60, P768, DOI 10.1016/j.archoralbio.2015.01.014; de Winter N.J., 2016, SEDIMENTOLOGY; DEBOER DKG, 1991, PHYS REV B, V44, P498, DOI 10.1103/PhysRevB.44.498; Domingo L, 2009, PALAEOGEOGR PALAEOCL, V272, P53, DOI 10.1016/j.palaeo.2008.11.006; Driessens F. C. M., 1990, BIOMINERALS, Patent No. 37087491; Ehleringer JR., 1989, STABLE ISOTOPES ECOL, V68, P525, DOI [10.1007/978-1-4612-3498-2_3, DOI 10.1007/978-1-4612-3498-2_3, DOI 10.1007/978-1-4612-3498-23]; Elliot M, 2009, PALAEOGEOGR PALAEOCL, V280, P132, DOI 10.1016/j.palaeo.2009.06.007; EMRICH K, 1970, EARTH PLANET SC LETT, V8, P363, DOI 10.1016/0012-821X(70)90109-3; Evrard O, 2008, EARTH SURF PROC LAND, V33, P1285, DOI 10.1002/esp.1613; EZZO JA, 1995, AM J PHYS ANTHROPOL, V98, P471, DOI 10.1002/ajpa.1330980407; Fairchild IJ, 2000, CHEM GEOL, V166, P255, DOI 10.1016/S0009-2541(99)00216-8; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Feranec RS, 2009, PALAEOGEOGR PALAEOCL, V271, P153, DOI 10.1016/j.palaeo.2008.10.005; Fremondeau D, 2012, J ARCHAEOL SCI, V39, P2023, DOI 10.1016/j.jas.2012.04.004; Fricke HC, 1998, GEOCHIM COSMOCHIM AC, V62, P1839, DOI 10.1016/S0016-7037(98)00114-8; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; FRIEDMAN I, 1982, GEOSTANDARD NEWSLETT, V6, P11, DOI 10.1111/j.1751-908X.1982.tb00340.x; Garrevoet J, 2015, ANAL CHEM, V87, P6544, DOI 10.1021/acs.analchem.5b00770; Gat J.R., 1980, TERRESTRIAL ENVIRONM, P21; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gill E.L., 1987, FACTORS AFFECTING BO; Gourcy LL, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P39, DOI 10.1007/1-4020-3023-1_4; Harris AJ, 2014, J SYST EVOL, V52, P16, DOI 10.1111/jse.12053; Helena B, 2000, WATER RES, V34, P807, DOI 10.1016/S0043-1354(99)00225-0; Herwartz D, 2013, GEOCHIM COSMOCHIM AC, V103, P161, DOI 10.1016/j.gca.2012.10.038; Hillson S., 1986, TEETH; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V206, P355, DOI 10.1016/j.palaeo.2004.01.012; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V203, P299, DOI 10.1016/S0031-0182(03)00688-6; Jones J., 2004, NEW YORK AFRICAN BUR, VI, P216; Kaiser TM, 2003, J MORPHOL, V258, P67, DOI 10.1002/jmor.10125; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2013, J ARCHAEOL SCI, V40, P1689, DOI 10.1016/j.jas.2012.11.012; Kohn MJ, 2013, P NATL ACAD SCI USA, V110, P419, DOI 10.1073/pnas.1209513110; Kohn MJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2737, DOI 10.1016/S0016-7037(99)00208-2; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; KUBILAY N, 1995, ATMOS ENVIRON, V29, P2289, DOI 10.1016/1352-2310(95)00101-4; KYLE JH, 1986, J ARCHAEOL SCI, V13, P403, DOI 10.1016/0305-4403(86)90011-7; Lane DW, 1997, BIOL TRACE ELEM RES, V60, P1, DOI 10.1007/BF02783305; Lazareth CE, 2003, ESTUAR COAST SHELF S, V57, P1103, DOI 10.1016/S0272-7714(03)00013-1; Lee-Thorp J, 2003, J ANTHROPOL ARCHAEOL, V22, P208, DOI 10.1016/S0278-4165(03)00035-7; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; LeGeros, 1986, J DENT RES, V65, P1619; LeGeros HZ, 1990, MONOGRAPHS ORAL SCI, V15, P1; Lewis L.D., 1996, FEEDING CARE HORSE, P446; LIEBSCHER K, 1968, ARCH ENVIRON HEALTH, V17, P881, DOI 10.1080/00039896.1968.10665346; Liu ZP, 2003, SCI TOTAL ENVIRON, V309, P117, DOI 10.1016/S0048-9697(03)00011-1; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lorrain A, 2005, GEOLOGY, V33, P965, DOI 10.1130/G22048.1; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; MacFadden BJ, 1999, GLOBAL ECOL BIOGEOGR, V8, P137, DOI 10.1046/j.1466-822X.1999.00127.x; MacFadden BJ, 1996, PALAIOS, V11, P319, DOI 10.2307/3515242; MacFadden BJ., 1994, FOSSIL HORSES SYSTEM; Michael HA, 2005, NATURE, V436, P1145, DOI 10.1038/nature03935; Moghaddam A, 2013, EUR J AGRON, V50, P82, DOI 10.1016/j.eja.2013.05.010; Mook W. G., 1970, ISOTOPE HYDROLOGY, V1970, P163; Moulin C, 1998, J GEOPHYS RES-ATMOS, V103, P13137, DOI 10.1029/98JD00171; Norra S, 2004, ENVIRON MONIT ASSESS, V93, P203, DOI 10.1023/B:EMAS.0000016803.95952.b2; Ntegeka V, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006471; OFLAHERTY EJ, 1991, TOXICOL APPL PHARM, V111, P313, DOI 10.1016/0041-008X(91)90033-B; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3; Pellegrini M, 2016, CHEM GEOL, V420, P88, DOI 10.1016/j.chemgeo.2015.10.038; Pellegrini M, 2011, PALAEOGEOGR PALAEOCL, V310, P71, DOI 10.1016/j.palaeo.2011.02.023; Pike-Tay A, 2002, J ARCHAEOL METHOD TH, V9, P101, DOI 10.1023/A:1016526207956; PRICE TD, 1992, J ARCHAEOL SCI, V19, P513, DOI 10.1016/0305-4403(92)90026-Y; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; Quinn RL, 2008, J ARCHAEOL SCI, V35, P2346, DOI 10.1016/j.jas.2008.02.013; Reitznerova E, 2000, FRESEN J ANAL CHEM, V367, P748, DOI 10.1007/s002160000461; Robinson BH, 2008, ENVIRON POLLUT, V153, P668, DOI 10.1016/j.envpol.2007.08.034; Rowley B, 2015, SYMPOSIUM, V2, P1, DOI DOI 10.15368/SYMP.2015V2N1.5; Segalen L, 2008, PALAEOGEOGR PALAEOCL, V266, P246, DOI 10.1016/j.palaeo.2008.03.035; Sharp ZD, 1998, GEOLOGY, V26, P219, DOI 10.1130/0091-7613(1998)026<0219:FIROSC>2.3.CO;2; SHEMESH A, 1990, GEOCHIM COSMOCHIM AC, V54, P2433, DOI 10.1016/0016-7037(90)90230-I; SILLEN A, 1992, J HUM EVOL, V23, P495, DOI 10.1016/0047-2484(92)90049-F; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; Skinner HCW, 2005, MINERAL MAG, V69, P621, DOI 10.1180/0026461056950275; Snoeck C, 2015, CHEM GEOL, V417, P394, DOI 10.1016/j.chemgeo.2015.10.004; Sorensen AM, 2015, PALAEOGEOGR PALAEOCL, V433, P191, DOI 10.1016/j.palaeo.2015.05.025; Sponheimer M, 2006, GEOCHIM COSMOCHIM AC, V70, P1644, DOI 10.1016/j.gca.2005.12.022; Sponheimer M, 2005, J HUM EVOL, V48, P147, DOI 10.1016/j.jhevol.2004.09.003; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; STACK MV, 1955, ANN NY ACAD SCI, V60, P585, DOI 10.1111/j.1749-6632.1955.tb40053.x; Steuber T, 1999, INT J EARTH SCI, V88, P551, DOI 10.1007/s005310050284; Stevens RE, 2011, PALAEOGEOGR PALAEOCL, V301, P64, DOI 10.1016/j.palaeo.2010.12.021; STIRTON R. A., 1941, JOUR MAMMAL, V22, P434, DOI 10.2307/1374940; Stowe MJ, 2016, QUATERN INT, V404, P57, DOI 10.1016/j.quaint.2015.09.055; SYDNEYZAX M, 1991, J DENT RES, V70, P913, DOI 10.1177/00220345910700051001; THORP JL, 1987, S AFR J SCI, V83, P712; Tornero C, 2016, J ARCHAEOL SCI-REP, V6, P810, DOI 10.1016/j.jasrep.2015.10.038; Trueman CN, 2002, REV MINERAL GEOCHEM, V48, P489, DOI 10.2138/rmg.2002.48.13; Trueman CN, 1997, GEOLOGY, V25, P263, DOI 10.1130/0091-7613(1997)025<0263:AGMTTT>2.3.CO;2; Tutken T, 2008, PALAEOGEOGR PALAEOCL, V266, P254, DOI 10.1016/j.palaeo.2008.03.037; Tutken T, 2011, GEOCHIM COSMOCHIM AC, V75, P5951, DOI 10.1016/j.gca.2011.07.024; Underwood E., 2012, TRACE ELEMENTS HUMAN; van Dam JA, 2009, PALAEOGEOGR PALAEOCL, V274, P64, DOI 10.1016/j.palaeo.2008.12.022; Vander Putten E, 2000, GEOCHIM COSMOCHIM AC, V64, P997; Vo-Dinh T., 2003, HDB SPECTROSCOPY; VOGEL JC, 1977, AM ANTIQUITY, V42, P238, DOI 10.2307/278984; VONGUNTEN HR, 1991, GEOCHIM COSMOCHIM AC, V55, P3597, DOI 10.1016/0016-7037(91)90058-D; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P269, DOI 10.1016/0031-0182(94)90099-X; Waran NK, 2008, APPL ANIM BEHAV SCI, V110, P42, DOI 10.1016/j.applanim.2007.03.024; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; Weinzierl B, 2009, TELLUS B, V61, P96, DOI 10.1111/j.1600-0889.2008.00392.x; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Yan H, 2013, GEOCHIM COSMOCHIM AC, V112, P52, DOI 10.1016/j.gca.2013.03.007; Yoder CH, 2012, CALCIFIED TISSUE INT, V90, P60, DOI 10.1007/s00223-011-9542-9; Zanazzi A, 2015, PALAEOGEOGR PALAEOCL, V417, P561, DOI 10.1016/j.palaeo.2014.10.024; Zazzo A, 2010, GEOCHIM COSMOCHIM AC, V74, P3571, DOI 10.1016/j.gca.2010.03.017; Zazzo A, 2006, J ARCHAEOL SCI, V33, P1177, DOI 10.1016/j.jas.2005.12.006	136	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166678	10.1371/journal.pone.0166678	http://dx.doi.org/10.1371/journal.pone.0166678			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5IV	27875538	gold, Green Published			2022-12-26	WOS:000388886000021
J	Ikeda, M; Honda, H; Takahashi, K; Shishido, K; Shibata, T				Ikeda, Misa; Honda, Hirokazu; Takahashi, Keiko; Shishido, Kanji; Shibata, Takanori			N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TOTAL-BODY WATER; HEART-FAILURE; SERUM-ALBUMIN; EXTRACELLULAR VOLUME; MORTALITY; MALNUTRITION; INFLAMMATION; PROTEIN; MARKER	Protein-energy wasting (PEW) is common in hemodialysis (HD) patients. A recent study demonstrated that a high level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) may be associated with PEW in those patients. This prospective study aimed to assess the association of NT-proBNP with body composition and muscle loss. A cohort of prevalent HD patients (n = 238) was examined. Blood samples were obtained at baseline to measure high-sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), adiponectin and NT-proBNP. Nutritional status and changes in muscle mass were assessed by subjective global assessment, percentage creatinine generation rate (% CGR), creatinine index (CI) and lean body mass (LBM) estimated by dual-energy X-ray absorptiometry (DXA). The % CGR and CI were calculated five times for one year, and DXA was performed at baseline and one year later. Cardiac function was estimated by ultrasonography at baseline. NT-proBNP was significantly higher in HD patients with PEW. High NT-proBNP was associated with cardiac dysfunction, increased levels of hsCRP and IL-6, and serially decreased levels of the indexes for muscle mass. Multiple regression analysis adjusted with confounders showed that NT-proBNP was an independent predictor for decrease in LBM and serial lower levels of % CGR and CI. In conclusion, the present study demonstrated a novel association between NT-proBNP and muscle loss. NT-proBNP may be an independent biomarker for malnutrition in HD patients, especially in patients with muscles loss, regardless of chronic inflammation, cardiac dysfunction, or overhydration.	[Ikeda, Misa; Shibata, Takanori] Showa Univ, Sch Med, Div Nephrol, Dept Med, Tokyo, Japan; [Honda, Hirokazu] Showa Univ, Koto Toyosu Hosp, Div Nephrol, Dept Med, Tokyo, Japan; [Takahashi, Keiko] Kitami Higashiyama Clin, Div Dialysis, Tokyo, Japan; [Shishido, Kanji] Kawasaki Clin, Dept Med, Kawasaki, Kanagawa, Japan	Showa University; Showa University	Honda, H (corresponding author), Showa Univ, Koto Toyosu Hosp, Div Nephrol, Dept Med, Tokyo, Japan.	hondah@med.showa-u.ac.jp		Honda, Hirokazu/0000-0002-5634-6145	Grants-in-Aid for Scientific Research [16K08975] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arkouche W, 1997, J AM SOC NEPHROL, V8, P1906; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; BALLMER PE, 1995, J CLIN INVEST, V95, P39, DOI 10.1172/JCI117668; Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Canaud B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093286; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Christensen HM, 2013, ENDOCRINE, V43, P626, DOI 10.1007/s12020-012-9836-3; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Engeli S, 2012, J CLIN INVEST, V122, P4675, DOI 10.1172/JCI64526; Fahim MA, 2015, CLIN J AM SOC NEPHRO, V10, P620, DOI 10.2215/CJN.09060914; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Guo Q, 2009, AM J NEPHROL, V29, P516, DOI 10.1159/000185628; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Jacobs LH, 2010, NEPHROL DIAL TRANSPL, V25, P243, DOI 10.1093/ndt/gfp417; Johansson AC, 1997, KIDNEY INT, V51, P855, DOI 10.1038/ki.1997.120; Kaysen GA, 2004, KIDNEY INT, V65, P1408, DOI 10.1111/j.1523-1755.2004.00520.x; Kidney Disease Outcomes Quality Initiative (K/DOQI) Group, 2003, AM J KIDNEY DIS S, V41, pI; Kovesdy CP, 2012, SEMIN DIALYSIS, V25, P423, DOI 10.1111/j.1525-139X.2012.01097.x; Kuhn M, 2009, J CLIN INVEST, V119, P2019, DOI 10.1172/JCI37430; Lee SW, 2001, NEPHROL DIAL TRANSPL, V16, P91, DOI 10.1093/ndt/16.1.91; Madsen LH, 2007, KIDNEY INT, V71, P548, DOI 10.1038/sj.ki.5002087; Martins T, 2014, CLIN BIOCHEM, V47, P8, DOI 10.1016/j.clinbiochem.2013.10.025; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Moro C, 2013, AM J PHYSIOL-HEART C, V304, pH358, DOI 10.1152/ajpheart.00704.2012; Nongnuch A, 2014, AM J NEPHROL, V40, P251, DOI 10.1159/000368376; Park SW, 2014, J KOREAN NEUROSURG S, V56, P79, DOI 10.3340/jkns.2014.56.2.79; Paulo Araujo J, 2009, EUR J HEART FAIL, V11, P567, DOI 10.1093/eurjhf/hfp046; Polak J, 2011, J AM COLL CARDIOL, V58, P1119, DOI 10.1016/j.jacc.2011.05.042; Prontera C, 2004, CLIN CHEM LAB MED, V42, P37, DOI 10.1515/CCLM.2004.008; Roberts TK, 2008, KIDNEY INT, V74, P143, DOI 10.1038/ki.2008.220; Satyan S, 2007, AM J KIDNEY DIS, V50, P1009, DOI 10.1053/j.ajkd.2007.08.017; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Snaedal S, 2014, BLOOD PURIFICAT, V37, P138, DOI 10.1159/000360267; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Tai R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-189; ter Maaten JM, 2014, CLIN RES CARDIOL, V103, P976, DOI 10.1007/s00392-014-0738-7; Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233	42	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166804	10.1371/journal.pone.0166804	http://dx.doi.org/10.1371/journal.pone.0166804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870908	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400033
J	Shang, LY; Zhang, Y; Lyu, SH; Wang, SY				Shang, Lunyu; Zhang, Yu; Lyu, Shihua; Wang, Shaoying			Seasonal and Inter-Annual Variations in Carbon Dioxide Exchange over an Alpine Grassland in the Eastern Qinghai-Tibetan Plateau	PLOS ONE			English	Article							ECOSYSTEM CO2 EXCHANGE; SONIC ANEMOMETER; SOIL-MOISTURE; TEMPERATURE; STEPPE; FLUX; RESPIRATION; BALANCE; MEADOW; ENERGY	This work analyzed carbon dioxide exchange and its controlling factors over an alpine grassland on the eastern Qinghai-Tibetan Plateau. The main results show that air temperature and photosynthetically active radiation are two dominant factors controlling daily gross primary production. Soil temperature and soil water content are the main factors controlling ecosystem respiration. Canopy photosynthetic activity is also responsible for the variation of daily ecosystem respiration other than environmental factors. No clear correlation between net ecosystem exchange and environmental factors was observed at daily scale. Temperature sensitive coefficient was observed to increase with larger soil water content. High values of temperature sensitive coefficient occurred during the periods when soil water content was high and grass was active. Annual integrated net ecosystem exchange, gross primary production and ecosystem respiration were -191, 1145 and 954 g C m(-2) for 2010, and -250, 975 and 725 g C m(-2) for 2011, respectively. Thus, this alpine grassland was a moderate carbon sink in both of the two years. Compared to alpine grasslands on the Qinghai-Tibetan Plateau, this alpine grassland demonstrated a much greater potential for carbon sequestration than others. Annual precipitation is a dominant factor controlling the variation of annual net ecosystem exchange over this grassland. The difference in gross primary production between the two years was not caused by the variation in annual precipitation. Instead, air temperature and the length of growing season had an important impact on annual gross primary production. Variation of annual ecosystem respiration was closely related to annual gross primary production and soil water content during the growing season.	[Shang, Lunyu; Zhang, Yu; Lyu, Shihua; Wang, Shaoying] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Land Surface Proc & Climate Change Cold &, Lanzhou, Peoples R China; [Lyu, Shihua] Chengdu Univ Informat Technol, Coll Atmospher Sci, Chengdu, Peoples R China	Chinese Academy of Sciences; Chengdu University of Information Technology	Shang, LY (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Land Surface Proc & Climate Change Cold &, Lanzhou, Peoples R China.	sly@lzb.ao.an			National Natural Science Foundation of China [41205006, 41275016, 41405016, 41275014, 91537104, 91537106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41205006, 41275016, 41405016, 41275014, 91537104, and 91537106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HELP US GUID; Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; Gu S, 2010, J GEOPHYS RES, V108, P4670; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Mauder M., 2004, DOCUMENTATION INSTRU; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rey A, 2014, BIOGEOCHEMISTRY, V118, P83, DOI 10.1007/s10533-013-9907-4; SCHOTANUS P, 1983, BOUND-LAY METEOROL, V26, P81, DOI 10.1007/BF00164332; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Shang LY, 2015, SCI BULL, V60, P435, DOI 10.1007/s11434-014-0685-8; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Vickers D, 1997, J ATMOS OCEAN TECH, V14, P512, DOI 10.1175/1520-0426(1997)014<0512:QCAFSP>2.0.CO;2; Wang B, 2008, GEOPHYS RES LETT, V35; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wang SH, 2015, IEEE SIGNAL PROC LET, V22, DOI 10.1109/LSP.2015.2464791; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Xu WX, 2007, CHINESE GEOGR SCI, V17, P151, DOI 10.1007/s11769-007-0151-5; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yu GR, 2006, SCI CHINA SER D, V49, P1, DOI 10.1007/s11430-006-8001-3; Zhao L, 2010, BIOGEOSCIENCES, V7, P1207, DOI 10.5194/bg-7-1207-2010; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x; Zhu ZK, 2015, AGR FOREST METEOROL, V203, P169, DOI 10.1016/j.agrformet.2014.12.013	38	12	13	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166837	10.1371/journal.pone.0166837	http://dx.doi.org/10.1371/journal.pone.0166837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861616	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300121
J	Li, JB; Wang, YF; Matye, DJ; Chavan, H; Krishnamurthy, P; Li, F; Li, TG				Li, Jibiao; Wang, Yifeng; Matye, David J.; Chavan, Hemantkumar; Krishnamurthy, Partha; Li, Feng; Li, Tiangang			Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER HYDROLASE; NONALCOHOLIC STEATOHEPATITIS; REDUCES ATHEROSCLEROSIS; TRANSGENIC EXPRESSION; INSULIN-RESISTANCE; DIABETIC MICE; STEATOSIS; RECEPTOR; DISEASE; DIET	The liver plays a key role in cholesterol metabolism. Impaired hepatic cholesterol homeostasis causes intracellular free cholesterol accumulation and hepatocyte injury. Sortilin 1 (SORT1) is a lysosomal trafficking receptor that was identified by genome-wide association studies (GWAS) as a novel regulator of cholesterol metabolism in humans. Here we report that SORT1 deficiency protected against cholesterol accumulation-induced liver injury and inflammation in mice. Using an LC-MS/MS-based proteomics approach, we identified liver carboxylesterase 1 (CES1) as a novel SORT1-interacting protein. Mechanistic studies further showed that SORT1 may regulate CES1 lysosomal targeting and degradation and that SORT1 deficiency resulted in higher liver CES1 protein abundance. Previous studies have established an important role of hepatic CES1 in promoting intracellular cholesterol mobilization, cholesterol efflux, and bile acid synthesis. Consistently, high cholesterol atherogenic diet-challenged Sort1 knock-out mice showed less hepatic free cholesterol accumulation, increased bile acid synthesis, decreased biliary cholesterol secretion, and the absence of gallstone formation. SORT1 deficiency did not alter hepatic ceramide and fatty acid metabolism in high cholesterol atherogenic diet-fed mice. Finally, knockdown of liver CES1 in mice markedly increased the susceptibility to high cholesterol diet-induced liver injury and abolished the protective effect against cholesterol lipotoxicity in Sort1 knock-out mice. In summary, this study identified a novel SORT1-CES1 axis that regulates cholesterol-induced liver injury, which provides novel insights that improve our current understanding of the molecular links between SORT1 and cholesterol metabolism. This study further suggests that therapeutic inhibition of SORT1 may be beneficial in improving hepatic cholesterol homeostasis in metabolic and inflammatory liver diseases.	[Li, Jibiao; Wang, Yifeng; Matye, David J.; Chavan, Hemantkumar; Krishnamurthy, Partha; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Li, Feng] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Kansas; University of Kansas Medical Center; Baylor College of Medicine	Li, TG (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tli@kumc.edu	Li, Jibiao/A-5627-2017; Chavan, Hemant/ABA-4925-2021; Chavan, Hemantkumar/AAN-6756-2020; Li, Feng/M-5334-2016	Chavan, Hemantkumar/0000-0002-9963-6230; Li, Feng/0000-0002-9680-4614; Matye, David/0000-0001-6655-803X	American Diabetes Association Junior Faculty Award; National Institutes of Health [1R01DK102487-01]; National Center for Research Resources [5P20RR021940-07]; NIGMS from the National Institutes of Health [8 P20 GM103549-07, P30GM118247]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549, P30GM118247] Funding Source: NIH RePORTER	American Diabetes Association Junior Faculty Award(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an American Diabetes Association Junior Faculty Award (to T. L.), National Institutes of Health Grant 1R01DK102487-01 (to T. L.), National Center for Research Resources Grant 5P20RR021940-07, and NIGMS Grants 8 P20 GM103549-07 and P30GM118247 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baghdasaryan A, 2016, J HEPATOL, V64, P674, DOI 10.1016/j.jhep.2015.10.024; Bahitham W, 2016, BBA-MOL CELL BIOL L, V1861, P482, DOI 10.1016/j.bbalip.2016.03.009; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Bie JH, 2014, J LIPID RES, V55, P729, DOI 10.1194/jlr.M046524; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Canuel M, 2008, BIOCHEM BIOPH RES CO, V373, P292, DOI 10.1016/j.bbrc.2008.06.021; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Gan LT, 2014, J HEPATOL, V61, P1376, DOI 10.1016/j.jhep.2014.07.024; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hendrikx T, 2014, OBES REV, V15, P424, DOI 10.1111/obr.12159; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Ko KWS, 2009, BBA-MOL CELL BIOL L, V1791, P1133, DOI 10.1016/j.bbalip.2009.07.006; Li JB, 2014, J BIOL CHEM, V289, P22437, DOI 10.1074/jbc.M114.548933; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Rabinowich L, 2015, J HEPATOL, V62, P175, DOI 10.1016/j.jhep.2014.08.030; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Wang S, 2015, P NATL ACAD SCI USA, V112, P3728, DOI 10.1073/pnas.1422455112; Wang YF, 2017, CELL MOL GASTROENTER, V3, P245, DOI 10.1016/j.jcmgh.2016.10.002; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu JS, 2014, HEPATOLOGY, V59, P1761, DOI 10.1002/hep.26714; Yuan Q, 2013, J LIPID RES, V54, P3078, DOI 10.1194/jlr.M040998; Zhao B, 2005, PHYSIOL GENOMICS, V23, P304, DOI 10.1152/physiolgenomics.00187.2005; Zhao B, 2008, J LIPID RES, V49, P2212, DOI 10.1194/jlr.M800277-JLR200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	43	30	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					146	160		10.1074/jbc.M116.762005	http://dx.doi.org/10.1074/jbc.M116.762005			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881673	hybrid, Green Published			2022-12-26	WOS:000391578000013
J	Fu, PF; Ebenezer, DL; Berdyshev, EV; Bronova, IA; Shaaya, M; Harijith, A; Natarajan, V				Fu, Panfeng; Ebenezer, David L.; Berdyshev, Evgeny V.; Bronova, Irina A.; Shaaya, Mark; Harijith, Anantha; Natarajan, Viswanathan			Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER CELLS; FACTOR RECEPTOR; 1-PHOSPHATE; MIGRATION; MOTILITY; SPHINGOSINE-1-PHOSPHATE; POTENT; PROTRUSION; ACTIVATION	Hepatocyte growth factor (HGF) signaling via c-Met is known to promote endothelial cell motility and angiogenesis. We have previously reported that HGF stimulates lamellipodia formation and motility of human lung microvascular endothelial cells (HLMVECs) via PI3K/Akt signal transduction and reactive oxygen species generation. Here, we report a role for HGF-induced intracellular sphingosine-1-phosphate (S1P) generation catalyzed by sphingosine kinase 1 (SphK1), S1P transporter, spinster homolog 2 (Spns2), and S1P receptor, S1P(1), in lamellipodia formation and perhaps motility of HLMVECs. HGF stimulated SphK1 phosphorylation and enhanced intracellular S1P levels in HLMVECs, which was blocked by inhibition of SphK1. HGF enhanced co-localization of SphK1/p-SphK1 with actin/cortactin in lamellipodia and down-regulation or inhibition of SphK1 attenuated HGF-induced lamellipodia formation in HLMVECs. In addition, down-regulation of Spns2 also suppressed HGF-induced lamellipodia formation, suggesting a key role for inside-out S1P signaling. The HGF-mediated phosphorylation of SphK1 and its localization in lamellipodia was dependent on c-Met and ERK1/2 signaling, but not the PI3K/Akt pathway; however, blocking PI3K/Akt signaling attenuated HGF-mediated phosphorylation of Spns2. Down-regulation of S1P(1), but not S1P(2) or S1P(3), with specific siRNA attenuated HGF-induced lamellipodia formation. Further, HGF enhanced association of Spns2 with S1P(1) that was blocked by inhibiting SphK1 activity with PF-543. Moreover, HGF-induced migration of HLMVECs was attenuated by down-regulation of Spns2. Taken together, these results suggest that HGF/c-Met-mediated lamellipodia formation, and perhaps motility is dependent on intracellular generation of S1P via activation and localization of SphK1 to cell periphery and Spns2-mediated extracellular transportation of S1P and its inside-out signaling via S1P(1).	[Fu, Panfeng; Shaaya, Mark; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Ebenezer, David L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Harijith, Anantha] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Berdyshev, Evgeny V.; Bronova, Irina A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Jewish Health	Natarajan, V (corresponding author), Univ Illinois, Dept Med & Pharmacol, COMRB, Rm 3137,909 South Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Harijith, Anantha/AAA-5708-2021		National Institutes of Health [P01 HL060678, P01 HL098050]; College of Medicine, University of Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050, T32HL007829, P01HL060678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine, University of Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant P01 HL060678 Project 4 (to V.N.) and Grant P01 HL098050 (to V.N.) and by the College of Medicine, University of Illinois. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berdyshev E. V., 2011, ANAL BIOCHEM, V408, P12; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Bradley E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110119; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Cai WY, 2000, INVEST OPHTH VIS SCI, V41, P1885; Cerutis DR, 2004, J PERIODONTOL, V75, P297, DOI 10.1902/jop.2004.75.2.297; Duan HF, 2004, EXP CELL RES, V298, P593, DOI 10.1016/j.yexcr.2004.04.049; Endo A, 2002, J BIOL CHEM, V277, P23747, DOI 10.1074/jbc.M111794200; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fu PF, 2013, AM J RESP CELL MOL, V48, P477, DOI 10.1165/rcmb.2012-0242OC; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gschwind A, 2002, CANCER RES, V62, P6329; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liebmann C, 2000, CURR MED CHEM, V7, P911, DOI 10.2174/0929867003374589; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Mendoza MC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8859; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oh YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143695; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Purdie KJ, 2002, CARDIOVASC RES, V54, P659, DOI 10.1016/S0008-6363(02)00255-9; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Shida D, 2005, BIOCHEM BIOPH RES CO, V327, P907, DOI 10.1016/j.bbrc.2004.12.088; So J, 2005, GYNECOL ONCOL, V97, P870, DOI 10.1016/j.ygyno.2005.03.004; Sukocheva O, 2013, EXP CELL RES, V319, P455, DOI 10.1016/j.yexcr.2012.10.014; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; Usatyuk PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063007; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Wang XY, 2003, MOL CANCER THER, V2, P1085; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	43	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27187	27203		10.1074/jbc.M116.758946	http://dx.doi.org/10.1074/jbc.M116.758946			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864331	Green Published, hybrid			2022-12-26	WOS:000391576300018
J	Lok, HC; Sahni, S; Jansson, PJ; Kovacevic, Z; Hawkins, CL; Richardson, DR				Lok, Hiu Chuen; Sahni, Sumit; Jansson, Patric J.; Kovacevic, Zaklina; Hawkins, Clare L.; Richardson, Des R.			A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; TRANSCRIPTION FACTOR NRF2; MULTIDRUG-RESISTANCE PROTEIN-1; DINITROSYL-IRON COMPLEXES; NITROGEN MONOXIDE NO; MOLECULAR-MECHANISMS; INTERFERON-GAMMA; CARCINOMA CELLS; MELANOMA-CELLS; TUMOR-CELLS	Nitric oxide (NO) is integral to macrophage cytotoxicity against tumors due to its ability to induce iron release from cancer cells. However, the mechanism for how activated macrophages protect themselves from endogenous NO remains unknown. We previously demonstrated by using tumor cells that glutathione S-transferase P1 (GSTP1) sequesters NO as dinitrosyl-dithiol iron complexes (DNICs) and inhibits NO-mediated iron release from cells via the transporter multidrug resistance protein 1 (MRP1/ABCC1). These prior studies also showed that MRP1 and GSTP1 protect tumor cells against NO cytotoxicity, which parallels their roles in defending cancer cells from cytotoxic drugs. Considering this, and because GSTP1 and MRP1 are up-regulated during macrophage activation, this investigation examined whether this NO storage/transport system protects macrophages against endogenous NO cytotoxicity in two well characterized macrophage cell types (J774 and RAW 264.7). MRP1 expression markedly increased upon macrophage activation, and the role ofMRP1in NO-induced Fe-59 release was demonstrated by Mrp1 siRNA and the MRP1 inhibitor, MK571, which inhibited NO-mediated iron efflux. Furthermore, Mrp1 silencing increased DNIC accumulation in macrophages, indicating a role for MRP1 in transporting DNICs out of cells. In addition, macrophage Fe-59 release was enhanced by silencing Gstp1, suggesting GSTP1 was responsible for DNIC binding/storage. Viability studies demonstrated that GSTP1 and MRP1 protect activated macrophages from NO cytotoxicity. This was confirmed by silencing nuclear factor-erythroid 2-related factor 2 (Nrf2), which decreased MRP1 and GSTP1 expression, concomitant with reduced Fe-59 release and macrophage survival. Together, these results demonstrate a mechanism by which macrophages protect themselves against NO cytotoxicity.	[Lok, Hiu Chuen; Sahni, Sumit; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Lok, Hiu Chuen; Sahni, Sumit; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Hawkins, Clare L.] Heart Res Inst, Sydney, NSW 2042, Australia	University of Sydney; University of Sydney; University of Sydney; Heart Research Institute	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.; Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Hawkins, Clare/AAV-7424-2021; Hawkins, Clare L/F-6696-2014; Kovacevic, Zaklina/ABD-9581-2021; Jansson, Patric/AAC-4221-2022	Hawkins, Clare/0000-0003-2738-5089; Hawkins, Clare L/0000-0003-2738-5089; Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274; Sahni, Sumit/0000-0002-2900-8845	National Health and Medical Research Council of Australia [1062026]; National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation; National Health and Medical Research Peter Doherty Early Career Fellowship [1037323]; Cancer Institute New South Wales Early Career Fellowship [12-ECF2-17]; Australian Research Council [FT120100682]; National Health and Medical Research Council of Australia; National Breast Cancer Foundation [PS-16-030] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation; National Health and Medical Research Peter Doherty Early Career Fellowship; Cancer Institute New South Wales Early Career Fellowship; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 1062026 (to D. R. R. and C. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the National Breast Cancer Foundation and Avner Pancreatic Cancer Foundation.; Supported by National Health and Medical Research Peter Doherty Early Career Fellowship 1037323 and Cancer Institute New South Wales Early Career Fellowship 12-ECF2-17.; Supported by Australian Research Council Future Fellowship FT120100682.; Supported by the National Health and Medical Research Council of Australia Senior Principal Research Fellowship.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDRADE SP, 1992, BRIT J PHARMACOL, V107, P1092, DOI 10.1111/j.1476-5381.1992.tb13412.x; BAKER E, 1985, AM J PHYSIOL, V248, pG93, DOI 10.1152/ajpgi.1985.248.1.G93; BAKER E, 1981, BRIT J HAEMATOL, V47, P493, DOI 10.1111/j.1365-2141.1981.tb02678.x; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; BASTIAN NR, 1994, J BIOL CHEM, V269, P5127; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; COLE SPC, 1994, CANCER RES, V54, P5902; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; de Oliveira GA, 2017, ANTIOXID REDOX SIGN, V26, P1059, DOI 10.1089/ars.2016.6850; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Depeille P, 2004, MOL PHARMACOL, V65, P897, DOI 10.1124/mol.65.4.897; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; GomezFlores R, 1997, J IMMUNOL, V158, P3796; GRANT CE, 1994, CANCER RES, V54, P357; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Held TK, 1999, INFECT IMMUN, V67, P206, DOI 10.1128/IAI.67.1.206-212.1999; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Koley D, 2012, P NATL ACAD SCI USA, V109, P11522, DOI 10.1073/pnas.1201555109; LAMARRE J, 1993, J CLIN INVEST, V91, P1219, DOI 10.1172/JCI116283; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Li CQ, 2009, P NATL ACAD SCI USA, V106, P14547, DOI 10.1073/pnas.0907539106; Li Q, 2014, J BIOL CHEM, V289, P19917, DOI 10.1074/jbc.M114.569764; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Lok HC, 2014, FREE RADICAL BIO MED, V75, P14, DOI 10.1016/j.freeradbiomed.2014.07.002; Lok HC, 2012, J BIOL CHEM, V287, P607, DOI 10.1074/jbc.M111.310987; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; MCLEOD R, 1977, CELL IMMUNOL, V34, P156, DOI 10.1016/0008-8749(77)90238-6; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Morrow CS, 1998, BIOCHEM PHARMACOL, V56, P1013, DOI 10.1016/S0006-2952(98)00240-8; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1981, J EXP MED, V153, P1690, DOI 10.1084/jem.153.6.1690; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; NATHAN CF, 1981, J EXP MED, V153, P767, DOI 10.1084/jem.153.4.766; Paumi CM, 2001, J BIOL CHEM, V276, P7952, DOI 10.1074/jbc.M009400200; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Peklak-Scott C, 2008, MOL CANCER THER, V7, P3247, DOI 10.1158/1535-7163.MCT-08-0250; Rahmanto YS, 2012, J BIOL CHEM, V287, P6960, DOI 10.1074/jbc.R111.329847; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; RICHARDSON DR, 1991, BIOCHIM BIOPHYS ACTA, V1091, P294, DOI 10.1016/0167-4889(91)90192-Z; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Ruetten H, 1996, BIOCHEM BIOPH RES CO, V225, P525, DOI 10.1006/bbrc.1996.1206; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sibhatu MB, 2008, CARCINOGENESIS, V29, P807, DOI 10.1093/carcin/bgn013; Silverstein PS, 2010, J NEUROIMMUNE PHARM, V5, P516, DOI 10.1007/s11481-009-9180-4; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tozer GM, 1997, CANCER RES, V57, P948; Vanin AF, 1998, NITRIC OXIDE-BIOL CH, V2, P224, DOI 10.1006/niox.1998.0180; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wardrop SL, 2000, EUR J BIOCHEM, V267, P6586, DOI 10.1046/j.1432-1327.2000.01752.x; Wardrop SL, 2000, BIOCHEMISTRY-US, V39, P2748, DOI 10.1021/bi991099t; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Watts RN, 2001, J BIOL CHEM, V276, P4724, DOI 10.1074/jbc.M006318200; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936	85	29	31	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27042	27061		10.1074/jbc.M116.763714	http://dx.doi.org/10.1074/jbc.M116.763714			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27866158	hybrid, Green Published			2022-12-26	WOS:000391576300007
J	Bule, P; Alves, VD; Leitao, A; Ferreira, LMA; Bayer, EA; Smith, SP; Gilbert, HJ; Najmudin, S; Fontes, CMGA				Bule, Pedro; Alves, Victor D.; Leitao, Andre; Ferreira, Luis M. A.; Bayer, Edward A.; Smith, Steven P.; Gilbert, Harry J.; Najmudin, Shabir; Fontes, Carlos M. G. A.			Single Binding Mode Integration of Hemicellulose-degrading Enzymes via Adaptor Scaffoldins in Ruminococcus flavefaciens Cellulosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DOCKERIN; COHESIN; ATTACHMENT; COMPLEXES; REVEAL	The assembly of one of Nature's most elaborate multienzyme complexes, the cellulosome, results from the binding of enzyme-borne dockerins to reiterated cohesin domains located in a noncatalytic primary scaffoldin. Generally, dockerins present two similar cohesin-binding interfaces that support a dual binding mode. The dynamic integration of enzymes in cellulosomes, afforded by the dual binding mode, is believed to incorporate additional flexibility in highly populated multienzyme complexes. Ruminococcus flavefaciens, the primary degrader of plant structural carbohydrates in the rumen of mammals, uses a portfolio of more than 220 different dockerins to assemble the most intricate cellulosome known to date. A sequence-based analysis organized R. flavefaciens dockerins into six groups. Strikingly, a subset of R. flavefaciens cellulosomal enzymes, comprising dockerins of groups 3 and 6, were shown to be indirectly incorporated into primary scaffoldins via an adaptor scaffoldin termed ScaC. Here, we report the crystal structure of a group 3 R. flavefaciens dockerin, Doc3, in complex with ScaC cohesin. Doc3 is unusual as it presents a large cohesin-interacting surface that lacks the structural symmetry required to support a dual binding mode. In addition, dockerins of groups 3 and 6, which bind exclusively to ScaC cohesin, display a conserved mechanism of protein recognition that is similar to Doc3. Groups 3 and 6 dockerins are predominantly appended to hemicellulose-degrading enzymes. Thus, single binding mode dockerins interacting with adaptor scaffoldins exemplify an evolutionary pathway developed by R. flavefaciens to recruit hemicellulases to the sophisticated cellulosomes acting in the gastrointestinal tract of mammals.	[Bule, Pedro; Alves, Victor D.; Leitao, Andre; Ferreira, Luis M. A.; Najmudin, Shabir; Fontes, Carlos M. G. A.] Polo Univ Alto da Ajuda, ULisboa, Fac Med Vet, CIISA, Ave Univ Tecn, P-1300477 Lisbon, Portugal; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Weizmann Institute of Science; Queens University - Canada; Newcastle University - UK	Fontes, CMGA (corresponding author), Polo Univ Alto da Ajuda, ULisboa, Fac Med Vet, CIISA, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt	Bule, Pedro/W-6838-2019	Bule, Pedro/0000-0003-2531-9926; Leitao, Andre/0000-0003-0500-3545; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Smith, Steven/0000-0003-2710-4400	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-MIC/5947/2014];  [SFRH/BD/86821/2012]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); 	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) Grant PTDC/BIA-MIC/5947/2014. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the individual fellowship SFRH/BD/86821/2012.	[Anonymous], [No title captured]; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 2007, CURR OPIN BIOTECH, V18, P237, DOI 10.1016/j.copbio.2007.04.004; Bras JLA, 2012, J BIOL CHEM, V287, P44394, DOI 10.1074/jbc.M112.407700; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1065, DOI 10.1107/S2053230X14013181; Burton RA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00456; Cameron K, 2015, J BIOL CHEM, V290, P16215, DOI 10.1074/jbc.M115.653303; Cameron K, 2015, J BIOL CHEM, V290, P13578, DOI 10.1074/jbc.M114.633339; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Handelsman T, 2004, FEBS LETT, V572, P195, DOI 10.1016/j.febslet.2004.07.040; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Ruimy V., 2013, THESIS; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010	33	9	9	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26658	26669		10.1074/jbc.M116.761643	http://dx.doi.org/10.1074/jbc.M116.761643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875311	hybrid, Green Published			2022-12-26	WOS:000391571400007
J	Messina, F; Finocchio, A; Akar, N; Loutradis, A; Michalodimitrakis, EI; Brdicka, R; Jodice, C; Novelletto, A				Messina, Francesco; Finocchio, Andrea; Akar, Nejat; Loutradis, Aphrodite; Michalodimitrakis, Emmanuel I.; Brdicka, Radim; Jodice, Carla; Novelletto, Andrea			Spatially Explicit Models to Investigate Geographic Patterns in the Distribution of Forensic STRs: Application to the North-Eastern Mediterranean	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-STRUCTURE; HAPLOGROUP-J; DIVERSITY; COLONIZATION; EUROPE; SIGNATURE; DIFFUSION; INFERENCE; ANCESTRY	Human forensic STRs used for individual identification have been reported to have little power for inter-population analyses. Several methods have been developed which incorporate information on the spatial distribution of individuals to arrive at a description of the arrangement of diversity. We genotyped at 16 forensic STRs a large population sample obtained from many locations in Italy, Greece and Turkey, i.e. three countries crucial to the understanding of discontinuities at the European/Asian junction and the genetic legacy of ancient migrations, but seldom represented together in previous studies. Using spatial PCA on the full dataset, we detected patterns of population affinities in the area. Additionally, we devised objective criteria to reduce the overall complexity into reduced datasets. Independent spatially explicit methods applied to these latter datasets converged in showing that the extraction of information on long- to medium-range geographical trends and structuring from the overall diversity is possible. All analyses returned the picture of a background clinal variation, with regional discontinuities captured by each of the reduced datasets. Several aspects of our results are confirmed on external STR datasets and replicate those of genome-wide SNP typings. High levels of gene flow were inferred within the main continental areas by coalescent simulations. These results are promising from a microevolutionary perspective, in view of the fast pace at which forensic data are being accumulated for many locales. It is foreseeable that this will allow the exploitation of an invaluable genotypic resource, assembled for other (forensic) purposes, to clarify important aspects in the formation of local gene pools.	[Messina, Francesco; Finocchio, Andrea; Jodice, Carla; Novelletto, Andrea] Univ Tor Vergata, Dept Biol, Rome, Italy; [Akar, Nejat] TOBB Econ & Technol Univ Hosp, Dept Pediat, Ankara, Turkey; [Loutradis, Aphrodite] Natl Ctr Thalassemias, Athens, Greece; [Michalodimitrakis, Emmanuel I.] Univ Crete, Dept Forens Sci, Sch Med, Iraklion, Crete, Greece; [Brdicka, Radim] Inst Hematol & Blood Transfus, Prague, Czech Republic	University of Rome Tor Vergata; TOBB Ekonomi ve Teknoloji University; University of Crete; Institute of Hematology Prague	Novelletto, A (corresponding author), Univ Tor Vergata, Dept Biol, Rome, Italy.	novelletto@bio.uniroma2.it	Messina, Francesco/AAC-1675-2019; Akar, Nejat/H-2949-2019; Messina, Francesco/AAC-1816-2019; Messina, Francesco/AAB-5363-2022	Messina, Francesco/0000-0001-8076-7217; Novelletto, Andrea/0000-0002-1146-7680	Italian Ministry of Justice [CUP E81J10001270005]; Italian Ministry of Education [PRIN-MIUR 2012JA4BTY]	Italian Ministry of Justice; Italian Ministry of Education	This work was supported by grants of the Italian Ministry of Justice (grant number CUP E81J10001270005) to C.J. and of the Italian Ministry of Education (grant number PRIN-MIUR 2012JA4BTY) to A.N. F.M. was supported by a fellowship from the Italian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Algee-Hewitt BFB, 2016, CURR BIOL, V26, P935, DOI 10.1016/j.cub.2016.01.065; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Bradburd GS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005703; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Cann HM, 2002, SCIENCE, V296, P261; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Capocasa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056371; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Davis C, 2012, FORENSIC SCI INT-GEN, V6, P494, DOI 10.1016/j.fsigen.2011.12.002; Di Gaetano C, 2008, EUR J HUM GENET, V17, P1; Di Gaetano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043759; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Fix A.G ., 1999, MIGRATION COLONIZATI; Gazal S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17453; Green RL, 2013, FORENSIC SCI INT-GEN, V7, P41, DOI 10.1016/j.fsigen.2012.05.012; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Haining R, 2003, SPATIAL DATA ANAL; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; King RJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-69; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; Malaspina P, 2001, ANN HUM GENET, V65, P339, DOI 10.1017/S0003480001008727; Malone C, 2003, J WORLD PREHIST, V17, P235, DOI 10.1023/B:JOWO.0000012729.36053.42; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; Mellars P, 2011, NATURE, V479, P483, DOI 10.1038/479483a; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Paschou P, 2014, P NATL ACAD SCI USA, V111, P9211, DOI 10.1073/pnas.1320811111; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pemberton TJ, 2014, HUM HERED, V77, P37, DOI 10.1159/000362878; Pemberton TJ, 2013, G3-GENES GENOM GENET, V3, P891, DOI 10.1534/g3.113.005728; Petkova D, 2016, NAT GENET, V48, P94, DOI 10.1038/ng.3464; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Pritchard JK, 2000, GENETICS, V155, P945; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Rowold DJ, 2003, FORENSIC SCI INT, V133, P260, DOI 10.1016/S0379-0738(03)00073-2; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Sarno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096074; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Silva NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049666; Steele CD, 2014, ANN HUM GENET, V78, P468, DOI 10.1111/ahg.12081; Tagarelli G, 2007, COLLEGIUM ANTROPOL, V31, P331; Tofanelli S, 2016, EUR J HUM GENET, V24, P429, DOI 10.1038/ejhg.2015.124; Wang CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002886; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	84	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167065	10.1371/journal.pone.0167065	http://dx.doi.org/10.1371/journal.pone.0167065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898725	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000032
J	Drechsler, R; Chen, SW; Dancy, BCR; Mehrabkhani, L; Olsen, CP				Drechsler, Robin; Chen, Shaw-Wen; Dancy, Blair C. R.; Mehrabkhani, Lena; Olsen, Carissa Perez			HPLC-Based Mass Spectrometry Characterizes the Phospholipid Alterations in Ether-Linked Lipid Deficiency Models Following Oxidative Stress	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LC-MS; PLASMALOGENS; HOMEOSTASIS; REVEALS	Despite the fact that the discovery of ether-linked phospholipids occurred nearly a century ago, many unanswered questions remain concerning these unique lipids. Here, we characterize the ether-linked lipids of the nematode with HPLC-MS/MS and find that more than half of the phosphoethanolamine-containing lipids are ether-linked, a distribution similar to that found in mammalian membranes. To explore the biological role of ether lipids in vivo, we target fatty acyl-CoA reductase (fard-1), an essential enzyme in ether lipid synthesis, with two distinct RNAi strategies. First, when fard-1 RNAi is initiated at the start of development, the treated animals have severely reduced ether lipid abundance, resulting in a shift in the phosphatidylethanolamine lipid population to include more saturated fatty acid chains. Thus, the absence of ether lipids during development drives a significant remodeling of the membrane landscape. A later initiation of fard-1 RNAi in adulthood results in a dramatic reduction of new ether lipid synthesis as quantified with N-15-tracers; however, there is only a slight decrease in total ether lipid abundance with this adult-only fard-1 RNAi. The two RNAi strategies permit the examination of synthesis and ether lipid abundance to reveal a relationship between the amount of ether lipids and stress survival. We tested whether these species function as sacrificial antioxidants by directly examining the phospholipid population with HPLC-MS/MS after oxidative stress treatment. While there are significant changes in other phospholipids, including polyunsaturated fatty acid-containing species, we did not find any change in ether-linked lipids, suggesting that the role of ether lipids in stress resistance is not through their general consumption as free radical sinks. Our work shows that the nematode will be a useful model for future interrogation of ether lipid biosynthesis and the characterization of phospholipid changes in various stress conditions.	[Drechsler, Robin; Chen, Shaw-Wen; Dancy, Blair C. R.; Mehrabkhani, Lena; Olsen, Carissa Perez] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Dancy, Blair C. R.] US Army, Ctr Environm Hlth Res, Ft Detrick, MD USA	Fred Hutchinson Cancer Center	Olsen, CP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	cpolsen@fredhutch.org		Olsen, Carissa/0000-0003-1261-9364	NIH Early Independence Award from the Office of the Director [5 DP5 OD009189]; National Institute of Dental and Craniofacial Research; University of Washington's Nathan Shock Center for Excellence in Aging [P30AG013280]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009189] Funding Source: NIH RePORTER	NIH Early Independence Award from the Office of the Director; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Washington's Nathan Shock Center for Excellence in Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by an NIH Early Independence Award (5 DP5 OD009189) from the Office of the Director and the National Institute of Dental and Craniofacial Research (www.nih.gov) and funding (P30AG013280) from the University of Washington's Nathan Shock Center for Excellence in Aging (uwaging.org/shock-center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini G, 2006, CHEMMEDCHEM, V1, P1045, DOI 10.1002/cmdc.200600075; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Dancy BCR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141850; Donovan EL, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-24; Dorninger F, 2015, BBA-MOL CELL BIOL L, V1851, P117, DOI 10.1016/j.bbalip.2014.11.005; Gaposchkin DP, 2008, BBA-MOL CELL BIOL L, V1781, P213, DOI 10.1016/j.bbalip.2008.01.007; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Kaddurah-Daouk R, 2012, PSYCHIAT RES, V198, P347, DOI 10.1016/j.psychres.2012.02.019; Kou JQ, 2011, ACTA NEUROPATHOL, V122, P271, DOI 10.1007/s00401-011-0836-9; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shi X, 2016, J LIPID RES, V57, P265, DOI 10.1194/jlr.M064808; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stadelmann-Ingrand S, 2001, FREE RADICAL BIO MED, V31, P1263, DOI 10.1016/S0891-5849(01)00720-1; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Wanders Ronald J A, 2013, Subcell Biochem, V69, P23, DOI 10.1007/978-94-007-6889-5_2; Watschinger K, 2013, BIOCHIMIE, V95, P59, DOI 10.1016/j.biochi.2012.06.027; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	27	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167229	10.1371/journal.pone.0167229	http://dx.doi.org/10.1371/journal.pone.0167229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893806	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400105
J	Saldivar-Lucio, R; Di Lorenzo, E; Nakamura, M; Villalobos, H; Lluch-Cota, D; Del Monte-Luna, P				Saldivar-Lucio, Romeo; Di Lorenzo, Emanuele; Nakamura, Miguel; Villalobos, Hector; Lluch-Cota, Daniel; Del Monte-Luna, Pablo			Macro-Scale Patterns in Upwelling/Downwelling Activity at North American West Coast	PLOS ONE			English	Article							SEA-LEVEL; INTERANNUAL VARIABILITY; CLIMATE; CALIFORNIA; SARDINE; REGIME; FLUCTUATIONS; OSCILLATION; TEMPERATURE; CIRCULATION	The seasonal and interannual variability of vertical transport (upwelling/downwelling) has been relatively well studied, mainly for the California Current System, including low-frequency changes and latitudinal heterogeneity. The aim of this work was to identify potentially predictable patterns in upwelling/downwelling activity along the North American west coast and discuss their plausible mechanisms. To this purpose we applied the min/max Autocorrelation Factor technique and time series analysis. We found that spatial co-variation of seawater vertical movements present three dominant low-frequency signals in the range of 33, 19 and 11 years, resembling periodicities of: atmospheric circulation, nodal moon tides and solar activity. Those periodicities might be related to the variability of vertical transport through their influence on dominant wind patterns, the position/intensity of pressure centers and the strength of atmospheric circulation cells (wind stress). The low-frequency signals identified in upwelling/downwelling are coherent with temporal patterns previously reported at the study region: sea surface temperature along the Pacific coast of North America, catch fluctuations of anchovy Engraulis mordax and sardine Sardinops sagax, the Pacific Decadal Oscillation, changes in abundance and distribution of salmon populations, and variations in the position and intensity of the Aleutian low. Since the vertical transport is an oceanographic process with strong biological relevance, the recognition of their spatio-temporal patterns might allow for some reasonable forecasting capacity, potentially useful for marine resources management of the region.	[Saldivar-Lucio, Romeo; Del Monte-Luna, Pablo] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas CICIMAR, La Paz, Baja Calif Sur, Mexico; [Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Nakamura, Miguel] Ctr Invest Matemat AC, Area Probabilidad & Estadist, Guanajuato, Mexico; [Saldivar-Lucio, Romeo; Lluch-Cota, Daniel] Ctr Invest Biol Noroeste, La Paz, Baja Calif Sur, Mexico	Instituto Politecnico Nacional - Mexico; University System of Georgia; Georgia Institute of Technology; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Saldivar-Lucio, R; Del Monte-Luna, P (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas CICIMAR, La Paz, Baja Calif Sur, Mexico.; Saldivar-Lucio, R (corresponding author), Ctr Invest Biol Noroeste, La Paz, Baja Calif Sur, Mexico.	romeo26_1979@yahoo.com; pdelmontel@ipn.mx	Villalobos, Héctor/I-9440-2019; Saldívar-Lucio, Romeo/T-6275-2019; Lluch-Cota, Daniel B./AEU-0658-2022; Di Lorenzo, Emanuele/E-9107-2012	Villalobos, Héctor/0000-0002-6424-4050; Saldívar-Lucio, Romeo/0000-0002-9893-3540; Di Lorenzo, Emanuele/0000-0002-1935-7363; Lluch-Cota, Daniel Bernardo/0000-0002-9045-9821; Del Monte, Pablo/0000-0002-9526-0846	SEP-CONACYT [101550]; IPN-SIP [20121079, 20130517]; COFAA scholarship of the Instituto Politecnico Nacional; EDI scholarship of the Institute Politecnico Nacional; Directorate For Geosciences [1356924] Funding Source: National Science Foundation; Division Of Ocean Sciences [1026607] Funding Source: National Science Foundation	SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IPN-SIP; COFAA scholarship of the Instituto Politecnico Nacional; EDI scholarship of the Institute Politecnico Nacional; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We want to thank partial financial supports from SEP-CONACYT 101550, IPN-SIP 20121079 and 20130517. We also thank COFAA and EDI scholarships of the Institute Politecnico Nacional for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In honor to Dr. Daniel Lluch-Belda (1942-2014). We want to thank partial financial supports from SEP-CONACYT 101550, IPN-SIP 20121079 and 20130517. We also thank COFAA and EDI scholarships of the Instituto Politecnico Nacional for financial support. Special thanks for advice to enhance the present work: Dr. German Ponce Diaz, MC. Gustavo De la Cruz, Dr. Adriano Mazzarella, Dr. Jose Luis Castro Ortiz, Dr. Christian Salvadeo, Dr. Francisco Arreguin Sanchez and three anonimous reviewers.	Aravena G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090276; Baart F, 2012, J COASTAL RES, V28, P511, DOI 10.2112/JCOASTRES-D-11-00169.1; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BAKUN A, 1991, J PHYS OCEANOGR, V21, P1815, DOI 10.1175/1520-0485(1991)021<1815:TSCOWS>2.0.CO;2; Barth JA, 2000, DEEP-SEA RES PT II, V47, P783, DOI 10.1016/S0967-0645(99)00127-7; Bates JR, 1974, GEN CIRCULATION TROP; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Bliss CI, 1958, CONN AES B; Bloomfield P, 2004, WILEY SERIES PROBABI; Bograd S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013790; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2355, DOI 10.1016/S0967-0645(03)00131-0; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Camuffo D, 2001, EARTH MOON PLANETS, V85-6, P99, DOI 10.1023/A:1017099427908; Cayan D.R., 1990, P 7 ANN PAC CLIM PAC, P115; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chen JY, 2002, SCIENCE, V295, P838, DOI 10.1126/science.1065835; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; CORNEJOGARRIDO AG, 1977, J ATMOS SCI, V34, P1155, DOI 10.1175/1520-0469(1977)034<1155:OTHBOT>2.0.CO;2; Cummins PF, 2007, PROG OCEANOGR, V75, P253, DOI 10.1016/j.pocean.2007.08.006; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Diffenbaugh NS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000865; DiLorenzo E, 2008, GEOPHYS RES LETT, V35, P6; Erzini K, 2005, ICES J MAR SCI, V62, P353, DOI 10.1016/j.icesjms.2004.12.009; Filonov AE, 2000, CIENC MAR, V26, P303; FILONOV AE, 2003, GEOFIS INT, V42, P307; Garcia-Reyes M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007629; Gonzalez-Rodriguez E., 2015, OPEN J SYSTEMS, V5, P604, DOI 10.4236/ojs.2015.56062; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hempel G, 2003, LARGE MARINE ECOSYTE; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; HOLLOWED AB, 1992, ICES MAR SC, V195, P433; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; HUYER A, 1991, J GEOPHYS RES-OCEANS, V96, P14809, DOI 10.1029/91JC00641; Jenkins G., 1968, SPECTRAL ANAL ITS AP; King JR, 1998, 318 N PAC AN FISH CO; Klyashtorin LB., 2007, CYCLIC CLIMATE CHANG; Laws E., MATH METHODS OCEANOG; Lindegren M, 2013, P NATL ACAD SCI USA, V110, P13672, DOI 10.1073/pnas.1305733110; Lluch-Belda D, 2003, J OCEANOGR, V59, P503, DOI 10.1023/A:1025596717470; Lluch-Belda D, 2001, CAL COOP OCEAN FISH, V42, P129; LLUCHBELDA D, 1992, CAL COOP OCEAN FISH, V33, P50; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; LLUCHCOTA SE, 2000, COLECCION INFORM AMB; Lohmann G, 2004, INT J CLIMATOL, V24, P1045, DOI 10.1002/joc.1054; Macias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030436; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mazzarella A, 2007, THEOR APPL CLIMATOL, V88, P193, DOI 10.1007/s00704-005-0219-z; McClatchie S, 2014, REGIONAL FISHERIES O; McFarlane GA, 2000, PROG OCEANOGR, V47, P147, DOI 10.1016/S0079-6611(00)00034-3; Mendes HC, 2015, ADV COMPLEX SYST, V18, DOI 10.1142/S0219525915500174; Mendoza B, 2001, J ATMOS SOL-TERR PHY, V63, P1891, DOI 10.1016/S1364-6826(01)00075-X; Munk W, 2007, J PHYS OCEANOGR, V37, P135, DOI 10.1175/JPO3002.1; Navrotsky V.V., 2013, AM J CLIM CHAN, V2, P183; Norton JG, 2013, QUATERN INT, V310, P7, DOI 10.1016/j.quaint.2011.10.041; Norton JG, 1985, PACIFIC OCEAN; Overland JE, 1978, 140 NOAAOCSEAP RU; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; Pearce KF, 1999, J MAR BIOL ASSOC UK, V79, P183, DOI 10.1017/S0025315498000216; PINEDA J, 1995, CONT SHELF RES, V15, P1023, DOI 10.1016/0278-4343(94)00046-P; Pizarro O, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020998; Pugh D. T., 1987, SURGES MEAN SEA LEVE; R Core Team, 2013, R LANG ENV STAT COMP; Ray RD, 2007, GEOPHYS J INT, V168, P999, DOI 10.1111/j.1365-246X.2006.03293.x; REBERT JP, 1985, J GEOPHYS RES-OCEANS, V90, P1719, DOI 10.1029/JC090iC06p11719; REID JL, 1988, CAL COOP OCEAN FISH, V29, P42; Royer TC, 1983, COASTAL OCEANOGRAPHY, V11; Samorodnitsky G, 2006, ANN FACULTE SCI TOUL, V15, P107; Scafetta N, 2010, J ATMOS SOL-TERR PHY, V72, P951, DOI 10.1016/j.jastp.2010.04.015; Schwing FB, 2002, PROG OCEANOGR, V53, P115, DOI 10.1016/S0079-6611(02)00027-7; Shapiro DE, 1989, 132 STANF U DEP STAT; Sharma S., 1996, APPL MULTIVARIATE TE; SOLOW AR, 1994, BIOMETRICS, V50, P556, DOI 10.2307/2533401; Stewart R., 2008, INTRO PHYS OCEANOGRA; Strub PT, 1987, J GEOPHYS RES, V92, P6445; Susanto RD, 2001, GEOPHYS RES LETT, V28, P1599, DOI 10.1029/2000GL011844; Switzer P, 1984, 6 STANF U DEP STAT S; Trenary LL, 2012, J PHYS OCEANOGR, V42, P602, DOI 10.1175/JPO-D-11-084.1; Vargas G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028812; WAHR JM, 1988, ANNU REV EARTH PL SC, V16, P231; Ware DM, 1995, FISH OCEANOGR, V4, P267, DOI 10.1111/j.1365-2419.1995.tb00072.x; Wooster Warren S., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P81; Wooster WS, 1985, EFFECTS E SUBARTIC P; Xue Y, 2003, J CLIMATE, V16, P1601, DOI 10.1175/1520-0442-16.10.1601; Yndestad H, 2006, ICES J MAR SCI, V63, P401, DOI 10.1016/j.icesjms.2005.07.015; Zhang A, 2006, 24 NOAA NOS CS US DE; [No title captured]	88	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166962	10.1371/journal.pone.0166962	http://dx.doi.org/10.1371/journal.pone.0166962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893826	Green Published, gold			2022-12-26	WOS:000389472400063
J	van Maanen, L; Couto, J; Lebreton, M				van Maanen, Leendert; Couto, Joaquina; Lebreton, Mael			Three Boundary Conditions for Computing the Fixed-Point Property in Binary Mixture Data	PLOS ONE			English	Article							ACCURACY TRADE-OFF; TO-ENGAGE THEORY; TIME; MODEL; SPEED; ACCOUNTS	The notion of "mixtures" has become pervasive in behavioral and cognitive sciences, due to the success of dual-process theories of cognition. However, providing support for such dual-process theories is not trivial, as it crucially requires properties in the data that are specific to mixture of cognitive processes. In theory, one such property could be the fixed-point property of binary mixture data, applied-for instance- to response times. In that case, the fixed-point property entails that response time distributions obtained in an experiment in which the mixture proportion is manipulated would have a common density point. In the current article, we discuss the application of the fixed-point property and identify three boundary conditions under which the fixed-point property will not be interpretable. In Boundary condition 1, a finding in support of the fixed-point will be mute because of a lack of difference between conditions. Boundary condition 2 refers to the case in which the extreme conditions are so different that a mixture may display bimodality. In this case, a mixture hypothesis is clearly supported, yet the fixed-point may not be found. In Boundary condition 3 the fixed-point may also not be present, yet a mixture might still exist but is occluded due to additional changes in behavior. Finding the fixed-property provides strong support for a dual-process account, yet the boundary conditions that we identify should be considered before making inferences about underlying psychological processes.	[van Maanen, Leendert] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [van Maanen, Leendert; Couto, Joaquina; Lebreton, Mael] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Couto, Joaquina; Lebreton, Mael] Univ Amsterdam, FEB, ASE, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	van Maanen, L (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.; van Maanen, L (corresponding author), Univ Amsterdam, ABC, Amsterdam, Netherlands.	lvmaanen@gmail.com	Lebreton, Maël/J-3179-2019; Van Maanen, Leendert/Z-5637-2019	Lebreton, Maël/0000-0002-2071-4890; Van Maanen, Leendert/0000-0001-9120-1075	EU [657904]; Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant; Bettencourt-Schueller Foundation	EU(European Commission); Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant; Bettencourt-Schueller Foundation	ML is supported by an EU Marie Sklodowska-Curie Individual Fellowship (IF-2015 Grant nr 657904, http://ec.europa.eu/research/mariecurieactions/about-msca/actions/if/index_en.htm), a Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant (http://abc.uva.nl/abc-grants/abc-talent-grant/abc-talent-grant.html), and acknowledges the support of the Bettencourt-Schueller Foundation (http://www.fondationbs.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML is supported by an EU Marie Sklodowska-Curie Individual Fellowship (IF-2015 Grant 657904), a Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant, and acknowledges the support of the Bettencourt-Schueller Foundation.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boehm U, 2014, NEUROIMAGE, V96, P95, DOI 10.1016/j.neuroimage.2014.03.063; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brown S, 2006, PSYCHON B REV, V13, P152, DOI 10.3758/BF03193827; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Burnham P., 2000, MODEL SELECTION MULT; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Dixon P, 2012, BEHAV RES METHODS, V44, P706, DOI 10.3758/s13428-012-0244-7; Dolan CV, 2002, BEHAV RES METH INS C, V34, P304, DOI 10.3758/BF03195458; Donkin C, 2014, J MATH PSYCHOL, V62-63, P22, DOI 10.1016/j.jmp.2014.09.006; Dutilh G, 2011, COGNITIVE SCI, V35, P211, DOI 10.1111/j.1551-6709.2010.01147.x; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; FALMAGNE JC, 1968, BRIT J MATH STAT PSY, V21, P131, DOI 10.1111/j.2044-8317.1968.tb00403.x; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2012, TECHNICAL REPORT; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Grange JA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00251; Hartelman PAI, 1998, BRIT J DEV PSYCHOL, V16, P97, DOI 10.1111/j.2044-835X.1998.tb00751.x; Kahneman D., 2013, THINKING FAST SLOW; Krajbich I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8455; Meijering B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045961; Mulder MJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1048, DOI 10.3758/s13414-013-0447-8; Ollman R., 1966, PSYCHON SCI, V6, P155, DOI [10.3758/BF03328004, DOI 10.3758/BF03328004]; Poboka D, 2014, COGNITIVE PSYCHOL, V72, P108, DOI 10.1016/j.cogpsych.2014.02.003; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Roberts S, 2000, PSYCHOL REV, P107; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Sprenger SA, 2013, MENT LEX, V8, P1, DOI 10.1075/ml.8.1.01spr; van Maanen L, 2016, TOP COGN SCI, V8, P279, DOI 10.1111/tops.12182; van Maanen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106113; VANDERMAAS HLJ, 1992, PSYCHOL REV, V99, P395, DOI 10.1037/0033-295X.99.3.395	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167377	10.1371/journal.pone.0167377	http://dx.doi.org/10.1371/journal.pone.0167377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893868	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400115
J	Wang, JF; Huang, YM; Li, KX; Chen, YY; Vanegas, D; McLamore, ES; Shen, YB				Wang, Jinfei; Huang, Yumin; Li, Kaixiang; Chen, Yingying; Vanegas, Diana; McLamore, Eric Scott; Shen, Yingbai			Leaf Extract from Lithocarpus polystachyus Rehd. Promote Glycogen Synthesis in T2DM Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; LIVER; DIHYDROCHALCONES; LEAVES; DIET; PHLORHIZIN; METABOLISM; ABSORPTION; TRILOBATIN	The purpose of this study was to investigate the effects of leaf extract from Lithocarpus polystachyus Rehd. on type II diabetes mellitus (T2DM) and the active ingredients of this effect. In addition, this study determined, for the first time, the underlying molecular and pharmacological mechanisms of the extracts on hyperglycemia using long-term double high diet-fed and streptozotocin (STZ) induced type II diabetic mice. In the present study, leaf extract, phloridzin and trilobatin were assessed in vivo (gavage) and in vitro (non-invasive micro-test technique, NMT) in experimental T2DM mice. The biochemical parameters were measured including blood glucose and blood lipid level, liver biochemical indexes, and hepatic glycogen. The relative expression of glycometabolism-related genes was detected. The effect of leaf extracts on physiological glucose flux in liver tissue from control and T2DM mice was also investigated. Body weight of experimental T2DM mice increased significantly after the first week, but stabilized over the subsequent three weeks; body weight of all other groups did not change during the four weeks' study. After four weeks, all treatment groups decreased blood glucose, and treatment with leaf extract had numerous positive effects: a) promoted in glucose uptake in liver, b) increased synthesis of liver glycogen, c) reduced oxidative stress, d) up-regulation of glucokinase (GK), glucose transporter 2 (GLUT2), insulin receptor (IR) and insulin receptor substrate (IRS) expression in liver, e) down-regulation of glucose-6-phosphatase (G-6-P) expression, and f) ameliorated blood lipid levels. Both treatment with trilobatin or phloridzin accelerated liver glycogen synthesis, decreased oxidative stress and increased expression of GK. IRS and phosphoenolpyruvate carboxykinase (PEPCK) were both up-regulated after treatment with trilobatin. Expression of GLUT2, PEPCK and G-6-P were also increased in liver tissue after treatment with phloridzin. Our data indicate that leaf extract from L. polystachyus Rehd. has a preferable hypoglycemic effects than trilobatin or phloridzin alone. Leaf extract significantly increased glucose uptake and hepatic glycogen synthesis while also inducing a decline of hepatic gluconeogenesis and oxidative stress in T2DM mice. From this study, we draw conclusions that L.polystachyus promoted glycogen synthesis in T2DM mice, and that the active compounds were not only the trilobatin or phloridzin.	[Wang, Jinfei; Huang, Yumin; Li, Kaixiang; Chen, Yingying; Shen, Yingbai] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Li, Kaixiang] Guangxi Forestry Res Inst, Nanning, Guangxi, Peoples R China; [Vanegas, Diana] Univ Valle, Dept Food Engn, Cali, Valle Del Cauca, Colombia; [McLamore, Eric Scott] Univ Florida, Inst Agr & Food Sci, Agr & Biol Engn Dept, Gainesville, FL USA	Beijing Forestry University; Universidad del Valle; State University System of Florida; University of Florida	Shen, YB (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	ybshen@bjfu.edu.cn	chen, ying/HHS-8254-2022; Vanegas, Diana/K-9187-2019; McLamore, Eric S/H-3441-2011	Vanegas, Diana/0000-0001-9858-0960; McLamore, Eric S/0000-0002-1662-7372; Huang, Yumin/0000-0002-3595-3093	Ministry of Science and Technology of the People's Republic of China (Beijing, China) [201204612]	Ministry of Science and Technology of the People's Republic of China (Beijing, China)(Ministry of Science and Technology, China)	This study was supported by the forestry public welfare projects (Number 201204612), Ministry of Science and Technology of the People's Republic of China (Beijing, China).	Azevedo MF, 2010, PHYTOTHER RES, V24, pS220, DOI 10.1002/ptr.3118; Bai Y, 2012, ACTA METALLURGICA SI, V48, P6; Beath S V, 2003, Semin Neonatol, V8, P337; Bravo-Nuevo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090031; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buettner C, 2005, J CLIN INVEST, V115, P1306, DOI 10.1172/JCI200523109; Burgos-Ramos E, 2015, MOL CELL ENDOCRINOL, V415, P157, DOI 10.1016/j.mce.2015.08.014; Calabuig-Navarro V, 2015, J BIOL CHEM, V290, P15581, DOI 10.1074/jbc.M115.650994; Camer D, 2015, MOL CELL ENDOCRINOL, V412, P36, DOI 10.1016/j.mce.2015.05.018; Chaturvedi P, 2014, BIOSENS BIOELECTRON, V58, P179, DOI 10.1016/j.bios.2014.02.021; Chen P, 2014, NUTRITION, V30, P1061, DOI 10.1016/j.nut.2014.03.022; Cho JY, 2008, INT J MOL SCI, V9, P2217, DOI 10.3390/ijms9112217; Cotton B, 2018, CALLS HALTELECTRONIC; DeMambro VE, 2010, J ENDOCRINOL, V204, P241, DOI 10.1677/JOE-09-0328; Di Carli MF, 2003, J AM COLL CARDIOL, V41, P1387, DOI 10.1016/S0735-1097(03)00166-9; Dong HQ, 2012, FOOD CHEM, V130, P261, DOI 10.1016/j.foodchem.2011.07.030; [董华强 DONG Hua-qiang], 2009, [食品科学, Food Science], V30, P279; [董华强 DONG Huaqiang], 2006, [食品科学, Food Science], V27, P714; Dong Y, 2015, PLOS ONE, V10, P963; Dudash J, 2004, BIOORG MED CHEM LETT, V14, P5121, DOI 10.1016/j.bmcl.2004.07.082; Emami-Riedmaier A, 2015, J INTERN MED, V277, P235, DOI 10.1111/joim.12330; Fan XL, 2015, FOOD CHEM, V166, P609, DOI 10.1016/j.foodchem.2014.06.022; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Gan L, 2015, ACTA PHARMACOL SIN, V36, P597, DOI 10.1038/aps.2015.11; Gaucher M, 2013, PHYTOCHEMISTRY, V90, P78, DOI 10.1016/j.phytochem.2013.02.009; Gromova LV, 2006, J EVOL BIOCHEM PHYS+, V42, P454, DOI 10.1134/S0022093006040119; Guo XH, 2002, CHINESE J DIABETES, V10, P90; Haluzik M, 2014, DRUG SAFETY, V37, P1003, DOI 10.1007/s40264-014-0238-8; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; Hou SZ, 2011, J ETHNOPHARMACOL, V138, P142, DOI 10.1016/j.jep.2011.08.067; [黄德强 Huang Deqiang], 2011, [中国细胞生物学学报, Chinese Journal of Cell Biology], V33, P1220; Huang J, 2003, STRUCTURE SOYBEAN BI, P1; Ikegami M, 2013, DIABETES OBES METAB, V15, P1128, DOI 10.1111/dom.12148; Ikumi Y, 2008, J CONTROL RELEASE, V125, P42, DOI 10.1016/j.jconrel.2007.10.001; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513; Jiao P, 2013, MOL CELL ENDOCRINOL, V375, P157, DOI 10.1016/j.mce.2013.05.021; Kammerer J, 2011, LWT-FOOD SCI TECHNOL, V44, P1079, DOI 10.1016/j.lwt.2010.10.008; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Leng Y, 2004, REV ENDOCR METAB DIS, V5, P111, DOI 10.1023/B:REMD.0000021432.84588.f6; Li JC, 2011, SYSTEMIC STUDY JIU Z; Li XiangRong, 2005, Journal of Zhejiang University (Agriculture and Life Sciences), V31, P203; [刘淑梅 Liu Shumei], 2003, [第四军医大学学报, Journal of the Fourth Military Medical University], V24, P1815; Liu ZQ, 2015, TOXICOL APPL PHARM, V285, P61, DOI 10.1016/j.taap.2015.03.011; McLamore ES, 2011, BIOSENS BIOELECTRON, V26, P2237, DOI 10.1016/j.bios.2010.09.041; Murovets VO, 2014, J EVOL BIOCHEM PHYS+, V50, P334, DOI 10.1134/S0022093014040061; Newsholme EA, 2001, EXP CLIN ENDOCR DIAB, V109, pS122, DOI 10.1055/s-2001-18575; Ouchfoun M, 2016, EUR J NUTR, V55, P941, DOI 10.1007/s00394-015-0908-z; Paulo A, 2008, PHYTOTHER RES, V22, P539, DOI 10.1002/ptr.2403; Renaud HJ, 2014, PLOS ONE, V9, P1; Shi J, 2013, BIOSENS BIOELECTRON, V40, P127, DOI 10.1016/j.bios.2012.06.059; Shi J, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/35/355502; Shi J, 2011, ANAL BIOCHEM, V411, P185, DOI 10.1016/j.ab.2010.12.019; Sun YS, 2015, J CHROMATOGR B, V1002, P372, DOI 10.1016/j.jchromb.2015.08.045; Taguchi Masashige, 2014, J Diabetes Sci Technol, V8, P403; Wang JZ, 2010, BIOL PHARM BULL, V33, P592, DOI 10.1248/bpb.33.592; Wang L, 2007, CHINESE J BIRTH HLTH, V15, P10; Wei BW, 2008, INTERNAL MED CHINA, V3, P510; Wei JC, 2012, WORLD NOTES ON ANTIB, V33, P214; Wu ZX, 1982, EDITORIAL BOARD GUAN, V4, P34; Xiao KunFu, 2006, Chemistry and Industry of Forest Products, V26, P85; Yang WM, 2004, Z NATURFORSCH C, V59, P481; [曾宝 ZENG Bao], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P879; Zeng XB, 2010, GUANGXI MED J, V32, P1326; Zhang FL, 2002, ACTA LAB ANIMALIS SC, V10, P16; [张毅 ZHANG Yi], 2011, [食品科学, Food Science], V32, P32; Zhao Y, 2014, ANAL METHODS-UK, V6, P1359, DOI 10.1039/c3ay41288a; Zhen C., 2011, CHINESE J EXPT TRADI, V17, P194, DOI [10.3969/j.issn.1005-9903.2011.22.054, DOI 10.3969/J.ISSN.1005-9903.2011.22.054]; Zhou CJ, 2013, J ETHNOPHARMACOL, V145, P386, DOI 10.1016/j.jep.2012.09.057; Zhou Y. S., 2005, ACTA LAB ANIMALS SCI, V13, P154	72	37	39	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166557	10.1371/journal.pone.0166557	http://dx.doi.org/10.1371/journal.pone.0166557			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893760	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400030
J	Zager, Y; Kain, D; Landa, N; Leor, J; Maor, E				Zager, Yaniv; Kain, David; Landa, Natalie; Leor, Jonathan; Maor, Elad			Optimization of Irreversible Electroporation Protocols for In-vivo Myocardial Decellularization	PLOS ONE			English	Article							MUSCLE-CELLS ABLATION; CATHETER ABLATION; SAFETY; CANCER; FEASIBILITY; TECHNOLOGY; EFFICACY	Background Irreversible electroporation (IRE) is a non-thermal cell ablation approach that induces selective damage to cell membranes only. The purpose of the current study was to evaluate and optimize its use for in-vivo myocardial decellularization. Methods Forty-two Sprague-Dawley rats were used to compare myocardial damage of seven different IRE protocols with anterior myocardial infarction damage. An in-vivo open thoracotomy model was used, with two-needle electrodes in the anterior ventricular wall. IRE protocols included different combinations of pulse lengths (70 vs. 100 mu seconds), frequency (1, 2, 4 Hz), and number (10 vs. 20 pulses), as well as voltage intensity (50, 250 and 500 Volts). All animals underwent baseline echocardiographic evaluation. Degree of myocardial ablation was determined using repeated echocardiography measurements (days 7 and 28) as well as histologic and morphometric analysis at 28 days. Results All animals survived 28 days of follow-up. Compared with 50V and 250V, electroporation with 500V was associated with significantly increased myocardial scar and reduction in ejection fraction (67.4%+/- 4% at baseline vs. 34.6%+/- 20% at 28 days; p <0.01). Also, compared with pulse duration of 70 mu sec, pulses of 100 mu sec were associated with markedly reduced left ventricular function and markedly increased relative scar area ratio (28%+/- 9% vs. 16% +/- 3%, p = 0.02). Decreasing electroporation pulse frequency (1Hz vs. 2Hz, 2Hz vs. 4Hz) was associated with a significant increase in myocardial damage. Electroporation protocols with a greater number of pulses (20 vs. 10) correlated with more profound tissue damage (p<0.05). When compared with myocardial infarction damage, electroporation demonstrated a considerable likeness regarding the extent of the inflammatory process, but with relatively higher levels of extra-cellular preservation. Conclusions IRE has a graded effect on the myocardium. The extent of ablation can be controlled by changing pulse length, frequency and number, as well as by changing electric field intensity.	[Zager, Yaniv; Kain, David; Landa, Natalie; Leor, Jonathan; Maor, Elad] Sheba Med Ctr, Tamman Cardiovasc Res Inst, Ramat Gan, Israel; [Kain, David; Landa, Natalie; Leor, Jonathan] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Maor, Elad] Sheba Med Ctr, Pinches Borenstein Talpiot Med Leadership Program, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Maor, E (corresponding author), Sheba Med Ctr, Tamman Cardiovasc Res Inst, Ramat Gan, Israel.; Maor, E (corresponding author), Sheba Med Ctr, Pinches Borenstein Talpiot Med Leadership Program, Ramat Gan, Israel.	eladmaor@gmail.com	Maor, Elad/J-9157-2015; Leor, Jonathan/O-2930-2017; Leor, Jonathan/T-8038-2019	Maor, Elad/0000-0002-5087-0464; kain, david/0000-0002-8410-9390; Zager, Yaniv/0000-0002-7631-4757	Elizabeth and Nicholas Slezak Super Center Grant for Cardiac Research (Tel-Aviv University); Jochebed Cohen Cardiovascular Research Grant (Sheba Medical Center)	Elizabeth and Nicholas Slezak Super Center Grant for Cardiac Research (Tel-Aviv University); Jochebed Cohen Cardiovascular Research Grant (Sheba Medical Center)	Funding of the study was covered by the Elizabeth and Nicholas Slezak Super Center Grant for Cardiac Research (Tel-Aviv University) (Award Number: None, Recipient: Dr. Maor), and by the Jochebed Cohen Cardiovascular Research Grant (Sheba Medical Center) (Award Number: None, Recipient: Dr. Maor). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore MP, 2015, INT J SURG, V21, pS34, DOI 10.1016/j.ijsu.2015.06.049; Cannon R, 2013, J SURG ONCOL, V107, P544, DOI 10.1002/jso.23280; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dollinger M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137480; du Pre BC, 2013, EUROPACE, V15, P144, DOI 10.1093/europace/eus171; Faroja M, 2013, RADIOLOGY, V266, P462, DOI 10.1148/radiol.12120609; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2010, J VASC INTERV RADIOL, V21, P1708, DOI 10.1016/j.jvir.2010.06.024; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Martin RCG, 2015, ANN SURG, V262, P486, DOI 10.1097/SLA.0000000000001441; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P913, DOI 10.1161/CIRCEP.114.001607; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P728, DOI 10.1161/CIRCEP.114.001659; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Valerio M, 2014, PROSTATE CANCER P D, V17, P343, DOI 10.1038/pcan.2014.33; Van Driel VJHM, 2014, CIRC-ARRHYTHMIA ELEC, V7, P573; Xei F, 2015, PLOS ONE, V10; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622	19	27	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165475	10.1371/journal.pone.0165475	http://dx.doi.org/10.1371/journal.pone.0165475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893744	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400009
J	Tadic, B; Andjelkovic, M; Boshkoska, BM; Levnajic, Z				Tadic, Bosiljka; Andjelkovic, Miroslav; Boshkoska, Biljana Mileva; Levnajic, Zoran			Algebraic Topology of Multi-Brain Connectivity Networks Reveals Dissimilarity in Functional Patterns during Spoken Communications	PLOS ONE			English	Article							NEURAL SYNCHRONIZATION; FMRI; ORGANIZATION; INTEGRATION; HOLOGRAPHY; ATTENTION; LANGUAGE; MOTIFS; CORTEX	Human behaviour in various circumstances mirrors the corresponding brain connectivity patterns, which are suitably represented by functional brain networks. While the objective analysis of these networks by graph theory tools deepened our understanding of brain functions, the multi-brain structures and connections underlying human social behaviour remain largely unexplored. In this study, we analyse the aggregate graph that maps coordination of EEG signals previously recorded during spoken communications in two groups of six listeners and two speakers. Applying an innovative approach based on the algebraic topology of graphs, we analyse higher-order topological complexes consisting of mutually interwoven cliques of a high order to which the identified functional connections organise. Our results reveal that the topological quantifiers provide new suitable measures for differences in the brain activity patterns and inter-brain synchronisation between speakers and listeners. Moreover, the higher topological complexity correlates with the listener's concentration to the story, confirmed by self-rating, and closeness to the speaker's brain activity pattern, which is measured by network-to-network distance. The connectivity structures of the frontal and parietal lobe consistently constitute distinct clusters, which extend across the listener's group. Formally, the topology quantifiers of the multi-brain communities exceed the sum of those of the participating individuals and also reflect the listener's rated attributes of the speaker and the narrated subject. In the broader context, the presented study exposes the relevance of higher topological structures ( besides standard graph measures) for characterising functional brain networks under different stimuli.	[Tadic, Bosiljka; Andjelkovic, Miroslav] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana 1001, Slovenia; [Andjelkovic, Miroslav] Univ Belgrade, Inst Nucl Sci Vinca, Belgrade, Serbia; [Boshkoska, Biljana Mileva; Levnajic, Zoran] Fac Informat Studies, Novo Mesto 8000, Slovenia; [Boshkoska, Biljana Mileva] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana 1001, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Belgrade; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Tadic, B (corresponding author), Jozef Stefan Inst, Dept Theoret Phys, Ljubljana 1001, Slovenia.	Bosiljka.Tadic@ijs.si	Boshkoska, Biljana Mileva/N-6298-2015; Tadic, Bosiljka/X-3144-2019	Boshkoska, Biljana Mileva/0000-0002-1137-9795; Andjelkovic, Miroslav/0000-0002-4449-8934; Tadic, Bosiljka/0000-0002-8147-2741	Research Agency of the Republic of Slovenia [P1-0044, P1-0388, P1-0383, J1-5454, L2-7663]; Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije [ON174014]; European Cooperation in Science and Technology [KNOWeSCAPE TD1210]; Horizon [COSMOS 642563]	Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia); Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije; European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Horizon	This work was supported by Research Agency of the Republic of Slovenia https://www.arrs.gov.si/ Program P1-0044, Program P1-0388, P1-0383, project J1-5454, L2-7663; Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije, http://www.mpn.gov.rs/ project ON174014; European Cooperation in Science and Technology http://www.cost.eu/COST_Actions/, KNOWeSCAPE TD1210; and Horizon 2020 https://ec.europa.eu/programmes/horizon2020/ project COSMOS 642563.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andjelkovic M, 2015, PHYSICA A, V436, P582, DOI 10.1016/j.physa.2015.05.075; Andjelkovic M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052817; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; ATKIN RH, 1976, INT J MAN MACH STUD, V8, P483, DOI 10.1016/S0020-7373(76)80015-6; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Bandelt HJ, 2008, CONTEMP MATH, V453, P49; Baruchi I, 2004, NEUROINFORMATICS, V2, P333, DOI 10.1385/NI:2:3:333; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bollobas B., 1998, MODERN GRAPH THEORY; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Deco G, 2015, NAT REV NEUROSCI, V16, P430, DOI 10.1038/nrn3963; Dorogovtsev S., 2010, LECT COMPLEX NETWORK, DOI [10.1093/acprof:oso/9780199548927.001.0001, DOI 10.1093/ACPROF:OSO/9780199548927.001.0001]; Duan L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00267; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064590; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1980, INT J MAN MACH STUD, V12, P367, DOI 10.1016/S0020-7373(80)80021-6; Gao XB, 2010, PATTERN ANAL APPL, V13, P113, DOI 10.1007/s10044-008-0141-y; Garcia-Martinez B, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18060221; Geier C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00462; GOULD P, 1980, INT J MAN MACH STUD, V13, P169, DOI 10.1016/S0020-7373(80)80009-5; Gronchi G, 2014, J COMPLEX NETW, V2, P637, DOI 10.1093/comnet/cnu035; Gu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9414; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; Hatcher A., 2005, ALGEBRAIC TOPOLOGY; Jiang J, 2015, P NATL ACAD SCI USA, V112, P4274, DOI 10.1073/pnas.1422930112; Jiang J, 2012, J NEUROSCI, V32, P16064, DOI 10.1523/JNEUROSCI.2926-12.2012; Jonsson J, 2008, LECT NOTES MATH, DOI [10.1007/978-3-540-75859-4, DOI 10.1007/978-3-540-75859-4]; Kim SY, 2016, NEUROIMAGE, V129, P25, DOI 10.1016/j.neuroimage.2015.11.068; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Kozlov D, 2008, ALGORITHM COMP MATH, V21, P1; Krauzlis RJ, 2014, TRENDS COGN SCI, V18, P457, DOI 10.1016/j.tics.2014.05.008; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Kuhlen AK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00266; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Li J, 2014, ARXIV14034303; LIU N, 2016, FRONT HUM NEUROSCI, V10, DOI DOI 10.3389/FNHUM.2016.00082; Madi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002708; Mantegna R. N., 2000, INTRO ECONOPHYSICS C, DOI [10.1063/1.1341926, DOI 10.1063/1.1341926]; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003982; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003427; Mitrovic M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026123; Muller V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073852; Padovani EC, 2016, ARXIV160400002; Parker CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111262; Phillips HN, 2015, J NEUROSCI, V35, P9255, DOI 10.1523/JNEUROSCI.5095-14.2015; Riemer M, 2016, NEUROIMAGE, V129, P72, DOI 10.1016/j.neuroimage.2016.01.030; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Sockeel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146845; Tadic B, 2009, EUR PHYS J B, V71, P631, DOI 10.1140/epjb/e2009-00190-7; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Womelsdorf T, 2015, TRENDS NEUROSCI, V38, P682, DOI 10.1016/j.tins.2015.08.009; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zivkovic J, 2009, STUD COMPUT INTELL, V207, P23	70	23	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166787	10.1371/journal.pone.0166787	http://dx.doi.org/10.1371/journal.pone.0166787			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880802	Green Published, gold			2022-12-26	WOS:000388889500033
J	He, M; Qiao, ZX; Wang, YB; Kuai, QY; Li, CL; Wang, Y; Jiang, XW; Wang, XL; Li, WJ; He, M; Ren, SP; Yu, Q				He, Mu; Qiao, Zhixin; Wang, Yanbing; Kuai, Qiyuan; Li, Changlan; Wang, Yu; Jiang, Xingwei; Wang, Xuanlin; Li, Weijing; He, Min; Ren, Suping; Yu, Qun			Chidamide Inhibits Aerobic Metabolism to Induce Pancreatic Cancer Cell Growth Arrest by Promoting Mcl-1 Degradation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; GEMCITABINE; APOPTOSIS	Pancreatic cancer is a fatal malignancy worldwide and urgently requires valid therapies. Previous research showed that the HDAC inhibitor chidamide is a promising anti-cancer agent in pancreatic cancer cell lines. In this study, we elucidate a probable underlying anticancer mechanism of chidamide involving the degradation of Mcl-1. Mcl-1 is frequently upregulated in human cancers, which has been demonstrated to participate in oxidative phosphorylation, in addition to its anti-apoptotic actions as a BcI-2 family member. The pancreatic cancer cell lines BxPC-3 and PANC-1 were treated with chidamide, resulting in Mcl-1 degradation accompanied by induction of Mcl-1 ubiquitination. Treatment with MG132, a proteasome inhibitor reduced Mcl-1 degradation stimulated by chidamide. Chidamide decreased 02 consumption and ATP production to inhibit aerobic metabolism in both pancreatic cancer cell lines and primary cells, similar to knockdown of Mcl-1, while overexpression of Mcl-1 in pancreatic cancer cells could restore the aerobic metabolism inhibited by chidamide. Furthermore, chidamide treatment or Mcl-1 knockdown significantly induced cell growth arrest in pancreatic cancer cell lines and primary cells, and Mcl-1 overexpression could reduce this cell growth inhibition. In conclusion, our results suggest that chidamide promotes Mcl-1 degradation through the ubiquitin-proteasome pathway, suppressing the maintenance of mitochondrial aerobic respiration by Mcl-1, and resulting in inhibition of pancreatic cancer cell proliferation. Our work supports the claim that chidamide has therapeutic potential for pancreatic cancer treatment.	[He, Mu; Wang, Yanbing; Kuai, Qiyuan; Li, Changlan; Wang, Yu; Jiang, Xingwei; Wang, Xuanlin; Li, Weijing; He, Min; Ren, Suping; Yu, Qun] Beijing Inst Transfus Med, Dept Blood Prod & Substitutes, Beijing, Peoples R China; [He, Mu] Shunyi Dist Ctr Dis Control & Prevent, Microbiol Lab, Beijing, Peoples R China; [Qiao, Zhixin] Capital Med Univ, Beijing Tongren Hosp, Med Res Ctr, Beijing, Peoples R China	Capital Medical University	Ren, SP; Yu, Q (corresponding author), Beijing Inst Transfus Med, Dept Blood Prod & Substitutes, Beijing, Peoples R China.	rensp12@yahoo.com; yugun1970@outlook.com	Ren, Suping/AAC-9167-2020		Program for the 12th Five-year Plan of China [AWS13J004]; National Key Research and Development Program of China [2016YFC1300600]; Beijing Natural Science Foundation of China [7162143]; Beijing Science and Technology Program of China [Z141100000214003]	Program for the 12th Five-year Plan of China; National Key Research and Development Program of China; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); Beijing Science and Technology Program of China	This project was supported by the Program for the 12th Five-year Plan of China (AWS13J004), the National Key Research and Development Program of China (2016YFC1300600), Beijing Natural Science Foundation of China (7162143), and Beijing Science and Technology Program of China (Z141100000214003).	Dong M, 2012, CANCER CHEMOTH PHARM, V69, P1413, DOI 10.1007/s00280-012-1847-5; Epping MT, 2009, INT J BIOCHEM CELL B, V41, P16, DOI 10.1016/j.biocel.2008.07.020; Gong K, 2012, BIOCHEM J, V443, P735, DOI 10.1042/BJ20111685; Gu RL, 2015, J CHROMATOGR B, V1000, P181, DOI 10.1016/j.jchromb.2015.07.001; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Krska Zdenek, 2015, Prague Med Rep, V116, P253, DOI 10.14712/23362936.2015.65; Lehmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-395; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Qiao ZX, 2013, BIOCHEM BIOPH RES CO, V434, P95, DOI 10.1016/j.bbrc.2013.03.059; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wei SH, 2008, CANCER CHEMOTH PHARM, V62, P1055, DOI 10.1007/s00280-008-0697-7; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Zhao B, 2015, ONCOL REP, V33, P304, DOI 10.3892/or.2014.3595; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	19	23	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166896	10.1371/journal.pone.0166896	http://dx.doi.org/10.1371/journal.pone.0166896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875574	Green Submitted, Green Published, gold			2022-12-26	WOS:000388886000035
J	Chang, ML; Kuo, CJ; Huang, HC; Chu, YY; Chiu, CT				Chang, Ming-Ling; Kuo, Chia-Jung; Huang, Hsin-Chih; Chu, Yin-Yi; Chiu, Cheng-Tang			Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; FATTY LIVER-DISEASE; SERUM LEPTIN; INSULIN-RESISTANCE; INFLAMMATORY MARKERS; CORE PROTEIN; STEATOSIS; FIBROSIS; ADIPOCYTOKINES; EXPRESSION	Background The association between leptin and complement in hepatitis C virus (HCV) infection remains unknown. Methods A prospective study was conducted including 474 (250 genotype 1, 224 genotype 2) consecutive chronic hepatitis C (CHC) patients who had completed an anti-HCV therapy course and undergone pre-therapy and 24-week post-therapy assessments of interferon lambda 3-rs12979860 and HCV RNA/genotypes, anthropometric measurements, metabolic and liver profiles, and complement component 3 (C3), C4, and leptin levels. Results Of the 474 patients, 395 had a sustained virological response (SVR). Pre-therapy leptin levels did not differ between patients with and without an SVR. Univariate and multivariate analyses showed that sex (pre-and post-therapy, p<0.001), body mass index (BMI) (pre-and post-therapy, p<0.001), and C3 levels (pre-therapy, p = 0.027; post-therapy, p = 0.02) were independently associated with leptin levels with or without HCV infection. Pre-therapy BMI, total cholesterol (TC), C4 levels, and the rs12979860 genotype were independently associated with pre-therapy C3 levels in all patients. Post-therapy BMI, alanine aminotransferase, TC, C4 levels, white blood cell counts, and hepatic steatosis were independently associated with the post-therapy C3 levels of SVR patients. Compared with pre-therapy levels, SVR patients showed higher 24-week post-therapy C4 (20.32+/-7.30 vs. 21.55+/-7.07 mg/dL, p<0.001) and TC (171.68+/-32.67 vs. 186.97+/-36.09 mg/dL, p<0.001) levels; however, leptin and C3 levels remained unchanged after therapy in patients with and without an SVR. Conclusions Leptin and C3 may maintain immune and metabolic homeostasis through association with C4 and TC. Positive alterations in C4 and TC levels reflect viral clearance after therapy in CHC patients.	[Chang, Ming-Ling; Kuo, Chia-Jung; Huang, Hsin-Chih; Chu, Yin-Yi; Chiu, Cheng-Tang] Chang Gung Mem Hosp, Div Hepatol, Dept Gastroenterol & Hepatol, Liver Res Ctr, Taoyuan, Taiwan; [Chang, Ming-Ling] Chang Gung Univ, Dept Med, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chang, ML (corresponding author), Chang Gung Mem Hosp, Div Hepatol, Dept Gastroenterol & Hepatol, Liver Res Ctr, Taoyuan, Taiwan.; Chang, ML (corresponding author), Chang Gung Univ, Dept Med, Coll Med, Taoyuan, Taiwan.	mlchang8210@gmail.com			Chang Gung Medical Research Program [CMRPG3F0471, CRRPG3F0011, XMRPG3A0521, CIRPG3D0121]; National Science Council, Taiwan [102-2628-B-182-021-MY3, MOST 105-2314-B-182-023, MOST 105-2629-B-182-001-]	Chang Gung Medical Research Program; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Chang Gung Medical Research Program (CMRPG3F0471, CRRPG3F0011, XMRPG3A0521 and CIRPG3D0121) and the National Science Council, Taiwan (102-2628-B-182-021-MY3, MOST 105-2314-B-182-023, and MOST 105-2629-B-182-001-) to Ming-Ling Chang. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ali Ola S M, 2005, Egypt J Immunol, V12, P91; Basu A, 2006, VIROLOGY, V349, P347, DOI 10.1016/j.virol.2006.02.023; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Chang ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep30799; Chang ML, 2016, WORLD J GASTROENTERO, V22, P1461, DOI 10.3748/wjg.v22.i4.1461; Chang ML, 2015, J GASTROEN HEPATOL, V30, P329, DOI 10.1111/jgh.12705; Chang ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104783; Chang ML, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-51; Cua IHY, 2007, HEPATOLOGY, V46, P66, DOI 10.1002/hep.21703; Eguchi Y, 2006, WORLD J GASTROENTERO, V12, P556, DOI 10.3748/wjg.v12.i4.556; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Gabrielsson BG, 2003, OBES RES, V11, P699, DOI 10.1038/oby.2003.100; Giannini E, 2000, AM J GASTROENTEROL, V95, P3211, DOI 10.1111/j.1572-0241.2000.03294.x; Hickman IJ, 2003, J HEPATOL, V39, P1042, DOI 10.1016/S0168-8278(03)00463-X; Hu JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003546; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Kim H, 2014, J VIROL, V88, P2564, DOI 10.1128/JVI.02988-13; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Leclercq IA, 2002, J HEPATOL, V37, P206, DOI 10.1016/S0168-8278(02)00102-2; LeGrand J, 2012, BLOOD, V119, P1018, DOI 10.1182/blood-2011-06-363887; Lemoine M, 2015, J VIRAL HEPATITIS, V22, P890, DOI 10.1111/jvh.12408; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu H, 2013, EXP CLIN ENDOCR DIAB, V121, P194, DOI 10.1055/s-0032-1333231; Mazumdar B, 2012, J VIROL, V86, P2221, DOI 10.1128/JVI.06577-11; Nestvold TK, 2015, METAB SYNDR RELAT D, V13, P29, DOI 10.1089/met.2014.0099; Nkontchou G, 2010, J HEPATOL, V53, P827, DOI 10.1016/j.jhep.2010.04.035; Patel K, 2003, AM J GASTROENTEROL, V98, P952; Pavlidis C, 2011, WORLD J GASTROENTERO, V17, P5097, DOI 10.3748/wjg.v17.i46.5097; Petit JM, 2005, J CLIN ENDOCR METAB, V90, P2240, DOI 10.1210/jc.2004-1266; Romero-Gomez M, 2003, AM J GASTROENTEROL, V98, P1135, DOI [10.1016/S0002-9270(03)00185-0, 10.1111/j.1572-0241.2003.07450.x]; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Siegmund B, 2002, GASTROENTEROLOGY, V122, P2011, DOI 10.1053/gast.2002.33631; Szabova M, 2012, HUM IMMUNOL, V73, P486, DOI 10.1016/j.humimm.2012.02.006; Widjaja A, 2001, SCAND J GASTROENTERO, V36, P426, DOI 10.1080/003655201300051333	38	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166712	10.1371/journal.pone.0166712	http://dx.doi.org/10.1371/journal.pone.0166712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870883	Green Submitted, gold, Green Published			2022-12-26	WOS:000388846400021
J	Chatterjee, S; Bhardwaj, N; Saxena, RK				Chatterjee, Sreoshi; Bhardwaj, Nitin; Saxena, Rajiv K.			Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; OXIDATIVELY MODIFIED AUTOANTIGENS; REACTIVE B-LYMPHOCYTES; NORMAL MICE; IN-VIVO; CELL; EXPRESSION; CLEARANCE; STRESS; ERYTHROPOIESIS	Repeated weekly injections of rat erythrocytes produced autoimmune hemolytic anemia (AIHA) in C57BL/6 mice after 5-6 weeks. Using the double in vivo biotinylation (DIB) technique, recently developed in our laboratory, turnover of erythrocyte cohorts of different age groups during AIHA was monitored. Results indicate a significant decline in the proportion of reticulocytes, young and intermediate age groups of erythrocytes, but a significant increase in the proportion of old erythrocytes in blood circulation. Binding of the autoantibody was relatively higher to the young erythrocytes and higher levels of intracellular reactive oxygen species (ROS) were also seen in these cells. Erythropoietic activity in the bone marrows and the spleen of AIHA induced mice was examined by monitoring the relative proportion of erythroid cells at various stages of differentiation in these organs. Cells at different stages of differentiation were enumerated flow cytometrically by double staining with anti-Ter119 and anti-transferrin receptor (CD71) monoclonal antibodies. Erythroid cells in bone marrow declined significantly in AIHA induced mice, erythroblast C being most affected (50% decline). Erythroblast C also recorded high intracellular ROS level along with increased levels of membrane-bound autoantibody. No such decline was observed in spleen. A model of AIHA has been proposed indicating that binding of autoantibodies may not be a sufficient condition for destruction of erythroid cells in bone marrow and in blood circulation. Last stage of erythropoietic differentiation in bone marrow and early stages of erythrocytes in blood circulation are specifically susceptible to removal in AIHA.	[Chatterjee, Sreoshi] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India; [Chatterjee, Sreoshi; Bhardwaj, Nitin; Saxena, Rajiv K.] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; South Asian University (SAU)	Saxena, RK (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rajivksaxena@hotmail.com		Chatterjee, Sreoshi/0000-0001-7731-1243	Department of Science and Technology [SR/SO/HS-0261/2012]; Council of Scientific and Industrial Research (CSIR), New Delhi	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was funded by two research grants from the Department of Science and Technology through grant no. SR/SO/HS-0261/2012 to RKS. SC received Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi.	Arndt PA, 2004, TRANSFUS MED HEMOTH, V31, P163, DOI 10.1159/000079075; Barker RN, 2002, CLIN EXP IMMUNOL, V129, P208, DOI 10.1046/j.1365-2249.2002.01917.x; Bhardwaj N, 2015, NANOTOXICOLOGY, V9, P1032, DOI 10.3109/17435390.2014.998307; Bhardwaj N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099364; Chatterjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132697; COX KO, 1974, CLIN EXP IMMUNOL, V17, P319; Dacie J, 2001, BRIT J HAEMATOL, V114, P770, DOI 10.1046/j.1365-2141.2001.02945.x; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; ENGELFRIET CP, 1992, SEMIN HEMATOL, V29, P3; Fagiolo E, 2004, AUTOIMMUN REV, V3, P143, DOI 10.1016/S1568-9972(03)00085-5; Fujii Junichi, 2015, World J Nephrol, V4, P213, DOI 10.5527/wjn.v4.i2.213; Gehrs BC, 2002, AM J HEMATOL, V69, P258, DOI 10.1002/ajh.10062; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hashimoto C, 1998, CLIN REV ALLERG IMMU, V16, P285, DOI 10.1007/BF02737638; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; IZUI S, 1994, TOHOKU J EXP MED, V173, P15, DOI 10.1620/tjem.173.15; JEFFERIES LC, 1994, HEMATOL ONCOL CLIN N, V8, P1087, DOI 10.1016/S0889-8588(18)30123-0; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; KIELY PDW, 1995, LUPUS, V4, P407, DOI 10.1177/096120339500400512; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Kurien BT, 2006, FREE RADICAL BIO MED, V41, P549, DOI 10.1016/j.freeradbiomed.2006.05.020; Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; LOUTIT JF, 1946, J PATHOL BACTERIOL, V58, P711, DOI 10.1002/path.1700580412; Luchi Y, 2010, FREE RADIC BIOL MED, V48, P935; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Michel P, 1997, ACTA PAEDIATR, V86, P609, DOI 10.1111/j.1651-2227.1997.tb08943.x; NAYSMITH JD, 1981, IMMUNOL REV, V55, P55, DOI 10.1111/j.1600-065X.1981.tb00339.x; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; PLAYFAIR JH, 1973, NATURE-NEW BIOL, V243, P213, DOI 10.1038/newbio243213a0; ROFFE C, 1991, BRIT J RHEUMATOL, V30, P301; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Saxena RK, 2012, TRANSFUS MED HEMOTH, V39, P335, DOI 10.1159/000342524; Saxena RK, 2009, CURR SCI INDIA, V97, P500; Semple JW, 2005, SEMIN HEMATOL, V42, P122, DOI 10.1053/j.seminhematol.2005.04.002; SMITH HR, 1983, ANNU REV IMMUNOL, V1, P175, DOI 10.1146/annurev.iy.01.040183.001135; SOKOL RJ, 1992, J CLIN PATHOL, V45, P1047, DOI 10.1136/jcp.45.12.1047; SOKOL RJ, 1985, CRC CR REV ONCOL-HEM, V4, P125, DOI 10.1016/S1040-8428(85)80013-5; Thedsawad A, 2011, ASIAN PAC J ALLERGY, V29, P364; WEIGLE WO, 1971, CLIN EXP IMMUNOL, V9, P437	45	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166878	10.1371/journal.pone.0166878	http://dx.doi.org/10.1371/journal.pone.0166878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870894	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400039
J	Melloul, E; Luiggi, S; Anais, L; Arne, P; Costa, JM; Fihman, V; Briard, B; Dannaoui, E; Guillot, J; Decousser, JW; Beauvais, A; Botterel, F				Melloul, Elise; Luiggi, Stephanie; Anais, Leslie; Arne, Pascal; Costa, Jean-Marc; Fihman, Vincent; Briard, Benoit; Dannaoui, Eric; Guillot, Jacques; Decousser, Jean-Winoc; Beauvais, Anne; Botterel, Francoise			Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; BACTERIAL-FUNGAL INTERACTIONS; PSEUDOMONAS-AERUGINOSA; OPPORTUNISTIC PATHOGEN; GROWTH; CELLS; PCR; SUSCEPTIBILITY; INFECTIONS; DIAGNOSIS	Background Biofilms are communal structures of microorganisms that have long been associated with a variety of persistent infections poorly responding to conventional antibiotic or antifungal therapy. Aspergillus fumigatus fungus and Stenotrophomonas maltophilia bacteria are examples of the microorganisms that can coexist to form a biofilm especially in the respiratory tract of immunocompromised patients or cystic fibrosis patients. The aim of the present study was to develop and assess an in vitro model of a mixed biofilm associating S. maltophilia and A. fumigatus by using analytical and quantitative approaches. Materials and Methods An A. fumigatus strain (ATCC 13073) expressing a Green Fluorescent Protein (GFP) and an S. maltophilia strain (ATCC 13637) were used. Fungal and bacterial inocula (10(5) conidia/ mL and 10(6) cells/mL, respectively) were simultaneously deposited to initiate the development of an in vitro mixed biofilm on polystyrene supports at 37 degrees C for 24 h. The structure of the biofilm was analysed via qualitative microscopic techniques like scanning electron and transmission electron microscopy, and fluorescence microscopy, and by quantitative techniques including qPCR and crystal violet staining. Results Analytic methods revealed typical structures of biofilm with production of an extracellular matrix (ECM) enclosing fungal hyphae and bacteria. Quantitative methods showed a decrease of A. fumigatus growth and ECM production in the mixed biofilm with antibiosis effect of the bacteria on the fungi seen as abortive hyphae, limited hyphal growth, fewer conidia, and thicker fungal cell walls. Conclusion For the first time, a mixed A. fumigatus-S. maltophilia biofilm was validated by various analytical and quantitative approaches and the bacterial antibiosis effect on the fungus was demonstrated. The mixed biofilm model is an interesting experimentation field to evaluate efficiency of antimicrobial agents and to analyse the interactions between the biofilm and the airways epithelium.	[Melloul, Elise; Luiggi, Stephanie; Anais, Leslie; Arne, Pascal; Costa, Jean-Marc; Fihman, Vincent; Dannaoui, Eric; Guillot, Jacques; Decousser, Jean-Winoc; Botterel, Francoise] Univ Paris Est Creteil, Ecole Natl Vet Alfort, IMRB, EA Dynamyc 7380, Creteil, France; [Arne, Pascal; Guillot, Jacques] Ecole Natl Vet Maisons Alfort, Maisons Alfort, France; [Costa, Jean-Marc] Cerba, St Ouen Laurnone, France; [Fihman, Vincent; Decousser, Jean-Winoc] Hop Henri Mondor, AP HP, Unite Bacteriol Hyg, DHU VIC,Dept Microbiol, Creteil, France; [Briard, Benoit; Beauvais, Anne] Inst Pasteur, Unite Aspergillus, Paris, France; [Dannaoui, Eric] Hop Europeen Georges Pompidou, Unite Parasitol Mycol, Dept Microbiol, Paris, France; [Botterel, Francoise] Univ Paris Est Creteil, Grp Hosp Henri Mondor Albert Chenevier, APHP, Unite Mycol,DHU VIC, Creteil, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole Nationale Veterinaire d'Alfort (ENVA); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Botterel, F (corresponding author), Univ Paris Est Creteil, Ecole Natl Vet Alfort, IMRB, EA Dynamyc 7380, Creteil, France.	francoise.botterel@aphp.fr	Briard, Benoit/AAH-9650-2019; Beauvais, Anne/A-6358-2012; , DECOUSSER/AFM-9917-2022; FIHMAN, Vincent/AAK-2285-2020; Guillot, Jacques/J-9428-2016; dannaoui, eric/N-1712-2019	FIHMAN, Vincent/0000-0001-9327-7524; Guillot, Jacques/0000-0003-3577-6979; dannaoui, eric/0000-0002-2817-3830; Arne, Pascal/0000-0001-9727-7716; Briard, Benoit/0000-0002-1496-9408				Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; Bafadhel M, 2014, EUR RESPIR J, V43, P64, DOI 10.1183/09031936.00162912; Baxter CG, 2013, THORAX, V68, P652, DOI 10.1136/thoraxjnl-2012-202412; Beauvais A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0017-2015; Brand MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025553; Briard B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08220; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Calza L, 2003, INFECTION, V31, P155, DOI 10.1007/s15010-003-3113-6; Challier S, 2004, J CLIN MICROBIOL, V42, P844, DOI 10.1128/JCM.42.2.844-846.2004; Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI 10.1016/j.biocel.2014.03.001; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; De Brucker K, 2015, ANTIMICROB AGENTS CH, V59, P3052, DOI 10.1128/AAC.04650-14; Di Bonaventura G, 2007, INT J IMMUNOPATH PH, V20, P529, DOI 10.1177/039463200702000311; Di Bonaventura G, 2007, FOLIA MICROBIOL, V52, P86, DOI 10.1007/BF02932144; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; Di Bonaventura G, 2014, FUTURE MICROBIOL, V9, P1303, DOI 10.2217/fmb.14.96; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Jacquier H, 2011, EUR J CLIN MICROBIOL, V30, P1579, DOI 10.1007/s10096-011-1263-5; Jeanson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108671; Kaur S, 2014, MED MYCOL, V52, P2, DOI 10.3109/13693786.2013.819592; Kerr JR, 1996, J MED MICROBIOL, V45, P380, DOI 10.1099/00222615-45-5-380; Kirakodu SS, 2008, OPEN DENT J, V2, P49, DOI 10.2174/1874210600802010049; Leon-Romero A, 2016, APPL ENVIRON MICROB, V82, P689, DOI 10.1128/AEM.02727-15; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Li SJ, 2009, J EUKARYOT MICROBIOL, V56, P182, DOI 10.1111/j.1550-7408.2008.00384.x; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Manavathu EK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-53; Marchac V, 2004, EUR RESPIR J, V23, P98, DOI 10.1183/09031936.03.00007203; Melloul E, 2014, COMP IMMUNOL MICROB, V37, P271, DOI 10.1016/j.cimid.2014.07.005; Morales DK, 2013, MBIO, V4, DOI 10.1128/mBio.00526-12; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Mowat E, 2010, FEMS MICROBIOL LETT, V313, P96, DOI 10.1111/j.1574-6968.2010.02130.x; Muller FMC, 2011, MED MYCOL, V49, pS96, DOI 10.3109/13693786.2010.502190; de Rossi BP, 2014, REV ARGENT MICROBIOL, V46, P288, DOI 10.1016/S0325-7541(14)70084-7; Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; Qu Y, 2016, J ANTIMICROB CHEMOTH, V71, P413, DOI 10.1093/jac/dkv334; Granillo AR, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0363-2; Ritz N, 2005, EUR J PEDIATR, V164, P577, DOI 10.1007/s00431-005-1701-4; Sabino R, 2015, J CYST FIBROS, V14, P474, DOI 10.1016/j.jcf.2014.10.005; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Shopova I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00141; Suzuki N, 2004, J CLIN MICROBIOL, V42, P3827, DOI 10.1128/JCM.42.8.3827-3830.2004; Taff HT, 2012, MED MYCOL, V50, P214, DOI 10.3109/13693786.2011.580016; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002	50	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166325	10.1371/journal.pone.0166325	http://dx.doi.org/10.1371/journal.pone.0166325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870863	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400008
J	Ogneva, IV; Belyakin, SN; Sarantseva, SV				Ogneva, Irina V.; Belyakin, Stepan N.; Sarantseva, Svetlana V.			The Development Of Drosophila Melanogaster under Different Duration Space Flight and Subsequent Adaptation to Earth Gravity	PLOS ONE			English	Article							LARGE GENE LISTS; ALTERED GRAVITY; CORTICAL CYTOSKELETON; RNA-SEQ; FIBERS; TRANSCRIPTOME; MUSCLES	In prospective human exploration of outer space, the need to preserve a species over several generations under changed gravity conditions may arise. This paper demonstrates our results in the creation of the third generation of fruit fly Drosophila melanogaster (third-stage larvae) during the 44.5-day space flight (Foton-M4 satellite (2014, Russia)), then the fourth generation on Earth and the fifth generation again in conditions of the 12-day space flight (2014, in the Russian Segment of the ISS). The species preserves fertility despite a number of changes in the level of expression and content of cytoskeletal proteins, which are the key components of the cleavage spindle and the contractile ring of cells. The results of transcriptome screening and space analysis of cytoskeletal proteins show that the exposure to weightless conditions leads to the increased transcription of metabolic genes, cuticle components and the decreased transcription of genes involved in morphogenesis, cell differentiation, cytoskeletal organization and genes associated with the plasma membrane. "Subsequent" exposure to the microgravity for 12 days resulted in an even more significant increase/decrease in the transcription of the same genes. On the contrary, the transition from the microgravity conditions to the gravity of Earth leads to the increased transcription of genes whose products are involved in the morphogenesis, cytoskeletal organization, motility of cells and transcription regulation, and to the decreased transcription of cuticle genes and proteolytic processes.	[Ogneva, Irina V.] Russian Acad Sci, Russian Federat Inst Biomed Problems, State Sci Ctr, Cell Biophys Grp, Moscow, Russia; [Ogneva, Irina V.] IM Sechenov First Moscow State Med Univ, Moscow, Russia; [Belyakin, Stepan N.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Sarantseva, Svetlana V.] BP Konstantinov Petersburg Nucl Phys Inst Natl Re, Gatchina, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; Russian Academy of Sciences	Ogneva, IV (corresponding author), Russian Acad Sci, Russian Federat Inst Biomed Problems, State Sci Ctr, Cell Biophys Grp, Moscow, Russia.; Ogneva, IV (corresponding author), IM Sechenov First Moscow State Med Univ, Moscow, Russia.	iogneva@yandex.ru	Belyakin, Stepan/N-5921-2015; Ogneva, Irina V/Q-8783-2018	Belyakin, Stepan/0000-0002-2315-4382; Ogneva, Irina V/0000-0003-0125-5876	program of fundamental research SSC RF - IBMP RAS, program "Cell and Molecular Biology" of the RAS Presidium	program of fundamental research SSC RF - IBMP RAS, program "Cell and Molecular Biology" of the RAS Presidium	The study was supported by the program of fundamental research SSC RF - IBMP RAS, program "Cell and Molecular Biology" of the RAS Presidium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; CLAASSEN DE, 1994, INT REV CYTOL, V156, P301, DOI 10.1016/S0074-7696(08)62257-3; Dubinin N P, 1976, Life Sci Space Res, V14, P47; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Herranz R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-133; Herranz R, 2010, MOL ECOL, V19, P4255, DOI 10.1111/j.1365-294X.2010.04795.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marco R, 1996, J BIOTECHNOL, V47, P179, DOI 10.1016/0168-1656(96)01408-3; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; Miquel J, 1991, ADV SPACE BIOL MED, V1, P104; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogneva IV, 2014, J APPL PHYSIOL, V116, P1315, DOI 10.1152/japplphysiol.00134.2014; Ogneva IV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/598461; Ogneva IV, 2010, J APPL PHYSIOL, V109, P1702, DOI 10.1152/japplphysiol.00793.2010; Ogneva IV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153650; Ogneva IV, 2015, J APPL PHYSIOL, V118, P613, DOI 10.1152/japplphysiol.00812.2014; Ogneva IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096395; Parfyonov G P, 1979, Life Sci Space Res, V17, P297; Ross M D, 1984, Adv Space Res, V4, P305, DOI 10.1016/0273-1177(84)90575-1; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tairbekov MG, 1997, IZV AKAD NAUK BIOL+, P517; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; VERNOS I, 1989, International Journal of Developmental Biology, V33, P213; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009	30	13	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166885	10.1371/journal.pone.0166885	http://dx.doi.org/10.1371/journal.pone.0166885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861601	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300127
J	Liu, WT; Huang, KY; Lu, MC; Huang, HL; Chen, CY; Cheng, YL; Yu, HC; Liu, SQ; Lai, NS; Huang, HB				Liu, W-T; Huang, K-Y; Lu, M-C; Huang, H-L; Chen, C-Y; Cheng, Y-L; Yu, H-C; Liu, S-Q; Lai, N-S; Huang, H-B			TGF-beta upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability	ONCOGENE			English	Article							CELL SURVIVAL; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITION; P53-MDM2 PATHWAY; DNA-DAMAGE; ACTIVATION; USP7/HAUSP; RESPONSES; SMADS; MDM2	Crosstalk between transforming growth factor beta (TGF-beta) signaling and p53 has a critical role in cancer progression. TGF-beta signals via Smad and non-Smad pathways. Under normal conditions, wild-type p53 forms a complex with Smad2/3 and co-activates transcription of a variety of tumor suppressor genes, resulting in tumor suppressive effects. Thus, p53 stability is essential in progression of tumor suppressive responses mediated by TGF-beta signaling. However, it remains unknown whether p53 stability is regulated by TGF-beta. In the current study, we identify that USP15 binds to and stabilizes p53 through deubiquitination in U2OS and HEK293 cells. TGF-beta promotes the translation of USP15 through activation of mammalian target of rapamycin by the phosphoinositide 3-kinase/AKT pathway. Upregulation of USP15 translation links the crosstalk between TGF-beta signaling and p53 stability, allowing this cytokine to have a critical role in cancer progression.	[Liu, W-T; Huang, K-Y; Chen, C-Y; Cheng, Y-L; Yu, H-C; Huang, H-B] Natl Chung Cheng Univ, Dept Life Sci, 168 Univ Rd, Chiayi 62102, Taiwan; [Liu, W-T; Huang, K-Y; Chen, C-Y; Cheng, Y-L; Yu, H-C; Huang, H-B] Natl Chung Cheng Univ, Inst Mol Biol, 168 Univ Rd, Chiayi 62102, Taiwan; [Huang, K-Y; Lu, M-C; Yu, H-C; Liu, S-Q; Lai, N-S] DaLin Tzu Chi Buddhist Hosp, Dept Med, Sect Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Huang, K-Y; Lu, M-C; Lai, N-S] Tzu Chi Univ, Coll Med, Dept Med, Hualien, Taiwan; [Huang, H-L] Fooyin Univ, Dept Nutr & Hlth Sci, Kaohsiung, Taiwan	National Chung Cheng University; National Chung Cheng University; Buddhist Tzu Chi General Hospital; Tzu Chi University; Fooyin University	Huang, HB (corresponding author), Natl Chung Cheng Univ, Dept Life Sci, 168 Univ Rd, Chiayi 62102, Taiwan.; Huang, HB (corresponding author), Natl Chung Cheng Univ, Inst Mol Biol, 168 Univ Rd, Chiayi 62102, Taiwan.; Lai, NS (corresponding author), DaLin Tzu Chi Buddhist Hosp, Dept Med, Sect Allergy Immunol & Rheumatol, Chiayi, Taiwan.	Q12015@tzuchi.com.tw; biohbh@ccu.edu.tw			DaLin Tzu-Chi Buddhist Hospital [DTCRD 97-14, DTCRD 102-E-06, DTCRD103(2)-I-10]; National Science Council, ROC [NSC 102-2320-B194-002]	DaLin Tzu-Chi Buddhist Hospital; National Science Council, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the DaLin Tzu-Chi Buddhist Hospital (DTCRD 97-14, DTCRD 102-E-06 and DTCRD103(2)-I-10) and from the National Science Council, ROC (NSC 102-2320-B194-002).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Huang T, 2011, EMBO J, V30, P1263, DOI 10.1038/emboj.2011.54; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Khoronenkova SV, 2012, CELL CYCLE, V11, P2409, DOI 10.4161/cc.20800; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lee H, 2000, INT J CANCER, V88, P454, DOI 10.1002/1097-0215(20001101)88:3<454::AID-IJC19>3.0.CO;2-T; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Vinals F, 2001, MOL CELL BIOL, V21, P7218, DOI 10.1128/MCB.21.21.7218-7230.2001; Vos RM, 2009, J VIROL, V83, P8885, DOI 10.1128/JVI.00605-09; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; WYLLIE FS, 1991, MOL CELL ENDOCRINOL, V76, P13, DOI 10.1016/0303-7207(91)90255-Q; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	36	57	60	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2715	2723		10.1038/onc.2016.424	http://dx.doi.org/10.1038/onc.2016.424			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27893708	Green Published, hybrid			2022-12-26	WOS:000401120900009
J	Rose, S; Bennuri, SC; Wynne, R; Melnyk, S; James, SJ; Frye, RE				Rose, Shannon; Bennuri, Sirish C.; Wynne, Rebecca; Melnyk, Stepan; James, S. Jill; Frye, Richard E.			Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study	FASEB JOURNAL			English	Article						autistic disorder; bioenergetics; glutathione; oxidative stress; UCP2	OXIDATIVE STRESS; DYSFUNCTION; BIOMARKERS; CHILDREN	Autism spectrum disorder (ASD) is associated with physiological abnormalities including abnormal redox and mitochondrial metabolism. Lymphoblastoid cell lines (LCLs) from some children with ASD exhibit increased oxidative stress, decreased glutathione redox capacity, and highly active mitochondria with increased vulnerability to reactive oxygen species (ROS). Because unaffected siblings (Sibs) of individuals with ASD share some redox abnormalities, we sought to determine whether LCLs from Sibs share ASD-associated mitochondrial abnormalities. We evaluated mitochondrial bioenergetics in 10 sets of LCLs from children with ASD, Sib, and unrelated/unaffected controls (Cons) after acute increases in ROS. Additionally, intracellular glutathione and uncoupling protein 2 (UCP2) gene expressions were quantified. Compared to sib, ASD LCLs exhibited significantly higher ATP-linked respiration, higher maximal and reserve respiratory capacity, and greater glycolysis and glycolytic reserve. ASD LCLs exhibited a significantly greater change in these parameters, with acute increases in ROS compared to both Sib and Con LCLs. Compared to Con, both ASD and Sib LCLs exhibited significantly higher proton leak respiration. Consistent with this, intracellular glutathione redox capacity was decreased and UCP2 gene expression was increased in both ASD and Sib compared to Con LCLs. These data indicate that mitochondrial respiratory function, not abnormal redox homeostasis, distinguishes ASD from unaffected LCLs.Rose, S., Bennuri, S. C., Wynne, R., Melnyk, S., James, S. J., Frye, R. E. Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study.	[Rose, Shannon; Bennuri, Sirish C.; Wynne, Rebecca; Melnyk, Stepan; James, S. Jill; Frye, Richard E.] Arkansas Childrens Res Inst, 13 Childrens Way,Slot 512-41B, Little Rock, AR 72202 USA; [Rose, Shannon; Bennuri, Sirish C.; Wynne, Rebecca; Melnyk, Stepan; James, S. Jill; Frye, Richard E.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Rose, S (corresponding author), Arkansas Childrens Res Inst, 13 Childrens Way,Slot 512-41B, Little Rock, AR 72202 USA.	srose@uams.edu	Frye, Richard/AAB-5543-2020	Rose, Shannon/0000-0003-0595-4367	Arkansas Biosciences Institute (Little Rock, AR, USA); Jane Botsford Johnson Foundation (New York, NY, USA); Arkansas Children's Research Institute	Arkansas Biosciences Institute (Little Rock, AR, USA); Jane Botsford Johnson Foundation (New York, NY, USA); Arkansas Children's Research Institute	The authors thank the individuals who participated in the Autism Genetic Resource Exchange and Coriell Cell Repository. Support for this study was provided the Arkansas Biosciences Institute (Little Rock, AR, USA), the Jane Botsford Johnson Foundation (New York, NY, USA), and Arkansas Children's Research Institute. The authors declare no conflicts of interest.	Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Dengjel J, 2017, CELL TISSUE RES, V367, P95, DOI 10.1007/s00441-016-2472-0; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Frye RE, 2012, N AM J MED SCI, V5, P141; Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Han CY, 2016, ARCH PHARM RES, V39, P1062, DOI 10.1007/s12272-016-0812-y; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136	24	39	39	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					904	909		10.1096/fj.201601004R	http://dx.doi.org/10.1096/fj.201601004R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27864377	Green Published, hybrid			2022-12-26	WOS:000395671200007
J	Aguer, C; Piccolo, BD; Fiehn, O; Adams, SH; Harper, ME				Aguer, Celine; Piccolo, Brian D.; Fiehn, Oliver; Adams, Sean H.; Harper, Mary-Ellen			A novel amino acid and metabolomics signature in mice overexpressing muscle uncoupling protein 3	FASEB JOURNAL			English	Article						mitochondria; bioenergetics; UCP3; glutathione; redox	OXYGEN SPECIES PRODUCTION; SKELETAL-MUSCLE; UCP3 OVEREXPRESSION; MITOCHONDRIAL ROS; INCREASES; TISSUE	Uncoupling protein 3 (UCP3) is highly selectively expressed in skeletal muscle and is known to lower mitochondrial reactive oxygen species and promote fatty acid oxidation; however, the global impact of UCP3 activity on skeletal muscle and whole-body metabolism have not been extensively studied. We utilized untargeted metabolomics to identify novel metabolites that distinguish mice overexpressing UCP3 in muscle, both at rest and after exercise regimens that challenged muscle metabolism, to potentially unmask subtle phenotypes. Male wild-type (WT) and muscle-specific UCP3-overexpressing transgenic (UCP3 Tg) C57BL/6J mice were compared with or without a 5 wk endurance training protocol at rest or after an acute exercise bout (EB). Skeletal muscle, liver, and plasma samples were analyzed by gas chromatography time-of-flight mass spectrometry. Discriminant metabolites were considered if within the top 99th percentile of variable importance measurements obtained from partial least-squares discriminant analysis models. A total of 80 metabolites accurately discriminated UCP3 Tg mice from WT when modeled within a specific exercise condition (i.e., untrained/rested, endurance trained/rested, untrained/EB, and endurance trained/EB). Results revealed that several amino acids and amino acid derivatives in skeletal muscle and plasma of UCP3 Tg mice (e.g., Asp, Glu, Lys, Tyr, Ser, Met) were significantly reduced after an EB; that metabolites associated with skeletal muscle glutathione/Met/Cys metabolism (2-hydroxybutanoic acid, oxoproline, Gly, and Glu) were altered in UCP3 Tg mice across all training and exercise conditions; and that muscle metabolite indices of dehydrogenase activity were increased in UCP3 Tg mice, suggestive of a shift in tissue NADH/NAD(+) ratio. The results indicate that mitochondrial UCP3 activity affects metabolism well beyond fatty acid oxidation, regulating biochemical pathways associated with amino acid metabolism and redox status. That select metabolites were altered in liver of UCP3 Tg mice highlights that changes in muscle UCP3 activity can also affect other organ systems, presumably through changes in systemic metabolite trafficking.	[Aguer, Celine; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Harper, Mary-Ellen] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Aguer, Celine] Inst Rech Hop Montfort, Ottawa, ON, Canada; [Piccolo, Brian D.; Adams, Sean H.] Arkansas Childrens Nutr Ctr, Little Rock, AR USA; [Piccolo, Brian D.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Fiehn, Oliver] Univ Calif Davis, Genome Ctr, West Coast Metabol Ctr, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Dept Biochem, Jeddah, Saudi Arabia	University of Ottawa; University of Ottawa; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Davis; King Abdulaziz University	Adams, SH (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Dept Pediat, Little Rock, AR 72205 USA.; Harper, ME (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	shadams@uams.edu; mharper@uottawa.ca	Aguer, Celine/U-7848-2019; ADAMS, SEAN/N-9262-2018	Aguer, Celine/0000-0001-8828-8472; ADAMS, SEAN/0000-0002-9515-2319	Canadian Institutes of Health Research [FDN 143278]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK078328-01]; U.S. Department of Agriculture, Agricultural Research Service [5306-51530-019-00, 6026-51000-010-5S]; Heart and Stroke Foundation of Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER; ARS [ARS-0426492] Funding Source: Federal RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Heart and Stroke Foundation of Canada Postdoctoral Fellowship(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors acknowledge financial support from the Canadian Institutes of Health Research (FDN 143278; to M.E.H.), U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK078328-01 (to S.H.A., M.E.H., and O.F.), U.S. Department of Agriculture, Agricultural Research Service Intramural Projects 5306-51530-019-00 and 6026-51000-010-5S (to S.H.A.), and a Heart and Stroke Foundation of Canada Postdoctoral Fellowship (to C.A.). The authors thank M. Salkhordeh, J. Xuan, A. Daniels, M. Dysart, K. Kim (all from the University of Ottawa) and, M. Palazoglu, M. Atta, K. Cloos, and W. Tan (all from UC Davis) for technical assistance.	Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4; Lex A, 2014, NAT METHODS, V11, P779, DOI 10.1038/nmeth.3033; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; Mailloux RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393538; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Makinen KK, 2000, MED HYPOTHESES, V54, P603, DOI 10.1054/mehy.1999.0904; Mills EM, 2004, J MOL MED, V82, P787, DOI 10.1007/s00109-004-0591-7; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; Nabben M, 2011, FEBS LETT, V585, P4010, DOI 10.1016/j.febslet.2011.11.012; Nabben M, 2008, FEBS LETT, V582, P4147, DOI 10.1016/j.febslet.2008.11.016; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; QUADFLIEG KH, 1976, Z ERNAHRUNGSWISS, V15, P345, DOI 10.1007/BF02020503; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	37	10	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					814	827		10.1096/fj.201600914R	http://dx.doi.org/10.1096/fj.201600914R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871066	Green Published			2022-12-26	WOS:000394235400033
J	Chandrasekar, S; Sweredoski, MJ; Sohn, CH; Hess, S; Shan, SO				Chandrasekar, Sowmya; Sweredoski, Michael J.; Sohn, Chang Ho; Hess, Sonja; Shan, Shu-ou			Co-evolution of Two GTPases Enables Efficient Protein Targeting in an RNA-less Chloroplast Signal Recognition Particle Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRP RNA; TRANSLATING RIBOSOME; SUBUNIT; RECEPTOR; ACTIVATION; SEQUENCE; MECHANISM; COMPLEX; DOMAIN; REQUIREMENT	The signal recognition particle (SRP) is an essential ribonucleoprotein particle that mediates the co-translational targeting of newly synthesized proteins to cellular membranes. The SRP RNA is a universally conserved component of SRP that mediates key interactions between two GTPases in SRP and its receptor, thus enabling rapid delivery of cargo to the target membrane. Notably, this essential RNA is bypassed in the chloroplast (cp) SRP of green plants. Previously, we showed that the cpSRP and cpSRP receptor GTPases (cpSRP54 and cpFtsY, respectively) interact efficiently by themselves without the SRP RNA. Here, we explore the molecular mechanism by which this is accomplished. Fluorescence analyses showed that, in the absence of SRP RNA, the M-domain of cpSRP54 both accelerates and stabilizes complex assembly between cpSRP54 and cpFtsY. Crosslinking coupled with mass spectrometry and mutational analyses identified a new interaction between complementarily charged residues on the cpFtsY G-domain and the vicinity of the cpSRP54 M-domain. These residues are specifically conserved in plastids, and their evolution coincides with the loss of SRP RNA in green plants. These results provide an example of how proteins replace the functions of RNA during evolution.	[Chandrasekar, Sowmya; Sohn, Chang Ho; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Beckman Inst, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Hess, Sonja] CALTECH, Beckman Inst, Div Biol & Biol Engn, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Beckman Inst, Pasadena, CA 91125 USA.	sshan@caltech.edu	Sohn, Chang Ho/D-9492-2015		Beckman Institute; Gordon and Betty Moore Foundation [GBMF775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114390] Funding Source: NIH RePORTER	Beckman Institute; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jesse Beauchamp for helpful discussions on the cross-linking and mass spectrometry experiments; members of the Proteome Exploration Laboratory for help with mass spectrometry experiments and analyses; the Guttman laboratory for help with phylogenic analysis, and members of the Shan laboratory for comments on the manuscript. The Proteome Exploration Laboratory was supported by the Beckman Institute and the Gordon and Betty Moore Foundation through Grant GBMF775.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; CLINE K, 1986, J BIOL CHEM, V261, P4804; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dunschede B, 2015, J BIOL CHEM, V290, P13104, DOI 10.1074/jbc.M114.597922; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eichacker LA, 2001, BBA-MOL CELL RES, V1541, P120, DOI 10.1016/S0167-4889(01)00151-3; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Nguyen TX, 2011, BIOCHEMISTRY-US, V50, P7208, DOI 10.1021/bi200742a; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Richter CV, 2008, FEBS LETT, V582, P3223, DOI 10.1016/j.febslet.2008.08.014; Rosenblad MA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26848; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shen K, 2013, J BIOL CHEM, V288, P36385, DOI 10.1074/jbc.M113.513614; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Sohn CH, 2012, ANAL CHEM, V84, P2662, DOI 10.1021/ac202637n; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wild K, 2016, J MOL BIOL, V428, P2880, DOI 10.1016/j.jmb.2016.05.015; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; ZOPF D, 1993, J CELL BIOL, V120, P1113, DOI 10.1083/jcb.120.5.1113; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	47	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					386	396		10.1074/jbc.M116.752931	http://dx.doi.org/10.1074/jbc.M116.752931			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895118	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000391578000033
J	Girard, BJ; Knutson, TP; Kuker, B; McDowell, L; Schwertfeger, KL; Ostrander, JH				Girard, Brian J.; Knutson, Todd P.; Kuker, Bethanie; McDowell, Laura; Schwertfeger, Kathryn L.; Ostrander, Julie H.			Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of kappa B Kinase epsilon and Inflammatory Cross-talk with Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MOUSE MODEL; CANCER; IKK; PROGRESSION; CYTOKINES; GROWTH; PHOSPHORYLATION; PROLIFERATION; COREGULATOR	Cytoplasmic localization of proline, glutamic acid, leucine-rich protein 1 (PELP1) is observed in similar to 40% of women with invasive breast cancer. In mouse models, PELP1 overexpression in the mammary gland leads to premalignant lesions and eventually mammary tumors. In preliminary clinical studies, cytoplasmic localization of PELP1 was seen in 36% of women at high risk of developing breast cancer. Here, we investigated whether cytoplasmic PELP1 signaling promotes breast cancer initiation in models of immortalized human mammary epithelial cells (HMECs). Global gene expression analysis was performed on HMEC lines expressing vector control, PELP1-wt, or mutant PELP1 in which the nuclear localization sequence was altered, resulting in cytoplasmic localization of PELP1 (PELP1-cyto). Global gene expression analysis identified that PELP1-cyto expression in HMECs induced NF-kappa B signaling pathways. Western blotting analysis of PELP1-cyto HMECs showed up-regulation of inhibitor of kappa B kinase epsilon (IKK epsilon) and increased phosphorylation of the NF-kappa B subunit RelB. To determine whether secreted factors produced by PELP1-cyto HMECs promote macrophage activation, THP-1 macrophages were treated with HMEC-conditioned medium (CM). PELP1-cyto CM induced changes in THP-1 gene expression as compared with control cell CM. Double conditioned medium (DCM) from the activated THP-1 cells was then applied to HMECs to determine whether paracrine signaling from PELP1-cyto-activated macrophages could in turn promote migration of HMECs. PELP1-cyto DCM induced robust HMEC migration, which was reduced in DCM from PELP1-cyto HMECs expressing IKK epsilon shRNA. Our findings suggest that cytoplasmic localization of PELP1 up-regulates pro-tumorigenic IKK epsilon and secreted inflammatory signals, which through paracrine macrophage activation regulates the migratory phenotype associated with breast cancer initiation.	[Girard, Brian J.; Knutson, Todd P.; Kuker, Bethanie; McDowell, Laura; Schwertfeger, Kathryn L.; Ostrander, Julie H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Ostrander, Julie H.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ostrander, JH (corresponding author), Univ Minnesota, Canc Cardiol Res Bldg,MMC 2812A,2231 6th St SE, Minneapolis, MN 55455 USA.	hans1354@umn.edu	Knutson, Todd P/H-8304-2012		National Institutes of Health [K07CA131501]; Institutional Research Grant from the American Cancer Society [124166-IRG-58-001-52-IRG5]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; Masonic Cancer Center, University of Minnesota; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA132827, K07CA131501] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000113, UL1TR000114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research Grant from the American Cancer Society; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Masonic Cancer Center, University of Minnesota(University of Minnesota System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by National Institutes of Health Grant K07CA131501, Institutional Research Grant 124166-IRG-58-001-52-IRG5 from the American Cancer Society, National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1TR000114, and funds from the Masonic Cancer Center, University of Minnesota (to J. H. O.). J. H. O. received support from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bohrer LR, 2012, MOL CANCER RES, V10, P1294, DOI 10.1158/1541-7786.MCR-12-0275; Chakravarty D, 2011, CLIN CANCER RES, V17, P2250, DOI 10.1158/1078-0432.CCR-10-2718; Chakravarty D, 2010, CANCER RES, V70, P4092, DOI 10.1158/0008-5472.CAN-09-3834; Cortez V, 2014, CANCER RES, V74, P7395, DOI 10.1158/0008-5472.CAN-14-0993; Cortez V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3229; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davidson NE, 2015, JAMA-J AM MED ASSOC, V313, P1109, DOI 10.1001/jama.2015.1945; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Degnim AC, 2007, J CLIN ONCOL, V25, P2671, DOI 10.1200/JCO.2006.09.0217; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girard BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121206; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Hartmann LC, 2015, NEW ENGL J MED, V372, P1271, DOI 10.1056/NEJMc1501046; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hussein MR, 2006, J CLIN PATHOL, V59, P972, DOI 10.1136/jcp.2005.031252; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Jiang Zhe, 2014, Oncoscience, V1, P180; Kendellen MF, 2014, ONCOGENE, V33, P1297, DOI 10.1038/onc.2013.64; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Leek RD, 1996, CANCER RES, V56, P4625; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mann M, 2013, CARCINOGENESIS, V34, P1468, DOI 10.1093/carcin/bgt091; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marsigliante S, 2016, MOL CARCINOGEN, V55, P1175, DOI 10.1002/mc.22360; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nair SS, 2004, CANCER RES, V64, P6416, DOI 10.1158/0008-5472.CAN-04-1786; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Rajhans R, 2007, CANCER RES, V67, P5505, DOI 10.1158/0008-5472.CAN-06-3647; Rayala SK, 2006, MOL CANCER THER, V5, P230, DOI 10.1158/1535-7163.MCT-05-0276; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Roy S, 2012, MOL CANCER RES, V10, P25, DOI 10.1158/1541-7786.MCR-11-0456; Sareddy GR, 2015, P NATL ACAD SCI USA, V112, pE6673, DOI 10.1073/pnas.1516729112; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Shen RR, 2012, MOL CELL BIOL, V32, P4756, DOI 10.1128/MCB.00468-12; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449	58	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					339	350		10.1074/jbc.M116.739847	http://dx.doi.org/10.1074/jbc.M116.739847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881676	hybrid, Green Published			2022-12-26	WOS:000391578000029
J	El Hage, K; Pandyarajan, V; Phillips, NB; Smith, BJ; Menting, JG; Whittaker, J; Lawrence, MC; Meuwly, M; Weiss, MA				El Hage, Krystel; Pandyarajan, Vijay; Phillips, Nelson B.; Smith, Brian J.; Menting, John G.; Whittaker, Jonathan; Lawrence, Michael C.; Meuwly, Markus; Weiss, Michael A.			Extending Halogen-based Medicinal Chemistry to Proteins IODO-INSULIN AS A CASE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL AMINO-ACID; PARTICLE MESH EWALD; RECEPTOR-BINDING; LIGAND-BINDING; MOLECULAR-DYNAMICS; DIMERIC INSULIN; FORCE-FIELD; MODEL; SITE; MUTAGENESIS	Insulin, a protein critical for metabolic homeostasis, provides a classical model for protein design with application to human health. Recent efforts to improve its pharmaceutical formulation demonstrated that iodination of a conserved tyrosine (Tyr(B26)) enhances key properties of a rapid-acting clinical analog. Moreover, the broad utility of halogens in medicinal chemistry has motivated the use of hybrid quantum-and molecular-mechanical methods to study proteins. Here, we (i) undertook quantitative atomistic simulations of 3-[iodo-Tyr(B26)] insulin to predict its structural features, and (ii) tested these predictions by X-ray crystallography. Using an electrostatic model of the modified aromatic ring based on quantum chemistry, the calculations suggested that the analog, as a dimer and hexamer, exhibits subtle differences in aromatic-aromatic interactions at the dimer interface. Aromatic rings (Tyr(B16), Phe(B24), Phe(B25), 3-I-Tyr(B26), and their symmetry-related mates) at this interface adjust to enable packing of the hydrophobic iodine atoms within the core of each monomer. Strikingly, these features were observed in the crystal structure of a 3-[iodo-Tyr(B26)] insulin analog (determined as an R-6 zinc hexamer). Given that residues B24-B30 detach from the core on receptor binding, the environment of 3-I-Tyr(B26) in a receptor complex must differ from that in the free hormone. Based on the recent structure of a "micro-receptor" complex, we predict that 3-I-Tyr(B26) engages the receptor via directional halogen bonding and halogen-directed hydrogen bonding as follows: favorable electrostatic interactions exploiting, respectively, the halogen's electron-deficient sigma-hole and electronegative equatorial band. Inspired by quantum chemistry and molecular dynamics, such "halogen engineering" promises to extend principles of medicinal chemistry to proteins.	[El Hage, Krystel; Meuwly, Markus] Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland; [Pandyarajan, Vijay; Phillips, Nelson B.; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Menting, John G.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Basel; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Meuwly, M (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.; Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.; Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	m.meuwly@unibas.ch; michael.weiss@case.edu	Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009	Smith, Brian J/0000-0003-0498-1910; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801; El Hage, Krystel/0000-0003-4837-3888; Pandyarajan, Vijay/0000-0002-8835-5601	National Institutes of Health from NIDDK [R01 DK04949 and DK079233]; Swiss National Science Foundation [200021-117810]; National Competence Center for Research Molecular and Ultrafast Science and Technology (CCR MUST); Australian National Health and Medical Research Council [1005896, 1058233]; Hazel and Pip Appel Fund; Sanofi (Germany); NCCR MUST through the Swiss National Science Foundation; Case Western Reserve University Medical Scientist Training Program by National Institutes of Heath Institutional Grant [T32 GM007250]; National Institutes of Health [F30 DK094685-04]; American Diabetes Association; National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant [361646]; Victorian State Government Operational Infrastructure Support Grant; NCCR MUST; University of Basel; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094685, R01DK079233, R01DK040949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center for Research Molecular and Ultrafast Science and Technology (CCR MUST); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; Sanofi (Germany)(Sanofi-Aventis); NCCR MUST through the Swiss National Science Foundation; Case Western Reserve University Medical Scientist Training Program by National Institutes of Heath Institutional Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant; Victorian State Government Operational Infrastructure Support Grant; NCCR MUST; University of Basel; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 DK04949 and DK079233 from NIDDK (to M. A. W.), Swiss National Science Foundation Grant 200021-117810, National Competence Center for Research Molecular and Ultrafast Science and Technology (CCR MUST) (to M. M.), Australian National Health and Medical Research Council Project Grants 1005896 and 1058233, and the Hazel and Pip Appel Fund (to M. C. L.). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Scientific Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research and Development Corp. N. B. P. and J. W. are consultants to Thermalin Diabetes, LLC. Part of M. C. L.'s research is funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the NCCR MUST through the Swiss National Science Foundation.r Supported by a predoctoral fellowship of the Case Western Reserve University Medical Scientist Training Program supported by National Institutes of Heath Institutional Grant T32 GM007250 and National Institutes of Health Fellowship F30 DK094685-04.r Supported in part by the American Diabetes Association.r Recipient of National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute).r Supported by the NCCR MUST and the University of Basel.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; BADER RFW, 1987, J AM CHEM SOC, V109, P7968, DOI 10.1021/ja00260a006; BADGER J, 1991, ACTA CRYSTALLOGR B, V47, P127, DOI 10.1107/S0108768190009570; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bereau T, 2013, J CHEM THEORY COMPUT, V9, P5450, DOI 10.1021/ct400803f; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjorn LO, 2010, INTEGR COMP BIOL, V50, P138, DOI 10.1093/icb/icq017; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BURANT CF, 1988, BIOCHEM BIOPH RES CO, V152, P1353, DOI 10.1016/S0006-291X(88)80434-0; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; Chatterjee A, 2012, P NATL ACAD SCI USA, V109, P14841, DOI 10.1073/pnas.1212454109; Clark T, 2007, J MOL MODEL, V13, P291, DOI 10.1007/s00894-006-0130-2; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Dennington R., 2016, GAUSSVIEW VERSION 6; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DODSON GG, 1993, BIOCHEM SOC T, V21, P609, DOI 10.1042/bst0210609; El Hage K, 2016, J CHEM THEORY COMPUT, V12, P3008, DOI 10.1021/acs.jctc.6b00202; El Hage K, 2015, J COMPUT CHEM, V36, P210, DOI 10.1002/jcc.23786; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falconi M, 2001, J BIOMOL STRUCT DYN, V18, P761, DOI 10.1080/07391102.2001.10506705; Feller D, 1996, J COMPUT CHEM, V17, P1571, DOI 10.1002/jcc.9; FRANK BH, 1983, DIABETES, V32, P705, DOI 10.2337/diab.32.8.705; Frisch G. W., 2013, GAUSSIAN 09; GURSKY O, 1992, BIOPHYS J, V63, P1210, DOI 10.1016/S0006-3495(92)81697-1; HAMLIN JL, 1974, J BIOL CHEM, V249, P21; Hedin F, 2016, J CHEM INF MODEL, V56, P1479, DOI 10.1021/acs.jcim.6b00280; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jorgensen WL, 2012, J CHEM THEORY COMPUT, V8, P3895, DOI 10.1021/ct300180w; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kolar M, 2014, PHYS CHEM CHEM PHYS, V16, P9987, DOI 10.1039/c3cp55188a; Kramer C, 2013, J CHEM INF MODEL, V53, P3410, DOI 10.1021/ci400548w; Kristensen C, 2002, J BIOL CHEM, V277, P18340, DOI 10.1074/jbc.M112249200; KRISTENSEN SM, 1991, J MOL BIOL, V218, P221, DOI 10.1016/0022-2836(91)90886-B; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; Kupper FC, 2011, ANGEW CHEM INT EDIT, V50, P11598, DOI 10.1002/anie.201100028; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; LINDE S, 1981, H-S Z PHYSIOL CHEM, V362, P573, DOI 10.1515/bchm2.1981.362.1.573; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lommerse JPM, 1996, J AM CHEM SOC, V118, P3108, DOI 10.1021/ja953281x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARK AE, 1991, BIOCHEMISTRY-US, V30, P10866, DOI 10.1021/bi00109a009; Matter H, 2009, ANGEW CHEM INT EDIT, V48, P2911, DOI 10.1002/anie.200806219; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pace CN, 2000, PROTEINS, P1; Pandyarajan V, 2012, CURR DIABETES REP, V12, P697, DOI 10.1007/s11892-012-0318-z; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; PEAVY DE, 1984, ENDOCRINOLOGY, V114, P1818, DOI 10.1210/endo-114-5-1818; Peterson KA, 2006, J PHYS CHEM A, V110, P13877, DOI 10.1021/jp065887l; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Politzer P, 2013, PHYS CHEM CHEM PHYS, V15, P11178, DOI 10.1039/c3cp00054k; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Poznanski J, 2016, ACTA BIOCHIM POL, V63, P203, DOI 10.18388/abp.2015_1106; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Riley KE, 2013, ACCOUNTS CHEM RES, V46, P927, DOI 10.1021/ar300083h; Sandler B, 2004, J BIOL CHEM, V279, P55801, DOI 10.1074/jbc.M410124200; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Swallow S., 2012, FLUORINE PHARM MED C, P34; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	112	22	22	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27023	27041		10.1074/jbc.M116.761015	http://dx.doi.org/10.1074/jbc.M116.761015			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875310	Green Published, hybrid			2022-12-26	WOS:000391576300006
J	Parag-Sharma, K; Leyme, A; DiGiacomo, V; Marivin, A; Broselid, S; Garcia-Marcos, M				Parag-Sharma, Kshitij; Leyme, Anthony; DiGiacomo, Vincent; Marivin, Arthur; Broselid, Stefan; Garcia-Marcos, Mikel			Membrane Recruitment of the Non-receptor Protein GIV/Girdin (G alpha-interacting, Vesicle-associated Protein/Girdin) Is Sufficient for Activating Heterotrimeric G Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GROWTH-FACTOR RECEPTORS; CELL-MIGRATION; COUPLED RECEPTORS; TUMOR PROGRESSION; BREAST-CANCER; HUMAN-DISEASE; LIPID RAFTS; GIRDIN; GIV	GIV (aka Girdin) is a guanine nucleotide exchange factor that activates heterotrimeric G protein signaling downstream of RTKs and integrins, thereby serving as a platform for signaling cascade cross-talk. GIV is recruited to the cytoplasmic tail of receptors upon stimulation, but the mechanism of activation of its G protein regulatory function is not well understood. Here we used assays in humanized yeast models and G protein activity biosensors in mammalian cells to investigate the role of GIV subcellular compartmentalization in regulating its ability to promote G protein signaling. We found that in unstimulated cells GIV does not co-fractionate with its substrate G protein G alpha(i3) on cell membranes and that constitutive membrane anchoring of GIV in yeast cells or rapid membrane translocation in mammalian cells via chemically induced dimerization leads to robust G protein activation. We show that membrane recruitment of the GIV "G alpha binding and activating" motif alone is sufficient for G protein activation and that it does not require phosphomodification. Furthermore, we engineered a synthetic protein to show that recruitment of the GIV "G alpha binding and activating" motif to membranes via association with active RTKs, instead of via chemically induced dimerization, is also sufficient for G protein activation. These results reveal that recruitment of GIV to membranes in close proximity to its substrate G protein is a major mechanism responsible for the activation of its G protein regulatory function.	[Parag-Sharma, Kshitij; Leyme, Anthony; DiGiacomo, Vincent; Marivin, Arthur; Broselid, Stefan; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208, Boston, MA 02118 USA.	mgm1@bu.edu		Parag-Sharma, Kshitij/0000-0003-3638-0941	National Institutes of Health [R01GM108733, R01GM112631]; American Cancer Society [RSG-13-362-01-TBE]; Karin Grunebaum Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108733, R01GM112631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Karin Grunebaum Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM108733 and R01GM112631, American Cancer Society Grant RSG-13-362-01-TBE, and funds from the Karin Grunebaum Research Foundation (to M. G.-M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; Bhandari D, 2015, P NATL ACAD SCI USA, V112, pE4874, DOI 10.1073/pnas.1514157112; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Findlay GM, 2008, NAT STRUCT MOL BIOL, V15, P538, DOI 10.1038/nsmb0608-538; Garcia-Marcos M, 2006, BBA-BIOMEMBRANES, V1758, P796, DOI 10.1016/j.bbamem.2006.05.008; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Gupta V, 2016, P NATL ACAD SCI USA, V113, pE5721, DOI 10.1073/pnas.1609502113; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hartung A, 2013, BBA-MOL CELL RES, V1833, P2803, DOI 10.1016/j.bbamcr.2013.07.012; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jun BY, 2013, DIS COLON RECTUM, V56, P51, DOI 10.1097/DCR.0b013e31826b9b7e; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Leyme A, 2016, J BIOL CHEM, V291, P8269, DOI 10.1074/jbc.M115.691550; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; LIANG M, 1991, J BIOL CHEM, V266, P13342; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Liu C, 2012, MOL BIOL REP, V39, P8717, DOI 10.1007/s11033-012-1731-8; Lo IC, 2015, DEV CELL, V33, P189, DOI 10.1016/j.devcel.2015.02.009; Lopez-Sanchez I, 2015, MOL BIOL CELL, V26, P4313, DOI 10.1091/mbc.E15-07-0496; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Ma GS, 2015, MOL BIOL CELL, V26, P4209, DOI 10.1091/mbc.E15-08-0553; Ma GS, 2015, P NATL ACAD SCI USA, V112, pE2602, DOI 10.1073/pnas.1505543112; Mao JZ, 2012, CANCER SCI, V103, P1780, DOI 10.1111/j.1349-7006.2012.02378.x; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Marty C, 2010, MOL PHARMACOL, V78, P12, DOI 10.1124/mol.110.063453; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; Muntean BS, 2016, J BIOL CHEM, V291, P7195, DOI 10.1074/jbc.M115.713446; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; Sasaki K, 2015, J CELL SCI, V128, P2244, DOI 10.1242/jcs.160879; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Song XS, 2001, J BIOL CHEM, V276, P34651, DOI 10.1074/jbc.M105894200; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Wang HH, 2015, J AM SOC NEPHROL, V26, P314, DOI 10.1681/ASN.2013090985; Weng L, 2014, EMBO J, V33, P2098, DOI 10.15252/embj.201488289	70	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27098	27111		10.1074/jbc.M116.764431	http://dx.doi.org/10.1074/jbc.M116.764431			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864364	hybrid, Green Published			2022-12-26	WOS:000391576300011
J	Johnson, ZI; Shapiro, IM; Risbud, MV				Johnson, Zariel I.; Shapiro, Irving M.; Risbud, Makarand V.			RNA Sequencing Reveals a Role of TonEBP Transcription Factor in Regulation of Pro-inflammatory Genes in Response to Hyperosmolarity in Healthy Nucleus Pulposus Cells A HOMEOSTATIC RESPONSE?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERVERTEBRAL DISC; OSMOTIC-STRESS; DNA-BINDING; EXPRESSION; NFAT5; HYPERTONICITY; INDUCTION; CYTOKINE; SURVIVAL; LIPOPOLYSACCHARIDE	Transcription factor tonicity-responsive enhancer-binding protein (TonEBP/NFAT5) is critical for osmo-adaptation and extracellular matrix homeostasis of nucleus pulposus (NP) cells in their hypertonic tissue niche. Recent studies implicate TonEBP signaling in inflammatory disease and rheumatoid arthritis pathogenesis. However, broader functions of TonEBP in the disc remain unknown. RNA sequencing was performed on NP cells with TonEBP knockdown under hypertonic conditions. 1140 TonEBP-dependent genes were identified and categorized using Ingenuity Pathway Analysis. Bioinformatic analysis showed enrichment of matrix homeostasis and cytokine/chemokine signaling pathways. C-C motif chemokine ligand 2 (CCL2), interleukin 6 (IL6), tumor necrosis factor (TNF), and nitric oxide synthase 2 (NOS2) were studied further. Knockdown experiments showed that TonEBP was necessary to maintain expression levels of these genes. Gain-and loss-of-function experiments and site-directed mutagenesis demonstrated that TonEBP binding to a specific site in the CCL2 promoter is required for hypertonic inducibility. Despite inhibition by dominant-negative TonEBP, IL6 and NOS2 promoters were not hypertonicity-inducible. Whole-disc response to hypertonicity was studied in an ex vivo organ culture model, using wild-type and haploinsufficient TonEBP mice. Pro-inflammatory targets were induced by hypertonicity in discs from wild-type but not TonEBP-haploinsufficient mice. Mechanistically, NF-kappa B activity increased with hypertonicity and was necessary for hypertonic induction of target genes IL6, TNF, and NOS2 but not CCL2. Although TonEBP maintains transcription of genes traditionally considered pro-inflammatory, it is important to note that some of these genes also serve anabolic and pro-survival roles. Therefore, in NP cells, this phenomenon may reflect a physiological adaptation to diurnal osmotic loading of the intervertebral disc.	[Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511,Coll Bldg, Philadelphia, PA 19107 USA; [Johnson, Zariel I.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511,Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR055655, AR064733, T32 AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR052273, R01AR064733, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR055655 and AR064733 (to M. V. R.) and by National Institutes of Health Grant T32 AR052273 (to I. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altun I, 2016, SPINE J, V16, P857, DOI 10.1016/j.spinee.2016.03.019; Borthakur A, 2011, SPINE, V36, P2190, DOI 10.1097/BRS.0b013e31820287bf; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Chen QC, 2015, MOL MED REP, V12, P219, DOI 10.3892/mmr.2015.3375; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Do Lee S, 2011, AM J PHYSIOL-RENAL, V300, pF707, DOI 10.1152/ajprenal.00227.2010; Dudek M, 2017, ANN RHEUM DIS, V76, P576, DOI 10.1136/annrheumdis-2016-209428; Esensten JH, 2005, NUCLEIC ACIDS RES, V33, P3845, DOI 10.1093/nar/gki701; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Gajghate S, 2009, J BONE MINER RES, V24, P992, DOI [10.1359/JBMR.090103, 10.1359/jbmr.090103]; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Hiyama A, 2009, J BIOL CHEM, V284, P9824, DOI 10.1074/jbc.M807081200; Hollborn M, 2015, MOL VIS, V21, P360; Huang WF, 2011, NUCLEIC ACIDS RES, V39, P475, DOI 10.1093/nar/gkq818; Inoue N, 2011, ORTHOP CLIN N AM, V42, P487, DOI 10.1016/j.ocl.2011.07.001; Ji WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088952; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kim NH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.61; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lee HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24921; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Matsumura Y, 2009, J ORTHOP SCI, V14, P45, DOI 10.1007/s00776-008-1288-5; Phillips KLE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4408; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; SATOMI K, 1992, SPINE, V17, P1329, DOI 10.1097/00007632-199211000-00012; Schleich C, 2015, J MAGN RESON IMAGING, V42, P1057, DOI 10.1002/jmri.24877; Suyama K, 2016, ONCOTARGET, V7, P23056, DOI 10.18632/oncotarget.8521; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; Ueno M, 2013, J LIPID RES, V54, P734, DOI 10.1194/jlr.M033365; van der Windt AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3031; Watanabe Takuya, 2005, Kurume Medical Journal, V52, P39, DOI 10.2739/kurumemedj.52.39; Wright FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114129; Zenker S, 2014, J IMMUNOL, V192, P2830, DOI 10.4049/jimmunol.1300157	47	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26686	26697		10.1074/jbc.M116.757732	http://dx.doi.org/10.1074/jbc.M116.757732			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875309	Green Published, hybrid			2022-12-26	WOS:000391571400009
J	Briceno, O; Pinto-Cardoso, S; Rodriguez-Bernabe, N; Murakami-Ogasawara, A; Reyes-Teran, G				Briceno, Olivia; Pinto-Cardoso, Sandra; Rodriguez-Bernabe, Nataly; Murakami-Ogasawara, Akio; Reyes-Teran, Gustavo			Gut Homing CD4+and CD8+T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment	PLoS One			English	Article							CD8(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; MUCOSAL IMMUNE RECONSTITUTION; HUMAN TH17 CELLS; INTEGRIN ALPHA(4)BETA(7); GASTROINTESTINAL-TRACT; TYPE-1 INFECTION; ACTIVATION; DEPLETION; SUBSET	The depletion of mucosal CD4+ T-cells occurs early in HIV infection and despite years on antiretroviral treatment (ART), this population never reconstitutes to pre-HIV infection levels. In an effort to understand the effect of ART initiation and different ART regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue (GALT), we quantified the frequency of CD4+ and CD8+ T cells expressing the gut homing receptors CCR9 and eta 7 in peripheral blood (PB) of HIV infected individuals naive to ART and treated individuals on both short-term (less than a year) and long-term ART (more than 2 years). We found that the gut homing CD4+ T cells were depleted in ART-naive individuals and increased after ART initiation but levels were not comparable to HIV uninfected individuals. Gut homing CD4+ T cell activation decreased after ART initiation whilst gut homing CD8+ T cell activation remained elevated in ART experienced individuals, especially in those individuals taking protease inhibitors. Our findings provide new insights into the effects of ART initiation and ART regimens on the frequency and immune status of gut homing CD4+ and CD8+ T cells.	[Briceno, Olivia; Pinto-Cardoso, Sandra; Rodriguez-Bernabe, Nataly; Murakami-Ogasawara, Akio; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico		Pinto-Cardoso, S; Reyes-Teran, G (corresponding author), Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	sandra.pinto@cieni.org.mx; gustavo.reyesteran@gmail.com		Reyes-Teran, Gustavo/0000-0002-4115-4888	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana)	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana)	This work was supported by grants from the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI and Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Ciccone EJ, 2011, J VIROL, V85, P5880, DOI 10.1128/JVI.02643-10; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Greathead L, 2014, AIDS, V28, P1690, DOI 10.1097/QAD.0000000000000351; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Peng QL, 2013, JAIDS-J ACQ IMM DEF, V64, P25, DOI 10.1097/QAI.0b013e318293a114; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166496	10.1371/journal.pone.0166496	http://dx.doi.org/10.1371/journal.pone.0166496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898686	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000009
J	Noinarin, P; Chareonsudjai, P; Wangsomnuk, P; Wongratanacheewin, S; Chareonsudjai, S				Noinarin, Parumon; Chareonsudjai, Pisit; Wangsomnuk, Pinich; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri			Environmental Free-Living Amoebae Isolated from Soil in Khon Kaen, Thailand, Antagonize Burkholderia pseudomallei	PLOS ONE			English	Article							LONG-TERM SURVIVAL; ACANTHAMOEBA-CASTELLANII; LEGIONELLA-PNEUMOPHILA; LISTERIA-MONOCYTOGENES; BACTERIAL PATHOGENS; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; WATER AMEBAS; MELIOIDOSIS; POLYPHAGA	Presence of Burkholderia pseudomallei in soil and water is correlated with endemicity of melioidosis in Southeast Asia and northern Australia. Several biological and physicochemical factors have been shown to influence persistence of B. pseudomallei in the environment of endemic areas. This study was the first to evaluate the interaction of B. pseudomallei with soil amoebae isolated from B. pseudomallei-positive soil site in Khon Kaen, Thailand. Four species of amoebae, Paravahlkampfia ustiana, Acanthamoeba sp., Naegleria pagei, and isolate A-ST39-E1, were isolated, cultured and identified based on morphology, movement and 18S rRNA gene sequence. Co-cultivation combined with a kanamycin-protection assay of B. pseudomallei with these amoebae at MOI 20 at 30 degrees C were evaluated during 0-6 h using the plate count technique on Ashdown's agar. The fate of intracellular B. pseudomallei in these amoebae was also monitored by confocal laser scanning microscopy (CLSM) observation of the CellTracker (TM) Orange-B. pseudomallei stained cells. The results demonstrated the ability of P. ustiana, Acanthamoeba sp. and isolate A-ST39-E1 to graze B. pseudomallei. However, the number of internalized B. pseudomallei substantially decreased and the bacterial cells disappeared during the observation period, suggesting they had been digested. We found that B. pseudomallei promoted the growth of Acanthamoeba sp. and isolate A-ST39-E1 in co-cultures at MOI 100 at 30 degrees C, 24 h. These findings indicated that P. ustiana, Acanthamoeba sp. and isolate A-ST39-E1 may prey upon B. pseudomallei rather than representing potential environmental reservoirs in which the bacteria can persist.	[Noinarin, Parumon; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Chareonsudjai, Pisit] Khon Kaen Univ, Dept Environm Sci, Fac Sci, Khon Kaen, Thailand; [Wangsomnuk, Pinich] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand; [Noinarin, Parumon; Chareonsudjai, Pisit; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Chareonsudjai, Pisit; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chareonsudjai, S (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand.	sorujsr@kku.ac.th	Chareonsudjai, Pisit/AAC-5390-2021; Chareonsudjai, Pisit/AAC-6695-2021; Chareonsudjai, Sorujsiri/AFM-5607-2022	Chareonsudjai, Pisit/0000-0002-3717-5889; Chareonsudjai, Pisit/0000-0002-3717-5889; Chareonsudjai, Sorujsiri/0000-0001-7176-2924	Office of the Higher Education Commission, Thailand; CHE Ph.D. Scholarship The Office of the Higher Education Commission, Thailand	Office of the Higher Education Commission, Thailand; CHE Ph.D. Scholarship The Office of the Higher Education Commission, Thailand	This work was supported by the Office of the Higher Education Commission, Thailand. Parumon Noinarin was supported by CHE Ph.D. Scholarship The Office of the Higher Education Commission, Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Office of the Higher Education Commission. Parumon Noinarin was supported by CHE Ph.D. Scholarship. We would like to acknowledge Prof. David Blair for editing the manuscript via the Publication Clinic of KKU, Thailand.	Abd H, 2005, ENVIRON MICROBIOL, V7, P1003, DOI 10.1111/j.1462-2920.2005.00771.x; Akya A, 2010, MICROBIOL-SGM, V156, P809, DOI 10.1099/mic.0.031146-0; [Anonymous], 1988, NEW KEY FRESHWATER S; BAMFORTH SS, 1995, METHODS APPL SOIL MI, P174; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Chekabab SM, 2012, MICROBIOLOGYOPEN, V1, P427, DOI 10.1002/mbo3.40; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Dey R, 2009, FEMS MICROBIOL LETT, V290, P10, DOI 10.1111/j.1574-6968.2008.01387.x; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Greub, 2004, J EUKARYOT MICROBIOL, V51, P509; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Inglis TJJ, 2000, INFECT IMMUN, V68, P1681, DOI 10.1128/IAI.68.3.1681-1686.2000; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kamjumphol W, 2015, AM J TROP MED HYG, V93, P1058, DOI 10.4269/ajtmh.15-0177; Levy A, 2003, APPL ENVIRON MICROB, V69, P6250, DOI 10.1128/AEM.69.10.6250-6256.2003; Lin HH, 2011, MICROBIOL IMMUNOL, V55, P616, DOI 10.1111/j.1348-0421.2011.00365.x; Liu XY, 2006, MICROB ECOL, V51, P315, DOI 10.1007/s00248-006-9031-2; Mardare C, 2013, J APPL MICROBIOL, V114, P1388, DOI 10.1111/jam.12166; Marshall K, 2010, SE ASIAN J TROP MED, V41, P904; Matin A, 2011, KOREAN J PARASITOL, V49, P349, DOI 10.3347/kjp.2011.49.4.349; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Michel R, 1997, ZBL BAKT-INT J MED M, V285, P541; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; POSTMA J, 1990, MICROB ECOL, V19, P149, DOI 10.1007/BF02012096; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Saeed A, 2009, ARCH MICROBIOL, V191, P83, DOI 10.1007/s00203-008-0422-2; Smith CD, 2012, CURR MICROBIOL, V65, P805, DOI 10.1007/s00284-012-0232-2; Suebrasri T., 2013, African Journal of Microbiology Research, V7, P1940; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Techawiwattanaboon T, 2015, J MICROBIOL, V53, P134, DOI 10.1007/s12275-015-4522-9; THOM S, 1992, J MED MICROBIOL, V36, P303, DOI 10.1099/00222615-36-5-303; Thomas V, 2010, FEMS MICROBIOL REV, V34, P231, DOI 10.1111/j.1574-6976.2009.00190.x; Wang-Ngarm S, 2014, AM J TROP MED HYG, V90, P480, DOI 10.4269/ajtmh.13-0446; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; Wuthiekanun V, 2002, AM J TROP MED HYG, V66, P759, DOI 10.4269/ajtmh.2002.66.759; Bui XT, 2012, ENVIRON MICROBIOL, V14, P2034, DOI 10.1111/j.1462-2920.2011.02655.x; Zhou XH, 2007, ENVIRON MICROBIOL, V9, P913, DOI 10.1111/j.1462-2920.2006.01213.x	44	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167355	10.1371/journal.pone.0167355	http://dx.doi.org/10.1371/journal.pone.0167355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898739	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000057
J	Yokota, J; Ogawa, Y; Yamanaka, S; Takahashi, Y; Fujita, H; Yamaguchi, N; Onoue, N; Ishizuka, T; Shinozaki, T; Kohzuki, M				Yokota, Junichi; Ogawa, Yoshiko; Yamanaka, Shinsuke; Takahashi, Yoshimi; Fujita, Hiroshi; Yamaguchi, Nobuhiro; Onoue, Noriko; Ishizuka, Takeshi; Shinozaki, Tsuyoshi; Kohzuki, Masahiro			Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OROPHARYNGEAL DYSPHAGIA; DEMENTIA; PREVALENCE; ASPIRATION; JAPAN	Early detection and intervention for dysphagia is important in patients with congestive heart failure (CHF). However, previous studies have focused on how many patients with dysphagia develop CHF. Studies focusing on the comorbidity of dysphagia in patients with CHF are rare. Additionally, risk factors for dysphagia in patients with CHF are unclear. Thus, the aim of this study was to clarify risk factors for dysphagia in patients with acute exacerbation of CHF. A total of 105 patients, who were admitted with acute exacerbation of CHF, were enrolled. Clinical interviews, blood chemistry analysis, electrocardiography, echocardiography, Mini-Mental State Examination (MMSE), exercise tolerance tests, phonatory function tests, and evaluation of activities of daily living (ADL) and nutrition were conducted on admission. After attending physicians permitted the drinking of water, swallowing screening tests were performed. Patients were divided into a dysphagia group (DG) or a non-dysphagia group (non-DG) based on Functional Oral Intake Scale level. Among the 105 patients, 38 had dysphagia. A greater number of patients had history of aspiration pneumonia and dementia, and there was a higher age, N-terminal pro-B-type natriuretic peptide level in the DG compared with the non-DG. MMSE scores, exercise tolerance, phonatory function, status of ADL, nutrition, albumin, and transthyretin were lower in the DG compared with the non-DG. In multivariate analysis, after adjusting for age and sex, MMSE, BI score, and transthyretin was independently associated with dysphagia. Comorbidity of dysphagia was 36.1% in patients with acute exacerbation of CHF, and cognitive dysfunction and malnutrition may be an independent predictor of dysphagia.	[Yokota, Junichi; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan; [Yokota, Junichi] Sendai Med Ctr, Dept Rehabil, Sendai, Miyagi, Japan; [Ogawa, Yoshiko] Teikyo Univ, Fac Med Technol, Dept Sport & Med Sci, Tokyo, Japan; [Yamanaka, Shinsuke; Takahashi, Yoshimi; Fujita, Hiroshi; Yamaguchi, Nobuhiro; Onoue, Noriko; Ishizuka, Takeshi; Shinozaki, Tsuyoshi] Sendai Med Ctr, Dept Cardiol, Sendai, Miyagi, Japan	Tohoku University; Teikyo University	Kohzuki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan.	kohzuki@med.tohoku.ac.jp		Yokota, Junichi/0000-0002-9725-6322				Alagiakrishnan K, 2013, ARCH GERONTOL GERIAT, V56, P1, DOI 10.1016/j.archger.2012.04.011; Altman KW, 2010, ARCH OTOLARYNGOL, V136, P784, DOI 10.1001/archoto.2010.129; Anker SD, 2009, CLIN NUTR, V28, P455, DOI 10.1016/j.clnu.2009.04.023; [Anonymous], MED REV S; ARORA NS, 1982, AM REV RESPIR DIS, V126, P5; Bassi D, 2014, CODAS, V26, P17, DOI 10.1590/s2317-17822014000100004; Choi BR, 2006, AM J CARDIOL, V97, P1365, DOI 10.1016/j.amjcard.2005.11.059; Coates C, 1997, EUR NEUROL, V38, P49, DOI 10.1159/000112902; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glantz S. A., 2001, APPL REGRESSION ANAL; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Good-Fratturelli MD, 2000, J COMMUN DISORD, V33, P93, DOI 10.1016/S0021-9924(99)00026-X; Goto Y., 2009, JJCR, V14, P115; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; HILLEL AD, 1989, ARCH PHYS MED REHAB, V70, P618; Hudson HM, 2000, DYSPHAGIA, V15, P31, DOI 10.1007/s004559910007; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Izawa K, 2004, CIRC J, V68, P315, DOI 10.1253/circj.68.315; Katsura H, 1998, Nihon Ronen Igakkai Zasshi, V35, P363; Kim Y, 2015, ARCH PHYS MED REHAB, V96, P1269, DOI 10.1016/j.apmr.2015.02.026; Maeda K, 2015, DYSPHAGIA, V30, P80, DOI 10.1007/s00455-014-9577-y; MAHONEY F I, 1965, Md State Med J, V14, P61; Mirza SS, 2015, J NEUROL NEUROSUR PS, P27; Mirzakhani H, 2013, ANESTHESIOLOGY, V119, P389, DOI 10.1097/ALN.0b013e31829373fe; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Oguchi K., 2000, JPN J REHABIL MED, V37, P375, DOI [10.2490/jjrm1963.37.375, DOI 10.2490/JJRM1963.37.375]; Oguchi K., 2000, JPN J REHAB MED, V38, P383, DOI [10.2490/jjrm1963.37.383, DOI 10.2490/jjrm1963.37.383, DOI 10.2490/JJRM1963.37.383]; Oh JE, 2012, J CLIN NEUROL, V8, P123, DOI 10.3988/jcn.2012.8.2.123; Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Serra-Prat M, 2012, AGE AGEING, V41, P376, DOI 10.1093/ageing/afs006; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; SHIZGAL HM, 1986, AM J CLIN NUTR, V44, P761, DOI 10.1093/ajcn/44.6.761; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Speyer R, 2010, J VOICE, V24, P281, DOI 10.1016/j.jvoice.2008.10.004; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; VELDEE M S, 1992, Dysphagia, V7, P86, DOI 10.1007/BF02493439; Wakahara T, 2007, NUTRITION, V23, P634, DOI 10.1016/j.nut.2007.06.005; Wojkowska-Mach J, 2013, INT J INFECT DIS, V17, pE37, DOI 10.1016/j.ijid.2012.07.020; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782; Zuccala G, 1997, J NEUROL NEUROSUR PS, V63, P509, DOI 10.1136/jnnp.63.4.509	43	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167326	10.1371/journal.pone.0167326	http://dx.doi.org/10.1371/journal.pone.0167326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898735	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000053
J	Krupkova, S; Aguete, GP; Kocmanova, L; Volna, T; Grepl, M; Novakova, L; Miller, MJ; Hlavac, J				Krupkova, Sona; Aguete, Gonzalo Pazos; Kocmanova, Leona; Volna, Tereza; Grepl, Martin; Novakova, Lucie; Miller, Marvin John; Hlavac, Jan			Solid-Phase Synthesis of gamma-Lactone and 1,2-Oxazine Derivatives and Their Efficient Chiral Analysis	PLOS ONE			English	Article							DIELS-ALDER REACTIONS; SESQUITERPENE LACTONES; REDUCTIVE CLEAVAGE; O BONDS; BUTENOLIDES; ACIDS	Derivatives of 3-methyl-3,6-dihydro-2H-1,2-oxazine-6-carboxylic acid prepared by regioselective hetero Diels-Alder reaction of arylnitroso compounds with sorbic acid were used for solid-phase synthesis of a library of derivatives that included modification of carboxylic group, dihydroxylation of double bond and cleavage of N-O bond. Derivatives of 2,3,4-trihydroxyhexanoic acid obtained from 3,6-dihydro-2H-1,2-oxazines after double bond dihydroxylation and N-O cleavage were used for simple and stereoselective formation of chiral lactones derived from 3,4-dihydroxydihydrofuran-2(3H)-one. The final compounds obtained as a mixture of stereoisomers were analyzed with use of chiral HPLC and SFC. HPLC analyses were not successful for all derivatives or required lengthy chromatography. On the other hand SFC afforded much shorter analyses and was effective for all studied derivatives. The method of synthesis and analysis is thus suitable for future study of stereoselective synthesis of lactones and other derivatives from single oxazine derivatives and application of high-throughput synthesis on solid-support and combinatorial chemistry.	[Krupkova, Sona; Aguete, Gonzalo Pazos; Kocmanova, Leona; Volna, Tereza; Hlavac, Jan] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic; [Grepl, Martin] Palacky Univ, Dept Organ Chem, Fac Sci, Olomouc, Czech Republic; [Novakova, Lucie] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Analyt Chem, Prague, Czech Republic; [Miller, Marvin John] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Palacky University Olomouc; Palacky University Olomouc; Charles University Prague; University of Notre Dame	Hlavac, J (corresponding author), Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.	hlavac@orgchem.upol.cz	Novakova, Lucie/S-6604-2017	Novakova, Lucie/0000-0003-3570-5871; Kratka, Leona/0000-0002-9210-9788	Ministry of Education, Youth and Sport of the Czech Republic [IGA_PrF_2016_020]; European Social Fund [CZ.1.07/2.3.00/20.0009]; National Program of Sustainability [L01304]	Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Social Fund(European Social Fund (ESF)); National Program of Sustainability	This work was supported by Ministry of Education, Youth and Sport of the Czech Republic; IGA_PrF_2016_020; http://www.msmt.cz/, the European Social Fund; CZ.1.07/2.3.00/20.0009; http://ec.europleu/esf/home.jsp, National Program of Sustainability; L01304; http://www.msrnt.cz/.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2011, EUR J ORG CHEM, V2011, P2747, DOI 10.1002/ejoc.201001486; Amaral PA, 2008, TETRAHEDRON LETT, V49, P6607, DOI 10.1016/j.tetlet.2008.07.102; Bodnar BS, 2011, ANGEW CHEM INT EDIT, V50, P5629, DOI 10.1002/anie.201005764; Boucard V, 2007, EUR J ORG CHEM, V2007, P225, DOI 10.1002/ejoc.200600570; Calvet G, 2007, ORG LETT, V9, P1485, DOI 10.1021/ol0702066; Cesario C, 2009, J ORG CHEM, V74, P448, DOI 10.1021/jo802184y; CICCHI S, 1990, TETRAHEDRON LETT, V31, P3351, DOI 10.1016/S0040-4039(00)89062-0; Collins I, 1999, J CHEM SOC PERK T 1, P1377, DOI 10.1039/a808137i; DEFOIN A, 1994, TETRAHEDRON LETT, V35, P5653, DOI 10.1016/S0040-4039(00)77271-6; Dekaris V, 2011, EUR J ORG CHEM, V2011, P3210, DOI 10.1002/ejoc.201100230; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; GRIECO PA, 1975, SYNTHESIS-STUTTGART, P67; Harrison A, 2014, NEW J CHEM, V38, P5491, DOI 10.1039/c4nj00974f; Hwang DR, 2006, BIOORGAN MED CHEM, V14, P83, DOI 10.1016/j.bmc.2005.07.055; Jimenez V, 2014, PHYTOMEDICINE, V21, P1411, DOI 10.1016/j.phymed.2014.06.005; Keck GE, 1999, TETRAHEDRON, V55, P11755, DOI 10.1016/S0040-4020(99)00486-X; Krchanak V, 2008, J COMB CHEM, V10, P112, DOI 10.1021/cc700142d; Krchnak V, 2008, J ORG CHEM, V73, P4559, DOI 10.1021/jo8004827; Krchnak V, 2008, J COMB CHEM, V10, P104, DOI 10.1021/cc7001414; KRESZE G, 1969, TETRAHEDRON, V25, P4481, DOI 10.1016/S0040-4020(01)82990-2; Ma SM, 2000, ORG LETT, V2, P1419, DOI 10.1021/ol0057481; PETRAGNANI N, 1986, SYNTHESIS-STUTTGART, P157; RIEDIKER M, 1979, HELV CHIM ACTA, V62, P1586, DOI 10.1002/hlca.19790620524; RUTTIMANN A, 1975, HELV CHIM ACTA, V58, P2237, DOI 10.1002/hlca.19750580802; Shao LD, 2014, NAT PRODUCT BIOPROSP, V4, P181, DOI 10.1007/s13659-014-0022-6; Sheng SR, 2006, J COMB CHEM, V8, P805, DOI 10.1021/cc060104r; Wang CL, 2012, SYNTHETIC COMMUN, V42, P320, DOI 10.1080/00397911.2010.524064; Werner L, TETRAHEDRON; Yekta S, 2007, SYNLETT, P2069, DOI 10.1055/s-2007-984907	29	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166558	10.1371/journal.pone.0166558	http://dx.doi.org/10.1371/journal.pone.0166558			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893812	Green Submitted, gold, Green Published			2022-12-26	WOS:000389472400031
J	Michel, A; Bosc, R; Meningaud, JP; Hernigou, P; Haiat, G				Michel, Adrien; Bosc, Romain; Meningaud, Jean-Paul; Hernigou, Philippe; Haiat, Guillaume			Assessing the Acetabular Cup Implant Primary Stability by Impact Analyses: A Cadaveric Study	PLOS ONE			English	Article							CEMENTLESS HIP PROSTHESES; INITIAL STABILITY; FIT; FIXATION; MICROMOTION; INSERTION; PRINCIPLES; COMPONENTS; INTERFACE; STEM	Background The primary stability of the acetabular cup (AC) implant is an important determinant for the long term success of cementless hip surgery. However, it remains difficult to assess the AC implant stability due to the complex nature of the bone-implant interface. A compromise should be found when inserting the AC implant in order to obtain a sufficient implant stability without risking bone fracture. The aim of this study is to evaluate the potential of impact signals analyses to assess the primary stability of AC implants inserted in cadaveric specimens. Methods AC implants with various sizes were inserted in 12 cadaveric hips following the same protocol as the one employed in the clinic, leading to 86 different configurations. A hammer instrumented with a piezoelectric force sensor was then used to measure the variation of the force as a function of time produced during the impact between the hammer and the ancillary. Then, an indicator I was determined for each impact based on the impact momentum. For each configuration, twelve impacts were realized with the hammer, the value of the maximum amplitude being comprised between 2500 and 4500 N, which allows to determine an averaged value I-M of the indicator for each configuration. The pull-out force F was measured using a tangential pull-out biomechanical test. Results A significant correlation (R-2 = 0.69) was found between IM and F when pooling all data, which indicates that information related to the AC implant biomechanical stability can be retrieved from the analysis of impact signals obtained in cadavers. Conclusion These results open new paths in the development of a medical device that could be used in the future in the operative room to help orthopedic surgeons adapt the surgical protocol in a patient specific manner.	[Michel, Adrien; Haiat, Guillaume] CNRS, Lab Modelisat & Simulat Multiechelle, Creteil, France; [Bosc, Romain; Meningaud, Jean-Paul] Univ Paris Est, INSERM, U955, IMRB, Creteil, France; [Hernigou, Philippe] Univ Paris Est, Hop Henri Mondor, AP HP, Serv Chirurg Orthoped & Traumatol,CHU Paris 12, Creteil, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Haiat, G (corresponding author), CNRS, Lab Modelisat & Simulat Multiechelle, Creteil, France.	guillaume.haiat@univ-paris-est.fr			French National Research Agency (ANR) [ANR-13-PRTS-0015-02]; l'Ecole de Chirurgie du Fer a Moulin (Paris, FRANCE); European Research Council (ERC) under the European Union's Horizon research and innovation program (project ERC Consolidator Grant) [682001]	French National Research Agency (ANR)(French National Research Agency (ANR)); l'Ecole de Chirurgie du Fer a Moulin (Paris, FRANCE); European Research Council (ERC) under the European Union's Horizon research and innovation program (project ERC Consolidator Grant)	This work has been supported by French National Research Agency (ANR) through the PRTS program (project OsseoWave no ANR-13-PRTS-0015-02). This work has been realized thanks to the support of l'Ecole de Chirurgie du Fer a Moulin (Paris, FRANCE). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 682001, project ERC Consolidator Grant 2015 Bonelmplant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by French National Research Agency (ANR) through the PRTS program (project OsseoWave no ANR-13-PRTS-0015-02). This work has been realized thanks to the support of l'Ecole de Chirurgie du Fer a Moulin (Paris, FRANCE).; This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 682001, project ERC Consolidator Grant 2015 Bonelmplant).	Adler E, 1992, J Arthroplasty, V7, P295, DOI 10.1016/0883-5403(92)90052-R; Anderson LA, 2012, CLIN ORTHOP RELAT R, V470, P3375, DOI 10.1007/s11999-012-2509-y; Baleani M, 2001, ARTIF ORGANS, V25, P664, DOI 10.1046/j.1525-1594.2001.025008664.x; Baleani M, 2000, J BIOMED MATER RES, V50, P605, DOI 10.1002/(SICI)1097-4636(20000615)50:4<605::AID-JBM17>3.0.CO;2-P; CURTIS MJ, 1992, J BONE JOINT SURG BR, V74, P372, DOI 10.1302/0301-620X.74B3.1587880; Haiat G, 2014, ANNU REV BIOMED ENG, V16, P187, DOI 10.1146/annurev-bioeng-071813-104854; Hamilton WG, 2007, J ARTHROPLASTY, V22, P75, DOI 10.1016/j.arth.2006.12.115; Hecht S, 2011, VET RADIOL ULTRASOUN, V52, P409, DOI 10.1111/j.1740-8261.2011.01809.x; Henys P, 2015, P I MECH ENG H, V229, P3, DOI 10.1177/0954411914561485; Kwong L M, 1994, J Arthroplasty, V9, P163, DOI 10.1016/0883-5403(94)90065-5; Lannocca M, 2007, MED ENG PHYS, V29, P886, DOI 10.1016/j.medengphy.2006.09.011; Macdonald W, 1999, P I MECH ENG H, V213, P33, DOI 10.1243/0954411991534780; Markel DC, 2002, INT ORTHOP, V26, P72, DOI 10.1007/s00264-001-0314-4; Mathieu V, 2014, J BIOMECH, V47, P3, DOI 10.1016/j.jbiomech.2013.09.021; Mathieu V, 2013, MED ENG PHYS, V35, P1558, DOI 10.1016/j.medengphy.2013.04.005; Michel A, MED BIOL EN IN PRESS; Michel A, CMBBE UNPUB; Michel A, 2016, MED ENG PHYS, V38, P80, DOI 10.1016/j.medengphy.2015.10.006; Michel A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029505; Michel A, 2014, P I MECH ENG H, V228, P1027, DOI 10.1177/0954411914552433; MORSCHER E, 1989, CLIN ORTHOP RELAT R, P12; Pastrav LC, 2008, J APPL BIOMATER BIOM, V6, P23; Pastrav Leonard C, 2009, J Orthop Surg Res, V4, P10, DOI 10.1186/1749-799X-4-10; Perona P G, 1992, J Arthroplasty, V7, P537; Pierce TP, 2015, EXPERT REV MED DEVIC, V12, P307, DOI 10.1586/17434440.2015.991313; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; Sakai R, 2011, HIP INT, V21, P718, DOI 10.5301/HIP.2011.8823; Saleh Khaled J, 2008, Am J Orthop (Belle Mead NJ), V37, P519; Shalabi MM, 2007, J MATER SCI-MATER M, V18, P2033, DOI 10.1007/s10856-007-3160-0; Varini E, 2010, SENSOR ACTUAT A-PHYS, V163, P526, DOI 10.1016/j.sna.2010.08.029; Viceconti M, 2001, CLIN BIOMECH, V16, P765, DOI 10.1016/S0268-0033(01)00052-3; West C, 2008, AM SOC BIOMECH, P173; WON CH, 1995, J BONE JOINT SURG BR, V77B, P484, DOI 10.1302/0301-620X.77B3.7744942	33	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166778	10.1371/journal.pone.0166778	http://dx.doi.org/10.1371/journal.pone.0166778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893757	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400044
J	Freitas, ACS; Figueiredo, MJ; Campos, EC; Soave, DF; Ramos, SG; Tanowitz, HB; Celes, MRN				Silva Freitas, Ana Caroline; Figueiredo, Maria Jose; Campos, Erica Carolina; Soave, Danilo Figueiredo; Ramos, Simone Gusmao; Tanowitz, Herbert B.; Celes, Mara Rubia N.			Activation of Both the Calpain and Ubiquitin-Proteasome Systems Contributes to Septic Cardiomyopathy through Dystrophin Loss/Disruption and mTOR Inhibition	PLOS ONE			English	Article							ADVANCED HEART-FAILURE; MYOCARDIAL DYSFUNCTION; KAPPA-B; CONTRACTILE DYSFUNCTION; CARDIAC DYSFUNCTION; PROTEIN-DEGRADATION; STRUCTURAL-CHANGES; SEVERE SEPSIS; PATHWAY; MUSCLE	Cardiac dysfunction caused by the impairment of myocardial contractility has been recognized as an important factor contributing to the high mortality in sepsis. Calpain activation in the heart takes place in response to increased intracellular calcium influx resulting in proteolysis of structural and contractile proteins with subsequent myocardial dysfunction. The purpose of the present study was to test the hypothesis that increased levels of calpain in the septic heart leads to disruption of structural and contractile proteins and that administration of calpain inhibitor-1 (N-acetyl-leucinyl-leucinyl-norleucinal (ALLN)) after sepsis induced by cecal ligation and puncture prevents cardiac protein degradation. We also tested the hypothesis that calpain plays a role in the modulation of protein synthesis/degradation through the activation of proteasome-dependent proteolysis and inhibition of the mTOR pathway. Severe sepsis significantly increased heart calpain-1 levels and promoted ubiquitin and Pa28 beta over-expression with a reduction in the mTOR levels. In addition, sepsis reduced the expression of structural proteins dystrophin and beta-dystroglycan as well as the contractile proteins actin and myosin. ALLN administration prevented sepsis-induced increases in calpain and ubiquitin levels in the heart, which resulted in decreased of structural and contractile proteins degradation and basal mTOR expression levels were re-established. Our results support the concept that increased calpain concentrations may be part of an important mechanism of sepsis-induced cardiac muscle proteolysis.	[Silva Freitas, Ana Caroline; Figueiredo, Maria Jose; Ramos, Simone Gusmao; Celes, Mara Rubia N.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil; [Campos, Erica Carolina] Univ Fed Uberlandia, Fac Phys Educ, Dept Physiotherapy, Uberlandia, MG, Brazil; [Soave, Danilo Figueiredo] Univ Fed Goias, Dept Histol Embryol & Cellular Biol, Jatai, Go, Brazil; [Tanowitz, Herbert B.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pathol & Med, Bronx, NY USA; [Celes, Mara Rubia N.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Jatai, Go, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Federal de Goias; Yeshiva University; Albert Einstein College of Medicine; Universidade Federal de Goias	Celes, MRN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil.; Celes, MRN (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Jatai, Go, Brazil.	rubia.celes@gmail.com	Celes, Mara Rubia/I-8707-2019; Celes, Mara/K-7274-2013; Freitas, Ana CS/H-8953-2012; Ramos, Simone G./C-4720-2012	Celes, Mara Rubia/0000-0002-4733-007X; Celes, Mara/0000-0002-4733-007X; Ramos, Simone G./0000-0002-1981-5248; Soave, Danilo Figueiredo/0000-0001-9782-3940	FAPESP (Fundacao Amparo a Pesquisa do Estado de Sao Paulo) [07/58843-2, 12/23649-0, 12/17542-8]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [303308/2013-3]	FAPESP (Fundacao Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MRNC has received grants (07/58843-2) from FAPESP (Fundacao Amparo a Pesquisa do Estado de Sao Paulo) and is currently receiving a grant (303308/2013-3) from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). SGR is currently receiving grants (12/23649-0, 12/17542-8) from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran L, 2011, P NATL ACAD SCI USA, V108, P16217, DOI 10.1073/pnas.1107692108; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x; Celes MRN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068809; Celes MRN, 2010, SHOCK, V33, P322, DOI 10.1097/SHK.0b013e3181b38ef6; Celes MRN, 2010, LAB INVEST, V90, P531, DOI 10.1038/labinvest.2010.3; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Duguez S, 2003, AM J PHYSIOL-ENDOC M, V285, pE206, DOI 10.1152/ajpendo.00331.2002; Ervasti J M, 1993, Mol Cell Biol Hum Dis Ser, V3, P139; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hernandez G, 2011, EXP CELL RES, V317, P2938, DOI 10.1016/j.yexcr.2011.09.011; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HILT W, 1993, ENZYME PROTEIN, V47, P189, DOI 10.1159/000468678; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Kawada T, 2005, BBA-PROTEINS PROTEOM, V1751, P73, DOI 10.1016/j.bbapap.2005.01.001; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Li Y, 2009, CARDIOVASC RES, V84, P100, DOI 10.1093/cvr/cvp189; Maass DL, 2002, SHOCK, V17, P293, DOI 10.1097/00024382-200204000-00009; Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; Muller AL, 2012, HEART FAIL REV, V17, P395, DOI 10.1007/s10741-011-9269-8; Nishida K, 2015, J MOL CELL CARDIOL, V84, P212, DOI 10.1016/j.yjmcc.2015.05.004; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Prins KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002419; Rossi MA, 2007, SHOCK, V27, P10, DOI 10.1097/01.shk.0000235141.05528.47; Ruetten H, 1997, BRIT J PHARMACOL, V121, P695, DOI 10.1038/sj.bjp.0701180; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Sequeira V, 2014, BBA-BIOMEMBRANES, V1838, P700, DOI 10.1016/j.bbamem.2013.07.011; Smeding L, 2012, SHOCK, V37, P449, DOI 10.1097/SHK.0b013e31824c3238; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Tissier S, 2004, SHOCK, V21, P352, DOI 10.1097/00024382-200404000-00010; Toyo-Oka T, 2004, P NATL ACAD SCI USA, V101, P7381, DOI 10.1073/pnas.0401944101; Wagner C, 2010, MOL CELL BIOCHEM, V339, P135, DOI 10.1007/s11010-009-0377-x; Werdan K, 2009, YEARB INTENSIVE CARE, P183, DOI 10.1007/978-3-540-92276-6_18; Willis MS, 2014, J MOL CELL CARDIOL, V71, P43, DOI 10.1016/j.yjmcc.2013.11.008; Yamaguchi O, 2012, CARDIOVASC RES, V96, P46, DOI 10.1093/cvr/cvs236; Zafrani L, 2012, AM J RESP CRIT CARE, V185, P744, DOI 10.1164/rccm.201109-1686OC; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166839	10.1371/journal.pone.0166839	http://dx.doi.org/10.1371/journal.pone.0166839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880847	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500037
J	Shore, S; Henderson, JM; Lebedev, A; Salcedo, MP; Zon, G; McCaffrey, AP; Paul, N; Hogrefe, RI				Shore, Sabrina; Henderson, Jordana M.; Lebedev, Alexandre; Salcedo, Michelle P.; Zon, Gerald; McCaffrey, Anton P.; Paul, Natasha; Hogrefe, Richard I.			Small RNA Library Preparation Method for Next-Generation Sequencing Using Chemical Modifications to Prevent Adapter Dimer Formation	PLOS ONE			English	Article							MICRORNA; MIRBASE	For most sample types, the automation of RNA and DNA sample preparation workflows enables high throughput next-generation sequencing (NGS) library preparation. Greater adoption of small RNA (sRNA) sequencing has been hindered by high sample input requirements and inherent ligation side products formed during library preparation. These side products, known as adapter dimer, are very similar in size to the tagged library. Most sRNA library preparation strategies thus employ a gel purification step to isolate tagged library from adapter dimer contaminants. At very low sample inputs, adapter dimer side products dominate the reaction and limit the sensitivity of this technique. Here we address the need for improved specificity of sRNA library preparation workflows with a novel library preparation approach that uses modified adapters to suppress adapter dimer formation. This workflow allows for lower sample inputs and elimination of the gel purification step, which in turn allows for an automatable sRNA library preparation protocol.	[Shore, Sabrina; Henderson, Jordana M.; Lebedev, Alexandre; Salcedo, Michelle P.; Zon, Gerald; McCaffrey, Anton P.; Hogrefe, Richard I.] TriLink BioTechnol LLC, Res & Dev Cell & Mol Biol, San Diego, CA 92121 USA; [Paul, Natasha] Synthetic Genomics Inc, Engn & Instrumentat, La Jolla, CA USA		Shore, S; McCaffrey, AP (corresponding author), TriLink BioTechnol LLC, Res & Dev Cell & Mol Biol, San Diego, CA 92121 USA.	sshore@trilinkbiotech.com; amccaffrey@trilinkbiotech.com		Henderson, Jordana/0000-0001-6122-4663	Small Business Innovation Research (SBIR) grant through the National Institutes of Health (NIH) [1R43HG006820-01A1]; TriLink BioTechnologies, LLC	Small Business Innovation Research (SBIR) grant through the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TriLink BioTechnologies, LLC	This research was funded with a Small Business Innovation Research (SBIR) grant through the National Institutes of Health (NIH), Grant Number: 1R43HG006820-01A1, https://sbir.nih.gov/. Grant money was funded to NP. The funder provided support in the form of salaries for authors (SS, AL, MS, GZ, NP, RIH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Several of the authors (SS, JMH, AL, MS, GZ, APM, RIH) are employed by a commercial company: TriLink BioTechnologies, LLC. One of the authors (NP) was previously employed by TriLink BioTechnologies, LLC but is currently at Synthetic Genomics, Inc. TriLink BioTechnologies, LLC provided support in the form of salaries for authors after grant funding had ended (SS, JMH, AL, MS, GZ, APM, NP, RIH) and did have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Synthetic Genomics, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2014, BIOM BRAIN INJ NEUR; Dhahbi Joseph M, 2014, Biomark Cancer, V6, P37, DOI 10.4137/BIC.S20764; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fuchs RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126049; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Inc. NEB, 2015, NEBNEXT SMALL RNA LI; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larry A., 2015, patent, Patent No. [US20150072870 A1, 20150072870]; Lopez JP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0109-x; Luo JY, 1996, NUCLEIC ACIDS RES, V24, P3071, DOI 10.1093/nar/24.15.3071; Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Rasband WS, IMAGEJ 1997 2016; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Sabrina Shore, 2016, KEYSTONE S SMALL RNA; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Song YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094619; Technologies ITbL, ION TOT RNA SEQ KIT; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2015, TRENDS BIOCHEM SCI, V40, P4, DOI 10.1016/j.tibs.2014.10.009; Zhang P, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau110	34	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167009	10.1371/journal.pone.0167009	http://dx.doi.org/10.1371/journal.pone.0167009			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875576	gold, Green Published, Green Submitted			2022-12-26	WOS:000388886000043
J	Haas, TC; Ferreira, SM				Haas, Timothy C.; Ferreira, Sam M.			Combating Rhino Horn Trafficking: The Need to Disrupt Criminal Networks	PLOS ONE			English	Article							AGENT-BASED MODEL; LEGAL TRADE; INTERNATIONAL-TRADE; CONSERVATION; COMPETITION; DYNAMICS; AFRICA; BANS	The onslaught on the World's wildlife continues despite numerous initiatives aimed at curbing it. We build a model that integrates rhino horn trade with rhino population dynamics in order to evaluate the impact of various management policies on rhino sustainability. In our model, an agent-based sub-model of horn trade from the poaching event up through a purchase of rhino horn in Asia impacts rhino abundance. A data-validated, individual-based sub-model of the rhino population of South Africa provides these abundance values. We evaluate policies that consist of different combinations of legal trade initiatives, demand reduction marketing campaigns, increased anti-poaching measures within protected areas, and transnational policing initiatives aimed at disrupting those criminal syndicates engaged in horn trafficking. Simulation runs of our model over the next 35 years produces a sustainable rhino population under only one management policy. This policy includes both a transnational policing effort aimed at dismantling those criminal networks engaged in rhino horn trafficking D coupled with increases in legal economic opportunities for people living next to protected areas where rhinos live. This multi-faceted approach should be the focus of the international debate on strategies to combat the current slaughter of rhino rather than the binary debate about whether rhino horn trade should be legalized. This approach to the evaluation of wildlife management policies may be useful to apply to other species threatened by wildlife trafficking.	[Haas, Timothy C.] Univ Wisconsin, Lubar Sch Business, Milwaukee, WI 53201 USA; [Ferreira, Sam M.] SANParks, Sci Serv, Skukuza, South Africa	University of Wisconsin System; University of Wisconsin Milwaukee	Haas, TC (corresponding author), Univ Wisconsin, Lubar Sch Business, Milwaukee, WI 53201 USA.	haas@uwm.edu		Haas, Timothy/0000-0003-2408-2744	World Wildlife Fund, South Africa [ZA2321]; WWF South Africa	World Wildlife Fund, South Africa; WWF South Africa	This work was supported by the World Wildlife Fund, South Africa, Grant ZA2321 awarded to SF and TH (www.wwf.org.za). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Travel for Timothy C. Haas was supported with funding provided by a WWF South Africa grant. We do not have any conflicts of interest.	African Wildlife Foundation (AWF), 2014, RHIN; Ammann K, 2014, RHINO HORN STORY CON; [Anonymous], 2013, CITY PRESS; [Anonymous], 2014, ANIMAL FILES WHITE R; [Anonymous], 2014, NEWS24          0501; Ayling J., 2013, Journal of International Wildlife Law & Policy, V16, P57, DOI 10.1080/13880292.2013.764776; Barbanera F, 2010, BIOL CONSERV, V143, P1259, DOI 10.1016/j.biocon.2010.02.035; Biggs D, 2013, SCIENCE, V339, P1038, DOI 10.1126/science.1229998; Birchall O, 2016, INTRO EC, P36; Blaine S., 2013, BUSINESS DAY; Borrini-Feyerabend G, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P169; Bulte EH, 2005, CONSERV BIOL, V19, P1222, DOI 10.1111/j.1523-1739.2005.00149.x; Butt KM, 2014, J POLITICAL STUDIES, V21, P271; Catullo E, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2155; Caulderwood K., 2014, INT BUSINESS TIMES; Challender DWS, 2015, GLOB ECOL CONSERV, V3, P129, DOI 10.1016/j.gecco.2014.11.010; Charnovitz S., 1994, AM U J INT L POLY, V9, P751; Cheteni P., 2014, ENV EC, V5, P63; Child B, 2012, S AFR J SCI, V108, P1, DOI 10.4102/sajs.v108i7/8.1338; Collins A, 2013, SCIENCE, V340, P1167, DOI 10.1126/science.340.6137.1167-a; Conrad K, 2012, TROP CONSERV SCI, V5, P245, DOI 10.1177/194008291200500302; Contreras-Hermosilla A, 2011, FORESTS, V2, P168, DOI 10.3390/f2010168; Cooney R., 2004, PRECAUTIONARY PRINCI; Corbett CJ, 2001, MANAGE SCI, V47, P966, DOI 10.1287/mnsc.47.7.966.9799; Cousins J. A., 2010, ECOLOGY SOC, V15, P28, DOI DOI 10.5751/ES-03349-150228; Crookes DJ, 2015, J NAT CONSERV, V28, P11, DOI 10.1016/j.jnc.2015.08.001; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Di Minin E, 2015, CONSERV BIOL, V29, P545, DOI 10.1111/cobi.12412; Dixon H., 1990, FDN EC THOUGHT, P356; Duffy R, 2014, INT AFF, V90, P819, DOI 10.1111/1468-2346.12142; Econecol, 2015, EC EC MOD SOURC COD; Eloff C, 2014, CRIM SCI SER, V15, P18; Elsner W., 2015, MICROECONOMICS COMPL, P193, DOI [10.1016/b978-0-12-411585-9.00008-7, DOI 10.1016/B978-0-12-411585-9.00008-7]; Emslie R., 1999, AFRICAN RHINO STATUS; Emslie R. H., 2013, AFRICAN RHINOCEROSES; Europol, 2013, 667574V8 EDOC EUR; Ferreira SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127783; Ferreira SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045989; FERREIRA SM, 2012, PACHYDERM, V51, P60; Ferreira SM, 2014, S AFR J SCI, V110; Fresard L, 2014, WORKING PAPER SERIES; Geanakoplos J, 2012, AM ECON REV, V102, P53, DOI 10.1257/aer.102.3.53; Griffiths M. L., 2015, THESIS; Guilford G., 2013, ATLANTIC; Haas T.C., 2015, SECURITY INFORMATICS, V4, P2, DOI [10.1186/s13388-015-0018-8, DOI 10.1186/S13388-015-0018-8]; Haas TC, 2016, IEEE T CYBERNETICS, V46, P1721, DOI 10.1109/TCYB.2015.2470520; Havocscope, EX AN SAL; Havocscope, RHIN POACH; Hsiang S, 2016, NATL BUREAU EC RES W; Humphreys J, 2014, INT AFF, V90, P795, DOI 10.1111/1468-2346.12141; Jahoda W., 2010, COMMUNICATION; James Tom, 2016, ATLANTIC; Joyce SM, 2014, BLOOMBERG BUSINESSWE; Kariega, 2014, HAN CONN INV RHIN HO; Kelly M, 2000, REV ECON STAT, V82, P530, DOI 10.1162/003465300559028; Kostova T, 2004, CR BIOL, V327, P261, DOI 10.1016/j.crvi.2003.11.010; Litchfield CA, 2013, SCIENCE, V340, P1168, DOI 10.1126/science.340.6137.1168-a; Liu H., 2013, IS CHINAS APPETITIE; Lunstrum E, 2014, ANN ASSOC AM GEOGR, V104, P816, DOI 10.1080/00045608.2014.912545; Lusseau D, 2016, CURRENT BIOL; Maggs K., 2011, K2C RHIN FOR WORKSH; Marshall L, 2012, VOICES; Mason CF, 2012, OXFORD REV ECON POL, V28, P180, DOI 10.1093/oxrep/grs006; Milliken T, 2012, S AFRICA VIETNAM RHI; Milliken T, 2014, ILLEGAL IVORY RHINO; Moore L, 2011, GEOFORUM, V42, P51, DOI 10.1016/j.geoforum.2010.09.002; Nadal A, 2014, LCSV WORKING PAPER S, V6; Ng TS, 2013, IEEE T SYST MAN CY-S, V43, P416, DOI 10.1109/TSMCA.2012.2195167; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Prins HHT, 2013, SCIENCE, V340, P1167, DOI 10.1126/science.340.6137.1167-b; Rees W., 2003, ORG CRIME CHALLENGE; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; Roberts SL, 2014, DAILY MAIL; Rodriguez-Pose A, 2015, APPL GEOGR, V61, P11, DOI 10.1016/j.apgeog.2015.02.005; Ropeik A, 2014, IND BLAMES PIRATE FI; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Ruetschlin CM, 2012, J INT DIVERSITY, V2012, P94; SAH RK, 1984, AM ECON REV, V74, P125; SANParks, 2014, S AFR NAT PAR DAT RE; Shelley Louise., 2003, BROWN J WORLD AFFAIR, V10, P119; Skeldon R, 2003, MIGRATION AND THE LABOUR MARKET IN ASIA: RECENT TRENDS AND POLICIES, P9; Smillie S., 2013, INT BOULEVARD   0101; Smith D., 2016, TUCSON SENTINEL 0607; Smith RJ, 2013, ORYX, V47, P323, DOI 10.1017/S0030605313000768; State of New Jersey Commission of Investigation, 2004, CHANG FAC ORG CRIM N; Stoddard E., 2012, REUTERS         0426; Tesfatsion L., 2005, HDB COMPUTATIONAL EC, V2, P831, DOI DOI 10.1016/S1574-0021(05)02016-2; Thai Sarnsamak P., 2013, NATION; The World Bank, 2015, POP EST PROJ; Warchol GL, 2004, CRIM JUSTICE STUD CR, V1, P57, DOI DOI 10.1080/08884310420001679334; Wildliferanching, 2011, BLACK RHIN DEC BIC; WWF/Dalberg, 2012, FIGHT ILL WILDL TRAF	92	32	32	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0167040	10.1371/journal.pone.0167040	http://dx.doi.org/10.1371/journal.pone.0167040			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED4UE	27870917	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400056
J	Holtfrerich, SKC; Schwarz, KA; Sprenger, C; Reimers, L; Diekhof, EK				Holtfrerich, Sarah K. C.; Schwarz, Katharine A.; Sprenger, Christian; Reimers, Luise; Diekhof, Esther K.			Endogenous Testosterone and Exogenous Oxytocin Modulate Attentional Processing of Infant Faces	PLOS ONE			English	Article							BABY SCHEMA; CUTENESS PERCEPTION; COGNITIVE EMPATHY; VASOPRESSIN; SENSITIVITY; PARTURITION; EXPRESSION; MOTIVATION; CHALLENGE; RECEPTORS	Evidence indicates that hormones modulate the intensity of maternal care. Oxytocin is known for its positive influence on maternal behavior and its important role for childbirth. In contrast, testosterone promotes egocentric choices and reduces empathy. Further, testosterone decreases during parenthood which could be an adaptation to increased parental investment. The present study investigated the interaction between testosterone and oxytocin in attentional control and their influence on attention to baby schema in women. Higher endogenous testosterone was expected to decrease selective attention to child portraits in a face-in-the-crowd-paradigm, while oxytocin was expected to counteract this effect. As predicted, women with higher salivary testosterone were slower in orienting attention to infant targets in the context of adult distractors. Interestingly, reaction times to infant and adult stimuli decreased after oxytocin administration, but only in women with high endogenous testosterone. These results suggest that oxytocin may counteract the adverse effects of testosterone on a central aspect of social behavior and maternal caretaking.	[Holtfrerich, Sarah K. C.; Reimers, Luise; Diekhof, Esther K.] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Holtfrerich, Sarah K. C.; Reimers, Luise; Diekhof, Esther K.] Inst Human Biol, Zool Museum, Neuroendocrinol Unit, Hamburg, Germany; [Schwarz, Katharine A.; Sprenger, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Schwarz, Katharine A.] Univ Wurzburg, Inst Psychol, Wurzburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Holtfrerich, SKC (corresponding author), Univ Hamburg, Bioctr Grindel, Hamburg, Germany.; Holtfrerich, SKC (corresponding author), Inst Human Biol, Zool Museum, Neuroendocrinol Unit, Hamburg, Germany.	sarah.holtfrerich@gmx.de	Schwarz, Katharina/AAQ-1427-2021; Diekhof, Esther/AAA-1487-2020	Schwarz, Katharina/0000-0001-8714-790X; Holtfrerich, Sarah/0000-0002-1841-6907; Diekhof, Esther/0000-0003-3826-8494	European Research Council [ERC-2010-AdG_20100407]	European Research Council(European Research Council (ERC)European Commission)	KAS was supported by the European Research Council, ERC-2010-AdG_20100407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY TR, 1983, MERRILL PALMER QUART, V29, P411; Bakermans-Kranenburg MJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.34; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bate S, 2014, CORTEX, V50, P55, DOI 10.1016/j.cortex.2013.08.006; BAUCOM DH, 1985, J PERS SOC PSYCHOL, V48, P1218, DOI 10.1037/0022-3514.48.5.1218; Borgi M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00411; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bos PA, 2010, PSYCHONEUROENDOCRINO, V35, P114, DOI 10.1016/j.psyneuen.2009.09.013; Bridges RS, 1997, ENDOCRINOLOGY, V138, P756, DOI 10.1210/en.138.2.756; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Cameron NM, 2008, HORM BEHAV, V54, P178, DOI 10.1016/j.yhbeh.2008.02.013; Cardenas RA, 2013, EVOL HUM BEHAV, V34, P280, DOI 10.1016/j.evolhumbehav.2013.04.001; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Crespi BJ, 2016, BIOL REV, V91, P390, DOI 10.1111/brv.12175; Diekhof EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098977; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Ewert JP, 1997, TRENDS NEUROSCI, V20, P332; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; FRAYNE J, 1995, BIOL REPROD, V52, P1268, DOI 10.1095/biolreprod52.6.1268; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Golle J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121554; Golle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058248; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Hahn AC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0978; Hahn AC, 2015, HORM BEHAV, V67, P54, DOI 10.1016/j.yhbeh.2014.11.010; Han SJ, 2008, ERNST SCHERING FOUND, V1, P25, DOI 10.1007/2789_2007_056; Harris JA, 1996, AGGRESSIVE BEHAV, P22; Herrero S., 1990, BEARS THEIR BIOL MAN, V8, P25, DOI DOI 10.2307/3872659; Hildebrandt K. A., 1981, INFANT MENT HEALTH J, V2, P56, DOI DOI 10.1002/1097-0355(198121)2:1<56::AID-IMHJ2280020109>3.0.C0;2-G; Hodsoll J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012509; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Jaeggi AV, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0058; Kringelbach ML, 2016, TRENDS IN PRESS 0519; Kuzawa CW, 2010, HORM BEHAV, V57, P441, DOI 10.1016/j.yhbeh.2010.01.014; Kuzawa CW, 2009, HORM BEHAV, V56, P429, DOI 10.1016/j.yhbeh.2009.07.010; Lewis John G, 2006, Clin Biochem Rev, V27, P139; Liening SH, 2010, SOC PERSONAL PSYCHOL, V4, P982, DOI 10.1111/j.1751-9004.2010.00316.x; Little AC, 2012, ETHOLOGY, V118, P775, DOI 10.1111/j.1439-0310.2012.02068.x; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Naber FBA, 2013, J AUTISM DEV DISORD, V43, P224, DOI 10.1007/s10803-012-1536-6; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; PRINS HHT, 1989, BEHAVIOUR, V108, P262, DOI 10.1163/156853989X00330; Reimers L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00183; Rilling JK, 2013, NEUROPSYCHOLOGIA, V51, P731, DOI 10.1016/j.neuropsychologia.2012.12.017; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Saltzman W, 2011, PROG NEURO-PSYCHOPH, V35, P1192, DOI 10.1016/j.pnpbp.2010.09.017; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Splndler P., 1961, ANTHROPOL ANZ, V25, P60; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; van Anders SM, 2011, PSYCHONEUROENDOCRINO, V36, P1265, DOI 10.1016/j.psyneuen.2011.06.001; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Weisman O, 2015, PSYCHONEUROENDOCRINO, V58, P23, DOI 10.1016/j.psyneuen.2015.04.007; Weisman O, 2014, PROG NEURO-PSYCHOPH, V49, P47, DOI 10.1016/j.pnpbp.2013.11.006; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINSLOW JT, 1991, J NEUROSCI, V11, P2032; Wright ND, 2012, P ROY SOC B-BIOL SCI, V279, P2275, DOI 10.1098/rspb.2011.2523; Zink CF, 2003, J NEUROSCI, V23, P8092	73	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166617	10.1371/journal.pone.0166617	http://dx.doi.org/10.1371/journal.pone.0166617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861588	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300079
J	Benredjem, B; Girard, M; Rhainds, D; St-Onge, G; Heveker, N				Benredjem, Besma; Girard, Melanie; Rhainds, David; St-Onge, Genevieve; Heveker, Nikolaus			Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; EXTRACELLULAR LOOP; DEPENDENT ACTIVATION; SCAVENGING ACTIVITY; STRUCTURAL BASIS; SMALL-MOLECULE; INSECT CELLS; HUMAN CXCR4; BINDING	Atypical chemokine receptors do not mediate chemotaxis or G protein signaling, but they recruit arrestin. They also efficiently scavenge their chemokine ligands, thereby contributing to gradient maintenance and termination. ACKR3, also known as CXCR7, binds and degrades the constitutive chemokine CXCL12, which also binds the canonical receptor CXCR4, and CXCL11, which also binds CXCR3. Here we report comprehensive mutational analysis of the ACKR3 interaction with its chemokine ligands, using 30 substitution mutants. Readouts are radioligand binding competition, arrestin recruitment, and chemokine scavenging. Our results suggest different binding modes for both chemokines. CXCL11 depends on the ACKR3N terminus and some extracellular loop (ECL) positions for primary binding, ECL residues mediate secondary binding and arrestin recruitment potency. CXCL12 binding required key residues Asp-179(4.60) and Asp-275(6.58) (residue numbering follows the Ballesteros-Weinstein scheme), with no evident involvement of N-terminal residues, suggesting an uncommon mode of receptor engagement. Mutation of residues corresponding to CRS2 in CXCR4 (positions Ser-103(2.63) and Gln-301(7.39)) increased CXCL11 binding, but reduced CXCL12 affinity. Mutant Q301E(7.39) did not recruit arrestin. Mutant K118A(3.26) in ECL1 showed moderate baseline arrestin recruitment with ablation of ligand-induced responses. Substitutions that affected CXCL11 binding also diminished scavenging. However, detection of reduced CXCL12 scavenging by mutants with impaired CXCL12 affinity required drastically reduced receptor expression levels, suggesting that scavenging pathways can be saturated and that CXCL12 binding exceeds scavenging at higher receptor expression levels. Arrestin recruitment did not correlate with scavenging; although Q301E(7.39) degraded chemokines in the absence of arrestin, S103D(2.63) had reduced CXCL11 scavenging despite intact arrestin responses.	[Benredjem, Besma; Girard, Melanie; Rhainds, David; Heveker, Nikolaus] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada; [Benredjem, Besma; Girard, Melanie; Rhainds, David; St-Onge, Genevieve; Heveker, Nikolaus] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Heveker, N (corresponding author), St Justine Hosp, Res Ctr, Dept Biochem & Mol Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca			Canadian Institutes of Health Research (CIHR) [MOP123421]; "Fondation Sainte Justine"; "Fonds de Recherche du Quebec Sante" (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); "Fondation Sainte Justine"; "Fonds de Recherche du Quebec Sante" (FRQS)	The work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP123421. The authors declare that they have no conflicts of interest with the contents of this article.r Both authors contributed to this work equally and held scholarships from the "Fondation Sainte Justine."r Recipient of scholarships from CIHR and "Fonds de Recherche du Quebec Sante" (FRQS).	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Borroni EM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003627; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hanes MS, 2015, J BIOL CHEM, V290, P22385, DOI 10.1074/jbc.M115.675108; Hewit KD, 2014, J BIOL CHEM, V289, P12330, DOI 10.1074/jbc.M113.534545; Hoffmann F, 2012, J BIOL CHEM, V287, P28362, DOI 10.1074/jbc.M111.335679; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Montpas N, 2015, BIOCHEMISTRY-US, V54, P1505, DOI 10.1021/bi501526s; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nedjai B, 2012, BRIT J PHARMACOL, V166, P912, DOI 10.1111/j.1476-5381.2011.01660.x; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Ott TR, 2004, J BIOL CHEM, V279, P42383, DOI 10.1074/jbc.M401097200; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rana S, 2010, J BIOL CHEM, V285, P31472, DOI 10.1074/jbc.M110.129213; Scholten DJ, 2014, MOL PHARMACOL, V85, P116, DOI 10.1124/mol.113.088633; Szpakowska M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005664; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhou HP, 1999, ARCH BIOCHEM BIOPHYS, V369, P267, DOI 10.1006/abbi.1999.1368; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	45	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					31	42		10.1074/jbc.M116.762252	http://dx.doi.org/10.1074/jbc.M116.762252			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27875312	hybrid, Green Published			2022-12-26	WOS:000391578000003
J	Kadyrova, LY; Dahal, BK; Kadyrov, FA				Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.			The Major Replicative Histone Chaperone CAF-1 Suppresses the Activity of the DNA Mismatch Repair System in the Cytotoxic Response to a DNA-methylating Agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTL-ALPHA ENDONUCLEASE; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXTRACTS; TUMOR-CELLS; MUTATION AVOIDANCE; POLYMERASES DELTA; ALKYLATING-AGENTS; EXONUCLEASE-I; CHROMATIN	The DNA mismatch repair (MMR) system corrects DNA mismatches in the genome. It is also required for the cytotoxic response of O-6-methylguanine-DNA methyltransferase (MGMT)-deficient mammalian cells and yeast mgt1 Delta rad52 Delta cells to treatment with S(n)1-type methylating agents, which produce cytotoxic O-6-methylguanine (O-6-mG) DNA lesions. Specifically, an activity of the MMR system causes degradation of irreparable O-6-mG-T mispair-containing DNA, triggering cell death; this process forms the basis of treatments of MGMT-deficient cancers with S(n)1-type methylating drugs. Recent research supports the view that degradation of irreparable O-6-mG-T mispair-containing DNA by the MMR system and CAF-1-dependent packaging of the newly replicated DNA into nucleosomes are two concomitant processes that interact with each other. Here, we studied whether CAF-1 modulates the activity of the MMR system in the cytotoxic response to S(n)1-type methylating agents. We found that CAF-1 suppresses the activity of the MMR system in the cytotoxic response of yeast mgt1 Delta rad52 Delta cells to the prototypic S(n)1-type methylating agent N-methyl-N'-nitro-Nnitrosoguanidine. We also report evidence that in human MGMT-deficient cell-free extracts, CAF-1-dependent packaging of irreparable O-6-mG-T mispair-containing DNA into nucleosomes suppresses its degradation by the MMR system. Taken together, these findings suggest that CAF-1-dependent incorporation of irreparable O-6-mG-T mispair-containing DNA into nucleosomes suppresses its degradation by the MMR system, thereby defending the cell against killing by the S(n)1-type methylating agent.	[Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Kadyrov, FA (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	fkadyrov@siumed.edu			NIGMS, National Institutes of Health [R01GM095758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095758] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant R01GM095758. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Blanko ER, 2016, J BIOL CHEM, V291, P9203, DOI 10.1074/jbc.M115.713271; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cejka P, 2005, CURR BIOL, V15, P1395, DOI 10.1016/j.cub.2005.07.032; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; CROSS SL, 1988, MOL CELL BIOL, V8, P945, DOI 10.1128/MCB.8.2.945; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Earley MC, 1998, P NATL ACAD SCI USA, V95, P15487, DOI 10.1073/pnas.95.26.15487; Erdeniz N, 2007, DNA REPAIR, V6, P1463, DOI 10.1016/j.dnarep.2007.04.013; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greene CN, 2001, GENETICS, V159, P65; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; HSIANG YH, 1989, CANCER RES, V49, P5077; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kadyrova LY, 2015, J BIOL CHEM, V290, P24051, DOI 10.1074/jbc.M115.660357; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kolodner RD, 2016, DNA REPAIR, V38, P3, DOI 10.1016/j.dnarep.2015.11.009; KRAKOFF IH, 1968, CANCER RES, V28, P1559; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Li F, 2016, DNA REPAIR, V38, P68, DOI 10.1016/j.dnarep.2015.11.021; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Liang D, 2012, NUCLEIC ACIDS RES, V40, P9604, DOI 10.1093/nar/gks722; Longley MJ, 1997, J BIOL CHEM, V272, P10917; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pena-Diaz J, 2012, TRENDS BIOCHEM SCI, V37, P206, DOI 10.1016/j.tibs.2012.03.001; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Shao HB, 2014, NUCLEIC ACIDS RES, V42, P7104, DOI 10.1093/nar/gku420; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Stone JE, 2006, GENETICS, V173, P1223, DOI 10.1534/genetics.106.055616; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Tsaryk R, 2006, CANCER LETT, V239, P305, DOI 10.1016/j.canlet.2005.08.036; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Umar A, 1997, CANCER RES, V57, P3949; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; XIAO W, 1991, EMBO J, V10, P2179, DOI 10.1002/j.1460-2075.1991.tb07753.x; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; ZHUKOVSKAYA N, 1994, CARCINOGENESIS, V15, P2189, DOI 10.1093/carcin/15.10.2189	86	6	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27298	27312		10.1074/jbc.M116.760561	http://dx.doi.org/10.1074/jbc.M116.760561			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27872185	Green Published, hybrid			2022-12-26	WOS:000391576300027
J	Diaz-Garcia, S; Ahmed, S; Baonza, A				Diaz-Garcia, Sandra; Ahmed, Sara; Baonza, Antonio			Analysis of the Function of Apoptosis during Imaginal Wing Disc Regeneration in Drosophila melanogaster	PLOS ONE			English	Article							JNK SIGNALING PATHWAY; CELL-DEATH; DEPENDENT APOPTOSIS; TISSUE REGENERATION; TRANSDETERMINATION; PROLIFERATION; GROWTH; REQUIRES; ENCODES; KINASE	Regeneration is the ability that allows organisms to replace missing organs or lost tissue after injuries. This ability requires the coordinated activity of different cellular processes, including programmed cell death. Apoptosis plays a key role as a source of signals necessary for regeneration in different organisms. The imaginal discs of Drosophila melanogaster provide a particularly well-characterised model system for studying the cellular and molecular mechanisms underlying regeneration. Although it has been shown that signals produced by apoptotic cells are needed for homeostasis and regeneration of some tissues of this organism, such as the adult midgut, the contribution of apoptosis to disc regeneration remains unclear. Using a new method for studying disc regeneration in physiological conditions, we have defined the pattern of cell death in regenerating discs. Our data indicate that during disc regeneration, cell death increases first at the wound edge, but as regeneration progresses dead cells can be observed in regions far away from the site of damage. This result indicates that apoptotic signals initiated in the wound spread throughout the disc. We also present results which suggest that the partial inhibition of apoptosis does not have a major effect on disc regeneration. Finally, our results suggest that during disc regeneration distinct apoptotic signals might be acting simultaneously.	[Ahmed, Sara; Baonza, Antonio] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Ahmed, Sara; Baonza, Antonio] Univ Autonoma Madrid, Madrid, Spain; [Diaz-Garcia, Sandra] Univ Calif San Diego, Biol Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of California System; University of California San Diego	Baonza, A (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.; Baonza, A (corresponding author), Univ Autonoma Madrid, Madrid, Spain.	abaonza@cbm.csic.es		Baonza, Antonio/0000-0003-3252-0038	MEC [BFU2014-54153-P]; FPI fellowship from the MICINN	MEC(European Commission); FPI fellowship from the MICINN	This work was supported by a grant obtained from the MEC (BFU2014-54153-P). SDG was supported by an FPI fellowship from the MICINN.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Bergantinos C, 2010, BIOESSAYS, V32, P207, DOI 10.1002/bies.200900105; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Bosch M, 2008, INT J DEV BIOL, V52, P1043, DOI 10.1387/ijdb.082608mb; BRYANT PJ, 1971, DEV BIOL, V26, P606, DOI 10.1016/0012-1606(71)90146-1; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Diaz-Garcia S, 2013, P NATL ACAD SCI USA, V110, P13032, DOI 10.1073/pnas.1220543110; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hadorn E., 1968, Revue Suisse de Zoologie, V75, P557; HADORN E., 1962, REV SUISSE ZOOL, V69, P302; Harris RE, 2016, ELIFE, V5, DOI 10.7554/eLife.11588; HAY BA, 1994, DEVELOPMENT, V120, P2121; Herrera SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003446; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Khoo P, 2013, DIS MODEL MECH, V6, P661, DOI 10.1242/dmm.010066; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mattila J, 2005, INT J DEV BIOL, V49, P391, DOI 10.1387/ijdb.052006jm; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2015, DEVELOPMENT, V142, P3253, DOI 10.1242/dev.127878; Perez-Garijo A, 2013, ELIFE, V2, DOI 10.7554/eLife.01004; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Santabarbara-Ruiz P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005595; SCHUBIGER G, 1971, DEV BIOL, V26, P277, DOI 10.1016/0012-1606(71)90127-8; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Sun GP, 2014, CURR TOP DEV BIOL, V108, P95, DOI 10.1016/B978-0-12-391498-9.00003-6; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Vriz S, 2014, CURR TOP DEV BIOL, V108, P121, DOI 10.1016/B978-0-12-391498-9.00002-4; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637	40	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165554	10.1371/journal.pone.0165554	http://dx.doi.org/10.1371/journal.pone.0165554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893747	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400010
J	Igarashi, N; Matsuura, M; Hashimoto, Y; Hirasawa, K; Murata, H; Inoue, T; Ryo, O; Aihara, M; Asaoka, R				Igarashi, Nozomi; Matsuura, Masato; Hashimoto, Yohei; Hirasawa, Kazunori; Murata, Hiroshi; Inoue, Tatsuya; Ryo, Obata; Aihara, Makoto; Asaoka, Ryo			Assessing Visual Fields in Patients with Retinitis Pigmentosa Using a Novel Microperimeter with Eye Tracking: The MP-3	PLOS ONE			English	Article							LONG-TERM FLUCTUATION; MEASURING RATES; GAZE TRACKING; PERIMETRY; THRESHOLD; GLAUCOMA	Purpose The purpose of the current study is to investigate the test-retest reproducibility of visual fields (VFs) measured with the MP-3 microperimeter, in patients with retinitis pigmentosa (RP). Method VFs were twice measured with the MP-3 and also the Humphrey Field Analyzer, using the 10-2 test grid pattern in both perimeters, in 30 eyes (15 right and 15 left eyes) of 18 RP patients (11 males and 7 females). Test-retest reproducibility was assessed using the mean absolute deviation (MAD) measure at all 68 points in the test grid. Reproducibility was also evaluated using the intraclass correlation coefficient (ICC) of VF sensitivities. Result The mean sensitivity measured in the HFA 10-2 was significantly higher than that measured in the MP-3 in both the first and second VF tests (p < 0.0001, linear mixed model). The MAD was 2.4 +/- 0.6 [1.1 to 3.6] dB for MP-3 and 2.4 +/- 0.9 [1.1 to 5.1] dB for HFA 10-2, which was not significantly different (p = 0.76, linear mixed model). The ICC value associated with the MP-3 VFs was 0.81 +/- 0.13 [0.49 to 0.98], which was significantly larger than that observed for the HFA 10-2 VFs: 0.77 +/- 0.19 [0.20 to 0.94] (p = 0.043, linear mixed model). Conclusion The MP-3 microperimeter appears to be useful to evaluate central visual function in RP eyes, exhibiting test-retest reproducibility that is equal to, or better than, that observed in HFA 10-2 VFs.	[Igarashi, Nozomi; Matsuura, Masato; Hashimoto, Yohei; Hirasawa, Kazunori; Murata, Hiroshi; Inoue, Tatsuya; Ryo, Obata; Aihara, Makoto; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan; [Hirasawa, Kazunori] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthopt & Visual Sci, Sagamihara, Kanagawa, Japan	University of Tokyo; Kitasato University	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp		Hirasawa, Kazunori/0000-0001-5100-005X; Igarashi, Nozomi/0000-0002-2275-6285				Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; [Anonymous], 1997, GLOB IN EL AV BLINDN, V97; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Battu R, 2015, EYE, V29, P895, DOI 10.1038/eye.2015.61; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; Demirel S, 1994, J Glaucoma, V3, P28; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; FLAMMER J, 1984, ARCH OPHTHALMOL-CHIC, V102, P880; FLAMMER J, 1984, ARCH OPHTHALMOL-CHIC, V102, P704, DOI 10.1001/archopht.1984.01040030560017; Gonzalez de la Rosa M, 1997, Eur J Ophthalmol, V7, P29; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hirooka K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151000; Ishiyama Y, 2015, INVEST OPHTH VIS SCI, V56, P7801, DOI 10.1167/iovs.15-17988; Ishiyama Y, 2015, INVEST OPHTH VIS SCI, V56, P6233, DOI 10.1167/iovs.15-17661; Jansonius NM, 2010, BRIT J OPHTHALMOL, V94, P1404, DOI 10.1136/bjo.2009.164897; JOHNSON CA, 1988, APPL OPTICS, V27, P1030, DOI 10.1364/AO.27.001030; Murata H, 2014, INVEST OPHTH VIS SCI, V55, P8386, DOI 10.1167/iovs.14-14625; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Schiefer U, 1999, VISION RES, V39, P1897, DOI 10.1016/S0042-6989(98)00295-8; Thylefors B, 1995, OPHTHAL EPIDEMIOL, V2, P5; Wang YF, 2011, INVEST OPHTH VIS SCI, V52, P4546, DOI 10.1167/iovs.10-6553; Zhu HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085654	22	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166666	10.1371/journal.pone.0166666	http://dx.doi.org/10.1371/journal.pone.0166666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893769	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400038
J	Tschinkel, WR; Kwapich, CL				Tschinkel, Walter R.; Kwapich, Christina L.			The Florida Harvester Ant, Pogonomyrmex badius, Relies on Germination to Consume Large Seeds	PLOS ONE			English	Article							VEROMESSOR-PERGANDEI; COLONY SIZE; SOCIOGENESIS; SOCIOMETRY; DESERT; HYMENOPTERA; ALLOCATION; BEHAVIOR; GARDENS	The Florida harvester ant, Pogonomyrmex badius, is one of many ant species and genera that stores large numbers of seeds in damp, underground chambers for later consumption. A comparison of the sizes of seeds recovered from storage chambers with those of seed husks discarded following consumption revealed that the used seeds are far smaller than stored seeds. This difference in use-rate was confirmed in field and laboratory colonies by offering marked seeds of various sizes and monitoring the appearance of size-specific chaff. Because foragers collect a range of seed sizes but only open small seeds, large seeds accumulate, forming 70% or more of the weight of seed stores. Major workers increase the rates at which small and medium seeds are opened, but do not increase the size range of opened seeds. Experiments limiting ant access to portions of natural seed chambers showed that seeds germinate during storage, but that the ants rapidly remove them. When offered alongside non germinating seeds, germinating seeds were preferentially fed to larvae. The rate of germination during the annual cycle was determined by both burial in artificial chambers at various depths and under four laboratory temperatures. The germination rate depends upon the species of seed, the soil/laboratory temperature and/or the elapsed time. The seasonal soil temperature cycle generated germination patterns that vary with the mix of locally-available seeds. Taken together, exploitation of germination greatly increases the resources available to the ants in space and time. While the largest seeds may have the nutritional value of 15 small seeds, the inability of workers to open large seeds at will precludes them from rapid use during catastrophic events. The harvester ant's approach to seed harvesting is therefore two-pronged, with both immediate and delayed payoffs arising from the tendency to forage for a wide variety of seeds sizes.	[Tschinkel, Walter R.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Kwapich, Christina L.] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ USA	State University System of Florida; Florida State University; Arizona State University; Arizona State University-Tempe	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu		Kwapich, Christina/0000-0001-5141-7605	National Science Foundation (US) [IOS 1021632]	National Science Foundation (US)(National Science Foundation (NSF))	This work was funded by National Science Foundation (US) grant IOS 1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the competent and enthusiastic technical help of Nicholas Hanley and Daniel Dominguez. We thank Nichole Ramirez and Danielle Taylor for allowing us to use the results of their student research. Kent Perkins of the University of Florida Herbarium kindly gave us access to their seed collection. Loran Anderson of the Florida State University Herbarium greatly helped with seed identification. This work was carried out under US Forest Service permit APA56302, and was partially supported by National Science Foundation grant IOS 1021632.	CHEW AE, 1980, INSECT SOC, V27, P189, DOI 10.1007/BF02223663; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; Davison E.A., 1982, Geobotany, V4, P1; Eddy TA, 1970, THESIS; Ferster B, 2006, ETHOL ECOL EVOL, V18, P19, DOI 10.1080/08927014.2006.9522723; FEWELL JH, 1991, BEHAV ECOL SOCIOBIOL, V28, P377, DOI 10.1007/BF00164118; Goetsch W, 1957, STAATEN AMEISEN; HANSEN SR, 1978, OECOLOGIA, V35, P109, DOI 10.1007/BF00345544; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Pirk GI, 2010, ECOL RES, V25, P439, DOI 10.1007/s11284-009-0673-7; INOUYE RS, 1980, OECOLOGIA, V46, P235, DOI 10.1007/BF00540131; Jerdon TC, 1851, MADRAS J LIT SCI, V17, P103, DOI DOI 10.1080/03745485709496303; Jones CR, 1927, J COLORADO WYOMING A, V1; Kaufmann E, 2001, INSECT SOC, V48, P125, DOI 10.1007/PL00001754; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; Kwapich CL, 2016, BEHAV ECOL SOCIOBIOL, V70, P221, DOI 10.1007/s00265-015-2039-1; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; Landers JLJ, 1976, TALL TIMBERS MISCELL, V4; LAVIGNE RJ, 1969, ANN ENTOMOL SOC AM, V62, P1166, DOI 10.1093/aesa/62.5.1166; MacGown JA, 2007, MISSISSIPPI NATIVE P, V25, p[1, 4]; MACKAY W P, 1981, Psyche (Cambridge), V88, P25, DOI 10.1155/1981/78635; MACKAY WP, 1984, SOCIOBIOLOGY, V9, P31; Moggridge J.T., 1873, HARVESTING ANTS TRAP; Oettler J, 2009, J INSECT BEHAV, V22, P217, DOI 10.1007/s10905-008-9167-7; Oster G.F., 1978, Monographs in Population Biology, pi; RISSING SW, 1981, BEHAV ECOL SOCIOBIOL, V9, P149, DOI 10.1007/BF00293586; RISSING SW, 1976, PAN-PAC ENTOMOL, V52, P63; Rosene WF, 1988, GUIDE CULTURE FLOWER; Skyes WH, 1835, T ROY; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Smith CR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1479, DOI 10.1007/s00265-007-0380-8; TEVIS L, 1958, ECOLOGY, V39, P695, DOI 10.2307/1931610; TEVIS L, 1958, ECOLOGY, V39, P681, DOI 10.2307/1931608; Treat M, 1879, HARPERS HALF HOUR SE, V123, P5; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120407; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; TSCHINKEL WR, 2004, J INSECT SCI, V0004; WENT FW, 1972, BIOSCIENCE, V22, P82, DOI 10.2307/1296037; Wheeler W, 1910, AM NAT, V91, P5927; WHITFORD WG, 1979, ECOLOGY, V60, P686, DOI 10.2307/1936605; Willard JRA, 1964, THESIS; WILSON E O, 1978, Journal of the Kansas Entomological Society, V51, P615	46	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166907	10.1371/journal.pone.0166907	http://dx.doi.org/10.1371/journal.pone.0166907			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893844	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400054
J	Tappeiner, C; Maurer, E; Sallin, P; Bise, T; Enzmann, V; Tschopp, M				Tappeiner, Christoph; Maurer, Ellinor; Sallin, Pauline; Bise, Thomas; Enzmann, Volker; Tschopp, Markus			Inhibition of the TGF beta Pathway Enhances Retinal Regeneration in Adult Zebrafish	PLOS ONE			English	Article							METHYL-N-NITROSOUREA; MULLER GLIA; CELL-DEATH; PROLIFERATIVE VITREORETINOPATHY; NEURONAL PROGENITORS; GENE-EXPRESSION; GROWTH; PHOTORECEPTORS; DEGENERATION; RECEPTORS	In contrast to the mammalian retina, the zebrafish retina exhibits the potential for lifelong retinal neurogenesis and regeneration even after severe damage. Previous studies have shown that the transforming growth factor beta (TGF beta) signaling pathway is activated during the regeneration of different tissues in the zebrafish and is needed for regeneration in the heart and the fin. In this study, we have investigated the role of the TGF beta pathway in the Nmethyl- N-nitrosourea (MNU)-induced chemical model of rod photoreceptor de-and regeneration in adult zebrafish. Immunohistochemical staining for phosphorylated Smad3 was elevated during retinal regeneration, and phosphorylated Smad3 co-localized with proliferating cell nuclear antigen and glutamine synthetase, indicating TGF beta pathway activation in proliferating Mu E ller glia. Inhibiting the TGF beta signaling pathway using a small molecule inhibitor (SB431542) resulted in accelerated recovery from retinal degeneration. Accordingly, we observed increased cell proliferation in the outer nuclear layer at days 3 to 8 after MNU treatment. In contrast to the observations in the heart and the fin, the inhibition of the TGF beta signaling pathway resulted in increased proliferation after the induction of retinal degeneration. A better understanding of the underlying pathways with the possibility to boost retinal regeneration in adult zebrafish may potentially help to stimulate such proliferation also in other species.	[Tappeiner, Christoph; Maurer, Ellinor; Enzmann, Volker; Tschopp, Markus] Univ Bern, Inselspital, Univ Hosp Bern, Dept Ophthalmol, Bern, Switzerland; [Sallin, Pauline; Bise, Thomas] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Tschopp, Markus] Univ Basel Hosp, Dept Ophthalmol, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Fribourg; University of Basel	Tschopp, M (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Ophthalmol, Bern, Switzerland.	markus.tschopp@windowslive.com		Tschopp, Markus/0000-0001-6684-7325	Berne University Research Foundation; Peter Mayor Gedachtnisstiftung	Berne University Research Foundation; Peter Mayor Gedachtnisstiftung	This research was supported by an unrestricted grant from the Berne University Research Foundation and by the Peter Mayor Gedachtnisstiftung.	Alvarez Y, 2010, DIS MODEL MECH, V3, P236, DOI 10.1242/dmm.003772; Behzadian MA, 1995, GLIA, V15, P480, DOI 10.1002/glia.440150411; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Brand Michael, 2002, P7; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Chablais F, 2012, DEVELOPMENT, V139, P1921, DOI 10.1242/dev.078543; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Close JL, 2005, DEVELOPMENT, V132, P3015, DOI 10.1242/dev.01882; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Davis AA, 2000, MOL CELL NEUROSCI, V15, P11, DOI 10.1006/mcne.1999.0806; Eichler W, 2004, NEUROREPORT, V15, P1633, DOI 10.1097/01.wnr.0000133071.00786.a4; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Hochmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030365; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Huang Y, 2009, J GUANGXI AGR MECHAN, V4, P4, DOI DOI 10.1371/J0URNAL.P0NE.0006550; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035256; Ikeda T, 1998, CURR EYE RES, V17, P546, DOI 10.1076/ceyr.17.5.546.5197; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; JOHNS PR, 1982, J NEUROSCI, V2, P178; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Lenkowski JR, 2013, GLIA, V61, P1687, DOI 10.1002/glia.22549; Maurer E, 2014, JOVE-J VIS EXP, DOI 10.3791/51909; MILLER B, 1986, ARCH OPHTHALMOL-CHIC, V104, P281, DOI 10.1001/archopht.1986.01050140139037; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; OGINO H, 1993, TOXICOL PATHOL, V21, P21, DOI 10.1177/019262339302100103; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; PFEFFER BA, 1994, EXP EYE RES, V59, P323, DOI 10.1006/exer.1994.1114; Powell C, 2013, P NATL ACAD SCI USA, V110, P19814, DOI 10.1073/pnas.1312009110; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; RAYMOND PA, 1988, J COMP NEUROL, V276, P231, DOI 10.1002/cne.902760207; Reisenhofer M, 2015, GRAEF ARCH CLIN EXP, V253, P721, DOI 10.1007/s00417-014-2906-x; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Tappeiner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071064; Tappeiner C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-10; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Tsubura A, 2010, HISTOL HISTOPATHOL, V25, P933, DOI 10.14670/HH-25.933; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Westerfield M, 2007, ZEBRAFISH BOOK	52	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167073	10.1371/journal.pone.0167073	http://dx.doi.org/10.1371/journal.pone.0167073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880821	Green Published, gold			2022-12-26	WOS:000388889500064
J	Heyworth, ER; Ferrari, J				Heyworth, Eleanor R.; Ferrari, Julia			Heat Stress Affects Facultative Symbiont-Mediated Protection from a Parasitoid Wasp	PLOS ONE			English	Article							PEA APHID; ACYRTHOSIPHON-PISUM; BACTERIAL SYMBIONTS; SECONDARY SYMBIONTS; GENETIC-VARIATION; HOST-PLANT; RESISTANCE; ENDOSYMBIONTS; TEMPERATURE; POPULATION	Many insects carry facultative bacterial symbionts, which provide benefits including resistance to natural enemies and abiotic stresses. Little is known about how these beneficial phenotypes are affected when biotic or abiotic threats occur simultaneously. The pea aphid (Acyrthosiphon pisum) can host several well-characterized symbiont species. The symbiont known as X-type can protect against both parasitoid wasps and heat stress. Here, we used three pea aphid genotypes that were naturally infected with X-type and the symbiont Spiroplasma sp. We compared aphids coinfected with these two symbionts with those cured from X-type and infected with only Spiroplasma to investigate the ability of X-type to confer benefits to the host when two threats are experienced simultaneously. Our aim is to explore how robust symbiont protection may be outside a benign laboratory environment. Aphids were subjected to heat shock either before or after attack by parasitoid wasps. Under a benign temperature regime, the aphids carrying X-type tended to be better protected from the parasitoid than those cured. When the aphids experienced a heat shock before being parasitized aphids carrying X-type were more susceptible than those cured. Regardless of infection with the symbiont, the aphids benefitted from being heat shocked after parasitization. The results demonstrate how resistance to parasitoid wasps can be strongly environment-dependent and that a beneficial phenotype conferred by a symbiont under controlled conditions in the laboratory does not necessarily equate to a consistently useful effect in natural populations.	[Heyworth, Eleanor R.; Ferrari, Julia] Univ York, Dept Biol, York, N Yorkshire, England; [Heyworth, Eleanor R.] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	University of York - UK; Uppsala University	Ferrari, J (corresponding author), Univ York, Dept Biol, York, N Yorkshire, England.	julia.ferrari@york.ac.uk	Ferrari, Julia/B-2376-2009	Ferrari, Julia/0000-0001-6519-4254	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F016751/1]; BBSRC [BB/J00524X/1]; Biotechnology and Biological Sciences Research Council [1098546, BB/J00524X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ERH was supported by a studentship from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/, BBSRC award BB/F016751/1) and JF was supported by award BB/J00524X/1 from BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Boivin G, 2012, CAN J PLANT SCI, V92, P1, DOI [10.4141/cjps2011-045, 10.4141/CJPS2011-045]; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Cayetano L, 2013, J EVOLUTION BIOL, V26, P1603, DOI 10.1111/jeb.12154; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Diehl E, 2013, J APPL ECOL, V50, P262, DOI 10.1111/1365-2664.12032; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gauthier JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120664; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Henry LM, 2013, CURR BIOL, V23, P1713, DOI 10.1016/j.cub.2013.07.029; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; Heyworth ER, 2015, J EVOLUTION BIOL, V28, P1753, DOI 10.1111/jeb.12705; Ingels B, 2011, BIOCONTROL, V56, P871, DOI 10.1007/s10526-011-9363-9; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2014, FUNCT ECOL, V28, P315, DOI 10.1111/1365-2435.12089; Lukasik P, 2013, J EVOLUTION BIOL, V26, P2654, DOI 10.1111/jeb.12260; Lukasik P, 2013, OECOLOGIA, V173, P985, DOI 10.1007/s00442-013-2660-5; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Malina Radovan, 2008, Plant Protection Science, V44, P19; Martinez AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154670; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Neelakanta G, 2010, J CLIN INVEST, V120, P3179, DOI 10.1172/JCI42868; Nyabuga FN, 2010, ENTOMOL EXP APPL, V136, P243, DOI 10.1111/j.1570-7458.2010.01021.x; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; R Core Team, 2012, R LANG ENV STAT COMP; Rothacher L, 2016, ECOLOGY, V97, P1712, DOI 10.1890/15-2022.1; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Sanders D, 2016, ECOL LETT, V19, P789, DOI 10.1111/ele.12616; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Simon JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021831; Smith AH, 2015, MOL ECOL, V24, P1135, DOI 10.1111/mec.13095; Steinkraus DC, 2006, J INVERTEBR PATHOL, V92, P125, DOI 10.1016/j.jip.2006.03.009; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vorburger C, 2008, BIOL LETTERS, V4, P674, DOI 10.1098/rsbl.2008.0382; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; White JA, 2011, BIOESSAYS, V33, P823, DOI 10.1002/bies.201100095; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149	52	25	25	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167180	10.1371/journal.pone.0167180	http://dx.doi.org/10.1371/journal.pone.0167180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875577	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000388886000055
J	Kanda, E; Al, M; Okazaki, M; Yoshida, M; Maeda, Y				Kanda, Eiichiro; Al, Masumi; Okazaki, Mitsuyo; Yoshida, Masayuki; Maeda, Yoshitaka			Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; INSULIN-RESISTANCE; PREDIALYSIS PATIENTS; DOWN-REGULATION; RENAL-DISEASE; CHOLESTEROL; RISK; DYSLIPIDEMIA; GENE; METABOLISM	Background Atherosclerosis is often a complication of chronic kidney disease (CKD) because of dyslipidemia and CKD-mineral and bone disorder. High-density lipoproteins (HDLs) are grouped into various subclasses composed of multiple proteins and lipids, and their transformation is altered in CKD. We investigated the roles of lipoprotein subclasses in CKD progression, and atherosclerosis, and the relationships with Klotho and fibroblast growth factor (FGF) 23. Methods Seventy-one CKD patients were enrolled in this prospective cohort study in Japan. The proportions of cholesterol level to total cholesterol level (cholesterol proportion) and lipoprotein particle numbers in 20 lipoprotein fractions were measured by a newly developed high-performance gel permeation chromatography. Results Diabetic nephropathy was observed in 23.9% of the patients. The mean age was 75.0 years and estimated glomerular filtration rate (eGFR) was 17.2 ml/min./1.73m(2). The lipoprotein particle numbers in small HDLs were higher in Stage 4 group than in Stage 5 group (p = 0.002). Multivariate regression analysis adjusted for baseline characteristics showed that the cholesterol proportions in very small HDLs were associated with eGFR change rate [F19 beta = -17.63, p = 0.036] and ABI [F19 beta = 0.047, p = 0.047] in Stage 4 group, and that serum soluble a-Klotho level was associated with the lipoprotein particle numbers in very small HDLs [F19 beta = 0.00026, p = 0.012; F20 beta = 0.00041, p = 0.036] in Stage 5 group. Conclusions This study showed that HDL subclasses are associated with CKD progression, ABI, and Klotho level in CKD-stage-specific manner.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro; Yoshida, Masayuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Al, Masumi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Insured Med Care Management, Bunkyo Ku, Tokyo, Japan; [Okazaki, Mitsuyo] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan; [Maeda, Yoshitaka] JA Toride Med Ctr, Dept Nephrol, Toride, Ibaraki, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.; Kanda, E (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com			Japanese Association of Dialysis Physicians; JADP [2014-6]	Japanese Association of Dialysis Physicians; JADP	The funder was the Japanese Association of Dialysis Physicians. The grant number was JADP Grant 2014-6, and the URL is http://www.touseki.ikai.or.jp/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Japanese Association of Dialysis Physicians. The authors declare that there is no conflict of interest regarding the publication of this paper.	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Ashikaga E, 2010, THER APHER DIAL, V14, P315, DOI 10.1111/j.1744-9987.2009.00796.x; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Chu M, 2012, BRIT J BIOMED SCI, V69, P99, DOI 10.1080/09674845.2012.12069133; Deighan CJ, 2000, AM J KIDNEY DIS, V35, P852, DOI 10.1016/S0272-6386(00)70255-1; Fang YF, 2014, KIDNEY INT, V85, P142, DOI 10.1038/ki.2013.271; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GUARNIERI GF, 1978, KIDNEY INT, pS26; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Honda H, 2016, J ATHEROSCLER THROMB, V23, P81, DOI 10.5551/jat.30015; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kimura H, 2003, KIDNEY INT, V64, P1829, DOI 10.1046/j.1523-1755.2003.00285.x; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kwan BCH, 2007, J AM SOC NEPHROL, V18, P1246, DOI 10.1681/ASN.2006091006; Lamprea-Montealegre JA, 2012, CLIN J AM SOC NEPHRO, V7, P1777, DOI 10.2215/CJN.02090212; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Maeda S, 2012, J ATHEROSCLER THROMB, V19, P444; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mirza MAI, 2011, ARTERIOSCL THROM VAS, V31, P219, DOI 10.1161/ATVBAHA.110.214619; Montford JR, 2013, AM J NEPHROL, V37, P183, DOI 10.1159/000346941; MORDASINI R, 1977, NEW ENGL J MED, V297, P1362, DOI 10.1056/NEJM197712222972502; Moriyama K, 2014, DIABETES RES CLIN PR, V106, P360, DOI 10.1016/j.diabres.2014.08.007; Nephrology JSo, 2014, EVIDENCE BASED CLIN; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Okazaki M, 2016, J OLEO SCI, V65, P265, DOI 10.5650/jos.ess16020; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rajman I, 1998, NEPHROL DIAL TRANSPL, V13, P2281, DOI 10.1093/ndt/13.9.2281; Rhee EJ, 2006, J ENDOCRINOL INVEST, V29, P613, DOI 10.1007/BF03344160; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Shimoyama Y, 2009, AM J NEPHROL, V30, P383, DOI 10.1159/000235686; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Shoji T, 2002, KIDNEY INT, V61, P2187, DOI 10.1046/j.1523-1755.2002.00372.x; Superko HR, 2012, J CLIN LIPIDOL, V6, P496, DOI 10.1016/j.jacl.2012.03.001; TASKINEN MR, 1995, CURR OPIN LIPIDOL, V6, P153, DOI 10.1097/00041433-199506000-00007; Unger RH, 2006, NAT MED, V12, P56, DOI 10.1038/nm0106-56; Usui S, 2002, J LIPID RES, V43, P805; Vaziri ND, 2002, HYPERTENSION, V39, P135, DOI 10.1161/hy0102.100540; Vaziri ND, 2001, KIDNEY INT, V59, P2192, DOI 10.1046/j.1523-1755.2001.00734.x; Vaziri ND, 1998, AM J PHYSIOL-RENAL, V274, pF642, DOI 10.1152/ajprenal.1998.274.4.F642; Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204; Wojcik M, 2012, CLIN ENDOCRINOL, V77, P537, DOI 10.1111/j.1365-2265.2011.04299.x; Yaghoubi F, 2016, J RENAL INJ PREV, V5, P104, DOI 10.15171/jrip.2016.22; Zewinger S, 2014, J AM SOC NEPHROL, V25, P1073, DOI 10.1681/ASN.2013050482	49	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166459	10.1371/journal.pone.0166459	http://dx.doi.org/10.1371/journal.pone.0166459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861640	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300058
J	Wilson, C; Qiu, L; Hong, Y; Karnik, T; Tadros, G; Mau, B; Ma, T; Mu, Y; New, J; Louie, RJ; Gunewardena, S; Godwin, AK; Tawfik, OW; Chien, J; Roby, KF; Krieg, AJ				Wilson, C.; Qiu, L.; Hong, Y.; Karnik, T.; Tadros, G.; Mau, B.; Ma, T.; Mu, Y.; New, J.; Louie, R. J.; Gunewardena, S.; Godwin, A. K.; Tawfik, O. W.; Chien, J.; Roby, K. F.; Krieg, A. J.			The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer	ONCOGENE			English	Article							LYSINE DEMETHYLASE; GENE-EXPRESSION; GROWTH-FACTOR; COPY GAIN; HYPOXIA; METASTASIS; TARGET; JMJD2B; CELLS; METHYLATION	Epithelial ovarian cancer (EOC) has poor prognosis and rapid recurrence because of widespread dissemination of peritoneal metastases at diagnosis. Multiple pathways contribute to the aggressiveness of ovarian cancer, including hypoxic signaling mechanisms. In this study, we have determined that the hypoxia-inducible histone demethylase KDM4B is expressed in similar to 60% of EOC tumors assayed, including primary and matched metastatic tumors. Expression of KDM4B in tumors is positively correlated with expression of the tumor hypoxia marker CA-IX, and is robustly induced in EOC cell lines exposed to hypoxia. KDM4B regulates expression of metastatic genes and pathways, and loss of KDM4B increases H3K9 trimethylation at the promoters of target genes like LOXL2, LCN2 and PDGFB. Suppressing KDM4B inhibits ovarian cancer cell invasion, migration and spheroid formation in vitro. KDM4B also regulates seeding and growth of peritoneal tumors in vivo, where its expression corresponds to hypoxic regions. This is the first demonstration that a Jumonji-domain histone demethylase regulates cellular processes required for peritoneal dissemination of cancer cells, one of the predominant factors affecting prognosis of EOC. The pathways regulated by KDM4B may present novel opportunities to develop combinatorial therapies to improve existing therapies for EOC patients.	[Wilson, C.; Qiu, L.; Hong, Y.; Mu, Y.; Krieg, A. J.] Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Kansas City, KS 66103 USA; [Wilson, C.; Qiu, L.; Karnik, T.; Tadros, G.; Mau, B.; Ma, T.; Godwin, A. K.; Tawfik, O. W.; Krieg, A. J.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [New, J.] Univ Kansas, Med Ctr, Med Scholars Program, Kansas City, KS 66103 USA; [Louie, R. J.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Gunewardena, S.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Chien, J.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA; [Roby, K. F.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Krieg, A. J.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of California System; University of California San Francisco; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Oregon Health & Science University	Krieg, AJ (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave,Mail Stop L584, Beaverton, OR 97006 USA.	kriega@ohsu.edu	Chien, Jeremy/AID-8939-2022	New, Jacob/0000-0003-0707-9324; Chien, Jeremy/0000-0003-4744-8374; Krieg, Adam/0000-0002-3069-0378	Institutional Development Award (IDeA) [P20GM104936]; American Cancer Society Institutional Research Grant [ACS IRG-09-062-04]; KUMC Department of OB/GYN start-up funds; KU Cancer Center's Cancer Center Support Grant [P30 CA168524]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER	Institutional Development Award (IDeA); American Cancer Society Institutional Research Grant(American Cancer Society); KUMC Department of OB/GYN start-up funds; KU Cancer Center's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by an Institutional Development Award (IDeA) P20GM104936 (to AJK and SG), an American Cancer Society Institutional Research Grant ACS IRG-09-062-04 (to AJK) and KUMC Department of OB/GYN start-up funds (to AJK). We thank the staff of the University of Kansas Cancer Center's Biospecimen Repository Core Facility staff for specimen collection (Colleen Reilly and Zaid Naima) and for excellent histological assistance in the creation of the TMAs (Dr Rashna Madan and Tara Meyer). We acknowledge the KU Cancer Center's Cancer Center Support Grant (P30 CA168524 to AJK, AKG, JC, KFR). Special appreciation is given to Dr Denise A Chan (UCSF), whose untimely passing in 2014 prevents inclusion as a co-author.	ACS, 2015, AM CANC SOC CANC FAC; Agger K, 2016, GENE DEV, V30, P1278, DOI 10.1101/gad.280495.116; Apte SM, 2004, GYNECOL ONCOL, V93, P78, DOI 10.1016/j.ygyno.2003.12.041; Barker HE, 2011, FUTURE ONCOL, V7, P707, DOI [10.2217/fon.11.46, 10.2217/FON.11.46]; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Birner P, 2001, CLIN CANCER RES, V7, P1661; Black JC, 2015, GENE DEV, V29, P1018, DOI 10.1101/gad.259796.115; Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Goode EL, 2011, CANCER EPIDEM BIOMAR, V20, P1638, DOI 10.1158/1055-9965.EPI-11-0455; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; Joberty G, 2016, ACS CHEM BIOL, V11, P2002, DOI 10.1021/acschembio.6b00080; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lu CH, 2010, CANCER BIOL THER, V9, P176, DOI 10.4161/cbt.9.3.10635; Maes C, 2012, NAT REV RHEUMATOL, V8, P358, DOI 10.1038/nrrheum.2012.36; Maes T, 2015, CURR OPIN PHARMACOL, V23, P52, DOI 10.1016/j.coph.2015.05.009; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Pack LR, 2016, J BIOL CHEM, V291, P6060, DOI 10.1074/jbc.M115.696864; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rai G., 2010, PROBE REPORTS NIH MO; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Swenson-Fields KI, 2013, KIDNEY INT, V83, P855, DOI 10.1038/ki.2012.446; Thalhammer A, 2011, ORG BIOMOL CHEM, V9, P127, DOI 10.1039/c0ob00592d; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Zhao L, 2013, CLIN CANCER RES, V19, P6419, DOI 10.1158/1078-0432.CCR-13-0254	52	34	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2565	2576		10.1038/onc.2016.412	http://dx.doi.org/10.1038/onc.2016.412			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27869162	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000400597300007
J	Alcaino, C; Musgaard, M; Minguez, T; Mazzaferro, S; Faundez, M; Iturriaga-Vasquez, P; Biggin, PC; Bermudez, I				Alcaino, Constanza; Musgaard, Maria; Minguez, Teresa; Mazzaferro, Simone; Faundez, Manuel; Iturriaga-Vasquez, Patricio; Biggin, Philip C.; Bermudez, Isabel			Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; BINDING-SITES; AGONIST-BINDING; SUBUNIT; POTENTIATION; SENSITIVITY; IDENTIFICATION; INTERFACE; DESFORMYLFLUSTRABROMINE	Allosteric modulators of pentameric ligand-gated ion channels are thought to act on elements of the pathways that couple agonist binding to channel gating. Using alpha 4 beta 2 nicotinic acetylcholine receptors and the alpha 4 beta 2-selective positive modulators 17 beta-estradiol (beta EST) and desformylflustrabromine (dFBr), we have identified pathways that link the binding sites for these modulators to the Cys loop, a region that is critical for channel gating in all pentameric ligand-gated ion channels. Previous studies have shown that the binding site for potentiating beta EST is in the C-terminal (post-M4) region of the alpha 4 subunit. Here, using homology modeling in combination with mutagenesis and electrophysiology, we identified the binding site for potentiating dFBr on the top half of a cavity between the third (M3) and fourth transmembrane (M4) alpha-helices of the alpha 4 subunit. We found that the binding sites for beta EST and dFBr communicate with the Cys loop, through interactions between the last residue of post-M4 and Phe(170) of the conserved FPF sequence of the Cys loop, and that these interactions affect potentiating efficacy. In addition, interactions between a residue in M3 (Tyr(309)) and Phe(167), a residue adjacent to the Cys loop FPF motif, also affect dFBr potentiating efficacy. Thus, the Cys loop acts as a key control element in the allosteric transduction pathway for potentiating beta EST and dFBr. Overall, we propose that positive allosteric modulators that bind the M3-M4 cavity or post-M4 region increase the efficacy of channel gating through interactions with the Cys loop.	[Alcaino, Constanza; Minguez, Teresa; Mazzaferro, Simone; Bermudez, Isabel] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Musgaard, Maria; Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Faundez, Manuel] Univ Chile, Fac Sci, Santiago 7800003, Chile; [Iturriaga-Vasquez, Patricio] Univ La Frontera, Fac Ingn & Ciencias, Dept Ciencias Quim & Recursos Nat, Temuco 4811230, Chile	Oxford Brookes University; University of Oxford; Universidad de Chile; Universidad de La Frontera	Bermudez, I (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England.	ibermudez@brookes.ac.uk	Viñas, Teresa Minguez/ABI-7354-2020; Alcaino, Constanza/AAD-9788-2020	Viñas, Teresa Minguez/0000-0001-8049-3869; Alcaino, Constanza/0000-0001-9595-4330; Mazzaferro, Simone/0000-0003-4402-5325; Faundez Parraguez, Manuel/0000-0002-1621-5327; Bermudez, Isabel/0000-0001-7692-1509; Musgaard, Maria/0000-0001-6096-9014; Biggin, Philip/0000-0001-5100-8836	Oxford Brookes University; Leverhulme Trust [RPG-059]; Alfred Benzon Foundation; CONYCIT [1150615]	Oxford Brookes University; Leverhulme Trust(Leverhulme Trust); Alfred Benzon Foundation; CONYCIT	The work was supported by Oxford Brookes University funding (to C. A. and S. M.), Leverhulme Trust Grant RPG-059 (to M. M.), Alfred Benzon Foundation funding (to M. M.), and CONYCIT Grant 1150615 (to P. I.-V. and M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bondarenko V, 2013, BBA-BIOMEMBRANES, V1828, P398, DOI 10.1016/j.bbamem.2012.09.014; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Broad LM, 2006, J PHARMACOL EXP THER, V318, P1108, DOI 10.1124/jpet.106.104505; Cadugan DJ, 2007, BIOPHYS J, V93, P859, DOI 10.1529/biophysj.107.105171; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Cecchini M, 2015, NEUROPHARMACOLOGY, V96, P137, DOI 10.1016/j.neuropharm.2014.12.006; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; De Rosa MJ, 2002, MOL PHARMACOL, V62, P406, DOI 10.1124/mol.62.2.406; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hsiao B, 2001, J NEUROSCI, V21, P1848, DOI 10.1523/JNEUROSCI.21-06-01848.2001; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Jin XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144631; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Pandya A, 2011, J MOL NEUROSCI, V45, P42, DOI 10.1007/s12031-011-9509-3; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Sala F, 2005, NEUROSCI LETT, V373, P144, DOI 10.1016/j.neulet.2004.10.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Weltzin MM, 2015, J PHARMACOL EXP THER, V354, P184, DOI 10.1124/jpet.115.223933; Weltzin MM, 2014, EUR J PHARMACOL, V732, P159, DOI 10.1016/j.ejphar.2012.06.001; Weltzin MM, 2010, J PHARMACOL EXP THER, V334, P917, DOI 10.1124/jpet.110.167684; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	45	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					551	562		10.1074/jbc.M116.751206	http://dx.doi.org/10.1074/jbc.M116.751206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27864368	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000392316100012
J	Harshbarger, W; Gondi, S; Ficarro, SB; Hunter, J; Udayakumar, D; Gurbani, D; Singer, WD; Liu, Y; Li, LB; Marto, JA; Westover, KD				Harshbarger, Wayne; Gondi, Sudershan; Ficarro, Scott B.; Hunter, John; Udayakumar, Durga; Gurbani, Deepak; Singer, William D.; Liu, Yan; Li, Lianbo; Marto, Jarrod A.; Westover, Kenneth D.			Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; TUMOR-CELLS; EXPRESSION; POTENT; GST; JNK; CONJUGATE; APOPTOSIS; AUTOPHAGY; BINDING	Glutathione S-transferase pi 1 (GSTP1) is frequently overexpressed in cancerous tumors and is a putative target of the plant compound piperlongumine (PL), which contains two reactive olefins and inhibits proliferation in cancer cells but not normal cells. PL exposure of cancer cells results in increased reactive oxygen species and decreased GSH. These data in tandem with other information led to the conclusion that PL inhibits GSTP1, which forms covalent bonds between GSH and various electrophilic compounds, through covalent adduct formation at the C7-C8 olefin of PL, whereas the C2-C3 olefin of PL was postulated to react with GSH. However, direct evidence for this mechanism has been lacking. To investigate, we solved the X-ray crystal structure of GSTP1 bound to PL and GSH at 1.1 angstrom resolution to rationalize previously reported structure activity relationship studies. Surprisingly, the structure showed that a hydrolysis product of PL (hPL) was conjugated to glutathione at the C7-C8 olefin, and this complex was bound to the active site of GSTP1; no covalent bond formation between hPL and GSTP1 was observed. Mass spectrometry (MS) analysis of the reactions between PL and GSTP1 confirmed that PL does not label GSTP1. Moreover, MS data also indicated that nucleophilic attack on PL at the C2-C3 olefin led to PL hydrolysis. Although hPL inhibits GSTP1 enzymatic activity in vitro, treatment of cells susceptible to PL with hPL did not have significant antiproliferative effects, suggesting that hPL is not membrane-permeable. Altogether, our data suggest a model wherein PL is a prodrug whose intracellular hydrolysis initiates the formation of the hPL-GSH conjugate, which blocks the active site of and inhibits GSTP1 and thereby cancer cell proliferation.	[Harshbarger, Wayne; Gondi, Sudershan; Hunter, John; Udayakumar, Durga; Gurbani, Deepak; Singer, William D.; Liu, Yan; Li, Lianbo; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Harshbarger, Wayne; Gondi, Sudershan; Hunter, John; Udayakumar, Durga; Gurbani, Deepak; Singer, William D.; Liu, Yan; Li, Lianbo; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	kenneth.westover@utsouthwestern.edu	Westover, Ken/AAZ-1795-2020; Li, Lianbo/H-1152-2011	Westover, Ken/0000-0003-3653-5923; Li, Lianbo/0000-0003-0107-7125; GURBANI, DEEPAK/0000-0002-0982-7173	U.S. Department of Energy, Office of Biological and Environmental Research [DEAC02-06CH11357]	U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DEAC02-06CH11357.	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Asakura T, 2007, APOPTOSIS, V12, P1269, DOI 10.1007/s10495-007-0053-0; Bharadwaj U, 2015, ONCOGENE, V34, P1341, DOI 10.1038/onc.2014.72; Boskovic ZV, 2013, TETRAHEDRON, V69, P7559, DOI 10.1016/j.tet.2013.05.080; Chen JL, 2014, BIOCHEM BIOPH RES CO, V447, P77, DOI 10.1016/j.bbrc.2014.03.100; CIACCIO PJ, 1990, CANCER COMMUN, V2, P279, DOI 10.3727/095535490820874263; Elsby R, 2003, J BIOL CHEM, V278, P22243, DOI 10.1074/jbc.M301211200; Federici L, 2009, CANCER RES, V69, P8025, DOI 10.1158/0008-5472.CAN-09-1314; Ficarro SB, 2009, ANAL CHEM, V81, P4566, DOI 10.1021/ac9004452; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Ginzburg S, 2014, PROSTATE, V74, P177, DOI 10.1002/pros.22739; Han JG, 2014, MOL CANCER THER, V13, P2422, DOI 10.1158/1535-7163.MCT-14-0171; Han SS, 2013, LEUKEMIA RES, V37, P146, DOI 10.1016/j.leukres.2012.11.009; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Jarvius M, 2013, BIOCHEM BIOPH RES CO, V431, P117, DOI 10.1016/j.bbrc.2013.01.017; Jin HO, 2014, J CANCER RES CLIN, V140, P2039, DOI 10.1007/s00432-014-1777-1; Kim TH, 2014, NEURO-ONCOLOGY, V16, P1354, DOI 10.1093/neuonc/nou088; KODERA Y, 1994, CANCER CHEMOTH PHARM, V34, P203; Lee H.H., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0134486; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Liu JM, 2013, BIOCHEM BIOPH RES CO, V437, P87, DOI 10.1016/j.bbrc.2013.06.042; Liu YY, 2014, NANOSCALE, V6, P4325, DOI 10.1039/c3nr06599e; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; MANNERVIK B, 1987, CARCINOGENESIS, V8, P1929, DOI 10.1093/carcin/8.12.1929; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morgan AS, 1996, CANCER CHEMOTH PHARM, V37, P363, DOI 10.1007/s002800050398; Niu MS, 2015, CHEM-BIOL INTERACT, V237, P66, DOI 10.1016/j.cbi.2015.05.016; Niu MS, 2015, BIOCHEM BIOPH RES CO, V462, P326, DOI 10.1016/j.bbrc.2015.04.136; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; Parikh JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-364; Patel K, 2015, J PHARM SCI-US, V104, P4417, DOI 10.1002/jps.24637; Pei SS, 2013, J BIOL CHEM, V288, P33542, DOI 10.1074/jbc.M113.511170; PLOEMEN JHTM, 1993, XENOBIOTICA, V23, P913, DOI 10.3109/00498259309059418; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Randhawa H, 2013, TOXICOL IN VITRO, V27, P1626, DOI 10.1016/j.tiv.2013.04.006; SINGER WD, 1992, BIOCHEM PHARMACOL, V43, P545, DOI 10.1016/0006-2952(92)90577-6; Tsuboi K, 2011, J AM CHEM SOC, V133, P16605, DOI 10.1021/ja2066972; Wang F, 2015, INT J IMMUNOPATH PH, V28, P362, DOI 10.1177/0394632015598849; Wang W, 2007, EUR J PHARMACOL, V568, P61, DOI 10.1016/j.ejphar.2007.04.021; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.358; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zou P, 2015, ONCOTARGET, V6, P36505, DOI 10.18632/oncotarget.5364	46	51	52	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					112	120		10.1074/jbc.M116.750299	http://dx.doi.org/10.1074/jbc.M116.750299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872191	Green Published, hybrid			2022-12-26	WOS:000391578000010
J	Kesavardhana, S; Das, R; Citron, M; Datta, R; Ecto, L; Srilatha, NS; DiStefano, D; Swoyer, R; Joyce, JG; Dutta, S; LaBranche, CC; Montefiori, DC; Flynn, JA; Varadarajan, R				Kesavardhana, Sannula; Das, Raksha; Citron, Michael; Datta, Rohini; Ecto, Linda; Srilatha, Nonavinakere Seetharam; DiStefano, Daniel; Swoyer, Ryan; Joyce, Joseph G.; Dutta, Somnath; LaBranche, Celia C.; Montefiori, David C.; Flynn, Jessica A.; Varadarajan, Raghavan			Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMOLECULAR DISULFIDE BOND; TYPE-1 ENVELOPE GLYCOPROTEIN; STANDARDIZED ASSESSMENTS; VACCINE; POTENT; BROAD; ENV; IMMUNOGEN; EFFICACY; RESPONSES	A major goal for HIV-1 vaccine development is an ability to elicit strong and durable broadly neutralizing antibody (bNAb) responses. The trimeric envelope glycoprotein (Env) spikes on HIV-1 are known to contain multiple epitopes that are susceptible to bNAbs isolated from infected individuals. Nonetheless, all trimeric and monomeric Env immunogens designed to date have failed to elicit such antibodies. We report the structure-guided design of HIV-1 cyclically permuted gp120 that forms homogeneous, stable trimers, and displays enhanced binding to multiple bNAbs, including VRC01, VRC03, VRCPG04, PGT128, and the quaternary epitope-specific bNAbs PGT145 and PGDM1400. Constructs that were cyclically permuted in the V1 loop region and contained an N-terminal trimerization domain to stabilize V1V2-mediated quaternary interactions, showed the highest homogeneity and the best antigenic characteristics. In guinea pigs, a DNA prime-protein boost regimen with these new gp120 trimer immunogens elicited potent neutralizing antibody responses against highly sensitive Tier 1A isolates and weaker neutralizing antibody responses with an average titer of about 115 against a panel of heterologous Tier 2 isolates. A modest fraction of the Tier 2 virus neutralizing activity appeared to target the CD4 binding site on gp120. These results suggest that cyclically permuted HIV-1 gp120 trimers represent a viable platform in which further modifications may be made to eventually achieve protective bNAb responses.	[Kesavardhana, Sannula; Das, Raksha; Datta, Rohini; Srilatha, Nonavinakere Seetharam; Dutta, Somnath; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Citron, Michael; Ecto, Linda; DiStefano, Daniel; Swoyer, Ryan; Joyce, Joseph G.; Flynn, Jessica A.] Merck & Co Inc, West Point, PA 19486 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27705 USA	Indian Institute of Science (IISC) - Bangalore; Merck & Company; Duke University	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.; Flynn, JA (corresponding author), Merck & Co Inc, West Point, PA 19486 USA.	jessica_flynn@merck.com; varadar@mbu.iisc.ernet.in	Datta, Rohini/ABB-7867-2020; Dutta, Somnath/AAI-2977-2020	Dutta, Somnath/0000-0002-3181-0108; Datta, Rohini/0000-0003-2693-1922	Department of Biotechnology Government of India; Department of Science and Technology Government of India; International AIDS Vaccine Initiative; National Institutes of Health NIAID [R01AI118366, HHSN27201100016C]; Council of Scientific and Industrial Research, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118366] Funding Source: NIH RePORTER	Department of Biotechnology Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology Government of India(Department of Science & Technology (India)); International AIDS Vaccine Initiative; National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Departments of Biotechnology and Science and Technology Government of India, the International AIDS Vaccine Initiative, and National Institutes of Health NIAID Grant R01AI118366 (to R. V.), and National Institutes of Health NIAID Contract HHSN27201100016C (to D. C. M.) for the neutralizing antibody assays. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a fellowship from the Council of Scientific and Industrial Research, Government of India.	Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Dames SA, 1998, NAT STRUCT BIOL, V5, P687, DOI 10.1038/1382; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kesavardhana S, 2014, J VIROL, V88, P9590, DOI 10.1128/JVI.00494-14; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2007, CHANNELS, V1; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu J., 2008, EURASIP J ADV SIG PR, V2008, P1, DOI DOI 10.1074/JBC.M802695200; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Nicely NI, 2015, EBIOMEDICINE, V2, P713, DOI 10.1016/j.ebiom.2015.06.016; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; Priya RS, 2015, J BIOL CHEM, V290, P9195, DOI 10.1074/jbc.M114.621185; Rathore U, 2014, BBA-PROTEINS PROTEOM, V1844, P1891, DOI 10.1016/j.bbapap.2014.05.010; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2016, J VIROL, V90, P636, DOI 10.1128/JVI.01645-15	71	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					278	291		10.1074/jbc.M116.725614	http://dx.doi.org/10.1074/jbc.M116.725614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879316	Green Published, hybrid			2022-12-26	WOS:000391578000024
J	Gierisch, ME; Pfistner, F; Lopez-Garcia, LA; Harder, L; Schafer, BW; Niggli, FK				Gierisch, Maria E.; Pfistner, Franziska; Lopez-Garcia, Laura A.; Harder, Lena; Schafer, Beat W.; Niggli, Felix K.			Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS TRANSCRIPTION FACTORS; EWINGS-SARCOMA; DNA-BINDING; PROSTATE-CANCER; ONCOGENIC PHENOTYPE; GENE FUSIONS; TUMOR-CELLS; TARGET GENE; FAMILY; DOMAIN	E-26 transformation-specific (ETS) proteins are transcription factors directing gene expression through their conserved DNA binding domain. They are implicated as truncated forms or interchromosomal rearrangements in a variety of tumors including Ewing sarcoma, a pediatric tumor of the bone. Tumor cells express the chimeric oncoprotein EWS-FLI1 from a specific t(22;11)(q24;12) translocation. EWS-FLI1 harbors a strong transactivation domain from EWSR1 and the DNA-binding ETS domain of FLI1 in the C-terminal part of the protein. Although Ewing cells are crucially dependent on continuous expression of EWS-FLI1, its regulation of turnover has not been characterized in detail. Here, we identify the EWS-FLI1 protein as a substrate of the ubiquitin-proteasome system with a characteristic polyubiquitination pattern. Using a global protein stability approach, we determined the half-life of EWS-FLI1 to lie between 2 and 4 h, whereas full-length EWSR1 and FLI1 were more stable. By mass spectrometry, we identified two ubiquitin acceptor lysine residues of which only mutation of Lys-380 in the ETS domain of the FLI1 part abolished EWS-FLI1 ubiquitination and stabilized the protein posttranslationally. Expression of this highly stable mutant protein in Ewing cells while simultaneously depleting the endogenous wild type protein differentially modulates two subgroups of target genes to be either EWS-FLI1 protein-dependent or turnover-dependent. The majority of target genes are in an unaltered state and cannot be further activated. Our study provides novel insights into EWS-FLI1 turnover, a critical pathway in Ewing sarcoma pathogenesis, and lays new ground to develop novel therapeutic strategies in Ewing sarcoma.	[Schafer, Beat W.] Univ Childrens Hosp, Dept Oncol, Steinwiesstr 32, CH-8032 Zurich, Switzerland; [Schafer, Beat W.] Univ Childrens Hosp, Childrens Res Ctr, Steinwiesstr 32, CH-8032 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich	Schafer, BW (corresponding author), Univ Childrens Hosp, Dept Oncol, Steinwiesstr 32, CH-8032 Zurich, Switzerland.; Schafer, BW (corresponding author), Univ Childrens Hosp, Childrens Res Ctr, Steinwiesstr 32, CH-8032 Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch	Niggli, Felix/L-6547-2017	Niggli, Felix/0000-0002-7553-3712; Schafer, Beat/0000-0001-5988-2915; Gierisch, Maria/0000-0002-8053-4402	Swiss National Science Foundation [31003A-144177]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A-144177. The authors declare that they have no conflicts of interest with the contents of this article.	An J, 2015, MOL CELL, V59, P904, DOI 10.1016/j.molcel.2015.07.025; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Bolstad B, 2005, BIOINFORMATICS COMPU; Boro A, 2012, INT J CANCER, V131, P2153, DOI 10.1002/ijc.27472; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Davidson B, 2001, CLIN CANCER RES, V7, P551; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Elzi DJ, 2014, J PROTEOME RES, V13, P3783, DOI 10.1021/pr500387m; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Gan WJ, 2015, MOL CELL, V59, P917, DOI 10.1016/j.molcel.2015.07.026; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Hagenbuchner J., 2016, BIOCHEM PHARMACOL, V107, P1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Howarth MM, 2014, J CLIN INVEST, V124, P5275, DOI 10.1172/JCI72124; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaenicke LA, 2016, MOL CELL, V61, P54, DOI 10.1016/j.molcel.2015.11.007; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Klevernic IV, 2009, BIOCHEM J, V418, P625, DOI 10.1042/BJ20082097; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Matsunobu T, 2006, CANCER RES, V66, P803, DOI 10.1158/0008-5472.CAN-05-1972; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Schlottmann S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00107; Selvanathan SP, 2015, P NATL ACAD SCI USA, V112, pE1307, DOI 10.1073/pnas.1500536112; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toretsky JA, 1997, J NEURO-ONCOL, V31, P9, DOI 10.1023/A:1005716926800; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	62	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26922	26933		10.1074/jbc.M116.752063	http://dx.doi.org/10.1074/jbc.M116.752063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875302	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000391571400028
J	Davidson, R; Pontasch, JA; Wu, JQ				Davidson, Reshma; Pontasch, Josef A.; Wu, Jian-Qiu			Sbg1 Is a Novel Regulator for the Localization of the beta-Glucan Synthase Bgs1 in Fission Yeast	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SCHIZOSACCHAROMYCES-POMBE; CONTRACTILE-RING; CELL-WALL; SACCHAROMYCES-CEREVISIAE; 1,3-BETA-GLUCAN SYNTHASE; CANDIDA-ALBICANS; POLARIZED GROWTH; SEPTUM FORMATION; ACTOMYOSIN RING	Glucan synthases synthesize glucans, complex polysaccharides that are the major components in fungal cell walls and division septa. Studying regulation of glucan synthases is important as they are essential for fungal cell survival and thus popular targets for anti-fungal drugs. Linear 1,3-beta-glucan is the main component of primary septum and is synthesized by the conserved beta-glucan synthase Bgs1 in fission yeast cytokinesis. It is known that Rho1 GTPase regulates Bgs1 catalytic activity and the F-BAR protein Cdc15 plays a role in Bgs1 delivery to the plasma membrane. Here we characterize a novel protein Sbg1 that is present in a complex with Bgs1 and regulates its protein levels and localization. Sbg1 is essential for contractile-ring constriction and septum formation during cytokinesis. Sbg1 and Bgs1 physically interact and are interdependent for localization to the plasma membrane. Bgs1 is less stable and/or mis-targeted to vacuoles in sbg1 mutants. Moreover, Sbg1 plays an earlier and more important role in Bgs1 trafficking and localization than Cdc15. Together, our data reveal a new mode of regulation for the essential beta-glucan synthase Bgs1 by the novel protein Sbg1.	[Davidson, Reshma; Pontasch, Josef A.; Wu, Jian-Qiu] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Wu, Jian-Qiu] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, JQ (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.; Wu, JQ (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	wu.620@osu.edu	Wu, Jian-qiu/G-6835-2012		National Institutes of Health [GM118746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (https://www.nih.gov/) grant GM118746 to J-QW.	Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Arasada R, 2015, J CELL SCI, V128, P2259, DOI 10.1242/jcs.162974; Arasada R, 2014, CELL REP, V8, P1533, DOI 10.1016/j.celrep.2014.07.048; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Basha A, 2013, CURR MED CHEM, V20, P4859, DOI 10.2174/092986732038131128102220; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; BROWN JL, 1993, GENETICS, V133, P837; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Coffman VC, 2013, J CELL BIOL, V203, P101, DOI 10.1083/jcb.201305022; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Cortes JCG, 2012, J CELL BIOL, V198, P637, DOI 10.1083/jcb.201202015; Davidson R, 2016, METHODS MOL BIOL, V1369, P9, DOI 10.1007/978-1-4939-3145-3_2; Davidson R, 2015, MOL BIOL CELL, V26, P453, DOI 10.1091/mbc.E14-07-1252; de Leon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071510; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Estravis Miguel, 2012, Commun Integr Biol, V5, P370, DOI 10.4161/cib.19977; Hayat M.A., 1986, BASIC TECHNIQUES TRA, V1st ed.; Hayat MA, 2000, PRINCIPLES TECHNIQUE, Vxix; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; Kurita T, 2012, THESIS, V287, P17415, DOI [10.1074/jbc.M111.321018, DOI 10.1074/JBC.M111.321018]; Lackner M, 2014, ANTIMICROB AGENTS CH, V58, P3626, DOI 10.1128/AAC.00123-14; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Lee DW, 1999, BBA-MOL CELL RES, V1450, P145, DOI 10.1016/S0167-4889(99)00041-5; Lee HH, 2002, FEMS MICROBIOL LETT, V208, P253, DOI 10.1016/S0378-1097(02)00463-9; Lee IJ, 2014, MOL BIOL CELL, V25, P2735, DOI 10.1091/mbc.E13-11-0699; Lee IJ, 2012, J CELL SCI, V125, P2973, DOI 10.1242/jcs.102574; Liu JH, 1999, GENETICS, V153, P1193; Liu JH, 2002, MOL BIOL CELL, V13, P989, DOI 10.1091/mbc.01-12-0581; Liu YJ, 2016, MOL BIOL CELL, V27, P2528, DOI 10.1091/mbc.E16-03-0156; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MANNERS DJ, 1973, BIOCHEM J, V135, P31, DOI 10.1042/bj1350031; Martins IM, 2011, J BIOL CHEM, V286, P3484, DOI 10.1074/jbc.M110.174300; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Munoz J, 2013, J CELL BIOL, V203, P265, DOI 10.1083/jcb.201304132; Nakamata K, 2007, J BIOL CHEM, V282, P34315, DOI 10.1074/jbc.M706486200; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Perez P, 2016, CELL MICROBIOL, V18, P1201, DOI 10.1111/cmi.12611; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Proctor SA, 2012, CURR BIOL, V22, P1601, DOI 10.1016/j.cub.2012.06.042; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sethi K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006383; SIETSMA JH, 1981, J GEN MICROBIOL, V125, P209; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Tang X, 2011, YEAST, V28, P205, DOI 10.1002/yea.1831; Thiyagarajan S, 2015, J CELL SCI, V128, P3672, DOI 10.1242/jcs.166926; Wang N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002437; Wang N, 2015, MOL BIOL CELL, V26, P238, DOI 10.1091/mbc.E14-07-1196; WATANABE S, 1988, J ELECTRON MICROSC, V37, P89; Wloka C, 2012, CYTOSKELETON, V69, P710, DOI 10.1002/cm.21046; WOODS A, 1989, J CELL SCI, V93, P491; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Ye YF, 2012, MOL BIOL CELL, V23, P1181, DOI 10.1091/mbc.E11-09-0800; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045324; Zhou Z, 2015, MOL BIOL CELL, V26, P78, DOI 10.1091/mbc.E14-10-1441; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167043	10.1371/journal.pone.0167043	http://dx.doi.org/10.1371/journal.pone.0167043			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898700	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000031
J	Jeurissen, MLJ; Walenbergh, SMA; Houben, T; Hendrikx, T; Li, JY; Oligschlaeger, Y; van Gorp, PJ; Gijbels, MJJ; Bitorina, A; Nessel, I; Radtke, F; Vooijs, M; Theys, J; Shiri-Sverdlov, R				Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Radtke, Freddy; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit			Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in LdIr(-/-) Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DELTA-LIKE 4; NOTCH LIGAND; MACROPHAGE ACTIVATION; ADAPTIVE IMMUNITY; QUANTITATIVE PCR; ATHEROSCLEROSIS; EXPRESSION; RECEPTORS; REGULATOR	Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (LdIr(-/-) mice reduces hepatic inflammation. Irradiated LdIr(-/-) mice were transplanted (tp) with bone marrow from wild type (Wt) or DLL4(f/f)LysMCre(+0) (DLL4(del)) mice and fed either chow or high fat, high cholesterol (HFC) diet for 11 weeks. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) of DLL4(f/f)LysM-Cre(WT) and DLL(f/f)LysMCre(+/0) mice. In contrast to our hypothesis, inflammation was not decreased in HFC-fed DLL4(del)-transplanted mice. In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrow derived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.	[Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Mol Genet, Maastricht, Netherlands; [Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Pathol, Maastricht, Netherlands; [Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Radiotherapy, Maastricht, Netherlands; [Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, MAASTRO Sch Dev Biol & Oncol GROW, Maastricht, Netherlands; [Gijbels, Marion J. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Expt Vasc Biol, Amsterdam, Netherlands; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Expt Canc Res Inst, Lausanne, Switzerland	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Mol Genet, Maastricht, Netherlands.; Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Pathol, Maastricht, Netherlands.; Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Radiotherapy, Maastricht, Netherlands.; Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, MAASTRO Sch Dev Biol & Oncol GROW, Maastricht, Netherlands.	r.sverdlov@maastrichtuniversity.nl	Radtke, Freddy/Q-3198-2017; Hendrikx, Tim/AAI-8252-2021; Vooijs, Marc/K-3522-2019; Shiri-Sverdlov, Ronit/X-2642-2019; Theys, Jan/K-6685-2015; Hendrikx, Tim/AAE-2329-2020; Houben, Tom/T-1083-2017; van Gorp, Patrick/S-3892-2019; Theys, Jan/AAI-9211-2021; van Gorp, Patrick/L-9580-2018; Shiri-Sverdlov, Ronit/E-5571-2017	Radtke, Freddy/0000-0003-4315-4045; Hendrikx, Tim/0000-0002-3381-2107; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Houben, Tom/0000-0002-0441-3166; van Gorp, Patrick/0000-0002-0355-5349; Theys, Jan/0000-0002-9718-8251; van Gorp, Patrick/0000-0002-0355-5349; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Nessel, Isabell/0000-0001-6621-4149	Maag Lever Darm Stichting (MLDS) [WO 08-16, WO 11-35]; Netherlands Organisation for Scientific Research (NWO) [016.126.327, 015.008.043]; Cardiovascular Research Netherlands (CVON) IN-CONTROL grant [CVON 2012-03]	Maag Lever Darm Stichting (MLDS); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Cardiovascular Research Netherlands (CVON) IN-CONTROL grant	This research was supported by the Maag Lever Darm Stichting (MLDS) (WO 08-16 and WO 11-35), the Netherlands Organisation for Scientific Research (NWO) (Vidi grant number: 016.126.327) and (ASPASIA grant number:015.008.043), and by the Cardiovascular Research Netherlands (CVON) IN-CONTROL grant (CVON 2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Bi PP, 2015, TRENDS ENDOCRIN MET, V26, P248, DOI 10.1016/j.tem.2015.02.006; Bieghs V, 2013, GASTROENTEROLOGY, V144, P167, DOI 10.1053/j.gastro.2012.09.062; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hoebe KHN, 2001, AM J PHYSIOL-GASTR L, V280, pG720, DOI 10.1152/ajpgi.2001.280.4.G720; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopec KL, 2011, NUTR CLIN PRACT, V26, P565, DOI 10.1177/0884533611419668; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Lu RC, 2013, ONCOL LETT, V5, P845, DOI 10.3892/ol.2013.1113; Martinez JC, 2009, HISTOPATHOLOGY, V54, P598, DOI 10.1111/j.1365-2559.2009.03279.x; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Niida T, 2013, CIRCULATION, V128; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Portincasa Piero, 2005, Rom J Gastroenterol, V14, P43; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Shutter JR, 2000, GENE DEV, V14, P1313; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Valenti L, 2013, DIABETES, V62, P4052, DOI 10.2337/db13-0769; Yoshida T, 2013, CIRCULATION, V128; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167199	10.1371/journal.pone.0167199	http://dx.doi.org/10.1371/journal.pone.0167199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898698	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000037
J	Yao, W; Gan, Y; Myers, KM; Vink, JY; Wapner, RJ; Hendon, CP				Yao, Wang; Gan, Yu; Myers, Kristin M.; Vink, Joy Y.; Wapner, Ronald J.; Hendon, Christine P.			Collagen Fiber Orientation and Dispersion in the Upper Cervix of Non-Pregnant and Pregnant Women	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MECHANICAL-PROPERTIES; CONSTITUENTS; STROMA; MODEL	The structural integrity of the cervix in pregnancy is necessary for carrying a pregnancy until term, and the organization of human cervical tissue collagen likely plays an important role in the tissue's structural function. Collagen fibers in the cervical extracellular matrix exhibit preferential directionality, and this collagen network ultrastructure is hypothesized to reorient and remodel during cervical softening and dilation at time of parturition. Within the cervix, the upper half is substantially loaded during pregnancy and is where the premature funneling starts to happen. To characterize the cervical collagen ultrastructure for the upper half of the human cervix, we imaged whole axial tissue slices from non-pregnant and pregnant women undergoing hysterectomy or cesarean hysterectomy respectively using optical coherence tomography (OCT) and implemented a pixel-wise fiber orientation tracking method to measure the distribution of fiber orientation. The collagen fiber orientation maps show that there are two radial zones and the preferential fiber direction is circumferential in a dominant outer radial zone. The OCT data also reveal that there are two anatomic regions with distinct fiber orientation and dispersion properties. These regions are labeled: Region 1 the posterior and anterior quadrants in the outer radial zone and Region 2 the left and right quadrants in the outer radial zone and all quadrants in the inner radial zone. When comparing samples from nulliparous vs multiparous women, no differences in these fiber properties were noted. Pregnant tissue samples exhibit an overall higher fiber dispersion and more heterogeneous fiber properties within the sample than non-pregnant tissue. Collectively, these OCT data suggest that collagen fiber dispersion and directionality may play a role in cervical remodeling during pregnancy, where distinct remodeling properties exist according to anatomical quadrant.	[Yao, Wang; Myers, Kristin M.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Gan, Yu; Hendon, Christine P.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Vink, Joy Y.; Wapner, Ronald J.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY USA	Columbia University; Columbia University; Columbia University	Hendon, CP (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	cpf2115@columbia.edu	Myers, Kristin M/E-5689-2017	Myers, Kristin M/0000-0002-5989-0242; Wapner, Ronald/0000-0003-0727-1244; Gan, Yu/0000-0003-3409-3412	National Science Foundation [CMMI 1454412]; National Institutes of Health [1DP2HL127776-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD040485, K08HD088758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL127776] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was supported by the National Science Foundation CAREER award CMMI 1454412 (http://nsf.gov/awardsearch/showAward? AWD_1D=1454412) to KMM, National Institutes of Health 1DP2HL127776-01 (https://projectreporter nih.gov/project_description.cfm?projectnurnberz= 1DP2HL127776-01) to CPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by the National Science Foundation CAREER award (CMMI 1454412) to KMM and the National Institutes of Health (DP2) to CPH (1DP2HL127776-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation nor the National Institutes of Health.	ASPDEN RM, 1988, COLLAGEN REL RES, V8, P103; Bauer M, 2007, ANN NY ACAD SCI, V1101, P186, DOI 10.1196/annals.1389.004; Chue-Sang J, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.7.071109; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Feltovich H, 2013, ULTRASOUND OBST GYN, V41, P121, DOI 10.1002/uog.12383; Feltovich H, 2012, AM J OBSTET GYNECOL, V207, P345, DOI 10.1016/j.ajog.2012.05.015; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Fernandez M, 2016, COMPUT METHOD BIOMEC, V19, P404, DOI 10.1080/10255842.2015.1033163; Fleming CP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937470; Gan Y, 2014, ENG MED BIOL SOC EMB; Gan Y, 2015, BIOMED OPT EXPRESS, V6, P1090, DOI 10.1364/BOE.6.001090; Gan Y, 2013, BIOMED OPT EXPRESS, V4, P2150, DOI 10.1364/BOE.4.002150; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; House M, 2009, SEMIN PERINATOL, V33, P300, DOI 10.1053/j.semperi.2009.06.002; House M, 2009, EUR J OBSTET GYN R B, V144, pS65, DOI 10.1016/j.ejogrb.2009.02.027; Kang W, 2011, MED PHYS, V38, P107, DOI 10.1118/1.3523098; Karlon WJ, 1998, ANAT RECORD, V252, P612, DOI 10.1002/(SICI)1097-0185(199812)252:4<612::AID-AR12>3.0.CO;2-1; KIRBY MC, 1988, J APPL CRYSTALLOGR, V21, P929, DOI 10.1107/S0021889888008040; Lee SW, 2008, OPT EXPRESS, V16, P2709, DOI 10.1364/OE.16.002709; Liu ZY, 2015, BIOMED OPT EXPRESS, V6, P2294, DOI 10.1364/BOE.6.002294; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; Myers KM, 2015, J BIOMECH, V48, P1511, DOI 10.1016/j.jbiomech.2015.02.065; Myers KM, 2015, J BIOMECH, V48, P1533, DOI 10.1016/j.jbiomech.2015.02.060; Orfanoudaki IM, 2011, ARCH GYNECOL OBSTET, V284, P1197, DOI 10.1007/s00404-011-2009-4; Quinn KP, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046003; Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845; Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508; Sacks MS, 1998, J BIOMED MATER RES, V41, P131, DOI 10.1002/(SICI)1097-4636(199807)41:1<131::AID-JBM16>3.0.CO;2-Q; Stoff S, 2016, CERVICAL COLLAGEN IM; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Weiss S, 2006, ANAT REC PART A, V288A, P84, DOI 10.1002/ar.a.20274; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; WOLMAN M, 1975, J HISTOCHEM CYTOCHEM, V23, P21, DOI 10.1177/23.1.1090645; Yao W, 2014, J MECH BEHAV BIOMED, V34, P18, DOI 10.1016/j.jmbbm.2014.01.016; Yao XW, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.061006; Yaqoob Z, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2400214; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109; Zork NM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.09.036; Zysk AM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793736	39	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166709	10.1371/journal.pone.0166709	http://dx.doi.org/10.1371/journal.pone.0166709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898677	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000015
J	Zhu, XB; Qiu, HL				Zhu, Xiangbin; Qiu, Huiling			High Accuracy Human Activity Recognition Based on Sparse Locality Preserving Projections	PLOS ONE			English	Article								Human activity recognition (HAR) from the temporal streams of sensory data has been applied to many fields, such as healthcare services, intelligent environments and cyber security. However, the classification accuracy of most existed methods is not enough in some applications, especially for healthcare services. In order to improving accuracy, it is necessary to develop a novel method which will take full account of the intrinsic sequential characteristics for time-series sensory data. Moreover, each human activity may has correlated feature relationship at different levels. Therefore, in this paper, we propose a three-stage continuous hidden Markov model (TSCHMM) approach to recognize human activities. The proposed method contains coarse, fine and accurate classification. The feature reduction is an important step in classification processing. In this paper, sparse locality preserving projections (SpLPP) is exploited to determine the optimal feature subsets for accurate classification of the stationary-activity data. It can extract more discriminative activities features from the sensor data compared with locality preserving projections. Furthermore, all of the gyro-based features are used for accurate classification of the moving data. Compared with other methods, our method uses significantly less number of features, and the over-all accuracy has been obviously improved.	[Zhu, Xiangbin; Qiu, Huiling] Zhejiang Normal Univ, Coll Math Phys & Informat Engn, Jinhua, Zhejiang, Peoples R China	Zhejiang Normal University	Zhu, XB (corresponding author), Zhejiang Normal Univ, Coll Math Phys & Informat Engn, Jinhua, Zhejiang, Peoples R China.	zhuxb@zjnu.cn						Anguita D., 2012, INT WORKSH AMB ASS L, P216, DOI DOI 10.1007/978-3-642-35395-6_30; Anguita D., 2013, ESANN, P437, DOI DOI 10.1007/978-3-642-40728-4_54; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Bilmes J., 2002, WHAT HMMS CAN DO; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cook DJ, 2012, PERVASIVE MOB COMPUT, V8, P22, DOI 10.1016/j.pmcj.2011.10.004; Ekholm J., 2011, GARTNER MOBILE COMMU; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Hastie T., 2003, ELEMENTS STAT LEARNI; He X., 2003, ADV NEURAL INFORM PR, V16, P153; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Huynh N., PREDICTION MODEL SMA; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Lee JM, 2003, INTRO TOPOLOGICAL MA; Lee YS, 2011, LECT NOTES ARTIF INT, V6678, P460, DOI 10.1007/978-3-642-21219-2_58; Li SN, 2016, IEEE ACCESS, V4, P4484, DOI 10.1109/ACCESS.2016.2600623; Lichman M., 2013, HUMAN ACTIVITY RECOG; Lin C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0446-0; Lv ZH, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0475-8; Lv ZH, 2015, PERS UBIQUIT COMPUT, V19, P551, DOI 10.1007/s00779-015-0844-1; McIlroy T., 2015, MOBILE STRATEGIES DI; Natarajan P, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2562; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ronao CA, 2014, P INT CONF NAT COMPU, P681, DOI 10.1109/ICNC.2014.6975918; Sharma A, 2008, THIRD 2008 INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, VOL 1, PROCEEDINGS, P430, DOI 10.1109/ICCIT.2008.394; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Yu JB, 2011, MECH SYST SIGNAL PR, V25, P2573, DOI 10.1016/j.ymssp.2011.02.006; Zhang Yunqiang, 2015, Journal of Central South University (Science and Technology), V46, P2937, DOI 10.11817/j.issn.1672-7207.2015.08.025; Zheng ZL, 2015, INFORM SCIENCES, V303, P1, DOI 10.1016/j.ins.2015.01.004	29	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166567	10.1371/journal.pone.0166567	http://dx.doi.org/10.1371/journal.pone.0166567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893761	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400033
J	Illies, T; Saering, D; Kinoshita, M; Fujinaka, T; Bester, M; Fiehler, J; Tomiyama, N; Watanabe, Y				Illies, Till; Saering, Dennis; Kinoshita, Manabu; Fujinaka, Toshiyuki; Bester, Maxim; Fiehler, Jens; Tomiyama, Noriyuki; Watanabe, Yoshiyuki			Feasibility of Quantification of Intracranial Aneurysm Pulsation with 4D CTA with Manual and Computer-Aided Post-Processing	PLOS ONE			English	Article							CEREBRAL ANEURYSMS; GENERATION; RUPTURE; MODEL; TOOL; 3D	Background and Purpose The analysis of the pulsation of unruptured intracranial aneurysms might improve the assessment of their stability and risk of rupture. Pulsations can easily be concealed due to the small movements of the aneurysm wall, making post-processing highly demanding. We hypothesized that the quantification of aneurysm pulsation is technically feasible and can be improved by computer-aided post-processing. Materials and Methods Images of 14 cerebral aneurysms were acquired with an ECG-triggered 4D CTA. Aneurysms were post-processed manually and computer-aided on a 3D model. Volume curves and random noise-curves were compared with the arterial pulse wave and volume curves were compared between both post-processing modalities. Results The aneurysm volume curves showed higher similarity with the pulse wave than the random curves (Hausdorff-distances 0.12 vs 0.25, p<0.01). Both post-processing methods did not differ in intra-(r = 0.45 vs r = 0.54, p>0.05) and inter-observer (r = 0.45 vs r = 0.54, p>0.05) reliability. Time needed for segmentation was significantly reduced in the computer-aided group (3.9 +/- 1.8 min vs 20.8 +/- 7.8 min, p<0.01). Conclusion Our results show pulsatile changes in a subset of the studied aneurysms with the final prove of underlying volume changes remaining unsettled. Semi-automatic post-processing significantly reduces post-processing time but cannot yet replace manual segmentation.	[Illies, Till; Bester, Maxim; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Saering, Dennis] Univ Appl Sci, Informat Technol & Image Proc, Wedel, Germany; [Kinoshita, Manabu; Fujinaka, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Tomiyama, Noriyuki; Watanabe, Yoshiyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Osaka, Japan	University of Hamburg; University Medical Center Hamburg-Eppendorf; Osaka University; Osaka University	Illies, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	tillies@uke.de		Kinoshita, Manabu/0000-0001-7923-6902	Grants-in-Aid for Scientific Research [16K10778] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Alt H, 2004, ALGORITHMICA, V38, P45, DOI 10.1007/s00453-003-1042-5; Cardenes R, 2013, MED BIOL ENG COMPUT, V51, P343, DOI 10.1007/s11517-012-1003-8; Cardenes R, 2011, IEEE T MED IMAGING, V30, P1863, DOI 10.1109/TMI.2011.2157698; Fiehler J, 2009, AM J NEURORADIOL, V30, P356, DOI 10.3174/ajnr.A1351; Forkert ND, 2011, METHOD INFORM MED, V50, P74, DOI 10.3414/ME10-02-0003; Forkert ND, 2009, METHOD INFORM MED, V48, P399, DOI 10.3414/ME9237; Forkert ND, 2012, J MAGN RESON IMAGING, V36, P443, DOI 10.1002/jmri.23652; Groth M, 2013, NEURORADIOLOGY, V55, P171, DOI 10.1007/s00234-012-1095-8; Hasan DM, 2012, ARTERIOSCL THROM VAS, V32, P1032, DOI 10.1161/ATVBAHA.111.239871; Hayakawa M, 2005, AM J; Hufnagel H, 2008, INT J COMPUT ASS RAD, V2, P265, DOI 10.1007/s11548-007-0138-9; Illies T, PERSISTENT HEMODYNAM; Ishida F, 2005, NEUROSURGERY, V57, P460, DOI 10.1227/01.NEU.0000170540.17300.DD; Kato Y, 2004, MINIM INVAS NEUROSUR, V47, P131, DOI 10.1055/s-2004-818492; Kohout J, 2013, COMPUT METH PROG BIO, V109, P32, DOI 10.1016/j.cmpb.2012.08.018; Kuroda J, 2012, STROKE, V43, P61, DOI 10.1161/STROKEAHA.111.626846; Larrabide I, 2012, COMPUT METH PROG BIO, V108, P806, DOI 10.1016/j.cmpb.2012.05.006; Matouk CC, 2013, NEUROSURGERY, V72, P492, DOI 10.1227/NEU.0b013e31827d1012; Matsumoto Masato, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEU.0000217323.32623.F7; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Neugebauer M, 2013, INT J COMPUT ASS RAD, V8, P279, DOI 10.1007/s11548-012-0779-1; Nishida T, 2011, AM J NEURORADIOL, V32, pE206, DOI 10.3174/ajnr.A2354; Piccinelli M, 2012, ANN BIOMED ENG, V40, P2188, DOI 10.1007/s10439-012-0577-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Umeda Y, 2011, STROKE, V42, P815, DOI 10.1161/STROKEAHA.110.591008; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yaghmai V, 2007, J VASC INTERV RADIOL, V18, P785, DOI 10.1016/j.jvir.2007.02.037	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166810	10.1371/journal.pone.0166810	http://dx.doi.org/10.1371/journal.pone.0166810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880805	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500034
J	Mokry, M; Harakalova, M; Asselbergs, FW; de Bakker, PIW; Nieuwenhuis, EES				Mokry, Michel; Harakalova, Magdalena; Asselbergs, Folkert W.; de Bakker, Paul I. W.; Nieuwenhuis, Edward E. S.			Extensive Association of Common Disease Variants with Regulatory Sequence	PLOS ONE			English	Article							BONE-MINERAL DENSITY; IMMUNE CELLS; RISK; LOCI; MECHANISMS; EXPRESSION; CYTOKINES; TRAITS	Overlap between non-coding DNA regulatory sequences and common variant associations can help to identify specific cell and tissue types that are relevant for particular diseases. In a systematic manner, we analyzed variants from 94 genome-wide association studies (reporting at least 12 loci at p<5x10(-8)) by projecting them onto 466 epigenetic datasets (characterizing DNase I hypersensitive sites; DHSs) derived from various adult and fetal tissue samples and cell lines including many biological replicates. We were able to confirm many expected associations, such as the involvement of specific immune cell types in immune-related diseases and tissue types in diseases that affect specific organs, for example, inflammatory bowel disease and coronary artery disease. Other notable associations include adrenal glands in coronary artery disease, the immune system in Alzheimer's disease, and the kidney for bone marrow density. The association signals for some GWAS (for example, myopia or age at menarche) did not show a clear pattern with any of the cell or tissue types studied. In general, the identified variants from GWAS tend to be located outside coding regions. Altogether, we have performed an extensive characterization of GWAS signals in relation to cell and tissue-specific DHSs, demonstrating a key role for regulatory mechanisms in common diseases and complex traits.	[Mokry, Michel; Nieuwenhuis, Edward E. S.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, NL-3584 EA Utrecht, Netherlands; [Harakalova, Magdalena; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3508 GA Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Rrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London WC1E 6BT, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, NL-3508 GA Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of London; University College London; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Mokry, M; Nieuwenhuis, EES (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, NL-3584 EA Utrecht, Netherlands.	M.Mokry@umcutrecht.nl; E.E.S.Nieuwenhuis@umcutrecht.nl	Mokry, Michal/AAN-3809-2021; Asselbergs, Folkert W./ABD-6752-2021	Mokry, Michal/0000-0002-5298-4852; Asselbergs, Folkert W./0000-0002-1692-8669	WIZ Fonds; UCL Hospitals NIHR Biomedical Research Centre; Netherlands Heart Foundation [2014T001]; E.U. [HEALTH-F2-2013-601456]	WIZ Fonds; UCL Hospitals NIHR Biomedical Research Centre; Netherlands Heart Foundation(Netherlands Heart Foundation); E.U.(European Commission)	This work was supported by the WIZ Fonds to MM (2012). FWA is supported by UCL Hospitals NIHR Biomedical Research Centre and by a Dekker scholarship-Junior Staff Member 2014T001 - Netherlands Heart Foundation. This work was, in part, supported by a E.U.-funded FP7 project CVgenes@Target (HEALTH-F2-2013-601456) to PIWdB and FWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the WKZ Fonds to M.M. (2012). F.W.A. is supported by UCL Hospitals NIHR Biomedical Research Centre and by a Dekker scholarship-Junior Staff Member 2014T001 -Netherlands Heart Foundation. This work was, in part, supported by a E.U.-funded FP7 project CVgenes@Target (HEALTH-F2-2013-601456) to P.I.W.d.B. and F.W.A..	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Arntz HR, 2012, NAT REV CARDIOL, V9, P380, DOI 10.1038/nrcardio.2012.71; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/epi.12.18, 10.2217/EPI.12.18]; Dovio A, 2007, J CLIN ENDOCR METAB, V92, P1803, DOI 10.1210/jc.2006-2283; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gerasimova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054359; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; HAUTANEN A, 1994, ATHEROSCLEROSIS, V105, P191, DOI 10.1016/0021-9150(94)90049-3; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Iarlori C, 2005, EXP GERONTOL, V40, P605, DOI 10.1016/j.exger.2005.04.007; Jiang H, 2010, BIOINFORMATICS, V26, P1781, DOI 10.1093/bioinformatics/btq286; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KAPLAN JR, 1991, CIRCULATION, V84, P23; Martin KJ, 2007, J AM SOC NEPHROL, V18, P875, DOI 10.1681/ASN.2006070771; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mokry M, 2014, GASTROENTEROLOGY, V146, P1040, DOI 10.1053/j.gastro.2013.12.003; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shankland SJ, 2014, NAT REV NEPHROL, V10, P158, DOI 10.1038/nrneph.2014.1; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van der Sluis RJ, 2012, ATHEROSCLEROSIS, V221, P76, DOI 10.1016/j.atherosclerosis.2011.12.022; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wetzsteon RJ, 2011, J BONE MINER RES, V26, P2235, DOI 10.1002/jbmr.427; Xiong W, 2014, NAT REV RHEUMATOL, V10, P97, DOI 10.1038/nrrheum.2013.157; Zhang RZ, 2013, J NEUROIMMUNOL, V256, P38, DOI 10.1016/j.jneuroim.2013.01.002	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0165893	10.1371/journal.pone.0165893	http://dx.doi.org/10.1371/journal.pone.0165893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875544	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000005
J	Sarfo-Kantanka, O; Sarfo, FS; Ansah, EO; Eghan, B; Ayisi-Boateng, NK; Acheamfour-Akowuah, E				Sarfo-Kantanka, Osei; Sarfo, Fred Stephen; Ansah, Eunice Oparebea; Eghan, Benjamin; Ayisi-Boateng, Nana Kwame; Acheamfour-Akowuah, Emmanuel			Secular Trends in Admissions and Mortality Rates from Diabetes Mellitus in the Central Belt of Ghana: A 31-Year Review	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; HEALTH; KETOACIDOSIS; HYPERTENSION; PREVALENCE; COMMUNITY; WOMEN; ACCRA	Introduction Diabetes Mellitus is currently a leading cause of morbidity and mortality throughout the world, particularly in sub-Saharan Africa where a significant proportion of diabetes cases are now found. Longitudinal profiling of in-patient admissions and mortality trends from diabetes provide useful insights into the magnitude of the burden of diabetes, serve as a sentinel on the state of out-patient diabetes care and provide effective tools for planning, delivering and evaluating the health care needs relating to the disease in sub-Saharan Africa. Objective To evaluate the 31-year trend in diabetic admissions and mortality rates in central Ghana. Methods This is a retrospective analysis of data on diabetes admissions and deaths at a tertiary referral hospital in central Ghana between 1983 and 2014. Rates of diabetes admissions or deaths were expressed as diabetes admissions or deaths divided by the total number of admissions or deaths respectively. Yearly crude fatality rates for diabetes were calculated. Trends were analysed for in patient diabetes admissions and mortality for the period. Predictors of diabetes mortality were determined using multiple logistic regression. Results A total of 11,414 diabetes patients were admitted over the period with a female predominance; female:male ratio of 1.3:1.0. Over the study period, diabetes admission rates increased significantly from 2.36 per 1000 admissions in 1983 to 14.94 per 1000 admissions in 2014 (p<0.0001for linear trend), representing a 633% rise over the 31-year period. Inpatient diabetes fatality rates increased from 7.6 per 1000 deaths in 1983 to 30 per 1000 deaths in 2012. The average 28-day mortality rate was 18.5%. The median age of patients increased significantly over the period. So was the proportion of females admitted over the years. Predictors of in-patient mortality were increasing age-aOR of 1.23 (CI: 1.15-1.32) for age > 80 years compared with < 20 years, admissions in 2000s compared to 1980s-aOR of 1.56 (1.21-2.01), male gender-aOR of 1.45 (1.19-1.61), the presence of glycemic complications such as ketoacidosis- aOR-2.67(CI: 2.21-3.21), hyperosmolar hyperglycemic states- aOR 1.52 (1.33-1.73) symptomatic hypoglycemiaa-OR 1.64 (1.24-2.17) and presence of end organ complications including peripheral neuropathic ulcers-aOR 1.31 (1.12-1.56), nephropathy- aOR-1.11 (1.03-1.23), cerebrovascular disease aOR-1.52 (1.32-1.98), coronary artery disease- aOR-3.21 (1.91-5.15) and peripheral artery disease- aOR-1.15 (1.12-1.21) were associated with increased risk of death compared with normoglycemic diabetic admissions and admissions without end organ complications respectively. Conclusion Diabetes admission and mortality rates have increased significantly over the past three decades in central Ghana. More intensive education on the risk factors for diabetes, acute diabetes care as well as instituting hospital guidelines for diabetes control and reduction of modifiable risk factors for diabetes are urgently needed to reduce the poor case fatality associated with diabetes in resource-limited settings.	[Sarfo-Kantanka, Osei; Sarfo, Fred Stephen; Ansah, Eunice Oparebea; Eghan, Benjamin; Acheamfour-Akowuah, Emmanuel] Komfo Anokye Teaching Hosp, Directorate Med, Kumasi, Ghana; [Sarfo, Fred Stephen; Eghan, Benjamin] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Med, Kumasi, Ghana; [Ayisi-Boateng, Nana Kwame] Kwame Nkrumah Univ Sci & Technol, Univ Hlth Serv, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Sarfo-Kantanka, O (corresponding author), Komfo Anokye Teaching Hosp, Directorate Med, Kumasi, Ghana.	osarfokantarka21@gmail.com						Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; Addo J, 2008, ETHNIC DIS, V18, P505; Adedoyin RA, 2008, EUR J CARDIOV PREV R, V15, P683, DOI 10.1097/HJR.0b013e32830edc32; Adem A, 2011, ETHIOPIAN MED J, V41, P231; Adubofour KOM, 1997, DIABETES IN AFRICA, P83; Adubofour KOM, 1993, INT DIABETES DIGEST, V4, P90; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; [Anonymous], 2005, PREV CHRON DIS VIT I; Bagg W, 1998, AUST NZ J MED, V28, P604, DOI 10.1111/j.1445-5994.1998.tb00655.x; BASU A, 1993, DIABETIC MED, V10, P282, DOI 10.1111/j.1464-5491.1993.tb00060.x; BILD D, 1988, J CLIN EPIDEMIOL, V41, P999, DOI 10.1016/0895-4356(88)90039-X; Bosu W K, 2012, Ghana Med J, V46, P69; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Dake FAA, 2011, PUBLIC HEALTH NUTR, V14, P1285, DOI 10.1017/S1368980010002879; Dodu SRAdH N, 1964, GHANA MED J, p75 ~ 80, DOI [10.1136/heartjnl-2012-303316, DOI 10.1136/HEARTJNL-2012-303316]; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hill AG, 2007, INT J GYNECOL OBSTET, V99, P150, DOI 10.1016/j.ijgo.2007.05.024; International Diabetes Federation, 2013, IDF ATL, VSixth; Kengne PA, 2005, AFRICA, V112, P3592, DOI [10.1161/CIRCULATIONAHA.105.544312, DOI 10.1161/CIRCULATIONAHA.105.544312]; Ko SH, 2005, DIABETIC MED, V22, P466, DOI 10.1111/j.1464-5491.2005.01450.x; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Micah F B, 2012, Ghana Med J, V46, P14; Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008; Ocansey R, 2014, J PHYS ACT HEALTH, V11, pS58, DOI 10.1123/jpah.2014-0171; Ogedegbe G, 2008, J CLIN HYPERTENS, V10, P644, DOI 10.1111/j.1751-7176.2008.08329.x; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; WHO, 2010, GLOB STAT REP NONC D; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, GHAN COUNTR PROF; Yu EH, 1998, J FORMOS MED ASSOC, V97, P85; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	34	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0165905	10.1371/journal.pone.0165905	http://dx.doi.org/10.1371/journal.pone.0165905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875539	Green Submitted, Green Published, gold			2022-12-26	WOS:000388886000006
J	Gadalla, AAH; Schneider, P; Churcher, TS; Nassir, E; Abdel-Muhsin, AMA; Ranford-Cartwright, LC; Reece, SE; Babiker, HA				Gadalla, Amal A. H.; Schneider, Petra; Churcher, Thomas S.; Nassir, Elkhansaa; Abdel-Muhsin, Abdel-Muhsin A.; Ranford-Cartwright, Lisa C.; Reece, Sarah E.; Babiker, Hamza A.			Associations between Season and Gametocyte Dynamics in Chronic Plasmodium falciparum Infections	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; DRY SEASON; REPRODUCTIVE RESTRAINT; RURAL AREA; PARASITES; MOSQUITOS; CARRIAGE; PREVALENCE; CHABAUDI	Introduction In a markedly seasonal malaria setting, the transition from the transmission-free dry season to the transmission season depends on the resurgence of the mosquito population following the start of annual rains. The sudden onset of malaria outbreaks at the start of the transmission season suggests that parasites persist during the dry season and respond to either the reappearance of vectors, or correlated events, by increasing the production of transmission stages. Here, we investigate whether Plasmodium falciparum gametocyte density and the correlation between gametocyte density and parasite density show seasonal variation in chronic (largely asymptomatic) carriers in eastern Sudan. Materials and Methods We recruited and treated 123 malaria patients in the transmission season 2001. We then followed them monthly during four distinct consecutive epidemiological seasons: transmission season 1, transmission-free season, pre-clinical period, and transmission season 2. In samples collected from 25 participants who fulfilled the selection criteria of the current analysis, we used quantitative PCR (qPCR) and RT-qPCR to quantify parasite and gametocyte densities, respectively. Results and Discussion We observed a significant increase in gametocyte density and a significantly steeper positive correlation between gametocyte density and total parasite density during the pre-clinical period compared to the preceding transmission-free season. However, there was no corresponding increase in the density or prevalence of total parasites or gametocyte prevalence. The increase in gametocyte production during the pre-clinical period supports the hypothesis that P. falciparum may respond to environmental cues, such as mosquito biting, to modulate its transmission strategy. Thus, seasonal changes may be important to ignite transmission in unstable-malaria settings.	[Gadalla, Amal A. H.; Babiker, Hamza A.] Sultan Qaboos Univ, Dept Biochem, Fac Med & Hlth Sci, Muscat, Oman; [Gadalla, Amal A. H.] Natl Res Ctr, Res Inst Trop Med, Dept Mol Epidemiol, Khartoum, Sudan; [Schneider, Petra; Reece, Sarah E.; Babiker, Hamza A.] Univ Edinburgh, Inst Evolut, Edinburgh, Midlothian, Scotland; [Schneider, Petra; Reece, Sarah E.; Babiker, Hamza A.] Univ Edinburgh, Inst Immunol, Edinburgh, Midlothian, Scotland; [Schneider, Petra; Reece, Sarah E.; Babiker, Hamza A.] Univ Edinburgh, Inst Infect Res, Edinburgh, Midlothian, Scotland; [Churcher, Thomas S.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Nassir, Elkhansaa] Natl Res Ctr, Med & Aromat Plants Res Inst, Khartoum, Sudan; [Nassir, Elkhansaa] Natl Res Ctr, Tradit Med, Khartoum, Sudan; [Abdel-Muhsin, Abdel-Muhsin A.] Univ Hail, Dept Biol, Fac Sci, Baqaa, Saudi Arabia; [Ranford-Cartwright, Lisa C.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Reece, Sarah E.] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Sultan Qaboos University; University of Edinburgh; University of Edinburgh; University of Edinburgh; Imperial College London; University Ha'il; University of Glasgow; University of Edinburgh	Babiker, HA (corresponding author), Sultan Qaboos Univ, Dept Biochem, Fac Med & Hlth Sci, Muscat, Oman.; Babiker, HA (corresponding author), Univ Edinburgh, Inst Evolut, Edinburgh, Midlothian, Scotland.; Babiker, HA (corresponding author), Univ Edinburgh, Inst Immunol, Edinburgh, Midlothian, Scotland.; Babiker, HA (corresponding author), Univ Edinburgh, Inst Infect Res, Edinburgh, Midlothian, Scotland.	h.babiker@ed.ac.uk	Ranford-Cartwright, Lisa C/H-4701-2013; Reece, Sarah/AAA-6426-2020; Abdel-Muhsin, Abdel-Muhsin/AAQ-6201-2021; Abdel-Muhsin, Abdel-Muhsin/GQZ-7548-2022; Reece, Sarah E/C-9447-2009	Ranford-Cartwright, Lisa C/0000-0003-1992-3940; Reece, Sarah/0000-0001-6716-6732; Reece, Sarah E/0000-0001-6716-6732; Churcher, Thomas/0000-0002-8442-0525; Schneider, Petra/0000-0002-2616-237X; Abdelmuhsin, Abdelmuhsin/0000-0003-1430-8308; Gadalla, Amal/0000-0002-3131-725X	National Environment Research Council [NE/I015329/1]; Sultan Qaboos University PhD studentship; Research Council, Muscat, Oman [RC/MED/BIO/03]; Department of Biochemistry staff, College of Medicine and Health Sciences, Sultan Qaboos University; MRC [MR/K010174/1] Funding Source: UKRI; NERC [NE/K006029/1, NE/I015329/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; Natural Environment Research Council [NE/K006029/1, NE/I015329/1] Funding Source: researchfish	National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sultan Qaboos University PhD studentship; Research Council, Muscat, Oman; Department of Biochemistry staff, College of Medicine and Health Sciences, Sultan Qaboos University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by National Environment Research Council (NE/I015329/1) to SER, by Sultan Qaboos University PhD studentship (2010) to AAHG and HB and by The Research Council, Muscat, Oman (RC/MED/BIO/03) to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Steve Lindsay at Durham University and Dr Joanne Thompson at University of Edinburgh for comments on earlier version of the manuscript. We thank Dr Davis Nwakanma at Medical Research Council (United Kingdom) Laboratories, Fajara, Banjul, The Gambia for providing culture material for total parasite quantification. We also thank Department of Biochemistry staff, College of Medicine and Health Sciences, Sultan Qaboos University for support.	Ali E, 2006, T ROY SOC TROP MED H, V100, P176, DOI 10.1016/j.trstmh.2005.04.021; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; BARNISH G, 1993, ANN TROP MED PARASIT, V87, P137, DOI 10.1080/00034983.1993.11812747; Billingsley PF, 2005, BIOL LETT-UK, V1, P185, DOI 10.1098/rsbl.2004.0260; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Buckling A, 1999, PARASITOLOGY, V118, P339, DOI 10.1017/S0031182099003960; Buckling A, 1999, EXP PARASITOL, V93, P45, DOI 10.1006/expr.1999.4429; Cameron A, 2013, EVOL APPL, V6, P365, DOI 10.1111/eva.12005; Carter Lucy M., 2013, Evolution Medicine and Public Health, P135, DOI 10.1093/emph/eot011; Carter R, 1979, Bull World Health Organ, V57 Suppl 1, P37; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Cornet S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004308; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Da DF, 2015, EXP PARASITOL, V149, P74, DOI 10.1016/j.exppara.2014.12.010; Dao A, 2014, NATURE, V516, P387, DOI 10.1038/nature13987; Diebner HH, 2000, J THEOR BIOL, V202, P113, DOI 10.1006/jtbi.1999.1041; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P131, DOI 10.1046/j.1365-3156.1999.00361.x; Dyer M, 2000, PARASITOL TODAY, V16, P102, DOI 10.1016/S0169-4758(99)01608-7; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Galardo AKR, 2009, MED VET ENTOMOL, V23, P335, DOI 10.1111/j.1365-2915.2009.00839.x; GRAVES PM, 1984, AM J TROP MED HYG, V33, P1045, DOI 10.4269/ajtmh.1984.33.1045; Greischar MA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004718; Hamad AA, 2002, ACTA TROP, V83, P71, DOI 10.1016/S0001-706X(02)00059-1; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Huestis DL, 2014, INFECT GENET EVOL, V28, P648, DOI 10.1016/j.meegid.2014.05.027; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Lawaly R, 2012, INFECT IMMUN, V80, P2240, DOI 10.1128/IAI.06414-11; Lehmann T, 2014, MALARIA J, V13, pO2, DOI DOI 10.1186/1475-2875-13-S1-O2; LINDSAY SW, 1991, J TROP MED HYG, V94, P313; Mideo N, 2012, FUTURE MICROBIOL, V7, P17, DOI [10.2217/fmb.11.134, 10.2217/FMB.11.134]; Nacher M, 2004, T ROY SOC TROP MED H, V98, P322, DOI 10.1016/j.trstmh.2003.10.005; Nacher M, 2002, J PARASITOL, V88, P97, DOI 10.1645/0022-3395(2002)088[0097:DHCHAS]2.0.CO;2; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Ouedraogo AL, 2008, ACTA TROP, V105, P28, DOI 10.1016/j.actatropica.2007.09.003; Ouedraogo AL, 2016, J INFECT DIS, V213, P90, DOI 10.1093/infdis/jiv370; Paul REL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-39; Piper KP, 1999, INFECT IMMUN, V67, P6369; Pollitt LC, 2011, AM NAT, V177, P358, DOI 10.1086/658175; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Reece SE, 2010, P ROY SOC B-BIOL SCI, V277, P3123, DOI 10.1098/rspb.2010.0564; Roberts CH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-31; RUEBUSH TK, 1995, B WORLD HEALTH ORGAN, V73, P229; Schneider P, 2015, MOL BIOCHEM PARASIT, V199, P29, DOI 10.1016/j.molbiopara.2015.03.006; Shutler D, 2005, P ROY SOC B-BIOL SCI, V272, P2397, DOI 10.1098/rspb.2005.3232; Skaug H., 2013, GEN LINEAR MIXED MOD; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; Walker M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0402-2	63	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166699	10.1371/journal.pone.0166699	http://dx.doi.org/10.1371/journal.pone.0166699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870874	Green Published, Green Accepted, gold			2022-12-26	WOS:000388846400019
J	Newman, T; Jhinku, N; Meier, M; Horsfield, J				Newman, Trent; Jhinku, Noel; Meier, Michael; Horsfield, Julia			Dietary Intake Influences Adult Fertility and Offspring Fitness in Zebrafish	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; BIOLOGICAL NETWORKS; INDUCED OBESITY; DANIO-RERIO; MODEL; GENE; CONTRIBUTE; CHILDHOOD; CYTOSCAPE; MAMMALS	The burden of malnutrition, including both over- and undernutrition, is a major public health concern. Here we used a zebrafish model of diet-induced obesity to analyze the impact of dietary intake on fertility and the phenotype of the next generation. Over an eight-week period, one group received 60 mg of food each day (60 mg arm), while another received 5 mg (5 mg arm). At the end of the diet, the body mass index of the 60 mg arm was 1.5 fold greater than the 5 mg arm. The intervention also had a marked impact on fertility; breeding success and egg production in the 60 mg arm were increased 2.1- and 6.2-fold compared to the 5 mg arm, respectively. Transcriptome analysis of eggs revealed that transcripts involved in metabolic biological processes differed according to dietary intake. The progeny from the differentially fed fish were more likely to survive when the parents had access to more food. An intergenerational crossover study revealed that while parental diet did not influence weight gain in the offspring, the progeny of well-fed parents had increased levels of physical activity when exposed again to high nutrient availability. We conclude that dietary intake has an important influence on fertility and the subsequent fitness of offspring, even prior to breeding.	[Newman, Trent; Jhinku, Noel; Meier, Michael; Horsfield, Julia] Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin 9054, New Zealand; [Meier, Michael; Horsfield, Julia] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Horsfield, Julia] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Newman, Trent] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of Otago; University of Auckland; University of Auckland; University of California System; University of California Davis	Horsfield, J (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin 9054, New Zealand.; Horsfield, J (corresponding author), Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand.; Horsfield, J (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.	julia.horsfield@otago.ac.nz	Horsfield, Julia A/B-5091-2012	Horsfield, Julia A/0000-0002-9536-7790; Newman, Trent/0000-0002-6767-1429	Gravida: The National Center for Growth and Development [STF-14-27]	Gravida: The National Center for Growth and Development	This research was supported by a grant from Gravida: The National Center for Growth and Development (STF-14-27) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from Gravida: The National Center for Growth and Development (STF-14-27). The authors declare no conflicts of interest.	Aldrich JC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005148; Arnold BF, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-94; Aspiras AC, 2015, P NATL ACAD SCI USA, V112, P9668, DOI 10.1073/pnas.1510802112; Baker TR, 2014, TOXICOL SCI, V138, P403, DOI 10.1093/toxsci/kfu006; Bonduriansky R, 2012, TRENDS ECOL EVOL, V27, P330, DOI 10.1016/j.tree.2012.02.003; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036474; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Edgar R, 2002, THE GENE EXPRESSION; FAO, 2009, UNDERNOURISHMENT ARO; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443; Kirkwood TBL, 2008, J INTERN MED, V263, P117, DOI 10.1111/j.1365-2796.2007.01901.x; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Newman TAC, 2015, REDOX BIOL, V6, P648, DOI 10.1016/j.redox.2015.10.010; Novak CM, 2005, NEUROSCI LETT, V383, P99, DOI 10.1016/j.neulet.2005.03.048; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Pannevis MC, 1994, J NUTR, p2616S; Patel MS, 2002, J BIOL CHEM, V277, P1629, DOI 10.1074/jbc.R100017200; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Penglase S, 2012, NATURE, V491, P333, DOI 10.1038/491333a; R Development Core Team, 2012, R A LANGUAGE AND ENV; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sermondade N, 2012, ARCH INTERN MED, V172, P440, DOI 10.1001/archinternmed.2011.1382; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; Sharov AA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-24; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tytler P, 2012, FISH ENERGETICS NEW, P9673, DOI [10.1073/pnas.1510802112, DOI 10.1073/PNAS.1510802112]; Vanhaecke P, 1983, ANN SOC R ZOOL BELGI, P155; Watson ED, 2016, NAT GENET, V48, P478, DOI 10.1038/ng.3554; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wright MW, 2005, MAMM GENOME, V16, P827, DOI 10.1007/s00335-005-0103-2; Wu CT, 2001, SCIENCE, V293, P1103, DOI 10.1126/science.293.5532.1103; Zain MM, 2008, WOMENS HEALTH, V4, P183, DOI 10.2217/17455057.4.2.183; Zang L, 2014, J FUNCT FOODS, V10, P499, DOI 10.1016/j.jff.2014.08.002	48	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166394	10.1371/journal.pone.0166394	http://dx.doi.org/10.1371/journal.pone.0166394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870856	Green Submitted, gold, Green Published			2022-12-26	WOS:000388846400010
J	Peltonen-Sainio, P; Jauhiainen, L; Lehtonen, H				Peltonen-Sainio, Pirjo; Jauhiainen, Lauri; Lehtonen, Heikki			Land Use, Yield and Quality Changes of Minor Field Crops: Is There Superseded Potential to Be Reinvented in Northern Europe?	PLOS ONE			English	Article							CLIMATE-CHANGE; SPRING CEREALS; MANAGEMENT; NITROGEN; LEGUMES; GRAIN; IMPROVEMENTS; ROTATIONS; RAPESEED; BENEFITS	Diversification of agriculture was one of the strengthened aims of the greening payment of European Agricultural Policy (CAP) as diversification provides numerous ecosystems services compared to cereal-intensive crop rotations. This study focuses on current minor crops in Finland that have potential for expanded production and considers changes in their cropping areas, yield trends, breeding gains, roles in crop rotations and potential for improving resilience. Long-term datasets of Natural Resources Institute Finland and farmers' land use data from the Agency of Rural Affairs were used to analyze the above-mentioned trends and changes. The role of minor crops in rotations declined when early and late CAP periods were compared and that of cereal monocultures strengthened. Genetic yield potentials of minor crops have increased as also genetic improvements in quality traits, although some typical trade-offs with improved yields have also appeared. However, the gap between potential and attained yields has expanded, depending on the minor crop, as national yield trends have either stagnated or declined. When comparing genetic improvements of minor crops to those of the emerging major crop, spring wheat, breeding achievements in minor crops were lower. It was evident that the current agricultural policies in the prevailing market and the price environment have not encouraged cultivation of minor crops but further strengthened the role of cereal monocultures. We suggest optimization of agricultural land use, which is a core element of sustainable intensification, as a future means to couple longterm environmental sustainability with better success in economic profitability and social acceptability. This calls for development of effective policy instruments to support farmer's diversification actions.	[Peltonen-Sainio, Pirjo; Jauhiainen, Lauri] Nat Resources Inst Finland Luke, Management & Prod Renewable Resources, FI-31600 Jokioinen, Finland; [Lehtonen, Heikki] Nat Resources Inst Finland Luke, Econ & Soc, FI-00790 Helsinki, Finland	Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Peltonen-Sainio, P (corresponding author), Nat Resources Inst Finland Luke, Management & Prod Renewable Resources, FI-31600 Jokioinen, Finland.	pirjo.peltonen-sainio@luke.fi		Jauhiainen, Lauri/0000-0003-2073-1057	Ministry of Agriculture and Forestry; Natural Resources Institute Finland (Luke); Sustainable Intensification of Crop Production through Land Use Changes (PeltoOptimi)	Ministry of Agriculture and Forestry; Natural Resources Institute Finland (Luke); Sustainable Intensification of Crop Production through Land Use Changes (PeltoOptimi)	The work was financed by the Ministry of Agriculture and Forestry and Natural Resources Institute Finland (Luke) as a part of a consortium of projects entitled Improving Resilience to Climate Change and Variation Induced Risks in Agriculture (ILMAPUSKURI) and Sustainable Intensification of Crop Production through Land Use Changes (PeltoOptimi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was financed by the Ministry of Agriculture and Forestry and Natural Resources Institute Finland (Luke) as a part of a consortium of projects entitled Improving Resilience to Climate Change and Variation Induced Risks in Agriculture (ILMAPUSKURI) and Sustainable Intensification of Crop Production through Land Use Changes (PeltoOptimi).	Alston JM, 2008, HORTSCIENCE, V43, P1461, DOI 10.21273/HORTSCI.43.5.1461; FAO, 2016, AGR STAT; Fischer RA, 2015, FIELD CROP RES, V182, P9, DOI 10.1016/j.fcr.2014.12.006; Gaudin ACM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113261; Howieson JG, 2000, FIELD CROP RES, V65, P107, DOI 10.1016/S0378-4290(99)00081-7; Jalli M, 2011, AGR FOOD SCI, V20, P62, DOI 10.2137/145960611795163015; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; Kankanen H, 2011, EUR J AGRON, V34, P35, DOI 10.1016/j.eja.2010.10.002; Kirkegaard J, 2008, FIELD CROP RES, V107, P185, DOI 10.1016/j.fcr.2008.02.010; Laidig F, 2014, THEOR APPL GENET, V127, P2599, DOI 10.1007/s00122-014-2402-z; Laine A, 2015, LUONNONVARA JA BIOTA; Lamichhane JR, 2015, CROP PROT, V74, P42, DOI 10.1016/j.cropro.2015.04.005; Lehtonen H, 2016, ROUT ADV CLIMATE, P132; Littell RC, 2006, SAS MIXED MODELS, V2nd; Liu X, 2016, AGR SYST, V144, P65, DOI 10.1016/j.agsy.2015.12.003; Mackay I, 2011, THEOR APPL GENET, V122, P225, DOI 10.1007/s00122-010-1438-y; Makinen H, 2015, FIELD CROP RES, V183, P23, DOI 10.1016/j.fcr.2015.07.006; Monjardino M, 2015, AGR SYST, V137, P108, DOI 10.1016/j.agsy.2015.04.006; Myyra S, 2005, LAND ECON, V81, P557, DOI 10.3368/le.81.4.557; Nemecek T, 2008, EUR J AGRON, V28, P380, DOI 10.1016/j.eja.2007.11.004; Nemecek T, 2015, EUR J AGRON, V65, P40, DOI 10.1016/j.eja.2015.01.005; Paananen I, 2014, VILJATILOILLA TARVIT; Peltonen-Sainio P, 2007, J AGR SCI, V145, P587, DOI 10.1017/S0021859607007381; Peltonen-Sainio P, 2011, SOIL USE MANAGE, V27, P229, DOI 10.1111/j.1475-2743.2011.00331.x; Peltonen-Sainio P, 2009, ACTA AGR SCAND B-S P, V59, P129, DOI 10.1080/09064710802022895; Peltonen-Sainio P, 2016, CLIM RES, V67, P221, DOI 10.3354/cr01378; Peltonen-Sainio P, 2015, AMBIO, V44, P544, DOI 10.1007/s13280-015-0637-9; Peltonen-Sainio P, 2011, FIELD CROP RES, V121, P248, DOI 10.1016/j.fcr.2010.12.010; Peltonen-Sainio P, 2010, AGR FOOD SCI, V19, P341, DOI 10.2137/145960610794197588; Pietila A, 2008, KUUDEN VUODEN VILJEL; Pouta E, 2012, LAND USE POLICY, V29, P367, DOI 10.1016/j.landusepol.2011.08.001; Pradhan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129487; Preissel S, 2015, FIELD CROP RES, V175, P64, DOI 10.1016/j.fcr.2015.01.012; Rankinen K, 2013, AGR FOOD SCI, V22, P342, DOI 10.23986/afsci.7500; Rastas M, 2013, ACTA PHYTOPATHOLOGIC, V43, P530; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Seymour M, 2012, CROP PASTURE SCI, V63, P1, DOI 10.1071/CP11320; Solberg SO, 2015, AGR FOOD SCI, V24, P150, DOI 10.23986/afsci.48629; Triboi E, 2002, EUR J AGRON, V16, P163, DOI 10.1016/S1161-0301(01)00146-0; Voisin AS, 2014, AGRON SUSTAIN DEV, V34, P361, DOI 10.1007/s13593-013-0189-y; Wezel A, 2014, AGRON SUSTAIN DEV, V34, P1, DOI 10.1007/s13593-013-0180-7; World Bank, 2008, AGR DEV WORLD DEV RE, DOI DOI 10.1596/978-0-8213-7233-3	42	14	14	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166403	10.1371/journal.pone.0166403	http://dx.doi.org/10.1371/journal.pone.0166403			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870865	Green Submitted, Green Published, gold			2022-12-26	WOS:000388846400011
J	Plesofsky, N; Higgins, L; Markowski, T; Brambl, R				Plesofsky, Nora; Higgins, LeeAnn; Markowski, Todd; Brambl, Robert			Glucose Starvation Alters Heat Shock Response, Leading to Death of Wild Type Cells and Survival of MAP Kinase Signaling Mutant	PLOS ONE			English	Article							NEUROSPORA-CRASSA; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGI; OXIDATIVE STRESS; GENOME SEQUENCE; GENE-EXPRESSION; YEAST; DEGRADATION; PATHWAY	A moderate heat shock induces Neurospora crassa to synthesize large quantities of heat shock proteins that are protective against higher, otherwise lethal temperatures. However, wild type cells do not survive when carbohydrate deprivation is added to heat shock. In contrast, a mutant strain defective in a stress-activated protein kinase does survive the combined stresses. In order to understand the basis for this difference in survival, we have determined the relative levels of detected proteins in the mutant and wild type strain during dual stress, and we have identified gene transcripts in both strains whose quantities change in response to heat shock or dual stress. These data and supportive experimental evidence point to reasons for survival of the mutant strain. By using alternative respiratory mechanisms, these cells experience less of the oxidative stress that proves damaging to wild type cells. Of central importance, mutant cells recycle limited resources during dual stress by undergoing autophagy, a process that we find utilized by both wild type and mutant cells during heat shock. Evidence points to inappropriate activation of TORC1, the central metabolic regulator, in wild type cells during dual stress, based upon behavior of an additional signaling mutant and inhibitor studies.	[Plesofsky, Nora; Brambl, Robert] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Higgins, LeeAnn; Markowski, Todd] Univ Minnesota, Dept Biochem, 1479 Gortner Ave, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Plesofsky, N (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	norap@umn.edu			University of Minnesota Retiree Association grants	University of Minnesota Retiree Association grants	Aside from two small University of Minnesota Retiree Association grants to NP, the authors received no specific funding for this work.	BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carneiro P, 2004, BBA-BIOENERGETICS, V1608, P45, DOI 10.1016/j.bbabio.2003.10.004; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Castro A, 2008, J BIOL CHEM, V283, P19314, DOI 10.1074/jbc.M802112200; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Deng YZ, 2008, METHOD ENZYMOL, V451, P295, DOI 10.1016/S0076-6879(08)03220-5; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Giles GI, 2001, FREE RADICAL BIO MED, V31, P1279, DOI 10.1016/S0891-5849(01)00710-9; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann B, 1999, MOL MICROBIOL, V31, P807, DOI 10.1046/j.1365-2958.1999.01219.x; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kumar R, 2014, ARCH MICROBIOL, V196, P295, DOI 10.1007/s00203-014-0966-2; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li LD, 2006, EUKARYOT CELL, V5, P1287, DOI 10.1128/EC.00109-06; Li XH, 2007, BIOCHEM CELL BIOL, V85, P741, DOI 10.1139/O07-141; Lin AL, 2015, NEUROBIOL AGING, V36, P2296, DOI 10.1016/j.neurobiolaging.2015.03.012; Lin-Moshier Y, 2013, J BIOL CHEM, V288, P355, DOI 10.1074/jbc.M112.405761; Lopez-Aviles S, 2008, MOL BIOL CELL, V19, P1670, DOI 10.1091/mbc.E07-07-0639; Lund TC, 2007, J PROTEOME RES, V6, P644, DOI 10.1021/pr0603912; Maddi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042374; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Mascaraque V, 2013, MOL CELL PROTEOMICS, V12, P557, DOI 10.1074/mcp.M112.020438; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Nadal-Ribelles M, 2014, MOL CELL, V53, P549, DOI 10.1016/j.molcel.2014.01.006; Nakamura N, 1997, J BIOCHEM, V121, P338; Noguchi R, 2007, FUNGAL GENET BIOL, V44, P208, DOI 10.1016/j.fgb.2006.08.003; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; PAIETTA JV, 1992, MOL CELL BIOL, V12, P1568, DOI 10.1128/MCB.12.4.1568; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Park YC, 2007, APPL MICROBIOL BIOT, V76, P349, DOI 10.1007/s00253-007-0998-5; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Peraza-Reyes L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P191; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Plesofsky N, 1999, BBA-MOL CELL RES, V1449, P73, DOI 10.1016/S0167-4889(98)00172-4; Plesofsky N, 2004, MYCOTA, V3, P143; Plesofsky NS, 2008, EUKARYOT CELL, V7, P2147, DOI 10.1128/EC.00147-08; Radford A, 2004, ADV GENET, V52, P165, DOI 10.1016/S0065-2660(04)52005-9; REAVEN PD, 1992, ARTERIOSCLER THROMB, V12, P318, DOI 10.1161/01.ATV.12.3.318; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Sattlegger E, 1998, J BIOL CHEM, V273, P20404, DOI 10.1074/jbc.273.32.20404; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Swinnen E, 2014, FEMS YEAST RES, V14, P17, DOI 10.1111/1567-1364.12097; Tanton LL, 2003, FUNGAL GENET BIOL, V39, P176, DOI 10.1016/S1087-1845(03)00002-1; Teixeira V, 2014, MICROB CELL, V1, P21, DOI 10.15698/mic2014.01.121; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tran PV, 2013, AM J PHYSIOL-REG I, V305, pR1297, DOI 10.1152/ajpregu.00292.2013; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang H, 2012, J BIOL CHEM, V287, P16890, DOI 10.1074/jbc.M111.322636; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Xu Y, 2014, AM SOC MASS SPEC, V254; Yamashita K, 2007, GENES GENET SYST, V82, P301, DOI 10.1266/ggs.82.301; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	75	5	5	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0165980	10.1371/journal.pone.0165980	http://dx.doi.org/10.1371/journal.pone.0165980			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870869	gold, Green Submitted, Green Published			2022-12-26	WOS:000388846400004
J	Vogels, CBF; Mohlmann, TWR; Melsen, D; Favia, G; Wennergren, U; Koenraadt, CJM				Vogels, Chantal B. F.; Mohlmann, Tim W. R.; Melsen, Diede; Favia, Guido; Wennergren, Uno; Koenraadt, Constantianus J. M.			Latitudinal Diversity of Culex pipiens Biotypes and Hybrids in Farm, Peri-Urban, and Wetland Habitats in Europe	PLOS ONE			English	Article							WEST-NILE-VIRUS; DIPTERA-CULICIDAE; FEEDING PATTERNS; NEW-YORK; HYBRIDIZATION; MOLESTUS; COMPLEX; FORMS; EPIDEMIOLOGY; EMERGENCE	Despite the presence of Culex (Cx.) pipiens mosquitoes and circulation of West Nile virus (WNV), WNV outbreaks have so far not occurred in northern Europe. The species Cx. pipiens consists of two morphologically identical biotypes, pipiens and molestus, which can form hybrids. Until now, population dynamic studies of Cx. pipiens have not differentiated between biotypes and hybrids at the European scale, nor have they used comparative surveillance approaches. We therefore aimed to elucidate the relative abundance of Cx. pipiens biotypes and hybrids in three habitat types at different latitudes across Europe, using two different surveillance traps. BG-Sentinel and Mosquito-Magnet Liberty Plus traps were placed in three habitat types (farms, peri-urban, wetlands), in three European countries (Sweden, The Netherlands, Italy). Collected Cx. pipiens mosquitoes were identified to biotype with real-time PCR. Both trap types collected equal ratios of the biotypes and their hybrids. From northern to southern latitudes there was a significant decrease of pipiens and an increase of molestus. Habitat types influenced the relative ratios of biotypes and hybrids, but results were not consistent across latitudes. Our results emphasize the need to differentiate Cx. pipiens to the biotype level, especially for proper future WNV risk assessments for Europe.	[Vogels, Chantal B. F.; Mohlmann, Tim W. R.; Melsen, Diede; Koenraadt, Constantianus J. M.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Mohlmann, Tim W. R.; Wennergren, Uno] Linkoping Univ, IFM Theory & Modelling, Linkoping, Sweden; [Favia, Guido] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy	Wageningen University & Research; Linkoping University; University of Camerino	Vogels, CBF (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	chantal.vogels@wur.nl		Vogels, Chantal/0000-0003-0027-6480; Favia, Guido/0000-0002-4420-8482; Koenraadt, Constantianus/0000-0001-7861-8781	ANIHWA-EraNet (Animal Health and Welfare) program (LIVEepi) - Ministry of Economic Affairs, The Netherlands; FORMAS, Sweden; European Community's Seventh Framework Programme (FP7 VECTORIE) [261466]	ANIHWA-EraNet (Animal Health and Welfare) program (LIVEepi) - Ministry of Economic Affairs, The Netherlands; FORMAS, Sweden(Swedish Research Council Formas); European Community's Seventh Framework Programme (FP7 VECTORIE)	This study was part of the ANIHWA-EraNet (Animal Health and Welfare) program (LIVEepi) funded by the Ministry of Economic Affairs, The Netherlands; FORMAS, Sweden; and the European Community's Seventh Framework Programme (FP7 VECTORIE project number 261466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Byrne K, 1999, HEREDITY, V82, P7, DOI 10.1038/sj.hdy.6884120; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Di Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146476; Dohm DJ, 2001, J MED ENTOMOL, V38, P462, DOI 10.1603/0022-2585-38.3.462; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fritz ML, 2015, MED VET ENTOMOL, V29, P115, DOI 10.1111/mve.12096; Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956; Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006; Gomes B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-93; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Hesson JC, 2014, MED VET ENTOMOL, V28, P179, DOI 10.1111/mve.12024; Hesson JC, 2011, VECTOR-BORNE ZOONOT, V11, P1383, DOI 10.1089/vbz.2011.0630; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; MARSHALL J. F., 1936, Nature, V137, P580, DOI 10.1038/137580c0; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Osorio HC, 2014, MED VET ENTOMOL, V28, P103, DOI 10.1111/mve.12020; Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135; Rudolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071832; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; SANBURG LL, 1973, J INSECT PHYSIOL, V19, P1173, DOI 10.1016/0022-1910(73)90202-3; Schafer M, 2001, ANN ENTOMOL SOC AM, V94, P576, DOI 10.1603/0013-8746(2001)094[0576:COMDCF]2.0.CO;2; Shute PG, 1941, LANCET, V1, P6; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Snapinn KW, 2007, J VIROL, V81, P2531, DOI 10.1128/JVI.02169-06; Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0; Vogels CBF, 2015, VECTOR-BORNE ZOONOT, V15, P619, DOI 10.1089/vbz.2015.1820; Weitzel Thomas, 2011, European Mosquito Bulletin, V29, P22; Willcox W, 1941, LANCET, V1, P126; Zittra C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1495-4	36	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166959	10.1371/journal.pone.0166959	http://dx.doi.org/10.1371/journal.pone.0166959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870890	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400046
J	Fan, WC; Liu, CW; Ou, SM; Huang, CC; Li, TH; Lee, KC; Huang, SF; Yang, YY; Hsieh, YC; Hsieh, SL; Hou, MC; Lin, HC				Fan, Wen -Chien; Liu, Chih-Wei; Ou, Shuo-Ming; Huang, Chia-Chang; Li, Tzu-Hao; Lee, Kuei-Chuan; Huang, Shiang-Fen; Yang, Ying-Ying; Hsieh, Yun-Cheng; Hsieh, Shie-Liang; Hou, Ming-Chih; Lin, Han-Chieh			TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients	PLOS ONE			English	Article							SEPTIC SHOCK SUSCEPTIBILITY; SOLUBLE CD14; RISK-FACTORS; MORTALITY; POLYMORPHISM; RECEPTOR; ASSOCIATION; EXPRESSION; MONOCYTES; PROCALCITONIN	Genetic variants and dysfunctional monocyte had been reported to be associated with infection susceptibility in advanced cirrhotic patients. This study aims to explore genetic predictive markers and relevant immune dysfunction that contributed to severe sepsis in febrile acute de-compensated cirrhotic patents. Polymorphism analysis of candidate genes was undergone in 108 febrile acute de-compensated cirrhotic patients and 121 healthy volunteers. Various plasma inflammatory/regulatory cytokines, proportion of classical (CD 16(-), phagocytic) and non-classical (CD16(+), inflammatory) monocytes, lipopolysaccharide (LPS)stimulated toll-like receptor 4 (TLR4) and intracellular/extracellular cytokines on cultured non-classical monocytes, mCD14/HLA-DR expression and phagocytosis of classical monocytes were measured. For TLR4+896A/G variant allele carriers with severe sepsis, high plasma endotoxin/IL-10 inhibits HLA-DR expression and impaired phagocytosis were noted in their classical monocyte. In the same group, increased non-classical monocyte subset, enhanced LPS-stimulated TLR4 expression and TNFa/nitrite production, and systemic inflammation [high plasma soluble CD14 (sCD14) and total nitric oxide (NOx) levels] were noted. For CD14-159C/T variant allele carriers with severe sepsis, persist endotoxemia inhibited mCD14/HLA-DR expression and impaired phagocytosis of their classical monocyte. In the same group, increased non-classical monocyte subset up-regulated TLR4-NF kappa B-iNOS and p38MAPK pathway, stimulated TNFa/nitrite production and elicited systemic inflammation. In febrile acute de-compensated cirrhotic patients, TLR4+896A/G and CD14-159C/T polymorphisms-related non-classical and classical monocytes dysfunction resulted in increased severe sepsis risk. Malnutrition, high plasma endotoxin and sCD14 levels, single TLR4+896A/G or CD14-159C/T variant allele carriers and double variant allele carriers are significant predictive factors for the development of severe sepsis among them.	[Fan, Wen -Chien; Huang, Shiang-Fen] Taipei Vet Gen Hosp, Dept Med, Div Infect, Taipei, Taiwan; [Yang, Ying-Ying] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan; [Lee, Kuei-Chuan; Yang, Ying-Ying; Hsieh, Yun-Cheng; Hou, Ming-Chih; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Fan, Wen -Chien; Liu, Chih-Wei; Ou, Shuo-Ming; Huang, Chia-Chang; Li, Tzu-Hao; Lee, Kuei-Chuan; Huang, Shiang-Fen; Yang, Ying-Ying; Hsieh, Yun-Cheng; Hou, Ming-Chih; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Huang, Chia-Chang; Li, Tzu-Hao; Yang, Ying-Ying; Hsieh, Shie-Liang] Natl Yang Ming Univ, Sch Med, Dept Med, Inst Clin Med, Taipei, Taiwan; [Fan, Wen -Chien; Liu, Chih-Wei; Ou, Shuo-Ming; Huang, Chia-Chang; Li, Tzu-Hao; Lee, Kuei-Chuan; Huang, Shiang-Fen; Yang, Ying-Ying; Hsieh, Yun-Cheng; Hsieh, Shie-Liang; Hou, Ming-Chih; Lin, Han-Chieh] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Yang, YY (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan.; Yang, YY; Lin, HC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Yang, YY; Lin, HC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Yang, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Inst Clin Med, Taipei, Taiwan.; Yang, YY; Lin, HC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.	yangyy@vghtpe.gov.tw; hclin@vghtpe.gov.tw	Lin, Han/GRF-1081-2022; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Huang, Shiang-Fen/ABA-5375-2021	Huang, Shiang-Fen/0000-0003-0390-9108; Huang, Chia-Chang/0000-0002-1313-4628; Yang, Ying-Ying/0000-0002-7719-0397	National Science Council [105-2314-B-010-024-MY3]; Taipei Veterans General Hospital [V104-023, V105C-010, VGHUST105-G1-2-2]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the National Science Council (grant: 105-2314-B-010-024-MY3) and the Taipei Veterans General Hospital (grants: V104-023, V105C-010, VGHUST105-G1-2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto H, 2005, INFLAMM RES, V54, P428, DOI 10.1007/s00011-005-1374-5; Aalto H, 2007, SCAND J INFECT DIS, V39, P596, DOI 10.1080/00365540701199808; Abraham E, 2003, J INFECT DIS, V187, pS364, DOI 10.1086/374750; Alberino F, 2001, NUTRITION, V17, P445, DOI 10.1016/S0899-9007(01)00521-4; Albillos A, 2004, LANCET, V363, P1608, DOI 10.1016/S0140-6736(04)16206-5; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Berres ML, 2009, LIVER INT, V29, P536, DOI 10.1111/j.1478-3231.2008.01870.x; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Chen YY, 2014, J CHIN MED ASSOC, V77, P68, DOI 10.1016/j.jcma.2013.10.006; Cholongitas E, 2006, ALIMENT PHARM THER, V23, P883, DOI 10.1111/j.1365-2036.2006.02842.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dijkstra G, 2002, SCAND J GASTROENTERO, V37, P546, DOI 10.1080/00365520252903099; Fortin CF, 2010, SHOCK, V33, P344, DOI 10.1097/SHK.0b013e3181c0f068; Gao JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118843; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibot S, 2002, CRIT CARE MED, V30, P969, DOI 10.1097/00003246-200205000-00003; Guarner-Argente C, 2010, ALIMENT PHARM THER, V31, P1192, DOI 10.1111/j.1365-2036.2010.04291.x; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Kothari N, 2013, CYTOKINE, V61, P676, DOI 10.1016/j.cyto.2012.11.016; Landmann R, 1996, J INFECT DIS, V173, P661, DOI 10.1093/infdis/173.3.661; Levan TD, 2008, J ALLERGY CLIN IMMUN, V121, P434, DOI 10.1016/j.jaci.2007.08.050; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Lin CY, 2007, J HEPATOL, V46, P816, DOI 10.1016/j.jhep.2006.12.018; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; Means TK, 2000, J LEUKOCYTE BIOL, V67, P885, DOI 10.1002/jlb.67.6.885; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Oberkofler CE, 2010, CRIT CARE, V14, DOI 10.1186/cc9068; PRUITT JH, 1995, SHOCK, V3, P235, DOI 10.1097/00024382-199504000-00001; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; Santolaya ME, 2008, PEDIATR INFECT DIS J, V27, P538, DOI 10.1097/INF.0b013e3181673c3c; Shi Y, 2015, J HEPATOL, V63, P60, DOI 10.1016/j.jhep.2015.02.020; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; von Baehr V, 2000, GUT, V47, P281, DOI 10.1136/gut.47.2.281; Yang YY, 2014, J HEPATOL, V61, P1004, DOI 10.1016/j.jhep.2014.05.049; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166458	10.1371/journal.pone.0166458	http://dx.doi.org/10.1371/journal.pone.0166458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861595	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300057
J	Irvine, KM; Wockner, LF; Hoffmann, I; Horsfall, LU; Fagan, KJ; Bijin, V; Lee, B; Clouston, AD; Lampe, G; Connolly, JE; Powell, EE				Irvine, Katharine M.; Wockner, Leesa F.; Hoffmann, Isabel; Horsfall, Leigh U.; Fagan, Kevin J.; Bijin, Veonice; Lee, Bernett; Clouston, Andrew D.; Lampe, Guy; Connolly, John E.; Powell, Elizabeth E.			Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALPHA-FETOPROTEIN; NONINVASIVE ASSESSMENT; ELF; METALLOPROTEINASES; PROGRESSION; REGRESSION; FIBROTEST; OUTCOMES; MARKERS	Background and Aims Non-invasive markers of liver fibrosis are urgently required, especially for use in non-specialist settings. The aim of this study was to identify novel serum biomarkers of advanced fibrosis. Methods We performed an unbiased screen of 120 serum analytes including cytokines, chemokines and proteases in 70 patients (35 without fibrosis, 35 with cirrhosis on biopsy), and selected a panel of 44 candidate biomarkers, which were subsequently measured in a mixed-etiology cohort of 432 patients with known serum HA, PIIINP and TIMP1 (which comprise the validated Enhanced Liver Fibrosis (ELF) test). Multivariate logistic regression modelling was used to generate models for the prediction of advanced or significant fibrosis (METAVIR >= F3 and >= F2, respectively); in addition to identifying biomarkers of disease activity and steatohepatitis. Results Seventeen analytes were significantly differentially expressed between patients with no advanced fibrosis and patients with advanced fibrosis, the most significant being hyaluronic acid (HA) and matrix metalloproteinase (MMP) 7 (p = 2.9E-41 and p = 1.0E-26, respectively). The optimal model for the prediction of advanced fibrosis comprised HA, MMP7, MMP1, alphafetoprotein (AFP) and the AST to platelet ratio index (APRI). We demonstrate enhanced diagnostic accuracy ( AUROC = 0.938) compared to a model comprising HA, PIIINP and TIMP1 alone ( ELF) ( AUROC = 0.898, p<0.0001, De Long's test). Conclusions We have identified novel serum biomarkers of advanced liver fibrosis, which have the potential to enhance the diagnostic accuracy of established biomarkers. Our data suggest MMP7 is a valuable indicator of advanced fibrosis and may play a role in liver fibrogenesis.	[Irvine, Katharine M.; Horsfall, Leigh U.; Fagan, Kevin J.; Clouston, Andrew D.; Powell, Elizabeth E.] Univ Queensland, Sch Med, Ctr Liver Dis Res, Brisbane, Qld, Australia; [Wockner, Leesa F.; Hoffmann, Isabel] QIMR Berghofer Med Res Inst, Stat Unit, Brisbane, Qld, Australia; [Horsfall, Leigh U.; Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia; [Bijin, Veonice; Lee, Bernett; Connolly, John E.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Bijin, Veonice; Lee, Bernett; Connolly, John E.] Singapore Immunol Network, Singapore 138648, Singapore; [Bijin, Veonice; Lee, Bernett; Connolly, John E.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA; [Lampe, Guy] Princess Alexandra Hosp, Pathol Queensland, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Baylor University	Irvine, KM (corresponding author), Univ Queensland, Sch Med, Ctr Liver Dis Res, Brisbane, Qld, Australia.	katharine.irvine@uq.edu.au	Powell, Elizabeth/B-4455-2011; Irvine, Katharine M/A-5559-2011; Clouston, Andrew/E-7199-2011	Powell, Elizabeth/0000-0001-5008-8061; Irvine, Katharine M/0000-0002-6716-1605; Wockner, Leesa/0000-0002-8921-9265; Clouston, Andrew/0000-0002-9601-7952	Pathology Queensland; Australian Liver Foundation Pauline Hall Fellowship; National Medical Research Council Practitioner Fellowship [APP1004242]	Pathology Queensland; Australian Liver Foundation Pauline Hall Fellowship; National Medical Research Council Practitioner Fellowship	This study was funded by Pathology Queensland (https://www.health.qld.gov.au/pathology-queensiand), an Australian Liver Foundation Pauline Hall Fellowship to KMI (https//www.liver.org.au) and a National Medical Research Council Practitioner Fellowship to EEP (APP1004242). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2011, J GASTROEN HEPATOL, V26, P1536, DOI 10.1111/j.1440-1746.2011.06774.x; Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chen L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-157; Chinnaratha MA, 2014, LIVER INT, V34, P720, DOI 10.1111/liv.12306; Fagan KJ, 2015, LIVER INT, V35, P1673, DOI 10.1111/liv.12760; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Halfon P, 2008, GASTROEN CLIN BIOL, V32, P22, DOI 10.1016/S0399-8320(08)73991-5; Huang CC, 2005, MODERN PATHOL, V18, P941, DOI 10.1038/modpathol.3800374; Irvine KM, 2016, LIVER INT, V36, P370, DOI 10.1111/liv.12896; Irvine KM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0036-7; Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851; Kakisaka K, 2015, HEPATOL RES, V45, pE12, DOI 10.1111/hepr.12448; Leelawat K, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-30; Leroy V, 2007, J HEPATOL, V46, P775, DOI 10.1016/j.jhep.2006.12.013; Lichtinghagen R, 1999, HEPATOL RES, V14, P119, DOI 10.1016/S1386-6346(98)00112-0; Liu YR, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-145; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Morais A, 2015, RESP MED, V109, P1063, DOI 10.1016/j.rmed.2015.06.003; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Petersen JR, 2014, J CLIN GASTROENTEROL, V48, P370, DOI 10.1097/MCG.0b013e3182a87e78; Poynard T, 2012, CLIN GASTROENTEROL H, V10, P657, DOI 10.1016/j.cgh.2012.01.023; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sands CJ, 2015, AM J GASTROENTEROL, V110, P159, DOI 10.1038/ajg.2014.370; Stasi C, 2016, WORLD J GASTROENTERO, V22, P1711, DOI 10.3748/wjg.v22.i4.1711; Tachi Y, 2016, J GASTROEN HEPATOL, V31, P1001, DOI 10.1111/jgh.13245; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Xie QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092772; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Yoshimura K, 2016, HEPATOLOGY, V63, P462, DOI 10.1002/hep.28226	31	20	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0167001	10.1371/journal.pone.0167001	http://dx.doi.org/10.1371/journal.pone.0167001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861569	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300142
J	Kimura, K; Inoue, KI; Kuroiwa, Y; Tanaka, F; Takada, M				Kimura, Katsuo; Inoue, Ken-Ichi; Kuroiwa, Yoshiyuki; Tanaka, Fumiaki; Takada, Masahiko			Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques	PLOS ONE			English	Article							PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; COMPARTMENTAL ORGANIZATION; DOPAMINERGIC INNERVATION; CEREBRAL-CORTEX; DEMENTIA; SYSTEM; BRAIN; DEGENERATION; PATHOLOGY	In neurodegenerative disorders, such as Parkinson's disease (PD), alpha-synuclein (alpha-syn) accumulates to induce cell death and/or form a cytoplasmic inclusion called Lewy body (LB). This alpha-syn-related pathology is termed synucleinopathy. It remains unclear how a-syn accumulation expands during the progress of synucleinopathy in the human brain. In our study, we investigated the patterns of distribution and propagation of forebrain neurons expressing a-syn in aged macaques. It was found that the occurrence of alpha-syn-positive neurons proceeded topologically based on the midbrain dopamine pathways arising from the substantia nigra and the ventral tegmental area where they were primarily observed. In the nigrostriatal or mesolimbic dopamine pathway, the age-dependent increase in a-syn-positive neurons was evident in the striatum or the nucleus accumbens, respectively. Concerning the nigrostriatal pathway, a mediolateral or rostrocaudal gradient was seen in the substantia nigra or the striatum, respectively, and a compensatory increase in dopamine transporter occurred in the striatum regardless of the decreased dopamine level. In the mesocortical dopamine pathway, a-syn-positive neurons appeared in the prefrontal and then motor areas of the frontal lobe. Given that neither LB formation nor clinical phenotype manifestation was detected in any of the monkeys examined in the present study, aged macaques may be useful as a potential presymptomatic model for PD and LB-related neuropsychiatric disorders.	[Kimura, Katsuo; Inoue, Ken-Ichi; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi, Japan; [Kimura, Katsuo; Kuroiwa, Yoshiyuki; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa, Japan; [Kuroiwa, Yoshiyuki] Teikyo Univ, Sch Med, Univ Hosp Mizonokuchi, Dept Neurol, Kawasaki, Kanagawa, Japan; [Kuroiwa, Yoshiyuki] Teikyo Univ, Sch Med, Univ Hosp Mizonokuchi, Stroke Ctr, Kawasaki, Kanagawa, Japan	Kyoto University; Yokohama City University; Teikyo University; Teikyo University	Takada, M (corresponding author), Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi, Japan.	takada.masahiko.7x@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25110716, 16H01611]; Grants-in-Aid for Scientific Research [16H01611, 15H01434, 16KT0193] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (25110716 and 16H01611 to M. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Andersen AH, 1999, BRAIN RES, V829, P90, DOI 10.1016/S0006-8993(99)01343-8; [Anonymous], 2007, J COGNITIVE NEUROSCI, V19, P275, DOI [10.1162/jocn.2007.19.2.27, DOI 10.1162/JOCN.2007.19.2.275]; Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; BERGER B, 1974, BRAIN RES, V81, P332, DOI 10.1016/0006-8993(74)90948-2; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; Booth TC, 2015, AM J NEURORADIOL, V36, P229, DOI 10.3174/ajnr.A3970; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Canron MH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00910; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Collier TJ, 2005, EXP NEUROL, V191, pS60, DOI 10.1016/j.expneurol.2004.08.018; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; Garcia-Cabezas MA, 2009, CEREB CORTEX, V19, P424, DOI 10.1093/cercor/bhn093; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Haber SN, 2000, J NEUROSCI, V20, P2369; Halliday GM, 2014, MOVEMENT DISORD, V29, P634, DOI 10.1002/mds.25857; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jellinger KA, 2004, J NEURAL TRANSM, V111, P1219, DOI 10.1007/s00702-004-0138-7; Jellinger Kurt A., 2009, V24, P114, DOI 10.1159/000197890; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Logothetis NK, 2007, COMBINED MRI HISTOLO; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Ma SY, 1997, J NEUROL SCI, V151, P83, DOI 10.1016/S0022-510X(97)00100-7; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Masilamoni GJ, 2011, BRAIN, V134, P2057, DOI 10.1093/brain/awr137; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; McCann Heather, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS62, DOI 10.1016/S1353-8020(13)70017-8; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Paxinos G., 2009, RHESUS MONKEY BRAIN; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Puschmann Andreas, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS24, DOI 10.1016/S1353-8020(11)70010-4; Rajput AH, 2008, NEUROLOGY, V70, P1403, DOI 10.1212/01.wnl.0000285082.18969.3a; Rolls ET, 2010, NEUROSCI BIOBEHAV R, V34, P237, DOI 10.1016/j.neubiorev.2008.03.010; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P742, DOI 10.1093/jnen/63.7.742; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Vezoli J, 2014, NEUROIMAGE, V102, P249, DOI 10.1016/j.neuroimage.2014.07.059; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yasuda T, 2010, APOPTOSIS, V15, P1312, DOI 10.1007/s10495-010-0486-8	58	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166861	10.1371/journal.pone.0166861	http://dx.doi.org/10.1371/journal.pone.0166861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861638	gold, Green Published			2022-12-26	WOS:000388350300126
J	Luck, M; Bertho, G; Bateson, M; Karras, A; Yartseva, A; Thervet, E; Damon, C; Pallet, N				Luck, Margaux; Bertho, Gildas; Bateson, Mathilde; Karras, Alexandre; Yartseva, Anastasia; Thervet, Eric; Damon, Cecilia; Pallet, Nicolas			Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data	PLOS ONE			English	Article							DIMETHYL SULFONE; IDENTIFICATION; FIBROSIS	H-1 Nuclear Magnetic Resonance (NMR)-based metabolic profiling is very promising for the diagnostic of the stages of chronic kidney disease (CKD). Because of the high dimension of NMR spectra datasets and the complex mixture of metabolites in biological samples, the identification of discriminant biomarkers of a disease is challenging. None of the widely used chemometric methods in NMR metabolomics performs a local exhaustive exploration of the data. We developed a descriptive and easily understandable approach that searches for discriminant local phenomena using an original exhaustive rule-mining algorithm in order to predict two groups of patients: 1) patients having low to mild CKD stages with no renal failure and 2) patients having moderate to established CKD stages with renal failure. Our predictive algorithm explores the m-dimensional variable space to capture the local overdensities of the two groups of patients under the form of easily interpretable rules. Afterwards, a L2-penalized logistic regression on the discriminant rules was used to build predictive models of the CKD stages. We explored a complex multi-source dataset that included the clinical, demographic, clinical chemistry, renal pathology and urine metabolomic data of a cohort of 110 patients. Given this multi-source dataset and the complex nature of metabolomic data, we analyzed 1- and 2-dimensional rules in order to integrate the information carried by the interactions between the variables. The results indicated that our local algorithm is a valuable analytical method for the precise characterization of multivariate CKD stage profiles and as efficient as the classical global model using chi2 variable section with an approximately 70% of good classification level. The resulting predictive models predominantly identify urinary metabolites (such as 3-hydroxyisovalerate, carnitine, citrate, dimethylsulfone, creatinine and N-methylnicotinamide) as relevant variables indicating that CKD significantly affects the urinary metabolome. In addition, the simple knowledge of the concentration of urinary metabolites classifies the CKD stage of the patients correctly.	[Luck, Margaux; Bertho, Gildas; Karras, Alexandre; Thervet, Eric; Pallet, Nicolas] Paris Descartes Univ, Paris, France; [Luck, Margaux; Bateson, Mathilde; Yartseva, Anastasia; Damon, Cecilia] Hypercube Inst, Paris, France; [Karras, Alexandre; Thervet, Eric; Pallet, Nicolas] Georges Pompidou European Hosp, Div Renal, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Luck, M (corresponding author), Paris Descartes Univ, Paris, France.; Luck, M (corresponding author), Hypercube Inst, Paris, France.	margaux.luck@institut-hypercube.org		Bateson, Mathilde/0000-0002-3931-8249; Bertho, Gildas/0000-0002-4929-763X; Pallet, Nicolas/0000-0002-8486-3596				BEILKE MA, 1987, J LAB CLIN MED, V110, P91; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Boussadi A, 2012, J AM MED INFORM ASSN, V19, P782, DOI 10.1136/amiajnl-2012-000850; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; Danciu I, 2014, J BIOMED INFORM, V52, P28, DOI 10.1016/j.jbi.2014.02.003; Dona AC, 2016, COMPUT STRUCT BIOTEC, V14, P135, DOI 10.1016/j.csbj.2016.02.005; Ghule AE, 2012, INT IMMUNOPHARMACOL, V14, P740, DOI 10.1016/j.intimp.2012.10.004; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Holmes JH, 2014, J AM MED INFORM ASSN, V21, P730, DOI 10.1136/amiajnl-2013-002370; Kalim S, 2017, KIDNEY INT, V91, P61, DOI 10.1016/j.kint.2016.08.021; Kloesch B, 2011, LIFE SCI, V89, P473, DOI 10.1016/j.lfs.2011.07.015; Kosmides Alyssa K., 2013, Critical Reviews in Biomedical Engineering, V41, P205; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Luck MM, 2015, 2015 IEEE 14TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P176, DOI 10.1109/ICMLA.2015.155; Mutsaers HAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071199; Pallet N, 2014, KIDNEY INT, V85, P1239, DOI 10.1038/ki.2014.34; Phisitkul S, 2010, KIDNEY INT, V77, P617, DOI 10.1038/ki.2009.519; Portilla D, 2007, SEMIN NEPHROL, V27, P609, DOI 10.1016/j.semnephrol.2007.09.006; Posada-Ayala M, 2014, KIDNEY INT, V85, P103, DOI 10.1038/ki.2013.328; Post AR, 2013, J BIOMED INFORM, V46, P410, DOI 10.1016/j.jbi.2013.01.005; Servais A, 2007, TRANSPLANTATION, V84, P1595, DOI 10.1097/01.tp.0000295749.50525.bd; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Shulaev V, 2006, BRIEF BIOINFORM, V7, P128, DOI 10.1093/bib/bbl012; Sugimoto M, 2012, CURR BIOINFORM, V7, P96, DOI 10.2174/157489312799304431; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; WILLIAMS KI, 1966, ARCH BIOCHEM BIOPHYS, V113, P251, DOI 10.1016/0003-9861(66)90182-2; Wishart DS, 2008, CONTRIB NEPHROL, V160, P76, DOI 10.1159/000125935; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhao YY, 2014, CLIN BIOCHEM, V47, P16, DOI 10.1016/j.clinbiochem.2014.07.019; Zhao YY, 2014, ADV CLIN CHEM, V65, P69, DOI 10.1016/B978-0-12-800141-7.00003-6; Zhao YY, 2014, CHEM-BIOL INTERACT, V215, P7, DOI 10.1016/j.cbi.2014.02.014; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033	34	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166905	10.1371/journal.pone.0166905	http://dx.doi.org/10.1371/journal.pone.0166905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861591	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300130
J	Maccarone, R; Rapino, C; Zerti, D; di Tommaso, M; Battista, N; Di Marco, S; Bisti, S; Maccarrone, M				Maccarone, Rita; Rapino, Cinzia; Zerti, Darin; di Tommaso, Monia; Battista, Natalia; Di Marco, Stefano; Bisti, Silvia; Maccarrone, Mauro			Modulation of Type-1 and Type-2 Cannabinoid Receptors by Saffron in a Rat Model of Retinal Neurodegeneration	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; DAMAGING LIGHT; ENDOCANNABINOIDS; DEGENERATION; MECHANISMS; APOPTOSIS; RESPONSES; NEUROPROTECTION; SUPPLEMENTATION; LOCALIZATION	Experimental studies demonstrated that saffron (Crocus sativus) given as a dietary supplement counteracts the effects of bright continuous light (BCL) exposure in the albino rat retina, preserving both morphology and function and probably acting as a regulator of programmed cell death [1]. The purpose of this study was to ascertain whether the neuroprotective effect of saffron on rat retina exposed to BCL is associated with a modulation of the endocannabinoid system (ECS). To this aim, we used eight experimental groups of Sprague-Dawley rats, of which six were exposed to BCL for 24 hours. Following retinal function evaluation, retinas were quickly removed for biochemical and morphological analyses. Rats were either saffron-prefed or intravitreally injected with selective type-1 (CB1) or type-2 (CB2) cannabinoid receptor antagonists before BCL. Prefeeding and intravitreally injections were combined in two experimental groups before BCL. BCL exposure led to enhanced gene and protein expression of retinal CB1 and CB2 without affecting the other ECS elements. This effect of BCL on CB1 and CB2 was reversed by saffron treatment. Selective CB1 and CB2 antagonists reduced photoreceptor death, preserved morphology and visual function of retina, and mitigated the outer nuclear layer (ONL) damage due to BCL. Of interest, CB2-dependent neuroprotection was more pronounced than that conferred by CB1. These data suggest that BCL modulates only distinct ECS elements like CB1 and CB2, and that saffron and cannabinoid receptors could share the same mechanism in order to afford retinal protection.	[Maccarone, Rita; Zerti, Darin; Di Marco, Stefano; Bisti, Silvia] Univ Aquila, Biotechnol & Appl Clin Sci Dept, Laquila, Italy; [Rapino, Cinzia; di Tommaso, Monia] Univ Teramo, Fac Vet Med, Teramo, Italy; [Battista, Natalia] Univ Teramo, Fac Biosci, Teramo, Italy; [Bisti, Silvia] Australian Natl Univ, John Curtin Sch Med Res, ARC Ctr Excellence Vis Sci, Canberra, ACT 0200, Australia; [Bisti, Silvia] Interuniv Consortium Ist Nazl Biostrutture & Bios, Rome, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Dept Med, Rome, Italy; [Maccarrone, Mauro] IRCCS Santa Lucia Fdn, European Ctr Brain Res, Rome, Italy	University of L'Aquila; University of Teramo; University of Teramo; Australian National University; John Curtin School of Medical Research; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia	Bisti, S (corresponding author), Univ Aquila, Biotechnol & Appl Clin Sci Dept, Laquila, Italy.; Bisti, S (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, ARC Ctr Excellence Vis Sci, Canberra, ACT 0200, Australia.; Bisti, S (corresponding author), Interuniv Consortium Ist Nazl Biostrutture & Bios, Rome, Italy.; Maccarrone, M (corresponding author), Campus Biomed Univ Rome, Dept Med, Rome, Italy.; Maccarrone, M (corresponding author), IRCCS Santa Lucia Fdn, European Ctr Brain Res, Rome, Italy.	silvia.bisti@univaq.it; m.maccarrone@unicampus.it	Zerti, Darin/AAF-7078-2021; Battista, Natalia/AAC-2529-2019; Maccarrone, Mauro/K-5398-2012; Di Marco, Stefano/AAO-8073-2020	Zerti, Darin/0000-0003-0865-8088; Maccarrone, Mauro/0000-0002-3990-2963; Di Marco, Stefano/0000-0003-4847-6270; MACCARONE, Rita/0000-0003-0648-3771; Battista, Natalia/0000-0002-1936-6710	Ministero dell'Istruzione, dell'Universita e della Ricerca	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This investigation was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2010-2011 grant) to MM, to SB and by Mr. Francesco Segafredo, Essse Caffe S.p.A. The company Hortus Novus s.r.l. provided the saffron used in this study. These supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAEV FI, 1993, BIOFACTORS, V4, P83; Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bisti S, 2014, VISUAL NEUROSCI, V31, P355, DOI 10.1017/S0952523814000108; Bouchard JF, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9247057; Cairns EA, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9364091; Cecyre B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00150; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chiurchiu V, 2015, J NEUROIMMUNE PHARM, V10, P268, DOI 10.1007/s11481-015-9584-2; Corso L, 2016, PURINERG SIGNAL, V12, P161, DOI 10.1007/s11302-015-9490-3; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; El-Remessy AB, 2003, AM J PATHOL, V163, P1997, DOI 10.1016/S0002-9440(10)63558-4; Falsini B, 2010, INVEST OPHTH VIS SCI, V51, P6118, DOI 10.1167/iovs.09-4995; Fezza F, 2014, MOLECULES, V19, P17078, DOI 10.3390/molecules191117078; Gargini C, 2004, NEUROSCIENCE, V126, P775, DOI 10.1016/j.neuroscience.2004.04.028; Gasperi V, 2007, CELL MOL LIFE SCI, V64, P219, DOI 10.1007/s00018-006-6445-4; Guabiraba R, 2013, INFLAMM RES, V62, P811, DOI 10.1007/s00011-013-0638-8; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Kishimoto S, 2004, J BIOCHEM, V135, P517, DOI 10.1093/jb/mvh063; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Latini L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.364; Lograno MD, 2004, EUR J PHARMACOL, V494, P55, DOI 10.1016/j.ejphar.2004.04.039; Maccarone R, 2008, INVEST OPHTH VIS SCI, V49, P1254, DOI 10.1167/iovs.07-0438; Maccarrone M, 2014, NAT REV NEUROSCI, V15, P786, DOI 10.1038/nrn3846; Marangoni D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-228; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Murakami Y, 2013, PROG RETIN EYE RES, V37, P114, DOI 10.1016/j.preteyeres.2013.08.001; Natoli R, 2010, MOL VIS, V16, P1801; Nucci C, 2007, INVEST OPHTH VIS SCI, V48, P2997, DOI 10.1167/iovs.06-1355; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Piccardi M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429124; Pucci M, 2012, J BIOL CHEM, V287, P15466, DOI 10.1074/jbc.M111.314880; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Ryskamp Daniel A, 2014, Cells, V3, P914, DOI 10.3390/cells3030914; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Soeda S, 2001, LIFE SCI, V69, P2887, DOI 10.1016/S0024-3205(01)01357-1; Starowicz K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060040; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Ueda N, 2011, BIOFACTORS, V37, P1, DOI 10.1002/biof.131; Unsicker K, 2013, CELL TISSUE RES, V353, P205, DOI 10.1007/s00441-013-1585-y; Urquhart P, 2015, J LIPID RES, V56, P1419, DOI 10.1194/jlr.M055772; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wei Y, 2013, MOL VIS, V19, P357; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yazulla S, 1999, J COMP NEUROL, V415, P80, DOI 10.1002/(SICI)1096-9861(19991206)415:1<80::AID-CNE6>3.0.CO;2-H; Yazulla S, 2008, PROG RETIN EYE RES, V27, P501, DOI 10.1016/j.preteyeres.2008.07.002	53	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166827	10.1371/journal.pone.0166827	http://dx.doi.org/10.1371/journal.pone.0166827			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861558	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300117
J	Olivares-Gonzalez, L; de la Camara, CMF; Hervas, D; Marin, MP; Lahoz, A; Millan, JM; Rodrigo, R				Olivares-Gonzalez, Lorena; Martinez-Fernandez de la Camara, Cristina; Hervas, David; Pilar Marin, Maria; Lahoz, Agustin; Maria Millan, Jose; Rodrigo, Regina			cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants	PLOS ONE			English	Article							PROTEIN-KINASE-G; NITRIC-OXIDE; INDUCED APOPTOSIS; OXIDATIVE STRESS; GANGLION-CELLS; CYCLIC-GMP; BLOOD-FLOW; OXYGEN; ISCHEMIA; SURVIVAL	Retinal hypoxia and oxidative stress are involved in several retinal degenerations including diabetic retinopathy, glaucoma, central retinal artery occlusion, or retinopathy of prematurity. The second messenger cyclic guanosine monophosphate (cGMP) has been reported to be protective for neuronal cells under several pathological conditions including ischemia/hypoxia. The purpose of this study was to evaluate whether the accumulation of cGMP through the pharmacological inhibition of phosphodiesterase (PDE) with Zaprinast prevented retinal degeneration induced by mild hypoxia in cultures of porcine retina. Exposure to mild hypoxia (5% O-2) for 24h reduced cGMP content and induced retinal degeneration by caspase dependent and independent (PARP activation) mechanisms. Hypoxia also produced a redox imbalance reducing antioxidant response (superoxide dismutase and catalase activities) and increasing superoxide free radical release. Zaprinast reduced mild hypoxia-induced cell death through inhibition of caspase-3 or PARP activation depending on the cell layer. PDE inhibition also ameliorated the effects of mild hypoxia on antioxidant response and the release of superoxide radical in the photoreceptor layer. The use of a PKG inhibitor, KT5823, suggested that cGMP-PKG pathway is involved in cell survival and antioxidant response. The inhibition of PDE, therefore, could be useful for reducing retinal degeneration under hypoxic/ischemic conditions.	[Olivares-Gonzalez, Lorena; Martinez-Fernandez de la Camara, Cristina; Maria Millan, Jose; Rodrigo, Regina] Inst Invest Sanitaria La Fe, Grp Biomed Mol Celular & Genom, Valencia, Spain; [Olivares-Gonzalez, Lorena; Maria Millan, Jose; Rodrigo, Regina] CIBERER, Madrid, Spain; [Hervas, David] Inst Invest Sanitaria La Fe, Unidad Bioestadist, Valencia, Spain; [Pilar Marin, Maria] Inst Invest Sanitaria La Fe, Unidad Microscopia, Valencia, Spain; [Lahoz, Agustin] Inst Invest Sanitaria La Fe, Unidad Hepatol Expt, Unidad Analit, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Rodrigo, R (corresponding author), Inst Invest Sanitaria La Fe, Grp Biomed Mol Celular & Genom, Valencia, Spain.; Rodrigo, R (corresponding author), CIBERER, Madrid, Spain.	regina.rodrigo@yahoo.es	Martinez, Cristina/ABH-7295-2020; Lahoz, Agustin/B-8048-2014; Rodrigo, Regina/I-1868-2015; Olivares-González, Lorena/ABG-8737-2020; Hervas, David/L-1322-2016	Martinez, Cristina/0000-0002-6612-6162; Lahoz, Agustin/0000-0001-7232-0626; Rodrigo, Regina/0000-0001-5875-986X; Olivares-González, Lorena/0000-0001-8180-1229; Hervas, David/0000-0003-0635-4961	European Regional Development Fund, Institute of Health Carlos III (ISCIII) from the Spanish Ministry of Economy and Competitiveness [PI12/0481, PI114/00026]; ISCIII [CA12/00329, CP09/118]	European Regional Development Fund, Institute of Health Carlos III (ISCIII) from the Spanish Ministry of Economy and Competitiveness; ISCIII(Instituto de Salud Carlos III)	This work was supported by the European Regional Development Fund, Institute of Health Carlos III (ISCIII) [PI12/0481, PI114/00026] from the Spanish Ministry of Economy and Competitiveness (MEC). CIBERER [CB06/07/1030] is an initiative of the ISCIII from the MEC. Maria Pilar Marin has a technician-contract SNS [CA12/00329] from ISCIII and Regina Rodrigo has a research-contract SNS Miguel Servet [CP09/118] from ISCIII.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Azuma M, 2014, CURR EYE RES, V39, P421, DOI 10.3109/02713683.2013.845225; Bek T, 2009, ACTA OPHTHALMOL, V87, P362, DOI 10.1111/j.1755-3768.2008.01429.x; Bickler PE, 2004, J EXP BIOL, V207, P3243, DOI 10.1242/jeb.00977; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Canals S, 2003, J BIOL CHEM, V278, P21542, DOI 10.1074/jbc.M213174200; Canzoniero LMT, 2006, J NEUROSCI RES, V84, P692, DOI 10.1002/jnr.20971; Caprara C, 2012, PROG RETIN EYE RES, V31, P89, DOI 10.1016/j.preteyeres.2011.11.003; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chen XM, 2014, EXP NEUROL, V261, P267, DOI 10.1016/j.expneurol.2014.07.007; Chen YN, 2007, BRAIN RES, V1148, P28, DOI 10.1016/j.brainres.2007.02.027; Costa VP, 2003, PROG RETIN EYE RES, V22, P769, DOI 10.1016/S1350-9462(03)00064-8; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Downie LE, 2007, J COMP NEUROL, V504, P404, DOI 10.1002/cne.21449; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Eshaq RS, 2014, REDOX BIOL, V2, P661, DOI 10.1016/j.redox.2014.04.006; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Foresta C, 2008, EYE, V22, P144, DOI 10.1038/sj.eye.6702908; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Fu Y., 2010, PHOTOTRANSDUCTION RO; Gao YS, 2003, AM J PHYSIOL-LUNG C, V285, pL611, DOI 10.1152/ajplung.00411.2002; Gomelsky M, 2013, EMBO J, V32, P2421, DOI 10.1038/emboj.2013.193; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Harris A, 1999, PROG RETIN EYE RES, V18, P669; Hoon M, 2014, PROG RETIN EYE RES, V42, P44, DOI 10.1016/j.preteyeres.2014.06.003; Ishizuka F, 2013, PHARMACOL RES PERSPE, V1, DOI 10.1002/prp2.6; Iwama D, 2007, J THROMB HAEMOST, V5, P818, DOI 10.1111/j.1538-7836.2007.02425.x; Jiao K, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.40; Joo CK, 1999, INVEST OPHTH VIS SCI, V40, P713; Kashimoto R, 2008, NEUROSCI LETT, V436, P116, DOI 10.1016/j.neulet.2008.03.002; Kermorvant-Duchemin E, 2010, DOC OPHTHALMOL, V120, P51, DOI 10.1007/s10633-009-9201-x; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Killilea DW, 2000, AM J PHYSIOL-LUNG C, V279, pL408, DOI 10.1152/ajplung.2000.279.2.L408; Kim SY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.80; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Ko IG, 2009, PHARMACOL BIOCHEM BE, V91, P629, DOI 10.1016/j.pbb.2008.10.009; Kumar S, 2015, STEM CELLS DEV, V24, P1332, DOI 10.1089/scd.2014.0288; Li SY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/426769; Lin YB, 2012, J PHYSIOL SCI, V62, P309, DOI 10.1007/s12576-012-0201-3; Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647; Liu HW, 2015, MOL MED REP, V12, P2495, DOI 10.3892/mmr.2015.3731; Liu JQ, 2003, AM J PHYSIOL-LUNG C, V285, pL322, DOI 10.1152/ajplung.00337.2002; Liu LP, 2010, ACTA PHARMACOL SIN, V31, P405, DOI 10.1038/aps.2010.7; Liu X, 2013, AEROSP MANUF TECHNOL, V1, P1, DOI DOI 10.1109/TNNLS.2013.2287275; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; de la Camara CMF, 2013, EXP EYE RES, V111, P122, DOI 10.1016/j.exer.2013.03.015; Mastrodimou N, 2008, INVEST OPHTH VIS SCI, V49, P342, DOI 10.1167/iovs.07-0341; Mejia-Garcia TA, 2013, CELL SIGNAL, V25, P2424, DOI 10.1016/j.cellsig.2013.08.001; Nagai-Kusuhara A, 2007, EXP EYE RES, V84, P152, DOI 10.1016/j.exer.2006.09.010; Narayanan SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022460; Negash S, 2007, AM J PHYSIOL-LUNG C, V293, pL1012, DOI 10.1152/ajplung.00061.2007; Neo BH, 2010, RESP PHYSIOL NEUROBI, V174, P259, DOI 10.1016/j.resp.2010.08.024; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Podda MV, 2014, PFLUG ARCH EUR J PHY, V466, P1241, DOI 10.1007/s00424-013-1373-2; Produit-Zengaffinen N, 2016, ADV EXP MED BIOL, V854, P677, DOI 10.1007/978-3-319-17121-0_90; Rimachi R, 2012, ANAESTH INTENS CARE, V40, P427, DOI 10.1177/0310057X1204000307; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Santone R, 2006, J NEUROSCI RES, V84, P1020, DOI 10.1002/jnr.21009; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Schatz A, 2014, GRAEF ARCH CLIN EXP, V252, P43, DOI 10.1007/s00417-013-2504-3; Sennlaub F, 2002, J NEUROSCI, V22, P3987, DOI 10.1523/JNEUROSCI.22-10-03987.2002; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Siu AW, 2006, J PINEAL RES, V40, P101, DOI 10.1111/j.1600-079X.2005.00304.x; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Tatsumi Y, 2008, CURR EYE RES, V33, P683, DOI 10.1080/02713680802323157; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Weise J, 2001, CELL DEATH DIFFER, V8, P801, DOI 10.1038/sj.cdd.4400872; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928; Yu DY, 2007, INVEST OPHTH VIS SCI, V48, P2290, DOI 10.1167/iovs.06-1197; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257; Zhang Y, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2014-6; Zhang ZZ, 2011, NEUROSCI LETT, V504, P88, DOI 10.1016/j.neulet.2011.09.003	87	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166717	10.1371/journal.pone.0166717	http://dx.doi.org/10.1371/journal.pone.0166717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861632	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300094
J	Corbisier, J; Huszagh, A; Gales, C; Parmentier, M; Springael, JY				Corbisier, Jenny; Huszagh, Alexandre; Gales, Celine; Parmentier, Marc; Springael, Jean-Yves			Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID RECEPTOR; SMALL-MOLECULE; HEALTHY-VOLUNTEERS; POTENT INHIBITION; ANTAGONIST; ACTIVATION; MECHANISM; PHARMACOKINETICS; PHARMACODYNAMICS; INTERNALIZATION	Biased agonism at G protein-coupled receptors constitutes a promising area of research for the identification of new therapeutic molecules. In this study we identified two novel biased ligands for the chemokine receptors CCR2 and CCR5 and characterized their functional properties. We showed that J113863 and its enantiomer UCB35625, initially identified as high affinity antagonists for CCR1 and CCR3, also bind with low affinity to the closely related receptors CCR2 and CCR5. Binding of J113863 and UCB35625 to CCR2 or CCR5 resulted in the full or partial activation of the three G(i) proteins and the two Go isoforms. Unlike chemokines, the compounds did not activate G12. Binding of J113863 to CCR2 or CCR5 also induced the recruitment of beta-arrestin 2, whereas UCB35625 did not. UCB35625 induced the chemotaxis of L1.2 cells expressing CCR2 or CCR5. In contrast, J113863 induced the migration of L1.2-CCR2 cells but antagonized the chemokine-induced migration of L1.2-CCR5 cells. We also showed that replacing the phenylalanine 3.33 in CCR5 TM3 by the corresponding histidine of CCR2 converts J113863 from an antagonist for cell migration and a partial agonist in other assays to a full agonist in all assays. Further analyses indicated that F3.33H substitution strongly increased the activation of G proteins and beta-arrestin 2 by J113863. These results highlight the biased nature of the J113863 and UCB35625 that act either as antagonist, partial agonist, or full agonist according to the receptor, the enantiomer, and the signaling pathway investigated.	[Corbisier, Jenny; Huszagh, Alexandre; Parmentier, Marc; Springael, Jean-Yves] ULB, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium; [Gales, Celine] Univ Toulouse III Paul Sabatier, INSERM, Inst Malad Metab & Cardiovasc, F-31432 Toulouse, France; [Huszagh, Alexandre] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Irvine	Springael, JY (corresponding author), ULB, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	jyspring@ulb.ac.be		GALES, Celine/0000-0002-4938-1583				Ajram L, 2014, EUR J PHARMACOL, V729, P75, DOI 10.1016/j.ejphar.2014.02.007; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARTSCH W, 1990, EUR J CLIN PHARMACOL, V38, pS104, DOI 10.1007/BF01409475; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Bonner K, 2013, J ALLERGY CLIN IMMUN, V132, P942, DOI 10.1016/j.jaci.2013.04.015; COOPER MJ, 1974, LIFE SCI, V15, P1665, DOI 10.1016/0024-3205(74)90333-6; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; de Mendonca FL, 2005, J BIOL CHEM, V280, P4808, DOI 10.1074/jbc.M412267200; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Mehvar R, 2001, J PHARM PHARM SCI, V4, P185; NICHOLS AJ, 1989, CHIRALITY, V1, P265, DOI 10.1002/chir.530010404; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rentsch KM, 2002, J BIOCHEM BIOPH METH, V54, P1, DOI 10.1016/S0165-022X(02)00124-0; Sabroe I, 2000, J BIOL CHEM, V275, P25985, DOI 10.1074/jbc.M908864199; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Soergel DG, 2013, J CLIN PHARMACOL, V53, P892, DOI 10.1002/jcph.111; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Viney JM, 2014, J IMMUNOL, V192, P3419, DOI 10.4049/jimmunol.1300232; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wise EL, 2007, J BIOL CHEM, V282, P27935, DOI 10.1074/jbc.M703255200; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	37	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					575	584		10.1074/jbc.M116.757559	http://dx.doi.org/10.1074/jbc.M116.757559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27895119	Green Published, hybrid			2022-12-26	WOS:000392316100014
J	Kajitani, N; Miyano, K; Okada-Tsuchioka, M; Abe, H; Itagaki, K; Hisaoka-Nakashima, K; Morioka, N; Uezono, Y; Takebayashi, M				Kajitani, Naoto; Miyano, Kanako; Okada-Tsuchioka, Mami; Abe, Hiromi; Itagaki, Kei; Hisaoka-Nakashima, Kazue; Morioka, Norimitsu; Uezono, Yasuhito; Takebayashi, Minoru			Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; SIGNAL-REGULATED KINASE; PROTEIN ALPHA-SUBUNIT; PERTUSSIS-TOXIN; AMITRIPTYLINE; ASTROCYTES; GDNF; ACTIVATION; RELEASE; LPA(1)	Preclinical and clinical evidence suggests that glial cell line-derived neurotrophic factor (GDNF) is important in the therapeutic effect of antidepressants. A previous study demonstrated that the tricyclic antidepressant amitriptyline induces G alpha(i/o) activation, which leads to GDNF expression in astrocytes. However, the specific target expressed in astrocytes that mediates antidepressant-evoked G alpha(i/o) activation has yet to be identified. Thus, the current study explored the possibility that antidepressant-induced G alpha(i/o) activation depends on lysophosphatidic acid receptor 1 (LPAR1), a G alpha(i/o)-coupled receptor. GDNF mRNA expression was examined using real-time PCR and G alpha(i/o) activation was examined using the cell-based receptor assay system CellKey (TM) in rat C6 astroglial cells and rat primary cultured astrocytes. LPAR1 antagonists blocked GDNF mRNA expression and G alpha(i/o) activation evoked by various classes of antidepressants (amitriptyline, nortriptyline, mianserin, and fluoxetine). In addition, deletion of LPAR1 by RNAi suppressed amitriptyline-evoked GDNF mRNA expression. Treatment of astroglial cells with the endogenous LPAR agonist LPA increased GDNF mRNA expression through LPAR1, whereas treatment of primary cultured neurons with LPA failed to affect GDNF mRNA expression. Astrocytic GDNF expression evoked by either amitriptyline or LPA utilized, in part, transactivation of fibroblast growth factor receptor and a subsequent ERK cascade. The current results suggest that LPAR1 is a novel, specific target of antidepressants that leads to GDNF expression in astrocytes.	[Kajitani, Naoto; Okada-Tsuchioka, Mami; Abe, Hiromi; Itagaki, Kei; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, 3-1 Aoyama, Kure 7370023, Japan; [Kajitani, Naoto; Okada-Tsuchioka, Mami; Abe, Hiromi; Itagaki, Kei; Takebayashi, Minoru] Chugoku Canc Ctr, 3-1 Aoyama, Kure 7370023, Japan; [Miyano, Kanako; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan; [Itagaki, Kei; Takebayashi, Minoru] Natl Hosp Org, Dept Psychiat, Kure Med Ctr, 3-1 Aoyama, Kure 7370023, Japan; [Hisaoka-Nakashima, Kazue; Morioka, Norimitsu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Div Support Care Res, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan	National Cancer Center - Japan; Hiroshima University; National Cancer Center - Japan	Takebayashi, M (corresponding author), Chugoku Canc Ctr, 3-1 Aoyama, Kure 7370023, Japan.; Takebayashi, M (corresponding author), Natl Hosp Org, Dept Psychiat, Kure Med Ctr, 3-1 Aoyama, Kure 7370023, Japan.	mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Miyano, Kanako/0000-0003-1673-6074; Kajitani, Naoto/0000-0001-7245-9206	Japan Society for the Promotion of Science KAKENHI Grants [25860199, 15K09819, 15K08686, 16K08568, 16K19796, 16K18883]; SENSHIN Medical Research; Grants-in-Aid for Scientific Research [15K09819] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 25860199, 15K09819, 15K08686, 16K08568, 16K19796, and 16K18883 and a grant from SENSHIN Medical Research. The authors declare that they have no conflicts of interest with the contents of this article.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Erb SJ, 2016, J BIOL CHEM, V291, P19725, DOI 10.1074/jbc.M116.727263; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Galeotti N, 2002, NEUROPSYCHOPHARMACOL, V27, P554; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Hisaoka-Nakashima K, 2015, J BIOL CHEM, V290, P13678, DOI 10.1074/jbc.M114.622415; Kajitani N, 2015, J NEUROCHEM, V135, P27, DOI 10.1111/jnc.13247; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kowal D, 2002, BIOCHEM BIOPH RES CO, V294, P655, DOI 10.1016/S0006-291X(02)00535-1; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Lin PY, 2015, J PSYCHIATR RES, V63, P20, DOI 10.1016/j.jpsychires.2015.02.004; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; McAlhany RE, 1999, ALCOHOL CLIN EXP RES, V23, P1691, DOI 10.1111/j.1530-0277.1999.tb04062.x; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Miyano K, 2014, J PHARMACOL SCI, V126, P302, DOI 10.1254/jphs.14R13CP; Olianas MC, 2015, BIOCHEM PHARMACOL, V95, P311, DOI 10.1016/j.bcp.2015.04.002; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Sato K, 2011, J NEUROCHEM, V117, P164, DOI 10.1111/j.1471-4159.2011.07188.x; Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004; Zhao J, 2014, CELL SIGNAL, V26, P2406, DOI 10.1016/j.cellsig.2014.07.005	30	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27364	27370		10.1074/jbc.M116.753871	http://dx.doi.org/10.1074/jbc.M116.753871			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864362	Green Published, hybrid			2022-12-26	WOS:000391576300033
J	He, JM; Zhu, H; Zheng, GS; Liu, PP; Wang, J; Zhao, GP; Zhu, GQ; Jiang, WH; Lu, YH				He, Juan-Mei; Zhu, Hong; Zheng, Guo-Song; Liu, Pan-Pan; Wang, Jin; Zhao, Guo-Ping; Zhu, Guo-Qiang; Jiang, Wei-Hong; Lu, Yin-Hua			Direct Involvement of the Master Nitrogen Metabolism Regulator GlnR in Antibiotic Biosynthesis in Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; SECONDARY METABOLISM; 2-COMPONENT SYSTEM; COELICOLOR; IDENTIFICATION; AVERMITILIS; PROMOTERS; REGULON; BINDING	GlnR, an OmpR-like orphan two-component system response regulator, is a master regulator of nitrogen metabolism in the genus Streptomyces. In this work, evidence that GlnR is also directly involved in the regulation of antibiotic biosynthesis is provided. In the model strain Streptomyces coelicolor M145, an in-frame deletion of glnR resulted in markedly increased actinorhodin (ACT) production but reduced undecylprodigiosin (RED) biosynthesis when exposed to R2YE culture medium. Transcriptional analysis coupled with DNA binding studies revealed that GlnR represses ACT but activates RED production directly via the pathway-specific activator genes actII-ORF4 and redZ, respectively. The precise GlnR-binding sites upstream of these two target genes were defined. In addition, the direct involvement of GlnR in antibiotic biosynthesis was further identified in Streptomyces avermitilis, which produces the important anthelmintic agent avermectin. We found that S. avermitilis GlnR (GlnRsav) could stimulate avermectin but repress oligomycin production directly through the respective pathway-specific activator genes, aveR and olmRI/RII. To the best of our knowledge, this report describes the first experimental evidence demonstrating that GlnR regulates antibiotic biosynthesis directly through pathway-specific regulators in Streptomyces. Our results suggest that GlnR-mediated regulation of antibiotic biosynthesis is likely to be universal in streptomycetes. These findings also indicate that GlnR is not only a master nitrogen regulator but also an important controller of secondary metabolism, which may help to balance nitrogen metabolism and antibiotic biosynthesis in streptomycetes.	[He, Juan-Mei; Zhu, Hong; Zheng, Guo-Song; Liu, Pan-Pan; Wang, Jin; Zhao, Guo-Ping; Jiang, Wei-Hong; Lu, Yin-Hua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [He, Juan-Mei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Guo-Qiang] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Jiang, Wei-Hong] SICAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 210009, Jiangsu, Peoples R China; [Lu, Yin-Hua] Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yangzhou University	Jiang, WH; Lu, YH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.; Zhu, GQ (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China.; Jiang, WH (corresponding author), SICAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 210009, Jiangsu, Peoples R China.; Lu, YH (corresponding author), Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai 200237, Peoples R China.	yzgqzhu@yzu.edu.cn; whjiang@sibs.ac.cn; yhlu@sibs.ac.cn	Wang, Jin/P-5458-2019	Wang, Jin/0000-0003-4008-9284; Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [31630003, 31421061, 31370081, 31570072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31630003, 31421061, 31370081, and 31570072. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMIDIS T, 1990, J BACTERIOL, V172, P2962, DOI 10.1128/jb.172.6.2962-2969.1990; Cen XF, 2016, BIOCHEM BIOPH RES CO, V471, P510, DOI 10.1016/j.bbrc.2016.02.044; Chen YH, 2010, APPL MICROBIOL BIOT, V86, P19, DOI 10.1007/s00253-009-2428-3; Chen YL, 2013, MICROBIOL-SGM, V159, P2571, DOI 10.1099/mic.0.071449-0; Fedoryshyn M, 2008, APPL MICROBIOL BIOT, V78, P1065, DOI 10.1007/s00253-008-1382-9; Fink D, 2002, MOL MICROBIOL, V46, P331, DOI 10.1046/j.1365-2958.2002.03150.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hesketh A, 2009, MOL MICROBIOL, V74, P1427, DOI 10.1111/j.1365-2958.2009.06941.x; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Liao CH, 2015, P NATL ACAD SCI USA, V112, P15630, DOI 10.1073/pnas.1508465112; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lu YH, 2011, J BACTERIOL, V193, P3020, DOI 10.1128/JB.00017-11; Martin Juan F, 2012, Subcell Biochem, V64, P115, DOI 10.1007/978-94-007-5055-5_6; Martin JF, 2010, CURR OPIN MICROBIOL, V13, P263, DOI 10.1016/j.mib.2010.02.008; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Qiu JF, 2011, APPL MICROBIOL BIOT, V92, P337, DOI 10.1007/s00253-011-3439-4; Qu S, 2015, APPL MICROBIOL BIOT, V99, P4771, DOI 10.1007/s00253-015-6437-0; Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Sambrook J., 2001, MOL CLONING LAB MANU; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; Tiffert Y, 2011, APPL MICROBIOL BIOT, V89, P1149, DOI 10.1007/s00253-011-3086-9; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Wang R, 2013, MOL MICROBIOL, V87, P30, DOI 10.1111/mmi.12080; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417; Yao LL, 2014, APPL MICROBIOL BIOT, V98, P7935, DOI 10.1007/s00253-014-5878-1; Yu H, 2007, ARCH MICROBIOL, V188, P89, DOI 10.1007/s00203-007-0228-7; Yu ZY, 2012, MOL MICROBIOL, V85, P535, DOI 10.1111/j.1365-2958.2012.08126.x	35	31	36	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26443	26454		10.1074/jbc.M116.762476	http://dx.doi.org/10.1074/jbc.M116.762476			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27875313	Green Published, hybrid			2022-12-26	WOS:000391568200018
J	Samyn, DR; Van der Veken, J; Van Zeebroeck, G; Persson, BL; Karlsson, BCG				Samyn, Dieter R.; Van der Veken, Jeroen; Van Zeebroeck, Griet; Persson, Bengt L.; Karlsson, Bjorn C. G.			Key Residues and Phosphate Release Routes in the Saccharomyces cerevisiae Pho84 Transceptor THE ROLE OF TYR179 IN FUNCTIONAL REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEERED MOLECULAR-DYNAMICS; MAJOR FACILITATOR SUPERFAMILY; FORCE-FIELD; MEAN FORCE; SIMULATIONS; TRANSPORTER; PARAMETERS; MEMBRANE; POTENTIALS; MECHANISM	Pho84, a major facilitator superfamily (MFS) protein, is the main high-affinity Pi transceptor in Saccharomyces cerevisiae. Although transport mechanisms have been suggested for other MFS members, the key residues and molecular events driving transport by Pi: H+ symporters are unclear. The current Pho84 transport model is based on the inward-facing occluded crystal structure of the Pho84 homologue PiPT in the fungus Piriformospora indica. However, this model is limited by the lack of experimental data on the regulatory residues for each stage of the transport cycle. In this study, an open, inward-facing conformation of Pho84 was used to study the release of Pi. A comparison of this conformation with the model for Pi release in PiPT revealed that Tyr(179) in Pho84 (Tyr150 in PiPT) is not part of the Pi binding site. This difference may be due to a lack of detailed information on the Pi release step in PiPT. Molecular dynamics simulations of Pho84 in which a residue adjacent to Tyr(179), Asp(178), is protonated revealed a conformational change in Pho84 from an open, inward-facing state to an occluded state. Tyr(179) then became part of the binding site as was observed in the PiPT crystal structure. The importance of Tyr(179) in regulating Pi release was supported by site-directed mutagenesis and transport assays. Using trehalase activity measurements, we demonstrated that the release of Pi is a critical step for transceptor signaling. Our results add to previous studies on PiPT, creating a more complete picture of the proton-coupled Pi transport cycle of a transceptor.	[Karlsson, Bjorn C. G.] Linnaeus Univ, Computat Chem & Biochem Grp, SE-39182 Kalmar, Sweden; [Samyn, Dieter R.; Van der Veken, Jeroen; Persson, Bengt L.; Karlsson, Bjorn C. G.] Linnaeus Univ, Ctr Biomat Chem, SE-39182 Kalmar, Sweden; [Van Zeebroeck, Griet] VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31, BE-3001 Leuven Heverlee, Flanders, Belgium; [Van Zeebroeck, Griet] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Kasteelpk Arenberg 31, BE-3001 Leuven Heverlee, Flanders, Belgium; [Samyn, Dieter R.] Concordia Univ, Dept Biol, Loyola Campus,7141 Sherbrooke St W, Montreal, PQ H4B 1R6, Canada; [Van der Veken, Jeroen] Inst Agr & Fisheries Res ILVO, Appl Genet & Breeding, Plant Sci Unit, Caritasstr 39, BE-9090 Melle, Belgium	Linnaeus University; Linnaeus University; Flanders Institute for Biotechnology (VIB); KU Leuven; Concordia University - Canada; Institute For Agricultural & Fisheries Research	Karlsson, BCG (corresponding author), Linnaeus Univ, Ctr Biomat Chem, Computat Chem & Biochem Grp, SE-39182 Kalmar, Sweden.	bjorn.karlsson@lnu.se	Samyn, Dieter/ABG-2291-2021; Karlsson, Björn/AAS-8956-2021; Samyn, Dieter/K-6887-2017	Karlsson, Björn/0000-0002-7392-0591; Samyn, Dieter/0000-0002-0381-251X; Van der Veken, Jeroen/0000-0002-8615-6502	Linnaeus University; Crafoord Foundation	Linnaeus University; Crafoord Foundation	This work was supported by the Linnaeus University and the Crafoord Foundation. The authors declare that they have no conflicts of interest regarding the contents of this article.	Andersson M, 2012, STRUCTURE, V20, P1893, DOI 10.1016/j.str.2012.08.021; [Anonymous], 2008, AMBER 10; BORSTPAUWELS GWFH, 1993, BIOCHIM BIOPHYS ACTA, V1145, P15, DOI 10.1016/0005-2736(93)90376-B; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Frisch M.J, 2009, GAUSSIAN 09 REVISION; Gullingsrud JR, 1999, J COMPUT PHYS, V151, P190, DOI 10.1006/jcph.1999.6218; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hummer G, 2010, P NATL ACAD SCI USA, V107, P21441, DOI 10.1073/pnas.1015661107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kosztin D, 1999, BIOPHYS J, V76, P188, DOI 10.1016/S0006-3495(99)77188-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerstedt JO, 2004, FEBS LETT, V578, P262, DOI 10.1016/j.febslet.2004.11.012; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Liu YF, 2015, BIOPHYS J, V109, P542, DOI 10.1016/j.bpj.2015.06.037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Samyn DR, 2016, ADV EXP MED BIOL, V892, P253, DOI 10.1007/978-3-319-25304-6_10; Samyn DR, 2012, BIOCHEM J, V445, P413, DOI 10.1042/BJ20112086; Schothorst J, 2013, CURR GENET, V59, P197, DOI 10.1007/s00294-013-0413-y; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Stroud RM, 2007, P NATL ACAD SCI USA, V104, P1445, DOI 10.1073/pnas.0610349104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Wykoff DD, 2001, GENETICS, V159, P1491; Xu YC, 2003, J AM CHEM SOC, V125, P11340, DOI 10.1021/ja029775t; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u	43	7	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26388	26398		10.1074/jbc.M116.738112	http://dx.doi.org/10.1074/jbc.M116.738112			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27875295	hybrid, Green Published			2022-12-26	WOS:000391568200013
J	Broad, KD; Hassell, J; Fleiss, B; Kawano, G; Ezzati, M; Rocha-Ferreira, E; Hristova, M; Bennett, K; Fierens, I; Burnett, R; Chaban, B; Alonso-Alconada, D; Oliver-Taylor, A; Tachsidis, I; Rostami, J; Gressens, P; Sanders, RD; Robertson, NJ				Broad, Kevin D.; Hassell, Jane; Fleiss, Bobbi; Kawano, Go; Ezzati, Mojgan; Rocha-Ferreira, Eridan; Hristova, Mariya; Bennett, Kate; Fierens, Igor; Burnett, Ryan; Chaban, Badr; Alonso-Alconada, Daniel; Oliver-Taylor, Aaron; Tachsidis, Ilias; Rostami, Jamshid; Gressens, Pierre; Sanders, Robert D.; Robertson, Nicola J.			Isoflurane Exposure Induces Cell Death, Microglial Activation and Modifies the Expression of Genes Supporting Neurodevelopment and Cognitive Function in the Male Newborn Piglet Brain	PLoS One			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEVELOPING RAT-BRAIN; DEVELOPMENTAL PLASTICITY; NEURONAL APOPTOSIS; CHILDHOOD EXPOSURE; NEURAL CIRCUITS; NERVOUS-SYSTEM; ADULT RATS; ANESTHESIA; MEMORY	Exposure of the brain to general anesthesia during early infancy may adversely affect its neural and cognitive development. The mechanisms mediating this are complex, incompletely understood and may be sexually dimorphic, but include developmentally inappropriate apoptosis, inflammation and a disruption to cognitively salient gene expression. We investigated the effects of a 6h isoflurane exposure on cell death, microglial activation and gene expression in the male neonatal piglet brain. Piglets (n = 6) were randomised to: (i) naive controls or (ii) 6h isoflurane. Cell death (TUNEL and caspase-3) and microglial activation were recorded in 7 brain regions. Changes in gene expression (microarray and qPCR) were assessed in the cingulate cortex. Electroencephalography (EEG) was recorded throughout. Isoflurane anesthesia induced significant increases in cell death in the cingulate and insular cortices, caudate nucleus, thalamus, putamen, internal capsule, periventricular white matter and hippocampus. Dying cells included both neurons and oligodendrocytes. Significantly, microglial activation was observed in the insula, pyriform, hippocampus, internal capsule, caudate and thalamus. Isoflurane induced significant disruption to the expression of 79 gene transcripts, of these 26 are important for the control of transcription and 23 are important for the mediation of neural plasticity, memory formation and recall. Our observations confirm that isoflurane increases apoptosis and inflammatory responses in the neonatal piglet brain but also suggests novel additional mechanisms by which isoflurane may induce adverse neural and cognitive development by disrupting the expression of genes mediating activity dependent development of neural circuits, the predictive adaptive responses of the brain, memory formation and recall.	[Broad, Kevin D.; Hassell, Jane; Kawano, Go; Ezzati, Mojgan; Rocha-Ferreira, Eridan; Hristova, Mariya; Bennett, Kate; Fierens, Igor; Burnett, Ryan; Chaban, Badr; Alonso-Alconada, Daniel; Oliver-Taylor, Aaron; Rostami, Jamshid; Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England; [Fleiss, Bobbi; Gressens, Pierre] Kings Coll London, Ctr Developing Brain, St Thomass Campus, London, England; [Fleiss, Bobbi; Gressens, Pierre] INSERM, Paris, France; [Fleiss, Bobbi; Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tachsidis, Ilias] UCL, Dept Med Phys & Biomed Engn, London, England; [Sanders, Robert D.] Univ Wisconsin, Dept Anesthesiol, Madison, WI USA; [Sanders, Robert D.] UCL, Wellcome Dept Imaging Neurosci, London, England; [Sanders, Robert D.] Univ Coll London Hosp, Surg Outcomes Res Ctr, London, England	University of London; University College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Robertson, NJ (corresponding author), UCL, Inst Womens Hlth, London, England.	n.robertson@ucl.ac.uk	Robertson, Nicola/GWR-2021-2022; Kawano, Go/AAI-5080-2021; gressens, pierre/M-7557-2017; Fleiss, Bobbi/F-9899-2011	Kawano, Go/0000-0003-2962-0556; gressens, pierre/0000-0002-0909-4221; Fleiss, Bobbi/0000-0001-7828-673X; Alonso-Alconada, Daniel/0000-0002-9874-2947; Sanders, Robert/0000-0003-0113-0328; Rocha Ferreira, Eridan/0000-0002-9342-4691	UK Department of Health's National Institute for Health Research Biomedical Research Centre; MRC Medical Research Council UK [MR/J00457X/1]; Basque Government Postdoctoral Program [POS_2013_1_191]; MRC [MR/M006743/1] Funding Source: UKRI; Medical Research Council [MR/M006743/1] Funding Source: researchfish	UK Department of Health's National Institute for Health Research Biomedical Research Centre; MRC Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basque Government Postdoctoral Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme. This study was funded by the MRC Medical Research Council UK (Grant: MR/J00457X/1 URL: http://www.mrc.ac.uk) as part of a larger project. DAA was funded by the Basque Government Postdoctoral Program (POS_2013_1_191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2007, J NUTR, V137, P1060, DOI 10.1093/jn/137.4.1060; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Broad KD, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6827135; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Cao WY, 2014, BEHAV BRAIN RES, V265, P76, DOI 10.1016/j.bbr.2014.02.022; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Crawford Charles, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P39; Creeley CE, 2014, ANESTHESIOLOGY, V120, P626, DOI 10.1097/ALN.0000000000000037; Culley DJ, 2013, BRIT J ANAESTH, V110, P19, DOI 10.1093/bja/aet169; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Edmonds H L Jr, 1985, Int J Clin Monit Comput, V1, P201, DOI 10.1007/BF01720184; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Glenn AL, 2009, INT J LAW PSYCHIAT, V32, P253, DOI 10.1016/j.ijlp.2009.04.002; Gluckman PD, 2005, FETAL MATRIX EVOLUTI; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Gordon KA, 2011, BRAIN TOPOGR, V24, P204, DOI 10.1007/s10548-011-0181-2; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Hayashi K, 2012, NEUROSCI LETT, V517, P87, DOI 10.1016/j.neulet.2012.04.028; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Hewitson TD, 2010, METHODS MOL BIOL, V611, P161, DOI 10.1007/978-1-60327-345-9_13; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Ji MH, 2014, MOL NEUROBIOL, V50, P937, DOI 10.1007/s12035-014-8659-z; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kalenka A, 2010, J NEUROSURG ANESTH, V22, P144, DOI 10.1097/ANA.0b013e3181cb7cb8; Kargaran P, 2015, EUR J ANAESTH, V32, P336, DOI 10.1097/EJA.0000000000000128; Kotani N, 1999, ANESTH ANALG, V89, P1250, DOI 10.1213/00000539-199911000-00032; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; LERMAN J, 1990, ANESTHESIOLOGY, V73, P717, DOI 10.1097/00000542-199010000-00018; Li H, 2013, NEUROBIOL DIS, V54, P216, DOI 10.1016/j.nbd.2012.12.014; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lunardi N, 2010, NEUROTOX RES, V17, P179, DOI 10.1007/s12640-009-9088-z; Ma DQ, 2007, ANESTHESIOLOGY, V106, P746, DOI 10.1097/01.anes.0000264762.48920.80; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Pilge S, 2014, BRIT J ANAESTH, V112, P1067, DOI 10.1093/bja/aeu016; Priebe NJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI [10.3389/fncir.2014.00123, 10.3389/tncir.2014.00123]; Rizzi S, 2010, ANN NY ACAD SCI, V1199, P43, DOI 10.1111/j.1749-6632.2009.05173.x; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; Sabir H, 2013, ANESTHESIOLOGY, V119, P345, DOI 10.1097/ALN.0b013e318294934d; Schubert H, 2012, INTENS CARE MED, V38, P1205, DOI 10.1007/s00134-012-2576-2; Senhadji L, 2000, ACTA BIOTHEOR, V48, P289, DOI 10.1023/A:1010233615281; Seubert CN, 2013, ANESTHESIOLOGY, V119, P358, DOI 10.1097/ALN.0b013e318291c04e; ShelleyTremblay JF, 1996, J GENET PSYCHOL, V157, P443, DOI 10.1080/00221325.1996.9914877; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Shu Y, 2012, NEUROBIOL DIS, V45, P743, DOI 10.1016/j.nbd.2011.10.021; Shulha HP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003433; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Sponheim S, 2003, ACTA ANAESTH SCAND, V47, P932, DOI 10.1034/j.1399-6576.2003.00199.x; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tropea D, 2009, PHILOS T R SOC B, V364, P341, DOI 10.1098/rstb.2008.0269; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; WILKINSON LS, 1994, NEUROPSYCHOPHARMACOL, V10, P61, DOI 10.1038/npp.1994.8; Wu J, 2016, ANESTHESIOLOGY, V124, P624, DOI 10.1097/ALN.0000000000000981; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang F, 2014, EXP THER MED, V8, P471, DOI 10.3892/etm.2014.1769; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	75	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166784	10.1371/journal.pone.0166784	http://dx.doi.org/10.1371/journal.pone.0166784			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898690	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000017
J	van Gemst, JJ; Loeven, MA; de Graaf, MJJ; Berden, JHM; Rabelink, TJ; Smit, CH; van der Vlag, J				van Gemst, Jasper J.; Loeven, Markus A.; de Graaf, Mark J. J.; Berden, Jo H. M.; Rabelink, Ton J.; Smit, Cornelis H.; van der Vlag, Johan			RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues	PLoS One			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GLOMERULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; MAC-1 CD11B/CD18; SKELETAL-MUSCLE; MICRO-ASSAY; IN-VITRO; ADHESION; RAT; QUANTIFICATION	Glycosaminoglycans (GAGs) are linear negatively charged polysaccharides and important components of extracellular matrices and cell surface glycan layers such as the endothelial glycocalyx. The GAG family includes sulfated heparin, heparan sulfate (HS), dermatan sulfate (DS), chondroitin sulfate (CS), keratan sulfate, and non-sulfated hyaluronan. Because relative expression of GAGs is dependent on cell-type and niche, isolating GAGs from cell cultures and tissues may provide insight into cell- and tissue-specific GAG structure and functions. In our objective to obtain structural information about the GAGs expressed on a specialized mouse glomerular endothelial cell culture (mGEnC-1) we adapted a recently published GAG isolation protocol, based on cell lysis, proteinase K and DNase I digestion. Analysis of the GAGs contributing to the mGEnC-1 glycocalyx indicated a large HS and a minor CS content on barium acetate gel. However, isolated GAGs appeared resistant to enzymatic digestion by heparinases. We found that these GAG extracts were heavily contaminated with RNA, which co-migrated with HS in barium acetate gel electrophoresis and interfered with 1,9-dimethylmethylene blue (DMMB) assays, resulting in an overestimation of GAG yields. We hypothesized that RNA may be contaminating GAG extracts from other cell cultures and possibly tissue, and therefore investigated potential RNA contaminations in GAG extracts from two additional cell lines, human umbilical vein endothelial cells and retinal pigmental epithelial cells, and mouse kidney, liver, spleen and heart tissue. GAG extracts from all examined cell lines and tissues contained varying amounts of contaminating RNA, which interfered with GAG quantification using DMMB assays and characterization of GAGs by barium acetate gel electrophoresis. We therefore recommend routinely evaluating the RNA content of GAG extracts and propose a robust protocol for GAG isolation that includes an RNA digestion step.	[van Gemst, Jasper J.; Loeven, Markus A.; de Graaf, Mark J. J.; Berden, Jo H. M.; Smit, Cornelis H.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Einthoven Lab Vasc Med, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	Johan.vanderVlag@radboudumc.nl	Loeven, Markus/F-7863-2016; Van der Vlag, Johan/E-4636-2010; Rabelink, Ton J./A-5316-2008	Van der Vlag, Johan/0000-0001-7843-5918; Rabelink, Ton J./0000-0001-6780-5186	Dutch Kidney Foundation [CP09.03]; Radboud university medical center	Dutch Kidney Foundation; Radboud university medical center	Research was supported by the Dutch Kidney Foundation (www.nierstichting.nl), Consortium Grant CP09.03 (GLYCOREN) (received by JvdV), and the Radboud university medical center (www.radboudurric.nl), PhD project grant (received by MAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviezer D, 1999, BIOCHEM BIOPH RES CO, V263, P621, DOI 10.1006/bbrc.1999.1434; Bahrom NA, 2013, FOOD SCI NUTR, V1, P83, DOI 10.1002/fsn3.10; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; BEATY NB, 1987, J CHROMATOGR-BIOMED, V418, P187, DOI 10.1016/0378-4347(87)80009-9; Brito AS, 2008, BIOORGAN MED CHEM, V16, P9588, DOI 10.1016/j.bmc.2008.09.020; Cahu TB, 2012, PROCESS BIOCHEM, V47, P570, DOI 10.1016/j.procbio.2011.12.012; Canals I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13654; COHN RH, 1976, J CELL BIOL, V71, P280, DOI 10.1083/jcb.71.1.280; COOMBE DR, 1994, BLOOD, V84, P739; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; DEY P, 1992, CONNECT TISSUE RES, V28, P317, DOI 10.3109/03008209209016823; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Esko J.D., 2001, CURR PROTOC MOL BIOL, DOI 10.1002/0471142727.mb1702s22; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fedarko N S, 1994, EXS, V70, P9; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Goulas A, 2000, INT J BIOCHEM CELL B, V32, P975, DOI 10.1016/S1357-2725(00)00038-8; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; LARSSON SE, 1974, CALC TISS RES, V14, P49, DOI 10.1007/BF02060282; LEBARON RG, 1988, J CELL BIOL, V106, P945, DOI 10.1083/jcb.106.3.945; Lehri-Boufala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116641; Malavaki CJ, 2008, ANAL BIOCHEM, V374, P213, DOI 10.1016/j.ab.2007.11.006; Matalonga L, 2015, NEUROTHERAPEUTICS, V12, P874, DOI 10.1007/s13311-015-0368-4; MERRILEES MJ, 1981, ATHEROSCLEROSIS, V38, P19, DOI 10.1016/0021-9150(81)90099-X; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Mitropoulos D, 2007, EUR UROL, V51, P447, DOI 10.1016/j.eururo.2006.06.028; NISHINAGA M, 1993, J CLIN INVEST, V92, P1381, DOI 10.1172/JCI116712; OGURI K, 1987, BLOOD, V70, P501; Oivanen M, 1998, CHEM REV, V98, P961, DOI 10.1021/cr960425x; Papakonstantinou E, 1999, ARCH BIOCHEM BIOPHYS, V370, P250, DOI 10.1006/abbi.1999.1405; PAPAKONSTANTINOU E, 1995, P NATL ACAD SCI USA, V92, P9881, DOI 10.1073/pnas.92.21.9881; Papakonstantinou E, 2003, ARCH DERMATOL RES, V295, P138, DOI 10.1007/s00403-003-0413-8; Puvirajesinghe TM, 2012, METABOLITES, V2, P1060, DOI 10.3390/metabo2041060; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; ROLLINS BJ, 1979, BIOCHEMISTRY-US, V18, P141, DOI 10.1021/bi00568a022; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rops AL, 2007, NEPHROL DIAL TRANSPL, V22, P1070, DOI 10.1093/ndt/gfl801; Rops ALWMM, 2014, KIDNEY INT, V86, P932, DOI 10.1038/ki.2014.115; Tipson RS, 1985, ADV CARBOHYD CHEM, V43, P84; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; van Wijk XMR, 2010, EXP CELL RES, V316, P2504, DOI 10.1016/j.yexcr.2010.04.025; VANDELEST CHA, 1994, ANAL BIOCHEM, V221, P356, DOI 10.1006/abio.1994.1425; Wassenaar JW, 2015, BIOMATERIALS, V64, P108, DOI 10.1016/j.biomaterials.2015.06.033; WIGHT TN, 1975, J CELL BIOL, V67, P675, DOI 10.1083/jcb.67.3.675; Zheng CH, 2015, EUR CELLS MATER, V29, P224, DOI 10.22203/eCM.v029a17	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167336	10.1371/journal.pone.0167336	http://dx.doi.org/10.1371/journal.pone.0167336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898729	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000054
J	Averos, X; de Heredia, IB; Ruiz, R; Estevez, I				Averos, Xavier; Beltran de Heredia, Ignacia; Ruiz, Roberto; Estevez, Inma			The Impact of Group Size on Welfare Indicators of Ewes during Pregnancy	PLOS ONE			English	Article							TERM MOVEMENT PATTERNS; CONFINED ENVIRONMENTS; BROILER-CHICKENS; CONDITION SCORE; BLOOD VALUES; SPACE; SHEEP; BEHAVIOR; RESPONSES; DENSITY	Group size (GS) and space allowance have major implications for the welfare of production species, however their effects are often confounded. In a previous study we investigated the impact of varying space allowance at constant GS. In the present work we report the consequences of varying GS on pregnant ewes while controlling space allowance. We housed ewes at 6 (GS6) or 12 ewes/enclosure (GS12), while controlling space allowance to 1.5 m(2) /ewe (3 enclosures/treatment), and necessarily varying enclosure size. Therefore, when indicating GS effects we implicitly reflect a confounding effect with that of enclosure size. Movement, use of space, behaviour, serum cortisol concentration and body condition score (BCS) were collected during the last 12 gestation weeks. Movement, use of space, and behaviour were collected every other week, during 2 days/week, using 10 minute continuous scan samplings. Blood was collected during weeks 10, 13, 17, and 21 of gestation, and BCS during weeks 15 and 21. Data were analysed using repeated measures, generalized linear mixed models, with GS, week, and their interaction as fixed effects, and enclosure as random effect. GS mainly affected movement and use of space. GS12 ewes walked longer distances using longer steps (P<0.001). An interaction GS by week was observed for angular dispersion (P<0.0001), which was smaller for GS12 from week 10 onwards. Initial restlessness levels were lower for GS12, as shown by the reduced frequency of location changes (P<0.0001). Furthest and mean neighbour distances increased with GS (P<0.0001). The effect of GS on behaviour was only evident for eating behaviour as an interaction with gestation week (P<0.05). Changes in behaviour, movement and use of space along the study indicated an activity peak during weeks 3 to 5. Cortisol changes during gestation (P<0.01) also reflected this activity peak, while BCS (P<0.001) reflected normal physical condition changes during pregnancy. Although the separate effects of GS and enclosure size cannot be disentangled, we conclude that if enough space/ewe is given during gestation, larger GS will result in larger effective space, and no major implications for the welfare of ewes should be expected as GS increases. Ewes will adapt their movement patterns and use of space to enclosure size, and no further behavioural, physiological and physical consequences should be expected.	[Averos, Xavier; Beltran de Heredia, Ignacia; Ruiz, Roberto; Estevez, Inma] Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain; [Estevez, Inma] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Basque Foundation for Science	Estevez, I (corresponding author), Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain.; Estevez, I (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	iestevez@neiker.eus	Santos, Roberto J. Ruiz/F-3352-2019; Averos, Xavier/K-1185-2014	Santos, Roberto J. Ruiz/0000-0002-3074-7362; Averos, Xavier/0000-0002-7279-3420; Estevez, Inma/0000-0002-9054-9528	European Union [FP7-414 KBBE-2010-4]	European Union(European Commission)	The authors gratefully acknowledge the European Union financial support for conducting the experiments and the salary for X. Averos under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, of the Project Animal Welfare Indicators (AWIN; FP7-414 KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the European Union financial support for conducting the experiments and the salary for X. Averos under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, of the Project Animal Welfare Indicators (AWIN; FP7-KBBE-2010-4). The authors are grateful to Josune Arranz for her invaluable help in the preparation of the experimental setup, and to Imanol Etxebarria and Juan Carlos Ochoa de Zuazola for the excellent care of ewes during the study.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Averos X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094767; Averos X, 2014, APPL ANIM BEHAV SCI, V150, P17, DOI 10.1016/j.applanim.2013.11.002; BELL ME, 1991, DOMEST ANIM ENDOCRIN, V8, P245, DOI 10.1016/0739-7240(91)90060-W; Boyazoglu J, 2001, SMALL RUMINANT RES, V40, P1, DOI 10.1016/S0921-4488(00)00203-0; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Christman MC, 2007, APPL ANIM BEHAV SCI, V103, P265, DOI 10.1016/j.applanim.2006.05.020; Leme TMD, 2013, SMALL RUMINANT RES, V115, P1, DOI 10.1016/j.smallrumres.2013.07.010; DELVALLE J, 1983, ARCH MED VET, V15, P65; Estevez I, 2006, APPL ANIM BEHAV SCI, V97, P221, DOI 10.1016/j.applanim.2005.01.013; Estevez I, 2010, POULTRY SCI, V89, P643, DOI 10.3382/ps.2009-00433; Estevez I, 1997, BROILER CHICKENS TOL; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Gonzalez M, 2013, APPL ANIM BEHAV SCI, V149, P13, DOI 10.1016/j.applanim.2013.09.011; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Jorgensen GHM, 2009, APPL ANIM BEHAV SCI, V116, P198, DOI 10.1016/j.applanim.2008.08.014; Leone EH, 2008, POULTRY SCI, V87, P3, DOI 10.3382/ps.2007-00026; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; Leone EH, 2010, BEHAV PROCESS, V83, P16, DOI 10.1016/j.beproc.2009.08.009; Mallapur A, 2009, APPL ANIM BEHAV SCI, V117, P28, DOI 10.1016/j.applanim.2008.11.005; MCGLONE JJ, 1994, APPL ANIM BEHAV SCI, V39, P331, DOI 10.1016/0168-1591(94)90166-X; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; Michelena P, 2009, BEHAV ECOL, V20, P145, DOI 10.1093/beheco/arn126; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Roche JR, 2009, J DAIRY SCI, V92, P5769, DOI 10.3168/jds.2009-2431; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sanchez C., 1998, CHICKITIZER SOFTWARE; Shrestha JNB, 2011, ENCY DAIRY SCI, P67; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; TADICH N, 1994, ARCH MED VET, V26, P43; Turchin Peter, 1998	36	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167061	10.1371/journal.pone.0167061	http://dx.doi.org/10.1371/journal.pone.0167061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893817	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400078
J	Eder, J; Rogojanu, R; Jerney, W; Erhart, F; Dohnal, A; Kitzwogerer, M; Steiner, G; Moser, J; Trautinger, F				Eder, Johanna; Rogojanu, Radu; Jerney, Waltraud; Erhart, Friedrich; Dohnal, Alexander; Kitzwoegerer, Melitta; Steiner, Georg; Moser, Julia; Trautinger, Franz			Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; POOR-PROGNOSIS; CANCER; ANGIOGENESIS; DENSITY; BREAST; TRYPTASE; INFILTRATION; PROGRESSION	Background Mast cells (MC) are bone marrow derived haematopoetic cells playing a crucial role not only in immune response but also in the tumor microenvironment with protumorigenic and antitumorigenic functions. The role of MC in primary cutaneous T-cell lymphomas (CTCL), a heterogeneous group of non-Hodgkin lymphomas with initial presentation in the skin, is largely unknown. Objective To gain more accurate information about presence, number, distribution and state of activation (degranulated vs. non-degranulated) of MC in CTCL variants and clinical stages. Materials and Methods We established a novel computer-aided tissue analysis method on digitized skin sections. Immunohistochemistry with an anti-MC tryptase antibody was performed on 34 biopsies of different CTCL subtypes and on control skin samples. An algorithm for the automatic detection of the epidermis and of cell density based CTCL areas was developed. Cells were stratified as being within the CTCL infiltrate, in P1 (a surrounding area 0-30 mu m away from CTCL), or in P2 (30-60 mu m away from CTCL) area. Results We found high MC counts within CTCL infiltrates and P1 and a decreased MC number in the surrounding dermis P2. Higher MC numbers were found in MF compared to all other CTCL subgroups. Regarding different stages of MF, we found significantly higher mast cell counts in stages IA and IB than in stages IIA and IIB. Regarding MC densities, we found a higher density of MC in MF compared to all other CTCL subgroups. More MC were non-degranulated than degranulated. Conclusion Here for the first time an automated method for MC analysis on tissue sections and its use in CTCL is described. Eliminating error from investigator bias, the method allows for precise cell identification and counting. Our results provide new insights on MC distribution in CTCL reappraising their role in the pathophysiology of CTCL.	[Eder, Johanna; Moser, Julia; Trautinger, Franz] Karl Landsteiner Univ Hlth Sci, Dept Dermatol & Venereol, St Polten, Austria; [Eder, Johanna; Moser, Julia; Trautinger, Franz] Karl Landsteiner Inst Dermatol Res, St Polten, Austria; [Rogojanu, Radu] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Rogojanu, Radu; Steiner, Georg] TissueGnost GmbH, Vienna, Austria; [Jerney, Waltraud] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Erhart, Friedrich; Dohnal, Alexander] CCRI St Anna Kinderkrebsforsch, Lab Tumor Immunol, Vienna, Austria; [Kitzwoegerer, Melitta] Karl Landsteiner Univ Hlth Sci, Inst Clin Pathol, St Polten, Austria	Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital	Eder, J (corresponding author), Karl Landsteiner Univ Hlth Sci, Dept Dermatol & Venereol, St Polten, Austria.; Eder, J (corresponding author), Karl Landsteiner Inst Dermatol Res, St Polten, Austria.	johanna.eder@stpoelten.lknoe.at	Trautinger, Franz/M-5041-2019	Dohnal, Alexander/0000-0002-5844-7329	TissueGnostics; EC Marie Curie Actions, AIDPATH project [612471]	TissueGnostics; EC Marie Curie Actions, AIDPATH project	Georg Steiner is co-owner and founder of TissueGnostics. TissueGnostics supported the project by scanning and by developing software algorithms for the analysis of the slides. Georg Steiner did not influence the data and data interpretation. Writing of the manuscript was done without Georg Steiners influence. Radu Rogujanu is an employee of Tissue Gnostics Gmbh and is paid a salary from TissueGnostics Gmbh. Radu Rogujau and Georg Steiner acknowledge financial support from the EC Marie Curie Actions, AIDPATH project (num. 612471). The funder provided support in the form of salaries for authors [RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Radu Rogujanu and Georg Steiner acknowledge financial support from the EC Marie Curie Actions, AIDPATH project (num. 612471)	AALTOMAA S, 1993, ANTICANCER RES, V13, P785; Ammendola M, 2016, TRANSFUS MED HEMOTH, V43, P109, DOI 10.1159/000444942; Ammendola M, 2016, EXPERT OPIN THER TAR, V20, P533, DOI 10.1517/14728222.2016.1158811; Bradford PT, 2009, BLOOD, V113, P5064, DOI 10.1182/blood-2008-10-184168; Bulfone-Paus S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00394; Chan JK, 2005, GYNECOL ONCOL, V99, P20, DOI 10.1016/j.ygyno.2005.05.042; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Dabiri S, 2004, MODERN PATHOL, V17, P690, DOI 10.1038/modpathol.3800094; Ehrlich P., 1878, THESIS; FISHER ER, 1989, HUM PATHOL, V20, P159, DOI 10.1016/0046-8177(89)90180-9; FISHER ER, 1985, BREAST CANCER RES TR, V5, P285, DOI 10.1007/BF01806023; Galinsky DST, 2008, CRIT REV ONCOL HEMAT, V68, P115, DOI 10.1016/j.critrevonc.2008.06.001; GALLI SJ, 1990, LAB INVEST, V62, P5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedstrom G, 2007, BRIT J HAEMATOL, V138, P68, DOI 10.1111/j.1365-2141.2007.06612.x; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; Marech I, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-534; Marech I, 2014, WORLD J GASTROENTERO, V20, P8910, DOI 10.3748/wjg.v20.i27.8910; Molin D, 2002, BRIT J HAEMATOL, V119, P122, DOI 10.1046/j.1365-2141.2002.03768.x; Nielsen HJ, 1999, J PATHOL, V189, P487, DOI 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patruno R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/730246; Pittoni P, 2011, CANCER RES, V71, P5987, DOI 10.1158/0008-5472.CAN-11-1637; Rabenhorst A, 2012, BLOOD, V120, P2042, DOI 10.1182/blood-2012-03-415638; Ribatti D, 2000, INT J CANCER, V85, P171, DOI 10.1002/(SICI)1097-0215(20000115)85:2<171::AID-IJC4>3.0.CO;2-W; Ribatti D, 1999, BRIT J CANCER, V79, P451, DOI 10.1038/sj.bjc.6690070; Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010; Ribatti D, 2010, INT J EXP PATHOL, V91, P350, DOI 10.1111/j.1365-2613.2010.00714.x; Rogojanu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/569071; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tan SY, 2005, WORLD J GASTROENTERO, V11, P1210, DOI 10.3748/wjg.v11.i8.1210; Terada T, 2000, J HEPATOL, V33, P961, DOI 10.1016/S0168-8278(00)80129-4; Tuna B, 2006, EUR UROL, V50, P530, DOI 10.1016/j.eururo.2005.12.040; Vyas Harsha, 2006, Methods Mol Biol, V315, P3; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502	38	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0163661	10.1371/journal.pone.0163661	http://dx.doi.org/10.1371/journal.pone.0163661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893746	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400002
J	Tehrani, S; Davis, L; Cepurna, WO; Choe, TE; Lozano, DC; Monfared, A; Cooper, L; Cheng, J; Johnson, EC; Morrison, JC				Tehrani, Shandiz; Davis, Lauren; Cepurna, William O.; Choe, Tiffany E.; Lozano, Diana C.; Monfared, Ashley; Cooper, Lauren; Cheng, Joshua; Johnson, Elaine C.; Morrison, John C.			Astrocyte Structural and Molecular Response to Elevated Intraocular Pressure Occurs Rapidly and Precedes Axonal Tubulin Rearrangement within the Optic Nerve Head in a Rat Model	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; TYROSINE PHOSPHORYLATION; OCULAR HYPERTENSION; FIBER LAYER; MOUSE MODEL; F-ACTIN; CORTACTIN; REACTIVITY; MIGRATION	Glaucomatous axon injury occurs at the level of the optic nerve head (ONH) in response to uncontrolled intraocular pressure (IOP). The temporal response of ONH astrocytes (glial cells responsible for axonal support) to elevated IOP remains unknown. Here, we evaluate the response of actin-based astrocyte extensions and integrin-based signaling within the ONH to 8 hours of IOP elevation in a rat model. IOP elevation of 60 mm Hg was achieved under isoflurane anesthesia using anterior chamber cannulation connected to a saline reservoir. ONH astrocytic extension orientation was significantly and regionally rearranged immediately after IOP elevation (inferior ONH, 43.2 degrees +/- 13.3 degrees with respect to the anterior-posterior axis versus 84.1 degrees +/- 1.3 degrees in controls, p<0.05), and re-orientated back to baseline orientation 1 day post IOP normalization. ONH axonal microtubule filament label intensity was significantly reduced 1 and 3 days post IOP normalization, and returned to control levels on day 5. Phosphorylated focal adhesion kinase (FAK) levels steadily decreased after IOP normalization, while levels of phosphorylated paxillin (a downstream target of FAK involved in focal adhesion dynamics) were significantly elevated 5 days post IOP normalization. The levels of phosphorylated cortactin (a downstream target of Src kinase involved in actin polymerization) were significantly elevated 1 and 3 days post IOP normalization and returned to control levels by day 5. No significant axon degeneration was noted by morphologic assessment up to 5 days post IOP normalization. Actin-based astrocyte structure and signaling within the ONH are significantly altered within hours after IOP elevation and prior to axonal cytoskeletal rearrangement, producing some responses that recover rapidly and others that persist for days despite IOP normalization.	[Tehrani, Shandiz; Davis, Lauren; Cepurna, William O.; Choe, Tiffany E.; Lozano, Diana C.; Monfared, Ashley; Cooper, Lauren; Cheng, Joshua; Johnson, Elaine C.; Morrison, John C.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University	Tehrani, S (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA.	tehrani@ohsu.edu		Tehrani, Shandiz/0000-0001-6083-3336	American Glaucoma Society Young Clinician Scientist Award; Glaucoma Research Foundation Shaffer Grant; Research to Prevent Blindness (RPB); RPB; National Institute of Health [K08EY024025, R01EY010145, P30EY010572]; NATIONAL EYE INSTITUTE [P30EY010572, R01EY010145, K08EY024025] Funding Source: NIH RePORTER	American Glaucoma Society Young Clinician Scientist Award; Glaucoma Research Foundation Shaffer Grant; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); RPB(Research to Prevent Blindness (RPB)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by the American Glaucoma Society Young Clinician Scientist Award (ST), the Glaucoma Research Foundation Shaffer Grant (ST), the Research to Prevent Blindness (RPB) Career Development Award (ST), an unrestricted grant from RPB (CEI/OHSU), and the National Institute of Health (K08EY024025 to ST, R01EY010145 to JCM, P30EY010572 to OHSU). The funders agove had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5; Beckel JM, 2014, GLIA; Brubaker RF, 1996, AM J OPHTHALMOL, V121, P473, DOI 10.1016/S0002-9394(14)75421-2; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Camassa LM., 2015, GLIA; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chen A, 2002, GLIA, V38, P115, DOI 10.1002/glia.10061; Choi HJ, 2015, MOL VIS, V21; Dai C, 2012, GLIA, V60, P13, DOI 10.1002/glia.21242; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Dong JM, 2009, BIOCHEM J, V418, P173, DOI 10.1042/BJ20080170; Fahy ET, 2016, EXP EYE RES, V146, P289, DOI 10.1016/j.exer.2016.03.001; Fang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107134; Feng J, 2016, J CELL SCI; Feola AJ, 2016, INVEST OPHTH VIS SCI, V57, P1901, DOI 10.1167/iovs.15-17573; Feuer WJ, 2002, AM J OPHTHALMOL, V133, P19, DOI 10.1016/S0002-9394(01)01338-1; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; Fujikawa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119361; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Giralt A, 2015, GLIA; Gnanaguru G, 2013, DEVELOPMENT, V140, P2050, DOI 10.1242/dev.087817; GRANT WM, 1982, OPHTHALMOLOGY, V89, P991; Ho KW, 2014, GLIA; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang XR, 2009, EXP EYE RES, V88, P1107, DOI 10.1016/j.exer.2009.01.014; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Ito A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0667; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; Jo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091582; Johnson E, 2006, INVEST OPHTHALMOL VI; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Katiyar KS, 2016, J TISSUE ENG REGEN M, P104, DOI 10.1242/jcs.053850; Koke Joseph R, 2010, BMC Res Notes, V3, P50, DOI 10.1186/1756-0500-3-50; Konopka A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155053; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Kwong JMK, 2013, EXP EYE RES, V112, P21, DOI 10.1016/j.exer.2013.04.008; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Maruyama S, 1996, J BIOL CHEM, V271, P6631, DOI 10.1074/jbc.271.12.6631; Mierke CT, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065005; Mills EA, 2015, P NATL ACAD SCI US; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Morrison JC, 2002, INVEST OPHTH VIS SCI, V43, pU813; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Morrison John C, 2006, Trans Am Ophthalmol Soc, V104, P453; Morrison JC, 2011, EXP EYE RES, V93, P156, DOI 10.1016/j.exer.2010.08.005; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nguyen TD, 2015, EXP EYE RES, V141, P125, DOI 10.1016/j.exer.2015.05.024; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Pazos M, 2015, EXP EYE RES, V139, P1, DOI 10.1016/j.exer.2015.05.011; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Posada-Duque RA, 2015, MOL CELL NEUROSCI; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Romanova LY, 2011, CELL ADHES MIGR, V5, P457, DOI 10.4161/cam.5.6.18219; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigal IA, 2007, EXP EYE RES, V85, P312, DOI 10.1016/j.exer.2007.05.005; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Smith MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069378; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; St-Pierre J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071531; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Tamm ER, 2007, SURV OPHTHALMOL, V52, pS101, DOI 10.1016/j.survophthal.2007.08.002; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Tehrani S, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14969; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thi MM, 2013, P NATL ACAD SCI USA, V110, P21012, DOI 10.1073/pnas.1321210110; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Wang JT, 2015, NEUROSCIENCE, V292, P90, DOI 10.1016/j.neuroscience.2015.02.025; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012; YANG H, 2009, INVEST OPHTHALMOL VI; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	94	38	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167364	10.1371/journal.pone.0167364	http://dx.doi.org/10.1371/journal.pone.0167364			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893827	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400113
J	Kellenberger, RT; Schluter, PM; Schiestl, FP				Kellenberger, Roman T.; Schlueter, Philipp M.; Schiestl, Florian P.			Herbivore-Induced DNA Demethylation Changes Floral Signalling and Attractiveness to Pollinators in Brassica rapa	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; PHENOTYPIC PLASTICITY; JASMONIC ACID; TOBACCO PLANTS; GENOMIC DNA; METHYLATION; STRESS; POPULATION; 5-AZACYTIDINE; RESISTANCE	Plants have to fine-tune their signals to optimise the trade-off between herbivore deterrence and pollinator attraction. An important mechanism in mediating plant-insect interactions is the regulation of gene expression via DNA methylation. However, the effect of herbivore induced DNA methylation changes on pollinator-relevant plant signalling has not been systematically investigated. Here, we assessed the impact of foliar herbivory on DNA methylation and floral traits in the model crop plant Brassica rapa. Methylation-sensitive amplified fragment length polymorphism (MSAP) analysis showed that leaf damage by the caterpillar Pieris brassicae was associated with genome-wide methylation changes in both leaves and flowers of B. rapa as well as a downturn in flower number, morphology and scent. A comparison to plants with jasmonic acid-induced defence showed similar demethylation patterns in leaves, but both the floral methylome and phenotype differed significantly from P. brassicae infested plants. Standardised genome-wide demethylation with 5-azacytidine in five different B. rapa full-sib groups further resulted in a genotype-specific downturn of floral morphology and scent, which significantly reduced the attractiveness of the plants to the pollinator bee Bombus terrestris. These results suggest that DNA methylation plays an important role in adjusting plant signalling in response to changing insect communities.	[Kellenberger, Roman T.; Schlueter, Philipp M.; Schiestl, Florian P.] Univ Zurich, Dept Systemat & Evolutionary Bot, Zurich, Switzerland	University of Zurich	Kellenberger, RT (corresponding author), Univ Zurich, Dept Systemat & Evolutionary Bot, Zurich, Switzerland.	roman.kellenberger@uzh.ch	Schlüter, Philipp M./A-3571-2011	Schlüter, Philipp M./0000-0002-6057-0908; Schiestl, Florian/0000-0001-7637-6918; Kellenberger, Roman/0000-0003-0274-2115	Zurich Basel PSC Syngenta fellowship; Research Priority Program "Evolution in action" of the University of Zurich; European Union's Seventh Framework Programme (FP7) [281093]	Zurich Basel PSC Syngenta fellowship(Syngenta); Research Priority Program "Evolution in action" of the University of Zurich; European Union's Seventh Framework Programme (FP7)	The research leading to these results received funding from a Zurich Basel PSC Syngenta fellowship to FPS (http://www. plantsciences.uzh.ch/en/research/fellowships/syngenta.html), from the Research Priority Program "Evolution in action" of the University of Zurich to FPS (http://www.evolution.uzh.ch/en.html), and from the European Union's Seventh Framework Programme (FP7/2007-2013, FP7/2007-2011) to FPS under grant agreement no. 281093 (https://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; AGREN J, 1994, AM NAT, V143, P1, DOI 10.1086/285593; Amoah S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-193; Barber NA, 2012, ECOLOGY, V93, P1560, DOI 10.1890/11-1691.1; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bozorov TA, 2012, J INTEGR PLANT BIOL, V54, P189, DOI 10.1111/j.1744-7909.2012.01104.x; Bruinsma M, 2009, J EXP BOT, V60, P2575, DOI 10.1093/jxb/erp101; Byers KJRP Schiestl FP, 2015, ELIFE, V4, DOI [10.7554/eLife.09919, DOI 10.7554/ELIFE.09919]; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; CIHAK A, 1974, ONCOLOGY-BASEL, V30, P405; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Desurmont GA, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0047-7; Dudareva N, 2005, CURR OPIN PLANT BIOL, V8, P113, DOI 10.1016/j.pbi.2004.11.007; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Feeny P, 1976, PLANT APPARENCY CHEM, P1; Fritz VA, 2010, HORTSCIENCE, V45, P1188, DOI 10.21273/HORTSCI.45.8.1188; Gao WJ, 2014, MOL CELL PROBE, V28, P163, DOI 10.1016/j.mcp.2014.02.002; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Holliday R, 1996, COLD SPRING HARBOR M, V32, P639, DOI [10.1101/087969490.32.639, DOI 10.1101/087969490.32.639]; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Junker RR, 2015, J INDIAN I SCI, V95, P43; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; KING GJ, 1995, J HORTIC SCI BIOTECH, V70, P333, DOI 10.1080/14620316.1995.11515304; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Kugimiya S, 2010, J CHEM ECOL, V36, P620, DOI 10.1007/s10886-010-9802-6; LAMB RJ, 1989, ANNU REV ENTOMOL, V34, P211, DOI 10.1146/annurev.en.34.010189.001235; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Marfil CF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-21; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Migicovsky Z, 2013, BIOCHEM CELL BIOL, V91, P1, DOI 10.1139/bcb-2012-0046; Moon HS, 2011, BIOTECHNOL J, V6, P118, DOI 10.1002/biot.201000258; Niederhuth CE, 2014, MOL PLANT, V7, P472, DOI 10.1093/mp/sst165; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Purrington CB, 2000, CURR OPIN PLANT BIOL, V3, P305, DOI 10.1016/S1369-5266(00)00085-6; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rico L, 2014, PLANT BIOLOGY, V16, P419, DOI 10.1111/plb.12049; Rusholme RL, 2007, J GEN VIROL, V88, P3177, DOI 10.1099/vir.0.83194-0; Schiestl FP, 2014, NEW PHYTOL, V203, P257, DOI 10.1111/nph.12783; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sletvold N, 2015, ECOLOGY, V96, P214, DOI 10.1890/14-0119.1; Sotelo P, 2014, J CHEM ECOL, V40, P136, DOI 10.1007/s10886-014-0386-4; Stowe KA, 2013, COSTS GLUCOSINOLATES, DOI [10.4236/oje.2013.32022, DOI 10.4236/OJE.2013.32022]; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; Strauss SY, 1999, EVOLUTION, V53, P1105, DOI [10.2307/2640815, 10.1111/j.1558-5646.1999.tb04525.x]; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Tatra GS, 2000, PHYSIOL PLANTARUM, V109, P313, DOI 10.1034/j.1399-3054.2000.100313.x; Theis N, 2012, ECOLOGY, V93, P430, DOI 10.1890/11-0825.1; Tytgat TOG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065502; Verhoeven KJF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038605; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Widman N, 2014, EPIGENETICS-US, V9, P236, DOI 10.4161/epi.26869; Wiesner M, 2013, INT J MOL SCI, V14, P14996, DOI 10.3390/ijms140714996; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Worley AC, 2000, INT J PLANT SCI, V161, P69, DOI 10.1086/314225; WYATT R, 1982, AM J BOT, V69, P585, DOI 10.2307/2443068; Xiong ZL, MOL GEN GENETICS MGG, V261, P439, DOI [10.1007/s004380050986, DOI 10.1007/S004380050986]; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	79	25	25	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166646	10.1371/journal.pone.0166646	http://dx.doi.org/10.1371/journal.pone.0166646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870873	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000388846400017
J	Ushiki, A; Matsuzaki, H; Ishida, J; Fukamizu, A; Tanimoto, K				Ushiki, Aki; Matsuzaki, Hitomi; Ishida, Junji; Fukamizu, Akiyoshi; Tanimoto, Keiji			Long-Range Control of Renin Gene Expression in Tsukuba Hypertensive Mice	PLOS ONE			English	Article							TRANSGENIC MICE; BLOOD-PRESSURE; ANGIOTENSIN SYSTEM; DISTAL ENHANCER; KIDNEY; GENOME; CELLS; ORGANIZATION; MECHANISMS; ELEMENTS	Renin, a rate-limiting enzyme in the renin-angiotensin system, is regulated to maintain blood pressure homeostasis: renin gene expression in the kidney is suppressed in a hypertensive environment. We found that expression of a 15-kb human RENIN (hREN) transgene was aberrantly upregulated (>4.2-fold), while the endogenous mouse renin (mRen) gene was suppressed (>1.7-fold) in Tsukuba hypertensive mice (THM), a model for genetically induced hypertension. We then generated transgenic mice using a 13-kb mRen gene fragment that was homologous to the 15-kb hREN transgene and found that its expression was also upregulated (>3.1-fold) in THM, suggesting that putative silencing elements of the renin genes were distally located in the loci. We next examined the possible role of a previously identified mouse distal enhancer (mdE) located outside of the 13-kb mRen gene fragment. Deletion of the mdE in the context of a 156-kb mRen transgene did not affect its transcriptional repression in THM, implying that although the silencing element of the mRen gene is located within the 156-kb fragment tested, it is distinct from the mdE. Consistent with these results, deletion of the 63-kb region upstream of the mdE from the endogenous mRen gene locus abrogated its transcriptional repression in THM. We finally tested whether dysregulation of the short renin transgenes also occurred in the fetal or neonatal kidneys of THM and found that their expression was not aberrantly upregulated, demonstrating that aberrant regulation of short renin transgenes commences sometime between neonate and adult periods.	[Ushiki, Aki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Matsuzaki, Hitomi; Tanimoto, Keiji] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Matsuzaki, Hitomi; Ishida, Junji; Fukamizu, Akiyoshi; Tanimoto, Keiji] Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Tanimoto, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Tanimoto, K (corresponding author), Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki, Japan.	keiji@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014	Ushiki, Aki/0000-0002-0889-4577; Tanimoto, Keiji/0000-0003-1971-6546	Astellas Foundation for Research on Metabolic Disorders; Japan Heart Foundation; Uehara Memorial Foundation; Tokyo Biochemical Research Foundation; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS KAKENHI) [16J04305]	Astellas Foundation for Research on Metabolic Disorders; Japan Heart Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Tokyo Biochemical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by The Astellas Foundation for Research on Metabolic Disorders (https://www.astellas.com/jp/byoutai/) (KT); The Japan Heart Foundation (http://www.jhf.or.jp/english/) (KT); The Uehara Memorial Foundation (http://www.ueharazaidan.or.jp) (KT); The Tokyo Biochemical Research Foundation (http://www.tokyobrf.or.jp/english/) (KT); The Takeda Science Foundation (http://www.takeda-sci.or.jp) (KT); The Japan Society for the Promotion of Science (JSPS KAKENHI grant number 16J04305) (https://www.jsps.go.jp/english/) (AU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2006, J BIOL CHEM, V281, P31753, DOI 10.1074/jbc.M605720200; Bader M, 2000, J MOL MED, V78, P130, DOI 10.1007/s001090000089; Castrop H, 2010, PHYSIOL REV, V90, P607, DOI 10.1152/physrev.00011.2009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Desch M, 2011, PFLUG ARCH EUR J PHY, V461, P567, DOI 10.1007/s00424-011-0956-z; FIELD LJ, 1984, MOL CELL BIOL, V4, P2321, DOI 10.1128/MCB.4.11.2321; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; HATAE T, 1994, MOL CELL BIOCHEM, V131, P43, DOI 10.1007/BF01075723; Keen HL, 2001, HYPERTENSION, V37, P403, DOI 10.1161/01.HYP.37.2.403; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lopez MLSS, 2010, CURR HYPERTENS REP, V12, P26, DOI 10.1007/s11906-009-0080-z; Lorenz JN, 1993, AM J PHYSL 2, V265, pF187; Markus MA, 2007, HYPERTENSION, V50, P933, DOI 10.1161/HYPERTENSIONAHA.107.096891; Pan L, 2005, HYPERTENSION, V45, P3, DOI 10.1161/01.HYP.0000149717.55920.45; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; Petrovic N, 1996, J BIOL CHEM, V271, P22499, DOI 10.1074/jbc.271.37.22499; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Schnermann J, 2012, KIDNEY INT, V81, P529, DOI 10.1038/ki.2011.451; SIEGEL SR, 1981, DEV PHARMACOL THERAP, V3, P144, DOI 10.1159/000457435; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; SIGMUND CD, 1992, CIRC RES, V70, P1070, DOI 10.1161/01.RES.70.5.1070; Sinn PL, 1999, J BIOL CHEM, V274, P35785, DOI 10.1074/jbc.274.50.35785; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Tanimoto K, 2008, J CLIN INVEST, V118, P1006, DOI 10.1172/JCI33824; Tanimoto K, 2014, J RECEPT SIG TRANSD, V34, P401, DOI 10.3109/10799893.2014.908917; Thompson MW, 1996, HYPERTENSION, V28, P290, DOI 10.1161/01.HYP.28.2.290; TOBIAN L, 1959, J CLIN INVEST, V38, P605, DOI 10.1172/JCI103838; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yan Y, 1997, CIRC RES, V81, P558, DOI 10.1161/01.RES.81.4.558; Yang G, 1998, AM J PHYSL 2, V274, pF932; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhou XY, 2006, J BIOL CHEM, V281, P35296, DOI 10.1074/jbc.M608055200	41	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166974	10.1371/journal.pone.0166974	http://dx.doi.org/10.1371/journal.pone.0166974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861631	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300138
J	Wilhelms, DB; Mirrasekhian, E; Zajdel, J; Singh, AK; Engblom, D				Wilhelms, Daniel Bjork; Mirrasekhian, Elahe; Zajdel, Joanna; Singh, Anand Kumar; Engblom, David			Cyclooxygenase Isoform Exchange Blocks Brain-Mediated Inflammatory Symptoms	PLOS ONE			English	Article							PROSTAGLANDIN-E SYNTHASE; MESSENGER-RNA; ENDOTHELIAL-CELLS; GENE DISRUPTION; INHIBITION; ANOREXIA; FEVER; RAT; LIPOPOLYSACCHARIDE; EXPRESSION	Cyclooxygenase-2 (COX-2) is the main source of inducible prostaglandin E-2 production and mediates inflammatory symptoms including fever, loss of appetite and hyperalgesia. COX-1 is dispensable for fever, anorexia and hyperalgesia but is important for several other functions both under basal conditions and during inflammation. The differential functionality of the COX isoforms could be due to differences in the regulatory regions of the genes, leading to different expression patterns, or to differences in the coding sequence, resulting in distinct functional properties of the proteins. To study the molecular underpinnings of the functional differences between the two isoforms in the context of inflammatory symptoms, we used mice in which the coding sequence of COX-2 was replaced by the corresponding sequence of COX-1. In these mice, COX-1 mRNA was induced by inflammation but COX-1 protein expression did not fully mimic inflammation-induced COX-2 expression. Just like mice globally lacking COX-2, these mice showed a complete lack of fever and inflammation-induced anorexia as well as an impaired response to inflammatory pain. However, as previously reported, they displayed close to normal survival rates, which contrasts to the high fetal mortality in COX-2 knockout mice. This shows that the COX activity generated from the hybrid gene was strong enough to allow survival but not strong enough to mediate the inflammatory symptoms studied, making the line an interesting alternative to COX-2 knockouts for the study of inflammation. Our results also show that the functional differences between COX-1 and COX-2 in the context of inflammatory symptoms are not only dependent on the features of the promoter regions. Instead they indicate that there are fundamental differences between the isoforms at translational or posttranslational levels.	[Wilhelms, Daniel Bjork; Mirrasekhian, Elahe; Zajdel, Joanna; Singh, Anand Kumar; Engblom, David] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Wilhelms, Daniel Bjork] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res Emergency Med, Linkoping, Sweden; [Wilhelms, Daniel Bjork] Linkoping Univ Hosp, Dept Emergency Med, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Wilhelms, DB (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.; Wilhelms, DB (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res Emergency Med, Linkoping, Sweden.; Wilhelms, DB (corresponding author), Linkoping Univ Hosp, Dept Emergency Med, Linkoping, Sweden.	daniel.wilhelms@liu.se	Singh, Anand Kumar/AAJ-1841-2021	Singh, Anand Kumar/0000-0001-8076-6142; Bjork Wilhelms, Daniel/0000-0001-6347-3970	European Research Council [260820]; Swedish Medical Research Council [25084, 25052, 77044]; Knut och Alice Wallenbergs Stiftelse; Hjarnfonden; County Council of Ostergotland	European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Hjarnfonden; County Council of Ostergotland	This work was funded by the European Research Council (erc.europa.eu; #260820,DE), Swedish Medical Research Council (www.vr.se; #25084, 25052, 77044, DE), Knut och Alice Wallenbergs Stiftelse (www.wallenberg.com/kaw; DE), Hjarnfonden (www.hjamfonden.se; DE) and County Council of Ostergotland (www.regionostergotland.se; DE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAO CY, 1995, BRAIN RES, V697, P187, DOI 10.1016/0006-8993(95)00839-I; Cao CY, 1996, BRAIN RES, V733, P263, DOI 10.1016/0006-8993(96)00575-6; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Elander L, 2010, NEUROSCI LETT, V470, P10, DOI 10.1016/j.neulet.2009.12.036; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Engblom D, 2002, J COMP NEUROL, V452, P205, DOI 10.1002/cne.10380; FELDBERG W, 1971, J PHYSIOL-LONDON, V217, P547, DOI 10.1113/jphysiol.1971.sp009585; FELDBERG W, 1971, J PHYSIOL-LONDON, V215, pP23; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Fritz M, 2016, J CLIN INVEST, V126, P695, DOI 10.1172/JCI83844; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; HELLERSTEIN MK, 1989, J CLIN INVEST, V84, P228, DOI 10.1172/JCI114145; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Johnson PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE650, DOI 10.1152/ajpendo.00388.2001; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Li XZ, 2012, PROSTAG OTH LIPID M, V99, P38, DOI 10.1016/j.prostaglandins.2012.04.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugarini F, 2002, AM J PHYSIOL-REG I, V283, pR862, DOI 10.1152/ajpregu.00200.2002; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; MILTON AS, 1970, J PHYSIOL-LONDON, V207, pP76; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Reyes TM, 2003, J NEUROSCI, V23, P5607; Ruud J, 2013, FASEB J, V27, P1973, DOI 10.1096/fj.12-225433; Ruud LE, 2013, NEUROPHARMACOLOGY, V71, P124, DOI 10.1016/j.neuropharm.2013.03.012; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Wilhelms DB, 2014, J NEUROSCI, V34, P11684, DOI 10.1523/JNEUROSCI.1838-14.2014; Yamamoto T, 2002, JAERI RES, V2002-011, P1; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166153	10.1371/journal.pone.0166153	http://dx.doi.org/10.1371/journal.pone.0166153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861574	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300029
J	Jia, H; Song, L; Cong, Q; Wang, J; Xu, H; Chu, Y; Li, Q; Zhang, Y; Zou, X; Zhang, C; Chin, YE; Zhang, X; Li, Z; Zhu, K; Wang, B; Peng, H; Hou, Z				Jia, H.; Song, L.; Cong, Q.; Wang, J.; Xu, H.; Chu, Y.; Li, Q.; Zhang, Y.; Zou, X.; Zhang, C.; Chin, Y. E.; Zhang, X.; Li, Z.; Zhu, K.; Wang, B.; Peng, H.; Hou, Z.			The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network	ONCOGENE			English	Article							TRANSCRIPTIONAL REPRESSION; EXPRESSION; RECEPTOR; PATHWAY; FAMILY; GAMMA; SOCS; LOCALIZATION; MIGRATION; ACTIVATOR	The LIM protein AJUBA is a scaffold protein participating in the regulation of cell adhesion, mitosis, DNA damage, cell differentiation, proliferation, migration and gene transcription. However, its roles in tumorigenesis and progression are poorly defined. Here, we report that AJUBA is highly expressed in colorectal cancer (CRC) and promotes CRC cell growth in culture and in xenografted mice via an inhibition of apoptosis. AJUBA represses the expression of IFIT2 gene, an interferon-stimulated gene and a known apoptosis inducer and tumour suppressor to mediate its resistance to apoptosis. Mechanistic investigations reveal that AJUBA specifically binds the FERM domain of JAK1 to dissociate JAK1 from the IFN gamma recepter, resulting in an inhibition of STAT1 phosporylation and concomitantly its nuclear translocation. Clinically, the level of AJUBA in CRC specimens is negatively correlated with the levels of IFIT2 and pSTAT1. Collectively, these studies demonstrate that AJUBA can promote CRC growth via inhibiting apoptosis and serve as a target for the therapeutics and a marker for diagnosis of CRC.	[Jia, H.; Song, L.; Wang, J.; Xu, H.; Li, Q.; Zhang, Y.; Zou, X.; Peng, H.; Hou, Z.] Shanghai Jiao Tong Univ, Sch Med, Fac Basic Med, Hongqiao Inst Med,Shanghai Tongren Hosp, Shanghai, Peoples R China; [Jia, H.; Chu, Y.; Peng, H.; Hou, Z.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Digest Endoscopy Ctr, 1111 Xianxia Rd, Shanghai 200336, Peoples R China; [Jia, H.; Wang, J.; Xu, H.; Li, Q.; Zhang, Y.; Zou, X.; Hou, Z.] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cellular Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai, Peoples R China; [Song, L.; Wang, B.] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Gen Surg, Shanghai 200011, Peoples R China; [Cong, Q.] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai, Peoples R China; [Zhang, C.; Chin, Y. E.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhang, X.; Li, Z.] Dalian Med Univ, Canc Ctr, Inst Canc Stem Cells, Dalian, Liaoning, Peoples R China; [Zhu, K.] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China; [Hou, Z.] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis Chinese Min, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Dalian Medical University; Fudan University; Shanghai Jiao Tong University	Peng, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Digest Endoscopy Ctr, 1111 Xianxia Rd, Shanghai 200336, Peoples R China.; Wang, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Gen Surg, Shanghai 200011, Peoples R China.; Hou, Z (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med, 280 South Chongqing Rd,Bldg 7,Room 110, Shanghai 200025, Peoples R China.	wangbin1766@163.com; haixiapeng@163.com; houzy@sjtu.edu.cn	Cong, Qian/AAZ-4404-2021	Jia, Hao/0000-0003-1856-6013; Cong, Qian/0000-0002-9493-5784	Ministry of Sciences & Technology of China [2013CB 910900]; National Science Foundation of China [81372309, 81402376, 31671415, 31601114, 81402177]; Shanghai Committee of Science and Technology [13JC1401302, 15410724200]; Shanghai Municipal Commission of Health and Family Planning [201440426]; Science and Technology Commission of Changning District of Shanghai [CNKW2014F01]; China Postdoctoral Science Foundation [2015M570369]	Ministry of Sciences & Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Municipal Commission of Health and Family Planning; Science and Technology Commission of Changning District of Shanghai; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Dr Frank J Rauscher III for his critical reading and insightful suggestions, and Xinyu Hou for her technical support. This work was supported by the Ministry of Sciences & Technology of China (2013CB 910900); the National Science Foundation of China (grant Nos. 81372309, 81402376, 31671415, 31601114, 81402177); Shanghai Committee of Science and Technology (13JC1401302, 15410724200); Shanghai Municipal Commission of Health and Family Planning (No. 201440426); and Science and Technology Commission of Changning District of Shanghai No. CNKW2014F01); and the China Postdoctoral Science Foundation (No. 2015M570369).	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Blouin CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00267; BLUYSSEN HAR, 1994, GENOMICS, V24, P137, DOI 10.1006/geno.1994.1591; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Chen JZ, 2014, CANCER RES, V74, P4353, DOI 10.1158/0008-5472.CAN-14-0181; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Du LY, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-51; Gongora C, 1999, B CANCER, V86, P911; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jia H, 2015, ONCOGENE, V34, P3568, DOI 10.1038/onc.2014.287; Kotenko SV, 2000, ONCOGENE, V19, P2557, DOI 10.1038/sj.onc.1203524; Krebs DL, 2000, J CELL SCI, V113, P2813; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Li Q, 2016, CELL DEATH DIFFER, V23, P158, DOI 10.1038/cdd.2015.83; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; O'Connell D, 2015, AM J PHYSIOL-LUNG C, V309, pL348, DOI 10.1152/ajplung.00099.2015; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Quispel WT, 2014, J CLIN IMMUNOL, V34, P84, DOI 10.1007/s10875-013-9959-1; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159; Schimizzi GV, 2015, CURR BIOL, V25, pR445, DOI 10.1016/j.cub.2015.02.034; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tiwari M, 2015, APOPTOSIS, V20, P1019, DOI 10.1007/s10495-015-1136-y; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613	34	43	44	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2655	2666		10.1038/onc.2016.418	http://dx.doi.org/10.1038/onc.2016.418			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27893714				2022-12-26	WOS:000401120900004
J	Xue, Y; Raharja, A; Sim, W; Wong, ESM; Rahmat, SAB; Lane, DP				Xue, Y.; Raharja, A.; Sim, W.; Wong, E. S. M.; Rahmat, S. A. B.; Lane, D. P.			The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage	ONCOGENE			English	Article							LIGHT-MICROSCOPIC CHARACTERIZATION; GERM-CELL TUMORS; STEM-CELLS; PROLIFERATING CELLS; CERVICAL-CARCINOMA; SERTOLI-CELLS; IN-VITRO; P53; MOUSE; EXPRESSION	Overexpression of mutant p53 is a common finding in most cancers but testicular tumours accumulate wild-type p53 (wtp53). In contrast to the accepted concept that p53 homozygous mutant mice do not accumulate mutant p53 in normal cells, our study on a mutant p53 mouse model of Li-Fraumeni syndrome harbouring the hot-spot p53R172H mutation described an elevated level of mutant p53 in non-cancerous mouse tissues. Here we use detailed immunohistochemical analysis to document the expression of p53R172H in mouse testis. In developing and adult testes, p53R172H was expressed in gonocytes, type A, Int, B spermatogonia as well as in pre-Sertoli cells and Leydig cells but was undetectable in spermatocytes and spermatids. A similar staining pattern was demonstrated for wtp53. However, the intensity of wtp53 staining was generally weaker than that of p53R172H, which indicates that the expression of p53R172H can be a surrogate marker of p53 gene transcription. Comparing the responses of wtp53 and p53R172H to irradiation, we found persistent DNA double-strand breaks in p53R172H testes and the formation of giant spermatogonia (GSG) following persistent DNA damage in p53R172H and p53-null mice. Strikingly, we found that p53R172H promotes spontaneous formation of GSG in non-stressed p53R172H ageing mice. Two types of GSG: Viable and Degenerative GSG were defined. We elucidate the factors involved in the formation of GSG: the loss of p53 function is a requirement for the formation of GSG whereas DNA damage acts as a promoting trigger. The formation of GSG does not translate to higher efficacy of testicular tumorigenesis arising from mutant p53 cells, which might be due to the presence of delayed-onset of p53-independent apoptosis.	[Xue, Y.; Sim, W.; Rahmat, S. A. B.; Lane, D. P.] ASTAR, Lab p53, Singapore, Singapore; [Raharja, A.] Barts & London Queen Marys Sch Med & Dent, London, England; [Wong, E. S. M.] ASTAR, Inst Med Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); University of London; Queen Mary University London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Lane, DP (corresponding author), 8A Biomed Grove,Neuros Immunos 06-04-05, Singapore 138648, Singapore.	dplane@p53Lab.a-star.edu.sg	Raharja, Antony/AAR-6885-2020	Raharja, Antony/0000-0001-6163-7927; Lane, David/0000-0003-0551-3545	Agency for Science, Technology and Research (A*STAR) of Singapore	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	We thank Dr Farid John Ghadessy for critical reading of the manuscript. We thank Ms Sarah Binte Zulkifli for microscope technical assistance. This work was funded by the Agency for Science, Technology and Research (A*STAR) of Singapore.	Ahmed EA, 2009, BIOL REPROD, V80, P1084, DOI 10.1095/biolreprod.108.071662; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; Ariizumi T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-44; Barker Nick, 2010, Curr Protoc Stem Cell Biol, VChapter 5, DOI 10.1002/9780470151808.sc05a04s13; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Chiarini-Garcia Helio, 2008, V450, P95, DOI 10.1007/978-1-60327-214-8_6; Chung P, 2016, BMJ CLIN EVID, V2016; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; DEROOIJ DG, 1988, J CELL SCI, P181; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ERICKSON BH, 1983, MUTAT RES, V108, P317, DOI 10.1016/0027-5107(83)90129-X; GINSBERG SS, 1992, CANCER-AM CANCER SOC, V70, P606, DOI 10.1002/1097-0142(19920801)70:3<606::AID-CNCR2820700311>3.0.CO;2-L; Goh AM, 2015, ONCOTARGET, V6, P17968, DOI 10.18632/oncotarget.4956; Guillou L, 1996, AM J PATHOL, V149, P1221; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Manecksha RP, 2009, BJU INT, V104, P1329, DOI 10.1111/j.1464-410X.2009.08854.x; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Okwun OE, 1996, J REPROD FERTIL, V107, P137, DOI 10.1530/jrf.0.1070137; PENG HQ, 1993, CANCER RES, V53, P3574; Rajpert-De Meyts E, 2016, LANCET, V387, P1762, DOI 10.1016/S0140-6736(15)00991-5; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; VONHOCHSTETTER AR, 1985, VIRCHOWS ARCH A, V407, P309; Xue Y, 2015, ONCOTARGET, V6, P34979, DOI 10.18632/oncotarget.5512; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789; Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64	35	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					2002	2013		10.1038/onc.2016.374	http://dx.doi.org/10.1038/onc.2016.374			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27869164	Green Published, hybrid			2022-12-26	WOS:000398898500010
J	Antoniades, I; Stylianou, P; Christodoulou, N; Skourides, PA				Antoniades, Ioanna; Stylianou, Panayiota; Christodoulou, Neophytos; Skourides, Paris A.			Addressing the Functional Determinants of FAK during Ciliogenesis in Multiciliated Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CILIATED EPITHELIAL-CELLS; PROTEIN-TYROSINE KINASES; AMINO-TERMINAL DOMAIN; GROWTH-FACTOR; BASAL BODIES; FERM DOMAIN; CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; DEPENDENT FUNCTIONS	We previously identified focal adhesion kinase (FAK) as an important regulator of ciliogenesis in multiciliated cells. FAK and other focal adhesion (FA) proteins associate with the basal bodies and their striated rootlets and form complexes named ciliary adhesions (CAs). CAs display similarities with FAs but are established in an integrin independent fashion and are responsible for anchoring basal bodies to the actin cytoskeleton during ciliogenesis as well as in mature multiciliated cells. FAK down-regulation leads to aberrant ciliogenesis due to impaired association between the basal bodies and the actin cytoskeleton, suggesting that FAK is an important regulator of the CA complex. However, the mechanism through which FAK functions in the complex is not clear, and in this study we examined the role of this protein in both ciliogenesis and ciliary function. Weshow that localization of FAK at CAs depends on interactions taking place at the amino-terminal (FERM) and carboxyl-terminal (FAT) domains and that both domains are required for proper ciliogenesis and ciliary function. Furthermore, we show that an interaction with another CA protein, paxillin, is essential for correct localization of FAK in multiciliated cells. This interaction is indispensable for both ciliogenesis and ciliary function. Finally, we provide evidence that despite the fact that FAK is in the active, open conformation at CAs, its kinase activity is dispensable for ciliogenesis and ciliary function revealing that FAK plays a scaffolding role in multiciliated cells. Overall these data show that the role of FAK at CAs displays similarities but also important differences compared with its role at FAs.	[Antoniades, Ioanna; Stylianou, Panayiota; Christodoulou, Neophytos; Skourides, Paris A.] Univ Cyprus, Dept Biol Sci, Lab Cell Biol & Mol Embryol, 1 Univ Ave, CY-2109 Nicosia, Cyprus	University of Cyprus	Skourides, PA (corresponding author), Univ Cyprus, Dept Biol Sci, Lab Cell Biol & Mol Embryol, 1 Univ Ave, CY-2109 Nicosia, Cyprus.	skourip@ucy.ac.cy	Christodoulou, Neophytos/AAB-7645-2019	Christodoulou, Neophytos/0000-0003-4338-5847				ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Antoniades I, 2014, DEV CELL, V28, P70, DOI 10.1016/j.devcel.2013.12.003; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Burke MC, 2014, J CELL BIOL, V207, P123, DOI 10.1083/jcb.201406140; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Cibois M., 2014, INDUCTION DIFFERENTI, P112; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fonar Y, 2011, MOL BIOL CELL, V22, P2409, DOI 10.1091/mbc.E10-12-0932; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ioannou A, 2013, DEV BIOL, V380, P243, DOI 10.1016/j.ydbio.2013.05.004; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; KLOTZ C, 1986, J CELL BIOL, V103, P613, DOI 10.1083/jcb.103.2.613; Lawson C, 2012, CELL ADHES MIGR, V6, P302, DOI 10.4161/cam.20488; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Otey CA, 1996, INT REV CYTOL, V167, P161, DOI 10.1016/S0074-7696(08)61347-9; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Papusheva E, 2009, J CELL SCI, V122, P656, DOI 10.1242/jcs.028738; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Petridou NI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6240; Petridou NI, 2013, DEVELOPMENT, V140, P4266, DOI 10.1242/dev.096073; Petridou NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042577; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Serrels B, 2012, J CELL BIOL, V196, P185, DOI 10.1083/jcb.201112128; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stewart A, 2002, BIOCHEM BIOPH RES CO, V299, P62, DOI 10.1016/S0006-291X(02)02547-0; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Thomas SM, 1999, J CELL SCI, V112, P181; Thordarson P, 2003, ORG BIOMOL CHEM, V1, P1216, DOI 10.1039/b211015f; TURNER CE, 1994, J CELL SCI, V107, P1583; Walentek P, 2016, ELIFE, V5, DOI 10.7554/eLife.17557; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Zachary I, 1997, INT J BIOCHEM CELL B, V29, P929, DOI 10.1016/S1357-2725(97)00008-3; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhang J, 2000, MOL CARCINOGEN, V27, P177, DOI 10.1002/(SICI)1098-2744(200003)27:3<177::AID-MC4>3.3.CO;2-J; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094	83	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					488	504		10.1074/jbc.M116.767111	http://dx.doi.org/10.1074/jbc.M116.767111			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27895123	Green Published, hybrid			2022-12-26	WOS:000392316100007
J	Groeschel, S; Hagberg, GE; Schultz, T; Balla, DZ; Klose, U; Hauser, TK; Nagele, T; Bieri, O; Prasloski, T; MacKay, AL; Krageloh-Mann, I; Scheffler, K				Groeschel, Samuel; Hagberg, Gisela E.; Schultz, Thomas; Balla, David Z.; Klose, Uwe; Hauser, Till-Karsten; Naegele, Thomas; Bieri, Oliver; Prasloski, Thomas; MacKay, Alex L.; Kraegeloh-Mann, Ingeborg; Scheffler, Klaus			Assessing White Matter Microstructure in Brain Regions with Different Myelin Architecture Using MRI	PLoS One			English	Article							DIFFUSION-TENSOR MRI; GRADIENT-ECHO MRI; MAGNETIZATION-TRANSFER RATIO; TIME-DEPENDENT DIFFUSION; IN-VIVO QUANTIFICATION; L-ASPARTIC ACID; METABOLITE CONCENTRATIONS; CORTICOSPINAL TRACT; MULTIPLE-SCLEROSIS; FIBER ORIENTATION	Objective We investigate how known differences in myelin architecture between regions along the cortico-spinal tract and frontal white matter (WM) in 19 healthy adolescents are reflected in several quantitative MRI parameters that have been proposed to non-invasively probe WM microstructure. In a clinically feasible scan time, both conventional imaging sequences as well as microstructural MRI parameters were assessed in order to quantitatively characterise WM regions that are known to differ in the thickness of their myelin sheaths, and in the presence of crossing or parallel fibre organisation. Results We found that diffusion imaging, MR spectroscopy (MRS), myelin water fraction (MWF), Magnetization Transfer Imaging, and Quantitative Susceptibility Mapping were myelin-sensitive in different ways, giving complementary information for characterising WM microstructure with different underlying fibre architecture. From the diffusion parameters, neurite density (NODDI) was found to be more sensitive than fractional anisotropy ( FA), underlining the limitation of FA in WM crossing fibre regions. In terms of sensitivity to different myelin content, we found that MWF, the mean diffusivity and chemical-shift imaging based MRS yielded the best discrimination between areas. Conclusion Multimodal assessment of WM microstructure was possible within clinically feasible scan times using a broad combination of quantitative microstructural MRI sequences. By assessing new microstructural WM parameters we were able to provide normative data and discuss their interpretation in regions with different myelin architecture, as well as their possible application as biomarker for WM disorders.	[Groeschel, Samuel; Kraegeloh-Mann, Ingeborg] Univ Childrens Hosp Tubingen, Tubingen, Germany; [Hagberg, Gisela E.; Scheffler, Klaus] Max Planck Inst Biol Cybernet, High Field Magnet Resonance, Tubingen, Germany; [Hagberg, Gisela E.; Scheffler, Klaus] Univ Tubingen Hosp, Biomed Magnet Resonance, Tubingen, Germany; [Schultz, Thomas] Univ Bonn, Inst Comp Sci, Bonn, Germany; [Balla, David Z.] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Tubingen, Germany; [Klose, Uwe; Hauser, Till-Karsten; Naegele, Thomas] Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany; [Bieri, Oliver] Univ Basel, Radiol Phys, Basel, Switzerland; [Prasloski, Thomas; MacKay, Alex L.] Univ British Columbia, Vancouver, BC, Canada	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bonn; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; University of British Columbia	Groeschel, S (corresponding author), Univ Childrens Hosp Tubingen, Tubingen, Germany.	Samuel.groeschel@med.uni-tuebingen.de	Klose, Uwe/M-7110-2013; Hagberg, Gisela E/A-2134-2010	Klose, Uwe/0000-0001-5236-3450; Hagberg, Gisela E/0000-0003-2176-7086; Scheffler, Klaus/0000-0001-6316-8773	Medical Faculty of the University of Tubingen, Germany; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of the University of Tubingen, Germany; DFG [SCHU 3040/1-1]; Ministry of Science, Research and the Arts of Baden-Wurttemberg [Az: 32-771-8-1504.12/1/1]	Medical Faculty of the University of Tubingen, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen, Germany; DFG(German Research Foundation (DFG)); Ministry of Science, Research and the Arts of Baden-Wurttemberg	This study was funded by the Medical Faculty of the University of Tubingen, Germany. We also acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of the University of Tubingen, Germany. T.S. was funded by DFG grant SCHU 3040/1-1, G.E.H. by the Ministry of Science, Research and the Arts of Baden-Wurttemberg (Az: 32-771-8-1504.12/1/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Adluru G, 2014, IEEE ENG MED BIO, P742, DOI 10.1109/EMBC.2014.6943697; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ankele M, 2015, LECT NOTES COMPUT SC, V9349, P150, DOI 10.1007/978-3-319-24553-9_19; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Barth M, 2015, MAGN RESON MED; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bender B, 2010, NMR BIOMED, V23, P1071, DOI 10.1002/nbm.1534; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Billiet T, 2014, NEUROIMAGE-CLIN, V4, P649, DOI 10.1016/j.nicl.2014.04.005; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Bock NA, 2009, J NEUROSCI METH, V185, P15, DOI 10.1016/j.jneumeth.2009.08.022; BRENNER RE, 1993, MAGNET RESON MED, V29, P737, DOI 10.1002/mrm.1910290605; Burcaw LM, 2015, NEUROIMAGE, V114, P18, DOI 10.1016/j.neuroimage.2015.03.061; Callaghan MF, 2015, MAGN RESON MED, V73, P1309, DOI 10.1002/mrm.25210; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cercignani M, 2006, NEUROIMAGE, V31, P181, DOI 10.1016/j.neuroimage.2005.11.028; Chang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123656; Cherubini A, 2009, MAGN RESON MED, V61, P1066, DOI 10.1002/mrm.21978; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Concha L., 2013, NEUROSCIENCE, DOI 10.1016; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; de Rochefort L, 2008, MAGN RESON MED, V60, P1003, DOI 10.1002/mrm.21710; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Deoni SCL, 2008, NEUROIMAGE, V40, P662, DOI 10.1016/j.neuroimage.2007.11.052; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Dreha-Kulaczewski SF, 2012, J MAGN RESON IMAGING, V36, P1329, DOI 10.1002/jmri.23774; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Frahm J, 1996, NEUROPEDIATRICS, V27, P64, DOI 10.1055/s-2007-973751; Garcia M, 2011, NEURORADIOLOGY, V53, P159, DOI 10.1007/s00234-010-0714-5; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Gloor M, 2008, MAGN RESON MED, V60, P691, DOI 10.1002/mrm.21705; Gloor M, 2011, MAGN RESON MED, V65, P1113, DOI 10.1002/mrm.22694; Grinberg F, 2016, NEUROIMAGE; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Hagberg GE, 2010, MAGN RESON IMAGING, V28, P297, DOI 10.1016/j.mri.2009.06.001; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Helms G, 2010, MAGN RESON MED, V64, P177, DOI 10.1002/mrm.22379; Helms G, 2009, PHYS MED BIOL, V54, pN529, DOI 10.1088/0031-9155/54/23/N01; Herve PY, 2011, BRAIN STRUCT FUNCT, V216, P255, DOI 10.1007/s00429-011-0306-0; HIRAYAMA K, 1962, NEUROLOGY, V12, P337, DOI 10.1212/WNL.12.5.337; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaden E, 2016, NEUROIMAGE, V139, P346, DOI 10.1016/j.neuroimage.2016.06.002; Kaden E, 2016, MAGN RESON MED, V75, P1752, DOI 10.1002/mrm.25734; Kiselev VG, 2007, MAGN RESON MED, V57, P464, DOI 10.1002/mrm.21164; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; Kunz N, 2014, NEUROIMAGE; Labadie C, 2014, MAGN RESON MED, V71, P375, DOI 10.1002/mrm.24670; Langkammer C, 2015, NEUROIMAGE, V111, P622, DOI 10.1016/j.neuroimage.2015.02.041; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Liu C, 2014, J MAGN RESON IMAGING; Liu CL, 2012, NEUROIMAGE, V59, P1290, DOI 10.1016/j.neuroimage.2011.07.096; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Minati L, 2007, MAGN RESON MATER PHY, V20, P241, DOI 10.1007/s10334-007-0091-1; Moffett John R, 2006, Adv Exp Med Biol, V576, pvii; Mohammadi S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00441; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Panagiotaki E, 2014, CANCER RES, V74, P1902, DOI 10.1158/0008-5472.CAN-13-2511; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Pouwels PJW, 2014, ANN NEUROL, V76, P5, DOI 10.1002/ana.24194; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Prasloski T, 2012, MAGN RESON MED, V67, P1803, DOI 10.1002/mrm.23157; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raffelt D., 2012, P 20 ANN M ISMRM MEL, P3555; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Rioux JA, 2015, MAGN RESON MED; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Russell-Schulz B, 2013, MAGN RESON IMAGING, V31, P329, DOI 10.1016/j.mri.2012.07.003; Sati P, 2013, NEUROIMAGE, V77, P268, DOI 10.1016/j.neuroimage.2013.03.005; Schafer A, 2009, NEUROIMAGE, V48, P126, DOI 10.1016/j.neuroimage.2009.05.093; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schneider J, 2015, AJNR AM J NEURORADIO; Schweser F, 2016, Z MED PHYS, V26, P6, DOI 10.1016/j.zemedi.2015.10.002; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stikov N, 2015, NEUROIMAGE, V118, P397, DOI 10.1016/j.neuroimage.2015.05.023; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Sukstanskii AL, 2004, J MAGN RESON, V170, P56, DOI 10.1016/j.jmr.2004.05.020; Sun HF, 2014, MAGN RESON MED, V71, P1151, DOI 10.1002/mrm.24765; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tofts PS, 2006, MAGN RESON MATER PHY, V19, P209, DOI 10.1007/s10334-006-0049-8; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; Vos SB, 2016, MAGN RESON MED; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Weiskopf N, 2015, CURR OPIN NEUROL, V28, P313, DOI 10.1097/WCO.0000000000000222; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Wharton S, 2015, MAGN RESON MED, V73, P1258, DOI 10.1002/mrm.25189; Wharton S, 2013, NEUROIMAGE, V83, P1011, DOI 10.1016/j.neuroimage.2013.07.054; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; Yablonskiy DA, 2015, MAGN RESON MED, V73, P757, DOI 10.1002/mrm.25538; YAGISHITA A, 1994, RADIOLOGY, V191, P455, DOI 10.1148/radiology.191.2.8153321; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang J, 2015, MAGN RESON MED, V73, P223, DOI 10.1002/mrm.25125	135	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167274	10.1371/journal.pone.0167274	http://dx.doi.org/10.1371/journal.pone.0167274			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898701	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000044
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			Association between Alcohol Intake and Hemoglobin A1c in the Korean Adults: The 2011-2013 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							DIABETES-MELLITUS; CONSUMPTION; DRINKING; GLUCOSE; RISK; ACETALDEHYDE; DETERMINANTS; METAANALYSIS; POPULATION; HBA(1C)	Background Although alcohol consumption is commonly encountered in clinical practice, few studies have investigated the clinical significance of alcohol intake on the use of the hemoglobin A1c (HbA1c) level. Objectives This study was performed to investigate the association between alcohol intake and HbA1c level in the general population. Methods Among the 24,594 participants who participated in the 2011-2013 Korea National Health and Nutrition Examination Survey (KNHANES), 12,923 participants were analyzed in this study. We excluded diabetic patients currently taking antidiabetes medication. We compared the HbA1c level and proportions of patients with an HbA1c level of >= 5.7%, >= 6.1%, and >= 6.5% according to the fasting plasma glucose (FPG) concentration range and the amount of alcohol intake. The average amounts of daily alcohol intake were categorized into three groups: 0 g/day, <30 g/day, >= 30 g/day. Results The mean HbA1c level was 5.65%, and the mean FPG concentration was 95.3 mg/dl. The percentages of patients with an HbA1c level of >= 5.7%, >= 6.1%, and >= 6.5% were 42.6%, 13.4%, and 4.5%, respectively. The average amount of alcohol intake was 12.3 g/day. The percentages of subjects with alcohol intake 0, <30, and >= 30 g/day were 16.5%, 69.7%, and 13.8%, respectively. There was a significant positive relationship between alcohol intake and FPG concentration (P < 0.001), the prevalence of impaired fasting glucose (P < 0.001), and the prevalence of diabetes (P < 0.001). However, there was no significant relationship between the alcohol intake and HbA1c level. Overall, the adjusted HbA1c levels decreased across alcohol intake (5.70%+/- 0.01%, 5.66%+/- 0.01%, and 5.55%+/- 0.01%) after adjustment for confounding factors such as age, sex, FPG concentration, college graduation, smoking history, presence of hypertension, waist circumference, serum total cholesterol concentration, serum high density lipoprotein cholesterol concentration, serum triglyceride concentration, presence of anemia, serum white blood cell count, and serum alanine aminotransferase concentration (P < 0.001). The adjusted proportions (%) of patients with an HbA1c level of >= 5.7% (P < 0.001), >= 6.1% (P < 0.001), and >= 6.5% (P < 0.001) showed significant negative trends across alcohol intake after adjustment for confounders. Logistic regression analyses showed that, when using the group that abstained as the control, the group that consumed >= 30g/day was negatively associated with the risk of an HbA1c level of >= 5.7% (P < 0.001), >= 6.1% (P < 0.001), and >= 6.5% (P < 0.001), using the above-mentioned variables as covariates. Conclusions Higher alcohol intake was associated with lower HbA1c levels, even after adjusting for confounding factors, including the FPG concentration, in this nationally representative sample of Korean adults. These results suggest that excessive drinking shifts the HbA1c level downward, which might complicate use of the HbA1c level for the diagnosis of diabetes or prediabetes.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; da Costa JSD, 2004, REV SAUDE PUBL, V38, P284, DOI 10.1590/S0034-89102004000200019; ECKEY R, 1990, Z RECHTSMED, V103, P169; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; GOEDDE HW, 1987, ENZYME, V37, P29, DOI 10.1159/000469239; Gulliford MC, 2001, EUR J CLIN NUTR, V55, P615, DOI 10.1038/sj.ejcn.1601233; Harding AH, 2002, EUR J CLIN NUTR, V56, P882, DOI 10.1038/sj.ejcn.1601408; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Hong SW, 2015, ALCOHOL, V49, P275, DOI 10.1016/j.alcohol.2015.02.004; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; HUISMAN THJ, 1983, J LAB CLIN MED, V102, P163; Hyeon JH, 2016, ASIA PAC J CLIN NUTR, V25, P308, DOI 10.6133/apjcn.2016.25.2.17; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Koskinen LK, 1998, CLIN CHIM ACTA, V275, P53, DOI 10.1016/S0009-8981(98)00076-X; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Moreira LB, 1996, J STUD ALCOHOL, V57, P253, DOI 10.15288/jsa.1996.57.253; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Song DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163222; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043; TURPEINEN U, 1989, CLIN CHEM, V35, P33; World Health Organization, WORLDWIDE PREVALENCE; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zilkens RR, 2003, J CARDIOVASC RISK, V10, P25, DOI 10.1097/00043798-200302000-00006	28	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167210	10.1371/journal.pone.0167210	http://dx.doi.org/10.1371/journal.pone.0167210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893805	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400101
J	Jutras, PV; Marusic, C; Lonoce, C; Deflers, C; Goulet, MC; Benvenuto, E; Michaud, D; Donini, M				Jutras, Philippe V.; Marusic, Carla; Lonoce, Chiara; Deflers, Carole; Goulet, Marie-Claire; Benvenuto, Eugenio; Michaud, Dominique; Donini, Marcello			An Accessory Protease Inhibitor to Increase the Yield and Quality of a Tumour-Targeting mAb in Nicotiana benthamiana Leaves	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; RECOMBINANT PROTEINS; PROTEOLYTIC DEGRADATION; HETEROLOGOUS PROTEINS; TRANSIENT EXPRESSION; PLANT PROTEASES; PROTECTION; PURIFICATION; CYSTATIN	The overall quality of recombinant IgG antibodies in plants is dramatically compromised by host endogenous proteases. Different approaches have been developed to reduce the impact of endogenous proteolysis on IgGs, notably involving site-directed mutagenesis to eliminate protease-susceptible sites or the in situ mitigation of host protease activities to minimize antibody processing in the cell secretory pathway. We here characterized the degradation profile of H10, a human tumour-targeting monoclonal IgG, in leaves of Nicotiana benthamiana also expressing the human serine protease inhibitor alpha(1)-antichymotrypsin or the cysteine protease inhibitor tomato cystatin S/CYS8. Leaf extracts revealed consistent fragmentation patterns for the recombinant antibody regardless of leaf age and a strong protective effect of S/CYS8 in specific regions of the heavy chain domains. As shown using an antigen-binding ELISA and LC-MS/MS analysis of antibody fragments, SlCYS8 had positive effects on both the amount of fully-assembled antibody purified from leaf tissue and the stability of biologically active antibody fragments containing the heavy chain Fc domain. Our data confirm the potential of Cys protease inhibitors as convenient antibody-stabilizing expression partners to increase the quality of therapeutic antibodies in plant protein biofactories.	[Jutras, Philippe V.; Deflers, Carole; Goulet, Marie-Claire; Michaud, Dominique] Univ Laval, Dept Phytol, Quebec City, PQ, Canada; [Marusic, Carla; Lonoce, Chiara; Benvenuto, Eugenio; Donini, Marcello] ENEA Res Ctr, Biotechnol Lab, Rome, Italy	Laval University; Italian National Agency New Technical Energy & Sustainable Economics Development	Michaud, D (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ, Canada.; Donini, M (corresponding author), ENEA Res Ctr, Biotechnol Lab, Rome, Italy.	dominique.michaud@fsaa.ulaval.ca; marcello.donini@enea.it	Donini, Marcello/AAJ-1079-2020	Deflers, Carole/0000-0001-7966-4114; Donini, Marcello/0000-0001-9183-0728; Goulet, Marie-Claire/0000-0001-7538-5783	Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione del Sistema Paese, Unita per la Cooperazione Scientifica e Tecnologica bilaterale e multilateral'; Natural Science and Engineering Research Council (NSERC) of Canada; AgroPhytoSciences NSERC-CREATE network; NSERC; Fonds de Recherche Quebec Nature et Technologies and Medicago inc	Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione del Sistema Paese, Unita per la Cooperazione Scientifica e Tecnologica bilaterale e multilateral'; Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); AgroPhytoSciences NSERC-CREATE network; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Quebec Nature et Technologies and Medicago inc	This work was supported by a Great Relevance collaborative grant from the Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione del Sistema Paese, Unita per la Cooperazione Scientifica e Tecnologica bilaterale e multilateral' to EB and MD, and by a Discovery grant from the Natural Science and Engineering Research Council (NSERC) of Canada to DM. PVJ was the recipient of a graduate scholarship from the AgroPhytoSciences NSERC-CREATE network and a BMP graduate scholarship funded by NSERC, the Fonds de Recherche Quebec Nature et Technologies and Medicago inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov V, 2010, PROTEIN EXPRES PURIF, V70, P158, DOI 10.1016/j.pep.2009.09.016; Benchabane M, 2009, PLANT BIOTECHNOL J, V7, P146, DOI 10.1111/j.1467-7652.2008.00382.x; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; Buyel JF, 2012, BIOTECHNOL BIOENG, V109, P2575, DOI 10.1002/bit.24523; D'Aoust Marc-Andre, 2009, V483, P41, DOI 10.1007/978-1-59745-407-0_3; De Meyer T, 2015, PLANT BIOTECHNOL J, V13, P938, DOI 10.1111/pbi.12330; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Donini M, 2015, BIOENGINEERED, V6, P299, DOI 10.1080/21655979.2015.1067740; Duwadi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130556; Fahad S, 2015, BIOTECHNOL LETT, V37, P265, DOI 10.1007/s10529-014-1699-7; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Fulton A, 2015, J CHROMATOGR A, V1389, P128, DOI 10.1016/j.chroma.2015.02.013; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goulet C, 2012, PLANT BIOTECHNOL J, V10, P83, DOI 10.1111/j.1467-7652.2011.00643.x; Goulet C, 2010, PLANT BIOTECHNOL J, V8, P142, DOI 10.1111/j.1467-7652.2009.00470.x; Goulet MC, 2008, PLANT PHYSIOL, V146, P1010, DOI 10.1104/pp.108.115741; Hehle VK, 2016, FASEB J, V30, P1590, DOI 10.1096/fj.15-283226; Hehle VK, 2015, PLANT BIOTECHNOL J, V13, P235, DOI 10.1111/pbi.12266; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; Huang C, 2013, FUSION PROTEIN TECHN, P123; Kim NS, 2008, PLANT MOL BIOL, V68, P263, DOI 10.1007/s11103-008-9367-8; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Krenek P, 2015, BIOTECHNOL ADV, V33, P1024, DOI 10.1016/j.biotechadv.2015.03.012; Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217; Lallemand J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00037; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521; Lombardi R, 2010, TRANSGENIC RES, V19, P1083, DOI 10.1007/s11248-010-9382-9; Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416; Mandal MK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00267; Mandal MK, 2014, BIOTECHNOL J, V9, P1065, DOI 10.1002/biot.201300424; Marusic C, 2015, PLANT BIOTECHNOL J, V8, P1; Mei B, 2013, FUSION PROTEIN TECHN, P107; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niemer M, 2014, BIOTECHNOL J, V9, P493, DOI 10.1002/biot.201300207; Outchkourov NS, 2003, PLANT PHYSIOL, V133, P379, DOI 10.1104/pp.102.017293; Pillay P, 2012, APPL BIOCHEM BIOTECH, V168, P1608, DOI 10.1007/s12010-012-9882-6; Pillay P, 2014, BIOENGINEERED, V5, P15, DOI 10.4161/bioe.25158; Rivard D, 2006, PLANT BIOTECHNOL J, V4, P359, DOI 10.1111/j.1467-7652.2006.00187.x; Robert S, 2016, METHODS MOL BIOL, V1385, P115, DOI 10.1007/978-1-4939-3289-4_8; Robert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070203; Sack M, 2015, CURR OPIN BIOTECH, V32, P163, DOI 10.1016/j.copbio.2014.12.008; Sainsbury F, 2013, PLANT BIOTECHNOL J, V11, P1058, DOI 10.1111/pbi.12098; Sainsbury F, 2012, J PROTEOME RES, V11, P5983, DOI 10.1021/pr300699n; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; SHORROSH BS, 1991, P NATL ACAD SCI USA, V88, P10941, DOI 10.1073/pnas.88.23.10941; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207; Zischewski J, 2016, BIOTECHNOL J, V11, P107, DOI 10.1002/biot.201500255	53	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167086	10.1371/journal.pone.0167086	http://dx.doi.org/10.1371/journal.pone.0167086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893815	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400081
J	Khachatryan, E; Camarrone, F; Fias, W; Van Hulle, MM				Khachatryan, Elvira; Camarrone, Flavio; Fias, Wim; Van Hulle, Marc M.			ERP Response Unveils Effect of Second Language Manipulation on First Language Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; LEXICAL ACCESS; PHONOLOGICAL REPRESENTATIONS; INTERLINGUAL HOMOGRAPHS; BILINGUALS; N400; TRANSLATION; ACTIVATION; BRAIN; RECOGNITION	Lexical access in bilinguals has been considered either selective or non-selective and evidence exists in favor of both hypotheses. We conducted a linguistic experiment to assess whether a bilingual's language mode influences the processing of first language information. We recorded event related potentials during a semantic priming paradigm with a covert manipulation of the second language (L2) using two types of stimulus presentations (short and long). We observed a significant facilitation of word pairs related in L2 in the short version reflected by a decrease in N400 amplitude in response to target words related to the English meaning of an inter-lingual homograph (homograph-unrelated group). This was absent in the long version, as the N400 amplitude for this group was similar to the one for the control-unrelated group. We also interviewed the participants whether they were aware of the importance of L2 in the experiment. We conclude that subjects participating in the long and short versions were in different language modes: closer to monolingual mode for the long and closer to bilingual mode for the short version; and that awareness about covert manipulation of L2 can influence the language mode, which in its turn influences the processing of the first language.	[Khachatryan, Elvira; Camarrone, Flavio; Van Hulle, Marc M.] Katholieke Univ Leuven, Dept Neurosci, Lab Neuro & Psychophysiol, Leuven, Belgium; [Khachatryan, Elvira] Yerevan State Med Univ, Dept Neurol, Yerevan, Armenia; [Fias, Wim] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	KU Leuven; Yerevan State Medical University; Ghent University	Khachatryan, E (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Lab Neuro & Psychophysiol, Leuven, Belgium.; Khachatryan, E (corresponding author), Yerevan State Med Univ, Dept Neurol, Yerevan, Armenia.	elvira.khachatryan@med.kuleuven.be	Fias, Wim/D-6861-2010	Fias, Wim/0000-0002-5788-7306; Van Hulle, Marc/0000-0003-1060-7044; Khachatryan, Elvira/0000-0003-1828-8324	Belgian Fund for Scientific Research - Flanders [GOA0914N, G088314N, G0A0914N]; Agency for Innovation by Science and Technology in Flanders (IWT); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Interuniversity Attraction Poles Program of the Belgian Federal Government [P7/11]; program Financing program [PFV/10/008]; interdisciplinary research project [IDO/12/007]; industrial research fund project of the KU Leuven [IOF/HB/12/021]; Interuniversity Attraction Poles Programme - Belgian Science Policy [IUAP P7/11]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Hercules Foundation [AKUL 043]	Belgian Fund for Scientific Research - Flanders(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Interuniversity Attraction Poles Program of the Belgian Federal Government(Belgian Federal Science Policy Office); program Financing program; interdisciplinary research project; industrial research fund project of the KU Leuven; Interuniversity Attraction Poles Programme - Belgian Science Policy(Belgian Federal Science Policy Office); Flemish Regional Ministry of Education (Belgium)(FWO); Hercules Foundation	EK is supported by the Belgian Fund for Scientific Research - Flanders (GOA0914N). FC is supported by the Agency for Innovation by Science and Technology in Flanders (IWT). WF is supported by Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; and by the Interuniversity Attraction Poles Program of the Belgian Federal Government [grant number P7/11]. MMVH is supported by research grants received from the program Financing program (PFV/10/008), an interdisciplinary research project (IDO/12/007), and an industrial research fund project (IOF/HB/12/021) of the KU Leuven, the Belgian Fund for Scientific Research - Flanders (G088314N, G0A0914N), the Interuniversity Attraction Poles Programme - Belgian Science Policy (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), and the Hercules Foundation (AKUL 043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou M, 2013, J ACOUST SOC AM, V133, P2397, DOI 10.1121/1.4792358; Antoniou M, 2012, J PHONETICS, V40, P582, DOI 10.1016/j.wocn.2012.05.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonfiglio L, 2015, ARCH ITAL BIOL, V153, P1, DOI 10.4449/aib.v153i1.3629; Bornkessel-Schlesewsky I., 2009, PROCESSING SYNTAX MO; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CARAMAZZA A, 1979, B PSYCHONOMIC SOC, V13, P212, DOI 10.3758/BF03335062; Carrasco-Ortiz H, 2012, PSYCHOPHYSIOLOGY, V49, P531, DOI 10.1111/j.1469-8986.2011.01333.x; Chauncey K, 2008, BRAIN LANG, V105, P161, DOI 10.1016/j.bandl.2007.11.006; Coe R., 2002, BRIT ED RES ASS ANN, P1214; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; De Bruijn E. R. A., 2001, BILING-LANG COGN, V4, P155, DOI [10.1017/S1366728901000256, DOI 10.1017/S1366728901000256]; De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213; de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891; Dewaele JM, 2014, INT J MULTILING, V11, P225, DOI 10.1080/14790718.2013.878347; Dijkstra T., 1998, BILING-LANG COGN, V1, P51, DOI [10.1017/S1366728998000121, DOI 10.1017/S1366728998000121]; Dunn a. L, 2012, INT J BILINGUAL, P1; Elston-Guttler KE, 2005, COGNITIVE BRAIN RES, V25, P57, DOI 10.1016/j.cogbrainres.2005.04.007; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; GERARD LD, 1989, J EXP PSYCHOL LEARN, V15, P305, DOI 10.1037/0278-7393.15.2.305; Grosjean F., 1994, ENCY LANG LINGUIST; Grosjean F., 1999, ONE MIND 2 LANGUAGES, P1; Hoffer B.L., 2005, INTERCULT COMMUN STU, V14, P53; Hoversten L, 2015, J COGNITIVE NEUROSCI, V23, P1; Jared D, 2001, J MEM LANG, V44, P2, DOI 10.1006/jmla.2000.2747; Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kiss GR, 1973, COMPUTER LIT STUDIES, P153; KOYAMA S, 1992, BRAIN LANG, V43, P668, DOI 10.1016/0093-934X(92)90089-W; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kutas M., 2009, SCHOLARPEDIA, V4, DOI [10.4249/scholarpedia.7790, DOI 10.4249/SCHOLARPEDIA.7790]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013; Luck SJ, 2005, MONOGRAPHS SOC RES C; Mari-Beffa P, 2007, BRAIN RES, V1147, P209, DOI 10.1016/j.brainres.2007.01.124; Martin CD, 2009, NEUROIMAGE, V47, P326, DOI 10.1016/j.neuroimage.2009.04.025; McKinney W., 2012, PYTHON DATA ANAL DAT; Midgley KJ, 2008, BRAIN RES, V1246, P123, DOI 10.1016/j.brainres.2008.09.078; Moon J, 2012, BILING-LANG COGN, V15, P173, DOI 10.1017/S1366728911000022; Moreno EM, 2008, J NEUROLINGUIST, V21, P477, DOI 10.1016/j.jneuroling.2008.01.003; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; Okita T, 1998, PSYCHOPHYSIOLOGY, V35, P260, DOI 10.1017/S0048577298961042; Paulmann S, 2006, NEUROREPORT, V17, P727, DOI 10.1097/01.wnr.0000214400.88845.fa; Proverbio AM, 2002, J COGNITIVE NEUROSCI, V14, P994, DOI 10.1162/089892902320474463; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Roelofs A, 2002, BILING-LANG COGN, V5, P214, DOI 10.1017/S1366728902263014; SOARES C, 1984, MEM COGNITION, V12, P380, DOI 10.3758/BF03198298; Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151; Team RDC, 2008, R LANG ENV STAT COMP; Thierry G, 2007, P NATL ACAD SCI USA, V104, P12530, DOI 10.1073/pnas.0609927104; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Van Petten C, 2014, INT J PSYCHOPHYSIOL, V94, P407, DOI 10.1016/j.ijpsycho.2014.10.012; Van Vliet M, 2014, PLOS ONE, P9; van Vliet M, 2016, IEEE T BIO-MED ENG, V63, P55, DOI 10.1109/TBME.2015.2468588; Wong B, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7069274; Wu Y., 2010, FRONTIERS LANGUAGE S, V1, P1; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zhou X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039011, 10.1371/journal.pone.0043230]	65	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167194	10.1371/journal.pone.0167194	http://dx.doi.org/10.1371/journal.pone.0167194			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893807	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400099
J	Politis, M; Wajnsztajn, D; Rosin, B; Block, C; Solomon, A				Politis, Michael; Wajnsztajn, Denise; Rosin, Boris; Block, Colin; Solomon, Abraham			Trends of Bacterial Keratitis Culture Isolates in Jerusalem; a 13-Years Analysis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MICROBIAL KERATITIS; SUSCEPTIBILITY PATTERNS; ANTIBIOTIC-RESISTANCE; 10-YEAR EXPERIENCE; SOUTH FLORIDA; INFECTIONS; MANAGEMENT; THERAPY; STATES	Purpose To describe the trends in pathogens and antibacterial resistance of corneal culture isolates in infectious keratitis during a period of 13 years at Hadassah-Hebrew University Medical Center. Methods A Retrospective analysis of bacterial corneal isolates was performed during the months of January 2002 to December 2014 at Hadassah-Hebrew University Medical Center. Demographics, microbiological data and antibiotic resistance and sensitivity were collected. Results A total of 943 corneal isolates were analyzed during a 13 year period. A total of 415 positive bacterial cultures and 37 positive fungal cultures were recovered, representing 48% of the total cultures. The Annual incidence was 34.78 +/- 6.54 cases. The most common isolate was coagulase-negative staphylococcus (32%), which had a significant decrease in trend throughout the study period (APC = -8.1, p = 0.002). Methicillin-resistant Staphylococcus aureus (MRSA) appears to have a decrease trend (APC = -31.2, P = 0.5). There was an increase in the resistance trend of coagulase-negative staphylococci to penicillin (APC = 5.0, P = <0.001). None of the pathogens had developed any resistance to Vancomycin. (P = 0.88). Conclusions Coagulase negative staphylococci were the predominant bacteria isolated from patients with keratitis. There was no significant change in the annual incidence of cases of bacterial keratitis seen over the past 13 years. Keratitis caused by MRSA appeared to decrease in contrast to the reported literature.	[Politis, Michael; Wajnsztajn, Denise; Rosin, Boris; Solomon, Abraham] Hadassah Hebrew Univ, Dept Ophthalmol, Med Ctr, Jerusalem, Israel; [Block, Colin] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Solomon, A (corresponding author), Hadassah Hebrew Univ, Dept Ophthalmol, Med Ctr, Jerusalem, Israel.	dr.avi.solomon@gmail.com		Solomon, Abraham/0000-0003-3222-9507				Abdel-moein KA, 2012, TRANSBOUND EMERG DIS, V59, P331, DOI 10.1111/j.1865-1682.2011.01273.x; Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1497, DOI 10.1016/S0161-6420(00)00179-2; [Anonymous], 2015, MICROBIAL KERATITIS, V122, P918, DOI [10.16/j.ophtha.2014.11.027, DOI 10.1016/J.OPHTHA.2014.11.027]; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Chang VS, 2015, CORNEA, V34, P698, DOI 10.1097/ICO.0000000000000431; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Elsahn AF, 2010, CORNEA, V29, P1131, DOI 10.1097/ICO.0b013e3181d2ce25; Falcone M, 2012, INT J ANTIMICROB AG, V39, P64, DOI 10.1016/j.ijantimicag.2011.09.011; Hernandez-Camarena JC, 2015, CORNEA, V34, P778, DOI 10.1097/ICO.0000000000000428; Hong JX, 2013, OPHTHALMOLOGY, V120, P647, DOI 10.1016/j.ophtha.2012.10.038; Hsu HY, 2010, EYE CONTACT LENS, V36, P195, DOI 10.1097/ICL.0b013e3181e3ef45; Ibrahim MM, 2011, ARQ BRAS OFTALMOL, V74, P7, DOI 10.1590/S0004-27492011000100002; Kaye SB, 2003, J CLIN MICROBIOL, V41, P3192, DOI 10.1128/JCM.41.7.3192-3197.2003; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kowalski Regis P, 2003, Ophthalmol Clin North Am, V16, P1, DOI 10.1016/S0896-1549(02)00061-5; Lalitha P, 2015, BRIT J OPHTHALMOL, V99, P192, DOI 10.1136/bjophthalmol-2014-305000; Lavinsky F, 2013, ARQ BRAS OFTALMOL, V76, P175, DOI 10.1590/S0004-27492013000300009; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; McDonald EM, 2014, BRIT J OPHTHALMOL, V98, P1470, DOI 10.1136/bjophthalmol-2013-304660; Mezer E, 1999, EUR J OPHTHALMOL, V9, P120, DOI 10.1177/112067219900900208; Mills R, 2003, BRIT J OPHTHALMOL, V87, P1167, DOI 10.1136/bjo.87.9.1167-a; Ng ALK, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/769436; Orlans HO, 2011, EYE, V25, P489, DOI 10.1038/eye.2010.231; PURCELL EM, 1953, P SOC EXP BIOL MED, V82, P124, DOI 10.3181/00379727-82-20042; Shalchi Z, 2011, OPHTHALMOLOGY, V118, P2161, DOI 10.1016/j.ophtha.2011.04.021; Shifting Trends in Bacterial Keratitis in Toronto, 2012, SHIFTING TRENDS BACT, V119, P1785; Zhang C, 2008, CLIN OPHTHALMOL, V2, P575	27	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165223	10.1371/journal.pone.0165223	http://dx.doi.org/10.1371/journal.pone.0165223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893743	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400006
J	Santana, VM; Alday, JG; Lee, H; Allen, KA; Marrs, RH				Santana, Victor M.; Alday, Josu G.; Lee, HyoHyeMi; Allen, Katherine A.; Marrs, Rob H.			Modelling Carbon Emissions in Calluna vulgaris-Dominated Ecosystems when Prescribed Burning and Wildfires Interact	PLOS ONE			English	Article							POSTFIRE SUCCESSION; MOORLAND FIRE; MANAGEMENT; INTENSITY; ACCUMULATION; HEATHER; PATTERNS; ECOLOGY; UPLANDS; EXTENT	A present challenge in fire ecology is to optimize management techniques so that ecological services are maximized and C emissions minimized. Here, we modeled the effects of different prescribed-burning rotation intervals and wildfires on carbon emissions (present and future) in British moorlands. Biomass-accumulation curves from four Calluna-dominated ecosystems along a north-south gradient in Great Britain were calculated and used within a matrix-model based on Markov Chains to calculate above-ground biomass-loads and annual C emissions under different prescribed-burning rotation intervals. Additionally, we assessed the interaction of these parameters with a decreasing wildfire return intervals. We observed that litter accumulation patterns varied between sites. Northern sites (colder and wetter) accumulated lower amounts of litter with time than southern sites (hotter and drier). The accumulation patterns of the living vegetation dominated by Calluna were determined by site-specific conditions. The optimal prescribed-burning rotation interval for minimizing annual carbon emissions also differed between sites: the optimal rotation interval for northern sites was between 30 and 50 years, whereas for southern sites a hump-backed relationship was found with the optimal interval either between 8 to 10 years or between 30 to 50 years. Increasing wildfire frequency interacted with prescribed-burning rotation intervals by both increasing C emissions and modifying the optimum prescribed-burning interval for minimum C emission. This highlights the importance of studying site-specific biomass accumulation patterns with respect to environmental conditions for identifying suitable fire-rotation intervals to minimize C emissions.	[Santana, Victor M.] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain; [Alday, Josu G.] Univ Lleida, AGROTECNIO Ctr, Dept Crop & Forest Sci, Lleida, Spain; [Lee, HyoHyeMi] Natl Inst Ecol, Team Environm Impact Assessment, Seocheon, South Korea; [Allen, Katherine A.; Marrs, Rob H.] Univ Liverpool, Sch Environm Sci, Liverpool, Merseyside, England	University of Barcelona; Universitat de Lleida; National Institute of Ecology; University of Liverpool	Santana, VM (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain.	vm.santana@ua.es	Alday, Josu G./F-6175-2010; Santana, Victor M./J-2299-2014; Lee, Hyohyemi/L-3351-2013	Alday, Josu G./0000-0001-7510-8655; Santana, Victor M./0000-0002-6121-1747; Lee, Hyohyemi/0000-0002-5088-4751	BiodivERsA FIREMAN program [NERC/Defra: NE/G002096/1]; Ecological Continuity Trust; Heather Trust; Generalitat de Catalunya [2014BP-B 00056]; Juan de la Cierva-fellowship [IJCI-2014-21393]	BiodivERsA FIREMAN program; Ecological Continuity Trust; Heather Trust; Generalitat de Catalunya(Generalitat de Catalunya); Juan de la Cierva-fellowship	This project was supported financially by the BiodivERsA FIREMAN program (NERC/Defra: NE/G002096/1), the Ecological Continuity Trust and the Heather Trust. VMS was supported by Beatriu de Pinos fellowship (2014BP-B 00056) from the Generalitat de Catalunya. JGA was supported by Juan de la Cierva-fellowship (IJCI-2014-21393).	Albertson K, 2010, CLIM RES, V45, P105, DOI 10.3354/cr00926; Albertson K, 2009, J ENVIRON MANAGE, V90, P2642, DOI 10.1016/j.jenvman.2009.02.011; Alday JG, 2015, PERSPECT PLANT ECOL, V17, P388, DOI 10.1016/j.ppees.2015.06.007; Allen KA, 2013, J APPL ECOL, V50, P614, DOI 10.1111/1365-2664.12075; [Anonymous], 2014, ENV MANAGEMENT GUIDA; Bain C., 2011, IUCN UK COMMISSION I; Bealey WJ, 2003, F9001538 JNCC CTR EC; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bonn A., 2009, DRIVERS ENV CHANGE U, P34; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradstock RA, 2012, INT J WILDLAND FIRE, V21, P629, DOI 10.1071/WF11023; CHAPMAN SB, 1975, J ECOL, V63, P259, DOI 10.2307/2258853; CHAPMAN SB, 1980, B ECOL, V11, P221; CHAPMAN SB, 1967, J ECOL, V55, P677, DOI 10.2307/2258418; Collins L, 2015, J ENVIRON MANAGE, V150, P196, DOI 10.1016/j.jenvman.2014.11.009; Davies GM, 2008, WIT TRANS ECOL ENVIR, V119, P225, DOI 10.2495/FIVA080231; Davies GM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0342; Douglas DJT, 2015, BIOL CONSERV, V191, P243, DOI 10.1016/j.biocon.2015.06.014; Eriksson O, 2002, J VEG SCI, V13, P743, DOI 10.1111/j.1654-1103.2002.tb02102.x; Fernandes PM, 2013, FRONT ECOL ENVIRON, V11, pE4, DOI 10.1890/120298; Galford GL, 2010, P NATL ACAD SCI USA, V107, P19649, DOI 10.1073/pnas.1000780107; Gimingham C.H., 1972, ECOLOGY HEATHLANDS; Harris MPK, 2011, J APPL ECOL, V48, P1411, DOI 10.1111/j.1365-2664.2011.02052.x; Heal O. W., 1978, Production ecology of British moors and montane grasslands., P3; HEAL OW, 1978, PRODUCTION ECOLOGY B; HESTER AJ, 1992, BIOL CONSERV, V60, P25, DOI 10.1016/0006-3207(92)90795-O; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Jenkins GJ, 2009, UK CLIMATE PROJECTIO; KASISCHKE ES, 1995, REMOTE SENS ENVIRON, V51, P263, DOI 10.1016/0034-4257(93)00074-J; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Lee H, 2013, J APPL ECOL, V50, P625, DOI 10.1111/1365-2664.12078; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; MALTBY E, 1990, J ECOL, V78, P490, DOI 10.2307/2261126; MILLER GR, 1979, J ECOL, V67, P109, DOI 10.2307/2259340; Milne JA, 2002, GRASS FORAGE SCI, V57, P373, DOI 10.1046/j.1365-2494.2002.00339.x; Natural England, 2007, HEATH GRASS BURN COD; Palmer SCF, 1997, GRASS FORAGE SCI, V52, P408, DOI 10.1111/j.1365-2494.1997.tb02373.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pausas JG, 2013, GLOBAL ECOL BIOGEOGR, V22, P728, DOI 10.1111/geb.12043; Pinheiro J, 2001, MIXED EFFECTS MODELS; Post WM, 2012, FRONT ECOL ENVIRON, V10, P554, DOI 10.1890/120065; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenburgh A, 2013, GEODERMA, V211, P98, DOI 10.1016/j.geoderma.2013.07.012; Schimel D, 2002, NATURE, V420, P29, DOI 10.1038/420029a; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Scottish Government, 2011, THE MUIRB COD; Stewart GB, 2005, BIOL CONSERV, V126, P270, DOI 10.1016/j.biocon.2005.06.003; Tucker GT., 2003, 55 NAT ENGL; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Vandvik V, 2005, J APPL ECOL, V42, P139, DOI 10.1111/j.1365-2664.2005.00982.x; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; WATT AS, 1955, J ECOL, V43, P490, DOI 10.2307/2257009; Yallop AR, 2006, J APPL ECOL, V43, P1138, DOI 10.1111/j.1365-2664.2006.01222.x	54	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167137	10.1371/journal.pone.0167137	http://dx.doi.org/10.1371/journal.pone.0167137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880840	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500071
J	Tamimi, A; Ashhab, Y; Tamimi, H				Tamimi, Ahmad; Ashhab, Yaqoub; Tamimi, Hashem			Accelerating Information Retrieval from Profile Hidden Markov Model Databases	PLOS ONE			English	Article							PROTEIN FAMILIES; SEQUENCE; ALIGNMENT; ALGORITHM; COMPASS; PROGRAM; TOOL	Profile Hidden Markov Model (Profile-HMM) is an efficient statistical approach to represent protein families. Currently, several databases maintain valuable protein sequence information as profile-HMMs. There is an increasing interest to improve the efficiency of searching Profile-HMM databases to detect sequence-profile or profile-profile homology. However, most efforts to enhance searching efficiency have been focusing on improving the alignment algorithms. Although the performance of these algorithms is fairly acceptable, the growing size of these databases, as well as the increasing demand for using batch query searching approach, are strong motivations that call for further enhancement of information retrieval from profile-HMM databases. This work presents a heuristic method to accelerate the current profile-HMM homology searching approaches. The method works by cluster-based remodeling of the database to reduce the search space, rather than focusing on the alignment algorithms. Using different clustering techniques, 4284 TIGRFAMs profiles were clustered based on their similarities. A representative for each cluster was assigned. To enhance sensitivity, we proposed an extended step that allows overlapping among clusters. A validation benchmark of 6000 randomly selected protein sequences was used to query the clustered profiles. To evaluate the efficiency of our approach, speed and recall values were measured and compared with the sequential search approach. Using hierarchical, k-means, and connected component clustering techniques followed by the extended overlapping step, we obtained an average reduction in time of 41%, and an average recall of 96%. Our results demonstrate that representation of profile-HMMs using a clustering-based approach can significantly accelerate data retrieval from profile-HMM databases.	[Tamimi, Ahmad; Tamimi, Hashem] Palestine Polytech Univ, Coll Informat Technol & Comp Engn, Hebron, Palau; [Ashhab, Yaqoub; Tamimi, Hashem] Palestine Polytech Univ, Palestine Korea Biotechnol Ctr, Hebron, Palau		Tamimi, A; Tamimi, H (corresponding author), Palestine Polytech Univ, Coll Informat Technol & Comp Engn, Hebron, Palau.; Tamimi, H (corresponding author), Palestine Polytech Univ, Palestine Korea Biotechnol Ctr, Hebron, Palau.	ah.tamimi@gmail.com; htamimi@ppu.edu	Tamimi, Hashem/R-1745-2016; Ashhab, Yaqoub/AAC-8789-2019	Tamimi, Hashem/0000-0002-7571-3377; Tamimi, Ahmad/0000-0002-5968-8562				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Deng X, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-252; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Elofsson A, 1999, BIOINFORMATICS, V15, P480, DOI 10.1093/bioinformatics/15.6.480; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Gilat A, 2009, MATLAB INTRO APPL; Gollery M, 2008, HDB HIDDEN MARKOV MO, DOI [10.1111/j.1541-0420.2008.01138_16.x, DOI 10.1111/J.1541-0420.2008.01138_16.X]; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; HOPCROFT J, 1973, COMMUN ACM, V16, P372, DOI 10.1145/362248.362272; Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95; Hughey R, 1995, SAM SEQUENCE ALIGNME; Krishnadev O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-275; Kumar V, 2004, NEW DIRECTIONS STAT, P273, DOI DOI 10.1007/978-3-662-08968-2_16; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Madera M, 2008, BIOINFORMATICS, V24, P2630, DOI 10.1093/bioinformatics/btn504; Nepusz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-120; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Sadreyev RI, 2003, PROTEIN SCI, V12, P2262, DOI 10.1110/ps.03197403; SIBSON R, 1973, COMPUT J, V16, P30, DOI 10.1093/comjnl/16.1.30; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293	33	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166358	10.1371/journal.pone.0166358	http://dx.doi.org/10.1371/journal.pone.0166358			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875548	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000010
J	Trgovcich, J; Kincaid, M; Thomas, A; Griessl, M; Zimmerman, P; Dwivedi, V; Bergdall, V; Klenerman, P; Cook, CH				Trgovcich, Joanne; Kincaid, Michelle; Thomas, Alicia; Griessl, Marion; Zimmerman, Peter; Dwivedi, Varun; Bergdall, Valerie; Klenerman, Paul; Cook, Charles H.			Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MURINE CYTOMEGALOVIRUS; CELL RESPONSES; LATENT CYTOMEGALOVIRUS; LONG-TERM; QUANTITATIVE DETECTION; INFECTION; VIRUS; REACTIVATION; POPULATIONS	Cytomegalovirus (CMV) has been shown to induce large populations of CD8 T-effector memory cells that unlike central memory persist in large quantities following infection, a phenomenon commonly termed "memory inflation". Although murine models to date have shown very large and persistent CMV-specific T-cell expansions following infection, there is considerable variability in CMV-specific T-memory responses in humans. Historically such memory inflation in humans has been assumed a consequence of reactivation events during the life of the host. Because basic information about CMV infection/re-infection and reactivation in immune competent humans is not available, we used a murine model to test how primary infection, reinfection, and reactivation stimuli influence memory inflation. We show that low titer infections induce partial memory inflation of both mCMV specific CD8 T-cells and antibody. We show further that reinfection with different strains can boost partial memory inflation. Finally, we show preliminary results suggesting that a single strong reactivation stimulus does not stimulate memory inflation. Altogether, our results suggest that while high titer primary infections can induce memory inflation, reinfections during the life of a host may be more important than previously appreciated.	[Trgovcich, Joanne; Kincaid, Michelle; Thomas, Alicia; Zimmerman, Peter; Dwivedi, Varun] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Griessl, Marion; Cook, Charles H.] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bergdall, Valerie] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Klenerman, Paul] Univ Oxford, Dept Med, Oxford, England	University System of Ohio; Ohio State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; Ohio State University; University of Oxford	Cook, CH (corresponding author), Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	chcook@bidmc.harvard.edu	Cook, Charles/AAE-3222-2020; Cook, Charles/D-5574-2009	klenerman, paul/0000-0003-4307-9161; Cook, Charles/0000-0003-4446-3616	National Institutes of Health-NIGMS [GM066115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066115] Funding Source: NIH RePORTER	National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health-NIGMS, Grant Number GM066115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER SP, 1995, J INFECT DIS, V171, P26, DOI 10.1093/infdis/171.1.26; Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; Andrews DM, 2008, J VIROL, V82, P4931, DOI 10.1128/JVI.02127-07; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Beswick M, 2013, J VIROL, V87, P779, DOI 10.1128/JVI.02427-12; Beverley PCL, 2014, J IMMUNOL, V193, P2306, DOI 10.4049/jimmunol.1302523; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Bohm V, 2008, MED MICROBIOL IMMUN, V197, P135, DOI 10.1007/s00430-008-0092-3; Bohm V, 2009, J VIROL, V83, P10293, DOI 10.1128/JVI.01143-09; Bolinger B, 2013, J IMMUNOL, V190, P4162, DOI 10.4049/jimmunol.1202665; BOOTH TWM, 1993, ARCH VIROL, V132, P209, DOI 10.1007/BF01309855; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Campbell J, 2012, J LEUKOCYTE BIOL, V92, P933, DOI 10.1189/jlb.1211635; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; Cicin-Sain L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002849; Clari MA, 2013, J MED VIROL, V85, P1802, DOI 10.1002/jmv.23621; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; Gamadia LE, 2004, J IMMUNOL, V172, P6107, DOI 10.4049/jimmunol.172.10.6107; Gorzer I, 2010, J VIROL, V84, P7195, DOI 10.1128/JVI.00475-10; Gorzer I, 2010, J CLIN VIROL, V48, P100, DOI 10.1016/j.jcv.2010.03.005; Gorman S, 2006, J GEN VIROL, V87, P1123, DOI 10.1099/vir.0.81583-0; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hoffmann TW, 2010, J MED GENET, V47, P54, DOI 10.1136/jmg.2009.068841; Holtappels R, 2002, J VIROL, V76, P151, DOI 10.1128/JVI.76.1.151-164.2002; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; JORDAN MC, 1978, INFECT IMMUN, V21, P275, DOI 10.1128/IAI.21.1.275-280.1978; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Klyushnenkova EN, 2012, J IMMUNOTHER, V35, P390, DOI 10.1097/CJI.0b013e3182585d50; Komatsu H, 2003, CLIN EXP IMMUNOL, V134, P9, DOI 10.1046/j.1365-2249.2003.02266.x; Komatsu Haruki, 2006, Immun Ageing, V3, P11, DOI 10.1186/1742-4933-3-11; Kotsimbos ATC, 1997, AM J RESP CRIT CARE, V156, P1241, DOI 10.1164/ajrccm.156.4.96-09106; Lachmann R, 2012, J VIROL, V86, P1001, DOI 10.1128/JVI.00873-11; Lang A, 2009, J IMMUNOL, V183, P8077, DOI 10.4049/jimmunol.0801117; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lidehall AK, 2005, J CLIN IMMUNOL, V25, P473, DOI 10.1007/s10875-005-5372-8; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; MUSIANI M, 1988, J CLIN PATHOL, V41, P722, DOI 10.1136/jcp.41.7.722; Norbeck O, 2005, J VIROL, V79, P12117, DOI 10.1128/JVI.79.18.12117-12121.2005; Pahl-Seibert MF, 2005, J VIROL, V79, P5400, DOI 10.1128/JVI.79.9.5400-5413.2005; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Podlech J, 2000, J VIROL, V74, P7496, DOI 10.1128/JVI.74.16.7496-7507.2000; Qin OY, 2003, J CLIN IMMUNOL, V23, P247, DOI 10.1023/A:1024580531705; REDDEHASE MJ, 1994, J EXP MED, V179, P185, DOI 10.1084/jem.179.1.185; REDDEHASE MJ, 1984, EUR J IMMUNOL, V14, P56, DOI 10.1002/eji.1830140111; Redeker A, 2014, EUR J IMMUNOL, V44, P1046, DOI 10.1002/eji.201343946; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; SHANLEY JD, 1982, J INFECT DIS, V146, P388, DOI 10.1093/infdis/146.3.388; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Simon CO, 2005, J VIROL, V79, P326, DOI 10.1128/JVI.79.1.326-340.2005; Slavuljica I, 2010, J CLIN INVEST, V120, P4532, DOI 10.1172/JCI43961; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Snyder CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002295; Stahl FR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003828; Steffens HP, 1998, J VIROL, V72, P1797, DOI 10.1128/JVI.72.3.1797-1804.1998; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Swanson PA, 2009, J IMMUNOL, V182, P5198, DOI 10.4049/jimmunol.0900421; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Thomas AC, 2010, TRANSPL IMMUNOL, V23, P86, DOI 10.1016/j.trim.2010.03.005; Torti N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002313; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Tsuda Y, 2015, VACCINE, V33, P2261, DOI 10.1016/j.vaccine.2015.03.029; van Leeuwen EMM, 2005, BLOOD, V106, P2091, DOI 10.1182/blood-2005-02-0449; Vescovini R, 2004, EXP GERONTOL, V39, P1233, DOI 10.1016/j.exger.2004.04.004; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Wallace DL, 2011, IMMUNOLOGY, V132, P27, DOI 10.1111/j.1365-2567.2010.03334.x; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Westall G, 2006, AM J TRANSPLANT, V6, P577, DOI 10.1111/j.1600-6143.2005.01212.x; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Zhang SC, 2015, VET RES, V46, DOI 10.1186/s13567-015-0228-6	81	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0167097	10.1371/journal.pone.0167097	http://dx.doi.org/10.1371/journal.pone.0167097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870919	Green Published, gold			2022-12-26	WOS:000388846400059
J	Hung, YP; Huang, IH; Lin, HJ; Tsai, BY; Liu, HC; Liu, HC; Lee, JC; Wu, YH; Tsai, PJ; Ko, WC				Hung, Yuan-Pin; Huang, I-Hsiu; Lin, Hsiao-Ju; Tsai, Bo-Yang; Liu, Hsiao-Chieh; Liu, Hsiu-Chuan; Lee, Jen-Chieh; Wu, Yi-Hui; Tsai, Pei-Jane; Ko, Wen-Chien			Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DIARRHEA; INFECTIONS; RESISTANCE; GENOTYPES; OUTBREAK	Ribotypes and toxin genotypes of clinical C. difficile isolates in Taiwan are rarely reported. A prospective surveillance study from January 2011 to January 2013 was conducted at the medical wards of a district hospital in southern Taiwan. Of the first toxigenic isolates from 120 patients, 68 (56.7%) of 120 isolates possessed both tcdA and tcdB. Of 52 (43.3%) with tcdB and truncated tcdA (tcdA-/tcdB+), all were ribotype 017 and none had binary toxin or tcdC deletion. Eighteen (15%) toxigenic isolates harbored binary toxins (cdtA and cdtB) and all had tcdC deletion, including Delta 39(C184T) deletion (14 isolates), Delta 18 in-frame deletion (3 isolates), and Delta 18 (Delta 117A) deletion (1 isolate). Eleven of 14 isolates with Delta 39 (C184T) deletion belonged to the ribotype 078 family, including ribotype 127 (6 isolates), ribotype 126 (4 isolates), and ribotype 078 (1 isolate). Among 8 patients with consecutive C. difficile isolates, these isolates from 6 (75%) patients were identical, irrespective of the presence or absence of diarrhea, suggestive of persistent fecal carriage or colonization. In conclusion in southern Taiwan, ribotype 017 isolates with a tcdA-/tcdB+ genotype were not uncommon and of C. difficile isolates with binary toxin, the ribotype 078 family was predominant.	[Hung, Yuan-Pin; Lin, Hsiao-Ju; Liu, Hsiao-Chieh] Tainan Hosp, Minist Hlth & Welf, Dept Internal Med, Tainan, Taiwan; [Liu, Hsiao-Chieh; Liu, Hsiu-Chuan] Tainan Hosp, Minist Hlth & Welf, Dept Expt & Diag, Tainan, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju; Lee, Jen-Chieh; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju] Natl Cheng Kung Univ Hosp, Grad Inst Clin Med, Tainan, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan, Taiwan; [Huang, I-Hsiu; Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan, Taiwan; [Tsai, Bo-Yang; Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Wu, Yi-Hui] Eda Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, I-Hsiu; Tsai, Pei-Jane] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; E-Da Hospital; National Cheng Kung University	Ko, WC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan.; Ko, WC (corresponding author), Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan, Taiwan.; Ko, WC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan, Taiwan.; Tsai, PJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan, Taiwan.; Tsai, PJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.; Tsai, PJ (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan.	peijtsai@mail.ncku.edu.com; winston3415@gmail.com	Huang, I-Hsiu/CAF-2125-2022; Ko, Wen-Chien/ABG-4316-2020; Huang, Ihsiu/AAD-8769-2019; hong, hesse/EUM-0179-2022	Huang, I-Hsiu/0000-0001-9667-0612; Ko, Wen-Chien/0000-0001-7497-149X; hong, hesse/0000-0003-1006-705X; Tsai, Bo-Yang/0000-0002-7122-4752	Ministry of Science and Technology (MOST) [102-2628-B-006-015-MY3, 105-2321-B-006-012, 105-2321-B-006-013]; Ministry of Health and Welfare, Taiwan (MOHW) [104-CDC-C-114-11, 105-TDU-B-211-133016]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Health and Welfare, Taiwan (MOHW)	This study was supported by the grants from the Ministry of Science and Technology (MOST 102-2628-B-006-015-MY3, 105-2321-B-006-012 and 105-2321-B-006-013) and Ministry of Health and Welfare, Taiwan (MOHW 104-CDC-C-114-11 and 105-TDU-B-211-133016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Prof. M. Wilcox at the Leeds Teaching Hospitals NHS Trust for typing our clinical strains. This study was supported by the grants from the Ministry of Science and Technology (MOST 102-2628-B-006-015-MY3, 105-2321-B-006-012 and 105-2321-B-006-013) and Ministry of Health and Welfare, Taiwan (MOHW 104-CDC-C-114-11 and 105-TDU-B-211-133016).	Ackermann G, 2001, DIAGN MICR INFEC DIS, V40, P103, DOI 10.1016/S0732-8893(01)00259-0; Barbut F, 2007, CLIN MICROBIOL INFEC, V13, P1048, DOI 10.1111/j.1469-0691.2007.01824.x; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; Barbut F, 2003, CLIN MICROBIOL INFEC, V9, P989, DOI 10.1046/j.1469-0691.2003.00683.x; Bliss DZ, 1998, ANN INTERN MED, V129, P1012, DOI 10.7326/0003-4819-129-12-199812150-00004; Chopra T, 2015, CLIN INFECT DIS, V60, pS72, DOI 10.1093/cid/civ053; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Dridi L, 2002, ANTIMICROB AGENTS CH, V46, P3418, DOI 10.1128/AAC.46.11.3418-3421.2002; Fang WJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-523; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Hawkey PM, 2013, J CLIN MICROBIOL, V51, P3308, DOI 10.1128/JCM.00587-13; Huang H, 2009, CLIN MICROBIOL INFEC, V15, P1170, DOI 10.1111/j.1469-0691.2009.02992.x; Hung YP, 2015, J INFECTION, V70, P98, DOI 10.1016/j.jinf.2014.08.003; Hung YP, 2014, ANAEROBE, V30, P188, DOI 10.1016/j.anaerobe.2014.06.005; Hung YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069577; Hung YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042415; Hunley TE, 2008, PEDIATR NEPHROL, V23, P1171, DOI 10.1007/s00467-008-0774-5; Jarvis WR, 2009, AM J INFECT CONTROL, V37, P263, DOI 10.1016/j.ajic.2009.01.001; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kim H, 2010, KOREAN J LAB MED, V30, P491, DOI 10.3343/kjlm.2010.30.5.491; Kim J, 2014, CLIN MICROBIOL INFEC, V20, P1198, DOI 10.1111/1469-0691.12704; Kim J, 2013, CLIN MICROBIOL INFEC, V19, P521, DOI 10.1111/j.1469-0691.2012.03910.x; Liao CH, 2012, ANTIMICROB AGENTS CH, V56, P3943, DOI 10.1128/AAC.00191-12; Lin HJ, 2015, J MICROBIOL IMMUNOL, V48, P183, DOI 10.1016/j.jmii.2013.08.003; Lin YC, 2011, ANTIMICROB AGENTS CH, V55, P1701, DOI 10.1128/AAC.01440-10; Longtin Y, 2016, JAMA INTERN MED, V176, P796, DOI [10.1001/jamainternmed.2016.0177, 10.1001/jama]; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; O'Keefe SJD, 2010, WORLD J GASTROENTERO, V16, P139, DOI 10.3748/wjg.v16.i2.139; Oka K, 2012, J CLIN MICROBIOL, V50, P915, DOI 10.1128/JCM.05588-11; Persson S, 2011, J CLIN MICROBIOL, V49, P4299, DOI 10.1128/JCM.05161-11; Satomura Hideyuki, 2009, Kansenshogaku Zasshi, V83, P549; Sawabe E, 2007, EUR J CLIN MICROBIOL, V26, P695, DOI 10.1007/s10096-007-0355-8; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wong-McClure RA, 2012, REV PANAM SALUD PUBL, V32, P413, DOI 10.1590/S1020-49892012001400004	36	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166159	10.1371/journal.pone.0166159	http://dx.doi.org/10.1371/journal.pone.0166159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861606	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300030
J	Van Echelpoel, W; Boets, P; Goethals, PLM				Van Echelpoel, Wout; Boets, Pieter; Goethals, Peter L. M.			Functional Response (FR) and Relative Growth Rate (RGR) Do Not Show the Known Invasiveness of Lemna minuta (Kunth)	PLOS ONE			English	Article							DIKEROGAMMARUS-VILLOSUS; PLANT INVASION; IMPACTS; AVAILABILITY; COMPETITION; NITROGEN; DUCKWEED; REMOVAL; TEMPERATURE; MACROPHYTES	Growing travel and trade threatens biodiversity as it increases the rate of biological invasions globally, either by accidental or intentional introduction. Therefore, avoiding these impacts by forecasting invasions and impeding further spread is of utmost importance. In this study, three forecasting approaches were tested and combined to predict the invasive behaviour of the alien macrophyte Lemna minuta in comparison with the native Lemna minor: the functional response (FR) and relative growth rate (RGR), supplemented with a combined biomass-based nutrient removal (BBNR). Based on the idea that widespread invasive species are more successful competitors than local, native species, a higher FR and RGR were expected for the invasive compared to the native species. Five different nutrient concentrations were tested, ranging from low (4 mgN. L-1 and 1 mgP. L-1) to high (70 mgN. L-1 and 21 mgP. L-1). After four days, a significant amount of nutrients was removed by both Lemna spp., though significant differences among L. minor and L. minuta were only observed at lower nutrient concentrations (lower than 17 mgN. L-1 and 6 mgP. L-1) with higher nutrient removal exerted by L. minor. The derived FR did not show a clear dominance of the invasive L. minuta, contradicting field observations. Similarly, the RGR ranged from 0.4 to 0.6 d(-1), but did not show a biomass-based dominance of L. minuta (0.5 +/- 0.1 d(-1) versus 0.63 +/- 0.09 d(-1) for L. minor). BBNR showed similar results as the FR. Contrary to our expectations, all three approaches resulted in higher values for L. minor. Consequently, based on our results FR is sensitive to differences, though contradicted the expectations, while RGR and BBNR do not provide sufficient power to differentiate between a native and an invasive alien macrophyte and should be supplemented with additional ecosystem-based experiments to determine the invasion impact.	[Van Echelpoel, Wout; Boets, Pieter; Goethals, Peter L. M.] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium; [Boets, Pieter] Prov Ctr Environm Res, B-9000 Ghent, Belgium	Ghent University	Van Echelpoel, W (corresponding author), Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium.	wout.vanechelpoel@ugent.be	Van Echelpoel, Wout/AAH-3755-2019; Goethals, Peter LM/A-1116-2008	Van Echelpoel, Wout/0000-0001-9636-5861; 	research foundation Flanders (FWO-Vlaanderen)	research foundation Flanders (FWO-Vlaanderen)(FWO)	PB was supported by a postdoctoral grant from the research foundation Flanders (FWO-Vlaanderen). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Pieter Boets was supported by a postdoctoral grant from the research foundation Flanders (FWO-Vlaanderen). The authors like to thank two reviewers for helpful suggestions to improve the manuscript.	Alexander ME, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0946; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Baldy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118844; Barrat-Segretain MH, 2005, PLANT ECOL, V180, P153, DOI 10.1007/s11258-004-7374-7; Born W, 2005, ECOL ECON, V55, P321, DOI 10.1016/j.ecolecon.2005.08.014; Brain RA, 2009, REV ENVIRON CONTAM T, V198, P49, DOI 10.1007/978-0-387-09647-6_2; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; Cedergreen N, 2002, NEW PHYTOL, V155, P285, DOI 10.1046/j.1469-8137.2002.00463.x; Colin N, 2016, SCI TOTAL ENVIRON, V540, P307, DOI 10.1016/j.scitotenv.2015.06.099; CULLEY DD, 1973, J WATER POLLUT CON F, V45, P337; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dick JTA, 2014, BIOL INVASIONS, V16, P735, DOI 10.1007/s10530-013-0550-8; Dodd JA, 2014, FRESHWATER BIOL, V59, P337, DOI 10.1111/fwb.12268; Driever SM, 2005, AQUAT BOT, V81, P245, DOI 10.1016/j.aquabot.2004.12.002; Eller F, 2015, FRESHWATER BIOL, V60, P929, DOI 10.1111/fwb.12547; Friberg N, 2011, ADV ECOL RES, V44, P1, DOI 10.1016/B978-0-12-374794-5.00001-8; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gerard J., 2014, ISRN BOT, V2014, DOI [10.1155/2014/514294, DOI 10.1155/2014/514294]; Gioria M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00501; Gooden B, 2015, OIKOS, V124, P298, DOI 10.1111/oik.01724; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Haddaway NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032229; HAMMOUDA O, 1995, ENZYME MICROB TECH, V17, P317, DOI 10.1016/0141-0229(94)00013-1; Henry-Silva GG, 2008, HYDROBIOLOGIA, V610, P153, DOI 10.1007/s10750-008-9430-0; Hussner A, 2009, WEED RES, V49, P506, DOI 10.1111/j.1365-3180.2009.00721.x; Janes RA, 1996, HYDROBIOLOGIA, V340, P23, DOI 10.1007/BF00012729; Janse JH, 1998, ENVIRON POLLUT, V102, P547, DOI 10.1016/S0269-7491(98)80082-1; Korner S, 1998, WATER RES, V32, P3651, DOI 10.1016/S0043-1354(98)00166-3; Kovalenko KE, 2010, J APPL ECOL, V47, P318, DOI 10.1111/j.1365-2664.2009.01768.x; Lambinon J, 1998, GROOTHERTOGDOM LUXEM; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Medoc V, 2015, BIOL INVASIONS, V17, P3625, DOI 10.1007/s10530-015-0984-2; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Netten JJC, 2010, FUND APPL LIMNOL, V177, P125, DOI 10.1127/1863-9135/2010/0177-0125; Njambuya J, 2011, AQUAT BOT, V94, P158, DOI 10.1016/j.aquabot.2011.02.001; OECD, 2006, OECD GUID TEST CHEM, P22; ORON G, 1988, WATER RES, V22, P179, DOI 10.1016/0043-1354(88)90076-0; Perrings C., 2002, ECOL SOC, V6; Pysek Petr, 2007, V193, P97; R Development Core Team, 2008, COMPUTING RFFS; Riis T, 2012, AQUAT BOT, V102, P56, DOI 10.1016/j.aquabot.2012.05.002; Riley LA, 2015, FRESHWATER BIOL, V60, P1308, DOI 10.1111/fwb.12566; Rodriguez M, 2015, ECOL ENG, V74, P364, DOI 10.1016/j.ecoleng.2014.11.005; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Thiebaut G, 2007, BIOL INVASIONS, V9, P1, DOI 10.1007/s10530-006-9000-1; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; Trinder CJ, 2013, FUNCT ECOL, V27, P918, DOI 10.1111/1365-2435.12078; Van Landuyt W., 2007, DUMORTIERA, V91, P16; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wundrow EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048444; Yu CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115023; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	58	8	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166132	10.1371/journal.pone.0166132	http://dx.doi.org/10.1371/journal.pone.0166132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861603	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300028
J	Vranic, S; Ghosh, N; Kimbrough, J; Bilalovic, N; Bender, R; Arguello, D; Veloso, Y; Dizdarevic, A; Gatalica, Z				Vranic, Semir; Ghosh, Nilanjan; Kimbrough, Jeffery; Bilalovic, Nurija; Bender, Ryan; Arguello, David; Veloso, Yvonne; Dizdarevic, Aida; Gatalica, Zoran			PD-L1 Status in Refractory Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMAS; HODGKIN LYMPHOMA; PDL1 EXPRESSION; AMPLIFICATION; JAK2; ANTIBODIES	Targeted immunotherapy based on PD-1/PD-L1 suppression has revolutionized the treatment of various solid tumors. A remarkable improvement has also been observed in the treatment of patients with refractory/relapsing classical Hodgkin lymphoma (cHL). We investigated PD-L1 status in a variety of treatment resistant lymphomas. Tumor samples from 78 patients with therapy resistant lymphomas were immunohistochemically (IHC) investigated for the expression of PD-L1 using two antibody clones (SP142 and SP263, Ventana). Thirteen PD-L1 + cases were further analyzed for gene copy number variations (CNV) by NGS and for PD-L1/JAK2/PD-L2co-amplification using fluorescent in-situ hybridization assay (FISH). PD-L1 positivity (>= 5% positive cancer cells, IHC) was present in 32/77 (42%) and 33/71 cases (46%) using SP142 and SP263 antibodies, respectively. Concordance between the two anti-PD-L1 clones was high with only three (4%) discrepant cases. The strongest and consistent (10/11 cases) expression was observed in cHL and primary mediastinal B-cell lymphomas (3/3). Diffuse large B-cell lymphomas (DLBCL) were frequently positive (13/26) irrespective of subtype. Follicular (1/8), peripheral T-cell (3/11) and mantle cell (1/8) lymphomas were rarely positive, while small lymphocytic lymphoma/CLL and marginal zone lymphomas were consistently negative (3/3). Co-amplification/CNVs of PD-L1/JAK2/PD-L2 were observed in 3 cases of DLBCL and cHL, respectively. Of note, all three cHL-amplified cases were positive by FISH, but not by NGS. Since only a fraction of the IHC positive lymphoma cases were positive by FISH and NGS assays, other mechanisms are involved in PD-L1 upregulation, especially in DLBCL. FISH assay may be more suitable than NGS assay for determination of PD-L1 alterations in cHL.	[Vranic, Semir; Bilalovic, Nurija] Univ Sarajevo, Ctr Clin, Dept Pathol, Sarajevo, Bosnia & Herceg; [Vranic, Semir] Univ Sarajevo, Sch Med, Sarajevo, Bosnia & Herceg; [Ghosh, Nilanjan] Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA; [Kimbrough, Jeffery; Bender, Ryan; Arguello, David; Veloso, Yvonne; Gatalica, Zoran] Cans Life Sci, Phoenix, AZ 85013 USA; [Dizdarevic, Aida] Univ Sarajevo, Dept Hematol, Ctr Clin, Sarajevo, Bosnia & Herceg	University of Sarajevo; University of Sarajevo; University of Sarajevo	Gatalica, Z (corresponding author), Cans Life Sci, Phoenix, AZ 85013 USA.	semir.vranic@gmail.com	Vranic, Semir/I-6823-2019	Vranic, Semir/0000-0001-9743-7265; Bender, Ralf/0000-0001-7179-0626	Canis Life Sciences and Agilent Technologies Inc.	Canis Life Sciences and Agilent Technologies Inc.	The funding companies Canis Life Sciences and Agilent Technologies Inc. only provided financial support in the form of authors' salaries and/or research materials.	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Azzaoui I, 2016, BLOOD, V128, P1081, DOI 10.1182/blood-2015-08-662783; Barrett MT, 2015, ONCOTARGET, V6, P26483, DOI 10.18632/oncotarget.4494; Budczies J, 2016, GENE CHROMOSOME CANC, V55, P626, DOI 10.1002/gcc.22365; Carbognin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130142; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Gandini S, 2016, CRIT REV ONCOL HEMAT, V100, P88, DOI 10.1016/j.critrevonc.2016.02.001; Gatalica Z, 2015, ONCOTARGET, V6, P19819, DOI 10.18632/oncotarget.4378; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Georgiou K, 2016, BLOOD, V127, P3026, DOI 10.1182/blood-2015-12-686550; Goldmann T, 2016, ANN ONCOL, V27, P206, DOI 10.1093/annonc/mdv510; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hubbard-Lucey VM, 2016, CANCER IMMUNOL RES, V4, P3, DOI 10.1158/2326-6066.CIR-15-0279; Ikeda S, 2016, J THORAC ONCOL, V11, P62, DOI 10.1016/j.jtho.2015.09.010; Joseph RW, 2015, CANCER IMMUNOL RES, V3, P1303, DOI 10.1158/2326-6066.CIR-15-0150; Keane C, 2015, LANCET HAEMATOL, V2, pE445, DOI 10.1016/S2352-3026(15)00150-7; Kerr KM, 2016, ARCH PATHOL LAB MED, V140, P326, DOI 10.5858/arpa.2015-0522-SA; Mahoney KM, 2015, CANCER IMMUNOL RES, V3, P1308, DOI 10.1158/2326-6066.CIR-15-0116; Menter T, 2016, HUM PATHOL, V54, P17, DOI 10.1016/j.humpath.2016.03.005; Moskowitz CH, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.290.290; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Roemer MGM, 2016, J CLIN ONCOL, V34, P2690, DOI 10.1200/JCO.2016.66.4482; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Steven H, 2008, WHO CLASSIFICATION T; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Twa DDW, 2014, BLOOD, V123, P2062, DOI 10.1182/blood-2013-10-535443; Voena C, 2016, DISCOV MED, V21, P125	29	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166266	10.1371/journal.pone.0166266	http://dx.doi.org/10.1371/journal.pone.0166266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861596	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300040
J	Xu, YL; Zhu, J; Hu, X; Wang, C; Lu, DZ; Gong, CX; Yang, JH; Zong, L				Xu, Yingling; Zhu, Ji; Hu, Xiao; Wang, Cui; Lu, Dezhao; Gong, Chenxue; Yang, Jinhuan; Zong, Lei			CLIC1 Inhibition Attenuates Vascular Inflammation, Oxidative Stress, and Endothelial Injury	PLOS ONE			English	Article							ADHESION MOLECULE-1 EXPRESSION; INTRACELLULAR CHANNEL 1; CHLORIDE-ION CHANNEL; LIPID-PEROXIDATION; REDOX REGULATION; PROTEIN; ATHEROSCLEROSIS; VCAM-1; HOMOCYSTEINE; DYSFUNCTION	Endothelial dysfunction, which includes endothelial oxidative damage and vascular inflammation, is a key initiating step in the pathogenesis of atherosclerosis (AS) and an independent risk factor for this disorder. Intracellular chloride channel 1 (CLIC1), a novel metamorphic protein, acts as a sensor of cell oxidation and is involved in inflammation. In this study, we hypothesize that CLIC1 plays an important role in AS. Apolipoprotein E-deficient mice were supplied with a normal diet or a high-fat and high-cholesterol diet for 8 weeks. Overexpressed CLIC1 was associated with the accelerated atherosclerotic plaque development, amplified oxidative stress, and in vivo release of inflammatory cytokines. We subsequently examined the underlying molecular mechanisms through in vitro experiments. Treatment of cultured human umbilical vein endothelial cells (HUVECs) with H2O2 induced endothelial oxidative damage and enhanced CLIC1 expression. Suppressing CLIC1 expression through gene knocked-out (CLIC1(-/-)) or using the specific inhibitor indanyloxyacetic acid-94 (IAA94) reduced ROS production, increased SOD enzyme activity, and significantly decreased MDA level. CLIC1(-/-) HUVECs exhibited significantly reduced expression of TNF-alpha and IL-1 beta as well as ICAM-1 and VCAM-1 at the protein levels. In addition, H2O2 promoted CLIC1 translocation to the cell membrane and insertion into lipid membranes, whereas IAA94 inhibited CLIC1 membrane translocation induced by H2O2. By contrast, the majority of CLIC1 did not aggregate on the cell membrane in normal HUVECs, and this finding is consistent with the changes in cytoplasmic chloride ion concentration. This study demonstrates for the first time that CLIC1 is overexpressed during AS development both in vitro and in vivo and can regulate the accumulation of inflammatory cytokines and production of oxidative stress. Our results also highlight that deregulation of endothelial functions may be associated with the membrane translocation of CLIC1 and active chloride-selective ion channels in endothelial cells.	[Xu, Yingling; Hu, Xiao; Wang, Cui; Lu, Dezhao; Gong, Chenxue; Yang, Jinhuan; Zong, Lei] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhu, Ji] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Clin Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Lu, DZ (corresponding author), Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	ludezhao@126.com			National Natural Science Foundation of China [81102841, 81403133]; Zhejiang Provincial Natural Science Foundation of China [LQ14H280004, LY15H280005]; China Postdoctoral Science Foundation [2013M541800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China (No. 81102841, No.81403133); Zhejiang Provincial Natural Science Foundation of China (No. LQ14H280004, No.LY15H280005); China Postdoctoral Science Foundation (No.2013M541800).	Averaimo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074523; Averaimo S, 2010, FEBS LETT, V584, P2076, DOI 10.1016/j.febslet.2010.02.073; Bellezza Ilaria, 2010, Cancers (Basel), V2, P483, DOI 10.3390/cancers2020483; Bhandari P, 2012, GENES BRAIN BEHAV, V11, P387, DOI 10.1111/j.1601-183X.2012.00765.x; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Chen CD, 2007, PROTEOMICS, V7, P155, DOI 10.1002/pmic.200600663; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimitrova KR, 2002, CARDIOVASC RES, V53, P589, DOI 10.1016/S0008-6363(01)00403-5; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Ferre N, 2001, MOL CELL BIOCHEM, V218, P165, DOI 10.1023/A:1007296919243; Goodchild Sophia C, 2011, Biophys Rev, V3, P143, DOI 10.1007/s12551-011-0053-8; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; Gritti M, 2014, ONCOTARGET, V5, P11252, DOI 10.18632/oncotarget.2617; Harrison D, 2003, AM J CARDIOL, V91, p7A; Haubner F, 2007, BIOCHEM BIOPH RES CO, V360, P560, DOI 10.1016/j.bbrc.2007.06.044; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Hou XH, 2015, CELL BIOCHEM BIOPHYS, V72, P709, DOI 10.1007/s12013-015-0522-y; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Kader T, 2014, ATHEROSCLEROSIS, V237, P725, DOI 10.1016/j.atherosclerosis.2014.10.101; Kalsch T, 2007, BASIC RES CARDIOL, V102, P460, DOI 10.1007/s00395-007-0667-y; Kang MW, 2015, KOREAN J PHYSIOL PHA, V19, P229, DOI 10.4196/kjpp.2015.19.3.229; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Kim S, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0230-y; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Kinlay S, 1997, AM J CARDIOL, V80, pI11, DOI 10.1016/S0002-9149(97)00793-5; Kronbak J., 2012, CLEAN SHIPPING CURR, V1, P1, DOI DOI 10.1242/JCS.110072; Leopold Jane A, 2008, Drug Discov Today Ther Strateg, V5, P5, DOI 10.1016/j.ddstr.2008.02.001; Li GH, 2015, ATHEROSCLEROSIS, V243, P223, DOI 10.1016/j.atherosclerosis.2015.09.020; LI H, 1993, ARTERIOSCLER THROMB, V13, P197, DOI 10.1161/01.ATV.13.2.197; Li RK, 2012, BIOMED PHARMACOTHER, V66, P167, DOI 10.1016/j.biopha.2011.10.002; Liang B, 2015, CELL PHYSIOL BIOCHEM, V35, P2472, DOI 10.1159/000374047; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Ma PF, 2012, WORLD J GASTROENTERO, V18, P3070, DOI 10.3748/wjg.v18.i24.3070; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Martinez-Solano L, 2009, PROTEOMICS, V9, P2995, DOI 10.1002/pmic.200800016; Menon SG, 2003, CANCER RES, V63, P2109; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nizamutdinova IT, 2007, INT IMMUNOPHARMACOL, V7, P343, DOI 10.1016/j.intimp.2006.11.004; Novarino G, 2004, J NEUROSCI, V24, P5322, DOI 10.1523/JNEUROSCI.1170-04.2004; Onat D, 2011, CURR DIABETES REP, V11, P193, DOI 10.1007/s11892-011-0182-2; Petrova DT, 2008, CLIN BIOCHEM, V41, P1224, DOI 10.1016/j.clinbiochem.2008.07.012; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmidt A, 2006, BASIC RES CARDIOL, V101, P109, DOI 10.1007/s00395-005-0582-z; SCHWARTZ CJ, 1992, CIRCULATION, V86, P117; Seguin C, 2008, BIOMED PHARMACOTHER, V62, P395, DOI 10.1016/j.biopha.2008.02.008; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Ulmasov B, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-8; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; VIETOR I, 1993, J BIOL CHEM, V268, P18994; Wang JW, 2009, CANCER LETT, V281, P71, DOI 10.1016/j.canlet.2009.02.020; Wang L, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-44; Wang P, 2012, MOL CELL BIOCHEM, V365, P313, DOI 10.1007/s11010-012-1271-5; YOUNES M, 1981, CHEM-BIOL INTERACT, V34, P257, DOI 10.1016/0009-2797(81)90098-3; Zernecke A, 2005, BASIC RES CARDIOL, V100, P93, DOI 10.1007/s00395-005-0511-6; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	63	11	12	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166790	10.1371/journal.pone.0166790	http://dx.doi.org/10.1371/journal.pone.0166790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861612	Green Submitted, gold, Green Published			2022-12-26	WOS:000388350300107
J	Agamasu, C; Ghanam, RH; Xu, F; Sun, Y; Chen, YB; Saad, JS				Agamasu, Constance; Ghanam, Ruba H.; Xu, Fei; Sun, Yong; Chen, Yabing; Saad, Jamil S.			The Interplay between Calmodulin and Membrane Interactions with the Pleckstrin Homology Domain of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; PROTEIN-KINASE-B; PHOSPHOLIPID-BILAYER NANODISCS; HIGH-RESOLUTION STRUCTURE; HIV-1 MATRIX PROTEIN; TARGET RECOGNITION; PHOSPHATIDYLINOSITOL 3-KINASE; BIOPHYSICAL CHARACTERIZATION; INOSITOL PHOSPHATES; NMR-SPECTROSCOPY	The Akt protein, a serine/threonine kinase, plays important roles in cell survival, apoptosis, and oncogenes. Akt is translocated to the plasma membrane for activation. Akt-membrane binding is mediated by direct interactions between its pleckstrin homology domain (PHD) and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3). It has been shown that Akt activation in breast cancer cells is modulated by calmodulin (CaM). However, the molecular mechanism of the interplay between CaM and membrane binding is not established. Here, we employed nuclear magnetic resonance (NMR) and biochemical and biophysical techniques to characterize how PI(3,4,5)P-3, CaM, and membrane mimetics (nanodisc) bind to Akt(PHD). We show that PI(3,4,5)P-3 binding to Akt(PHD) displaces the C-terminal lobe of CaM but not the weakly binding N-terminal lobe. However, binding of a PI(3,4,5)P-3-embedded membrane nanodisc to Akt(PHD) with a 10(3)-fold tighter affinity than PI(3,4,5)P-3 is able to completely displace CaM. We also show that Akt(PHD) binds to both layers of the nanodisc, indicating proper incorporation of PI(3,4,5)P-3 on the nanodisc surface. No detectable binding has been observed between Akt(PHD) and PI(3,4,5)P-3-free nanodiscs, demonstrating that PI(3,4,5)P-3 is required for membrane binding, CaM displacement, and Akt activation. Using pancreatic cancer cells, we demonstrate that inhibition of Akt-CaM binding attenuated Akt activation. Our findings support a model by which CaM binds to Akt to facilitate its translocation to the membrane. Elucidation of the molecular details of the interplay between membrane and CaM binding to Akt may help in the development of potential targets to control the pathophysiological processes of cell survival.	[Agamasu, Constance; Ghanam, Ruba H.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Xu, Fei; Sun, Yong; Chen, Yabing] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sun, Yong; Chen, Yabing] Birmingham Vet Affairs Med Ctr, Res Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Saad, JS (corresponding author), 845 19th St South, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1S10RR026478]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002296, IK6BX003617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	We thank the Comprehensive Cancer Center, University of Alabama at Birmingham, for supporting the High-Field NMR facility and the X-ray core facility that houses the Auto-ITC200 (acquired through National Institutes of Health Grant 1S10RR026478).	Agamasu C, 2015, J BIOL CHEM, V290, P27403, DOI 10.1074/jbc.M115.673939; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kobashigawa Y, 2011, ANAL BIOCHEM, V410, P77, DOI 10.1016/j.ab.2010.11.021; KRISHNARAJU K, 1991, BRIT J CANCER, V63, P346, DOI 10.1038/bjc.1991.82; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Liao Y, 2010, AM J TRANSL RES, V2, P19; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Miao BC, 2011, AUTOPHAGY, V7, P650, DOI 10.4161/auto.7.6.15248; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Parikh C, 2012, P NATL ACAD SCI USA, V109, P19368, DOI 10.1073/pnas.1204384109; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Sauer K, 2013, BLOOD, V121, P286, DOI 10.1182/blood-2012-05-429241; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Wu WT, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5730; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yokogawa M, 2012, J BIOL CHEM, V287, P34936, DOI 10.1074/jbc.M112.398255; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516; Yun SJ, 2009, FEBS LETT, V583, P685, DOI 10.1016/j.febslet.2009.01.005	67	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					251	263		10.1074/jbc.M116.752816	http://dx.doi.org/10.1074/jbc.M116.752816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872186	hybrid, Green Published			2022-12-26	WOS:000391578000022
J	Dai, QG; Xie, FR; Han, YJ; Ma, XH; Zhou, SR; Jiang, LY; Zou, WG; Wang, J				Dai, Qinggang; Xie, Furong; Han, Yujiao; Ma, Xuhui; Zhou, Siru; Jiang, Lingyong; Zou, Weiguo; Wang, Jun			Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; EVEROLIMUS; MARKER; GROWTH; ROLES; PROLIFERATION; ACTIVATION; PROMOTES; SURVIVAL; CANCER	Mammalian target of rapamycin complex 1 (mTORC1) is involved in anabolic metabolism in both osteoblasts and chondrocytes, but the role of mTORC1 in osteoclast biology in vivo remains to be elucidated. In this study, we showed that deletion of regulatory-associated protein of mTOR (Raptor) in osteoclasts led to an increase in bone mass with decreased bone resorption. Raptor-deficient bone marrow-derived macrophages exhibited lower mTORC1-S6K1 signaling and retarded osteoclast differentiation, as determined by the number of osteoclasts, tartrate-resistant acid phosphatase activity, and expression of osteoclast-specific genes. Enforced expression of constitutively active S6K1 rescued the impaired osteoclast differentiation in Raptor-deficient bone marrow-derived macrophages. Furthermore, pharmacological inhibition of mTORC1 signaling by rapamycin could also inhibit osteoclast differentiation and osteoclast-specific gene expression. Taken together, our findings demonstrate that mTORC1 plays a key role in the network of catabolic bone resorption in osteoclasts and may serve as a potential pharmacological target for the regulation of osteoclast activity in bone metabolic disorders.	[Dai, Qinggang; Xie, Furong; Wang, Jun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Pediat Dent,Shanghai Key Lab Stomatol, Shanghai 200011, Peoples R China; [Ma, Xuhui] Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200011, Peoples R China; [Zhou, Siru; Jiang, Lingyong] Shanghai Jiao Tong Univ, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont, Shanghai Key Lab Stomatol,Sch Med,Peoples Hosp 9, Shanghai 200011, Peoples R China; [Dai, Qinggang; Han, Yujiao; Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, LY (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Wang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Pediat Dent, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	jly117@sina.com; zouwg94@sibcb.ac.cn; wangjun202@126.com		Dai, Qinggang/0000-0002-8177-2496	973 Program from the Chinese Ministry of Science and Technology [2014CB964704, 2015CB964503]; Science and Technology Commission of Shanghai [124119b0101]; National Natural Science Foundation of China [31371463, 81371121, 81570950]; Shanghai Summit and Plateau Disciplines; "Chen Xing" project from Shanghai Jiaotong University; National Science Fund for Excellent Young Scholars [81322027]	973 Program from the Chinese Ministry of Science and Technology; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Summit and Plateau Disciplines; "Chen Xing" project from Shanghai Jiaotong University; National Science Fund for Excellent Young Scholars	This work was supported in part by grants from the 973 Program from the Chinese Ministry of Science and Technology (2014CB964704 and 2015CB964503), the Science and Technology Commission of Shanghai (124119b0101), the National Natural Science Foundation of China (31371463, 81371121, and 81570950), Shanghai Summit and Plateau Disciplines, and the "Chen Xing" project from Shanghai Jiaotong University. The authors declare that they have no conflicts of interest with the contents of this article.r A scholar of the National 1000 Young Talents Program of China. Supported by the National Science Fund for Excellent Young Scholars (81322027). To whom correspondence may be addressed: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Rd., SIBCB Bldg., Rm. 1401, Shanghai 200031, China. Tel.: 86-21-54921320; Fax: 86-21-54921320; E-mail: zouwg94@sibcb.ac.cn.	ANDERSSON GN, 1989, J HISTOCHEM CYTOCHEM, V37, P115, DOI 10.1177/37.1.2461980; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen C, 2015, J EXP MED, V212, P73, DOI 10.1084/jem.20140643; Chen J.-H., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1037/COU0000095; Chen JQ, 2014, DEVELOPMENT, V141, P2848, DOI 10.1242/dev.108811; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Gnant M, 2013, JNCI-J NATL CANCER I, V105, P654, DOI 10.1093/jnci/djt026; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Hadji P, 2013, CRIT REV ONCOL HEMAT, V87, P101, DOI 10.1016/j.critrevonc.2013.05.015; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hu YW, 2016, J CELL BIOCHEM, V117, P413, DOI 10.1002/jcb.25287; Huang B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005426; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Kneissel M, 2004, BONE, V35, P1144, DOI 10.1016/j.bone.2004.07.013; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu XQ, 2014, BIOMATERIALS, V35, P5721, DOI 10.1016/j.biomaterials.2014.04.006; Martin SK, 2015, STEM CELLS, V33, P1359, DOI 10.1002/stem.1931; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Simone V, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1717-8; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Wang SY, 2011, BIOMATERIALS, V32, P4546, DOI 10.1016/j.biomaterials.2011.03.014; Xia TT, 2012, DIABETES, V61, P2461, DOI 10.2337/db11-1278; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xu S, 2016, J BONE MINER RES, V31, P1320, DOI 10.1002/jbmr.2800; Yan B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11151; Yeh LCC, 2013, J CELL BIOCHEM, V114, P1760, DOI 10.1002/jcb.24519; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005; Zou WG, 2013, J EXP MED, V210, P1793, DOI 10.1084/jem.20111790	36	55	63	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					196	204		10.1074/jbc.M116.764761	http://dx.doi.org/10.1074/jbc.M116.764761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879318	Green Published, hybrid			2022-12-26	WOS:000391578000017
J	Poms, M; Ansorge, P; Martinez-Gil, L; Jurt, S; Gottstein, D; Fracchiolla, KE; Cohen, LS; Guntert, P; Mingarro, I; Naider, F; Zerbe, O				Poms, Martin; Ansorge, Philipp; Martinez-Gil, Luis; Jurt, Simon; Gottstein, Daniel; Fracchiolla, Katrina E.; Cohen, Leah S.; Guentert, Peter; Mingarro, Ismael; Naider, Fred; Zerbe, Oliver			NMR Investigation of Structures of G-protein Coupled Receptor Folding Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE HELICES; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BIOPHYSICAL ANALYSIS; MOVEMENT PROTEIN; NASCENT CHAINS	Folding of G-protein coupled receptors (GPCRs) according to the two-stage model (Popot, J. L., and Engelman, D. M. (1990) Biochemistry 29, 4031-4037) is postulated to proceed in 2 steps: partitioning of the polypeptide into the membrane followed by diffusion until native contacts are formed. Herein we investigate conformational preferences of fragments of the yeast Ste2p receptor using NMR. Constructs comprising the first, the first two, and the first three transmembrane (TM) segments, as well as a construct comprising TM1-TM2 covalently linked to TM7 were examined. We observed that the isolated TM1 does not form a stable helix nor does it integrate well into the micelle. TM1 is significantly stabilized upon interaction with TM2, forming a helical hairpin reported previously (Neumoin, A., Cohen, L. S., Arshava, B., Tantry, S., Becker, J. M., Zerbe, O., and Naider, F. (2009) Biophys. J. 96, 3187-3196), and in this case the protein integrates into the hydrophobic interior of the micelle. TM123 displays a strong tendency to oligomerize, but hydrogen exchange data reveal that the center of TM3 is solvent exposed. In all GPCRs so-far structurally characterized TM7 forms many contacts with TM1 and TM2. In our study TM127 integrates well into the hydrophobic environment, but TM7 does not stably pack against the remaining helices. Topology mapping in microsomal membranes also indicates that TM1 does not integrate in a membrane-spanning fashion, but that TM12, TM123, and TM127 adopt predominantly native-like topologies. The data from our study would be consistent with the retention of individual helices of incompletely synthesized GPCRs in the vicinity of the translocon until the complete receptor is released into the membrane interior.	[Poms, Martin; Ansorge, Philipp; Jurt, Simon; Zerbe, Oliver] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Martinez-Gil, Luis; Mingarro, Ismael] Univ Valencia, Dept Biochem & Mol Biol, ERI BioTecMed, E-46100 Burjassot, Spain; [Gottstein, Daniel; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Gottstein, Daniel; Guentert, Peter] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Fracchiolla, Katrina E.; Cohen, Leah S.; Naider, Fred] CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10314 USA; [Fracchiolla, Katrina E.; Cohen, Leah S.; Naider, Fred] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA; [Fracchiolla, Katrina E.; Cohen, Leah S.; Naider, Fred] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA; [Guentert, Peter] ETH, Phys Chem Lab, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	University of Zurich; University of Valencia; Goethe University Frankfurt; Goethe University Frankfurt; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zerbe, O (corresponding author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	oliver.zerbe@chem.uzh.ch	Mingarro, Ismael/B-4745-2014	Mingarro, Ismael/0000-0002-1910-1229; Poms, Martin/0000-0002-4426-314X	Swiss National Science Foundation [31003A_124469]; Spanish Ministry of Economy and Competitiveness [BFU2016-79487]; Generalitat Valenciana [PROMETEOII/2014/061]; National Institutes of Health NIGMS [22087]; Leonard and Esther Kurtz Term Professorship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leonard and Esther Kurtz Term Professorship	This work was supported in part by Swiss National Science Foundation Grant 31003A_124469, Spanish Ministry of Economy and Competitiveness Grant BFU2016-79487, and Generalitat Valenciana Grant PROMETEOII/2014/061. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health NIGMS Grant 22087, the Leonard and Esther Kurtz Term Professorship, and during the writing of this paper was a Erna and Jakob Michael Visiting Professor at the Weizmann Institute of Science.	Albert AD, 2000, METHOD ENZYMOL, V315, P107; Baeza-Delgado C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23397; Bano-Polo M, 2013, J MOL BIOL, V425, P830, DOI 10.1016/j.jmb.2012.12.001; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bowie JU, 2013, SCIENCE, V339, P398, DOI 10.1126/science.1228655; Buchner L, 2015, J BIOMOL NMR, V62, P81, DOI 10.1007/s10858-015-9921-z; Caroccia KE, 2011, BIOPOLYMERS, V96, P757, DOI 10.1002/bip.21614; Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Cohen LS, 2008, BIOPOLYMERS, V90, P117, DOI 10.1002/bip.20950; Cohen LS, 2010, J PEPT SCI, V16, P213, DOI 10.1002/psc.1222; Donate-Macian P, 2015, BIOCHEM BIOPH RES CO, V462, P221, DOI 10.1016/j.bbrc.2015.04.120; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; FESIK SW, 1988, BIOCHEMISTRY-US, V27, P8297, DOI 10.1021/bi00422a001; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katragadda M, 2001, J PEPT RES, V58, P79, DOI 10.1034/j.1399-3011.2001.00904.x; KILLIAN JA, 1994, FEBS LETT, V348, P161, DOI 10.1016/0014-5793(94)00594-X; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Krishnamani V, 2012, BIOCHEMISTRY-US, V51, P1061, DOI 10.1021/bi201770y; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; LIAO MJ, 1983, J BIOL CHEM, V258, P9949; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; Marino J, 2012, BBA-BIOMEMBRANES, V1818, P3055, DOI 10.1016/j.bbamem.2012.07.023; Martin NP, 1999, BIOCHEMISTRY-US, V38, P682, DOI 10.1021/bi982062w; Martin NP, 2002, J MOL BIOL, V317, P765, DOI 10.1006/jmbi.2002.5444; Martinez-Gil L, 2008, BIOPHYS J, V95, pL36, DOI 10.1529/biophysj.108.138602; Martinez-Gil L, 2007, VIROLOGY, V367, P348, DOI 10.1016/j.virol.2007.06.006; Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; MIOZZARI GF, 1978, J BACTERIOL, V133, P1457, DOI 10.1128/JB.133.3.1457-1466.1978; MUTO Y, 1993, J BIOMOL NMR, V3, P165; Neumoin A, 2009, BIOPHYS J, V96, P3187, DOI 10.1016/j.bpj.2009.01.012; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PERVUSHIN K V, 1991, Journal of Biomolecular NMR, V1, P313, DOI 10.1007/BF02192857; PERVUSHIN KV, 1994, EUR J BIOCHEM, V219, P571, DOI 10.1111/j.1432-1033.1994.tb19973.x; PERVUSHIN KV, 1992, FEBS LETT, V308, P190, DOI 10.1016/0014-5793(92)81272-N; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Popot JL, 2016, BIOCHEMISTRY-US, V55, P5, DOI 10.1021/acs.biochem.5b01134; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rasmussen S. G., 2007, NATURE; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; ROSS A, 1993, J BIOMOL NMR, V3, P215; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Sauri A, 2005, J BIOL CHEM, V280, P25907, DOI 10.1074/jbc.M412476200; Sauri A, 2007, J MOL BIOL, V366, P366, DOI 10.1016/j.jmb.2006.11.052; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shao X, 2012, BIOPHYS J, V103, P817, DOI 10.1016/j.bpj.2012.07.012; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shenkarev ZO, 2013, BBA-BIOMEMBRANES, V1828, P776, DOI 10.1016/j.bbamem.2012.11.005; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; Tamborero S, 2011, J MOL BIOL, V406, P571, DOI 10.1016/j.jmb.2011.01.009; Tastan O, 2014, BBA-BIOENERGETICS, V1837, P656, DOI 10.1016/j.bbabio.2013.11.021; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Virkki MT, 2014, PROTEIN SCI, V23, P981, DOI 10.1002/pro.2483; White SH, 2003, FEBS LETT, V555, P116, DOI 10.1016/S0014-5793(03)01153-0; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Whitley P, 2014, BIOL CHEM, V395, P1417, DOI 10.1515/hsz-2014-0205; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xie HB, 2000, BIOCHEMISTRY-US, V39, P15462, DOI 10.1021/bi001432p; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zou C, 2008, CHEMBIOCHEM, V9, P2276, DOI 10.1002/cbic.200800221	91	6	6	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27170	27186		10.1074/jbc.M116.740985	http://dx.doi.org/10.1074/jbc.M116.740985			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864365	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000391576300017
J	Fatima, R; Qadeer, E; Yaqoob, A; Haq, MU; Majumdar, SS; Shewade, HD; Stevens, R; Creswell, J; Mahmood, N; Kumar, AMV				Fatima, Razia; Qadeer, Ejaz; Yaqoob, Aashifa; Haq, Mahboob Ul; Majumdar, Suman S.; Shewade, Hemant D.; Stevens, Robert; Creswell, Jacob; Mahmood, Nasir; Kumar, Ajay M. V.			Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; INFECTIOUS TUBERCULOSIS; PREVALENCE; BURDEN; IMPACT	Background Currently, only 62% of incident tuberculosis (TB) cases are reported to the national programme in Pakistan. Several innovative interventions are being recommended to detect the remaining 'missed' TB cases. One such intervention involved expanding contact investigation to the community using the Xpert MTB/RIF test. Methods This was a before and after intervention study involving retrospective record review. Passive case finding and household contact investigation was routinely done in the pre-intervention period July 2011-June 2013. Four districts with a high concentration of slums were selected as intervention areas; Lahore, Rawalpindi, Faisalabad and Islamabad. Here, in the intervention period, July 2013-June 2015, contact investigation beyond household was conducted: all people staying within a radius of 50 metres (using Geographical Information System) from the household of smear positive TB patients were screened for tuberculosis. Those with presumptive TB were investigated using smear microscopy and the Xpert MTB/RIF test was performed on smear negative patients. All the diagnosed TB patients were linked to TB treatment and care. Results A total of 783043 contacts were screened for tuberculosis: 23741(3.0%) presumptive TB patients were identified of whom, 4710 (19.8%) all forms and 4084(17.2%) bacteriologically confirmed TB patients were detected. The contribution of Xpert MTB/RIF to bacteriologically confirmed TB patients was 7.6%. The yield among investigated presumptive child TB patients was 5.1%. The overall yield of all forms TB patients among investigated was 22.3% among household and 19.1% in close community. The intervention contributed an increase of case detection of bacteriologically confirmed tuberculosis by 6.8% and all forms TB patients by 7.9%. Conclusion Community contact investigation beyond household not only detected additional TB patients but also increased TB case detection. However, further long term assessments and costeffectiveness studies are required before national scale-up.	[Fatima, Razia; Qadeer, Ejaz; Yaqoob, Aashifa; Haq, Mahboob Ul; Mahmood, Nasir] Natl TB Control Program, Islamabad, Pakistan; [Majumdar, Suman S.] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; [Shewade, Hemant D.] Mahatma Gandhi Inst Med Sci, Dept Community Med, Sevagram, Wardha, India; [Shewade, Hemant D.; Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Stevens, Robert] Mott MacDonald, London, England; [Creswell, Jacob] Stop TB Partnership, Geneva, Switzerland; [Kumar, Ajay M. V.] Int Union TB & Lung Dis, Paris, France	Burnet Institute; Mahatma Gandhi Institute of Medical Sciences, Sevagram; The Mott MacDonald Group	Yaqoob, A (corresponding author), Natl TB Control Program, Islamabad, Pakistan.	aashifa.yaqoob@gmail.com	Shewade MD PhD, Hemant Deepak/J-3907-2019; Majumdar, Suman/AAL-3070-2020	Shewade MD PhD, Hemant Deepak/0000-0002-8242-1911; Majumdar, Suman/0000-0002-9656-557X; Ul Haq, Mahboob/0000-0002-3709-3496; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Creswell, Jacob/0000-0002-4885-940X	TB REACH secretariat of Stop TB Partnership; Provincial TB Control Programme Pakistan	TB REACH secretariat of Stop TB Partnership; Provincial TB Control Programme Pakistan	Mott MacDonald was contracted by Stop TB to provide independent monitoring and evaluation of TB REACH projects. Robert Stevens receives a salary from Mott MacDonald. We gratefully acknowledge the support from the TB REACH secretariat of Stop TB Partnership for funding the study and the Provincial TB Control Programme Pakistan. The specific roles of these authors are articulated in the 'author contributions' section. Mott MacDonald contributed professional services and opinion independently of the funder, Stop TB and the grantee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT STRAT PLAN VIS 2; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Fatima R, 2014, INT J TUBERC LUNG D, V18, P1099, DOI 10.5588/ijtld.14.0001; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Kretzschmar M, 2004, EMERG INFECT DIS, V10, P832, DOI 10.3201/eid1005.030419; Lonnroth K, 2013, SYSTEMATIC REV NUMBE; Lorent N, 2014, PLOS ONE, P9; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P611; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; WHO, 2011, SCOP M DEV GUID SCRE; World Health Organization, 2013, WHO SYST SCREEN ACT; World Health Organization, 2015, GLOB TUB REP 2015	24	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0165813	10.1371/journal.pone.0165813	http://dx.doi.org/10.1371/journal.pone.0165813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898665	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000002
J	Wise, MJ				Wise, Michael J.			dCITE: Measuring Necessary Cladistic Information Can Help You Reduce Polytomy Artefacts in Trees	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PHYLOGENETIC INFERENCE; EXPERIMENTAL-DESIGN; POTENTIAL UTILITY; PROTEIN; INCONGRUENCE; SEARCH	Biologists regularly create phylogenetic trees to better understand the evolutionary origins of their species of interest, and often use genomes as their data source. However, as more and more incomplete genomes are published, in many cases it may not be possible to compute genome-based phylogenetic trees due to large gaps in the assembled sequences. In addition, comparison of complete genomes may not even be desirable due to the presence of horizontally acquired and homologous genes. A decision must therefore be made about which gene, or gene combinations, should be used to compute a tree. Deflated Cladistic Information based on Total Entropy (dCITE) is proposed as an easily computed metric for measuring the cladistic information in multiple sequence alignments representing a range of taxa, without the need to first compute the corresponding trees. dCITE scores can be used to rank candidate genes or decide whether input sequences provide insufficient cladistic information, making artefactual polytomies more likely. The dCITE method can be applied to protein, nucleotide or encoded phenotypic data, so can be used to select which data-type is most appropriate, given the choice. In a series of experiments the dCITE method was compared with related measures. Then, as a practical demonstration, the ideas developed in the paper were applied to a dataset representing species from the order Campylobacterales; trees based on sequence combinations, selected on the basis of their dCITE scores, were compared with a tree constructed to mimic Multi-Locus Sequence Typing (MLST) combinations of fragments. We see that the greater the dCITE score the more likely it is that the computed phylogenetic tree will be free of artefactual polytomies. Secondly, cladistic information saturates, beyond which little additional cladistic information can be obtained by adding additional sequences. Finally, sequences with high cladistic information produce more consistent trees for the same taxa.	[Wise, Michael J.] Univ Western Australia, Comp Sci & Software Engn, Perth, WA, Australia; [Wise, Michael J.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia	University of Western Australia; University of Western Australia	Wise, MJ (corresponding author), Univ Western Australia, Comp Sci & Software Engn, Perth, WA, Australia.; Wise, MJ (corresponding author), Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia.	Michael.Wise@uwa.edu.au	Wise, Michael J./B-5676-2012	Wise, Michael J./0000-0001-6559-4303				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bogdanowicz D, 2012, EVOL BIOINFORM, V8, P475, DOI 10.4137/EBO.S9657; COLLESS DH, 1980, SYST ZOOL, V29, P289; Cotton JA, 2008, TAXON, V57, P131, DOI 10.2307/25065954; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen JA, 1995, J MOL EVOL, V41, P1105; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glenner H, 2004, CURR BIOL, V14, P1644, DOI 10.1016/j.cub.2004.09.027; Gotelli Nicholas J., 2011, P39; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kallersjo M, 1999, CLADISTICS, V15, P91; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kroger A, 2005, BERGEYS MANUAL SYSTE, V2, P1191; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Massingham T, 2000, BIOINFORMATICS, V16, P294, DOI 10.1093/bioinformatics/16.3.294; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Nelson G, 1981, SYSTEMATICS BIOGEOGR, P169; On S. L. W., 2005, BERGEYS MANUAL SYS C, V2, P1169; Pal C, 2001, GENETICS, V158, P927; Park C, 2012, GENOME BIOL EVOL, V4, P523, DOI 10.1093/gbe/evs030; PENNY D, 1990, Australian Systematic Botany, V3, P21, DOI 10.1071/SB9900021; R Development Core Team, 2014, R LANG ENV STAT COMP; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Spielman SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139047; Steel Mike, 2005, P163; Strimmer K, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P111; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Thorley J. L, 2000, THESIS; Thorley JL, 1998, 6 C INT FED CLASS SO; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; Vandamme P., 2005, BERGEYS MANUAL SYSTE, P1161; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wise MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061276; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wortley AH, 2006, TAXON, V55, P431, DOI 10.2307/25065589; Zhang JZ, 2015, NAT REV GENET, V16, P409, DOI 10.1038/nrg3950	53	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166991	10.1371/journal.pone.0166991	http://dx.doi.org/10.1371/journal.pone.0166991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898695	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474000029
J	Avrahami, I; Kersh, D; Liberzon, A				Avrahami, Idit; Kersh, Dikla; Liberzon, Alexander			Pulsatility Index as a Diagnostic Parameter of Reciprocating Wall Shear Stress Parameters in Physiological Pulsating Waveforms	PLOS ONE			English	Article							CEREBRAL ANEURYSM; RISK-FACTOR; HEART-RATE; IN-VIVO; FLOW; ULTRASOUND; BLOOD; ATHEROSCLEROSIS; ARTERIES; DISEASE	Arterial wall shear stress (WSS) parameters are widely used for prediction of the initiation and development of atherosclerosis and arterial pathologies. Traditional clinical evaluation of arterial condition relies on correlations of WSS parameters with average flow rate (Q) and heart rate (HR) measurements. We show that for pulsating flow waveforms in a straight tube with flow reversals that lead to significant reciprocating WSS, the measurements of HR and Q are not sufficient for prediction of WSS parameters. Therefore, we suggest adding a third quantity-known as the pulsatility index (PI)-which is defined as the peak-to-peak flow rate amplitude normalized by Q. We examine several pulsating flow waveforms with and without flow reversals using a simulation of a Womersley model in a straight rigid tube and validate the simulations through experimental study using particle image velocimetry (PIV). The results indicate that clinically relevant WSS parameters such as the percentage of negative WSS (P[%]), oscillating shear index (OSI) and the ratio of minimum to maximum shear stress rates (min/max), are better predicted when the PI is used in conjunction with HR and Q. Therefore, we propose to use PI as an additional and essential diagnostic quantity for improved predictability of the reciprocating WSS.	[Avrahami, Idit] Ariel Univ, Dept Mech Engn & Mechatron, Ariel, Israel; [Kersh, Dikla; Liberzon, Alexander] Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel	Ariel University; Tel Aviv University	Liberzon, A (corresponding author), Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel.	alexlib@eng.tau.ac.il	Avrahami, Idit/AAF-8175-2019; Liberzon, Alex/A-8596-2008	Avrahami, Idit/0000-0003-4927-3491; Liberzon, Alex/0000-0002-6882-4191	Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University; Israel Science Foundation [782/08]	Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University; Israel Science Foundation(Israel Science Foundation)	This study was supported in part by a grant from the Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University and partially by the Israel Science Foundation, under Grant no. 782/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake JR, 2008, ULTRASOUND MED BIOL, V34, P760, DOI 10.1016/j.ultrasmedbio.2007.11.003; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Bouillot P, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1746-0; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019; Cezeaux JL, 1997, ANN BIOMED ENG, V25, P536, DOI 10.1007/BF02684193; Daidzic NE, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4026481; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; EVANS DH, 1980, CIRC RES, V46, P470, DOI 10.1161/01.RES.46.4.470; Finol Ender A, 2002, Comput Methods Biomech Biomed Engin, V5, P319, DOI 10.1080/1025584021000009751; Formaggia L., 2010, CARDIOVASCULAR MATH; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Gharib M, 2003, ANN BIOMED ENG, V31, P678, DOI 10.1114/1.1574025; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hashimoto J, 2010, HYPERTENSION, V56, P926, DOI 10.1161/HYPERTENSIONAHA.110.159368; Kaspera W, 2014, STROKE, V45, P2906, DOI 10.1161/STROKEAHA.114.006055; Kawaguchi T, 2012, J NEUROSURG, V117, P774, DOI 10.3171/2012.7.JNS111991; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Le TB, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002702; Leguy CAD, 2009, MED BIOL ENG COMPUT, V47, P641, DOI 10.1007/s11517-009-0473-9; Leow CH, 2015, ULTRASOUND MED BIOL, V41, P2913, DOI 10.1016/j.ultrasmedbio.2015.06.012; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Marto A, 2003, NEUROLOGY, V61, P1051; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; Nichols W, 1998, MCDONALDS BLOOD FLOW; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Patti J, 2014, J NEUROINTERV SURG, V6, P103, DOI 10.1136/neurintsurg-2013-010660; Peiffer V., 2013, CARDIOVASCULAR RES; Poelma C, 2012, EUR J MECH B-FLUID, V35, P70, DOI 10.1016/j.euromechflu.2012.03.003; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Resnick N, 2003, ENDOTHELIUM-J ENDOTH, V10, P197, DOI 10.1080/713715231; Sahtout Wassila, 2012, Nonlinear Biomed Phys, V6, P2, DOI 10.1186/1753-4631-6-2; Shimogonya Y, 2009, J BIOMECH, V42, P550, DOI 10.1016/j.jbiomech.2008.10.006; Tang DL, 2014, J BIOMECH, V47, P834, DOI 10.1016/j.jbiomech.2014.01.012; Tarbell JM, 2014, ANNU REV FLUID MECH, V46, P591, DOI 10.1146/annurev-fluid-010313-141309; Taylor ZJ, 2010, IEEE T INSTRUM MEAS, V59, P3262, DOI 10.1109/TIM.2010.2047149; THURSTON GB, 1996, ADV HEMODY HEMORH, V1, P1; TSANGARIS S, 1988, J BIOMECH, V21, P263, DOI 10.1016/0021-9290(88)90176-5; van Grondelle A, 1990, BIOFLUID MECH, P545; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; YOMOSA S, 1987, J PHYS SOC JPN, V56, P506, DOI 10.1143/JPSJ.56.506; Zamir M., 2000, PHYS PULSATILE FLOW	45	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166426	10.1371/journal.pone.0166426	http://dx.doi.org/10.1371/journal.pone.0166426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893801	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400026
J	Silva, JLGD; Guitarte, CB; Valladares, PM; Noboa, JCR; Kestler, K; Millan, RD				de Veas Silva, Jose Luis Garcia; Guitarte, Carmen Bermudo; Valladares, Paloma Menendez; Rojas Noboa, Johanna Carolina; Kestler, Krysta; Millan, Rafael Duro			Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients	PLOS ONE			English	Article							INTERNATIONAL STAGING SYSTEM; INDEPENDENT RISK-FACTOR; RATIO; AGENTS; STRATIFICATION; PROGRESSION; DIAGNOSIS; CRITERIA	Background The outcome for patients with Multiple Myeloma (MM) is highly variable, therefore, the existence of robust and easy to determine prognostic markers is extremely important for an efficient management of these patients. Presently, there is a debate about the role of the serum free light chains (sFLC) in the prognosis of MM patients both at diagnosis and after treatment. The aim of this study is to evaluate in a cohort of newly diagnosed MM patients from the Southern area of Spain, the prognostic value of sFLC both at baseline and after treatment. Materials and Methods 180 patients with a median age of 69 years were followed-up for a median time of 35 (18-61) months. The sFLC ratio (sFLCR) was calculated using the monoclonal sFLC as numerator. Patients were divided in two groups according to a sFLCR cut-off based on ROC analysis. The primary endpoints were the Overall Survival (OS) and the Progression-free Survival (PFS). Additionally, thirty-six MM patients treated with novel agents (Bortezomib/Dexamethasone) that achieved Complete Response (CR) or stringent CR (sCR) before autologous stem cell transplantation were studied to assess the impact of sCR in Disease Free Survival (DFS) and OS. Results During follow-up there were 72 disease-related deaths. The 5-years OS for the whole group was 51%. However, separate analysis of patients with sFLCR above (group "high") or below (groups "low") the cut-off value of 47 shows an OS of 23% and 73%, respectively (HR = 5.03, 95% CI 2.99-8.50, p<0.001). In addition, analysis by ISS stage, showed that the presence of high sFLCR was always significantly associated with a worse OS. Multivariate analysis identified sFLCR (HR = 4.42, 95% CI 2.57-7.60, p<0.001) and beta-2-microglobulin (B2M) (HR = 3.04, 95%IC 1.75-5.31, p<0.001) as independent risk factors for adverse outcome. A new risk stratification model based on sFLCR >= 47 and B2M>3.5 mg/L provided a statistically more significant result for this cohort when compared with the conventional ISS system. The HR for the new model were 2.84 (95% CI, 1.39-5.79, p = 0.004) for patients in stage 2 and 15.39 (95% CI, 6.35-37.33, p<0.001) for those in stage 3. Finally, in the group of patients reaching CR (19/36) or sCR (17/36) after induction, the median DFS for CR patients was 29 months, and NR for sCR patients (HR = 3.73; 95% CI 1.15-12.13, p = 0.03). Importantly, achieving sCR also translated into a significantly longer OS (5y-OS: sCR-89% versus CR-49%; p = 0.003; OS: sCR-NR versus CR-52 months). Conclusions Our findings confirm the observations that the sFLCR has a major role in the survival of MM patients. A cut-off of sFLCR >= 47 was shown to have an independent prognostic value at diagnosis, and a proposed "New Staging System" allows an accurate and simple method to risk stratify MM patients. Furthermore, because achievement of sCR was shown to represent a response state deeper than conventional CR resulting in greater OS and DFS, our study supports the continuity of sFLC ratio as part of the response criteria for MM patients.	[de Veas Silva, Jose Luis Garcia; Guitarte, Carmen Bermudo; Valladares, Paloma Menendez] Hosp Univ Virgen Macarena, Dept Clin Biochem, Seville, Spain; [de Veas Silva, Jose Luis Garcia] Complejo Hosp Univ Granada, Dept Immunol, Granada, Spain; [Rojas Noboa, Johanna Carolina; Kestler, Krysta; Millan, Rafael Duro] Hosp Univ Virgen Macarena, Dept Hematol, Seville, Spain	Hospital Universitario Virgen Macarena; University of Granada; Hospital Universitario Virgen Macarena	Silva, JLGD (corresponding author), Hosp Univ Virgen Macarena, Dept Clin Biochem, Seville, Spain.; Silva, JLGD (corresponding author), Complejo Hosp Univ Granada, Dept Immunol, Granada, Spain.	jose6@outlook.com	Garcia de Veas Silva, Jose Luis/O-7786-2015; Valladares, Paloma Menéndez/D-9207-2015; de Veas Silva, Jose Luis Garcia/N-5765-2019	Garcia de Veas Silva, Jose Luis/0000-0001-8119-7842; Valladares, Paloma Menéndez/0000-0002-8313-8720; de Veas Silva, Jose Luis Garcia/0000-0001-8119-7842				Dingli D, 2006, BLOOD, V108, P1979, DOI 10.1182/blood-2006-04-015784; Dispenzieri A, 2008, BLOOD, V111, P785, DOI 10.1182/blood-2007-08-108357; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Iriuchishima H, 2015, EUR J HAEMATOL, V94, P145, DOI 10.1111/ejh.12407; Iwama K, 2013, EUR J HAEMATOL, V90, P134, DOI 10.1111/ejh.12050; Jekarl DW, 2013, ANN LAB MED, V33, P248, DOI 10.3343/alm.2013.33.4.248; Kapoor P, 2013, J CLIN ONCOL, V31, P4529, DOI 10.1200/JCO.2013.49.0086; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Katzmann JA, 2009, CLIN CHEM, V55, P1517, DOI 10.1373/clinchem.2009.126664; Kumar S, 2010, LEUKEMIA, V24, P1498, DOI 10.1038/leu.2010.128; Kyle RA, 2014, LEUKEMIA, V28, P980, DOI 10.1038/leu.2014.11; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyrtsonis MC, 2007, BRIT J HAEMATOL, V137, P240, DOI 10.1111/j.1365-2141.2007.06561.x; Maltezas D, 2013, HEMATOL ONCOL, V31, P356, DOI 10.1002/hon.2026; Moustafa MA, 2015, LEUKEMIA, V29, P2033, DOI 10.1038/leu.2015.118; Paiva B, 2011, J CLIN ONCOL, V29, P1627, DOI 10.1200/JCO.2010.33.1967; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Radocha J, EUR J HAEMATOL; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Snozek CLH, 2008, LEUKEMIA, V22, P1933, DOI 10.1038/leu.2008.171; Sthaneshwar P, 2009, CLIN CHEM LAB MED, V47, P1101, DOI 10.1515/CCLM.2009.260; van Rhee F, 2007, BLOOD, V110, P827, DOI 10.1182/blood-2007-01-067728; Xu Y, 2013, LEUKEMIA LYMPHOMA, V54, P123, DOI 10.3109/10428194.2012.704033	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166841	10.1371/journal.pone.0166841	http://dx.doi.org/10.1371/journal.pone.0166841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893836	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400047
J	Fu, Y; Zheng, ZY; Shi, HB; Xiao, R				Fu, Yang; Zheng, Zeyu; Shi, Haibo; Xiao, Rui			A Novel Large-Scale Temperature Dominated Model for Predicting the End of the Growing Season	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; LAND-SURFACE PHENOLOGY; VEGETATION PHENOLOGY; CARBON BALANCE; CLIMATE-CHANGE; WATER-BALANCE; FOREST; COVER; RESPONSES; ADAPTABILITY	Vegetation phenology regulates many ecosystem processes and is an indicator of the biological responses to climate change. It is important to model the timing of leaf senescence accurately, since the canopy duration and carbon assimilation are strongly determined by the timings of leaf senescence. However, the existing phenology models are unlikely to accurately predict the end of the growing season (EGS) on large scales, resulting in the misrepresentation of the seasonality and interannual variability of biosphere-atmosphere feedbacks and interactions in coupled global climate models. In this paper, we presented a novel large-scale temperature dominated model integrated with the physiological adaptation of plants to the local temperature to assess the spatial pattern and interannual variability of the EGS. Our model was validated in all temperate vegetation types over the Northern Hemisphere. The results indicated that our model showed better performance in representing the spatial and interannual variability of leaf senescence, compared with the original phenology model in the Integrated Biosphere Simulator (IBIS). Our model explained approximately 63% of the EGS variations, whereas the original model explained much lower variations (coefficient of determination R-2 = 0.01-0.18). In addition, the differences between the EGS reproduced by our model and the MODIS EGS at 71.3% of the pixels were within 10 days. For the original model, it is only 26.1%. We also found that the temperature threshold (TcritTm) of grassland was lower than that of woody species in the same latitudinal zone.	[Fu, Yang; Zheng, Zeyu; Shi, Haibo] Chinese Acad Sci, Shenyang Inst Automat, Shenyang, Peoples R China; [Fu, Yang; Zheng, Zeyu; Shi, Haibo] Chinese Acad Sci, Key Lab Network Control Syst, Shenyang, Peoples R China; [Xiao, Rui] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Pennsylvania; Pennsylvania Medicine	Zheng, ZY (corresponding author), Chinese Acad Sci, Shenyang Inst Automat, Shenyang, Peoples R China.; Zheng, ZY (corresponding author), Chinese Acad Sci, Key Lab Network Control Syst, Shenyang, Peoples R China.	zhengzeyu@sia.cn			Program for One-hundred Talent Program of the Chinese Academy of Sciences [Y5AA100A01]	Program for One-hundred Talent Program of the Chinese Academy of Sciences	This study was supported by the Program for One-hundred Talent Program of the Chinese Academy of Sciences (Y5AA100A01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT FT, 1968, PLANT PHYSIOL, V43, P1471; Ahrends HE, 2009, CLIM RES, V39, P261, DOI 10.3354/cr00811; Atkinson PM, 2012, REMOTE SENS ENVIRON, V123, P400, DOI 10.1016/j.rse.2012.04.001; Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Barr AG, 2007, GLOBAL CHANGE BIOL, V13, P561, DOI 10.1111/j.1365-2486.2006.01220.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Chuine I, 1999, NEW PHYTOL, V143, P339, DOI 10.1046/j.1469-8137.1999.00445.x; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; Davi H, 2006, AGR FOREST METEOROL, V141, P35, DOI 10.1016/j.agrformet.2006.09.003; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Ganguly S, 2010, REMOTE SENS ENVIRON, V114, P1805, DOI 10.1016/j.rse.2010.04.005; Hmimina G, 2013, REMOTE SENS ENVIRON, V132, P145, DOI 10.1016/j.rse.2013.01.010; Hunter P, 2013, EMBO REP, V14, P769, DOI 10.1038/embor.2013.122; Jeong S. J., 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI DOI 10.1111/J.1365-2486.2011.02397.X; Jordan NS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013777; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; KOIKE T, 1990, TREE PHYSIOL, V7, P21, DOI 10.1093/treephys/7.1-2-3-4.21; Kross A, 2011, REMOTE SENS ENVIRON, V115, P1564, DOI 10.1016/j.rse.2011.02.015; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; Joshi PKK, 2006, REMOTE SENS ENVIRON, V103, P190, DOI 10.1016/j.rse.2006.04.010; Lee DW, 2003, ECOL RES, V18, P677, DOI 10.1111/j.1440-1703.2003.00588.x; Li XL, 2013, ECOL MODEL, V261, P80, DOI 10.1016/j.ecolmodel.2013.03.024; Liang D, 2015, ISPRS INT J GEO-INF, V4, P2519, DOI 10.3390/ijgi4042519; Menzel A, 2003, CLIMATIC CHANGE, V57, P243, DOI 10.1023/A:1022880418362; Migliavacca M, 2008, INT J BIOMETEOROL, V52, P587, DOI 10.1007/s00484-008-0152-9; NASA LP DAAC, 2012, MCD12Q1 VERS 5; NASA LP DAAC, 2012, MCD12Q2 VERS 5; NunezOlivera E, 1996, FUNCT ECOL, V10, P636, DOI 10.2307/2390174; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Piao SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7911; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Schnase JL, 2014, COMPUTERS ENV URBAN; Shen MG, 2014, INT J REMOTE SENS, V35, P1162, DOI 10.1080/01431161.2013.875636; Verger A, 2015, REMOTE SENS ENVIRON, V166, P126, DOI 10.1016/j.rse.2015.05.027; Vicente-Serrano SM, 2004, ENVIRON MANAGE, V34, P802, DOI 10.1007/s00267-003-0022-5; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Vrbnicanin S, 2009, TURK J AGRIC FOR, V33, P325, DOI 10.3906/tar-0810-24; Wang YF, 2014, THEOR APPL CLIMATOL, V118, P569, DOI 10.1007/s00704-013-1078-7; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Xia JZ, 2014, REMOTE SENS-BASEL, V6, P1783, DOI 10.3390/rs6031783; Xiao W, 2013, J APPL REMOTE SENS, V7, P609; Yang X, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001977; Yi YH, 2011, J CLIMATE, V24, P3797, DOI 10.1175/2011JCLI4034.1; Yu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111056; [Yu Xinfang 于信芳], 2005, Journal of Geographical Sciences, V15, P239, DOI 10.1007/BF02872689; Yuan W, 2011, GLOBAL BIOGEOCHEMICA, V25, P1441; Yuan WP, 2012, WATER RESOUR MANAG, V26, P2147, DOI 10.1007/s11269-012-0007-3; Zhang HC, 2015, J GEOPHYS RES-BIOGEO, V120, P1658, DOI 10.1002/2015JG003112; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/175940; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	63	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167302	10.1371/journal.pone.0167302	http://dx.doi.org/10.1371/journal.pone.0167302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893828	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400110
J	Hurtado-Alvarado, G; Dominguez-Salazar, E; Velazquez-Moctezuma, J; Gomez-Gonzalez, B				Hurtado-Alvarado, Gabriela; Dominguez-Salazar, Emilio; Velazquez-Moctezuma, Javier; Gomez-Gonzalez, Beatriz			A(2A) Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction	PLOS ONE			English	Article							INFLAMMATION; DEPRIVATION; PERMEABILITY; IMPAIRMENT; MODULATION; JUNCTIONS; CAFFEINE; DEFICITS; IMPROVES; MEMORY	Chronic sleep restriction induces blood-brain barrier disruption and increases pro-inflammatory mediators in rodents. Those inflammatory mediators may modulate the blood-brain barrier and constitute a link between sleep loss and blood-brain barrier physiology. We propose that adenosine action on its A(2A) receptor may be modulating the blood-brain barrier dynamics in sleep-restricted rats. We administrated a selective A(2A) adenosine receptor antagonist (SCH58261) in sleep-restricted rats at the 10(th) day of sleep restriction and evaluated the blood-brain barrier permeability to dextrans coupled to fluorescein (FITC-dextrans) and Evans blue. In addition, we evaluated by western blot the expression of tight junction proteins (claudin-5, occludin, ZO-1), adherens junction protein (E-cadherin), A(2A) adenosine receptor, adenosine-synthesizing enzyme (CD73), and neuroinflammatory markers (lba-1 and GFAP) in the cerebral cortex, hippocampus, basal nuclei and cerebellar vermis. Sleep restriction increased blood-brain barrier permeability to FITC-dextrans and Evans blue, and the effect was reverted by the administration of SCH58261 in almost all brain regions, excluding the cerebellum. Sleep restriction increased the expression of A(2A) adenosine receptor only in the hippocampus and basal nuclei without changing the expression of CD73 in all brain regions. Sleep restriction reduced the expression of tight junction proteins in all brain regions, except in the cerebellum; and SCH58261 restored the levels of tight junction proteins in the cortex, hippocampus and basal nuclei. Finally, sleep restriction induced GFAP and lba-1 overexpression that was attenuated with the administration of SCH58261. These data suggest that the action of adenosine on its A(2A) receptor may have a crucial role in blood-brain barrier dysfunction during sleep loss probably by direct modulation of brain endothelial cell permeability or through a mechanism that involves gliosis with subsequent inflammation and increased blood-brain barrier permeability.	[Hurtado-Alvarado, Gabriela; Dominguez-Salazar, Emilio; Velazquez-Moctezuma, Javier; Gomez-Gonzalez, Beatriz] Univ Autonoma Metropolitana, Area Neurosci, Dept Biol Reprod, CBS,Unidad Iztapalapa, Mexico City, DF, Mexico; [Hurtado-Alvarado, Gabriela] Univ Autonoma Metropolitana, Postgrad Program Expt Biol, CBS, Unidad Iztapalapa, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico	Gomez-Gonzalez, B (corresponding author), Univ Autonoma Metropolitana, Area Neurosci, Dept Biol Reprod, CBS,Unidad Iztapalapa, Mexico City, DF, Mexico.	bgomezglez@gmail.com	HURTADO-ALVARADO, GABRIELA/AAH-5979-2021	Dominguez-Salazar, Emilio/0000-0003-2145-0863; Gomez-Gonzalez, Beatriz/0000-0003-1388-0118; Hurtado-Alvarado, Gabriela/0000-0002-6137-663X	Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP) [CB 2012-180792, 371992]	Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP)	This work was supported by Grant CB 2012-180792 from Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP) to BGG and Fellowship 371992 from Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP) to GHA. URL: http://www.conacyt.mx. None of the funding sources had any role in the study design, analysis or interpretation of the data, nor in writing the report.	Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Bynoe MS, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0017-7; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Cheng CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23882; Christiansen SL, 2016, NEUROSCIENCE RESEARC; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; DeMet EM, 2002, N-S ARCH PHARMACOL, V366, P478, DOI 10.1007/s00210-002-0613-3; Dixon AK, 1996, BRIT J PHARMACOL, V118, P1461, DOI 10.1111/j.1476-5381.1996.tb15561.x; Dohadwala MM, 2008, CARDIOVASC THER, V26, P276, DOI 10.1111/j.1755-5922.2008.00059.x; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Gomez-Gonzalez B, 2013, CURR NEUROVASC RES, V10, P197, DOI 10.2174/15672026113109990002; Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; He JY, 2014, J NEUROSCI, V34, P14697, DOI 10.1523/JNEUROSCI.2111-14.2014; Hines DJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.136; Hoffmann A, 2011, TRANSL STROKE RES, V2, P106, DOI 10.1007/s12975-010-0049-x; Hurtado-Alvarado G, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4576012; Hurtado-Alvarado G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/801341; Jorg M, 2014, CURR MED CHEM, V21, P3188; Kahan V, 2010, BASIC CLIN PHARMACOL, V107, P598, DOI 10.1111/j.1742-7843.2010.00540.x; Killgore WDS, 2014, J CLIN PSYCHOPHARM, V34, P660, DOI 10.1097/JCP.0000000000000184; Kim DG, 2015, MOL NEUROBIOL, V52, P664, DOI 10.1007/s12035-014-8879-2; Kim Y, 2012, SLEEP, V35, P861, DOI 10.5665/sleep.1890; Leite MR, 2011, EXP GERONTOL, V46, P309, DOI 10.1016/j.exger.2010.11.034; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Mohamed RA, 2012, NEUROCHEM RES, V37, P538, DOI 10.1007/s11064-011-0640-x; MORII S, 1987, AM J PHYSIOL, V253, pH165, DOI 10.1152/ajpheart.1987.253.1.H165; Ng SK, 2015, EXP NEUROL, V267, P115, DOI 10.1016/j.expneurol.2015.03.004; Novati A, 2012, J SLEEP RES, V21, P3, DOI 10.1111/j.1365-2869.2011.00932.x; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Pezzola A, 1998, NEUROSCI LETT, V31, P251; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Porkka-Heiskanen T, 1999, ANN MED, V31, P125, DOI 10.3109/07853899908998788; Preti D, 2015, MED RES REV, V35, P790, DOI 10.1002/med.21344; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Rochfort KD, 2015, MICROVASC RES, V100, P48, DOI 10.1016/j.mvr.2015.04.010; Sanchez-Espinosa MP, 2014, NEUROIMAGE, V98, P395, DOI 10.1016/j.neuroimage.2014.05.027; Santiago AR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/465694; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Sumi N, 2010, CELL MOL NEUROBIOL, V30, P247, DOI 10.1007/s10571-009-9446-7; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398	51	28	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167236	10.1371/journal.pone.0167236	http://dx.doi.org/10.1371/journal.pone.0167236			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893847	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400106
J	Mgaya, AH; Kidanto, HL; Nystrom, L; Essen, B				Mgaya, Andrew H.; Kidanto, Hussein L.; Nystrom, Lennarth; Essen, Birgitta			Improving Standards of Care in Obstructed Labour: A Criteria-Based Audit at a Referral Hospital in a Low-Resource Setting in Tanzania	PLOS ONE			English	Article							CESAREAN-SECTION RATES; DAR-ES-SALAAM; EMERGENCY OBSTETRIC CARE; PERINATAL-MORTALITY; MATERNAL MORTALITY; ECLAMPSIA PATIENTS; LIMITED COUNTRIES; RURAL TANZANIA; CLINICAL AUDIT; QUALITY	Objective In low-resource settings, obstructed labour is strongly associated with severe maternal morbidity and intrapartum asphyxia, and consequently maternal and perinatal deaths. This study evaluated the impact of a criteria-based audit of the diagnosis and management of obstructed labour in a low-resource setting. Methods A baseline criteria-based audit was conducted from October 2013 to March 2014, followed by a workshop in which stakeholders gave feedback on interventions agreed upon to improve obstetric care. The implemented interventions included but were not limited to introducing standard guidelines for diagnosis and management of obstructed labour, agreeing on mandatory review by specialist for cases that are assigned caesarean section, re-training and supervision on use and interpretation of partograph and, strengthening team work between doctors, mid-wives and theatre staff. After implementing these interventions in March, a re-audit was performed from July 2015 to November, 2015, and the results were compared to those of the baseline audit. Results Two hundred and sixty deliveries in the baseline survey and 250 deliveries in the follow-up survey were audited. Implementing the new criteria improved the diagnosis from 74% to 81% (p = 0.049) and also the management of obstructed labour from 4.2% at baseline audit to 9.2% at re-audit (p = 0.025). Improved detection of prolonged labour through heightened observation of regular contractions, protracted cervical dilatation, protracted descent of presenting part, arrested cervical dilation, and severe moulding contributed to improved standards of diagnosis (all p < 0.04). Patient reviews by senior obstetricians increased from 34% to 43% (p = 0.045) and reduced time for caesarean section intervention from the median time of 120 to 90 minutes (p = 0.001) improved management (all p < 0.05). Perinatal outcomes, neonatal distress and fresh stillbirths, were reduced from 16% to. 8.8% (p = 0.01). Conclusion A criteria-based audit proved to be a feasible and useful tool in improving diagnosis and management of obstructed labour using available resources. Some of the observed changes in practice were of modest magnitude implying demand for further improvements, while sustaining those already put in place.	[Mgaya, Andrew H.] Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania; [Mgaya, Andrew H.; Kidanto, Hussein L.; Essen, Birgitta] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden; [Kidanto, Hussein L.] Minist Hlth Community Dev Gender Elderly & Childr, Reprod & Child Hlth Sect, Dar Es Salaam, Tanzania; [Nystrom, Lennarth] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden	Uppsala University; Umea University	Mgaya, AH (corresponding author), Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania.; Mgaya, AH (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden.	andrew.mgaya@kbh.uu.se			Muhimbili National Referral Hospital; Laerdal Foundation for Acute Medicine; Faculty of Medicine, Uppsala University	Muhimbili National Referral Hospital; Laerdal Foundation for Acute Medicine; Faculty of Medicine, Uppsala University	All the funding received during this study was used to incur study activities costs. Laerdal Foundation for Acute Medicine funded the costs of stationary and audit criteria setting meetings. The audit evaluation meetings and the feedback workshop was co-funded by Muhimbili National Referral Hospital, Laerdal Foundation for Acute Medicine and the Faculty of Medicine, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MAN COMPL PREGN CHIL; Bayou G, 2012, ETHIOP J HEALTH SCI, V22, P153; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Central Statistics Authority, 2012, HIOP EDERMOGRAPHIC H; Dolea C., 2003, GLOBAL BURDEN OBSTRU; Drennan K, 2008, ABNORMAL LABOR DIAGN; Fenton PM, 2003, BRIT MED J, V327, P587, DOI 10.1136/bmj.327.7415.587; Gesme D, 2010, J ONCOL PRACT, V6, P257, DOI 10.1200/JOP.000089; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Hofmeyr GJ, 2004, INT J GYNECOL OBSTET, V85, pS62, DOI 10.1016/j.ijgo.2004.01.011; Hunyinbo K I, 2008, Afr J Reprod Health, V12, P59; Kabakyenga JK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-73; Kidanto H, 2015, INT J GYNECOL OBSTET, V130, P70, DOI 10.1016/j.ijgo.2015.01.012; Kidanto Hussein L, 2006, Afr J Reprod Health, V10, P72; Kidanto HL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-134; Kidanto HL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-13; Kongnyuy EJ, 2009, ARCH GYNECOL OBSTET, V279, P649, DOI 10.1007/s00404-008-0786-1; Kumar S, 2013, WHO REC PREV TREATM; Litorp H, 2015, SOC SCI MED, V143, P232, DOI 10.1016/j.socscimed.2015.09.003; Litorp H, 2015, MIDWIFERY, V31, P713, DOI 10.1016/j.midw.2015.03.008; Litorp H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-244; Litorp H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-107; Maaloe N, 2012, BJOG-INT J OBSTET GY, V119, P605, DOI 10.1111/j.1471-0528.2012.03284.x; McGivern G, 2012, SOC SCI MED, V74, P289, DOI 10.1016/j.socscimed.2011.09.035; Mdegela M, 2012, TANZANIA J HLTH RES, V14, P1; Melah GS, 2007, J OBSTET GYNAECOL, V27, P819, DOI 10.1080/01443610701709825; Ministry of Health and Social Welfare, 2008, EM OBST CAR JOB AID; Mmbaga BT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-139; Mohammadi S, 2012, J REPROD MED, V57, P43; National Population Commission, 2013, NIG DEM HLTH SURV 20; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-94; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Okong P, 2006, ACTA OBSTET GYN SCAN, V85, P797, DOI 10.1080/00016340600593331; Ould El Joud D, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P51; Pembe AB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-320; PHILPOTT RH, 1972, J OBSTET GYN BR COMM, V79, P592; Pirkle CM, 2011, INT J QUAL HEALTH C, V23, P456, DOI 10.1093/intqhc/mzr033; Postgraduate Medical Council of Victoria, 2015, SUP JUN DOCT GUID; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Simba Daudi O, 2008, East Afr J Public Health, V5, P6; Sorensen BL, 2010, TROP MED INT HEALTH, V15, P894, DOI 10.1111/j.1365-3156.2010.02554.x; Stal KB, 2015, TROP MED INT HEALTH, V20, P934, DOI 10.1111/tmi.12496; Uganda Bureau of Statistics, 2014, UG DEM HLTH SURV 201; van Heekhuizen HJ, 2006, LANCET, V368, P1210, DOI 10.1016/S0140-6736(06)69477-4; Wagaarachchi PT, 2001, INT J GYNECOL OBSTET, V74, P119, DOI 10.1016/S0020-7292(01)00427-1; WHO, 2015, HLTH HUMAN RIGHTS; World Health Organization, 2012, WHO GUID MAN POSTP H; World Health Organization, 2013, MOTH BAB PACK IMPL S; World Health Organization, TRENDS MAT MORT 1990	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166619	10.1371/journal.pone.0166619	http://dx.doi.org/10.1371/journal.pone.0166619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893765	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400035
J	Schawkat, K; Kuhn, W; Inderbitzin, D; Gloor, B; Heverhagen, JT; Runge, VM; Christe, A				Schawkat, Khoschy; Kuhn, Wolfgang; Inderbitzin, Daniel; Gloor, Beat; Heverhagen, Johannes T.; Runge, Val Murray; Christe, Andreas			Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT	PLOS ONE			English	Article							MULTIDETECTOR CT; ADENOCARCINOMA; DUCT; SCANS; ABNORMALITIES; CARCINOMAS; CELL	Objective The aim of this retrospective study was to evaluate the diagnostic value and measure inter-reader agreement of the pancreaticolienal gap (PLG) in the assessment of imaging features of pancreatic carcinoma (PC) on contrast-enhanced multi-detector computed tomography (CE-MDCT). Materials and Methods CE-MDCT studies in the portal venous phase were retrospectively reviewed for 66 patients with PC. The age-and gender-matched control group comprised 103 healthy individuals. Three radiologists with different levels of experience independently measured the PLG (the minimum distance of the pancreatic tail to the nearest border of the spleen) in the axial plane. The interreader agreement of the PLG and the receiver operating characteristic (ROC) curve was used to calculate the accuracy of the technique. Results While the control group (n = 103) showed a median PLG of 3 mm (Range: 0-39mm) the PC patients had a significantly larger PLG of 15mm (Range: 0-53mm)(p < 0.0001). A ROC curve demonstrated a cutoff-value of > 12 mm for PC, with a sensitivity of 58.2% (95% CI = 45.5-70.1), specificity of 84.0% (95% CI = 75.6-90.4) and an area under the ROC curve of 0.714 (95% CI = 0.641 to 0.780). The mean interreader agreement showed correlation coefficient r of 0.9159. The extent of the PLG did not correlate with tumor stage but did correlate with pancreatic density (fatty involution) and age, the density decreased by 4.1 HU and the PLG increased by 0.8 mm within every 10 y. Conclusion The significant interreader agreement supports the use of the PLG as a characterizing feature of pancreatic cancer independent of the tumor stage on an axial plane. The increase in the PLG with age may represent physiological atrophy of the pancreatic tail.	[Schawkat, Khoschy; Kuhn, Wolfgang; Heverhagen, Johannes T.; Runge, Val Murray; Christe, Andreas] Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Inderbitzin, Daniel; Gloor, Beat] Univ Hosp Bern, Inselspital, Dept Visceral & Transplant Surg, Bern, Switzerland; [Inderbitzin, Daniel] Tiefenau Hosp, Dept Surg, Bern, Switzerland; [Christe, Andreas] Tiefenau Hosp, Dept Radiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Schawkat, K (corresponding author), Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland.	k_schawkat@hotmail.com	Schawkat, Khoschy/AAX-1235-2020	Heverhagen, Johannes/0000-0002-5416-6650				Chari ST, 2008, GASTROENTEROLOGY, V134, P95, DOI 10.1053/j.gastro.2007.10.040; Chari ST, 2015, PANCREAS, V44, P693, DOI 10.1097/MPA.0000000000000368; De Groef S, 2015, JOVE-J VIS EXP, DOI 10.3791/52765; Gangi S, 2004, AM J ROENTGENOL, V182, P897, DOI 10.2214/ajr.182.4.1820897; de la Santa LG, 2014, WORLD J GASTRO ONCOL, V6, P330, DOI 10.4251/wjgo.v6.i9.330; Hruban RH, 2007, MODERN PATHOL, V20, pS61, DOI 10.1038/modpathol.3800685; Hruban RH, 2010, ADV SURG, V11, P581; Kalady MF, 2004, ANN SURG ONCOL, V11, P581, DOI 10.1245/ASO.2004.03.070; Kim JH, 2010, RADIOLOGY, V257, P87, DOI 10.1148/radiol.10100015; Klauss M, 2013, EUR J RADIOL, V82, P208, DOI 10.1016/j.ejrad.2012.09.012; Krishna N, 2012, PANCREAS, V41, P767, DOI 10.1097/MPA.0b013e31823ba536; Legmann P, 1998, AM J ROENTGENOL, V170, P1315, DOI 10.2214/ajr.170.5.9574609; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P2157, DOI 10.1111/j.1572-0241.2007.01480.x; Porta Miquel, 2005, Clin Transl Oncol, V7, P189, DOI 10.1007/BF02712816; Prokesch RW, 2003, EUR RADIOL, V13, P2147, DOI 10.1007/s00330-003-1926-4; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; RALLS PW, 1980, RADIOLOGY, V134, P347, DOI 10.1148/radiology.134.2.7352212; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Sato T, 2012, EUR J RADIOL, V81, P2093, DOI 10.1016/j.ejrad.2011.07.014; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; TSUCHIYA R, 1986, ANN SURG, V203, P77, DOI 10.1097/00000658-198601000-00013; Van Gassen N, 2015, EUR J IMMUNOL, V45, P1482, DOI 10.1002/eji.201445013; van Gulik TM, 1999, ANN ONCOL, V10, P85, DOI 10.1023/A:1008353223014; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang MJ, 2013, QUANT IMAGING MED SU, V3, P113, DOI 10.3978/j.issn.2223-4292.2013.04.02; Yasuda H, 1999, J INTERF CYTOK RES, V19, P637, DOI 10.1089/107999099313785; Yoon SH, 2011, RADIOLOGY, V259, P442, DOI 10.1148/radiol.11101133	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166003	10.1371/journal.pone.0166003	http://dx.doi.org/10.1371/journal.pone.0166003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893776	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400014
J	Huang, M; Zhou, XF; Xie, XB; Zhao, CR; Chen, JN; Cao, FB; Zou, YB				Huang, Min; Zhou, Xuefeng; Xie, Xiaobing; Zhao, Chunrong; Chen, Jiana; Cao, Fangbo; Zou, Yingbin			Rice Yield and the Fate of Fertilizer Nitrogen as Affected by Addition of Earthworm Casts Collected from Oilseed Rape Fields: A Pot Experiment	PLOS ONE			English	Article							INCREASING HARVEST INDEX; USE EFFICIENCY; CROP PRODUCTIVITY; IRRIGATED RICE; CHINA; SOIL; SYSTEMS; STRATEGIES; MANAGEMENT	The mechanism associated with improvement of soil nutritional status by oilseed rape crop, leading to better performance of rice crop, in rice-oilseed rape cropping systems is little known. The present study was aimed to test the hypothesis that earthworm casts produced during oilseed rape-growing season have positive effects on grain yield and fertilizer nitrogen (N) utilization in the subsequent flooded rice crop. A N-15-tracing pot experiment was conducted to determine the effects of earthworm casts collected from oilseed rape fields on yield attributes in rice and the fate of fertilizer N. Soil treated with earthworm casts (soil: earthworm casts = 4: 1, w/w) (EC1) produced 39% higher grain yield than soil only (EC0). EC1 had 18% more panicle number and 10% higher spikelet filling percentage than EC0. Aboveground biomass and harvest index were higher in EC1 than in EC0 by 20% and 15%, respectively. SPAD values in flag leaves were 10% and 22% higher under EC1 than EC0 at 15 and 20 days after heading, respectively. EC1 had 19% higher total N uptake and 18% higher physiological N-use efficiency than EC0. These positive effects of earthworm casts on yield attributes offset negative effects of decreasing N rate from 0.74 g pot(-1) (equivalent to the recommended field rate of 150 kg ha(-1)) to 0.44 g pot(-1) (equivalent to 60% of the recommended rate). Fertilizer N retention rate was 7% higher while fertilizer N loss rate was 6% lower in EC1 than in EC0. Our study suggests that earthworm casts produced during oilseed rape-growing season are expected to have the following benefits on the subsequent flooded rice system: (1) improving growth and physiological processes in rice plants and consequently increasing rice grain yield, and (2) increasing fertilizer N retention rate and hence decreasing fertilizer N loss rate and reducing environmental risk.	[Huang, Min; Zhou, Xuefeng; Xie, Xiaobing; Zhao, Chunrong; Chen, Jiana; Cao, Fangbo; Zou, Yingbin] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Huang, M (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China.	jxhuangmin@163.com		Huang, Min/0000-0002-6944-8538	Earmarked Fund for China Agriculture Research System [CARS-01]	Earmarked Fund for China Agriculture Research System	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-01).	Badshah MA, 2014, CROP J, V2, P79, DOI 10.1016/j.cj.2013.11.004; Bao S., 2005, SOIL AGROCHEMISTRY A; Bhadauria Tunira, 2010, Applied and Environmental Soil Science, V2010, P1, DOI 10.1155/2010/816073; BLUM A, 1993, INTERNATIONAL CROP SCIENCE I, P343; BULLOCK DG, 1992, CRIT REV PLANT SCI, V11, P309, DOI 10.1080/07352689209382349; Choosai C, 2010, APPL SOIL ECOL, V45, P298, DOI 10.1016/j.apsoil.2010.05.006; Dominguez J, 2000, PEDOBIOLOGIA, V44, P24, DOI 10.1078/S0031-4056(04)70025-6; ELLIOTT PW, 1990, SOIL BIOL BIOCHEM, V22, P601, DOI 10.1016/0038-0717(90)90004-J; Evans LT., 1993, CROP EVOLUTION ADAPT; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Groffman PM, 2015, SOIL BIOL BIOCHEM, V87, P51, DOI 10.1016/j.soilbio.2015.03.025; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Huang JL, 2008, FIELD CROP RES, V105, P70, DOI 10.1016/j.fcr.2007.07.006; Huang M, 2016, ARCH AGRON SOIL SCI, V62, P725, DOI 10.1080/03650340.2015.1082031; Huang M, 2016, FIELD CROP RES, V185, P40, DOI 10.1016/j.fcr.2015.10.017; Huang M, 2015, BIOTECHNOL AGRON SOC, V19, P153; Huang M, 2014, BIOL FERT SOILS, V50, P997, DOI 10.1007/s00374-014-0908-9; Huang Min, 2013, Australian Journal of Crop Science, V7, P600; Huang M, 2011, EUR J AGRON, V34, P278, DOI 10.1016/j.eja.2011.02.005; JAYAWEERA GR, 1990, SOIL SCI SOC AM J, V54, P1447, DOI 10.2136/sssaj1990.03615995005400050039x; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; LIN B, 1991, SOIL SCI CHINA PRESE, P29; Liu LL, 2012, AGR ECOSYST ENVIRON, V149, P20, DOI 10.1016/j.agee.2011.12.008; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; PENG SB, 1993, AGRON J, V85, P987, DOI 10.2134/agronj1993.00021962008500050005x; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Shang QY, 2014, PLANT SOIL, V381, P13, DOI 10.1007/s11104-014-2089-6; Wang GH, 2001, AGRON J, V93, P869, DOI 10.2134/agronj2001.934869x; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida S., 1983, Potential productivity of field crops under different environments., P103; Zegada-Lizarazu W, 2011, BIOMASS BIOENERG, V35, P12, DOI 10.1016/j.biombioe.2010.08.001; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang SJ, 2010, AGR ECOSYST ENVIRON, V139, P463, DOI 10.1016/j.agee.2010.08.007; ZOU C, 2008, MICRONUTRIENT DEFICI	36	10	14	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167152	10.1371/journal.pone.0167152	http://dx.doi.org/10.1371/journal.pone.0167152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880837	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500075
J	Livesey, EJ; Livesey, DJ				Livesey, Evan J.; Livesey, David J.			Validation of a Bayesian Adaptive Estimation Technique in the Stop-Signal Task	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; RESPONSE-TIME DISTRIBUTIONS; INHIBITORY CONTROL; BEHAVIORAL-INHIBITION; MAXIMUM-LIKELIHOOD; EXECUTIVE FUNCTION; PERFORMANCE; ABILITY; MODEL; AUTOMATICITY	The Stop Signal Task (SST), a commonly used measure of response inhibition, uses standard psychophysical methods to gain an estimate of the time needed to withhold a prepotent response. Under some circumstances, conventional forms of the SST are impractical to use because of the large number of trials necessary to gain a reliable estimate of the speed of inhibition. Here we applied to the SST an adaptive method for estimating psychometric parameters that can find reliable threshold estimates over a relatively small number of trials. The psi adaptive staircase, which uses a Bayesian algorithm to find the most likely parameters of a psychophysical function, was used to estimate the critical stop signal delay at which the probability of successful response inhibition equals 0.5. Using computational modeling and adult participants, estimates of stop signal reaction time (SSRT) based on the. staircase were compared to estimates using the method of constant stimuli and a standard staircase method of adjustment. Results demonstrate that a reliable estimate of SSRT can be gained very quickly (20-30 stop trials), making the method very useful for testing populations that cannot maintain concentration for long periods or for rapidly obtaining multiple SSRT estimates from healthy adult participants.	[Livesey, Evan J.; Livesey, David J.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of Sydney	Livesey, EJ (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	evan.livesey@sydney.edu.au			Australian Research Council [DP160102871]	Australian Research Council(Australian Research Council)	This research was supported by Australian Research Council grant DP160102871.	Abrahamyan A, 2011, J NEUROSCI, V31, P3290, DOI 10.1523/JNEUROSCI.6256-10.2011; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barrett LC, 2010, J EXP PSYCHOL LEARN, V36, P864, DOI 10.1037/a0019403; Carver AC, 2001, INT J NEUROSCI, V107, P43, DOI 10.3109/00207450109149756; COLONIUS H, 1990, PSYCHOL REV, V97, P309, DOI 10.1037/0033-295X.97.2.309; Debey E, 2015, ACTA PSYCHOL, V160, P58, DOI 10.1016/j.actpsy.2015.06.007; EMERSON PL, 1986, PERCEPT PSYCHOPHYS, V39, P151, DOI 10.3758/BF03211498; Gomes L, 2008, CHILD CARE HLTH DEV, V34, P763, DOI 10.1111/j.1365-2214.2008.00878.x; HALL JL, 1968, J ACOUST SOC AM, V44, P370, DOI 10.1121/1.1970490; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; HOCKLEY WE, 1984, J EXP PSYCHOL LEARN, V10, P598, DOI 10.1037/0278-7393.10.4.598; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lem VALC, 2015, J EXP PSYCHOL-ANIM L, V41, P385, DOI 10.1037/xan0000079; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Livesey D, 2006, HUM MOVEMENT SCI, V25, P50, DOI 10.1016/j.humov.2005.10.008; Livesey EJ, 2014, Q J EXP PSYCHOL, V67, P646, DOI 10.1080/17470218.2013.824014; Logan G. D., 1981, ATTENTION PERFORM, VIX, P205; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Matzke D, 2013, J EXP PSYCHOL GEN, V142, P1047, DOI 10.1037/a0030543; MEWHORT DJK, 1992, J EXP PSYCHOL HUMAN, V18, P872, DOI 10.1037/0096-1523.18.3.872; Pasalich DS, 2010, INFANT CHILD DEV, V19, P252, DOI 10.1002/icd.667; PELLI D G, 1987, Investigative Ophthalmology and Visual Science, V28, P366; Perruchet P, 2006, J EXP PSYCHOL LEARN, V32, P955, DOI 10.1037/0278-7393.32.5.955; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Ridderinkhof KR, 1999, ACTA PSYCHOL, V101, P315; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Verbruggen F, 2014, NEUROPSYCHOLOGIA, V65, P263, DOI 10.1016/j.neuropsychologia.2014.08.014; Verbruggen F, 2009, J EXP PSYCHOL LEARN, V35, P1381, DOI 10.1037/a0016645; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165525	10.1371/journal.pone.0165525	http://dx.doi.org/10.1371/journal.pone.0165525			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5KB	27880815	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500010
J	Chiapponi, C; Witt, M; Dlugosch, GE; Gulberg, V; Siebeck, M				Chiapponi, Costanza; Witt, Maxie; Dlugosch, Gabriele E.; Guelberg, Veit; Siebeck, Matthias			The Perception of Physician Empathy by Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							PRIMARY-CARE; CONSULTATION; SATISFACTION; OUTCOMES; QUALITY; NURSES; STRESS	Background and Aims This study focused on the difference between perceived and desired physician empathy pPE and dPE) in the eye of patients with inflammatory bowel disease (IBD). It was investigated if a discrepancy (Delta PE) correlates with trust and satisfaction of patients. At the same time the aim was to gain detailed information about the subjective burden of disease and the resources of IBD patients, in order to better understand them. Methods A modified version of the German Version of the Consultation and Relational Empathy (CARE) measure was completed as a paper-and-pencil questionnaire by IBD patients attending our facility (n = 32) and as an online survey by IBD patients at other locations throughout Germany (n = 89). Patients were in average 36.3 +/- 12 years old. Results The mean SD) rating of pPE was 3.93 (0.96) on a scale of 1 to 5 ("poor" to "excellent"); however, the mean SD) dPE was 4.38 (0.48) on the same scale. Delta PE correlated with perceived empathy and with patients' satisfaction with treatment and trust in their health care providers. Patients reported quite a high subjective burden mean [SD]: 2.93 [.63]) and named family, friends, and support groups as resources. Conclusions Rather than assessing patient satisfaction with treatment and trust in their physician only with perceived PE, we suggest Delta PE as a useful additional parameter.	[Chiapponi, Costanza; Siebeck, Matthias] Hosp Univ Munich LMU, Dept Gen Visceral Vasc & Transplantat Surg, Munich, Germany; [Witt, Maxie; Dlugosch, Gabriele E.] Univ Koblenz Landau, Ctr Empir Educ Res Zepf, Campus Landau, Landau, Germany; [Guelberg, Veit] Hosp Univ Munich LMU, Div Gastroenterol, Med Klin 4, Munich, Germany; [Chiapponi, Costanza] Univ Cologne, Dept Gen Visceral & Canc Surg, Cologne, Germany	University of Munich; University of Koblenz & Landau; University of Munich; University of Cologne	Chiapponi, C (corresponding author), Hosp Univ Munich LMU, Dept Gen Visceral Vasc & Transplantat Surg, Munich, Germany.; Chiapponi, C (corresponding author), Univ Cologne, Dept Gen Visceral & Canc Surg, Cologne, Germany.	Costanza.Chiapponi@uk-koeln.de	Chiapponi, Costanza/GQQ-0319-2022	Chiapponi, Costanza/0000-0002-4681-2835				Belling R, 2008, INT J NURS PRACT, V14, P67, DOI 10.1111/j.1440-172X.2007.00661.x; Burisch J, 2014, J CROHNS COLITIS, V8, P811, DOI 10.1016/j.crohns.2013.12.023; Del Canale S, 2012, ACAD MED, V87, P1243, DOI 10.1097/ACM.0b013e3182628fbf; Foley KA, 2016, INT J RADIAT ONCOL, V94, P280, DOI 10.1016/j.ijrobp.2015.10.023; Ikas G, 2002, Z Gastroenterol, V40 Suppl 1, pS100; Jelsness-Jorgensen LP, 2016, SCAND J GASTROENTERO, V51, P434, DOI 10.3109/00365521.2015.1102319; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; Martin-Subero M, 2016, CNS SPECTRUMS, V21, P184, DOI 10.1017/S1092852915000449; Matsumoto T, 2015, J CROHNS COLITIS, V9, P477, DOI 10.1093/ecco-jcc/jjv052; Maunder RG, 1997, CAN J GASTROENTEROL, V11, P681, DOI 10.1155/1997/183841; Menendez ME, 2015, J HAND SURG-AM, V40, P1860, DOI 10.1016/j.jhsa.2015.06.105; Mercer SW, 2008, PATIENT EDUC COUNS, V73, P240, DOI 10.1016/j.pec.2008.07.022; Mercer SW, 2004, FAM PRACT, V21, P699, DOI 10.1093/fampra/cmh621; Mercer SW, 2002, BRIT J GEN PRACT, V52, pS9; Mocciaro F, 2014, DIGEST LIVER DIS, V46, P893, DOI 10.1016/j.dld.2014.07.009; Neumann M, 2008, PSYCHOTHER PSYCH MED, V58, P5, DOI 10.1055/s-2007-970791; Neumann M, 2007, PATIENT EDUC COUNS, V69, P63, DOI 10.1016/j.pec.2007.07.003; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Neumann M, 2011, PATIENT EDUC COUNS, V84, P208, DOI 10.1016/j.pec.2010.07.012; Nicolai J, 2016, PATIENT EDUC COUNS, V99, P739, DOI 10.1016/j.pec.2015.11.019; Nyuyki KD, 2015, ANN NY ACAD SCI, V1351, P149, DOI 10.1111/nyas.12935; Reynolds WJ, 2000, J ADV NURS, V31, P226, DOI 10.1046/j.1365-2648.2000.01242.x; Steinhausen S, 2014, PATIENT PREFER ADHER, V8, P1239, DOI 10.2147/PPA.S62925; Targownik LE, 2015, AM J GASTROENTEROL, V110, P1001, DOI 10.1038/ajg.2015.147; Yanartas O, 2016, NEUROPSYCH DIS TREAT, V12, DOI 10.2147/NDT.S106039	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167113	10.1371/journal.pone.0167113	http://dx.doi.org/10.1371/journal.pone.0167113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5IV	27875561	Green Submitted, gold, Green Published			2022-12-26	WOS:000388886000051
J	Zhao, YT; Wang, H; Zhang, SY; Du, JF; Zhuang, SG; Zhao, TC				Zhao, Yu Tina; Wang, Hao; Zhang, Shouyan; Du, Jianfeng; Zhuang, Shougang; Zhao, Ting C.			Irisin Ameliorates Hypoxia/Reoxygenation-Induced Injury through Modulation of Histone Deacetylase 4	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PRESERVES MYOCARDIAL PERFORMANCE; CARDIAC-HYPERTROPHY; DIABETIC MICE; INHIBITION; CARDIOPROTECTION; DISEASE; HDAC4; CELLS; STIMULATION	Irisin is a recently identified myokine which brings increases in energy expenditure and contributes to the beneficial effects of exercise through the browning of white adipose tissues. However, its effects in the heart remains unknown. This study sought to determine the effects of irisin on hypoxia/reoxygenation injury and its relationship with HDAC4. Wild type and stable HDAC4-overexpression cells were generated from H9c2 cardiomyoblasts. HDAC4 overexpression cells and wild type H9c2 cells were exposed to 24 hours of hypoxia followed by one hour of reoxygenation in vitro in the presence or absence of irisin (5 ng/ml). Cell cytotoxicity, apoptosis, mitochondrial respiration, and mitochondrial permeability transition pore (mPTP) were determined. Western blotting was employed to determine active-caspase 3, annexin V, and HDAC4 expression. As compared to wild type H9c2 group, HDAC4 overexpression remarkably led to a great increase in cell death as evident by the increased lactate dehydrogenase (LDH) leakage, ratio of caspase-3-positive cells as well as the upregulated levels of active-caspase 3 and annexin V shown by western blot analysis. In addition, HDAC4 overexpression also induced much severe mitochondrial dysfunction, as indicated by apoptotic mitochondria and increased mPTP. However, irisin treatment significantly attenuated all of these effects. Though irisin treatment did not influence the expression of HDAC4 at the transcriptional level, western blot analysis showed that HDAC4 protein levels decreased in a time-dependent way after administration of irisin, which is associated with the degradation of HDAC4 mediated by small ubiquitin-like modification (SUMO). Our results are the first to demonstrate that the protective effects of irisin in cardiomyoblasts exposed to hypoxia/reoxygenation might be associated with HDAC4 degradation.	[Zhao, Yu Tina; Wang, Hao; Du, Jianfeng; Zhao, Ting C.] Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Surg, Providence, RI 02918 USA; [Zhang, Shouyan] Zhengzhou Univ, Luoyang Cent Hosp, Dept Cardiol, Luoyang, Henan, Peoples R China; [Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA	Boston University; Roger Williams Medical Center; Zhengzhou University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhao, TC (corresponding author), Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Surg, Providence, RI 02918 USA.	tzhao@bu.edu		Zhang, Shouyan/0000-0003-2902-1668; Wang, Hao/0000-0001-5694-1203	National Heart, Lung, and Blood Institute [R01 HL089405, R01 HL115265]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work is supported by the National Heart, Lung, and Blood Institute Grant (R01 HL089405 and R01 HL115265), received by Dr. Ting C Zhao. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernuzzi F, 2009, CHEM-BIOL INTERACT, V177, P12, DOI 10.1016/j.cbi.2008.09.012; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chen HP, 2011, J CELL BIOCHEM, V112, P3246, DOI 10.1002/jcb.23251; Chen YF, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0262-8; DeNicola M, 2014, AM J PHYSIOL-ENDOC M, V307, pE630, DOI 10.1152/ajpendo.00109.2014; Du JF, 2015, J CELL PHYSIOL, V230, P1321, DOI 10.1002/jcp.24871; Dulian K, 2015, CRYOBIOLOGY, V71, P398, DOI 10.1016/j.cryobiol.2015.10.143; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Park MJ, 2015, CELL SIGNAL, V27, P1831, DOI 10.1016/j.cellsig.2015.04.010; Polyzos SA, 2014, METABOLISM, V63, P207, DOI 10.1016/j.metabol.2013.09.013; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Suleiman MS, 2001, PHARMACOL THERAPEUT, V89, P29, DOI 10.1016/S0163-7258(00)00102-9; Takai N, 2008, INT J MOL MED, V21, P637; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tong WN, 2013, AM J PHYSIOL-REG I, V304, pR613, DOI 10.1152/ajpregu.00515.2012; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yoon JC, 2014, P NATL ACAD SCI USA, V111, P3781, DOI 10.1073/pnas.1400705111; Zhang LX, 2010, AM J PHYSIOL-HEART C, V298, pH2154, DOI 10.1152/ajpheart.01015.2009; Zhang L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.379115; Zhang L, 2012, J PHARMACOL EXP THER, V341, P285, DOI 10.1124/jpet.111.189910; Zhang LX, 2014, AM J PHYSIOL-CELL PH, V307, pC358, DOI 10.1152/ajpcell.00187.2013; Zhao TC, 2007, CARDIOVASC RES, V76, P473, DOI 10.1016/j.cardiores.2007.08.010; Zhao TC, 2010, BBA-MOL CELL RES, V1803, P872, DOI 10.1016/j.bbamcr.2010.04.007; Zhu D, 2015, J MOL CELL CARDIOL, V87, P138, DOI 10.1016/j.yjmcc.2015.07.015	35	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166182	10.1371/journal.pone.0166182	http://dx.doi.org/10.1371/journal.pone.0166182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875543	Green Submitted, Green Published, gold			2022-12-26	WOS:000388886000008
J	Layton, KKS; Corstorphine, EA; Hebert, PDN				Layton, Kara K. S.; Corstorphine, Erin A.; Hebert, Paul D. N.			Exploring Canadian Echinoderm Diversity through DNA Barcodes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SPECIES COMPLEX; GENETIC-STRUCTURE; PACIFIC; SPECIATION; EVOLUTION; HISTORY; IDENTIFICATIONS; PHYLOGEOGRAPHY; HOLOTHUROIDEA	DNA barcoding has proven an effective tool for species identification in varied groups of marine invertebrates including crustaceans, molluscs, polychaetes and echinoderms. In this study, we further validate its utility by analyzing almost half of the 300 species of Echinodermata known from Canadian waters. COI sequences from 999 specimens were assigned to 145 BINs. In most cases, species discrimination was straightforward due to the large difference (25-fold) between mean intra- (0.48%) and inter- (12.0%) specific divergence. Six species were flagged for further taxonomic investigation because specimens assigned to them fell into two or three discrete sequence clusters. The potential influence of larval dispersal capacity and glacial events on patterns of genetic diversity is discussed for 19 trans-oceanic species. Although additional research is needed to clarify biogeographic patterns and resolve taxonomic questions, this study represents an important step in the assembly of a DNA barcode library for all Canadian echinoderms, a valuable resource for future biosurveillance programs.	[Layton, Kara K. S.; Corstorphine, Erin A.; Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Layton, Kara K. S.] Univ Western Australia, Ctr Evolutionary Biol, 35 Stirling Highway, Crawley, WA 6009, Australia	University of Guelph; University of Western Australia	Layton, KKS (corresponding author), Univ Guelph, Ctr Biodivers Genom, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.; Layton, KKS (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	kara.laytan@research.uvea.edu.au	Layton, Kara/AAC-6007-2019	Layton, Kara/0000-0002-4302-3048	Natural Sciences and Engineering Research Council (NSERC); government of Canada through Genome Canada; Ontario Genomics Institute [OGI-036]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This research was funded, in part, by the Natural Sciences and Engineering Research Council (NSERC) through a Discovery Grant to PDNH and a postgraduate scholarship to EAC. Sequence analysis was enabled by funding from the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project (OGI-036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt A, 1996, MOL PHYLOGENET EVOL, V6, P425, DOI 10.1006/mpev.1996.0091; Barber P, 2006, P ROY SOC B-BIOL SCI, V273, P2053, DOI 10.1098/rspb.2006.3540; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Carr CM, 2010, PLOS ONE, V6; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clark A.M., 1992, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dodson JJ, 2007, MOL ECOL, V16, P5030, DOI 10.1111/j.1365-294X.2007.03559.x; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Durham J. W., 1967, P326; Flowers JM, 2001, MAR BIOL, V139, P475, DOI 10.1007/s002270100595; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foltz DW, ECHINODERMS 2006, P167; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; Harper FM, 2007, INVERTEBR BIOL, V126, P373, DOI 10.1111/j.1744-7410.2007.00107.x; Harper FM, 2007, EVOLUTION, V61, P2410, DOI 10.1111/j.1558-5646.2007.00200.x; Hart MW, 1997, EVOLUTION, V51, P1848, DOI 10.1111/j.1558-5646.1997.tb05108.x; Hart MW, 2003, J MAR BIOL ASSOC UK, V83, P1109, DOI 10.1017/S002531540300835Xh; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hrincevich AW, 2000, AM ZOOL, V40, P365, DOI 10.1668/0003-1569(2000)040[0365:PAOMLI]2.0.CO;2; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozloff E.N., 1987, MARINE INVERTEBRATES; Lambert P, 2011, CANADIAN TECHNICAL R, V2929; Lambert P, 2000, SEA STARS BRIT COLUM; Lambert P, 1997, SEA CUCUMBERS BRIT C; Lambert P, 2007, BRITTLE STARS SEA UR; Layton KKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095003; MCCLARY DJ, 1989, MAR BIOL, V103, P531, DOI 10.1007/BF00399585; Mercier A, 2008, MAR BIOL, V156, P205, DOI 10.1007/s00227-008-1077-x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mikkelsen NT, 2007, ZOOL SCR, V36, P455, DOI 10.1111/j.1463-6409.2006.00289.x; Mortensen T., 1977, HDB ECHINODERMS BRIT; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; PALUMBI SR, 1990, EVOLUTION, V44, P403, DOI 10.1111/j.1558-5646.1990.tb05208.x; PALUMBI SR, 1991, EVOLUTION, V45, P1790, DOI 10.1111/j.1558-5646.1991.tb02688.x; Palumbi SR, 1997, EVOLUTION, V51, P1506, DOI 10.1111/j.1558-5646.1997.tb01474.x; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Pollock LW, 1998, PRACTICAL GUIDE MARI; Puillandre N, 2009, MOL ECOL RESOUR, V9, P1311, DOI 10.1111/j.1755-0998.2009.02576.x; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; SEWELL MA, 1995, CAN J ZOOL, V73, P469, DOI 10.1139/z95-054; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sponer R, 2002, EVOLUTION, V56, P1954; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; STICKLE WB, 1992, CAN J ZOOL, V70, P1723, DOI 10.1139/z92-239; Stohr S., 2015, WORLD OPHIUROIDEA DA; Strathmann MF, 1987, REPROD DEV MARINE IN; Svitoch AA, 1994, OCEANOLOGY, V34, P400; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MOL ECOL RESOUR, V8, P1202, DOI 10.1111/j.1755-0998.2008.02332.x; Wares JP, 2001, BIOL BULL-US, V201, P95, DOI 10.2307/1543530; Waters JM, 2004, MOL PHYLOGENET EVOL, V32, P236, DOI 10.1016/j.ympev.2003.11.014; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zigler KS, 2004, EVOLUTION, V58, P1225, DOI 10.1111/j.0014-3820.2004.tb01702.x	71	27	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166118	10.1371/journal.pone.0166118	http://dx.doi.org/10.1371/journal.pone.0166118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870868	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400005
J	Cho, J; Choi, SM; Lee, J; Lee, CH; Lee, SM; Yim, JJ; Chung, DH; Yoo, CG; Kim, YW; Han, SK; Park, YS				Cho, Jaeyoung; Choi, Sun Mi; Lee, Jinwoo; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Chung, Doo Hyun; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Park, Young Sik			The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INTERNATIONAL ASSOCIATION; GENE-MUTATIONS; NEVER-SMOKERS; CANCER; CLASSIFICATION; KRAS; PROGNOSIS; EPIDEMIOLOGY; CHEMOTHERAPY	Background The prognostic role of epidermal growth factor receptor (EGFR) mutations in patients with lung adenocarcinomas remains controversial and the association between EGFR mutations and stage at the time of the initial diagnosis is debatable. In this study, we evaluated the association of EGFR mutations with stage at diagnosis in lung adenocarcinomas. Materials and Methods We retrospectively analyzed 1004 consecutive patients who were diagnosed with lung adenocarcinomas and tested for EGFR mutations between June 2011 and December 2014. Results EGFR mutations were detected in 49.2% of 1004 patients with lung adenocarcinomas. In multivariable analysis, EGFR mutations were significantly associated with early stage disease (stage I to II) at diagnosis (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.49 +/- 0.87; P = 0.003). When adjusted for age, sex, smoking status, and screening, the adjusted proportion of EGFR mutations significantly decreased according to stage. The adjusted proportions of EGFR mutations were 57.6% (95% CI, 51.7%-63.3%) for stage I, 47.9% (95% CI, 36.9%-59.0%) for stage II, 47.5% (95% CI, 39.6%-55.5%) for stage III, and 43.4% (95% CI, 38.3%-48.6%) for stage IV (P = 0.0082). Conclusions The presence of EGFR mutations is significantly associated with early stage disease at initial diagnosis in lung adenocarcinomas after adjusting for age, sex, smoking status, andscreening. This finding implies that EGFR mutations may play a role as a positive prognostic marker.	[Cho, Jaeyoung; Choi, Sun Mi; Lee, Jinwoo; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Park, Young Sik] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Jaeyoung; Choi, Sun Mi; Lee, Jinwoo; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Park, Young Sik] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Park, YS (corresponding author), Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea.	mdyspark@gmail.com	Lee, Chang-Hoon/AAC-7650-2021; Cho, Jaeyoung/AAK-6561-2021	Cho, Jaeyoung/0000-0002-6537-8843; Yim, Jae-Joon/0000-0002-9605-0074				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Edge SB, 2010, AJCC CANC STAGING MA; Fang S, 2014, DRUG DES DEV THER, V8, P1595, DOI 10.2147/DDDT.S69690; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Han HS, 2012, J THORAC ONCOL, V7, P355, DOI 10.1097/JTO.0b013e31823c4c1b; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Izar B, 2013, ANN THORAC SURG, V96, P962, DOI 10.1016/j.athoracsur.2013.05.091; Jeon JH, 2015, EUR J CARDIO-THORAC, V47, P556, DOI 10.1093/ejcts/ezu177; Kim YT, 2013, J THORAC ONCOL, V8, P171, DOI 10.1097/JTO.0b013e318277a3bb; Kobayashi N, 2008, J THORAC ONCOL, V3, P704, DOI 10.1097/JTO.0b013e31817c6080; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Liu WS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0771-9; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mansuet-Lupo A, 2014, CHEST, V146, P633, DOI 10.1378/chest.13-2499; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Nakamura R, 2014, J THORAC ONCOL, V9, P1340, DOI 10.1097/JTO.0000000000000022; OROURKE MA, 1987, JAMA-J AM MED ASSOC, V258, P921, DOI 10.1001/jama.258.7.921; Ramalingam S, 1998, J CLIN ONCOL, V16, P651, DOI 10.1200/JCO.1998.16.2.651; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shepherd FA, 2006, J CLIN ONCOL, V24, P1219, DOI 10.1200/JCO.2005.04.4420; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Sholl LM, 2015, J THORAC ONCOL, V10, P768, DOI 10.1097/JTO.0000000000000516; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Usuda K, 2014, ASIAN PAC J CANCER P, V15, P657, DOI 10.7314/APJCP.2014.15.2.657; Wu MN, 2010, LUNG CANCER, V67, P343, DOI 10.1016/j.lungcan.2009.04.011; Xu DM, 2006, LUNG CANCER, V54, P177, DOI 10.1016/j.lungcan.2006.08.006; Xu DM, 2009, RADIOLOGY, V250, P264, DOI 10.1148/radiol.2493070847; Yanagawa N, 2014, ANN THORAC SURG, V98, P453, DOI 10.1016/j.athoracsur.2014.04.108; Yang P, 2012, J THORAC ONCOL, V7, P90, DOI 10.1097/JTO.0b013e31823c5c32; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511	35	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166821	10.1371/journal.pone.0166821	http://dx.doi.org/10.1371/journal.pone.0166821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861565	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300114
J	Lajko, M; Cardona, HJ; Taylor, JM; Shah, RS; Farrow, KN; Fawzi, AA				Lajko, Michelle; Cardona, Herminio J.; Taylor, Joann M.; Shah, Ronil S.; Farrow, Kathryn N.; Fawzi, Amani A.			Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; BRONCHOPULMONARY DYSPLASIA; LUNG DEVELOPMENT; NAD(P)H OXIDASE; GENE-EXPRESSION; ANIMAL-MODELS; MOUSE RETINA; MULLER CELLS; VEGF	Bronchopulmonary dysplasia (BPD) is a major cause of neonatal morbidity in premature infants, occurring as a result of arrested lung development combined with multiple postnatal insults. Infants with BPD exposed to supplemental oxygen are at risk of retinopathy of prematurity as well. Thus, we studied the effects of hyperoxia on the retinal vasculature in a murine model of BPD. The retinal phenotype of this model, which we termed hyperoxia-induced proliferative retinopathy (HIPR), shows severe disruption of retinal vasculature and loss of vascular patterning, disorganized intra-retinal angiogenesis, inflammation and retinal detachment. Neonatal mice were subjected to 75% oxygen exposure from postnatal day (P)0 to P14 to model BPD, then allowed to recover in room air for 1 (P15), 7 (P21), or 14 days (P28). We quantified retinal thickness, protein levels of HIF-1 alpha, NOX2, and VEGF, and examined the cellular locations of these proteins by immunohistochemistry. We examined the retinal blood vessel integrity and inflammatory markers, including macrophages (F4/80) and lymphocytes (CD45R). Compared to controls, normal retinal vascular development was severely disrupted and replaced by a disorganized sheet of intra-retinal angiogenesis in the HIPR mice. At all time-points, HIPR showed persistent hyaloidal vasculature and a significantly thinner central retina compared to controls. HIF-1 alpha protein levels were increased at P15, while VEGF levels continued to increase until P21. Intra-retinal fibrinogen was observed at P21 followed by sub-retinal deposition in at P28. Inflammatory lymphocytes and macrophages were observed at P21 and P28, respectively. This model presents a severe phenotype of disrupted retinal vascular development, intra-retinal angiogenesis inflammation and retinal detachment.	[Lajko, Michelle; Shah, Ronil S.; Fawzi, Amani A.] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; [Cardona, Herminio J.; Taylor, Joann M.; Farrow, Kathryn N.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	afawzirnd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	National Institutes of Health [5R21HD077336, R01HL109478]; Friends of Prentice Grants Initiative of the Northwestern Memorial Foundation; NCI CCSG [P30 CA060553]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077336] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Prentice Grants Initiative of the Northwestern Memorial Foundation; NCI CCSG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (5R21HD077336, K.N.F. and A.A.F.; and R01HL109478, K.N.F.) and The Friends of Prentice Grants Initiative of the Northwestern Memorial Foundation (K.N.F.). Histology services were provided by the Northwestern University Research Histology and Phenotyping Laboratory; confocal microscopy was performed at the Northwestern University Center for Advanced Microscopy. Both core facilities are supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Adams RA, 2004, MOL INTERV, V4, P163; Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P397, DOI 10.1136/bjo.38.7.397; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; BIGNAMI A, 1979, EXP EYE RES, V28, P63; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan EC, 2013, INVEST OPHTH VIS SCI, V54, P7061, DOI 10.1167/iovs.13-12883; Check J, 2013, J PERINATOL, V33, P553, DOI 10.1038/jp.2012.164; Chou JC, 2014, INVEST OPHTH VIS SCI, V55, P2516, DOI 10.1167/iovs.13-13676; Datta A, 2015, AM J PHYSIOL-LUNG C, V309, pL369, DOI 10.1152/ajplung.00176.2014; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; de Visser YP, 2008, EUR RESPIR J, V31, P633, DOI 10.1183/09031936.00071307; de Visser YP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-30; Dorrell MI, 2010, GLIA, V58, P43, DOI 10.1002/glia.20900; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; ERICKSON PA, 1987, EXP EYE RES, V44, P37, DOI 10.1016/S0014-4835(87)80023-4; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Fawzi AA, 2014, INVEST OPHTH VIS SCI, V55, P1493, DOI 10.1167/iovs.13-13207; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Guduric-Fuchs J, 2009, MOL VIS, V15, P1915; Hamilton BE, 2015, NATL VITAL STAT REP, V65, P1; Han RNN, 1996, PEDIATR RES, V39, P921, DOI 10.1203/00006450-199606000-00001; Hartnett ME, 2015, OPHTHALMOLOGY, V122, P200, DOI 10.1016/j.ophtha.2014.07.050; Hofman P, 2001, OPHTHALMIC RES, V33, P156, DOI 10.1159/000055663; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; JIANG B, 1995, GLIA, V15, P1, DOI 10.1002/glia.440150102; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; Lashkari K, 2000, AM J PATHOL, V156, P1337, DOI 10.1016/S0002-9440(10)65004-3; Lee KJ, 2014, AM J RESP CELL MOL, V50, P369, DOI 10.1165/rcmb.2013-0118OC; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040347; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; McEvoy CT, 2015, CLIN PERINATOL, V42, P911, DOI 10.1016/j.clp.2015.08.014; McEvoy Cindy T, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS146, DOI 10.1513/AnnalsATS.201312-424LD; MILLER B, 1986, ARCH OPHTHALMOL-CHIC, V104, P281, DOI 10.1001/archopht.1986.01050140139037; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; MURATA T, 1992, GRAEF ARCH CLIN EXP, V230, P428, DOI 10.1007/BF00175927; Nayagam DAX, 2013, TECHNIQUES PROCESSIN; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Noma H, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-38; O'Reilly M, 2014, AM J PHYSIOL-LUNG C, V307, pL948, DOI 10.1152/ajplung.00160.2014; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; PENN JS, 1994, PEDIATR RES, V36, P724, DOI 10.1203/00006450-199412000-00007; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Poon AWH, 2016, BIOL OPEN, V5, P475, DOI 10.1242/bio.017665; Provis JM, 1997, EXP EYE RES, V65, P555, DOI 10.1006/exer.1997.0365; Rieger-Fackeldey E, 2014, AM J PATHOL, V184, P1010, DOI 10.1016/j.ajpath.2013.12.021; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Soetikno BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16752; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; VINORES SA, 1995, HISTOL HISTOPATHOL, V10, P141; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; WATTS CL, 1992, J PEDIATR-US, V120, P614, DOI 10.1016/S0022-3476(05)82492-8; Wheatley CM, 2002, ARCH DIS CHILD-FETAL, V87, pF78, DOI 10.1136/fn.87.2.F78; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827; Yanni SE, 2010, NEUROMETHODS, V46, P99, DOI 10.1007/978-1-60761-541-5_6; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117	82	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166886	10.1371/journal.pone.0166886	http://dx.doi.org/10.1371/journal.pone.0166886			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861592	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300128
J	Tochio, T; Kitaura, Y; Nakamura, S; Sugawa, C; Takahashi, M; Endo, A; Shimomura, Y				Tochio, Takumi; Kitaura, Yasuyuki; Nakamura, Saki; Sugawa, Chie; Takahashi, Motoki; Endo, Akihito; Shimomura, Yoshiharu			An Alteration in the Cecal Microbiota Composition by Feeding of 1-Kestose Results in a Marked Increase in the Cecal Butyrate Content in Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PREBIOTIC OLIGOSACCHARIDE; FECAL BIFIDOBACTERIA; FRUCTOOLIGOSACCHARIDES; FERMENTATION; EXCRETION; COLON	Functional food ingredients, including prebiotics, have been ardently developed for improving the intestinal environment. Fructooligosaccarides (FOS), including fructans, are the well researched and commercialized prebiotics. However, to our knowledge, few studies have been conducted on the physiological effects of each component of FOS as prebiotics. 1-Kestose, a component of FOS, is composed of one glucose and two fructose molecules, and is considered as a key prebiotic component in short-chain FOS. In the present study, we examined the effects of dietary 1-kestose using 0.5-5% 1-kestose diets on cecal micro biota composition and cecal contents of short-chain fatty acids and lactate in rats. The findings indicate that dietary 1-kestose induced cecal hypertrophy and alterations in the cecal microbiota composition, including a marked increase in the cell number of Bifidobacterium spp. These alterations were associated with significant increases in acetate and lactate, and a marked increase in butyrate in cecal contents. Furthermore, dietary 1-kestose induced a significant decrease in serum insulin concentration in rats fed 2.5-5% 1-kestose diet. These findings suggest a potential of 1-kestose to be a prebiotic for improving the metabolism of the host.	[Tochio, Takumi; Nakamura, Saki; Sugawa, Chie] B Food Sci Co Ltd, Chita, Aichi, Japan; [Kitaura, Yasuyuki; Takahashi, Motoki; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Nutr Biochem, Nagoya, Aichi, Japan; [Endo, Akihito] Tokyo Univ Agr, Fac Bioind, Dept Food & Cosmet Sci, Abashiri, Hokkaido, Japan	Nagoya University; Tokyo University of Agriculture	Shimomura, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Nutr Biochem, Nagoya, Aichi, Japan.	shimo@agr.nagoya-u.ac.jp			B Food Science Co., Ltd.; Graduate School of Bioagricultural Sciences, Nagoya University	B Food Science Co., Ltd.; Graduate School of Bioagricultural Sciences, Nagoya University	The project was partially funded by the B Food Science Co., Ltd. Support for this project was also provided by the Graduate School of Bioagricultural Sciences, Nagoya University. The funder provided support in the form of salaries for authors [TT, SN, CS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bouhnik Y, 1999, J NUTR, V129, P113, DOI 10.1093/jn/129.1.113; Campbell JM, 1997, J AGR FOOD CHEM, V45, P3076, DOI 10.1021/jf970087g; Campbell JM, 1997, J NUTR, V127, P130, DOI 10.1093/jn/127.1.130; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Delzenne NM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S10; Endo A, 2016, INT J FOOD SCI NUTR, V67, P125, DOI 10.3109/09637486.2016.1147019; Gomidesl AFF, 2014, NUTR HOSP, V30, P883, DOI 10.3305/nh.2014.30.4.7672; Fuller R., 1998, CLIN MICROBIOL INFEC, V4, P477, DOI [DOI 10.1111/j.1469-0691.1998.tb00401.x, 10.1111/j.1469-0691.1998.tb00401.x, DOI 10.1111/J.1469-0691.1998.TB00401.X]; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Isolauri E, 2012, J PAEDIATR CHILD H, V48, P1, DOI 10.1111/j.1440-1754.2012.02489.x; Jinno S, 2014, BIOSCI BIOTECH BIOCH, V78, P861, DOI 10.1080/09168451.2014.905179; MASHIGE F, 1981, CLIN CHEM, V27, P1352; Merino-Aguilar H, 2014, NUTRIENTS, V6, P591, DOI 10.3390/nu6020591; Molis C, 1996, AM J CLIN NUTR, V64, P324, DOI 10.1093/ajcn/64.3.324; Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568; Nakamura S, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/303184; Oishi K, 2015, J NUTR, V145, P199, DOI 10.3945/jn.114.202754; OKU T, 1984, J NUTR, V114, P1574, DOI 10.1093/jn/114.9.1574; Paineau D, 2014, J NUTR SCI VITAMINOL, V60, P167, DOI 10.3177/jnsv.60.167; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Pineiro M, 2008, J CLIN GASTROENTEROL, V42, pS156, DOI 10.1097/MCG.0b013e31817f184e; Sakaguchi E, 1998, BRIT J NUTR, V80, P469, DOI 10.1017/S0007114598001548; Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Shibata R, 2009, CLIN EXP ALLERGY, V39, P1397, DOI 10.1111/j.1365-2222.2009.03295.x; Suzuki N., 2006, Bioscience and Microflora, V25, P109; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Zhang Y, 2010, CHEM-BIOL INTERACT, V185, P174, DOI 10.1016/j.cbi.2010.03.035	33	25	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166850	10.1371/journal.pone.0166850	http://dx.doi.org/10.1371/journal.pone.0166850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861621	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300125
J	Tse, A; Verkhivker, GM				Tse, Amanda; Verkhivker, Gennady M.			Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways	PLOS ONE			English	Article							B-RAF KINASE; PROTEIN-TYROSINE KINASES; ONCOGENIC MUTATIONS; FORCE-FIELD; DELETION MUTATIONS; MUTUAL INFORMATION; INHIBITOR TAK-632; DRUG DISCOVERY; MAPK PATHWAY; BINDING MODE	The recent studies have revealed that most BRAF inhibitors can paradoxically induce kinase activation by promoting dimerization and enzyme transactivation. Despite rapidly growing number of structural and functional studies about the BRAF dimer complexes, the molecular basis of paradoxical activation phenomenon is poorly understood and remains largely hypothetical. In this work, we have explored the relationships between inhibitor binding, protein dynamics and allosteric signaling in the BRAF dimers using a network-centric approach. Using this theoretical framework, we have combined molecular dynamics simulations with coevolutionary analysis and modeling of the residue interaction networks to determine molecular determinants of paradoxical activation. We have investigated functional effects produced by paradox inducer inhibitors PLX4720, Dabrafenib, Vemurafenib and a paradox breaker inhibitor PLX7904. Functional dynamics and binding free energy analyses of the BRAF dimer complexes have suggested that negative cooperativity effect and dimer-promoting potential of the inhibitors could be important drivers of paradoxical activation. We have introduced a protein structure network model in which coevolutionary residue dependencies and dynamic maps of residue correlations are integrated in the construction and analysis of the residue interaction networks. The results have shown that coevolutionary residues in the BRAF structures could assemble into independent structural modules and form a global interaction network that may promote dimerization. We have also found that BRAF inhibitors could modulate centrality and communication propensities of global mediating centers in the residue interaction networks. By simulating allosteric communication pathways in the BRAF structures, we have determined that paradox inducer and breaker inhibitors may activate specific signaling routes that correlate with the extent of paradoxical activation. While paradox inducer inhibitors may facilitate a rapid and efficient communication via an optimal single pathway, the paradox breaker may induce a broader ensemble of suboptimal and less efficient communication routes. The central finding of our study is that paradox breaker PLX7904 could mimic structural, dynamic and network features of the inactive BRAF-WT monomer that may be required for evading paradoxical activation. The results of this study rationalize the existing structure-functional experiments by offering a network-centric rationale of the paradoxical activation phenomenon. We argue that BRAF inhibitors that amplify dynamic features of the inactive BRAF-WT monomer and intervene with the allosteric interaction networks may serve as effective paradox breakers in cellular environment.	[Tse, Amanda; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Dept Computat & Data Sci, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Irvine, CA USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Dept Computat & Data Sci, Orange, CA 92866 USA.; Verkhivker, GM (corresponding author), Chapman Univ, Sch Pharm, Irvine, CA USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471				Aguilar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041430; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Arora R, 2015, J MED CHEM, V58, P1818, DOI 10.1021/jm501667n; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Basile KJ, 2014, PIGM CELL MELANOMA R, V27, P479, DOI 10.1111/pcmr.12218; Bayliss R, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120136; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blacklock K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071936; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Bren U, 2012, J CHEM INF MODEL, V52, P1573, DOI 10.1021/ci300118x; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Caballero J, 2011, J CHEM INF MODEL, V51, P2920, DOI 10.1021/ci200306w; Chakrabarti S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008591; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Choi J, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12197; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Coronel L, 2015, CURR COMPUT-AID DRUG, V11, P124, DOI 10.2174/1573409911666150702100245; Cowan-Jacob SW, 2006, CELL MOL LIFE SCI, V63, P2608, DOI 10.1007/s00018-006-6202-8; Cowan-Jacob SW, 2014, FUTURE MED CHEM, V6, P541, DOI 10.4155/fmc.13.216; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Dam TK, 2002, BIOCHEMISTRY-US, V41, P1351, DOI 10.1021/bi015830j; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dodson CA, 2013, BIOCHEM SOC T, V41, P1037, DOI 10.1042/BST20130066; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eyal E, 2015, BIOINFORMATICS, V31, P1487, DOI 10.1093/bioinformatics/btu847; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Freed DM, 2016, CANCER CELL, V29, P423, DOI 10.1016/j.ccell.2016.03.017; Frisch MJ, 2009, GAUSSIAN 09 VERSION; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hantschel Oliver, 2012, Genes Cancer, V3, P436, DOI 10.1177/1947601912458584; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Holderfield M, 2014, BRIT J CANCER, V111, P640, DOI 10.1038/bjc.2014.139; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jambrina PG, 2014, BIOCHEM SOC T, V42, P784, DOI 10.1042/BST20140025; James KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113488; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Keskin O, 2002, J BIOMOL STRUCT DYN, V20, P333, DOI 10.1080/07391102.2002.10506852; Keskin O, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-31; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lavoie H, 2014, TRENDS BIOCHEM SCI, V39, P475, DOI 10.1016/j.tibs.2014.08.004; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/NCHEMBIO.1257, 10.1038/nchembio.1257]; Le K, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12092; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Li Y, 2014, CHEM BIOL DRUG DES, V83, P643, DOI 10.1111/cbdd.12276; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Marino KA, 2015, J AM CHEM SOC, V137, P5280, DOI 10.1021/jacs.5b01421; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Masterson LR, 2012, ADV PROTEIN CHEM STR, V87, P363, DOI 10.1016/B978-0-12-398312-1.00012-3; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Mayne CG, 2013, J COMPUT CHEM, V34, P2757, DOI 10.1002/jcc.23422; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Meireles L, 2011, PROTEIN SCI, V20, P1645, DOI 10.1002/pro.711; Moretti S, 2009, BBA-MOL CELL RES, V1793, P1634, DOI 10.1016/j.bbamcr.2009.09.001; Nakamura A, 2013, CANCER RES, V73, P7043, DOI 10.1158/0008-5472.CAN-13-1825; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okaniwa M, 2013, J MED CHEM, V56, P6478, DOI 10.1021/jm400778d; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Panjarian S, 2013, J BIOL CHEM, V288, P5443, DOI 10.1074/jbc.R112.438382; Pei JF, 2014, J AM CHEM SOC, V136, P11556, DOI 10.1021/ja504810z; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Sacquin-Mora S, 2010, BIOPHYS J, V99, P3412, DOI 10.1016/j.bpj.2010.09.026; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Stetz G, 2016, J CHEM INF MODEL, V56, P1490, DOI 10.1021/acs.jcim.5b00755; Stetz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143752; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Telesco SE, 2011, MOL BIOSYST, V7, P2066, DOI 10.1039/c0mb00345j; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tse A, 2015, J CHEM INF MODEL, V55, P1645, DOI 10.1021/acs.jcim.5b00240; Tse A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130203; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Verkhivker GM, 2016, MOL BIOSYST, V12, P3146, DOI 10.1039/c6mb00298f; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Waizenegger IC, 2016, MOL CANCER THER, V15, P354, DOI 10.1158/1535-7163.MCT-15-0617; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wan SZ, 2011, J COMPUT CHEM, V32, P2843, DOI 10.1002/jcc.21866; Wenglowsky S, 2012, BIOORG MED CHEM LETT, V22, P6237, DOI 10.1016/j.bmcl.2012.08.007; Williams TE, 2015, ACS MED CHEM LETT, V6, P961, DOI 10.1021/ml500526p; Wu P, 2015, PHARMACOL THERAPEUT, V156, P59, DOI 10.1016/j.pharmthera.2015.10.002; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Xu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005913; Yang LW, 2006, NUCLEIC ACIDS RES, V34, pW24, DOI 10.1093/nar/gkl084; Yang L, 2008, STRUCTURE, V16, P321, DOI 10.1016/j.str.2007.12.011; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117506	150	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166583	10.1371/journal.pone.0166583	http://dx.doi.org/10.1371/journal.pone.0166583			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861609	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300074
J	Vishnu, VY; Modi, M; Sharma, S; Mohanty, M; Goyal, MK; Lal, V; Khandelwal, N; Mittal, BR; Prabhakar, S				Vishnu, Venugopalan Y.; Modi, Manish; Sharma, Sandeep; Mohanty, Manju; Goyal, Manoj Kumar; Lal, Vivek; Khandelwal, Niranjan; Mittal, Bhagwant Rai; Prabhakar, Sudesh			Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; RISK; CLU; PICALM; CR-1; LOCI	Objective To evaluate the role of plasma clusterin in Alzheimer's disease (AD). Background Plasma clusterin is a promising biomarker as various studies have shown it to be associated with AD. But other studies have shown that plasma clusterin levels were not related to Alzheimer's disease or presymptomatic AD. Hence the diagnostic value of plasma clusterin is still not conclusive. Methods Neuropsychological assessment, MRI brain, FDG-PET brain and CSF biomarkers of AD were used for establishing the diagnosis of MCI, AD or Vascular dementia. The CSF control group included patients who were having knee or hip surgery and plasma control group included the spouses of patients. Results Forty-six patients who gave consent for CSF examination and FDG PET brain were included in the study along with 19 control samples. Alzheimer's group had 34 patients and Vascular group had 12 patients. Both had a significantly lower value of clusterin than the control samples (p< 0.01). The median plasma clusterin level was 84.38 mu g/ml in control group, 57.98 mu g/ml in Alzheimer's group and 49.93 mu g/ml in the vascular group. Alzheimer and Vascular group did not differ in plasma clusterin levels. Moreover there was no correlation of plasma clusterin with AD severity. The sensitivity and specificity of plasma clusterin was low for any significance for clinical use. Conclusion Our pilot study shows that plasma clusterin is lower in Alzheimer's disease with respect to control population. Plasma clusterin levels and severity of Alzheimer's disease had no significant correlation. There was no difference in plasma clusterin between Alzheimer's disease and Vascular Dementia. The sensitivity and specificity of plasma clusterin is low for any use in clinical practice. More studies are required to ascertain the utility of plasma clusterin as a biomarker in Alzheimer's disease.	[Vishnu, Venugopalan Y.; Modi, Manish; Sharma, Sandeep; Goyal, Manoj Kumar; Lal, Vivek; Prabhakar, Sudesh] Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India; [Mohanty, Manju] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Khandelwal, Niranjan] Postgrad Inst Med Educ & Res, Dept Radiol, Chandigarh 160012, India; [Mittal, Bhagwant Rai] Postgrad Inst Med Educ & Res, Dept Nucl Med, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Modi, M (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.		Vishnu, Venugopalan Y/Q-1382-2019	Vishnu, Venugopalan Y/0000-0002-3654-8137; Modi, Manish/0000-0002-5494-3704				Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; [Anonymous], 2013, POLICY BRIEF HEADS G; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; GHISO J, BIOCH J, V293, P27; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Ijsselstijn L, 2011, J PROTEOME RES, V10, P2006, DOI 10.1021/pr101221h; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Ling IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033923; Pedraza O, 2014, ALZHEIMERS DEMENT, V10, P205, DOI 10.1016/j.jalz.2013.01.016; Rosenthal Samantha L, 2014, Curr Genet Med Rep, V2, P85; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schurmann B, 2011, J ALZHEIMERS DIS, V25, P421, DOI 10.3233/JAD-2011-110251; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Silajdzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050237; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Xing YY, 2012, J ALZHEIMERS DIS, V29, P515, DOI 10.3233/JAD-2011-111844; Yu JT, 2012, MOL NEUROBIOL, V45, P314, DOI 10.1007/s12035-012-8237-1	18	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166369	10.1371/journal.pone.0166369	http://dx.doi.org/10.1371/journal.pone.0166369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861589	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300051
J	Goreczny, GJ; Ouderkirk-Pecone, JL; Olson, EC; Krendel, M; Turner, CE				Goreczny, G. J.; Ouderkirk-Pecone, J. L.; Olson, E. C.; Krendel, M.; Turner, C. E.			Hic-5 remodeling of the stromal matrix promotes breast tumor progression	ONCOGENE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; EXTRACELLULAR-MATRIX; FOCAL ADHESIONS; TGF-BETA; MESENCHYMAL TRANSITION; COLLECTIVE INVASION; GENE-EXPRESSION; CELL-MIGRATION; MYOFIBROBLAST; PAXILLIN	The remodeling of the stromal extracellular matrix (ECM) has a crucial, but incompletely understood role during tumor progression and metastasis. Hic-5, a focal adhesion scaffold protein, has previously been implicated in tumor cell invasion, proliferation and metastasis. To investigate the role of Hic-5 in breast tumor progression in vivo, Hic-(5-/-) mice were generated and crossed with the Mouse Mammary Tumor Virus-Polyoma Middle T-Antigen mouse. Tumors from the Hic-5(-/-) ;PyMT mice exhibited increased latency and reduced growth, with fewer lung metastases, as compared with Hic-5(+/-); PyMT mice. Immunohistochemical analysis showed that Hic-5 is primarily expressed in the cancer-associated fibroblasts (CAFs). Further analysis revealed that the Hic-5(-/-); PyMT tumor stroma contains fewer CAFs and exhibits reduced ECM deposition. The remodeling of the stromal matrix by CAFs has been shown to increase tumor rigidity to indirectly regulate FAK Y397 phosphorylation in tumor cells to promote their growth and invasion. Accordingly, the Hic-5(-/-) ;PyMT tumor cells exhibited a reduction in FAK Y397 phosphorylation. Isolated Hic-5(-/-); PyMT CAFs were defective in stress fiber organization and exhibited reduced contractility. These cells also failed to efficiently deposit and organize the ECM in two and three dimensions. This, in turn, impacted three-dimensional MDA-MB-231 tumor cell migration behavior. Thus, using a new knockout mouse model, we have identified Hic-5 expression in CAFs as a key requirement for deposition and remodeling of the stromal ECM to promote non-cell autonomous breast tumor progression.	[Goreczny, G. J.; Ouderkirk-Pecone, J. L.; Krendel, M.; Turner, C. E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, 750 East Adams St, Syracuse, NY 13210 USA; [Olson, E. C.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Turner, CE (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, 750 East Adams St, Syracuse, NY 13210 USA.	turnerce@upstate.edu			National Institutes of Health [R01 CA163296, R01 GM047607, R01 NS066071, R01 DK083345]; Carol M Baldwin Breast Cancer Research Fund of CNY; NATIONAL CANCER INSTITUTE [R01CA163296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol M Baldwin Breast Cancer Research Fund of CNY; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Turner lab for critical reading of this manuscript and for insightful discussions. We are grateful to Ian Forsythe for the mouse genotyping and additional technical assistance. We also thank Nicholas Deakin for his assistance in isolating CTCs. This work was supported by the National Institutes of Health Grant R01 CA163296 and R01 GM047607 to CET R01 NS066071 to ECO and CET, R01 DK083345 to MK and the Carol M Baldwin Breast Cancer Research Fund of CNY awards to CET and MK.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Cirri P, 2011, AM J CANCER RES, V1, P482; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Deakin NO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037990; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kuo JC, 2013, J CELL MOL MED, V17, P704, DOI 10.1111/jcmm.12054; Kutys ML, 2013, EXP CELL RES, V319, P2434, DOI 10.1016/j.yexcr.2013.05.030; Lei XF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000747; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nguyen-Ngoc KV, 2015, METHODS MOL BIOL, V1189, P135, DOI 10.1007/978-1-4939-1164-6_10; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ouderkirk-Pecone JL, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10139; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Plante Isabelle, 2011, J Vis Exp, DOI 10.3791/2828; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shola DTN, 2012, ONCOGENE, V31, P2480, DOI 10.1038/onc.2011.422; Tchou J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-39; Thomas SM, 1999, J CELL SCI, V112, P181; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Varney SD, 2016, J CELL SCI, V129, P774, DOI 10.1242/jcs.170589; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	52	31	32	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2693	2703		10.1038/onc.2016.422	http://dx.doi.org/10.1038/onc.2016.422			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27893716	Green Accepted			2022-12-26	WOS:000401120900007
J	Sato, K; Fujita, S; Iemitsu, M				Sato, Koji; Fujita, Satoshi; Iemitsu, Motoyuki			Dioscorea esculenta-induced increase in muscle sex steroid hormones is associated with enhanced insulin sensitivity in a type 2 diabetes rat model	FASEB JOURNAL			English	Article						diosgenin; insulin resistance; exercise; DHT	SKELETAL-MUSCLE; IMPROVES HYPERGLYCEMIA; GLUCOSE-METABOLISM; CANCER CELLS; DHEA; EXERCISE; RESISTANCE; PATHWAY; DIOSGENIN; RECEPTOR	The effects of chronic Dioscorea esculenta administration and exercise training on muscle sex steroid hormone levels and insulin resistance in type 2 diabetes rats was assessed. Twenty-week-old male Otsuka Long Evans Tokushima Fatty (OLETF) rats were assigned randomly to the control, D. esculenta treatment, D. esculenta with 5-reductase inhibitor treatment, or the exercise training groups (running at 25 m/min for 1 h, 5 d/wk; n = 10 each group). Eight weeks of D. esculenta treatment or exercise training significantly attenuated the increase in plasma insulin and fasting glucose levels. Plasma and muscle concentrations of dehydroepiandrosterone and 5-dihydrotestosterone (DHT) and the expression of 5-reductase increased significantly in the D. esculenta-treated and exercise training groups, and both treatments led to the upregulation of glucose transporter-4 translocation with concomitant increases in PKB and PKC-/ phosphorylation. Furthermore, the glucose metabolic clearance rate, which represents insulin sensitivity, increased significantly in both the D. esculenta-treated and exercise training groups. These effects were suppressed by administration of the DHT synthetic inhibitor. Together, these findings suggest that the D. esculenta-induced increase in muscle sex steroid hormone levels helps decrease insulin resistance in type 2 diabetes.	[Sato, Koji; Fujita, Satoshi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Japan; [Sato, Koji] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan	Ritsumeikan University; Kobe University	Sato, K (corresponding author), Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo, Japan.	sato712@people.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H03091]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Prof. Noboru Mesaki, University of Tsukuba, for his support during the study. This work was supported by Grant-in-Aid for Scientific Research 15H03091 (to M.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare no conflicts of interest.	Aizawa K, 2010, STEROIDS, V75, P219, DOI 10.1016/j.steroids.2009.12.002; Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Campbell CSG, 2004, LIFE SCI, V76, P57, DOI 10.1016/j.lfs.2004.06.017; Fujita S, 2007, DIABETES, V56, P1615, DOI 10.2337/db06-1566; Han DH, 1998, J GERONTOL A-BIOL, V53, pB19, DOI 10.1093/gerona/53A.1.B19; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Mukasa K, 1998, J STEROID BIOCHEM, V67, P355, DOI 10.1016/S0960-0760(98)00126-5; Raju J, 2004, CANCER EPIDEM BIOMAR, V13, P1392; Sato K, 2014, J STEROID BIOCHEM, V143, P152, DOI 10.1016/j.jsbmb.2014.02.020; Sato K, 2009, ACTA PHYSIOL, V197, P217, DOI 10.1111/j.1748-1716.2009.02011.x; Sato K., 2013, J DIAB METAB, V4, P1; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Sato Y, 2003, EXP BIOL MED, V228, P1208, DOI 10.1177/153537020322801017; SHEPHERD A, 1984, AM J PHYSIOL, V246, pE123, DOI 10.1152/ajpendo.1984.246.2.E123; Tworoger SS, 2008, AM J EPIDEMIOL, V167, P211, DOI 10.1093/aje/kwm278; Villareal DT, 2004, JAMA-J AM MED ASSOC, V292, P2243, DOI 10.1001/jama.292.18.2243; Weiss EP, 2011, AGING-US, V3, P533, DOI 10.18632/aging.100327; Zheng YC, 2011, ENDOCR-RELAT CANCER, V18, P451, DOI 10.1530/ERC-11-0010; Zierath JR, 2002, J APPL PHYSIOL, V93, P773, DOI 10.1152/japplphysiol.00126.2002	21	14	16	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					793	801		10.1096/fj.201600874R	http://dx.doi.org/10.1096/fj.201600874R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871063				2022-12-26	WOS:000394235400031
J	Bowen, A; Wear, MP; Cordero, RJB; Oscarson, S; Casadevall, A				Bowen, Anthony; Wear, Maggie P.; Cordero, Radames J. B.; Oscarson, Stefan; Casadevall, Arturo			A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN; CAPSULAR GLUCURONOXYLOMANNAN; CATALYTIC ANTIBODIES; CRYSTAL-STRUCTURE; FINE SPECIFICITY; SITE; IDENTIFICATION; ISOTYPE; DNA; AUTOANTIBODIES	Studies in the 1980s first showed that some natural antibodies were "catalytic" and able to hydrolyze peptide or phosphodiester bonds in antigens. Many naturally occurring catalytic antibodies have since been isolated from human sera and associated with positive and negative outcomes in autoimmune disease and infection. The function and prevalence of these antibodies, however, remain unclear. A previous study suggested that the 18B7 monoclonal antibody against glucuronoxylomannan (GXM), the major component of the Cryptococcus neoformans polysaccharide capsule, hydrolyzed a peptide antigen mimetic. Using mass spectrometry and Forster resonance energy transfer techniques, we confirm and characterize the hydrolytic activity of 18B7 against peptide mimetics and show that 18B7 is able to hydrolyze an oligosaccharide substrate, providing the first example of a naturally occurring catalytic antibody for polysaccharides. Additionally, we show that the catalytic 18B7 antibody increases release of capsular polysaccharide from fungal cells. A serine protease inhibitor blocked peptide and oligosaccharide hydrolysis by 18B7, and a putative serine protease-like active site was identified in the light chain variable region of the antibody. An algorithm was developed to detect similar sites present in unique antibody structures in the Protein Data Bank. The putative site was found in 14 of 63 (22.2%) catalytic antibody structures and 119 of 1602 (7.4%) antibodies with no annotation of catalytic activity. The ability of many antibodies to cleave antigen, albeit slowly, supports the notion that this activity is an important immunoglobulin function in host defense. The discovery of GXM hydrolytic activity suggests new therapeutic possibilities for polysaccharide-binding antibodies.	[Bowen, Anthony] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Wear, Maggie P.; Cordero, Radames J. B.; Casadevall, Arturo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Rm E5132,615 N Wolfe St, Baltimore, MD 21205 USA; [Oscarson, Stefan] Univ Coll Dublin, UCD Sch Chem & Chem Biol, Ctr Synth & Chem Biol, Dublin 4, Ireland	Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University College Dublin	Casadevall, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Rm E5132,615 N Wolfe St, Baltimore, MD 21205 USA.	acasade1@jhu.edu	Bowen, Anthony/O-4982-2015; Cordero, Radamés JB/F-6912-2011	Bowen, Anthony/0000-0003-1064-8372; Cordero, Radamés JB/0000-0002-3026-7094; Oscarson, Stefan/0000-0002-8273-4918; Wear, Maggie/0000-0002-8581-7831	National Institutes of Health Medical Scientist Training Program Training Grant [T32-GM007288]; National Institutes of Health [R37-AI033142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033142, T32AI007417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Medical Scientist Training Program Training Grant T32-GM007288 and National Institutes of Health Award R37-AI033142. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baranova SV, 2010, INT IMMUNOL, V22, P671, DOI 10.1093/intimm/dxq051; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Barrera GJ, 2009, IMMUNOL LETT, V123, P52, DOI 10.1016/j.imlet.2009.02.001; Bowen A, 2016, TRENDS IMMUNOL, V2016; Bryan RA, 2013, FUTURE MICROBIOL, V8, P1081, DOI 10.2217/fmb.13.79; Buneva VN, 1998, APPL BIOCHEM BIOTECH, V75, P63, DOI 10.1007/BF02787709; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dong ZM, 1996, J CLIN INVEST, V97, P689, DOI 10.1172/JCI118466; Dong ZM, 1997, INFECT IMMUN, V65, P557, DOI 10.1128/IAI.65.2.557-563.1997; Eryilmaz E, 2013, MOL IMMUNOL, V56, P588, DOI 10.1016/j.molimm.2013.06.006; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Ivan G, 2009, BIOCHEM BIOPH RES CO, V383, P417, DOI 10.1016/j.bbrc.2009.04.022; JACKSON DY, 1991, P NATL ACAD SCI USA, V88, P58, DOI 10.1073/pnas.88.1.58; Janda A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00022; Janda A, 2015, J BIOL CHEM, V290, P12090, DOI 10.1074/jbc.M114.618975; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; Jencks W, 1969, CATALYSIS CHEM ENZYM, P288; Kim HK, 2005, ACTA CRYSTALLOGR D, V61, P920, DOI 10.1107/S0907444905009042; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; Kirshner DA, 2013, NUCLEIC ACIDS RES, V41, pW256, DOI 10.1093/nar/gkt403; KOZEL TR, 1977, INFECT IMMUN, V18, P701, DOI 10.1128/IAI.18.3.701-707.1977; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Lang YZ, 2014, MAR DRUGS, V12, P4005, DOI 10.3390/md12074005; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; LI L, 1995, J IMMUNOL, V154, P3328; Martinez LR, 2004, INFECT IMMUN, V72, P3674, DOI 10.1128/IAI.72.6.3674-3679.2004; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; MUKHERJEE J, 1995, J EXP MED, V181, P405, DOI 10.1084/jem.181.1.405; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; MUKHERJEE J, 1993, J EXP MED, V177, P1105, DOI 10.1084/jem.177.4.1105; MUKHERJEE J, 1994, CAN J MICROBIOL, V40, P888, DOI 10.1139/m94-141; Nakouzi A, 2009, VACCINE, V27, P3513, DOI 10.1016/j.vaccine.2009.03.089; Nam KH, 2009, BIOCHEM BIOPH RES CO, V389, P247, DOI 10.1016/j.bbrc.2009.08.123; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Nilmeier JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062535; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; Odintsova ES, 2006, BIOCHEMISTRY-MOSCOW+, V71, P251, DOI 10.1134/S0006297906030047; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; Oscarson S, 2005, VACCINE, V23, P3961, DOI 10.1016/j.vaccine.2005.02.029; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; RASO V, 1975, BIOCHEMISTRY-US, V14, P591, DOI 10.1021/bi00674a020; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Sapparapu G, 2012, J BIOL CHEM, V287, P36096, DOI 10.1074/jbc.M112.401075; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SUN M, 1994, J BIOL CHEM, V269, P734; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Wootla B, 2008, J IMMUNOL, V180, P7714, DOI 10.4049/jimmunol.180.11.7714; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Xia YM, 2016, MOL IMMUNOL, V69, P33, DOI 10.1016/j.molimm.2015.11.001; Yang YH, 2010, RHEUMATOLOGY, V49, P34, DOI 10.1093/rheumatology/kep328; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407; Yu J, 1998, P NATL ACAD SCI USA, V95, P2880, DOI 10.1073/pnas.95.6.2880; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444	77	25	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					417	434		10.1074/jbc.M116.767582	http://dx.doi.org/10.1074/jbc.M116.767582			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27872188	Green Published, hybrid			2022-12-26	WOS:000392316100002
J	Bagenholm, V; Reddy, SK; Bouraoui, H; Morrill, J; Kulcinskaja, E; Bahr, CM; Aurelius, O; Rogers, T; Xiao, Y; Logan, DT; Martens, EC; Koropatkin, NM; Stalbrand, H				Bagenholm, Viktoria; Reddy, Sumitha K.; Bouraoui, Hanene; Morrill, Johan; Kulcinskaja, Evelina; Bahr, Constance M.; Aurelius, Oskar; Rogers, Theresa; Xiao, Yao; Logan, Derek T.; Martens, Eric C.; Koropatkin, Nicole M.; Stalbrand, Henrik			Galactomannan Catabolism Conferred by a Polysaccharide Utilization Locus of Bacteroides ovatus ENZYME SYNERGY AND CRYSTAL STRUCTURE OF A beta-MANNANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; HUMAN GUT MICROBIOTA; SUBSTRATE-SPECIFICITY; BIOCHEMICAL ANALYSES; SYMBIOTIC PROTIST; SIGNAL PEPTIDES; GUAR GUM; PURIFICATION; HYDROLASE; THETAIOTAOMICRON	A recently identified polysaccharide utilization locus (PUL) from Bacteroides ovatus ATCC 8483 is transcriptionally up-regulated during growth on galacto-and glucomannans. It encodes two glycoside hydrolase family 26 (GH26) beta-mannanases, BoMan26A and BoMan26B, and a GH36 alpha-galactosidase, BoGal36A. The PUL also includes two glycan-binding proteins, confirmed by beta-mannan affinity electrophoresis. When this PUL was deleted, B. ovatus was no longer able to grow on locust bean galactomannan. BoMan26A primarily formed mannobiose from mannan polysaccharides. BoMan26B had higher activity on galactomannan with a high degree of galactosyl substitution and was shown to be endo-acting generating a more diverse mixture of oligosaccharides, including mannobiose. Of the two beta-mannanases, only BoMan26B hydrolyzed galactoglucomannan. A crystal structure of BoMan26A revealed a similar structure to the exo-mannobiohydrolase CjMan26C from Cellvibrio japonicus, with a conserved glycone region (-1 and -2 subsites), including a conserved loop closing the active site beyond subsite -2. Analysis of cellular location by immunolabeling and fluorescence microscopy suggests that BoMan26B is surface-exposed and associated with the outer membrane, although BoMan26A and BoGal36A are likely periplasmic. In light of the cellular location and the biochemical properties of the two characterized beta-mannanases, we propose a scheme of sequential action by the glycoside hydrolases encoded by the beta-mannan PUL and involved in the beta-mannan utilization pathway in B. ovatus. The outer membrane-associated BoMan26B initially acts on the polysaccharide galactomannan, producing comparably large oligosaccharide fragments. Galactomanno-oligosaccharides are further processed in the periplasm, degalactosylated by BoGal36A, and subsequently hydrolyzed into mainly mannobiose by the beta-mannanase BoMan26A.	[Aurelius, Oskar; Logan, Derek T.; Stalbrand, Henrik] Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden; [Bahr, Constance M.; Rogers, Theresa; Xiao, Yao; Martens, Eric C.; Koropatkin, Nicole M.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA; [Kulcinskaja, Evelina] Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England; [Aurelius, Oskar] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	Lund University; University of Michigan System; University of Michigan; University of Nottingham; Diamond Light Source	Stalbrand, H (corresponding author), Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden.	henrik.stalbrand@biochemistry.lu.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Kulcinskaja, Evelina/0000-0002-0557-7672; Rogers, Theresa/0000-0002-9741-5768	Swedish Foundation for Strategic Research Grant [RBP 14-0046]; Swedish Innovation Agency [2013-03024]; Swedish Research Agency FORMAS Grant [213-2014-1254]	Swedish Foundation for Strategic Research Grant; Swedish Innovation Agency; Swedish Research Agency FORMAS Grant	This work was supported by The Swedish Foundation for Strategic Research Grant RBP 14-0046 (to H. S.), Swedish Innovation Agency Grant 2013-03024 (to H. S.), and Swedish Research Agency FORMAS Grant 213-2014-1254 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2011, J AGR FOOD CHEM, V59, P12658, DOI 10.1021/jf203091h; Barak S, 2014, INT J BIOL MACROMOL, V66, P74, DOI 10.1016/j.ijbiomac.2014.02.017; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Cameron E. A., 2014, MBIO, V5, DOI DOI 10.1128/MBI0.01441-14; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GHERARDINI F, 1985, J BACTERIOL, V161, P500, DOI 10.1128/JB.161.2.500-506.1985; GHERARDINI FC, 1987, J BACTERIOL, V169, P2038, DOI 10.1128/jb.169.5.2038-2043.1987; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hekmat O, 2010, BIOCHEMISTRY-US, V49, P4884, DOI 10.1021/bi100097f; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Hong PY, 2014, APPL ENVIRON MICROB, V80, P2084, DOI 10.1128/AEM.03176-13; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawaguchi K, 2014, ARCH MICROBIOL, V196, P17, DOI 10.1007/s00203-013-0938-y; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kulcinskaja E, 2013, APPL ENVIRON MICROB, V79, P133, DOI 10.1128/AEM.02118-12; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundqvist J, 2002, CARBOHYD POLYM, V48, P29, DOI 10.1016/S0144-8617(01)00210-7; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Morrill J, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0055-4; Mudgil D, 2014, J FOOD SCI TECH MYS, V51, P409, DOI 10.1007/s13197-011-0522-x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reddy SK, 2016, FEBS LETT, V590, P2106, DOI 10.1002/1873-3468.12250; Reddy SK, 2013, FEBS LETT, V587, P3444, DOI 10.1016/j.febslet.2013.08.029; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Rosengren A, 2012, BIOCATAL BIOTRANSFOR, V30, P338, DOI 10.3109/10242422.2012.674726; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schorsch C, 1997, CARBOHYD POLYM, V34, P165, DOI 10.1016/S0144-8617(97)00095-7; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tsukagoshi H, 2014, BIOCHEM BIOPH RES CO, V452, P520, DOI 10.1016/j.bbrc.2014.08.103; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; VALENTINE PJ, 1992, APPL ENVIRON MICROB, V58, P1534, DOI 10.1128/AEM.58.5.1534-1540.1992; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu BZ, 2002, J BIOTECHNOL, V92, P267, DOI 10.1016/S0168-1656(01)00367-4; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yan XX, 2008, J MOL BIOL, V379, P535, DOI 10.1016/j.jmb.2008.03.068; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345; Zhang ML, 2014, P NATL ACAD SCI USA, V111, pE3708, DOI 10.1073/pnas.1406156111	63	65	66	6	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					229	243		10.1074/jbc.M116.746438	http://dx.doi.org/10.1074/jbc.M116.746438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872187	Green Published, hybrid			2022-12-26	WOS:000391578000020
J	Upton, HE; Chan, H; Feigon, J; Collins, K				Upton, Heather E.; Chan, Henry; Feigon, Juli; Collins, Kathleen			Shared Subunits of Tetrahymena Telomerase Holoenzyme and Replication Protein A Have Different Functions in Different Cellular Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; CRYPTOSPORIDIUM-PARVUM; LENGTH REGULATION; GENE-EXPRESSION; CST COMPLEX; RPA; BINDING; RNA; MAINTENANCE; SEQUENCE	In most eukaryotes, telomere maintenance relies on telomeric repeat synthesis by a reverse transcriptase named telomerase. To synthesize telomeric repeats, the catalytic subunit telomerase reverse transcriptase (TERT) uses the RNA subunit (TER) as a template. In the ciliate Tetrahymena thermophila, the telomerase holoenzyme consists of TER, TERT, and eight additional proteins, including the telomeric repeat single-stranded DNA-binding protein Teb1 and its heterotrimer partners Teb2 and Teb3. Teb1 is paralogous to the large subunit of the general single-stranded DNA binding heterotrimer replication protein A (RPA). Little is known about the function of Teb2 and Teb3, which are structurally homologous to the RPA middle and small subunits, respectively. Here, epitope-tagging Teb2 and Teb3 expressed at their endogenous gene loci enabled affinity purifications that revealed that, unlike other Tetrahymena telomerase holoenzyme subunits, Teb2 and Teb3 are not telomerase-specific. Teb2 and Teb3 assembled into other heterotrimer complexes, which when recombinantly expressed had the general single-stranded DNA binding activity of RPA complexes, unlike the telomere-specific DNA binding of Teb1 or the TEB heterotrimer of Teb1, Teb2, and Teb3. TEB had no more DNA binding affinity than Teb1 alone. In contrast, heterotrimers reconstituted with Teb2 and Teb3 and two other Tetrahymena RPA large subunit paralogs had higher DNA binding affinity than their large subunit alone. Teb1 and TEB, but not RPA, increased telomerase processivity. We conclude that in the telomerase holoenzyme, instead of binding DNA, Teb2 and Teb3 are Teb1 assembly factors. These findings demonstrate that Tetrahymena telomerase holoenzyme and RPA complexes share subunits and that RPA subunits have distinct functions in different heterotrimer assemblies.	[Upton, Heather E.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chan, Henry; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [S10RR025622]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048123, R01GM054198, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at UC Berkeley, supported in part by National Institutes of Health Grant S10RR025622.	Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Bhattacharjee A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006342; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Couvillion MT, 2012, METHOD CELL BIOL, V109, P347, DOI 10.1016/B978-0-12-385967-9.00012-8; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Doksani Y, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016576; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Hockemeyer D, 2015, NAT STRUCT MOL BIOL, V22, P848, DOI 10.1038/nsmb.3083; Hong K, 2013, MOL CELL BIOL, V33, P3962, DOI 10.1128/MCB.00792-13; Jacob NK, 2001, EMBO J, V20, P4299, DOI 10.1093/emboj/20.15.4299; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Linger BR, 2011, MOL BIOL CELL, V22, P4161, DOI 10.1091/mbc.E11-06-0551; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lloyd NR, 2016, BIOCHEMISTRY-US, V55, P5326, DOI 10.1021/acs.biochem.6b00496; Londono-Vallejo JA, 2012, TRENDS BIOCHEM SCI, V37, P391, DOI 10.1016/j.tibs.2012.05.004; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Martinez P, 2015, TRENDS BIOCHEM SCI, V40, P504, DOI 10.1016/j.tibs.2015.06.003; Mason AC, 2010, BIOCHEMISTRY-US, V49, P5919, DOI 10.1021/bi100380n; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; O'Connor CM, 2006, MOL CELL BIOL, V26, P2029, DOI 10.1128/MCB.26.6.2029-2036.2006; Podlevsky JD, 2016, RNA BIOL, V13, P720, DOI 10.1080/15476286.2016.1205768; Rice C, 2016, COMPUT STRUCT BIOTEC, V14, P161, DOI 10.1016/j.csbj.2016.04.002; Rider SD, 2005, J BIOL CHEM, V280, P31460, DOI 10.1074/jbc.M504466200; Rider SD, 2008, J CELL BIOCHEM, V104, P2207, DOI 10.1002/jcb.21784; Rubtsova MP, 2009, BIOCHEMISTRY-MOSCOW+, V74, P92, DOI 10.1134/S0006297909010143; Ruehle MD, 2016, GENETICS, V203, P649, DOI 10.1534/genetics.114.169748; Sakaguchi K, 2009, FEBS J, V276, P943, DOI 10.1111/j.1742-4658.2008.06841.x; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Sugitani N, 2015, PROG BIOPHYS MOL BIO, V117, P206, DOI 10.1016/j.pbiomolbio.2014.12.001; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Upton HE, 2014, MOL CELL BIOL, V34, P4200, DOI 10.1128/MCB.01030-14; Wan BB, 2015, NAT STRUCT MOL BIOL, V22, P1023, DOI 10.1038/nsmb.3126; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Xiong J, 2011, SCI CHINA LIFE SCI, V54, P65, DOI 10.1007/s11427-010-4114-1; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063	53	16	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					217	228		10.1074/jbc.M116.763664	http://dx.doi.org/10.1074/jbc.M116.763664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895115	Green Published, hybrid			2022-12-26	WOS:000391578000019
J	Israyilova, A; Buroni, S; Forneris, F; Scoffone, VC; Shixaliyev, NQ; Riccardi, G; Chiarelli, LR				Israyilova, Aygun; Buroni, Silvia; Forneris, Federico; Scoffone, Viola Camilla; Shixaliyev, Namiq Q.; Riccardi, Giovanna; Chiarelli, Laurent Roberto			Biochemical Characterization of Glutamate Racemase - A New Candidate Drug Target against Burkholderia cenocepacia Infections	PLOS ONE			English	Article							KILL MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-ANTHRACIS; RESISTANCE; INHIBITORS; PURIFICATION; MURI; EXPRESSION; MECHANISM; DISCOVERY; HALOGEN	The greatest obstacle for the treatment of cystic fibrosis patients infected with the Burkholderia species is their intrinsic antibiotic resistance. For this reason, there is a need to develop new effective compounds. Glutamate racemase, an essential enzyme for the biosynthesis of the bacterial cell wall, is an excellent candidate target for the design of new antibacterial drugs. To this aim, we recombinantly produced and characterized glutamate racemase from Burkholderia cenocepacia J2315. From the screening of an in-house library of compounds, two Zn (II) and Mn (III) 1,3,5-triazapentadienate complexes were found to efficiently inhibit the glutamate racemase activity with IC50 values of 35.3 and 10.0 mu M, respectively. Using multiple biochemical approaches, the metal complexes have been shown to affect the enzyme activity by binding to the enzyme-substrate complex and promoting the formation of an inhibited dimeric form of the enzyme. Our results corroborate the value of glutamate racemase as a good target for the development of novel inhibitors against Burkholderia.	[Israyilova, Aygun; Buroni, Silvia; Forneris, Federico; Scoffone, Viola Camilla; Riccardi, Giovanna; Chiarelli, Laurent Roberto] Univ Pavia, Dipartimento Biol & Biotecnol, Pavia, Italy; [Israyilova, Aygun] Baku State Univ, Dept Microbiol, Baku, Azerbaijan; [Shixaliyev, Namiq Q.] Baku State Univ, Dept Organ Chem, Baku, Azerbaijan	University of Pavia; Ministry of Education of Azerbaijan Republic; Baku State University; Ministry of Education of Azerbaijan Republic; Baku State University	Chiarelli, LR (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol, Pavia, Italy.	laurent.chiarelli@unipv.it	Chiarelli, Laurent Roberto/J-8368-2016; Buroni, Silvia/AAX-5454-2020; Israilova, Aygun Israyilova/X-5353-2019; Shikhaliyev, Namig/P-8586-2019; Forneris, Federico/B-1145-2011; Forneris, Federico/AAL-5361-2020; Scoffone, Viola Camilla/F-7586-2017	Chiarelli, Laurent Roberto/0000-0003-0348-9764; Israilova, Aygun Israyilova/0000-0002-6526-132X; Shikhaliyev, Namig/0000-0002-6842-151X; Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; Buroni, Silvia/0000-0002-6979-2275; RICCARDI, Giovanna/0000-0003-3295-0070; Scoffone, Viola Camilla/0000-0001-9979-1655	Italian Cystic Fibrosis Foundation [19/2015]; Armenise-Harvard Foundation; "Rita Levi-Montalcini" award from the Italian Ministry of University and Education (MIUR)	Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Armenise-Harvard Foundation; "Rita Levi-Montalcini" award from the Italian Ministry of University and Education (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Cystic Fibrosis Foundation (FFC#19/2015 to G.R., adopted by Gruppo di Sostegno FFC di Como Dongo, Delegazione FFC di Olbia Tempio, Delegazione FFC di Reggio Calabria). F.F. is supported by a Career Development Award from the Armenise-Harvard Foundation and by the "Rita Levi-Montalcini" award from the Italian Ministry of University and Education (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa-Jove D, 2014, ACS CHEM BIOL, V9, P1567, DOI 10.1021/cb500149m; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bazzini S, 2014, BURKHOLDERIA GENOMES, P183, DOI [10.1186/1471-2180-9-200, DOI 10.1186/1471-2180-9-200]; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bohmer N, 2013, PROTEIN EXPRES PURIF, V88, P54, DOI 10.1016/j.pep.2012.11.012; Breault GA, 2008, BIOORG MED CHEM LETT, V18, P6100, DOI 10.1016/j.bmcl.2008.10.022; Buroni S, 2014, ANTIMICROB AGENTS CH, V58, P7424, DOI 10.1128/AAC.03800-14; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Conti P, 2011, CHEM REV, V111, P6919, DOI 10.1021/cr2000702; Copeland A.R, 2000, ENZYMES PRACTICAL IN, V2nd; de Dios A, 2002, J MED CHEM, V45, P4559, DOI 10.1021/jm020901d; Dodd D, 2007, J BACTERIOL, V189, P5265, DOI 10.1128/JB.00352-07; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Fisher SL, 2008, MICROB BIOTECHNOL, V1, P345, DOI 10.1111/j.1751-7915.2008.00031.x; Folescu TW, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0148-2; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; Geng B, 2009, BIOORG MED CHEM LETT, V19, P930, DOI 10.1016/j.bmcl.2008.11.113; Horsley A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub2; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; Israyilova A, 2015, J BIOTECHNOL, V208, pS27, DOI 10.1016/j.jbiotec.2015.06.072; Kim KH, 2007, J MOL BIOL, V372, P434, DOI 10.1016/j.jmb.2007.05.003; Kluger R, 2004, BIOORG CHEM, V32, P451, DOI 10.1016/j.bioorg.2004.08.002; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lundqvist T, 2007, NATURE, V447, P817, DOI 10.1038/nature05689; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Martin A, 2006, J ANTIMICROB CHEMOTH, V58, P327, DOI 10.1093/jac/dkl231; May M, 2007, J MOL BIOL, V371, P1219, DOI 10.1016/j.jmb.2007.05.093; Mehboob S, 2009, BIOCHEMISTRY-US, V48, P7045, DOI 10.1021/bi9005072; Mori G, 2015, CHEM BIOL, V22, P917, DOI 10.1016/j.chembiol.2015.05.016; Neres J, 2015, ACS CHEM BIOL, V10, P705, DOI 10.1021/cb5007163; Nzula S, 2002, J ANTIMICROB CHEMOTH, V50, P265, DOI 10.1093/jac/dkf137; Potrykus J, 2009, ARCH BIOCHEM BIOPHYS, V491, P16, DOI 10.1016/j.abb.2009.09.009; Ruzheinikov SN, 2005, STRUCTURE, V13, P1707, DOI 10.1016/j.str.2005.07.024; Sambrook J., 2001, MOL CLONING LAB MANU; Schrodinger L., 2020, PYMOL; Scoffone VC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00815; Scoffone VC, 2014, ANTIMICROB AGENTS CH, V58, P2415, DOI 10.1128/AAC.02438-13; Shixaliyev NQ, 2013, CATAL TODAY, V217, P76, DOI 10.1016/j.cattod.2013.06.013; Shixallyev NQ, 2014, NEW J CHEM, V38, P4807, DOI 10.1039/c4nj00797b; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sousa SA, 2011, INT J MICROBIOL, DOI [10.1155/2011/607575, DOI 10.1155/2011/607575]; Spies MA, 2009, J AM CHEM SOC, V131, P5274, DOI 10.1021/ja809660g; Taal MA, 2004, ACTA CRYSTALLOGR D, V60, P2031, DOI 10.1107/S0907444904021134; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whalen KL, 2013, CHEMMEDCHEM, V8, P1681, DOI 10.1002/cmdc.201300271; Whalen KL, 2011, MOL INFORM, V30, P459, DOI 10.1002/minf.201100014; Whalen KL, 2011, J PHYS CHEM B, V115, P3416, DOI 10.1021/jp201037t; Whalen KL, 2010, ACS MED CHEM LETT, V1, P9, DOI 10.1021/ml900005b; YAGASAKI M, 1995, BIOSCI BIOTECH BIOCH, V59, P610, DOI 10.1271/bbb.59.610	54	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167350	10.1371/journal.pone.0167350	http://dx.doi.org/10.1371/journal.pone.0167350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898711	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000056
J	Nagamitsu, T; Yasuda, M; Saito-Morooka, F; Inoue, MN; Nishiyama, M; Goka, K; Sugiura, S; Maeto, K; Okabe, K; Taki, H				Nagamitsu, Teruyoshi; Yasuda, Mika; Saito-Morooka, Fuki; Inoue, Maki N.; Nishiyama, Mio; Goka, Koichi; Sugiura, Shinji; Maeto, Kaoru; Okabe, Kimiko; Taki, Hisatomo			Genetic Structure and Potential Environmental Determinants of Local Genetic Diversity in Japanese Honeybees (Apis cerana japonica)	PLOS ONE			English	Article							BEES; MELLIFERA; HYMENOPTERA; RANGE; CONSERVATION; INFERENCE; RESPONSES; MARKERS	Declines in honeybee populations have been a recent concern. Although causes of the declines remain unclear, environmental factors may be responsible. We focused on the potential environmental determinants of local populations of wild honeybees, Apis cerana japonica, in Japan. This subspecies has little genetic variation in terms of its mitochondrial DNA sequences, and genetic variations at nuclear loci are as yet unknown. We estimated the genetic structure and environmental determinants of local genetic diversity in nuclear microsatellite genotypes of fathers and mothers, inferred from workers collected at 139 sites. The genotypes of fathers and mothers showed weak isolation by distance and negligible genetic structure. The local genetic diversity was high in central Japan, decreasing toward the peripheries, and depended on the climate and land use characteristics of the sites. The local genetic diversity decreased as the annual precipitation increased, and increased as the proportion of urban and paddy field areas increased. Positive effects of natural forest area, which have also been observed in terms of forager abundance in farms, were not detected with respect to the local genetic diversity. The findings suggest that A. cerana japonica forms a single population connected by gene flow in its main distributional range, and that climate and landscape properties potentially affect its local genetic diversity.	[Nagamitsu, Teruyoshi] FFPRI, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Yasuda, Mika; Okabe, Kimiko; Taki, Hisatomo] FFPRI, Dept Forest Entomol, Tsukuba, Ibaraki, Japan; [Saito-Morooka, Fuki] Ibaraki Univ, Fac Sci, Mito, Ibaraki, Japan; [Inoue, Maki N.] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Nishiyama, Mio; Goka, Koichi] NIES, Global Environm Div, Tsukuba, Ibaraki, Japan; [Sugiura, Shinji; Maeto, Kaoru] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Ibaraki University; Tokyo University of Agriculture & Technology; National Institute for Environmental Studies - Japan; Kobe University	Nagamitsu, T (corresponding author), FFPRI, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan.	nagamit@affrc.go.jp	Nagamitsu, Teruyoshi/J-7710-2015; INOUE, Maki/H-6581-2013; Maeto, Kaoru/AAB-7318-2019	Nagamitsu, Teruyoshi/0000-0003-3366-7197; INOUE, Maki/0000-0002-9815-3480; 	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25740051]; Ministry of the Environment, Japan [S-9, 5-1407]; Global Environment Research Funds	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of the Environment, Japan(Ministry of the Environment, Japan); Global Environment Research Funds	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI https://www.jsps.go.jp/english/e-grants/index.html, Grant Number 25740051 to HT and Global Environment Research Funds https://www.env.go.jp/en/earth/research/gerf_E/index2.htm, S-9 and 5-1407 from the Ministry of the Environment, Japan to HT.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; [Anonymous], 2015, NAT SURV NAT ENV 2 5; [Anonymous], 2014, NAT LAND NUM INF; Arthur AD, 2010, BASIC APPL ECOL, V11, P406, DOI 10.1016/j.baae.2010.05.001; Baum KA, 2005, ENVIRON ENTOMOL, V34, P610, DOI 10.1603/0046-225X-34.3.610; Baum KA, 2008, LANDSCAPE URBAN PLAN, V85, P123, DOI 10.1016/j.landurbplan.2007.10.005; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Chapman NC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1185, DOI 10.1007/s00265-006-0348-0; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FUJIWARA S, 1994, APIDOLOGIE, V25, P331, DOI 10.1051/apido:19940309; Gary N. E., 1963, Journal of Apicultural Research London, V2, P3; Goka K, 2001, MOL ECOL, V10, P2095, DOI 10.1046/j.0962-1083.2001.01323.x; Harpur BA, 2012, MOL ECOL, V21, P4414, DOI 10.1111/j.1365-294X.2012.05614.x; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kark S, 2008, EVOL ECOL RES, V10, P391; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Moritz RFA, 2007, J INSECT CONSERV, V11, P391, DOI 10.1007/s10841-006-9054-5; Nagamitsu T, 2015, J APICULT RES; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Oldroyd BP, 2009, APIDOLOGIE, V40, P296, DOI 10.1051/apido/2009021; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R Core Team, 2015, R LANG ENV STAT COMP; Rollin O, 2013, AGR ECOSYST ENVIRON, V179, P78, DOI 10.1016/j.agee.2013.07.007; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueppell O, 2011, INSECT SOC, V58, P445, DOI 10.1007/s00040-011-0161-2; Ruttner F., 1988, SPRINGER SCI BUSINES; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Smith DR, 1996, J KANSAS ENTOMOLOGIC; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Takahashi J, 2007, APIDOLOGIE, V38, P335, DOI 10.1051/apido:2007018; Takahashi JI, 2009, MOL ECOL RESOUR, V9, P819, DOI 10.1111/j.1755-0998.2009.02268.x; Taki H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00132; Taki H, 2010, BASIC APPL ECOL, V11, P594, DOI 10.1016/j.baae.2010.08.004; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; WILLIAMS JL, 1987, J ECON ENTOMOL, V80, P532, DOI 10.1093/jee/80.2.532; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	42	5	5	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167233	10.1371/journal.pone.0167233	http://dx.doi.org/10.1371/journal.pone.0167233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898704	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000041
J	Zhu, S; Wang, YJ; Chen, WQ; Li, W; Wang, A; Wong, S; Bao, GQ; Li, JH; Yang, H; Tracey, KJ; D'Angelo, J; Wang, HC				Zhu, Shu; Wang, Yongjun; Chen, Weiqiang; Li, Wei; Wang, Angelina; Wong, Sarabeth; Bao, Guoqiang; Li, Jianhua; Yang, Huan; Tracey, Kevin J.; D'Angelo, John; Wang, Haichao			High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA(2)-IIE and sPLA(2)-V Expression in Macrophages	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); LETHAL SEPSIS; RESCUES MICE; SEPTIC SHOCK; PROTEIN SAA; RECEPTOR; RELEASE; MEDIATOR; INTERLEUKIN-1; INDUCTION	Human serum amyloid A (SAA) has been demonstrated as a chemoattractant and proinflammatory mediator of lethal systemic inflammatory diseases. In the circulation, it can be sequestered by a high-density lipoprotein, HDL, which carries cholesterol, triglycerides, phospholipids and apolipoproteins (Apo-AI). The capture of SAA by HDL results in the displacement of Apo-AI, and the consequent inhibition of SAA's chemoattractant activities. It was previously unknown whether HDL similarly inhibits SAA-induced sPLA(2) expression, as well as the resultant HMGB1 release, nitric oxide (NO) production and autophagy activation. Here we provided compelling evidence that human SAA effectively upregulated the expression and secretion of both sPLA(2)-IIE and sPLA(2)-V in murine macrophages, which were attenuated by HDL in a dose-dependent fashion. Similarly, HDL dose-dependently suppressed SAA-induced HMGB1 release, NO production, and autophagy activation. In both RAW 264.7 cells and primary macrophages, HDL inhibited SAAinduced secretion of several cytokines (e.g., IL-6) and chemokines (e. g., MCP-1 and RANTES) that were likely dependent on functional TLR4 signaling. Collectively, these findings suggest that HDL counter-regulates SAA-induced upregulation and secretion of sPLA2-IIE/V in addition to other TLR4-dependent cytokines and chemokines in macrophage cultures.	[Zhu, Shu; Chen, Weiqiang; Li, Wei; D'Angelo, John; Wang, Haichao] North Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA; [Zhu, Shu; Wang, Yongjun; Chen, Weiqiang; Li, Wei; Wang, Angelina; Wong, Sarabeth; Bao, Guoqiang; Li, Jianhua; Yang, Huan; Tracey, Kevin J.; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY USA; [Bao, Guoqiang] 4th Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian, Shaanxi, Peoples R China	Northwell Health; North Shore University Hospital; Northwell Health; Air Force Military Medical University	Wang, HC (corresponding author), North Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA.; Wang, HC (corresponding author), Feinstein Inst Med Res, Manhasset, NY USA.	hwang@northwell.edu	LI, JIAN/GRY-2197-2022; Wang, Haichao/AAU-2237-2021; li, jian/GSE-0245-2022	Wang, Haichao/0000-0002-0211-9000; Li, Wei/0000-0002-7941-7022; Wang, Yongjun/0000-0003-3515-9137; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences (NIGMS) [R01GM063075]; National Center of Complementary and Alternative Medicine (NCCAM) [R01AT05076]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118182, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center of Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (NIGMS, R01GM063075) and the National Center of Complementary and Alternative Medicine (NCCAM, R01AT05076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of General Medical Sciences (NIGMS, R01GM063075) and the National Center of Complementary and Alternative Medicine (NCCAM, R01AT05076).	BADOLATO R, 1995, J IMMUNOL, V155, P4004; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baek SH, 2000, J IMMUNOL, V164, P6359, DOI 10.4049/jimmunol.164.12.6359; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Dos Santos S, 2007, ANN NY ACAD SCI, V1096, P70, DOI 10.1196/annals.1397.071; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; HOFFMAN JS, 1982, J BIOL CHEM, V257, P518; Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200; Ito C, 2013, MOL CELL, V52, P794, DOI 10.1016/j.molcel.2013.10.024; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Kessen UA, 2005, J LIPID RES, V46, P2488, DOI 10.1194/jlr.M500325-JLR200; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Li B, 2013, ATHEROSCLEROSIS, V228, P370, DOI 10.1016/j.atherosclerosis.2013.03.023; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li W, 2015, MOL MED, V21, P515, DOI 10.2119/molmed.2015.00109; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MARSHALL LA, 1994, J LIPID MEDIAT CELL, V10, P295; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; Morin EE, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00244; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ohta S, 2009, CHEM PHYS LIPIDS, V162, P62, DOI 10.1016/j.chemphyslip.2009.07.008; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; Patel H, 1998, SCAND J IMMUNOL, V48, P410; RAMADORI G, 1985, J EXP MED, V162, P930, DOI 10.1084/jem.162.3.930; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sharifov OF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064486; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; STEINKASSERER A, 1990, BIOCHEM J, V268, P187, DOI 10.1042/bj2680187; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Sullivan CP, 2010, J BIOL CHEM, V285, P565, DOI 10.1074/jbc.M109.070565; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; VADAS P, 1991, IMMUNOL LETT, V28, P187, DOI 10.1016/0165-2478(91)90002-R; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang LM, 2004, BIOCHEM BIOPH RES CO, V317, P157, DOI 10.1016/j.bbrc.2004.03.027; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; XU LL, 1995, J IMMUNOL, V155, P1184; Yamamoto K, 2016, J BIOL CHEM, V291, P15602, DOI 10.1074/jbc.M116.734657; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Zhang YS, 2012, BIOCHEM PHARMACOL, V84, P1492, DOI 10.1016/j.bcp.2012.09.015; Zhang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH866, DOI 10.1152/ajpheart.01232.2008	51	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167468	10.1371/journal.pone.0167468	http://dx.doi.org/10.1371/journal.pone.0167468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898742	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000064
J	Pan, CH; Chang, CC; Su, CT; Tsai, PS				Pan, Chieh-Hsin; Chang, Chun-Chao; Su, Chien-Tien; Tsai, Pei-Shan			Trends in Irritable Bowel Syndrome Incidence among Taiwanese Adults during 2003-2013: A Population-Based Study of Sex and Age Differences	PLOS ONE			English	Article							CHINESE POPULATION; DISEASE; PREVALENCE; GENDER; METAANALYSIS; SYMPTOMS; QUESTIONNAIRE; COLONOSCOPY; DISORDERS; DIAGNOSIS	Background No population-based irritable bowel syndrome (IBS) incidence data among Taiwanese adults are available. Whether IBS is associated with risk of organic colonic diseases remains unanswered. We investigated 1) the sex-and age-stratified trends in the annual incidence of IBS, and 2) the risk of selected organic diseases in patients with IBS compared with those without IBS among Taiwanese adults during 2003-2013. Methods Medical claims data for 1 million randomly selected beneficiaries were obtained and analyzed. Patients with IBS were considered eligible for enrollment if they aged between 20 and 100 and had at least two medical encounters with IBS codes within 1 year. To test whether there was a linear secular trend in IBS incidence over time, multivariate Poisson regression with generalized estimating equation model was conducted. The risk of selected organic diseases associated with IBS was examined using multivariate Cox proportional hazard regression. Results From 2003 to 2013, the incidence of IBS significantly decreased over time [adjusted incidence rate ratio (IRR) = 0.97, p<0.001]; the incidence of IBS significantly increased with age (adjusted IRR = 1.03, p < 0.001) and was significantly higher in women than in men (adjusted IRR = 1.14, p<0.001). IBS significantly associated with increased risk of microscopic colitis, inflammatory bowel disease, and colorectal cancer during a 10-year follow-up period. Conclusions The incidence of IBS increased with age and was slightly higher in women than in men among Taiwanese adults. During 2003-2013, IBS incidence gradually decreased over time. IBS may increase risk of several colonic organic diseases.	[Pan, Chieh-Hsin; Tsai, Pei-Shan] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Pan, Chieh-Hsin] Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan; [Chang, Chun-Chao] Taipei Med Univ, Coll Med, Sch Med, Div Gastroenterol & Hepatol,Dept Internal Med, Taipei, Taiwan; [Chang, Chun-Chao] Taipei Med Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan; [Su, Chien-Tien] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth, Taipei, Taiwan; [Su, Chien-Tien] Taipei Med Univ, Sch Med, Div Family Med, Coll Med, Taipei, Taiwan; [Tsai, Pei-Shan] Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital	Tsai, PS (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Tsai, PS (corresponding author), Wan Fang Hosp, Dept Nursing, Taipei, Taiwan.; Tsai, PS (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	ptsai@tmu.edu.tw			Taipei Medical University Hospital, Taipei, Taiwan [105TMU-TMUH-22]	Taipei Medical University Hospital, Taipei, Taiwan	This study is supported by a grant from Taipei Medical University Hospital, Taipei, Taiwan (105TMU-TMUH-22).	Barbara G, 2014, CURR OPIN GASTROEN, V30, P352, DOI 10.1097/MOG.0000000000000070; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Canavan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106478; Chang FY, 2012, ASIA PAC J CLIN NUTR, V21, P594; Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; Ishihara S, 2012, J GASTROENTEROL, V47, P1084, DOI 10.1007/s00535-012-0573-4; Kamp EJCA, 2016, CLIN GASTROENTEROL H, V14, P659, DOI 10.1016/j.cgh.2015.09.031; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Lu CL, 2003, ALIMENT PHARM THERAP, V18, P1159, DOI 10.1046/j.1365-2036.2003.01711.x; Lu CL, 2005, ALIMENT PHARM THER, V21, P1497, DOI 10.1111/j.1365-2036.2005.02512.x; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Mulak A, 2014, WORLD J GASTROENTERO, V20, P2433, DOI 10.3748/wjg.v20.i10.2433; Patel P, 2015, SCAND J GASTROENTERO, V50, P816, DOI 10.3109/00365521.2015.1007079; Porter CK, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-55; Rodriguez LAG, 2000, SCAND J GASTROENTERO, V35, P306; Sperber AD, 2017, GUT, V66, P1075, DOI 10.1136/gutjnl-2015-311240; Thompson WG, 1999, GUT, V45, P43; Welch LC, 2012, J HEALTH SOC BEHAV, V53, P313, DOI 10.1177/0022146512456026	21	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166922	10.1371/journal.pone.0166922	http://dx.doi.org/10.1371/journal.pone.0166922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893818	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400058
J	Shin, JA; Kim, HS; Vargas, A; Yu, WQ; Eom, YS; Craft, CM; Lee, EJ				Shin, Jung-A; Kim, Hwa Sun; Vargas, Andrew; Yu, Wan-Qing; Eom, Yun Sung; Craft, Cheryl Mae; Lee, Eun-Jin			Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; MEDIATED GENE-TRANSFER; PHOTORECEPTOR DEGENERATION; RAT MODEL; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; TISSUE INHIBITORS; CELL-DEATH; RETINAL DEGENERATION; UP-REGULATION	Retinitis Pigmentosa (RP) is one of the most common forms of inherited visual loss with the initial degeneration of rod photoreceptors, followed by a progressive cone photoreceptor deterioration. Coinciding with this visual loss, the extracellular matrix (ECM) is reorganized, which alters matrix metalloproteinase (MMP) activity levels. A potential pathological role of MMPs, MMP-9 in particular, involves an excitotoxicity-mediated physiological response. In the current study, we examine the MMP-9 and MMP-2 expression levels in the rhodopsin S334ter-line3 RP rat model and investigate the impact of treatment with SB-3CT, a specific MMP-9 and MMP-2 inhibitor, on rod cell survival was tested. Retinal MMP-9 and MMP-2 expression levels were quantified by immunoblot analysis from S334ter-line3 rats compared to controls. Gelatinolytic activities of MMP-9 and MMP-2 by zymography were examined. The geometry of rod death was further evaluated using Voronoi analysis. Our results revealed that MMP-9 was elevated while MMP-2 was relatively unchanged when S334terline 3 retinas were compared to controls. With SB-3CT treatment, we observed gelatinolytic activity of both MMPs was decreased and diminished clustering associated with rod death, in addition to a robust preservation of rod photoreceptors. These results demonstrate that up-regulation of MMP-9 in retinas of S334ter-line3 are associated with rod death. The application of SB-3CT dramatically interferes with mechanisms leading to apoptosis in an MMP-9-dependent manner. Future studies will determine the feasibility of using SB-3CT as a potential therapeutic strategy to slow progression of vision loss in genetic inherited forms of human RP.	[Shin, Jung-A; Kim, Hwa Sun; Vargas, Andrew; Yu, Wan-Qing; Eom, Yun Sung; Craft, Cheryl Mae; Lee, Eun-Jin] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, USC Roski Eye Inst,Mary D Allen Lab Vis Res, Los Angeles, CA 90007 USA; [Shin, Jung-A] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Craft, Cheryl Mae] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA USA; [Yu, Wan-Qing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Craft, Cheryl Mae] Univ Southern Calif, Neurosci Grad Program, Los Angeles, CA USA; [Lee, Eun-Jin] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA USA	University of Southern California; Ewha Womans University; University of Southern California; University of Washington; University of Washington Seattle; University of Southern California; University of Southern California	Lee, EJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, USC Roski Eye Inst,Mary D Allen Lab Vis Res, Los Angeles, CA 90007 USA.; Lee, EJ (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA USA.	eunjinl@usc.edu		Yu, Wan-Qing/0000-0002-9275-391X	VSoE Research Innovation Fund; Ewha Womans University Research Grant; NEI [EY03040]; Research to Prevent Blindness (USC Ophthalmology); Mary D. Allen Foundation; William Hansen Sandberg Memorial Foundation;  [EY015851]	VSoE Research Innovation Fund; Ewha Womans University Research Grant; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (USC Ophthalmology)(Research to Prevent Blindness (RPB)); Mary D. Allen Foundation; William Hansen Sandberg Memorial Foundation; 	The work was supported by a VSoE Research Innovation Fund to E-JL, by Ewha Womans University Research Grant of 2015 to JAS, and by EY015851 to CMC. NEI core grant: EY03040 (Doheny Eye Institute), Research to Prevent Blindness (USC Ophthalmology), the Mary D. Allen Foundation (AV, HSK), and the William Hansen Sandberg Memorial Foundation (YSE). CMC is the inaugural Mary D. Allen Endowed Chair in Vision Research (Doheny Eye Institute).	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Ahuja S, 2006, OPHTHAL RES, V38, P125, DOI 10.1159/000090533; Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536; Anasagasti A, 2012, VISION RES, V75, P117, DOI 10.1016/j.visres.2012.09.012; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Berger AS, 2003, OPHTHALMOLOGY, V110, P383, DOI 10.1016/S0161-6420(02)01738-4; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Chabot V, 2006, J LEUKOCYTE BIOL, V79, P767, DOI 10.1189/jlb.0804464; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Conlon TJ, 2013, HUM GENE THER CL DEV, V24, P23, DOI 10.1089/humc.2013.037; Cusato K, 2003, BIOL BULL-US, V205, P197, DOI 10.2307/1543250; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; De Groef L, 2014, INVEST OPHTH VIS SCI, V55, P1953, DOI 10.1167/iovs.13-13630; Delyfer MN, 2005, MOL VIS, V11, P688; Deming JD, 2015, INVEST OPHTH VIS SCI, V56, P5407, DOI 10.1167/iovs.15-16647; Descamps FJ, 2002, LAB INVEST, V82, P1607, DOI 10.1097/01.LAB.0000038556.54069.73; Di Girolamo N, 2006, J IMMUNOL, V177, P2638, DOI 10.4049/jimmunol.177.4.2638; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guimaraes-Santos A, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/918174, 10.1155/2012/747969]; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Hu Xueyou, 2010, J Vis Exp, DOI 10.3791/2445; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Jacobsen FE, 2007, CHEMMEDCHEM, V2, P152, DOI 10.1002/cmdc.200600204; Ji Y, 2015, INVEST OPHTH VIS SCI, V56, P352, DOI 10.1167/iovs.14-15398; Ji Y, 2012, J COMP NEUROL, V520, P874, DOI 10.1002/cne.22800; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jung Young Suk, 2012, PLoS One, V7, pe38773, DOI 10.1371/journal.pone.0038773; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kowluru RA, 2010, INVEST OPHTH VIS SCI, V51, P4320, DOI 10.1167/iovs.09-4851; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lee EJ, 2011, GLIA, V59, P1107, DOI 10.1002/glia.21183; Lee M, 2015, ACS CHEM NEUROSCI, V6, P1658, DOI 10.1021/acschemneuro.5b00140; Lee SY, 2011, J CELL PHYSIOL, V226, P1843, DOI 10.1002/jcp.22508; Lheriteau E, 2014, MOL THER, V22, P265, DOI 10.1038/mt.2013.232; LILLIEN LE, 1990, J CELL BIOL, V111, P635, DOI 10.1083/jcb.111.2.635; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; Majka S, 2001, INVEST OPHTH VIS SCI, V42, P210; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Nagase H, 1999, ANN NY ACAD SCI, V878, P1, DOI 10.1111/j.1749-6632.1999.tb07670.x; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Pons M, 2011, AM J PATHOL, V178, P2665, DOI 10.1016/j.ajpath.2011.02.006; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Rhodes JM, 2007, J CELL MOL MED, V11, P176, DOI 10.1111/j.1582-4934.2007.00031.x; Ripps H, 2002, EXP EYE RES, V74, P327, DOI 10.1006/exer.2002.1155; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Sahel Jose-Alain, 2005, Retina, V25, pS38, DOI 10.1097/00006982-200512001-00015; Shin JA, 2015, EXP EYE RES, V140, P41, DOI 10.1016/j.exer.2015.08.005; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Siqueira RC, 2011, RETINA-J RET VIT DIS, V31, P1207, DOI 10.1097/IAE.0b013e3181f9c242; Tan HK, 2003, MOL CELL NEUROSCI, V22, P98, DOI 10.1016/S1044-7431(02)00024-6; Tanihara H, 1997, ARCH OPHTHALMOL-CHIC, V115, P752, DOI 10.1001/archopht.1997.01100150754011; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Woch G, 2001, INVEST OPHTH VIS SCI, V42, P1669; Woessner JF, 1999, ANN NY ACAD SCI, V878, P388, DOI 10.1111/j.1749-6632.1999.tb07697.x; Yong VW, 2007, NEUROTHERAPEUTICS, V4, P580, DOI 10.1016/j.nurt.2007.07.005; Yu WQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151668; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang X, 2004, EXP EYE RES, V78, P849, DOI 10.1016/j.exer.2003.10.018; Zhang X, 2002, EXP EYE RES, V74, P577, DOI 10.1006/exer.2001.1152; Zhu CL, 2013, CELL TISSUE RES, V351, P29, DOI 10.1007/s00441-012-1522-5	81	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167102	10.1371/journal.pone.0167102	http://dx.doi.org/10.1371/journal.pone.0167102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893855	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400086
J	Burra, N; Kerzel, D; George, N				Burra, Nicolas; Kerzel, Dirk; George, Nathalie			Early Left Parietal Activity Elicited by Direct Gaze: A High-Density EEG Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EYE CONTACT; FEARFUL FACES; VISUAL-CORTEX; AVERTED GAZE; TIME-COURSE; AFFECTIVE BLINDSIGHT; SELECTIVE ATTENTION; SPATIAL ATTENTION; TARGET SELECTION	Gaze is one of the most important cues for human communication and social interaction. Inparticular, gaze contact is the most primary form of social contact and it is thought to capture attention. A very early-differentiated brain response to direct versus averted gaze has been hypothesized. Here, we used high-density electroencephalography to test this hypothesis. Topographical analysis allowed us to uncover a very early topographic modulation (40-80 ms) of event-related responses to faces with direct as compared to averted gaze. This modulation was obtained only in the condition where intact broadband faces-as opposed to high-pass or low-pas filtered faces-were presented. Source estimation indicated that this early modulation involved the posterior parietal region, encompassing the left precuneus and inferior parietal lobule. This supports the idea that it reflected an early orienting response to direct versus averted gaze. Accordingly, in a follow-up behavioural experiment, we found faster response times to the direct gaze than to the averted gaze broadband faces. In addition, classical evoked potential analysis showed that the N170 peak amplitude was larger for averted gaze than for direct gaze. Taken together, these results suggest that direct gaze may be detected at a very early processing stage, involving a parallel route to the ventral occipito-temporal route of face perceptual analysis.	[Burra, Nicolas; George, Nathalie] ICM, Inst Cerveau & Moelle Epiniere, Social & Affect Neurosci SAN Lab, Paris, France; [Burra, Nicolas; George, Nathalie] Ctr MEG EEG, Paris, France; [Burra, Nicolas; George, Nathalie] Univ Paris 06, Sorbonne Univ, UMR S 1127, Paris, France; [Burra, Nicolas; George, Nathalie] Ctr MEG EEG, Paris, France; [Burra, Nicolas; George, Nathalie] CNRS, UMR 7225, Paris, France; [Burra, Nicolas; George, Nathalie] Ctr MEG EEG, Paris, France; [Burra, Nicolas; George, Nathalie] INSERM, U 1127, Paris, France; [Burra, Nicolas; George, Nathalie] Ctr MEG EEG, Paris, France; [Burra, Nicolas; Kerzel, Dirk] Univ Geneva, Fac Psychol & Sci Educ, Geneva, Switzerland; [George, Nathalie] Ctr MEG EEG, ENS, Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Burra, N (corresponding author), ICM, Inst Cerveau & Moelle Epiniere, Social & Affect Neurosci SAN Lab, Paris, France.; Burra, N (corresponding author), Ctr MEG EEG, Paris, France.; Burra, N (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S 1127, Paris, France.; Burra, N (corresponding author), Ctr MEG EEG, Paris, France.; Burra, N (corresponding author), CNRS, UMR 7225, Paris, France.; Burra, N (corresponding author), Ctr MEG EEG, Paris, France.; Burra, N (corresponding author), INSERM, U 1127, Paris, France.; Burra, N (corresponding author), Ctr MEG EEG, Paris, France.; Burra, N (corresponding author), Univ Geneva, Fac Psychol & Sci Educ, Geneva, Switzerland.	Nicolas.burra@unige.ch		GEORGE, Nathalie/0000-0002-1556-973X	Swiss National Science Foundation for Scientific Research [PDFMP1_129459, P2GEP1_151945]; French "Investissements d'avenir" programmes [ANR-10-IAIHU-06, ANR-11-INBS-0006]; Center for Biomedical Imaging (CIBM) of Geneva and Lausanne	Swiss National Science Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); French "Investissements d'avenir" programmes(French National Research Agency (ANR)); Center for Biomedical Imaging (CIBM) of Geneva and Lausanne	This research was supported by the Swiss National Science Foundation for Scientific Research (PDFMP1_129459 grant to NB and DK and Early Postdoc.Mobility fellowship project P2GEP1_151945 for NB) and by the French Investissements davenir programmes (grant numbers ANR-10-IAIHU-06 & ANR-11-INBS-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Renaud Marquis for his help during the data recording. The Cartool software (brainmapping.unige.ch/cartool) has been programmed by Denis Brunet, from the Functional Brain Mapping Laboratory, Geneva, Switzerland, and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne.	Acunzo DJ, 2012, J NEUROSCI METH, V209, P212, DOI 10.1016/j.jneumeth.2012.06.011; Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Anders S, 2004, NAT NEUROSCI, V7, P339, DOI 10.1038/nn1213; ARY JP, 1981, IEEE T BIO-MED ENG, V28, P447, DOI 10.1109/TBME.1981.324817; ASANUMA C, 1985, J COMP NEUROL, V241, P357, DOI 10.1002/cne.902410309; BAIZER JS, 1983, INVEST OPHTH VIS SCI, V24, P1436; Balan PF, 2006, J NEUROSCI, V26, P9239, DOI 10.1523/JNEUROSCI.1898-06.2006; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Baron-Cohen S, 1997, MINDBLINDNESS AN ESS; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; BEAR DM, 1983, ARCH NEUROL-CHICAGO, V40, P195, DOI 10.1001/archneur.1983.04050040025003; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bonda E, 1996, J NEUROSCI, V16, P3737; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; Burra N, 2013, J NEUROSCI, V33, P10483, DOI 10.1523/JNEUROSCI.3994-12.2013; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Collin CA, 2012, PERCEPTION, V41, P717, DOI 10.1068/p7056; Conty L, 2007, NEUROPSYCHOLOGIA, V45, P3024, DOI 10.1016/j.neuropsychologia.2007.05.017; Conty L, 2006, SPATIAL VISION, V19, P529, DOI 10.1163/156856806779194026; Conty L, 2010, COGNITION, V115, P133, DOI 10.1016/j.cognition.2009.12.005; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Fleuaris AV, 2008, BRAIN RES, V1194, P100, DOI 10.1016/j.brainres.2007.11.071; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P1584, DOI 10.1162/jocn.2009.21103; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Gianotti LRR, 2008, BRAIN TOPOGR, V20, P143, DOI 10.1007/s10548-007-0041-2; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Grave-de Peralta R, 2004, REV NEUROLOGIA, V39, P748, DOI 10.33588/rn.3908.2004038; Grice SJ, 2005, CORTEX, V41, P342, DOI 10.1016/S0010-9452(08)70271-5; Hamm AO, 2003, BRAIN, V126, P267, DOI 10.1093/brain/awg037; HARDY SGP, 1992, CEREB CORTEX, V2, P217, DOI 10.1093/cercor/2.3.217; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heisz JJ, 2006, VISION RES, V46, P47, DOI 10.1016/j.visres.2005.09.028; Hung YW, 2010, NEUROIMAGE, V50, P727, DOI 10.1016/j.neuroimage.2009.12.093; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2007, BRAIN RES, V1177, P79, DOI 10.1016/j.brainres.2007.07.094; Johnson MH, 2015, NEUROSCI BIOBEHAV R, V50, P169, DOI 10.1016/j.neubiorev.2014.10.009; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klucharev V, 2004, NEUROREPORT, V15, P621, DOI 10.1097/00001756-200403220-00010; Knebel JF, 2012, NEUROIMAGE, V59, P2808, DOI 10.1016/j.neuroimage.2011.09.031; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Lachat F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050499; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Latinus M, 2015, SOC COGN AFFECT NEUR, V10, P1557, DOI 10.1093/scan/nsv049; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Macrae CN, 2002, PSYCHOL SCI, V13, P460, DOI 10.1111/1467-9280.00481; Maior RS, 2010, BEHAV BRAIN RES, V215, P129, DOI 10.1016/j.bbr.2010.07.009; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 1999, J CLIN NEUROPHYSIOL, V16, P239, DOI 10.1097/00004691-199905000-00005; Michel CM, 2004, J CLIN NEUROPHYSIOL, V21, P71, DOI 10.1097/00004691-200403000-00001; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Morand SM, 2014, CEREB CORTEX, V24, P898, DOI 10.1093/cercor/bhs368; Mormann F, 2015, NAT NEUROSCI, V18, P1568, DOI 10.1038/nn.4139; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Mosher CP, 2014, CURR BIOL, V24, P2459, DOI 10.1016/j.cub.2014.08.063; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; OHMAN A, 1986, PSYCHOPHYSIOLOGY, V23, P123, DOI 10.1111/j.1469-8986.1986.tb00608.x; Ouellette BG, 2006, EXP BRAIN RES, V175, P332, DOI 10.1007/s00221-006-0555-y; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pizzagalli D, 2000, CLIN NEUROPHYSIOL, V111, P521, DOI 10.1016/S1388-2457(99)00252-7; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Schweinberger SR, 2007, NEUROREPORT, V18, P693, DOI 10.1097/WNR.0b013e3280c1e2d2; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Senju A, 2006, PSYCHON B REV, V13, P223, DOI 10.3758/BF03193834; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Taylor MJ, 2001, NEUROSCI LETT, V316, P173, DOI 10.1016/S0304-3940(01)02378-3; Taylor MJ, 2001, COGNITIVE BRAIN RES, V10, P333, DOI 10.1016/S0926-6410(00)00051-3; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Troiani V, 2014, SOC COGN AFFECT NEUR, V9, P133, DOI 10.1093/scan/nss116; Ulloa JL, 2014, SOC COGN AFFECT NEUR, V9, P350, DOI 10.1093/scan/nss141; Vizioli L, 2010, P NATL ACAD SCI USA, V107, P20081, DOI 10.1073/pnas.1005751107; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Watanabe S, 2002, NEUROSCI LETT, V325, P163, DOI 10.1016/S0304-3940(02)00257-4; Watanabe S, 2006, BRAIN RES, V1092, P152, DOI 10.1016/j.brainres.2006.03.091; West GL, 2011, J COGNITIVE NEUROSCI, V23, P3410, DOI 10.1162/jocn.2011.21605; Yokoyama T, 2013, NEUROPSYCHOLOGIA, V51, P1161, DOI 10.1016/j.neuropsychologia.2013.04.002; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007; Zenon A, 2010, J COGNITIVE NEUROSCI, V22, P918, DOI 10.1162/jocn.2009.21233; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhu XR, 2012, NEUROSCI LETT, V526, P118, DOI 10.1016/j.neulet.2012.08.011	118	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166430	10.1371/journal.pone.0166430	http://dx.doi.org/10.1371/journal.pone.0166430			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880776	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500021
J	Fiester, SE; Arivett, BA; Schmidt, RE; Beckett, AC; Ticak, T; Carrier, MV; Ghosh, R; Ohneck, EJ; Metz, ML; Jeffries, MKS; Actis, LA				Fiester, Steven E.; Arivett, Brock A.; Schmidt, Robert E.; Beckett, Amber C.; Ticak, Tomislav; Carrier, Mary V.; Ghosh, Rajarshi; Ohneck, Emily J.; Metz, Maeva L.; Jeffries, Marlo K. Sellin; Actis, Luis A.			Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii	PLOS ONE			English	Article							LIPID ACYL HYDROLASE; SP-NOV.; ACQUISITION FUNCTIONS; EMENDED DESCRIPTION; HEMOLYTIC-ACTIVITY; SEQUENCE; PATATIN; PROTEIN; STRAIN; CELLS	Acinetobacter baumannii is an opportunistic Gram-negative pathogen that causes a wide range of infections including pneumonia, septicemia, necrotizing fasciitis and severe wound and urinary tract infections. Analysis of A. baumannii representative strains grown in Chelex 100-treated medium for hemolytic activity demonstrated that this pathogen is increasingly hemolytic to sheep, human and horse erythrocytes, which interestingly contain increasing amounts of phosphatidylcholine in their membranes. Bioinformatic, genetic and functional analyses of 19 A. baumannii isolates showed that the genomes of each strain contained two phosphatidylcholine-specific phospholipase C (PC-PLC) genes, which were named plc1 and plc2. Accordingly, all of these strains were significantly hemolytic to horse erythrocytes and their culture supernatants tested positive for PC-PLC activity. Further analyses showed that the transcriptional expression of plc1 and plc2 and the production of phospholipase and thus hemolytic activity increased when bacteria were cultured under iron-chelation as compared to iron-rich conditions. Testing of the A. baumannii ATCC 19606T plc1::aph-FRT and plc2::aph isogenic insertion derivatives showed that these mutants had a significantly reduced PC-PLC activity as compared to the parental strain, while testing of plc1::ermAM/ plc2::aph demonstrated that this double PC-PLC isogenic mutant expressed significantly reduced cytolytic and hemolytic activity. Interestingly, only plc1 was shown to contribute significantly to A. baumanniivirulence using the Galleria mellonella infection model. Taken together, our data demonstrate that both PLC1 and PLC2, which have diverged from a common ancestor, play a concerted role in hemolytic and cytolytic activities; although PLC1 seems to play a more critical role in the virulence of A. baumannii when tested in an invertebrate model. These activities would provide access to intracellular iron stores this pathogen could use during growth in the infected host.	[Fiester, Steven E.; Arivett, Brock A.; Schmidt, Robert E.; Beckett, Amber C.; Ticak, Tomislav; Carrier, Mary V.; Ohneck, Emily J.; Metz, Maeva L.; Jeffries, Marlo K. Sellin; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Ghosh, Rajarshi] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA; [Fiester, Steven E.] Miami Univ, Dept Biol Sci, Middletown, OH USA; [Arivett, Brock A.] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA; [Beckett, Amber C.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Ticak, Tomislav] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Jeffries, Marlo K. Sellin] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA	University System of Ohio; Miami University; Middle Tennessee State University; University System of Ohio; Miami University; Middle Tennessee State University; Vanderbilt University; Idaho; University of Idaho; Texas Christian University	Actis, LA (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@MiarniOH.edu	Fiester, Steven/K-6058-2019; Arivett, Brock/T-2569-2018; Jeffries, Marlo/AAG-2354-2019	Arivett, Brock/0000-0002-1291-3814; Jeffries, Marlo/0000-0003-0118-5222; Metz, Maeva/0000-0002-4575-8347; Ghosh, Rajarshi/0000-0002-2654-6867	U.S. Public Health [AI070174]; U.S. Department of Defense [W81XWH-12-2-0035]; Miami University research funds; Department of Defense [W81XWH-12-2-0035]; U.S. Public Health Service [AI070174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070174] Funding Source: NIH RePORTER	U.S. Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. Department of Defense(United States Department of Defense); Miami University research funds; Department of Defense(United States Department of Defense); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from U.S. Public Health AI070174 and U.S. Department of Defense W81XWH-12-2-0035, and Miami University research funds awarded to Luis Actis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funds from Department of Defense W81XWH-12-2-0035 grant, U.S. Public Health Service AI070174 award, and Miami University research funds. We thank Drs. D. Zurawski (Walter Reed Army Institute of Research, Silver Spring, Maryland, USA) and L. Dijkshoorn (Leiden University Medical Center, Department of Infectious Diseases, Leiden, The Netherlands) for providing the wound clinical isolates and the LUH and RUH strains, respectively, which are listed in Table 1. We are also grateful to Dr. E. Lafontaine (College of Veterinary Medicine, University of Georgia, USA) for providing the A549 cell line. The findings and opinions expressed herein belong to the authors and do not necessarily reflect the official views of the WRAIR, the U.S. Army, or the Department of Defense.	Actis LA, 2010, VIRULENCE, V1, P6, DOI 10.4161/viru.1.1.10210; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Barcak JG, 1991, METHOD ENZYMOL, V204, P321; Bevivino A, 2002, J CLIN MICROBIOL, V40, P846, DOI 10.1128/JCM.40.3.846-851.2002; Blackwell A, 2013, MULTIOMICS COMPATIBL; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Carruthers Michael D, 2013, Genome Announc, V1, DOI 10.1128/genomeA.00906-13; Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08; Clark, 2011, ANAL LIPIDS HPLC CAD; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Dorsey CW, 2002, APPL ENVIRON MICROB, V68, P6353, DOI 10.1128/AEM.68.12.6353-6360.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; El-Feky E. A. M., 2011, Australian Journal of Basic and Applied Sciences, V5, P747; Fiester SE, 2015, INFECT IMMUN, V83, P1354, DOI 10.1128/IAI.02925-14; Fiester SE, 2013, FUTURE MICROBIOL, V8, P353, DOI [10.2217/FMB.12.150, 10.2217/fmb.12.150]; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Fry NK, 2007, J MED MICROBIOL, V56, P1700, DOI 10.1099/jmm.0.47482-0; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gallagher LA, 2015, J BACTERIOL, V197, P2027, DOI 10.1128/JB.00131-15; Gebhardt MJ, 2015, MBIO, V6, DOI 10.1128/mBio.01660-15; Gerrits GP, 2005, EMERG INFECT DIS, V11, P1115, DOI 10.3201/eid1107.041290; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Ji GH, 2008, BIOL CONTROL, V45, P288, DOI 10.1016/j.biocontrol.2008.01.004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; LEHMANN V, 1971, ACTA PATHOLOG MICROB, VB 79, P61, DOI 10.1111/j.1699-0463.1971.tb00033.x; LEHMANN V, 1973, ACTA PATH MICRO IM B, VB 81, P427, DOI 10.1111/j.1699-0463.1973.tb02226.x; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Lindquist D, 2003, J CLIN MICROBIOL, V41, P192, DOI 10.1128/JCM.41.1.192-196.2003; Lund MB, 2012, ANTON LEEUW INT J G, V101, P507, DOI 10.1007/s10482-011-9659-x; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; MCCORMICK JB, 1977, J INFECT DIS, V135, P103, DOI 10.1093/infdis/135.1.103; MUCKLE CA, 1983, AM J VET RES, V44, P1149; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; Nwugo CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051936; OHMAN DE, 1980, INFECT IMMUN, V28, P899; OSTROFF RM, 1990, J BACTERIOL, V172, P5915, DOI 10.1128/jb.172.10.5915-5923.1990; Ozaki T, 2009, J INFECT CHEMOTHER, V15, P322, DOI 10.1007/s10156-009-0704-x; Park JH, 2008, INT J SYST EVOL MICR, V58, P387, DOI 10.1099/ijs.0.65290-0; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sambrook J., 2001, MOL CLONING LAB MANU; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shimuta K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-261; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Stahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138360; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van den Broek PJ, 2006, CLIN MICROBIOL INFEC, V12, P837, DOI 10.1111/j.1469-0691.2006.01510.x; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yeoh-Ellerton S, 2003, J INVEST DERMATOL, V121, P918, DOI 10.1046/j.1523-1747.2003.12471.x; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	75	36	37	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167068	10.1371/journal.pone.0167068	http://dx.doi.org/10.1371/journal.pone.0167068			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875572	Green Published, gold, Green Submitted			2022-12-26	WOS:000388886000048
J	Stenkewitz, U; Nielsen, OK; Skirnisson, K; Stefansson, G				Stenkewitz, Ute; Nielsen, Olafur K.; Skirnisson, Karl; Stefansson, Gunnar			Host-Parasite Interactions and Population Dynamics of Rock Ptarmigan	PLOS ONE			English	Article							LAGOPUS-MUTA; RED GROUSE; REPRODUCTIVE SUCCESS; LONG-TERM; ICELAND; STABILITY; CYCLES; FLUCTUATIONS; AGGREGATION; PREVALENCE	Populations of rock ptarmigan (Lagopus muta) in Iceland fluctuate in multiannual cycles with peak numbers c. every 10 years. We studied the ptarmigan-parasite community and how parasites relate to ptarmigan age, body condition, and population density. We collected 632 ptarmigan in northeast Iceland in early October from 2006 to 2012; 630 (99.7%) were infected with at least one parasite species, 616 (98%) with ectoparasites, and 536 (85%) with endoparasites. We analysed indices for the combined parasite community (16 species) and known pathogenic parasites, two coccidian protozoans Eimeria muta and Eimeria rjupa, two nematodes Capillaria caudinflata and Trichostrongylus tenuis, one chewing louse Amyrsidea lagopi, and one skin mite Metamicrolichus islandicus. Juveniles overall had more ectoparasites than adults, but endoparasite levels were similar in both groups. Ptarmigan population density was associated with endoparasites, and in particular prevalence of the coccidian parasite Eimeria muta. Annual aggregation level of this eimerid fluctuated inversely with prevalence, with lows at prevalence peak and vice versa. Both prevalence and aggregation of E. muta tracked ptarmigan population density with a 1.5 year time lag. The time lag could be explained by the host specificity of this eimerid, host density dependent shedding of oocysts, and their persistence in the environment from one year to the next. Ptarmigan body condition was negatively associated with E. muta prevalence, an indication of their pathogenicity, and this eimerid was also positively associated with ptarmigan mortality and marginally inversely with fecundity. There were also significant associations between fecundity and chewing louse Amyrsidea lagopi prevalence (negative), excess juvenile mortality and nematode Capillaria caudinflata prevalence (positive), and adult mortality and skin mite Metamicrolichus islandicus prevalence (negative). Though this study is correlational, it provides strong evidence that E. muta through time-lag in prevalence with respect to host population size and by showing significant relations with host body condition, mortality, and fecundity could destabilize ptarmigan population dynamics in Iceland.	[Stenkewitz, Ute] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Stenkewitz, Ute; Nielsen, Olafur K.] Iceland Inst Nat Hist, Gardabaer, Iceland; [Stenkewitz, Ute; Skirnisson, Karl] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Stefansson, Gunnar] Univ Iceland, Inst Sci, Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland	Stenkewitz, U (corresponding author), Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland.; Stenkewitz, U (corresponding author), Iceland Inst Nat Hist, Gardabaer, Iceland.; Stenkewitz, U (corresponding author), Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland.	ute@ni.is	Stenkewitz, Ute/AAV-1535-2020; Stefansson, Gunnar/A-2209-2008; Nielsen, Olafur/AAH-1447-2019; Stefansson, Gunnar/AAV-9432-2020	Stefansson, Gunnar/0000-0002-2693-9142; Stefansson, Gunnar/0000-0002-2693-9142	Icelandic Research Fund [090207021]; Hunting Card Fund; Landsvirkjun Energy Fund; Institute for Experimental Pathology, Keldur, University of Iceland	Icelandic Research Fund; Hunting Card Fund; Landsvirkjun Energy Fund; Institute for Experimental Pathology, Keldur, University of Iceland	This work was supported by the Icelandic Research Fund, grant number 090207021: salary including funding of this work; Hunting Card Fund: salary including funding of this work; Landsvirkjun Energy Fund: salary and funding of this work; Institute for Experimental Pathology, Keldur, University of Iceland: Provision of research material; Icelandic Institute of Natural History: Salary and provision of office space and research material. The funder provided support in the form of salary for author [US], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2011, GYRFALCONS PTARMIGAN; Atkinson CT, 2008, PARASITIC DIS WILD B; Baumel J. J., 1979, NOMINA ANATOMICA AVI; Berryman, 2002, POPULATION CYCLES CA, DOI 10.1093/oso/9780195140989.001.0001; Bicudo JEPW, 2010, ECOLOGICALAND ENV PH, P1; Bochkov AV, 2011, PARASITOL RES, V108, P715, DOI 10.1007/s00436-010-2118-1; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CLAYTON DH, 1995, PARASITOLOGY, V110, P195, DOI 10.1017/S0031182000063964; CLAYTON DH, 1990, AM ZOOL, V30, P251, DOI 10.1093/icb/30.2.251; Clayton DH., 2015, COEVOLUTION LIFE HOS; DEVANEY JA, 1976, POULTRY SCI, V55, P430, DOI 10.3382/ps.0550430; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; Esch GW, 1997, AM MIDL NAT, V137, P369, DOI 10.2307/2426856; FARR MM, 1949, ANN NY ACAD SCI, V52, P468, DOI 10.1111/j.1749-6632.1949.tb53932.x; Fuller E, 2012, AM NAT, V179, pE70, DOI 10.1086/664488; Gardarsson A., 1988, P300; Garoarssori A., 1971, FOOD ECOLOGY SPACING; Grenfell BT, 1995, ECOLOGY WILDLIFE HOS; HERRICK C. A., 1936, POULTRY SCI, V15, P322, DOI 10.3382/ps.0150322; Holmstad PR, 2005, OIKOS, V111, P377, DOI 10.1111/j.0030-1299.2005.13640.x; Holmstad PR, 2005, OIKOS, V109, P429, DOI 10.1111/j.0030-1299.2005.13702.x; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; HUDSON PJ, 1986, J ANIM ECOL, V55, P85, DOI 10.2307/4694; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Hughes DP, 2012, HOST MANIPULATION BY PARASITES, P140; Keith L.B., 1963, WILDLIFES 10 YEAR CY; Kennedy MW, 1997, PARASITIC NEMATODES; Keymer AE, 1991, PARASITE HOST ASS CO, P1750; Kloster R, 1923, BERGENS JAEGEROG FIS, V5, P1; Krebs CJ, 2001, BIOSCIENCE, V51, P25, DOI 10.1641/0006-3568(2001)051[0025:WDTYCO]2.0.CO;2; LANDERS EJ, 1953, J PARASITOL, V39, P547, DOI 10.2307/3273857; Madsen Holger, 1945, DANISH REV GAME BIOL, V1, P1; Magnusson KG, 2004, RH192004 U IC; Martinez-Padilla J, 2014, J ANIM ECOL, V83, P85, DOI 10.1111/1365-2656.12098; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; McDonald ME., 1974, KEY NEMATODES REPORT; Merila J, 2000, J AVIAN BIOL, V31, P504, DOI 10.1034/j.1600-048X.2000.310410.x; Mironov SV, 2010, SYST PARASITOL, V75, P187, DOI 10.1007/s11230-009-9219-1; Morehouse NF., 1942, LIFE CYCLE CAPILLARI; Moreno-Rueda G, 2012, BEHAV ECOL, V23, P271, DOI 10.1093/beheco/arr182; Moss R, 2001, ADV ECOL RES, V32, P53, DOI 10.1016/S0065-2504(01)32011-1; Newey S, 2005, INT J PARASITOL, V35, P367, DOI 10.1016/j.ijpara.2004.12.003; Nielsen OK, 1999, J ANIM ECOL, V68, P1034, DOI 10.1046/j.1365-2656.1999.00351.x; Nielsen OK., 1986, POPULATION ECOLOGY G; Nielsen OK, 1996, NATTURUFRAEDINGURINN, V65, P137; NIelsen OK, 2004, MONITORING PTARMIGAN; Nielsen OK, 1995, WILDLIFE BIOL, V1, P65, DOI 10.2981/wlb.1995.0011; Olsen O. W, 1974, ANIMAL PARASITES THE; Pellerdy L. P., 1974, COCCIDIA COCCIDIOSIS, V2nd; POULIN R, 1993, INT J PARASITOL, V23, P937, DOI 10.1016/0020-7519(93)90060-C; Redpath SM, 2006, ECOL LETT, V9, P410, DOI 10.1111/j.1461-0248.2006.00895.x; Reiczigel J, 2013, QUANTITATIVE PARASIT; Rommel M., 2000, VETERINARMEDIZINISCH, VFifth; SCHARF WC, 1983, ANN ENTOMOL SOC AM, V76, P441, DOI 10.1093/aesa/76.3.441; Seed, 2001, PARASITISM DIVERSITY; Skimisson K, 2016, PARASITOL RES, V115, P2597, DOI [10.1007/s00436-016-5006-5, DOI 10.1007/S00436-016-5006-5]; Skimisson K, WILDLIFE BI IN PRESS; Skirnisson K, 2007, PARASITOL RES, V101, P1077, DOI 10.1007/s00436-007-0589-5; Skirnisson K, 2015, J ORNITHOL, V156, P429, DOI [10.1007/s10336-014-1141-x, DOI 10.1007/S10336-014-1141-X]; Skirnisson K, 2012, COMP PARASITOL, V79, P44, DOI 10.1654/4481.1; Sturludottir E, 2015, STAT ANAL TRENDS DAT; Theodor O, 1964, FLIEGEN PALAARKTISCH, V64, P1; Thorarinsdottir Solrun Th., 2010, Natturufraedingurinn, V80, P33; Timmermann VG., 1950, MISCELLANEOUS PAPERS, P1; Tompkins DM, 1996, FUNCT ECOL, V10, P733, DOI 10.2307/2390508; Watson A, 1998, ECOLOGY, V79, P1174; Watson JM, 1965, INTRO PARASITOLOGY B; WEEDEN RB, 1967, J WILDLIFE MANAGE, V31, P825, DOI 10.2307/3797990; Weeden RB, 1965, GROUSE PTARMIGAN ALA; Wehr E. E., 1971, P185	75	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0165293	10.1371/journal.pone.0165293	http://dx.doi.org/10.1371/journal.pone.0165293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870855	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400002
J	Bell, JD; Lyle, JM				Bell, Justin David; Lyle, Jeremy Martin			Post-Capture Survival and Implications for By-Catch in a Multi-Species Coastal Gillnet Fishery	PLOS ONE			English	Article							DISCARD MORTALITY; BYCATCH; MANAGEMENT; BIRDS; RATES; NETS; TASMANIA; SEABIRDS; MAMMALS; CAUGHT	As fisheries shift towards ecosystem-based management, the need to reduce impacts on by-catch has been increasingly recognised. In this study the catch composition, discard rate, and post-capture survival of species caught by gillnets in Tasmania, Australia, was investigated. Over half the commercial gillnet catch was discarded, with discard rates of similar to 20% for target and >80% for non-target species. Capture condition, including initial mortality, was assessed using simple criteria for a range of species and related to soak duration. Delayed mortality was also assessed using tank trials and related to capture condition. By combining initial and delayed mortality rates post-capture survival was estimated. Longer soak durations generally resulted in slight, but significant, declines in capture condition and lower initial survival. Nonetheless, when combined with delayed survival, four of the five most commonly caught species (Cheilodactylus spectabilis, Latridopsis forsteri, Aplodactylus arctidens, Cephaloscyllium laticeps) exhibited high post-capture survival (83- 100%) for soak durations within the maximum regulated range. Post-capture survival of the one remaining commonly caught species, Notolabrus tetricus, (typically discarded) declined with increased soak duration from 84% to 62%, suggesting that this species would benefit from a further reduction in maximum soak duration. Initial and delayed survival rates for the species retained for tank trials exhibited a significant linear relationship, which was used to estimate delayed survival rates for the rarer species. This method enabled the estimation of potential post-capture survival rates for a diverse range of species and may have application in other data-limited situations where the relationships between fishing practices and by-catch survival are uncertain. Overall, our results suggest that soak duration regulation has been effective in reducing by-catch mortality for many species, noting that some species have low survival rates regardless of soak duration.	[Bell, Justin David; Lyle, Jeremy Martin] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Tasmania	Bell, JD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Justin.Bell@utas.edu.au	Lyle, Jeremy M/J-7170-2014	Lyle, Jeremy M/0000-0001-9670-5854	Australian Government through the Fisheries Research and Development Corporation [2010/16]	Australian Government through the Fisheries Research and Development Corporation(Fisheries R&D Corp)	This study was funded by the Australian Government through the Fisheries Research and Development Corporation (Project 2010/16) and in kind contributions by the Institute for Marine and Antarctic Studies, University of Tasmania.; We acknowledge the considerable contributions of our late colleague Ben Chuwen, who sadly passed away during the course of the study. The assistance provided by the various commercial fishers who welcomed us on board their vessels is gratefully appreciated, as is the field support provided by E. Forbes, A. Mapleston and G. Ewing. We also wish to thank Petri Suuronen, Heather Patterson and an anonymous reviewer, whose constructive comments and suggestions greatly improved this study. Funding for this project was provided by the Australian Government through the Fisheries Research and Development Corporation (Project No. 2010/16).	Benjamini Y, 2001, ANN STAT, V29, P1165; Benoit HP, 2010, FISH RES, V106, P436, DOI 10.1016/j.fishres.2010.09.018; Bettoli PW, 2006, FISH RES, V77, P343, DOI 10.1016/j.fishres.2005.11.008; Braccini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032547; Broadhurst MK, 2008, DIS AQUAT ORGAN, V80, P51, DOI 10.3354/dao01904; Broadhurst MK, 2009, DIS AQUAT ORGAN, V85, P157, DOI 10.3354/dao02063; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; CHOPIN FS, 1995, FISH RES, V21, P315, DOI 10.1016/0165-7836(94)00301-C; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Dunn DC, 2011, FISH FISH, V12, P110, DOI 10.1111/j.1467-2979.2010.00388.x; Emery T, 2016, TASMANIAN SCALEFISH; Gallinat Michael P., 1997, North American Journal of Fisheries Management, V17, P136, DOI 10.1577/1548-8675(1997)017<0136:STSOLT>2.3.CO;2; Gilman E, 2013, J FISH BIOL, V83, P766, DOI 10.1111/jfb.12148; Grixti D, 2010, N AM J FISH MANAGE, V30, P723, DOI 10.1577/M09-037.1; HARRIES D N, 1989, Papers and Proceedings of the Royal Society of Tasmania, V123, P97; Hueter RE, 2006, T AM FISH SOC, V135, P500, DOI 10.1577/T05-065.1; Hyodo S, 2007, J EXP BIOL, V210, P1303, DOI 10.1242/jeb.003418; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Last PR, 2007, ZOOTAXA, P45; Lyle JM, 2007, MAR FRESHWATER RES, V58, P445, DOI 10.1071/MF06233; Lyle JM, 2016, FISH RES, V177, P50, DOI 10.1016/j.fishres.2016.01.021; Lyle JM, 2000, 1996161 FISH RES DEV; Lyons K, 2013, FISH RES, V147, P370, DOI 10.1016/j.fishres.2013.07.009; Majluf P, 2002, CONSERV BIOL, V16, P1333, DOI 10.1046/j.1523-1739.2002.00564.x; Murphy Michael D., 1995, North American Journal of Fisheries Management, V15, P748, DOI 10.1577/1548-8675(1995)015<0748:MOSSRF>2.3.CO;2; Norman FI, 2000, BIOL CONSERV, V92, P217, DOI 10.1016/S0006-3207(99)00055-5; R Core Team, 2013, R LANG ENV STAT COMP; Rulifson RA, 2007, N AM J FISH MANAGE, V27, P279, DOI 10.1577/M06-071.1; Samsun Necati, 2005, Turkish Journal of Fisheries and Aquatic Sciences, V5, P57; Sonntag N, 2012, ICES J MAR SCI, V69, P578, DOI 10.1093/icesjms/fss030; Stevenson Caryn, 2007, Marine Ornithology, V35, P71; Stobart B, 2016, MAR FRESHWATER RES, V67, P612, DOI 10.1071/MF14340; Uhlmann SS, 2015, FISH FISH, V16, P183, DOI 10.1111/faf.12049; Vander Haegen GE, 2004, FISH RES, V68, P123, DOI 10.1016/j.fishres.2004.02.003; Watson R, 2006, FISH RES, V79, P97, DOI 10.1016/j.fishres.2006.01.010; Woehler EJ, 2013, 201305 BIRDL TASM; Ziegler PE, 2012, FISH RES, V134, P52, DOI 10.1016/j.fishres.2012.08.011; Zydelis R, 2013, BIOL CONSERV, V162, P76, DOI 10.1016/j.biocon.2013.04.002; [No title captured]; [No title captured]	41	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166632	10.1371/journal.pone.0166632	http://dx.doi.org/10.1371/journal.pone.0166632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861602	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300081
J	Hilbun, A; Karsai, I				Hilbun, Allison; Karsai, Istvan			Task Allocation of Wasps Governed by Common Stomach: A Model Based on Electric Circuits	PLOS ONE			English	Article							DIVISION-OF-LABOR; NEST CONSTRUCTION BEHAVIOR; COLLECTIVE BEHAVIOR; ORGANIZATION; WORK; SOCIETIES	Simple regulatory mechanisms based on the idea of the saturable 'common stomach' can control the regulation of construction behavior and colony-level responses to environmental perturbations in Metapolybia wasp societies. We mapped the different task groups to mutual inductance electrical circuits and used Kirchoff's basic voltage laws to build a model that uses master equations from physics, yet is able to provide strong predictions for this complex biological phenomenon. Similar to real colonies, independently of the initial conditions, the system shortly sets into an equilibrium, which provides optimal task allocation for a steady construction, depending on the influx of accessible water. The system is very flexible and in the case of perturbations, it reallocates its workforce and adapts to the new situation with different equilibrium levels. Similar to the finding of field studies, decreasing any task groups caused decrease of construction; increasing or decreasing water inflow stimulated or reduced the work of other task groups while triggering compensatory behavior in water foragers. We also showed that only well connected circuits are able to produce adequate construction and this agrees with the finding that this type of task partitioning only exists in larger colonies. Studying the buffer properties of the common stomach and its effect on the foragers revealed that it provides stronger negative feedback to the water foragers, while the connection between the pulp foragers and the common stomach has a strong fixed-point attractor, as evidenced by the dissipative trajectory.	[Hilbun, Allison] East Tennessee State Univ, Dept Biomed Sci, Johnson City, TN USA; [Karsai, Istvan] East Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University	Karsai, I (corresponding author), East Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	karsai@etsu.edu						Agrawal D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145560; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; BANNISTER JA, 1983, ACTA INFORM, V20, P261, DOI 10.1007/BF01257086; BARLOW R, 1960, OPER RES, V8, P90, DOI 10.1287/opre.8.1.90; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Bonabeau E, 1998, B MATH BIOL, V60, P753, DOI 10.1006/bulm.1998.0041; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Forsyth AB, 1978, THESIS; Gerkey BP, 2004, INT J ROBOT RES, V23, P939, DOI 10.1177/0278364904045564; Giancoli D.C., 2000, PHYS ED, V35, P370; Gordon DM, 2016, BEHAV ECOL SOCIOBIOL, V70, P1101, DOI 10.1007/s00265-015-2045-3; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Hamann H, 2013, B MATH BIOL, V75, P1181, DOI 10.1007/s11538-013-9851-4; Heimburg Thomas, 2007, Biophysical Reviews and Letters, V2, P57, DOI 10.1142/S179304800700043X; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Holldobler B., 2008, SUPERORGANISM BEAUTY; Jeanne RL, 1996, ANIM BEHAV, V52, P473, DOI 10.1006/anbe.1996.0191; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 1998, P NATL ACAD SCI USA, V95, P8665, DOI 10.1073/pnas.95.15.8665; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Karsai I, 2012, MATH COMP MODEL DYN, V18, P13, DOI 10.1080/13873954.2011.601423; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; Klugl F, 2003, 2 INT WORKSH MATH AL; Lemaire T, P IEEE INT C ROB AUT, V4, P3622; Middleton EJT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1022; Naug D, 2016, BEHAV ECOL SOCIOBIOL, V70, P1113, DOI 10.1007/s00265-016-2092-4; Newcomb JM, 2012, P NATL ACAD SCI USA, V109, P10669, DOI 10.1073/pnas.1201877109; ROBINSON GE, 1989, WESTV STUD, P61; Robson SKA, 2016, BEHAV ECOL SOCIOBIOL, V70, P995, DOI 10.1007/s00265-016-2147-6; Schmickl T, 2016, J THEOR BIOL, V389, P274, DOI 10.1016/j.jtbi.2015.10.036; Schmickl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114611; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; SEELEY TD, 1985, FORTS ZOOL, V31, P75; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Sinha N, 2006, J NEUROPHYSIOL, V95, P3146, DOI 10.1152/jn.01184.2005	36	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0167041	10.1371/journal.pone.0167041	http://dx.doi.org/10.1371/journal.pone.0167041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861633	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300145
J	Khosa, JS; Lee, R; Brauning, S; Lord, J; Pither-Joyce, M; McCallum, J; Macknight, RC				Khosa, Jiffinvir S.; Lee, Robyn; Brauning, Sophia; Lord, Janice; Pither-Joyce, Meeghan; McCallum, John; Macknight, Richard C.			Doubled Haploid 'CUDH2107' as a Reference for Bulb Onion (Allium cepa L.) Research: Development of a Transcriptome Catalogue and Identification of Transcripts Associated with Male Fertility	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; CYTOPLASMIC MALE-STERILITY; NEXT-GENERATION SEQUENCE; RNA-SEQ DATA; FUNCTIONAL CONSERVATION; TARGETED MUTAGENESIS; POLLEN DEVELOPMENT; GENE-EXPRESSION; FINGER PROTEIN; CODING REGIONS	Researchers working on model plants have derived great benefit from developing genomic and genetic resources using 'reference' genotypes. Onion has a large and highly heterozygous genome making the sharing of germplasm and analysis of sequencing data complicated. To simplify the discovery and analysis of genes underlying important onion traits, we are promoting the use of the homozygous double haploid line 'CUDH2107' by the onion research community. In the present investigation, we performed transcriptome sequencing on vegetative and reproductive tissues of CUDH2107 to develop a multi-organ reference transcriptome catalogue. A total of 396 million 100 base pair paired reads was assembled using the Trinity pipeline, resulting in 271,665 transcript contigs. This dataset was analysed for gene ontology and transcripts were classified on the basis of putative biological processes, molecular function and cellular localization. Significant differences were observed in transcript expression profiles between different tissues. To demonstrate the utility of our CUDH2107 transcriptome catalogue for understanding the genetic and molecular basis of various traits, we identified orthologues of rice genes involved in male fertility and flower development. These genes provide an excellent starting point for studying the molecular regulation, and the engineering of reproductive traits.	[Khosa, Jiffinvir S.; Lee, Robyn; Brauning, Sophia; McCallum, John; Macknight, Richard C.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Brauning, Sophia; Lord, Janice] Univ Otago, Dept Bot, Dunedin, New Zealand; [Pither-Joyce, Meeghan; McCallum, John; Macknight, Richard C.] New Zealand Inst Plant & Food Res, Lincoln, New Zealand	University of Otago; University of Otago; New Zealand Institute for Plant & Food Research Ltd	Macknight, RC (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.; Macknight, RC (corresponding author), New Zealand Inst Plant & Food Res, Lincoln, New Zealand.	richard.macknight@otago.ac.nz	Lord, Janice Marjorie/A-8869-2012	Lord, Janice Marjorie/0000-0001-8314-0428; Macknight, Richard/0000-0003-1146-9042; Pither-Joyce, Meeghan/0000-0002-4454-0514; Macknight, Richard/0000-0002-3300-7124; McCallum, John/0000-0002-7773-6732	Indian Council of Agricultural Research (ICAR) International fellowship; Otago University doctoral scholarship; New Zealand Onion Industry Postgraduate Scholarship	Indian Council of Agricultural Research (ICAR) International fellowship; Otago University doctoral scholarship; New Zealand Onion Industry Postgraduate Scholarship	Jiffinvir S. Khosa's PhD research is supported by an Indian Council of Agricultural Research (ICAR) International fellowship, an Otago University doctoral scholarship, and a New Zealand Onion Industry Postgraduate Scholarship.; Jiffinvir S. Khosa's PhD research is supported by an Indian Council of Agricultural Research (ICAR) International fellowship, an Otago University doctoral scholarship, and a New Zealand Onion Industry Postgraduate Scholarship. We thank Bronwyn Carlisle (University of Otago) for assisting with figure preparations.	Ai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150892; Alan AR, 2004, PLANT SCI, V167, P1055, DOI 10.1016/j.plantsci.2004.06.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aya K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1552; Baldwin S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-637; Berbel A, 2005, PLANT PHYSIOL, V139, P174, DOI 10.1104/pp.104.057687; Bohra A, 2016, PLANT CELL REP, V35, P967, DOI 10.1007/s00299-016-1949-3; Chang L, 2009, CELL RES, V19, P768, DOI 10.1038/cr.2009.52; Che LX, 2011, CELL RES, V21, P654, DOI 10.1038/cr.2011.7; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Djukanovic V, 2013, PLANT J, V76, P888, DOI 10.1111/tpj.12335; Duangjit J, 2013, THEOR APPL GENET, V126, P2093, DOI 10.1007/s00122-013-2121-x; Farrell JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103567; Fritsch R. M., 2002, P5, DOI 10.1079/9780851995106.0005; Gao XQ, 2012, PLANTA, V235, P713, DOI 10.1007/s00425-011-1532-7; Glemin S, 2014, TRENDS GENET, V30, P263, DOI 10.1016/j.tig.2014.05.002; Gomez JF, 2015, J INTEGR PLANT BIOL, V57, P876, DOI 10.1111/jipb.12425; Gomez JF, 2014, PLANT BIOTECHNOL J, V12, P765, DOI 10.1111/pbi.12181; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo JX, 2012, J INTEGR PLANT BIOL, V54, P967, DOI 10.1111/j.1744-7909.2012.01172.x; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hong JC., 2016, PLANT TRANSCRIPTION, P35, DOI 10.1016/B978-0-12-800854-6/00003-8; Hord CLH, 2008, MOL PLANT, V1, P645, DOI 10.1093/mp/ssn029; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Hyde PT, 2012, HORTSCIENCE, V47, P1690, DOI 10.21273/HORTSCI.47.12.1690; Ito T, 2002, PLANT CELL PHYSIOL, V43, P1285, DOI 10.1093/pcp/pcf154; Ito T, 2007, PLANT CELL, V19, P3549, DOI 10.1105/tpc.107.054536; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jiang SY, 2007, DEV BIOL, V304, P579, DOI 10.1016/j.ydbio.2007.01.008; Jin JP, 2015, MOL BIOL EVOL, V32, P1767, DOI 10.1093/molbev/msv058; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kamenetsky R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1212-2; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Khosa JS, 2016, PLANT BREEDING, V135, P9, DOI 10.1111/pbr.12330; Kim B, 2016, CURR GENET, V62, P873, DOI 10.1007/s00294-016-0595-1; Kim S, 2015, DNA RES, V22, P19, DOI 10.1093/dnares/dsu035; Kim S, 2015, THEOR APPL GENET, V128, P2289, DOI 10.1007/s00122-015-2584-z; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Lee R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3884; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Han, 2011, J Biomed Biotechnol, V2011, P281651, DOI 10.1155/2011/281651; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li QL, 2016, J GENET GENOMICS, V43, P415, DOI 10.1016/j.jgg.2016.04.011; Li XW, 2011, PLANT CELL, V23, P1416, DOI 10.1105/tpc.110.082636; Lu SH, 2010, J PLANT PHYSIOL, V167, P1613, DOI 10.1016/j.jplph.2010.06.028; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; McCallum J, 2014, ACTA HORTIC, V1110, P606, DOI [10.1146/annurev-arplant-050213-040119, DOI 10.1146/ANNUREV-ARPLANT-050213-040119]; McCallum John, 2007, V5, P331; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Murmu J, 2010, PLANT PHYSIOL, V154, P1492, DOI 10.1104/pp.110.159111; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; Nonomura KI, 2003, PLANT CELL, V15, P1728, DOI 10.1105/tpc.012401; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shao T, 2011, PLANT PHYSIOL, V156, P1386, DOI 10.1104/pp.111.177428; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh SP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11274; Skipper M, 2002, ANN BOT-LONDON, V89, P83, DOI 10.1093/aob/mcf009; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Stewart D, 2016, FEBS J, V283, P1823, DOI 10.1111/febs.13640; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Taoka K, 2013, TRENDS PLANT SCI, V18, P287, DOI 10.1016/j.tplants.2013.02.002; Toriba T, 2010, PLANT CELL, V22, P1452, DOI 10.1105/tpc.110.075291; Tsai WC, 2014, J SYST EVOL, V52, P397, DOI 10.1111/jse.12010; Tsukazaki H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0265-x; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Wang K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00092; Wang M, 2010, PLANT CELL, V22, P417, DOI 10.1105/tpc.109.070789; Wellmer Frank, 2014, Methods Mol Biol, V1110, P103, DOI 10.1007/978-1-4614-9408-9_5; Wu YZ, 2016, PLANT BIOTECHNOL J, V14, P1046, DOI 10.1111/pbi.12477; Xiao H, 2009, PLANT J, V59, P789, DOI 10.1111/j.1365-313X.2009.03913.x; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yang XH, 2003, PLANT CELL, V15, P1281, DOI 10.1105/tpc.010447; Yao SG, 2008, PLANT CELL PHYSIOL, V49, P853, DOI 10.1093/pcp/pcn050; Yoshida H, 2011, J EXP BOT, V62, P4719, DOI 10.1093/jxb/err272; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780; Zhang H, 2010, PLANT CELL, V22, P672, DOI 10.1105/tpc.109.073668; Zhang L, 2015, PLANT SCI, V238, P188, DOI 10.1016/j.plantsci.2015.06.007; Zhao XA, 2008, PLANT J, V54, P375, DOI 10.1111/j.1365-313X.2008.03426.x; Zhou SR, 2011, PLANT CELL, V23, P111, DOI 10.1105/tpc.109.073692	84	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166568	10.1371/journal.pone.0166568	http://dx.doi.org/10.1371/journal.pone.0166568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861615	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300072
J	Laurenzano, C; Costa, TM; Schubert, CD				Laurenzano, Claudia; Costa, Tania M.; Schubert, Christoph D.			Contrasting Patterns of Clinal Genetic Diversity and Potential Colonization Pathways in Two Species of Western Atlantic Fiddler Crabs	PLOS ONE			English	Article							LARVAL DISPERSAL; POPULATION-STRUCTURE; GENUS UCA; ADAPTIVE SIGNIFICANCE; COMPARATIVE PHYLOGEOGRAPHY; LOCAL RETENTION; OCEAN CURRENTS; REEF FISHES; OCYPODIDAE; FLOW	Fiddler crabs (Brachyura, Ocypodidae), like many other marine organisms, disperse via planktonic larvae. A lengthy pelagic larval duration is generally assumed to result in genetic connectivity even among distant populations. However, major river outflows, such as of the Amazon or Orinoco, or strong currents may act as phylogeographic barriers to ongoing gene flow. For example, the Mona Passage, located between Puerto Rico and Hispaniola, has been postulated to impair larval exchange of several species. In this study, Cox1 mtDNA data was used to analyze population genetic structure of two fiddler crab species from the western Atlantic, comparing the continental coastline and Caribbean islands. The results indicate genetic homogeneity in Minuca rapax among Atlantic (continental) populations (Suriname, Brazil), whereas Caribbean populations show significantly restricted gene flow among the constituent islands and towards continental populations. Our data support the hypothesis of the Mona Passage hindering larval exchange. Contrastingly, Caribbean Leptuca leptodactyla populations appear to be devoid of detectable variation, while Atlantic-continental (i.e. Brazilian) populations show much higher haplotype and nucleotide diversities and display slight genetic differentiation among populations within the Atlantic region, though not statistically significant. Both species show a pronounced divergence between regions, supporting the presence of a phylogeographic barrier.	[Laurenzano, Claudia; Schubert, Christoph D.] Univ Regensburg, Zool, Regensburg, Germany; [Laurenzano, Claudia] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Costa, Tania M.] Sao Paulo State Univ UNESP, Biosci Inst, Sao Paulo, Brazil	University of Regensburg; University of Louisiana Lafayette; Universidade Estadual Paulista	Laurenzano, C (corresponding author), Univ Regensburg, Zool, Regensburg, Germany.; Laurenzano, C (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	claudia.laurenzano@louisiana.edu	Costa, Tania M/C-8066-2012; Costa, Tânia Marcia/AAC-6750-2019	Costa, Tania M/0000-0003-0230-8431; Costa, Tânia Marcia/0000-0003-0230-8431	DAAD project [56266761]; PROBRAL exchange project;  [50706184]	DAAD project; PROBRAL exchange project; 	This study resulted from a DAAD-Capes exchange projects. Funding for PI and student travel between Brazil and Germany was facilitated by PROBRAL exchange projects between C.D. Schubart and Brazilian colleagues from 2009-2010 (Project-ID 50706184 with Fernando L.M. Mantelatto) and 2013-2014 (DAAD project ID 56266761) with T.M. Costa.; The authors graciously acknowledge Nick Schizas, Ferndando Mantelatto, Karine Colpo, Richard Landstorfer, Nicole Rivera and Peter Koller for help collecting fiddler crab specimens. Special thanks go to the Naturalis Museum Leiden and the Senckenberg Museum Frankfurt for specimen loans. This study resulted from a DAAD-Capes exchange projects. Funding for PI and student travel between Brazil and Germany was facilitated by PROBRAL exchange projects between C.D. Schubart and Brazilian colleagues from 2009-2010 (Project-ID 50706184 with Fernando L.M. Mantelatto) and 2013-2014 (DAAD project ID 56266761) with T.M. Costa. Furthermore, the authors would like to thank three anonymous reviewers for very detailed and helpful comments that greatly improved the quality of this manuscript.	Avise J C, 2000, PHYLOGEOGRAPHY, DOI [10.1006/rwgn.2001.1470, DOI 10.1006/RWGN.2001.1470]; Avise John C., 1994, pi; BARNWELL FH, 1984, ZOOL J LINN SOC-LOND, V81, P23, DOI 10.1111/j.1096-3642.1984.tb02558.x; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Behum ME, 2005, MAR ECOL PROG SER, V288, P211, DOI 10.3354/meps288211; BERGER EM, 1973, BIOL BULL-US, V145, P83, DOI 10.2307/1540349; Boschi EE, 2000, REV INVEST DESARR PE, V13; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Brodie RJ, 2005, MAR BIOL, V147, P105, DOI 10.1007/s00227-005-1557-1; CHRISTY JH, 1982, BIOL BULL, V163, P251, DOI 10.2307/1541264; Christy JH, 1998, MAR ECOL PROG SER, V174, P51, DOI 10.3354/meps174051; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colin PL, 2003, SCIENCE, V300, P1657; Colin PL, 1975, NEON GOBIES COMP BIO; Collette B.B., 1977, P 3 INT COR REEF S; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cox C.B., 2000, BIOGEOGRAPHY ECOLOGI; Crane J, 2015, FIDDLER CRABS WORLD, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Crisp D.J., 1978, NATO Conference Series IV Marine Sciences, V2, P257; Simith DDD, 2014, J EXP MAR BIOL ECOL, V457, P22, DOI 10.1016/j.jembe.2014.03.021; Dennis GD, 2005, CARIBB J SCI, V41, P716; Diaz-Ferguson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012675; EMERY AR, 1973, COPEIA, P590; Epifanio C.E., 1988, Lecture Notes on Coastal and Estuarine Studies, V22, P291; EPIFANIO CE, 1988, MAR ECOL PROG SER, V43, P181, DOI 10.3354/meps043181; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Galetti PM, 2006, GENETICA, V126, P161, DOI 10.1007/s10709-005-1446-z; Galligan TH, 2012, MOL ECOL, V21, P2106, DOI 10.1111/j.1365-294X.2012.05511.x; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; GILBERT C R, 1972, Quarterly Journal of the Florida Academy of Sciences, V35, P130; GILBERT CR, 1977, COPEIA, P25; Gooch J.L., 1975, Marine Ecol, V2, P349; Gusmao J, 2005, GENET MOL BIOL, V28, P165, DOI 10.1590/S1415-47572005000100029; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampton KR, 2014, AQUAT BIOL, V20, P53, DOI 10.3354/ab00545; HEDGECOCK D, 1986, B MAR SCI, V39, P550; Hopkins MJ, 2010, BIOL J LINN SOC, V100, P248, DOI 10.1111/j.1095-8312.2010.01402.x; Hyman OW, 1920, J MORPHOL, V33, P485; Ituarte RB, 2012, ESTUAR COAST, V35, P1249, DOI 10.1007/s12237-012-9516-9; KOEHN RK, 1969, SCIENCE, V163, P943, DOI 10.1126/science.163.3870.943; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Largier JL, 2003, ECOL APPL, V13, pS71; Laurenzano C, 2013, J EXP MAR BIOL ECOL, V449, P22, DOI 10.1016/j.jembe.2013.08.007; Laurenzano Claudia, 2012, Nauplius, V20, P15; LENTZ SJ, 1995, J GEOPHYS RES-OCEANS, V100, P2377, DOI 10.1029/94JC00343; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; MCMILLENJACKSON AL, 1994, MAR BIOL, V118, P53, DOI 10.1007/BF00699219; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; MORGAN SG, 1995, AM NAT, V145, P457, DOI 10.1086/285749; MORGAN SG, 1987, J EXP MAR BIOL ECOL, V113, P71, DOI 10.1016/0022-0981(87)90083-9; Morgan SG, 2008, P NATL ACAD SCI USA, V105, P222, DOI 10.1073/pnas.0704725105; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi Stephen R., 1996, P101; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Poulin E, 2002, LIMNOL OCEANOGR, V47, P1248, DOI 10.4319/lo.2002.47.4.1248; Powers LW, 1977, PUBLICATIONS I MAR S, V20, P1; Queiroga H, 2005, ADV MAR BIOL, V47, P107; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rocha LA., 2002, REEF FISH IDENTIFICA, P462; Rocha Luiz A., 2001, Aqua (Miradolo Terme), V4, P105; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SALMON M, 1987, CONTRIB MAR SCI, V30, P63; Sarver SK, 1998, J CRUSTACEAN BIOL, V18, P177, DOI 10.2307/1549532; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shih HT, 2016, RAFFLES B ZOOL, V64, P139; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Sotka EE, 2012, INTEGR COMP BIOL, V52, P538, DOI 10.1093/icb/ics084; Spivak Eduardo D., 1997, Investigaciones Marinas Universidad Catolica de Valparaiso, V25, P69; STARCK WA, 1978, B MAR SCI, V28, P146; Stemmer M, 2013, STUD NEOTROP FAUNA E, V48, P95, DOI 10.1080/01650521.2013.835614; Strathmann R., 1982, ESTUARINE COMP, P521; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Terossi M, 2012, CRUSTACEANA, V85, P685, DOI 10.1163/156854012X643762; Thurman Carl L., 2013, Marine Biodiversity Records, V6, pe1, DOI 10.1017/S1755267212000942; THURMAN CL, 1987, CRUSTACEANA, V53, P94, DOI 10.1163/156854087X00664; Warner RR, 2002, B MAR SCI, V70, P245; Webley JAC, 2007, J EXP MAR BIOL ECOL, V341, P196, DOI 10.1016/j.jembe.2006.10.001; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Wieman AC, 2014, MAR BIOL, V161, P173, DOI 10.1007/s00227-013-2327-0; Williams A.B., 1984, SHRIMPS LOBSTERS CRA	94	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166518	10.1371/journal.pone.0166518	http://dx.doi.org/10.1371/journal.pone.0166518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861598	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300067
J	Xiao, T; Zhu, JJ; Huang, S; Peng, C; He, S; Du, J; Hong, R; Chen, X; Bode, AM; Jiang, W; Dong, Z; Zheng, D				Xiao, T.; Zhu, J. J.; Huang, S.; Peng, C.; He, S.; Du, J.; Hong, R.; Chen, X.; Bode, A. M.; Jiang, W.; Dong, Z.; Zheng, D.			Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NFAT1; CYCLIN-DEPENDENT KINASES; NUCLEAR FACTOR; CYCLOOXYGENASE-2 INDUCTION; BEAS-2B CELLS; CL41 CELLS; DIFFERENTIATION; ACTIVATION; EXPRESSION; PATHWAY	The nuclear factor of activated T cells (NFAT) family proteins are transcription factors that regulate the expression of pro-inflammatory cytokines and other genes during the immune response. Although the NFAT proteins have been extensively investigated in the immune system, their role in cancer progression remains controversial. Here, we report that NFAT3 is highly expressed in various skin cancer cell lines and tumor tissues. Knockdown of endogenous NFAT3 expression by short hairpin RNA (shRNA) significantly inhibited tumor cell proliferation, colony formation and anchorage-independent cell growth. Furthermore, results of the mammalian two-hybrid assay showed that cyclin-dependent kinase 3 (CDK3) directly interacted with NFAT3 and phosphorylated NFAT3 at serine 259 (Ser259), which enhanced the transactivation and transcriptional activity of NFAT3. The phosphorylation site of NFAT3 was critical for epidermal growth factor (EGF)-stimulated cell transformation of the HaCaT immortalized skin cell line and mutation of NFAT3 at Ser259 led to a reduction of colony formation in soft agar. We also found that overexpressing wildtype NFAT3, but not mutant NFAT3-S259A, promoted A431 xenograft tumor growth. Importantly, we showed that CDK3, NFAT3 and phosphorylated NFAT3-Ser259 were highly expressed in skin cancer compared with normal skin tissues. These results provided evidence supporting the oncogenic potential of NFAT3 and suggested that CDK3-mediated phosphorylation of NFAT3 has an important role in skin tumorigenesis.	[Xiao, T.; Zhu, J. J.; Huang, S.; He, S.; Du, J.; Hong, R.; Chen, X.; Jiang, W.; Zheng, D.] Shenzhen Univ, Dept Cell Biol & Genet, Hlth Sci Ctr, Shenzhen Key Lab Translat Med Tumor, 3688 Nanhai Ave, Shenzhen 518060, Peoples R China; [Peng, C.] Cent S Univ, Dept Dermatol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, 801 16th Ave Northeast, Austin, MN 55912 USA	Shenzhen University; Central South University; University of Minnesota System	Zheng, D (corresponding author), Shenzhen Univ, Dept Cell Biol & Genet, Hlth Sci Ctr, Shenzhen Key Lab Translat Med Tumor, 3688 Nanhai Ave, Shenzhen 518060, Peoples R China.; Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave Northeast, Austin, MN 55912 USA.	zgdong@hi.umn.edu; dzheng@szu.edu.cn		Zhu, Joe/0000-0003-4416-7040	National Natural Science Foundation of China [81071655, 81372149, 81401894, 81402289]; National Science Foundation Projects of Guangdong Province [2014A030313547]; High level Talents Project of Guangdong Province; Shenzhen Municipal Government of China [KQCX20140519104925300, JCYJ20140418193546118, JCYJ20140418091413510, ZDSY20130329101130496]; Natural Science Foundation of SZU [201406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation Projects of Guangdong Province; High level Talents Project of Guangdong Province; Shenzhen Municipal Government of China; Natural Science Foundation of SZU	This study was supported by grants from the National Natural Science Foundation of China (81071655, 81372149, 81401894, 81402289), the National Science Foundation Projects of Guangdong Province (2014A030313547), the High level Talents Project of Guangdong Province (2013), the Shenzhen Municipal Government of China (KQCX20140519104925300, JCYJ20140418193546118, JCYJ20140418091413510, ZDSY20130329101130496) and Natural Science Foundation of SZU (201406). We thank Dr Barrett J. Rollins for the pRcCMV-cdk3 (pCMV-cdk3); Dr Yong-Yeon Cho for the pACT-TFs and Dr Ke Yao for pGal4-NFAT3 and p3xFlag-NFAT3.	Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Braun K, 1998, ONCOGENE, V17, P2259, DOI 10.1038/sj.onc.1202145; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Fougere M, 2010, ONCOGENE, V29, P2292, DOI 10.1038/onc.2009.499; Friday BB, 2001, J CELL SCI, V114, P303; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Hofmann F, 1996, GENE DEV, V10, P851, DOI 10.1101/gad.10.7.851; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Keezer SM, 2002, J CELL BIOCHEM, V85, P545, DOI 10.1002/jcb.10162; Li JX, 2006, J CELL BIOCHEM, V99, P1010, DOI 10.1002/jcb.20834; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Mizuno H, 2006, MOL CARCINOGEN, V45, P1, DOI 10.1002/mc.20160; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ouyang W, 2007, CARCINOGENESIS, V28, P2218, DOI 10.1093/carcin/bgm115; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Salazar C, 2005, FEBS LETT, V579, P621, DOI 10.1016/j.febslet.2004.12.029; Tang H, 2007, ARCH BIOCHEM BIOPHYS, V468, P92, DOI 10.1016/j.abb.2007.09.016; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Yamochi T, 2001, EUR J BIOCHEM, V268, P6076, DOI 10.1046/j.0014-2956.2001.02555.x; Yan Y, 2006, J CELL SCI, V119, P2985, DOI 10.1242/jcs.03014; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yao K, 2007, CANCER RES, V67, P8725, DOI 10.1158/0008-5472.CAN-06-4788; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137	31	19	19	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2835	2845		10.1038/onc.2016.434	http://dx.doi.org/10.1038/onc.2016.434			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27893713	hybrid, Green Published			2022-12-26	WOS:000401697800006
J	Leung, E; Xue, A; Wang, Y; Rougerie, P; Sharma, VP; Eddy, R; Cox, D; Condeelis, J				Leung, E.; Xue, A.; Wang, Y.; Rougerie, P.; Sharma, V. P.; Eddy, R.; Cox, D.; Condeelis, J.			Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; CANCER METASTASIS; TYROSINE KINASE; MAMMARY-TUMORS; IN-VIVO; PROGNOSTIC MARKER; CARCINOMA CELLS; TRANSENDOTHELIAL MIGRATION; HEMATOGENOUS DISSEMINATION	During metastasis to distant sites, tumor cells migrate to blood vessels. In vivo, breast tumor cells utilize a specialized mode of migration known as streaming, where a linear assembly of tumor cells migrate directionally towards blood vessels on fibronectin-collagen I-containing extracellular matrix (ECM) fibers in response to chemotactic signals. We have successfully reconstructed tumor cell streaming in vitro by co-plating tumors cells, macrophages and endothelial cells on 2.5 mu m thick ECM-coated micro-patterned substrates. We found that tumor cells and macrophages, when plated together on the micro-patterned substrates, do not demonstrate sustained directional migration in only one direction (sustained directionality) but show random bi-directional walking. Sustained directionality of tumor cells as seen in vivo was established in vitro when beads coated with human umbilical vein endothelial cells were placed at one end of the micro-patterned 'ECM fibers' within the assay. We demonstrated that these endothelial cells supply the hepatocyte growth factor (HGF) required for the chemotactic gradient responsible for sustained directionality. Using this in vitro reconstituted streaming system, we found that directional streaming is dependent on, and most effectively blocked, by inhibiting the HGF/C-Met signaling pathway between endothelial cells and tumor cells. Key observations made with the in vitro reconstituted system implicating C-Met signaling were confirmed in vivo in mammary tumors using the in vivo invasion assay and intravital multiphoton imaging of tumor cell streaming. These results establish HGF/ C-Met as a central organizing signal in blood vessel-directed tumor cell migration in vivo and highlight a promising role for C-Met inhibitors in blocking tumor cell streaming and metastasis in vivo, and for use in human trials.	[Leung, E.; Xue, A.; Wang, Y.; Rougerie, P.; Sharma, V. P.; Eddy, R.; Cox, D.; Condeelis, J.] Albert Einstein Coll Med, Dept Anat & Struct Biol, 1301 Morris Pk Ave,Price 208, Bronx, NY 10461 USA; [Wang, Y.; Condeelis, J.] Albert Einstein Coll Med, Integrated Imaging Program, Bronx, NY 10467 USA; [Sharma, V. P.; Cox, D.; Condeelis, J.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Condeelis, J (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1301 Morris Pk Ave,Price 208, Bronx, NY 10461 USA.	john.condeelis@einstein.yu.edu	; rougerie, pablo/I-9006-2017	Cox, Dianne/0000-0002-0591-9767; rougerie, pablo/0000-0001-5290-3939	NCI [CA100324, CA150344]; Integrated Imaging Program; Gruss Lipper Biophotonics Center; NATIONAL CANCER INSTITUTE [P01CA100324, P30CA013330, R01CA150344] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Integrated Imaging Program; Gruss Lipper Biophotonics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank P Guo (Analytical Imaging Facility, Albert Einstein College of Medicine) for technical assistance. They also thank B Smith and D Flynn (Deciphera) for providing Rebastinib, DCC-3014 and Altiratinib. This work was supported by the NCI CA100324, CA150344, the Integrated Imaging Program and the Gruss Lipper Biophotonics Center.	Agarwal S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3318; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; Araki H, 2004, BLOOD, V103, P2973, DOI 10.1182/blood-2003-08-2742; Boimel PJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3108; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Brooks JP, 2005, INT J RADIAT ONCOL, V62, P785, DOI 10.1016/j.ijrobp.2004.12.001; Cabioglu N, 2004, J CLIN ONCOL, V22, p841S; Casbas-Hernandez P, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3476; Cassatella MC, 2012, FUTURE ONCOL, V8, P1253, DOI [10.2217/FON.12.119, 10.2217/fon.12.119]; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Eichler W, 2004, EXP CELL RES, V299, P68, DOI 10.1016/j.yexcr.2004.05.020; Entenberg D, 2011, NAT PROTOC, V6, P1500, DOI 10.1038/nprot.2011.376; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Flynn DL, 2014, AACR SPEC C CELL HET; Flynn DL, 2013, ACS NAT M 8 APR NEW; Forse CL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1468-6; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Giuliani N, 2003, BLOOD, V102, P638, DOI 10.1182/blood-2002-10-3257; Gligorijevic B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001995; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Gupton SL, 2012, J CELL BIOL, V198, P657, DOI 10.1083/jcb.201202079; Harney AS, 2015, CANCER DISCOV, V5, P932, DOI 10.1158/2159-8290.CD-15-0012; Hellen E H, 1991, J Fluoresc, V1, P113, DOI 10.1007/BF00865207; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Hernandez L, 2009, CANCER RES, V69, P3221, DOI 10.1158/0008-5472.CAN-08-2871; Hesselgesser J, 1998, J IMMUNOL, V160, P877; HIGUCHI O, 1992, FEBS LETT, V301, P282, DOI 10.1016/0014-5793(92)80257-H; Ho-Yen CM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0547-6; Hughes SK, 2015, MOL BIOL CELL, V26, P3867, DOI 10.1091/mbc.E15-06-0442; Kang JY, 2003, CANCER RES, V63, P1101; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Knutsdottir H, 2016, INTEGR BIOL-UK, V8, P104, DOI 10.1039/c5ib00201j; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Locker J, 2011, AM J PATHOL, V178, P966, DOI 10.1016/j.ajpath.2010.12.013; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Magbanua MJM, 2015, ONCOTARGET, V6, P30715, DOI 10.18632/oncotarget.5568; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Martins D, 2014, CYTOPATHOLOGY, V25, P225, DOI 10.1111/cyt.12158; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Minami T, 2009, J CLIN INVEST, V119, P2257, DOI 10.1172/JCI35738; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oktay MH, 2012, J HISTOCHEM CYTOCHEM, V60, P168, DOI 10.1369/0022155411435153; Ottewell PD, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.10; Patsialou A, 2015, ONCOGENE, V34, P2721, DOI 10.1038/onc.2014.226; Patsialou Antonia, 2013, Intravital, V2, pe25294; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pignatelli J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005329; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Rohan TE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju136; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Roussos ET, 2011, CLIN EXP METASTAS, V28, P515, DOI 10.1007/s10585-011-9388-6; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Segall JE, 1996, CLIN EXP METASTAS, V14, P61, DOI 10.1007/BF00157687; Sharma VP, 2014, METHODS MOL BIOL, V1172, P115, DOI 10.1007/978-1-4939-0928-5_10; Sharma Ved P, 2012, Intravital, V1, P77; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sidani M, 2006, J MAMMARY GLAND BIOL, V11, P151, DOI 10.1007/s10911-006-9021-5; Smith BD, 2013, CANC RES S24, V73; Smith BD, 2013, P AACR SPEC C TUM IN; Smith BD, 2015, MOL CANCER THER, V14, P2023, DOI 10.1158/1535-7163.MCT-14-1105; Smith BD, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.CHTME14-A53; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Williams JK, 2015, INTRAVITAL IN PRESS; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2000, CANCER RES, V60, P5401; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1232, DOI 10.1101/pdb.prot065912; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1167, DOI 10.1101/pdb.top065904; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; ZE W, 1993, MOL CELL BIOL, V13, P5348, DOI 10.1128/MCB.13.9.5348; Zhao Z, 2016, CANCER RES, V76, P2094, DOI 10.1158/0008-5472.CAN-15-2662	91	56	57	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2680	2692		10.1038/onc.2016.421	http://dx.doi.org/10.1038/onc.2016.421			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27893712	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000401120900006
J	Cheng, F; Twardowski, L; Fehr, S; Aner, C; Schaeffeler, E; Joos, T; Knorpp, T; Dorweiler, B; Laufer, S; Schwab, M; Torzewski, M				Cheng, Fei; Twardowski, Laura; Fehr, Sarah; Aner, Christoph; Schaeffeler, Elke; Joos, Thomas; Knorpp, Thomas; Dorweiler, Bernhard; Laufer, Stefan; Schwab, Matthias; Torzewski, Michael			Selective p38 alpha MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis	FASEB JOURNAL			English	Article						cardiovascular research; IL-8; MIP-1 beta/CCL4; modified lipoproteins; scavenger receptor CD36	LOW-DENSITY-LIPOPROTEIN; ACTIVATED PROTEIN-KINASE; FOAM CELL-FORMATION; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; FATTY-ACIDS; MACROPHAGE PROLIFERATION; COMPLEMENT ACTIVATION; DEGRADED LDL; OXIDIZED LDL	The first ATP-competitive p38 alpha MAPK/MAPK14 inhibitor with excellent in vivo efficacy and selectivity, skepinone-L, is now available. We investigated the impact of selective p38 alpha MAPK/MAPK14 inhibition on enzymatically modified LDL (eLDL) stimulated human monocytes with its implications for atherosclerosis. Among the different p38 MAPK isoforms, p38 alpha/MAPK14 was the predominantly expressed and activated isoform in isolated human peripheral blood monocytes. Moreover, eLDL colocalized with macrophages positive for p38 alpha MAPK/MAPK14 in human carotid endarterectomy specimens. Using the human leukemia cell line THP-1 and/or primary monocyte-derived macrophages, skepinone-L inhibited eLDL-induced activation of the p38 MAPK pathway, inhibited eLDL induced expression of both cluster of differentiation 36 (CD36) and ATP-binding cassette, subfamily A, member 1 (ABCA1), without a net effect on foam cell formation, had a cell- and time-dependent effect on eLDL-triggered apoptosis, and inhibited eLDL-stimulated secretion of IL-8 and MIP-1 beta/CCL4 (macrophage inflammatory protein-1 beta/chemokine, CC motif, ligand 4). Inhibition of a key signaling molecule of the p38 MAPK pathway, p38 alpha MAPK/MAPK14, by selective inhibitors like skepinone-L, conclusively facilitates elucidation of the impact of the complex network of p38 MAPK signaling on atherogenesis and might provide a promising therapeutic tool to prevent inflammatory cascades in atherosclerosis.	[Cheng, Fei; Twardowski, Laura; Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Auerbachstr 110, D-70736 Stuttgart, Germany; [Fehr, Sarah; Aner, Christoph; Schaeffeler, Elke; Schwab, Matthias; Torzewski, Michael] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Joos, Thomas; Knorpp, Thomas] Univ Tubingen, Nat & Med Sci Inst, Reutlingen, Germany; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Cardiothorac & Vasc Surg, Div Vasc Surg, Mainz, Germany; [Laufer, Stefan; Schwab, Matthias] Univ Tubingen, Inst Pharm, Tubingen, Germany; [Schwab, Matthias] Univ Hosp Tubingen, Dept Clin Pharmacol, Tubingen, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Torzewski, M (corresponding author), Robert Bosch Krankenhaus, Dept Lab Med, Auerbachstr 110, D-70736 Stuttgart, Germany.	michael.torzewski@rbk.de	Schwab, Matthias/ABH-7449-2020	Laufer, Stefan/0000-0001-6952-1486	Robert Bosch Stiftung, Stuttgart, Germany; IZEPHA Grant Tubingen-Stuttgart, Germany; EU-Cinazept Grant	Robert Bosch Stiftung, Stuttgart, Germany; IZEPHA Grant Tubingen-Stuttgart, Germany; EU-Cinazept Grant	The authors thank K. Winter for expert technical assistance and U. Hofmann, S. Kath, and H. van der Kuip (all from University of Tubingen) for excellent technical support. This work was supported, in part, by the Robert Bosch Stiftung, Stuttgart, Germany; the IZEPHA Grant Tubingen-Stuttgart, Germany; and the EU-Cinazept Grant. The authors also thank S. Bhakdi (University Medical Center, Johannes Gutenberg University Mainz), for pointing out the physiological relevance of the eLDL concentrations used.	Andres V, 2012, CURR OPIN LIPIDOL, V23, P429, DOI 10.1097/MOL.0b013e328357a379; Apostolopoulos J, 1996, ARTERIOSCL THROM VAS, V16, P1007, DOI 10.1161/01.ATV.16.8.1007; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bhakdi S, 2004, THROMB HAEMOSTASIS, V91, P639, DOI 10.1160/TH-03-12-d733; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Cheng B, 2014, MICROB PATHOGENESIS, V69-70, P1, DOI 10.1016/j.micpath.2014.03.001; Dersch K, 2005, CELL DEATH DIFFER, V12, P1107, DOI 10.1038/sj.cdd.4401633; Dobreva I, 2006, CURR OPIN LIPIDOL, V17, P110, DOI 10.1097/01.mol.0000217891.92993.53; Dobreva I, 2006, J BIOL CHEM, V281, P199, DOI 10.1074/jbc.M508857200; Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357; Dorweiler B, 2014, EUR J VASC ENDOVASC, V48, P248, DOI 10.1016/j.ejvs.2014.06.038; Eder K, 2008, IMMUNOL LETT, V116, P178, DOI 10.1016/j.imlet.2007.12.011; Fenske D, 2008, THROMB HAEMOSTASIS, V100, P1146, DOI 10.1160/TH08-03-0166; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Hakala JK, 2006, ARTERIOSCL THROM VAS, V26, P2504, DOI 10.1161/01.ATV.0000245796.97133.ad; Jing Q, 1999, CIRC RES, V84, P831; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kapinsky M, 2001, ARTERIOSCL THROM VAS, V21, P1004, DOI 10.1161/01.ATV.21.6.1004; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kardakaris R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021055; Klouche M, 1998, ARTERIOSCL THROM VAS, V18, P1376, DOI 10.1161/01.ATV.18.9.1376; KOCH AE, 1993, AM J PATHOL, V142, P1423; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee SA, 2011, BIOCHEM BIOPH RES CO, V408, P132, DOI 10.1016/j.bbrc.2011.03.136; Liu Y, 1997, ARTERIOSCL THROM VAS, V17, P317, DOI 10.1161/01.ATV.17.2.317; Mei S, 2012, J BIOL CHEM, V287, P11761, DOI 10.1074/jbc.M111.333575; Moreau M, 1999, CIRCULATION, V99, P420, DOI 10.1161/01.CIR.99.3.420; Proctor BM, 2008, CIRCULATION, V118, P658, DOI 10.1161/CIRCULATIONAHA.107.734848; Reiss K, 2011, J BIOL CHEM, V286, P26931, DOI 10.1074/jbc.M111.243485; Rus HG, 1996, ATHEROSCLEROSIS, V127, P263, DOI 10.1016/S0021-9150(96)05968-0; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Suriyaphol P, 2002, CIRCULATION, V106, P2581, DOI 10.1161/01.CIR.0000038366.11851.D0; Torzewski M, 2004, ARTERIOSCL THROM VAS, V24, P2130, DOI 10.1161/01.ATV.0000144016.85221.66; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Torzewski M, 2006, CLIN CHEM LAB MED, V44, P1389, DOI 10.1515/CCLM.2006.259; Torzewski M, 2013, CLIN BIOCHEM, V46, P20, DOI 10.1016/j.clinbiochem.2012.09.012; Twardowski L, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002156; Vistnes M, 2012, CARDIOLOGY, V121, P149, DOI 10.1159/000336484; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1; Zernecke A, 2014, ARTERIOSCL THROM VAS, V34, P742, DOI 10.1161/ATVBAHA.113.301655; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x; Zhu Y, 2001, ARTERIOSCL THROM VAS, V21, P1159, DOI 10.1161/hq0701.092473	52	15	16	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					674	686		10.1096/fj.201600669R	http://dx.doi.org/10.1096/fj.201600669R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871059				2022-12-26	WOS:000394235400020
J	Merriman, C; Huang, Q; Rutter, GA; Fu, D				Merriman, Chengfeng; Huang, Qiong; Rutter, Guy A.; Fu, Dax			Lipid-tuned Zinc Transport Activity of Human ZnT8 Protein Correlates with Risk for Type-2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SECRETORY GRANULES; PANCREATIC BETA-CELLS; GLUCOSE-HOMEOSTASIS; YIIP; MUTATIONS; MICE	Zinc is a critical element for insulin storage in the secretory granules of pancreatic beta cells. The islet-specific zinc transporter ZnT8 mediates granular sequestration of zinc ions. A genetic variant of human ZnT8 arising from a single nonsynonymous nucleotide change contributes to increased susceptibility to type-2 diabetes (T2D), but it remains unclear how the high risk variant (Arg-325), which is also a higher frequency (>50%) allele, is correlated with zinc transport activity. Here, we compared the activity of Arg-325 with that of a low risk ZnT8 variant (Trp-325). The Arg-325 variant was found to be more active than the Trp-325 form following induced expression in HEK293 cells. We further examined the functional consequences of changing lipid conditions to mimic the impact of lipid remodeling on ZnT8 activity during insulin granule biogenesis. Purified ZnT8 variants in proteoliposomes exhibited more than 4-fold functional tunability by the anionic phospholipids, lysophosphatidylcholine and cholesterol. Over a broad range of permissive lipid compositions, the Arg-325 variant consistently exhibited accelerated zinc transport kinetics versus the Trp-form. In agreement with the human genetic finding that rare loss-of-function mutations in ZnT8 are associated with reduced T2D risk, our results suggested that the common high risk Arg-325 variant is hyperactive, and thus may be targeted for inhibition to reduce T2D risk in the general populations.	[Merriman, Chengfeng; Huang, Qiong; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA; [Rutter, Guy A.] Imperial Coll London, Dept Med, Sect Cell Biol & Funct Genom, London W12 ONN, England	Johns Hopkins University; Johns Hopkins Medicine; Imperial College London	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	Huang, Qiong/HGC-7895-2022	Huang, Qiong/0000-0002-0570-5961; Rutter, Guy/0000-0001-6360-0343; Fu, Dax/0000-0002-2663-1316	National Institutes of Health [R01 GM065137]; National Nature Science Foundation of China [GP 81673492]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM065137. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported in part by National Nature Science Foundation of China Grant GP 81673492.	Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Chabosseau P, 2016, ARCH BIOCHEM BIOPHYS, V611, P79, DOI 10.1016/j.abb.2016.05.022; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kim I, 2011, PHARMACOGENOMICS J, V11, P191, DOI 10.1038/tpj.2010.22; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MacDonald MJ, 2015, J BIOL CHEM, V290, P11075, DOI 10.1074/jbc.M114.628420; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tsuchiya M, 2010, ENDOCRINOLOGY, V151, P4705, DOI 10.1210/en.2010-0623; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200	22	54	55	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26950	26957		10.1074/jbc.M116.764605	http://dx.doi.org/10.1074/jbc.M116.764605			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875315	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000391576300001
J	Halperin, I; Hughes, S; Panchuk, D; Abbiss, C; Chapman, DW				Halperin, Israel; Hughes, Steven; Panchuk, Derek; Abbiss, Chris; Chapman, Dale W.			The Effects of Either a Mirror, Internal or External Focus Instructions on Single and Multi-Joint Tasks	PLOS ONE			English	Article							FORCE PRODUCTION; ATTENTIONAL FOCUS; MUSCULAR-ACTIVITY; SELF; PERFORMANCE; ENVIRONMENTS; FEEDBACK; LOCUS; WOMEN; BODY	Training in front of mirrors is common, yet little is known about how the use of mirrors effects muscle force production. Accordingly, we investigated how performing in front of a mirror influences performance in single and multi-joint tasks, and compared the mirror condition to the established performance effects of internal focus (IF) and external focus (EF) instructions in a two part experiment. In the single-joint experiment 28 resistance-trained participants (14 males and 14 females) completed two elbow flexion maximal voluntary isometric contractions under four conditions: mirror, IF, EF and neutral instructions. During these trials, surface EMG activity of the biceps and triceps were recorded. In the multi-joint experiment the same participants performed counter-movement jumps on a force plate under the same four conditions. Single-joint experiment: EF led to greater normalized force production compared to all conditions (P <= 0.02, effect-size range [ES] = 0.46-1.31). No differences were observed between neutral and mirror conditions (P=0.15, ES = 0.15), but both were greater than IF (P<0.01, ES = 0.79-1.84). Surface EMG activity was comparable across conditions (P >= 0.1, ES = 0.10-0.21). Multi-joint experiment: Despite no statistical difference (P=0.10), a moderate effect size was observed for jump height whereby EF was greater than IF (ES = 0.51). No differences were observed between neutral and mirror conditions (ES = 0.01), but both were greater than IF (ES = 0.20-22). The mirror condition led to superior performance compared to IF, inferior performance compared to EF, and was equal to a neutral condition in both tasks. These results provide novel and practical evidence concerning mirror training during resistance type training.	[Halperin, Israel; Hughes, Steven; Chapman, Dale W.] Australian Inst Sport, Discipline Physiol, Canberra, ACT, Australia; [Halperin, Israel; Hughes, Steven; Abbiss, Chris; Chapman, Dale W.] Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sport Sci Res, Joondalup, WA, Australia; [Panchuk, Derek] Victoria Univ, Inst Sport Exercise & Act Living, Coll Sport & Exercise Sci, Footscray, Vic, Australia; [Panchuk, Derek] Australian Inst Sport, Skill Acquisit Discipline, Canberra, ACT, Australia	Australian Institute of Sport; Edith Cowan University; Victoria University; Australian Institute of Sport	Halperin, I (corresponding author), Australian Inst Sport, Discipline Physiol, Canberra, ACT, Australia.; Halperin, I (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sport Sci Res, Joondalup, WA, Australia.	Israel.halperin@ausport.gov.au	Chapman, Dale Wilson/I-3125-2019	Chapman, Dale Wilson/0000-0002-3393-1261; Abbiss, Chris/0000-0003-3940-5542				BENNETT S, 1995, RES Q EXERCISE SPORT, V66, P210, DOI 10.1080/02701367.1995.10608835; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dearborn K., 2006, J DANCE ED, V6, P109, DOI [DOI 10.1080/15290824.2006.10387323, 10.1080/15290824.2006.10387323]; Eaves DL, 2008, MED SCI SPORT EXER, V40, P1506, DOI 10.1249/MSS.0b013e31817057a8; Ehrlenspiel F, 2004, PERCEPT MOTOR SKILL, V99, P127, DOI 10.2466/PMS.99.5.127-130; Ginis KAM, 2003, HEALTH PSYCHOL, V22, P354, DOI 10.1037/0278-6133.22.4.354; Greig M, 2014, HUM MOVEMENT SCI, V33, P135, DOI 10.1016/j.humov.2013.08.008; Halperin I, 2016, J STRENGTH COND RES, V30, P919, DOI 10.1519/JSC.0000000000001194; Ille A, 2013, J SPORT SCI, V31, P1705, DOI 10.1080/02640414.2013.797097; Katula JA, 2001, INT J BEHAV MED, V8, P319, DOI 10.1207/s15327558ijbm0804_6; Lamarche L, 2009, PSYCHOL SPORT EXERC, V10, P67, DOI 10.1016/j.psychsport.2008.06.006; Lynch JA, 2009, J BODYW MOV THER, V13, P283, DOI 10.1016/j.jbmt.2008.09.003; Marchant DC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00210; Marchant DC, 2009, INT J SPORT EXERC PS, V7, P488, DOI 10.1080/1612197X.2009.9671921; Marchant DC, 2009, J STRENGTH COND RES, V23, P2358, DOI 10.1519/JSC.0b013e3181b8d1e5; McKay B, 2015, Q J EXP PSYCHOL, V68, P1910, DOI 10.1080/17470218.2014.997765; Notarnicola Angela, 2014, BMC Res Notes, V7, P426, DOI 10.1186/1756-0500-7-426; Porter JM, 2013, J STRENGTH COND RES, V27, P2073, DOI 10.1519/JSC.0b013e31827e1521; Radell SA, 2003, PERCEPT MOTOR SKILL, V97, P960, DOI 10.2466/PMS.97.7.960-964; Radell SA, 2002, PERCEPT MOTOR SKILL, V95, P1239, DOI 10.2466/PMS.95.7.1239-1247; Radell SA, 2014, RES DANC EDUC, V15, P161, DOI 10.1080/14647893.2013.879256; Rougier P, 2002, ANN READAPTATION MED; SEWALL LP, 1988, PERCEPT MOTOR SKILL, V67, P715, DOI 10.2466/pms.1988.67.3.715; Vaillant J, 2004, ARCH PHYS MED REHAB, V85, P1962, DOI 10.1016/j.apmr.2004.02.019; Weiss SM, 2008, J SPORT SCI, V26, P1049, DOI 10.1080/02640410802098874; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166799	10.1371/journal.pone.0166799	http://dx.doi.org/10.1371/journal.pone.0166799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898743	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000389474000019
J	Betekhtin, A; Rojek, M; Milewska-Hendel, A; Gawecki, R; Karcz, J; Kurczynska, E; Hasterok, R				Betekhtin, Alexander; Rojek, Magdalena; Milewska-Hendel, Anna; Gawecki, Robert; Karcz, Jagna; Kurczynska, Ewa; Hasterok, Robert			Spatial Distribution of Selected Chemical Cell Wall Components in the Embryogenic Callus of Brachypodium distachyon	PLOS ONE			English	Article							MATRIX SURFACE NETWORK; ARABINOGALACTAN-PROTEIN EPITOPE; SOMATIC EMBRYOGENESIS; EXTRACELLULAR-MATRIX; PLANT-REGENERATION; MODEL SYSTEM; PECTIN; POLYSACCHARIDES; LOCALIZATION; EXPRESSION	Brachypodium distachyon L. Beauv. (Brachypodium) is a species that has become an excellent model system for gaining a better understanding of various areas of grass biology and improving plant breeding. Although there are some studies of an in vitro Brachypodium culture including somatic embryogenesis, detailed knowledge of the composition of the main cell wall components in the embryogenic callus in this species is missing. Therefore, using the immunocytochemical approach, we targeted 17 different antigens of which five were against the arabinogalactan proteins (AGP), three were against extensins, six recognised pectic epitopes and two recognised hemicelluloses. These studies were complemented by histological and scanning electron microscopy (SEM) analyses. We revealed that the characteristic cell wall components of Brachypodium embryogenic calli are AGP epitopes that are recognised by the JIM16 and LM2 antibodies, an extensin epitope that is recognised by the JIM11 antibody and a pectic epitopes that is recognised by the LM6 antibody. Furthermore, we demonstrated that AGPs and pectins are the components of the extracellular matrix network in Brachypodium embryogenic culture. Additionally, SEM analysis demonstrated the presence of an extracellular matrix on the surface of the calli cells. In conclusion, the chemical compositions of the cell walls and ECMSN of Brachypodium callus show spatial differences that correlate with the embryogenic character of the cells. Thus, the distribution of pectins, AGPs and hemicelluloses can be used as molecular markers of embryogenic cells. The presented data extends the knowledge about the chemical composition of the embryogenic callus cells of Brachypodium.	[Betekhtin, Alexander; Rojek, Magdalena; Hasterok, Robert] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland; [Milewska-Hendel, Anna; Gawecki, Robert; Kurczynska, Ewa] Univ Silesia, Fac Biol & Environm Protect, Dept Cell Biol, Katowice, Poland; [Karcz, Jagna] Univ Silesia, Fac Biol & Environm Protect, Scanning Electron Microscopy Lab, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Betekhtin, A (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	alexander.betekhtin@us.edu.pl	Betekhtin, Alexander/O-4619-2018; Hasterok, Robert/A-1629-2008	Betekhtin, Alexander/0000-0001-6146-1669; Kurczynska, Ewa/0000-0003-0772-8961; Milewska-Hendel, Anna/0000-0002-9066-477X; Hasterok, Robert/0000-0001-6667-2721; Gawecki, Robert/0000-0002-7752-000X	National Science Centre, Poland [DEC-2014/14/M/NZ2/00519]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland [grant no. DEC-2014/14/M/NZ2/00519]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam J, 2011, SAUDI J BIOL SCI, V18, P369, DOI 10.1016/j.sjbs.2011.06.002; BABLAK P, 1995, PLANT CELL TISS ORG, V42, P97, DOI 10.1007/BF00037687; BRADLEY DJ, 1988, PLANTA, V173, P149, DOI 10.1007/BF00403006; Buckeridge MS, 2010, PLANT PHYSIOL, V154, P1017, DOI 10.1104/pp.110.158642; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chapman A, 2000, PLANTA, V211, P305, DOI 10.1007/s004250000299; [陈红伟 Chen Hongwei], 2014, [生物技术通报, Biotechnology Bulletin], P25; Christiansen P, 2005, PLANT CELL REP, V23, P751, DOI 10.1007/s00299-004-0889-5; Clausen MH, 2004, PLANTA, V219, P1036, DOI 10.1007/s00425-004-1309-3; Din AJM, 2016, SAUDI J BIOL SCI, V23, pS69, DOI 10.1016/j.sjbs.2015.10.022; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Eeckhout S, 2014, ANN BOT-LONDON, V114, P1295, DOI 10.1093/aob/mcu039; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Feher A, 2002, BIOLOGIA, V57, P5; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Gonzalez-Perez L, 2014, MOL BIOL REP, V41, P6803, DOI 10.1007/s11033-014-3566-y; Hammami R, 2011, BIOL PLANTARUM, V55, P797, DOI 10.1007/s10535-011-0191-7; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hoch G, 2007, FUNCT ECOL, V21, P823, DOI 10.1111/j.1365-2435.2007.01305.x; International_Brachypodium_Initiative, 2014, TRENDS PLANT SCI, V19, P414, DOI [10.1016/j.tplants.2014.05.002, DOI 10.1016/J.TPLANTS.2014.05.002]; Jeon WoongBae, 2010, Korean Journal of Breeding Science, V42, P351; Jimenez VM, 2005, PLANT GROWTH REGUL, V47, P91, DOI 10.1007/s10725-005-3478-x; Jothi R, 2010, OPEN ACCESS BIOINFOR, V2, P157; KNOX JP, 1991, PLANT J, V1, P317, DOI 10.1046/j.1365-313X.1991.t01-9-00999.x; KNOX JP, 1989, DEVELOPMENT, V106, P47; Konieczny R, 2005, PLANT CELL TISS ORG, V83, P201, DOI 10.1007/s11240-005-5771-9; Konieczny R, 2007, PLANT CELL REP, V26, P355, DOI 10.1007/s00299-006-0222-6; Kurczynska E, 2012, EMBRYOGENESIS, P27; Kurczynska EU, 2007, PLANTA, V226, P619, DOI 10.1007/s00425-007-0510-6; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Lee YI, 2013, AM J BOT, V100, P2121, DOI 10.3732/ajb.1300193; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Mazarei M, 2011, PLANT SCI, V181, P712, DOI 10.1016/j.plantsci.2010.12.010; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moller I, 2007, GLYCOCONJUGATE J, V25; Ovecka M, 1999, ACTA PHYSIOL PLANT, V21, P117, DOI 10.1007/s11738-999-0065-1; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; PENNELL RI, 1989, J CELL BIOL, V108, P1967, DOI 10.1083/jcb.108.5.1967; Pilarska M, 2007, ACTA BIOL CRACOV BOT, V49, P69; Pilarska M, 2014, ACTA SOC BOT POL, V83, P67, DOI 10.5586/asbp.2014.009; Pilarska M, 2013, PLANT CELL TISS ORG, V115, P35, DOI 10.1007/s11240-013-0337-8; Popielarska-Konieczna M, 2010, PROTOPLASMA, V247, P121, DOI 10.1007/s00709-010-0149-1; Popielarska-Konieczna M, 2008, PLANT SIGNAL BEHAV, V3, P707, DOI 10.4161/psb.3.9.6433; Rancour DM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00266; Ribeiro JM, 2006, J EXP BOT, V57, P2025, DOI 10.1093/jxb/erj153; Rumyantseva N I, 2003, Dokl Biol Sci, V391, P375, DOI 10.1023/A:1025127323165; Samaj J, 1999, J MICROSC-OXFORD, V193, P150, DOI 10.1046/j.1365-2818.1999.00441.x; SAMAJ J, 1995, PROTOPLASMA, V186, P45, DOI 10.1007/BF01276934; Samaj J, 2008, PLANT CELL REP, V27, P221, DOI 10.1007/s00299-007-0429-1; Samaj J, 2006, PLANT CELL MONOGR, V2, P35, DOI 10.1007/7089_024; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seifert GJ, 2010, PLANT PHYSIOL, V153, P467, DOI 10.1104/pp.110.153940; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SMALLWOOD M, 1995, PLANTA, V196, P510, DOI 10.1007/BF00203651; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Smallwood M, 1996, PLANTA, V198, P452, DOI 10.1007/BF00620063; Toonen MAJ, 1997, PLANTA, V203, P188, DOI 10.1007/s004250050181; Trifunovi M., 2015, GENTIANACEAE VOLUME, V2, P113; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Verdeil JL, 2001, ANN BOT-LONDON, V88, P9, DOI 10.1006/anbo.2001.1408; Verhertbruggen Y, 2009, PLANT J, V59, P413, DOI 10.1111/j.1365-313X.2009.03876.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2015, GENETICS GENOMICS BR, P353; Wang JB, 2004, AQUAT BOT, V79, P163, DOI 10.1016/j.aquabot.2004.02.003; Wietholter N, 2003, CARBOHYD RES, V338, P423, DOI 10.1016/S0008-6215(02)00498-6; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022992; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Zagorchev L, 2011, BIOTECHNOL BIOTEC EQ, V25, P2321, DOI 10.5504/BBEQ.2011.0050; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411	77	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167426	10.1371/journal.pone.0167426	http://dx.doi.org/10.1371/journal.pone.0167426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893856	gold, Green Submitted, Green Published			2022-12-26	WOS:000389472400116
J	Inaoka, DK; Iida, M; Tabuchi, T; Honma, T; Lee, N; Hashimoto, S; Matsuoka, S; Kuranaga, T; Sato, K; Shiba, T; Sakamoto, K; Balogun, EO; Suzuki, S; Nara, T; da Rocha, JR; Montanari, CA; Tanaka, A; Inoue, M; Kita, K; Harada, S				Inaoka, Daniel Ken; Iida, Maiko; Tabuchi, Toshiyuki; Honma, Teruki; Lee, Nayoung; Hashimoto, Satoshi; Matsuoka, Shigeru; Kuranaga, Takefumi; Sato, Kazuhito; Shiba, Tomoo; Sakamoto, Kimitoshi; Balogun, Emmanuel Oluwadare; Suzuki, Shigeo; Nara, Takeshi; Rodrigues da Rocha, Josmar; Alberto Montanari, Carlos; Tanaka, Akiko; Inoue, Masayuki; Kita, Kiyoshi; Harada, Shigeharu			The Open Form Inducer Approach for Structure-Based Drug Design	PLOS ONE			English	Article							HUMAN DIHYDROOROTATE DEHYDROGENASE; NEMATODE ASCARIS-SUUM; TRYPANOSOMA-CRUZI; FUMARATE REDUCTASE; PYRIMIDINE BIOSYNTHESIS; RHEUMATOID-ARTHRITIS; ALTERNATIVE OXIDASE; COMPLEX-II; INHIBITOR; CHEMOTHERAPY	Many open form (OF) structures of drug targets were obtained a posteriori by analysis of co-crystals with inhibitors. Therefore, obtaining the OF structure of a drug target a priori will accelerate development of potent inhibitors. In addition to its small active site, Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH) is fully functional in its monomeric form, making drug design approaches targeting the active site and protein-protein interactions unrealistic. Therefore, a novel a priori approach was developed to determination the TcDHODH active site in OF. This approach consists of generating an "OF inducer" (predicted in silico) to bind the target and cause steric repulsion with flexible regions proximal to the active site that force it open. We provide the first proof-of-concept of this approach by predicting and crystallizing TcDHODH in complex with an OF inducer, thereby obtaining the OF a priori with its subsequent use in designing potent and selective inhibitors. Fourteen co-crystal structures of TcDHODH with the designed inhibitors are presented herein. This approach has potential to encourage drug design against diseases where the molecular targets are such difficult proteins possessing small AS volume. This approach can be extended to study open/close conformation of proteins in general, the identification of allosteric pockets and inhibitors for other drug targets where conventional drug design approaches are not applicable, as well as the effective exploitation of the increasing number of protein structures deposited in Protein Data Bank.	[Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Inaoka, Daniel Ken; Balogun, Emmanuel Oluwadare; Suzuki, Shigeo; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan; [Iida, Maiko; Tabuchi, Toshiyuki; Lee, Nayoung; Hashimoto, Satoshi; Matsuoka, Shigeru; Kuranaga, Takefumi; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Integrated Analyt Chem, Tokyo, Japan; [Honma, Teruki; Sato, Kazuhito; Tanaka, Akiko] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Shiba, Tomoo; Harada, Shigeharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Kyoto, Japan; [Sakamoto, Kimitoshi] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Aomori, Japan; [Nara, Takeshi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Rodrigues da Rocha, Josmar; Alberto Montanari, Carlos] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil	Nagasaki University; University of Tokyo; University of Tokyo; RIKEN; Kyoto Institute of Technology; Hirosaki University; Juntendo University; Universidade de Sao Paulo	Inaoka, DK (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.; Inaoka, DK (corresponding author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan.	danielken@nagasaki-u.ac.jp	Balogun, Emmanuel Oluwadare/AAF-3352-2020; Montanari, Carlos A/C-2799-2012; Sakamoto, Kimitoshi/G-4539-2014; Inaoka, Daniel Ken/GMX-4344-2022	Montanari, Carlos A/0000-0002-4963-0316; Inaoka, Daniel Ken/0000-0002-9791-927X; Balogun, Emmanuel/0000-0002-2092-0045	Japanese Society for the Promotion of Science [18GS0314, 18073004, 26253025, 26870119, 16K19114]; Targeted Proteins Research Program from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) [10000284, 1400738]; Grants-in-Aid for Scientific Research [26304041] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Creative Scientific Research Grant 18GS0314 (to K. K.), Grant-in-aid for Scientific Research 18073004 and 26253025 (to K.K.), 26870119 and 16K19114 (to D.K.I.) from the Japanese Society for the Promotion of Science, and Targeted Proteins Research Program (to K.K. and Sh.H.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT). The authors also acknowledge the support from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to K.K. and Sh.H.) and JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) 10000284 (to K.K.) and 1400738 (to D.K.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed using synchrotron beamlines BL44XU and BL41XU at Spring-8, and beamlines BL5A, BL17A, NE3A, and NW12A at Photon Factory. We thank all beamline staff members for their help with X-ray diffraction data collection. This work was supported in part by Creative Scientific Research Grant 18GS0314 (to K.K.), Grant-in-aid for Scientific Research 18073004 and 26253025 (to K.K.), 26870119 and 16K19114 (to D.K.I.) from the Japanese Society for the Promotion of Science, and Targeted Proteins Research Program (to K.K. and Sh.H.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT). We also acknowledge the support from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to K.K. and Sh.H.) and JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) 10000284 (to K.K.) and 1400738 (to D.K.I.).	Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Baumgartner R, 2006, J MED CHEM, V49, P1239, DOI 10.1021/jm0506975; Bedingfield PTP, 2012, J MED CHEM, V55, P5841, DOI 10.1021/jm300157n; Breedveld FC, 2000, ANN RHEUM DIS, V59, P841, DOI 10.1136/ard.59.11.841; Cheleski J, 2010, EUR J MED CHEM, V45, P5899, DOI 10.1016/j.ejmech.2010.09.055; Chemical Computing Group Inc, 2012, SSW SUIT 910; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fritzson I, 2010, CHEMMEDCHEM, V5, P608, DOI 10.1002/cmdc.200900454; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; Harada S, 2013, BBA-BIOENERGETICS, V1827, P658, DOI 10.1016/j.bbabio.2013.01.005; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; Heikkila T, 2007, J MED CHEM, V50, P186, DOI 10.1021/jm060687j; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Inaoka DK, 2008, BIOCHEMISTRY-US, V47, P10881, DOI 10.1021/bi800413r; Inaoka DK, 2015, INT J MOL SCI, V16, P15287, DOI 10.3390/ijms160715287; Inaoka DK, 2005, ACTA CRYSTALLOGR F, V61, P875, DOI 10.1107/S174430910502659X; Jensen KF, 1998, PATHS PYRIMIDINES, V6, P20; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; MacDonald FE., 2010, HDB BIOCH MOL BIOL; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ong HB, 2013, MOL MICROBIOL, V90, P443, DOI 10.1111/mmi.12376; Osanai A, 2009, ACTA CRYSTALLOGR F, V65, P941, DOI 10.1107/S1744309109031352; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips Margaret A., 2010, Infectious Disorders - Drug Targets, V10, P226; Pipeline Pilot, 2007, PIP PIL; Rowland P, 2000, STRUCTURE, V8, P1227, DOI 10.1016/S0969-2126(00)00530-X; ROZENCWEIG M, 1979, CANCER CHEMOTH PHARM, V3, P135, DOI 10.1007/BF00262414; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Shimizu H, 2012, J BIOCHEM, V151, P589, DOI 10.1093/jb/mvs051; Takashima E, 2002, MOL BIOCHEM PARASIT, V122, P189, DOI 10.1016/S0166-6851(02)00100-7; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Wilson ZN, 2012, J BIOL CHEM, V287, P12759, DOI 10.1074/jbc.M112.346502; Yabu Y, 2006, PARASITOL INT, V55, P39, DOI 10.1016/j.parint.2005.09.003; Yabu Y, 2003, PARASITOL INT, V52, P155, DOI 10.1016/S1383-5769(03)00012-6	57	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167078	10.1371/journal.pone.0167078	http://dx.doi.org/10.1371/journal.pone.0167078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893848	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400079
J	Lecube, A; Valladares, S; Lopez-Cano, C; Gutierrez, L; Ciudin, A; Fort, JM; Rene, JM; Matias-Guiu, X; de Torres, I; Bueno, M; Pallares, J; Baena, JA				Lecube, Albert; Valladares, Silvia; Lopez-Cano, Carolina; Gutierrez, Liliana; Ciudin, Andreea; Fort, Jose Manuel; Rene, Josep Maria; Matias-Guiu, Xavier; de Torres, Ines; Bueno, Marta; Pallares, Judit; Baena, Juan Antonio			The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; BARIATRIC SURGERY; GASTRIC BYPASS; INFECTION; ASSOCIATION; ERADICATION; PREVALENCE; POPULATION	Background Helicobacter pylory (HP) infection has been associated to an increased rate of type 2 diabetes (T2D) and liver disease through its effect on insulin resistance and systemic inflammation. However, results are inconstant and no studies exist in morbidly obese patients, in which both insulin resistance and inflammation coexist. Material and Methods Cross-sectional study to evaluate the relationship between HP infection and alterations in carbohydrate metabolism, lipid profile, inflammation markers, and liver disease in patients awaiting for bariatric surgery. HP infection was histologically assessed in gastric antrum biopsy from 416 subjects. Liver biopsy was also available in 93 subjects. Results Both impaired fasting glucose and T2D were similar when comparing subjects with and without HP infection (24.2% vs. 22%, p = 0.290 and 29.4% vs. 29.1%, p = 0.916, respectively), with no differences between groups in the HOMA-IR, lipid profile neither inflammatory parameters. However, HP infection was higher among subjects with a BMI >= 40.0 kg/m(2) in comparison with lower degrees of obesity (71.7% vs. 60.0%, p = 0.041). In addition, subjects without HP infection showed higher degrees of steatosis (44.1 +/- 26.4% vs. 32.0 +/- 20.7%, p = 0.038), as well as a lower prevalence of non-alcoholic steatohepatitis (9.3% vs. 30.7%, p = 0.023). Conclusions In patients with morbid obesity, HP infection does not seem to be associated with abnormal carbohydrate metabolism. In addition, less advanced degrees of non-alcoholic fatty disease were observed. We suggest that low-grade inflammation that accompanies obesity mitigates the diabetogenic effect of HP, so the presence of obesity should be considered in studies that evaluate the HP metabolic effects.	[Lecube, Albert; Lopez-Cano, Carolina; Gutierrez, Liliana; Bueno, Marta] Arnau de Vilanova Univ Hosp, Endocrinol & Nutr Dept, EASO Collaborating Ctr Obes Management, IRB, Lleida, Spain; [Lecube, Albert; Lopez-Cano, Carolina; Gutierrez, Liliana; Rene, Josep Maria; Matias-Guiu, Xavier; Bueno, Marta; Pallares, Judit; Baena, Juan Antonio] Univ Lleida, Lleida, Spain; [Lecube, Albert] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Valladares, Silvia; Ciudin, Andreea] Autonomous Univ Barcelona, Endocrinol & Nutr Dept, EASO Collaborating Ctr Obes Management, Vall dHebron Univ Hosp,Vall dHebron Inst Recerca, Barcelona, Spain; [Fort, Jose Manuel] Autonomous Univ Barcelona, Endocrine Bariatr & Metab Surg Unit, IFSO Ctr Excellence, Vall dHebron Univ Hosp,Vall dHebron Inst Recerca, Barcelona, Spain; [Rene, Josep Maria] Arnau de Vilanova Univ Hosp, Dept Gastroenterol, IRB, Lleida, Spain; [Matias-Guiu, Xavier; Pallares, Judit] Arnau de Vilanova Univ Hosp, Dept Pathol & Mol Genet, IRB, Lleida, Spain; [de Torres, Ines] Autonomous Univ Barcelona, Dept Pathol, Vall dHebron Univ Hosp, Vall dHebron Inst Recerca, Barcelona, Spain; [Baena, Juan Antonio] Arnau de Vilanova Univ Hosp, Gastrointestinal Surg Dept, IRB, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut de Recerca Biomedica - IRB Lleida; Institut de Recerca Biomedica - IRB Lleida; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut de Recerca Biomedica - IRB Lleida	Lecube, A (corresponding author), Arnau de Vilanova Univ Hosp, Endocrinol & Nutr Dept, EASO Collaborating Ctr Obes Management, IRB, Lleida, Spain.; Lecube, A (corresponding author), Univ Lleida, Lleida, Spain.; Lecube, A (corresponding author), Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain.	alecube@gmail.com	CIUDIN, ANDREEA/O-5250-2016; Fustegueras, Juan Antonio Baena/E-2912-2012; Lecube, Albert/H-3813-2019; matias-guiu, xavier/C-3039-2009	CIUDIN, ANDREEA/0000-0001-5622-0203; Fustegueras, Juan Antonio Baena/0000-0001-8543-6863; Lecube, Albert/0000-0001-9684-0183; matias-guiu, xavier/0000-0002-7201-6605; Lopez-Cano, Carolina/0000-0001-7458-5871; Bueno, Marta/0000-0001-9488-4553				Abenavoli L, 2013, MED HYPOTHESES, V81, P913, DOI 10.1016/j.mehy.2013.08.011; Al-Akwaa Ahmad M, 2010, Saudi J Gastroenterol, V16, P264, DOI 10.4103/1319-3767.70610; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Aslan M, 2006, WORLD J GASTROENTERO, V12, P6865, DOI 10.3748/wjg.v12.i42.6865; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Buzas GM, 2014, WORLD J GASTROENTERO, V20, P5226, DOI 10.3748/wjg.v20.i18.5226; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Erim T, 2008, WORLD J SURG, V32, P2021, DOI 10.1007/s00268-008-9608-7; Estep JM, 2013, GASTROENTEROLOGY, V144, pS125; Franceschi F, 2014, WORLD J GASTROENTERO, V20, P12809, DOI 10.3748/wjg.v20.i36.12809; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; Gen R, 2010, SOUTH MED J, V103, P190, DOI 10.1097/SMJ.0b013e3181cf373f; Goo MJ, 2009, LAB INVEST, V89, P1291, DOI 10.1038/labinvest.2009.90; Gunji T, 2009, HELICOBACTER, V14, P144, DOI 10.1111/j.1523-5378.2009.00705.x; Hamed Sherifa Ahmed, 2008, J Stroke Cerebrovasc Dis, V17, P86, DOI 10.1016/j.jstrokecerebrovasdis.2007.10.006; Hansen PS, 1999, INFECT IMMUN, V67, P3171, DOI 10.1128/IAI.67.6.3171-3174.1999; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Kamada T, 2005, DIGEST LIVER DIS, V37, P39, DOI 10.1016/j.dld.2004.07.017; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kountouras J, 2011, EUR J INTERN MED, V22, pE146, DOI 10.1016/j.ejim.2011.07.013; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Li M, 2013, WORLD J GASTROENTERO, V19, P7024, DOI 10.3748/wjg.v19.i41.7024; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Fort JM, 2013, OBES SURG, V23, P1324, DOI 10.1007/s11695-013-0980-5; Marrollo M, 2001, DIGEST LIVER DIS, V33, P21, DOI 10.1016/S1590-8658(01)80131-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Okushin K, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0247-9; Papasavas PK, 2008, SURG OBES RELAT DIS, V4, P383, DOI 10.1016/j.soard.2007.08.014; Park SH, 2005, J NATL MED ASSOC, V97, P508; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Ramaswamy A, 2004, ARCH SURG-CHICAGO, V139, P1094, DOI 10.1001/archsurg.139.10.1094; Renshaw AA, 2001, OBES SURG, V11, P281, DOI 10.1381/096089201321336601; Shin DW, 2012, J CLIN GASTROENTEROL, V46, P840, DOI 10.1097/MCG.0b013e3182522477; So WY, 2009, DIABETES RES CLIN PR, V86, P89, DOI 10.1016/j.diabres.2009.08.010; Sumida Y, 2015, J GASTROENTEROL, V50, P996, DOI 10.1007/s00535-015-1039-2; Talebi-Taher Mahshid, 2012, Acta Med Iran, V50, P315; Waluga M, 2015, WORLD J HEPATOL, V7, P2136, DOI 10.4254/wjh.v7.i18.2136; Xia HHX, 2001, AM J GASTROENTEROL, V96, P1039, DOI 10.1111/j.1572-0241.2001.03604.x; Zhou XY, 2013, DIABETES RES CLIN PR, V99, P200, DOI 10.1016/j.diabres.2012.11.012	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166741	10.1371/journal.pone.0166741	http://dx.doi.org/10.1371/journal.pone.0166741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893763	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400041
J	Munoz-Aguirrel, P; Denova-Gutierrez, E; Flores, M; Salazar-Martinez, E; Salmeron, J				Munoz-Aguirrel, Paloma; Denova-Gutierrez, Edgar; Flores, Mario; Salazar-Martinez, Eduardo; Salmeron, Jorge			High Vitamin D Consumption Is Inversely Associated with Cardiovascular Disease Risk in an Urban Mexican Population	PLOS ONE			English	Article							METABOLIC SYNDROME; D SUPPLEMENTATION; DIETARY PATTERNS; 25-HYDROXYVITAMIN-D; EXPRESSION; PREDICTION; NUTRITION; ARTERIES; CALCIUM; HEALTH	Background Vitamin D deficiency is a major global public health problem. Recent epidemiological studies have assessed the relationship between vitamin D and multiple outcomes, including cardiovascular disease. However, this evidence is limited and inconclusive. Our purpose in this study was to evaluate the association between dietary vitamin D intake and cardiovascular disease risk in adult Mexican population. Methods We conducted a cross-sectional analysis with the baseline data from 6294 men and women aged 20-80 years participating in the Health Workers Cohort Study. Data on sociodemographic, lifestyle, and medical history factors were collected with a self-administered questionnaire. Dietary intake was evaluated by using a semi-quantitative food-frequency questionnaire. Cardiovascular disease risk was calculated using a recalibration of the Framingham heart disease prediction score. To evaluate the association between vitamin D intake and 10-year cardiovascular disease risk, odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using multiple logistic regression analysis. Results A total of 6294 subjects (1820 men and 4474 women) with a mean age of 42 years, were included. Of these, subjects in the highest quintile of vitamin D intake presented lower levels of triglycerides 14.6 mg/dL (P for trend = 0.001); 2.0 cm less in waist circumference (P for trend = 0.001) and 0.8 points less in the Framingham cardiovascular disease risk score (P for trend = 0.002) compared with the subjects in the lower quintile of vitamin D intake. Additionally, participants in the highest quintile of vitamin D consumption were less likely to develop elevated 10-year cardiovascular disease risk, compared with those in the lowest quintile (OR = 0.51; 95% CI: 0.33, 0.77; P for trend = 0.007). Conclusion Our data suggest that higher consumption of vitamin D is associated with a reduced risk of cardiovascular disease in Mexican population.	[Munoz-Aguirrel, Paloma; Salmeron, Jorge] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Cuernavaca, Morelos, Mexico; [Denova-Gutierrez, Edgar] Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Epidemiol & Clin, Mexico City, DF, Mexico; [Flores, Mario] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico; [Salazar-Martinez, Eduardo; Salmeron, Jorge] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico	Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico Gomez; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Denova-Gutierrez, E (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Epidemiol & Clin, Mexico City, DF, Mexico.	edenovag@gmail.com	Gutierrez, Edgar Denova/E-4600-2011; Cardoso, Isadora/H-5757-2017	Gutierrez, Edgar Denova/0000-0001-9671-9682; Salmeron, Jorge/0000-0002-5113-299X; Flores, Mario/0000-0001-5522-6849	Consejo Nacional de Ciencia y Tecnologia Mexico City [87783, 7876]	Consejo Nacional de Ciencia y Tecnologia Mexico City(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was supported by Consejo Nacional de Ciencia y Tecnologia (grant: 87783, and grant: 7876) Mexico City.	American Heart Association, HEART ATT RISK ASS; [Anonymous], 2010, CAUS SEL MORT SEX 20, P93; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Borges ACR, 1999, BRIT J PHARMACOL, V127, P772, DOI 10.1038/sj.bjp.0702581; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Denova-Gutierrez E, 2016, NUTR HOSP, V33, P663, DOI 10.20960/nh.276; Denova-Gutierrez E, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/170680; Denova-Gutierrez E, 2011, J NUTR, V141, P921, DOI 10.3945/jn.110.132332; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Denova-Gutierrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145; Flores M., 2011, RESULTADOS ENSANUT 2; Getz GS, 2007, ARTERIOSCL THROM VAS, V27, P2499, DOI 10.1161/ATVBAHA.107.155853; Hernandez-Avila JE, 2003, USER MANUAL EVALUATI; Hernandez-Avila M, 1998, SALUD PUBLICA MEXICO, V40, P133, DOI 10.1590/S0036-36341998000200005; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jaimungal S, 2011, NUTR RES, V31, P805, DOI 10.1016/j.nutres.2011.09.005; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Lee DM, 2009, EUR J ENDOCRINOL, V161, P947, DOI 10.1530/EJE-09-0496; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; MACCARTHY EP, 1989, HYPERTENSION, V13, P954, DOI 10.1161/01.HYP.13.6.954; Maki KC, 2009, J CLIN LIPIDOL, V3, P289, DOI 10.1016/j.jacl.2009.07.003; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Michos ED, 2007, CIRCULATION, V115, P827, DOI 10.1161/CIRCULATIONAHA.106.686238; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Munoz-Aguirre P, 2015, CLIN NUTR, V34, P799, DOI 10.1016/j.clnu.2014.10.002; Norman A.W., 2006, PRESENT KNOWLEDGE NU; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; Ohsawa M, 2000, CIRCULATION, V102, P2867; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Poliquin S, 2009, CAN J DIET PRACT RES, V70, P21, DOI 10.3148/70.1.2009.21; Ramly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110476; Ross AC, 2006, MODERN NUTR HLTH DIS, V10th; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Sun Q, 2011, AM J CLIN NUTR, V94, P534, DOI 10.3945/ajcn.110.008763; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Willet W, 1998, NUTR EPIDEMIOLOGY; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolpowitz D, 2006, J AM ACAD DERMATOL, V54, P301, DOI 10.1016/j.jaad.2005.11.1057; World Health Organization (WHO), 2008, FRAM MON EV IMPL GLO; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zittermann A, 2014, ANTICANCER RES, V34, P4641; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166869	10.1371/journal.pone.0166869	http://dx.doi.org/10.1371/journal.pone.0166869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893863	gold, Green Submitted, Green Published			2022-12-26	WOS:000389472400051
J	Yu, J; Chen, RS; Tan, YF; Wu, JS; Qi, JY; Zhang, MZ; Gu, WW				Yu, Juan; Chen, Renshan; Tan, Yafang; Wu, Jiashin; Qi, Jianyong; Zhang, Minzhou; Gu, Weiwang			Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice	PLOS ONE			English	Article							CARDIOMYOCYTE HYPERTROPHY; CARDIAC-HYPERTROPHY; UP-REGULATION; ACTIVATION; PROTECTS; CELLS; GATA4; MILTIORRHIZA; DYSFUNCTION; INHIBITION	Background Heart failure(HF) is a dangerous disease that affects millions of patients. Radix Salvia is widely used in Chinese clinics to treat heart diseases. Salvianolic acid B(SalB) is the major active component of Radix Salvia. This study investigated the mechanisms of action and effects of SalB on HF in an experimental mouse model of HF. Methods We created a mouse model of HF by inducing pressure overload with transverse aortic constriction( TAC) surgery for 2 weeks and compared among 4 study groups: SHAM group (n = 10), TAC group (n = 9), TAC+MET group (metprolol, positive drug treatment, n = 9) and TAC+SalB group (SalB, 240 mg.kg(-1).day(-1), n = 9). Echocardiography was used to evaluate the dynamic changes in cardiac structure and function in vivo. Plasma brain natriuretic peptide (BNP) concentration was detected by Elisa method. In addition, H9C2 rat cardiomyocytes were cultured and Western blot were implemented to evaluate the phosphorylation of ERK1/2, AKT, and protein expression of GATA4. Results SalB significantly inhibited the phosphorylation of Thr202/Tyr204 sites of ERK1/2, but not Ser473 site of AKT, subsequently inhibited protein expression of GATA4 and plasma BNP (P < 0.001), and then inhibited HF at 2 weeks after TAC surgery. Conclusions Our data provide a mechanism of inactivating the ERK1/2/GATA4 signaling pathway for SalB inhibition of the TAC-induced HF.	[Yu, Juan; Gu, Weiwang] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Renshan; Tan, Yafang; Qi, Jianyong; Zhang, Minzhou] Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2,AMI Key Lab Chinese Med Guangzh, Guangzhou, Guangdong, Peoples R China; [Yu, Juan] Guangdong Prov Acad Chinese Med, Anim Lab, Guangzhou, Guangdong, Peoples R China; [Wu, Jiashin] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Coll Pharm, Rootstown, OH USA	Southern Medical University - China; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Northeast Ohio Medical University (NEOMED)	Gu, WW (corresponding author), Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China.; Qi, JY; Zhang, MZ (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2,AMI Key Lab Chinese Med Guangzh, Guangzhou, Guangdong, Peoples R China.	drqjy@163.com; minzhouzhang8@163.com; guweiwang8@163.com			National Natural Science Foundation of China [81473471, 81603429]; National Natural Science Foundation of Guangdong [2014A030313402]; Guangdong Medical Research Fund [A2014271]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20134425110001]; Guangdong science and Technology Foundation [2016KT1170]; Special Funds of Guangdong hospital of Chinese Medicine [YK2013B2N11, YN2014ZH01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Guangdong Medical Research Fund; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong science and Technology Foundation; Special Funds of Guangdong hospital of Chinese Medicine	This study was supported by the National Natural Science Foundation of China (#81473471 to M.Z., #81603429 to J.Y.), of Guangdong (#2014A030313402 to J.Q.), Guangdong Medical Research Fund (#A2014271 to J.Q.), Specialized Research Fund for the Doctoral Program of Higher Education of China 20134425110001 (to M.Z.), Guangdong science and Technology Foundation 2016KT1170 (to J.Q.), Special Funds of Guangdong hospital of Chinese Medicine YK2013B2N11, YN2014ZH01 (to M.Z.),	Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Deng YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135435; Guo HD, 2014, INT J CARDIOL, V177, P538, DOI 10.1016/j.ijcard.2014.08.104; Huang MA, 2015, PHARM BIOL, V53, P1058, DOI 10.3109/13880209.2014.959611; Kovacs K, 2009, MOL CELL BIOCHEM, V321, P155, DOI 10.1007/s11010-008-9929-8; Li Q, 2015, J CARDIOVASC PHARM, V66, P196, DOI 10.1097/FJC.0000000000000265; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liu CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001321; Liu M, 2015, BIOCHEM BIOPH RES CO, V468, P214, DOI 10.1016/j.bbrc.2015.10.127; Lv HD, 2015, BRAIN RES BULL, V115, P30, DOI 10.1016/j.brainresbull.2015.05.002; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pan RH, 2008, CHIN J INTEGR TRADIT, V9, P779; Qi JY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/769515; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Tang YB, 2014, BIOCHEM PHARMACOL, V90, P34, DOI 10.1016/j.bcp.2014.04.008; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Ulm S, 2014, J MOL CELL CARDIOL, V72, P104, DOI 10.1016/j.yjmcc.2014.03.002; Wu YT, 2006, INT J PHARM, V326, P25, DOI 10.1016/j.ijpharm.2006.07.003; Xu X, 2013, MOL MED REP, V8, P385, DOI 10.3892/mmr.2013.1548; Yu FJ, 2015, J CELL MOL MED, V19, P2617, DOI 10.1111/jcmm.12655; Zeng WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16013; Zhang HS, 2006, J MOL CELL CARDIOL, V41, P138, DOI 10.1016/j.yjmcc.2006.03.007; Zhao Y, 2011, J ONCOL, V2011, DOI 10.1155/2011/534548	31	18	18	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166560	10.1371/journal.pone.0166560	http://dx.doi.org/10.1371/journal.pone.0166560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893819	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400032
J	Chen, T; Chen, TM; Liu, RC; Xu, CL; Wang, DY; Chen, FM; Zhu, WF; Zhang, XX; Yang, J; Wang, LJ; Xie, Z; Chen, YK; Bai, T; Li, YL; Wang, ZY; Zhang, M; Chen, SL; Shu, YL				Chen, Tao; Chen, Tianmu; Liu, Ruchun; Xu, Cuiling; Wang, Dayan; Chen, Faming; Zhu, Wenfei; Zhang, Xixing; Yang, Jing; Wang, Lijie; Xie, Zhi; Chen, Yongkun; Bai, Tian; Li, Yelan; Wang, Zhiyu; Zhang, Min; Chen, Shuilian; Shu, Yuelong			Transmissibility of the Influenza Virus during Influenza Outbreaks and Related Asymptomatic Infection in Mainland China, 2005-2013	PLOS ONE			English	Article							PANDEMIC INFLUENZA; H1N1; EPIDEMICS; INSIGHTS	We collected 2768 Influenza-like illness emergency public health incidents from April 1, 2005 to November 30, 2013reported in the Emergency Public Reporting System. After screening by strict inclusion and exclusion criteria, there were 613 outbreaks analyzed with susceptible-exposed-infectious/asymptomatic-removed model in order to estimate the proportion of asymptomatic individuals (p) and the effective reproduction number (R-t). The relation between Rt and viral subtypes, regions, outbreak sites, populations, and seasons were analyzed. The mean values of p of different subtypes ranged from 0.09 to 0.15, but could be as high as up to 0.94. Different subtypes, provinces, regions, and sites of outbreak had statistically significantly different Rt. In particular, the southern region also manifested different Rt by affected population size and seasonality. Our results provide China and also the rest of the world a reference to understand characteristics of transmission and develop prevention and control strategies.	[Chen, Tao; Xu, Cuiling; Wang, Dayan; Zhu, Wenfei; Yang, Jing; Wang, Lijie; Chen, Yongkun; Bai, Tian; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol,Natl Hlth & Family Planning Com, Beijing 102206, Peoples R China; [Chen, Tianmu] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Dept Malaria, Shanghai, Peoples R China; [Chen, Tianmu; Liu, Ruchun; Chen, Faming; Zhang, Xixing; Xie, Zhi; Li, Yelan; Wang, Zhiyu; Zhang, Min; Chen, Shuilian] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention	Shu, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol,Natl Hlth & Family Planning Com, Beijing 102206, Peoples R China.	yshu@cnic.org.cn			China-U.S. Collaborative Program on Emerging and Reemerging Infectious Disease	China-U.S. Collaborative Program on Emerging and Reemerging Infectious Disease	This study was supported by China-U.S. Collaborative Program on Emerging and Reemerging Infectious Disease. The funder had no role in study design, data collection and analysis, decision to publish, o rpreparation of the manuscript.	[Anonymous], 2015, EPIDEMIOLOGY, V26, P862; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Chen SC, 2008, EPIDEMIOL INFECT, V136, P1035, DOI 10.1017/S0950268807009284; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Dushoff J, 2004, PNAS, V101, P16195; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Kermack WO, 1927, P ROYAL SOC LONDON; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mikolajczyk R, 2009, DTSCH ARZTEBL INT, V106, P777, DOI 10.3238/arztebl.2009.0777; National Health and Family Planning Commission of the People's Republic of China, 2011, DIAGN TREATM GUID IN; National Health and Family Planning Commission of the People's Republic of China, 2010, INFL SURV PROGR CHIN; Sertsou G, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-38; shedding Viral, 2010, J INFECT DIS, V201, P1509, DOI [10.1086/652241, DOI 10.1086/652241]; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; World Health Organization, 2015, MAN EST DIS BURD ASS; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	19	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166180	10.1371/journal.pone.0166180	http://dx.doi.org/10.1371/journal.pone.0166180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880774	Green Submitted, gold, Green Published			2022-12-26	WOS:000388889500018
J	Leifels, M; Hamza, IA; Krieger, M; Wilhelm, M; Mackowiak, M; Jurzik, L				Leifels, Mats; Hamza, Ibrahim Ahmed; Krieger, Marion; Wilhelm, Michael; Mackowiak, Martin; Jurzik, Lars			From Lab to Lake - Evaluation of Current Molecular Methods for the Detection of Infectious Enteric Viruses in Complex Water Matrices in an Urban Area	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE PCR; REAL-TIME PCR; PROPIDIUM MONOAZIDE; HUMAN ADENOVIRUS; QUANTITATIVE PCR; ENVIRONMENTAL-SAMPLES; ETHIDIUM MONOAZIDE; CELL-CULTURE; PMA-QPCR; ROTAVIRUS	Quantitative PCR methods are commonly used to monitor enteric viruses in the aquatic environment because of their high sensitivity, short reaction times and relatively low operational cost. However, conclusions for public health drawn from results of such molecular techniques are limited due to their inability to determine viral infectivity. Ethidium monoazide (EMA) and propidium monoazide (PMA) are capable to penetrate the damaged or compromised capsid of the inactivated viruses and bind to the viral nucleic acids. We assessed whether dye treatment is a suitable approach to improve the ability of qPCR to distinguish between infectious and non-infectious human adenovirus, enterovirus and rotavirus A in surface water of an urban river and sewage before and after UV disinfection. Like the gold standard of cell culture assays, pretreatment EMA-/PMA-qPCR succeeded in removing false positive results which would lead to an overestimation of the viral load if only qPCR of the environmental samples was considered. A dye pretreatment could therefore provide a rapid and relatively inexpensive tool to improve the efficacy of molecular quantification methods in regards to viral infectivity.	[Leifels, Mats; Krieger, Marion; Wilhelm, Michael; Jurzik, Lars] Ruhr Univ Bochum, Dept Hyg Social & Environm Med, Bochum, Germany; [Hamza, Ibrahim Ahmed] Natl Res Ctr, Dept Water Pollut Res, Environm Virol Lab, Cairo, Egypt; [Mackowiak, Martin] Univ Duisburg Essen, Biofilm Ctr Aquat Microbiol, Fac Chem, Essen, Germany	Ruhr University Bochum; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Duisburg Essen	Leifels, M (corresponding author), Ruhr Univ Bochum, Dept Hyg Social & Environm Med, Bochum, Germany.	mats.leifels@rub.de	Ewess, Ibrahim A Hamza/C-7604-2014; Leifels, Mats/U-4137-2019	Ewess, Ibrahim A Hamza/0000-0002-7163-265X; Leifels, Mats/0000-0002-1295-3410; Jurzik, Lars/0000-0002-8086-0427	Ministry of Innovation, Science and Research North Rhine Westphalia, Germany; Ministry of Education and Research [02WRS1283A]	Ministry of Innovation, Science and Research North Rhine Westphalia, Germany; Ministry of Education and Research	This study was performed within the PhD Framework "Fortschrittskolleg FUTURE WATER" and funded by the Ministry of Innovation, Science and Research North Rhine Westphalia, Germany. http://www.wissenschaft.nrw.de/ministerium/leitlinien-des-ministeriums/fortschritt-nrw/. The project Safe Ruhr, in which the analyzed samples have been taken, was funded by the Federal Ministry of Education and Research (Grant Numbers 02WRS1283A to J) within the research program FONA-RiskWa. http://www.bmbf.riskwa.de/.; The authors sincerely thank Daniel Teschlade and Jonathan Rathjens for their geographical and statistical advice in the article. This study was performed within the Fortschrittskolleg FUTURE WATER and funded by the Ministry of Innovation, Science and Research North Rhine Westphalia, Germany. A part of this study was funded by the Federal Ministry of Education and Research ( Grant Numbers 02WRS1283A to J) within the research program FONARiskWa.	AGBALIKA F, 1984, APPL ENVIRON MICROB, V47, P378, DOI 10.1128/AEM.47.2.378-380.1984; Andorra I, 2010, INT J FOOD MICROBIOL, V144, P257, DOI 10.1016/j.ijfoodmicro.2010.10.003; Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08; Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07; Ballester Nicola A., 2005, Journal of Water and Health, V3, P59; Bellehumeur C, 2015, J VIROL METHODS, V222, P182, DOI 10.1016/j.jviromet.2015.06.014; Bertrand I, 2009, WATER RES, V43, P2728, DOI 10.1016/j.watres.2009.03.028; Bofill-Mas S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/192089; Bosch A, 2016, CURR OPIN FOOD SCI, V8, P110, DOI 10.1016/j.cofs.2016.04.002; Christoforou M, 2014, PLANT PATHOL, V63, P1185, DOI 10.1111/ppa.12193; Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330; Coudray-Meunier C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-216; Ditommaso S, 2014, DIAGN MICR INFEC DIS, V80, P260, DOI 10.1016/j.diagmicrobio.2014.09.010; Dona D, 2016, INT J PEDIAT, V2016, DOI 10.1155/2016/5236243; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Fittipaldi M, 2011, J EUKARYOT MICROBIOL, V58, P359, DOI 10.1111/j.1550-7408.2011.00557.x; Fuster N, 2016, WATER RES, V101, P226, DOI 10.1016/j.watres.2016.05.086; Girones R, 2010, WATER RES, V44, P4325, DOI 10.1016/j.watres.2010.06.030; Guerrero-Latorre L, 2016, INT J HYG ENV HLTH; Hamza IA, 2014, J VIROL METHODS, V204, P65, DOI 10.1016/j.jviromet.2014.04.002; Hamza IA, 2011, INT J HYG ENVIR HEAL, V214, P424, DOI 10.1016/j.ijheh.2011.07.014; Hamza IA, 2011, WATER RES, V45, P1358, DOI 10.1016/j.watres.2010.10.021; Hamza IA, 2009, WATER RES, V43, P2657, DOI 10.1016/j.watres.2009.03.020; Hata A, 2015, APPL ENVIRON MICROB, V81, P1585, DOI 10.1128/AEM.03082-14; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hewitt J, 2013, WATER RES, V47, P6750, DOI 10.1016/j.watres.2013.09.001; Humphrey B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132954; Kahler AM, 2011, WATER RES, V45, P1745, DOI 10.1016/j.watres.2010.11.026; Karim MR, 2015, J VIROL METHODS, V219, P51, DOI 10.1016/j.jviromet.2015.02.020; Kyriakopoulou Z, 2010, VIRUS GENES, V40, P183, DOI 10.1007/s11262-009-0446-y; Leifels M, 2015, INT J HYG ENVIR HEAL, V218, P686, DOI 10.1016/j.ijheh.2015.02.003; Li D, 2009, WATER RES, V43, P3261, DOI 10.1016/j.watres.2009.03.044; Mayindou G, 2016, J MED VIROL, V88, P596, DOI 10.1002/jmv.24382; Moreno-Mesonero L, 2016, RES MICROBIOL, V167, P29, DOI 10.1016/j.resmic.2015.08.002; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nuanualsuwan S, 2003, APPL ENVIRON MICROB, V69, P350, DOI 10.1128/AEM.69.1.350-357.2003; Parshionikar S, 2010, APPL ENVIRON MICROB, V76, P4318, DOI 10.1128/AEM.02800-09; Pereira LA, 2013, J PEDIAT-BRAZIL, V89, P278, DOI 10.1016/j.jped.2012.11.002; Pollard SL, 2015, VACCINE, V33, P3795, DOI 10.1016/j.vaccine.2015.06.064; Prevost B, 2016, WATER RES, V91, P68, DOI 10.1016/j.watres.2015.12.049; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Rames E, 2016, WATER RES, V96, P308, DOI 10.1016/j.watres.2016.03.042; Randazzo W, 2016, INT J FOOD MICROBIOL, V229, P1, DOI 10.1016/j.ijfoodmicro.2016.04.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rigotto C, 2010, J APPL MICROBIOL, V109, P1979, DOI 10.1111/j.1365-2672.2010.04827.x; Rodriguez RA, 2013, WATER RES, V47, P3183, DOI 10.1016/j.watres.2013.03.022; Shieh YC, 2008, J VIROL METHODS, V149, P184, DOI 10.1016/j.jviromet.2007.12.013; Strathmann M, 2016, INT J HYG ENV HLTH; Takahashi M, 2016, INT J FOOD MICROBIOL, V216, P127, DOI 10.1016/j.ijfoodmicro.2015.09.018; Timm C, 2016, INT J HYG ENVIR HEAL, V51, DOI [10.1016/j.watres.2010.11.026, DOI 10.1016/J.WATRES.2010.11.026]; Tondera K, 2016, INT J HYG ENV HLTH; Tondera K, 2015, INT J HYG ENVIR HEAL, V218, P731, DOI 10.1016/j.ijheh.2015.09.002; Verboon-Maciolek MA, 2012, J PEDIATR-US, V160, P165, DOI 10.1016/j.jpeds.2011.08.053; Vesper S, 2008, J MICROBIOL METH, V72, P180, DOI 10.1016/j.mimet.2007.11.017; Wagner AO, 2015, APPL SOIL ECOL, V93, P56, DOI 10.1016/j.apsoil.2015.04.005; Zacharias N, 2015, INT J HYG ENVIR HEAL, V218, P714, DOI 10.1016/j.ijheh.2015.04.001	57	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167105	10.1371/journal.pone.0167105	http://dx.doi.org/10.1371/journal.pone.0167105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880820	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500068
J	Thornbrough, JM; Gopinath, A; Hundley, T; Worley, MJ				Thornbrough, Joshua M.; Gopinath, Adarsh; Hundley, Tom; Worley, Micah J.			Human Genome-Wide RNAi Screen for Host Factors That Facilitate Salmonella Invasion Reveals a Role for Potassium Secretion in Promoting Internalization	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INFLUENZA-VIRUS REPLICATION; NUCLEOTIDE EXCHANGE FACTOR; PATHOGENICITY ISLAND 2; III SECRETION; CONTAINING VACUOLE; INTRACELLULAR REPLICATION; MEMBRANE MICRODOMAINS; ENDOPLASMIC-RETICULUM; ACTIN CYTOSKELETON	Salmonella enterica can actively invade the gastro- intestinal epithelium. This frequently leads to diarrheal disease, and also gives the pathogen access to phagocytes that can serve as vehicles for dissemination into deeper tissue. The ability to invade host cells is also important in maintaining the carrier state. While much is known about the bacterial factors that promote invasion, relatively little is known about the host factors involved. To gain insight into how Salmonella enterica serovar Typhimurium is able to invade normally nonphagocytic cells, we undertook a global RNAi screen with S. Typhimurium- infected human epithelial cells. In all, we identified 633 genes as contributing to bacterial internalization. These genes fall into a diverse group of functional categories revealing that cytoskeletal regulators are not the only factors that modulate invasion. In fact, potassium ion transport was the most enriched molecular function category in our screen, reinforcing a link between potassium and internalization. In addition to providing new insights into the molecular mechanisms underlying the ability of pathogens to invade host cells, all 633 host factors identified are candidates for new anti- microbial targets for treating Salmonella infections, and may be useful in curtailing infections with other pathogens as well.	[Thornbrough, Joshua M.; Gopinath, Adarsh; Hundley, Tom; Worley, Micah J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Worley, Micah J.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Worley, MJ (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	micah.worley@louisville.edu			National Institutes of Health from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]	National Institutes of Health from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense	The work was supported by National Institutes of Health grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Boyle EC, 2007, J BACTERIOL, V189, P1489, DOI 10.1128/JB.01730-06; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Criss AK, 2003, INFECT IMMUN, V71, P2885, DOI 10.1128/IAI.71.5.2885-2891.2003; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dostal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093549; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Gaind R, 2006, J ANTIMICROB CHEMOTH, V58, P1139, DOI 10.1093/jac/dkl391; GALAN JE, 1992, J BACTERIOL, V174, P4338; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Giacomodonato MN, 2007, MICROBIOL-SGM, V153, P1221, DOI 10.1099/mic.0.2006/002758-0; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Humphreys D, 2012, CELL HOST MICROBE, V11, P129, DOI 10.1016/j.chom.2012.01.006; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jutras I, 2003, INFECT IMMUN, V71, P260, DOI 10.1128/IAI.71.1.260-266.2003; Kasten MR, 2007, J PHYSIOL-LONDON, V584, P565, DOI 10.1113/jphysiol.2007.141135; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Liu YH, 2013, MICROBIOL-SGM, V159, P1705, DOI 10.1099/mic.0.068700-0; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; MEERZAMAN D, 1994, J BIOL CHEM, V269, P12932; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; Munoz S, 2009, SCAND J IMMUNOL, V70, P256, DOI 10.1111/j.1365-3083.2009.02295.x; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Riff JD, 2005, INFECT IMMUN, V73, P7113, DOI 10.1128/IAI.73.11.7113-7125.2005; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; Swanson MS, 2002, TRAFFIC, V3, P170, DOI 10.1034/j.1600-0854.2002.030302.x; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Thornbrough JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045245; Thornbrough JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038097; VANHILLE B, 1993, BIOCHEM BIOPH RES CO, V197, P15, DOI 10.1006/bbrc.1993.2434; Viaud J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5080; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yu HB, 2014, MBIO, V5, DOI 10.1128/mBio.00865-14	71	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166916	10.1371/journal.pone.0166916	http://dx.doi.org/10.1371/journal.pone.0166916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880807	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500044
J	Fakarayi, T; Mashapa, C; Gandiwa, E; Kativu, S				Fakarayi, Togarasei; Mashapa, Clayton; Gandiwa, Edson; Kativu, Shakkie			Varying Land-Use Has an Influence on Wattled and Grey Crowned Cranes' Abundance and Distribution in Driefontein Grasslands Important Bird Area, Zimbabwe	PLOS ONE			English	Article							RECENT DEFORESTATION; SOUTH-AFRICA	Three species of cranes are distributed widely throughout southern Africa, but little is known about how they respond to the changes in land-use that have occurred in this region. This study assessed habitat preference of the two crane species across land-use categories of the self contained small scale commercial farms of 30 to 40 ha per household (A1), large scale commercial agriculture farms of > 50 ha per household (A2) and Old Resettlement, farms of < 5 ha per household with communal grazing land in Driefontein Grasslands Important Bird Area (IBA), Zimbabwe. The study further explored how selected explanatory (environmental) habitat variables influence crane species abundance. Crane bird counts and data on influencing environmental variables were collected between June and August 2012. Our results show that varying land-use categories had an influence on the abundance and distribution of the Wattled Crane (Bugeranus carunculatus) and the Grey Crowned Crane (Belearica regulorum) across Driefontein Grasslands IBA. The Wattled Crane was widely distributed in the relatively undisturbed A2 farms while the Grey Crowned Crane was associated with the more disturbed land of A1 farms, Old Resettlement and its communal grazing land. Cyperus esculentus and percent (%) bare ground were strong environmental variables best explaining the observed patterns in Wattled Crane abundance across land-use categories. The pattern in Grey Crowned Crane abundance was best explained by soil penetrability, moisture and grass height variables. A holistic sustainable land-use management that takes into account conservation of essential habitats in Driefontein Grasslands IBA is desirable for crane populations and other wetland dependent species that include water birds.	[Fakarayi, Togarasei; Kativu, Shakkie] Univ Zimbabwe, Trop Resource Ecol Programme, POB MP 167, Harare, Zimbabwe; [Fakarayi, Togarasei] BirdLife Zimbabwe, POB RVL 100, Harare, Zimbabwe; [Mashapa, Clayton; Gandiwa, Edson] Chinhoyi Univ Technol, Sch Wildlife Ecol & Conservat, Private Bag 7724, Chinhoyi, Zimbabwe	University of Zimbabwe	Mashapa, C (corresponding author), Chinhoyi Univ Technol, Sch Wildlife Ecol & Conservat, Private Bag 7724, Chinhoyi, Zimbabwe.	clayiemashapa@yahoo.co.uk	Gandiwa, Edson/I-2925-2019; Mashapa, Clayton/R-8458-2019	Gandiwa, Edson/0000-0003-0708-350X; 	German Academic Exchange Services (DAAD)	German Academic Exchange Services (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was funded by the German Academic Exchange Services (DAAD).; This study was funded by the German Academic Exchange Service (DAAD). We are thankful to the residents of Driefontein Grassland IBA and their leadership for their cooperation during field work of this study. Comments from Carmen Paz Silva and an anonymous reviewer helped improve the quality of the manuscript.	Allan DG, 1997, BIOL CONSERV, V79, P173, DOI 10.1016/S0006-3207(96)00098-5; Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Beilfuss RD, 2007, OSTRICH, V78, P175, DOI 10.2989/OSTRICH.2007.78.2.11.91; Bento CM, 2007, OSTRICH, V78, P185, DOI 10.2989/OSTRICH.2007.78.2.12.92; Bibby C, 1998, EXPEDITION FIELD TEC; Buchanan GM, 2008, BIOL CONSERV, V141, P56, DOI 10.1016/j.biocon.2007.08.023; Childes S., 2001, IMPORTANT BIRD AREAS, P1025; Chirara C., 2011, J BIRDLIFE ZIMBABWE, V57, P10; Couto J. T., 2000, J BIRDLIFE ZIMBABWE, V46, P123; Fakarayi T, 2015, TROP CONSERV SCI, V8, P274, DOI 10.1177/194008291500800120; Giri C, 2005, CAN J REMOTE SENS, V31, P274, DOI 10.5589/m05-014; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harrison JA, 1997, ATLAS SO AFRICAN BIR, V1, P316; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Javed S., 2002, FIELD METHODS BIRD S; Maozeka F, 2000, P 12 S AFR CRAN WORK; McCann KI, 2006, OSTRICH, V77, P186, DOI 10.2989/00306520609485532; Meine C.D., 1996, CRANES STATUS SURVEY; milauer P, 2002, CANOCO REFERENCE MAN; Morrison KL, 1998, THESIS; Muheebwa JM, 2004, THESIS; Mundy P. J., 2001, J BIRDLIFE ZIMBABWE, V47, P129; Rockingham-Gill David V., 1996, P337	24	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166209	10.1371/journal.pone.0166209	http://dx.doi.org/10.1371/journal.pone.0166209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875552	Green Published, gold			2022-12-26	WOS:000388886000009
J	Roesel, K; Nockler, K; Baumann, MPO; Fries, R; Dione, MM; Clausen, PH; Grace, D				Roesel, Kristina; Noeckler, Karsten; Baumann, Maximilian P. O.; Fries, Reinhard; Dione, Michel M.; Clausen, Peter-Henning; Grace, Delia			First Report of the Occurrence of Trichinella-Specific Antibodies in Domestic Pigs in Central and Eastern Uganda	PLOS ONE			English	Article							CROCODILES CROCODYLUS-NILOTICUS; KRUGER-NATIONAL-PARK; WILD BOAR MEAT; SOUTH-AFRICA; WESTERN-BLOT; TRICHINOSIS; ZIMBABWENSIS; ANIMALS; SPP.; INFECTIONS	Previous research on trichinellosis in Africa focused on isolating Trichinella from wildlife while the role of domestic pigs has remained highly under-researched. Pig keeping in Uganda is historically recent, and evidence on zoonotic pig diseases, including infection with Trichinella species, is scarce. A cross-sectional survey on Trichinella seroprevalence in pigs was conducted in three districts in Central and Eastern Uganda from April 2013 to January 2015. Serum from a random sample of 1125 pigs from 22 villages in Eastern and Central Uganda was examined to detect immunoglobulin G (IgG) against any Trichinella spp. using a commercially available ELISA based on excretory-secretory antigen. ELISA positive samples were confirmed using Western Blot based on somatic antigen of Trichinella spiralis as recommended in previous validation studies. Diaphragm pillar muscle samples (at least 5 g each) of 499 pigs from areas with high ELISA positivity were examined using the artificial digestion method. Overall, 78 of all 1125 animals (6.9%, 95% CI: 5.6-8.6%) tested positive for antibodies against Trichinella spp. in the ELISA at significantly higher levels in Kamuli district compared to Masaka and Mukono districts. Thirty-one percent of the ELISA positive samples were confirmed IgG positive by the Western Blot leading to an overall seroprevalence of 2.1% (95% CI: 1.4-3.2%). The large proportion of ELISA positive samples that could not be confirmed using Western blot may be the result of cross-reactivity with other gastrointestinal helminth infections or unknown host-specific immune response mechanisms in local pig breeds in Uganda. Attempts to isolate muscle larvae for species determination using the artificial digestion method were unsuccessful. Due to the large number of muscle samples examined we are confident that even if pigs are infected, the larval burden in pork is too low to pose a major risk to consumers of developing trichinellosis. This was the first large systematic field investigation of Trichinella infection in domestic pigs in Uganda and its results imply that further studies are needed to identify the Trichinella species involved, and to identify potential sources of infection for humans.	[Roesel, Kristina; Clausen, Peter-Henning] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Dept Vet Med, Berlin, Germany; [Roesel, Kristina; Grace, Delia] Int Livestock Res Inst, Food Safety & Zoonoses Program, Nairobi, Kenya; [Noeckler, Karsten] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Baumann, Maximilian P. O.] Free Univ Berlin, FAO Reference Ctr Vet Publ Hlth, Dept Vet Med, Berlin, Germany; [Fries, Reinhard] Free Univ Berlin, Inst Meat Hyg, Dept Vet Med, Berlin, Germany; [Dione, Michel M.] Int Livestock Res Inst, Anim Sci Sustainable Prod Program, Kampala, Uganda; [Fries, Reinhard] Obernkirchen OT Krainhagen, Obernkirchen, Germany	Free University of Berlin; CGIAR; International Livestock Research Institute (ILRI); Federal Institute for Risk Assessment; Free University of Berlin; Free University of Berlin; CGIAR; International Livestock Research Institute (ILRI)	Roesel, K (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Dept Vet Med, Berlin, Germany.; Roesel, K (corresponding author), Int Livestock Res Inst, Food Safety & Zoonoses Program, Nairobi, Kenya.	k.roesel@cgiar.org		Wennert, Nadine/0000-0002-1948-0433; Grace, Delia/0000-0002-0195-9489; Roesel, Kristina/0000-0002-2553-1129; Dione, Michel/0000-0001-7812-5776	CGIAR Research Program on Agriculture for Nutrition and Health; Safe Food, Fair Food project - Federal Ministry for Economic Cooperation and Development, Germany [81141843]; CGIAR Research Program on Livestock and Fish through the Smallholder Pig Value Chains Development project in Uganda (International Fund for Agricultural Development European Commission) [COFIN-ECG-63-ILRI]	CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR); Safe Food, Fair Food project - Federal Ministry for Economic Cooperation and Development, Germany; CGIAR Research Program on Livestock and Fish through the Smallholder Pig Value Chains Development project in Uganda (International Fund for Agricultural Development European Commission)(CGIAR)	The field research was funded by the CGIAR Research Program on Agriculture for Nutrition and Health, led by the International Food Policy Research Institute (http://www.ifpri.org/division/agriculture-nutrition-and-health-a4nh), the Safe Food, Fair Food project funded by the Federal Ministry for Economic Cooperation and Development, Germany (grant no.: 81141843) in cooperation with the CGIAR Research Program on Livestock and Fish (https://livestockfish.cgiar.org/) through the Smallholder Pig Value Chains Development project in Uganda (funded by the International Fund for Agricultural Development European Commission, grant no. COFIN-ECG-63-ILRI). We also acknowledge the CGIAR Fund Donors (http://www.cgiar.org/who-we-are/cgiar-fund/fund-donors-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adediran O. A., 2015, Alexandria Journal of Veterinary Sciences, V47, P183, DOI 10.5455/ajvs.191632; Alonso S, 2016, ANIM HEALTH RES REV, V17, P28, DOI 10.1017/S1466252316000104; Blench R.M., 2000, ORIGINS DEV AFRICAN, P355; Bruschi F, 2012, J INFECT DEV COUNTR, V6, P216, DOI 10.3855/jidc.2478; Buholzer P., 2008, 111 M US AN HLTH ASS, P116; BURA MWT, 1977, E AFR MED J, V54, P185; Dione MM, 2014, PREV VET MED, V117, P565, DOI 10.1016/j.prevetmed.2014.10.012; Dupouy-Camet J., 2007, FAO WHO OIE GUIDELIN; Dupouy-Camet J., 2009, EUROSURVEILLANCE, V14, P14; Forbes LB, 1999, J FOOD PROTECT, V62, P1308, DOI 10.4315/0362-028X-62.11.1308; Frey CF, 2009, PARASITOL RES, V104, P1269, DOI 10.1007/s00436-008-1321-9; Frey CF, 2009, J VET DIAGN INVEST, V21, P692, DOI 10.1177/104063870902100516; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gomez-Morales MA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-171; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; International Organization for Migration (IOM), 2015, MIGR UG RAP COUNTR P; KAMINSKY RG, 1977, E AFR MED J, V54, P643; Kapel CMO, 2005, VET PARASITOL, V132, P101, DOI 10.1016/j.vetpar.2005.05.036; Kapel CMO, 2000, INT J PARASITOL, V30, P215, DOI 10.1016/S0020-7519(99)00202-7; KEFENIE H, 1992, TROP GEOGR MED, V44, P278; KEFENIE H, 1988, ETHIOPIAN MED J, V26, P97; La Grange LJ, 2013, J HELMINTHOL, V87, P91, DOI 10.1017/S0022149X12000089; La Grange LJ, 2010, J HELMINTHOL, V84, P35, DOI 10.1017/S0022149X09990241; La Grange LJ, 2014, ONDERSTEPOORT J VET, V81; La Grange LJ, 2009, VET PARASITOL, V161, P88, DOI 10.1016/j.vetpar.2008.12.015; Loutfy Naguiba F., 1999, Journal of the Egyptian Society of Parasitology, V29, P897; Marucci G, 2009, VET PARASITOL, V159, P225, DOI 10.1016/j.vetpar.2008.10.041; MCAULEY JB, 1991, J INFECT DIS, V164, P1013, DOI 10.1093/infdis/164.5.1013; MIKHAIL EM, 1994, J PARASITOL, V80, P151, DOI 10.2307/3283360; Momoh HA, 2013, TROP ANIM HEALTH PRO, V45, P1149, DOI 10.1007/s11250-012-0338-3; Morsy Tosson A., 2000, Journal of the Egyptian Society of Parasitology, V30, P753; Mukaratirwa S, 2013, ACTA TROP, V125, P82, DOI 10.1016/j.actatropica.2012.09.005; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Nakamura Tetsuya, 2003, Kansenshogaku Zasshi, V77, P839; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Nockler K, 2000, VET PARASITOL, V93, P335, DOI 10.1016/S0304-4017(00)00350-2; Nockler K, 2009, VET PARASITOL, V163, P341, DOI 10.1016/j.vetpar.2009.04.034; OIE, 2016, WORLD AN HLTH INF DA; OIE. Trichinellosis (infection with Trichinella spp.), 2012, OIE TERR MAN, P305; Ouma EA, 2014, LIVEST RES RURAL DEV; Permin A, 1999, VET PARASITOL, V87, P63, DOI 10.1016/S0304-4017(99)00159-4; Pozio E, 1997, J PARASITOL, V83, P1195, DOI 10.2307/3284388; Pozio E, 2005, INT J PARASITOL, V35, P955, DOI 10.1016/j.ijpara.2005.03.013; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Pozio E, 2007, VET PARASITOL, V143, P305, DOI 10.1016/j.vetpar.2006.08.029; Roesel K, 2014, 6 ALL AFR C AN AGR T, P166; Sayed A. S. M., 2010, Assiut Veterinary Medical Journal, V56, P280; [UBOS MAAIF], 2009, NAT LIV CENS REP 200; WCS, 2016, WILDL CONS SOC; YOUNG E, 1975, Journal of the South African Veterinary Association, V46, P233	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166258	10.1371/journal.pone.0166258	http://dx.doi.org/10.1371/journal.pone.0166258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870858	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400007
J	Cihlar, J; Fussy, Z; Horak, A; Obornik, M				Cihlar, Jaromir; Fussy, Zoltan; Horak, Ales; Obornik, Miroslav			Evolution of the Tetrapyrrole Biosynthetic Pathway in Secondary Algae: Conservation, Redundancy and Replacement	PLOS ONE			English	Article							DELTA-AMINOLEVULINIC-ACID; PLASTID EVOLUTION; EUGLENA-GRACILIS; GENE-TRANSFER; DIATOM ENDOSYMBIONTS; BIGELOWIELLA-NATANS; CHLOROPLAST GENOME; SEQUENCE ALIGNMENT; NUCLEAR GENOMES; PROTEIN IMPORT	Tetrapyrroles such as chlorophyll and heme are indispensable for life because they are involved in energy fixation and consumption, i.e. photosynthesis and oxidative phosphorylation. In eukaryotes, the tetrapyrrole biosynthetic pathway is shaped by past endosymbioses. We investigated the origins and predicted locations of the enzymes of the heme pathway in the chlorarachniophyte Bigelowiella natans, the cryptophyte Guillardia theta, the "green" dinoflagellate Lepidodinium chlorophorum, and three dinoflagellates with diatom endosymbionts ("dinotoms"): Durinskia baltica, Glenodinium foliaceum and Kryptoperidinium foliaceum. Bigelowiella natans appears to contain two separate heme pathways analogous to those found in Euglena gracilis; one is predicted to be mitochondrial-cytosolic, while the second is predicted to be plastid-located. In the remaining algae, only plastid-type tetrapyrrole synthesis is present, with a single remnant of the mitochondrial-cytosolic pathway, a ferrochelatase of G. theta putatively located in the mitochondrion. The green dinoflagellate contains a single pathway composed of mostly rhodophyte-origin enzymes, and the dinotoms hold two heme pathways of apparently plastidal origin. We suggest that heme pathway enzymes in B. natans and L. chlorophorum share a predominantly rhodophytic origin. This implies the ancient presence of a rhodophyte-derived plastid in the chlorarachniophyte alga, analogous to the green dinoflagellate, or an exceptionally massive horizontal gene transfer.	[Cihlar, Jaromir; Fussy, Zoltan; Horak, Ales; Obornik, Miroslav] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic; [Cihlar, Jaromir; Horak, Ales; Obornik, Miroslav] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Obornik, Miroslav] Acad Sci Czech Republic, Inst Microbiol, Trebon, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Obornik, M (corresponding author), Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic.; Obornik, M (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Obornik, M (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Trebon, Czech Republic.	obornik@paru.cas.cz	Füssy, Zoltán/A-6025-2013; Cihlář, Jan/P-6848-2017; Horak, Ales/H-6723-2012; Obornik, Miroslav/G-9350-2014	Füssy, Zoltán/0000-0002-0820-6359; Cihlář, Jan/0000-0002-6038-1226; Horak, Ales/0000-0002-3364-7383; 	Czech Science Foundation [GAP506/12/1522]; Czech Academy of Sciences	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	The Czech Science Foundation (GAP506/12/1522) and the Czech Academy of Sciences provided funding to MO and ZF. Computation resources were provided by CERIT-SC and MetaCentrum, Brno, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Archibald JM, 2015, P NATL ACAD SCI USA, V112, P10147, DOI 10.1073/pnas.1421374112; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Basak I, 2013, PLANTA, V237, P389, DOI 10.1007/s00425-012-1743-6; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bodyl A, 2009, TRENDS ECOL EVOL, V24, P119, DOI 10.1016/j.tree.2008.11.003; Brown MW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1755; Burki F, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2802; Burki F, 2014, EUKARYOT CELL, V13, P246, DOI 10.1128/EC.00299-13; Burki F, 2012, GENOME BIOL EVOL, V4, P738, DOI 10.1093/gbe/evs049; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Chesnick JM, 1996, J PHYCOL, V32, P850, DOI 10.1111/j.0022-3646.1996.00850.x; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; DODGE JD, 1983, BIOSYSTEMS, V16, P259, DOI 10.1016/0303-2647(83)90009-6; Doolittle WE, 1998, TRENDS GENET, V14, P307; Dorrell RG, 2011, EUKARYOT CELL, V10, P856, DOI 10.1128/EC.00326-10; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbrachter M, 1996, PHYCOLOGIA, V35, P381, DOI 10.2216/i0031-8884-35-5-381.1; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Felsner G, 2011, GENOME BIOL EVOL, V3, P140, DOI 10.1093/gbe/evq074; GILLOTT MA, 1980, J PHYCOL, V16, P558; Gilson PR, 1997, BIOESSAYS, V19, P167, DOI 10.1002/bies.950190212; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gould SB, 2015, CURR BIOL, V25, pR515, DOI 10.1016/j.cub.2015.04.033; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Hehenberger E, 2014, GENOME BIOL EVOL, V6, P2321, DOI 10.1093/gbe/evu182; Hirakawa Y, 2012, EUKARYOT CELL, V11, P324, DOI 10.1128/EC.05264-11; Hrda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033746; Huang S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00016; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iida K, 2002, EUR J BIOCHEM, V269, P291, DOI 10.1046/j.0014-2956.2001.02651.x; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Imanian B, 2014, GENOME BIOL EVOL, V6, P333, DOI 10.1093/gbe/evu014; Inagaki Y, 2000, INT J SYST EVOL MICR, V50, P2075, DOI 10.1099/00207713-50-6-2075; Ishida K, 2002, P NATL ACAD SCI USA, V99, P9294, DOI 10.1073/pnas.142091799; Janouskovec J, 2015, P NATL ACAD SCI USA, V112, P10200, DOI 10.1073/pnas.1423790112; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; JORDAN PM, 1994, CIBA F SYMP, V180, P70; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Koreny L, 2011, GENOME BIOL EVOL, V3, P359, DOI 10.1093/gbe/evr029; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Larkum AWD, 2007, TRENDS PLANT SCI, V12, P189, DOI 10.1016/j.tplants.2007.03.011; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MAIER UG, 1995, MOL GEN GENET, V246, P128, DOI 10.1007/BF00290141; Masuda T, 2003, PLANTA, V217, P602, DOI 10.1007/s00425-003-1019-2; MAYER SM, 1987, J BIOL CHEM, V262, P12541; MAYER SM, 1991, PLANT PHYSIOL, V97, P1094, DOI 10.1104/pp.97.3.1094; McFadden GI, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016105; Moreira D, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016014; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Petersen J, 2014, GENOME BIOL EVOL, V6, P666, DOI 10.1093/gbe/evu043; Pittis AA, 2016, NATURE, V531, P101, DOI 10.1038/nature16941; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Robledo JAF, 2011, INT J PARASITOL, V41, P1217, DOI 10.1016/j.ijpara.2011.07.008; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Sanchez-Puerta MV, 2008, J PHYCOL, V44, P1097, DOI 10.1111/j.1529-8817.2008.00559.x; Sevcikova T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10134; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr001, 10.1093/gbe/evr068]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6764; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Van de Peer Y, 2002, GENE, V295, P205, DOI 10.1016/S0378-1119(02)00689-3; Waller Ross F., 2016, Communicative & Integrative Biology, V9, pe1116653, DOI 10.1080/19420889.2015.1116653; WEINSTEIN JD, 1983, J BIOL CHEM, V258, P6799; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; Woo YH, 2015, ELIFE, V4, DOI 10.7554/eLife.06974; Yabuki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04641; Yamaguchi A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-29; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101158; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	94	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166338	10.1371/journal.pone.0166338	http://dx.doi.org/10.1371/journal.pone.0166338			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861576	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300048
J	Han, JH; Lee, YS; Im, YJ; Kim, SW; Lee, MJ; Han, SW				Han, Jang Hee; Lee, Yong Seung; Im, Young Jae; Kim, Sang Woon; Lee, Mi-Jung; Han, Sang Won			Clinical Implications of Obstructed Hemivagina and Ipsilateral Renal Anomaly (OHVIRA) Syndrome in the Prepubertal Age Group	PLOS ONE			English	Article							WERNER-WUNDERLICH-SYNDROME; MANAGEMENT; DIDELPHYS; DIAGNOSIS; AGENESIS; UTERUS	Purpose Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome is a rare syndrome characterized by Mullerian duct and renal anomalies. It is usually regarded as a disease of adolescence; however, due to a number of possible problems, the management of patients before puberty should not be overlooked. We assessed the clinical course of prepubertal patients to propose appropriate management. Materials and Methods We retrospectively assessed 43 prepubertal OHVIRA syndrome patients who were diagnosed and followed up at our institution from July 2004 to June 2015. We reviewed medical records, focusing on presentation, radiologic findings, surgical management, and the overall clinical course. Results Median age at diagnosis was 1.3 months and median follow-up period was 25.5 months. The most common accompanying ipsilateral urologic anomalies were ectopic ureter and ureterocele, while the most common contralateral anomaly was vesicoureteral reflux. During the follow-up period, six patients (14.0%) required surgery at a median age of 31.2 months due to recurrent urinary tract infection, uncontrolled vaginal distention compressing adjacent organs, urinary incontinence, or intractable abdominal pain. Conclusions While OHVIRA syndrome is known as a postpubertal disease, about 13% of prepubertal patients in our study required surgery. When ectopic ureter insertion into the vagina is present, further treatment may be needed to address the complications caused by continuous urine production. Patients should be monitored for complications arising from either obstructed hemivagina or renal anomalies with regular follow-up, especially before the age of five years.	[Han, Jang Hee; Lee, Yong Seung; Kim, Sang Woon; Han, Sang Won] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; [Han, Jang Hee; Lee, Yong Seung; Kim, Sang Woon; Han, Sang Won] Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea; [Im, Young Jae] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea; [Lee, Mi-Jung] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Han, SW (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.; Han, SW (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea.	swhan@yuhs.ac		Kim, Sang Woon/0000-0002-5790-1948; Han, Sang Won/0000-0003-0941-1300; Lee, Mi-Jung/0000-0003-3244-9171; Lee, Yong Seung/0000-0003-3778-9888				Angotti R, 2015, INT J SURG CASE REP, V11, P59, DOI 10.1016/j.ijscr.2015.04.027; Capito C, 2008, PEDIATRICS, V122, pE891, DOI 10.1542/peds.2008-0219; Carrico C, 1998, PEDIATR RADIOL, V28, P942, DOI 10.1007/s002470050506; Ceriotti F, 2008, CLIN CHEM, V54, P559, DOI 10.1373/clinchem.2007.099648; Falkner B, 2010, PEDIATR NEPHROL, V25, P1219, DOI 10.1007/s00467-009-1200-3; Gholoum S, 2006, J PEDIATR SURG, V41, P987, DOI 10.1016/j.jpedsurg.2006.01.021; GIDWANI GP, 1987, CLIN OBSTET GYNECOL, V30, P643, DOI 10.1097/00003081-198709000-00020; Han BH, 2013, J CLIN ULTRASOUND, V41, P380, DOI 10.1002/jcu.21950; Kiechl-Kohlendorfer U, 2011, PEDIATR RADIOL, V41, P1112, DOI 10.1007/s00247-011-2045-z; Lee YS, 2016, J PEDIATR SURG, V51, P469, DOI 10.1016/j.jpedsurg.2015.09.004; Mandava A, 2012, J PEDIATR ADOL GYNEC, V25, P23, DOI DOI 10.1016/J.JPAG.2011.11.004; Nassif Joseph, 2012, Surg Technol Int, V22, P173; PANSINI L, 1988, J PEDIATR SURG, V23, P984, DOI 10.1016/S0022-3468(88)80402-0; Roth M, 2010, J PEDIATR UROL, V6, P464, DOI 10.1016/j.jpurol.2009.12.009; Sanghvi Y, 2011, J PEDIATR SURG, V46, P1277, DOI 10.1016/j.jpedsurg.2011.02.067; Schlomer B, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2014.12.004; Smith NA, 2007, FERTIL STERIL, V87, P918, DOI 10.1016/j.fertnstert.2006.11.015; Tong JL, 2013, INT J GYNECOL OBSTET, V121, P173, DOI 10.1016/j.ijgo.2012.11.023; Ugurlucan FG, 2014, CLIN IMAG, V38, P357, DOI 10.1016/j.clinimag.2013.12.011; Vivier PH, 2011, PEDIATR RADIOL, V41, P1205, DOI 10.1007/s00247-011-2046-y; Wang ZJ, 2010, PEDIATR RADIOL, V40, P358, DOI 10.1007/s00247-009-1454-8; Wu TH, 2012, PEDIATR NEONATOL, V53, P68, DOI 10.1016/j.pedneo.2011.11.014	22	25	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166776	10.1371/journal.pone.0166776	http://dx.doi.org/10.1371/journal.pone.0166776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861623	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300106
J	Mlitz, V; Gendronneau, G; Berlin, I; Buchberger, M; Eckhart, L; Tschachler, E				Mlitz, Veronika; Gendronneau, Gaelle; Berlin, Irina; Buchberger, Maria; Eckhart, Leopold; Tschachler, Erwin			The Expression of the Endogenous mTORC1 Inhibitor Sestrin 2 Is Induced by UVB and Balanced with the Expression Level of Sestrin 1	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; AUTOPHAGIC DEGRADATION; MAMMALIAN TARGET; UP-REGULATION; SKIN; PATHWAY; ACTIVATION; INDUCTION; METABOLISM; LEUCINE	Sestrin 2 (SESN2) is an evolutionarily conserved regulator of mechanistic target of rapamycin complex 1 (mTORC1) which controls central cellular processes such as protein translation and autophagy. Previous studies have suggested that SESN2 itself is subjected to regulation at multiple levels. Here, we investigated the expression of SESN2 in the skin and in isolated skin cells. SESN2 was detected by immunofluorescence analysis in fibroblasts and keratinocytes of human skin. Differentiation of epidermal keratinocytes was not associated with altered SESN2 expression and siRNA-mediated knockdown of SESN2 did not impair stratum corneum formation in vitro. However, SESN2 was increased in both cell types when the expression of its paralog SESN1 was blocked by siRNA-mediated knock down, indicating a compensatory mechanism for the control of expression. Irradiation with UVB but not with UVA significantly increased SESN2 expression in both keratinocytes and fibroblasts. Upregulation of SESN2 expression could be completely blocked by suppression of p53. These results suggest that SESN2 is dispensable for normal epidermal keratinization but involved in the UVB stress response of skin cells.	[Mlitz, Veronika; Buchberger, Maria; Eckhart, Leopold; Tschachler, Erwin] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria; [Gendronneau, Gaelle; Berlin, Irina] Chanel R&T, Dept Biol & Women Beauty, Pantin, France	Medical University of Vienna	Eckhart, L; Tschachler, E (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria.	leopoldeckhart@meduniwien.ac.at; erwin.tschachler@meduniwien.ac.at		Eckhart, Leopold/0000-0002-5645-2036	Chanel R&T, Pantin, France	Chanel R&T, Pantin, France	This study was funded by a research grant from Chanel R&T, Pantin, France to the Department of Dermatology, Medical University of Vienna. The funder provided support in the form of salaries for authors (GG, IB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contribution" section.	Averous J, 2014, CELL SIGNAL, V26, P1918, DOI 10.1016/j.cellsig.2014.04.019; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Battie C, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12388; Benjamin CL, 2008, PHOTOCHEM PHOTOBIOL, V84, P55, DOI 10.1111/j.1751-1097.2007.00213.x; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Clark RAF, 2009, J INVEST DERMATOL, V129, P529, DOI 10.1038/jid.2008.441; Deng WB, 2016, J CLIN INVEST, V126, P2941, DOI 10.1172/JCI87715; Fogel AL, 2015, J AM ACAD DERMATOL, V72, P879, DOI 10.1016/j.jaad.2015.01.014; Garaeva AA, 2016, CELL CYCLE, V15, P64, DOI 10.1080/15384101.2015.1120929; GRANDO SA, 1993, J AM ACAD DERMATOL, V28, P981, DOI 10.1016/0190-9622(93)70141-F; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Ho A, 2016, TRENDS BIOCHEM SCI, V41, P621, DOI 10.1016/j.tibs.2016.04.005; Jager K, 2007, DIFFERENTIATION, V75, P939; Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081; Lee JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2885; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lee SH, 2012, CONSUM COMM NETWORK, P1, DOI 10.1109/CCNC.2012.6181052; Leo MS, 2014, ARCH DERMATOL RES, V306, P861, DOI 10.1007/s00403-014-1480-8; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Mildner M, 2007, J INVEST DERMATOL, V127, P2637, DOI 10.1038/sj.jid.5700938; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Nishisgori C, 2015, PHOTOCH PHOTOBIO SCI, V14, P1713, DOI 10.1039/c5pp00185d; Parmigiani A, 2016, INT REV CEL MOL BIO, V327, P1, DOI 10.1016/bs.ircmb.2016.05.003; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Rhee SG, 2015, FREE RADICAL BIO MED, V88, P205, DOI 10.1016/j.freeradbiomed.2015.06.007; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Saveljeva S, 2016, ONCOTARGET, V7, P12254, DOI 10.18632/oncotarget.7601; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Scholzen T, 1998, EXP DERMATOL, V7, P81, DOI 10.1111/j.1600-0625.1998.tb00307.x; Shin BY, 2012, FREE RADICAL BIO MED, V53, P834, DOI 10.1016/j.freeradbiomed.2012.06.026; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Syed F, 2013, J INVEST DERMATOL, V133, P1340, DOI 10.1038/jid.2012.483; Tzaneva S, 2001, J AM ACAD DERMATOL, V45, P503, DOI 10.1067/mjd.2001.114743; Vahidnezhad H, 2016, J INVEST DERMATOL, V136, P15, DOI 10.1038/JID.2015.331; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yang Y., 2013, INT J ADV MANUF TECH, V2013, P1, DOI [DOI 10.1007/S00170-013-5017-7, DOI 10.1155/2013/257487]; Zhang XY, 2013, CELL SIGNAL, V25, P150, DOI 10.1016/j.cellsig.2012.09.004; Zhao BZ, 2017, PHOTOCHEM PHOTOBIOL, V93, P375, DOI 10.1111/php.12624; Zhao BZ, 2014, J BIOL CHEM, V289, P35806, DOI 10.1074/jbc.M114.595397; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26	53	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166832	10.1371/journal.pone.0166832	http://dx.doi.org/10.1371/journal.pone.0166832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861561	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300119
J	Tan, WC; Hague, CJ; Leipsic, J; Bourbeau, J; Zheng, LY; Li, PZ; Sin, DD; Coxson, HO; Kirby, M; Hogg, JC; Raju, R; Road, J; O'Donnell, DE; Maltais, F; Hernandez, P; Cowie, R; Chapman, KR; Marciniuk, DD; FitzGerald, JM; Aaron, SD				Tan, Wan C.; Hague, Cameron J.; Leipsic, Jonathon; Bourbeau, Jean; Zheng, Liyun; Li, Pei Z.; Sin, Don D.; Coxson, Harvey O.; Kirby, Miranda; Hogg, James C.; Raju, Rekha; Road, Jeremy; O'Donnell, Denis E.; Maltais, Francois; Hernandez, Paul; Cowie, Robert; Chapman, Kenneth R.; Marciniuk, Darcy D.; FitzGerald, J. Mark; Aaron, Shawn D.		Canadian Resp Res Network; CanCOLD Collaborative Res Grp	Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study	PLOS ONE			English	Article							SMALL-AIRWAY OBSTRUCTION; QUALITY-OF-LIFE; LUNG-DISEASE; FLEISCHNER-SOCIETY; ECLIPSE COHORT; COPD; SMOKERS; PHENOTYPES; EMPHYSEMA; SYMPTOMS	Background Thoracic computed tomography (CT) scans are widely performed in clinical practice, often leading to detection of airway or parenchymal abnormalities in asymptomatic or minimally symptomatic individuals. However, clinical relevance of CT abnormalities is uncertain in the general population. Methods We evaluated data from 1361 participants aged >= 40 years from a Canadian prospective cohort comprising 408 healthy never-smokers, 502 healthy ever-smokers, and 451 individuals with spirometric evidence of chronic obstructive pulmonary disease (COPD) who had thoracic CT scans. CT images of subjects were visually scored for respiratory bronchiolitis (RB), emphysema(E), bronchial-wall thickening(BWT), expiratory air-trapping(AT), and bronchiectasis(B). Multivariable logistic regression models were used to assess associations of CT features with respiratory symptoms, dyspnea, health status as determined by COPD assessment test, and risk of clinically significant exacerbations during 12 months follow-up. Results About 11% of life-time never-smokers demonstrated emphysema on CT scans. Prevalence increased to 30% among smokers with normal lung function and 36%, 50%, and 57% among individuals with mild, moderate or severe/very severe COPD, respectively. Presence of emphysema on CT was associated with chronic cough (OR,2.11; 95%CI,1.4-3.18); chronic phlegm production (OR,1.87; 95%CI,1.27-2.76); wheeze (OR,1.61; 95%CI,1.05-2.48); dyspnoea (OR,2.90; 95% CI,1.41-5.98); CAT score >= 10(OR,2.17; 95%CI,1.42-3.30) and risk of >= 2 exacerbations over 12 months (OR,2.17; 95% CI, 1.42-3.0). Conclusions Burden of thoracic CT abnormalities is high among Canadians >= 40 years of age, including never-smokers and smokers with normal lung function. Detection of emphysema on CT scans is associated with pulmonary symptoms and increased risk of exacerbations, independent of smoking or lung function.	[Tan, Wan C.; Zheng, Liyun; Sin, Don D.; Coxson, Harvey O.; Kirby, Miranda; Hogg, James C.] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Hague, Cameron J.; Leipsic, Jonathon; Raju, Rekha] Univ British Columbia, St Pauls Hosp, Dept Radiol, Vancouver, BC, Canada; [Bourbeau, Jean; Li, Pei Z.] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Road, Jeremy; FitzGerald, J. Mark] Univ British Columbia, Vancouver Gen Hosp, Inst Heart & Lung Hlth, Vancouver, BC, Canada; [O'Donnell, Denis E.] Queens Univ, Div Resp & Crit Care Med, Kingston, ON, Canada; [Maltais, Francois] Univ Laval, Hosp Laval, Ctr Pneumol, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Hernandez, Paul] Dalhousie Univ, Div Respirol, QEII Hlth Sci Ctr, Halifax, NS, Canada; [Cowie, Robert] Univ Calgary, Dept Med, Calgary, AB, Canada; [Cowie, Robert] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Chapman, Kenneth R.] Univ Hlth Network, Asthma & Airway Ctr, Toronto, ON, Canada; [Marciniuk, Darcy D.] Univ Saskatchewan, Div Respirol Crit Care & Sleep Med, Saskatoon, SK, Canada; [Marciniuk, Darcy D.] Univ Saskatchewan, Airway Res Grp, Saskatoon, SK, Canada; [Aaron, Shawn D.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University; University of British Columbia; Queens University - Canada; Laval University; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Calgary; University of Calgary; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Saskatchewan; University of Saskatchewan; University of Ottawa; Ottawa Hospital Research Institute	Tan, WC (corresponding author), Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada.	wan.tan@hli.ubc.ca	Leipsic, Jonathon/ABE-6194-2020; Coxson, Harvey O/A-9861-2017; Kirby, Miranda/P-4690-2017; Sin, Don/AAC-2219-2021	Coxson, Harvey O/0000-0001-5750-9711; Sadatsafavi, Mohsen/0000-0002-0419-7862; Aaron, Shawn/0000-0002-4762-3542	Canadian Respiratory Research Network (CRRN); Astra Zeneca Canada Ltd; Boehringer Ingelheim Canada Ltd; GlaxoSmithKline Canada Ltd; Novartis; Forest; Amgen; Roche; CSL Behring; Grifolds; Genentech; Kamada; Merck; Novartis Pharma Canada Inc	Canadian Respiratory Research Network (CRRN); Astra Zeneca Canada Ltd(AstraZeneca); Boehringer Ingelheim Canada Ltd(Boehringer Ingelheim); GlaxoSmithKline Canada Ltd; Novartis(Novartis); Forest; Amgen(Amgen); Roche(Roche Holding); CSL Behring; Grifolds; Genentech(Roche HoldingGenentech); Kamada; Merck(Merck & Company); Novartis Pharma Canada Inc	The Canadian Cohort Obstructive Lung Disease (CanCOLD) study is currently funded by the Canadian Respiratory Research Network (CRRN); and industry partners Astra Zeneca Canada Ltd, Boehringer Ingelheim Canada Ltd, GlaxoSmithKline Canada Ltd, and Novartis. The project is led by researchers at RI-MUHC Montreal and the UBC Center for Heart Lung Innovation, Vancouver. Previous funding partners were CIHR (CIHR/Rx&D Collaborative Research Program Operating Grants- 93326), the Respiratory Health Network of the FRSQ; and industry partners Almirall, Merck, Nycomed, Pfizer Canada Ltd, and Theratechnologies. Other related funders include Forest, Amgen, Roche, CSL Behring, Grifolds, Genentech, Kamada, Merck, and Novartis Pharma Canada Inc. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bourbeau J, 2012, COPD, DOI 10.3109/15412555.2012.665520; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Coxson HO, 2014, AM J RESP CRIT CARE, V190, P135, DOI 10.1164/rccm.201402-0256PP; Gietema HA, 2013, RESP MED, V107, P1201, DOI 10.1016/j.rmed.2013.04.016; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Grenier P, 1996, EUR RADIOL, V6, P199; Hague CJ, 2014, J THORAC IMAG, V29, P350, DOI 10.1097/RTI.0000000000000118; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hoesein FAAM, 2014, RESP MED, V108, P136, DOI 10.1016/j.rmed.2013.08.014; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kitaguchi Y, 2006, RESP MED, V100, P1742, DOI 10.1016/j.rmed.2006.02.003; Labonte LE, 2016, AM J RESP CRIT CARE, V194, P285, DOI 10.1164/rccm.201509-1795OC; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; MACKLEM PT, 1967, ARCH ENVIRON HEALTH, V14, P5, DOI 10.1080/00039896.1967.10664685; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; McAllister DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093221; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Sayiner A, 2013, RESP MED, V107, P732, DOI 10.1016/j.rmed.2012.12.023; Sorlie P, 2011, J AM COLL CARDIOL, V58, P2010, DOI 10.1016/j.jacc.2011.08.020; Tan WC, 2014, THORAX, V69, P709, DOI 10.1136/thoraxjnl-2013-205048; Tan WC, 2011, INT J TUBERC LUNG D, V15, P1691, DOI 10.5588/ijtld.11.0211; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vestbo J, 2014, CLIN CHEST MED, V35, P1, DOI 10.1016/j.ccm.2013.10.010; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Xu W, 2010, EUR RESPIR J, V35, P1022, DOI 10.1183/09031936.00079409	34	39	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166745	10.1371/journal.pone.0166745	http://dx.doi.org/10.1371/journal.pone.0166745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861566	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300098
J	Katsiougiannis, S; Chia, D; Kim, Y; Singh, RP; Wong, DTW				Katsiougiannis, Stergios; Chia, David; Kim, Yong; Singh, Ram P.; Wong, David T. W.			Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity	FASEB JOURNAL			English	Article						extracellular vesicles; immune surveillance; cancer	NATURAL-KILLER-CELL; EXTRACELLULAR VESICLES; CANCER EXOSOMES; EMERGING ROLE; MARKERS; BIOMARKERS; INNATE	Tumor exosomes are emerging as antitumor immunity regulators; however, their effects on secondary exosome secretion by distal organs have not been explored. We have previously demonstrated that suppression of exosomes at the distal tumor site of pancreatic ductal adenocarcinoma (PDAC) ablated the development of salivary biomarker profile. Here, we explore the function of salivary exosomes from tumor-bearing mice in immune surveillance. We provide evidence that salivary exosomes from mice with PDA Cexhibit a suppressive effect that results in reduced tumor-killing capacity by NK cells. Salivary exosomes from mice with PDAC where pancreatic tumors were engineered to suppress exosome biogenesis failed to suppress NK cell cytotoxic potential against tumor cells, as opposed to salivary exosomes from mice with PDAC with normal tumor exosome biogenesis. These results reveal an important and previously unknown mechanism of antitumor immune regulation and provide new in sights into our understanding of the alterations of this biofluid during tumor development.	[Katsiougiannis, Stergios; Kim, Yong; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Ctr Oral Head & Neck Oncol Res, 10833 Le Conte Ave,Box 951668, Los Angeles, CA 90024 USA; [Chia, David; Kim, Yong; Wong, David T. W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Kim, Yong] Univ Calif Los Angeles, Lab Stem Cell & Canc Epigenet Res, Los Angeles, CA USA; [Chia, David] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Singh, Ram P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Singh, Ram P.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Wong, DTW (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Oral Head & Neck Oncol Res, 10833 Le Conte Ave,Box 951668, Los Angeles, CA 90024 USA.	dwong@dentistry.ucla.edu	Katsiougiannis, Stergios/ABB-8564-2020	Singh, Ram/0000-0002-3203-4454	NCATS NIH HHS [UH2 TR000923, UH3 TR000923] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000923, UH2TR000923] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		An TX, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27522; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Humeau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130996; Jakobsen KR, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26659; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lau C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/jbc.M113.452458; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Navarro AG, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00202; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PROSS HF, 1993, NAT IMMUN, V12, P279; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Wong DTW, 2015, CLIN THER, V37, P540, DOI 10.1016/j.clinthera.2015.02.017; Yang JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110641; Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573	29	48	54	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					998	+		10.1096/fj.201600984R	http://dx.doi.org/10.1096/fj.201600984R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895106	Green Published			2022-12-26	WOS:000395671200016
J	Snyder, AJ; Danthi, P				Snyder, Anthony J.; Danthi, Pranav			Lipids Cooperate with the Reovirus Membrane Penetration Peptide to Facilitate Particle Uncoating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE SUBVIRAL PARTICLES; REVERSE GENETICS SYSTEM; CAPSID PROTEIN MU-1; MAMMALIAN REOVIRUSES; L-CELLS; PERSISTENT INFECTIONS; IMAGE-RECONSTRUCTION; IN-VITRO; ELECTRON CRYOMICROSCOPY; PUTATIVE AUTOCLEAVAGE	Virus-host interactions play a role in many stages of the viral lifecycle, including entry. Reovirus, a model system for studying the entry mechanisms of nonenveloped viruses, undergoes a series of regulated structural transitions that culminate in delivery of the viral genetic material. Lipids can trigger one of these conformational changes, infectious subviral particle (ISVP)-to-ISVP* conversion. ISVP* formation releases two virally encoded peptides, myristoylated mu 1N (myr-mu 1N) and Phi. Among these, myr-mu 1N is sufficient to form pores within membranes. Released myr-mu 1N can also promote ISVP* formation in trans. Using thermal inactivation as a readout for ISVP-to-ISVP* conversion, we demonstrate that lipids render ISVPs less thermostable in a virus concentration-dependent manner. Under conditions in which neither lipids alone nor myr-mu 1N alone promotes ISVP-to-ISVP* conversion, myr-mu 1N induces particle uncoating when lipids are present. These data suggest that the pore-forming activity and the ISVP*-promoting activity of myr-mu 1N are linked. Lipid-associated myr-mu 1N interacts with ISVPs and triggers efficient ISVP* formation. The cooperativity between a reovirus component and lipids reveals a distinct virus-host interaction in which membranes can facilitate nonenveloped virus entry.	[Snyder, Anthony J.; Danthi, Pranav] Indiana Univ, Dept Biol, Simon Hall MSB1,212 South Hawthorne Dr, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Danthi, P (corresponding author), Indiana Univ, Dept Biol, Simon Hall MSB1,212 South Hawthorne Dr, Bloomington, IN 47405 USA.	pdanthi@indiana.edu	Danthi, Pranav/H-6330-2019	Danthi, Pranav/0000-0001-6199-6022	NIAID, National Institutes of Health [1R01AI110637]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110637] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant 1R01AI110637 (to P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agosto MA, 2008, P NATL ACAD SCI USA, V105, P10571, DOI 10.1073/pnas.0802039105; Agosto MA, 2007, J VIROL, V81, P7400, DOI 10.1128/JVI.02720-06; Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; AMERONGEN HM, 1994, J VIROL, V68, P8428, DOI 10.1128/JVI.68.12.8428-8432.1994; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Baer GS, 1997, J VIROL, V71, P4921, DOI 10.1128/JVI.71.7.4921-4928.1997; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; BASS DM, 1990, J VIROL, V64, P1830, DOI 10.1128/JVI.64.4.1830-1833.1990; BODKIN DK, 1989, J VIROL, V63, P4676, DOI 10.1128/JVI.63.11.4676-4681.1989; BORSA J, 1973, J VIROL, V11, P207, DOI 10.1128/JVI.11.2.207-217.1973; BORSA J, 1974, INTERVIROLOGY, V4, P171; BORSA J, 1974, INTERVIROLOGY, V3, P15, DOI 10.1159/000149739; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1973, J VIROL, V11, P552, DOI 10.1128/JVI.11.4.552-564.1973; BORSA J, 1976, BIOCHIM BIOPHYS ACTA, V451, P619, DOI 10.1016/0304-4165(76)90157-4; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Dermody T.S., 2013, FIELDS VIROLOGY, P1304; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GENTSCH JR, 1987, VIROLOGY, V161, P245, DOI 10.1016/0042-6822(87)90192-9; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; JOKLIK WK, 1972, VIROLOGY, V49, P700, DOI 10.1016/0042-6822(72)90527-2; Kielian M, 2014, ANNU REV VIROL, V1, P171, DOI 10.1146/annurev-virology-031413-085521; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; LI QH, 1994, J VIROL, V68, P3965, DOI 10.1128/JVI.68.6.3965-3970.1994; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Luisoni S, 2015, CELL HOST MICROBE, V18, P75, DOI 10.1016/j.chom.2015.06.006; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Middleton JK, 2002, J VIROL, V76, P1051, DOI 10.1128/JVI.76.3.1051-1061.2002; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; Nygaard RM, 2012, J VIROL, V86, P1238, DOI 10.1128/JVI.06429-11; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Patel A, 2016, J BIOL CHEM, V291, P12408, DOI 10.1074/jbc.M115.700856; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; Pollard EC., 1953, PHYSICS VIRUSES, P103, DOI [10.5962/bhl.title.10187, DOI 10.5962/BHL.TITLE.10187]; Sarkar P, 2010, J VIROL, V84, P12723, DOI 10.1128/JVI.01385-10; SILVERSTEIN SC, 1972, VIROLOGY, V47, P797, DOI 10.1016/0042-6822(72)90571-5; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; Snyder AJ, 2016, J VIROL, V90, P2628, DOI 10.1128/JVI.02997-15; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Wetzel JD, 1997, J VIROL, V71, P299, DOI 10.1128/JVI.71.1.299-306.1997; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zhang L, 2009, J VIROL, V83, P7004, DOI 10.1128/JVI.00377-09; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	63	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26773	26785		10.1074/jbc.M116.747477	http://dx.doi.org/10.1074/jbc.M116.747477			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875299	Green Published, hybrid			2022-12-26	WOS:000391571400016
J	Dai, L; Sun, CX; Wang, D; Gao, YX				Dai, Lei; Sun, Cuixia; Wang, Di; Gao, Yanxiang			The Interaction between Zein and Lecithin in Ethanol-Water Solution and Characterization of Zein-Lecithin Composite Colloidal Nanoparticles	PLOS ONE			English	Article							MORPHOLOGICAL-CHARACTERISTICS; ANTISOLVENT PRECIPITATION; PICKERING EMULSION; PROTEIN; FLUORESCENCE; STABILITY; COMPLEX; PH; PHOSPHOLIPIDS; LACTOGLOBULIN	Lecithin, a naturally small molecular surfactant, which is widely used in the food industry, can delay aging, enhance memory, prevent and treat diabetes. The interaction between zein and soy lecithin with different mass ratios (20:1, 10:1, 5:1, 3:1, 2:1, 1:1 and 1:2) in ethanol- water solution and characterisation of zein and lecithin composite colloidal nanoparticles prepared by antisolvent co-precipitation method were investigated. The mean size of zein-lecithin composite colloidal nanoparticles was firstly increased with the rise of lecithin concentration and then siginificantly decreased. The nanoparticles at the zein to lecithin mass ratio of 5: 1 had the largest particle size (263 nm), indicating that zein and lecithin formed composite colloidal nanoparticles, which might aggregate due to the enhanced interaction at a higher proportion of lecithin. Continuing to increase lecithin concentration, the zein-lecithin nanoparticles possibly formed a reverse micelle-like or a vesicle-like structure with zein in the core, which prevented the formation of nanoparticle aggregates and decreased the size of composite nanoparticles. The presence of lecithin significantly reduced the.-potential of zein-lecithin composite colloidal nanoparticles. The interaction between zein and lecithin enhanced the intensity of the fluorescence emission of zein in ethanol-water solution. The secondary structure of zein was also changed by the addition of lecithin. Differential scanning calorimetry thermograms revealed that the thermal stability of zein-lecithin nanoparticles was enhanced with the rise of lecithin level. The composite nanoparticles were relatively stable to elevated ionic strengths. Possible interaction mechanism between zein and lecithin was proposed. These findings would help further understand the theory of the interaction between the alcohol soluble protein and the natural small molecular surfactant. The composite colloidal nanoparticles formed in this study can broaden the application of zein and be suitable for incorporating water-insoluble bioactive components in functional food and beverage products.	[Dai, Lei; Sun, Cuixia; Wang, Di; Gao, Yanxiang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing Key Lab Funct Food Plant Resources, Coll Food Sci & Nutr Engn,Beijing Lab Food Qual &, Beijing, Peoples R China	China Agricultural University	Gao, YX (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing Key Lab Funct Food Plant Resources, Coll Food Sci & Nutr Engn,Beijing Lab Food Qual &, Beijing, Peoples R China.	gyxcau@126.com	Gao, Y./GWZ-3665-2022; Gao, Yu/HGE-1937-2022; Dai, Lei/HCH-4898-2022; gao, yi/HCI-8298-2022	Dai, Lei/0000-0002-9491-6567; 	National Natural Science Foundation of China [31371835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by the National Natural Science Foundation of China (No.31371835).	Alcantara ACS, 2010, J MAT CHEM, V20; Chen JJ, 2014, FOOD CHEM, V158, P466, DOI 10.1016/j.foodchem.2014.03.003; Comas DI, 2006, FOOD HYDROCOLLOID, V20, P990, DOI 10.1016/j.foodhyd.2005.11.006; Gao ZM, 2014, J AGR FOOD CHEM, V62, P2672, DOI 10.1021/jf500005y; Hu DD, 2012, J FOOD ENG, V109, P545, DOI 10.1016/j.jfoodeng.2011.10.025; Hu K, 2015, FOOD HYDROCOLLOID, V44, P101, DOI 10.1016/j.foodhyd.2014.09.015; Hu K, 2014, FOOD RES INT, V64, P329, DOI 10.1016/j.foodres.2014.07.004; Joye IJ, 2015, FOOD CHEM, V185, P261, DOI 10.1016/j.foodchem.2015.03.128; Kongsawat P., 2011, Proceedings of the 49th Kasetsart University Annual Conference, Kasetsart University, Thailand, 1-4 February, 2011. Volume 7. Subject: Agro-Industry, P406; Li JF, 2014, FOOD SCI BIOTECHNOL, V23, P1785, DOI 10.1007/s10068-014-0244-8; Luo YC, 2011, COLLOID SURFACE B, V85, P145, DOI 10.1016/j.colsurfb.2011.02.020; Maikokera R, 2007, COLLOID SURFACE B, V55, P173, DOI 10.1016/j.colsurfb.2006.11.029; Mantovani RA, 2016, FOOD HYDROCOLLOID, V60, P288, DOI 10.1016/j.foodhyd.2016.03.039; Mc Clements D.J., 2005, FOOD EMULSIONS PRINC, P269; Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p; Patel A, 2010, SOFT MATTER, V6, P6192, DOI 10.1039/c0sm00800a; Patel AR, 2012, FOOD CHEM, V133, P423, DOI 10.1016/j.foodchem.2012.01.054; Patel AR, 2010, J AGR FOOD CHEM, V58, P12497, DOI 10.1021/jf102959b; Podaralla S, 2012, AAPS PHARMSCITECH, V13, P919, DOI 10.1208/s12249-012-9816-1; Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9; Sun CX, 2016, INNOV FOOD SCI EMERG, V34, P161, DOI 10.1016/j.ifset.2016.01.016; Sun CX, 2016, FOOD HYDROCOLLOID, V58, P11, DOI 10.1016/j.foodhyd.2016.02.014; Sun CX, 2015, IND CROP PROD, V77, P476, DOI 10.1016/j.indcrop.2015.09.028; Surh J, 2008, J FOOD ENG, V89, P164, DOI 10.1016/j.jfoodeng.2008.04.023; van Nieuwenhuyzen W, 1998, FETT-LIPID, V100, P282; Wang Q., 2014, J APPL POLYM SCI, V131, P12; Wang XG, 2014, CARBOHYD POLYM, V101, P1027, DOI 10.1016/j.carbpol.2013.10.042; Wang YH, 2016, FOOD HYDROCOLLOID, V54, P40, DOI 10.1016/j.foodhyd.2015.09.020; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xue J, 2014, J AGR FOOD CHEM, V62, P2956, DOI 10.1021/jf405828s; Yin HY, 2015, INT J BIOL MACROMOL, V72, P480, DOI 10.1016/j.ijbiomac.2014.08.025; Yong YH, 2004, J AGR FOOD CHEM, V52, P7094, DOI 10.1021/jf040133u; Zhang Y, 2003, COLLOID SURFACE A, V223, P11, DOI 10.1016/S0927-7757(03)00099-2; Zhou CP, 2012, J PEPT SCI, V18, P541, DOI 10.1002/psc.2423; Zou LQ, 2016, FOOD RES INT, V81, P74, DOI 10.1016/j.foodres.2015.12.035; Zou Y, 2015, J AGR FOOD CHEM, V63, P7405, DOI 10.1021/acs.jafc.5b03113	36	62	68	14	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167172	10.1371/journal.pone.0167172	http://dx.doi.org/10.1371/journal.pone.0167172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893802	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400094
J	Stephens, ZD; Hudson, ME; Mainzer, LS; Taschuk, M; Weber, MR; Iyer, RK				Stephens, Zachary D.; Hudson, Matthew E.; Mainzer, Liudmila S.; Taschuk, Morgan; Weber, Matthew R.; Iyer, Ravishankar K.			Simulating Next-Generation Sequencing Datasets from Empirical Mutation and Sequencing Models	PLOS ONE			English	Article							GENOMES; DNA	An obstacle to validating and benchmarking methods for genome analysis is that there are few reference datasets available for which the "ground truth" about the mutational landscape of the sample genome is known and fully validated. Additionally, the free and public availability of real human genome datasets is incompatible with the preservation of donor privacy. In order to better analyze and understand genomic data, we need test datasets that model all variants, reflecting known biology as well as sequencing artifacts. Read simulators can fulfill this requirement, but are often criticized for limited resemblance to true data and overall inflexibility. We present NEAT (NExt-generation sequencing Analysis Toolkit), a set of tools that not only includes an easy-to-use read simulator, but also scripts to facilitate variant comparison and tool evaluation. NEAT has a wide variety of tunable parameters which can be set manually on the default model or parameterized using real datasets.	[Stephens, Zachary D.; Iyer, Ravishankar K.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Hudson, Matthew E.; Mainzer, Liudmila S.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Mainzer, Liudmila S.; Weber, Matthew R.] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL USA; [Taschuk, Morgan] Ontario Inst Canc Res, Toronto, ON, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Stephens, ZD (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.	zstephe2@illinois.edu	Hudson, Matthew E/A-4438-2008; Taschuk, Morgan/H-9348-2019	Hudson, Matthew E/0000-0002-4737-0936; Taschuk, Morgan/0000-0003-0677-6902	NSF [MRI13-37732]	NSF(National Science Foundation (NSF))	ZS and RI were supported by NSF grant MRI13-37732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andrews S, 2011, FASTQC QUALITY CONTR; [Anonymous], DAT SINGL NUCL POL D; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brinda K, 2016, BIOINFORMATICS, V32, P136, DOI 10.1093/bioinformatics/btv524; Caboche S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-264; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gaffney DJ, 2005, GENOME RES, V15, P1086, DOI 10.1101/gr.3895005; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holtgrewe M, 2010, MASON READ SIMULATOR; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Isidore E, 2005, GENOME RES, V15, P526, DOI 10.1101/gr.3131005; Kim S, 2013, BIOINFORMATICS, V29, P1076, DOI 10.1093/bioinformatics/btt074; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Mu JC, 2015, BIOINFORMATICS, V31, P1469, DOI 10.1093/bioinformatics/btu828; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pattnaik S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-40; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Premachandran M. N., 2011, Journal of Sugarcane Research, V1, P1; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167047	10.1371/journal.pone.0167047	http://dx.doi.org/10.1371/journal.pone.0167047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893777	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400075
J	Iafrate, JD; Watwood, SL; Reyier, EA; Scheidt, DM; Dossot, GA; Crocker, SE				Iafrate, Joseph D.; Watwood, Stephanie L.; Reyier, Eric A.; Scheidt, Douglas M.; Dossot, Georges A.; Crocker, Steven E.			Effects of Pile Driving on the Residency and Movement of Tagged Reef Fish	PLOS ONE			English	Article							GROWTH; SOUND; NOISE; COAST; AGE	The potential effects of pile driving on fish populations and commercial fisheries have received significant attention given the prevalence of pile driving occurring in coastal habitats throughout the world. Behavioral impacts of sound generated from these activities on fish typically have a greater area of influence than physical injury, and may therefore adversely affect a greater portion of the local population. This study used acoustic telemetry to assess the movement, residency, and survival of 15 sheepshead (Archosargus probatocephalus) and 10 grey snapper (Lutjanus griseus) in Port Canaveral, Florida, USA, in response to 35 days of pile driving at a wharf complex. No obvious signs of mortality or injury to tagged fish were evident from the data. Received sound pressure levels from pile strikes on the interior of the wharf, where reef fish primarily occur, were on average 152 -157 dB re 1 mu Pa (peak). No significant decrease in sheepshead daytime residency was observed during pile driving within the central portion of the wharf and area of highest sound exposure, and no major indicators of displacement from the exposure wharf with the onset of pile driving were observed. There was evidence of potential displacement from the exposure wharf that coincided with the start of pile driving observed for 2 out of 4 grey snapper, along with a decrease in daytime residency for a subset of this species with high site fidelity prior to the event. Results indicate that snapper may be more likely to depart an area of pile driving disturbance more readily than sheepshead, but were less at risk for behavioral impact given the lower site fidelity of this species.	[Iafrate, Joseph D.; Watwood, Stephanie L.; Dossot, Georges A.; Crocker, Steven E.] Naval Undersea Warfare Ctr Div, Newport, RI 02841 USA; [Reyier, Eric A.; Scheidt, Douglas M.] Kennedy Space Ctr Ecol Program, Kennedy Space Ctr, FL USA; [Reyier, Eric A.; Scheidt, Douglas M.] Integrated Miss Support Serv, Kennedy Space Ctr, FL USA		Iafrate, JD (corresponding author), Naval Undersea Warfare Ctr Div, Newport, RI 02841 USA.	joseph.iafrate@navy.mil	Watwood, Stephanie/AAE-7191-2019		United States Fleet Forces Command [N46, N4657911PO005NR]	United States Fleet Forces Command	Funding was provided by United States Fleet Forces Command N46, Funding Document N4657911PO005NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study was provided by the United States Fleet Forces Command (USFF). We would like to thank the Kennedy Space Center Ecological Program, Naval Ordnance Test Unit at Port Canaveral, Jane Provancha from InoMedic Health Applications, Don George and Angy Chambers at Air Force 45th Space Wing Natural Assets Office, and Dave Mac Duffee at USFF for key logistical support of the study. We would also like to thank Carla Bourtis, Russell Lowers, Karen Holloway-Adkins, and Colin Lazauski for field support that made the project possible. Thank you to Nord Lange, BertNeales, and Matthew Gilchrest for assistance with acoustical analyses. The Florida Atlantic Coast Telemetry Array community, and specifically Florida Fish and Wildlife Conservation Commission, provided fish detection data at sites outside of Port Canaveral. Finally, Canaveral Port Authority contributed receivers for the West Basin in Port Canaveral. Thanks to Jessica Kutcher, Brandon Casper, and two anonymous reviewers for constructive comments on the manuscript.	Burton ML, 2001, FISH B-NOAA, V99, P254; Caltrans, 2009, TECHN GUID ASS MIT H; DIJKGRAAF S, 1952, Z VERGL PHYSIOL, V34, P104; Dutka-Gianelli J, 2001, B MAR SCI, V68, P69; Everley KA, 2016, ADV EXP MED BIOL, V875, P273, DOI 10.1007/978-1-4939-2981-8_32; Halvorsen MB, 2011, NCHRP RES RES DIG NA, P1; Halvorsen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038968; Hawkins AD, 2015, REV FISH BIOL FISHER, V25, P39, DOI 10.1007/s11160-014-9369-3; Hawkins AD, 2014, J ACOUST SOC AM, V135, P3101, DOI 10.1121/1.4870697; Hazelwood RA, 2012, ADV EXP MED BIOL, V730, P449, DOI [10.1007/978-1-4419-7311-.5_101, 10.1007/978-1-4419-7311-5_101]; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; Luo JG, 2009, MAR ECOL PROG SER, V380, P255, DOI 10.3354/meps07911; Mueller C, 2010, EFFECTS PILE DRIVING; Nedwell JR, 2006, J ACOUST SOC AM, V120, P2550, DOI 10.1121/1.2335573; Pafford, 1984, POPULATION DYNAMICS; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper A. N., 2014, S3SC14TR2014 ASA; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Rogers P.H., 1988, P131; Ruggerone G.T., 2008, BEHAV RESPONSE SURVI; SEDBERRY G R, 1987, Northeast Gulf Science, V9, P29; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Stadler JH, 2009, INTERNOISE 2009; Ziomek L. J., 1995, FUNDAMENTALS ACOUSTI	25	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0163638	10.1371/journal.pone.0163638	http://dx.doi.org/10.1371/journal.pone.0163638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880786	Green Submitted, gold, Green Published			2022-12-26	WOS:000388889500003
J	Shi, JJ; Getun, I; Torres, B; Petrie, HT				Shi, Jianjun; Getun, Irina; Torres, Bivian; Petrie, Howard T.			Foxn1[Cre] Expression in the Male Germline	PLOS ONE			English	Article							CELLS; CRE; MOUSE; NUDE; GENE; PROTEIN	Foxn1 (forkhead box N1), also known as the nude gene or winged- helix nude (Whn), is a forkhead transcription factor thought to be restricted to keratinocytes in the skin and thymus. Consistent with this tissue distribution, spontaneous or targeted mutation of Foxn1 results in the absence of both hair and a thymus. Genetic manipulation of the Foxn1 locus thus represents a powerful tool for tissue specific gene control in the skin and thymus, and tools such as Cre recombinase under control of the Foxn1 locus are widely used for this purpose. Unexpectedly, we show that Foxn1[ Cre] exhibits unexpected activity in male germ cells, resulting in ubiquitous targeting of loxP- flanked alleles in all tissues in offspring from Foxn1 [ Cre] expressing male mice. Inheritance of recombined loxP alleles occurs independently of Cre inheritance (i. e., offspring lacking Cre nonetheless exhibit recombined alleles), suggesting that Foxn1[ Cre] induced recombination in male germ cells must occur prior to meiosis in diploid germ cells. Together with previously published data, our results show that Foxn1, and alleles under its control, are expressed in the pre- meiotic male germline, revealing a new tool for germline targeting of genes, and raising important concerns for gender selection when using Foxn1 regulatory elements.	[Shi, Jianjun; Getun, Irina; Torres, Bivian; Petrie, Howard T.] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA; [Shi, Jianjun] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Getun, Irina] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA	Scripps Research Institute; University of Miami; University of Tennessee System; University of Tennessee Health Science Center	Petrie, HT (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA.	htpetrie@scripps.edu			National Institute of Allergy and Infectious Diseases/National Institute for Aging [R01AI103340]; National Institute for Aging [R21AI115289]	National Institute of Allergy and Infectious Diseases/National Institute for Aging; National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by PHS grant R01AI103340 from the National Institute of Allergy and Infectious Diseases/National Institute for Aging, and by PHS grant R21AI115289 from the National Institute for Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Choi CI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.14; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frutkin AD, 2007, CIRC RES, V101, pE124, DOI 10.1161/CIRCRESAHA.107.165415; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Itoh M, 1997, J ANDROL, V18, P672; Kobayashi Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00168; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626	12	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166967	10.1371/journal.pone.0166967	http://dx.doi.org/10.1371/journal.pone.0166967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880796	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500046
J	Gitsels, LA; Kulinskaya, E; Steel, N				Gitsels, Lisanne A.; Kulinskaya, Elena; Steel, Nicholas			Survival Benefits of Statins for Primary Prevention: A Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RISK; VALIDATION; WOMEN; MEN; METAANALYSIS; CHOLESTEROL; PRAVASTATIN; EVENTS; PEOPLE	Objectives Estimate the effect of statin prescription on mortality in the population of England and Wales with no previous history of cardiovascular disease. Methods Primary care records from The Health Improvement Network 1987-2011 were used. Four cohorts of participants aged 60, 65, 70, or 75 years at baseline included 118,700, 199,574, 247,149, and 194,085 participants; and 1.4, 1.9, 1.8, and 1.1 million person-years of data, respectively. The exposure was any statin prescription at any time before the participant reached the baseline age (60, 65, 70 or 75) and the outcome was all-cause mortality at any age above the baseline age. The hazard of mortality associated with statin prescription was calculated by Cox's proportional hazard regressions, adjusted for sex, year of birth, socioeconomic status, diabetes, antihypertensive medication, hypercholesterolaemia, body mass index, smoking status, and general practice. Participants were grouped by QRISK2 baseline risk of a first cardiovascular event in the next ten years of <10%, 10-19%, or >= 20%. Results There was no reduction in all-cause mortality for statin prescription initiated in participants with a QRISK2 score <10% at any baseline age, or in participants aged 60 at baseline in any risk group. Mortality was lower in participants with a QRISK2 score >= 20% if statin prescription had been initiated by age 65 (adjusted hazard ratio (HR) 0.86 (0.79-0.94)), 70 (HR 0.83 (0.79-0.88)), or 75 (HR 0.82 (0.79-0.86)). Mortality reduction was uncertain with a QRISK2 score of 10-19%: the HR was 1.00 (0.91-1.11) for statin prescription by age 65, 0.89 (0.810.99) by age 70, or 0.79 (0.52-1.19) by age 75. Conclusions The current internationally recommended thresholds for statin therapy for primary prevention of cardiovascular disease in routine practice may be too low and may lead to overtreatment of younger people and those at low risk.	[Gitsels, Lisanne A.; Kulinskaya, Elena] Univ East Anglia, Sch Comp Sci, Norwich, Norfolk, England; [Steel, Nicholas] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	University of East Anglia; University of East Anglia	Gitsels, LA (corresponding author), Univ East Anglia, Sch Comp Sci, Norwich, Norfolk, England.	l.gitsels@uea.ac.uk	Steel, Nicholas/K-1592-2014	Steel, Nicholas/0000-0003-1528-140X; Kulinskaya, Elena/0000-0002-9843-1663; /0000-0001-9066-3702	University of East Anglia; Economic and Social Research Council [ES/L011859/1]; ESRC [ES/L011859/1] Funding Source: UKRI	University of East Anglia; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Access to The Health Improvement Network (THIN) database was funded by the University of East Anglia. The work by the first two authors was in part funded by the Economic and Social Research Council [grant number ES/L011859/1]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Blak Betina T, 2011, Inform Prim Care, V19, P251; BRENNER H, 1993, EPIDEMIOLOGY, V4, P229, DOI 10.1097/00001648-199305000-00006; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Experian, 2015, MOS UK CONS CLASS UK; Germano G, 2012, EUR HEART J, V33, P137; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Harrell Jr FE, 2015, PACKAGE RMS VERSION; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067; Krumholz HM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4963; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mortensen MB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005991; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; National Health Service, 2014, TYP 2 DIAB; National Institute for Health and Care Excellence, 2014, LIP MOD CARD VASC RI; National Institute for Health and Care Excellence, WID US STAT CLOUD CU; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; O'Keeffe AG, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007207; Office for National Statistics, 2013, OP LIF SURV AD SMOK; Parish E, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3908; PEDERSEN TR, 1994, LANCET, V344, P1383; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Shephard E, 2011, FAM PRACT, V28, P352, DOI 10.1093/fampra/cmr039; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Swaro A, 2010, J ROY COLL PHYS EDIN, V40, P205, DOI 10.4997/JRCPE.2010.304; Taggar JS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-329; Therneau T.M., 2000, MODELING SURVIVAL DA; Therneau TM, PACKAGE SURVIVAL VER; Townsend N., 2014, CARDIOVASCULAR DIS S; UK Data Service Census Support, CARST TOWNS SCOR BAS; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166847	10.1371/journal.pone.0166847	http://dx.doi.org/10.1371/journal.pone.0166847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861639	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000388350300124
J	Ichinohe, S; Igarashi, T; Nakajima, D; Ono, M; Takahashi, H				Ichinohe, Sho; Igarashi, Tsutomu; Nakajima, Daisuke; Ono, Masafumi; Takahashi, Hiroshi			Symptoms of Dry Eye Disease and Personality Traits	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEPRESSION; ASSOCIATION; ANXIETY; STRESS	The essential targets of dry eye disease (DED) treatments include both objective signs and subjective symptoms. However, due to the numerous subjective symptoms, it is understandable why little association has been found between the signs and symptoms. Although psychological influences on the subjective symptoms have been reported, little is known about the influence of personality traits. The present study analyzed the relationship between the signs/symptoms of DED and the personality traits of patients using a cross-sectional design. We examined 56 DED patients (mean age; 62.4 +/- 12.9, range 34-85 years) visiting the outpatient clinic of the Department of Ophthalmology at the Nippon Medical School Hospital in Tokyo, Japan. Objective signs evaluated included the Schirmer I test, tear breakup time (BUT), fluorescein and lissamine green staining, and tear osmolality. Subjective symptoms were assessed by the Ocular Surface Disease Index (OSDI) and Dry Eye Related Quality-of-Life Score (DEQS) questionnaires. For personality traits, the Big Five personality traits model analysis was used. Correlations between the objective signs, subjective symptoms, and personality traits were analyzed. A significant correlation was found between the neuroticism in the Big Five Personality Inventory and the symptoms assessed by the DEQS (r = -0.35, p < 0.01), and the OSDI (r = -0.28, p < 0.05). There was no significant correlation observed between the signs and the symptoms, or between the signs and any personality traits. The results of our current study suggest that the personality of the patient, which appears to be the basis of various psychological factors, can have some impact on the subjective symptoms. This may be one of the reasons why there has been little association noted between the signs and symptoms of DED.	[Ichinohe, Sho; Igarashi, Tsutomu; Nakajima, Daisuke; Ono, Masafumi; Takahashi, Hiroshi] Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan	Nippon Medical School	Takahashi, H (corresponding author), Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	tash@nms.ac.jp		Igarashi, Tsutomu/0000-0002-7467-6746				Costa P.T., 1985, NEO PERSONALITY INVE; Fernandez CA, 2013, INVEST OPHTH VIS SCI, V54, P3666, DOI 10.1167/iovs.13-11635; Galor A, 2015, BRIT J OPHTHALMOL, V99, P1126, DOI 10.1136/bjophthalmol-2014-306481; Hallak JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082805; Hua R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005296; Kawashima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123299; Kim KW, 2011, INVEST OPHTH VIS SCI, V52, P7954, DOI 10.1167/iovs.11-8050; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Lautenschlager NT, 2013, CURR OPIN PSYCHIATR, V26, P97, DOI 10.1097/YCO.0b013e32835997b3; Lemp MA, 2007, OCUL SURF, V5, P75; Mabuchi F, 2005, JPN J OPHTHALMOL, V49, P31, DOI 10.1007/s10384-004-0134-3; Na KS, 2015, CORNEA, V34, P733, DOI 10.1097/ICO.0000000000000464; Nakaya N, 2014, J EPIDEMIOL, V24, P1, DOI 10.2188/jea.JE20130124; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Onogi H., 2004, JAPAN SOC PERSONALIT, V12, P82; Sakane Y, 2013, JAMA OPHTHALMOL, V131, P1331, DOI 10.1001/jamaophthalmol.2013.4503; Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Turhal NS, 2013, ASIAN PAC J CANCER P, V14, P4515, DOI 10.7314/APJCP.2013.14.8.4515; Van Der Vaart R, 2015, AM J OPHTHALMOL, V159, P470, DOI 10.1016/j.ajo.2014.11.028; Vedhara K, 2015, PSYCHONEUROENDOCRINO, V52, P72, DOI 10.1016/j.psyneuen.2014.10.028; Vehof J, 2013, JAMA OPHTHALMOL, V131, P1304, DOI 10.1001/jamaophthalmol.2013.4399; Wen W, 2012, CORNEA, V31, P686, DOI 10.1097/ICO.0b013e3182261590	23	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166838	10.1371/journal.pone.0166838	http://dx.doi.org/10.1371/journal.pone.0166838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861642	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300122
J	Yoo, TK; Kim, SW; Seol, KY				Yoo, Tae Keun; Kim, Sun Woong; Seol, Kyoung Yul			Age-Related Cataract Is Associated with Elevated Serum Immunoglobulin E Levels in the South Korean Population: A Cross-Sectional Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; RISK-FACTORS; MAST-CELLS; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; ATOPIC-DERMATITIS; NITRIC-OXIDE; IGE; DISEASE; ASTHMA	Background Previous research has suggested that immunoglobulin E (IgE)-mediated events lead to several chronic diseases. We investigated the association between allergic conditions and age related cataracts in the South Korean adult population. Methods A cross-sectional study was performed using data obtained from 1,170 participants aged 40 years or older who were enrolled in the Korean National Health and Nutrition Examination Survey 2010. Multivariable logistic regression was used to examine the relationship between age-related cataracts and allergic conditions, including total serum IgE and allergen-specific serum IgE levels, after adjustment for potential confounders (age, sex, alcohol consumption, smoking, sun exposure, blood pressure, plasma glucose and cholesterol levels, as well as histories of asthma, atopic dermatitis, and rheumatoid arthritis). Results After adjusting for potential confounders, the odds ratio (OR) for age-related cataract was greater in participants with higher total serum IgE levels (OR = 1.37; P = 0.044). In particular, increased IgE levels were significantly associated with nuclear cataract (OR = 1.42; P = 0.032). However, allergen-specific serum IgE levels did not differ significantly between groups. In the trend analysis, no significant relationship was observed between serum IgE and any type of age-related cataract. Conclusion Increased total serum IgE level is independently associated with age-related cataracts after adjustment for confounding factors.	[Yoo, Tae Keun; Seol, Kyoung Yul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Kim, Sun Woong] Yonsei Univ, Wonju Coll Med, Dept Ophthalmol, Wonju, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Seol, KY (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea.; Kim, SW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Ophthalmol, Wonju, South Korea.	eyedockim@yonsei.ac.kr; sooky@yuhs.ac	Yoo, Tae Keun/Q-3620-2019; Seo, Kyoung Yul/I-5484-2019	Yoo, Tae Keun/0000-0003-0890-8614; Seo, Kyoung Yul/0000-0002-9855-1980	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [H I 15C2237]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: H I 15C2237).; This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: H I 15C2237).	Alderaan K, 2015, RHEUMATOL INT, V35, P701, DOI 10.1007/s00296-014-3129-5; Asbell PA, 2005, LANCET, V365, P599; Bae JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136218; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Bot I, 2015, ARTERIOSCL THROM VAS, V35, P265, DOI 10.1161/ATVBAHA.114.303570; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109647; Cheng HM, 2014, J ALLERGY CLIN IMMUN, V133, P1048, DOI 10.1016/j.jaci.2013.10.055; Conner ER, 2005, CURR ALLERGY ASTHM R, V5, P191, DOI 10.1007/s11882-005-0037-5; Derby L, 2000, J ALLERGY CLIN IMMUN, V105, P912, DOI 10.1067/mai.2000.106044; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Ghahramani M, 2015, COLLOID SURFACE B, V125, P170, DOI 10.1016/j.colsurfb.2014.11.002; Gonzalez-Quintela A, 2003, CLIN EXP ALLERGY, V33, P199, DOI 10.1046/j.1365-2222.2003.01582.x; Hayashi T., 2000, PATHOPHYSIOLOGY, V6, P237, DOI [10.1016/S0928-4680(99)00022-X, DOI 10.1016/S0928-4680(99)00022-X]; Jick SS, 2001, EPIDEMIOLOGY, V12, P229, DOI 10.1097/00001648-200103000-00016; Klein BEK, 2006, AM J OPHTHALMOL, V141, P116, DOI 10.1016/j.ajo.2005.08.021; Klein BEK, 1997, AM J OPHTHALMOL, V123, P338, DOI 10.1016/S0002-9394(14)70129-1; Kritas SK, 2013, J BIOL REG HOMEOS AG, V27, P655; Kuang TM, 2005, ARCH OPHTHALMOL-CHIC, V123, P1109, DOI 10.1001/archopht.123.8.1109; Li L, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-94; Lippi G, 2014, ANN MED, V46, P456, DOI 10.3109/07853890.2014.927714; MANSON JE, 1994, AM J PREV MED, V10, P156, DOI 10.1016/S0749-3797(18)30612-3; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Micera A, 2008, CURR OPIN ALLERGY CL, V8, P466, DOI 10.1097/ACI.0b013e32830e6b17; Mintz R, 2004, INFLAMM BOWEL DIS, V10, P135, DOI 10.1097/00054725-200403000-00012; Mollazadegan K, 2011, AM J EPIDEMIOL, V174, P195, DOI 10.1093/aje/kwr069; Na KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096461; Oh K, 2007, KOREAN J EPIDEMIOL, V29, P139; Ornek K, 2003, EXP EYE RES, V76, P23, DOI 10.1016/S0014-4835(02)00268-3; Oryszczyn MP, 2000, AM J RESP CRIT CARE, V161, P1241, DOI 10.1164/ajrccm.161.4.9905027; Park S, 2015, INT J OPHTHALMOL-CHI, V8, P804, DOI 10.3980/j.issn.2222-3959.2015.04.29; Pierscionek BK, 1996, OPHTHALMIC RES, V28, P88, DOI 10.1159/000267879; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Rim THT, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-4; Schaumberg DA, 1999, ANN EPIDEMIOL, V9, P166, DOI 10.1016/S1047-2797(98)00049-0; Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107; Shinohara T, 2000, J OCUL PHARMACOL TH, V16, P181, DOI 10.1089/jop.2000.16.181; Swindle EJ, 2007, IMMUNOL REV, V217, P186, DOI 10.1111/j.1600-065X.2007.00513.x; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028962; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; WILLIAMSON J, 1969, BRIT J OPHTHALMOL, V53, P361, DOI 10.1136/bjo.53.6.361; Woodfolk JA, 2015, ALLERGOL INT, V64, P295, DOI 10.1016/j.alit.2015.06.001; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P14, DOI 10.1016/j.bbadis.2010.12.012	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166331	10.1371/journal.pone.0166331	http://dx.doi.org/10.1371/journal.pone.0166331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861567	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300047
J	Yu, L; Liang, Y; Cao, X; Wang, X; Gao, H; Lin, SY; Schiff, R; Wang, XS; Li, K				Yu, L.; Liang, Y.; Cao, X.; Wang, X.; Gao, H.; Lin, S-Y; Schiff, R.; Wang, X-S; Li, K.			Identification of MYST3 as a novel epigenetic activator of ER alpha frequently amplified in breast cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ACUTE MYELOID-LEUKEMIA; HOX GENE-EXPRESSION; HISTONE ACETYLTRANSFERASE; ENDOCRINE RESISTANCE; THERAPEUTIC TARGET; 8P11-P12 AMPLICON; CELL-LINES; STEM-CELLS; MOZ	Estrogen receptor a (ERa) is a master driver of a vast majority of breast cancers. Breast cancer cells often develop resistance to endocrine therapy via restoration of the ERa activity through survival pathways. Thus identifying the epigenetic activator of ERa that can be targeted to block ERa gene expression is a critical topic of endocrine therapy. Here, integrative genomic analysis identified MYST3 as a potential oncogene target that is frequently amplified in breast cancer. MYST3 is involved in histone acetylation via its histone acetyltransferase domain (HAT) and, as a result, activates gene expression by altering chromatin structure. We found that MYST3 was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers. Interestingly, MYST3 depletion drastically inhibited proliferation in MYST3-high, ER+ breast cancer cells, but not in benign breast epithelial cells or in MYST3-low breast cancer cells. Importantly, we discovered that knocking down MYST3 resulted in profound reduction of ERa expression, while ectopic expression of MYST3 had the reversed effect. Chromatin immunoprecipitation revealed that MYST3 binds to the proximal promoter region of ERa gene, and inactivating mutations in its HAT domain abolished its ability to regulate ERa, suggesting MYST3 functioning as a histone acetyltransferase that activates ERa promoter. Furthermore, MYST3 inhibition with inducible MYST3 shRNAs potently attenuated breast tumor growth in mice. Together, this study identifies the first histone acetyltransferase that activates ERa expression which may be potentially targeted to block ERa at transcriptional level.	[Yu, L.; Liang, Y.; Gao, H.; Li, K.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Liang, Y.; Cao, X.; Schiff, R.; Wang, X-S] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Cao, X.; Wang, X.; Schiff, R.; Wang, X-S] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Cao, X.; Wang, X.; Schiff, R.; Wang, X-S] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Cao, X.; Wang, X.; Wang, X-S] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wang, X.; Wang, X-S] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Wang, X.; Wang, X-S] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Lin, S-Y] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center	Wang, XS (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil,5117 Ctr Ave,Room G5a, Pittsburgh, PA 15213 USA.; Li, K (corresponding author), Baylor Coll Med, ABBR, Dept Surg, One Baylor Plaza, Houston, TX 77030 USA.	wangx13@pitt.edu; kli@bcm.edu			National Institutes of Health [CA161513, CA155151, CA181368, CA183976]; Dan L. Duncan Cancer Center at Baylor College of Medicine; Susan G. Komen foundation [PDF15333523, CDMRP W81XWH-13-1-0201]; Susan G. Komen for the cure grants Promise grant [PG12221410]; NIH SPORE Grants [P50 CA058183, CA186784-01]; NIH Cancer Center Grant [P30CA125123]; Breast Cancer Research Foundation; Cancer Prevention Research Institute of Texas [CPRIT RP140102, CRPIT RP130310]; Cancer Research UK; British Columbia Cancer Agency Branch; NATIONAL CANCER INSTITUTE [P50CA058183, R01CA181368, P30CA125123, P50CA186784, R01CA183976, R01CA155151, R21CA161513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center at Baylor College of Medicine; Susan G. Komen foundation(Susan G. Komen Breast Cancer Foundation); Susan G. Komen for the cure grants Promise grant; NIH SPORE Grants; NIH Cancer Center Grant; Breast Cancer Research Foundation; Cancer Prevention Research Institute of Texas; Cancer Research UK(Cancer Research UK); British Columbia Cancer Agency Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (KL, CA161513, CA155151; X-SW, CA181368 & CA183976), a Pilot Project Grant from the Dan L. Duncan Cancer Center at Baylor College of Medicine (KL), Susan G. Komen foundation PDF15333523 (XW), CDMRP W81XWH-13-1-0201(X-XC). This study was partly supported by the Susan G. Komen for the cure grants Promise grant PG12221410 (RS), NIH SPORE Grants P50 CA058183 (RS) and CA186784-01 (RS), and Cancer Center Grant P30CA125123 (RS), Breast Cancer Research Foundation (RS), Cancer Prevention Research Institute of Texas (RS, CPRIT RP140102) and SYL, CRPIT RP130310. We also thank Dr. Ana Rodriguez from the Research Core Team at Michael E. DeBakey Department of Surgery, Baylor College of Medicine for editing of this manuscript. The results published here are in part based upon data generated by TCGA (dbGaP accession: phs000178.v6.p6). This study also makes use of data generated by the Molecular Taxonomy of Breast Cancer International Consortium (funding for that project was provided by Cancer Research UK and the British Columbia Cancer Agency Branch).	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Bristow CAP, 2003, NUCLEIC ACIDS RES, V31, P2735, DOI 10.1093/nar/gkg401; Carlson S, 2014, J CELL PHYSIOL, V229, P1571, DOI 10.1002/jcp.24617; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Collins HM, 2006, J BIOL CHEM, V281, P17124, DOI 10.1074/jbc.M602633200; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Esteyries S, 2008, LEUKEMIA, V22, P663, DOI 10.1038/sj.leu.2404930; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Ignatiadis M, 2013, NAT REV CLIN ONCOL, V10, P494, DOI 10.1038/nrclinonc.2013.124; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kim MY, 2001, EMBO J, V20, P6084, DOI 10.1093/emboj/20.21.6084; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Paggetti J, 2010, ONCOGENE, V29, P5019, DOI 10.1038/onc.2010.254; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sheikh BN, 2015, ONCOGENE, V34, P5807, DOI 10.1038/onc.2015.33; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Turner-Ivey B, 2014, NEOPLASIA, V16, P644, DOI 10.1016/j.neo.2014.07.007; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang XS, 2009, NAT BIOTECHNOL, V27, P1005, DOI 10.1038/nbt.1584; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2004, CANCER GENET CYTOGEN, V155, P57, DOI 10.1016/j.cancergencyto.2004.03.013; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077	40	31	32	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2910	2918		10.1038/onc.2016.433	http://dx.doi.org/10.1038/onc.2016.433			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27893709	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000401697800013
J	Keppel, TR; Sarpong, K; Murray, EM; Monsey, J; Zhu, J; Bose, R				Keppel, Theodore R.; Sarpong, Kwabena; Murray, Elisa M.; Monsey, John; Zhu, Jian; Bose, Ron			Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; STRUCTURAL-ANALYSIS; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; SCATTERING; DYNAMICS; MECHANISMS; REGIONS; DOMAIN	The epidermal growth factor receptor (EGFR)/ErbB family of receptor tyrosine kinases includes oncogenes important in the progression of breast and other cancers, and they are targets for many drug development strategies. Each member of the ErbB family possesses a unique, structurally uncharacterized C-terminal tail that plays an important role in autophosphorylation and signal propagation. To determine whether these C-terminal tails are intrinsically disordered regions, we conducted a battery of biophysical experiments on the EGFR and HER3 tails. Using hydrogen/deuterium exchange mass spectrometry, we measured the conformational dynamics of intracellular half constructs and compared the tails with the ordered kinase domains. The C-terminal tails demonstrate more rapid deuterium exchange behavior when compared with the kinase domains. Next, we expressed and purified EGFR and HER3 tail-only constructs. Results from circular dichroism spectroscopy, size exclusion chromatography with multiangle light scattering, dynamic light scattering, analytical ultracentrifugation, and small angle X-ray scattering each provide evidence that the EGFR and HER3 C-terminal tails are intrinsically disordered with extended, non-globular structure in solution. The intrinsic disorder and extended conformation of these tails may be important for their function by increasing the capture radius and reducing the thermodynamic barriers for binding of downstream signaling proteins.	[Keppel, Theodore R.; Sarpong, Kwabena; Murray, Elisa M.; Monsey, John; Bose, Ron] Washington Univ, Sch Med, Dept Med, Div Oncol, 660 South Euclid Ave,Campus Box 8076, St Louis, MO 63110 USA; [Zhu, Jian] Washington Univ, Sch Med, Dept Med, Div Hematol, 660 South Euclid Ave,Campus Box 8076, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bose, R (corresponding author), Washington Univ, Sch Med, Dept Med, 660 South Euclid Ave,Campus Box 8076, St Louis, MO 63110 USA.	rbose@wustl.edu		Zhu, Jian/0000-0001-6679-8498	National Institutes of Health [R01 CA161001, 8P41 GM103422]; Cancer Biology Pathway Program at the Siteman Cancer Center through National Institutes of Health [5T32 CA113275]; NATIONAL CANCER INSTITUTE [R01CA161001, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Pathway Program at the Siteman Cancer Center through National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA161001 (to R. B.) and 8P41 GM103422 and by the Cancer Biology Pathway Program at the Siteman Cancer Center through National Institutes of Health Grant 5T32 CA113275. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Bae SH, 2009, J AM CHEM SOC, V131, P6814, DOI 10.1021/ja809687r; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Collier TS, 2013, J BIOL CHEM, V288, P25254, DOI 10.1074/jbc.M113.474882; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gajiwala KS, 2013, PROTEIN SCI, V22, P995, DOI 10.1002/pro.2283; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kathiriya JJ, 2014, MOL BIOSYST, V10, P2876, DOI 10.1039/c4mb00224e; Keppel TR, 2015, J AM SOC MASS SPECTR, V26, P547, DOI 10.1007/s13361-014-1033-6; Keppel TR, 2013, ANAL CHEM, V85, P5161, DOI 10.1021/ac4004979; Keppel TR, 2011, BIOCHEMISTRY-US, V50, P8722, DOI 10.1021/bi200875p; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Koland JG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003435; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kovacs E, 2015, MOL CELL BIOL, V35, P3083, DOI 10.1128/MCB.00248-15; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Lee NY, 2006, PROTEIN SCI, V15, P1142, DOI 10.1110/ps.052045306; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Manon F, 2010, ANONYMOUS INSTRUMENT, P431, DOI [DOI 10.1002/9780470602614CH15, 10.1002/9780470602614.ch15.]; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sapir T, 1999, EUR J BIOCHEM, V266, P1011, DOI 10.1046/j.1432-1327.1999.00942.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xia Y, 2013, J AM CHEM SOC, V135, P18840, DOI 10.1021/ja407644b; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhou HX, 2012, PHYS CHEM CHEM PHYS, V14, P10466, DOI 10.1039/c2cp41196b	74	19	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					597	610		10.1074/jbc.M116.747485	http://dx.doi.org/10.1074/jbc.M116.747485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27872189	hybrid, Green Published			2022-12-26	WOS:000392316100016
J	Survery, S; Moparthi, L; Kjellbom, P; Hogestatt, ED; Zygmunt, PM; Johanson, U				Survery, Sabeen; Moparthi, Lavanya; Kjellbom, Per; Hogestatt, Edward D.; Zygmunt, Peter M.; Johanson, Urban			The N-terminal Ankyrin Repeat Domain Is Not Required for Electrophile and Heat Activation of the Purified Mosquito TRPA1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; THERMAL SENSITIVITY; DICTATE SENSITIVITY; POTENTIAL CHANNELS; COLD; REVEALS; PAIN	Temperature sensors are crucial for animals to optimize living conditions. The temperature response of the ion channel transient receptor potential A1 (TRPA1) is intriguing; some orthologs have been reported to be activated by cold and others by heat, but the molecular mechanisms responsible for its activation remain elusive. Single-channel electrophysiological recordings of heterologously expressed and purified Anopheles gambiae TRPA1 (AgTRPA1), with and without the N-terminal ankyrin repeat domain, demonstrate that both proteins are functional because they responded to the electrophilic compounds allyl isothiocyanate and cinnamaldehyde as well as heat. The proteins' similar intrinsic fluorescence properties and corresponding quenching when activated by allyl isothiocyanate or heat suggest lipid bilayer-independent conformational changes outside the N-terminal domain. The results show that AgTRPA1 is an inherent thermo-and chemoreceptor, and analogous to what has been reported for the human TRPA1 ortholog, the N-terminal domain may tune the response but is not required for the activation by these stimuli.	[Survery, Sabeen; Moparthi, Lavanya; Kjellbom, Per; Johanson, Urban] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, SE-22100 Lund, Sweden; [Hogestatt, Edward D.; Zygmunt, Peter M.] Lund Univ, Dept Lab Med, Clin Chem & Pharmacol, SE-22185 Lund, Sweden	Lund University; Lund University	Johanson, U (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, SE-22100 Lund, Sweden.; Zygmunt, PM (corresponding author), Lund Univ, Dept Lab Med, Clin Chem & Pharmacol, SE-22185 Lund, Sweden.	peter.zygmunt@med.lu.se; urban.johanson@biochemistry.lu.se	Moparthi, Lavanya/AAX-1141-2020; Johanson, Urban/AHE-8231-2022	Moparthi, Lavanya/0000-0002-6030-3084; Johanson, Urban/0000-0001-8862-128X; Zygmunt, Peter/0000-0002-5102-8199; Survery, Sabeen/0000-0001-6740-5430	Vetenskapsradet Grants [2014-3801, 2010-5787, 2007-6110]; Svenska Forskningsradet Formas Grant [2007-718]; Research School of Pharmaceutical Sciences FLAK; Medicinska Fakulteten, Lunds Universitet	Vetenskapsradet Grants; Svenska Forskningsradet Formas Grant; Research School of Pharmaceutical Sciences FLAK; Medicinska Fakulteten, Lunds Universitet	This work was supported by Vetenskapsradet Grants 2014-3801, 2010-5787 (to P. M. Z. and E. D. H.), and 2007-6110 (to U. J.) and Svenska Forskningsradet Formas Grant 2007-718 (to P. M. Z., E. D. H., U. J., and P. K.); the Research School of Pharmaceutical Sciences FLAK (to U. J. and P. M. Z.); and the Medicinska Fakulteten, Lunds Universitet (to P. M. Z. and E. D. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Baez D, 2014, CURR TOP MEMBR, V74, P51, DOI 10.1016/B978-0-12-800181-3.00003-8; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hilton JK, 2015, BIOCHEMISTRY-US, V54, P2401, DOI 10.1021/acs.biochem.5b00071; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Latorre Ramon, 2007, P287; Laursen Willem J, 2015, Temperature (Austin), V2, P214, DOI 10.1080/23328940.2014.1000702; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072595; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Moparthi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28763; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Norden K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-47; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panzano VC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3127pe22; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Wang H, 2013, J PHYSIOL-LONDON, V591, P185, DOI 10.1113/jphysiol.2012.242842; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23	51	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26899	26912		10.1074/jbc.M116.743443	http://dx.doi.org/10.1074/jbc.M116.743443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875296	Green Published, hybrid			2022-12-26	WOS:000391571400026
J	Staples, KJ; Taylor, S; Thomas, S; Leung, S; Cox, K; Pascal, TG; Ostridge, K; Welch, L; Tuck, AC; Clarke, SC; Gorringe, A; Wilkinson, TMA				Staples, Karl J.; Taylor, Stephen; Thomas, Steve; Leung, Stephanie; Cox, Karen; Pascal, Thierry G.; Ostridge, Kristoffer; Welch, Lindsay; Tuck, Andrew C.; Clarke, Stuart C.; Gorringe, Andrew; Wilkinson, Tom M. A.			Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IGA; BACTERIAL; FREQUENCY; PROTEASES; SERUM	Non-typeable Haemophilus influenzae (NTHi) is a key pathogen in COPD, being associated with airway inflammation and risk of exacerbation. Why some patients are susceptible to colonisation is not understood. We hypothesised that this susceptibility may be due to a deficiency in mucosal humoral immunity. The aim of our study (NCT01701869) was to quantify the amount and specificity of antibodies against NTHi in the lungs and the associated risk of infection and inflammation in health and COPD. Phlebotomy, sputum induction and bronchoscopy were performed on 24 mild-to-moderate COPD patients and 8 age and smoking-matched controls. BAL (Bronchoalveolar lavage) total IgG1, IgG2, IgG3, IgM and IgA concentrations were significantly increased in COPD patients compared to controls. NTHi was detected in the lungs of 7 of the COPD patients (NTHi+ve-29%) and these patients had a higher median number of previous exacerbations than NTHi-ve patients as well as evidence of increased systemic inflammation. When comparing NTHi+ve versus NTHi-ve patients we observed a decrease in the amount of both total IgG1 (p = 0.0068) and NTHi-specific IgG1 (p = 0.0433) in the BAL of NTHi+ve patients, but no differences in total IgA or IgM. We observed no evidence of decreased IgG1 in the serum of NTHi+ve patients, suggesting this phenomenon is restricted to the airway. Furthermore, the NTHi+ve patients had significantly greater levels of IL-1 beta (p = 0.0003), in BAL than NTHi-ve COPD patients. This study indicates that the presence of NTHi is associated with reduced levels and function of IgG1 in the airway of NTHi-colonised COPD patients. This decrease in total and NTHI-specific IgG1 was associated with greater systemic and airway inflammation and a history of more frequent exacerbations and may explain the susceptibility of some COPD patients to the impacts of NTHi.	[Staples, Karl J.; Cox, Karen; Tuck, Andrew C.; Clarke, Stuart C.; Wilkinson, Tom M. A.] Univ Southampton, Fac Med, Southampton Gen Hosp, Clin & Expt Sci, Tremona Rd, Southampton, Hants, England; [Staples, Karl J.; Clarke, Stuart C.; Wilkinson, Tom M. A.] Univ Southampton, Fac Med, Southampton Gen Hosp, Wessex Invest Sci Hub, Tremona Rd, Southampton, Hants, England; [Taylor, Stephen; Thomas, Steve; Leung, Stephanie; Gorringe, Andrew] Publ Hlth England, Salisbury, Wilts, England; [Pascal, Thierry G.] GSK Vaccines, Wavre, Belgium; [Ostridge, Kristoffer; Welch, Lindsay; Clarke, Stuart C.; Wilkinson, Tom M. A.] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Tremona Rd, Southampton, Hants, England	University of Southampton; University of Southampton; Public Health England; GlaxoSmithKline; University of Southampton	Staples, KJ (corresponding author), Univ Southampton, Fac Med, Southampton Gen Hosp, Clin & Expt Sci, Tremona Rd, Southampton, Hants, England.; Staples, KJ (corresponding author), Univ Southampton, Fac Med, Southampton Gen Hosp, Wessex Invest Sci Hub, Tremona Rd, Southampton, Hants, England.	k.staples@southampton.ac.uk	Gorringe, Andrew R/L-6022-2017	Gorringe, Andrew R/0000-0003-2193-7954; Ostridge, Kristoffer/0000-0001-8910-3900; Leung, Stephanie/0000-0002-8880-2977; Welch, Lindsay/0000-0001-5564-2252; Wilkinson, Tom/0000-0003-1771-3851; Thomas, Stephen/0000-0003-2368-8058; Staples, Karl/0000-0003-3844-6457; Osman, Karen/0000-0002-8095-3850; Taylor, Stephen/0000-0002-9936-8539; Clarke, Stuart/0000-0002-7009-1548	GlaxoSmithKline Biologicals, SA, Belgium via a Collaborative Research & Development Agreement (CRADA)	GlaxoSmithKline Biologicals, SA, Belgium via a Collaborative Research & Development Agreement (CRADA)	This work was supported by GlaxoSmithKline Biologicals, SA, Belgium via a Collaborative Research & Development Agreement (CRADA). The funder provided support in the form of salaries for TGP and project management but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of TGP are articulated in the 'author contributions' section. No restrictions were placed on authors regarding the statements made in the manuscript.	Bafadhel M, 2015, INT J CHRONIC OBSTR, V10, P1075, DOI 10.2147/COPD.S80091; Brandsma CA, 2012, EUR RESPIR J, V40, P313, DOI 10.1183/09031936.00011211; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16; Freeman CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096421; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; GROENEVELD K, 1990, AM REV RESPIR DIS, V141, P1316, DOI 10.1164/ajrccm/141.5_Pt_1.1316; Hawdon N, 2012, VACCINE, V30, P1235, DOI 10.1016/j.vaccine.2011.12.113; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jalalvand F, 2014, VACCINE, V32, P2261, DOI 10.1016/j.vaccine.2014.02.082; Jung Y, 2015, MUCOSAL IMMUNOL, V8, P930, DOI 10.1038/mi.2014.123; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Ladjemi MZ, 2015, EUR RESPIR J, V45, P980, DOI 10.1183/09031936.00063914; Lee J, 2016, FASEB J; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Lugade AA, 2014, J IMMUNOL, V192, P5226, DOI 10.4049/jimmunol.1302584; McKendry RT, 2015, AM J RESP CRITICAL C; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILLER RD, 1979, AM REV RESPIR DIS, V119, P229; Murphy TF, 2015, J INFECT DIS, V212, P1798, DOI 10.1093/infdis/jiv299; Ostridge K, 2016, THORAX, V71, P126, DOI 10.1136/thoraxjnl-2015-207428; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042664; Sandstedt SA, 2008, J MICROBIOL METH, V75, P369, DOI 10.1016/j.mimet.2008.06.023; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Singh R, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0114-1; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090	38	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167250	10.1371/journal.pone.0167250	http://dx.doi.org/10.1371/journal.pone.0167250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898728	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000389474000042
J	Benard, A; Sala, C; Pluschke, G				Benard, Angele; Sala, Claudia; Pluschke, Gerd			Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates	PLOS ONE			English	Article							BURULI ULCER; DIVERSITY; MICE; SUSCEPTIBILITY; MYCOLACTONE; INFECTION; EVOLUTION; ECOLOGY; LESIONS; TOXIN	Buruli Ulcer is a neglected tropical disease leading to extensive disabilities and morbidity in West Africa. In this paper we sought to characterize various strains of Mycobacterium ulcerans (M. ulcerans) with different origins and laboratory passage records while refining a mouse model for Buruli ulcer. We described, compared and followed the kinetics of the histo-pathological outcome of infection of a collection of strains at various anatomical sites of infection in order to find a suitable model for further immunization studies. Moreover we compared the outcome of infection in C57Bl/6 and Balbc/J mice. Specifically we described thoroughly one M. ulcerans strain characterized by slow growth rate and limited tissue necrosis, which presents close ressemblance with the infection kinetics in humans. This strain caused macrophages as well as T and B cells infiltration, correlating with mycobacterial proliferation at the site of infection as well as in the draining lymph nodes, making it a suitable strain to screen vaccine candidates efficacy.	[Benard, Angele; Pluschke, Gerd] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Sala, Claudia] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Benard, Angele] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England	University of Basel; Swiss Tropical & Public Health Institute; Ecole Polytechnique Federale de Lausanne; Wellcome Trust Sanger Institute	Benard, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Benard, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	ab35@sanger.ac.uk	Sala, Claudia/R-6037-2017; Sala, Claudia/AAM-8395-2020	Sala, Claudia/0000-0003-4031-4648; Sala, Claudia/0000-0003-4031-4648; Benard, Angele/0000-0003-2099-149X; Pluschke, Gerd/0000-0003-1957-2925	European Community's Seventh Framework Programme (FP7) [241500]	European Community's Seventh Framework Programme (FP7)	The work presented here was funded by the European Community's Seventh Framework Programme (FP7 No 241500, Buruli Vac). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bratschi MW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002252; Chackerian AA, 2003, TUBERCULOSIS, V83, P279, DOI 10.1016/S1472-9792(03)00017-9; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; Dega H, 2000, ANTIMICROB AGENTS CH, V44, P2367, DOI 10.1128/AAC.44.9.2367-2372.2000; Demangel C, 2009, NAT REV MICROBIOL, V7, P50, DOI 10.1038/nrmicro2077; Doig KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-258; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Hilty M, 2006, J BACTERIOL, V188, P1462, DOI 10.1128/JB.188.4.1462-1465.2006; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Kim SH, 2004, J MOL HISTOL, V35, P409; LOCKSLEY RM, 1987, ANN INST PASTEUR IMM, V138, P744, DOI 10.1016/S0769-2625(87)80030-2; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Roltgen K, 2012, INFECT GENET EVOL, V12, P522, DOI 10.1016/j.meegid.2012.01.018; Schutte D, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000002; Sopoh GE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000746; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; Yeboah-Manu D, 2004, J CLIN MICROBIOL, V42, P5875, DOI 10.1128/JCM.42.12.5875-5876.2004	20	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167059	10.1371/journal.pone.0167059	http://dx.doi.org/10.1371/journal.pone.0167059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893778	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000389472400077
J	Nugent, G; Yockney, IJ; Whitford, EJ; Cross, ML; Aldwell, FE; Buddle, BM				Nugent, Graham; Yockney, Ivor J.; Whitford, E. Jackie; Cross, Martin L.; Aldwell, Frank E.; Buddle, Bryce M.			Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula)	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; CALMETTE-GUERIN VACCINATION; ORAL RABIES VACCINATION; LIPID-FORMULATED BCG; BADGERS MELES-MELES; NEW-ZEALAND; IMMUNE-RESPONSES; EFFICACY; EPIDEMIOLOGY; PROTECTION	Oral-delivery Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine in a lipid matrix has been shown to confer protection against M. bovis infection and reduce the severity of tuberculosis (TB) when fed to brushtail possums (Trichosurus vulpecula), the major wildlife vector of bovine TB in New Zealand. Here we demonstrate the feasibility of aerial delivery of this live vaccine in bait form to an M. bovis-infected wild possum population, and subsequently assess vaccine uptake and field efficacy. Pre-trial studies indicated a resident possum population at very low density (<0.6 possums/ha) at the field site, with a 5.1% prevalence of macroscopic TB lesions. Pilot studies indicated that flavoured lipid matrix baits in weather-proof sachets could be successfully sown aerially via helicopter and were palatable to, and likely to be consumed by, a majority of wild possums under free-choice conditions. Subsequently, sachet-held lipid baits containing live BCG vaccine were sown at 3 baits/ha over a 1360 ha area, equating to >5 baits available per possum. Blood sampling conducted two months later provided some evidence of vaccine uptake. A necropsy survey conducted one year later identified a lower prevalence of culture-confirmed M. bovis infection and/or gross TB lesions among adult possums in vaccinated areas (1.1% prevalence; 95% CI, 0-3.3%, n = 92) than in unvaccinated areas (5.6%; 0.7-10.5%, n = 89); P = 0.098. Although not statistically different, the 81% efficacy in protecting possums against natural infection calculated from these data is within the range of previous estimates of vaccine efficacy in trials where BCG vaccine was delivered manually. We conclude that, with further straightforward refinement to improve free-choice uptake, aerial delivery of oral BCG vaccine is likely to be effective in controlling TB in wild possums. We briefly discuss contexts in which this could potentially become an important complementary tool in achieving national eradication of TB from New Zealand wildlife.	[Nugent, Graham; Yockney, Ivor J.; Whitford, E. Jackie; Cross, Martin L.] Landcare Res Manaaki Whenua, Lincoln, New Zealand; [Aldwell, Frank E.] Univ Otago, Ctr Innovat, Dunedin, New Zealand; [Buddle, Bryce M.] AgResearch, Hopkirk Inst, Palmerston North, New Zealand	Landcare Research - New Zealand; University of Otago; AgResearch - New Zealand	Nugent, G (corresponding author), Landcare Res Manaaki Whenua, Lincoln, New Zealand.	nugentg@landcareresearch.co.nz		Buddle, Bryce/0000-0001-6197-6689; Nugent, Graham/0000-0001-6223-8450	New Zealand Ministry for Science and Innovation [C09X0803]; OSPRI (TBfree programme) (Wellington, New Zealand)	New Zealand Ministry for Science and Innovation; OSPRI (TBfree programme) (Wellington, New Zealand)	This work was funded by the New Zealand Ministry for Science and Innovation (Contract C09X0803) with co-funding from OSPRI (TBfree programme) (Wellington, New Zealand). Neither body had any role in the study design, acquisition or analysis of data, decision to publish or presentation of results.	Aldwell FE, 2003, VACCINE, V22, P70, DOI 10.1016/S0264-410X(03)00539-5; Aldwell FE, 2003, INFECT IMMUN, V71, P101, DOI 10.1128/IAI.71.1.101-108.2003; [Anonymous], 2002, ORAL VACCINATION FOX, P1; [Anonymous], 2016, OSPRI TBFREE INFORM, P1; Aznar I, 2011, VET MICROBIOL, V151, P104, DOI 10.1016/j.vetmic.2011.02.032; Barlow ND, 2000, J ANIM ECOL, V69, P703, DOI 10.1046/j.1365-2656.2000.00428.x; Blackwell BF, 2004, J WILDLIFE DIS, V40, P222, DOI 10.7589/0090-3558-40.2.222; Buddle BM, 2006, NEW ZEAL VET J, V54, P224, DOI 10.1080/00480169.2006.36701; Buddle BM, 2015, NEW ZEAL VET J, V63, P19, DOI 10.1080/00480169.2014.929518; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; BUDDLE BM, 1992, NEW ZEAL VET J, V40, P155, DOI 10.1080/00480169.1992.35721; Byrom AE, 2008, LC0708110, P1; Byrom AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145636; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Clark S, 2008, INFECT IMMUN, V76, P3771, DOI 10.1128/IAI.00052-08; Coleman J.D., 1980, New Zealand Journal of Ecology, V3, P69; Coleman Jim, 2000, P92; Collins DM, 2007, VACCINE, V25, P4659, DOI 10.1016/j.vaccine.2007.04.014; Corner LAL, 2009, J WILDLIFE DIS, V45, P1042, DOI 10.7589/0090-3558-45.4.1042; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Corner LAL, 2002, RES VET SCI, V73, P145, DOI 10.1016/S0034-5288(02)00038-3; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Cousins DV, 2001, REV SCI TECH OIE, V20, P71, DOI 10.20506/rst.20.1.1263; Cowan Phil, 2000, P24; Cross ML, 2007, VET J, V174, P472, DOI 10.1016/j.tvjl.2006.10.005; Cross ML, 2009, J WILDLIFE DIS, V45, P754, DOI 10.7589/0090-3558-45.3.754; Cross ML, 2016, VERTEBRATE PEST RES, V27, P8; DEFRA, 2014, DEP ENV FOOD RUR AFF; Farry SC, 1998, J WILDLIFE DIS, V34, P23, DOI 10.7589/0090-3558-34.1.23; Freuling CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0142; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; Kaden V, 2002, BERL MUNCH TIERARZTL, V115, P179; Kelly DJ, 2011, EUR J WILDLIFE RES, V57, P767, DOI 10.1007/s10344-010-0485-7; Livingstone PG, 2015, NEW ZEAL VET J, V63, P4, DOI 10.1080/00480169.2014.971082; Livingstone PG, 2015, NEW ZEAL VET J, V63, P98, DOI 10.1080/00480169.2015.1013581; Mainguy J, 2013, J WILDLIFE DIS, V49, P190, DOI 10.7589/2011-11-342; More SJ, 2015, VET REC, V177, P224, DOI 10.1136/vr.103163; Murphy D, 2014, VET J, V200, P362, DOI 10.1016/j.tvjl.2014.02.031; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Nugent G, 2015, NEW ZEAL VET J, V63, P28, DOI 10.1080/00480169.2014.963791; Nugent G, 2015, NEW ZEAL VET J, V63, P54, DOI 10.1080/00480169.2014.963792; Nugent G, 2013, J COMP PATHOL, V148, P33, DOI 10.1016/j.jcpa.2012.05.006; Nugent G, 2012, EPIDEMIOL INFECT, V140, P1036, DOI 10.1017/S0950268811001579; Nugent G, 2002, J WILDLIFE DIS, V38, P665, DOI 10.7589/0090-3558-38.4.665; Nugent G, 2013, PREV VET MED, V109, P168, DOI 10.1016/j.prevetmed.2012.09.008; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; OSPRI, 2015, OP SOL PRIM IND ANN, P1; Ramsey DSL, 2009, TUBERCULOSIS, V89, P163, DOI 10.1016/j.tube.2008.11.002; Ramsey DS, 2004, LC0304068 AN HLTH BO, P1; Rosatte RC, 2001, J WILDLIFE DIS, V37, P730, DOI 10.7589/0090-3558-37.4.730; Rouco C, 2013, NEW ZEAL J ECOL, V37, P12; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Shwiff SA, 2009, J WILDLIFE DIS, V45, P227, DOI 10.7589/0090-3558-45.1.227; Skinner MA, 2005, RES VET SCI, V78, P231, DOI 10.1016/j.rvsc.2004.07.007; Spencer A, 2011, POLITICS-OXFORD, V31, P91, DOI 10.1111/j.1467-9256.2011.01407.x; Sweetapple P, 2011, NEW ZEAL J ECOL, V32, P152; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Tompkins DM, 2013, VACCINE, V31, P893, DOI 10.1016/j.vaccine.2012.12.003; Warburton B, 2015, NEW ZEAL VET J, V63, P77, DOI 10.1080/00480169.2014.981315; Warburton B, 2009, MANY POSSUMS ARE NOW, P1; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; WINTER JW, 1980, AUST WILDLIFE RES, V7, P359, DOI 10.1071/WR9800359; Wright J., 2011, EVALUATING USE 1080, P1; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289; Yockney IJ, 2015, LC2485 OSPRI LANDC R, P1; Yockney IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121865	70	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167144	10.1371/journal.pone.0167144	http://dx.doi.org/10.1371/journal.pone.0167144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893793	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400092
J	Prema, A; Thenmozhi, AJ; Manivasagam, T; Essa, MM; Akbar, MD; Akbar, M				Prema, Asokan; Thenmozhi, Arokiasamy Justin; Manivasagam, Thamilarasan; Essa, Musthafa Mohamed; Akbar, Mohammed D.; Akbar, Mohammed			Fenugreek Seed Powder Nullified Aluminium Chloride Induced Memory Loss, Biochemical Changes, A beta Burden and Apoptosis via Regulating Akt/GSK3 beta Signaling Pathway	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMERS-DISEASE; NEURONAL SURVIVAL; PROTEIN-KINASE; RAT-BRAIN; ACETYLCHOLINESTERASE; NEUROTOXICITY; EXTRACT; DEATH; PHOSPHORYLATION	Alzheimer's disease (AD) is the most common form of dementia that mainly affects the cognitive functions of the aged populations. Trigonella foenum-graecum (L.) (fenugreek), a traditionally well utilized medicinal plant ubiquitously used as one of the main food additive worldwide, is known to have numerous beneficial health effects. Fenugreek seed extract could be able to inhibit the activity of acetylcholinesterase (AChE), a key enzyme involved in the pathogenesis of AD, and further shown to have anti-parkinsonic effect. The present study was aimed to explore the neuroprotective effect of fenugreek seed powder (FSP) against aluminium chloride (AlCl3) induced experimental AD model. Administration of germinated FSP (2.5, 5 and 10% mixed with ground standard rat feed) protected AlCl3 induced memory and learning impairments, Al overload, AChE hyperactivity, amyloid beta (A beta) burden and apoptosis via activating Akt/GSK3 beta pathway. Our present data could confirm the neuroprotective effect of fenugreek seeds. Further these results could lead a possible therapeutics for the management of neurodegenerative diseases including AD in future.	[Prema, Asokan; Thenmozhi, Arokiasamy Justin; Manivasagam, Thamilarasan] Annamalai Univ, Dept Biochem & Biotechnol, Fac Sci, Annamalainagar 608002, Tamil Nadu, India; [Essa, Musthafa Mohamed] Sultan Qaboos Univ, CAMS, Dept Food Sci & Nutr, Muscat, Oman; [Essa, Musthafa Mohamed] Sultan Qaboos Univ, Ageing & Dementia Res Grp, Muscat, Oman; [Essa, Musthafa Mohamed] Food & Brain Res Fdn, Madras 600094, Tamil Nadu, India; [Akbar, Mohammed D.; Akbar, Mohammed] NIAAA, SMPT, NIH, Rockville, MD 20852 USA	Annamalai University; Sultan Qaboos University; Sultan Qaboos University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Thenmozhi, AJ (corresponding author), Annamalai Univ, Dept Biochem & Biotechnol, Fac Sci, Annamalainagar 608002, Tamil Nadu, India.	justinthenmozhi@rediffmail.com	A, Justinthenmozhi/W-4465-2019; Thenmozhi, Arokiasamy Justin/U-7619-2019; Manivasagam, Thamilarasan/U-3209-2019; Essa, Mohamed/AAX-2596-2020	Manivasagam, Thamilarasan/0000-0003-4440-7323; Justin Thenmozhi, Arokiasamy/0000-0001-8822-4751; Manivasagam, Thamilarasan/0000-0002-3948-8328; Musthafa Mohamed, Essa/0000-0001-7505-9785	University Grants Commission-Basic Science Research Fellowship, New Delhi, India; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	University Grants Commission-Basic Science Research Fellowship, New Delhi, India; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We gratefully acknowledge the University Grants Commission-Basic Science Research Fellowship, New Delhi, India for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashem F., 2009, American Journal of Biochemistry and Biotechnology, V5, P98; [Anonymous], ASIA PAC J CLIN NUTR; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Basch Ethan, 2003, Altern Med Rev, V8, P20; Baydar T, 2003, BIOL TRACE ELEM RES, V92, P231, DOI 10.1385/BTER:92:3:231; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Braidy N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/685909; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Bukhari SB, 2008, PAK J ANAL ENV CHEM, V9; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carreiras MC, 2013, CURR TOP MED CHEM, V13, P1745, DOI 10.2174/15680266113139990135; Chaudhary M, 2014, ANN NEUROSCI, V21, P5, DOI 10.5214/ans.0972.7531.210103; CLAUBERG M, 1993, P NATL ACAD SCI USA, V90, P1009, DOI 10.1073/pnas.90.3.1009; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dhanalakshmi C, 2016, NEUROCHEM R IN PRESS; Flaten TP, 1996, J TOXICOL ENV HEALTH, V48, P527, DOI 10.1080/009841096161050; Fuller S, 2015, ADV NUTR, V6, P189, DOI 10.3945/an.114.007807; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Giacobini E, 2002, J NEURAL TRANSM, V109, P1053, DOI 10.1007/s007020200089; Hamza N, 2012, J ETHNOPHARMACOL, V142, P516, DOI 10.1016/j.jep.2012.05.028; HEISE GA, 1984, MED RES REV, V4, P535, DOI 10.1002/med.2610040405; Hu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064460; Humpel C, 2011, EXP GERONTOL, V46, P225, DOI 10.1016/j.exger.2010.11.032; Janakiraman U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146671; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jelenkovic A, 2014, PHYTOTHER RES, V28, P82, DOI 10.1002/ptr.4962; Ji LN, 2009, J ALZHEIMERS DIS, V18, P105, DOI 10.3233/JAD-2009-1127; Justin Thenmozhi A, 2015, NUTR NEUROS IN PRESS; Justin Thenmozhi A, 2016, NUTR NEUROS IN PRESS; Kaizer RR, 2004, NEUROCHEM RES, V29, P2251, DOI 10.1007/s11064-004-7033-3; Kandhare AD, 2015, CHEM-BIOL INTERACT, V237, P151, DOI 10.1016/j.cbi.2015.06.019; Khursheed R, 2014, PAK J PHARM SCI, V27, P1419; Kumar A, 2009, N-S ARCH PHARMACOL, V380, P431, DOI 10.1007/s00210-009-0442-8; Kumar A, 2009, BEHAV BRAIN RES, V205, P384, DOI 10.1016/j.bbr.2009.07.012; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mani V., 2009, PHARMACOLOGY, V2, P827; Marx J, 2001, SCIENCE, V293, P2192, DOI 10.1126/science.293.5538.2192; Mathiyazahan DB, 2015, J FUNCT FOODS, V16, P423, DOI 10.1016/j.jff.2015.05.001; Meghwal M, 2012, SCI REP, V1, P1, DOI DOI 10.4172/SCIENTIFICREPORTS.129; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; Modi PK, 2012, MOL BIOL CELL, V23, P3722, DOI 10.1091/mbc.E12-02-0125; Muirhead KEA, 2010, BIOCHEM J, V426, P255, DOI 10.1042/BJ20091941; Namikawa K, 2000, J NEUROSCI, V20, P2875; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Prakash A, 2013, NEUROL SCI, V34, P1403, DOI 10.1007/s10072-012-1252-1; Rao PU, 1996, NUTR RES, V16, P1495, DOI 10.1016/0271-5317(96)00163-7; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Saini D., 2011, AJPCR, V4, P76; SatheeshKumar N, 2010, PHYTOMEDICINE, V17, P292, DOI 10.1016/j.phymed.2009.06.006; Sharma P, 2006, REPROD TOXICOL, V21, P313, DOI 10.1016/j.reprotox.2005.06.004; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Thenmozhi AJ, 2015, NEUROCHEM RES, V40, P767, DOI 10.1007/s11064-015-1525-1; Walton J R, 2012, Int J Alzheimers Dis, V2012, P914947, DOI 10.1155/2012/914947; Wang LP, 2014, NEUROCHEM RES, V39, P1338, DOI 10.1007/s11064-014-1317-z; WANG QM, 1994, J BIOL CHEM, V269, P14566; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; Yellamma K, 2010, Toxicol Int, V17, P106, DOI 10.4103/0971-6580.72682; Yokel RA, 2002, ENVIRON HEALTH PERSP, V110, P699, DOI 10.1289/ehp.02110s5699; Yokel RA, 2002, COORDIN CHEM REV, V228, P97, DOI 10.1016/S0010-8545(02)00078-4; ZATTA P, 1994, NEUROREPORT, V5, P1777, DOI 10.1097/00001756-199409080-00023; Zhang H, 2016, NEUROTOX RE IN PRESS; Zhang HF, 2016, NEUROTOX RES, V29, P484, DOI 10.1007/s12640-016-9597-5; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	71	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165955	10.1371/journal.pone.0165955	http://dx.doi.org/10.1371/journal.pone.0165955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893738	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400013
J	Anson, M; Amado, I; Mailhe, MP; Donnadieu, E; Garcia, S; Huetz, F; Freitas, AA				Anson, Marie; Amado, Ines; Mailhe, Marie-Pierre; Donnadieu, Emmanuel; Garcia, Sylvie; Huetz, Francoiis; Freitas, Antonio A.			Regulation and Maintenance of an Adoptive T-Cell Dependent Memory B Cell Pool	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; IMMUNOLOGICAL MEMORY; IMMUNE-RESPONSE; PLASMA-CELL; ANTIGEN; HYPERMUTATION; EXPRESSION; LYMPHOCYTES; ACTIVATION; INDUCTION	We investigated the ability of monoclonal B cells to restore primary and secondary T-cell dependent antibody responses in adoptive immune-deficient hosts. Priming induced B cell activation and expansion, AID expression, antibody production and the generation of IgM(+) IgG(-) and IgM(-)IgG(+) antigen-experienced B-cell subsets that persisted in the lymphopenic environment by cell division. Upon secondary transfer and recall the IgM(-)IgG(+) cells responded by the production of antigen-specific IgG while the IgM(+) memory cells secreted mainly IgM and little IgG, but generated new B cells expressing germinal center markers. The recall responses were more efficient if the antigenic boost was delayed suggesting that a period of adaptation is necessary before the transferred cells are able to respond. Overall these findings indicate that reconstitution of a functional and complete memory pool requires transfer of all different antigen-experienced B cell subsets. We also found that the size of the memory B cell pool did not rely on the number of the responding naive B cells, suggesting autonomous homeostatic controls for naive and memory B cells. By reconstituting a stable memory B cell pool in immune-deficient hosts using a monoclonal high-affinity B cell population we demonstrate the potential value of B cell adoptive immunotherapy.	[Anson, Marie; Amado, Ines; Mailhe, Marie-Pierre; Garcia, Sylvie; Huetz, Francoiis; Freitas, Antonio A.] Inst Pasteur, Dept Immunol, Unite Biol Populat Lymphocytaires, Paris, France; [Anson, Marie; Amado, Ines; Mailhe, Marie-Pierre; Garcia, Sylvie; Huetz, Francoiis; Freitas, Antonio A.] CNRS, URA1961, Paris, France; [Donnadieu, Emmanuel] Inst Cochin, INSERM, U1016, Paris, France; [Donnadieu, Emmanuel] CNRS, UMR8104, Paris, France; [Donnadieu, Emmanuel] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Freitas, AA (corresponding author), Inst Pasteur, Dept Immunol, Unite Biol Populat Lymphocytaires, Paris, France.; Freitas, AA (corresponding author), CNRS, URA1961, Paris, France.	antonio.freitas@pasteur.fr	Donnadieu, Emmanuel/P-4566-2017; Huetz, François/T-3386-2019	Garcia, Sylvie/0000-0002-7655-8911; Huetz, Francois/0000-0001-8704-1881; freitas, antonio/0000-0001-6392-7178	European Research Council [AdG09 249740-QSIS]; Institut Pasteur; Centre National pour la Recherche Scientifique	European Research Council(European Research Council (ERC)European Commission); Institut Pasteur(European Commission); Centre National pour la Recherche Scientifique	This work was supported by grant AdG09 249740-QSIS from the European Research Council, the Institut Pasteur and the Centre National pour la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Bar-Or A, 2001, J IMMUNOL, V167, P5669, DOI 10.4049/jimmunol.167.10.5669; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; CELADA F, 1967, J EXP MED, V125, P199, DOI 10.1084/jem.125.2.199; COLLE JH, 1988, EUR J IMMUNOL, V18, P1307, DOI 10.1002/eji.1830180902; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Jones DD, 2015, J IMMUNOL; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166	30	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167003	10.1371/journal.pone.0167003	http://dx.doi.org/10.1371/journal.pone.0167003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880797	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500053
J	Caudill, SA; Rice, RA				Caudill, S. Amanda; Rice, Robert A.			Do Bird Friendly (R) Coffee Criteria Benefit Mammals? Assessment of Mammal Diversity in Chiapas, Mexico	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; WESTERN-GHATS; FOREST; AGROECOSYSTEMS; LANDSCAPES; FRAGMENTATION; CERTIFICATION; AGROFORESTRY; PLANTATIONS; QUALITY	Biodiversity-friendly coffee certifications offer a viable way to protect wildlife habitat while providing a financial incentive to farmers. Most studies related to these certifications focus on avian habitat requirements and it is not known whether these standards also apply to other wildlife, such as mammals, that inhabit the coffee landscapes. We assessed the non-volant mammalian fauna and their associated habitat requirements in 23 sites representing forest, Bird Friendly (R) shade, conventional shade, and sun coffee habitats. We used Sherman trap-grids to measure small mammal abundance and richness, while camera traps were set for medium-sized and large mammals. We detected 17 species of mammals, representing 11 families. This preliminary study indicates that coffee farms in this region provide an important refuge for mammalian wildlife. Mammal species density ranked significantly higher in Bird Friendly (R) coffee sites than other coffee habitats, although there was no significant difference for species richness (using Chao2 estimator) among the habitat types. No significant difference was found in small mammal abundance among the habitat types. We found a higher species density of medium and large mammals in sites with larger, more mature shade trees associated with, but not required by Bird Friendly (R) certification standards. However, lower strata vegetation (5 cm to 1 m tall), the only vegetation parameter found to increase abundance and density for small mammals, is not specified in the Bird Friendly (R) standards. Our findings suggest that although the standards devised for avian habitat do benefit mammals, further study is needed on the requirements specific for mammals that could be included to enhance the coffee habitat for mammals that inhabit these coffee landscapes.	[Caudill, S. Amanda; Rice, Robert A.] Natl Zool Pk, Smithsonian Conservat Biol Inst, MRC 5503, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Caudill, SA (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, MRC 5503, Washington, DC 20013 USA.	caudills@si.edu			Smithsonian Migratory Bird Center	Smithsonian Migratory Bird Center(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute)	SAC received financial support from the Smithsonian Migratory Bird Center.We would like to thank Finca Argovia and Dra. Consuelo Lorenzo Monterrubio for their supportand assistance with logistics for the study, as well as Bruno Giesemann E., Rainer E.Boehme Trueb, Eduardo Bracamontes for their participation in the study and for allowing usaccess to their farms. This study would not have been possible without the hard work of those who assisted with the field work: Megan Banner, Stephen Brennen, Caitlin Campbell, Tim Lima, Adaberto, and Daniel Dixon. We would like to thank Mirian Tsuchiya for the genetics lab work. We would also like to thank the valuable input of the anonymous reviewers whose comments and recommendations improved the manuscript. SAC received financial support from the Smithsonian Migratory Bird Center.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Andresen D, 2003, THESIS; [Anonymous], 2001, SAS SOFTW; Bali A, 2007, BIOL CONSERV, V139, P93, DOI 10.1016/j.biocon.2007.06.017; Bitterlich W., 1947, Allg. Forst- u. Holzw. Ztg., V58, P94; CARMER SG, 1973, J AM STAT ASSOC, V68, P66, DOI 10.2307/2284140; Caudill SA, 2015, AGR ECOSYST ENVIRON, V199, P85, DOI 10.1016/j.agee.2014.08.023; Caudill SA, 2014, AGROFOREST SYST, V88, P173, DOI 10.1007/s10457-013-9664-3; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Colwell RK, 2003, ESTIMATES STAT ESTIM; Cruz-Lara L, ACTA ZOOLOGICA MEXIC; DeClerck FAJ, 2010, BIOL CONSERV, V143, P2301, DOI 10.1016/j.biocon.2010.03.026; DeClerck FAJ, 2011, ECOSYSTEM SERVICES A, P65; Food and Agriculture Organization, 2002, STAT WORLDS FOR 2001; Food and Agriculture Organization, 2011, GLOB FOR RES ASS 201; Gallina S., 2008, AGROECOSISTEMAS CAFE, P161; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hall E. R., 1962, Miscellaneous Publications Museum of Natural History University of Kansas, VNo. 30, P1; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Mas AH, 2004, ECOL APPL, V14, P642, DOI 10.1890/02-5225; Mas AH, 2003, ECOL APPL, V13, P1491, DOI 10.1890/01-5229; Mendoza Saenz Victor Hugo, 2013, Therya, V4, P409; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Passamani M, 2009, BRAZ J BIOL, V69, P305, DOI 10.1590/S1519-69842009000200010; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Perfecto I, 2002, CONSERV BIOL, V16, P174, DOI 10.1046/j.1523-1739.2002.99536.x; Peters VE, 2013, INSECT CONSERV DIVER, V6, P45, DOI 10.1111/j.1752-4598.2012.00189.x; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; Philpott SM, 2007, CONSERV BIOL, V21, P975, DOI 10.1111/j.1523-1739.2007.00728.x; Philpott SM, 2012, AGR ECOSYST ENVIRON, V149, P171, DOI 10.1016/j.agee.2011.02.015; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; Reid FA, 2009, FIELD GUIDE MAMMALS, V2; Rice R., 2010, ECOLOGICAL BENEFITS; Sustainable Agriculture Network, 2010, SUST AGR NETW; Tscharntke T, 2015, CONSERV LETT, V8, P14, DOI 10.1111/conl.12110; UNEP-WCMC (World Conservation Monitoring Centre of the United Nations Environment Programme), 2004, UNPUB; Weist M, 2010, MAMM BIOL, V75, P567, DOI 10.1016/j.mambio.2009.09.004; Williams-Guillen K, 2010, BIOTROPICA, V42, P605, DOI 10.1111/j.1744-7429.2010.00626.x	41	15	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165662	10.1371/journal.pone.0165662	http://dx.doi.org/10.1371/journal.pone.0165662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880773	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500013
J	Robertson, C; Yee, L				Robertson, Colin; Yee, Lauren			Avian Influenza Risk Surveillance in North America with Online Media	PLOS ONE			English	Article							PUBLIC-HEALTH; WILDLIFE; DISEASES; EMERGENCE	The use of Internet-based sources of information for health surveillance applications has increased in recent years, as a greater share of social and media activity happens through online channels. The potential surveillance value in online sources of information about emergent health events include early warning, situational awareness, risk perception and evaluation of health messaging among others. The challenge in harnessing these sources of data is the vast number of potential sources to monitor and developing the tools to translate dynamic unstructured content into actionable information. In this paper we investigated the use of one social media outlet, Twitter, for surveillance of avian influenza risk in North America. We collected AI-related messages over a five-month period and compared these to official surveillance records of AI outbreaks. A fully automated data extraction and analysis pipeline was developed to acquire, structure, and analyze social media messages in an online context. Two methods of outbreak detection; a static threshold and a cumulative-sum dynamic threshold; based on a time series model of normal activity were evaluated for their ability to discern important time periods of AI-related messaging and media activity. Our findings show that peaks in activity were related to real-world events, with outbreaks in Nigeria, France and the USA receiving the most attention while those in China were less evident in the social media data. Topic models found themes related to specific AI events for the dynamic threshold method, while many for the static method were ambiguous. Further analyses of these data might focus on quantifying the bias in coverage and relation between outbreak characteristics and detectability in social media data. Finally, while the analyses here focused on broad themes and trends, there is likely additional value in developing methods for identifying low-frequency messages, operationalizing this methodology into a comprehensive system for visualizing patterns extracted from the Internet, and integrating these data with other sources of information such as wildlife, environment, and agricultural data.	[Robertson, Colin; Yee, Lauren] Wilfrid Laurier Univ, Dept Geog & Environm Studies, 75 Univ Ave West, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Robertson, C (corresponding author), Wilfrid Laurier Univ, Dept Geog & Environm Studies, 75 Univ Ave West, Waterloo, ON N2L 3C5, Canada.	crobertson@wlu.ca			CWHC	CWHC	C. Robertson received contract funds from CWHC for this work.The funders had no role in study design, data collection and analysis.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bevins SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104360; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Box G. E., 1976, TIME SERIES ANAL CON, p[10, 3226]; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Burns TE, 2012, CAN VET J, V53, P158; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Christou V, 2015, J STAT COMPUT SIM, V85, P357, DOI 10.1080/00949655.2013.823612; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Comin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035956; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Ferland R, 2006, J TIME SER ANAL, V27, P923, DOI 10.1111/j.1467-9892.2006.00496.x; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Gomide J., 2011, P 3 INT WEB SCI C, P3; Gonsalves G, 2014, NEW ENGL J MED, V371, P2348, DOI 10.1056/NEJMp1413425; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gruebner O, 2016, LANCET, V387, P2195, DOI 10.1016/S0140-6736(16)30602-X; Guberti V, 2014, HYSTRIX, V25, P3, DOI 10.4404/hystrix-25.1-10114; Heinen A., 2003, 1117187 SOC SCI RES; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Jin F, 2014, COMPUTER, V47, P90, DOI 10.1109/MC.2014.361; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Liboschik T, TSCOUNT R PACKAGE AN; Machalaba Catherine C, 2015, Emerg Infect Dis, V21, pe1, DOI 10.3201/eid2104.141415; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newcomb J, 2011, EC IMPACT SELECTED I; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Robertson C, 2010, SPAT SPATIO-TEMPORAL, V1, P105, DOI 10.1016/j.sste.2009.12.001; Rossi G, 1999, STAT MED, V18, P2111, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2111::AID-SIM171>3.3.CO;2-H; Schwind JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110236; Short KR, 2015, ONE HEALTH-AMSTERDAM, V1, P1, DOI [10.1016/j.onehlt.2015.03.001, 10.1016/j.onehit.2015.03.001]; Sosin Daniel M, 2004, MMWR Suppl, V53, P125; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zhiheng Xu, 2011, 2011 IEEE/WIC/ACM International Joint Conferences on Web Intelligence (WI) and Intelligent Agent Technologies, P422, DOI 10.1109/WI-IAT.2011.47	43	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165688	10.1371/journal.pone.0165688	http://dx.doi.org/10.1371/journal.pone.0165688			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880777	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500014
J	Elsner, JB; Jagger, TH; Fricker, T				Elsner, James B.; Jagger, Thomas H.; Fricker, Tyler			Statistical Models for Tornado Climatology: Long and Short-Term Views	PLOS ONE			English	Article							UNITED-STATES; POPULATION BIAS; CENTRAL PLAINS; GREAT-PLAINS; PROBABILITY; OSCILLATION; FREQUENCY; OUTBREAKS; ENSO	This paper estimates regional tornado risk from records of past events using statistical models. First, a spatial model is fit to the tornado counts aggregated in counties with terms that control for changes in observational practices over time. Results provide a long-term view of risk that delineates the main tornado corridors in the United States where the expected annual rate exceeds two tornadoes per 10,000 square km. A few counties in the Texas Panhandle and central Kansas have annual rates that exceed four tornadoes per 10,000 square km. Refitting the model after removing the least damaging tornadoes from the data (EFO) produces a similar map but with the greatest tornado risk shifted south and eastward. Second, a space-time model is fit to the counts aggregated in raster cells with terms that control for changes in climate factors. Results provide a short-term view of risk. The short-term view identifies a shift of tornado activity away from the Ohio Valley under El Nino conditions and away from the Southeast under positive North Atlantic oscillation conditions. The combined predictor effects on the local rates is quantified by fitting the model after leaving out the year to be predicted from the data. The models provide state-of-the-art views of tornado risk that can be used by government agencies, the insurance industry, and the general public.	[Elsner, James B.; Jagger, Thomas H.; Fricker, Tyler] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Elsner, JB (corresponding author), Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA.	jelsner@fsu.edu		Elsner, James/0000-0001-6805-7431; Fricker, Tyler/0000-0002-8186-7399	Risk Prediction Initiative of the Bermuda Institute for Ocean Studies (BIOS)	Risk Prediction Initiative of the Bermuda Institute for Ocean Studies (BIOS)	This work is supported by the Risk Prediction Initiative of the Bermuda Institute for Ocean Studies (BIOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the Risk Prediction Initiative of the Bermuda Institute for Ocean Studies (BIOS) with special thanks to Mark Guishard and John Wardman. The authors declare no competing interests.	Allen JT, 2015, NAT GEOSCI, V8, P278, DOI 10.1038/NGEO2385; Anderson CJ, 2007, WEATHER FORECAST, V22, P571, DOI 10.1175/WAF997.1; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Besag J, 1975, J R STAT SOC D-STAT, V24, P179, DOI [10.2307/2987782, DOI 10.2307/2987782]; Brooks HE, 2003, WEATHER FORECAST, V18, P626, DOI 10.1175/1520-0434(2003)018<0626:CEOLDT>2.0.CO;2; Carbin GW, 2016, B AM METEOROL SOC, V97, P1021, DOI 10.1175/BAMS-D-14-00136.1; Cook AR, 2008, MON WEATHER REV, V136, P3121, DOI 10.1175/2007MWR2171.1; Dixon PG, 2011, B AM METEOROL SOC, V92, P433, DOI 10.1175/2010BAMS3102.1; Doswell CA, 2005, WEATHER FORECAST, V20, P577, DOI 10.1175/WAF866.1; DOSWELL CA, 1988, MON WEATHER REV, V116, P495, DOI 10.1175/1520-0493(1988)116<0495:OSIOUS>2.0.CO;2; Elsner JB, 2013, WEATHER CLIM SOC, V5, P221, DOI 10.1175/WCAS-D-12-00040.1; Elsner JB, 2014, MON WEATHER REV, V142, P259, DOI 10.1175/MWR-D-13-00014.1; Elsner JB, 2013, MATH GEOSCI, V45, P667, DOI 10.1007/s11004-013-9458-1; Elsner JB., 2016, INT J SAFETY SECURIT, V6, P1, DOI [10.2495/SAFE-V6-N1-1-9, DOI 10.2495/SAFE-V6-N1-1-9]; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Grazulis TP., 1990, ENV FILMS; Jagger TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131876; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; King P, 1997, WEATHER FORECAST, V12, P939, DOI 10.1175/1520-0434(1997)012<0939:OTAOPB>2.0.CO;2; Lee SK, 2013, J CLIMATE, V26, P1626, DOI 10.1175/JCLI-D-12-00128.1; Marzban C, 2001, MON WEATHER REV, V129, P884, DOI 10.1175/1520-0493(2001)129<0884:TCBUST>2.0.CO;2; Muroz E, 2011, CLIM DYNAM, V36, P247; Ray PS, 2003, MON WEATHER REV, V131, P1026, DOI 10.1175/1520-0493(2003)131<1026:AIEOTO>2.0.CO;2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rue H, INLA FUNCTIONS WHICH; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Shafer C.M., 2011, ELECT J SEVERE STORM, V6, P1; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1	28	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166895	10.1371/journal.pone.0166895	http://dx.doi.org/10.1371/journal.pone.0166895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875581	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000034
J	Jang, TS; McCann, J; Parker, JS; Takayama, K; Hong, SP; Schneeweiss, GM; Weiss-Schneeweiss, H				Jang, Tae-Soo; McCann, Jamie; Parker, John S.; Takayama, Koji; Hong, Suk-Pyo; Schneeweiss, Gerald M.; Weiss-Schneeweiss, Hanna			rDNA Loci Evolution in the Genus Glechoma (Lamiaceae)	PLOS ONE			English	Article							NUCLEAR-DNA AMOUNTS; 5S RDNA; ALLOPOLYPLOID SPECIATION; CONTRASTING PATTERNS; GENOME EVOLUTION; RIBOSOMAL DNA; 45S RDNA; LABIATAE; POLYPLOIDY; RADIATION	Glechoma L. (Lamiaceae) is distributed in eastern Asia and Europe. Understanding chromosome evolution in Glechoma has been strongly hampered by its small chromosomes, constant karyotype and polyploidy. Here phylogenetic patterns and chromosomal variation in Glechoma species are considered, using genome sizes, chromosome mapping of 5S and 35S rDNAs by fluorescence in situ hybridisation (FISH), and phylogenetic analyses of internal transcribed spacers (nrITS) of 35S rDNA and 5S rDNA NTS sequences. Species and populations of Glechoma are tetraploid (2n = 36) with base chromosome number of x = 9. Four chromosomes carry pericentric 5S rDNA sites in their short arms in all the species. Two to four of these chromosomes also carry 35S rDNA in subterminal regions of the same arms. Two to four other chromosomes have 35S rDNA sites, all located subterminally within short arms; one individual possessed additional weak pericentric 35S rDNA signals on three other chromosomes. Five types of rDNA locus distribution have been defined on the basis of 35S rDNA variation, but none is species-specific, and most species have more than one type. Glechoma hederacea has four types. Genome size in Glechoma ranges from 0.80 to 0.94 pg (1C), with low levels of intrapopulational variation in all species. Phylogenetic analyses of ITS and NTS sequences distinguish three main clades coinciding with geographical distribution: European (G. hederacea - G. hirsuta), Chinese and Korean (G. longituba), and Japanese (G. grandis). The paper presents the first comparative cytogenetic analyses of Glechoma species including karyotype structure, rDNA location and number, and genome size interpreted in a phylogenetic context. The observed variation suggests that the genus is still in genomic flux. Genome size, but not rDNA loci number and distribution, provides a character for species delimitation which allows better inferences of interspecific relationships to be made, in the absence of well-defined morphological differentiation.	[Jang, Tae-Soo; McCann, Jamie; Schneeweiss, Gerald M.; Weiss-Schneeweiss, Hanna] Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, Vienna, Austria; [Parker, John S.] Univ Cambridge, Bot Garden, Cambridge, England; [Takayama, Koji] Museum Nat & Environm Hist, Suruga Ku, Oya 5762, Shizuoka, Sizuoka, Japan; [Hong, Suk-Pyo] Kyung Hee Univ, Dept Biol, Lab Plant Systemat, 1 Hoegi Dong, Seoul, South Korea	University of Vienna; University of Cambridge; Kyung Hee University	Jang, TS; Weiss-Schneeweiss, H (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, Vienna, Austria.	tae-soo.jang@univie.ac.at; hanna.schneeweiss@univie.ac.at	Schneeweiss, Gerald M./B-4344-2013; McCann, Jamie/AAP-9923-2020; Schneeweiss, Hanna/B-4011-2013	Schneeweiss, Gerald M./0000-0003-2811-3317; McCann, Jamie/0000-0003-2310-4462; Schneeweiss, Hanna/0000-0002-9530-6808; Jang, Tae-Soo/0000-0002-5527-1137	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.; We thank Prof. Ikeda H (University of Tokyo, Japan), Li X and Pan D (University of Vienna, Austria) for help with material collection for this study. We are also grateful to Dr. Temsch EM (University of Vienna, Austria) for technical support and advice concerning genome size measurements. This article was supported by the Open Access Publishing Fund of the University of Vienna.	Arrighi JF, 2014, NEW PHYTOL, V201, P1457, DOI 10.1111/nph.12594; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Deng T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117171; Dodsworth S, 2015, SYST BIOL, V64, P112, DOI 10.1093/sysbio/syu080; Drew BT, 2012, AM J BOT, V99, P933, DOI 10.3732/ajb.1100549; Emadzade K, 2014, ANN BOT-LONDON, V114, P1597, DOI 10.1093/aob/mcu178; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fredotovic Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-24; Fukushima K, 2011, J PLANT RES, V124, P231, DOI 10.1007/s10265-010-0366-x; Funamoto Tsuneo, 2000, Chromosome Science, V4, P107; Garcia S, 2014, PLANT RDNA DATABASE; GILL BS, 1981, J CYTOL GENET, V16, P35; GILL LS, 1979, GENETICA, V50, P111, DOI 10.1007/BF00123286; GILL LS, 1981, CYTOLOGIA, V46, P27, DOI 10.1508/cytologia.46.27; Govaerts R, 2015, WORLD CHECKLIST LAMI; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harley RM, 2004, FA GE VAS P, V7, P167; 장태수, 2010, [Korean Journal of plant Taxonomy, 식물분류학회지], V40, P50; Iwatsubo Y., 2004, J PHYTOGEOGR TAXON, V52, P67; Jang T-S, 2008, THESIS; Jang TS, 2015, NORD J BOT, V33, P708, DOI 10.1111/njb.00844; Jang TS, 2015, CYTOGENET GENOME RES, V146, P325, DOI 10.1159/000441210; Jang Tae-Soo, 2014, KOREAN JOURNAL OF PLANT TAXONOMY, V44, P22, DOI 10.11110/kjpt.2014.44.1.22; Jang TS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-136; Jang TS, 2010, J SYST EVOL, V48, P464, DOI 10.1111/j.1759-6831.2010.00101.x; JANG TS, 2007, KOREAN J PI TAXON, V37, P239; Kartashova NN, 1974, BIOL BIOFIS TOMSKI, P47; Kolano B, 2015, BOT J LINN SOC, V179, P218, DOI 10.1111/boj.12321; Ksiazczyk T, 2010, J APPL GENET, V51, P449, DOI 10.1007/BF03208874; Ksiazczyk T, 2011, CHROMOSOMA, V120, P557, DOI 10.1007/s00412-011-0331-z; Laane MM, 1971, BLYTTIA, V29, P4; Lan TY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-126; Li HW, 1994, FLORA CHINA, V17, P50; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Mahelka V, 2013, MOL BIOL EVOL, V30, P2065, DOI 10.1093/molbev/mst106; Mandakova T, 2012, TAXON, V61, P989, DOI 10.1002/tax.615006; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; Martinez J, 2010, PLANT SYST EVOL, V289, P223, DOI 10.1007/s00606-010-0345-7; Miura N, 2014, CYTOLOGIA, V79, P371, DOI 10.1508/cytologia.79.371; Miura N, 2010, CYTOLOGIA, V75, P255, DOI 10.1508/cytologia.75.255; Moreno NC, 2015, BOT J LINN SOC, V177, P263, DOI 10.1111/boj.12242; Moris JH, 1837, FLORA SARDOA, V3, P1837; MULLIGAN G A, 1984, Naturaliste Canadien (Quebec), V111, P447; OTTO FJ, 1981, CYTOMETRY, V2, P189, DOI 10.1002/cyto.990020311; Pignatti S, 1982, FLORA D LTALIA, V2; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; Roa F, 2015, CYTOGENET GENOME RES, V146, P243, DOI 10.1159/000440930; Sanders R.W., 1987, SYST BOT MONOGR, V15, P1, DOI [10.2307/25027677, DOI 10.2307/25027677]; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Sheng MY, 2010, PLANT SYST EVOL, V290, P65, DOI 10.1007/s00606-010-0349-3; SORSA VEIKKO, 1963, ANN ACAD SCI FENN SER A IV BIOL, V68, P1; Sousa A, 2011, MICRON, V42, P625, DOI 10.1016/j.micron.2011.03.002; Suda J, 2003, ANN BOT-LONDON, V92, P153, DOI 10.1093/aob/mcg104; Temsch EM, 2010, PRESLIA, V82, P63; Weiss-Schneeweiss H., 2013, PHYS STRUCTURE BEHAV, V2, P209, DOI DOI 10.1007/978-3-7091-1160-4_13; Weiss-Schneeweiss H, 2007, NEW PHYTOL, V174, P669, DOI 10.1111/j.1469-8137.2007.02019.x; Weiss-Schneeweiss H, 2012, EVOLUTION, V66, P211, DOI 10.1111/j.1558-5646.2011.01424.x; Widen B, 2000, HEREDITAS, V132, P229, DOI 10.1111/j.1601-5223.2000.t01-1-00229.x; Widen M, 1999, CAN J BOT, V77, P1689, DOI 10.1139/cjb-77-12-1689; ZUKOWSKI W, 1979, Fragmenta Floristica et Geobotanica, V25, P477	65	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0167177	10.1371/journal.pone.0167177	http://dx.doi.org/10.1371/journal.pone.0167177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870903	Green Submitted, Green Published, gold			2022-12-26	WOS:000388846400062
J	Lam, CS; Tipoe, GL; Wong, JKC; Youdim, MBH; Fung, ML				Lam, Chun-Sing; Tipoe, George Lim; Wong, Johnny Kong-Ching; Youdim, Moussa B. H.; Fung, Man-Lung			M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; ANTIDEPRESSANT-LIKE ACTIVITY; BRAIN MONOAMINE-OXIDASE; SYNAPTIC PLASTICITY; PARKINSONS-DISEASE; RAT MODEL; STRESS; NEUROGENESIS; INHIBITOR; BEHAVIOR	Monoamine oxidases (MAO), downstream targets of glucocorticoid, maintain the turnover and homeostasis of monoamine neurotransmitters; yet, its pathophysiological role in monoamine deficiency, oxidative stress and neuroinflammation remains controversial. Protective effects of M30, a brain selective MAO inhibitor with iron-chelating antioxidant properties, have been shown in models of neurodegenerative diseases. This study aims to examine the neuroprotective mechanism of M30 against depressive-like behavior induced by corticosterone (CORT). Sprague-Dawley rats were given CORT subcutaneous injections with or without concomitant M30 administration for two weeks. CORT-treated rats exhibited depressive-like behavior with significant elevated levels of MAO activities, serotonin turnover, oxidative stress, neuroinflammation and apoptosis in the hippocampus with significant losses of synaptic proteins when compared to the control. The expression and activity of cytokine-responsive indoleamine 2,3-dioxygenase (IDO-1), a catabolic enzyme of serotonin and tryptophan, was significantly increased in the CORT-treated group with lowered levels of serotonin. Besides, CORT markedly reduced dendritic length and spine density. Remarkably, M30 administration neutralized the aberrant changes in the hippocampus and prevented the induction of depressive-like behavior induced by CORT. Our results suggest that M30 is neuroprotective against CORT-induced depression targeting elevated MAO activities that cause oxidative stress and neuroinflammation, resulting in IDO-1 activation, serotonin deficiency and neurodegeneration.	[Lam, Chun-Sing; Tipoe, George Lim; Fung, Man-Lung] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tipoe, George Lim; Fung, Man-Lung] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Johnny Kong-Ching] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Youdim, Moussa B. H.] Technion Israel Inst Technol, Eve Topf Ctr Neurodegenerat Dis Res, Fac Med, IL-31096 Haifa, Israel	University of Hong Kong; University of Hong Kong; University of Hong Kong; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Fung, ML (corresponding author), Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.; Fung, ML (corresponding author), Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	fungml@hku.hk		George, Tipoe/0000-0002-2603-0625	University of Hong Kong [104003406]	University of Hong Kong(University of Hong Kong)	This study was supported by the University of Hong Kong, grant number: 104003406, www.hku.hk.	Bar-Am O, 2015, NEUROBIOL AGING, V36, P1529, DOI 10.1016/j.neurobiolaging.2014.10.026; Barton DA, 2008, ARCH GEN PSYCHIAT, V65, P38, DOI 10.1001/archgenpsychiatry.2007.11; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Carroll BJ, 2012, ACTA PSYCHIAT SCAND, V125, P478, DOI 10.1111/j.1600-0447.2011.01821.x; Castagne V, 2011, CURRENT PROTOCOLS NE, V55; Chen WZ, 2015, BIOL PHARM BULL, V38, P239, DOI 10.1248/bpb.b14-00599; Corona AW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-93; Dale E, 2015, BIOCHEM PHARMACOL, V95, P81, DOI 10.1016/j.bcp.2015.03.011; Dhingra D, 2014, PHARMACOL REP, V66, P1, DOI 10.1016/j.pharep.2013.06.001; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Du LS, 2002, NEUROREPORT, V13, P1195, DOI 10.1097/00001756-200207020-00025; Du LS, 2004, NEUROREPORT, V15, P2097, DOI 10.1097/00001756-200409150-00020; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gal S, 2005, J NEUROCHEM, V95, P79, DOI 10.1111/j.1471-4159.2005.03341.x; Gal S, 2010, NEUROTOX RES, V18, P143, DOI 10.1007/s12640-009-9128-8; Grunewald M, 2012, J BIOL CHEM, V287, P24195, DOI 10.1074/jbc.M112.373936; HABER R, 1993, J NEUROCHEM, V60, P1159, DOI 10.1111/j.1471-4159.1993.tb03269.x; Hasbani MJ, 2011, J NEUROSCIENCE, V21; Hellsten J, 2002, EUR J NEUROSCI, V16, P283, DOI 10.1046/j.1460-9568.2002.02093.x; Hung MW, 2008, J PINEAL RES, V44, P214, DOI 10.1111/j.1600-079X.2007.00514.x; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; Johnson S, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00180; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Kratsovnik E, 2005, J MOL NEUROSCI, V26, P27, DOI 10.1385/JMN:26:1:027; Kupershmidt L, 2012, ANTIOXID REDOX SIGN, V17, P860, DOI 10.1089/ars.2011.4279; Lam CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117990; Lee HY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03398; Liao JC, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-299; Liu J, 2009, J ALZHEIMERS DIS, V22, P541; Liu YN, 2015, EUR CYTOKINE NETW, V26, P15, DOI 10.1684/ecn.2015.0362; Lucassen PJ, 2004, BIOL PSYCHIAT, V55, P789, DOI 10.1016/j.biopsych.2003.12.014; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marttinen M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0013-z; Mechlovich D, 2010, J PHARMACOL EXP THER, V333, P874, DOI 10.1124/jpet.109.164269; Meyer JH, 2009, ARCH GEN PSYCHIAT, V66, P1304, DOI 10.1001/archgenpsychiatry.2009.156; Morais M, 2014, J PSYCHOPHARMACOL, V28, P1178, DOI 10.1177/0269881114553646; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Okuda S, 1998, J NEUROCHEM, V70, P299; Panarsky R, 2012, J NEUROIMMUNE PHARM, V7, P488, DOI 10.1007/s11481-012-9358-z; Pimentel LS, 2015, J ALZHEIMERS DIS, V47, P373, DOI 10.3233/JAD-143126; Poltyrev T, 2005, PSYCHOPHARMACOLOGY, V181, P118, DOI 10.1007/s00213-005-2229-z; Rizzoli SO, 2014, EMBO J; SCHURR A, 1991, BRAIN RES, V568, P199, DOI 10.1016/0006-8993(91)91398-K; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Trudler D, 2014, J NEUROCHEM, V129, P434, DOI 10.1111/jnc.12633; Uz T, 2002, NEUROSCI RES, V42, P309, DOI 10.1016/S0168-0102(02)00011-1; Weinreb O, 2016, BRIT J PHARMACOL, V173, P2080, DOI 10.1111/bph.13318; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wuwongse S, 2013, BBA-MOL BASIS DIS, V1832, P2245, DOI 10.1016/j.bbadis.2013.07.022; Xiao J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/607271; Xie W, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-41; Xu YJ, 2015, BEHAV BRAIN RES, V288, P71, DOI 10.1016/j.bbr.2015.04.017; Yau SY, 2014, CELL TRANSPLANT, V23, P481, DOI 10.3727/096368914X678490; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Youdim MBH, 2004, NEUROLOGY, V63, pS32, DOI 10.1212/WNL.63.7_suppl_2.S32; Youdim Moussa B H, 2013, Exp Neurobiol, V22, P1, DOI 10.5607/en.2013.22.1.1; Zhang ED, 2012, CELL TRANSPLANT, V21, P2635, DOI 10.3727/096368912X655181	63	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166966	10.1371/journal.pone.0166966	http://dx.doi.org/10.1371/journal.pone.0166966			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870896	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400048
J	Gupta, I; Chowdhury, S; Prinja, S; Trivedi, M				Gupta, Indrani; Chowdhury, Samik; Prinja, Shankar; Trivedi, Mayur			Out-of-Pocket Spending on Out-Patient Care in India: Assessment and Options Based on Results from a District Level Survey	PLOS ONE			English	Article							HEALTH-CARE; PAYMENTS; POOR	Out-of-pocket spending at out-patient departments (OPD) by households is relatively less analyzed compared to hospitalization expenses in India. This paper provides new evidence on the levels and drivers of expenditure on out-patient care, as well as choice of providers, using household survey data from 8 districts in 3 states of India. Results indicate that the economically vulnerable spend more on OPD as a proportion of per capita consumption expenditure, out-patient care remains overwhelmingly private and switches of providers-while not very prevalent-is mostly towards private providers. A key result is that choice of public providers tend to lower OPD spending significantly. It indicates that an improvement in the overall quality and accessibility of government facilities still remain an important tool that should be considered in the context of financial protection.	[Gupta, Indrani; Chowdhury, Samik] Inst Econ Growth, Delhi, India; [Prinja, Shankar] Post Grad Inst Med Educ & Res, Chandigarh, India; [Trivedi, Mayur] Indian Inst Publ Hlth, Gandhinagar, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, I (corresponding author), Inst Econ Growth, Delhi, India.	indrani@iegindia.org	Trivedi, Mayur/AFU-4877-2022; Chowdhury, Samik/AAM-9819-2020; Trivedi, Mayur/AHA-6256-2022	Trivedi, Mayur/0000-0002-4532-2340	Indian Council of Social Science Research (ICSSR)	Indian Council of Social Science Research (ICSSR)	This research was supported by a grant from the Indian Council of Social Science Research (ICSSR) (www.icssr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the Indian Council of Social Science Research (ICSSR).	Berman P., 2010, Economic and Political Weekly, V45, P65; CRAGG JG, 1971, ECONOMETRICA, V39, P829, DOI 10.2307/1909582; Deenadayalan Vaishnavi Salem, 2009, J INT DEV, V21, P169; Dror DM, 2008, INDIAN J MED RES, V127, P347; Gupta I, 2015, 346 IEG; Gupta Monica Das, 2010, ECON POLIT WEEKLY, V45, P46; Habibov Nazim, 2009, J Health Organ Manag, V23, P170; Hajizadeh M, 2011, INT J HEALTH CARE FI, V11, P267, DOI 10.1007/s10754-011-9099-1; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Joan Fontab Costa, 2007, APPL ECON, V39, P541; Joe W, 2015, HEALTH POLICY PLANN, V30, P728, DOI 10.1093/heapol/czu050; Kapur A, 2007, INDIAN J MED RES, V125, P473; Onwujekwe OE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-67; Patankar AM, 2011, PUBLIC HEALTH, V125, P157, DOI 10.1016/j.puhe.2010.11.009; Planning Commission, 2011, HIGH LEV EXP GROUP R; Ramani K V, 2006, J Health Organ Manag, V20, P560, DOI 10.1108/14777260610702307; Raza Wameq A., 2016, BMC HEALTH SERV RES, P1, DOI [10.1186/s12913-015-1254-9, DOI 10.1186/S12913-015-1254-9]; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Thomas D, 2015, SOC SCI MED, V145, P154, DOI 10.1016/j.socscimed.2015.06.010; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000	20	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166775	10.1371/journal.pone.0166775	http://dx.doi.org/10.1371/journal.pone.0166775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861559	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300105
J	Jayaprakash, TP; Wagner, EC; van Schalkwyk, J; Albert, AYK; Hill, JE; Money, DM				Jayaprakash, Teenus Paramel; Wagner, Emily C.; van Schalkwyk, Julie; Albert, Arianne Y. K.; Hill, Janet E.; Money, Deborah M.		PPROM Study Grp	High Diversity and Variability in the Vaginal Microbiome in Women following Preterm Premature Rupture of Membranes (PPROM): A Prospective Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; MYCOPLASMA-GENITALIUM; CHLAMYDIA-TRACHOMATIS; PREVOTELLA-BIVIA; INTRAAMNIOTIC INFECTION; UREAPLASMA-UREALYTICUM; POTENTIAL SIGNIFICANCE; GARDNERELLA-VAGINALIS; NEISSERIA-GONORRHOEAE	Objective To characterize the vaginal microbiota of women following preterm premature rupture of membranes (PPROM), and determine if microbiome composition predicts latency duration and perinatal outcomes. Design A prospective cohort study Setting Canada Population Women with PPROM between 24(+0) and 33(+6) weeks gestational age (GA). Methods Microbiome profiles, based on pyrosequencing of the cpn60 universal target, were generated from vaginal samples at time of presentation with PPROM, weekly thereafter, and at delivery. Main Outcome Measures Vaginal microbiome composition, latency duration, gestational age at delivery, perinatal outcomes.	[Jayaprakash, Teenus Paramel; Money, Deborah M.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada; [Wagner, Emily C.; van Schalkwyk, Julie; Albert, Arianne Y. K.; Money, Deborah M.] BC Womens Hosp & Hlth Ctr, Womens Hlth Res Inst, Vancouver, BC, Canada; [van Schalkwyk, Julie; Money, Deborah M.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada	University of Saskatchewan; University of British Columbia	Money, DM (corresponding author), BC Womens Hosp & Hlth Ctr, Womens Hlth Res Inst, Vancouver, BC, Canada.; Money, DM (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.	Deborah.Money@ubc.ca	Albert, Arianne/AAG-7518-2019; Hill, Janet E./B-5001-2011	Albert, Arianne/0000-0002-3050-0888; Hill, Janet E./0000-0002-2187-6277; Janssen, Patricia/0000-0002-4178-1195	March of Dimes Prematurity Research Initiative grant [MONEY 21-FY08-537]; University of Saskatchewan Graduate Scholarship	March of Dimes Prematurity Research Initiative grant; University of Saskatchewan Graduate Scholarship	This work was funded by a March of Dimes Prematurity Research Initiative grant awarded to DM (MONEY 21-FY08-537). TPJ was supported by a University of Saskatchewan Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins-Obstetrics, 2007, Obstet Gynecol, V109, P1007; Albert AYK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135620; American Academy of Pediatrics, 2006, Adv Neonatal Care, V6, P220; Aroutcheva A, 2008, ANAEROBE, V14, P256, DOI 10.1016/j.anaerobe.2008.08.002; Bayraktar MR, 2010, INT J INFECT DIS, V14, pE90, DOI 10.1016/j.ijid.2009.03.020; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cazanave C, 2012, MED MALADIES INFECT, V42, P381, DOI 10.1016/j.medmal.2012.05.006; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Clark GW, 2010, BIOCHEM CELL BIOL, V88, P185, DOI [10.1139/o09-157, 10.1139/O09-157]; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Cunningham FG, 2010, WILLIAMS OBSTET; da Mota VQ, 2013, J CLIN PATHOL, V66, P243, DOI 10.1136/jclinpath-2012-201124; Dare MR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005302.pub2; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; DAVIDSON KM, 1991, CLIN OBSTET GYNECOL, V34, P715, DOI 10.1097/00003081-199112000-00007; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Fortner KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083338; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Frenette P, 2013, J OBSTET GYNAECOL CA, V35, P710, DOI 10.1016/S1701-2163(15)30861-6; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gauthier S, 2011, J MATERN-FETAL NEO M, V24, P1329, DOI 10.3109/14767058.2010.550977; Gaydos C, 2009, SEX TRANSM DIS, V36, P598, DOI 10.1097/OLQ.0b013e3181b01948; Goldenberg RL, 2005, CLIN PERINATOL, V32, P523, DOI 10.1016/j.clp.2005.04.006; Goldenberg RL, 2003, CLIN PERINATOL, V30, P677, DOI 10.1016/S0095-5108(03)00110-6; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; GRATTARD F, 1995, PEDIATR INFECT DIS J, V14, P853, DOI 10.1097/00006454-199510000-00007; GRAVETT MG, 1986, JAMA-J AM MED ASSOC, V256, P1899; Hill G B, 1998, Ann Periodontol, V3, P222, DOI 10.1902/annals.1998.3.1.222; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson T, 2007, J CLIN MICROBIOL, V45, P3145, DOI 10.1128/JCM.00558-07; Jensen JS, 2003, J CLIN MICROBIOL, V41, P261, DOI 10.1128/JCM.41.1.261-266.2003; JOESOEF MR, 1995, AM J OBSTET GYNECOL, V173, P1527, DOI 10.1016/0002-9378(95)90644-4; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Larsen B, 2010, INFECT DIS OBSTET GY, V2010; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Links MG, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-23; Locksmith G, 2001, SEMIN PERINATOL, V25, P295, DOI 10.1053/sper.2001.27163; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; MARTIUS J, 1988, OBSTET GYNECOL, V71, P89; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Nelson DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/ppe.12106; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Paul VK, 1998, INT J GYNECOL OBSTET, V63, P109, DOI 10.1016/S0020-7292(98)00135-0; Pepin J, 2005, SEX TRANSM INFECT, V81, P67, DOI 10.1136/sti.2003.009100; Petricevic L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05136; Pybus V, 1998, FEMS IMMUNOL MED MIC, V22, P317, DOI 10.1016/S0928-8244(98)00103-5; Pybus V, 1997, J INFECT DIS, V175, P406, DOI 10.1093/infdis/175.2.406; READ JS, 1993, AM J OBSTET GYNECOL, V168, P514, DOI 10.1016/0002-9378(93)90484-Z; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Simhan HN, 2005, BJOG-INT J OBSTET GY, V112, P32, DOI 10.1111/j.1471-0528.2005.00582.x; Taylor-Robinson D, 2011, BJOG-INT J OBSTET GY, V118, P164, DOI 10.1111/j.1471-0528.2010.02766.x; TENG LJ, 1995, J FORMOS MED ASSOC, V94, P396; TENG LJ, 1994, J CLIN MICROBIOL, V32, P1464, DOI 10.1128/JCM.32.6.1464-1469.1994; Van Dyck E, 2001, J CLIN MICROBIOL, V39, P1751, DOI 10.1128/JCM.39.5.1751-1756.2001; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056131; Wen A, 2014, J INFECT DIS, V209, P1087, DOI 10.1093/infdis/jit632; Yoshida T, 2002, J CLIN MICROBIOL, V40, P105, DOI 10.1128/JCM.40.1.105-110.2002; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P863, DOI 10.1016/S1701-2163(16)34305-5; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	74	49	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166794	10.1371/journal.pone.0166794	http://dx.doi.org/10.1371/journal.pone.0166794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861554	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300109
J	Liu, JY; Zhang, N; Fang, ZY; Luo, N; Zhao, YK; Bi, XM; An, J; Chen, Z; Liu, DT; Wen, ZY; Fan, ZM; Li, DB				Liu, Jiayi; Zhang, Nan; Fang, Zhaoyang; Luo, Nan; Zhao, Yike; Bi, Xiaoming; An, Jing; Chen, Zhong; Liu, Dongting; Wen, Zhaoying; Fan, Zhanming; Li, Debiao			Image Quality and Stenosis Assessment of Non-Contrast-Enhanced 3-T Magnetic Resonance Angiography in Patients with Peripheral Artery Disease Compared with Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography	PLOS ONE			English	Article							INFLOW SINGLE-SHOT; MR-ANGIOGRAPHY; TECHNICAL CONSIDERATIONS; INITIAL-EXPERIENCE	Purpose To evaluate the diagnostic performance of flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) magnetic resonance angiography (MRA) at 3 T for imaging infragenual arteries relative to contrast-enhanced MRA (CE-MRA) and digital subtraction angiography (DSA). Materials and Methods A series of 16 consecutive patients with peripheral arterial disease (PAD) underwent a combined peripheral MRA protocol consisting of FSD-MRA for the calves and large field-of-view CE-MRA. DSA was performed on all patients within 1 week of the MR angiographies. Image quality and degree of stenosis was assessed by two readers with rich experience. Interobserver agreement was determined using kappa statistics. Receiver operating characteristic (ROC) curve analysis determined the diagnostic value of FSD-MRA, CE-MRA, and CE-MRA combined with FSD-MRA (CE+ FSD MRA) in predicting vascular stenosis. Results At the calf station, no significantly difference of subjective image quality scores was found between FSD-MRA and CE-MRA. Inter-reader agreement was excellent for both FSD-MRA and CE-MRA. Both of FSD-MRA and CE-MRA carry a stenosis overestimation risk relative to DSA standard. With DSA as the reference standard, ROC curve analysis showed that the area under the curve was largest for CE+FSD MRA. The greatest sensitivity and specificity were obtained when a cut-off stenosis score of 2 was used. Conclusion In patients with severe PAD, 3 T FSD-MRA provides good-quality diagnostic images without a contrast agent and is a good supplement for CE-MRA. CE+FSD MRA can improve the accuracy of vascular stenosis diagnosis.	[Liu, Jiayi; Zhang, Nan; Luo, Nan; Zhao, Yike; Liu, Dongting; Wen, Zhaoying; Fan, Zhanming] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Chaoyang Dist Anzhen Rd 2nd, Beijing 100029, Peoples R China; [Fang, Zhaoyang; Bi, Xiaoming; Li, Debiao] Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA; [An, Jing] Siemens Healthcare, MR Collaborat NE Asia, Beijing, Peoples R China; [Chen, Zhong] Capital Med Univ, Beijing Anzhen Hosp, Dept Vasc Surg, Chaoyang Dist Anzhen Rd 2nd, Beijing 100029, Peoples R China	Capital Medical University; Cedars Sinai Medical Center; Siemens AG; Capital Medical University	Fan, ZM (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Chaoyang Dist Anzhen Rd 2nd, Beijing 100029, Peoples R China.	fanzm120@126.com	Fan, Zhaoyang/ABC-6555-2020	, Nan/0000-0002-8309-4262	Beijing National Science Foundation [7142047]; National Natural Science Foundation of China [81401375]; Siemens Healthcare	Beijing National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Siemens Healthcare(Siemens AG)	This work was supported by the Beijing National Science Foundation (No. 7142047) and the National Natural Science Foundation of China (No. 81401375). Additionally, Siemens Healthcare provided support in the form of salary for author JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbach P, 2014, ACTA RADIOL, V55, P266, DOI 10.1177/0284185113498535; BAUM RA, 1995, JAMA-J AM MED ASSOC, V274, P875, DOI 10.1001/jama.274.11.875; Burbelko M, 2013, J MAGN RESON IMAGING, V37, P1427, DOI 10.1002/jmri.23944; Edelman RR, 2014, MAGN RESON MED, V72, P1522, DOI 10.1002/mrm.25477; Edelman RR, 2010, MAGN RESON MED, V63, P951, DOI 10.1002/mrm.22287; Fan ZY, 2009, MAGN RESON MED, V62, P1523, DOI 10.1002/mrm.22142; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Haneder S, 2011, EUR RADIOL, V21, P1452, DOI 10.1007/s00330-011-2063-0; Hansmann J, 2014, J MAGN RESON IMAGING, V39, P1486, DOI 10.1002/jmri.24324; Knobloch G, 2014, CLIN RADIOL, V69, P485, DOI 10.1016/j.crad.2013.12.006; Knobloch G, 2016, EUR RADIOL; Lim RP, 2013, RADIOLOGY, V267, P293, DOI 10.1148/radiol.12120859; Liu X, 2014, J MAGN RESON IMAGING, V40, P1422, DOI 10.1002/jmri.24477; Liu X, 2014, RADIOLOGY, V272, P885, DOI 10.1148/radiol.14132284; Miyazaki M, 2000, J MAGN RESON IMAGING, V12, P776, DOI 10.1002/1522-2586(200011)12:5<776::AID-JMRI17>3.0.CO;2-X; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Morelli JN, 2013, J MAGN RESON IMAGING, V37, P1326, DOI 10.1002/jmri.24174; Riffel P, 2012, EUR J RADIOL, V81, P2754, DOI 10.1016/j.ejrad.2011.12.003; Thierfelder KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091078; Thomsen HS, 2006, EUR RADIOL, V16, P2619, DOI 10.1007/s00330-006-0495-8; Ward EV, 2013, J MAGN RESON IMAGING, V38, P1531, DOI 10.1002/jmri.24124; Zhang N, 2015, J MAGN RESON IMAGING	22	6	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166467	10.1371/journal.pone.0166467	http://dx.doi.org/10.1371/journal.pone.0166467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861626	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300060
J	Won, EJ; Kim, SH; Kee, SJ; Shin, JH; Suh, SP; Chai, JY; Ryang, DW; Shin, MG				Won, Eun Jeong; Kim, Soo Hyun; Kee, Seung Jung; Shin, Jong Hee; Suh, Soon Pal; Chai, Jong Yil; Ryang, Dong Wook; Shin, Myung Geun			Multiplex Real-Time PCR Assay Targeting Eight Parasites Customized to the Korean Population: Potential Use for Detection in Diarrheal Stool Samples from Gastroenteritis Patients	PLOS ONE			English	Article							GYMNOPHALLOIDES-SEOI; ENTERIC PROTOZOA; INFECTIONS; PREVALENCE	Intestinal parasitic diseases occur worldwide and can cause diarrhea or gastroenteritis; however, their diagnosis is quite difficult, especially in low-endemism countries. We developed a multiplex real-time PCR assay for detection of eight intestinal parasites and prospectively evaluated it for patients with gastroenteritis. The assay targeted Cryptosporidium parvum, Giardia lamblia, Entamoeba histolytica, Blastocystis hominis, Dientamoeba fragilis, Clonorchis sinensis, Metagonimus yokogawai, and Gymnophalloides seoi. Performance characteristics were evaluated based on recovery after DNA extraction, analytical sensitivity, specificity, reproducibility, cross-reactivity, and interference characteristics. Clinical performance was validated against microscopy on 123 diarrheal samples. The assay demonstrated strong correlations between DNA concentrations and C-t values (R-2, 0.9924-0.9998), and had a high PCR efficiency (83.3%-109.5%). Polymerase chain reactions detected as few as 10-30 copies of genomic DNA, and coefficient of variance was 0-7%. There was no cross-reactivity to the other 54 microorganisms tested. Interference occurred only in presence of high concentrations of erythrocytes or leukocytes. This assay had a higher correct identification rate (100.0% vs. 90.2%) and lower incorrect ID rate (0.0% vs. 9.8%) when compared to microscopy. Overall, this assay showed a higher sensitivity (100.0%; 95% confidence interval [CI] of 80.5-100.0) than microscopy (29.4%; 95% CI 10.31-55.96), and the specificity levels were comparable for both methods (100.0%; 95% CI 96.58-100.0). This newly developed multiplex real-time PCR assay offers a potential use for detecting intestinal parasitic pathogens customized to the Korean population.	[Won, Eun Jeong; Kim, Soo Hyun; Kee, Seung Jung; Shin, Jong Hee; Suh, Soon Pal; Ryang, Dong Wook; Shin, Myung Geun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea; [Won, Eun Jeong; Kim, Soo Hyun; Kee, Seung Jung; Shin, Jong Hee; Suh, Soon Pal; Ryang, Dong Wook; Shin, Myung Geun] Chonnam Natl Univ Hosp, Gwangju, South Korea; [Chai, Jong Yil] Seoul Natl Univ, Dept Parasitol & Trop Med, Coll Med, Seoul, South Korea; [Shin, Myung Geun] Chonnam Natl Univ, Sch Med, Brain Korea Plus Project 21, Gwangju, South Korea; [Shin, Myung Geun] Chonnam Natl Univ, Sch Med, Environm Hlth Ctr Childhood Leukemia & Canc, Hwasun, Jeollanam Do, South Korea; [Shin, Myung Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, Jeollanam Do, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital; Seoul National University (SNU); Chonnam National University; Chonnam National University; Chonnam National University	Shin, MG (corresponding author), Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea.; Shin, MG (corresponding author), Chonnam Natl Univ Hosp, Gwangju, South Korea.; Shin, MG (corresponding author), Chonnam Natl Univ, Sch Med, Brain Korea Plus Project 21, Gwangju, South Korea.; Shin, MG (corresponding author), Chonnam Natl Univ, Sch Med, Environm Hlth Ctr Childhood Leukemia & Canc, Hwasun, Jeollanam Do, South Korea.; Shin, MG (corresponding author), Chonnam Natl Univ, Hwasun Hosp, Hwasun, Jeollanam Do, South Korea.	mgshin@chonnarn.ac.kr	Won, Eun Jeong/AGX-7670-2022	gi, seungjeong/0000-0001-9708-5837	Leading Foreign Research Institute Recruitment Program, through the NRF - Ministry of Education, Science and Technology (MEST) [2011-0030034]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [2013-1320070]	Leading Foreign Research Institute Recruitment Program, through the NRF - Ministry of Education, Science and Technology (MEST); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Leading Foreign Research Institute Recruitment Program (No. 2011-0030034), through the NRF, funded by the Ministry of Education, Science and Technology (MEST), with additional grant support from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (No. 2013-1320070).	Chai J.-Y., 1990, Korean Journal of Parasitology, V28, P103, DOI 10.3347/kjp.1990.28.Suppl.103; Chai Jong-Yil, 1998, Korean Journal of Parasitology, V36, P155, DOI 10.3347/kjp.1998.36.3.155; Chai JY, 2003, TRENDS PARASITOL, V19, P109, DOI 10.1016/S1471-4922(02)00068-5; Chai JY, 2002, PARASITOL INT, V51, P129, DOI 10.1016/S1383-5769(02)00008-9; Cirioni O, 1999, EUR J EPIDEMIOL, V15, P389, DOI 10.1023/A:1007551218671; CLSI, 2012, FP17A CLSI; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Wit MAS, 2001, CLIN INFECT DIS, V33, P280, DOI 10.1086/321875; Elghareeb Azza S, 2015, Trop Parasitol, V5, P36, DOI 10.4103/2229-5070.149919; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Kim TS, 2009, KOREAN J PARASITOL, V47, P37, DOI 10.3347/kjp.2009.47.1.37; LEE SH, 1993, J PARASITOL, V79, P677, DOI 10.2307/3283602; McHardy IH, 2014, J CLIN MICROBIOL, V52, P712, DOI 10.1128/JCM.02877-13; Mirelman D, 1997, J CLIN MICROBIOL, V35, P2405, DOI 10.1128/JCM.35.9.2405-2407.1997; Morgan UM, 1998, J CLIN MICROBIOL, V36, P995, DOI 10.1128/JCM.36.4.995-998.1998; Nazeer JT, 2013, PARASITOL RES, V112, P595, DOI 10.1007/s00436-012-3171-8; Guk Sang-Mee, 2006, Korean Journal of Parasitology, V44, P1, DOI [10.3347/kjp.2006.44.1.1, 10.3347/kjp.2006.44.4.367]; Sarafraz S, 2013, TROP BIOMED, V30, P113; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Surangsrirat Surapon, 2010, J Med Assoc Thai, V93 Suppl 6, pS119; Tantrawatpan C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-88; ten Hove R, 2007, CLIN MICROBIOL INFEC, V13, P1001, DOI 10.1111/j.1469-0691.2007.01788.x; van Coppenraet LESB, 2009, CLIN MICROBIOL INFEC, V15, P869, DOI 10.1111/j.1469-0691.2009.02894.x; Verweij JJ, 2014, PARASITOLOGY, V141, P1863, DOI 10.1017/S0031182014000419; Verweij JJ, 2003, MOL CELL PROBE, V17, P223, DOI 10.1016/S0890-8508(03)00057-4; Won EJ, 2015, ANN LAB MED, V35, P445, DOI 10.3343/alm.2015.35.4.445; World Health Organization, 2004, GLOB BURD DIS 2004 U	30	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166957	10.1371/journal.pone.0166957	http://dx.doi.org/10.1371/journal.pone.0166957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861635	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300136
J	Gu, P; Wang, Y; Bisht, KK; Wu, L; Kukova, L; Smith, EM; Xiao, Y; Bailey, SM; Lei, M; Nandakumar, J; Chang, S				Gu, P.; Wang, Y.; Bisht, K. K.; Wu, L.; Kukova, L.; Smith, E. M.; Xiao, Y.; Bailey, S. M.; Lei, M.; Nandakumar, J.; Chang, S.			Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis	ONCOGENE			English	Article							DNA-DAMAGE; CHECKPOINT ACTIVATION; PROTEIN; CANCER; REPAIR; PROTECTION; TPP1; CHROMOTHRIPSIS; CHROMOSOMES; BINDING	Chromosomal aberrations are a hallmark of human cancers, with complex cytogenetic rearrangements leading to genetic changes permissive for cancer initiation and progression. Protection of Telomere 1 (POT1) is an essential component of the shelterin complex and functions to maintain chromosome stability by repressing the activation of aberrant DNA damage and repair responses at telomeres. Sporadic and familial mutations in the oligosaccharide-oligonucleotide (OB) folds of POT1 have been identified in many human cancers, but the mechanism underlying how hPOT1 mutations initiate tumorigenesis has remained unclear. Here we show that the human POT1's OB-folds are essential for the protection of newly replicated telomeres. Oncogenic mutations in hPOT1 OB-fold fail to bind to single-stranded telomeric DNA, eliciting a DNA damage response at telomeres that promote inappropriate chromosome fusions via the mutagenic alternative non-homologous end joining (A-NHEJ) pathway. hPOT1 mutations also result in telomere elongation and the formation of transplantable hematopoietic malignancies. Strikingly, conditional deletion of both mPot1a and p53 in mouse mammary epithelium resulted in development of highly invasive breast carcinomas and the formation of whole chromosomes containing massive arrays of telomeric fusions indicative of multiple breakage-fusion-bridge cycles. Our results reveal that hPOT1 OB-folds are required to protect and prevent newly replicated telomeres from engaging in A-NHEJ mediated fusions that would otherwise promote genome instability to fuel tumorigenesis.	[Gu, P.; Wang, Y.; Kukova, L.; Chang, S.] Yale Univ, Sch Med, Dept Lab Med, BML 462,333 Cedar St, New Haven, CT 06520 USA; [Bisht, K. K.; Smith, E. M.; Nandakumar, J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Bisht, K. K.; Smith, E. M.; Nandakumar, J.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Wu, L.] UT MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX USA; [Xiao, Y.] Baylor Coll Med, Dept Med & Mol & Cellular Biol, Sect Hematol Oncol, Houston, TX 77030 USA; [Bailey, S. M.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Lei, M.] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chang, S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Chang, S.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Colorado State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Yale University	Chang, S (corresponding author), Yale Univ, Sch Med, Dept Lab Med, BML 462,333 Cedar St, New Haven, CT 06520 USA.	s.chang@yale.edu		Smith, Eric/0000-0002-5385-4558; Nandakumar, Jayakrishnan/0000-0001-9146-2785	NCI [RO1 CA129037, R01 CA202816, R21 CA200506, R21 CA182280]; CT Department of Public Health [15-002167]; NIH [NIH R00-CA-167644-03, NIH R01-AG050509]; NATIONAL CANCER INSTITUTE [R21CA182280, R01CA129037, R21CA200506, R00CA167644, R01CA202816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114, R01AG050509] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CT Department of Public Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr Asha Multani (MDACC, Houston, TX) for SKY analyses and Dr James You (MDACC, Houston, TX) for histological analyses and Dr Christos Hatzis (Yale university School of Medicine) for POT1 mutation analyses. We thank the Chang lab for helpful suggestions. This work was supported by the NCI (RO1 CA129037, R01 CA202816, R21 CA200506 and R21 CA182280) and the CT Department of Public Health (15-002167) to Sandy Chang. Support for Jayakrishnan Nandakumar is from the NIH (NIH R00-CA-167644-03, NIH R01-AG050509 (Jayakrishnan Nandakumar, co-investigator).	Abreu E, 2011, METHODS MOL BIOL, V735, P125, DOI 10.1007/978-1-61779-092-8_12; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Badie S, 2015, EMBO J, V34, P828, DOI 10.15252/embj.201570610; Bainbridge MN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju384; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Calvete O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9383; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chang S, 2013, NAT GENET, V45, P473, DOI 10.1038/ng.2617; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Gu P, 2013, CELL RES, V23, P705, DOI 10.1038/cr.2013.31; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McClintock B, 1941, GENETICS, V26, P234; Multani AS, 2011, METHODS MOL BIOL, V735, P139, DOI 10.1007/978-1-61779-092-8_13; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nandakumar J, 2010, P NATL ACAD SCI USA, V107, P651, DOI 10.1073/pnas.0911099107; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Thanasoula M, 2012, EMBO J, V31, P3398, DOI 10.1038/emboj.2012.191; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang Y, 2013, J CLIN INVEST, V123, P4489, DOI 10.1172/JCI69574; Wang Y, 2011, BLOOD, V118, P6068, DOI 10.1182/blood-2011-06-361527; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	64	35	36	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					1939	1951		10.1038/onc.2016.405	http://dx.doi.org/10.1038/onc.2016.405			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27869160	Green Accepted			2022-12-26	WOS:000398898500005
J	Lu, YF; Liu, Y; Fu, WM; Xu, J; Wang, B; Sun, YX; Wu, TY; Xu, LL; Chan, KM; Zhang, JF; Li, G				Lu, Ying-Fei; Liu, Yang; Fu, Wei-Ming; Xu, Jia; Wang, Bin; Sun, Yu-Xin; Wu, Tian-Yi; Xu, Liang-Liang; Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang			Long noncoding RNA H19 accelerates tenogenic differentiation and promotes tendon healing through targeting miR-29b-3p and activating TGF-beta 1 signaling	FASEB JOURNAL			English	Article						tendon differentiation; pathway; lncRNA; miRNA	MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; CANCER METASTASIS; ACHILLES-TENDON; EXPRESSION; REPAIR; FIBROSIS; FIBROBLASTS; BIOLOGY	Tendon injures are common orthopedic conditions, but tendon development and the pathogenesis of tendon injures, such as tendinopathy, remain largely unknown and have limited the development of clinical therapy. Studies on tenogenic differentiation at the molecular level may help in developing novel therapeutic strategies. As novel regulators, long noncoding RNAs (lncRNAs) have been found to have widespread biological functions, and emerging evidence demonstrates that lncRNAs may play important regulatory roles in cell differentiation and tissue regeneration. In this study, we found that lncRNA H19 stimulated tenogenesis of human tendon-derived stem cells. Stable overexpression of H19 significantly accelerated TGF-beta 1-induced tenogenic differentiation in vitro and accelerated tendon healing in a mouse tendon defect model. H19 directly targeted miR-29b-3p, which is considered to be a negative regulator of tenogenesis. Furthermore, miR-29b-3p directly suppressed the expression of TGF-beta 1 and type I collagen, thereby forming a novel regulatory feedback loop between H19 and TGF-beta 1 to mediate tenogenic differentiation. Our study demonstrated that H19 promotes tenogenic differentiation both in vitro and in vivo by targeting miR-29b-3p and activating TGF-beta 1 signaling. Regulation of the TGF-beta 1/H19/miR-29b-3p regulatory loop may be a new strategy for treating tendon injury.-Lu, Y.-F., Liu, Y., Fu, W.-M., Xu, J., Wang, B., Sun, Y.-X., Wu, T.-Y., Xu, L.-L, Chan, K.-M., Zhang, J.-F., Li, G. Long noncoding RNA H19 accelerates tenogenic differentiation and promotes tendon healing through targeting miR-29b-3p and activating TGF-beta 1 signaling.	[Lu, Ying-Fei; Liu, Yang; Xu, Jia; Wang, Bin; Sun, Yu-Xin; Wu, Tian-Yi; Xu, Liang-Liang; Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang] Chinese Univ Hong Kong, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang] Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Stem Cells & Regenerat Med Lab, Hong Kong, Hong Kong, Peoples R China; [Fu, Wei-Ming] Southern Med Univ, Sch Pharmaceut Sci, Guangzhouv, Peoples R China; [Xu, Jia] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Southern Medical University - China; Shanghai Jiao Tong University	Zhang, JF; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Room 904,9-F, Shatin, Hong Kong, Peoples R China.	zhangjf06@cuhk.edu.hk; gangli@cuhk.edu.hk	Liangliang, XU/K-9185-2019; WANG, BIN/O-2346-2019; Li, Gang/J-7830-2018	Liangliang, XU/0000-0002-5249-7480; WANG, BIN/0000-0002-1348-1494; Li, Gang/0000-0002-3981-2239	Young Scientist Mentorship and Research Training (SMART) program; Lui Che Woo Institute of Innovation Medicine (The Chinese University of Hong Kong)	Young Scientist Mentorship and Research Training (SMART) program; Lui Che Woo Institute of Innovation Medicine (The Chinese University of Hong Kong)	This work is partially supported by the Young Scientist Mentorship and Research Training (SMART) program and the Lui Che Woo Institute of Innovation Medicine (The Chinese University of Hong Kong). The authors declare no conflicts of interest.	Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chen Q, 2014, INT J CLIN EXP PATHO, V7, P8462; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Clayton RAE, 2008, INJURY, V39, P1338, DOI 10.1016/j.injury.2008.06.021; Cushing L, 2015, BIOCHEM CELL BIOL, V93, P109, DOI 10.1139/bcb-2014-0095; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Farhat YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051411; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Guo J, 2016, EXP CELL RES, V341, P1, DOI 10.1016/j.yexcr.2016.01.007; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Isfort RJ, 1997, MOL CARCINOGEN, V20, P189, DOI 10.1002/(SICI)1098-2744(199710)20:2<189::AID-MC5>3.3.CO;2-8; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; KVIST M, 1994, SPORTS MED, V18, P173, DOI 10.2165/00007256-199418030-00004; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Li JX, 2016, MOL MED REP, V13, P4229, DOI 10.3892/mmr.2016.5062; Li JX, 2016, REPROD SCI, V23, P386, DOI 10.1177/1933719115602768; Liang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20121; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; LUSTIG O, 1994, MOL REPROD DEV, V38, P239, DOI 10.1002/mrd.1080380302; Ma CC, 2014, TUMOR BIOL, V35, P9163, DOI 10.1007/s13277-014-2185-5; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pathak S, 2010, REPROD FERT DEVELOP, V22, P939, DOI 10.1071/RD09154; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Qiu YW, 2013, CELLS TISSUES ORGANS, V197, P27, DOI 10.1159/000341426; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Wang B, 2016, EXP CELL RES, V347, P360, DOI 10.1016/j.yexcr.2016.08.018; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Yang T, 2013, J CELL BIOCHEM, V114, P1336, DOI 10.1002/jcb.24474; Yin Z, 2016, STEM CELL TRANSL MED, V5, P1106, DOI 10.5966/sctm.2015-0215; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhu L, 2013, BIOCHEM BIOPH RES CO, V432, P612, DOI 10.1016/j.bbrc.2013.02.036; Zhu ZJ, 2015, INT J CLIN EXP PATHO, V8, P10082; Zuo CQ, 2013, MOL MED REP, V8, P463, DOI 10.3892/mmr.2013.1540	52	58	61	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					954	964		10.1096/fj.201600722R	http://dx.doi.org/10.1096/fj.201600722R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895107				2022-12-26	WOS:000395671200012
J	Wang, Y; Ou, Z; Sun, Y; Yeh, S; Wang, X; Long, J; Chang, C				Wang, Y.; Ou, Z.; Sun, Y.; Yeh, S.; Wang, X.; Long, J.; Chang, C.			Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals	ONCOGENE			English	Article							PROSTATE-CANCER; TRANSCRIPTION FACTOR; BLADDER-CANCER; CELL-MIGRATION; MITF; PROGRESSION; RESISTANCE; THERAPY; SURVIVAL; BEHAVIOR	Early studies demonstrated that male melanoma patients have worse survival than female patients, yet the detailed mechanisms for this gender difference remain unclear. We analyzed around 100 cases of human melanoma and found that androgen receptor (AR) positive melanoma patients have worse survival outcomes compared with AR-negative melanoma patients. Here we report that AR can have positive roles to increase melanoma cell invasion in multiple cell lines in vitro and a mouse model in vivo. Mechanism dissection suggest that AR increases melanoma cell invasion via modulating the MITF-AXL signals via altering the miRNA-539-3p/USP13 signaling to increase MITF protein degradation through a reduction of de-ubiquitination. Restoring MITF can reverse AR-enhanced melanoma cell invasion. Together, our results demonstrate that AR can promote melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signal and targeting this newly identified signal with AR degradation enhancer ASC-J9 may help us to better suppress the melanoma metastasis.	[Wang, Y.; Ou, Z.; Wang, X.; Long, J.] Cent South Univ, Xiangya Hosp, Dept Plast Surg, Changsha, Hunan, Peoples R China; [Wang, Y.; Ou, Z.; Sun, Y.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY USA; [Wang, Y.; Ou, Z.; Sun, Y.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY USA; [Wang, Y.; Ou, Z.; Sun, Y.; Yeh, S.; Chang, C.] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY USA; [Chang, C.] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Central South University; University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Long, J; Chang, C (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol,Wilmot Canc Ctr, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.; Long, J; Chang, C (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol,Wilmot Canc Ctr, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	jianhonglong@126.com; chang@urmc.rochester.edu			NIH [CA155477, CA156700]; George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial, Research Center of Excellence [DOH99-TD-B-111-004]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial, Research Center of Excellence	This work was supported by NIH grants (CA155477 and CA156700), George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial, Research Center of Excellence (DOH99-TD-B-111-004 to China Medical University, Taichung, Taiwan). We thank Karen Wolf for help with preparing the manuscript. ASC-J9 was patented by the University of Rochester, the University of North Carolina, and AndroScience Corp., and then licensed to AndroScience Corp. Both the University of Rochester and C. Chang own royalties and equity in AndroScience Corp.	Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; CLARK WH, 1969, CANCER RES, V29, P705; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eccles MR, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00229; Fernandez-Barral A, 2014, NEOPLASIA, V16, P529, DOI 10.1016/j.neo.2014.06.001; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; He DL, 2014, CANCER RES, V74, P4420, DOI 10.1158/0008-5472.CAN-13-2681; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hsu JW, 2013, AM J PATHOL, V182, P1811, DOI 10.1016/j.ajpath.2013.01.018; Izumi K, 2013, EMBO MOL MED, V5, P1383, DOI 10.1002/emmm.201202367; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Ji SR, 2015, CELL RES, V25, P561, DOI 10.1038/cr.2015.30; Joosse A, 2012, J CLIN ONCOL, V30, P2240, DOI 10.1200/JCO.2011.38.0584; Law MH, 2015, NAT GENET, V47, P987, DOI 10.1038/ng.3373; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li WQ, 2013, J CLIN ONCOL, V31, P4394, DOI 10.1200/JCO.2013.51.1915; Lin TH, 2013, J BIOL CHEM, V288, P19359, DOI 10.1074/jbc.M113.477216; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Ma WL, 2012, HEPATOLOGY, V56, P176, DOI 10.1002/hep.25644; Menzies AM, 2012, DRUG DES DEV THER, V6, P391, DOI 10.2147/DDDT.S38998; Mills IG, 2014, NAT REV CANCER, V14, P187, DOI 10.1038/nrc3678; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Niu Y, 2010, ONCOGENE, V29, P3593, DOI 10.1038/onc.2010.121; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; Sensi M, 2011, J INVEST DERMATOL, V131, P2448, DOI 10.1038/jid.2011.218; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Thomsen FB, 2016, INT J CANCER, V138, P2154, DOI 10.1002/ijc.29961; WHITE LP, 1959, NEW ENGL J MED, V260, P789, DOI 10.1056/NEJM195904162601601; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yajima I, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/730170; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421; Zhu G., 2014, UROLOGY, V83, pe19, DOI DOI 10.1016/J.UR0L0GY.2013.10.022	48	24	25	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1644	1654		10.1038/onc.2016.330	http://dx.doi.org/10.1038/onc.2016.330			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27869170				2022-12-26	WOS:000397460600004
J	van der Veen, DR; Gerkema, MP				van der Veen, Daan R.; Gerkema, Menno P.			Unmasking ultradian rhythms in gene expression	FASEB JOURNAL			English	Article						biological rhythm; circadian; metabolism; cell culture; transcriptome	COMMON VOLE; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; MICROTUS-ARVALIS; IN-VITRO; MOUSE; MECHANISMS; COMPONENT; LESIONS; ROLES	Biological oscillations with an ultradian time scale of 1 to several hours include cycles in behavioral arousal, episodic glucocorticoid release, and gene expression. Ultradian rhythms are thought to have an extrinsic origin because of a perceived absence of ultradian rhythmicity in vitro and a lack of known molecular ultradian oscillators. We designed a novel, non-spectral-analysis method of separating ultradian from circadian components and applied it to a published gene expression dataset with an ultradian sampling resolution. Ultradian rhythms in mouse hepatocytes in vivo have been published, and we validated our approach using this control by confirming 175 of 323 ultradian genes identified in a prior study and found 862 additional ultradian genes. For the first time, we now report ultradian expression of >900 genes in vitro. Sixty genes exhibited ultradian transcriptional rhythmicity, both in vivo and in vitro, including 5 genes involved in the cell cycle. Within these 60 genes, we identified significant enrichment of specific DNA motifs in the 1000 bp proximal promotor, some of which associate with known transcriptional factors. These findings are in strong support of instrinsically driven ultradian rhythms and expose potential molecular mechanisms and functions underlying ultradian rhythms that remain unknown.	[van der Veen, Daan R.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Gerkema, Menno P.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Chronobiol, NL-9700 AB Groningen, Netherlands	University of Surrey; University of Groningen	van der Veen, DR (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.	d.vanderveen@surrey.ac.uk	van der Veen, Daan R/T-1013-2017; gerkema, menno/GLN-3200-2022	van der Veen, Daan R/0000-0001-8037-1407; 				ASCHOFF J., 1954, PFLTLGERS ARCH GES PHYSIOL, V260, P81, DOI 10.1007/BF00363781; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bechtel W, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00118; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; Brodsky VY, 2014, BIOCHEMISTRY-MOSCOW+, V79, P483, DOI 10.1134/S0006297914060017; Brodsky VY, 2010, CELL BIOL INT, V34, P1199, DOI 10.1042/CBI20100036; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chaix A, 2016, J CELL BIOL, V215, P15, DOI 10.1083/jcb.201603076; DEPRINS J, 1993, CHRONOBIOL INT, V10, P395, DOI 10.3109/07420529309064493; Dowse H, 2010, J EXP BIOL, V213, P1788, DOI 10.1242/jeb.038877; DOWSE HB, 1987, BEHAV GENET, V17, P19, DOI 10.1007/BF01066008; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; DUTILLEUL P, 1995, BIOL RHYTHM RES, V26, P173, DOI 10.1080/09291019509360334; ENRIGHT JT, 1989, J BIOL RHYTHM, V4, P295; Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gerkema M, 1985, EXP BRAIN RES S, V12, P321, DOI DOI 10.1007/978-3-642-70483-3; GERKEMA MP, 1991, J COMP PHYSIOL A, V168, P591, DOI 10.1007/BF00215081; GERKEMA MP, 1990, J BIOL RHYTHM, V5, P81, DOI 10.1177/074873049000500201; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; IXART G, 1991, EXP BRAIN RES, V87, P153; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; MERSHON JL, 1992, ENDOCRINOLOGY, V130, P2991, DOI 10.1210/en.130.5.2991; Ono D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12310; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schenda J, 2000, CELL MOL LIFE SCI, V57, P1785, DOI 10.1007/PL00000658; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; Seki Y, 2014, J BIOSCIENCES, V39, P585, DOI 10.1007/s12038-014-9450-z; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Strijkstra AM, 1999, CHRONOBIOL INT, V16, P431, DOI 10.3109/07420529908998718; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Veen DR, 2011, CHRONOBIOL INT, V28, P563, DOI 10.3109/07420528.2011.591953; van der Veen DR, 2006, P NATL ACAD SCI USA, V103, P3393, DOI 10.1073/pnas.0507825103; van Oort BEH, 2007, NATURWISSENSCHAFTEN, V94, P183, DOI 10.1007/s00114-006-0174-2; Ventre S, 2015, J MOL BIOL, V427, P1887, DOI 10.1016/j.jmb.2015.03.007; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	47	19	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					743	750		10.1096/fj.201600872R	http://dx.doi.org/10.1096/fj.201600872R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871062	Green Published, hybrid			2022-12-26	WOS:000394235400026
J	Chandrasekar, S; Shan, SO				Chandrasekar, Sowmya; Shan, Shu-ou			Anionic Phospholipids and the Albino3 Translocase Activate Signal Recognition Particle-Receptor Interaction during Light-harvesting Chlorophyll a/b-binding Protein Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST SRP PATHWAY; THYLAKOID MEMBRANES; TRANSLATING RIBOSOME; ESCHERICHIA-COLI; STRUCTURAL BASIS; GTPASE ACTIVITY; CPSRP43; FTSY; RNA; SUBSTRATE	The universally conserved signal recognition particle (SRP) co-translationally delivers newly synthesized membrane and secretory proteins to the target cellular membrane. The only exception is found in the chloroplast of green plants, where the chloroplast SRP (cpSRP) post-translationally targets light-harvesting chlorophyll a/b-binding proteins (LHCP) to the thylakoid membrane. The mechanism and regulation of this post-translational mode of targeting by cpSRP remain unclear. Using biochemical and biophysical methods, here we show that anionic phospholipids activate the cpSRP receptor cpFtsY to promote rapid and stable cpSRP54.cpFtsY complex assembly. Furthermore, the stromal domain of the Alb3 translocase binds with high affinity to and regulates GTP hydrolysis in the cpSRP54.cpFtsY complex, suggesting that cpFtsY is primarily responsible for initial recruitment of the targeting complex to Alb3. These results suggest a new model for the sequential recruitment, remodeling, and unloading of the targeting complex at membrane translocase sites in the post-translational cpSRP pathway.	[Chandrasekar, Sowmya; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu			National Institutes of Health [1R01GM114390]; Gordon and Betty Moore Foundation; American Federation for Aging Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); American Federation for Aging Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM114390 and fellowships from the Gordon and Betty Moore Foundation and American Federation for Aging Research (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chandrasekar S, 2017, J BIOL CHEM, V292, P386, DOI 10.1074/jbc.M116.752931; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eichacker LA, 2001, BBA-MOL CELL RES, V1541, P120, DOI 10.1016/S0167-4889(01)00151-3; Falk S, 2010, J BIOL CHEM, V285, pLE25, DOI 10.1074/jbc.L110.160093; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Horn A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9875; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Liang FC, 2016, P NATL ACAD SCI USA, V113, pE1615, DOI 10.1073/pnas.1524777113; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Nguyen TX, 2011, BIOCHEMISTRY-US, V50, P7208, DOI 10.1021/bi200742a; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Richter CV, 2008, FEBS LETT, V582, P3223, DOI 10.1016/j.febslet.2008.08.014; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; Saraogi I, 2014, J CELL BIOL, V205, P693, DOI 10.1083/jcb.201311028; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; ZOPF D, 1993, J CELL BIOL, V120, P1113, DOI 10.1083/jcb.120.5.1113; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	58	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					397	406		10.1074/jbc.M116.752956	http://dx.doi.org/10.1074/jbc.M116.752956			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895124	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000391578000034
J	Hewett, SJ; Shi, JX; Gong, YF; Dhandapani, K; Pilbeam, C; Hewett, JA				Hewett, Sandra J.; Shi, Jingxue; Gong, Yifan; Dhandapani, Krishnan; Pilbeam, Carol; Hewett, James A.			Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons OPPOSING ROLES FOR THE TRANSCRIPTION FACTORS CREB (cAMP RESPONSE ELEMENT BINDING) PROTEIN AND Sp1 (STIMULATORY PROTEIN-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; CYCLOOXYGENASE-2 GENE-TRANSCRIPTION; DOMINANT-NEGATIVE INHIBITOR; CELL-SURFACE EXPRESSION; LONG-TERM POTENTIATION; NERVOUS-SYSTEM; UP-REGULATION; H SYNTHASE-1	Burgeoning evidence supports a role for cyclooxygenase metabolites in regulating membrane excitability in various forms of synaptic plasticity. Two cyclooxygenases, COX-1 and COX-2, catalyze the initial step in the metabolism of arachidonic acid to prostaglandins. COX-2 is generally considered inducible, but in glutamatergic neurons in some brain regions, including the cerebral cortex, it is constitutively expressed. However, the transcriptional mechanisms by which this occurs have not been elucidated. Here, we used quantitative PCR and also analyzed reporter gene expression in a mouse line carrying a construct consisting of a portion of the proximal promoter region of the mouse COX-2 gene upstream of luciferase cDNA to characterize COX-2 basal transcriptional regulation in cortical neurons. Extracts from the whole brain and from the cerebral cortex, hippocampus, and olfactory bulbs exhibited high luciferase activity. Moreover, constitutive COX-2 expression and luciferase activity were detected in cortical neurons, but not in cortical astrocytes, cultured from wild-type and transgenic mice, respectively. Constitutive COX-2 expression depended on spontaneous but not evoked excitatory synaptic activity and was shown to be N-methyl-D-aspartate receptor-dependent. Constitutive promoter activity was reduced in neurons transfected with a dominant-negative cAMP response element binding protein (CREB) and was eliminated by mutating the CRE-binding site on the COX-2 promoter. However, mutation of the stimulatory protein-1 (Sp1)-binding site resulted in an N-methyl-D-aspartate receptor-dependent enhancement of COX-2 promoter activity. Basal binding of the transcription factors CREB and Sp1 to the native neuronal COX-2 promoter was confirmed. In toto, our data suggest that spontaneous glutamatergic synaptic activity regulates constitutive neuronal COX-2 expression via Sp1 and CREB protein-dependent transcriptional mechanisms.	[Hewett, Sandra J.; Shi, Jingxue; Gong, Yifan; Hewett, James A.] Syracuse Univ, Dept Biol, Program Neurosci, Syracuse, NY 13210 USA; [Dhandapani, Krishnan] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA; [Pilbeam, Carol] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA	Syracuse University; University System of Georgia; Augusta University; University of Connecticut	Hewett, SJ; Hewett, JA (corresponding author), Syracuse Univ, Dept Biol, Program Neurosci, Syracuse, NY 13210 USA.	shewett@syr.edu; jhewett@syr.edu		Dhandapani, Krishnan/0000-0001-7044-1117	National Institutes of Health [NS036812, NS082982, T32 DC005355]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS082982, R29NS036812, R01NS036812, R21NS056304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grants NS036812 (to S. J. H. and J. A. H.), NS082982 (to J. A. H.), and T32 DC005355 (to K. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 1996, J NEUROCHEM, V66, P6; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Choudhary S, 2004, BIOCHEM BIOPH RES CO, V322, P395, DOI 10.1016/j.bbrc.2004.07.129; Chu C, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-44; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fang QC, 2014, DIABETES, V63, P4165, DOI 10.2337/db14-0182; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Fogal B, 2005, NEUROSCIENCE, V132, P929, DOI 10.1016/j.neuroscience.2005.01.036; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hewett SJ, 2006, PHARMACOL THERAPEUT, V112, P335, DOI 10.1016/j.pharmthera.2005.04.011; Hewett SJ, 2000, J PHARMACOL EXP THER, V293, P417; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jackman NA, 2010, GLIA, V58, P1806, DOI 10.1002/glia.21050; Jang JH, 2005, FREE RADICAL BIO MED, V38, P1604, DOI 10.1016/j.freeradbiomed.2005.02.023; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Koch H, 2010, J NEUROSCI, V30, P11678, DOI 10.1523/JNEUROSCI.4665-09.2010; KRAEMER SA, 1992, ARCH BIOCHEM BIOPHYS, V293, P391, DOI 10.1016/0003-9861(92)90411-O; Kuan CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147886; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Le TD, 2010, P NATL ACAD SCI USA, V107, P3198, DOI 10.1073/pnas.0915020107; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lubelski D, 2012, BRAIN RES, V1429, P18, DOI 10.1016/j.brainres.2011.10.033; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; McIlhinney RAJ, 1996, NEUROSCIENCE, V70, P989, DOI 10.1016/0306-4522(95)00419-X; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Monti B, 2002, EUR J NEUROSCI, V16, P1490, DOI 10.1046/j.1460-9568.2002.02232.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Murray HJ, 2003, NEUROPHARMACOLOGY, V44, P374, DOI 10.1016/S0028-3908(02)00375-1; Rakhit S, 2005, MOL PHARMACOL, V67, P1158, DOI 10.1124/mol.104.005447; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sang N, 2006, NEUROSCIENTIST, V12, P425, DOI 10.1177/1073858406290794; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Taylor AL, 2002, J BIOL CHEM, V277, P43881, DOI 10.1074/jbc.M205872200; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Tegeder I, 2004, J NEUROSCI, V24, P1637, DOI 10.1523/JNEUROSCI.3118-03.2004; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Trackey JL, 2001, J NEUROCHEM, V79, P445, DOI 10.1046/j.1471-4159.2001.00584.x; Uliasz TF, 2012, METHODS MOL BIOL, V814, P61, DOI 10.1007/978-1-61779-452-0_5; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WANG LH, 1993, BIOCHEM BIOPH RES CO, V190, P406, DOI 10.1006/bbrc.1993.1062; Wardlaw SA, 2002, MOL PHARMACOL, V62, P326, DOI 10.1124/mol.62.2.326; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Xu XM, 1997, J BIOL CHEM, V272, P6943, DOI 10.1074/jbc.272.11.6943; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Yang HW, 2008, MOL CELL NEUROSCI, V37, P682, DOI 10.1016/j.mcn.2007.12.019; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	78	13	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27279	27288		10.1074/jbc.M116.737353	http://dx.doi.org/10.1074/jbc.M116.737353			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875294	Green Published, hybrid			2022-12-26	WOS:000391576300025
J	Suzuki, S; Ogawa, M; Ohta, S; Nunomura, S; Nanri, Y; Shiraishi, H; Mitamura, Y; Yoshihara, T; Lee, JJ; Izuhara, K				Suzuki, Shoichi; Ogawa, Masahiro; Ohta, Shoichiro; Nunomura, Satoshi; Nanri, Yasuhiro; Shiraishi, Hiroshi; Mitamura, Yasutaka; Yoshihara, Tomohito; Lee, James J.; Izuhara, Kenji			Induction of Airway Allergic Inflammation by Hypothiocyanite via Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID; BRONCHIAL-ASTHMA; INNATE IMMUNITY; HOST-DEFENSE; INTERLEUKIN-13; SMOKING; ACTIVATION; REACTIVITY; APOPTOSIS; PERIOSTIN	Hypothiocyanite (OSCN-) serves as a potent innate defense system against microbes in the lungs. OSCN- is generated by the catalysis of peroxidases using thiocyanate transported via several anion transporters, including pendrin/SLC26A4 and hydrogen peroxide (H2O2) generated by Duox1 and Duox2. We previously demonstrated that expression of pendrin, peroxidases, and Duox1/Duox2 is up-regulated in bronchial asthma patients and/or asthma model mice and that these molecules are important in accelerating airway inflammation. However, it remained unclear how activating these molecules would lead to airway inflammation. In this study, we examined whether OSCN- produced via the pendrin/peroxidase/Duox pathway causes inflammation via airway epithelial cells. In an in vitro OSCN- production system, OSCN-, but not H2O2, activated NF-kappa B, a transcription factor critical for inflammatory responses, in the airway epithelial cells. OSCN- was sensed by protein kinase A (PKA) followed by formation of the dimerization of PKA. The dimerized PKA, the active form, was critical in activating NF-kappa B. Detoxifying H2O2, mainly by catalase, enabled the dominant abilities of OSCN- to dimerize PKA and activate NF-kappa B, compared with untreated H2O2. Furthermore, OSCN- in high doses caused necrosis of the cells, inducing release of IL-33, a trigger to initiate type 2 inflammation. These results demonstrate that OSCN- in low doses activates NF-kappa B via PKA in airway epithelial cells, whereas OSCN- in high doses causes necrosis, suggesting an important role in airway allergic inflammation for the production of OSCN- via the pendrin/peroxidase/Duox pathway.	[Suzuki, Shoichi; Ogawa, Masahiro; Ohta, Shoichiro; Nunomura, Satoshi; Nanri, Yasuhiro; Shiraishi, Hiroshi; Mitamura, Yasutaka; Yoshihara, Tomohito; Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan; [Lee, James J.] Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA	Saga University; Mayo Clinic; Mayo Clinic Phoenix	Izuhara, K (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp	Mitamura, Yasutaka/AAT-2110-2021; Mitamura, Yasutaka/X-2529-2019; Nunomura, Satoshi/Q-4249-2017	Mitamura, Yasutaka/0000-0001-6389-9285; Nunomura, Satoshi/0000-0002-9315-4185	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Barrett TJ, 2012, CHEM RES TOXICOL, V25, P263, DOI 10.1021/tx200219s; Bozonet SM, 2010, FREE RADICAL BIO MED, V49, P1054, DOI 10.1016/j.freeradbiomed.2010.06.028; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chandler JD, 2013, J BIOL CHEM, V288, P18421, DOI 10.1074/jbc.M113.468090; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hawkins CL, 2009, FREE RADICAL RES, V43, P1147, DOI 10.3109/10715760903214462; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; HUSGAFVELPURSIAINEN K, 1987, INT ARCH OCC ENV HEA, V59, P337, DOI 10.1007/BF00405277; Izuhara K, 2003, CLIN CHEM LAB MED, V41, P860, DOI 10.1515/CCLM.2003.130; Izuhara K, 2015, ALLERGOL INT, V64, pS3, DOI 10.1016/j.alit.2015.04.012; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320; Liu ZG, 2004, IMMUNOL REV, V201, P57, DOI 10.1111/j.0105-2896.2004.00186.x; Lloyd MM, 2008, BIOCHEM J, V414, P271, DOI 10.1042/BJ20080468; Lloyd MM, 2013, FREE RADICAL BIO MED, V65, P1352, DOI 10.1016/j.freeradbiomed.2013.10.007; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Midwinter RG, 2006, BIOCHEM J, V396, P71, DOI 10.1042/BJ20052026; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Niikura Y, 2002, J BIOCHEM, V132, P53, DOI 10.1093/oxfordjournals.jbchem.a003198; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Reber LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049512; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; SALOOJEE Y, 1982, THORAX, V37, P521, DOI 10.1136/thx.37.7.521; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Suzuki S, 2016, J ALLERGY CLIN IMMUN, V138, P1458, DOI 10.1016/j.jaci.2016.04.047; Tamimi A, 2012, RESP MED, V106, P319, DOI 10.1016/j.rmed.2011.11.003; Taniguchi K, 2014, J INVEST DERMATOL, V134, P1295, DOI 10.1038/jid.2013.500; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	43	17	20	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27219	27227		10.1074/jbc.M116.746909	http://dx.doi.org/10.1074/jbc.M116.746909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864363	hybrid, Green Published			2022-12-26	WOS:000391576300020
J	Eichenberger, PA; Scherer, TA; Spengler, CM				Eichenberger, Philipp A.; Scherer, Thomas A.; Spengler, Christina M.			Pre-Exercise Hyperpnea Attenuates Exercise Induced Bronchoconstriction Without Affecting Performance	PLOS ONE			English	Article							WARM-UP EXERCISE; INDUCED ASTHMA; REFRACTORY PERIOD; MUSCLE FATIGUE; INDOMETHACIN; RESISTANCE; TOLERANCE; SYMPTOMS; MANNITOL	Whole-body warm-up exercises were shown to attenuate exercise-induced bronchoconstriction (EIB). Whether intense pre-exercise hyperpnea offers similar protection and whether this might negatively affect exercise performance is unknown. Nine subjects with EIB (25 +/- 5 yrs; forced expiratory volume in 1s [FEV1], 104 +/- 15% predicted) performed an exercise challenge (ECh) followed after 30min by a constant-load cycling test to exhaustion. The ECh was preceded by one of four conditions: by i) control warm-up (CON) or by 10min of normocapnic hyperpnea with partial rebreathing at either ii) 50% (WU50) or iii) variable intensity (8x 30s-80%/45s-30%; WU80/30), or at iv) 70% (WU70) of maximal voluntary ventilation. FEVi was measured at baseline and in 5-min intervals until 15min after CON/ warm-up and 30min after ECh. None of the warm-up conditions induced EIB. The maximal post-ECh decrease in FEVi was-13.8 +/- 3.1% after CON,-9.3 +/- 5.0% after WU50 (p = 0.081 vs. CON),-8.6 +/- 7.5% after WU80/30 (p = 0.081 vs. CON) and-7.2 +/- 5.0% after WU70 (p = 0.006 vs. CON), and perception of respiratory exertion was significantly attenuated (all p <= 0.048), with no difference between warm-up conditions. Only after CON, FEVi remained significantly reduced up to the start of the cycling endurance test (-8.0 +/- 4.3%, p = 0.004). Cycling performance did not differ significantly between test days (CON: 13 +/- 7min; WU50: 14 +/- 9min; WU80/30: 13 +/- 9min; WU70: 14 +/- 7min; p = 0.582). These data indicate that intense hyperpnea warm-up is effective in attenuating EIB severity and accelerating lung function recovery while none of the warm-up condition do compromise cycling performance.	[Eichenberger, Philipp A.; Spengler, Christina M.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Exercise Physiol Lab, Zurich, Switzerland; [Scherer, Thomas A.] LungenZentrum Hirslanden, Zurich, Switzerland; [Spengler, Christina M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Spengler, CM (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Exercise Physiol Lab, Zurich, Switzerland.; Spengler, CM (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	christina.spengler@hest.ethz.ch	Spengler, Christina M./E-9776-2012	Spengler, Christina M./0000-0002-4598-3595	Swiss Federal Office of Sport [12-07]	Swiss Federal Office of Sport	This work was supported by Swiss Federal Office of Sport (grant no. 12-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	BENDOV I, 1983, THORAX, V38, P849, DOI 10.1136/thx.38.11.849; Bolger C, 2011, J APPL PHYSIOL, V111, P1059, DOI 10.1152/japplphysiol.00113.2011; Bood JR, 2015, J APPL PHYSIOL, V119, P272, DOI 10.1152/japplphysiol.00301.2015; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Currie GP, 2003, CLIN EXP ALLERGY, V33, P783, DOI 10.1046/j.1365-2222.2003.01688.x; Dahlen B, 2001, EUR RESPIR J, V17, P581, DOI 10.1183/09031936.01.17405810; de Bisschop C, 1999, BRIT J SPORT MED, V33, P100, DOI 10.1136/bjsm.33.2.100; Eck R, 2001, MAINZER SPORTMEDIZIN, V3, P97; EDMUNDS AT, 1978, AM REV RESPIR DIS, V117, P247; Eichenberger PA, 2013, SPORTS MED, V43, P1157, DOI 10.1007/s40279-013-0077-2; Franca-Pinto A, 2015, THORAX, V70, P732, DOI 10.1136/thoraxjnl-2014-206070; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Hancox RJ, 2002, AM J RESP CRIT CARE, V165, P1068, DOI 10.1164/ajrccm.165.8.200111-091bc; How SC, 2009, RESP PHYSIOL NEUROBI, V166, P159, DOI 10.1016/j.resp.2009.03.003; Inman MD, 1996, AM J RESP CRIT CARE, V153, P65, DOI 10.1164/ajrccm.153.1.8542164; Larsson J, 2013, IMMUNOL ALLERGY CLIN, V33, P329, DOI 10.1016/j.iac.2013.02.004; Larsson J, 2011, J APPL PHYSIOL, V110, P1029, DOI 10.1152/japplphysiol.00978.2010; MARGOLSKEE DJ, 1988, AM REV RESPIR DIS, V137, P842, DOI 10.1164/ajrccm/137.4.842; MCKENZIE DC, 1994, MED SCI SPORT EXER, V26, P951; MCNEILL RS, 1966, Q J MED, V35, P55; MEAD J, 1978, J APPL PHYSIOL, V44, P156, DOI 10.1152/jappl.1978.44.2.156; Mickleborough TD, 2007, INT J SPORTS MED, V28, P456, DOI 10.1055/s-2006-924583; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MORTON AR, 1979, ANN ALLERGY, V42, P257; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Parsons JP, 2011, ALLERGY ASTHMA PROC, V32, P431, DOI 10.2500/aap.2011.32.3501; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; REIFF DB, 1989, AM REV RESPIR DIS, V139, P479, DOI 10.1164/ajrccm/139.2.479; Renggli AS, 2008, RESP PHYSIOL NEUROBI, V164, P366, DOI 10.1016/j.resp.2008.08.008; Romer LM, 2008, J APPL PHYSIOL, V104, P879, DOI 10.1152/japplphysiol.01157.2007; Rossman MJ, 2014, MED SCI SPORT EXER, V46, P1104, DOI 10.1249/MSS.0000000000000206; Rundell KW, 2001, MED SCI SPORT EXER, V33, P208; Savla U, 1997, AM J PHYSIOL-LUNG C, V273, pL1013, DOI 10.1152/ajplung.1997.273.5.L1013; SCHNALL RP, 1980, THORAX, V35, P828, DOI 10.1136/thx.35.11.828; Stickland MK, 2012, MED SCI SPORT EXER, V44, P383, DOI 10.1249/MSS.0b013e31822fb73a; TWEEDDALE PM, 1981, THORAX, V36, P596, DOI 10.1136/thx.36.8.596; Verges S, 2007, AM J PHYSIOL-REG I, V292, pR1246, DOI 10.1152/ajpregu.00409.2006; Weiler John M, 2010, Ann Allergy Asthma Immunol, V105, pS1, DOI 10.1016/j.anai.2010.09.021; Wilson B. A., 1996, Medicine and Science in Sports and Exercise, V28, pS181; WILSON BA, 1994, EUR RESPIR J, V7, P2174, DOI 10.1183/09031936.94.07122174; Wuthrich TU, 2013, EXP PHYSIOL, V98, P1705, DOI 10.1113/expphysiol.2013.073635	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167318	10.1371/journal.pone.0167318	http://dx.doi.org/10.1371/journal.pone.0167318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898744	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000389474000051
J	Herraiz-Adillo, A; Martinez-Vizcaino, V; Cavero-Redondo, I; Alvarez-Bueno, C; Garrido-Miguel, M; Notario-Pacheco, B				Herraiz-Adillo, Angel; Martinez-Vizcaino, Vicente; Cavero-Redondo, Ivan; Alvarez-Bueno, Celia; Garrido-Miguel, Miriam; Notario-Pacheco, Blanca			Diagnostic Accuracy Study of an Oscillometric Ankle-Brachial Index in Peripheral Arterial Disease: The Influence of Oscillometric Errors and Calcified Legs	PLOS ONE			English	Article							DIABETIC-PATIENTS; PRESSURE INDEX; DOPPLER; METAANALYSIS; RISK; ASSOCIATION; CONCORDANCE; STATEMENT; DEVICE	Background Peripheral arterial disease (PAD) is an indicator of widespread atherosclerosis. However, most individuals with PAD, in spite of being at high cardiovascular risk, are asymptomatic. This fact, together with the limitations of the Doppler ankle-brachial index (ABI), contributes to PAD underdiagnose. The aim of this study was to compare oscillometric ABI and Doppler ABI to diagnose peripheral arterial disease, and also to examine the influence of oscillometric errors and calcified legs on the PAD diagnoses. Methods and Findings We measured the ankle-brachial indexes of 90 volunteers (n = 180 legs, age 70 +/- 14 years, 43% diabetics) using both oscillometer OMRON-M3 and Doppler. For concordance analyses we used the Bland and Altman method, and also estimated the intraclass correlation coefficient. Receiver Operating Characteristic Curves were used to examine the diagnostic performance of both methods. The ABI means were 1.06 +/- 0.14 and 1.04 +/- 0.16 (p = 0.034) measured by oscillometer and Doppler ABIs respectively, with limits of agreement of +/- 0.20 and intraclass correlation coefficient = 0.769. Oscillometer yielded 23 "error" measurements, and also overestimated the measurements in low ankle pressures. Using Doppler as gold standard, oscillometer performance for diagnosis of PAD showed an Area Under Curve = 0.944 (sensitivity: 66.7%, specificity: 96.8%). Moreover, when considered calcified legs and oscillometric "error" readings as arteriopathy equivalents, sensitivity rose to 78.2%, maintaining specificity in 96%. The best oscillometer cutoff point was 0.96 (sensitivity: 87%, specificity: 91%, positive likelihood ratio: 9.66 and negative likelihood ratio: 0.14). Conclusion Despite its limitations, oscillometric ABI could be a useful tool for the diagnosis of PAD, particularly when considering calcified legs and oscillometric "errors" readings as peripheral arterial disease equivalents.	[Herraiz-Adillo, Angel] Hlth Serv Castilla La Mancha SESCAM, Dept Primary Care, Tragacete, Cuenca, Spain; [Martinez-Vizcaino, Vicente; Cavero-Redondo, Ivan; Alvarez-Bueno, Celia; Garrido-Miguel, Miriam; Notario-Pacheco, Blanca] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.; Martinez-Vizcaino, V (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	Vicente.Martinez@uclm.es	VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Alvarez-Bueno, Celia/R-4075-2019; Cavero-Redondo, Ivan/R-4818-2019; Cavero Redondo, Iván/HII-7855-2022; Notario Pacheco, Blanca/G-2583-2016	VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Alvarez-Bueno, Celia/0000-0002-6176-1618; Cavero Redondo, Iván/0000-0003-2617-0430; GARRIDO MIGUEL, MIRIAM/0000-0003-4617-616X; Herraiz-Adillo, Angel/0000-0002-2691-0315; Notario Pacheco, Blanca/0000-0001-8406-6952				Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Beckman JA, 2006, HYPERTENSION, V47, P35, DOI 10.1161/01.HYP.0000196686.85286.9c; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, CROAT MED J, V44, P639; Brooks B, 2001, DIABETIC MED, V18, P528, DOI 10.1046/j.1464-5491.2001.00493.x; Clairotte C, 2009, DIABETES CARE, V32, P1231, DOI [10.2337/dc08-2015, 10.2337/dc08-2230]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diehm C, 2004, ATHEROSCLEROSIS, V172, P95, DOI 10.1016/S0021-9150(03)00204-1; Diehm N, 2009, SWISS MED WKLY, V139, P357, DOI smw-12636; Raurell RF, 2010, MED CLIN-BARCELONA, V135, P306, DOI 10.1016/j.medcli.2009.11.046; Gomez-Huelgas R, 2010, DIABETES CARE, V33, DOI [10.2337/dc09-2059, DOI 10.2337/DC09-2059PMID:20190289]; Gomez-Huelgas Ricardo, 2010, Diabetes Care, V33, pe42, DOI 10.2337/dc09-2059; Hamel JF, 2010, ANGIOLOGY, V61, P487, DOI 10.1177/0003319709360522; Heald CL, 2006, ATHEROSCLEROSIS, V189, P61, DOI 10.1016/j.atherosclerosis.2006.03.011; Kollias A, 2011, HYPERTENS RES, V34, P825, DOI 10.1038/hr.2011.53; Korno M, 2009, EUR J VASC ENDOVASC, V38, P610, DOI 10.1016/j.ejvs.2009.07.004; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Rodriguez-Roca GC, 2014, BLOOD PRESSURE, V23, P270, DOI 10.3109/08037051.2013.876796; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simundic Ana-Maria, 2006, Acta Med Croatica, V60 Suppl 1, P93; Takahashi I, 2013, VASC HEALTH RISK MAN, V9, P89, DOI 10.2147/VHRM.S39785; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; Topouchian J, 2011, VASC HEALTH RISK MAN, V7, P709, DOI 10.2147/VHRM.S27193; Vega J, 2011, REV ESP CARDIOL, V64, P619, DOI [10.1016/j.recesp.2010.10.019, 10.1016/j.rec.2010.12.006]; Verberk WJ, 2012, HYPERTENS RES, V35, P883, DOI 10.1038/hr.2012.83; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125; Vinyoles E, 2007, MED CLIN-BARCELONA, V128, P92, DOI 10.1016/S0025-7753(07)72499-5; Wohlfahrt P, 2011, INT ANGIOL, V30, P256; Xu DC, 2013, CAN J CARDIOL, V29, P492, DOI 10.1016/j.cjca.2012.06.014	31	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167408	10.1371/journal.pone.0167408	http://dx.doi.org/10.1371/journal.pone.0167408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898734	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000061
J	Song, LL; Li, YM; Jia, J; Zhou, GP; Wang, JM; Kang, Q; Jin, P; Sheng, JQ; Cai, GX; Cai, SJ; Han, XL				Song, Lele; Li, Yuemin; Jia, Jia; Zhou, Guangpeng; Wang, Jianming; Kang, Qian; Jin, Peng; Sheng, Jianqiu; Cai, Guoxiang; Cai, Sanjun; Han, Xiaoliang			Algorithm Optimization in Methylation Detection with Multiple RT-qPCR	PLOS ONE			English	Article							COLORECTAL-CANCER; SEPT9 DNA; BIOMARKER; PLASMA; BLOOD; ASSAY	Epigenetic markers based on differential methylation of DNA sequences are used in cancer screening and diagnostics. Detection of abnormal methylation at specific loci by real-time quantitative polymerase chain reaction (RT-qPCR) has been developed to enable high-throughput cancer screening. For tests that combine the results of multiple PCR replicates into a single reportable result, both individual PCR cutoff and weighting of the individual PCR result are essential to test outcome. In this opportunistic screening study, we tested samples from 1133 patients using the triplicate Epi proColon assay with various algorithms and compared it with the newly developed single replicate SensiColon assay that measures methylation status of the same SEPT9 gene sequence. The Epi proColon test approved by the US FDA (1/3 algorithm) showed the highest sensitivity (82.4%) at a lower specificity (82.0%) compared with the Epi proColon 2.0 CE version with 2/3 algorithm (75.1% sensitivity, 97.1% specificity) or 1/1 algorithm (71.3% sensitivity, 92.7% specificity). No significant difference in performance was found between the Epi proColon 2.0 CE and the SensiColon assays. The choice of algorithm must depend on specific test usage, including screening and early detection. These considerations allow one to choose the optimal algorithm to maximize the test performance. We hope this study can help to optimize the methylation detection in cancer screening and early detection.	[Song, Lele; Li, Yuemin; Jia, Jia] Chinese PLA 309th Hosp, Beijing, Peoples R China; [Zhou, Guangpeng; Wang, Jianming; Han, Xiaoliang] BioChain Beijing Sci & Technol Inc, Beijing, Peoples R China; [Kang, Qian; Jin, Peng; Sheng, Jianqiu] Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Cai, Guoxiang; Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China	Fudan University	Song, LL (corresponding author), Chinese PLA 309th Hosp, Beijing, Peoples R China.; Han, XL (corresponding author), BioChain Beijing Sci & Technol Inc, Beijing, Peoples R China.	songlele@sina.com; shan@biochain.com		Han, Xiaoliang/0000-0002-3043-6353; Jin, Peng/0000-0001-6685-1906	BioChain (Beijing) Science and Technology, Inc.; Beijing Municipal Science and Technology Project (capital public health project) - Beijing Municipal Science and Technology Commission [Z151100003915092]	BioChain (Beijing) Science and Technology, Inc.; Beijing Municipal Science and Technology Project (capital public health project) - Beijing Municipal Science and Technology Commission	This study was supported by BioChain (Beijing) Science and Technology, Inc. The funder provided support in the form of salaries for authors [LS, GZ, JW, XH] and had an additional role in the study design, data analysis, preparation of the manuscript and publication of the study. The specific roles of these authors are articulated in the 'author contributions' section. This work was also supported by the Beijing Municipal Science and Technology Project (capital public health project) No. Z151100003915092, sponsored by the Beijing Municipal Science and Technology Commission.	American Cancer Society, 2011, COL CANC FACTS FIG 2; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Jin P, 2015, J GASTROEN HEPATOL, V30, P830, DOI 10.1111/jgh.12855; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Li YM, 2014, BIOMARK MED, V8, P755, DOI [10.2217/bmm.14.8, 10.2217/BMM.14.8]; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Potter NT, 2014, CLIN CHEM, V60, P1183, DOI 10.1373/clinchem.2013.221044; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Song LL, 2015, ADV CLIN CHEM, V72, P171, DOI 10.1016/bs.acc.2015.07.004; Wu D, 2016, J MOL DIAGN	12	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0163333	10.1371/journal.pone.0163333	http://dx.doi.org/10.1371/journal.pone.0163333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898666	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000001
J	De Santis Puzzonia, M; Cozzolino, AM; Grassi, G; Bisceglia, F; Strippoli, R; Guarguaglini, G; Citarella, F; Sacchetti, B; Tripodi, M; Marchetti, A; Amicone, L				De Santis Puzzonia, Marco; Cozzolino, Angela Maria; Grassi, Germana; Bisceglia, Francesca; Strippoli, Raffaele; Guarguaglini, Giulia; Citarella, Franca; Sacchetti, Benedetto; Tripodi, Marco; Marchetti, Alessandra; Amicone, Laura			TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure	PLOS ONE			English	Article							TGF-BETA; AURORA-B; KINASE INHIBITOR; CLEAVAGE FURROW; RHOA ACTIVITY; LIVER; POLYPLOIDY; GROWTH; STRESS; PLOIDY	In all mammals, the adult liver shows binucleated as well as mononucleated polyploid hepatocytes. The hepatic polyploidization starts after birth with an extensive hepatocyte binucleation and generates hepatocytes of several ploidy classes. While the functional significance of hepatocyte polyploidy is becoming clearer, how it is triggered and maintained needs to be clarified. Aim of this study was to identify a major inducer of hepatocyte binucleation/polyploidization and the cellular and molecular mechanisms involved. We found that, among several cytokines analyzed, known to be involved in early liver development and/or mass control, TGFbeta1 was capable to induce, together with the expected morphological changes, binucleation in hepatocytes in culture. Most importantly, the pharmacological inhibition of TGFbeta signaling in healthy mice during weaning, when the physiological binucleation occurs, induced a significant decrease of hepatocyte binucleation rate, without affecting cell proliferation and hepatic index. The TGFbeta-induced hepatocyte binucleation resulted from a cytokinesis failure, as assessed by video microscopy, and is associated with a delocalization of the cytokinesis regulator RhoA-GTPase from the mid-body of dividing cells. The use of specific chemical inhibitors demonstrated that the observed events are Src-dependent. Finally, the restoration of a fully epithelial phenotype by TGFbeta withdrawal gave rise to a cell progeny capable to maintain the polyploid state. In conclusion, we identified TGFbeta as a major inducer of hepatocyte binucleation both in vitro and in vivo, thus ascribing a novel role to this pleiotropic cytokine. The production of binucleated/tetraploid hepatocytes is due to a cytokinesis failure controlled by the molecular axis TGFbeta/Src/RhoA.	[De Santis Puzzonia, Marco; Cozzolino, Angela Maria; Bisceglia, Francesca; Strippoli, Raffaele; Citarella, Franca; Tripodi, Marco; Marchetti, Alessandra; Amicone, Laura] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy; [Cozzolino, Angela Maria; Grassi, Germana; Tripodi, Marco] IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy; [Guarguaglini, Giulia] Univ Roma La Sapienza, Inst Mol Biol & Pathol, Dept Biol & Biotechnol, CNR,Natl Res Council, Rome, Italy; [Sacchetti, Benedetto] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Lazzaro Spallanzani; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome	Marchetti, A; Amicone, L (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy.	marchetti@bce.uniroma1.it; amicone@bce.uniroma1.it	Strippoli, Raffaele/J-2129-2018; Tripodi, Marco/F-1143-2011; Tripodi, Marco/ABO-1160-2022; COZZOLINO, ANGELA MARIA/ABD-2576-2020; Marchetti, Alessandra/AAD-5498-2019	Strippoli, Raffaele/0000-0003-3483-8381; Tripodi, Marco/0000-0001-6135-971X; Tripodi, Marco/0000-0001-6135-971X; COZZOLINO, ANGELA MARIA/0000-0002-3981-0639; De Santis Puzzonia, Marco/0000-0001-5691-1733; MARCHETTI, ALESSANDRA/0000-0001-9706-848X; Grassi, Germana/0000-0001-8168-8721	MT: Associazione Italiana Ricerca sul Cancro (AIRC) [IG-14114]; MT: Ministry for Health of Italy "Ricerca Corrente"; MT: Ministry of University and Research of Italy (PRIN); LA: Sapienza, Universita di ROMA "Progetti di Ateneo"	MT: Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); MT: Ministry for Health of Italy "Ricerca Corrente"; MT: Ministry of University and Research of Italy (PRIN)(Ministry of Education, Universities and Research (MIUR)); LA: Sapienza, Universita di ROMA "Progetti di Ateneo"	This work was supported by MT: Associazione Italiana Ricerca sul Cancro (AIRC IG-14114); MT: Ministry for Health of Italy "Ricerca Corrente"; MT: Ministry of University and Research of Italy (PRIN); LA: Sapienza, Universita di ROMA "Progetti di Ateneo".	Aiuti A, 1998, HEPATOLOGY, V28, P1645, DOI 10.1002/hep.510280626; Amicone L, 2002, ONCOGENE, V21, P1335, DOI 10.1038/sj.onc.1205199; Amicone L, 1997, EMBO J, V16, P495, DOI 10.1093/emboj/16.3.495; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Baek HA, 2012, AM J RESP CELL MOL, V46, P731, DOI 10.1165/rcmb.2011-0121OC; Bellovino D, 1998, EXP CELL RES, V243, P101, DOI 10.1006/excr.1998.4137; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bordoni V, 2004, HEPATOLOGY, V39, P1508, DOI 10.1002/hep.20234; Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Celton-Morizur S, 2010, CELL CYCLE, V9, P460, DOI 10.4161/cc.9.3.10542; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Cicchini C, 2006, J CELL PHYSIOL, V209, P230, DOI 10.1002/jcp.20730; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Cozzolino AM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5481493; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Flechsig P, 2012, CLIN CANCER RES, V18, P3616, DOI 10.1158/1078-0432.CCR-11-2855; Gentric G, 2015, J CLIN INVEST; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Giannelli G., 2014, CURRENT PHARM DESIGN, V18, P4071; Gorla GR, 2001, J CELL SCI, V114, P2943; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Guantario B, 2012, TOXICOL IN VITRO, V26, P7, DOI 10.1016/j.tiv.2011.09.020; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Houglum K, 1994, AM J PHYSIOL, V267, P908; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Napolitano M, 2001, FREE RADICAL BIO MED, V30, P506, DOI 10.1016/S0891-5849(00)00493-7; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Sacco MG, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-5; SAETER G, 1988, CARCINOGENESIS, V9, P939, DOI 10.1093/carcin/9.6.939; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Torres S, 1999, AM J PHYSIOL-GASTR L, V276, pG155, DOI 10.1152/ajpgi.1999.276.1.G155; Toyoda H, 2005, GUT, V54, P297, DOI 10.1136/gut.2004.043893; Troadec MB, 2006, J HEPATOL, V44, P391, DOI 10.1016/j.jhep.2005.07.033; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; WEBBER EM, 1994, AM J PATHOL, V145, P398; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	60	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167158	10.1371/journal.pone.0167158	http://dx.doi.org/10.1371/journal.pone.0167158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893804	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400093
J	Elovaara, H; Parkash, V; Fair-Makela, R; Salo-Ahen, OMH; Guedez, G; Bligt-Linden, E; Gronholm, J; Jalkanen, S; Salminen, TA				Elovaara, Heli; Parkash, Vimal; Fair-Makela, Ruth; Salo-Ahen, Outi M. H.; Guedez, Gabriela; Bligt-Linden, Eva; Gronholm, Janne; Jalkanen, Sirpa; Salminen, Tiina A.			Multivalent Interactions of Human Primary Amine Oxidase with the V and C2(2) Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; CD33-RELATED SIGLECS; 3-DIMENSIONAL STRUCTURES; MOLECULAR-DYNAMICS; VAP-1; MEMBER; IDENTIFICATION; INFLAMMATION; SPECIFICITY; RECOGNITION	Sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) on leukocyte surface is a counter-receptor for endothelial cell surface adhesin, human primary amine oxidase (hAOC3), a target protein for anti-inflammatory agents. This interaction can be used to detect inflammation and cancer in vivo, since the labeled peptides derived from the second C2 domain (C2(2)) of Siglec-9 specifically bind to the inflammation-inducible hAOC3. As limited knowledge on the interaction between Siglec-9 and hAOC3 has hampered both hAOC3-targeted drug design and in vivo imaging applications, we have now produced and purified the extracellular region of Siglec-9 (Siglec-9-EC) consisting of the V, C2(1) and C2(2) domains, modeled its 3D structure and characterized the hAOC3-Siglec-9 interactions using biophysical methods and activity/inhibition assays. Our results assign individual, previously unknown roles for the V and C2(2) domains. The V domain is responsible for the unusually tight Siglec-9-hAOC3 interactions whereas the intact C2(2) domain of Siglec-9 is required for modulating the enzymatic activity of hAOC3, crucial for the hAOC3-mediated leukocyte trafficking. By characterizing the Siglec-9-EC mutants, we could conclude that R120 in the V domain likely interacts with the terminal sialic acids of hAOC3 attached glycans whereas residues R284 and R290 in C2(2) are involved in the interactions with the active site channel of hAOC3. Furthermore, the C2(2) domain binding enhances the enzymatic activity of hAOC3 although the sialic acid-binding capacity of the V domain of Siglec-9 is abolished by the R120S mutation. To conclude, our results prove that the V and C2(2) domains of Siglec-9-EC interact with hAOC3 in a multifaceted and unique way, forming both glycan-mediated and direct protein-protein interactions, respectively. The reported results on the mechanism of the Siglec-9-hAOC3 interaction are valuable for the development of hAOC3-targeted therapeutics and diagnostic tools.	[Elovaara, Heli; Fair-Makela, Ruth; Jalkanen, Sirpa] Univ Turku, Medicity Res Lab, Turku, Finland; [Parkash, Vimal; Salo-Ahen, Outi M. H.; Guedez, Gabriela; Bligt-Linden, Eva; Gronholm, Janne; Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab Biochem, Turku, Finland; [Fair-Makela, Ruth] Univ Turku, Turku Doctoral Program Mol Med, Turku, Finland; [Salo-Ahen, Outi M. H.] Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, Pharm, Turku, Finland; [Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	University of Turku; Abo Akademi University; University of Turku; Abo Akademi University; University of Turku	Salminen, TA (corresponding author), Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab Biochem, Turku, Finland.	tiina.salminen@abo.fi	Salminen, Tiina A/G-7492-2019; Salminen, Tiina A./AAM-5443-2021; Guédez, Gabriela/O-2180-2019; Salo-Ahen, Outi M. H./J-9901-2019	Salminen, Tiina A/0000-0002-4135-8020; Salminen, Tiina A./0000-0002-4135-8020; Guédez, Gabriela/0000-0002-3711-8470; Salo-Ahen, Outi M. H./0000-0003-0725-126X; Fair-Makela, Ruth/0000-0003-2803-9890	Academy of Finland [132701, 132998, 288534, 137918, 118621]; National Doctoral Programme in Informational and Structural Biology; University of Turku Foundation; Maud Kuistila Foundation; Valdemar von Frenckell Foundation; Otto Malm Foundation; Sigrid Juselius Foundation; Tor, Joe, and Pentti Borg's Foundation; Medicinska Understodsforeningen Liv och Halsa; Magnus Ehrnrooth foundation	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology; University of Turku Foundation; Maud Kuistila Foundation; Valdemar von Frenckell Foundation; Otto Malm Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tor, Joe, and Pentti Borg's Foundation; Medicinska Understodsforeningen Liv och Halsa; Magnus Ehrnrooth foundation	This work has been funded by the Academy of Finland (HE #132701, TAS. #132998, #288534, OS-A #137918 and SJ # 118621), National Doctoral Programme in Informational and Structural Biology (EB-L), University of Turku Foundation (HE), Maud Kuistila Foundation (HE), Valdemar von Frenckell Foundation (HE) Otto Malm Foundation (HE), Sigrid Juselius Foundation (TAS), the Tor, Joe, and Pentti Borg's Foundation (TAS), Medicinska Understodsforeningen Liv och Halsa (TAS) and the Magnus Ehrnrooth foundation (TAS).	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Benkert P, 2009, NUCLEIC ACIDS RES; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bligt-Linden E, 2013, J MED CHEM, V56, P9837, DOI 10.1021/jm401372d; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; Dainese E, 2014, ACTA CRYSTALLOGR D, V70, P2101, DOI 10.1107/S1399004714012140; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Elovaara H, 2011, BIOCHEMISTRY-US, V50, P5507, DOI 10.1021/bi200117z; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; FOWLER CJ, 1981, BIOCHEM PHARMACOL, V30, P3329, DOI 10.1016/0006-2952(81)90607-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakkola K, 1999, AM J PATHOL, V155, P1953, DOI 10.1016/S0002-9440(10)65514-9; Johnson MS, 1996, METHOD ENZYMOL, V266, P575; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Maula SM, 2005, EUR J IMMUNOL, V35, P2718, DOI 10.1002/eji.200526351; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Mitsuki M, 2010, GLYCOBIOLOGY, V20, P395, DOI 10.1093/glycob/cwp195; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Rosa N, 2015, J BIOMOL SCREEN, V20, P898, DOI 10.1177/1087057115584059; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmi M, 2000, CIRC RES, V86, P1245, DOI 10.1161/01.RES.86.12.1245; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Salmi M, 1996, J EXP MED, V183, P569, DOI 10.1084/jem.183.2.569; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Salmi M, 2014, SEMIN IMMUNOPATHOL, V36, P163, DOI 10.1007/s00281-014-0417-9; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166935	10.1371/journal.pone.0166935	http://dx.doi.org/10.1371/journal.pone.0166935			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893774	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400060
J	Gaona-Lopez, C; Julian-Sanchez, A; Riveros-Rosas, H				Gaona-Lopez, Carlos; Julian-Sanchez, Adriana; Riveros-Rosas, Hector			Diversity and Evolutionary Analysis of Iron-Containing (Type-III) Alcohol Dehydrogenases in Eukaryotes	PLOS ONE			English	Article							HYDROXYACID-OXOACID TRANSHYDROGENASE; MALEYLACETATE-REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENE-CLUSTER; GLYCEROL DEHYDROGENASE; MOLECULAR CHARACTERIZATION; METHANOL DEHYDROGENASE; ENTAMOEBA-HISTOLYTICA; SEQUENCE-ANALYSIS	Background Alcohol dehydrogenase (ADH) activity is widely distributed in the three domains of life. Currently, there are three non-homologous NAD(P)(+)-dependent ADH families reported: Type I ADH comprises Zn-dependent ADHs; type II ADH comprises short-chain ADHs described first in Drosophila; and, type III ADH comprises iron-containing ADHs (FeADHs). These three families arose independently throughout evolution and possess different structures and mechanisms of reaction. While types I and II ADHs have been extensively studied, analyses about the evolution and diversity of (type III) FeADHs have not been published yet. Therefore in this work, a phylogenetic analysis of FeADHs was performed to get insights into the evolution of this protein family, as well as explore the diversity of FeADHs in eukaryotes. Principal Findings Results showed that FeADHs from eukaryotes are distributed in thirteen protein subfamilies, eight of them possessing protein sequences distributed in the three domains of life. Interestingly, none of these protein subfamilies possess protein sequences found simultaneously in animals, plants and fungi. Many FeADHs are activated by or contain Fe2+, but many others bind to a variety of metals, or even lack of metal cofactor. Animal FeADHs are found in just one protein subfamily, the hydroxyacid-oxoacid transhydrogenase (HOT) subfamily, which includes protein sequences widely distributed in fungi, but not in plants), and in several taxa from lower eukaryotes, bacteria and archaea. Fungi FeADHs are found mainly in two subfamilies: HOT and maleylacetate reductase (MAR), but some can be found also in other three different protein subfamilies. Plant FeADHs are found only in chlorophyta but not in higher plants, and are distributed in three different protein subfamilies. Conclusions/Significance FeADHs are a diverse and ancient protein family that shares a common 3D scaffold with a patchy distribution in eukaryotes. The majority of sequenced FeADHs from eukaryotes are distributed in just two subfamilies, HOT and MAR (found mainly in animals and fungi). These two subfamilies comprise almost 85% of all sequenced FeADHs in eukaryotes.	[Gaona-Lopez, Carlos; Julian-Sanchez, Adriana; Riveros-Rosas, Hector] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Riveros-Rosas, H (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico.	hriveros@unam.mx	Riveros-Rosas, Hector/B-6607-2008; Riveros-Rosas, Hector/ABD-6638-2020	Riveros-Rosas, Hector/0000-0003-0194-2537; Riveros-Rosas, Hector/0000-0003-0194-2537	Direccion General de Asuntos del Personal Academic; Universidad Nacional Autonoma de Mexico, PAPIIT [IN216513, IN225016]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [233791]; Programa de Doctorado en Ciencias, Universidad Nacional Autonoma de Mexico	Direccion General de Asuntos del Personal Academic; Universidad Nacional Autonoma de Mexico, PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Doctorado en Ciencias, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Direccion General de Asuntos del Personal Academic, Universidad Nacional Autonoma de Mexico, PAPIIT grants IN216513 and IN225016 to HRR, and Consejo Nacional de Ciencia y Tecnologia (Mexico), Ph.D. fellowship No. 233791, and Programa de Doctorado en Ciencias, Universidad Nacional Autonoma de Mexico, to CGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; Andersson B, 1934, H-S Z PHYSIOL CHEM, V225, P57, DOI 10.1515/bchm2.1934.225.2-3.57; Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Antoine E, 1999, EUR J BIOCHEM, V264, P880, DOI 10.1046/j.1432-1327.1999.00685.x; Arfman N, 1997, EUR J BIOCHEM, V244, P426, DOI 10.1111/j.1432-1033.1997.00426.x; Armengaud J, 1999, J BACTERIOL, V181, P3452, DOI 10.1128/JB.181.11.3452-3461.1999; Atteia A, 2003, PLANT MOL BIOL, V53, P175, DOI 10.1023/B:PLAN.0000009274.19340.36; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battelli F, 1910, BIOCHEM Z, V28, P145; Battelli F, 1909, CR SOC BIOL, V67, P419; Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; BONNICHSEN RK, 1948, ARCH BIOCHEM, V18, P361; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Borras E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-216; BRUCHHAUS I, 1994, BIOCHEM J, V303, P743, DOI 10.1042/bj3030743; Brzostowicz PC, 2002, APPL MICROBIOL BIOT, V58, P781, DOI 10.1007/s00253-002-0968-x; BUSWELL JA, 1979, FEBS LETT, V104, P258, DOI 10.1016/0014-5793(79)80827-3; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; Camara B, 2009, J BACTERIOL, V191, P4905, DOI 10.1128/JB.00331-09; Chan Cheong Xin, 2012, Mob Genet Elements, V2, P101; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Cheng SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047144; CONWAY T, 1989, J BACTERIOL, V171, P3754, DOI 10.1128/jb.171.7.3754-3759.1989; CONWAY T, 1987, J BACTERIOL, V169, P2591, DOI 10.1128/jb.169.6.2591-2597.1987; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dan MX, 2000, MOL BIOCHEM PARASIT, V109, P25, DOI 10.1016/S0166-6851(00)00233-4; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Daubaras DL, 1996, APPL ENVIRON MICROB, V62, P4276, DOI 10.1128/AEM.62.11.4276-4279.1996; DAUBARAS DL, 1995, APPL ENVIRON MICROB, V61, P1279, DOI 10.1128/AEM.61.4.1279-1289.1995; de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x; Deng YF, 2002, DNA SEQUENCE, V13, P301, DOI 10.1080/1042517021000011636; DEVRIES GE, 1992, J BACTERIOL, V174, P5346, DOI 10.1128/JB.174.16.5346-5353.1992; DREWKE C, 1988, BIOCHIM BIOPHYS ACTA, V950, P54, DOI 10.1016/0167-4781(88)90072-3; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; Elias M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-21; Elleuche S, 2014, APPL MICROBIOL BIOT, V98, P4041, DOI 10.1007/s00253-013-5374-z; Elleuche S, 2013, APPL MICROBIOL BIOT, V97, P8963, DOI 10.1007/s00253-013-4725-0; Endo R, 2005, J BACTERIOL, V187, P847, DOI 10.1128/JB.187.3.847-853.2005; Espinosa A, 2001, J BIOL CHEM, V276, P20136, DOI 10.1074/jbc.M101349200; Extance J, 2013, ACTA CRYSTALLOGR D, V69, P2104, DOI 10.1107/S0907444913020349; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fujii T, 2016, PROTEINS; GAAL AB, 1980, BIOCHEM J, V185, P783, DOI 10.1042/bj1850783; GANZHORN AJ, 1987, J BIOL CHEM, V262, P3754; Gattis SG, 2013, J BIOL CHEM, V288, P9216, DOI 10.1074/jbc.M113.453324; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; Gonzalez-Segura L, 2015, CHEM-BIOL INTERACT, V234, P59, DOI 10.1016/j.cbi.2014.12.039; Greco M, 2012, J EXP BOT, V63, P695, DOI 10.1093/jxb/err313; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han JS, 2002, EUR J BIOCHEM, V269, P969, DOI 10.1046/j.0014-2956.2001.02731.x; Hernandez-Tobias A, 2011, CHEM-BIOL INTERACT, V191, P14, DOI 10.1016/j.cbi.2011.02.008; HIU SF, 1987, APPL ENVIRON MICROB, V53, P697, DOI 10.1128/AEM.53.4.697-703.1987; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang Y, 2006, APPL ENVIRON MICROB, V72, P7238, DOI 10.1128/AEM.01494-06; Iwaki H, 2002, APPL ENVIRON MICROB, V68, P5671, DOI 10.1128/AEM.68.11.5671-5684.2002; JONES KH, 1995, ARCH MICROBIOL, V163, P176, DOI 10.1007/BF00305350; JORNVALL H, 1981, P NATL ACAD SCI-BIOL, V78, P4226, DOI 10.1073/pnas.78.7.4226; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; JORNVALL H, 1970, EUR J BIOCHEM, V16, P25, DOI 10.1111/j.1432-1033.1970.tb01049.x; JORNVALL H, 1977, EUR J BIOCHEM, V72, P443, DOI 10.1111/j.1432-1033.1977.tb11268.x; Jornvall H, 2015, CHEM-BIOL INTERACT, V234, P75, DOI 10.1016/j.cbi.2014.10.017; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; Kardon T, 2006, FEBS LETT, V580, P2347, DOI 10.1016/j.febslet.2006.02.082; KASCHABEK SR, 1993, J BACTERIOL, V175, P6075, DOI 10.1128/JB.175.19.6075-6081.1993; KAUFMAN EE, 1988, J BIOL CHEM, V263, P16872; KAUFMAN EE, 1991, NEUROCHEM RES, V16, P965, DOI 10.1007/BF00965839; KESSLER D, 1992, J BIOL CHEM, V267, P18073; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018; Koch Jason J, 2002, Pediatr Rev, V23, P310, DOI 10.1542/pir.23-9-310; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li DH, 1997, J BACTERIOL, V179, P4433, DOI 10.1128/jb.179.13.4433-4437.1997; Lia Yaoyao, 2013, Mycology, V4, P179, DOI 10.1080/21501203.2013.874540; Luers F, 1997, FEMS MICROBIOL LETT, V154, P337, DOI 10.1016/S0378-1097(97)00351-0; Lyon RC, 2009, CHEM-BIOL INTERACT, V178, P283, DOI 10.1016/j.cbi.2008.10.025; Ma F, 2014, J MICROBIOL BIOTECHN, V24, P748, DOI 10.4014/jmb.1312.12030; Ma KS, 2001, METHOD ENZYMOL, V331, P195; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Maitre M, 2016, MED RES REV, V36, P363, DOI 10.1002/med.21382; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Martin-Duran JM, 2013, GENOME BIOL EVOL, V5, P1435, DOI 10.1093/gbe/evt102; McGivney BA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-638; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Moon JH, 2011, J MOL BIOL, V407, P413, DOI 10.1016/j.jmb.2011.01.045; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Musille P, 2014, ACTA CRYSTALLOGR F, V70, P166, DOI 10.1107/S2053230X13034444; Negelein E, 1937, BIOCHEM Z, V293, P351; NELSON T, 1981, J NEUROCHEM, V37, P1345, DOI 10.1111/j.1471-4159.1981.tb04689.x; Nichols CE, 2004, J MOL BIOL, V343, P533, DOI 10.1016/j.jmb.2004.08.039; Obradors N, 1998, EUR J BIOCHEM, V258, P207, DOI 10.1046/j.1432-1327.1998.2580207.x; PAQUIN CE, 1986, MOL CELL BIOL, V6, P70, DOI 10.1128/MCB.6.1.70; PATEL TR, 1992, J BASIC MICROB, V32, P233, DOI 10.1002/jobm.3620320405; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Perez-Pantoja D, 2009, MICROBIOL-SGM, V155, P3641, DOI 10.1099/mic.0.032086-0; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; PERSSON B, 1994, EUR J BIOCHEM, V226, P15, DOI 10.1111/j.1432-1033.1994.tb20021.x; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pineda E, 2013, FEBS LETT, V587, P178, DOI 10.1016/j.febslet.2012.11.020; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Pundir Sangya, 2016, Curr Protoc Bioinformatics, V53, DOI 10.1002/0471250953.bi0129s53; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; RIEBLE S, 1994, J BACTERIOL, V176, P4838, DOI 10.1128/jb.176.16.4838-4844.1994; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Sakurai M, 2004, FEMS YEAST RES, V4, P649, DOI 10.1016/j.femsyr.2003.12.009; SCHWARTZ MF, 1976, EUR J BIOCHEM, V68, P159, DOI 10.1111/j.1432-1033.1976.tb10774.x; Schwarzenbacher R, 2004, PROTEINS, V54, P174, DOI 10.1002/prot.10594; SCOPES RK, 1983, FEBS LETT, V156, P303, DOI 10.1016/0014-5793(83)80517-1; Seibert V, 2004, MICROBIOL-SGM, V150, P463, DOI 10.1099/mic.0.26602-0; Seibert V, 1998, J BACTERIOL, V180, P3503, DOI 10.1128/JB.180.14.3503-3508.1998; SEIBERT V, 1993, J BACTERIOL, V175, P6745, DOI 10.1128/jb.175.21.6745-6754.1993; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; SHAILUBHAI K, 1983, EXPERIENTIA, V39, P70, DOI 10.1007/BF01960634; Shapiro JA, 2016, BIOLOGY, P5; Shasmal M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19936; SOFER W, 1968, J BIOL CHEM, V243, P3110; SPARNINS VL, 1979, J BACTERIOL, V138, P425, DOI 10.1128/JB.138.2.425-430.1979; SPENCER P, 1990, BIOCHIM BIOPHYS ACTA, V1040, P130, DOI 10.1016/0167-4838(90)90156-A; SPENCER P, 1989, BIOCHIM BIOPHYS ACTA, V994, P270, DOI 10.1016/0167-4838(89)90304-X; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Struys EA, 2005, J INHERIT METAB DIS, V28, P921, DOI 10.1007/s10545-005-0114-x; Sugahara M, 2005, PROTEINS, V58, P249, DOI 10.1002/prot.20281; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; Tae CH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-142; Tamarit J, 1997, J BACTERIOL, V179, P1102, DOI 10.1128/jb.179.4.1102-1104.1997; TRUNIGER V, 1994, J BACTERIOL, V176, P1796, DOI 10.1128/jb.176.6.1796-1800.1994; VALLEE BL, 1955, P NATL ACAD SCI USA, V41, P327, DOI 10.1073/pnas.41.6.327; VALLEE BL, 1957, J BIOL CHEM, V225, P185; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; VONCK J, 1991, J BIOL CHEM, V266, P3949; WALTER KA, 1992, J BACTERIOL, V174, P7149, DOI 10.1128/jb.174.22.7149-7158.1992; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; WILLIAMSON VM, 1987, MOL GEN GENET, V209, P374, DOI 10.1007/BF00329668; WILLS C, 1981, ARCH BIOCHEM BIOPHYS, V210, P775, DOI 10.1016/0003-9861(81)90245-9; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Ying XX, 2009, EXTREMOPHILES, V13, P299, DOI 10.1007/s00792-008-0217-z; Yoshida M, 2007, J BACTERIOL, V189, P1573, DOI 10.1128/JB.01675-06; YOUNGLESON JS, 1988, APPL ENVIRON MICROB, V54, P676, DOI 10.1128/AEM.54.3.676-682.1988; YOUNGLESON JS, 1989, GENE, V78, P355, DOI 10.1016/0378-1119(89)90238-2; Zheng YY, 2004, BIOTECHNOL LETT, V26, P251	156	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166851	10.1371/journal.pone.0166851	http://dx.doi.org/10.1371/journal.pone.0166851			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893862	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400048
J	Kistler, WM; Parlos, JA; Peper, ST; Dunham, NR; Kendall, RJ				Kistler, Whitney M.; Parlos, Julie A.; Peper, Steven T.; Dunham, Nicholas R.; Kendall, Ronald J.			A Quantitative PCR Protocol for Detection of Oxyspirura petrowi in Northern Bobwhites (Colinus virginianus)	PLOS ONE			English	Article							QUAIL CALLIPEPLA-SQUAMATA; THELAZIIDAE; NEMATODA; TEXAS	Oxyspirura petrowi is a parasitic nematode that infects wild birds. This parasite has a broad host range, but has recently been reported in high prevalences from native Galliformes species in the United States. In order to better understand the impact O. petrowi has on wild bird populations, we developed a quantitative PCR protocol to detect infections in wild northern bobwhites (Colinus virginianus). We used paired fecal and cloacal swab samples from wild caught and experimentally infected northern bobwhites and matching fecal float data from experimentally infected birds to validate our assay. Overall we detected more positive birds from fecal samples than the paired cloacal swabs and there was strong agreement between the qPCR results from fecal samples and from fecal flotation (84%; K = 0.69 [0.53-0.84 95% CI]). We also detected O. petrowi DNA in ten replicates of samples spiked with one O. petrowi egg. This qPCR assay is an effective assay to detect O. petrowi infections in wild birds. Our results suggest that fecal samples are the most appropriate sample for detecting infections; although, cloacal swabs can be useful for determining if O. petrowi is circulating in a population.	[Kistler, Whitney M.; Parlos, Julie A.; Peper, Steven T.; Dunham, Nicholas R.; Kendall, Ronald J.] Texas Tech Univ, Inst Environm & Human Hlth, Wildlife Toxicol Lab, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Kendall, RJ (corresponding author), Texas Tech Univ, Inst Environm & Human Hlth, Wildlife Toxicol Lab, Lubbock, TX 79409 USA.	ron.kendall@ttu.edu	Dunham, Nicholas/AAF-6592-2020		Park Cities Quail [24A125]; Rolling Plains Quail Research Foundation [23A470]	Park Cities Quail; Rolling Plains Quail Research Foundation	This work was supported by Park Cities Quail 24A125, Rolling Plains Quail Research Foundation 23A470. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like thank Spade Ranch for access to field locations for trapping wild birds. We also thank Park Cities Quail and the Rolling Plains Quail Research Foundation for their support.	Addison EM, 1969, REV EYEWORMS GENUS O; Bell AS, 2002, TRENDS PARASITOL, V18, P337, DOI 10.1016/S1471-4922(02)02331-0; Bruno A, 2015, J PARASITOL, V101, P364, DOI 10.1645/14-526.1; Dunham NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108244; Dunham NR, 2014, J WILDLIFE DIS, V50, P552, DOI 10.7589/2013-10-275; Harmon AF, 2006, VET PARASITOL, V135, P297, DOI 10.1016/j.vetpar.2005.10.014; Hernandez F, 2013, WILDLIFE SOC B, V37, P177, DOI 10.1002/wsb.223; Jensen William E., 2000, Prairie Naturalist, V32, P169; Johnson JA, 2004, MOL ECOL, V13, P2617, DOI 10.1111/j.1365-294X.2004.02264.x; Kistler Whitney M., 2016, Parasitology Open, V2, pe7, DOI 10.1017/pao.2016.5; Landgrebe JN, 2007, J PARASITOL, V93, P204, DOI 10.1645/GE-3578RN.1; Landis JR, 1977, BIOMETRICS, V33, P384; Learmount J, 2009, VET PARASITOL, V166, P268, DOI 10.1016/j.vetpar.2009.08.017; MCCLURE HE, 1949, J WILDLIFE MANAGE, V13, P304, DOI 10.2307/3795873; Miles KA, 2015, WILDLIFE SOC B, V39, P797, DOI 10.1002/wsb.600; Parent CJ, 2016, J WILDLIFE MANAGE, V80, P7, DOI 10.1002/jwmg.992; PENCE DB, 1972, P HELM SOC WASH, V39, P23; PENCE DB, 1975, P HELM SOC WASH, V42, P181; Rho Paikho, 2015, Journal of Ecology and Environment, V38, P185, DOI 10.5141/ecoenv.2015.020; Robel RJ, 2003, WILDLIFE BIOL, V9, P341, DOI 10.2981/wlb.2003.023; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Wang X., 2006, REAL TIME PCR, P93; Xiang LX, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-233; Zajac A., 2012, PENSION FUND PERFORM, V8th edn, DOI DOI 10.1002/9781119208945.CH8; Zarlenga DS, 2001, VET PARASITOL, V101, P215, DOI 10.1016/S0304-4017(01)00568-4	25	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166309	10.1371/journal.pone.0166309	http://dx.doi.org/10.1371/journal.pone.0166309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893772	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400021
J	Schroeders, U; Wilhelm, O; Olaru, G				Schroeders, Ulrich; Wilhelm, Oliver; Olaru, Gabriel			Meta-Heuristics in Short Scale Construction: Ant Colony Optimization and Genetic Algorithm	PLOS ONE			English	Article							COEFFICIENT ALPHA; PERSONALITY; SELECTION; RELIABILITY; INVENTORY; VALIDITY; PANEL	The advent of large-scale assessment, but also the more frequent use of longitudinal and multivariate approaches to measurement in psychological, educational, and sociological research, caused an increased demand for psychometrically sound short scales. Shortening scales economizes on valuable administration time, but might result in inadequate measures because reducing an item set could: a) change the internal structure of the measure, b) result in poorer reliability and measurement precision, c) deliver measures that cannot effectively discriminate between persons on the intended ability spectrum, and d) reduce test-criterion relations. Different approaches to abbreviate measures fare differently with respect to the above-mentioned problems. Therefore, we compare the quality and efficiency of three item selection strategies to derive short scales from an existing long version: a Step-wise COnfirmatory Factor Analytical approach (SCOFA) that maximizes factor loadings and two metaheuristics, specifically an Ant Colony Optimization (ACO) with a tailored user-defined optimization function and a Genetic Algorithm (GA) with an unspecific cost-reduction function. SCOFA compiled short versions were highly reliable, but had poor validity. In contrast, both metaheuristics outperformed SCOFA and produced efficient and psychometrically sound short versions (unidimensional, reliable, sensitive, and valid). We discuss under which circumstances ACO and GA produce equivalent results and provide recommendations for conditions in which it is advisable to use a metaheuristic with an unspecific out-of-the-box optimization function.	[Schroeders, Ulrich] Univ Bamberg, Dept Educ Sci, Bamberg, Germany; [Wilhelm, Oliver; Olaru, Gabriel] Univ Ulm, Dept Psychol & Educ, Ulm, Germany	Otto Friedrich University Bamberg; Ulm University	Schroeders, U (corresponding author), Univ Bamberg, Dept Educ Sci, Bamberg, Germany.	ulrich.schroeders@uni-bamberg.de	Schroeders, Ulrich/AAG-9800-2020; Olaru, Gabriel/AAL-5282-2020; Wilhelm, Oliver/K-6455-2012	Schroeders, Ulrich/0000-0002-5225-1122; Olaru, Gabriel/0000-0002-7430-7350; Wilhelm, Oliver/0000-0001-7980-1166				[Anonymous], 2010, IERI MONOGRAPH SERIE; Arendasy M, 2005, INT J TEST, V5, P197, DOI 10.1207/s15327574ijt0503_2; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Blossfeld HP, 2011, Z ERZIEHWISS, V14, P19, DOI 10.1007/s11618-011-0179-2; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Borsboom D, 2006, PSYCHOMETRIKA, V71, P425, DOI 10.1007/s11336-006-1447-6; Borsboom D, 2009, CONCEPT OF VALIDITY: REVISIONS, NEW DIRECTIONS AND APPLICATIONS, P135; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Costa PT, 2007, REVISED NEO PERSONAL; Courvoisier DS, 2012, PSYCHOL ASSESSMENT, V24, P713, DOI 10.1037/a0026733; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Dorigo M, 2010, INT SER OPER RES MAN, V146, P227, DOI 10.1007/978-1-4419-1665-5_8; Drezner Z, 1999, COMMUN STAT-SIMUL C, V28, P349, DOI 10.1080/03610919908813553; Duchhardt C, 2013, NEPS TECHNICAL REPOR, P1; Dunn L.M., 2007, PEABODY PICTURE VOCA, DOI [DOI 10.1037/T15144-000, 10.1037/t15144-000]; Eisenbarth H, 2015, PSYCHOL ASSESSMENT, V27, P194, DOI 10.1037/pas0000032; Embretson S, 2000, MULTIVARIATE APPL BO; Emons WHM, 2007, PSYCHOL METHODS, V12, P105, DOI 10.1037/1082-989X.12.1.105; Gehrer K., 2012, ASSESSMENT READING C; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; GREEN SB, 1977, EDUC PSYCHOL MEAS, V37, P827, DOI 10.1177/001316447703700403; Gulliksen H., 1945, PSYCHOMETRIKA, V10, P79, DOI [10.1007/BF02288877, DOI 10.1007/BF02288877]; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Heene M, 2011, PSYCHOL METHODS, V16, P319, DOI 10.1037/a0024917; Holland J. H., 1992, ADAPTATION NATURAL A; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Janssen AB, 2017, EUR J PSYCHOL ASSESS, V33, P409, DOI 10.1027/1015-5759/a000299; Kane M, 2002, J EDUC MEAS, V39, P165, DOI 10.1111/j.1745-3984.2002.tb01141.x; Kano Y, 2000, PSYCHOMETRIKA, V65, P7, DOI 10.1007/BF02294182; Kelley T. L., 1927, INTERPRETATION ED ME; Kruyen PM, 2013, INT J TEST, V13, P223, DOI 10.1080/15305058.2012.703734; Kruyen PM, 2012, INT J TEST, V12, P321, DOI 10.1080/15305058.2011.643517; Lang FR, 2014, ERFASSUNG FLUIDEN KO, P12; Leite WL, 2008, MULTIVAR BEHAV RES, V43, P411, DOI 10.1080/00273170802285743; LOEVINGER J, 1965, PSYCHOL REV, V72, P143, DOI 10.1037/h0021704; LOEVINGER J, 1954, PSYCHOL BULL, V51, P493, DOI 10.1037/h0058543; Marcoulides George A., 2001, NEW DEV TECHNIQUES S, P247; Markus K. A., 2013, MULTIVARIATE APPL SE, V341; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; McDonald R.P., 2003, ALTA J EDUC RES, V49, P212, DOI [10.11575/ajer.v49i3.54980, DOI 10.11575/AJER.V49I3.54980]; McDonald RP, 1999, TEST THEORY UNIFIED; Mellenbergh GJ, 1996, PSYCHOL METHODS, V1, P293, DOI 10.1037/1082-989X.1.3.293; Olaru G, 2015, J RES PERS, V59, P56, DOI 10.1016/j.jrp.2015.09.001; Olderbak S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01503; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sahdra BK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00189; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Schoeni RF, 2013, ANN AM ACAD POLIT SS, V645, P60, DOI 10.1177/0002716212456363; Schroeders U., 2016, METAHEURISTICS SCRIP; Schroeders U, 2016, INTELLIGENCE, V58, P22, DOI 10.1016/j.intell.2016.06.003; Scrucca L, 2016, GAABBREVIATE; Scrucca L, 2013, J STAT SOFTW, V53, P1; Sijtsma K, 2009, INT J TEST, V9, P167, DOI 10.1080/15305050903106883; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Thompson B, 2000, EDUC PSYCHOL MEAS, V60, P174, DOI 10.1177/00131640021970448; Van der Linden W.J., 1997, HDB MODERN ITEM RESP; Widaman K. F., 2011, SECONDARY DATA ANAL, P39, DOI [10.1037/12350-003, DOI 10.1037/12350-003]; Yarkoni T, 2010, J RES PERS, V44, P180, DOI 10.1016/j.jrp.2010.01.002; Ziegler M, 2014, J INDIVID DIFFER, V35, P185, DOI 10.1027/1614-0001/a000148; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	66	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167110	10.1371/journal.pone.0167110	http://dx.doi.org/10.1371/journal.pone.0167110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893845	Green Submitted, gold, Green Published			2022-12-26	WOS:000389472400087
J	Amigo, N; Zhang, Q; Amadio, A; Zhang, QJ; Silva, WM; Cui, BY; Chen, ZJ; Larzabal, M; Bei, JL; Cataldi, A				Amigo, Natalia; Zhang, Qi; Amadio, Ariel; Zhang, Qunjie; Silva, Wanderson M.; Cui, Baiyuan; Chen, Zhongjian; Larzabal, Mariano; Bei, Jinlong; Cataldi, Angel			Overexpressed Proteins in Hypervirulent Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 Compared to E-coli O157:H7 EDL933 Clade 3 Strain	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; REAL-TIME PCR; PROTEOMIC ANALYSIS; PATHOGENICITY ISLAND; MASS-SPECTROMETRY; SHIGA TOXIN-2; EXPRESSION; GENES; VIRULENCE; O157-H7	Escherichia coli O157: H7 is responsible for severe diarrhea and hemolytic uremic syndrome (HUS), and predominantly affects children under 5 years. The major virulence traits are Shiga toxins, necessary to develop HUS and the Type III Secretion System (T3SS) through which bacteria translocate effector proteins directly into the host cell. By SNPs typing, E. coli O157: H7 was separated into nine different clades. Clade 8 and clade 6 strains were more frequently associated with severe disease and HUS. In this study, we aimed to identify differentially expressed proteins in two strains of E. coli O157: H7 (clade 8 and clade 6), obtained from cattle and compared them with the well characterized reference EDL933 strain (clade 3). Clade 8 and clade 6 strains show enhanced pathogenicity in a mouse model and virulence-related properties. Proteins were extracted and analyzed using the TMT-6plex labeling strategy associated with two dimensional liquid chromatography and mass spectrometry in tandem. We detected 2241 proteins in the cell extract and 1787 proteins in the culture supernatants. Attention was focused on the proteins related to virulence, overexpressed in clade 6 and 8 strains compared to EDL933 strain. The proteins relevant overexpressed in clade 8 strain were the curli protein CsgC, a transcriptional activator (PchE), phage proteins, Stx2, FlgM and FlgD, a dienelactone hydrolase, CheW and CheY, and the SPATE protease EspP. For clade 6 strain, a high overexpression of phage proteins was detected, mostly from Stx2 encoding phage, including Stx2, flagellin and the protease TagA, EDL933_p0016, dienelactone hydrolase, and Haemolysin A, amongst others with unknown function. Some of these proteins were analyzed by RT-qPCR to corroborate the proteomic data. Clade 6 and clade 8 strains showed enhanced transcription of 10 out of 12 genes compared to EDL933. These results may provide new insights in E. coli O157: H7 mechanisms of pathogenesis.	[Amigo, Natalia; Silva, Wanderson M.; Larzabal, Mariano; Cataldi, Angel] Natl Inst Agr Technol Hurlingham, CICVyA, Inst Biotechnol, Buenos Aires, DF, Argentina; [Zhang, Qi; Zhang, Qunjie; Cui, Baiyuan; Chen, Zhongjian; Bei, Jinlong] Guangdong Acad Agr Sci GDAAS, AGRO Biol Gene Res Ctr, Guangzhou, Guangdong, Peoples R China; [Amadio, Ariel] Natl Inst Agr Technol, Rafaela Expt Stn, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Bei, JL (corresponding author), Guangdong Acad Agr Sci GDAAS, AGRO Biol Gene Res Ctr, Guangzhou, Guangdong, Peoples R China.	jinlongbei@agrogene.ac.cn		Larzabal, Mariano/0000-0002-1358-6982; Amadio, Ariel Fernando/0000-0002-1147-4485	FONCYT, Argentina [0211]; INTA, Argentina [PNBIO1131034]; Presidential Foundation of Guangdong Academy of Agricultural Sciences [201320]; Science and Technology Program of Guangdong Province China [2016B070701013]; CONICET	FONCYT, Argentina(FONCyT); INTA, Argentina; Presidential Foundation of Guangdong Academy of Agricultural Sciences; Science and Technology Program of Guangdong Province China; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The present study was supported by grants PICT #0211 from FONCYT, Argentina, PNBIO1131034 INTA, Argentina; Presidential Foundation of Guangdong Academy of Agricultural Sciences (No.: 201320), and Science and Technology Program of Guangdong Province, (2016B070701013) China. AA, ML and AC are CONICET fellows. NA holds a CONICET fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by grants PICT # 0211 from FONCYT, Argentina, PNBIO1131034 INTA, Argentina; Presidential Foundation of Guangdong Academy of Agricultural Sciences (No.: 201320), and Science and Technology Program of Guangdong Province, (2016B070701013) China.; AA, ML and AC are CONICET fellows. NA holds a CONICET fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AG, 2013, APPL ENVIRON MICROB, V79, P411, DOI 10.1128/AEM.02635-12; Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Amigo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127710; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bielaszewska M, 2014, INT J MED MICROBIOL, V304, P521, DOI 10.1016/j.ijmm.2014.05.005; BROWN KL, 1995, MOL MICROBIOL, V16, P397, DOI 10.1111/j.1365-2958.1995.tb02405.x; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Fernandez D, 2007, 11 C ARG MICR COR S1, V39, P178; Figueira R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17524; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gioffre A, 2002, VET MICROBIOL, V87, P301, DOI 10.1016/S0378-1135(02)00079-2; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Gruber CC, 2015, INFECT IMMUN, V83, P1286, DOI 10.1128/IAI.02918-14; Guignot J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005013; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Herold S, 2005, ANTIMICROB AGENTS CH, V49, P931, DOI 10.1128/AAC.49.3.931-944.2005; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Imamovic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032393; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Islam N, 2016, APPL ENVIRON MICROB, V82, P4371, DOI 10.1128/AEM.00977-16; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Iyoda S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu061; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; Koitabashi T, 2006, MICROBIOL IMMUNOL, V50, P135, DOI 10.1111/j.1348-0421.2006.tb03779.x; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Larzabal M, 2010, C ARG MICR BUEN AIR; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Luis P, 2014, INT J MED MICROBIOL, V304, P499, DOI 10.1016/j.ijmm.2014.02.011; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Mellor GE, 2012, APPL ENVIRON MICROB, V78, P4724, DOI 10.1128/AEM.00365-12; Moreira CG, 2016, ADV EXP MED BIOL, V874, P247, DOI 10.1007/978-3-319-20215-0_12; Noller AC, 2003, J CLIN MICROBIOL, V41, P675, DOI 10.1128/JCM.41.2.675-679.2003; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Olavesen KK, 2016, MICROB PATHOGENESIS, V97, P1, DOI 10.1016/j.micpath.2016.05.010; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Paton AW, 2002, J CLIN MICROBIOL, V40, P1395, DOI 10.1128/JCM.40.4.1395-1399.2002; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pianciola L, 2016, INT J MED MICROBIOL, V306, P123, DOI 10.1016/j.ijmm.2016.02.005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rangarajan ES, 2011, PROTEIN SCI, V20, P1208, DOI 10.1002/pro.649; Rangel A, 2016, J BACTERIOL, V198, P2803, DOI 10.1128/JB.00189-16; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2010, PATHOGENIC ESCHERICH, P142; Rosenshine I, 1996, INFECT IMMUN, V64, P966, DOI 10.1128/IAI.64.3.966-973.1996; Saile N, 2016, APPL ENVIRON MICROB, V82, P5940, DOI 10.1128/AEM.01671-16; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Sharma VK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149745; Suardana IW, 2018, J MICROBIOL IMMUNOL, V51, P132, DOI 10.1016/j.jmii.2016.04.006; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Taylor JD, 2011, STRUCTURE, V19, P1307, DOI 10.1016/j.str.2011.05.015; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; Williamson JC, 2016, PROTEOMICS, V16, P907, DOI 10.1002/pmic.201400545; Yang F, 2012, EXPERT REV PROTEOMIC, V9, P129, DOI [10.1586/EPR.12.15, 10.1586/epr.12.15]; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Yang ZJ, 2009, J BACTERIOL, V191, P3553, DOI 10.1128/JB.01738-08; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; Zhang GJ, 2006, NAT BIOTECHNOL, V24, P100, DOI 10.1038/nbt1174	75	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166883	10.1371/journal.pone.0166883	http://dx.doi.org/10.1371/journal.pone.0166883			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880834	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500042
J	Carpenter, KLH; Sprechmann, P; Calderbank, R; Sapiro, G; Egger, HL				Carpenter, Kimberly L. H.; Sprechmann, Pablo; Calderbank, Robert; Sapiro, Guillermo; Egger, Helen L.			Quantifying Risk for Anxiety Disorders in Preschool Children: A Machine Learning Approach	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; ADOLESCENT PSYCHOPATHOLOGY; COMMUNITY SAMPLE; PRIMARY-CARE; PREVALENCE; CHILDHOOD; AUTISM; EPIDEMIOLOGY; COMORBIDITY; RELIABILITY	Early childhood anxiety disorders are common, impairing, and predictive of anxiety and mood disorders later in childhood. Epidemiological studies over the last decade find that the prevalence of impairing anxiety disorders in preschool children ranges from 0.3% to 6.5%. Yet, less than 15% of young children with an impairing anxiety disorder receive a mental health evaluation or treatment. One possible reason for the low rate of care for anxious preschoolers is the lack of affordable, timely, reliable and valid tools for identifying young children with clinically significant anxiety. Diagnostic interviews assessing psychopathology in young children require intensive training, take hours to administer and code, and are not available for use outside of research settings. The Preschool Age Psychiatric Assessment (PAPA) is a reliable and valid structured diagnostic parent-report interview for assessing psychopathology, including anxiety disorders, in 2 to 5 year old children. In this paper, we apply machine-learning tools to already collected PAPA data from two large community studies to identify sub-sets of PAPA items that could be developed into an efficient, reliable, and valid screening tool to assess a young child's risk for an anxiety disorder. Using machine learning, we were able to decrease by an order of magnitude the number of items needed to identify a child who is at risk for an anxiety disorder with an accuracy of over 96% for both generalized anxiety disorder (GAD) and separation anxiety disorder (SAD). Additionally, rather than considering GAD or SAD as discrete/binary entities, we present a continuous risk score representing the child's risk of meeting criteria for GAD or SAD. Identification of a short question- set that assesses risk for an anxiety disorder could be a first step toward development and validation of a relatively short screening tool feasible for use in pediatric clinics and daycare/preschool settings.	[Carpenter, Kimberly L. H.; Egger, Helen L.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Sprechmann, Pablo; Calderbank, Robert; Sapiro, Guillermo] Duke Univ, Elect & Comp Engn Biomed Engn & Comp Sci, Durham, NC 27708 USA; [Sprechmann, Pablo] NYU, Courant Inst Math, New York, NY USA; [Egger, Helen L.] NYU Langone Med Ctr, NYU Child Study Ctr, Dept Child & Adolescent Psychiat, New York, NY USA	Duke University; Duke University; New York University; New York University; NYU Langone Medical Center	Carpenter, KLH (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	kimberly.carpenter@duke.edu		Egger, Helen/0000-0001-8447-5350; Carpenter, Kimberly/0000-0002-3838-798X	National Institute of Mental Health [R01-MH-075766, R01 MH-63670, K23 MH-02016]; Department of Defence [N00014-12-1-0839, A001413001, HM0177-13-1-0007]; National Science Foundation [NSF-CCF-13-18168, A002113701, A003891201]; Duke University	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defence; National Science Foundation(National Science Foundation (NSF)); Duke University	This work was supported by National Institute of Mental Health (www.nimh.nig.gov) grants R01-MH-075766, R01 MH-63670, and K23 MH-02016. This work has also been supported by Department of Defence (cdmrp.army.mil) Awards N00014-12-1-0839, A001413001, and HM0177-13-1-0007; and National Science Foundation (www.nsf.org) Awards NSF-CCF-13-18168, A002113701, and A003891201. Additionally, the work was funded in part by Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Angold A, 1996, J CHILD PSYCHOL PSYC, V37, P657, DOI 10.1111/j.1469-7610.1996.tb01457.x; [Anonymous], 2001, ICF INT CLASFUNCT; [Anonymous], 2005, DIAGNOSTIC CLASSIFIC; Bittner A, 2007, J CHILD PSYCHOL PSYC, V48, P1174, DOI 10.1111/j.1469-7610.2007.01812.x; Bone D, 2016, J CHILD PSYCHOL PSYC, V57, P927, DOI 10.1111/jcpp.12559; Bone D, 2015, J AUTISM DEV DISORD, V45, P1121, DOI 10.1007/s10803-014-2268-6; Bufferd SJ, 2012, AM J PSYCHIAT, V169, P1157, DOI 10.1176/appi.ajp.2012.12020268; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; Cantwell DP, 1996, J CHILD PSYCHOL PSYC, V37, P3, DOI 10.1111/j.1469-7610.1996.tb01377.x; Carballo JJ, 2010, EUR CHILD ADOLES PSY, V19, P395, DOI 10.1007/s00787-009-0064-1; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chavira DA, 2004, DEPRESS ANXIETY, V20, P155, DOI 10.1002/da.20039; Cieslak DA, 2008, LECT NOTES ARTIF INT, V5211, P241, DOI 10.1007/978-3-540-87479-9_34; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; Costello EJ, 2005, CHILD ADOL PSYCH CL, V14, P631, DOI 10.1016/j.chc.2005.06.003; Egger H.L., 2006, HDB PRESCHOOL MENTAL, P137; Egger HL, 2006, J AM ACAD CHILD PSY, V45, P538, DOI 10.1097/01.chi.0000205705.71194.b8; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Ehrenrelch JT, 2008, BEHAV PSYCHOL, V16, P389; Esbjorn BH, 2010, J ANXIETY DISORD, V24, P866, DOI 10.1016/j.janxdis.2010.06.009; Franz L, 2013, J AM ACAD CHILD PSY, V52, P1294, DOI 10.1016/j.jaac.2013.09.008; Freund Y., 1999, ALTERNATING DECISION; Freund Y., 1995, COMPUTATIONAL LEARNI; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Hastie T., 2009, UNSUPERVISED LEARNIN; Hirshfeld-Becker DR, 2002, CLIN CHILD FAM PSYCH, V5, P161, DOI 10.1023/A:1019687531040; Kumar M. N., 2013, ARXIV13057331; Lavigne J, 2009, J CLIN CHILD ADOLESC, V38, P315, DOI 10.1080/15374410902851382; Liu KY, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S132; Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682; Rapee RM, 2002, BIOL PSYCHIAT, V52, P947, DOI 10.1016/S0006-3223(02)01572-X; Schapire RE, 1998, ANN STAT, V26, P1651; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Stein MB, 2006, J CLIN PSYCHIAT, V67, P3; Wall DP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.10; Wall DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043855; Wichstrom L, 2013, J CHILD PSYCHOL PSYC, V54, P1327, DOI 10.1111/jcpp.12116; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x	40	11	11	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165524	10.1371/journal.pone.0165524	http://dx.doi.org/10.1371/journal.pone.0165524			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5KB	27880812	gold, Green Submitted, Green Published			2022-12-26	WOS:000388889500009
J	Liu, HMM; Ferrington, DA; Baumann, CW; Thompson, LV				Liu, Haiming M.; Ferrington, Deborah A.; Baumann, Cory W.; Thompson, LaDora V.			Denervation-Induced Activation of the Standard Proteasome and Immunoproteasome	PLOS ONE			English	Article							SKELETAL-MUSCLE ATROPHY; 20 S PROTEASOME; UBIQUITIN-PROTEASOME; GENOMIC ORGANIZATION; PROTEIN BREAKDOWN; TISSUE EXPRESSION; ACTIVE-SITES; AUTOPHAGY; IDENTIFICATION; DEGRADATION	The standard 26S proteasome is responsible for the majority of myofibrillar protein degradation leading to muscle atrophy. The immunoproteasome is an inducible form of the proteasome. While its function has been linked to conditions of atrophy, its contribution to muscle proteolysis remains unclear. Therefore, the purpose of this study was to determine if the immunoproteasome plays a role in skeletal muscle atrophy induced by denervation. Adult male C57BL/6 wild type (WT) and immunoproteasome knockout Imp7(-/-)/mec-1(-/-)/ (L7M1) mice underwent tibial nerve transection on the left hindlimb for either 7 or 14 days, while control mice did not undergo surgery. Proteasome activity (caspase-, chymotrypsin-, and trypsin- like), protein content of standard proteasome beta 1, beta 5 and beta 2) and immunoproteasome (LMP2, LMP7 and MECL-1) catalytic subunits were determined in the gastrocnemius muscle. Denervation induced significant atrophy and was accompanied by increased activities and protein content of the catalytic subunits in both WT and L7M1 mice. Although denervation resulted in a similar degree of muscle atrophy between strains, the mice lacking two immunoproteasome subunits showed a differential response in the extent and duration of proteasome features, including activities and content of the beta 1, beta 5 and LMP2 catalytic subunits. The results indicate that immunoproteasome deficiency alters the proteasome's composition and activities. However, the immunoproteasome does not appear to be essential for muscle atrophy induced by denervation.	[Liu, Haiming M.; Baumann, Cory W.; Thompson, LaDora V.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Ferrington, Deborah A.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN USA; [Liu, Haiming M.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Thompson, LaDora V.] Boston Univ, Sargent Coll, Coll Hlth Sci & Rehabil, Dept Phys Therapy & Athlet Training, Boston, MA 02215 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; Boston University	Thompson, LV (corresponding author), Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA.; Thompson, LV (corresponding author), Boston Univ, Sargent Coll, Coll Hlth Sci & Rehabil, Dept Phys Therapy & Athlet Training, Boston, MA 02215 USA.	lvthomp@bu.edu		Ferrington, Deborah/0000-0003-2561-7464	National Institute on Aging/National Institutes of Health [T32-AG029796, R01 AG017768]; University of Minnesota, Graduate School, Doctoral Dissertation Fellowship; NATIONAL INSTITUTE ON AGING [T32AG029796] Funding Source: NIH RePORTER	National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Minnesota, Graduate School, Doctoral Dissertation Fellowship(University of Minnesota System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging/National Institutes of Health, T32-AG029796; the National Institute on Aging/National Institutes of Health, R01 AG017768; and the University of Minnesota, Graduate School, Doctoral Dissertation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DATA SCI J, DOI DOI 10.1080/15384101.2015.1044188; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Bardag-Gorce F, 2010, WORLD J GASTROENTERO, V16, P1349, DOI 10.3748/wjg.v16.i11.1349; Batt JAE, 2013, JOVE-J VIS EXP, DOI 10.3791/50657; Baumann CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160839; Beharry AW, 2014, J CELL SCI, V127, P1441, DOI 10.1242/jcs.136390; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Chen CNJ, 2014, J MUSCLE RES CELL M, V35, P191, DOI 10.1007/s10974-014-9385-x; Choi MC, 2012, MOL CELL, V47, P122, DOI 10.1016/j.molcel.2012.04.025; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Cui ZY, 2014, MOL CELL BIOL, V34, P96, DOI 10.1128/MCB.00622-13; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Furuya N, 2014, AUTOPHAGY, V10, P631, DOI 10.4161/auto.27785; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; Gomes-Marcondes MCC, 2002, BRIT J CANCER, V86, P1628, DOI 10.1038/sj/bjc/6600236; Graber TG, 2015, J GERONTOL A-BIOL, V70, P1045, DOI 10.1093/gerona/glu163; Greising SM, 2011, J APPL PHYSIOL, V110, P109, DOI 10.1152/japplphysiol.00852.2010; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Loos B, 2014, AUTOPHAGY, V10, P2087, DOI 10.4161/15548627.2014.973338; Maldonado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056187; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Ostrowska H, 2006, INT J BIOCHEM CELL B, V38, P1778, DOI 10.1016/j.biocel.2006.04.011; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Raule M, 2014, BBA-MOL CELL RES, V1843, P1942, DOI 10.1016/j.bbamcr.2014.05.005; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schuld NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126768; Sha Z, 2011, P NATL ACAD SCI USA, V108, P18573, DOI 10.1073/pnas.1115315108; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Tajrishi MM, 2014, J BIOL CHEM, V289, P19985, DOI 10.1074/jbc.M114.568626; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; ZANELLI E, 1993, IMMUNOGENETICS, V38, P400, DOI 10.1007/BF00184520; ZHOU P, 1993, GENOMICS, V16, P664, DOI 10.1006/geno.1993.1245	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166831	10.1371/journal.pone.0166831	http://dx.doi.org/10.1371/journal.pone.0166831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875560	Green Submitted, Green Published, gold			2022-12-26	WOS:000388886000028
J	Maeda, K; Yasui, H; Yamamori, T; Matsuura, T; Takao, S; Suzuki, M; Matsuda, A; Inanami, O; Shirato, H				Maeda, Kenichiro; Yasui, Hironobu; Yamamori, Tohru; Matsuura, Taeko; Takao, Seishin; Suzuki, Motofumi; Matsuda, Akira; Inanami, Osamu; Shirato, Hiroki			A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-beta-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam	PLOS ONE			English	Article							RELATIVE BIOLOGICAL EFFECTIVENESS; CURRENT SITUATION; ION-BEAMS; RADIATION; TAS106; CONSEQUENCES; INACTIVATION; PERSPECTIVES; SENSITIVITY; THERAPY	The effect of 1-(3-C-ethyny1-beta-D-ribo-pentofuranosyl)cytosine (ECyd) on proton-induced cell death was evaluated in human lung carcinoma cell line A549 and Chinese hamster fibroblast cell line V79 to enhance relative biological effectiveness (RBE) within the spread-out Bragg peak (SOBP) of proton beams. Treatment with ECyd significantly enhanced the proton -induced loss of clonogenicity and increased senescence at the center, but not at the distal edge of SOBP. The p53-binding protein 1 foci formation assay showed that ECyd decelerated the rate of DNA double-strand break (DSB) repair at the center, but not the distal region of SOBP, suggesting that the ECyd-induced enhancement of proton-induced cell death is partially associated with the inhibition of DSB repair. This study demonstrated that ECyd enhances proton-induced cell killing at all positions of SOBP, except for the distal region and minimizes the site-dependent differences in RBE within SOBP. Thus, ECyd is a unique radiosensitizer for proton therapy that may be useful because it levels the biological dose within SOBP, which improves tumor control and reduces the risk of adverse effects at the distal edge of SOBP.	[Maeda, Kenichiro; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan; [Yasui, Hironobu; Yamamori, Tohru; Inanami, Osamu] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Radiat Biol Lab,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan; [Matsuura, Taeko] Hokkaido Univ, Fac Engn, Div Quantum Sci & Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan; [Takao, Seishin] Hokkaido Univ Hosp, Proton Beam Therapy Ctr, Kita Ku, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan; [Matsuda, Akira] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Kita-12 Nishi-6, Sapporo, Hokkaido 0600812, Japan; [Shirato, Hiroki] Hokkaido Univ, Global Inst Collaborat Res & Educ, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Shirato, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.; Inanami, O (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Radiat Biol Lab,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.; Shirato, H (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan.	inanami@vetmed.hokudai.ac.jp; shirato@med.hokudai.ac.jp	Inanami, Osamu/A-5197-2012; Suzuki, Motofumi/GXN-2635-2022; Yasui, Hironobu/E-3794-2010	Inanami, Osamu/0000-0001-7895-3918; Yasui, Hironobu/0000-0002-6757-1110	Japan Society for the Promotion of Science KAKENHI [15H04768, 24659551, 26461875, 15K09983, 15K09984]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Numbers: 15H04768 (HS) (https://kaken.nii. ac.jp/ja/grant/KAKENHI-PROJECT-15H04768/) (Data collection and analysis and decision to publish); 24659551(OI) (https://kaken.nii.ac.jp/ja/ grant/KAKENHI-PROJECT-24659551/), 26461875 (TY) (https://kaken.niiac..jp/ja/grant/KAKENHI-PROJECT 26461875/), and 15K09983 (HY) (https://kaken.nii.ac.jp/ja/grant/KAKENH-IPROJECT-15K09983i) (Study design); and 15K09984 (TM) (https://kaken.nill.ac.jp/en/grant/ KAKENHI-PROJECT-15K09984/) (Preparation of the manuscript).	Ando K, 2001, J RADIAT RES, V42, P79, DOI 10.1269/jrr.42.79; Ballarini F, 2015, RADIAT PROT DOSIM, V166, P75, DOI 10.1093/rpd/ncv135; Belli M, 1998, INT J RADIAT BIOL, V74, P501, DOI 10.1080/095530098141375; Belli M, 2008, J RADIAT RES, V49, P597, DOI 10.1269/jrr.08052; Chaudhary P, 2014, INT J RADIAT ONCOL, V90, P27, DOI 10.1016/j.ijrobp.2014.05.010; Doyen J, 2015, CANCER RADIOTHER, V19, P231, DOI 10.1016/j.canrad.2015.03.002; Doyen J, 2015, CANCER RADIOTHER, V19, P211, DOI 10.1016/j.canrad.2014.12.010; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hattori H, 1996, J MED CHEM, V39, P5005, DOI 10.1021/jm960537g; Kagawa K, 2002, INT J RADIAT ONCOL, V54, P928, DOI 10.1016/S0360-3016(02)02949-8; Kantemiris I, 2011, MED PHYS, V38, P6585, DOI 10.1118/1.3662911; Liu CJ, 2010, PHYS MED BIOL, V55, P931, DOI 10.1088/0031-9155/55/4/002; Lui VWY, 2010, BIOCHEM PHARMACOL, V79, P1772, DOI 10.1016/j.bcp.2010.02.012; Maeda K, 2016, J RAD RES; Matsuda A, 2004, CANCER SCI, V95, P105, DOI 10.1111/j.1349-7006.2004.tb03189.x; Matsumoto Y, 2014, J RADIAT RES, V55, P816, DOI 10.1093/jrr/rrt230; Meike S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-92; Oshiro Y, 2014, J RADIAT RES, V55, P959, DOI 10.1093/jrr/rru034; Polf JC, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589914; SCHOLZ M, 1996, ADV SPACE RES-SERIES, V18, P5, DOI 10.1016/0273-1177(95)00784-C; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; Shimamoto Y, 2002, JPN J CANCER RES, V93, P825, DOI 10.1111/j.1349-7006.2002.tb01325.x; Takayama K, 2016, J CANCER RES CLIN, V142, P659, DOI 10.1007/s00432-015-2069-0; Tilly N, 2005, PHYS MED BIOL, V50, P2765, DOI 10.1088/0031-9155/50/12/003; van de Water TA, 2011, ONCOLOGIST, V16, P366, DOI 10.1634/theoncologist.2010-0171; WARD JF, 1981, RADIAT RES, V86, P185, DOI 10.2307/3575500; Wilkens JJ, 2004, PHYS MED BIOL, V49, P2811, DOI 10.1088/0031-9155/49/13/004; Wilkens JJ, 2003, MED PHYS, V30, P806, DOI 10.1118/1.1567852; Yasui H, 2008, BRIT J CANCER, V99, P1442, DOI 10.1038/sj.bjc.6604720; Yasui H, 2007, INT J RADIAT ONCOL, V68, P218, DOI 10.1016/j.ijrobp.2006.12.061	30	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166848	10.1371/journal.pone.0166848	http://dx.doi.org/10.1371/journal.pone.0166848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875573	gold, Green Submitted, Green Published			2022-12-26	WOS:000388886000030
J	Necciari, T; Laback, B; Savel, S; Ystad, S; Balazs, P; Meunier, S; Kronland-Martinet, R				Necciari, Thibaud; Laback, Bernhard; Savel, Sophie; Ystad, Solvi; Balazs, Peter; Meunier, Sabine; Kronland-Martinet, Richard			Auditory Time-Frequency Masking for Spectrally and Temporally Maximally Compact Stimuli	PLOS ONE			English	Article							NARROW-BAND NOISE; OFF-FREQUENCY; PURE-TONE; NONSIMULTANEOUS MASKING; PSYCHOPHYSICAL MEASURES; COMPUTER-MODEL; AUDIO; ADDITIVITY; GAIN; COMPRESSION	Many audio applications perform perception-based time-frequency (TF) analysis by decomposing sounds into a set of functions with good TF localization (i.e. with a small essential support in the TF domain) using TF transforms and applying psychoacoustic models of auditory masking to the transform coefficients. To accurately predict masking interactions between coefficients, the TF properties of the model should match those of the transform. This involves having masking data for stimuli with good TF localization. However, little is known about TF masking for mathematically well-localized signals. Most existing masking studies used stimuli that are broad in time and/or frequency and few studies involved TF conditions. Consequently, the present study had two goals. The first was to collect TF masking data for well-localized stimuli in humans. Masker and target were 10-ms Gaussian shaped sinusoids with a bandwidth of approximately one critical band. The overall pattern of results is qualitatively similar to existing data for long maskers. To facilitate implementation in audio processing algorithms, a dataset provides the measured TF masking function. The second goal was to assess the potential effect of auditory efferents on TF masking using a modeling approach. The temporal window model of masking was used to predict present and existing data in two configurations: (1) with standard model parameters (i.e. without efferents), (2) with cochlear gain reduction to simulate the activation of efferents. The ability of the model to predict the present data was quite good with the standard configuration but highly degraded with gain reduction. Conversely, the ability of the model to predict existing data for long maskers was better with than without gain reduction. Overall, the model predictions suggest that TF masking can be affected by efferent (or other) effects that reduce cochlear gain. Such effects were avoided in the experiment of this study by using maximally -compact stimuli.	[Necciari, Thibaud; Laback, Bernhard; Balazs, Peter] Austrian Acad Sci, Acoust Res Inst, Vienna, Austria; [Savel, Sophie; Ystad, Solvi; Meunier, Sabine; Kronland-Martinet, Richard] Aix Marseille Univ, Cent Marseille, Equipe Sons, CNRS UPR 7051,Lab Mecan Acoust, Marseille, France	Austrian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite	Necciari, T (corresponding author), Austrian Acad Sci, Acoust Res Inst, Vienna, Austria.	thibaud.necciari@oeaw.ac.at	Ystad, Sølvi/AAN-4517-2020; Balazs, Peter/E-3020-2010; Necciari, Thibaud/N-7726-2015	Ystad, Sølvi/0000-0001-9022-9690; Balazs, Peter/0000-0003-4939-0831; Necciari, Thibaud/0000-0003-2574-0948; Laback, Bernhard/0000-0003-0929-6787	Austrian Science Fund [I 1362-N30, Y 551-N13]; Austrian Science Fund (FWF) [Y 551, I 1362] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund, http://www.fwf.ac.at, grant numbers I 1362-N30 and Y 551-N13 (received the funding: TN and PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BC, 2006, J ACOUST SOC AM, V119, P2889, DOI 10.1121/1.2169918; Bacon SP, 2004, J ACOUST SOC AM, V115, P1674, DOI 10.1121/1.1689344; BACON SP, 1987, J ACOUST SOC AM, V82, P1925, DOI 10.1121/1.395688; Balazs P, 2010, IEEE T AUDIO SPEECH, V18, P34, DOI 10.1109/TASL.2009.2023164; BENTLER RA, 1989, EAR HEARING, V10, P58, DOI 10.1097/00003446-198902000-00010; Boyev KP, 2002, JARO, V3, P362, DOI 10.1007/s101620020044; BRANDENBURG K, 1994, J AUDIO ENG SOC, V42, P780; Chardon G, 2014, P 39 INT C AC SPEECH, P3126; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Dai P, 2013, SPEECH COMMUN, V55, P387, DOI 10.1016/j.specom.2012.12.005; Dau T, 1996, J ACOUST SOC AM, V99, P3615, DOI 10.1121/1.414959; Defraene B, 2013, IEEE T AUDIO SPEECH, V21, P2627, DOI 10.1109/TASL.2013.2281570; Depalle P, 1997, P IEEE WORKSH APPL S, P93; Derrien O, 2015, P 23 EUR SIGN PROC C, P804; Eustaquio-Martin A, 2011, JARO-J ASSOC RES OTO, V12, P281, DOI 10.1007/s10162-010-0252-1; FASTL H, 1979, ACUSTICA, V43, P282; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; Feichtinger HG, 1998, GABOR ANAL ALGORITHM, DOI [10.1007/978-1-4612-2016-9, DOI 10.1007/978-1-4612-2016-9]; Ferry RT, 2007, J ACOUST SOC AM, V122, P3519, DOI 10.1121/1.2799914; Fevotte C, 2008, IEEE T AUDIO SPEECH, V16, P174, DOI 10.1109/TASL.2007.909290; Flandrin Patrick, 1999, TIME FREQUENCY TIME, V10; FLORENTINE M, 1986, J ACOUST SOC AM, V79, P792, DOI 10.1121/1.393469; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; GOLDSTEIN JL, 1967, J ACOUST SOC AM, V41, P676, DOI 10.1121/1.1910396; GRANTHAM DW, 1982, J ACOUST SOC AM, V72, P406, DOI 10.1121/1.388092; GREENWOOD D, 1961, J ACOUST SOC AM, V33, P484, DOI 10.1121/1.1908699; He X, 2008, J ELECTR COMPUT ENG, V2008, DOI 10.1155/2008/346767; Huang YH, 2002, IEEE T SPEECH AUDI P, V10, P325, DOI 10.1109/FSA.2002.800559; Irino T, 2006, IEEE T AUDIO SPEECH, V14, P2222, DOI 10.1109/TASL.2006.874669; Jennings SG, 2012, J ACOUST SOC AM, V132, P2497, DOI 10.1121/1.4746029; Jennings SG, 2012, J ACOUST SOC AM, V132, P2483, DOI 10.1121/1.4742723; Jennings SG, 2011, JARO-J ASSOC RES OTO, V12, P345, DOI 10.1007/s10162-011-0256-5; Jennings SG, 2009, J ACOUST SOC AM, V125, P2172, DOI 10.1121/1.3081383; KIDD G, 1981, HEARING RES, V5, P49, DOI 10.1016/0378-5955(81)90026-5; KIDD G, 1984, J ACOUST SOC AM, V75, P937, DOI 10.1121/1.390558; Laback B, 2013, J ACOUST SOC AM, V134, P1160, DOI 10.1121/1.4812773; Laback B, 2011, J ACOUST SOC AM, V129, P888, DOI 10.1121/1.3518781; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lopez-Poveda EA, 2003, J ACOUST SOC AM, V113, P951, DOI 10.1121/1.1534838; LUTFI RA, 1988, J ACOUST SOC AM, V83, P163, DOI 10.1121/1.396442; Meddis R, 2005, J ACOUST SOC AM, V117, P3787, DOI 10.1121/1.1893426; Meddis R, 2001, J ACOUST SOC AM, V109, P2852, DOI 10.1121/1.1370357; Miyasaka E., 1983, Journal of the Acoustical Society of Japan, V39, P614; MIYAZAKI K, 1984, JPN PSYCHOL RES, V26, P110, DOI 10.4992/psycholres1954.26.110; Moore BCJ, 1998, J ACOUST SOC AM, V104, P1023, DOI 10.1121/1.423321; Moore BCJ, 2002, HEARING RES, V163, P101, DOI 10.1016/S0378-5955(01)00390-2; Najaf-Zadeh H, 2003, P 114 CONV AUD ENG S; Necciari T, 2013, INT CONF ACOUST SPEE, P498, DOI 10.1109/ICASSP.2013.6637697; Necciari T., 2010, THESIS; Necciari T, 2012, P 45 AES C APPL TIM, P103; NEFF DL, 1986, J ACOUST SOC AM, V79, P1519, DOI 10.1121/1.393678; Oxenham AJ, 2001, J ACOUST SOC AM, V109, P732, DOI 10.1121/1.1336501; OXENHAM AJ, 1994, HEARING RES, V80, P105, DOI 10.1016/0378-5955(94)90014-0; Pichevar R, 2011, SPEECH COMMUN, V53, P643, DOI 10.1016/j.specom.2010.09.008; Plack CJ, 2010, J ACOUST SOC AM, V128, P771, DOI 10.1121/1.3455844; Plack CJ, 2002, ACTA ACUST UNITED AC, V88, P348; Plack CJ, 1998, J ACOUST SOC AM, V103, P1598, DOI 10.1121/1.421294; Plack CJ, 2007, P 19 INT C AC ICA 20, P1; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Roverud E, 2014, J ACOUST SOC AM, V135, P1321, DOI 10.1121/1.4864783; Siedenburg K, 2012, P 45 AES C APPL TIM, P241; Smalt CJ, 2014, JARO-J ASSOC RES OTO, V15, P159, DOI 10.1007/s10162-013-0430-z; SODERQUIST D R, 1981, Journal of Auditory Research, V21, P227; Strickland EA, 2004, J ACOUST SOC AM, V115, P2234, DOI 10.1121/1.1691036; Strickland EA, 2001, J ACOUST SOC AM, V109, P2062, DOI 10.1121/1.1357811; Strope B, 1997, IEEE T SPEECH AUDI P, V5, P451, DOI 10.1109/89.622569; Tabuchi H, 2016, J ACOUST SOC AM, V140, P2680, DOI 10.1121/1.4964328; Vafin R, 2000, INT CONF ACOUST SPEE, P901; van Schijndel NH, 1999, J ACOUST SOC AM, V105, P3425, DOI 10.1121/1.424683; Wojtczak M, 2010, J ACOUST SOC AM, V128, P247, DOI 10.1121/1.3436566; Yasin I, 2003, J ACOUST SOC AM, V114, P322, DOI 10.1121/1.1579003; Yasin I, 2014, J NEUROSCI, V34, P15319, DOI 10.1523/JNEUROSCI.1043-14.2014; Yasin I, 2013, J ACOUST SOC AM, V133, P4145, DOI 10.1121/1.4802827; Zilany MSA, 2006, J ACOUST SOC AM, V120, P1446, DOI 10.1121/1.2225512; Zilany MSA, 2014, J ACOUST SOC AM, V135, P283, DOI 10.1121/1.4837815; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	77	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166937	10.1371/journal.pone.0166937	http://dx.doi.org/10.1371/journal.pone.0166937			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875575	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000037
J	de Vasconcellos, JF; Lee, YT; Byrnes, C; Tumburu, L; Rebel, A; Miller, JL				de Vasconcellos, Jaira F.; Lee, Y. Terry; Byrnes, Colleen; Tumburu, Laxminath; Rebel, Antoinette; Miller, Jeffery L.			HMGA2 Moderately Increases Fetal Hemoglobin Expression in Human Adult Erythroblasts	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; BETA-THALASSEMIA; GENE; LET-7; PROTEINS; IDENTIFICATION; TRANSCRIPTION; ERYTHROCYTES; HYDROXYUREA; DETERMINES	Induction of fetal hemoglobin (HbF) has therapeutic importance for patients with beta-hemoglobin disorders. Previous studies showed that let-7 microRNAs (miRNAs) are highly regulated in erythroid cells during the fetal-to-adult developmental transition, and that targeting let-7 mediated the up-regulation of HbF to greater than 30% of the total globin levels in human adult cultured erythroblasts. HMGA2 is a member of the high-mobility group A family of proteins and a validated target of the let-7 family of miRNAs. Here we investigate whether expression of HMGA2 directly regulates fetal hemoglobin in adult erythroblasts. Let-7 resistant HMGA2 expression was studied after lentiviral transduction of CD34(+) cells. The transgene was regulated by the erythroid-specific gene promoter region of the human SPTA1 gene (HMGA2-OE). HMGA2-OE caused significant increases in gamma-globin mRNA expression and HbF to around 16% of the total hemoglobin levels compared to matched control transductions. Interestingly, no significant changes in KLF1, SOX6, GATA1, ZBTB7A and BCL11A mRNA levels were observed. Overall, our data suggest that expression of HMGA2, a downstream target of let-7 miRNAs, causes moderately increased gamma-globin gene and protein expression in adult human erythroblasts.	[de Vasconcellos, Jaira F.; Lee, Y. Terry; Byrnes, Colleen; Rebel, Antoinette; Miller, Jeffery L.] NIDDK, Mol Genom & Therapeut Sect, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Tumburu, Laxminath] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Tumburu, Laxminath] NHLBI, Sickle Cell Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Miller, JL (corresponding author), NIDDK, Mol Genom & Therapeut Sect, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov		Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025101, ZIADK025098, Z01DK025089, ZIADK025100] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work.	Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; de Vasconcellos JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106924; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Goh SH, 2005, BLOOD, V106, P1466, DOI 10.1182/blood-2005-03-0948; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Helsmoortel HH, 2016, BLOOD, V127, P1163, DOI 10.1182/blood-2015-09-667808; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Lee YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144977; Lee YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068307; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; NEEL JV, 1949, SCIENCE, V110, P64, DOI 10.1126/science.110.2846.64; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Noh SJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-98; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Pleasants S, 2014, NATURE, V515, pS2, DOI 10.1038/515S2a; Rogalla P, 1996, AM J PATHOL, V149, P775; SEWCHAND LS, 1983, BLOOD CELLS, V9, P147; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Telen MJ, 2016, BLOOD, V127, P810, DOI 10.1182/blood-2015-09-618553; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0; Zhou XJ, 1996, NUCLEIC ACIDS RES, V24, P4071, DOI 10.1093/nar/24.20.4071	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166928	10.1371/journal.pone.0166928	http://dx.doi.org/10.1371/journal.pone.0166928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861570	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300134
J	Sengupta, S; Rath, U; Yao, CF; Zavortink, M; Wang, C; Girton, J; Johansen, KM; Johansen, J				Sengupta, Saheli; Rath, Uttama; Yao, Changfu; Zavortink, Michael; Wang, Chao; Girton, Jack; Johansen, Kristen M.; Johansen, Jorgen			Digitor/dASCIZ Has Multiple Roles in Drosophila Development	PLOS ONE			English	Article							HISTONE H3 PHOSPHORYLATION; OXIDATIVE STRESS; BROAD-COMPLEX; CHROMATIN-STRUCTURE; GENE-EXPRESSION; DAMAGE RESPONSE; PROTEIN ASCIZ; DNA-DAMAGE; ECDYSONE; ATMIN	In this study we provide evidence that the spindle matrix protein Skeletor in Drosophila interacts with the human ASCIZ (also known as ATMIN and ZNF822) ortholog, Digitor/dASCIZ. This interaction was first detected in a yeast two-hybrid screen and subsequently confirmed by pull-down assays. We also confirm a previously documented function of Digitor/dASCIZ as a regulator of Dynein light chain/Cut up expression. Using transgenic expression of a mCitrine-labeled Digitor construct, we show that Digitor/dASCIZ is a nuclear protein that is localized to interband and developmental puff chromosomal regions during interphase but redistributes to the spindle region during mitosis. Its mitotic localization and physical interaction with Skeletor suggest the possibility that Digitor/dASCIZ plays a direct role in mitotic progression as a member of the spindle matrix complex. Furthermore, we have characterized a P-element insertion that is likely to be a true null Digitor/dASCIZ allele resulting in complete pupal lethality when homozygous, indicating that Digitor/dASCIZ is an essential gene. Phenotypic analysis of the mutant provided evidence that Digitor/dASCIZ plays critical roles in regulation of metamorphosis and organogenesis as well as in the DNA damage response. In the Digitor/dASCIZ null mutant larvae there was greatly elevated levels of gamma H2Av, indicating accumulation of DNA double-strand breaks. Furthermore, reduced levels of Digitor/dASCIZ decreased the resistance to paraquat-induced oxidative stress resulting in increased mortality in a stress test paradigm. We show that an early developmental consequence of the absence of Digitor/dASCIZ is reduced third instar larval brain size although overall larval development appeared otherwise normal at this stage. While Digitor/dASCIZ mutant larvae initiate pupation, all mutant pupae failed to eclose and exhibited various defects in metamorphosis such as impaired differentiation, incomplete disc eversion, and faulty apoptosis. Altogether we provide evidence that Digitor/dASCIZ is a nuclear protein that performs multiple roles in Drosophila larval and pupal development.	[Sengupta, Saheli; Rath, Uttama; Yao, Changfu; Zavortink, Michael; Wang, Chao; Girton, Jack; Johansen, Kristen M.; Johansen, Jorgen] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, KM; Johansen, J (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	kristen@iastate.edu; jorgen@iastate.edu		Sengupta, Saheli/0000-0002-1192-8467	National Institute of Health [GM62916]; National Science Foundation [MCB0817107]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	Work in the Johansen laboratory is supported by grants from the National Institute of Health [GM62916] and from the National Science Foundation [MCB0817107]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 1978, GENET BIOL DROSOPHIL, V2b, P453; BAEHRECKE EH, 1995, DEV BIOL, V171, P85, DOI 10.1006/dbio.1995.1262; Baehrecke EH, 1996, ARCH INSECT BIOCHEM, V33, P231, DOI 10.1002/(SICI)1520-6327(1996)33:3/4&lt;231::AID-ARCH5&gt;3.0.CO;2-V; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bao XM, 2005, J CELL SCI, V118, P5079, DOI 10.1242/jcs.02611; Bashirullah A, 2007, DEV DYNAM, V236, P3173, DOI 10.1002/dvdy.21350; Bolkan BJ, 2007, GENETICS, V177, P2233, DOI 10.1534/genetics.107.079939; Bonilla E, 2006, NEUROCHEM RES, V31, P1425, DOI 10.1007/s11064-006-9194-8; BOYD L, 1991, DEVELOPMENT, V112, P981; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Cai Weili, 2010, J Vis Exp, DOI 10.3791/1748; Ding Y, 2009, DEV BIOL, V334, P253, DOI 10.1016/j.ydbio.2009.07.027; FLETCHER JC, 1995, GENETICS, V141, P1025; Goggolidou P, 2014, DEVELOPMENT, V141, P3966, DOI 10.1242/dev.107755; Goggolidou P, 2014, HUM MOL GENET, V23, P5303, DOI 10.1093/hmg/ddu246; GRUENBAUM Y, 1988, J CELL BIOL, V106, P585, DOI 10.1083/jcb.106.3.585; Heierhorst J, 2011, CELL CYCLE, V10, P1222, DOI 10.4161/cc.10.8.15336; HUET F, 1993, DEVELOPMENT, V118, P613; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; Johansen KM, 2011, CHROMOSOME RES, V19, P345, DOI 10.1007/s10577-011-9187-6; Jurado S, 2012, J EXP MED, V209, P1629, DOI 10.1084/jem.20120785; Jurado S, 2012, J BIOL CHEM, V287, P3156, DOI 10.1074/jbc.M111.306019; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Kanu N, 2010, J BIOL CHEM, V285, P38534, DOI 10.1074/jbc.M110.145896; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; KARIM FD, 1993, DEVELOPMENT, V118, P977; KISS I, 1988, GENETICS, V118, P247; Lake CM, 2013, G3-GENES GENOM GENET, V3, P1539, DOI 10.1534/g3.113.006833; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lindsley D.L., 2012, GENOME DROSOPHILA ME; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sambrook J., 2001, MOL CLONING LAB MANU; Sengupta S, 2012, MOL BIOL CELL, V23; Sengupta S, 2011, MOL BIOL CELL, V22; Shaposhnikov M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15299; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tzolovsky G, 1999, GENETICS, V153, P1371; Vermeulen CJ, 2005, BIOGERONTOLOGY, V6, P387, DOI 10.1007/s10522-005-4903-2; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wang C, 2013, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ELECTRIC AND ELECTRONICS, P1, DOI 10.1109/CLEOE-IQEC.2013.6800695; Wang L, 2010, DEV DYNAM, V239, P954, DOI 10.1002/dvdy.22213; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yao CF, 2012, MOL BIOL CELL, V23, P3532, DOI 10.1091/mbc.E12-06-0429; Zaytseva O, 2014, GENETICS, V196, P443, DOI 10.1534/genetics.113.159541; Zhang TY, 2012, CELL REP, V2, P1498, DOI 10.1016/j.celrep.2012.11.002; Zhang WG, 2003, GENETICS, V165, P1341	63	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166829	10.1371/journal.pone.0166829	http://dx.doi.org/10.1371/journal.pone.0166829			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861562	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300118
J	Tang, X; Ding, CK; Wu, J; Sjol, J; Wardell, S; Spasojevic, I; George, D; McDonnell, DP; Hsu, DS; Chang, JT; Chi, JT				Tang, X.; Ding, C-K; Wu, J.; Sjol, J.; Wardell, S.; Spasojevic, I.; George, D.; McDonnell, D. P.; Hsu, D. S.; Chang, J. T.; Chi, J-T			Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RENAL-CELL CARCINOMA; MALIGNANT-CELLS; TUMOR-CELLS; DEPRIVATION; GLUTAMINE; INHIBITION; PHENOTYPE; APOPTOSIS; PATHWAYS	Despite the advances in the diagnosis and treatment of breast cancer, breast cancers still cause significant mortality. For some patients, especially those with triple-negative breast cancer, current treatments continue to be limited and ineffective. Therefore, there remains an unmet need for a novel therapeutic approach. One potential strategy is to target the altered metabolic state that is rewired by oncogenic transformation. Specifically, this rewiring may render certain outside nutrients indispensable. To identify such a nutrient, we performed a nutrigenetic screen by removing individual amino acids to identify possible addictions across a panel of breast cancer cells. This screen revealed that cystine deprivation triggered rapid programmed necrosis, but not apoptosis, in the basal-type breast cancer cells mostly seen in TNBC tumors. In contrast, luminal-type breast cancer cells are cystine-independent and exhibit little death during cystine deprivation. The cystine addiction phenotype is associated with a higher level of cystine-deprivation signatures noted in the basal type breast cancer cells and tumors. We found that the cystine-addicted breast cancer cells and tumors have strong activation of TNF alpha and MEKK4-p38-Noxa pathways that render them susceptible to cystine deprivation-induced necrosis. Consistent with this model, silencing of TNFa and MEKK4 dramatically reduces cystine-deprived death. In addition, the cystine addiction phenotype can be abrogated in the cystine-addictive cells by miR-200c, which converts the mesenchymal-like cells to adopt epithelial features. Conversely, the introduction of inducers of epithelial-mesenchymal transition (EMT) in cystine-independent breast cancer cells conferred the cystine-addiction phenotype by modulating the signaling components of cystine addiction. Together, our data reveal that cystine-addiction is associated with EMT in breast cancer during tumor progression. These findings provide the genetic and mechanistic basis to explain how cystine deprivation triggers necrosis by activating pre-existing oncogenic pathways in cystine-addicted TNBC with prominent mesenchymal features.	[Tang, X.; Ding, C-K; Wu, J.; Chi, J-T] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Tang, X.; Ding, C-K; Wu, J.; Hsu, D. S.; Chi, J-T] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Tang, X.] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Sjol, J.; Chang, J. T.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Wardell, S.; McDonnell, D. P.; Hsu, D. S.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Spasojevic, I.; George, D.] Duke Univ, Dept Med, Durham, NC USA	Duke University; Duke University; Michigan Technological University; University of Texas System; University of Texas Health Science Center Houston; Duke University; Duke University	Chi, JT (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	jentsan.chi@duke.edu		Chi, Jen-Tsan/0000-0003-3433-903X; Ding, Chien-Kuang/0000-0001-9047-0222	NIH [CA125618, CA106520]; Department of Defense [W81XWH-12-1-0148, W81XWH-14-1-0309, W81XWH-15-1-0486]; NATIONAL CANCER INSTITUTE [R01CA106520, R01CA125618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to acknowledge the financial support from the NIH (CA125618 and CA106520 to JTC) and Department of Defense (W81XWH-12-1-0148, W81XWH-14-1-0309, W81XWH-15-1-0486 to JTC). We appreciate the technical assistance of Ivan Spasojevic and the DCI's Pharmacokinetics and Investigational Chemotherapy share facility. We are also grateful to members of Chi lab for critical discussions and editing of the manuscript.	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Chen JLY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001093; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Harten SK, 2009, MOL BIOL CELL, V20, P1089, DOI 10.1091/mbc.E08-06-0566; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Keenan MM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005599; Keenan MM, 2015, CANCER J, V21, P49, DOI 10.1097/PPO.0000000000000104; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KREIS W, 1980, CANCER RES, V40, P634; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lampidis TJ, 2006, CANCER CHEMOTH PHARM, V58, P725, DOI 10.1007/s00280-006-0207-8; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Lucas JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000920; Moore T, 2013, J CHROMATOGR B, V929, P51, DOI 10.1016/j.jchromb.2013.04.004; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Murphy JM, 2014, EMBO REP, V15, P155, DOI 10.1002/embr.201337970; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohtawa K, 1998, LEUKEMIA, V12, P1651, DOI 10.1038/sj.leu.2401139; Paranjape AN, 2016, ONCOGENE, V35, P5963, DOI 10.1038/onc.2015.498; Scott L, 2000, BRIT J CANCER, V83, P800, DOI 10.1054/bjoc.2000.1353; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tang XH, 2016, CANCER RES, V76, P1892, DOI 10.1158/0008-5472.CAN-15-2328; Tang XH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005158; Tang XH, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0415-9; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang XJ, 2015, INT J ONCOL, V46, P1141, DOI 10.3892/ijo.2014.2809; Zhao WN, 2016, CANCER RES, V76, P2037, DOI 10.1158/0008-5472.CAN-15-1970	48	28	28	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 27	2017	36	30					4235	4242		10.1038/onc.2016.394	http://dx.doi.org/10.1038/onc.2016.394			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB8AH	27869167	Green Accepted			2022-12-26	WOS:000406360600001
J	Cross, M; Lepage, R; Rajan, S; Biberacher, S; Young, ND; Kim, BN; Coster, MJ; Gasser, RB; Kim, JS; Hofmann, A				Cross, Megan; Lepage, Romain; Rajan, Siji; Biberacher, Sonja; Young, Neil D.; Kim, Bo-Na; Coster, Mark J.; Gasser, Robin B.; Kim, Jeong-Sun; Hofmann, Andreas			Probing function and structure of trehalose-6phosphate phosphatases from pathogenic organisms suggests distigroupingsnct molecular	FASEB JOURNAL			English	Article						drug targets; enzyme inhibitors; molecular mechanism	TREHALOSE-6-PHOSPHATE PHOSPHATASE; TREHALOSE-PHOSPHATE; MYCOBACTERIUM-SMEGMATIS; SACCHAROMYCES-CEREVISIAE; PROTEIN; CLONING; GENE; PURIFICATION; SUPERFAMILY; EXPRESSION	The trehalose biosynthetic pathway is of great interest for the development of novel therapeutics because trehalose is an essential disaccharide in many pathogens but is neither required nor synthesized in mammalian hosts. As such, trehalose-6-phosphate phosphatase (TPP), a key enzyme in trehalose biosynthesis, is likely an attractive target for novel chemotherapeutics. Based on a survey of genomes from a panel of parasitic nematodes and bacterial organisms and by way of a structure-based amino acid sequence alignment, we derive the topological structure of monoenzyme TPPs and classify them into 3 groups. Comparison of the functional roles of amino acid residues located in the active site for TPPs belonging to different groups reveal nuanced variations. Because current literature on this enzyme family shows a tendency to infer functional roles for individual amino acid residues, we investigated the roles of the strictly conserved aspartate tetrad in TPPs of the nematode Brugia malayi by using a conservative mutation approach. In contrast to aspartate-213, the residue inferred to carry out the nucleophilic attack on the substrate, we found that aspartate-215 and aspartate-428 of BmTPP are involved in the chemistry steps of enzymatic hydrolysis of the substrate. Therefore, we suggest that homology-based inference of functionally important amino acids by sequence comparison for monoenzyme TPPs should only be carried out for each of the 3 groups.-Cross, M.,Lepage, R.,Rajan, S., Biberacher, S.,Young, N.D.,Kim, B.-N., Coster, M.J., Gasser, R.B., Kim, J.-S., Hofmann, A. Probing function and structure of trehalose-6-phosphate phosphatases from pathogenic organisms suggests distinct molecular groupings.	[Cross, Megan; Lepage, Romain; Rajan, Siji; Biberacher, Sonja; Coster, Mark J.; Hofmann, Andreas] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld, Australia; [Young, Neil D.; Gasser, Robin B.; Hofmann, Andreas] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Kim, Bo-Na; Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Gwangju, South Korea; [Hofmann, Andreas] Queensland Trop Hlth Alliance, Smithfield, Qld, Australia	Griffith University; University of Melbourne; Chonnam National University	Hofmann, A (corresponding author), N75 Don Young Rd, Nathan, Qld 4111, Australia.	a.hofmann@griffith.edu.au	Gasser, Robin/ABH-6185-2020; Young, Neil David/AAU-4572-2020; Hofmann, Andreas/M-9870-2019; Coster, Mark/C-4621-2008	Gasser, Robin/0000-0002-4423-1690; Young, Neil David/0000-0001-8756-229X; Hofmann, Andreas/0000-0003-4408-5467; Coster, Mark/0000-0002-0910-6819; Cross, Megan/0000-0001-7512-7223; Rajan, Siji/0000-0002-2142-0042; Lepage, Romain/0000-0001-6384-3142; /0000-0003-3370-0444	Australian Research Council; National Health and Medical Research Council (NHMRC); Chonnam National University [2015-0597]; NHMRC; Rebecca L.Cooper Medical Research Foundation; Equity Trustees PhD Scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Chonnam National University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L.Cooper Medical Research Foundation; Equity Trustees PhD Scholarship	This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC) (to A.H., R.B.G., and N.D.Y.), the Rebecca L.Cooper Medical Research Foundation (to A.H.), and Chonnam National University (Grant 2015-0597 to J.- S.K.); by an Equity Trustees PhD Scholarship ( to M. C.); and by the NHMRC Career Development Fellowship (to N. D. Y.). The authors thank Robert Huber (Max Planck Institute of Biochemistry, Martinsried, Germany) for fruitful discussions during this study and James Cameron (Griffith University) for help with the inductively coupled plasma atomic emission spectroscopy measurements. Mass spectrometric analysis was undertaken at the Australian Proteome Analysis Facility provided by the Australian Government through the National Collaborative Research Infrastructure Strategy.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; CABIB E, 1958, J BIOL CHEM, V231, P259; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; Farelli JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004245; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Kushwaha S, 2011, ACTA TROP, V119, P151, DOI 10.1016/j.actatropica.2011.05.008; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LAPP D, 1971, J BIOL CHEM, V246, P4567; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; MCDOUGALL J, 1993, FEMS MICROBIOL LETT, V107, P25, DOI 10.1111/j.1574-6968.1993.tb05998.x; Miao Y, 2016, P NATL ACAD SCI USA, V113, P7148, DOI 10.1073/pnas.1601774113; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; RONNOW TECL, 1994, CARBOHYD RES, V260, P323, DOI 10.1016/0008-6215(94)84050-4; Shan S, 2016, FASEB J, V30, P3989, DOI 10.1096/fj.201600463R; Wang CK, 2012, BIOINFORMATICS, V28, P1026, DOI 10.1093/bioinformatics/bts035	24	8	8	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					920	+		10.1096/fj.201601149R	http://dx.doi.org/10.1096/fj.201601149R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27864376				2022-12-26	WOS:000395671200009
J	Ludlow, MJ; Gaunt, HJ; Rubaiy, HN; Musialowski, KE; Blythe, NM; Vasudev, NS; Muraki, K; Beech, DJ				Ludlow, Melanie J.; Gaunt, Hannah J.; Rubaiy, Hussein N.; Musialowski, Katie E.; Blythe, Nicola M.; Vasudev, Naveen S.; Muraki, Katsuhiko; Beech, David J.			(-)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; RENAL-CELL CARCINOMA; TRPC5; ENGLERIN; CANCER; NA,K-ATPASE; CELLMINER; SUBUNIT; BRAIN; PKC	(-)-Englerin A ((-)-EA) has a rapid and potent cytotoxic effect on several types of cancer cell that is mediated by plasma membrane ion channels containing transient receptor potential canonical 4 (TRPC4) protein. Because these channels are Ca2+-permeable, it was initially thought that the cytotoxicity arose as a consequence of Ca2+ overload. Here we show that this is not the case and that the effect of (-)-EA is mediated by a heteromer of TRPC4 and TRPC1 proteins. Both TRPC4 and TRPC1 were required for (-)-EA cytotoxicity; however, although TRPC4 was necessary for the (-)-EA-evoked Ca2+ elevation, TRPC1 was not. TRPC1 either had no role or was a negative regulator of Ca2+ entry. By contrast, both TRPC4 and TRPC1 were necessary for monovalent cation entry evoked by (-)-EA, and (-)-EA-evoked cell death was dependent upon entry of the monovalent cation Na+. We therefore hypothesized that Na+/K+-ATPase might act protectively by counteracting the Na+ load resulting from sustained Na+ entry. Indeed, inhibition of Na+/K+-ATPase by ouabain potently and strongly increased (-)-EA-evoked cytotoxicity. The data suggest that (-)-EA achieves cancer cell cytotoxicity by inducing sustained Na+ entry through heteromeric TRPC1/TRPC4 channels and that the cytotoxic effect of (-)-EA can be potentiated by Na+/K+ ATPase inhibition.	[Ludlow, Melanie J.; Gaunt, Hannah J.; Rubaiy, Hussein N.; Musialowski, Katie E.; Blythe, Nicola M.; Vasudev, Naveen S.; Beech, David J.] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan	University of Leeds; Aichi Gakuin University	Beech, DJ (corresponding author), Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England.	D.J.Beech@leeds.ac.uk	- The Truth, HNR/AAO-2514-2020; Rubaiy, Hussein N./ABG-5191-2021	Rubaiy, Hussein N./0000-0002-1489-5576; Vasudev, Naveen/0000-0001-8470-7481; Ludlow, Melanie/0000-0002-0720-5581; Beech, David/0000-0002-7683-9422	Leeds Teaching Hospitals Trust Charitable Foundation; University of Leeds; British Heart Foundation [FS/14/22/30734] Funding Source: researchfish	Leeds Teaching Hospitals Trust Charitable Foundation; University of Leeds; British Heart Foundation(British Heart Foundation)	This work was supported by the Leeds Teaching Hospitals Trust Charitable Foundation and the University of Leeds. The authors declare that they have no conflicts of interest with the contents of this article.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Carson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127498; Dietrich Alexander, 2014, Cells, V3, P939, DOI 10.3390/cells3040939; Engl E, 2015, J PHYSIOL-LONDON, V593, P3417, DOI 10.1113/jphysiol.2014.282517; Fash DM, 2016, BIOORG MED CHEM LETT, V26, P2641, DOI 10.1016/j.bmcl.2016.04.016; Kim J, 2014, PFLUG ARCH EUR J PHY, V466, P491, DOI 10.1007/s00424-013-1332-y; Li ZW, 2011, J AM CHEM SOC, V133, P6553, DOI 10.1021/ja201921j; Lopez-Suarez L, 2016, CHEMMEDCHEM, V11, P1003, DOI 10.1002/cmdc.201600040; Naylor J, 2016, BRIT J PHARMACOL, V173, P562, DOI 10.1111/bph.13387; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Radtke L, 2011, ANGEW CHEM INT EDIT, V50, P3998, DOI 10.1002/anie.201007790; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Selvakumar P, 2014, EPIGENETICS-US, V9, P579, DOI 10.4161/epi.27795; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shi J, 2012, FASEB J, V26, P409, DOI 10.1096/fj.11-185611; Sourbier C, 2013, CANCER CELL, V23, P228, DOI 10.1016/j.ccr.2012.12.007; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2	24	29	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					723	731		10.1074/jbc.M116.755678	http://dx.doi.org/10.1074/jbc.M116.755678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27875305	Green Published, hybrid			2022-12-26	WOS:000392316100026
J	He, K; Hu, J; Yu, HY; Wang, LN; Tang, F; Gu, JJ; Ge, LX; Wang, HY; Li, S; Hu, P; Jin, Y				He, Ke; Hu, Jing; Yu, Hongyao; Wang, Lina; Tang, Fan; Gu, Junjie; Ge, Laixiang; Wang, Hongye; Li, Sheng; Hu, Ping; Jin, Ying			Serine/Threonine Kinase 40 (Stk40) Functions as a Novel Regulator of Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOGENIC DIFFERENTIATION; HISTONE DEACETYLASE-5; TRANSCRIPTION FACTOR; MEF2 PROTEINS; STEM-CELLS; REGENERATION; ENHANCER; ROLES; GENE; ACTIVATION	Skeletal muscle differentiation is a precisely coordinated process, and the molecular mechanism regulating the process remains incompletely understood. Here we report the identification of serine/threonine kinase 40 (Stk40) as a novel positive regulator of skeletal myoblast differentiation in culture and fetal skeletal muscle formation in vivo. We show that the expression level of Stk40 increases during skeletal muscle differentiation. Down-regulation and overexpression of Stk40 significantly decreases and increases myogenic differentiation of C2C12 myoblasts, respectively. In vivo, the number of myofibers and expression levels of myogenic markers are reduced in the fetal muscle of Stk40 knockout mice, indicating impaired fetal skeletal muscle formation. Mechanistically, Stk40 controls the protein level of histone deacetylase 5 (HDAC5) to maintain transcriptional activities of myocyte enhancer factor 2 (MEF2), a family of transcription factor important for skeletal myogenesis. Silencing of HDAC5 expression rescues the reduced myogenic gene expression caused by Stk40 deficiency. Together, our study reveals that Stk40 is required for fetal skeletal muscle development and provides molecular insights into the control of the HDAC5-MEF2 axis in skeletal myogenesis.	[He, Ke; Hu, Jing; Yu, Hongyao; Wang, Lina; Tang, Fan; Gu, Junjie; Ge, Laixiang; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Ctr Excellence Mol Cell Sci,Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, Hongye; Li, Sheng; Hu, Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn		Yu, Hongyao/0000-0003-3752-8442	Ministry of Science and Technology of China [2016YFA0100100, 2013CB966801]; National Natural Science Foundation [31301015, 91419309]; Chinese Academy of Sciences [XDB19020100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the Ministry of Science and Technology of China (2016YFA0100100 and 2013CB966801), the National Natural Science Foundation (31301015 and 91419309), and the Chinese Academy of Sciences (XDB19020100). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey P, 2001, CURR OPIN CELL BIOL, V13, P679, DOI 10.1016/S0955-0674(00)00271-4; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Li H S, 2009, J SAFETY SCI TECHNOL, V5, P5; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Swierczynski S, 2015, EXPERT OPIN BIOL TH, V15, P651, DOI 10.1517/14712598.2015.1025047; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Weeks KL, 2015, J PHYSIOL-LONDON, V593, P1785, DOI 10.1113/jphysiol.2014.282442; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yu HY, 2015, J CELL SCI, V128, P2881, DOI 10.1242/jcs.170282; Yu HY, 2013, J BIOL CHEM, V288, P5342, DOI 10.1074/jbc.M112.409433	40	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					351	360		10.1074/jbc.M116.719849	http://dx.doi.org/10.1074/jbc.M116.719849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27899448	Green Published, hybrid			2022-12-26	WOS:000391578000030
J	Hou, ST; Jiang, SX; Zaharia, LI; Han, XM; Benson, CL; Slinn, J; Abrams, SR				Hou, Sheng Tao; Jiang, Susan X.; Zaharia, L. Irina; Han, Xiumei; Benson, Chantel L.; Slinn, Jacqueline; Abrams, Suzanne R.			Phaseic Acid, an Endogenous and Reversible Inhibitor of Glutamate Receptors in Mouse Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEURONAL DEATH; CEREBRAL-ISCHEMIA; ABSCISIC-ACID; (+)-ABSCISIC ACID; RAT-BRAIN; IN-VIVO; ABA; NEUROPROTECTION; CALCIUM; RECOMMENDATIONS	Phaseic acid (PA) is a phytohormone regulating important physiological functions in higher plants. Here, we show the presence of naturally occurring (-)-PA in mouse and rat brains. (-)-PA is exclusively present in the choroid plexus and the cerebral vascular endothelial cells. Purified (-)-PA has no toxicity and protects cultured cortical neurons against glutamate toxicity through reversible inhibition of glutamate receptors. Focal occlusion of the middle cerebral artery elicited a significant induction in (-)-PA expression in the cerebrospinal fluid but not in the peripheral blood. Importantly, (-)-PA induction only occurred in the penumbra area, indicting a protective role of PA in the brain. Indeed, elevating the (-)-PA level in the brain reduced ischemic brain injury, whereas reducing the (-)-PA level using a monoclonal antibody against (-)-PA increased ischemic injury. Collectively, these studies showed for the first time that (-)-PA is an endogenous neuroprotective molecule capable of reversibly inhibiting glutamate receptors during ischemic brain injury.	[Hou, Sheng Tao] Southern Univ Sci & Technol, Brain Res Ctr, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China; [Hou, Sheng Tao] Southern Univ Sci & Technol, Dept Biol, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China; [Hou, Sheng Tao; Jiang, Susan X.; Slinn, Jacqueline] Natl Res Council Canada, Expt NeuroTherapeut, Human Hlth Therapeut Portfolio, 1200 Montreal Rd,Bldg M54, Ottawa, ON K1A 0R6, Canada; [Zaharia, L. Irina; Han, Xiumei; Benson, Chantel L.; Abrams, Suzanne R.] Natl Res Council Canada, Aquat & Crop Resource Dev, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Hou, Sheng Tao] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Abrams, Suzanne R.] Univ Saskatchewan, Saskatchewan Struct Sci Ctr, Rm 190 Thorvaldson Bldg,110 Sci Pl, Saskatoon, SK S7N 5C9, Canada	Southern University of Science & Technology; Southern University of Science & Technology; National Research Council Canada; National Research Council Canada; University of Ottawa; University of Saskatchewan	Hou, ST (corresponding author), Southern Univ Sci & Technol, Brain Res Ctr, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China.; Hou, ST (corresponding author), Southern Univ Sci & Technol, Dept Biol, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China.	hou.st@sustc.edu.cn	Hou, Sheng Tao/AAM-7756-2020; Hou, Sheng Tao/O-3202-2018	Hou, Sheng Tao/0000-0001-9736-342X	National Natural Science Foundation of China [81571287]; Shenzhen Science and Technology Innovation Committee Basic Science Research Grants [JCYJ20140417105742709, JCYJ20160301112230218]; State Key Laboratory of Neuroscience Open Competition Grant [SKLN-201403]; Southern University of Science and Technology (SUSTech) Peacock Program Start-up Fund Grant [22/Y01226109]; SUSTech Brain Research Centre Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Committee Basic Science Research Grants; State Key Laboratory of Neuroscience Open Competition Grant; Southern University of Science and Technology (SUSTech) Peacock Program Start-up Fund Grant; SUSTech Brain Research Centre Fund	This work was supported by National Natural Science Foundation of China Grant 81571287, Shenzhen Science and Technology Innovation Committee Basic Science Research Grants JCYJ20140417105742709 and JCYJ20160301112230218, State Key Laboratory of Neuroscience Open Competition Grant SKLN-201403, Southern University of Science and Technology (SUSTech) Peacock Program Start-up Fund Grant 22/Y01226109, and SUSTech Brain Research Centre Fund (to S. T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrams S. R., 2013, J LABELLED COMPD RAD, V46, P273; BALSEVICH JJ, 1994, PLANT PHYSIOL, V106, P135, DOI 10.1104/pp.106.1.135; Brandt B, 2015, ELIFE, V4, DOI 10.7554/eLife.03599; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Diaz M, 2016, P NATL ACAD SCI USA, V113, pE396, DOI 10.1073/pnas.1512779113; EBERLE J, 1986, PLANT PHYSIOL, V81, P516, DOI 10.1104/pp.81.2.516; Edel KH, 2016, CURR OPIN PLANT BIOL, V33, P83, DOI 10.1016/j.pbi.2016.06.010; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GERGS U, 1993, BOT ACTA, V106, P404, DOI 10.1111/j.1438-8677.1993.tb00767.x; Hou ST, 2008, BIOCHEM BIOPH RES CO, V367, P109, DOI 10.1016/j.bbrc.2007.12.103; Hou ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep01350; Hou ST, 2010, NEUROSCI RES, V66, P396, DOI 10.1016/j.neures.2009.12.010; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2002, INT REV CYTOL, V221, P93; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Jiang SX, 2010, BIOCHEM BIOPH RES CO, V401, P435, DOI 10.1016/j.bbrc.2010.09.074; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MACMANUS JP, 1994, NEUROREPORT, V5, P493, DOI 10.1097/00001756-199401120-00031; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Papadakis M, 2013, NAT MED, V19, P351, DOI 10.1038/nm.3097; Ross ARS, 2004, ANAL BIOCHEM, V329, P324, DOI 10.1016/j.ab.2004.02.026; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Tu YH, 1998, J CEREBR BLOOD F MET, V18, P658, DOI 10.1097/00004647-199806000-00008; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1; Zaharia LI, 2005, J PLANT GROWTH REGUL, V24, P274, DOI 10.1007/s00344-005-0066-2; Zaharia LI, 2005, J LABELLED COMPD RAD, V48, P435, DOI 10.1002/jlcr.939; Zaharia LI, 2004, PHYTOCHEMISTRY, V65, P3199, DOI 10.1016/j.phytochem.2004.09.007	38	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27007	27022		10.1074/jbc.M116.756429	http://dx.doi.org/10.1074/jbc.M116.756429			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864367	Green Published, hybrid			2022-12-26	WOS:000391576300005
J	Kasiappan, R; Jutooru, I; Karki, K; Hedrick, E; Safe, S				Kasiappan, Ravi; Jutooru, Indira; Karki, Keshav; Hedrick, Erik; Safe, Stephen			Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP TRANSCRIPTION FACTORS; NF-KAPPA-B; BETA-PHENYLETHYL ISOTHIOCYANATE; CELL-CYCLE ARREST; TUMOR-GROWTH; SIGNAL TRANSDUCER; BREAST-CANCER; CRUCIFEROUS VEGETABLES; INDUCED APOPTOSIS; LUNG-CANCER	The antineoplastic agent benzyl isothiocyanate (BITC) acts by targeting multiple pro-oncogenic pathways/genes, including signal transducer and activator of transcription 3 (STAT3); however, the mechanism of action is not well known. As reported previously, BITC induced reactive oxygen species (ROS) in Panc1, MiaPaCa2, and L3.6pL pancreatic cancer cells. This was accompanied by induction of apoptosis and inhibition of cell growth and migration, and these responses were attenuated in cells cotreated with BITC plus glutathione (GSH). BITC also decreased expression of specificity proteins (Sp) Sp1, Sp3, and Sp4 transcription factors (TFs) and several pro-oncogenic Sp-regulated genes, including STAT3 and phospho-STAT3 (pSTAT3), and GSH attenuated these responses. Knockdown of Sp TFs by RNA interference also decreased STAT3/pSTAT3 expression. BITC-induced ROS activated a cascade of events that included down-regulation of c-Myc, and it was also demonstrated that c-Myc knockdown decreased expression of Sp TFs and STAT3. These results demonstrate that in pancreatic cancer cells, STAT3 is an Sp-regulated gene that can be targeted by BITC and other ROS inducers, thereby identifying a novel therapeutic approach for targeting STAT3.	[Kasiappan, Ravi; Jutooru, Indira; Karki, Keshav; Hedrick, Erik; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Jutooru, Indira] Covance Inc, 3301 Kinsman Blvd, Madison, WI 53704 USA	Texas A&M University System; Texas A&M University College Station; Covance	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	Karki, Keshav/AAR-2421-2021	Kasiappan, Ravi/0000-0002-5351-9098	National Institutes of Health [P30-ES023512]; College of Veterinary Science and Biomedical Sciences; Texas AgriLife Research and Sid Kyle endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Science and Biomedical Sciences; Texas AgriLife Research and Sid Kyle endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant P30-ES023512 (to S. S.), a College of Veterinary Science and Biomedical Sciences postdoctoral research grant (to R. K.), and a Texas AgriLife Research and Sid Kyle endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez James V, 2007, Transl Oncogenomics, V2, P99; Boreddy S, 2011, PLOS ONE, V6; Chadalapaka G, 2012, CARCINOGENESIS, V33, P886, DOI 10.1093/carcin/bgs102; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Edman P, 1975, PROTEIN SEQUENCE DET, P232; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Frank DA, 2013, J CLIN ONCOL, V31, P4560, DOI 10.1200/JCO.2013.52.8414; Gupta P, 2014, MOL NUTR FOOD RES, V58, P1685, DOI 10.1002/mnfr.201300684; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hedrick E, 2016, ONCOTARGET, V7, P22245, DOI 10.18632/oncotarget.7925; Hedrick E, 2015, MOL CANCER THER, V14, P2143, DOI 10.1158/1535-7163.MCT-15-0148; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hong D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5272; Huang C, 2012, NEOPLASMA, V59, P52, DOI 10.4149/neo_2012_007; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Karlsson I, 2016, SCI REP-UK, V6, DOI 10.1038/srep21203; Kato K, 2000, BBA-GENE STRUCT EXPR, V1493, P91, DOI 10.1016/S0167-4781(00)00168-8; Khan N, 2015, CANCER LETT, V359, P155, DOI 10.1016/j.canlet.2015.01.038; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Lai KC, 2010, J AGR FOOD CHEM, V58, P2935, DOI 10.1021/jf9036694; Lee J, 2009, APMIS, V117, P598, DOI 10.1111/j.1600-0463.2009.02512.x; Li MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127356; Nakamura Y, 2000, CANCER RES, V60, P219; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Pathi SS, 2011, NUTR CANCER, V63, P1133, DOI 10.1080/01635581.2011.605984; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Rydberg P, 2002, CHEM RES TOXICOL, V15, P570, DOI 10.1021/tx000247+; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Singh SV, 2012, CARCINOGENESIS, V33, P1833, DOI 10.1093/carcin/bgs216; Srivastava SK, 2003, CARCINOGENESIS, V24, P1665, DOI 10.1093/carcin/bgg123; Tang L, 2005, MOL CANCER THER, V4, P1250, DOI 10.1158/1535-7163.MCT-05-0041; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Wong AL, 2015, ANN ONCOL, V26, P998, DOI 10.1093/annonc/mdv026; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiong H, 2012, J MOL MED, V90, P1037, DOI 10.1007/s00109-012-0869-0; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yang MD, 2010, ANTICANCER RES, V30, P2135; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803	52	38	39	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27122	27133		10.1074/jbc.M116.746339	http://dx.doi.org/10.1074/jbc.M116.746339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875298	hybrid, Green Published			2022-12-26	WOS:000391576300013
J	Lind, T; Ekebom, A; Kubler, KA; Ostensson, P; Bellander, T; Lohmus, M				Lind, Tomas; Ekebom, Agneta; Kubler, Kerstin Alm; Ostensson, Pia; Bellander, Tom; Lohmus, Mare			Pollen Season Trends (1973-2013) in Stockholm Area, Sweden	PLOS ONE			English	Article							BIRCH POLLEN; CLIMATE-CHANGE; AIRBORNE POLLEN; GRASS-POLLEN; ALLERGIC RHINITIS; BETULA POLLEN; START; PREVALENCE; QUANTITIES; EXPOSURE	In the present study, the phenological and quantitative changes in the pollen seasons between 1973 and 2013 in the Stockholm region of Sweden were studied for nine types of pollen (hazel, alder, elm, birch, oak, grass, mugwort, willow and pine). Linear regression models were used to estimate the long term trends in duration, start-and end-dates, peakvalues and the yearly accumulated pollen sums of the pollen seasons. The pollen seasons of several arboreal plant species (e.g. birch, oak and pine) were found to start significantly earlier today compared to 41 years earlier, and have an earlier peak-date, while the season of other species seemed largely unaffected. However, the long term trends in the end-dates of pollen seasons differed between arboreal and herbaceous species. For herbaceous species (grass and mugwort), a significant change towards later end-dates was observed and the duration of season was found to have increased. A significant trend towards an earlier end-date was found in the majority of the arboreal plant species (i.e. elm, oak, pine and birch), but the length of the season seemed unaffected. A trend towards an increase in yearly concentrations of pollen was observed for several species; however the reasons for this phenomenon cannot be explained unambiguously by the present study design. The trend of increasing yearly mean air temperatures in the Stockholm area may be the reason to changed phenological patterns of pollen seasons.	[Lind, Tomas; Bellander, Tom; Lohmus, Mare] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Lind, Tomas; Bellander, Tom; Lohmus, Mare] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Ekebom, Agneta; Kubler, Kerstin Alm; Ostensson, Pia] Swedish Museum Nat Hist, Dept Environm Res & Monitoring, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Swedish Museum of Natural History	Lohmus, M (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.; Lohmus, M (corresponding author), Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden.	mare.lohmus.sundstrom@ki.se		Lohmus, Mare/0000-0002-6619-9679				Bogawski P, 2014, INT J BIOMETEOROL, V58, P1759, DOI 10.1007/s00484-013-0781-5; Bonofiglio T, 2013, ENVIRON MONIT ASSESS, V185, P877, DOI 10.1007/s10661-012-2598-9; D'Amato G, 1998, ALLERGY, V53, P567, DOI 10.1111/j.1398-9995.1998.tb03932.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; D'Amato G, 2000, CLIN EXP ALLERGY, V30, P628; Djukanovic R, 1996, THORAX, V51, P575, DOI 10.1136/thx.51.6.575; Edenhofer O., 2014, CONTRIBUTION WORKING; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Emberlin J, 1997, GRANA, V36, P29, DOI 10.1080/00173139709362586; EMBERLIN J, 1994, GRANA, V33, P94, DOI 10.1080/00173139409427839; Estrella N, 2006, INT J BIOMETEOROL, V51, P49, DOI 10.1007/s00484-006-0038-7; Rodriguez SF, 2015, AEROBIOLOGIA, V31, P1, DOI 10.1007/s10453-014-9338-2; Fernandez-Llamazares A, 2014, INT J BIOMETEOROL, V58, P371, DOI 10.1007/s00484-013-0632-4; Frei T, 2008, INT J BIOMETEOROL, V52, P841, DOI 10.1007/s00484-008-0178-z; Frei T, 2008, INT J BIOMETEOROL, V52, P667, DOI 10.1007/s00484-008-0159-2; Galan C, 2016, SCI TOTAL ENVIRON, V550, P53, DOI 10.1016/j.scitotenv.2016.01.069; Gruzieva O, 2015, ALLERGY, V70, P1181, DOI 10.1111/all.12653; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; Jager S, 1996, GRANA, V35, P171, DOI 10.1080/00173139609429078; Jato V, 2015, INT J BIOMETEOROL, V59, P517, DOI 10.1007/s00484-014-0865-x; Karlsen SR, 2009, CLIM RES, V39, P275, DOI 10.3354/cr00828; Karolinska-Institutets-Folkhalsoakademi, 2009, MILJ STOCKH LAN 2009; Keiding L, 1997, ASTMA ALLERGI ANDEN; Linneberg A, 1999, ALLERGY, V54, P1194, DOI 10.1034/j.1398-9995.1999.00180.x; Newnham RM, 2013, INT J BIOMETEOROL, V57, P391, DOI 10.1007/s00484-012-0563-5; Puc M, 2003, ANN AGR ENV MED, V10, P143; Rasmussen Alix, 2002, Aerobiologia, V18, P253, DOI 10.1023/A:1021321615254; Rodriguez-Rajo FJ, 2011, CLIM RES, V48, P281, DOI 10.3354/cr00966; SPIEKSMA FTM, 1995, GRANA, V34, P51, DOI 10.1080/00173139509429033; Szema AM, 2014, RESPIR MED SER, V7, P155, DOI 10.1007/978-1-4614-8417-2_9; Van der Meer T, 2010, AM SOCIOL REV, V75, P173, DOI 10.1177/0003122409359166; Van Vliet AJH, 2002, INT J CLIMATOL, V22, P1757, DOI 10.1002/joc.820; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yli-Panula E, 2009, INT J ENV RES PUB HE, V6, P1706, DOI 10.3390/ijerph6061706; Zhang Y, 2014, INT J BIOMETEOROL, V58, P909, DOI 10.1007/s00484-013-0674-7; Zhang Y, 2013, ATMOS ENVIRON, V68, P64, DOI 10.1016/j.atmosenv.2012.11.028	36	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166887	10.1371/journal.pone.0166887	http://dx.doi.org/10.1371/journal.pone.0166887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898718	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000022
J	Alhaj, TA; Siraj, MM; Zainal, A; Elshoush, HT; Elhaj, F				Alhaj, Taqwa Ahmed; Siraj, Maheyzah Md; Zainal, Anazida; Elshoush, Huwaida Tagelsir; Elhaj, Fatin			Feature Selection Using Information Gain for Improved Structural-Based Alert Correlation	PLOS ONE			English	Article								Grouping and clustering alerts for intrusion detection based on the similarity of features is referred to as structurally base alert correlation and can discover a list of attack steps. Previous researchers selected different features and data sources manually based on their knowledge and experience, which lead to the less accurate identification of attack steps and inconsistent performance of clustering accuracy. Furthermore, the existing alert correlation systems deal with a huge amount of data that contains null values, incomplete information, and irrelevant features causing the analysis of the alerts to be tedious, time-consuming and error-prone. Therefore, this paper focuses on selecting accurate and significant features of alerts that are appropriate to represent the attack steps, thus, enhancing the structural-based alert correlation model. A two-tier feature selection method is proposed to obtain the significant features. The first tier aims at ranking the subset of features based on high information gain entropy in decreasing order. The second tier extends additional features with a better discriminative ability than the initially ranked features. Performance analysis results show the significance of the selected features in terms of the clustering accuracy using 2000 DARPA intrusion detection scenario-specific dataset.	[Alhaj, Taqwa Ahmed; Siraj, Maheyzah Md; Zainal, Anazida; Elhaj, Fatin] Univ Teknol Malaysia, Fac Comp, Informat Assurance & Secur Res Grp, Johor Baharu, Johor, Malaysia; [Elshoush, Huwaida Tagelsir] Univ Khartoum, Fac Math Sci, Khartoum, Sudan	Universiti Teknologi Malaysia; University of Khartoum	Alhaj, TA (corresponding author), Univ Teknol Malaysia, Fac Comp, Informat Assurance & Secur Res Grp, Johor Baharu, Johor, Malaysia.	taqwa-315@hotmail.com	Elhaj, Fatin Ahmed Mohammed/AAT-9967-2021; Elshoush, Huwaida Tagelsir/HGB-9342-2022	Elshoush, Huwaida Tagelsir/0000-0003-0142-393X; Ahmed, Taqwa/0000-0002-2366-0138	Ministry of Higher Education (MoHE); Universiti Teknologi Malaysia [PY/2014/02899]	Ministry of Higher Education (MoHE)(Ministry of Higher Education & Scientific Research (MHESR)); Universiti Teknologi Malaysia	We would like to thank Ministry of Higher Education (MoHE) and Universiti Teknologi Malaysia for funding this work under Potential Academic Staff research grant with reference number PY/2014/02899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ministry of Higher Education (MoHE) and Universiti Teknologi Malaysia for funding this work under Potential Academic Staff research grant with reference number PY/2014/02899.	Anderson D, 1993, TECHNICAL REPORT; Bolon-Canedo V, 2011, EXPERT SYST APPL, V38, P5947, DOI 10.1016/j.eswa.2010.11.028; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Debar H., 2001, P INT WORKSH REC ADV, P85; Elshoush H.T., 2012, P WORLD C ENG JUL LO, P1; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Lee W, 2001, AI REV, V4, P533; Man DP, 2012, PROCEDIA ENGINEER, V29, P3033, DOI 10.1016/j.proeng.2012.01.435; Mohamed A. B., 2012, Proceedings of the 2012 International Conference on Communication Systems and Network Technologies (CSNT 2012), P720, DOI 10.1109/CSNT.2012.212; Qin XZ, 2003, LECT NOTES COMPUT SC, V2820, P73; Ramaki AA, 2015, COMPUT SECUR, V49, P206, DOI 10.1016/j.cose.2014.10.006; Ren HL, 2010, LECT NOTES COMPUT SC, V6201, P153; Reuben S, 2008, ADV ARTIFICIAL INTEL, P308; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salim LF, 2007, INT J COMPUT SCI NET, V7, P210; Shittu R, 2015, COMPUT SECUR, V50, P1, DOI 10.1016/j.cose.2014.12.003; Siraj MM, THESIS; Srilatha C, 2005, FEATURE DEDUCTION EN; Tjhai GC, 2010, COMPUT SECUR, V29, P712, DOI 10.1016/j.cose.2010.02.001; Wang J-X, NEURAL INFORM PROCES, P217; Xing E.P., 2001, ICML CITESEER, V1, P601; Yang D., 2008, P 19 INT C PATT REC, P1, DOI DOI 10.1109/ICPR.2008.4761087; Yang Yiming, 1997, ICM 1997, P97; Zainal A, 2006, FEATURE SELECTION US	25	67	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166017	10.1371/journal.pone.0166017	http://dx.doi.org/10.1371/journal.pone.0166017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893821	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400015
J	Chen, PH; Cheng, CH; Shih, CM; Ho, KH; Lin, CW; Lee, CC; Liu, AJ; Chang, CK; Chen, KC				Chen, Peng-Hsu; Cheng, Chia-Hsiung; Shih, Chwen-Ming; Ho, Kuo-Hao; Lin, Cheng-Wei; Lee, Chin-Cheng; Liu, Ann-Jeng; Chang, Cheng-Kuei; Chen, Ku-Chung			The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; PROLIFERATION; P53; EXPRESSION; PATHWAYS; MIR-128; TARGETS; GENES	Temozolomide (TMZ), an alkylating agent of the imidazotetrazine series, is a first-line chemotherapeutic drug used in the clinical therapy of glioblastoma multiforme, the most common and high-grade primary glioma in adults. Micro (mi) RNAs, which are small noncoding RNAs, post-transcriptionally regulate gene expressions and are involved in gliomagenesis. However, no studies have reported relationships between TMZ and miRNA gene regulation. We investigated TMZ-mediated miRNA profiles and its molecular mechanisms underlying the induction of glioma cell death. By performing miRNA microarray and bioinformatics analyses, we observed that expression of 248 miRNAs was altered, including five significantly upregulated and 17 significantly downregulated miRNAs, in TMZ-treated U87MG cells. miR-128 expression levels were lower in different glioma cells and strongly associated with poor survival. TMZ treatment significantly upregulated miR-128 expression. TMZ significantly enhanced miR-128-1 promoter activity and transcriptionally regulated miR-128 levels through c-Jun N-terminal kinase 2/c-Jun pathways. The overexpression and knockdown of miR-128 expression significantly affected TMZ-mediated cell viability and apoptosis-related protein expression. Furthermore, the overexpression of miR-128 alone enhanced apoptotic death of glioma cells through caspase-3/9 activation, poly(ADP ribose) polymerase degradation, reactive oxygen species generation, mitochondrial membrane potential loss, and non-protective autophagy formation. Finally, we identified that key members in mammalian target of rapamycin (mTOR) signaling including mTOR, rapamycin-insensitive companion of mTOR, insulin-like growth factor 1, and PIK3R1, but not PDK1, were direct target genes of miR-128. TMZ inhibited mTOR signaling through miR-128 regulation. These results indicate that miR-128-inhibited mTOR signaling is involved in TMZ-mediated cytotoxicity. Our findings may provide a better understanding of cytotoxic mechanisms of TMZ involved in glioblastoma development.	[Chen, Peng-Hsu; Cheng, Chia-Hsiung; Shih, Chwen-Ming; Lin, Cheng-Wei; Chen, Ku-Chung] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Cheng, Chia-Hsiung; Shih, Chwen-Ming; Lin, Cheng-Wei; Chen, Ku-Chung] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan; [Ho, Kuo-Hao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Lee, Chin-Cheng] Shin Kong Wu Ho Su Mem Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Liu, Ann-Jeng] Taipei City Hosp, Ren Ai Branch, Dept Neurosurg, Taipei, Taiwan; [Chang, Cheng-Kuei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Chang, Cheng-Kuei] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei City Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan.	kuchung@tmu.edu.tw	Cheng, Chia-Hsiung/A-6044-2019	Cheng, Chia-Hsiung/0000-0003-0307-9650	Ministry of Science and Technology, Taiwan [MOST104-2320-B-038-046, MOST105-2320-B-038-019]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (nos. MOST104-2320-B-038-046 and MOST105-2320-B-038-019).	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Ananta JS, 2015, MOL PHARMACEUT, V12, P4509, DOI 10.1021/acs.molpharmaceut.5b00694; Bertucci A, 2015, SMALL, V11, P5687, DOI 10.1002/smll.201500540; Donzelli S, 2012, CELL DEATH DIFFER, V19, P1038, DOI 10.1038/cdd.2011.190; Duzgun Z, 2016, GENE, V575, P187, DOI 10.1016/j.gene.2015.08.060; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gratas C, 2014, ONCOTARGET, V5, P2428, DOI 10.18632/oncotarget.1642; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Hirose Y, 2004, J NEUROSURG, V100, P1060, DOI 10.3171/jns.2004.100.6.1060; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16422; Li ML, 2013, EXP CELL RES, V319, P3059, DOI 10.1016/j.yexcr.2013.07.031; Li X, 2016, ONCOTARGET; Li YP, 2015, CELL PROLIFERAT, V48, P643, DOI 10.1111/cpr.12223; Lin C.-L., 2012, COMPUTATIONAL INTELL, V2012, P7, DOI [DOI 10.1371/J0UMAL.P0NE.0038706, DOI 10.1371/J0URNAL.P0NE.0038706]; Lin CJ, 2012, FREE RADICAL BIO MED, V52, P377, DOI 10.1016/j.freeradbiomed.2011.10.487; Lin LN, 2013, ONCOL REP, V30, P1239, DOI 10.3892/or.2013.2596; Miao W, 2015, MOL MED REP, V11, P4165, DOI 10.3892/mmr.2015.3255; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Castro GN, 2015, CELL STRESS CHAPERON, V20, P253, DOI 10.1007/s12192-014-0537-0; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Persengiev S. P., 2012, CURR GERONTOL GERIAT, V2012, P359, DOI DOI 10.1155/2012/359369; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Rekers NH, 2011, J CHEMOTHERAPY, V23, P187, DOI 10.1179/joc.2011.23.4.187; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shang C, 2016, ONCOL LETT, V11, P904, DOI 10.3892/ol.2015.3927; Shea A, 2016, CANC MED; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Stavrovskaya AA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P91, DOI 10.1134/S0006297916020036; Sun J, 2015, INT J CLIN EXP MED, V8, P456; Tomicic MT, 2015, ONCOTARGET, V6, P33755, DOI 10.18632/oncotarget.5274; Urbanska K, 2014, WSPOLCZESNA ONKOL, V18, P307, DOI 10.5114/wo.2014.40559; Wang HT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1728-5; Wang J, 2013, CANCER CHEMOTH PHARM, V72, P147, DOI 10.1007/s00280-013-2180-3; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wilson Taylor A, 2014, Surg Neurol Int, V5, P64, DOI 10.4103/2152-7806.132138; Xie BH, 2016, CANCER BIOMARK, V16, P405, DOI 10.3233/CBM-160579; Yu ZY, 2015, CANCER LETT, V367, P58, DOI 10.1016/j.canlet.2015.07.007; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	43	35	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167096	10.1371/journal.pone.0167096	http://dx.doi.org/10.1371/journal.pone.0167096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893811	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400085
J	Daboval, T; Shidler, S; Thomas, D				Daboval, Thierry; Shidler, Sarah; Thomas, Daniel			Shared Decision Making at the Limit of Viability: A Blueprint for Physician Action	PLOS ONE			English	Article							PARENTS; CARE; COMMUNICATION; RESUSCITATION; PERCEPTIONS; INFORMATION; INFANTS; MOTHERS; ETHICS	Objective To document interactions during the antenatal consultation between parents and neonatologist that parents linked to their satisfaction with their participation in shared decision making for their infant at risk of being born at the limit of viability. Methods This multiple-case ethnomethodological qualitative research study, included mothers admitted for a threatened premature delivery between 20 0/7 and 26 6/7 weeks gestation, the father, and the staff neonatologist conducting the clinical antenatal consultation. Content analysis of an audiotaped post-antenatal consultation interview with parents obtained their satisfaction scores as well as their comments on physician actions that facilitated their desired participation. Results Five cases, each called a "system-infant at risk", included 10 parents and 6 neonatologists. From the interviews emerged a blueprint for action by physicians, including communication strategies that parents say facilitated their participation in decision making; such as building trustworthy physician-parent relationships, providing "balanced" information, offering choices, and allowing time to think. Conclusion Parent descriptions indicate that the opportunity to participate to their satisfaction in the clinical antenatal consultation depends on how the physician interacts with them. Practice implications The parent-identified communication strategies facilitate shared decision making regarding treatment in the best interest of the infant at risk to be born at the limit of viability.	[Daboval, Thierry] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Obstet & Gynecol, Ottawa Hosp,Dept Pediat, Ottawa, ON, Canada; [Shidler, Sarah] Univ Quebec Abitibi Temiscamingue, Dept Hlth Sci Sci, Rouyn Noranda, PQ, Canada; [Thomas, Daniel] Univ Quebec Abitibi Temiscamingue, Dept Human Sci, Rouyn Noranda, PQ, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; Ottawa Hospital Research Institute; University of Quebec; University Quebec Abitibi-Temiscamingue; University of Quebec; University Quebec Abitibi-Temiscamingue	Daboval, T (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Obstet & Gynecol, Ottawa Hosp,Dept Pediat, Ottawa, ON, Canada.	tdaboval@cheo.on.ca		Daboval, Thierry/0000-0002-5321-6193	Fonds Institutionnel de la Recherche (FIR), Universite du Quebec en Abitibi-Temiscamingue; Universite du Quebec en Abitibi-Temiscamingue	Fonds Institutionnel de la Recherche (FIR), Universite du Quebec en Abitibi-Temiscamingue; Universite du Quebec en Abitibi-Temiscamingue	This work was supported by the Fonds Institutionnel de la Recherche (FIR) 2011-2012, Universite du Quebec en Abitibi-Temiscamingue (April 2011). 3,500.00 $ CAN. Thierry Daboval received the funds mentioned above to complete the study. The remaining authors have no financial relationships relevant to this article to disclose. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the parents who participated to this study and shared their thoughts. We thank Jacques Charest, PhD, for his helpful and constructive suggestions that positively improved the quality of the manuscript. We also thank the Universite du Quebec en Abitibi-Temiscamingue who funded the study.	Anspach R.R, 1997, DECIDING WHO LIVES F; Audet M, 1995, ROLES DEFIS COMITES, P167; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Batton DG, 2009, PEDIATRICS, V124, P422, DOI 10.1542/peds.2009-1060; Bergeron V, 2008, MAY REAL SURROGATE S; Boss RD, 2008, PEDIATRICS, V122, P583, DOI 10.1542/peds.2007-1972; Caeymaex L, 2013, ARCH DIS CHILD-FETAL, V98, pF26, DOI 10.1136/archdischild-2011-301548; CHAREST J, 1996, REV QUEBECOISE PSYCH, V17, P43; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Coulon A, 1993, LETHNOMETHODOLOGIE, P127; Daboval T, NEONATAL ETHICS TEAC; Daboval T, PARTICIPATION PARENT, P1; Daboval T, 2014, PAED CHILD HEALT-CAN, V19, P302, DOI 10.1093/pch/19.6.302; Daboval T, 2013, MED TEACH, V35, P194, DOI 10.3109/0142159X.2012.733452; Daboval Thierry, 2005, Paediatr Child Health, V10, P87; Einarsdottir J, 2009, MED ANTHROPOL Q, V23, P34, DOI 10.1111/j.1548-1387.2009.01036.x; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Gaucher N, 2011, PAED CHILD HEALT-CAN, V16, P638, DOI 10.1093/pch/16.10.638; Geertz D, 1983, CONT FIELD RES COLLE, P37; Halamek LP, 2003, NEOREVIEWS, V4; HARRISON H, 1993, PEDIATRICS, V92, P643; Haward MF, 2011, CLIN PERINATOL, V38, P471, DOI 10.1016/j.clp.2011.06.004; Holstein J.A., 2006, HDB QUALITATIVE RES, P262; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P443; Kavanaugh Karen, 2005, J Pediatr Nurs, V20, P347, DOI 10.1016/j.pedn.2005.03.006; Keenan HT, 2005, PEDIATRICS, V116, P104, DOI 10.1542/peds.2004-1340; Kopelman AE, 2006, MT SINAI J MED, V73, P580; McHaffie HE, 2001, EUR J PEDIATR, V160, P339, DOI 10.1007/PL00008444; Miquel-Verges F, 2009, PEDIATRICS, V124, pE573, DOI 10.1542/peds.2008-2865; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Partridge J C, 2001, J Perinatol, V21, P27; Partridge JC, 2005, PEDIATRICS, V116, pE263, DOI 10.1542/peds.2004-2274; Payot A, 2007, SOC SCI MED, V64, P1487, DOI 10.1016/j.socscimed.2006.11.016; Stake R. E., 1995, ART CASE STUDY RES; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Watzlawick P., 1972, LOGIQUE COMMUNICATIO; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Yee WH, 2007, PAED CHILD HEALT-CAN, V12, P191, DOI 10.1093/pch/12.3.191; Young E, 2013, PAEDIAT CHILD HLTH, V17, P432; Zupancic JAF, 2002, ARCH DIS CHILD-FETAL, V87, pF113, DOI 10.1136/fn.87.2.F113	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166151	10.1371/journal.pone.0166151	http://dx.doi.org/10.1371/journal.pone.0166151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893823	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400018
J	Duplisea, DE; Frisk, MG; Trenkel, VM				Duplisea, Daniel E.; Frisk, Michael G.; Trenkel, Verena M.			Extinction Debt and Colonizer Credit on a Habitat Perturbed Fishing Bank	PLOS ONE			English	Article							GEORGES BANK; REGIME SHIFTS; ABUNDANCE; COMMUNITY; TRENDS; SHELF; FRAGMENTATION; DESTRUCTION; DISTURBANCE; IMPACTS	Temporal changes in occupancy of the Georges Bank (NE USA) fish and invertebrate community were examined and interpreted in the context of systems ecological theory of extinction debt (EDT). EDT posits that in a closed system with a mix of competitor and colonizer species and experiencing habitat fragmentation and loss, the competitor species will show a gradual decline in fitness (occupancy) eventually leading to their extinction (extirpation) over multiple generations. A corollary of this is a colonizer credit, where colonizer species occupancy may increase with fragmentation because the disturbance gives that life history a transient relative competitive advantage. We found that competitor species occupancy decreased in time concomitant with an increase in occupancy of colonizer species and this may be related to habitat fragmentation or loss owing to industrialized bottom trawl fishing. Mean species richness increased over time which suggests less specialization (decreased dominance) of the assemblage that may result from habitat homogenization. These analyses also showed that when abundance of species was decreased by fishing but eventually returned to previous levels, on average it had a lower occupancy than earlier in the series which could increase their vulnerability to depletion by fishing. Changing occupancy and diversity patterns of the community over time is consistent with EDT which can be exacerbated by direct impacts of fishery removals as well as climate change impacts on the fish community assemblage.	[Duplisea, Daniel E.] Inst Maurice Lamontagne, Fisheries & Oceans Canada Canada, Mont Joli, PQ, Canada; [Frisk, Michael G.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Trenkel, Verena M.] IFREMER, Nantes, France	Fisheries & Oceans Canada; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Ifremer	Duplisea, DE (corresponding author), Inst Maurice Lamontagne, Fisheries & Oceans Canada Canada, Mont Joli, PQ, Canada.	daniel.duplisea@dfo-mpo.gc.ca		Trenkel, Verena/0000-0001-7869-002X; Duplisea, Daniel/0000-0002-0844-359X	NSF [OCE-0738214]; EU project IMAGE [FP6-044227]	NSF(National Science Foundation (NSF)); EU project IMAGE	M.G.F. was funded to attend WGFE by NSF grant OCE-0738214 to NOAA. The work of V. M.T. was partially funded by the EU project IMAGE (contract FP6-044227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was initiated as part of the work conducted by members of the International Council for the Exploration of the Sea (ICES) Working Group on Fish Ecology (WGFE). We would like to thank the members of WGFE for support, review and assistance on this research, particularly Brad Harris. We are grateful to NOAA/NMFS/NEFC Woods Hole and particularly Bill Kramer for providing us with fall survey data. Participation of M.F. in WGFE was supported through NSF grant (OCE-0738214.). The work of V.T. was partially funded by the EU project IMAGE (contract FP6-044227). We are grateful to two other unnamed colleagues who improved the analysis and manuscript.	Abrams PA, 1997, MARINE ECOLOGY PROGR, V57, P2; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Banks JE, 1997, ECOLOGY, V78, P1597; Blanchard JL, 2005, ICES J MAR SCI, V62, P405, DOI 10.1016/j.icesjms.2005.01.006; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DIAMOND JM, 1976, SCIENCE, V193, P1027, DOI 10.1126/science.193.4257.1027; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; Fisher JAD, 2011, ICES J MAR SCI, V68, P2096, DOI 10.1093/icesjms/fsr147; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Friedland KD, 2007, CONT SHELF RES, V27, P2313, DOI 10.1016/j.csr.2007.06.001; Frisk MG, 2008, ECOL APPL, V18, P234, DOI 10.1890/06-1392.1; Frisk MG, 2011, ECOL APPL, V21, P227, DOI 10.1890/09-1698.1; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Harris BP, 2010, CONT SHELF RES, V30, P1840, DOI 10.1016/j.csr.2010.08.011; Hermsen JM, 2003, MAR ECOL PROG SER, V260, P97, DOI 10.3354/meps260097; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Jennings S, 2005, AM FISH S S, V41, P73; Kitzes J, 2015, ECOLOGY, V96, P2127, DOI 10.1890/14-1594.1; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Loehle C, 1996, ECOL APPL, V6, P784, DOI 10.2307/2269483; Malanson GP, 2008, PROG PHYS GEOG, V32, P277, DOI 10.1177/0309133308096028; Murawski SA, 2000, B MAR SCI, V66, P775; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pais Martinez C., 2014, THESIS; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Richardson DE, 2014, CAN J FISH AQUAT SCI, V71, P1349, DOI 10.1139/cjfas-2013-0489; Scott MG, 1988, ATLANTIC FISHES CANA; Shackell NL, 2005, ECOL APPL, V15, P1440, DOI 10.1890/04-0642; Shephard S, 2010, MAR BIOL, V157, P2375, DOI 10.1007/s00227-010-1502-9; Snover ML, 2008, B MAR SCI, V83, P53; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Webb TJ, 2007, J ANIM ECOL, V76, P123, DOI 10.1111/j.1365-2656.2006.01192.x; Wilson TL, 2009, LANDSCAPE ECOL, V24, P351, DOI 10.1007/s10980-008-9309-5; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]	42	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166409	10.1371/journal.pone.0166409	http://dx.doi.org/10.1371/journal.pone.0166409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893775	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400024
J	Chen, W; Li, YS; Gao, J; Lin, XY; Li, XH				Chen, Wen; Li, Yan-Shuang; Gao, Jing; Lin, Xiao-Ying; Li, Xiao-Hong			AMPA Receptor Antagonist NBQX Decreased Seizures by Normalization of Perineuronal Nets	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; RANDOMIZED PHASE-III; EXTRACELLULAR-MATRIX; ADJUNCTIVE PERAMPANEL; TENASCIN-R; BRAIN; ANTICONVULSANT; GYKI-52466; MODEL; INVOLVEMENT	Epilepsy is a serious brain disorder with diverse seizure types and epileptic syndromes. AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX) attenuates spontaneous recurrent seizures in rats. However, the anti-epileptic effect of NBQX in chronic epilepsy model is poorly understood. Perineuronal nets (PNNs), specialized extracellular matrix structures, surround parvalbumin-positive inhibitory interneurons, and play a critical role in neuronal cell development and synaptic plasticity. Here, we focused on the potential involvement of PNNs in the treatment of epilepsy by NBQX. Rats were intraperitoneally (i.p.) injected with pentylenetetrazole (PTZ, 50 mg/kg) for 28 consecutive days to establish chronic epilepsy models. Subsequently, NBQX (20 mg/kg, i.p.) was injected for 3 days for the observation of behavioral measurements of epilepsy. The Wisteria floribundi agglutinin (WFA)-labeled PNNs were measured by immunohistochemical staining to evaluate the PNNs. The levels of three components of PNNs such as tenascin-R, aggrecan and neurocan were assayed by Western blot assay. The results showed that there are reduction of PNNs and decrease of tenascin-R, aggrecan and neurocan in the medial prefrontal cortex (mPFC) in the rats injected with PTZ. However, NBQX treatment normalized PNNs, tenascin-R, aggrecan and neurocan levels. NBQX was sufficient to decrease seizures through increasing the latency to seizures, decrease the duration of seizure onset, and reduce the scores for the severity of seizures. Furthermore, the degradation of mPFC PNNs by chondroitinase ABC (ChABC) exacerbated seizures in PTZ-treated rats. Finally, the anti-epileptic effect of NBQX was reversed by pretreatment with ChABC into mPFC. These findings revealed that PNNs degradation in mPFC is involved in the pathophysiology of epilepsy and enhancement of PNNs may be effective for the treatment of epilepsy.	[Chen, Wen; Li, Yan-Shuang; Lin, Xiao-Ying; Li, Xiao-Hong] Shandong Univ, Jinan Cent Hosp, Dept Neurol, Jinan, Shandong, Peoples R China; [Gao, Jing] Affiliated Hosp Qingdao Univ, Dept Neurol, Qingdao, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Qingdao University	Li, XH (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Neurol, Jinan, Shandong, Peoples R China.	xiaohong-li@sdu.edu.cn						Aguiar DC, 2009, PSYCHOPHARMACOLOGY, V205, P217, DOI 10.1007/s00213-009-1532-5; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Brenneke F, 2004, EPILEPSY RES, V58, P133, DOI 10.1016/j.eplepsyres.2004.01.005; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; CHAPMAN AG, 1991, EPILEPSY RES, V9, P92, DOI 10.1016/0920-1211(91)90018-B; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; DURMULLER N, 1994, EPILEPSY RES, V17, P167, DOI 10.1016/0920-1211(94)90016-7; El Desoky ES, 2014, FUND CLIN PHARMACOL, V28, P473, DOI 10.1111/fcp.12081; Erdogan H, 2014, HUM EXP TOXICOL, V33, P1008, DOI 10.1177/0960327113520017; French JA, 2013, EPILEPSIA, V54, P117, DOI 10.1111/j.1528-1167.2012.03638.x; French JA, 2012, NEUROLOGY, V79, P589, DOI 10.1212/WNL.0b013e3182635735; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Goldenberg Marvin M, 2010, P T, V35, P392; Hanada T, 2011, EPILEPSIA, V52, P1331, DOI 10.1111/j.1528-1167.2011.03109.x; Katoh-Semba R, 1998, NEUROSCI RES, V31, P273, DOI 10.1016/S0168-0102(98)00047-9; Kerling F, 2013, ACTA NEUROL SCAND, V127, P25, DOI 10.1111/ane.12101; Krauss GL, 2012, NEUROLOGY, V78, P1408, DOI 10.1212/WNL.0b013e318254473a; Lippman-Bell JJ, 2013, EPILEPSIA, V54, P1922, DOI 10.1111/epi.12378; Loscher W, 2012, NAT REV NEUROL, V8, P661, DOI 10.1038/nrneurol.2012.222; Lopes MW, 2015, NEUROCHEM INT, V87, P22, DOI 10.1016/j.neuint.2015.05.003; MARES P, 1990, PHYSIOL BOHEMOSLOV, V39, P199; Matthews RT, 2002, J NEUROSCI, V22, P7536; Morawski M, 2014, PROG BRAIN RES, V214, P207, DOI 10.1016/B978-0-444-63486-3.00010-4; Morawski M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0046; NAMBA T, 1994, BRAIN RES, V638, P36, DOI 10.1016/0006-8993(94)90630-0; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Okamoto M, 2003, EXP NEUROL, V184, P179, DOI 10.1016/S0014-4886(03)00251-6; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Rocha L, 1996, EPILEPSY RES, V26, P105, DOI 10.1016/S0920-1211(96)00046-0; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P19, DOI 10.1111/ane.12100; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rogawski MA, 2011, EPILEPSY CURR, V11, P56, DOI 10.5698/1535-7511-11.2.56; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; SCHRODER H, 1993, J NEUROCHEM, V60, P1007, DOI 10.1111/j.1471-4159.1993.tb03248.x; Seeger G, 1996, J BRAIN RES, V37, P351; SMITH SE, 1991, EUR J PHARMACOL, V201, P179, DOI 10.1016/0014-2999(91)90342-N; Sylantyev S, 2008, SCIENCE, V319, P1845, DOI 10.1126/science.1154330; Trenite DKN, 2015, EPILEPSIA, V56, P924, DOI 10.1111/epi.13008; Twele F, 2015, NEUROPHARMACOLOGY, V95, P234, DOI 10.1016/j.neuropharm.2015.03.014; VELISEK L, 1992, N-S ARCH PHARMACOL, V346, P588, DOI 10.1007/BF00169017; Wilson MT, 2000, J COMP NEUROL, V424, P532, DOI 10.1002/1096-9861(20000828)424:3<532::AID-CNE10>3.0.CO;2-Z; WINTERGERST ES, 1993, EUR J NEUROSCI, V5, P299, DOI 10.1111/j.1460-9568.1993.tb00497.x; Xue YX, 2014, J NEUROSCI, V34, P6647, DOI 10.1523/JNEUROSCI.5390-13.2014; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yutsudo N, 2015, EXP NEUROL, V274, P126, DOI 10.1016/j.expneurol.2015.07.009; Zhu WL, 2013, J PSYCHIATR NEUROSCI, V38, P306, DOI 10.1503/jpn.120228	56	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166672	10.1371/journal.pone.0166672	http://dx.doi.org/10.1371/journal.pone.0166672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880801	Green Submitted, Green Published, gold			2022-12-26	WOS:000388889500029
J	Giampa, SQD; Monico-Neto, M; de Mello, MT; Souza, HD; Tufik, S; Lee, KS; Koike, MK; dos Santos, AA; Antonio, EL; Serra, AJ; Tucci, PJF; Antunes, HKM				de Campos Giampa, Sara Quaglia; Monico-Neto, Marcos; de Mello, Marco Tulio; Souza, Helton de Sa; Tufik, Sergio; Lee, Kil Sun; Koike, Marcia Kiyomi; dos Santos, Alexandra Alberta; Antonio, Ednei Luiz; Serra, Andrey Jorge; Ferreira Tucci, Paulo Jose; Moreira Antunes, Hanna Karen			Paradoxical Sleep Deprivation Causes Cardiac Dysfunction and the Impairment Is Attenuated by Resistance Training	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; ARTERIAL-BLOOD-PRESSURE; THYROID-HORMONE; PARAVENTRICULAR NUCLEUS; INFLAMMATORY MARKERS; HEALTHY-VOLUNTEERS; LEFT-VENTRICLE; HEART-FAILURE; RATS; HYPERTROPHY	Background Paradoxical sleep deprivation activates the sympathetic nervous system and the hypothalamus-pituitary-adrenal axis, subsequently interfering with the cardiovascular system. The beneficial effects of resistance training are related to hemodynamic, metabolic and hormonal homeostasis. We hypothesized that resistance training can prevent the cardiac remodeling and dysfunction caused by paradoxical sleep deprivation. Methods Male Wistar rats were distributed into four groups: control (C), resistance training (RT), paradoxical sleep deprivation for 96 hours (PSD96) and both resistance training and sleep deprivation (RT/ PSD96). Doppler echocardiograms, hemodynamics measurements, cardiac histomorphometry, hormonal profile and molecular analysis were evaluated. Results Compared to the C group, PSD96 group had a higher left ventricular systolic pressure, heart rate and left atrium index. In contrast, the left ventricle systolic area and the left ventricle cavity diameter were reduced in the PSD96 group. Hypertrophy and fibrosis were also observed. Along with these alterations, reduced levels of serum testosterone and insulin-like growth factor-1 (IGF-1), as well as increased corticosterone and angiotensin II, were observed in the PSD96 group. Prophylactic resistance training attenuated most of these changes, except angiotensin II, fibrosis, heart rate and concentric remodeling of left ventricle, confirmed by the increased of NFATc3 and GATA-4, proteins involved in the pathologic cardiac hypertrophy pathway. Conclusions Resistance training effectively attenuates cardiac dysfunction and hormonal imbalance induced by paradoxical sleep deprivation.	[de Campos Giampa, Sara Quaglia; Moreira Antunes, Hanna Karen] Univ Fed Sao Paulo, Programa Posgrad Interdisciplinar Ciencias Saude, Campus Baixada Santista, Santos, SP, Brazil; [de Campos Giampa, Sara Quaglia; Monico-Neto, Marcos; Souza, Helton de Sa; Moreira Antunes, Hanna Karen] LAIFE, Lab Interdisciplinar Fisiol & Exercicio, Sao Paulo, SP, Brazil; [Monico-Neto, Marcos; de Mello, Marco Tulio; Souza, Helton de Sa; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Campus Sao Paulo, Sao Paulo, SP, Brazil; [Lee, Kil Sun] Univ Fed Sao Paulo, Dept Bioquim, Campus Sao Paulo, Sao Paulo, SP, Brazil; [Koike, Marcia Kiyomi] Univ Sao Paulo, Dept Clin Med, Lab Emergencias Cienicas, Sao Paulo, SP, Brazil; [Koike, Marcia Kiyomi] Inst Assistencia Med Servidor Publ Estadual, Programa Posgrad Ciencias Saude, Sao Paulo, SP, Brazil; [dos Santos, Alexandra Alberta; Antonio, Ednei Luiz; Serra, Andrey Jorge; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, Dept Med, Disciplina Cardiol, Campus Sao Paulo, Sao Paulo, SP, Brazil; [Serra, Andrey Jorge] Univ Nove Julho, Programa Posgrad Ciencias Reabilitacao, Sao Paulo, SP, Brazil; [Serra, Andrey Jorge] Univ Nove Julho, Programa Posgradao Biofoton Aplicada Ciencias, Sao Paulo, SP, Brazil; [Moreira Antunes, Hanna Karen] Univ Fed Sao Paulo, Dept Biociencias, Campus Baixada Santista, Santos, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Instituto de Assistencia Medica ao Servidor Publico Estadual (IAMSPE); Universidade Federal de Sao Paulo (UNIFESP); Universidade Nove de Julho; Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP)	Antunes, HKM (corresponding author), Univ Fed Sao Paulo, Programa Posgrad Interdisciplinar Ciencias Saude, Campus Baixada Santista, Santos, SP, Brazil.; Antunes, HKM (corresponding author), LAIFE, Lab Interdisciplinar Fisiol & Exercicio, Sao Paulo, SP, Brazil.; Antunes, HKM (corresponding author), Univ Fed Sao Paulo, Dept Biociencias, Campus Baixada Santista, Santos, SP, Brazil.	hanna.karen@unifesp.br	Antunes, Hanna K/C-8070-2012; Koike, Marcia K/K-1841-2013; Lee, Kil Sun/AAL-8564-2020; Mônico-Neto, Marcos/E-5092-2017; de Sá Souza, Helton/H-5964-2012; Lee, Kil S/D-3678-2012; Serra, Andrey Jorge/E-7460-2015; Antonio, Ednei/AGG-9987-2022; Giampá, Sara/ABE-4272-2020; de Mello, Marco Tulio/G-3237-2010	Antunes, Hanna K/0000-0001-6648-0957; Koike, Marcia K/0000-0002-5556-8061; Mônico-Neto, Marcos/0000-0002-9515-1260; de Sá Souza, Helton/0000-0003-0525-5371; Lee, Kil S/0000-0002-2390-2774; Serra, Andrey Jorge/0000-0002-5407-8183; Antonio, Ednei/0000-0002-8254-5762; Giampá, Sara/0000-0001-9983-8812; de Mello, Marco Tulio/0000-0003-3896-2208	FAPESP [2013/00152-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	HKMA holds grants from FAPESP (#2013/00152-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Andersen ML, 2005, J SLEEP RES, V14, P83, DOI 10.1111/j.1365-2869.2004.00428.x; Antonio EL, 2009, J CARD FAIL, V15, P540, DOI 10.1016/j.cardfail.2009.01.007; Aserinsky E, 1996, J Hist Neurosci, V5, P213; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Biancardi VC, 2010, J COMP NEUROL, V518, P567, DOI 10.1002/cne.22256; Burgess HJ, 1999, J SLEEP RES, V8, P113, DOI 10.1046/j.1365-2869.1999.00149.x; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Pinter RDCE, 2008, EUR J APPL PHYSIOL, V103, P605, DOI 10.1007/s00421-008-0761-3; Danzi S, 2012, MED CLIN N AM, V96, P257, DOI 10.1016/j.mcna.2012.01.006; Dattilo M, 2012, MUSCLE NERVE, V45, P431, DOI 10.1002/mus.22322; De Jong AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072651; De P, 2011, J ENDOCRINOL, V209, P105, DOI 10.1530/JOE-10-0431; Dendorfer A, 2002, HYPERTENSION, V40, P348, DOI 10.1161/01.HYP.0000028001.65341.AA; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; Everson CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE85, DOI 10.1152/ajpendo.00558.2001; EVERSON CA, 1995, ENDOCRINOLOGY, V136, P1426, DOI 10.1210/en.136.4.1426; Fernandes T, 2011, BRAZ J MED BIOL RES, V44, P836, DOI 10.1590/S0100-879X2011000900003; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Hipolide DC, 2006, J NEUROENDOCRINOL, V18, P231, DOI 10.1111/j.1365-2826.2006.01412.x; Iber C., 2007, AASM MANUAL SCORING; Inoue BH, 2012, AM J PHYSIOL-REG I, V302, pR166, DOI 10.1152/ajpregu.00127.2011; Joo EY, 2012, J CLIN NEUROL, V8, P146, DOI 10.3988/jcn.2012.8.2.146; Joukar S, 2013, SLEEP MED, V14, P1277, DOI 10.1016/j.sleep.2013.07.008; Kato M, 2000, HYPERTENSION, V35, P1173, DOI 10.1161/01.HYP.35.5.1173; Kelley GA, 2000, HYPERTENSION, V35, P838, DOI 10.1161/01.HYP.35.3.838; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Galvao MDL, 2009, PSYCHONEUROENDOCRINO, V34, P1176, DOI 10.1016/j.psyneuen.2009.03.003; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Marks AR, 2003, J CLIN INVEST, V111, P597, DOI 10.1172/JCI200318067; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Mendes OD, 2010, ARQ BRAS CARDIOL, V94, P62, DOI 10.1590/S0066-782X2010000100011; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Monico-Neto M, 2015, APPL PHYSIOL NUTR ME, V40, P1143, DOI 10.1139/apnm-2015-0061; Monico-Neto M, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/908159; Murck H, 2006, PHARMACOPSYCHIATRY, V39, P23, DOI 10.1055/s-2006-931476; NEVES FAR, 1992, HYPERTENSION, V19, P202; Ogawa Y, 2003, SLEEP, V26, P986, DOI 10.1093/sleep/26.8.986; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Pagani M, 2009, AUTON NEUROSCI-BASIC, V145, P76, DOI 10.1016/j.autneu.2008.10.009; PANIDIS IP, 1984, J AM COLL CARDIOL, V3, P1309, DOI 10.1016/S0735-1097(84)80192-8; Pellieux C, 2000, J HYPERTENS, V18, P1307, DOI 10.1097/00004872-200018090-00017; Perry JC, 2014, J SLEEP RES, V23, P168, DOI 10.1111/jsr.12110; Perry JC, 2011, J RENIN-ANGIO-ALDO S, V12, P146, DOI 10.1177/1470320310391504; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Qian ZM, 1999, PHYSIOL BEHAV, V62, P241; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Rodrigues NC, 2015, EXP PHYSIOL, V100, P193, DOI 10.1113/expphysiol.2014.083303; Roy SG, 2009, CELL PHYSIOL BIOCHEM, V24, P1, DOI 10.1159/000227803; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Shiguemoto GE, 2012, SCAND J MED SCI SPOR, V22, P607, DOI 10.1111/j.1600-0838.2010.01284.x; Siegel JM, 2011, SLEEP MED REV, V15, P139, DOI 10.1016/j.smrv.2011.01.001; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Silvani A, 2008, CLIN EXP PHARMACOL P, V35, P987, DOI 10.1111/j.1440-1681.2008.04985.x; Silvani A, 2015, SLEEP MED, V16, P210, DOI 10.1016/j.sleep.2014.10.011; Sousa Antônio Carlos Sobral, 2006, Arq. Bras. Cardiol., V87, pe27, DOI 10.1590/S0066-782X2006001600031; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Steding K, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-8; Suchecki D, 2000, PHYSIOL BEHAV, V68, P309, DOI 10.1016/S0031-9384(99)00181-X; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Trinder J, 2012, PFLUG ARCH EUR J PHY, V463, P161, DOI 10.1007/s00424-011-1041-3; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Vetrivelan R, 2012, SLEEP, V35, P1511, DOI 10.5665/sleep.2200; Vicencio JM, 2006, ENDOCRINOLOGY, V147, P1386, DOI 10.1210/en.2005-1139; Vingren JL, 2010, SPORTS MED, V40, P1037, DOI 10.2165/11536910-000000000-00000; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004	72	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167029	10.1371/journal.pone.0167029	http://dx.doi.org/10.1371/journal.pone.0167029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880816	Green Submitted, gold, Green Published			2022-12-26	WOS:000388889500058
J	Lukashev, AN; Klimentov, AS; Smirnova, SE; Dzagurova, TK; Drexler, JF; Gmyl, AP				Lukashev, Alexander N.; Klimentov, Alexander S.; Smirnova, Svetlana E.; Dzagurova, Tamara K.; Drexler, Jan Felix; Gmyl, Anatoly P.			Phylogeography of Crimean Congo Hemorrhagic Fever Virus	PLOS ONE			English	Article							MOLECULAR EVOLUTION; RNA SEGMENTS; EUROPE; TICKS; EPIDEMIOLOGY; REASSORTMENT; MIGRATION; SEQUENCE; PATTERNS	Crimean Congo hemorrhagic fever virus (CCHFV) is one of the most severe viral zoonozes. It is prevalent throughout Africa, Asia and southern Europe. Limited availability of sequence data has hindered phylogeographic studies. The complete genomic sequence of all three segments of 14 Crimean Congo hemorrhagic fever virus strains isolated from 1958-2000 in Russia, Central Asia and Africa was identified. Each genomic segment was independently subjected to continuous Bayesian phylogeographic analysis. The origin of each genomic segment was traced to Africa about 1,000-5,000 years ago. The virus was first introduced to South and Central Asia in the Middle Ages, and then spread to China, India and Russia. Reverse transfers of genomic segments from Asia to Africa were also observed. The European CCHFV genotype V was introduced to Europe via the Astrakhan region in South Russia 280-400 years ago and subsequently gradually spread westward in Russia, to Turkey and the Balkans less than 150 years ago. Only a few recombination events could be suggested in S and L genomic segments, while segment reassortment was very common. The median height of a non-reassortant phylogenetic tree node was 68-156 years. There were reassortment events within the European CCHFV lineage, but not with viruses from other locations. Therefore, CCHFV in Europe is a recently emerged zoonosis that represents a spillover from the global gene pool.	[Lukashev, Alexander N.; Klimentov, Alexander S.; Smirnova, Svetlana E.; Dzagurova, Tamara K.; Gmyl, Anatoly P.] Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia; [Lukashev, Alexander N.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia; [Lukashev, Alexander N.] RUDN Univ, Moscow, Russia; [Klimentov, Alexander S.] NF Gamaleya Ctr Epidemiol & Microbiol, DI Ivanovsky Inst Virol, Moscow, Russia; [Drexler, Jan Felix] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Drexler, Jan Felix] German Ctr Infect Res DZIF, Bonn, Germany	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Sechenov First Moscow State Medical University; Peoples Friendship University of Russia; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; University of Bonn; German Center for Infection Research	Lukashev, AN (corresponding author), Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia.; Lukashev, AN (corresponding author), Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia.; Lukashev, AN (corresponding author), RUDN Univ, Moscow, Russia.	alexander_lukashev@hotmail.com	Lukashev, Alexander/G-2777-2013; Gmyl, Anatoly/J-8367-2012; Drexler, Jan Felix/GMW-5098-2022	Lukashev, Alexander/0000-0001-7365-0352; Drexler, Jan Felix/0000-0002-3509-0232; Dzagurova, Tamara/0000-0002-6656-1682; Tkachenko, Evgeniy/0000-0002-6829-1241	Russian Scientific Foundation [14-15-00619]; Russian Science Foundation [14-15-00619] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by Russian Scientific Foundation grant 14-15-00619. The funding source did not play any role in study design, collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the article for publication.	Anagnostou V, 2009, INFECT GENET EVOL, V9, P948, DOI 10.1016/j.meegid.2009.06.018; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Carroll SA, 2010, MOL PHYLOGENET EVOL, V55, P1103, DOI 10.1016/j.ympev.2010.01.006; Chamberlain J, 2005, J GEN VIROL, V86, P3337, DOI 10.1099/vir.0.81213-0; Chen SP, 2013, J GEN VIROL, V94, P843, DOI 10.1099/vir.0.049379-0; Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732; Elliott R. M., 2013, FIELDS VIROLOGY, P1244; Estrada-Pena A, 2012, EMERG INFECT DIS, V18, P179, DOI 10.3201/eid1801.111040; Goedhals D, 2014, EPIDEMIOL INFECT, V142, P1952, DOI 10.1017/S0950268814000818; Hewson R, 2004, VIRUS RES, V102, P185, DOI 10.1016/j.virusres.2003.12.035; Hewson R, 2004, J GEN VIROL, V85, P3059, DOI 10.1099/vir.0.80121-0; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kalaycioglu AT, 2012, J MED VIROL, V84, P471, DOI 10.1002/jmv.22224; Koonin EV, 2013, CURR OPIN VIROL, V3, P546, DOI 10.1016/j.coviro.2013.06.008; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lindeborg M, 2012, EMERG INFECT DIS, V18, P2095, DOI 10.3201/eid1812.120718; Lukashev AN, 2005, J GEN VIROL, V86, P2333, DOI 10.1099/vir.0.80974-0; Lvov D. K., 2004, Voprosy Virusologii, V49, P45; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mild M, 2010, J GEN VIROL, V91, P199, DOI 10.1099/vir.0.014878-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Papa A, 2014, TICKS TICK-BORNE DIS, V5, P590, DOI 10.1016/j.ttbdis.2014.04.008; Plyusnin A, 2012, VIRUS TAXONOMY, P725; Ray S, 1999, SIMPLOT WINDOWS 95 9; Sherifi K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003168; Zehender G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079663; Zhou ZR, 2013, J GEN VIROL, V94, P2536, DOI 10.1099/vir.0.056374-0	32	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166744	10.1371/journal.pone.0166744	http://dx.doi.org/10.1371/journal.pone.0166744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880794	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500031
J	Zheng, SP; Zhang, PG; Chen, YX; Zheng, SJ; Zheng, LP; Weng, ZH				Zheng, Shaoping; Zhang, Peige; Chen, Yixiong; Zheng, Shaojiang; Zheng, Liping; Weng, Zhihong			Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization	PLOS ONE			English	Article							ACTIVATED MACROPHAGES; IMMUNE-RESPONSES; MANSONI; EXPRESSION; RECEPTOR	Macrophages play a key role in the pathogenesis of liver granuloma and fibrosis in schistosomiasis. However, the underlying mechanisms have not been fully characterized. This study revealed that the macrophages infiltrating the liver tissues in a murine model of Schistosoma japonica infection exhibited M2 functional polarization, and Notch1/Jagged1 signaling was significantly upregulated in the M2 polarized macrophages in vivo and in vitro. Furthermore, the blockade of Notch signaling pathway by a gamma-secretase inhibitor could reverse macrophage M2 polarization in vitro and alleviate liver granuloma and fibrosis in the murine model of schistosomiasis. These results implied that the Notch1/Jagged1 signaling dependent M2 polarization of macrophages might play an important role in liver granuloma and fibrosis in schistosomiasis, and the inhibition of Notch1/Jagged1 signaling might provide a novel therapeutic approach to administrate patients with schistosomiasis.	[Zheng, Shaoping; Zhang, Peige] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ultrasound, Wuhan, Peoples R China; [Chen, Yixiong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan, Peoples R China; [Zheng, Shaojiang; Zheng, Liping] Hainan Canc Hosp, Affiliated Hosp Hainan Med Coll, Dept Pathol, Haikou, Peoples R China; [Zheng, Shaojiang; Zheng, Liping] Hainan Canc Hosp, Affiliated Hosp Hainan Med Coll, Key Lab Mol Tumor Pathol, Haikou, Peoples R China; [Weng, Zhihong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University; Huazhong University of Science & Technology	Weng, ZH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan, Peoples R China.	wzh941@126.com			National Natural Science Foundation of China [81201107, 81300328]; Hainan Provincial Science & Technology Cooperation Program [KJHZ2014-23]; Haikou Key Program of Science Technology [2014059, ZDYF2016159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Provincial Science & Technology Cooperation Program; Haikou Key Program of Science Technology	This work is supported by research grants from National Natural Science Foundation of China (81201107 to SPZ and 81300328 to YXC, http:/www.nsfc.gov.cn/publish/portal1), Hainan Provincial Science & Technology Cooperation Program (KJHZ2014-23 to SJZ, http://www.hist.gov.cn), and Haikou Key Program of Science & Technology (2014059 to SJZ and ZDYF2016159 to LPZ, http://www.hksti.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Aly IRB, 2010, MEM I OSWALDO CRUZ, V105, P729, DOI 10.1590/S0074-02762010000600001; Barsoum RS, 2013, J ADV RES, V4, P433, DOI 10.1016/j.jare.2013.01.005; Boonyatecha N, 2012, MOL IMMUNOL, V51, P255, DOI 10.1016/j.molimm.2012.03.017; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Chen YP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030437, 10.1371/journal.pone.0046512, 10.1371/journal.pone.0036329]; Chu D., 2008, FRONT MED-PRC, V2, P154, DOI [10.1007/s11684-008-0029-7, DOI 10.1007/S11684-008-0029-7]; Chu DY, 2011, PARASITOLOGY, V138, P1259, DOI 10.1017/S0031182011001065; Cioli D, 2014, MOL BIOCHEM PARASIT, V195, P23, DOI 10.1016/j.molbiopara.2014.06.002; Colley DG, 2014, PARASITE IMMUNOL, V36, P347, DOI 10.1111/pim.12087; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Dewals BG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000689; Fairfax K, 2012, SEMIN IMMUNOPATHOL, V34, P863, DOI 10.1007/s00281-012-0354-4; Goh F, 2009, IMMUNOLOGY, V127, P326, DOI 10.1111/j.1365-2567.2008.02979.x; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Sangphech N, 2014, IMMUNOBIOLOGY, V219, P653, DOI 10.1016/j.imbio.2014.03.020; Secor WE, 2015, FUTURE MED CHEM, V7, P681, DOI [10.4155/fmc.15.9, 10.4155/FMC.15.9]; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Wang W, 2012, PARASITOL RES, V111, P1871, DOI 10.1007/s00436-012-3151-z; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	27	23	28	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166808	10.1371/journal.pone.0166808	http://dx.doi.org/10.1371/journal.pone.0166808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875565	gold, Green Submitted, Green Published			2022-12-26	WOS:000388886000025
J	Choi, J; Choi, BK; Kim, JS; Lee, JW; Park, HA; Ryu, HW; Lee, SU; Hwang, KW; Yun, WK; Kim, HC; Ahn, KS; Oh, SR; Lee, HJ				Choi, Jin; Choi, Bo Kyong; Kim, Jin Seok; Lee, Jae-Won; Park, Hyun Ah; Ryu, Hyung Won; Lee, Su Ui; Hwang, Kwang Woo; Yun, Won-Kee; Kim, Hyoung-Chin; Ahn, Kyung-Seop; Oh, Sei-Ryang; Lee, Hyun-Jun			Picroside II Attenuates Airway Inflammation by Downregulating the Transcription Factor GATA3 and Th2-Related Cytokines in a Mouse Model of HDM-Induced Allergic Asthma	PLOS ONE			English	Article							MUC5AC EXPRESSION; T-BET; DIFFERENTIATION; VERPROSIDE; CELLS; SUFFICIENT; IMMUNITY; TH1/TH2; DIRECTS; CD4	Picroside II isolated from Pseudolysimachion rotundum var. subintegrum has been used as traditional medicine to treat inflammatory diseases. In this study, we assessed whether picroside II has inhibitory effects on airway inflammation in a mouse model of house dust mite (HDM)-induced asthma. In the HDM-induced asthmatic model, picroside II significantly reduced inflammatory cell counts in the bronchoalveolar lavage fluid (BALF), the levels of total immunoglobulin (Ig) E and HDM-specific IgE and IgG1 in serum, airway inflammation, and mucus hypersecretion in the lung tissues. ELISA analysis showed that picroside II down-regulated the levels of Th2-related cytokines (including IL-4, IL-5, and IL-13) and asthma-related mediators, but it up-regulated Th1-related cytokine, IFN. in BALF. Picroside II also inhibited the expression of Th2 type cytokine genes and the transcription factor GATA3 in the lung tissues of HDM-induced mice. Finally, we demonstrated that picroside II significantly decreased the expression of GATA3 and Th2 cytokines in developing Th2 cells, consistent with in vivo results. Taken together, these results indicate that picroside II has protective effects on allergic asthma by reducing GATA3 expression and Th2 cytokine bias.	[Choi, Jin; Choi, Bo Kyong; Kim, Jin Seok; Lee, Jae-Won; Park, Hyun Ah; Ryu, Hyung Won; Lee, Su Ui; Ahn, Kyung-Seop; Oh, Sei-Ryang; Lee, Hyun-Jun] KRIBB, Nat Med Res Ctr, Cheongju, Chungbuk, South Korea; [Choi, Bo Kyong; Hwang, Kwang Woo] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Yun, Won-Kee; Kim, Hyoung-Chin] KRIBB, Lab Anim Resource Ctr, Cheongju, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, HJ (corresponding author), KRIBB, Nat Med Res Ctr, Cheongju, Chungbuk, South Korea.	hjlee7@kribb.re.kr		Lee, Jae-Won/0000-0003-0438-6732				Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Rivera DG, 2011, J PHARM PHARMACOL, V63, P1336, DOI 10.1111/j.2042-7158.2011.01328.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Gulliver Tanya, 2007, Paediatr Drugs, V9, P185, DOI 10.2165/00148581-200709030-00007; He LJ, 2009, J ENDOCRINOL, V200, P347, DOI 10.1677/JOE-08-0481; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kim JK, 1984, ILLUSTRATED NATURAL, P141; Kim MG, 2012, MOLECULES, V17, P11990, DOI 10.3390/molecules171011990; Kumar V, 2016, J PLANT BIOCHEM BIOT, V25, P208, DOI 10.1007/s13562-015-0327-5; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee SU, 2016, CYTOKINE, V77, P168, DOI 10.1016/j.cyto.2015.08.262; Li JX, 1998, PHYTOCHEMISTRY, V48, P537, DOI 10.1016/S0031-9422(98)00030-2; Liu JW, 2007, PHARMACOL REP, V59, P573; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Oh SR, 2006, INT IMMUNOPHARMACOL, V6, P978, DOI 10.1016/j.intimp.2006.01.010; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shi YH, 2011, CHINESE MED J-PEKING, V124, P1951, DOI 10.3760/cma.j.issn.0366-6999.2011.13.006; Smit HF, 2000, J ETHNOPHARMACOL, V73, P101, DOI 10.1016/S0378-8741(00)00268-3; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tan YF, 2011, EUR REV MED PHARMACO, V15, P743; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	43	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0167098	10.1371/journal.pone.0167098	http://dx.doi.org/10.1371/journal.pone.0167098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870920	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400060
J	McCabe, C; Rocha-Rego, V				McCabe, Ciara; Rocha-Rego, Vanessa			Investigating the Predictive Value of Functional MRI to Appetitive and Aversive Stimuli: A Pattern Classification Approach	PLOS ONE			English	Article							NEURAL RESPONSE; ORBITOFRONTAL CORTEX; HUMAN BRAIN; REWARD; DOPAMINE; ANHEDONIA; INSIGHTS; HUMANS; REPRESENTATIONS; ANTICIPATION	Background Dysfunctional neural responses to appetitive and aversive stimuli have been investigated as possible biomarkers for psychiatric disorders. However it is not clear to what degree these are separate processes across the brain or in fact overlapping systems. To help clarify this issue we used Gaussian process classifier (GPC) analysis to examine appetitive and aversive processing in the brain. Method 25 healthy controls underwent functional MRI whilst seeing pictures and receiving tastes of pleasant and unpleasant food. We applied GPCs to discriminate between the appetitive and aversive sights and tastes using functional activity patterns. Results The diagnostic accuracy of the GPC for the accuracy to discriminate appetitive taste from neutral condition was 86.5% (specificity = 81%, sensitivity = 92%, p = 0.001). If a participant experienced neutral taste stimuli the probability of correct classification was 92. The accuracy to discriminate aversive from neutral taste stimuli was 82.5% (specificity = 73%, sensitivity = 92%, p = 0.001) and appetitive from aversive taste stimuli was 73% (specificity = 77%, sensitivity = 69%, p = 0.001). In the sight modality, the accuracy to discriminate appetitive from neutral condition was 88.5% (specificity = 85%, sensitivity = 92%, p = 0.001), to discriminate aversive from neutral sight stimuli was 92% (specificity = 92%, sensitivity = 92%, p = 0.001), and to discriminate aversive from appetitive sight stimuli was 63.5% (specificity = 73%, sensitivity = 54%, p = 0.009). Conclusions Our results demonstrate the predictive value of neurofunctional data in discriminating emotional and neutral networks of activity in the healthy human brain. It would be of interest to use pattern recognition techniques and fMRI to examine network dysfunction in the processing of appetitive, aversive and neutral stimuli in psychiatric disorders. Especially where problems with reward and punishment processing have been implicated in the pathophysiology of the disorder.	[McCabe, Ciara] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Rocha-Rego, Vanessa] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	University of Reading; Universidade Federal do Rio de Janeiro	McCabe, C (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	C.McCabe@Reading.ac.uk			University of Reading	University of Reading	This work was supported by the University of Reading. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2011, NEUROPSYCHOPHARMACOL, V36, P1837, DOI 10.1038/npp.2011.66; Adolphs R, 2000, LEARN MEMORY, V7, P180, DOI 10.1101/lm.7.3.180; Allen JG, 1998, B MENNINGER CLIN, V62, P547; Argyropoulos SV, 2013, J PSYCHOPHARMACOL, V27, P869, DOI 10.1177/0269881113494104; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Bishop C. M, 2006, PATTERN RECOGNITION; BOZARTH MA, 1983, PROG NEURO-PSYCHOPH, V7, P569, DOI 10.1016/0278-5846(83)90027-1; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dean Z, 2016, PSYCHOL MED, V46, P2263, DOI 10.1017/S003329171600088X; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harmer CJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0407; Hayes DJ, 2014, NEUROSCI BIOBEHAV R, V45, P350, DOI 10.1016/j.neubiorev.2014.06.018; Hayes DJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00049; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; McCabe C, 2007, EUR J NEUROSCI, V25, P1855, DOI 10.1111/j.1460-9568.2007.05445.x; McCabe C, 2013, PSYCHOPHARMACOLOGY, V228, P283, DOI 10.1007/s00213-013-3033-9; McCabe C, 2012, BIOL PSYCHIAT, V72, P588, DOI 10.1016/j.biopsych.2012.04.034; McCabe C, 2011, PSYCHOPHARMACOLOGY, V217, P271, DOI 10.1007/s00213-011-2278-4; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; McCabe C, 2009, PSYCHOPHARMACOLOGY, V205, P667, DOI 10.1007/s00213-009-1573-9; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Mitterschiffthaler MT, 2003, NEUROREPORT, V14, P177, DOI 10.1097/00001756-200302100-00003; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Mourao-Miranda J, 2012, PSYCHOL MED, V42, P1037, DOI 10.1017/S0033291711002005; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Murray E, 2014, PSYCHOPHARMACOLOGY, V231, P4323, DOI 10.1007/s00213-014-3573-7; Nutt D, 2007, J PSYCHOPHARMACOL, V21, P461, DOI 10.1177/0269881106069938; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060121; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Pringle A, 2013, J PSYCHOPHARMACOL, V27, P719, DOI 10.1177/0269881112474523; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Volman SF, 2013, J NEUROSCI, V33, P17569, DOI 10.1523/JNEUROSCI.3250-13.2013; Wager TD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004066; Wilson JL, 2002, NEUROIMAGE, V17, P967, DOI 10.1006/nimg.2002.1172; Wilson SM, 2009, NEUROIMAGE, V47, P1558, DOI 10.1016/j.neuroimage.2009.05.085; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0165295	10.1371/journal.pone.0165295	http://dx.doi.org/10.1371/journal.pone.0165295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED4UE	27870866	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000388846400003
J	Sareddy, GR; Viswanadhapalli, S; Surapaneni, P; Suzuki, T; Brenner, A; Vadlamudi, RK				Sareddy, G. R.; Viswanadhapalli, S.; Surapaneni, P.; Suzuki, T.; Brenner, A.; Vadlamudi, R. K.			Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HISTONE DEMETHYLASE; ER STRESS; GLIOBLASTOMA CELLS; LSD1; TARGET; MECHANISMS; GROWTH; HETEROGENEITY; CONTRIBUTES	Glioma stem cells (GSCs) have a central role in glioblastoma (GBM) development and chemo/radiation resistance, and their elimination is critical for the development of efficient therapeutic strategies. Recently, we showed that lysine demethylase KDM1A is overexpressed in GBM. In the present study, we determined whether KDM1A modulates GSCs stemness and differentiation and tested the utility of two novel KDM1A-specific inhibitors (NCL-1 and NCD-38) to promote differentiation and apoptosis of GSCs. The efficacy of KDM1A targeting drugs was tested on purified GSCs isolated from established and patient-derived GBMs using both in vitro assays and in vivo orthotopic preclinical models. Our results suggested that KDM1A is highly expressed in GSCs and knockdown of KDM1A using shRNA-reduced GSCs stemness and induced the differentiation. Pharmacological inhibition of KDM1A using NCL-1 and NCD-38 significantly reduced the cell viability, neurosphere formation and induced apoptosis of GSCs with little effect on differentiated cells. In preclinical studies using orthotopic models, NCL-1 and NCD-38 significantly reduced GSCs-driven tumor progression and improved mice survival. RNA-sequencing analysis showed that KDM1A inhibitors modulate several pathways related to stemness, differentiation and apoptosis. Mechanistic studies showed that KDM1A inhibitors induce activation of the unfolded protein response (UPR) pathway. These results strongly suggest that selective targeting of KDM1A using NCL-1 and NCD-38 is a promising therapeutic strategy for elimination of GSCs.	[Sareddy, G. R.; Viswanadhapalli, S.; Surapaneni, P.; Vadlamudi, R. K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Suzuki, T.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Suzuki, T.] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Brenner, A.; Vadlamudi, R. K.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Brenner, A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Hematol & Oncol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST); Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Sareddy, GR; Vadlamudi, RK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA.	Sareddy@uthscsa.edu; Vadlamudi@uthscsa.edu		Viswanadhapalli, Suryavathi/0000-0002-7381-6962	AACR-AMGEN Inc. [14-40-11-SARE]; CPRIT training grant [RP140105]; NCI Grant [CA178499]; NATIONAL CANCER INSTITUTE [R01CA178499] Funding Source: NIH RePORTER	AACR-AMGEN Inc.; CPRIT training grant; NCI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the 2014 AACR-AMGEN Inc. fellowship in clinical/translational cancer research (Grant Number: 14-40-11-SARE) and CPRIT training grant (RP140105) awarded to GRS and NCI Grant CA178499 (RKV and AB).	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Amente S, 2013, BBA-GENE REGUL MECH, V1829, P981, DOI 10.1016/j.bbagrm.2013.05.002; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bai Y, 2014, GLIA, V62, P1687, DOI 10.1002/glia.22708; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Cho YM, 2009, EXP MOL MED, V41, P440, DOI 10.3858/emm.2009.41.6.049; Cortez V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3229; Crespo I, 2015, AM J PATHOL, V185, P1820, DOI 10.1016/j.ajpath.2015.02.023; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Ding J, 2013, BRIT J CANCER, V109, P994, DOI 10.1038/bjc.2013.364; Diaz-Villanueva JF, 2015, INT J MOL SCI, V16, P17193, DOI 10.3390/ijms160817193; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Ge WS, 2014, BIOMATERIALS, V35, P6015, DOI 10.1016/j.biomaterials.2014.04.055; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Khan IS, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14509; Kondo Y, 2014, CANCER SCI, V105, P363, DOI 10.1111/cas.12379; Kozono D, 2015, P NATL ACAD SCI USA, V112, pE4055, DOI 10.1073/pnas.1501967112; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lee YS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/520578; Lei ZJ, 2015, ONCOGENE, V34, P3188, DOI 10.1038/onc.2015.129; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ogasawara D, 2013, ANGEW CHEM INT EDIT, V52, P8620, DOI 10.1002/anie.201303999; Ogasawara D, 2011, BIOORGAN MED CHEM, V19, P3702, DOI 10.1016/j.bmc.2010.12.024; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Pajtler KW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-19; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sareddy GR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24185; Sareddy GR, 2013, ONCOTARGET, V4, P18, DOI 10.18632/oncotarget.725; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Sato A, 2011, STEM CELLS, V29, P1942, DOI 10.1002/stem.753; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shao GB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15344; Singh MM, 2011, NEURO-ONCOLOGY, V13, P894, DOI 10.1093/neuonc/nor049; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/785437; Wang LW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004021; Wang M., 2015, CAN J AGR ECON, V1, P1; Wielenga MCB, 2015, CELL REP, V13, P489, DOI 10.1016/j.celrep.2015.09.016; Xie Q, 2015, ONCOTARGET, V6, P13241, DOI 10.18632/oncotarget.3676; Xu HM, 2014, J BIOL CHEM, V289, P26290, DOI 10.1074/jbc.M114.572560; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang XC, 2007, INT J DEV NEUROSCI, V25, P455, DOI 10.1016/j.ijdevneu.2007.08.007; Zhao X, 2015, ANIM BIOL, V65, P1, DOI 10.1163/15707563-00002455; Zhao ZK, 2012, WORLD J GASTROENTERO, V18, P6651, DOI 10.3748/wjg.v18.i45.6651	74	51	51	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2423	2434		10.1038/onc.2016.395	http://dx.doi.org/10.1038/onc.2016.395			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27893719	Green Accepted			2022-12-26	WOS:000400268900008
J	Hammel, M; Yu, YP; Radhakrishnan, SK; Chokshi, C; Tsai, MS; Matsumoto, Y; Kuzdovich, M; Remesh, SG; Fang, SJ; Tomkinson, AE; Lees-Miller, SP; Tainer, JA				Hammel, Michal; Yu, Yaping; Radhakrishnan, Sarvan K.; Chokshi, Chirayu; Tsai, Miaw-Sheue; Matsumoto, Yoshihiro; Kuzdovich, Monica; Remesh, Soumya G.; Fang, Shujuan; Tomkinson, Alan E.; Lees-Miller, Susan P.; Tainer, John A.			An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; X-RAY-SCATTERING; SMALL-ANGLE SCATTERING; IONIZING-RADIATION; BIOLOGICAL MACROMOLECULES; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; DAMAGE RESPONSE; REPAIR PROTEINS	DNA double-strand break (DSB) repair by non-homologous end joining (NHEJ) in human cells is initiated by Ku heterodimer binding to a DSB, followed by recruitment of core NHEJ factors including DNA-dependent protein kinase catalytic subunit (DNA-PKcs), XRCC4-like factor (XLF), and XRCC4 (X4)-DNA ligase IV (L4). Ku also interacts with accessory factors such as aprataxin and polynucleotide kinase/phosphatase-like factor (APLF). Yet, how these factors interact to tether, process, and ligate DSB ends while allowing regulation and chromatin interactions remains enigmatic. Here, small angle X-ray scattering (SAXS) and mutational analyses show APLF is largely an intrinsically disordered protein that binds Ku, Ku/DNA-PKcs (DNA-PK), and X4L4 within an extended flexible NHEJ core complex. X4L4 assembles with Ku heterodimers linked to DNA-PKcs via flexible Ku80 C-terminal regions (Ku80CTR) in a complex stabilized through APLF interactions with Ku, DNA-PK, and X4L4. Collective results unveil the solution architecture of the six-protein complex and suggest cooperative assembly of an extended flexible NHEJ core complex that supports APLF accessibility while possibly providing flexible attachment of the core complex to chromatin. The resulting dynamic tethering furthermore, provides geometric access of L4 catalytic domains to the DNA ends during ligation and of DNA-PKcs for targeted phosphorylation of other NHEJ proteins as well as trans-phosphorylation of DNA-PKcs on the opposing DSB without disrupting the core ligation complex. Overall the results shed light on evolutionary conservation of Ku, X4, and L4 activities, while explaining the observation that Ku80CTR and DNA-PKcs only occur in a subset of higher eukaryotes.	[Hammel, Michal; Chokshi, Chirayu; Tsai, Miaw-Sheue; Kuzdovich, Monica; Remesh, Soumya G.; Tainer, John A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA; [Yu, Yaping; Radhakrishnan, Sarvan K.; Fang, Shujuan; Lees-Miller, Susan P.] Univ Calgary, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Calgary; University of New Mexico; University of New Mexico's Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center	Hammel, M; Tainer, JA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA.; Lees-Miller, SP (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada.; Tainer, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mailmhammel@lbl.gov; leesmill@ucalgary.ca; JATainer@LBL.gov	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Remesh, Soumya G/I-3558-2019	Tainer, John/0000-0003-1659-2429; Hammel, Michal/0000-0002-5610-9289; Radhakrishnan, Sarvan Kumar/0000-0002-1618-7864; Matsumoto, Yoshihiro/0000-0001-6580-7188; Lees-Miller, Susan/0000-0001-5809-2516	National Institutes of Health MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) [GM105404]; United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047251, R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SAXS at the Advanced Light Source SIBYLS beamline is supported in part by the National Institutes of Health MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) Grant GM105404 and the United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT). We thank the Berkeley Lab Advanced Light Source and SIBYLS beam line staff at 12.3.1 for aiding solution scattering data collection, and Dr. M. Rey and L. Brechenmacher at the Southern Alberta Mass Spectrometry Centre for mass spectrometry.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Andres SN, 2012, NUCLEIC ACIDS RES, V40, P1868, DOI 10.1093/nar/gks022; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Brouwer I, 2016, NATURE, V535, P566, DOI 10.1038/nature18643; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Cherry AL, 2015, DNA REPAIR, V35, P116, DOI 10.1016/j.dnarep.2015.10.002; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Cottarel J, 2013, J CELL BIOL, V200, P173, DOI 10.1083/jcb.201203128; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fenton AL, 2013, NUCLEIC ACIDS RES, V41, P4080, DOI 10.1093/nar/gkt134; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grob P, 2012, DNA REPAIR, V11, P74, DOI 10.1016/j.dnarep.2011.10.023; Grundy GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11242; Grundy GJ, 2013, EMBO J, V32, P112, DOI 10.1038/emboj.2012.304; Gu JF, 2008, GENE DEV, V22, P411, DOI 10.1101/gad.1646608; Hammel M, 2011, J BIOL CHEM, V286, P32638, DOI 10.1074/jbc.M111.272641; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lehman JA, 2008, BIOCHEMISTRY-US, V47, P4359, DOI 10.1021/bi702284c; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mehrotra PV, 2011, MOL CELL, V41, P46, DOI 10.1016/j.molcel.2010.12.008; Ochi T, 2012, STRUCTURE, V20, P1212, DOI 10.1016/j.str.2012.04.012; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shirodkar P, 2013, J BIOL CHEM, V288, P19604, DOI 10.1074/jbc.M112.440388; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tamura K, 2002, PLANT J, V29, P771, DOI 10.1046/j.1365-313X.2002.01258.x; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679	73	42	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26987	27006		10.1074/jbc.M116.751867	http://dx.doi.org/10.1074/jbc.M116.751867			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875301	Green Published, hybrid			2022-12-26	WOS:000391576300004
J	Smith, IM; Baker, A; Christensen, JE; Boekhout, T; Frokiaer, H; Arneborg, N; Jespersen, L				Smith, Ida M.; Baker, Adam; Christensen, Jeffrey E.; Boekhout, Teun; Frokiaer, Hanne; Arneborg, Nils; Jespersen, Lene			Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; FUNGAL BETA-GLUCAN; CANDIDA-ALBICANS; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; IMMUNE RECOGNITION; MONONUCLEAR-CELLS; LECTIN RECEPTORS; INDUCED COLITIS; GUT MICROBIOTA	Interactions between members of the intestinal microbiota and the mucosal immune system can significantly impact human health, and in this context, fungi and food-related yeasts are known to influence intestinal inflammation through direct interactions with specialized immune cells in vivo. The aim of the present study was to characterize the immune modulating properties of the food-related yeast Kluyveromyces marxianus in terms of adaptive immune responses indicating inflammation versus tolerance and to explore the mechanisms behind the observed responses. Benchmarking against a Saccharomyces boulardii strain with probiotic effects documented in clinical trials, we evaluated the ability of K. marxianus to modulate human dendritic cell (DC) function in vitro. Further, we assessed yeast induced DC modulation of naive T cells toward effector responses dominated by secretion of IFN gamma and IL-17 versus induction of a Treg response characterized by robust IL-10 secretion. In addition, we blocked relevant DC surface receptors and investigated the stimulating properties of beta-glucan containing yeast cell wall extracts. K. marxianus and S. boulardii induced distinct levels of DC cytokine secretion, primarily driven by Dectin-1 recognition of beta-glucan components in their cell walls. Upon co-incubation of yeast exposed DCs and naive T cells, S. boulardii induced a potent IFN. response indicating T(H)1 mobilization. In contrast, K. marxianus induced a response dominated by Foxp3(+)T(reg) cells, a characteristic that may benefit human health in conditions characterized by excessive inflammation and positions K. marxianus as a strong candidate for further development as a novel yeast probiotic.	[Smith, Ida M.; Baker, Adam] Chr Hansen AS, Hlth & Nutr Div Discovery, Horsholm, Denmark; [Smith, Ida M.; Arneborg, Nils; Jespersen, Lene] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Christensen, Jeffrey E.] French Inst Hlth & Med Res INSERM, Inst Metab & Cardiovasc Dis, Toulouse, France; [Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Frokiaer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Smith, Ida M.] ALK AS, Global Clin Dev, Biometr Med Writing, Horsholm, Denmark	Chr Hansen; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Copenhagen; ALK-Abello AS	Smith, IM (corresponding author), Chr Hansen AS, Hlth & Nutr Div Discovery, Horsholm, Denmark.; Smith, IM (corresponding author), Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark.; Smith, IM (corresponding author), ALK AS, Global Clin Dev, Biometr Med Writing, Horsholm, Denmark.	ismdk@alk.net	Boekhout, Teunis/ABF-2538-2020; Jespersen, Lene/AAA-4230-2021	Boekhout, Teunis/0000-0002-0476-3609; Jespersen, Lene/0000-0002-2555-5948; Frokiaer, Hanne/0000-0003-1472-9698; Christensen, Jeffrey E./0000-0001-7357-7677	EU [PITN-GA-2010-264717]	EU(European Commission)	The research leading to these results was funded by the EU's Seventh Framework Programme (FP7) under grant agreement PITN-GA-2010-264717, in the form of a research fellowship for IMS. Thus, the funder provided support in the form of salary for IMS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034676; Batbayar S, 2012, BIOMOL THER, V20, P433, DOI 10.4062/biomolther.2012.20.5.433; Bazan SB, 2011, VACCINE, V29, P8165, DOI 10.1016/j.vaccine.2011.07.141; (BIOHAZ) EPoBH, 2010, EFSA J, V8; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Donkor ON, 2012, CLIN EXP IMMUNOL, V167, P282, DOI 10.1111/j.1365-2249.2011.04496.x; Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jespersen L, 2005, FEMS YEAST RES, V5, P441, DOI 10.1016/j.femsyr.2004.11.002; Justino PFC, 2014, BRIT J NUTR, V111, P1611, DOI 10.1017/S0007114513004248; Karumuthil-Melethil S, 2014, J IMMUNOL, V193, P3308, DOI 10.4049/jimmunol.1400186; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kuhle AVA, 2003, SYST APPL MICROBIOL, V26, P564, DOI 10.1078/072320203770865873; Kumura H, 2004, J DAIRY SCI, V87, P4050, DOI 10.3168/jds.S0022-0302(04)73546-8; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lang TJ, 2002, J IMMUNOL, V168, P3786, DOI 10.4049/jimmunol.168.8.3786; Lee SK, 2009, DIGEST DIS SCI, V54, P255, DOI 10.1007/s10620-008-0357-0; Liu YY, 2014, AM J PHYSIOL-GASTR L, V307, pG177, DOI 10.1152/ajpgi.00038.2014; Maccaferri S, 2012, APPL ENVIRON MICROB, V78, P956, DOI 10.1128/AEM.06385-11; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Marchesi JR, 2010, ADV APPL MICROBIOL, V72, P43, DOI 10.1016/S0065-2164(10)72002-5; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Martins FS, 2005, J GEN APPL MICROBIOL, V51, P83, DOI 10.2323/jgam.51.83; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Petersen ER, 2012, INFLAMM BOWEL DIS, V18, P131, DOI 10.1002/ibd.21709; Podojil JR, 2009, IMMUNOL REV, V229, P337, DOI 10.1111/j.1600-065X.2009.00773.x; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Romani L, 2004, INT IMMUNOL, V16, P149, DOI 10.1093/intimm/dxh012; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Seong Su Kyoung, 2010, Mycobiology, V38, P144, DOI 10.4489/MYCO.2010.38.2.144; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Smith IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096595; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Thomas S, 2009, CLIN EXP IMMUNOL, V156, P78, DOI 10.1111/j.1365-2249.2009.03878.x; Thomas S, 2011, AM J PHYSIOL-GASTR L, V301, pG1083, DOI 10.1152/ajpgi.00217.2011; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Wismar R, 2011, MOL NUTR FOOD RES, V55, P443, DOI 10.1002/mnfr.201000230; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441	63	14	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167410	10.1371/journal.pone.0167410	http://dx.doi.org/10.1371/journal.pone.0167410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898740	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474000062
J	Zwicker, S; Bureik, D; Bosma, M; Martinez, GL; Almer, S; Bostrom, EA				Zwicker, Stephanie; Bureik, Daniela; Bosma, Madeleen; Martinez, Gisele Lago; Almer, Sven; Bostrom, Elisabeth A.			Receptor-Type Protein-Tyrosine Phosphatase zeta and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1	PLoS One			English	Article							INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; MICE DEFICIENT; MACROPHAGES; IL-34; ANTIBODY; BLOOD; CELLS; SERUM	Differential intestinal expression of the macrophage growth factors colony stimulating factor-1 (CSF-1), interleukin (IL)-34, and their shared CSF-1 receptor (CSF-1R) in inflammatory bowel disease (IBD) has been shown. Diverse expression between CSF-1 and IL-34, suggest that IL-34 may signal via an alternate receptor. Receptor-type protein-tyrosine phosphatase (PTPRZ1, RPTP-zeta), an additional IL-34 receptor, was recently identified. Here, we aimed to assess PTPRZ1 expression in IBD and non-IBD intestinal biopsies. Further, we aimed to investigate cellular PTPRZ1 and CSF-1R expression, and cytokine- and chemokine responses by IL-34 and CSF-1. The expression of PTPRZ1 was higher in nonIBD colon compared to ileum. PTPRZ1 expression was not altered with inflammation in IBD, however, correlated to 1L34, CSF1, and CSF1R. The expression patterns of PTPRZ1 and CSF-1R differed in peripheral blood mononuclear cells (PBMCs), monocytes, macrophages, and intestinal epithelial cell line. PBMCs and monocytes of the same donors responded differently to IL-34 and CSF-1 with altered expression of tumor-necrosis factor a (TNF-alpha), IL-1 beta, interferon gamma(IFN-gamma), IL-13, IL-8, and monocyte chemotactic protein-1 (MCP 1) levels. This study shows that PTPRZ1 was expressed in bowel tissue. Furthermore, CSF-1R protein was detected in an intestinal epithelial cell line and donor dependently in primary PBMCs, monocytes, and macrophages, and first hints also suggest an expression in these cells for PTPRZ1, which may mediate IL-34 and CSF-1 actions.	[Zwicker, Stephanie; Bureik, Daniela; Martinez, Gisele Lago; Bostrom, Elisabeth A.] Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden; [Bosma, Madeleen] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Almer, Sven] Karolinska Inst, Dept Med, Stockholm, Sweden; [Almer, Sven] Karolinska Univ Hosp, GastroCtr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Bostrom, EA (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden.	elisabeth.bostrom@ki.se		Almer Bostrom, Elisabeth/0000-0003-1788-7501; Almer, Sven/0000-0001-9334-1821	Swedish Research Council [523-2012-2480]; Stockholm County Council/ALF project [20140367]; Karolinska Institutet Funds; Ake Wiberg Foundation; Ihre Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council/ALF project(Stockholm County Council); Karolinska Institutet Funds; Ake Wiberg Foundation; Ihre Foundation	This work was supported by grants from the Swedish Research Council (523-2012-2480 to EAB), Stockholm County Council/ALF project (20140367 to EAB), Karolinska Institutet Funds (EAB), Ake Wiberg Foundation (EAB) and the Ihre Foundation (SA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Booker Burthia E, 2015, Int J Biochem Mol Biol, V6, P1; Bostrom EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081665; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Ciccia F, 2013, RHEUMATOLOGY, V52, P1009, DOI 10.1093/rheumatology/kes435; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Eda H, 2010, CYTOKINE, V52, P215, DOI 10.1016/j.cyto.2010.08.005; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Franze E, 2015, CLIN SCI; Franze E, 2015, J CROHNS COLITIS; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Herradon G, 2009, CURR MED CHEM, V16, P3322, DOI 10.2174/092986709788803240; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Krishnan K, 2011, INFLAMM BOWEL DIS, V17, P410, DOI 10.1002/ibd.21316; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Millard AL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00125; Moon SJ, 2013, J RHEUMATOL, V40, P1842, DOI 10.3899/jrheum.130356; Nagashima R, 1996, J HISTOCHEM CYTOCHEM, V44, P721, DOI 10.1177/44.7.8675993; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Nandi S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.442731; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Paniagua RT, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2940; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Segaliny AI, 2015, BBA-MOL CELL RES, V1853, P1010, DOI 10.1016/j.bbamcr.2015.01.023; Stanley ER, 2014, COLD SPRING HARBOR P, V6; Strack S, 2015, J MUSCLE RES CELL M, V36, P517, DOI 10.1007/s10974-015-9418-0; Sullivan AR, 2014, J MAMMARY GLAND BIOL, V19, P149, DOI 10.1007/s10911-014-9320-1; Tian Y, 2013, J INTERF CYTOK RES, V33, P398, DOI 10.1089/jir.2012.0122; Toh ML, 2014, ARTHRITIS RHEUMATOL, V66, P2989, DOI 10.1002/art.38624; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025; Zwicker S, 2015, CLIN SCI	43	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167324	10.1371/journal.pone.0167324	http://dx.doi.org/10.1371/journal.pone.0167324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898738	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000052
J	Bender, JK; Fleige, C; Klare, I; Fiedler, S; Mischnik, A; Mutters, NT; Dingle, KE; Werner, G				Bender, Jennifer K.; Fleige, Carola; Klare, Ingo; Fiedler, Stefan; Mischnik, Alexander; Mutters, Nico T.; Dingle, Kate E.; Werner, Guido			Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.	PLOS ONE			English	Article							MULTIRESISTANCE GENE CFR; CLOSTRIDIUM-DIFFICILE; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC-RESISTANCE; ANIMAL ORIGIN; RIBOSOMAL-RNA; 1ST REPORT; FAECALIS; MECHANISMS; OXAZOLIDINONES	The National Reference Centre for Staphylococci and Enterococci in Germany has received an increasing number of clinical linezolid-resistant E. faecium isolates in recent years. Five isolates harbored a cfr(B) variant gene locus the product of which is capable of conferring linezolid resistance. The cfr(B)-like methyltransferase gene was also detected in Clostridium difficile. Antimicrobial susceptibility was determined for cfr(B)-positive and linezolid-resistant E. faecium isolates and two isogenic C. difficile strains. All strains were subjected to whole genome sequencing and analyzed with respect to mutations in the 23S rDNA, rplC, rplD and rplV genes and integration sites of the cfr(B) variant locus. To evaluate methyltransferase function, the cfr(B) variant of Enterococcus and Clostridium was expressed in both E. coli and Enterococcus spp. Ribosomal target site mutations were detected in E. faecium strains but absent in clostridia. Sequencing revealed 99.9% identity between cfr(B) of Enterococcus and cfr of Clostridium. The methyltransferase gene is encoded by transposon Tn6218 which was present in C. difficile Ox3196, truncated in some E. faecium and absent in C. difficile Ox3206. The latter finding explains the lack of linezolid and chloramphenicol resistance in C. difficile Ox3206 and demonstrates for the first time a direct correlation of elevated linezolid MICs in C. difficile upon cfr acquisition. Tn6218 insertion sites revealed novel target loci for integration, both within the bacterial chromosome and as an integral part of plasmids. Importantly, the very first plasmid-association of a cfr(B) variant was observed. Although we failed to measure cfr(B)-mediated resistance in transformed laboratory strains the occurrence of the multidrug resistance gene cfr on putatively highly mobile and/or extrachromosomal DNA in clinical isolates is worrisome with respect to dissemination of antibiotic resistances.	[Bender, Jennifer K.; Fleige, Carola; Klare, Ingo; Fiedler, Stefan; Werner, Guido] Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistances, Natl Reference Ctr Staphylococci & Enterococci, Dept Infect Dis,Wernigerode Branch, Wernigerode, Germany; [Mischnik, Alexander] Univ Freiburg, Fac Med, Med Ctr, Div Infect Dis,Dept Med, Freiburg, Germany; [Mischnik, Alexander; Mutters, Nico T.] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany; [Mischnik, Alexander; Mutters, Nico T.] German Ctr Infect Res DZIF, Heidelberg, Germany; [Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, Oxon, England; [Dingle, Kate E.] John Radcliffe Hosp, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, Oxon, England	Robert Koch Institute; University of Freiburg; Ruprecht Karls University Heidelberg; German Center for Infection Research; University of Oxford; University of Oxford	Bender, JK (corresponding author), Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistances, Natl Reference Ctr Staphylococci & Enterococci, Dept Infect Dis,Wernigerode Branch, Wernigerode, Germany.	benderj@rki.de	Mutters, Nico/B-5287-2013	Mutters, Nico/0000-0002-0156-9595; Dingle, Kate/0000-0002-2303-5957; Bender, Jennifer/0000-0001-5167-3836	Federal Ministry of Health [1369-234]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre; Federal Ministry for Health, Germany	Federal Ministry of Health; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Federal Ministry for Health, Germany	The work of the National Reference Centre for Staphylococci and Enterococci is supported by a grant from the Federal Ministry of Health (1369-234). KED was supported by the Oxford Partnership Comprehensive Biomedical Research Centre, with funding from the Department of Health's NIHR Biomedical Research Centre funding scheme.; We would like to thank Sandra Stengel, Anja Greiner and Uta Geringer for excellent technical support and all laboratories which provided us with strains. Further, we would like to acknowledge the contribution of Dr. Franziska Layer and Dr. Roman Gerlach for critical reading of the manuscript. K.E.D. was supported by the Oxford Partnership Comprehensive Biomedical Research Centre, with funding from the Department of Health's NIHR Biomedical Research Centre funding scheme. We acknowledge funding received from the Federal Ministry for Health, Germany, for our work as a National Reference Centre for Staphylococci and Enterococci.	Adams V, 2002, CELL MOL LIFE SCI, V59, P2033, DOI 10.1007/s000180200003; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bender J, 2015, J ANTIMICROB CHEMOTH, V70, P1630, DOI 10.1093/jac/dkv025; Bonilla H, 2010, CLIN INFECT DIS, V51, P796, DOI 10.1086/656281; Brenciani A, 2016, J ANTIMICROB CHEMOTH, V71, P1118, DOI 10.1093/jac/dkv438; Cafini F, 2016, J ANTIMICROB CHEMOTH, V71, P587, DOI 10.1093/jac/dkv391; Cai J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.007; Chen HB, 2013, INT J ANTIMICROB AG, V42, P317, DOI 10.1016/j.ijantimicag.2013.06.008; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Deshpande LM, 2015, ANTIMICROB AGENTS CH, V59, P6256, DOI 10.1128/AAC.01473-15; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Dingle KE, 2014, GENOME BIOL EVOL, V6, P36, DOI 10.1093/gbe/evt204; Fiedler S, 2016, J ANTIMICROB CHEMOTH, V71, P871, DOI 10.1093/jac/dkv420; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; Gomez JAL, 2011, INT J MED MICROBIOL, V301, P165, DOI 10.1016/j.ijmm.2010.08.015; Hansen LH, 2015, ANTIMICROB AGENTS CH, V59, P5841, DOI 10.1128/AAC.01274-15; Huang YL, 2014, J THORAC DIS, V6, pE48, DOI 10.3978/j.issn.2072-1439.2014.02.13; Jasni AS, 2010, ANTIMICROB AGENTS CH, V54, P4924, DOI 10.1128/AAC.00496-10; Johanesen PA, 2015, GENES-BASEL, V6, P1347, DOI 10.3390/genes6041347; Johnson AP, 2002, EUR J CLIN MICROBIOL, V21, P751, DOI 10.1007/s10096-002-0807-0; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Klare I, 2015, J GLOB ANTIMICROB RE, V3, P128, DOI 10.1016/j.jgar.2015.02.007; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; LaMarre J, 2013, ANTIMICROB AGENTS CH, V57, P1173, DOI 10.1128/AAC.02047-12; Launay A, 2006, ANTIMICROB AGENTS CH, V50, P1054, DOI 10.1128/AAC.50.3.1054-1062.2006; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu Y, 2014, VET MICROBIOL, V170, P352, DOI 10.1016/j.vetmic.2014.02.037; Liu Y, 2014, J ANTIMICROB CHEMOTH, V69, P892, DOI 10.1093/jac/dkt459; Liu Y, 2013, ANTIMICROB AGENTS CH, V57, P42, DOI 10.1128/AAC.01605-12; Liu Y, 2012, ANTIMICROB AGENTS CH, V56, P1650, DOI 10.1128/AAC.06091-11; Livermore DM, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg249; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Long KS, 2012, ANTIMICROB AGENTS CH, V56, P603, DOI 10.1128/AAC.05702-11; Marin M, 2015, ANTIMICROB AGENTS CH, V59, P586, DOI 10.1128/AAC.04082-14; Mendes RE, 2016, J ANTIMICROB CHEMOTH, V71, P1860, DOI 10.1093/jac/dkw052; Mendes RE, 2010, J ANTIMICROB CHEMOTH, V65, P2329, DOI 10.1093/jac/dkq331; Penders J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00087; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; de Gopegui ER, 2012, ANTIMICROB AGENTS CH, V56, P2139, DOI 10.1128/AAC.06042-11; Seedat J, 2006, ANTIMICROB AGENTS CH, V50, P4217, DOI 10.1128/AAC.00518-06; Shen JZ, 2013, J ANTIMICROB CHEMOTH, V68, P1697, DOI 10.1093/jac/dkt092; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Wang Y, 2015, J ANTIMICROB CHEMOTH, V70, P2182, DOI 10.1093/jac/dkv116; Wasels F, 2014, MICROB DRUG RESIST, V20, P555, DOI 10.1089/mdr.2014.0015; Werner G, 2004, J CLIN MICROBIOL, V42, P5327, DOI 10.1128/JCM.42.11.5327-5331.2004; Werner G, 2011, J ANTIMICROB CHEMOTH, V66, P273, DOI 10.1093/jac/dkq455	47	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167042	10.1371/journal.pone.0167042	http://dx.doi.org/10.1371/journal.pone.0167042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893790	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400073
J	Chang, MC; Tsai, YL; Liou, EJW; Tang, CM; Wang, TM; Liu, HC; Liao, MW; Yeung, SY; Chan, CP; Jeng, JH				Chang, Mei-Chi; Tsai, Yi-Ling; Liou, Eric Jein-Wein; Tang, Chia-Mei; Wang, Tong-Mei; Liu, Hsin-Cheng; Liao, Ming-Wei; Yeung, Sin-Yuet; Chan, Chiu-Po; Jeng, Jiiang-Huei			Effect of Butyrate on Collagen Expression, Cell Viability, Cell Cycle Progression and Related Proteins Expression of MG-63 Osteoblastic Cells	PLOS ONE			English	Article							CARBOXYLIC-ACID CONCENTRATION; HUMAN GINGIVAL FIBROBLASTS; DENTAL-PULP CELLS; SODIUM-BUTYRATE; CANCER-CELLS; PERIODONTAL-DISEASES; ORAL KERATINOCYTES; CREVICULAR FLUID; DNA-DAMAGE; APOPTOSIS	Aims Butyric acid is one major metabolic product generated by anaerobic Gram-negative bacteria of periodontal and root canal infection. Butyric acid affects the activity of periodontal cells such as osteoblasts. The purposes of this study were to investigate the effects of butyrate on MG-63 osteoblasts. Methods MG-63 cells were exposed to butyrate and cell viability was estimated by 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The mRNA and protein expression of type I collagen and cell cycle-related proteins were measured by reverse-transcriptase polymerase chain reaction (RT-PCR), western blotting or immunofluorescent staining. Cellular production of reactive oxygen species (ROS) was analyzed by 2', 7'-dichlorofluorescein (DCF) fluorescence flow cytometry. Results Exposure to butyrate suppressed cell proliferation, and induced G2/M (8 and 16 mM) cell cycle arrest of MG-63 cells. Some cell apoptosis was noted. The mRNA expression of cdc2 and cyclin-B1 decreased after exposure to butyrate. The protein expression of type I collagen, cdc2 and cyclin B1 were decreased, whereas the expression of p21, p27 and p57 was stimulated. Under the treatment of butyrate, ROS production in MG-63 cells markedly increased. Conclusions The secretion of butyric acid by periodontal and root canal microorganisms may inhibit bone cell growth and matrix turnover. This is possibly due to induction of cell cycle arrest and ROS generation and inhibition of collagen expression. These results suggest the involvement of butyric acid in the pathogenesis of periodontal and periapical tissue destruction by impairing bone healing responses.	[Chang, Mei-Chi] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Chang, Mei-Chi; Liou, Eric Jein-Wein; Yeung, Sin-Yuet; Chan, Chiu-Po] Chang Gung Mem Hosp, Dept Dent, Taipei, Taiwan; [Tsai, Yi-Ling; Tang, Chia-Mei; Wang, Tong-Mei; Liao, Ming-Wei; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Grad Inst Clin Dent, Taipei, Taiwan; [Tsai, Yi-Ling; Tang, Chia-Mei; Wang, Tong-Mei; Liao, Ming-Wei; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Tsai, Yi-Ling; Tang, Chia-Mei; Wang, Tong-Mei; Liao, Ming-Wei; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Liu, Hsin-Cheng] Wei Cheng Int Dent Grp, Taipei, Taiwan	Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chan, CP (corresponding author), Chang Gung Mem Hosp, Dept Dent, Taipei, Taiwan.; Jeng, JH (corresponding author), Natl Taiwan Univ Hosp, Grad Inst Clin Dent, Taipei, Taiwan.; Jeng, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan.; Jeng, JH (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	carol@adm.cgmh.org.tw; jhjeng@ntu.edu.tw			Chang Gung Memorial Hospital [CMRPF1F0071, CMRPF3E0021, CMRPF3E0022, NMRPF3E0041, NMRPF3E0042, NM RPF3C0091, NMRPF3C0092, NMRPF3C0093, NMRPF3C0061, NMRPF3C0062]; Ministry of Science and Technology, Taipei, Taiwan [MOST104-2314-B-255-010-MY3, NSC102-2628-B-255-001-MY3, NSC102-2314-B-255-003-MY2]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taipei, Taiwan	This study was supported by grants from Chang Gung Memorial Hospital (CMRPF1F0071, CMRPF3E0021, CMRPF3E0022, CMRPF1F0071, NMRPF3E0041, NMRPF3E0042, NM RPF3C0091, NMRPF3C0092, NMRPF3C0093, NMRPF3C0061, NMRPF3C0062) and Ministry of Science and Technology (MOST104-2314-B-255-010-MY3; NSC102-2628-B-255-001-MY3; NSC102-2314-B-255-003-MY2), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by grants from Chang Gung Memorial Hospital (CMRPF1F0071, CMRPF3E0021, CMRPF3E0022, CMRPF1F0071, NMRPF3E0041, NMRPF3E0042, NMRPF3C0091, NMRPF3C0092, NMRPF3C0093, NMRPF3C0061, NMRPF3C0062) and Ministry of Science and Technology (MOST104-2314-B-255-010-MY3; NSC102-2628-B-255-001-MY3; NSC102-2314-B-255-003-MY2), Taipei, Taiwan. The authors declare no conflict of interest for this paper.	Ansteinsson V, 2011, MUTAT RES-GEN TOX EN, V723, P158, DOI 10.1016/j.mrgentox.2011.04.011; Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Battino M, 1999, CRIT REV ORAL BIOL M, V10, P458, DOI 10.1177/10454411990100040301; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Chang MC, 2013, J PERIODONTAL RES, V48, P66, DOI 10.1111/j.1600-0765.2012.01504.x; Chang MC, 2004, J BIOL CHEM, V279, P50676, DOI 10.1074/jbc.M404465200; Chang MC, 2016, ONCOTARGETS, V7; Chang MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143663; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Galli C, 2011, J PERIODONTAL RES, V46, P397, DOI 10.1111/j.1600-0765.2011.01354.x; Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502; Iida T, 2011, ARCH ORAL BIOL, V56, P678, DOI 10.1016/j.archoralbio.2010.12.013; Jeng JH, 1999, J PERIODONTOL, V70, P1435, DOI 10.1902/jop.1999.70.12.1435; Jeng JH, 2000, CARCINOGENESIS, V21, P1365, DOI 10.1093/carcin/21.7.1365; Jeng JH, 2006, TOXICOLOGY, V223, P235, DOI 10.1016/j.tox.2006.04.033; Katono T, 2008, ARCH ORAL BIOL, V53, P903, DOI 10.1016/j.archoralbio.2008.02.016; Kurita-Ochiai T, 2008, J DENT RES, V87, P51, DOI 10.1177/154405910808700108; KURITAOCHIAI T, 1995, J DENT RES, V74, P1367, DOI 10.1177/00220345950740070801; Le Breton M, 2005, BIOCHIMIE, V87, P805, DOI 10.1016/j.biochi.2005.04.014; Lee PH, 2006, TOXICOLOGY, V220, P81, DOI 10.1016/j.tox.2005.07.026; Morozumi Akira, 2011, J Oral Sci, V53, P509; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269, DOI 10.1177/10454411970080030301; Niederman R, 1996, J CLIN PERIODONTOL, V23, P743, DOI 10.1111/j.1600-051X.1996.tb00604.x; Niederman R, 1997, J DENT RES, V76, P575, DOI 10.1177/00220345970760010801; Nishihara T, 2004, PERIODONTOL 2000, V36, P14, DOI 10.1111/j.1600-0757.2004.03671.x; OConnor PM, 1997, CANCER SURV, V29, P151; Pollanen MT, 1997, J PERIODONTAL RES, V32, P326, DOI 10.1111/j.1600-0765.1997.tb00541.x; Rossi MN, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/259325; Saita M, 2016, BIOMATERIALS, V76, P292, DOI 10.1016/j.biomaterials.2015.10.077; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Szemes T, 2010, REDOX REP, V15, P202, DOI 10.1179/135100010X12826446921581; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Thomas LV, 2007, BRAZ DENT J, V18, P267; Tury A, 2012, DEV NEUROBIOL, V72, P821, DOI 10.1002/dneu.20999; Uematsu H, 2003, ARCH ORAL BIOL, V48, P423, DOI 10.1016/S0003-9969(03)00031-1; Waddington RJ, 2000, ORAL DIS, V6, P138; Wakabayashi K, 2005, INT J ONCOL, V26, P233; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	41	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165438	10.1371/journal.pone.0165438	http://dx.doi.org/10.1371/journal.pone.0165438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893752	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400007
J	Alonso, S; dos Santos, RW; Bar, M				Alonso, Sergio; dos Santos, Rodrigo Weber; Baer, Markus			Reentry and Ectopic Pacemakers Emerge in a Three-Dimensional Model for a Slab of Cardiac Tissue with Diffuse Microfibrosis near the Percolation Threshold	PLOS ONE			English	Article							POSTERIOR LEFT ATRIUM; SPIRAL BREAKUP; IMPULSE PROPAGATION; CONDUCTION BLOCK; SLOW CONDUCTION; HUMAN HEART; FIBRILLATION; MECHANISMS; EXCITATION; ABLATION	Arrhythmias in cardiac tissue are generally associated with irregular electrical wave propagation in the heart. Cardiac tissue is formed by a discrete cell network, which is often heterogeneous. Recently, it was shown in simulations of two-dimensional (2D) discrete models of cardiac tissue that a wave crossing a fibrotic, heterogeneous region may produce reentry and transient or persistent ectopic activity provided the fraction of conducting connections is just above the percolation threshold. Here, we investigate the occurrence of these phenomena in three-dimensions by simulations of a discrete model representing a thin slab of cardiac tissue. This is motivated (i) by the necessity to study the relevance and properties of the percolation-related mechanism for the emergence of microreentries in three dimensions and (ii) by the fact that atrial tissue is quite thin in comparison with ventricular tissue. Here, we simplify the model by neglecting details of tissue anatomy, e. g. geometries of atria or ventricles and the anisotropy in the conductivity. Hence, our modeling study is confined to the investigation of the effect of the tissue thickness as well as to the comparison of the dynamics of electrical excitation in a 2D layer with the one in a 3D slab. Our results indicate a strong and non-trivial effect of the thickness even for thin tissue slabs on the probability of microreentries and ectopic beat generation. The strong correlation of the occurrence of microreentry with the percolation threshold reported earlier in 2D layers persists in 3D slabs. Finally, a qualitative agreement of 3D simulated electrograms in the fibrotic region with the experimentally observed complex fractional atrial electrograms (CFAE) as well as strong difference between simulated electrograms in 2D and 3D were found for the cases where reentry and ectopic activity were triggered by the micro-fibrotic region.	[Alonso, Sergio] Univ Politecn Cataluna, Dept Phys, Barcelona, Spain; [Alonso, Sergio; Baer, Markus] Phys Tech Bundesanstalt, Berlin, Germany; [Alonso, Sergio; Baer, Markus] Phys Tech Bundesanstalt, Braunschweig, Germany; [dos Santos, Rodrigo Weber] Univ Fed Juiz de Fora, Grad Program Computat Modeling, Juiz De Fora, Brazil	Universitat Politecnica de Catalunya; Physikalisch-Technische Bundesanstalt (PTB); Physikalisch-Technische Bundesanstalt (PTB); Universidade Federal de Juiz de Fora	Alonso, S (corresponding author), Univ Politecn Cataluna, Dept Phys, Barcelona, Spain.; Alonso, S (corresponding author), Phys Tech Bundesanstalt, Berlin, Germany.; Alonso, S (corresponding author), Phys Tech Bundesanstalt, Braunschweig, Germany.	s.alonso@upc.edu	Alonso, Sergio/GVR-8346-2022; Alonso, Sergio/L-6177-2014; dos Santos, Rodrigo Weber/E-6494-2015	Alonso, Sergio/0000-0002-3989-8757; dos Santos, Rodrigo Weber/0000-0002-0633-1391	German Science Foundation (DFG) [SFB 910]; CAPES of the Brazilian program Science without borders [88881.065002/2014-01]; MINECO of Spain under the Ramon y Cajal program [RYC-2012-11265]; Brazilian institute: CNPq; Brazilian institute: FAPEMIG; Brazilian institute: FINEP	German Science Foundation (DFG)(German Research Foundation (DFG)); CAPES of the Brazilian program Science without borders(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MINECO of Spain under the Ramon y Cajal program; Brazilian institute: CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian institute: FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian institute: FINEP	We acknowledge financial support from the German Science Foundation (DFG) within the framework of SFB 910 Control of self-organizing nonlinear systems; from CAPES by the grant 88881.065002/2014-01 of the Brazilian program Science without borders; from MINECO of Spain under the Ramon y Cajal program with the grant number RYC-2012-11265; and from the Brazilian institutes: CNPq, FAPEMIG and FINEP.	Alonso S, 2016, J PHYS CONF SER, V727, DOI 10.1088/1742-6596/727/1/012002; Alonso S, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/9/096601; Alonso S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.158101; Alonso S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.238302; Angel N, 2015, J CARDIOVASC ELECTR, V26, P1352, DOI 10.1111/jce.12773; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; BAR M, 1993, PHYS REV E, V48, pR1635; Brown TR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/465714; Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; Campos FO, 2013, IEEE T BIO-MED ENG, V60, P2339, DOI 10.1109/TBME.2013.2256359; Campos FO, 2012, MED BIOL ENG COMPUT, V50, P461, DOI 10.1007/s11517-012-0880-1; Casaleggio A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100288; Chen J., 2014, IJC HEART VESSELS, V4, P63, DOI DOI 10.1016/J.IJCHV.2014.06.013; Cherry EM, 2007, HEART RHYTHM, V4, P1553, DOI 10.1016/j.hrthm.2007.08.017; Christensen K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028104; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Costa CM, 2014, IEEE T BIO-MED ENG, V61, P900, DOI 10.1109/TBME.2013.2292320; de Barros BG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/713058; de Sa DDC, 2011, CIRC-ARRHYTHMIA ELEC, V4, P909, DOI 10.1161/CIRCEP.111.965145; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Dobrev D, 2003, BASIC RES CARDIOL, V98, P137, DOI 10.1007/s00395-003-0409-8; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; Eckstein J, 2011, CARDIOVASC RES, V89, P816, DOI 10.1093/cvr/cvq336; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Fenton F, 1998, PHYS REV LETT, V81, P481, DOI 10.1103/PhysRevLett.81.481; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gaztanaga L, 2012, REV ESP CARDIOL, V65, P174, DOI [10.1016/j.recesp.2011.09.018, 10.1016/j.rec.2011.09.020]; Haissaguerre M, 2016, J PHYSIOL-LONDON, V594, P2387, DOI 10.1113/JP270617; Hansen BJ, 2015, EUR HEART J, V36, P2390, DOI 10.1093/eurheartj/ehv233; Hubbard ML, 2014, AM J PHYSIOL-HEART C, V306, pH1341, DOI 10.1152/ajpheart.00385.2013; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jacquemet V, 2008, AM J PHYSIOL-HEART C, V294, pH2040, DOI 10.1152/ajpheart.01298.2007; Jacquemet V, 2009, HEART RHYTHM, V6, P803, DOI 10.1016/j.hrthm.2009.02.026; Kalifa JM, 2006, CIRCULATION, V113, P626, DOI 10.1161/CIRCULATIONAHA.105.575340; KAPLAN DT, 1988, MATH BIOSCI, V90, P19, DOI 10.1016/0025-5564(88)90056-9; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Kazbanov IV, 2016, SCI REP-UK, V6, DOI 10.1038/srep20835; Keener J P, 1998, MATH PHYSL, V1; Kim AM, 2009, HEART RHYTHM, V6, P811, DOI 10.1016/j.hrthm.2009.03.006; Krueger MW, 2014, J ELECTROCARDIOL, V47, P324, DOI 10.1016/j.jelectrocard.2013.11.003; Kumagai K, 2013, J CARDIOVASC ELECTR, V24, P975, DOI 10.1111/jce.12166; Magnani S, 2015, J THORAC DIS, V7, P178, DOI 10.3978/j.issn.2072-1439.2015.01.25; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Nademanee K, 2010, J CARDIOL, V55, P1, DOI 10.1016/j.jjcc.2009.11.002; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Oliveira RS, 2016, LECT N BIOINFORMAT, V9656, P346, DOI 10.1007/978-3-319-31744-1_31; PANFILOV A, 1993, PHYS LETT A, V176, P295, DOI 10.1016/0375-9601(93)90921-L; Panfilov AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118101; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Podziemski P, 2013, J CLIN MONIT COMPUT, V27, P481, DOI 10.1007/s10877-013-9429-6; Prudat Y, 2014, J MOL CELL CARDIOL, V76, P46, DOI 10.1016/j.yjmcc.2014.07.019; Pumir A, 2005, BIOPHYS J, V89, P2332, DOI 10.1529/biophysj.105.061820; Qu ZL, 2006, BIOPHYS J, V91, P793, DOI 10.1529/biophysj.106.080945; Rohr S, 1998, CIRC RES, V83, P781, DOI 10.1161/01.RES.83.8.781; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Ryu K, 2005, J CARDIOVASC ELECTR, V16, P1348, DOI 10.1111/j.1540-8167.2005.00266.x; Smaill BH, 2013, CIRC RES, V112, P834, DOI 10.1161/CIRCRESAHA.111.300157; Smith J, 1984, COMPUTERS CARDIOLOGY, V11; Spach MS, 2007, HEART RHYTHM, V4, P175, DOI 10.1016/j.hrthm.2006.10.023; SPACH MS, 1988, CIRC RES, V62, P811, DOI 10.1161/01.RES.62.4.811; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Ten Tusscher KHWJ, 2007, EUROPACE, V9, P38, DOI 10.1093/europace/eum206; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; Torquato S, 2002, RANDOM HETEROGENEOUS, DOI [10.1115/1.1483342, DOI 10.1115/1.1483342]; Vigmond E, 2016, HEART RHYTHM, V13, P1536, DOI 10.1016/j.hrthm.2016.03.019; Xie YF, 2009, HEART RHYTHM, V6, P1641, DOI 10.1016/j.hrthm.2009.08.003; Zahid S, 2016, CARDIOVASC RES, V110, P443, DOI 10.1093/cvr/cvw073; Zimik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144979	72	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166972	10.1371/journal.pone.0166972	http://dx.doi.org/10.1371/journal.pone.0166972			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875591	gold, Green Submitted, Green Published			2022-12-26	WOS:000388886000041
J	Xiang, Y; Wang, DW; Li, JY; Xie, H; Xu, CL; Li, Y				Xiang, Yu; Wang, Dong-Wei; Li, Jun-Yi; Xie, Hui; Xu, Chun-Ling; Li, Yu			Transcriptome Analysis of the Chrysanthemum Foliar Nematode, Aphelenchoides ritzemabosi (Aphelenchida: Aphelenchoididae)	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ROOT-LESION NEMATODE; PLANT PARASITISM; FUNCTIONAL GENOMICS; LIFE; TOOL; IDENTIFICATION; CELLULASES; EVOLUTION; RNAI	The chrysanthemum foliar nematode (CFN), Aphelenchoides ritzemabosi, is a plant parasitic nematode that attacks many plants. In this study, a transcriptomes of mixed-stage population of CFN was sequenced on the Illumina HiSeq 2000 platform. 68.10 million Illumina high quality paired end reads were obtained which generated 26,817 transcripts with a mean length of 1,032 bp and an N50 of 1,672 bp, of which 16,467 transcripts were annotated against six databases. In total, 20,311 coding region sequences (CDS), 495 simple sequence repeats (SSRs) and 8,353 single-nucleotide polymorphisms (SNPs) were predicted, respectively. The CFN with the most shared sequences was B. xylophilus with 16,846 (62.82%) common transcripts and 10,543 (39.31%) CFN transcripts matched sequences of all of four plant parasitic nematodes compared. A total of 111 CFN transcripts were predicted as homologues of 7 types of carbohydrate-active enzymes (CAZymes) with plant/fungal cell wall-degrading activities, fewer transcripts were predicted as homologues of plant cell wall-degrading enzymes than fungal cell wall-degrading enzymes. The phylogenetic analysis of GH5, GH16, GH43 and GH45 proteins between CFN and other organisms showed CFN and other nematodes have a closer phylogenetic relationship. In the CFN transcriptome, sixteen types of genes orthologues with seven classes of protein families involved in the RNAi pathway in C. elegans were predicted. This research provides comprehensive gene expression information at the transcriptional level, which will facilitate the elucidation of the molecular mechanisms of CFN and the distribution of gene functions at the macro level, potentially revealing improved methods for controlling CFN.	[Xie, Hui] South China Agr Univ, Coll Agr, Dept Plant Pathol, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China; South China Agr Univ, Coll Agr, Dept Plant Pathol, Res Ctr Nematodes Plant Quarantine, Guangzhou, Guangdong, Peoples R China; [Li, Yu] South China Agr Univ, Coll Agr, Dept Plant Pathol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; South China Agricultural University	Xie, H (corresponding author), South China Agr Univ, Coll Agr, Dept Plant Pathol, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China.	xiehui@scau.edu.cn	Wang, Dongwei/M-7768-2017	Wang, Dongwei/0000-0001-5226-4241	National Natural Science Foundation of China [31371920, 30871629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 31371920 and 30871629). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Basu T, 2014, NANOSCALE RES LETT, V9, DOI [10.1186/1556-276X-9-345, 10.1186/1556-276X-9-192]; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Chen XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059314; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Crozzoli R., 2008, Nematologia Mediterranea, V36, P79; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Eves-van den Akker S, 2014, GENOME BIOL EVOL, V6, P2181, DOI 10.1093/gbe/evu171; Fernando T, 2011, DEV BIOL, V352, P92, DOI 10.1016/j.ydbio.2011.01.016; Fu Z, 2012, PHYTOPATHOLOGY, V102, P804, DOI 10.1094/PHYTO-12-11-0336; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grabherr MG, 2011, METHODS MOL BIOL, V722, P1, DOI 10.1007/978-1-61779-040-9_1; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; HOOPER DJ, 1986, PLANT PATHOL, V35, P128, DOI 10.1111/j.1365-3059.1986.tb01992.x; Hunt DJ, 1993, APHELENCHIDA LONGIDO; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacob J, 2008, MOL GENET GENOMICS, V280, P1, DOI 10.1007/s00438-008-0340-7; Jones JT, 2005, NEMATOLOGY, V7, P641, DOI 10.1163/156854105775142919; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2014, NEMATOLOGY, V16, P99, DOI 10.1163/15685411-00002748; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu ZY, 2014, BBA-MOL CELL RES, V1843, P299, DOI 10.1016/j.bbamcr.2013.11.001; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Ohman EM, 2005, J THROMB THROMBOLYS, V19, P11, DOI 10.1007/s11239-005-0850-7; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; [彭晓放 Peng Xiaofang], 2015, [华中农业大学学报, Journal of Huazhong Agricultural University], V34, P048; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Siddiqi MR, 1974, CIH DESCRIPTIONS PLA; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Szakasits D, 2009, PLANT J, V57, P771, DOI 10.1111/j.1365-313X.2008.03727.x; Wang F. Q., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1080/10042857.2014.886802; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Xie H, 2005, TAXONOMY PLANT NEMAT, P286; Xie H., 2007, PLANT QUARANTINE, V21, P190; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	44	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166877	10.1371/journal.pone.0166877	http://dx.doi.org/10.1371/journal.pone.0166877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875578	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000033
J	Lin, G; Chua, E; Orban, L; Yue, GH				Lin, Grace; Chua, Elaine; Orban, Laszlo; Yue, Gen Hua			Mapping QTL for Sex and Growth Traits in Salt-Tolerant Tilapia (Oreochromis spp. X O. mossambicus)	PLOS ONE			English	Article							LINKAGE MAP; QUANTITATIVE TRAITS; GENETIC-IMPROVEMENT; MENDELIAN FACTORS; COMPLEX TRAITS; GENOME; LOCI; NILOTICUS; FISH; RESOLUTION	In aquaculture, growth and sex are economically important traits. To accelerate genetic improvement in increasing growth in salt-tolerant tilapia, we conducted QTL mapping for growth traits and sex with an F-2 family, including 522 offspring and two parents. We used 144 polymorphic microsatellites evenly covering the genome of tilapia to genotype the family. QTL analyses were carried out using interval mapping for all individuals, males and females in the family, respectively. Using all individuals, three suggestive QTL for body weight, body length and body thickness respectively were detected in LG20, LG22 and LG12 and explained 2.4% to 3.1% of phenotypic variance (PV). When considering only males, five QTL for body weight were detected on five LGs, and explained 4.1 to 6.3% of PV. Using only females from the F-2 family, three QTL for body weight were detected on LG1, LG6 and LG8, and explained 7.9-14.3% of PV. The QTL for body weight in males and females were located in different LGs, suggesting that in salt-tolerant tilapia, different set of genes 'switches' control the growth in males and females. QTL for sex were mapped on LG1 and LG22, indicating multigene sex determination in the salt-tolerant tilapia. This study provides new insights on the locations and effects of QTL for growth traits and sex, and sets the foundation for fine mapping for future marker-assisted selection for growth and sex in salt-tolerant tilapia aquaculture.	[Lin, Grace; Chua, Elaine; Orban, Laszlo; Yue, Gen Hua] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Lin, Grace; Yue, Gen Hua] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Orban, Laszlo] Univ Pannonia, Dept Anim Sci & Breeding, Georgikon Fac, Deak Ferenc Utca 16, H-8230 Keszthely, Hungary; [Orban, Laszlo] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia; [Yue, Gen Hua] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Pannonia; Murdoch University; National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.; Yue, GH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.; Yue, GH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015; Orbán, László/A-3030-2009	Yue, GH/0000-0002-3537-2248; Orbán, László/0000-0001-5435-5948	National Research Foundation, Singapore [NRFCRP7-2010-01]	National Research Foundation, Singapore(National Research Foundation, Singapore)	This research is supported by the National Research Foundation, Singapore under CRP Award No. NRFCRP7-2010-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranski M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-17; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; CHURCHILL GA, 1994, GENETICS, V138, P963; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Cnaani A, 2003, AQUACULTURE, V223, P117, DOI 10.1016/S0044-8486(03)00163-7; Cui Y, 2015, MAR BIOTECHNOL, V17, P693, DOI 10.1007/s10126-015-9646-8; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; EKNATH AE, 1993, AQUACULTURE, V111, P171, DOI 10.1016/0044-8486(93)90035-W; ElSayed AFM, 2006, TILAPIA CULTURE, P1, DOI 10.1079/9780851990149.0000; Eshel O, 2012, G3-GENES GENOM GENET, V2, P35, DOI 10.1534/g3.111.001545; Eshel O, 2011, ANIM GENET, V42, P222, DOI 10.1111/j.1365-2052.2010.02128.x; FAO, 2011, STAT WORLD FISH AQ O; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Guyon R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-222; Hamzah Azhar, 2014, Pertanika Journal of Tropical Agricultural Science, V37, P411; Head William D., 1994, Journal of the World Aquaculture Society, V25, P432, DOI 10.1111/j.1749-7345.1994.tb00227.x; Hena A, 2005, AQUACULTURE, V247, P189, DOI 10.1016/j.aquaculture.2005.02.008; Hulata G., 1995, Aquaculture Research, V26, P765, DOI 10.1111/j.1365-2109.1995.tb00869.x; Hutson AM, 2014, J ANIM SCI, V92, P1850, DOI 10.2527/jas.2013-7191; JANSEN RC, 1993, GENETICS, V135, P205; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Kobayashi M, 2015, AQUACULT ECON MANAG, V19, P282, DOI 10.1080/13657305.2015.994240; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Li HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017573; Lind CE, 2015, AQUACULT REP, V1, P20, DOI 10.1016/j.aqrep.2015.03.003; Liu F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07256; Liu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-58; Miller CT, 2014, GENETICS, V197, P405, DOI 10.1534/genetics.114.162420; Nguyen NH, 2016, FISH FISH, V17, P483, DOI 10.1111/faf.12122; Palaiokostas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068389; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Ponzoni RW, 2011, REV AQUACULT, V3, P27, DOI 10.1111/j.1753-5131.2010.01041.x; Reinecke M, 2010, J FISH BIOL, V76, P1233, DOI 10.1111/j.1095-8649.2010.02605.x; Rengmark AH, 2007, J FISH BIOL, V71, P409, DOI 10.1111/j.1095-8649.2007.01664.x; Romana-Eguia MRR, 1999, AQUACULTURE, V173, P161, DOI 10.1016/S0044-8486(98)00484-0; Rutten MJM, 2005, AQUACULTURE, V246, P125, DOI 10.1016/j.aquaculture.2005.01.006; Sandeep M, 2012, J GENET, V91, P97; Shirak A, 2006, GENETICS, V174, P1573, DOI 10.1534/genetics.106.059030; Sneller CH, 2009, CROP SCI, V49, P363, DOI 10.2135/cropsci2008.07.0420; van Bers NEM, 2012, MOL ECOL RESOUR, V12, P932, DOI 10.1111/j.1755-0998.2012.03144.x; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; VANOOIJEN JW, 2004, MAPQTL 5 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16358; Watanabe W, 1989, AQUACULTURE RED TILA; Xia JH, 2014, AQUACULTURE, V432, P67, DOI 10.1016/j.aquaculture.2014.04.028; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH., 2016, INT J MARINE SCI OCE, V3, P11, DOI [10.1907/2577-4395-160003, DOI 10.19070/2577-4395-160003]	55	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166723	10.1371/journal.pone.0166723	http://dx.doi.org/10.1371/journal.pone.0166723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870905	Green Published, gold			2022-12-26	WOS:000388846400022
J	Nelson, ED; Grishin, NV				Nelson, Erik D.; Grishin, Nick V.			Long-Range Epistasis Mediated by Structural Change in a Model of Ligand Binding Proteins	PLOS ONE			English	Article							DNA-BACTERIOPHAGE PHI-X174; PACKING DENSITY; EVOLUTION; POTENTIALS; MUTATIONS; DOMAINS	Recent analyses of amino acid mutations in proteins reveal that mutations at many pairs of sites are epistatic-i.e., their effects on fitness are non-additive-the combined effect of two mutations being significantly larger or smaller than the sum of their effects considered independently. Interestingly, epistatic sites are not necessarily near each other in the folded structure of a protein, and may even be located on opposite sides of a molecule. However, the mechanistic reasons for long-range epistasis remain obscure. Here, we study long-range epistasis in proteins using a previously developed model in which off-lattice polymers are evolved under ligand binding constraints. Epistatic effects in the model are qualitatively similar to those recently reported for small proteins, and many are long-range. We find that a major reason for long-range epistasis is conformational change-a recurrent theme in both positive and negative epistasis being the transfer, or exchange of material between the ordered nucleus, which supports the binding site, and the liquid-like surface of a folded molecule. These local transitions in phase and folded structure are largely responsible for long-range epistasis in our model.	[Nelson, Erik D.; Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Room ND10-124, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nelson, ED (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Room ND10-124, Dallas, TX 75390 USA.	nelsonerikd@gmail.com			National Institutes of Health [GM094575]; Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenberg O, 2013, P NATL ACAD SCI USA, V110, P21071, DOI 10.1073/pnas.1314781111; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Betancourt MR, 1999, PROTEIN SCI, V8, P361; Breen MS, 2013, NATURE, V497, pE2, DOI 10.1038/nature12220; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Dayhoff M. O., 1972, ATLAS PROTEIN SEQUEN, P345; England JL, 2011, STRUCTURE, V19, P967, DOI 10.1016/j.str.2011.04.009; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Golding GB, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001162, DOI 10.1371/JOURNAL.PGEN.1001162]; Hormoz S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02919; Huang TT, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-78; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jack BR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002452; Lin MM, 2012, P NATL ACAD SCI USA, V109, P9851, DOI 10.1073/pnas.1207382109; McCandlish DM, 2013, NATURE, V497, pE1, DOI 10.1038/nature12219; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Nelson ED, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.022410; Olson CA, 2014, CURR BIOL, V24, P2643, DOI 10.1016/j.cub.2014.09.072; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pollock DD, 2014, P NATL ACAD SCI USA, V111, pE1450, DOI 10.1073/pnas.1401112111; Pollock DD, 2012, P NATL ACAD SCI USA, V109, pE1352, DOI 10.1073/pnas.1120084109; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Poon AFY, 2006, EVOLUTION, V60, P2032, DOI 10.1111/j.0014-3820.2006.tb01841.x; Ramsey DC, 2011, GENETICS, V188, P479, DOI 10.1534/genetics.111.128025; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Starr TN, 2016, PROTEIN SCI, V25, P1204, DOI 10.1002/pro.2897; Tegamark M., 1996, ASTROPHYS J LETT, V470, pL81; VANGUNSTEREN WF, 1982, MOL PHYS, V45, P637, DOI 10.1080/00268978200100491; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166739	10.1371/journal.pone.0166739	http://dx.doi.org/10.1371/journal.pone.0166739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870911	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400024
J	Yao, YS; Han, P; Niu, CY; Dong, YC; Gao, XW; Cui, JJ; Desneux, N				Yao, Yong-Sheng; Han, Peng; Niu, Chang-Ying; Dong, Yong-Cheng; Gao, Xi-Wu; Cui, Jin-Jie; Desneux, Nicolas			Transgenic Bt Cotton Does Not Disrupt the Top-Down Forces Regulating the Cotton Aphid in Central China	PLOS ONE			English	Article							BOTTOM-UP FORCES; NATURAL ENEMIES; SOYBEAN APHID; POPULATION-DYNAMICS; PROPYLAEA-JAPONICA; INSECT HERBIVORES; GOSSYPII GLOVER; PEST-MANAGEMENT; NONTARGET RISK; CROPS	Top-down force is referred to arthropod pest management delivered by the organisms from higher trophic levels. In the context of prevalent adoption of transgenic Bt crops that produce insecticidal Cry proteins derived from Bacillus thuringiensis (Bt), it still remains elusive whether the top-down forces are affected by the insect-resistant traits that introduced into the Bt crops. We explored how Bt cotton affect the strength of top-down forces via arthropod natural enemies in regulating a non-target pest species, the cotton aphid Aphis gossypii Glover, using a comparative approach (i.e. Bt cotton vs. conventional cotton) under field conditions. To determine top-down forces, we manipulated predation/parasitism exposure of the aphid to their natural enemies using exclusion cages. We found that the aphid population growth was strongly suppressed by the dominant natural enemies including Coccinellids, spiders and Aphidiines parasitoids. Coccinellids, spiders and the assemblage of other arthropod natural enemies (mainly lacewings and Hemipteran bugs) are similarly abundant in both plots, but with the parasitoid mummies less abundant in Bt cotton plots compared to the conventional cotton plots. However, the lower abundance of parasitoids in Bt cotton plots alone did not translate into differential top-down control on A. gossypii populations compared to conventional ones. Overall, the top-down forces were equally strong in both plots. We conclude that transgenic Bt cotton does not disrupt the top-down forces regulating the cotton aphid in central China.	[Yao, Yong-Sheng; Gao, Xi-Wu] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Yao, Yong-Sheng] Tarim Univ, Coll Plant Sci, Alar, Peoples R China; [Han, Peng; Niu, Chang-Ying; Dong, Yong-Cheng] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Han, Peng; Desneux, Nicolas] Univ Nice Sophia Antipolis, INRA French Natl Inst Agr Res, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, Sophia Antipolis, France; [Cui, Jin-Jie] Inst Cotton Res CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China	China Agricultural University; Tarim University; Huazhong Agricultural University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.; Han, P (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.; Han, P (corresponding author), Univ Nice Sophia Antipolis, INRA French Natl Inst Agr Res, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, Sophia Antipolis, France.	penghan1394@gmail.com; gaoxiwu@263.net.cn	Desneux, Nicolas/J-6262-2013; Han, Peng/Y-4457-2019; Dong, YongCheng/ABG-7107-2021	Han, Peng/0000-0002-5941-9362	FP7-People-IRSES "APHIWEB" [611810]; National Natural Science Foundation of China [31330064]; State Key Laboratory of Cotton Biology Open Fund of China [CB2016A09]	FP7-People-IRSES "APHIWEB"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cotton Biology Open Fund of China	This work was supported by FP7-People-IRSES "APHIWEB" (611810), National Natural Science Foundation of China (31330064), and State Key Laboratory of Cotton Biology Open Fund of China (CB2016A09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2014, ENTOMOL GEN, V35, P129, DOI 10.1127/0171-8177/2014/0045; Moraes MCB, 2011, TRANSGENIC RES, V20, P99, DOI 10.1007/s11248-010-9399-0; BOULTER D, 1989, BIOTECHNOL ADV, V7, P489, DOI 10.1016/0734-9750(89)90720-9; Brookes G., 2006, AgBioForum, V9, P139; Chacon JM, 2010, OECOLOGIA, V164, P213, DOI 10.1007/s00442-010-1611-7; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Chen YG, 2010, ARTHROPOD-PLANT INTE, V4, P81, DOI 10.1007/s11829-010-9092-5; Choudhary JS, 2015, ENTOMOL GEN, V35, P187, DOI 10.1127/entomologia/2015/0061; COHEN AC, 1995, ANNU REV ENTOMOL, V40, P85, DOI 10.1146/annurev.en.40.010195.000505; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cornelissen T, 2009, ECOGRAPHY, V32, P459, DOI 10.1111/j.1600-0587.2008.05590.x; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Cui JJ, 2004, GUIDEBOOK IDENTIFICA; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Denno RF, 2003, ECOLOGY, V84, P1032, DOI 10.1890/0012-9658(2003)084[1032:PRARSO]2.0.CO;2; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Duan JJ, 2010, BIOL LETTERS, V6, P74, DOI 10.1098/rsbl.2009.0612; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Hagenbucher S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0042; Han P, 2016, J PEST SCI, V89, P859, DOI 10.1007/s10340-016-0791-2; Han P, 2015, ECOL EVOL, V5, P5468, DOI 10.1002/ece3.1788; Han P, 2015, J PEST SCI, V88, P685, DOI 10.1007/s10340-015-0662-2; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Karley AJ, 2003, B ENTOMOL RES, V93, P425, DOI 10.1079/BER2003252; Kumar L., 2013, RES J AGR FORESTRY S, V1, P27; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Liu J, 2004, ANN ENTOMOL SOC AM, V97, P235, DOI 10.1603/0013-8746(2004)097[0235:PDOAGH]2.0.CO;2; Liu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15295; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lundgren JG, 2009, CROP PROT, V28, P1017, DOI 10.1016/j.cropro.2009.06.001; Ma H, 2014, ARTHROPOD-PLANT INTE, V8, P1, DOI 10.1007/s11829-014-9291-6; Nogia VK, 2014, ENTOMOL GEN, V35, P11, DOI 10.1127/0171-8177/2014/0002; Park JR, 2011, PLANT BIOTECHNOL J, V9, P2, DOI 10.1111/j.1467-7652.2010.00565.x; Parolin P, 2012, INT J PEST MANAGE, V58, P368, DOI 10.1080/09670874.2012.734869; Plantegenest M, 2001, ECOL ENTOMOL, V26, P404, DOI 10.1046/j.1365-2311.2001.00330.x; Poelman EH, 2014, ANNU PLANT REV, V47, P309, DOI 10.1002/9781118472507.ch9; R Development Core Team, LANG ENV STAT COMP; Rhainds M, 2005, APPL ENTOMOL ZOOL, V40, P273, DOI 10.1303/aez.2005.273; Rodriguez-Saona C, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P89; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2011, J APPL ENTOMOL, V135, P1, DOI 10.1111/j.1439-0418.2010.01546.x; Rzanny M, 2013, OIKOS, V122, P967, DOI 10.1111/j.1600-0706.2012.00114.x; Schuler TH, 1999, NATURE, V400, P825, DOI 10.1038/23605; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Stary P., 1966, PHID PARASITES CZECH; Stary P., 1979, APHID PARASITES HYME; Stary P, 1967, REVISION FAR E ASIAN; Torres JB, 2006, BIOL CONTROL, V39, P47, DOI 10.1016/j.biocontrol.2006.03.006; Turlings TCJ, 2005, TRANSGENIC RES, V14, P807, DOI 10.1007/s11248-005-0008-6; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Yi F, 2012, MOLECULES, V17, P7533, DOI 10.3390/molecules17067533; Zhang GF, 2006, CROP PROT, V25, P527, DOI 10.1016/j.cropro.2005.08.008; Zhu SR, 2006, ZOOL STUD, V45, P98	64	15	15	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166771	10.1371/journal.pone.0166771	http://dx.doi.org/10.1371/journal.pone.0166771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870914	Green Submitted, gold, Green Published			2022-12-26	WOS:000388846400027
J	Pacheco, DA; Dudley, LS; Cabezas, J; Cavieres, LA; Arroyo, MTK				Andres Pacheco, Diego; Dudley, Leah S.; Cabezas, Josefina; Cavieres, Lohengrin A.; Arroyo, Mary T. K.			Plastic Responses Contribute to Explaining Altitudinal and Temporal Variation in Potential Flower Longevity in High Andean Rhodolirion montanum	PLOS ONE			English	Article							CAMPANULA-ROTUNDIFOLIA CAMPANULACEAE; FLORAL LONGEVITY; POLLEN LIMITATION; POLLINATOR VISITATION; MT-OLYMPOS; REPRODUCTIVE SUCCESS; SIZE VARIATION; CENTRAL CHILE; ALPINE; TEMPERATURE	The tendency for flower longevity to increase with altitude is believed by many alpine ecologists to play an important role in compensating for low pollination rates at high altitudes due to cold and variable weather conditions. However, current studies documenting an altitudinal increase in flower longevity in the alpine habitat derive principally from studies on open pollinated flowers where lower pollinator visitation rates at higher altitudes will tend to lead to flower senescence later in the life-span of a flower in comparison with lower altitudes, and thus could confound the real altitudinal pattern in a species' potential flower longevity. In a two-year study we tested the hypothesis that a plastic effect of temperature on flower longevity could contribute to an altitudinal increase in potential flower longevity measured in pollinator-excluded flowers in high Andean Rhodolirium montanum Phil. (Amaryllidaceae). Using supplemental warming we investigated whether temperature around flowers plastically affects potential flower longevity. We determined tightly temperature-controlled potential flower longevity and flower height for natural populations on three alpine sites spread over an altitudinal transect from 2350 and 3075 m a.s.l. An experimental increase of 3.1 degrees C around flowers significantly decreased flower longevity indicating a plastic response of flowers to temperature. Flower height in natural populations decreased significantly with altitude. Although temperature negatively affects flower longevity under experimental conditions, we found no evidence that temperature around flowers explains site variation in flower longevity over the altitudinal gradient. In a wetter year, despite a 3.5 degrees C temperature difference around flowers at the extremes of the altitudinal range, flower longevity showed no increase with altitude. However, in a drier year, flower longevity increased significantly with altitude. The emerging picture suggests an increase in flower longevity along the altitudinal gradient is less common for potential flower longevity than for open-pollination flower longevity. Independently of any selection that may occur on potential longevity, plastic responses of flowers to environmental conditions are likely to contribute to altitudinal variation in flower longevity, especially in dry alpine areas. Such plastic responses could push flowers of alpine species towards shorter life-lengths under climate change, with uncertain consequences for successful pollination and plant fitness in a warming world.	[Andres Pacheco, Diego; Cabezas, Josefina; Cavieres, Lohengrin A.; Arroyo, Mary T. K.] Inst Ecol & Biodiversidad, Santiago, Chile; [Andres Pacheco, Diego; Cabezas, Josefina; Arroyo, Mary T. K.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Dudley, Leah S.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI USA; [Cavieres, Lohengrin A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Bot, Concepcion, Chile	Universidad de Chile; University of Wisconsin System; University of Wisconsin Stout; Universidad de Concepcion	Pacheco, DA (corresponding author), Inst Ecol & Biodiversidad, Santiago, Chile.; Pacheco, DA (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.	southern@uchile.cl	Cavieres, Lohengrin/A-9542-2010; Dudley, Leah/HHZ-0034-2022	Cavieres, Lohengrin/0000-0001-9122-3020; Pacheco Sandoval, Diego Andres/0000-0002-2805-9341	Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant [1140541]; Iniciativa Cientifica Milenio Grant [ICM-MINECON P05-002]; CONICYT-PCHA/Magister Nacional Masters Fellowship [22131579]; Programa de Financiamiento Basal Grant [PBF-23]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant; Iniciativa Cientifica Milenio Grant; CONICYT-PCHA/Magister Nacional Masters Fellowship; Programa de Financiamiento Basal Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1140541 (URL: www.conicyt.cl/fondecyt/) to MTKA, Iniciativa Cientifica Milenio Grant ICM-MINECON P05-002 (URL: www.iniciativamilenio.cl/) to the Instituto of Ecologia y Biodiversidad and Programa de Financiamiento Basal Grant PBF-23 (URL: www.conicyt.cl/) to the Instituto of Ecologia y Biodiversidad. DAP was supported by a CONICYT-PCHA/Magister Nacional/2013 - 22131579 Masters Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; Ai HL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-195; Arceo-Gomez G, 2014, AM NAT, V183, pE50, DOI 10.1086/674358; Arroyo MTK, 2007, ARCT ANTARCT ALP RES, V39, P347, DOI 10.1657/1523-0430(06-017); Arroyo MTK, 2006, ACTA OECOL, V30, P248, DOI 10.1016/j.actao.2006.05.006; Arroyo MTK, 2013, NEW PHYTOL, V200, P1260, DOI 10.1111/nph.12443; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; ARROYO MTK, 1981, J ECOL, V69, P205, DOI 10.2307/2259826; ARROYO MTK, 1990, BIOL APPROACHES EVOL, P205; Ashman T. L., 1996, FLORAL BIOL STUDIES, P112, DOI DOI 10.1007/978-1-4613-1165-2_5; Ashman TL, 1997, EVOL ECOL, V11, P289, DOI 10.1023/A:1018416403530; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; Bergman P, 1996, ARCTIC ALPINE RES, V28, P196, DOI 10.2307/1551760; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Blionis GJ, 2001, ECOGRAPHY, V24, P696, DOI 10.1034/j.1600-0587.2001.240608.x; Blionis GJ, 2001, ECOGRAPHY, V24, P287, DOI 10.1034/j.1600-0587.2001.240306.x; Castro S, 2008, ANN BOT-LONDON, V102, P1043, DOI 10.1093/aob/mcn184; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Cavieres LA, 2000, REV CHIL HIST NAT, V73, P331; Celikel FG, 2002, HORTSCIENCE, V37, P148, DOI 10.21273/HORTSCI.37.1.148; Celikel FG, 2010, SCI HORTIC-AMSTERDAM, V125, P429, DOI 10.1016/j.scienta.2010.04.005; Centro de Ciencia del Clima y la Resiliencia, 2016, EXPL CLIM; Cevallos JC, 2000, ACTA HORTIC, P335, DOI 10.17660/ActaHortic.2000.517.42; COLLIER DE, 1990, ANN BOT-LONDON, V65, P533, DOI 10.1093/oxfordjournals.aob.a087966; Dart S, 2013, FUNCT ECOL, V27, P362, DOI 10.1111/1365-2435.12055; Duan YW, 2007, PLANT SYST EVOL, V267, P255, DOI 10.1007/s00606-007-0553-y; Dunn PK., 1996, J COMPUTATIONAL GRAP, V5, P236, DOI DOI 10.2307/1390802; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; Falvey M, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010519; Galen C, 1999, OECOLOGIA, V118, P461, DOI 10.1007/s004420050749; Galen C, 1996, EVOLUTION, V50, P120, DOI 10.1111/j.1558-5646.1996.tb04478.x; GALEN C, 1993, OECOLOGIA, V95, P187, DOI 10.1007/BF00323489; Galen C., 2005, REPROD ALLOCATION PL, P264; Garcia-Camacho R, 2009, ARCT ANTARCT ALP RES, V41, P103, DOI [10.1657/1938-4246(08-028)[GARCIA-CAMACHO]2.0.CO;2, 10.1657/1523-0430-41.1.103]; Giblin DE, 2005, AM J BOT, V92, P1714, DOI 10.3732/ajb.92.10.1714; Graae BJ, 2011, OECOLOGIA, V166, P565, DOI 10.1007/s00442-010-1878-8; Hoch G, 2005, FUNCT ECOL, V19, P941, DOI 10.1111/j.1365-2435.2005.01040.x; INOUYE DW, 1988, AUST J ECOL, V13, P191, DOI 10.1111/j.1442-9993.1988.tb00968.x; Jorgensen R, 2013, ANN BOT-LONDON, V112, P821, DOI 10.1093/aob/mct146; Jung HH, 2010, HORTIC ENVIRON BIOTE, V51, P153; KEARNS CA, 1994, AM J BOT, V81, P1091, DOI 10.2307/2445470; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Kwon YounJung, 2003, Korean Journal of Horticultural Science & Technology, V21, P369; Ladd PG, 2009, PLANT SPEC BIOL, V24, P2, DOI 10.1111/j.1442-1984.2009.00234.x; Lambrecht SC, 2013, INT J PLANT SCI, V174, P74, DOI 10.1086/668230; Lazaro A, 2015, OIKOS, V124, P174, DOI 10.1111/oik.01525; Lopez RG, 2004, HORTSCIENCE, V39, P1630, DOI 10.21273/HORTSCI.39.7.1630; Lundemo S, 2007, ACTA OECOL, V32, P262, DOI 10.1016/j.actao.2007.05.007; Maad J, 2013, NORD J BOT, V31, P361, DOI 10.1111/j.1756-1051.2013.01766.x; Makrodimos N, 2008, FLORA, V203, P449, DOI 10.1016/j.flora.2007.07.003; MCCALL C, 1992, AM J BOT, V79, P434, DOI 10.2307/2445156; MICHAUD JP, 1990, J APICULT RES, V29, P132, DOI 10.1080/00218839.1990.11101209; Molina-Montenegro MA, 2009, ECOL RES, V24, P31, DOI 10.1007/s11284-008-0477-1; ONeill SD, 1997, ANNU REV PLANT PHYS, V48, P547, DOI 10.1146/annurev.arplant.48.1.547; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; ROOK D A, 1969, New Zealand Journal of Botany, V7, P43; Rozzi R, 1997, PLANT ECOL, V132, P171, DOI 10.1023/A:1009747118914; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; SCHOLANDER SI, 1959, PLANT PHYSIOL, V34, P574, DOI 10.1104/pp.34.5.574; Seymour RS, 2009, PLANT CELL ENVIRON, V32, P1467, DOI 10.1111/j.1365-3040.2009.02015.x; Shinohara W, 2006, J PLANT RES, V119, P571, DOI 10.1007/s10265-006-0016-5; Sierra-Almeida A, 2012, ENVIRON EXP BOT, V80, P10, DOI 10.1016/j.envexpbot.2012.01.009; Sierra-Almeida A, 2010, OECOLOGIA, V163, P267, DOI 10.1007/s00442-010-1592-6; Steinacher G, 2010, FLORA, V205, P376, DOI 10.1016/j.flora.2009.12.012; STRATTON DA, 1989, BIOTROPICA, V21, P308, DOI 10.2307/2388281; Teixido AL, 2015, INT J PLANT SCI, V176, P131, DOI 10.1086/679477; Torres-Diaz C, 2007, REV CHIL HIST NAT, V80, P455, DOI 10.4067/S0716-078X2007000400007; Torres-Diaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019497; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; TOTLAND O, 1994, ARCTIC ALPINE RES, V26, P66, DOI 10.2307/1551879; Tripathi SK, 2007, PLANT SIGNAL BEHAV, V2, P437, DOI 10.4161/psb.2.6.4991; Trunschke J, 2017, ALPINE BOT, V127, P41, DOI 10.1007/s00035-016-0176-4; Tur C, 2016, ECOL LETT, V19, P576, DOI 10.1111/ele.12594; Utelli AB, 2000, OIKOS, V89, P461, DOI 10.1034/j.1600-0706.2000.890305.x; vanDoorn WG, 1997, J EXP BOT, V48, P1615, DOI 10.1093/jexbot/48.314.1615; Vera C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025759; Vesprini JL, 2005, PLANT SYST EVOL, V252, P63, DOI 10.1007/s00606-004-0261-9; Wagner J, 1998, BOT ACTA, V111, P159, DOI 10.1111/j.1438-8677.1998.tb00691.x; Wagner J, 2016, AM J BOT, V103, P375, DOI 10.3732/ajb.1500214; WARDLE P, 1971, New Zealand Journal of Botany, V9, P371; Weber JJ, 2007, AM J BOT, V94, P1338, DOI 10.3732/ajb.94.8.1338; Yasaka M, 1998, ECOL RES, V13, P211, DOI 10.1046/j.1440-1703.1998.00259.x; Zhao ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118299	86	12	13	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166350	10.1371/journal.pone.0166350	http://dx.doi.org/10.1371/journal.pone.0166350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861586	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300049
J	Nicolson, C; Harvey, R; Engelhardt, OG; Robertson, JS				Nicolson, Carolyn; Harvey, Ruth; Engelhardt, Othmar G.; Robertson, James S.			The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1) pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein	PLOS ONE			English	Article							INFLUENZA-VIRUS; HEMAGGLUTININ; REPLICATION; MUTATIONS; VACCINES; ANTIGEN; GENE; H5N1	Previous studies on influenza A(H1N1)pdm09 candidate vaccine viruses (CVVs) that had adapted to growth in embryonated chicken eggs by the acquisition of amino acid substitutions at HA positions 222 or 223 showed that improved protein yield could be conferred by additional amino acid substitutions in the haemagglutinin (HA) that arose naturally during passaging of the virus in eggs. In this study we investigated, by means of reverse genetics, the ability of a non-egg adapted (cell-like) A(H1N1) pdm09 virus to egg-adapt at HA loci other than 222/223, introducing amino acid substitutions previously identified as egg adaptations in pre-H1N1pdm09 H1N1 viruses and assessing their effect on protein yield and antigenicity. We also investigated the effect on the protein yield of these substitutions in viruses that had A(H1N1) pdm09 internal genes rather than the traditional PR8 internal genes of a CVV. The data show that a cell-like A/Christchurch/16/2010 can be egg-adapted via amino acid substitutions in at least three alternative HA loci (187, 190 and 216), in viruses with either PR8 or A/California/7/2009 internal genes, but that the effects on protein yield vary depending on the amino acid substitution and the internal genes of the virus. Since CVVs need to produce high protein yields to be suitable for vaccine manufacture, the findings of this study will assist in the future characterisation of both wild type viruses and lab-derived CVVs for vaccine use.	[Nicolson, Carolyn; Harvey, Ruth; Engelhardt, Othmar G.; Robertson, James S.] Natl Inst Biol Stand & Controls, MHRA, Blanche Lane, Potters Bar EN6 3QG, Herts, England	National Institute for Biological Standards & Control	Nicolson, C (corresponding author), Natl Inst Biol Stand & Controls, MHRA, Blanche Lane, Potters Bar EN6 3QG, Herts, England.	carolyn.nicolson@nibsc.org						Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Harvey R, 2008, VACCINE, V26, P6550, DOI 10.1016/j.vaccine.2008.09.050; Hsu J., 1996, MULTIPLE COMP THEORY; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Kendal AP, 1982, CONCEPTS PROCEDURES; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Nicolson C, 2012, VACCINE, V30, P745, DOI 10.1016/j.vaccine.2011.11.081; Plant EP, 2012, VACCINE, V31, P207, DOI 10.1016/j.vaccine.2012.10.060; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1993, REV MED VIROL, V3, P97, DOI 10.1002/rmv.1980030206; Suphaphiphat P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-157; Wang WJ, 2013, J VIROL, V87, P4642, DOI 10.1128/JVI.03271-12; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Yasugi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077892	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166761	10.1371/journal.pone.0166761	http://dx.doi.org/10.1371/journal.pone.0166761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861557	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300103
J	Rodriguez, MPI; Noctor, SC; Munoz, EM				Rodriguez, Maria P. Ibanez; Noctor, Stephen C.; Munoz, Estela M.			Cellular Basis of Pineal Gland Development: Emerging Role of Microglia as Phenotype Regulator	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CEREBRAL-CORTEX; RADIAL GLIA; ADULT RATS; EXPRESSION; CELLS; MACROPHAGES/MICROGLIA; MELATONIN; BRAIN; PAX6	The adult pineal gland is composed of pinealocytes, astrocytes, microglia, and other interstitial cells that have been described in detail. However, factors that contribute to pineal development have not been fully elucidated, nor have pineal cell lineages been well characterized. We applied systematic double, triple and quadruple labeling of cell-specific markers on prenatal, postnatal and mature rat pineal gland tissue combined with confocal microscopy to provide a comprehensive view of the cellular dynamics and cell lineages that contribute to pineal gland development. The pineal gland begins as an evagination of neuroepithelium in the roof of the third ventricle. The pineal primordium initially consists of radially aligned Pax6+ precursor cells that express vimentin and divide at the ventricular lumen. After the tubular neuroepithelium fuses, the distribution of Pax6+ cells transitions to include rosette-like structures and later, dispersed cells. In the developing gland all dividing cells express Pax6, indicating that Pax6+ precursor cells generate pinealocytes and some interstitial cells. The density of Pax6+ cells decreases across pineal development as a result of cellular differentiation and microglial phagocytosis, but Pax6+ cells remain in the adult gland as a distinct population. Microglial colonization begins after pineal recess formation. Microglial phagocytosis of Pax6+ cells is not common at early stages but increases as microglia colonize the gland. In the postnatal gland microglia affiliate with Tuj1+ nerve fibers, IB4+ blood vessels, and Pax6+ cells. We demonstrate that microglia engulf Pax6+ cells, nerve fibers, and blood vessel-related elements, but not pinealocytes. We conclude that microglia play a role in pineal gland formation and homeostasis by regulating the precursor cell population, remodeling blood vessels and pruning sympathetic nerve fibers.	[Rodriguez, Maria P. Ibanez; Munoz, Estela M.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, IHEM, Mendoza, Argentina; [Noctor, Stephen C.] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, MIND Inst, Sacramento, CA 95817 USA	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of California System; University of California Davis	Munoz, EM (corresponding author), Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, IHEM, Mendoza, Argentina.; Noctor, SC (corresponding author), Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, MIND Inst, Sacramento, CA 95817 USA.	scnoctor@ucdavis.edu; munoz.estela@fcm.uncu.edu.ar		Munoz, Estela/0000-0002-6701-1535	National Council of Scientific and Technical Research (CONICET; Argentina); National Agency for Scientific and Technological Promotion (ANPCyT; Argentina); National Institutes of Health (NIH; USA); PIP-CONICET [112-201101-00247]; PICT-CONICET [2012-174, R01-MH101188]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101188] Funding Source: NIH RePORTER	National Council of Scientific and Technical Research (CONICET; Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Scientific and Technological Promotion (ANPCyT; Argentina)(ANPCyT); National Institutes of Health (NIH; USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PIP-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); PICT-CONICET; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors were supported by the National Council of Scientific and Technical Research (CONICET; Argentina; http://www.conicet.gov.ar), the National Agency for Scientific and Technological Promotion (ANPCyT; Argentina; http://www.agencia.mincyt.gob.ar), National Institutes of Health (NIH; USA; https://www.nih.gov); PIP-CONICET 112-201101-00247 to EMM; PICT-CONICET 2012-174 to EMM; R01-MH101188 to SCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid H, 2009, MOL VIS, V15, P2074; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; CALVO J, 1984, J ANAT, V138, P45; Calvo JL, 2000, HISTOL HISTOPATHOL, V15, P1005, DOI 10.14670/HH-15.1005; Calvo JL, 2004, HISTOL HISTOPATHOL, V19, P137, DOI 10.14670/HH-19.137; Calvo JL, 1997, J PINEAL RES, V23, P1, DOI 10.1111/j.1600-079X.1997.tb00327.x; Carvalho-Sousa Claudia Emanuele, 2011, Front Endocrinol (Lausanne), V2, P10, DOI 10.3389/fendo.2011.00010; Castro AE, 2015, J PINEAL RES, V58, P439, DOI 10.1111/jpi.12228; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Duvernoy HM, 2007, BRAIN RES REV, V56, P119, DOI 10.1016/j.brainresrev.2007.06.002; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Ganguly S, 2002, CELL TISSUE RES, V309, P127, DOI 10.1007/s00441-002-0579-y; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Jiang-Shieh YF, 2005, J PINEAL RES, V38, P17, DOI 10.1111/j.1600-079X.2004.00170.x; Jiang-Shieh YF, 2003, J PINEAL RES, V35, P45, DOI 10.1034/j.1600-079X.2003.00054.x; Kaur C, 2007, GLIA, V55, P263, DOI 10.1002/glia.20452; Kaur C, 1999, J PINEAL RES, V26, P158, DOI 10.1111/j.1600-079X.1999.tb00578.x; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C, 1997, J PINEAL RES, V22, P137, DOI 10.1111/j.1600-079X.1997.tb00315.x; Kaur C, 2002, J NEUROSCI RES, V67, P533, DOI 10.1002/jnr.10136; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030178, 10.1371/journal.pone.0041386]; MCNULTY JA, 1993, BRAIN RES, V610, P108, DOI 10.1016/0006-8993(93)91223-F; MCNULTY JA, 1995, J PINEAL RES, V19, P40, DOI 10.1111/j.1600-079X.1995.tb00169.x; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ochocinska MJ, 2012, J NEUROCHEM, V123, P44, DOI 10.1111/j.1471-4159.2012.07870.x; PEDERSEN EB, 1993, CELL TISSUE RES, V272, P257, DOI 10.1007/BF00302731; Pedersen EB, 1997, J NEUROIMMUNOL, V76, P117, DOI 10.1016/S0165-5728(97)00038-6; PHIFER CB, 1986, PHYSIOL BEHAV, V38, P887, DOI 10.1016/0031-9384(86)90058-2; Power Christine A., 2001, Current Opinion in Pharmacology, V1, P417, DOI 10.1016/S1471-4892(01)00072-8; Rath MF, 2016, ENDOCRINOLOGY, V157, P2028, DOI 10.1210/en.2015-1888; Rath MF, 2013, NEUROCHEM RES, V38, P1100, DOI 10.1007/s11064-012-0906-y; Rath MF, 2009, ENDOCRINOLOGY, V150, P803, DOI 10.1210/en.2008-0882; Rohde K, 2014, ENDOCRINOLOGY, V155, P2966, DOI 10.1210/en.2014-1232; Rovsing L, 2011, J NEUROCHEM, V119, P262, DOI 10.1111/j.1471-4159.2011.07405.x; Shimauchi Y, 2002, DEV GENES EVOL, V212, P319, DOI 10.1007/s00427-002-0236-1; Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421; Tsai SY, 2001, CELL TISSUE RES, V303, P423, DOI 10.1007/s004410000330; Tsai SY, 1997, GLIA, V20, P243, DOI 10.1002/(SICI)1098-1136(199707)20:3<243::AID-GLIA8>3.0.CO;2-8; Tsai SY, 1999, J PINEAL RES, V27, P42, DOI 10.1111/j.1600-079X.1999.tb00595.x; Yamazaki F, 2015, BRAIN STRUCT FUNCT, V220, P1497, DOI 10.1007/s00429-014-0740-x; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yu HJ, 2016, J PINEAL RES, V61, P69, DOI 10.1111/jpi.12328	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0167063	10.1371/journal.pone.0167063	http://dx.doi.org/10.1371/journal.pone.0167063			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861587	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300146
J	Zakrzewski, M; Zakrzewska, E; Kicinski, P; Przybylska-Kuc, S; Dybala, A; Myslinski, W; Pastryk, J; Tomaszewski, T; Mosiewicz, J				Zakrzewski, Maciej; Zakrzewska, Ewelina; Kicinski, Pawel; Przybylska-Kuc, Sylwia; Dybala, Andrzej; Myslinski, Wojciech; Pastryk, Jolanta; Tomaszewski, Tomasz; Mosiewicz, Jerzy			Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ASSOCIATION; BLOOD; EPIDEMIOLOGY; EXPRESSION; MORTALITY	Obstructive sleep apnoea (OSA) induces thrombophilia and reduces fibrinolysis. Alpha-2antiplasmin (a-2-AP) and plasminogen activator inhibitor 1 (PAI-1) are major inhibitors of the fibrinolytic system. Increased concentrations of these factors are associated with a higher risk of cardiovascular diseases. The aim of this study was to assess plasma a-2-AP and PAI-1 in patients with OSA and evaluate correlations with the polysomnographic record and selected risk factors of cardiovascular diseases. The study group comprised 45 patients with OSA, and the control group consisted of 19 patients who did not meet the diagnostic criteria of OSA. Plasma a-2-AP and PAI-1 concentrations were assessed by enzyme-linked immunosorbent assay (ELISA). In the study group, the median value of plasma a-2-AP was higher than that of the control group (157.34 vs. 11.89 pg/ml, respectively, P<0.0001). A-2-AP concentration increased proportionally to the severity of OSA. The concentration of a-2-AP was positively correlated with the apnoea-hypopnoea index (AHI), apnoea index (AI), respiratory disturbances time (RDT), and desaturaion index (DI), and negatively correlated with mean and minimal oxygen saturation (SpO(2) mean, SPO2 min, respectively). The median value of PAI-1 was higher in the study group than the control group (12.55 vs. 5.40 ng/ml, respectively, P = 0.006) and increased along with OSA severity. PAI-1 concentration was positively correlated with AHI, Al, RDT, DI, and body mass index (BMI) and negatively correlated with SpO(2) mean and SpO(2) min. Higher plasma concentrations of a-2-AP and PAI-1 in patients with OSA indicated that these patients had increased prothrombotic activity. OSA increases the risk of cardiovascular complications as it enhances prothrombotic activity.	[Zakrzewski, Maciej; Przybylska-Kuc, Sylwia; Dybala, Andrzej; Myslinski, Wojciech; Mosiewicz, Jerzy] Med Univ Lublin, Dept Internal Dis, Lublin, Poland; [Zakrzewska, Ewelina] Med Univ Lublin, Dept Expt Haematooncol, Lublin, Poland; [Kicinski, Pawel] Med Univ Lublin, Dept Family Med, Lublin, Poland; [Tomaszewski, Tomasz] Med Univ Lublin, Clin Maxillofacial Surg, Lublin, Poland; [Pastryk, Jolanta] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Zakrzewski, M (corresponding author), Med Univ Lublin, Dept Internal Dis, Lublin, Poland.	misiowy3@wp.pl	Kiciński, Paweł/K-3839-2019; Kiciński, Paweł/AAU-3020-2021	Mosiewicz, Jerzy/0000-0003-0320-1863; Myslinski, Wojciech/0000-0003-1134-5920; Kicinski, Pawel/0000-0002-0142-4812; Pastryk, Jolanta/0000-0003-2766-8513	Medical University of Lublin Scientific Grant [DS 161]	Medical University of Lublin Scientific Grant	This work was supported by Medical University of Lublin Scientific Grant DS 161.	ALMER LO, 1987, THROMB RES, V47, P335, DOI 10.1016/0049-3848(87)90147-2; Aoki N, 2005, J THROMB HAEMOST, V3, P623, DOI 10.1111/j.1538-7836.2004.01055.x; BANGERT K, 1993, BIOCHEM J, V291, P623, DOI 10.1042/bj2910623; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Bogdanski P., 2012, ENDOCRINOL OBES META, V8, P1; Bujak R, 2002, CARDIOL J, V9, P311; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Chin K, 1998, QJM-MON J ASSOC PHYS, V91, P627, DOI 10.1093/qjmed/91.9.627; Clarenbach P, 2001, REV NEUROL, V157, P46; Diamantopoulos EJ, 2003, CLIN EXP HYPERTENS, V25, P1, DOI 10.1081/CEH-120017736; Dyken ME, 1996, STROKE, V27, P401, DOI 10.1161/01.STR.27.3.401; Einhorn Daniel, 2007, Endocr Pract, V13, P355; Flanders MM, 2006, J PEDIATR-US, V149, P275, DOI 10.1016/j.jpeds.2006.04.008; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; HASHIMOTO Y, 1987, THROMB RES, V46, P625, DOI 10.1016/0049-3848(87)90264-7; HUNG J, 1990, LANCET, V336, P261, DOI 10.1016/0140-6736(90)91799-G; Jordan AS, 2003, SLEEP MED REV, V7, P377, DOI 10.1053/smrv.2002.0260; Kolodziejczyk J, 2009, ONKOL POL, V12, P105; LIN CC, 1992, CHEST, V102, P1663, DOI 10.1378/chest.102.6.1663; MAIELLO M, 1992, DIABETES, V41, P1009, DOI 10.2337/diabetes.41.8.1009; MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P842; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; NORDT TK, 1993, ARTERIOSCLER THROMB, V13, P1822, DOI 10.1161/01.ATV.13.12.1822; PARAMO JA, 1985, BRIT MED J, V291, P573, DOI 10.1136/bmj.291.6495.573; Peker Y, 2000, AM J RESP CRIT CARE, V162, P81, DOI 10.1164/ajrccm.162.1.9905035; Plywaczewski R., 2003, THESIS; RANGEMARK C, 1995, SLEEP, V18, P188, DOI 10.1093/sleep/18.3.188; Reikeras O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107881; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; SHATOS MA, 1990, J BIOL CHEM, V265, P20443; Steiner S, 2005, CARDIOLOGY, V104, P92, DOI 10.1159/000086729; SUMI Y, 1989, J BIOCHEM-TOKYO, V106, P703, DOI 10.1093/oxfordjournals.jbchem.a122920; Surjawan Y, 2010, MED J INDONES, V19, P158; Tabak O, 2009, CLIN INVEST MED, V32, pE285; Thielemann A, 2012, NOWINY LEKARSKIE, V81, P164; Tomczykowska Malgorzata, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P15; von Kanel R, 2006, SLEEP BREATH, V10, P139, DOI 10.1007/s11325-006-0060-3; von Kanel R, 2007, CHEST, V131, P733, DOI 10.1378/chest.06-2006; Wojtukiewicz MZ, 1998, ONKOL POL, V2, P93; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zamarron C, 2008, LUNG, V186, P151, DOI 10.1007/s00408-008-9076-8	42	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166725	10.1371/journal.pone.0166725	http://dx.doi.org/10.1371/journal.pone.0166725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861608	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300097
J	Rathore, S; Dass, S; Kandari, D; Kaur, I; Gupta, M; Sharma, YD				Rathore, Sumit; Dass, Sheena; Kandari, Divya; Kaur, Inderjeet; Gupta, Mayank; Sharma, Yagya D.			Basigin Interacts with Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 as a Second Erythrocyte Receptor to Promote Parasite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURALLY ACQUIRED ANTIBODIES; PROTEIN-PROTEIN INTERACTIONS; MEROZOITE SURFACE PROTEIN-1; RED-BLOOD-CELLS; GLYCOPHORIN-A; BINDING LIGAND; SIALIC-ACID; INVASION; MALARIA; FALCIPARUM	Elucidating the molecular mechanisms of the host-parasite interaction during red cell invasion by Plasmodium is important for developing newer antimalarial therapeutics. Recently, we have characterized a Plasmodium vivax tryptophan-rich antigen PvTRAg38, which is expressed by its merozoites, binds to host erythrocytes, and interferes with parasite growth. Interaction of this parasite ligand with the host erythrocyte occurs through its two regions present at amino acid positions 167-178 (P-2) and 197-208 (P-4). Each region recognizes its own erythrocyte receptor. Previously, we identified band 3 as the chymotrypsin-sensitive erythrocyte receptor for the P-4 region, but the other receptor, binding to P-2 region, remained unknown. Here, we have identified basigin as the second erythrocyte receptor for PvTRAg38, which is resistant to chymotrypsin. The specificity of interaction between PvTRAg38 and basigin was confirmed by direct interaction where basigin was specifically recognized by P-2 and not by the P-4 region of this parasite ligand. Interaction between P-2 and basigin is stabilized through multiple amino acid residues, but Gly-171 and Leu-175 of P-2 were more critical. These two amino acids were also critical for parasite growth. Synthetic peptides P-2 and P-4 of PvTRAg38 interfered with the parasite growth independently but had an additive effect if combined together indicating involvement of both the receptors during red cell invasion. In conclusion, PvTRAg38 binds to two erythrocyte receptors basigin and band 3 through P-2 and P-4 regions, respectively, to facilitate parasite growth. This advancement in our knowledge on molecular mechanisms of host-parasite interaction can be exploited to develop therapeutics against P. vivax malaria.	[Rathore, Sumit; Dass, Sheena; Kandari, Divya; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Kaur, Inderjeet; Gupta, Mayank] Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi 110067, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rathore, S; Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	rathoresumit@gmail.com; ydsharma_aiims@yahoo.com		Kandari, Divya/0000-0002-9575-0263; Dass, Sheena/0000-0001-7694-8867; Kaur, Inderjeet/0000-0001-8778-1396	Indian Council of Medical Research [61/4/2012-BMS]; Department of Science and Technology-Indian National Science Academy INSPIRE Faculty Fellow Award from the Department of Science and Technology, Government of India [IFA12-LSBM42]; Department of Biotechnology, Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology-Indian National Science Academy INSPIRE Faculty Fellow Award from the Department of Science and Technology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by Indian Council of Medical Research Grant 61/4/2012-BMS and Department of Science and Technology-Indian National Science Academy INSPIRE Faculty Fellow Award IFA12-LSBM42 from the Department of Science and Technology, Government of India (to S. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of scholarships from the Department of Biotechnology, Government of India.	Abraham MJ, 2011, J COMPUT CHEM, V32, P2041, DOI 10.1002/jcc.21766; Alam MS, 2016, FEBS LETT, V590, P232, DOI 10.1002/1873-3468.12053; Alam MS, 2015, J BIOL CHEM, V290, P20257, DOI 10.1074/jbc.M115.644906; Bai Y, 2014, INT J MOL SCI, V15, P6356, DOI 10.3390/ijms15046356; Baldwin M, 2014, BBA-MOL CELL RES, V1843, P2855, DOI 10.1016/j.bbamcr.2014.08.008; Baldwin MR, 2015, BLOOD, V125, P2704, DOI 10.1182/blood-2014-11-611707; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Chan ER, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003566; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Griffiths RE, 2012, AUTOPHAGY, V8, P1150, DOI 10.4161/auto.20648; Gunalan K, 2016, P NATL ACAD SCI USA, V113, P6271, DOI 10.1073/pnas.1606113113; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hostetler JB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004264; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu B, 2007, J AM CHEM SOC, V129, P12348, DOI 10.1021/ja072904r; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mehndiratta S, 2013, J VECTOR DIS, V50, P71; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0103-4; Song F, 2011, ACTA BIOCH BIOPH SIN, V43, P900, DOI 10.1093/abbs/gmr060; SORETTE MP, 1991, BLOOD, V77, P628; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Tyagi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151065; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zeeshan M, 2015, INFECT IMMUN, V83, P2018, DOI 10.1128/IAI.03095-14; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650; Zenonos ZA, 2015, J EXP MED, V212, P1145, DOI 10.1084/jem.20150032; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]	51	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					462	476		10.1074/jbc.M116.744367	http://dx.doi.org/10.1074/jbc.M116.744367			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27881677	Green Published, hybrid			2022-12-26	WOS:000392316100005
J	Coster, AD; Thorne, CA; Wu, LFN; Altschuler, SJ				Coster, Adam D.; Thorne, Curtis A.; Wu, Lani F.; Altschuler, Steven J.			Examining Crosstalk among Transforming Growth Factor beta, Bone Morphogenetic Protein, and Wnt Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL SIGNALING NETWORKS; TGF-BETA; EPITHELIAL-CELLS; SMAD1/5 PHOSPHORYLATION; CATENIN; TRANSCRIPTION; TRANSDUCTION; INFORMATION; COMPLEXES; BINDING	The integration of morphogenic signals by cells is not well understood. A growing body of literature suggests increasingly complex coupling among classically defined pathways. Given this apparent complexity, it is difficult to predict where, when, or even whether crosstalk occurs. Here, we investigated pairs of morphogenic pathways, previously reported to have multiple points of crosstalk, which either do not share (TGF beta and Wnt/beta-catenin) or share (TGF beta and bone morphogenetic protein (BMP)) core signaling components. Crosstalk was measured by the ability of one morphogenic pathway to cross-activate core transcription factors and/or target genes of another morphogenic pathway. In contrast to previous studies, we found a surprising absence of crosstalk between TGF beta and Wnt/beta-catenin. Further, we did not observe expected cross-pathway inhibition in between TGF beta and BMP, despite the fact that both use (or could compete) for the shared component SMAD4. Critical to our assays was a separation of timescales, which helped separate crosstalk due to initial signal transduction from subsequent post-transcriptional feedback events. Our study revealed fewer (and different) inter-morphogenic pathway crosstalk connections than expected; even pathways that share components can be insulated from one another.	[Coster, Adam D.; Thorne, Curtis A.; Wu, Lani F.; Altschuler, Steven J.] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Wu, Lani F.; Altschuler, Steven J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Wu, LFN; Altschuler, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.; Wu, LFN; Altschuler, SJ (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	Lani.Wu@ucsf.edu; Steven.Altschuler@ucsf.edu			Howard Hughes Medical Institute (HHMI) Medinto Grad (MIG) Scholars Program; Cancer Biology Training Grant [T32 CA124334]; American Cancer Society-Lakeshore Division Postdoctoral Fellowship; National Institute of Health [DK103126, GM112690, CA184984]; Institute of Computational Health Sciences (ICHS) at University of California, San Francisco; NATIONAL CANCER INSTITUTE [R01CA184984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK103126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112690] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI) Medinto Grad (MIG) Scholars Program; Cancer Biology Training Grant; American Cancer Society-Lakeshore Division Postdoctoral Fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Computational Health Sciences (ICHS) at University of California, San Francisco; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (HHMI) Medinto Grad (MIG) Scholars Program (to A. D. C.), Cancer Biology Training Grant T32 CA124334 (to C. A. T.), an American Cancer Society-Lakeshore Division Postdoctoral Fellowship (to C. A. T.), the National Institute of Health Grants DK103126 (to C. A. T.), GM112690 (to S. J. A.), and CA184984 (to L. F. W.), and the Institute of Computational Health Sciences (ICHS) at University of California, San Francisco (to S. J. A. and L. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Attisano Liliana, 2013, F1000Prime Rep, V5, P17, DOI 10.12703/P5-17; Candia AF, 1997, DEVELOPMENT, V124, P4467; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Coster AD, 2014, NAT METHODS, V11, P602, DOI 10.1038/nmeth.2971; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Freeman TJ, 2012, GASTROENTEROLOGY, V142, p[562, e2]; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Mamidi A, 2012, CELL DEATH DIFFER, V19, P1689, DOI 10.1038/cdd.2012.50; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Minoo P, 2010, INT J BIOCHEM CELL B, V42, P809, DOI 10.1016/j.biocel.2010.02.011; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Noselli S, 2000, SCIENCE, V290, P68, DOI 10.1126/science.290.5489.68; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548; Rodriguez-Carballo E, 2011, J BONE MINER RES, V26, P718, DOI 10.1002/jbmr.260; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang YQ, 2013, CELL REP, V3, P1607, DOI 10.1016/j.celrep.2013.04.009; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Warner D R, 2005, Orthod Craniofac Res, V8, P123; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Zeng YA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003893; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22	62	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					244	250		10.1074/jbc.M116.759654	http://dx.doi.org/10.1074/jbc.M116.759654			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895117	Green Published, hybrid			2022-12-26	WOS:000391578000021
J	Faison, EK; DeStefano, S; Foster, DR; Rapp, JM; Compton, JA				Faison, Edward K.; DeStefano, Stephen; Foster, David R.; Rapp, Joshua M.; Compton, Justin A.			Multiple Browsers Structure Tree Recruitment in Logged Temperate Forests	PLOS ONE			English	Article							WHITE-TAILED DEER; UNGULATE BROWSERS; VEGETATION DYNAMICS; MOOSE; IMPACT; REGENERATION; MANAGEMENT; DIVERSITY; SONGBIRDS; REGIMES	Historical extirpations have resulted in depauperate large herbivore assemblages in many northern forests. In eastern North America, most forests are inhabited by a single wild ungulate species, white-tailed deer (Odocoileus virginianus), and relationships between deer densities and impacts on forest regeneration are correspondingly well documented. Recent recolonizations by moose (Alces americanus) in northeastern regions complicate established deer density thresholds and predictions of browsing impacts on forest dynamics because size and foraging differences between the two animals suggest a lack of functional redundancy. We asked to what extent low densities of deer + moose would structure forest communities differently from that of low densities of deer in recently logged patch cuts of Massachusetts, USA. In each site, a randomized block with three treatment levels of large herbivores-no-ungulates (full exclosure), deer (partial exclosure), and deer + moose (control) was established. After 6-7 years, deer + moose reduced stem densities and basal area by 2-3-fold, Prunus pensylvanica and Quercus spp. recruitment by 3-6 fold, and species richness by 1.7 species (19%). In contrast, in the partial exclosures, deer had non-significant effects on stem density, basal area, and species composition, but significantly reduced species richness by 2.5 species on average (28%). Deer browsing in the partial exclosure was more selective than deer + moose browsing together, perhaps contributing to the decline in species richness in the former treatment and the lack of additional decline in the latter. Moose used the control plots at roughly the same frequency as deer (as determined by remote camera traps), suggesting that the much larger moose was the dominant browser species in terms of animal biomass in these cuts. A lack of functional redundancy with respect to foraging behavior between sympatric large herbivores may explain combined browsing effects that were both large and complex.	[Faison, Edward K.] Highstead Fdn, Redding, CT 06896 USA; [DeStefano, Stephen] Univ Massachusetts, US Geol Survey, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Foster, David R.; Rapp, Joshua M.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Compton, Justin A.] Springfield Coll, Springfield, MA USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Springfield College	Faison, EK (corresponding author), Highstead Fdn, Redding, CT 06896 USA.	efaison@highstead.net			NSF [DEB 1237491, DEB 0620443]; Massachusetts Department of Conservation and Recreation; Massachusetts Division of Fisheries and Wildlife; U.S. Geological Survey Cooperative Research Unit Program; Highstead Foundation; Harvard Forest	NSF(National Science Foundation (NSF)); Massachusetts Department of Conservation and Recreation; Massachusetts Division of Fisheries and Wildlife; U.S. Geological Survey Cooperative Research Unit Program; Highstead Foundation; Harvard Forest	This project was funded by NSF grant # DEB 1237491: HFR LTER V: New Science, Synthesis, Scholarship, and Strategic Vision for Society; NSF grant # DEB 0620443: LTER IV: Integrated Studies of the Drivers, Dynamics, and Consequences of Landscape Change in New England. Additional support was provided by the Massachusetts Department of Conservation and Recreation, Massachusetts Division of Fisheries and Wildlife, U.S. Geological Survey Cooperative Research Unit Program, Highstead Foundation, and Harvard Forest.	Adams K. J., 2009, QDMAS WHITETAIL REPO; Askins RA, 2007, FOREST ECOL MANAG, V250, P137, DOI 10.1016/j.foreco.2007.05.009; Augustine DJ, 1998, CONSERV BIOL, V12, P995, DOI 10.1046/j.1523-1739.1998.97248.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1076, DOI 10.2307/3802560; Bagchi R, 2011, PHILOS T R SOC B, V366, P3246, DOI 10.1098/rstb.2011.0034; Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Bergeron Daniel H., 2011, Alces, V47, P39; Brouillet L, 1993, FLORA N AM N MEXICO, P15; Decalesta David S., 1997, P267; DECALESTA DS, 1994, J WILDLIFE MANAGE, V58, P711, DOI 10.2307/3809685; DeGraaf R.M., 2001, UPNE; EDENIUS L, 1991, J APPL ECOL, V28, P318, DOI 10.2307/2404132; Faison EK, 2016, ECOL EVOL, V6, P4591, DOI 10.1002/ece3.2223; Faison EK, 2016, FOREST ECOL MANAG, V362, P177, DOI 10.1016/j.foreco.2015.12.006; Faison EK, 2010, NORTHEAST NAT, V17, P1, DOI 10.1656/045.017.0101; FOSTER D, 2004, FORESTS TIME ENV CON, P43; Frelich LE, 2012, PHILOS T R SOC B, V367, P2955, DOI 10.1098/rstb.2012.0235; Frerker K, 2013, FOREST ECOL MANAG, V291, P55, DOI 10.1016/j.foreco.2012.11.041; Gill Robin, 2006, Conservation Biology Series (Cambridge), V11, P170; Gilliam F., 2014, HERBACEOUS LAYER FOR, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Healy WM, 1997, T N AM WILDL NAT RES, P249; Hester Alison J., 2006, Conservation Biology Series (Cambridge), V11, P97; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kuijper DPJ, 2009, FOREST ECOL MANAG, V258, P1528, DOI 10.1016/j.foreco.2009.07.010; Lagendijk DDG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017983; Loranger Andre J., 1991, Alces, V27, P100; MacCleery D.W., 2011, AM FORESTS HIST RESI, V4th ed.; Makhabu SW, 2006, ACTA OECOL, V30, P136, DOI 10.1016/j.actao.2006.02.005; Manier DJ, 2007, OECOLOGIA, V152, P739, DOI 10.1007/s00442-007-0689-z; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McDonald JE, 2007, J WILDLIFE MANAGE, V71, P1585, DOI 10.2193/2006-490; MIQUELLE DG, 1989, J WILDLIFE MANAGE, V53, P577, DOI 10.2307/3809179; Moe SR, 2009, J APPL ECOL, V46, P223, DOI 10.1111/j.1365-2664.2008.01595.x; Nuttle T, 2013, ECOL MONOGR, V83, P3, DOI 10.1890/11-2263.1; Oksanen J., 2015, VEGAN COMMUNITY ECOL; Oliver C.D., 1996, FOREST STAND DYNAMIC; Pringle RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0390; Rapp JM, 2013, J ECOL, V101, P1345, DOI 10.1111/1365-2745.12115; Renecker LA, 1997, ECOLOGY MANAGEMENT N, P403; RISENHOOVER KL, 1987, CAN J FOREST RES, V17, P357, DOI 10.1139/x87-062; Ristau TE, 2012, RES REV, V16, P1; Ritchie ME, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P175; Royo AA, 2010, ECOLOGY, V91, P93, DOI 10.1890/08-1680.1; Sankaran M, 2013, J ECOL, V101, P1389, DOI 10.1111/1365-2745.12147; Tanentzap AJ, 2009, J ZOOL, V278, P243, DOI 10.1111/j.1469-7998.2009.00572.x; Terborgh J, 2016, ECOGRAPHY, V39, P180, DOI 10.1111/ecog.01641; TIERSON WC, 1985, J WILDLIFE MANAGE, V49, P760, DOI 10.2307/3801708; TILGHMAN NG, 1989, J WILDLIFE MANAGE, V53, P524, DOI 10.2307/3809172; USA EPA, 2015, EC NEW ENGL; USDA, 2015, FIA DAT MART; Vera Frans W.M., 2006, Conservation Biology Series (Cambridge), V11, P203; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P191, DOI 10.2193/0091-7648(2006)34[191:FADMAR]2.0.CO;2; Wattles David W., 2011, Alces, V47, P53; Wisdom MJ, 2006, WILDLIFE SOC B, V34, P283, DOI 10.2193/0091-7648(2006)34[283:UUHDEO]2.0.CO;2; [No title captured]	59	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166783	10.1371/journal.pone.0166783	http://dx.doi.org/10.1371/journal.pone.0166783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893758	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400045
J	Wanninger, S; Donati, M; Di Francesco, A; Hassig, M; Hoffmann, K; Seth-Smith, HMB; Marti, H; Borel, N				Wanninger, Sabrina; Donati, Manuela; Di Francesco, Antonietta; Hassig, Michael; Hoffmann, Karolin; Seth-Smith, Helena M. B.; Marti, Hanna; Borel, Nicole			Selective Pressure Promotes Tetracycline Resistance of Chlamydia Suis in Fattening Pigs	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SAMPLES; INFECTIONS; VETERINARY; FAILURE	In pigs, Chlamydia suis has been associated with respiratory disease, diarrhea and conjunctivitis, but there is a high rate of inapparent C. suis infection found in the gastrointestinal tract of pigs. Tetracycline resistance in C. suis has been described in the USA, Italy, Switzerland, Belgium, Cyprus and Israel. Tetracyclines are commonly used in pig production due to their broad-spectrum activity and relatively low cost. The aim of this study was to isolate clinical C. suis samples in cell culture and to evaluate their antibiotic susceptibility in vitro under consideration of antibiotic treatment on herd level. Swab samples (n = 158) identified as C. suis originating from 24 farms were further processed for isolation, which was successful in 71% of attempts with a significantly higher success rate from fecal swabs compared to conjunctival swabs. The farms were divided into three treatment groups: A) farms without antibiotic treatment, B) farms with prophylactic oral antibiotic treatment of the whole herd consisting of trimethoprime, sulfadimidin and sulfathiazole (TSS), or C) farms giving herd treatment with chlortetracycline with or without tylosin and sulfadimidin (CTS). 59 isolates and their corresponding clinical samples were selected and tested for the presence or absence of the tetracycline resistance class C gene [tet(C)] by conventional PCR and isolates were further investigated for their antibiotic susceptibility in vitro. The phenotype of the investigated isolates was either classified as tetracycline sensitive (Minimum inhibitory concentration [MIC] < 2 mu g/ml), intermediate (2 mu g/ml <= MIC < 4 mu g/ml) or resistant (MIC >= 4 mu g/ml). Results of groups and individual pigs were correlated with antibiotic treatment and time of sampling (beginning/end of the fattening period). We found clear evidence for selective pressure as absence of antibiotics led to isolation of only tetracycline sensitive or intermediate strains whereas tetracycline treatment resulted in a greater number of tetracycline resistant isolates.	[Wanninger, Sabrina; Hoffmann, Karolin; Seth-Smith, Helena M. B.; Marti, Hanna; Borel, Nicole] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Donati, Manuela] Univ Bologna, Microbiol, DIMES, Policlin S Orsola, Bologna, Italy; [Di Francesco, Antonietta] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Hassig, Michael] Univ Zurich, Vetsuisse Fac, Dept Farm Anim, Zurich, Switzerland	University of Zurich; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Zurich	Borel, N (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland.	n.borel@access.uzh.ch	Borel, Nicole/M-6204-2016; Marti, Hanna/AAA-3955-2021; Borel, Nicole/GPP-1073-2022	Borel, Nicole/0000-0002-1556-9262; Marti, Hanna/0000-0002-8398-4708; Borel, Nicole/0000-0002-1556-9262	Federal Food Safety and Veterinary Office (FSVO) [1.13.03]	Federal Food Safety and Veterinary Office (FSVO)	This study was supported by the Federal Food Safety and Veterinary Office (FSVO), research grant number 1.13.03 (NB); http://www.blv.admin.ch//index.html?iang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874; Bachmann NL, 2015, J CLIN MICROBIOL, V53, P1573, DOI 10.1128/JCM.03534-14; Blumer S, 2011, VET MICROBIOL, V152, P385, DOI 10.1016/j.vetmic.2011.05.024; Borel N, 2016, CURR CLIN MICROBIOL, V3, P10, DOI 10.1007/s40588-016-0028-4; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Borges V, 2013, INFECT GENET EVOL, V17, P23, DOI 10.1016/j.meegid.2013.03.035; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; De Puysseleyr K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0560-x; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Donati M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149914; Donati M, 2010, ANTIMICROB AGENTS CH, V54, P5379, DOI 10.1128/AAC.00553-10; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Guscetti F, 2009, VET MICROBIOL, V135, P157, DOI 10.1016/j.vetmic.2008.09.038; Hoffmann K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143576; Kohlhoff SA, 2015, EXPERT OPIN PHARMACO, V16, P205, DOI 10.1517/14656566.2015.999041; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Pathak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034931; Petyaev IM, 2010, INT J MED SCI, V7, P181; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Regula G, 2009, J ANTIMICROB CHEMOTH, V63, P805, DOI 10.1093/jac/dkp009; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rodloff A, 2008, DTSCH ARZTEBL INT, V105, P657, DOI 10.3238/arztebl.2008.0657; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Schachter J., 1999, CHLAMYDIA, P156; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schautteet K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-29; Seth-Smith HMB, 2013, NAT PROTOC, V8, P2404, DOI 10.1038/nprot.2013.147; The Federal Council, 2015, STRAT ANT RES SWITZ, P11; US Food and Drug Administration, 2015, SUMM REP ANT SOLD DI, P15; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Vodstrcil LA, 2015, J INFECT DIS, V211, P1628, DOI 10.1093/infdis/jiu670	37	23	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166917	10.1371/journal.pone.0166917	http://dx.doi.org/10.1371/journal.pone.0166917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893834	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000389472400055
J	Egan, B; Yuan, CC; Craske, ML; Labhart, P; Guler, GD; Arnott, D; Maile, TM; Busby, J; Henry, C; Kelly, TK; Tindell, CA; Jhunjhunwala, S; Zhao, F; Hatton, C; Bryant, BM; Classon, M; Trojer, P				Egan, Brian; Yuan, Chih-Chi; Craske, Madeleine Lisa; Labhart, Paul; Guler, Gulfem D.; Arnott, David; Maile, Tobias M.; Busby, Jennifer; Henry, Chisato; Kelly, Theresa K.; Tindell, Charles A.; Jhunjhunwala, Suchit; Zhao, Feng; Hatton, Charlie; Bryant, Barbara M.; Classon, Marie; Trojer, Patrick			An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition	PLOS ONE			English	Article							METHYLTRANSFERASE EZH2; SOMATIC MUTATIONS; LYMPHOMA; CELLS; H3K27; METHYLATION; SPECIFICITY; LANDSCAPE; CANCER	Chromatin immunoprecipitation and DNA sequencing (ChIP-seq) has been instrumental in inferring the roles of histone post-translational modifications in the regulation of transcription, chromatin compaction and other cellular processes that require modulation of chromatin structure. However, analysis of ChIP-seq data is challenging when the manipulation of a chromatin-modifying enzyme significantly affects global levels of histone post-translational modifications. For example, small molecule inhibition of the methyltransferase EZH2 reduces global levels of histone H3 lysine 27 trimethylation (H3K27me3). However, standard ChIP-seq normalization and analysis methods fail to detect a decrease upon EZH2 inhibitor treatment. We overcome this challenge by employing an alternative normalization approach that is based on the addition of Drosophila melanogaster chromatin and a D. melanogaster-specific antibody into standard ChIP reactions. Specifically, the use of an antibody that exclusively recognizes the D. melanogaster histone variant H2Av enables precipitation of D. melanogaster chromatin as a minor fraction of the total ChIP DNA. The D. melanogaster ChIP-seq tags are used to normalize the human ChIP-seq data from DMSO and EZH2 inhibitor-treated samples. Employing this strategy, a substantial reduction in H3K27me3 signal is now observed in ChIP-seq data from EZH2 inhibitor treated samples.	[Egan, Brian; Craske, Madeleine Lisa; Labhart, Paul; Henry, Chisato; Kelly, Theresa K.] Act Motif Inc, Carlsbad, CA 92208 USA; [Yuan, Chih-Chi; Busby, Jennifer; Zhao, Feng; Hatton, Charlie; Bryant, Barbara M.; Trojer, Patrick] Constellat Pharmaceut Inc, Cambridge, MA 02142 USA; [Guler, Gulfem D.; Tindell, Charles A.; Classon, Marie] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Arnott, David; Maile, Tobias M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Jhunjhunwala, Suchit] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Egan, B (corresponding author), Act Motif Inc, Carlsbad, CA 92208 USA.; Egan, B; Trojer, P (corresponding author), Constellat Pharmaceut Inc, Cambridge, MA 02142 USA.	egan@activemotif.com; patrick.trojer@constellationpharma.com	Maile, Tobias M/A-7805-2016; Jhunjhunwala, Suchit/GNH-2256-2022	Maile, Tobias M/0000-0003-0376-8683; Jhunjhunwala, Suchit/0000-0003-3484-0588; Hatton, Charlie/0000-0001-9903-4291; Bryant, Barbara/0000-0003-2707-1186; Egan, Brian/0000-0002-6354-6575	Constellation Pharmaceuticals; Genentech Inc; Active Motif Inc	Constellation Pharmaceuticals; Genentech Inc(Roche HoldingGenentech); Active Motif Inc	No specific funding was obtained for this project. General funds from Constellation Pharmaceuticals, Genentech Inc and Active Motif Inc were used to support the work. The funders provided support in the form of salaries for authors [BE, CCY, MC, PL, GDG, DA, TMM JB, CH, TKK, CAT, SJ, FZ, CH, BMB, MC, PT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bonhoure N, 2014, GENOME RES, V24, P1157, DOI 10.1101/gr.168260.113; Bradley WD, 2014, CHEM BIOL, V21, P1463, DOI 10.1016/j.chembiol.2014.09.017; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enroth S, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-2; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mortazavi A, 2013, GENOME RES, V23, P2136, DOI 10.1101/gr.158261.113; Nair NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039573; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Xu B, 2014, INT J ENG MATH, V2014, P1; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	31	58	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166438	10.1371/journal.pone.0166438	http://dx.doi.org/10.1371/journal.pone.0166438			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875550	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000014
J	Choudhary, S; Save, SN; Kishore, N; Hosur, RV				Choudhary, Sinjan; Save, Shreyada N.; Kishore, Nand; Hosur, Ramakrishna V.			Synergistic Inhibition of Protein Fibrillation by Proline and Sorbitol: Biophysical Investigations	PLOS ONE			English	Article							NATURALLY-OCCURRING OSMOLYTES; CHEMICAL CHAPERONES; AMYLOID AGGREGATION; LIGAND INTERACTION; IN-VITRO; BINDING; INSULIN; ALZHEIMERS; LYSOZYME; DISEASE	We report here interesting synergistic effects of proline and sorbitol, two well-known chemical chaperones, in the inhibition of fibrillation of two proteins, insulin and lysozyme. A combination of many biophysical techniques has been used to understand the structural morphology and modes of interaction of the chaperones with the proteins during fibrillation. Both the chaperones establish stronger polar interactions in the elongation and saturation stages of fibrillation compared to that in the native stage. However, when presented as a mixture, we also see contribution of hydrophobic interactions. Thus, a co-operative adjustment of polar and hydrophobic interactions between the chaperones and the protein surface seems to drive the synergistic effects in the fibrillation process. In insulin, this synergy is quantitatively similar in all the stages of the fibrillation process. These observations would have significant implications for understanding protein folding concepts, in general, and for designing combination therapies against protein fibrillation, in particular.	[Choudhary, Sinjan; Save, Shreyada N.; Hosur, Ramakrishna V.] Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Kalina Campus, Bombay, Maharashtra, India; [Kishore, Nand] Indian Inst Technol, Dept Chem, Bombay, Maharashtra, India; [Hosur, Ramakrishna V.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay, Maharashtra, India	UM-DAE Centre for Excellence in Basic Sciences; University of Mumbai; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR)	Hosur, RV (corresponding author), Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Kalina Campus, Bombay, Maharashtra, India.; Hosur, RV (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Bombay, Maharashtra, India.	hosur@tifr.res.in			Department of Atomic Energy, Govt of India; Department of Science and Technology, Govt of India; DST SERB, New Delhi [SB/FT/CS-169/2013]	Department of Atomic Energy, Govt of India(Department of Atomic Energy (DAE)); Department of Science and Technology, Govt of India(Department of Science & Technology (India)); DST SERB, New Delhi	Support was provided by Department of Atomic Energy, Govt of India; Department of Science and Technology, Govt of India; and DST SERB (SB/FT/CS-169/2013), New Delhi is appreciatively acknowledged for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algamal M, 2013, BIOPHYS J, V105, P1700, DOI 10.1016/j.bpj.2013.08.025; Arora A, 2004, PROTEIN SCI, V13, P2429, DOI 10.1110/ps.04823504; BOLEN DW, 1971, BIOCHEMISTRY-US, V10, P4136, DOI 10.1021/bi00798a019; Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Borwankar T, 2011, BIOCHEMISTRY-US, V50, P2048, DOI 10.1021/bi1018368; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; BOYER PM, 1992, CHEM ENG SCI, V47, P241, DOI 10.1016/0009-2509(92)80218-2; Bruzdziak P, 2016, ACTA BIOCHIM POL, V63, P65, DOI 10.18388/abp.2014_950; Bruzdziak P, 2013, J PHYS CHEM B, V117, P11502, DOI 10.1021/jp404780c; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; CHAKRABORTY S, 1990, BIOCHEM PHARMACOL, V39, P1181, DOI 10.1016/0006-2952(90)90260-R; Chattopadhyay MK, 2004, J BACTERIOL, V186, P8149, DOI 10.1128/JB.186.23.8149-8152.2004; Chaudhari MI, 2013, P NATL ACAD SCI USA, V110, P20557, DOI 10.1073/pnas.1312458110; Chen DL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501240; Chen JH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806847; Choudhary NL, 2005, INDIAN J BIOCHEM BIO, V42, P366; Choudhary S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17599; Christensen J.J., 1976, HDB PROTON IONIZATIO; Cooper A, 1994, Methods Mol Biol, V22, P109; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; HAARDT M, 1995, MOL GEN GENET, V246, P783, DOI 10.1007/BF00290728; Habermann SM, 1996, PROTEIN SCI, V5, P1229, DOI 10.1002/pro.5560050702; HALES CN, 1971, P NUTR SOC, V30, P282, DOI 10.1079/PNS19710054; Hindo SS, 2009, J AM CHEM SOC, V131, P16663, DOI 10.1021/ja907045h; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Kanapathipillai M, 2005, FEBS LETT, V579, P4775, DOI 10.1016/j.febslet.2005.07.057; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; KEMBLE AR, 1954, BIOCHEM J, V58, P46, DOI 10.1042/bj0580046; Kumar R, 2009, ARCH BIOCHEM BIOPHYS, V491, P1, DOI 10.1016/j.abb.2009.09.007; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Lohman TM, 1996, BIOCHEMISTRY-US, V35, P5272, DOI 10.1021/bi9527606; Lolicato F, 2015, EUR J MED CHEM, V92, P876, DOI 10.1016/j.ejmech.2015.01.047; LOVRIEN R, 1971, BIOCHEMISTRY-US, V10, P3811, DOI 10.1021/bi00797a001; McCrary BS, 1998, J MOL BIOL, V276, P203, DOI 10.1006/jmbi.1998.1500; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nolte KD, 1997, J AM SOC HORTIC SCI, V122, P8, DOI 10.21273/JASHS.122.1.8; Pechkova E, 2012, SYNCHROTRON RAD STRU, P220; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Pithadia AS, 2016, CHEM COMMUN, V52, P942, DOI 10.1039/c5cc07792c; PORTER RR, 1953, BIOCHEM J, V53, P320, DOI 10.1042/bj0530320; Prasad S, 2011, APPL ENVIRON MICROB, V77, P4603, DOI 10.1128/AEM.05259-11; Ramamoorthy A, 2013, BIOPHYS J, V105, P287, DOI 10.1016/j.bpj.2013.05.004; Ribarits A, 2007, PLANTA, V225, P1313, DOI 10.1007/s00425-006-0429-3; Roth SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044505; Salentin S, 2014, PROG BIOPHYS MOL BIO, V116, P174, DOI 10.1016/j.pbiomolbio.2014.05.006; Sciacca MFM, 2016, BIOPHYS J, V111, P140, DOI 10.1016/j.bpj.2016.05.050; Seeliger J, 2013, PHYS CHEM CHEM PHYS, V15, P8902, DOI 10.1039/c3cp44412k; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Soto C, 1999, J MOL MED-JMM, V77, P412, DOI 10.1007/s001090050371; Stone AJ, 2002, THE THEORY OF INTERM, P36; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Sukenik S, 2015, J CHEM THEORY COMPUT, V11, P5918, DOI 10.1021/acs.jctc.5b00657; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Vaney MC, 1996, ACTA CRYSTALLOGR D, V52, P505, DOI 10.1107/S090744499501674X; Vernaglia BA, 2004, BIOMACROMOLECULES, V5, P1362, DOI 10.1021/bm0498979; Waldron TT, 2005, J MOL BIOL, V346, P895, DOI 10.1016/j.jmb.2004.12.018; Wall J, 1999, METHOD ENZYMOL, V309, P204; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yip CM, 1998, BIOPHYS J, V75, P1172, DOI 10.1016/S0006-3495(98)74036-6	70	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166487	10.1371/journal.pone.0166487	http://dx.doi.org/10.1371/journal.pone.0166487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870861	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400014
J	Curtis, CA; Bradley, BA				Curtis, Caroline A.; Bradley, Bethany A.			Plant Distribution Data Show Broader Climatic Limits than Expert-Based Climatic Tolerance Estimates	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; RANGE SHIFTS; POTENTIAL RANGE; NICHE SHIFT; SAMPLE-SIZE; FORECASTS; PERFORMANCE; PHYSIOLOGY; INVASIONS; RESPONSES	Background Although increasingly sophisticated environmental measures are being applied to species distributions models, the focus remains on using climatic data to provide estimates of habitat suitability. Climatic tolerance estimates based on expert knowledge are available for a wide range of plants via the USDA PLANTS database. We aim to test how climatic tolerance inferred from plant distribution records relates to tolerance estimated by experts. Further, we use this information to identify circumstances when species distributions are more likely to approximate climatic tolerance. Methods We compiled expert knowledge estimates of minimum and maximum precipitation and minimum temperature tolerance for over 1800 conservation plant species from the 'plant characteristics' information in the USDA PLANTS database. We derived climatic tolerance from distribution data downloaded from the Global Biodiversity and Information Facility (GBIF) and corresponding climate from WorldClim. We compared expert-derived climatic tolerance to empirical estimates to find the difference between their inferred climate niches (ACN), and tested whether ACN was influenced by growth form or range size. Results Climate niches calculated from distribution data were significantly broader than expert based tolerance estimates (Mann-Whitney p values << 0.001). The average plant could tolerate 24 mm lower minimum precipitation, 14 mm higher maximum precipitation, and 7 C lower minimum temperatures based on distribution data relative to expert-based tolerance estimates. Species with larger ranges had greater ACN for minimum precipitation and minimum temperature. For maximum precipitation and minimum temperature, forbs and grasses tended to have larger ACN while grasses and trees had larger ACN for minimum precipitation. Conclusion Our results show that distribution data are consistently broader than USDA PLANTS experts' knowledge and likely provide more robust estimates of climatic tolerance, especially for widespread forbs and grasses. These findings suggest that widely available expert-based climatic tolerance estimates underrepresent species' fundamental niche and likely fail to capture the realized niche.	[Curtis, Caroline A.; Bradley, Bethany A.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Bradley, Bethany A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Curtis, CA (corresponding author), Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA.	cacurtis@cns.umass.edu	Bradley, Bethany/B-1964-2008	Bradley, Bethany/0000-0003-4912-4971	NASA's Biodiversity and Ecological Forecasting Program [NESSF: 15-EARTH15F-133]; National Institute of Food and Agriculture, U.S. Department of Agriculture; Massachusetts Agricultural Experiment Station; Department of Environmental Conservation [MAS00016]	NASA's Biodiversity and Ecological Forecasting Program; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Massachusetts Agricultural Experiment Station; Department of Environmental Conservation	This research was supported by NASA's Biodiversity and Ecological Forecasting Program (NESSF: 15-EARTH15F-133) and by the National Institute of Food and Agriculture, U.S. Department of Agriculture, the Massachusetts Agricultural Experiment Station and the Department of Environmental Conservation under Project No. MAS00016.; This research was supported by NASA's Biodiversity and Ecological Forecasting Program (NESSF: 15-EARTH15F-133) and by the National Institute of Food and Agriculture, U.S. Department of Agriculture, the Massachusetts Agricultural Experiment Station and the Department of Environmental Conservation under Project No. MAS00016. We thank Jesse Bellemare and Jack Finn for helpful advice.	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bocsi T, 2016, DIVERS DISTRIB, V22, P615, DOI 10.1111/ddi.12432; Booth TH, 2015, FOREST ECOL MANAG, V347, P18, DOI 10.1016/j.foreco.2015.03.002; Booth TH, 2014, FOREST ECOL MANAG, V315, P95, DOI 10.1016/j.foreco.2013.12.028; Bradley BA, 2015, GLOBAL ECOL BIOGEOGR, V24, P348, DOI 10.1111/geb.12275; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Buckley LB, 2011, ECOLOGY, V92, P2214, DOI 10.1890/11-0066.1; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Ceia-Hasse A, 2014, ECOGRAPHY, V37, P679, DOI 10.1111/j.1600-0587.2013.00600.x; Chamberlain S., 2015, RGBIF INTERFACE GLOB; Chown SL, 2016, FUNCT ECOL, V30, P330, DOI 10.1111/1365-2435.12510; COLWELL RK, 1975, ANNU REV ECOL SYST, V6, P281, DOI 10.1146/annurev.es.06.110175.001433; Coops NC, 2009, ECOL MODEL, V220, P1787, DOI 10.1016/j.ecolmodel.2009.04.029; Cuddington K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00178.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Diamond SE, 2012, ECOLOGY, V93, P2305, DOI 10.1890/11-2296.1; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Evans TG, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov056; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Latimer CE, 2017, ECOGRAPHY, V40, P158, DOI 10.1111/ecog.02551; Li YM, 2014, GLOBAL ECOL BIOGEOGR, V23, P1094, DOI 10.1111/geb.12191; Martinez B, 2015, GLOBAL CHANGE BIOL, V21, P1422, DOI 10.1111/gcb.12655; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Zhang J, 2016, J APPL ECOL, DOI [10.1111/1365-2664, DOI 10.1111/1365-2664]	53	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166407	10.1371/journal.pone.0166407	http://dx.doi.org/10.1371/journal.pone.0166407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870859	Green Submitted, gold, Green Published			2022-12-26	WOS:000388846400012
J	Badr, E; ElHefnawi, M; Heath, LS				Badr, Eman; ElHefnawi, Mahmoud; Heath, Lenwood S.			Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq Data	PLOS ONE			English	Article							DEFINITION; EXPRESSION; EVENTS; CELL	Alternative splicing is a vital process for regulating gene expression and promoting proteomic diversity. It plays a key role in tissue-specific expressed genes. This specificity is mainly regulated by splicing factors that bind to specific sequences called splicing regulatory elements (SREs). Here, we report a genome-wide analysis to study alternative splicing on multiple tissues, including brain, heart, liver, and muscle. We propose a pipeline to identify differential exons across tissues and hence tissue-specific SREs. In our pipeline, we utilize the DEXSeq package along with our previously reported algorithms. Utilizing the publicly available RNA-Seq data set from the Human BodyMap project, we identified 28,100 differentially used exons across the four tissues. We identified tissue-specific exonic splicing enhancers that overlap with various previously published experimental and computational databases. A complicated exonic enhancer regulatory network was revealed, where multiple exonic enhancers were found across multiple tissues while some were found only in specific tissues. Putative combinatorial exonic enhancers and silencers were discovered as well, which may be responsible for exon inclusion or exclusion across tissues. Some of the exonic enhancers are found to be co-occurring with multiple exonic silencers and vice versa, which demonstrates a complicated relationship between tissue-specific exonic enhancers and silencers.	[Badr, Eman] Cairo Univ, Fac Computers & Informat, Dept Informat Technol, Giza, Egypt; [ElHefnawi, Mahmoud] Natl Res Ctr, Informat & Syst Dept, Ctr Excellence Adv Sci, Cairo, Egypt; [ElHefnawi, Mahmoud] Nile Univ, Ctr Informat Sci, Sheikh Zayed City, Egypt; [Heath, Lenwood S.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Nile University; Virginia Polytechnic Institute & State University	Badr, E (corresponding author), Cairo Univ, Fac Computers & Informat, Dept Informat Technol, Giza, Egypt.	ebadr@cu.edu.eg	Heath, Lenwood Scott/A-5861-2008; ElHefnawi, Mahmoud/S-7426-2016	Heath, Lenwood Scott/0000-0003-1608-431X; Badr, Eman M./0000-0001-9531-2266; ElHefnawi, Mahmoud/0000-0003-3896-6911				Alamancos GP, 2014, METHODS MOL BIOL, V1126, P357, DOI 10.1007/978-1-62703-980-2_26; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Badr E, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0698-6; Badr E, 2014, J COMPUT BIOL, V21, P880, DOI 10.1089/cmb.2014.0183; Barash Y, 2010, BIOINFORMATICS, V26, pi325, DOI 10.1093/bioinformatics/btq200; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Buendia P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S2-S1; Buratti E, 2013, BRIEF FUNCT GENOMICS, V12, P3, DOI 10.1093/bfgp/els048; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chang X, 2015, P NATL ACAD SCI USA, V112, pE1888, DOI 10.1073/pnas.1422490112; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Eichner J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-55; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fedorov A, 2001, NUCLEIC ACIDS RES, V29, P1464, DOI 10.1093/nar/29.7.1464; Giulietti M, 2013, NUCLEIC ACIDS RES, V41, pD125, DOI 10.1093/nar/gks997; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Ke SD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r84; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim J, 2009, LECT N BIOINFORMAT, V5542, P260; Lv Y, 2013, GENOMICS, V102, P229, DOI 10.1016/j.ygeno.2013.05.001; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; Reyes A., 2014, INFERRING DIFFERENTI; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang X, 2008, 8 IEEE INT C, P1; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054885; Wen J, 2010, NUCLEIC ACIDS RES, V38, P7895, DOI 10.1093/nar/gkq679; Xiao XS, 2010, WIRES SYST BIOL MED, V2, P550, DOI 10.1002/wsbm.84; Zhang J, 2012, J COMPUT BIOL, V19, P855, DOI 10.1089/cmb.2012.0063; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang XHF, 2003, GENOME RES, V13, P2637, DOI 10.1101/gr.1679003	38	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166978	10.1371/journal.pone.0166978	http://dx.doi.org/10.1371/journal.pone.0166978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861625	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300139
J	Salas-Gomez, D; Fernandez-Gorgojo, M; Pozueta, A; Diaz-Ceballos, I; Lamarain, M; Perez, C; Sanchez-Juan, P				Salas-Gomez, Diana; Fernandez-Gorgojo, Mario; Pozueta, Ana; Diaz-Ceballos, Isabel; Lamarain, Maider; Perez, Carmen; Sanchez-Juan, Pascual			Binge Drinking in Young University Students Is Associated with Alterations in Executive Functions Related to Their Starting Age	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; WORKING-MEMORY; ALCOHOL-CONSUMPTION; COGNITIVE FUNCTION; ADOLESCENT BRAIN; CANNABIS USE; PERFORMANCE; DRINKERS; POPULATION; ETHANOL	Our aim was to evaluate whether or not alcohol consumption in the form of binge drinking is associated with alterations of memory and executive functions in a population of university students. At the same time, we have studied the role of potential modulating factors, such as the APOE genotype or physical exercise. University students enrolled in academic year 2013-2014 at Escuelas Universitarias Gimbernat-Cantabria, affiliated with the University of Cantabria, were invited to participate in the study. We gathered sociodemographic data and details regarding the lifestyle of 206 students (mean age 19.55 +/- 2.39; 67.5% women). We evaluated memory and executive functions via a series of validated cognitive tests. Participants were classified as binge drinkers (BD) and non-BD. Using Student's t-distribution we studied the association between cognitive tests and BD patterns. Multivariate analyses were carried out via multiple linear regression. 47.6% of the students were found to be BD. The BD differed significantly from the non-BD in their results in the executive functions test TMT B (43.41 +/- 13.30 vs 37.40 +/- 9.77; p = 0.0003). Adjusting by age, sex, academic records, age at which they started consuming alcohol, cannabis consumption, level of physical activity and other possible modifying variables, the association was statistically significant (p = 0.009). We noticed a statistically significant inverse correlation (Pearson's r(2) = -0.192; p = 0.007) between TMT B and starting age of alcohol consumption. Differences were observed in another executive functions test, TMT A, but only in the group of women (19.73 +/- 6.1 BD vs 17.78 +/- 5.4 non-BD p = 0.05). In spite of the young age of our participants, BD was associated with a lower performance in the executive functions test (TMT B). These deficits were related to the age at which they started drinking alcohol, suggesting an accumulative effect.	[Salas-Gomez, Diana; Fernandez-Gorgojo, Mario; Perez, Carmen; Sanchez-Juan, Pascual] Univ Cantabria, Univ Sch Gimbernat Cantabria, Gimbernat Cantabria Res Unit SUIGC, Torrelavega, Spain; [Salas-Gomez, Diana; Fernandez-Gorgojo, Mario; Pozueta, Ana; Diaz-Ceballos, Isabel; Lamarain, Maider; Perez, Carmen; Sanchez-Juan, Pascual] Univ Cantabria, Univ Sch Gimbernat Cantabria, Torrelavega, Spain; [Pozueta, Ana; Sanchez-Juan, Pascual] Univ Cantabria, CIBERNED, IDIVAL, Serv Neurol,Univ Hosp Marques de Valdecilla, Santander, Spain	Universidad de Cantabria; Universidad de Cantabria; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Sanchez-Juan, P (corresponding author), Univ Cantabria, Univ Sch Gimbernat Cantabria, Gimbernat Cantabria Res Unit SUIGC, Torrelavega, Spain.; Sanchez-Juan, P (corresponding author), Univ Cantabria, Univ Sch Gimbernat Cantabria, Torrelavega, Spain.; Sanchez-Juan, P (corresponding author), Univ Cantabria, CIBERNED, IDIVAL, Serv Neurol,Univ Hosp Marques de Valdecilla, Santander, Spain.	psanchez@humv.es	Fernandez-Gorgojo, mario/H-7738-2012; Fernandez-Gorgojo, Mario/AAE-8768-2022; Sanchez-Juan, Pascual/B-9282-2009	Fernandez-Gorgojo, mario/0000-0001-8216-9472; Fernandez-Gorgojo, Mario/0000-0001-8216-9472; Sanchez-Juan, Pascual/0000-0002-6081-8037; Salas-Gomez, Diana/0000-0001-6794-7002; Lamarain Altuna, Maider/0000-0002-3551-375X				Aguirre-Acevedo DC, 2007, REV NEUROLOGIA, V45, P655, DOI 10.33588/rn.4511.2007086; Bartres-Faz D, 2002, ADDICT BIOL, V7, P227, DOI 10.1080/135562102200120451; Batalla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055821; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; Brown SA, 2015, J STUD ALCOHOL DRUGS, V76, P895, DOI 10.15288/jsad.2015.76.895; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Crego A, 2010, DRUG ALCOHOL DEPEN, V109, P45, DOI 10.1016/j.drugalcdep.2009.11.020; Crego A, 2009, ALCOHOL CLIN EXP RES, V33, P1870, DOI 10.1111/j.1530-0277.2009.01025.x; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Day AM, 2013, J STUD ALCOHOL DRUGS, V74, P635, DOI 10.15288/jsad.2013.74.635; Doallo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096380; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; ESTUDES, 2013, SPAN DRUG OBS; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; Garcia-Moreno L M, 2008, ADICCIONES, V20, P271, DOI DOI 10.20882/ADICCI0NES.269; Garcioa-Moreno L M, 2009, NEUROPSICOLOGIA NEUR, V9, P75; Gill JS, 2002, ALCOHOL ALCOHOLISM, V37, P109, DOI 10.1093/alcalc/37.2.109; Golden CJ, 1997, STROOP COLOR WORD TE; Gonzalez R, 2012, J CLIN EXP NEUROPSYC, V34, P962, DOI 10.1080/13803395.2012.703642; Green A, 2010, ALCOHOL CLIN EXP RES, V34, P443, DOI 10.1111/j.1530-0277.2009.01108.x; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; Harwood DG, 2010, INT J GERIATR PSYCH, V25, P511, DOI 10.1002/gps.2372; Heffernan T, 2010, DRUG ALCOHOL DEPEN, V109, P73, DOI 10.1016/j.drugalcdep.2009.12.013; Heffernan Thomas M, 2008, Curr Drug Abuse Rev, V1, P36; Hildebrandt H, 2004, NEUROPSYCHOLOGY, V18, P203, DOI 10.1037/0894-4105.18.2.203; Hildebrandt H, 2010, CLIN EXPT RES, V34, P443; Isorna F, 2009, J STUD ALCOHOL DRUGS, P69; Jamal M, 2012, PHARMACOL BIOCHEM BE, V101, P443, DOI 10.1016/j.pbb.2012.02.006; Lange JE, 2002, ALCOHOL CLIN EXP RES, V26, P723, DOI 10.1097/00000374-200205000-00019; Mann K, 2005, ALCOHOL CLIN EXP RES, V29, P896, DOI 10.1097/01.ALC.0000164376.69978.6B; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parada M, 2012, ADDICT BEHAV, V37, P167, DOI 10.1016/j.addbeh.2011.09.015; Parada M, 2011, ALCOHOL CLIN EXP RES, V35, P1475, DOI 10.1111/j.1530-0277.2011.01484.x; Parada M, 2011, ADICCIONES, V23, P53, DOI 10.20882/adicciones.167; Partington JE, 1949, PSYCHOL SERVICE CTR, V1, P11; Patrick ME, 2013, ALCOHOL RES-CURR REV, V35, P193; Phillips C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00170; Rey A., 1975, TEST COPIA REPROD ME; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Seisdedos N, 2004, WMS 3 ESCALA MEMORIA; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Sneider JT, 2013, J ADDICT RES THER S7; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Stephens DN, 2008, PHILOS T R SOC B, V363, P3169, DOI 10.1098/rstb.2008.0097; Tait RJ, 2011, ADDICTION, V106, P2195, DOI 10.1111/j.1360-0443.2011.03574.x; Townshend JM, 2005, ALCOHOL CLIN EXP RES, V29, P317, DOI 10.1097/01.ALC.0000156453.05028.F5; Townshend JM, 2003, NEUROPSYCHOLOGIA, V41, P773, DOI 10.1016/S0028-3932(02)00284-1; Wechsler D, 1997, WMS 3 WECHSLER MEMOR; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; Yu VWY, 2000, NEUROSCI LETT, V294, P179, DOI 10.1016/S0304-3940(00)01569-X	56	26	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166834	10.1371/journal.pone.0166834	http://dx.doi.org/10.1371/journal.pone.0166834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861563	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300120
J	Ziehe, D; Diinschede, B; Zenker, M; Funke, S; Nowaczyk, MM; Schunemann, D				Ziehe, Dominik; Diinschede, Beatrix; Zenker, Mira; Funke, Silke; Nowaczyk, Marc M.; Schunemann, Danja			The Chloroplast SRP Systems of Chaetosphaeridium globosum and Physcomitrella patens as Intermediates in the Evolution of SRP-Dependent Protein Transport in Higher Plants	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; 4.5S RNA; GTPASE ACTIVATION; STRUCTURAL BASIS; RECEPTOR; BINDING; DYNAMICS; TRANSLOCASE; SUBSTRATE; PATHWAY	The bacterial signal recognition particle (SRP) mediates the cotranslational targeting of membrane proteins and is a high affinity complex consisting of a SRP54 protein subunit (Ffh) and an SRP RNA. The chloroplast SRP (cpSRP) pathway has adapted throughout evolution to enable the posttranslational targeting of the light harvesting chlorophyll a/b binding proteins (LHCPs) to the thylakoid membrane. In spermatophytes (seed plants), the cpSRP lacks the SRP RNA and is instead formed by a high affinity interaction of the conserved 54-kD subunit (cpSRP54) with the chloroplast-specific cpSRP43 protein. This heterodimeric cpSRP recognizes LHCP and delivers it to the thylakoid membrane. However, in contrast to spermatophytes, plastid SRP RNAs were identified within all streptophyte lineages and in all chlorophyte branches. Furthermore, it was shown that cpSRP43 does not interact with cpSRP54 in chlorophytes (e.g., Chlamydomonas reinhardtii). In this study, we biochemically characterized the cpSRP system of the charophyte Chaetosphaeridium globosum and the bryophyte Physcomitrella patens. Interaction studies demonstrate low affinity binding of cpSRP54 to cpSRP43 (K-d similar to 10 mu M) in Chaetosphaeridium globosum and Physcomitrella patens as well as relatively low affinity binding of cpSRP54 to cpSRP RNA (K-d similar to 1 mu M) in Physcomitrella patens. CpSRP54/cpSRP43 complex formation in charophytes is supported by the finding that specific alterations in the second chromodomain of cpSRP43, that are conserved within charophytes and absent in land plants, do not interfere with cpSRP54 binding. Furthermore, our data show that the elongated apical loop structure of the Physcomitrella patens cpSRP RNA contributes to the low binding affinity between cpSRP54 and the cpSRP RNA.	[Ziehe, Dominik; Diinschede, Beatrix; Zenker, Mira; Funke, Silke; Schunemann, Danja] Ruhr Univ Bochum, Mol Biol Plant Organelles, D-44780 Bochum, Germany; [Nowaczyk, Marc M.] Ruhr Univ Bochum, Cyanobacterial Membrane Prot Complexes, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Schunemann, D (corresponding author), Ruhr Univ Bochum, Mol Biol Plant Organelles, D-44780 Bochum, Germany.	Danja.Schuenemann@rub.de	Nowaczyk, Marc/D-4214-2014	Nowaczyk, Marc/0000-0002-9269-0672; Schuenemann, Danja/0000-0001-8894-7685	Deutsche Forschungsgemeinschaft [SFB 642, EXC 1069]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) grant SFB 642 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Beate Kern (NanoTemper Technologies GmbH, Munich, Germany) for support in the design and analysis of the microscale thermophoresis experiments. We thank Klaus Hagemann for assistance with figure preparation. We also thank the Cluster of Excellence RESOLV (EXC 1069) funded by the Deutsche Forschungsgemeinschaft.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Buskiewicz I, 2005, RNA, V11, P947, DOI 10.1261/rna.7242305; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; Dunschede B, 2015, J BIOL CHEM, V290, P13104, DOI 10.1074/jbc.M114.597922; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Gao F, 2015, J BIOL CHEM, V290, P15462, DOI 10.1074/jbc.M114.624346; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Horn A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9875; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Liang FC, 2016, P NATL ACAD SCI USA, V113, pE1615, DOI 10.1073/pnas.1524777113; Menger M, 2000, BIOCHEMISTRY-US, V39, P4500, DOI 10.1021/bi992297n; Miner JC, 2016, P NATL ACAD SCI USA, V113, P6665, DOI 10.1073/pnas.1603154113; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; Rosenblad MA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26848; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; SELINGER D, 1993, P NATL ACAD SCI USA, V90, P5409, DOI 10.1073/pnas.90.12.5409; SELINGER D, 1993, MOL CELL BIOL, V13, P1353, DOI 10.1128/MCB.13.3.1353; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Voigts-Hoffmann F, 2013, MOL CELL, V52, P643, DOI 10.1016/j.molcel.2013.10.005; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166818	10.1371/journal.pone.0166818	http://dx.doi.org/10.1371/journal.pone.0166818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861610	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300112
J	Su, X; Napoli, M; Abbas, HA; Venkatanarayan, A; Bui, NHB; Coarfa, C; Gi, YJ; Kittrell, F; Gunaratne, PH; Medina, D; Rosen, JM; Behbod, F; Flores, ER				Su, X.; Napoli, M.; Abbas, H. A.; Venkatanarayan, A.; Bui, N. H. B.; Coarfa, C.; Gi, Y. J.; Kittrell, F.; Gunaratne, P. H.; Medina, D.; Rosen, J. M.; Behbod, F.; Flores, E. R.			TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway	ONCOGENE			English	Article							STEM-CELL MARKERS; BREAST-CANCER; EPITHELIAL MIGRATION; GLAND DEVELOPMENT; SELF-RENEWAL; P63; EXPRESSION; MORPHOGENESIS; POLARITY; DELTA-NP63	Mechanisms regulating the transition of mammary epithelial cells (MECs) to mammary stem cells (MaSCs) and to tumor-initiating cells (TICs) have not been entirely elucidated. The p53 family member, p63, is critical for mammary gland development and contains transactivation domain isoforms, which have tumor-suppressive activities, and the Delta N isoforms, which act as oncogenes. In the clinic, p63 is often used as a diagnostic marker, and further analysis of the function of TAp63 in the mammary gland is critical for improved diagnosis and patient care. Loss of TAp63 in mice leads to the formation of aggressive metastatic mammary adenocarcinoma at 9-16 months of age. Here we show that TAp63 is crucial for the transition of mammary cancer cells to TICs. When TAp63 is lost, MECs express embryonic and MaSC signatures and activate the Hippo pathway. These data indicate a crucial role for TAp63 in mammary TICs and provide a mechanism for its role as a tumor-and metastasis-suppressor in breast cancer.	[Su, X.; Napoli, M.; Abbas, H. A.; Venkatanarayan, A.; Bui, N. H. B.; Gi, Y. J.; Flores, E. R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Su, X.; Napoli, M.; Abbas, H. A.; Venkatanarayan, A.; Bui, N. H. B.; Gi, Y. J.; Flores, E. R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Venkatanarayan, A.; Bui, N. H. B.; Kittrell, F.; Flores, E. R.] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Coarfa, C.; Medina, D.; Rosen, J. M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gunaratne, P. H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Behbod, F.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Baylor College of Medicine; University of Houston System; University of Houston; University of Kansas; University of Kansas Medical Center	Flores, ER (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	elsa.flores@moffitt.org		Napoli, Marco/0000-0001-7192-5252; Bui, Ngoc/0000-0001-5161-1133	National Cancer Institute (NCI) [R35CA197452, R01CA160394, R01CA134796]; Cancer Prevention & Research Institute of Texas (CPRIT) [RP120124, RP150094]; Hildegardo E and Olga M. Flores Foundation; NCI-Cancer Center Core Grant (University of Texas MD Anderson Cancer Center) [CA-16672]; Cancer Prevention and Research Institute of Texas [RP140106]; American Cancer Society grant [IRG-09-062-01];  [R01CA16303]; NATIONAL CANCER INSTITUTE [R35CA197452, P30CA016672, R01CA134796, R01CA160394] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention & Research Institute of Texas (CPRIT); Hildegardo E and Olga M. Flores Foundation; NCI-Cancer Center Core Grant (University of Texas MD Anderson Cancer Center); Cancer Prevention and Research Institute of Texas; American Cancer Society grant(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the work of Henry P Adams, Microscopy Core of the Genetics Department. We also thank Leif Ellisen for the kind gift of the TAp63 shRNA. This study was funded by R35CA197452, R01CA160394 and R01CA134796 from the National Cancer Institute (NCI) and RP120124 and RP150094 from the Cancer Prevention & Research Institute of Texas (CPRIT) and funding from the Hildegardo E and Olga M. Flores Foundation to ERF, NCI-Cancer Center Core Grant (CA-16672) (University of Texas MD Anderson Cancer Center) and R01CA16303 to JMR. ERF is an NCI Outstanding Investigator, a Moffitt Distinguished Scholar, a scholar of the Leukemia and Lymphoma Society, the Rita Allen Foundation and the V Foundation for Cancer Research. MN is a CPRIT-TRIUMPH Scholar and was supported by a Research Training Award from the Cancer Prevention and Research Institute of Texas (RP140106). HAA is an Odyssey Fellow at MD Anderson Cancer Center. FB was supported in part by an American Cancer Society grant (IRG-09-062-01), awarded to the University of Kansas Medical Center.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Amin N, 2012, FRONT BIOSCI-LANDMRK, V17, P784, DOI 10.2741/3957; Anastas JN, 2012, ONCOGENE, V31, P3696, DOI 10.1038/onc.2011.528; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Chakravarti D, 2014, P NATL ACAD SCI USA, V111, pE572, DOI 10.1073/pnas.1319743111; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hiemer SE, 2013, BBA-GEN SUBJECTS, V1830, P2323, DOI 10.1016/j.bbagen.2012.07.005; Koker MM, 2004, AM J SURG PATHOL, V28, P1506, DOI 10.1097/01.pas.0000138183.97366.fd; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li J, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0070-0; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Muller PAJ, 2014, J BIOL CHEM, V289, P122, DOI 10.1074/jbc.M113.502138; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nguyen-Ngoc KV, 2015, METHODS MOL BIOL, V1189, P135, DOI 10.1007/978-1-4939-1164-6_10; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Shi PG, 2015, ACTA BIOCH BIOPH SIN, V47, P53, DOI 10.1093/abbs/gmu114; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Tsang JYS, 2012, BREAST CANCER RES TR, V136, P407, DOI 10.1007/s10549-012-2271-6; Vaira V, 2011, AM J PATHOL, V178, P2478, DOI 10.1016/j.ajpath.2011.02.028; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Yamben IF, 2013, DEV BIOL, V384, P41, DOI 10.1016/j.ydbio.2013.09.027; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004	51	23	24	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2377	2393		10.1038/onc.2016.388	http://dx.doi.org/10.1038/onc.2016.388			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27869165	Green Published, hybrid			2022-12-26	WOS:000400268900005
J	Kilroy, G; Burk, DH; Floyd, ZE				Kilroy, Gail; Burk, David H.; Floyd, Z. Elizabeth			Siah2 Protein Mediates Early Events in Commitment to an Adipogenic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; BONE MORPHOGENETIC PROTEINS; EMBRYONIC STEM-CELLS; ADIPOSE-TISSUE; BETA-CATENIN; CANONICAL WNT; ADIPOCYTE DIFFERENTIATION; PREADIPOCYTE COMMITMENT; PROGENITOR CELLS; IN-VITRO	Adipose tissue expansion occurs by increasing the size of existing adipocytes or by increasing the number of adipocytes via adipogenesis. Adipose tissue dysfunction in obesity is associated with adipocyte hypertrophy and impaired adipogenesis. We recently demonstrated that deletion of the ubiquitin ligase Siah2 is associated with enlarged adipocytes in lean or obese mice. In this study, we find that adipogenesis is impaired in 3T3-L1 preadipocytes stably transfected with Siah2 shRNA and that overexpression of Siah2 in non-precursor fibroblasts promotes adipogenesis. In the 3T3-L1 model, loss of Siah2 is associated with sustained beta-catenin expression post-induction, but depletion of beta-catenin only partially restores PPAR gamma expression and adipocyte formation. Using wild-type and Siah2(-/-) adipose tissue and adipose stromal vascular cells, we observe that Siah2 influences the expression of several factors that control adipogenesis, including Wnt pathway genes, beta-catenin, Zfp432, and Bmp-4. Consistent with increased beta-catenin levels in shSiah2 preadipocytes, Wnt10b is elevated in Siah2(-/-) adipose tissue and remains elevated in Siah2(-/-) primary stromal cells after addition of the induction mixture. However, addition of BMP-4 to Siah2(-/-) stromal cells reduces Wnt10b expression, reduces Zfp521 protein levels, and increases expression of Zfp423, a transcriptional regulator of peroxisome proliferator-activated receptor gamma expression that controls commitment to adipogenesis and is repressed by Zfp521. These results indicate that Siah2 acts upstream of BMP-4 to regulate factors that control the commitment of adipocyte progenitors to an adipogenic pathway. Our findings reveal an essential role for Siah2 in the early events that signal undifferentiated progenitor cells to become mature adipocytes.	[Kilroy, Gail; Burk, David H.; Floyd, Z. Elizabeth] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Floyd, ZE (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Elizabeth.Floyd@pbrc.edu	Floyd, Elizabeth/W-2758-2019; Floyd, Elizabeth/N-1962-2017; Burk, David/D-2056-2009	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186; 	COBRE [NIH 8P20-GM103528]; NORC center grants from the National Institutes of Health [NIH 2P30-DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099625, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	COBRE; NORC center grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the Cell Biology and Bioimaging Core and the Genomics Core facilities at Pennington Biomedical Research Center, which are supported in part by COBRE (NIH 8P20-GM103528) and NORC (NIH 2P30-DK072476) center grants from the National Institutes of Health.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Atkinson SP, 2012, STEM CELLS, V30, P1373, DOI 10.1002/stem.1113; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Dani C, 1997, J CELL SCI, V110, P1279; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grunberg JR, 2014, J BIOL CHEM, V289, P6899, DOI 10.1074/jbc.M113.511964; Grundy SM, 2000, ENDOCRINE, V13, P155, DOI 10.1385/ENDO:13:2:155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kilroy G, 2015, OBESITY, V23, P2223, DOI 10.1002/oby.21220; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Masserdotti G, 2010, J BIOL CHEM, V285, P30814, DOI 10.1074/jbc.M110.142869; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moran-Crusio K, 2012, TRENDS IMMUNOL, V33, P357, DOI 10.1016/j.it.2012.01.009; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Pal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065330; REDDI AH, 1993, J BONE MINER RES, V8, pS499; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Severe N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.217; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STERN JS, 1972, LANCET, V2, P948; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Watanabe M, 2015, ELIFE, V4, DOI 10.7554/eLife.05615; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yu G, 2011, METHODS MOL BIOL, V702, P29, DOI 10.1007/978-1-61737-960-4_3	50	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27289	27297		10.1074/jbc.M116.744672	http://dx.doi.org/10.1074/jbc.M116.744672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864366	Green Published, hybrid			2022-12-26	WOS:000391576300026
J	Elya, C; Zhang, V; Ludington, WB; Eisen, MB				Elya, Carolyn; Zhang, Vivian; Ludington, William B.; Eisen, Michael B.			Stable Host Gene Expression in the Gut of Adult Drosophila melanogaster with Different Bacterial Mono-Associations	PLoS One			English	Article							LIFE-SPAN; IMMUNE HOMEOSTASIS; PERITROPHIC MATRIX; MICROBIOTA; DYSBIOSIS; INSIGHTS; GROWTH; WORLD	There is growing evidence that the microbes found in the digestive tracts of animals influence host biology, but we still do not understand how they accomplish this. Here, we evaluated how different microbial species commonly associated with laboratory-reared Drosophila melanogaster impact host biology at the level of gene expression in the dissected adult gut and in the entire adult organism. We observed that guts from animals associated from the embryonic stage with either zero, one or three bacterial species demonstrated indistinguishable transcriptional profiles. Additionally, we found that the gut transcriptional profiles of animals reared in the presence of the yeast Saccharomyces cerevisiae alone or in combination with bacteria could recapitulate those of conventionally-reared animals. In contrast, we found whole body transcriptional profiles of conventionally-reared animals were distinct from all of the treatments tested. Our data suggest that adult flies are insensitive to the ingestion of the bacteria found in their gut, but that prior to adulthood, different microbes impact the host in ways that lead to global transcriptional differences observable across the whole adult body.	[Elya, Carolyn; Zhang, Vivian; Ludington, William B.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Elya, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	elyac@berkeley.edu		Elya, Carolyn/0000-0002-9634-0303	MBE's Investigator Award from the Howard Hughes Medical Institute; National Institutes of Health Director's Early Independence Award [DP50 D017851-01]; Bowes Research Fellowship from the MCB Department at UC Berkeley; CE's Graduate Research Fellowship from the National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017851] Funding Source: NIH RePORTER	MBE's Investigator Award from the Howard Hughes Medical Institute; National Institutes of Health Director's Early Independence Award; Bowes Research Fellowship from the MCB Department at UC Berkeley; CE's Graduate Research Fellowship from the National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by MBE's Investigator Award from the Howard Hughes Medical Institute, the National Institutes of Health Director's Early Independence Award DP50 D017851-01 to WBL, the Bowes Research Fellowship from the MCB Department at UC Berkeley to WBL, and CE's Graduate Research Fellowship from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the MBE's Investigator Award from the Howard Hughes Medical Institute, WBL's Early Investigator Award from the National Institutes of Health and CE's Graduate Research Fellowship from the National Science Foundation. The authors would like to thank Edan Foley and members of MBE's research group for comments on an earlier draft of this manuscript. The authors also gratefully acknowledge reviewers William Etges and Nichole Broderick for their helpful feedback on the submitted version.	BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Broderick NA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0295; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Combe BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094729; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Day A, 2003, YEAST CELL SYNCHRONI, P55; Erkosar B, 2015, CELL HOST MICROBE, V18, P445, DOI 10.1016/j.chom.2015.09.001; Fast D, 2016, LACTOBACILLUS PLANTA, DOI [10.1101/049981, DOI 10.1101/049981]; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; HARTMAN JR, 1993, J EXP ZOOL, V267, P365, DOI 10.1002/jez.1402670403; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lee WJ, 2008, CELL HOST MICROBE, V4, P91, DOI 10.1016/j.chom.2008.07.007; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li HJ, 2016, CELL HOST MICROBE, V19, P240, DOI 10.1016/j.chom.2016.01.008; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Najarro MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1173; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ridley EV, 2013, APPL ENVIRON MICROB, V79, P3209, DOI 10.1128/AEM.00206-13; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; SANG JH, 1961, J EXP BIOL, V38, P793; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xu W, 2011, FOOD MICROBIOL, V28, P1175, DOI 10.1016/j.fm.2011.03.011; Yamada R, 2015, CELL REP, V10, P865, DOI 10.1016/j.celrep.2015.01.018	42	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167357	10.1371/journal.pone.0167357	http://dx.doi.org/10.1371/journal.pone.0167357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898741	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474000058
J	He, H; Ye, A; Kim, H; Kim, J				He, Hongzhi; Ye, An; Kim, Hana; Kim, Joomyeong			PEG3 Interacts with KAP1 through KRAB-A	PLOS ONE			English	Article							ATP-CITRATE LYASE; IMPRINTED GENE; PROXIMAL CHROMOSOME-7; FINGER; MOUSE; METHYLATION; DOMAIN; HOMOLOG; PROTEIN; MOTIF	Peg3 (Paternally Expressed Gene 3) is an imprinted gene that encodes a zinc finger DNA-binding protein. Peg3 itself is localized in the middle of a KRAB-A (Kruppel-Associated Box) zinc finger gene cluster. The amino acid sequence encoded by its exon 7 also shows sequence similarity to that of KRAB-A, suggesting Peg3 as a KRAB-containing zinc finger gene. As predicted, the PEG3 protein was co-immunoprecipitated with KAP1, a co-repressor that interacts with KRAB-A. A series of follow-up experiments further demonstrated that the exon 7 of PEG3 is indeed responsible for its physical interaction with KAP1. ChIP and promoter assays also indicated that PEG3 likely controls its downstream genes through the KAP1-mediated repression mechanism. Overall, the current study identifies PEG3 as a KRAB-containing zinc finger protein that interacts with the co-repressor protein KAP1.	[He, Hongzhi; Ye, An; Kim, Hana; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Ryan Carl Kunz at Harvard Medical School for his help in tandem mass spectrometry. We also like to thank the members of JooKim Lab for their thoughtful feedback and discussion on the manuscript. This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).	Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Do Kim J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-108; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kim J, 2004, GENOMICS, V84, P47, DOI 10.1016/j.ygeno.2004.02.007; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2001, NATL FISH RES DEV I, V2001, P77; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim JY, 1999, HUM MOL GENET, V8, P847, DOI 10.1093/hmg/8.5.847; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liu H, 2014, GENOME BIOL EVOL, V6, P510, DOI 10.1093/gbe/evu030; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Shannon M, 1998, GENOMICS, V49, P112, DOI 10.1006/geno.1998.5230; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Trono D, 2015, COLD SH Q B, V80, P281, DOI 10.1101/sqb.2015.80.027573; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167541	10.1371/journal.pone.0167541	http://dx.doi.org/10.1371/journal.pone.0167541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898713	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000067
J	Wang, SP; Zhang, XX; Zhang, YL				Wang, Shangping; Zhang, Xiaoxue; Zhang, Yaling			Efficiently Multi-User Searchable Encryption Scheme with Attribute Revocation and Grant for Cloud Storage	PLOS ONE			English	Article							MANAGEMENT	Cipher-policy attribute-based encryption (CP-ABE) focus on the problem of access control, and keyword-based searchable encryption scheme focus on the problem of finding the files that the user interested in the cloud storage quickly. To design a searchable and attribute based encryption scheme is a new challenge. In this paper, we propose an efficiently multi-user searchable attribute-based encryption scheme with attribute revocation and grant for cloud storage. In the new scheme the attribute revocation and grant processes of users are delegated to proxy server. Our scheme supports multi attribute are revoked and granted simultaneously. Moreover, the keyword searchable function is achieved in our proposed scheme. The security of our proposed scheme is reduced to the bilinear Diffie-Hellman (BDH) assumption. Furthermore, the scheme is proven to be secure under the security model of indistinguishability against selective ciphertext-policy and chosen plaintext attack (IND-sCP-CPA). And our scheme is also of semantic security under indistinguishability against chosen keyword attack (IND-CKA) in the random oracle model.	[Wang, Shangping; Zhang, Xiaoxue] Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China; [Zhang, Yaling] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology; Xi'an University of Technology	Zhang, XX (corresponding author), Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China.	iszhangxiaoxue@163.com		Wang, Shangping/0000-0002-8964-5328	National Natural Science Foundation of China [61572019, 61173192]; Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China [2016JZ001]; Research Foundation of Education Department of Shaanxi Province of China [2013JK1142]; Research Foundation of science and technology of Xi'an Beilin district of China [GX1407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China; Research Foundation of Education Department of Shaanxi Province of China; Research Foundation of science and technology of Xi'an Beilin district of China	This work is supported by the National Natural Science Foundation of China under grants 61572019, 61173192, the Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China under Grant No. 2016JZ001, the Research Foundation of Education Department of Shaanxi Province of China under grants 2013JK1142, and the Research Foundation of science and technology of Xi'an Beilin district of China under grants GX1407.	Attrapadung N, 2009, IM INT C CRYPT COD 2; Bao F, 2008, LECT NOTES COMPUT SC, V4991, P71; Bethencourt J, 2008, IEEE S 2007 SEC PRIV; Boneh D, 2004, LECT NOTES COMPUT SC, V3027, P506; Bringer J, 2009, IEEE ICC, P768; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Chen JH, 2011, J INF SCI ENG, V27, P437; Duquesne S, 2004, MATHIISCERNETIN, V22, P573; Emura K, 2009, LECT NOTES COMPUT SC, V5451, P13, DOI 10.1007/978-3-642-00843-6_2; Goyal V, 2015, BOUNDED CIPHERTEXT; Goyal V, 2006, P 13 ACM C COMP COMM, P89, DOI DOI 10.1145/1180405.1180418; Hu CY, 2012, J COMPUT, V7, P716, DOI 10.4304/jcp.7.3.716-723; Javanmardi S, 2015, INT J GRID UTIL COMP, V6, P57, DOI 10.1504/IJGUC.2015.066397; Jian Y, 2014, INT C COMP COMM NETW; Kaci A, 2014, IEEE INT C INF REUS; Kallahalla M, 2003, US C FIL STOR TECHN; Li Q, 2012, GLOB COMM C GLOBECOM; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Liu Z, 2013, INT C EM INT DAT WEB; Lv Z, 2014, IEEE INT C CLOUD COM; Lv Z, 2014, IEEE INT C TRUST SEC; Martinez-Vara P, 2009, CTR TELEMATICS INFOR, V13, P325; Naruse T, 2015, HUM-CENT COMPUT INFO, V5, DOI 10.1186/s13673-015-0027-0; Rhee HS, 2010, J SYST SOFTWARE, V83, P763, DOI 10.1016/j.jss.2009.11.726; Sahai A, 2005, LECT NOTES COMPUT SC, V3494, P457, DOI 10.1007/11426639_27; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Shojafar M, 2015, PEER PEER NETW APPL, V8, P120, DOI 10.1007/s12083-013-0236-0; Umar MM, 2016, SECURITY COMMUNICATI; Wang Q, 2014, INT C CLOUD COMP BIG; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Wu QX, 2014, CHINA COMMUN, V11, P93, DOI 10.1109/CC.2014.7022531; Wu QX, 2012, CHINA COMMUN, V9, P22; Xu Q, 2016, IEEE ACCESS, V4, P2840, DOI 10.1109/ACCESS.2016.2575863; Yang Y, 2011, IEEE INT C CLOUD COM; Yu S, 2010, ACM S INF APR; Zhang Y, 2013, INT C INT NETW COLL; Zhang Y, 2014, IEEE INTERNET THINGS, V1, P311, DOI 10.1109/JIOT.2014.2329462	37	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167157	10.1371/journal.pone.0167157	http://dx.doi.org/10.1371/journal.pone.0167157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898703	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000036
J	Wang, XB; Luo, FJ; Qian, Y; Ranzi, G				Wang, Xibin; Luo, Fengji; Qian, Ying; Ranzi, Gianluca			A Personalized Electronic Movie Recommendation System Based on Support Vector Machine and Improved Particle Swarm Optimization	PLOS ONE			English	Article								With the rapid development of ICT and Web technologies, a large an amount of information is becoming available and this is producing, in some instances, a condition of information overload. Under these conditions, it is difficult for a person to locate and access useful information for making decisions. To address this problem, there are information filtering systems, such as the personalized recommendation system (PRS) considered in this paper, that assist a person in identifying possible products or services of interest based on his/her preferences. Among available approaches, collaborative Filtering (CF) is one of the most widely used recommendation techniques. However, CF has some limitations, e.g., the relatively simple similarity calculation, cold start problem, etc. In this context, this paper presents a new regression model based on the support vector machine (SVM) classification and an improved PSO (IPSO) for the development of an electronic movie PRS. In its implementation, a SVM classification model is first established to obtain a preliminary movie recommendation list based on which a SVM regression model is applied to predict movies' ratings. The proposed PRS not only considers the movie's content information but also integrates the users' demographic and behavioral information to better capture the users' interests and preferences. The efficiency of the proposed method is verified by a series of experiments based on the MovieLens benchmark data set.	[Wang, Xibin; Qian, Ying] Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China; [Wang, Xibin; Qian, Ying] Chongqing Engn Res Ctr Software Qual Assurance Te, Chongqing, Peoples R China; [Luo, Fengji] Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia; [Luo, Fengji] Chongqing Univ, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; University of Sydney; Chongqing University	Luo, FJ (corresponding author), Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia.; Luo, FJ (corresponding author), Chongqing Univ, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China.	tracyluofengji@gmail.com		Ranzi, Gianluca/0000-0003-4603-8349	National Natural Science Foundation of China [61171060, 61379158]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1600437]; Visiting Scholarship of State Key Laboratory of Power Transmission Equipment AMP; System Security and New Technology (Chongqing University, China) [2007DA10512716401]; Australian Research Council [FT140100130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Research Program of Chongqing Municipal Education Commission; Visiting Scholarship of State Key Laboratory of Power Transmission Equipment AMP; System Security and New Technology (Chongqing University, China); Australian Research Council(Australian Research Council)	This work was supported in part by the National Natural Science Foundation of China under Grant Nos. 61171060 and 61379158, in part by the Scientific and Technological Research Program of Chongqing Municipal Education Commission under Grant No. KJ1600437, in part by a Visiting Scholarship of State Key Laboratory of Power Transmission Equipment & System Security and New Technology (Chongqing University, China) (2007DA10512716401), and in part by an Australian Research Council through its Future Fellowship scheme (FT140100130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported in part by the National Natural Science Foundation of China under Grant Nos. 61171060 and 61379158, in part by the Scientific and Technological Research Program of Chongqing Municipal Education Commission under Grant No. KJ1600437, in part by a Visiting Scholarship of State Key Laboratory of Power Transmission Equipment & System Security and New Technology (Chongqing University, China) (2007DA10512716401), and in part by an Australian Research Council through its Future Fellowship scheme (FT140100130).	Berti G, 2006, FUTURE GENER COMP SY, V22, P110, DOI 10.1016/j.future.2003.09.002; Billsus D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P46; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Deng WY, 2011, NEUROCOMPUTING, V74, P1848, DOI 10.1016/j.neucom.2010.07.034; Du WB, 2017, IEEE T CIRCUITS-II, V64, P467, DOI 10.1109/TCSII.2016.2595597; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Gu JR, 2011, EXPERT SYST APPL, V38, P3383, DOI 10.1016/j.eswa.2010.08.123; Hassan R., 2005, STRUCT DYNAM-US, V7, P1, DOI [DOI 10.2514/6.2005-1897, 10.2514/6.2005-1897]; Herlocker JL, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P230, DOI 10.1145/312624.312682; Hong WX, 2012, EXPERT SYST APPL, V39, P12398, DOI 10.1016/j.eswa.2012.04.082; Jiao LC, 2012, PATTERN RECOGN, V45, P4358, DOI 10.1016/j.patcog.2012.05.007; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Lee SK, 2010, INFORM SCIENCES, V180, P2142, DOI 10.1016/j.ins.2010.02.004; Li L, 2011, J COMPUT SCI TECH-CH, V26, P754, DOI 10.1007/s11390-011-0175-2; Li P., 2007, ADV NEURAL INFORM PR, P897; Liang X, 2009, NEUROCOMPUTING, V72, P3055, DOI 10.1016/j.neucom.2009.03.015; Luo FJ, 2014, IEEE T SMART GRID, V5, P1892, DOI 10.1109/TSG.2014.2314451; Pazzani M, 1997, MACH LEARN, V27, P313, DOI 10.1023/A:1007369909943; Pucci A., 2006, P INT MULT COMP SCI, V1, P189; Resnick P., 1994, Transcending Boundaries, CSCW '94. Proceedings of the Conference on Computer Supported Cooperative Work, P175, DOI 10.1145/192844.192905; Shang RH, 2016, PATTERN RECOGN, V55, P172, DOI 10.1016/j.patcog.2016.01.035; Shang RH, 2016, NEUROCOMPUTING, V171, P1242, DOI 10.1016/j.neucom.2015.07.068; Shang RH, 2012, IEEE T EVOLUT COMPUT, V16, P35, DOI 10.1109/TEVC.2010.2046328; Ungar L.H., 1998, AAAI WORKSH REC SYST, V1, P114; Yang LX, 2015, KNOWL-BASED SYST, V79, P80, DOI 10.1016/j.knosys.2015.01.006; Zhang T, 2002, J MACH LEARN RES, V2, P313, DOI 10.1162/153244302760200641; Zhang Y, 2007, P 30 ANN INT ACM SIG, P47, DOI [10.1145/1277741.1277752, DOI 10.1145/1277741.1277752]; Zheng Y, 2014, IEEE T POWER SYST, V29, P212, DOI 10.1109/TPWRS.2013.2278850	28	6	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0165868	10.1371/journal.pone.0165868	http://dx.doi.org/10.1371/journal.pone.0165868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898691	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474000004
J	Cheng, YX; Luo, LZ; Sappington, TW; Jiang, XF; Zhang, L; Frolov, AN				Cheng, Yunxia; Luo, Lizhi; Sappington, Thomas W.; Jiang, Xingfu; Zhang, Lei; Frolov, Andrei N.			Onset of Oviposition Triggers Abrupt Reduction in Migratory Flight Behavior and Flight Muscle in the Female Beet Webworm, Loxostege sticticalis	PLOS ONE			English	Article							WING-DIMORPHIC CRICKET; LEPIDOPTERA-PYRALIDAE; EGG-PRODUCTION; HISTOLYSIS; INSECTS; REPRODUCTION; PERFORMANCE; DISPERSAL; BREAKDOWN; COTTON	Flight and reproduction are usually considered as two life history traits that compete for resources in a migratory insect. The beet webworm, Loxostege sticticalis L., manages the costs of migratory flight and reproduction through a trade-off in timing of these two life history traits, where migratory behavior occurs during the preoviposition period. To gain insight into how migratory flight and reproduction are coordinated in the female beet webworm, we conducted experiments beginning at the end of the preoviposition period. We used flight mills to test whether flight performance and supportive flight musculature and fuel are affected by the number of eggs oviposited, or by the age of mated and unmated females after onset of oviposition by the former. The results showed that flight distance, flight velocity, flight duration, and flight muscle mass decreased abruptly at the onset of oviposition, compared to that of virgin females of the same age which did not change over the next 7 d. These results indicate that onset of oviposition triggers a decrease in flight performance and capacity in female beet webworms, as a way of actively managing reallocation of resources away from migratory flight and into egg production. In addition to the abrupt switch, there was a gradual, linear decline in flight performance, flight muscle mass, and flight fuel relative to the number of eggs oviposited. The histolysis of flight muscle and decrease of triglyceride content indicate a progressive degradation in the ability of adults to perform additional migratory flights after onset of oviposition. Although the results show that substantial, albeit reduced, long-duration flights remain possible after oviposition begins, additional long-distance migratory flights probably are not launched after the initiation of oviposition.	[Cheng, Yunxia; Luo, Lizhi; Jiang, Xingfu; Zhang, Lei] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Sappington, Thomas W.] Iowa State Univ, Genet Lab, Corn Insects & Crop Genet Res Unit, USDA,ARS, Ames, IA USA; [Frolov, Andrei N.] All Russian Inst Plant Protect, St Petersburg, Russia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Iowa State University; United States Department of Agriculture (USDA); All-Russian Institute of Plant Protection	Luo, LZ; Jiang, XF (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	lzluo@ippcaas.cn; xfjiang@ippcaas.cn	Frolov, Andrey N./K-3409-2014	Frolov, Andrey N./0000-0002-6942-9951	National Natural Science Foundation of China [31301656, 31371947]; National Department of Public Benefit Research Project of China [201303057, 201403031]; International Science AMP; Technology Cooperation Program of China [2014DFR31250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department of Public Benefit Research Project of China; International Science AMP; Technology Cooperation Program of China	This work was funded by the National Natural Science Foundation of China (31301656; 31371947), the National Department of Public Benefit Research Project of China (201303057; 201403031), and the International Science & Technology Cooperation Program of China (2014DFR31250). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMES NJ, 1991, PHYSIOL ENTOMOL, V16, P131, DOI 10.1111/j.1365-3032.1991.tb00549.x; BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Chen Yang, 2012, Acta Entomologica Sinica, V55, P176; Cheng YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031562; Cheng YX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev135; [程云霞 Cheng Yunxia], 2013, [植物保护, Plant Protection], V39, P26; Cotto O, 2014, AM NAT, V183, P384, DOI 10.1086/675064; Denno R.F., 1981, INSECT LIFE HIST PAT, DOI 10.1007/978-1-4612-5941-1; DINGLE H, 1972, SCIENCE, V175, P1327, DOI 10.1126/science.175.4028.1327; DIXON AFG, 1993, J ANIM ECOL, V62, P182, DOI 10.2307/5492; EDWARDS FJ, 1969, J INSECT PHYSIOL, V15, P2013, DOI 10.1016/0022-1910(69)90069-9; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Gu HN, 2006, ECOL ENTOMOL, V31, P68, DOI 10.1111/j.0307-6946.2006.00761.x; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1631, DOI 10.1016/j.jinsphys.2010.06.006; Jiang Xing-Fu, 2002, Acta Entomologica Sinica, V45, P275; Jiang XF, 2010, ENVIRON ENTOMOL, V39, P232, DOI 10.1603/EN08315; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; JOHNSON B, 1957, J INSECT PHYSIOL, V1, P248, DOI 10.1016/0022-1910(57)90040-9; Johnson C.G., 1969, MIGRATION DISPERSAL; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; Kong HL, 2010, ENVIRON ENTOMOL, V39, P1579, DOI 10.1603/EN09314; Lorenz MW, 2007, J INSECT PHYSIOL, V53, P819, DOI 10.1016/j.jinsphys.2007.03.011; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P332; Luo Lizhi, 1995, Acta Entomologica Sinica, V38, P284; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; Ronce O, 2000, EVOL ECOL, V14, P233, DOI 10.1023/A:1011068005057; Ronce Ophelie, 2004, P227, DOI 10.1016/B978-012323448-3/50012-X; SAPPINGTON TW, 1992, ENVIRON ENTOMOL, V21, P677, DOI 10.1093/ee/21.4.677; Song W, 2016, PLANT PROT, V42, P23; Spurgeon DW, 1998, ENVIRON ENTOMOL, V22, P251; Stjernholm F, 2008, EUR J ENTOMOL, V105, P87, DOI 10.14411/eje.2008.012; TANAKA S, 1991, J INSECT PHYSIOL, V37, P517, DOI 10.1016/0022-1910(91)90028-X; Tanaka S, 2001, J INSECT PHYSIOL, V47, P83, DOI 10.1016/S0022-1910(00)00094-9; TANAKA S, 1993, J INSECT PHYSIOL, V39, P493, DOI 10.1016/0022-1910(93)90081-2; Xie DS, 2012, ENVIRON ENTOMOL, V41, P1199, DOI 10.1603/EN11068; ZAIDI ZS, 1985, B ZOOL, V52, P305, DOI 10.1080/11250008509440532; Zera AJ, 2001, J INSECT PHYSIOL, V47, P1147, DOI 10.1016/S0022-1910(01)00096-8; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121821; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	42	12	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166859	10.1371/journal.pone.0166859	http://dx.doi.org/10.1371/journal.pone.0166859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893835	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400050
J	Montaseri, S; Ganjtabesh, M; Zare-Mirakabad, F				Montaseri, Soheila; Ganjtabesh, Mohammad; Zare-Mirakabad, Fatemeh			Evolutionary Algorithm for RNA Secondary Structure Prediction Based on Simulated SHAPE Data	PLOS ONE			English	Article							SOFTWARE	Background Non-coding RNAs perform a wide range of functions inside the living cells that are related to their structures. Several algorithms have been proposed to predict RNA secondary structure based on minimum free energy. Low prediction accuracy of these algorithms indicates that free energy alone is not sufficient to predict the functional secondary structure. Recently, the obtained information from the SHAPE experiment greatly improves the accuracy of RNA secondary structure prediction by adding this information to the thermodynamic free energy as pseudo-free energy. Method In this paper, a new method is proposed to predict RNA secondary structure based on both free energy and SHAPE pseudo-free energy. For each RNA sequence, a population of secondary structures is constructed and their SHAPE data are simulated. Then, an evolutionary algorithm is used to improve each structure based on both free and pseudo-free energies. Finally, a structure with minimum summation of free and pseudo-free energies is considered as the predicted RNA secondary structure. Results and Conclusions Computationally simulating the SHAPE data for a given RNA sequence requires its secondary structure. Here, we overcome this limitation by employing a population of secondary structures. This helps us to simulate the SHAPE data for any RNA sequence and consequently improves the accuracy of RNA secondary structure prediction as it is confirmed by our experiments. The source code and web server of our proposed method are freely available at http://mostafa.utacdr/ESD-Fold/.	[Montaseri, Soheila; Ganjtabesh, Mohammad] Univ Tehran, Dept Comp Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Zare-Mirakabad, Fatemeh] Amirkabir Univ Technol, Dept Comp Sci, Fac Math & Comp Sci, Tehran, Iran	University of Tehran; Amirkabir University of Technology	Ganjtabesh, M (corresponding author), Univ Tehran, Dept Comp Sci, Sch Math Stat & Comp Sci, Tehran, Iran.	mgtabesh@ut.ac.ir	Zare-Mirakabad, Fatemeh/T-2862-2019; Zare-Mirakabad, Fatemeh/AAH-7191-2021	Zare-Mirakabad, Fatemeh/0000-0003-2849-3778				Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kladwang W, 2011, BIOCHEMISTRY-US, V50, P8049, DOI [10.1021/bi4200524n, 10.1021/bi200524n]; Leonard CW, 2013, BIOCHEMISTRY-US, V52, P588, DOI 10.1021/bi300755u; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathuriya A, 2009, 24 ANN ACM S APPL CO; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Storz G, 2006, COLD SPRING HARB MON, V43, P567; Sukosd Z, 2013, NUCLEIC ACIDS RES, V41, P2807, DOI 10.1093/nar/gks1283; Thulasi P, 2010, BIOCHEMISTRY-US, V49, P9058, DOI 10.1021/bi101164s; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1994, Methods Mol Biol, V25, P267	19	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166965	10.1371/journal.pone.0166965	http://dx.doi.org/10.1371/journal.pone.0166965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893832	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400064
J	Song, DL; Wilson, B; Zhao, LL; Bhuyan, R; Bandyopadhyay, M; Lyubarsky, A; Yu, C; Li, YF; Kanu, L; Miwa, T; Song, WC; Finnemann, SC; Rohrer, B; Dunaief, JL				Song, Delu; Wilson, Brooks; Zhao, Liangliang; Bhuyan, Rupak; Bandyopadhyay, Mausumi; Lyubarsky, Arkady; Yu, Chen; Li, Yafeng; Kanu, Levi; Miwa, Takashi; Song, Wen-Chao; Finnemann, Silvia C.; Rohrer, Barbel; Dunaief, Joshua L.			Retinal Pre-Conditioning by CD59a Knockout Protects against Light-Induced Photoreceptor Degeneration	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; PIGMENT EPITHELIAL-CELLS; COMPLEMENT REGULATORY PROTEINS; CHELATOR DEFERIPRONE PROTECTS; DECAY-ACCELERATING FACTOR; FACTOR-H DEFICIENCY; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FUNCTIONAL-CHARACTERIZATION; OXIDATIVE STRESS	Complement dysregulation plays a key role in the pathogenesis of age-related macular degeneration (AMD), but the specific mechanisms are incompletely understood. Complement also potentiates retinal degeneration in the murine light damage model. To test the retinal function of CD59a, a complement inhibitor, CD59a knockout (KO) mice were used for light damage (LD) experiments. Retinal degeneration and function were compared in WT versus KO mice following light damage. Gene expression changes, endoplasmic reticulum (ER) stress, and glial cell activation were also compared. At baseline, the ERG responses and rhodopsin levels were lower in CD59aKO compared to wild-type (WT) mice. Following LD, the ERG responses were better preserved in CD59aKO compared to WT mice. Correspondingly, the number of photoreceptors was higher in CD59aKO retinas than WT controls after LD. Under normal light conditions, CD59aKO mice had higher levels than WT for GFAP immunostaining in Muller cells, mRNA and protein levels of two ER-stress markers, and neurotrophic factors. The reduction in photon capture, together with the neurotrophic factor upregulation, may explain the structural and functional protection against LD in the CD59aKO.	[Song, Delu; Zhao, Liangliang; Bhuyan, Rupak; Lyubarsky, Arkady; Li, Yafeng; Kanu, Levi; Dunaief, Joshua L.] Univ Penn, Perelman Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Wilson, Brooks; Bandyopadhyay, Mausumi; Rohrer, Barbel] Med Univ South Carolina, Dept Ophthalmol, 171 Ashley Ave, Charleston, SC 29425 USA; [Zhao, Liangliang] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun, Jilin, Peoples R China; [Yu, Chen; Finnemann, Silvia C.] Fordham Univ, Dept Biol Sci, Ctr Canc Genet Dis & Gene Regulat, Bronx, NY 10458 USA; [Miwa, Takashi; Song, Wen-Chao] Univ Penn, Perelman Sch Med, Dept Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Rohrer, Barbel] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA	University of Pennsylvania; Pennsylvania Medicine; Medical University of South Carolina; Jilin University; Fordham University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Dunaief, JL (corresponding author), Univ Penn, Perelman Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.; Rohrer, B (corresponding author), Med Univ South Carolina, Dept Ophthalmol, 171 Ashley Ave, Charleston, SC 29425 USA.; Rohrer, B (corresponding author), Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA.	rohrer@musc.edu; jdunaief@upenn.edu	Yu, Chen/GPG-1530-2022	Yu, Chen/0000-0001-9651-9875; Song, Delu/0000-0002-9030-7211; Kanu, Levi/0000-0001-6428-4696	NIH [EY015240, CO6RR015455]; Research to Prevent Blindness; FM Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; National Center for Advancing Translational Sciences of the NIH [KL2TR001879]; National Institutes of Health [NIH R01EY019320, R01EY013295]; Department for Veteran Affairs merit award [RX000444]; Beckman Initiative for Macular Research; Research to Prevent Blindness (RPB), New York, NY; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001879] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320, R01EY013295, P30EY001583, R01EY015240] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); FM Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department for Veteran Affairs merit award; Beckman Initiative for Macular Research; Research to Prevent Blindness (RPB), New York, NY(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in the laboratory of J.D. by NIH EY015240, Research to Prevent Blindness, the FM Kirby Foundation, the Paul and Evanina Bell Mackall Foundation Trust, a gift in memory of Dr. Lee F. Mauger, and grant KL2TR001879 from the National Center for Advancing Translational Sciences of the NIH; in the laboratory of B.R. in part by the National Institutes of Health (NIH R01EY019320), a Department for Veteran Affairs merit award RX000444, the Beckman Initiative for Macular Research, an unrestricted grant to MUSC from Research to Prevent Blindness (RPB), New York, NY; and in the laboratory of S.C.F. by grants from the National Institutes of Health (R01EY013295) and the Beckman Initiative for Macular Research. B.R.'s animal studies were conducted in a facility constructed with support from the NIH CO6RR015455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in the laboratory of J.L.D. by NIH EY015240, Research to Prevent Blindness, the FM Kirby Foundation, the Paul and Evanina Bell Mackall Foundation Trust, a gift in memory of Dr. Lee F. Mauger, and grant KL2TR001879 from the National Center for Advancing Translational Sciences of the NIH; in the laboratory of B.R. in part by the National Institutes of Health (NIH R01EY019320), a Department for Veteran Affairs merit award RX000444, the Beckman Initiative for Macular Research, an unrestricted grant to MUSC from Research to Prevent Blindness (RPB), New York, NY; and in the laboratory of S.C.F. by grants from the National Institutes of Health (R01EY013295) and the Beckman Initiative for Macular Research. B.R.'s animal studies were conducted in a facility constructed with support from the NIH C06RR015455.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Bandyopadhyay M, 2010, MOL VIS, V16, P1178; Bayer AU, 2001, VISION RES, V41, P2173, DOI 10.1016/S0042-6989(01)00103-1; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORA NS, 1993, INVEST OPHTH VIS SCI, V34, P3579; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Chollangi S, 2009, NEUROBIOL DIS, V34, P535, DOI 10.1016/j.nbd.2009.03.012; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Ebrahimi KB, 2014, ADV EXP MED BIOL, V801, P259, DOI 10.1007/978-1-4614-3209-8_33; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Hadziahmetovic M, 2012, INVEST OPHTH VIS SCI, V53, P5231, DOI 10.1167/iovs.12-10204; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Herrmann P, 2015, NEUROBIOL AGING, V36, P2637, DOI 10.1016/j.neurobiolaging.2015.05.019; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kunchithapautham K, 2011, J BIOL CHEM, V286, P23717, DOI 10.1074/jbc.M110.214593; Liu CD, 1998, J NEUROSCI, V18, P1337; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; MEDOF ME, 1985, P NATL ACAD SCI USA, V82, P2980, DOI 10.1073/pnas.82.9.2980; Miwa T, 2002, BLOOD, V99, P3707, DOI 10.1182/blood.V99.10.3707; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; NICHOLSONWELLER A, 1983, P NATL ACAD SCI-BIOL, V80, P5066, DOI 10.1073/pnas.80.16.5066; Noell W K, 1966, Invest Ophthalmol, V5, P450; Ohlsson M, 2006, NEUROSCI LETT, V394, P179, DOI 10.1016/j.neulet.2005.10.037; PANGBURN MK, 1983, P NATL ACAD SCI-BIOL, V80, P5430, DOI 10.1073/pnas.80.17.5430; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; Powell MB, 1997, J IMMUNOL, V158, P1692; Qian YM, 2000, J IMMUNOL, V165, P2528, DOI 10.4049/jimmunol.165.5.2528; Radu RA, 2014, J BIOL CHEM, V289, P9113, DOI 10.1074/jbc.M114.548669; Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282; ROSSE WF, 1985, CLIN HAEMATOL, V14, P105; Schnabolk G, 2014, EXP EYE RES, V129, P18, DOI 10.1016/j.exer.2014.10.005; Sethna Saumil, 2013, Methods Mol Biol, V935, P245, DOI 10.1007/978-1-62703-080-9_17; SHAHINFAR S, 1991, CURR EYE RES, V10, P47, DOI 10.3109/02713689109007610; Song DL, 2014, AM J PATHOL, V184, P2721, DOI 10.1016/j.ajpath.2014.06.010; Song DL, 2014, INVEST OPHTH VIS SCI, V55, P4525, DOI 10.1167/iovs.14-14568; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Sulewski M., 2015, ARVO; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Torres PMM, 2001, J NEUROIMMUNOL, V117, P43, DOI 10.1016/S0165-5728(01)00303-4; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; Vogt SD, 2006, EXP EYE RES, V83, P834, DOI 10.1016/j.exer.2006.04.002; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wilson RB, 2007, INVEST OPHTH VIS SCI, V48, P2877, DOI 10.1167/iovs.06-1079; Wong P, 2001, CURR EYE RES, V23, P157, DOI 10.1076/ceyr.23.3.157.5463; Woodell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067894; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yu MZ, 2012, INVEST OPHTH VIS SCI, V53, P7684, DOI 10.1167/iovs.12-10069	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166348	10.1371/journal.pone.0166348	http://dx.doi.org/10.1371/journal.pone.0166348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893831	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400022
J	Asgedom, SW; Gudina, EK; Desse, TA				Asgedom, Solomon Woldegebriel; Gudina, Esayas Kebede; Desse, Tigestu Alemu			Assessment of Blood Pressure Control among Hypertensive Patients in Southwest Ethiopia	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION; UNCONTROLLED HYPERTENSION; PREVALENCE; PREDICTORS; POPULATION; ADHERENCE; ADULTS	Background The rate of blood pressure control among hypertensive patients is poor and the reasons for poor control of blood pressure remain poorly understood globally. Objective To assess the rate of blood pressure control among adult hypertensive patients at Jimma University Specialized Hospital. Materials and Methods We conducted a hospital based cross sectional study among adult hypertensive patients at Jimma University Specialized Hospital hypertension clinic from March 4, 2015 to April 3, 2015. Data on sociodemographic characteristics of the participants and adherence to antihypertensive medication(s) were collected from patients by face to face interview using a pretested structured questionnaire. Comorbidities, antihypertensive medication(s) and blood pressure measurements were collected retrospectively from medical records. Medication adherence was assessed using Morisky's Medication Adherence Scale-8 score. We did the statistical analysis using chi-square test and binary logistic regression with level of a set at 0.05. Statistical significance was considered for variables with p<0.05. Results Out of 311 participants, 286 patients were eligible and were studied. More than half, 154 (53.8%), of the participants were males. The mean age of the participants was 54.8 +/- 12.6 years (range 26 to 94). The majority, 196 (68.53%), of the participants were taking more than one antihypertensive medication. More than one third (39.5%) of the participants were non adherent to their medication(s). The rate of blood pressure control was 50.3%. In a univariate logistic regression analyses, age >= 65 years old (P = 0.008), physical inactivity (p<0.001), chat chewing (P<0.001), adding salt to food (P<0.001), and coffee use (P<0.001) are significantly associated with uncontrolled blood pressure Conclusion Almost half of the hypertensive patients on follow up had uncontrolled blood pressure. We recommend better health education and care of patients to improve the rate of blood pressure control at the hospital.	[Asgedom, Solomon Woldegebriel] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Clin Pharm Unit, Mekelle, Ethiopia; [Gudina, Esayas Kebede] Jimma Univ, Sch Med, Dept Internal Med, Jimma, Ethiopia; [Desse, Tigestu Alemu] Univ Addis Ababa, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia	Mekelle University; Jimma University; Addis Ababa University	Desse, TA (corresponding author), Univ Addis Ababa, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia.	tgfrekidan16@gmail.com	Gudina, Esayas Kebede/U-9370-2019; Desse, Tigestu Alemu/ADX-1554-2022; Gudina, Esayas Kebede/AAX-2374-2020; Desse, Tigestu Alemu/V-5992-2019	Gudina, Esayas Kebede/0000-0002-6264-9695; Gudina, Esayas Kebede/0000-0002-6264-9695; Desse, Tigestu Alemu/0000-0002-6116-0433				Adebolu FA, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.572; Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Al Bannay R, 2014, BAHRAIN MED B, V36, P163, DOI 10.12816/0008110; Ali ZH, 2015, J NURS ED PRACT, V5, P1; Ambaw AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-282; [Anonymous], 2002, NAT CHOL ED PROGR EX; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Asch Steven M, 2005, BMC Cardiovasc Disord, V5, P1, DOI 10.1186/1471-2261-5-1; Bader RJK, 2015, E MEDITERR HEALTH J, V21, P309; Baynouna LM, 2014, UN ARAB EMIRATES, V29, P234; Boima V, 2015, INT J HYPERTENS, V2015, P1; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Degli Esposti E, 2004, J HUM HYPERTENS, V18, P207, DOI 10.1038/sj.jhh.1001656; Dehghan M, 2011, BR J MED MED RES, V5, P235; Dennison-himmelfarb C, 2014, 2014 EVIDENCE BASED, V1097, P507; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Elzubier A G, 2000, East Mediterr Health J, V6, P100; Falase AO, 2012, BLOOD PRESSURE PREVA, V4, P327; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Getahun W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-390; Goverwa Tafadzwa Priscilla, 2014, BMC Res Notes, V7, P703, DOI 10.1186/1756-0500-7-703; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Hareri HA, 2014, EHIOPIA CROSS SECTIO, V3, P760; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Knight EL, 2001, HYPERTENSION, V38, P809, DOI 10.1161/hy0901.091681; Kubo MN, 2013, HINDAWI PUBL CORP J, V2015, P1; Lulebo Aimee M, 2015, BMC Res Notes, V8, P526, DOI 10.1186/s13104-015-1519-8; Mallat SG, 2014, BMC PUBLIC HEALTH, V14, P1; Misganaw A, 2014, J HEALTH POPUL NUTR, V32, P1; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Muxfeldt Elizabeth Silaid, 2004, Sao Paulo Med. J., V122, P87, DOI 10.1590/S1516-31802004000300003; Omuemu V. O., 2006, Journal of Medicine and Biomedical Research, V5, P79; Reddy K Srinath, 2006, Curr Cardiol Rep, V8, P399, DOI 10.1007/s11886-006-0096-9; Stern LN, 2009, PATIENT ADHERENCE DI; Tesfaye A., 2015, AM J BIOMEDICAL LIFE, V3, P41, DOI DOI 10.11648/J.AJBLS.20150303.13; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Van de Vijver S, 2013, PAN AFRICAN MED J; Weber MA, 2014, COMMUNICATION, V16; Youssef R M, 2002, East Mediterr Health J, V8, P579; Zhang M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-301	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166432	10.1371/journal.pone.0166432	http://dx.doi.org/10.1371/journal.pone.0166432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880781	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500022
J	Cardona, K; Trenor, B; Giles, WR				Cardona, Karen; Trenor, Beatriz; Giles, Wayne R.			Changes in Intracellular Na+ following Enhancement of Late Na+ Current in Virtual Human Ventricular Myocytes	PLOS ONE			English	Article							LATE SODIUM CURRENT; ACTION-POTENTIAL DURATION; FAILURE HEART-FAILURE; NA/K PUMP CURRENT; CA2+ CURRENT; EARLY AFTERDEPOLARIZATIONS; DIASTOLIC DYSFUNCTION; MYOCARDIAL-ISCHEMIA; HYDROGEN-PEROXIDE; IMPORTANT PLAYER	The slowly inactivating or late Na+ current, INa-L, can contribute to the initiation of both atrial and ventricular rhythm disturbances in the human heart. However, the cellular and molecular mechanisms that underlie these pro-arrhythmic influences are not fully understood. At present, the major working hypothesis is that the Na+ influx corresponding to I(Na-L)significantly increases intracellular Na+, [Na]; and the resulting reduction in the electrochemical driving force for Na+ reduces and (may reverse) Na+/Ca2+ exchange. These changes increase intracellular Ca2+, [Ca2+]; which may further enhance I(Na-L)due to calmodulindependent phosphorylation of the Na+ channels. This paper is based on mathematical simulations using the O'Hara et al (2011) model of baseline or healthy human ventricular action potential waveforms(s) and its [Ca2(+)]; homeostasis mechanisms. Somewhat surprisingly, our results reveal only very small changes (<= 1.5 mM) in [Na] even when INa-L is increased 5-fold and steady-state stimulation rate is approximately 2 times the normal human heart rate (i.e. 2 Hz). Previous work done using well-established models of the rabbit and human ventricular action potential in heart failure settings also reported little or no change in [Na] when I(Na-L)was increased. Based on our simulations, the major short-term effect of markedly augmenting I(Na-L)is a significant prolongation of the action potential and an associated increase in the likelihood of reactivation of the L-type Ca2+ current, Ica-L. Furthermore, this action potential prolongation does not contribute to [Na]; increase.	[Cardona, Karen; Trenor, Beatriz] Univ Politecn Valencia, Ctr Invest & Innovac Bioingn, Valencia, Spain; [Giles, Wayne R.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	Universitat Politecnica de Valencia; University of Calgary	Trenor, B (corresponding author), Univ Politecn Valencia, Ctr Invest & Innovac Bioingn, Valencia, Spain.	btrenor@eln.upv.es	Trenor, Beatriz/H-1716-2015	Trenor, Beatriz/0000-0001-9166-6112	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain [TIN2012-37546-C03-01]; European Commission (European Regional Development Funds-ERDF-FEDER); Direccion General de Politica Cientifica de la Generalitat Valenciana [GV/2013/119]; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana [PROMETEO/2016/088]	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain; European Commission (European Regional Development Funds-ERDF-FEDER); Direccion General de Politica Cientifica de la Generalitat Valenciana; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana	This work was supported by (i) the "VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain (grant number TIN2012-37546-C03-01) and the European Commission (European Regional Development Funds-ERDF-FEDER), (ii) by the Direccion General de Politica Cientifica de la Generalitat Valenciana (grant number GV/2013/119), and by (iii), Programa Prometeo (PROMETEO/2016/088) de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2011, J ELECTROCARDIOL, V44, P656, DOI 10.1016/j.jelectrocard.2011.07.026; Antzelevitch C, 2011, HEART RHYTHM, V8, P1281, DOI 10.1016/j.hrthm.2011.03.045; Aronsen JM, 2013, J MOL CELL CARDIOL, V61, P11, DOI 10.1016/j.yjmcc.2013.06.003; Ashamalla SM, 2001, J PHYSIOL-LONDON, V536, P439, DOI 10.1111/j.1469-7793.2001.0439c.xd; ATTWELL D, 1981, J PHYSIOL-LONDON, V313, P439, DOI 10.1113/jphysiol.1981.sp013675; Ballou LM, 2015, CIRC RES, V116, P127, DOI 10.1161/CIRCRESAHA.116.303975; Bay J, 2013, J MOL CELL CARDIOL, V61, P20, DOI 10.1016/j.yjmcc.2013.05.010; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; Belardinelli L, 2015, HEART RHYTHM, V12, P440, DOI 10.1016/j.hrthm.2014.11.009; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Bhargava A, 2013, CIRC RES, V112, P1112, DOI 10.1161/CIRCRESAHA.111.300445; Bocchi L, 2008, EXP PHYSIOL, V93, P347, DOI 10.1113/expphysiol.2007.040881; BOUCHARD RA, 1995, CIRC RES, V76, P790, DOI 10.1161/01.RES.76.5.790; BOYETT MR, 1988, J THEOR BIOL, V132, P15, DOI 10.1016/S0022-5193(88)80187-5; CARMELIET E, 1987, PFLUG ARCH EUR J PHY, V408, P18, DOI 10.1007/BF00581835; CARMELIET E, 1992, CARDIOVASC RES, V26, P433, DOI 10.1093/cvr/26.5.433; Carmeliet Edward, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS2, DOI 10.1111/j.1540-8167.2006.00378.x; Clancy CE, 2015, J PHYSIOL-LONDON, V593, P1331, DOI 10.1113/jphysiol.2014.281204; Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932; Crampin EJ, 2006, BIOPHYS J, V90, P3074, DOI 10.1529/biophysj.105.070557; Despa S, 2004, BIOPHYS J, V87, P1360, DOI 10.1529/biophysj.103.037895; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Despa S, 2002, CIRCULATION, V105, P2543, DOI 10.1161/01.CIR.0000016701.85760.97; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; EISNER DA, 1990, EXP PHYSIOL, V75, P437, DOI 10.1113/expphysiol.1990.sp003422; EISNER DA, 1984, J PHYSIOL-LONDON, V355, P251, DOI 10.1113/jphysiol.1984.sp015417; EISNER DA, 1981, J PHYSIOL-LONDON, V317, P163, DOI 10.1113/jphysiol.1981.sp013819; EISNER DA, 1983, J PHYSIOL-LONDON, V335, P723, DOI 10.1113/jphysiol.1983.sp014560; Eisner D, 2014, EXP PHYSIOL, V99, P1273, DOI 10.1113/expphysiol.2013.077305; Elshrif MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084401; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Giles WR, 2016, TRENDS CARDIOVAS MED, V26, P123, DOI 10.1016/j.tcm.2015.06.003; Glynn P, 2015, CIRCULATION, V132, P567, DOI 10.1161/CIRCULATIONAHA.114.015218; Gomez JF, 2015, J MOL CELL CARDIOL, V89, P146, DOI 10.1016/j.yjmcc.2015.10.016; Gomez JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106602; Gomez JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103273; Grandi E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00041; HAIGNEY MCP, 1994, CIRCULATION, V90, P391, DOI 10.1161/01.CIR.90.1.391; Hilgemann Donald W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS47, DOI 10.1111/j.1540-8167.2006.00383.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Imahashi K, 1999, CIRC RES, V84, P1401; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Karagueuzian HS, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00019; KIYOSUE T, 1989, CIRC RES, V64, P389, DOI 10.1161/01.RES.64.2.389; Levi AJ, 1996, J PHYSIOL-LONDON, V492, P1; Limbu S, 2015, BIOPHYS J, V109, P2037, DOI 10.1016/j.bpj.2015.09.031; Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673; Louch WE, 2010, J PHYSIOL-LONDON, V588, P465, DOI 10.1113/jphysiol.2009.183517; Lu ZJ, 2013, DIABETES, V62, P4257, DOI 10.2337/db13-0420; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Madhvani RV, 2015, J GEN PHYSIOL, V145, P395, DOI 10.1085/jgp.201411288; Maier LS, 2013, J MOL CELL CARDIOL, V61, P44, DOI 10.1016/j.yjmcc.2013.03.001; Makielski Jonathan C, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS15, DOI 10.1111/j.1540-8167.2006.00380.x; Makielski JC, 2016, TRENDS CARDIOVAS MED, V26, P115, DOI 10.1016/j.tcm.2015.05.006; Moreno JD, 2013, CIRC RES, V113, pE50, DOI 10.1161/CIRCRESAHA.113.301971; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nguyen TP, 2008, CIRC RES, V102, P364, DOI 10.1161/CIRCRESAHA.107.164673; Noble D, 2006, HEART, V92, P1, DOI 10.1136/hrt.2005.078782; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Papp Z, 2014, J PHYSIOL-LONDON, V592, P415, DOI 10.1113/jphysiol.2013.264242; Pasek M, 2012, EUR BIOPHYS J BIOPHY, V41, P491, DOI 10.1007/s00249-012-0804-x; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Pourrier M, 2014, J PHYSIOL-LONDON, V592, P411, DOI 10.1113/jphysiol.2013.262261; Ramirez RJ, 2011, BASIC RES CARDIOL, V106, P967, DOI 10.1007/s00395-011-0202-z; Remme CA, 2014, CURR OPIN PHARMACOL, V15, P53, DOI 10.1016/j.coph.2013.11.014; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Saegusa N, 2013, AM J PHYSIOL-HEART C, V304, pH1680, DOI 10.1152/ajpheart.00070.2013; Saegusa N, 2011, J GEN PHYSIOL, V138, P537, DOI 10.1085/jgp.201110658; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; SAINT DA, 1992, J PHYSIOL-LONDON, V453, P219, DOI 10.1113/jphysiol.1992.sp019225; Sakmann BFAS, 2000, CIRC RES, V87, P910, DOI 10.1161/01.RES.87.10.910; Sanchez-Alonso JL, 2016, CIRC RES, V119, P944, DOI 10.1161/CIRCRESAHA.116.308698; Semb SO, 1996, ACTA PHYSIOL SCAND, V156, P213, DOI 10.1046/j.1365-201X.1996.211000.x; Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X; Silverman BDZ, 2003, CARDIOVASC RES, V57, P1025, DOI 10.1016/S0008-6363(02)00645-4; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Song Z, 2015, BIOPHYS J, V108, P1908, DOI 10.1016/j.bpj.2015.03.011; Sossalla S, 2008, J MOL CELL CARDIOL, V45, P32, DOI 10.1016/j.yjmcc.2008.03.006; Stanley CM, 2015, BIOPHYS J, V109, P1852, DOI 10.1016/j.bpj.2015.09.015; Swietach P, 2015, CARDIOVASC RES, V105, P171, DOI 10.1093/cvr/cvu251; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Terkildsen JR, 2008, EXP PHYSIOL, V93, P919, DOI 10.1113/expphysiol.2007.041871; Trenor B, 2013, CHANNELS, V7, P249, DOI 10.4161/chan.24905; Trenor B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032659; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; VanEmous JG, 1997, J MOL CELL CARDIOL, V29, P85, DOI 10.1006/jmcc.1996.0254; Verdonck F, 2004, CELL CALCIUM, V35, P603, DOI 10.1016/j.ceca.2004.01.014; Verdonck F, 2003, J MOL CELL CARDIOL, V35, P5, DOI 10.1016/S0022-2828(02)00280-8; Verheijck EE, 1999, AM J PHYSIOL-HEART C, V276, pH1064, DOI 10.1152/ajpheart.1999.276.3.H1064; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Ward CA, 1997, J PHYSIOL-LONDON, V500, P631, DOI 10.1113/jphysiol.1997.sp022048; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Yang PC, 2015, J PHYSIOL-LONDON, V593, P1429, DOI 10.1113/jphysiol.2014.279554	99	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167060	10.1371/journal.pone.0167060	http://dx.doi.org/10.1371/journal.pone.0167060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875582	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000045
J	Yuan, HJ; Sehgal, PB				Yuan, Huijuan; Sehgal, Pravin B.			MxA Is a Novel Regulator of Endosome-Associated Transcriptional Signaling by Bone Morphogenetic Proteins 4 and 9 (BMP4 and BMP9)	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; ENDOPLASMIC-RETICULUM STRUCTURE; ANTIVIRAL ACTIVITY; GOLGI-APPARATUS; CONTACT SITES; NITRIC-OXIDE; INTERFERON; CELLS; ENDOCYTOSIS; RECEPTOR	There is confusion about the role that IFN-alpha plays in the pathogenesis of pulmonary arterial hypertension (PAH) with different investigators reporting a causative or a protective role. There is now clear evidence in PAH pathogenesis for the involvement of BMP4 and BMP9 signaling, and its disruption by mutations in BMPR2. In the present study, we investigated MxA, an IFN-alpha-inducible cytoplasmic dynamin-family GTPase for effects on BMP4/9 signaling, including in the presence of PAH-disease-associated mutants of BMPR2. In human pulmonary arterial endothelial cells (HPAECs), IFN-alpha-induced endogenous as well as exogenously expressed MxA was associated with endosomes that aligned alongside microtubules and tubules of the endoplasmic reticulum (ER). Moreover, IFN-alpha and MxA stimulated basal and BMP4/9 signaling to a Smad1/5/8-responsive pBRE-Luc reporter. In HEK293T cells, immunoelectron microscopy confirmed the association of MxA with endosomes, and immunofluorescence methods showed these to be positive for early endosome markers (early endosomal antigen 1, clathrin light chain and Rab5) and RSmad1/5/8. Functionally, using different genetic and inhibitor approaches, we observed that clathrin-mediated endocytosis enhanced and caveolin-mediated endocytosis inhibited the transcriptional response to BMP4 and BMP9. MxA produced a further 3-4-fold enhancement of the BMP-induced response in a clathrin-endocytosis dependent manner. The microtubule inhibitor nocodazole and stabilizer paclitaxel respectively attenuated and enhanced the effect of MxA, implicating microtubule integrity in this process. MxA enhanced BMP-induced signaling in the presence of wild-type BMPR2, and partially rescued signaling from some PAH-disease-associated BMPR2 mutants. Taken together, the data identify MxA as a novel stimulator of BMP4 and BMP9 transcriptional signaling, and suggest it to be a candidate IFN-alpha-inducible mechanism that might have a protective role against development of PAH and other vascular diseases.	[Yuan, Huijuan; Sehgal, Pravin B.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Sehgal, Pravin B.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Sehgal, PB (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.; Sehgal, PB (corresponding author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.	Pravin_sehgal@nymc.edu	Yuan, Huijuan/ABD-1037-2021	Yuan, Huijuan/0000-0002-9589-0098	National Institute of Health Research Grant [R03 HL114509]; New York Medical College	National Institute of Health Research Grant; New York Medical College	This work was supported, in part, by National Institute of Health Research Grant R03 HL114509 (PBS) and Bridge Funding by the New York Medical College (PBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Anderson RD, 2014, INTERN MED J, V44, P1027, DOI 10.1111/imj.12554; Bauer EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096720; Brown SG, 2015, PROSTATE, V75, P266, DOI 10.1002/pros.22912; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dick A, 2015, J BIOL CHEM, V290, P12779, DOI 10.1074/jbc.M115.650325; Fok A, 2015, MULT SCLER; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; George PM, 2014, CIRC RES, V114, P677, DOI 10.1161/CIRCRESAHA.114.302221; Grimes ML, 1996, J NEUROSCI, V16, P7950; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Haruki AN, 2011, J INTERF CYTOK RES, V31, P847, DOI 10.1089/jir.2010.0132; Hoff F, 2014, TRAFFIC, V15, P983, DOI 10.1111/tra.12186; Howe CL, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-43; Idilli AI, 2013, MOL PLANT, V6, P1109, DOI 10.1093/mp/sst099; Jatiani SS, 2004, BIOCHEM BIOPH RES CO, V323, P541, DOI 10.1016/j.bbrc.2004.08.134; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kramer H, 2013, J CELL BIOL, V201, P495, DOI 10.1083/jcb.201304065; Lee JE, 2013, NITRIC OXIDE-BIOL CH, V33, P64, DOI 10.1016/j.niox.2013.06.005; Lee JE, 2013, AM J PHYSIOL-CELL PH, V304, pC312, DOI 10.1152/ajpcell.00311.2012; Lee JE, 2012, AM J PHYSIOL-CELL PH, V302, pC804, DOI 10.1152/ajpcell.00379.2011; Lee JE, 2011, AM J PHYSIOL-HEART C, V300, pH1141, DOI 10.1152/ajpheart.00767.2010; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Savale L, 2014, EUR RESPIR J, V44, P1627, DOI 10.1183/09031936.00057914; Shah M, 2006, J BIOL CHEM, V281, P7302, DOI 10.1074/jbc.M508527200; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Voelkel NF, 2016, EXPERT REV CARDIOVAS, V14, P939, DOI 10.1080/14779072.2016.1180976; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Yang YM, 2013, PULM CIRC, V3, P533, DOI 10.1086/674336; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	44	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166382	10.1371/journal.pone.0166382	http://dx.doi.org/10.1371/journal.pone.0166382			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875556	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000011
J	Ziv, G; Mullin, K; Boeuf, B; Fincham, W; Taylor, N; Villalobos-Jimenez, G; von Vittorelli, L; Wolf, C; Fritsch, O; Strauch, M; Seppelt, R; Volk, M; Beckmann, M				Ziv, Guy; Mullin, Karen; Boeuf, Blandine; Fincham, William; Taylor, Nigel; Villalobos-Jimenez, Giovanna; von Vittorelli, Laura; Wolf, Christine; Fritsch, Oliver; Strauch, Michael; Seppelt, Ralf; Volk, Martin; Beckmann, Michael			Water Quality Is a Poor Predictor of Recreational Hotspots in England	PLOS ONE			English	Article							ECOSYSTEM SERVICES; FRAMEWORK; IMPLEMENTATION; PERCEPTION; PARTICIPATION; CRITERIA; TOURISM; CLARITY; EUROPE	Maintaining and improving water quality is key to the protection and restoration of aquatic ecosystems, which provide important benefits to society. In Europe, the Water Framework Directive (WFD) defines water quality based on a set of biological, hydro-morphological and chemical targets, and aims to reach good quality conditions in all river bodies by the year 2027. While recently it has been argued that achieving these goals will deliver and enhance ecosystem services, in particular recreational services, there is little empirical evidence demonstrating so. Here we test the hypothesis that good water quality is associated with increased utilization of recreational services, combining four surveys covering walking, boating, fishing and swimming visits, together with water quality data for all water bodies in eight River Basin Districts (RBDs) in England. We compared the percentage of visits in areas of good water quality to a set of null models accounting for population density, income, age distribution, travel distance, public access, and substitutability. We expect such association to be positive, at least for fishing (which relies on fish stocks) and swimming (with direct contact to water). We also test if these services have stronger association with water quality relative to boating and walking alongside rivers, canals or lakeshores. In only two of eight RBDs (Northumbria and Anglian) were both criteria met (positive association, strongest for fishing and swimming) when comparing to at least one of the null models. This conclusion is robust to variations in dataset size. Our study suggests that achieving the WFD water quality goals may not enhance recreational ecosystem services, and calls for further empirical research on the connection between water quality and ecosystem services.	[Ziv, Guy; Mullin, Karen; Fritsch, Oliver] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Boeuf, Blandine] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Fincham, William; Taylor, Nigel; von Vittorelli, Laura] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [von Vittorelli, Laura] UFZ, Helmholtz Ctr Environm Res, Dept Environm & Planning Law, Permoserstr 15, D-04318 Leipzig, Germany; [Wolf, Christine] UFZ, Helmholtz Ctr Environm Res, Dept Econ, Permoserstr 15, D-04318 Leipzig, Germany; [Strauch, Michael; Seppelt, Ralf; Volk, Martin; Beckmann, Michael] UFZ, Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Permoserstr 15, D-04318 Leipzig, Germany; [Seppelt, Ralf] Univ Halle Wittenberg, Inst Geosci & Geog, D-06099 Halle, Saale, Germany	University of Leeds; University of Leeds; University of Leeds; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Ziv, G (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	g.ziv@leeds.ac.uk	Villalobos-Jiménez, Giovanna/AAV-1027-2020; Volk, Martin/F-1172-2010; Fritsch, Oliver/K-5283-2017; Seppelt, Ralf/E-6056-2010; Strauch, Michael/P-1895-2015	Villalobos-Jiménez, Giovanna/0000-0003-3248-3644; Volk, Martin/0000-0003-0064-8133; Fritsch, Oliver/0000-0001-8995-8634; Seppelt, Ralf/0000-0002-2723-7150; Strauch, Michael/0000-0002-9872-6904; Beckmann, Michael/0000-0002-5678-265X; Ziv, Guy/0000-0002-6776-0763; Fincham, William/0000-0003-0614-3937	Helmholtz Research School for Ecosystem Services under Changing Landuse and Climate (ESCALATE) at the Helmholtz Centre for Environmental Research UFZ; University of Leeds International Research Collaboration Award; Natural Environment Research Council [1508763] Funding Source: researchfish	Helmholtz Research School for Ecosystem Services under Changing Landuse and Climate (ESCALATE) at the Helmholtz Centre for Environmental Research UFZ; University of Leeds International Research Collaboration Award; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was conducted within FAWKES, a project supported by the Helmholtz Research School for Ecosystem Services under Changing Landuse and Climate (ESCALATE) at the Helmholtz Centre for Environmental Research UFZ and the University of Leeds International Research Collaboration Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2016, ENVIRON SCI POLICY, V55, P368, DOI 10.1016/j.envsci.2015.07.019; Arkenford, 2014, WAT PART SURV 2014 F; Ball T, 2012, ASH STUD ENV POL PR, P255; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Blackstock K., 2015, WATER ECOSYSTEM SERV, P57, DOI DOI 10.1017/CBO9781316178904; Boeuf B, 2016, ECOL SOC, V21, DOI 10.5751/ES-08411-210219; Brown J, 2015, WAT HLTH C 2015 SCI; Center for International Earth Science Information Network-CIESIN-Columbia University, 2016, GRIDD POP WORLD VERS; Centre for Ecology and Hydrology, 2011, LAND COV MAP GREAT B; Connell J, 2005, TOURISM MANAGE, V26, P763, DOI 10.1016/j.tourman.2004.04.010; Crase L, 2008, AUSTRALAS J ENVIRON, V15, P21; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; DAVID EL, 1971, WATER RESOUR RES, V7, P453, DOI 10.1029/WR007i003p00453; DITTON RB, 1973, WATER RESOUR RES, V9, P569, DOI 10.1029/WR009i003p00569; Doherty E, 2013, J ENVIRON MANAGE, V125, P94, DOI 10.1016/j.jenvman.2013.03.056; Egan KJ, 2009, AM J AGR ECON, V91, P106, DOI 10.1111/j.1467-8276.2008.01182.x; Environment Agency, 2015, RIV BAS MAN PLANS; European Commission, 2012, COM2011941 EUR COMM, P5; European Commission, 2012, SWD2012393 EUR COMM; European Commission, 2012, COM2012673 EUR COMM; European Commission, 2012, SWD2012382 EUR COMM; Faulkner H, 2001, J ENVIRON MANAGE, V62, P239, DOI 10.1006/jema.2001.0435; Grant W, 2000, EFFECTIVENESS EUROPE; Grissom Robert J., 2011, EFFECT SIZES RES UNI; Hailu G, 2005, J ECON PSYCHOL, V26, P581, DOI 10.1016/j.joep.2004.11.003; Happs J., 1986, RES SCI EDUC, V16, P208; HEISKARY S A, 1988, Lake and Reservoir Management, V4, P1; Hering D, 2010, SCI TOTAL ENVIRON, V408, P4007, DOI 10.1016/j.scitotenv.2010.05.031; House MA, 1996, WATER SCI TECHNOL, V34, P25, DOI 10.1016/S0273-1223(96)00850-5; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Koteen J, 2002, PNWGTR548 USDA; Martin-Ortega J, 2012, ENVIRON SCI POLICY, V24, P83, DOI 10.1016/j.envsci.2012.06.002; Natural England, 2015, JP009 NAT ENGL; Natural England, 2015, JP015 NAT ENGL; Office for National Statistics, 2011, APPR SOC GRAD SEX AG; Office of National Statistics, 2011, US RES POP; Perry J., 1996, WATER QUALITY MANAGE; RIBAUDO MO, 1991, WATER RESOUR RES, V27, P1757, DOI 10.1029/91WR00798; SMITH DG, 1991, J ENVIRON MANAGE, V33, P285, DOI 10.1016/S0301-4797(91)80030-9; SMITH DG, 1992, J ENVIRON MANAGE, V36, P225, DOI 10.1016/S0301-4797(05)80136-7; Tolonen KT, 2014, J APPL ECOL, V51, P560, DOI 10.1111/1365-2664.12245; UK National Ecosystem Assessment, 2014, UK NAT EC ASS FOLL O; UKNEA, 2011, UK NAT EC ASS SYNTH; Vesterinen J, 2010, J ENVIRON MANAGE, V91, P984, DOI 10.1016/j.jenvman.2009.12.005; Vidal-Abarca MR, 2016, ENVIRON MANAGE, V57, P1139, DOI 10.1007/s00267-016-0674-6; Volkery A, 2011, 101934 ABAC DEL CONS; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	47	16	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166950	10.1371/journal.pone.0166950	http://dx.doi.org/10.1371/journal.pone.0166950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5IV	27875562	Green Published, gold			2022-12-26	WOS:000388886000038
J	Liu, M; Hammers, DW; Barton, ER; Sweeney, HL				Liu, Min; Hammers, David W.; Barton, Elisabeth R.; Sweeney, H. Lee			Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							SYSTEMIC MYOSTATIN INHIBITION; TARGETED GENE-TRANSFER; MOTOR-NEURON GENE; SURVIVAL; MICE; EXPRESSION; MASS; HYPERTROPHY; DISEASE; IDENTIFICATION	Spinal muscular atrophy (SMA) is a devastating neurodegenerative disorder that causes progressive muscle atrophy and weakness. Using adeno-associated virus-mediated gene transfer, we evaluated the potential to improve skeletal muscle weakness via systemic, postnatal inhibition of either myostatin or all signaling via the activin receptor type IIB (ActRIIB). After demonstrating elevated p-SMAD3 content and differential content of ActRIIB ligands, 4-week-old male C/C SMA model mice were treated intraperitoneally with 1x10(12) genome copies of pseudotype 2/8 virus encoding a soluble form of the ActRIIB extracellular domain (sActRIIB) or protease-resistant myostatin propeptide (dnMstn) driven by a liver specific promoter. At 12 weeks of age, muscle mass and function were improved in treated C/C mice by both treatments, compared to controls. The fast fiber type muscles had a greater response to treatment than did slow muscles, and the greatest therapeutic effects were found with sActRIIB treatment. Myostatin/activin inhibition, however, did not rescue C/C mice from the reduction in motor unit numbers of the tibialis anterior muscle. Collectively, this study indicates that myostatin/activin inhibition represents a potential therapeutic strategy to increase muscle mass and strength, but not neuromuscular junction defects, in less severe forms of SMA.	[Liu, Min; Hammers, David W.; Sweeney, H. Lee] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Hammers, David W.; Sweeney, H. Lee] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Hammers, David W.; Barton, Elisabeth R.; Sweeney, H. Lee] Univ Florida, Coll Med, Myol Inst, Gainesville, FL 32610 USA; [Barton, Elisabeth R.] Univ Florida, Coll Hlth & Human Performance, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	University of Pennsylvania; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sweeney, HL (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.; Sweeney, HL (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.; Sweeney, HL (corresponding author), Univ Florida, Coll Med, Myol Inst, Gainesville, FL 32610 USA.	lsweeney@ufl.edu			SMA Foundation; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	SMA Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a grant from the SMA Foundation to HLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2004, LAB INVEST, V84, P1271, DOI 10.1038/labinvest.3700163; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bish LT, 2011, HUM GENE THER, V22, P1499, DOI 10.1089/hum.2011.102; Boyer JG, 2014, HUM MOL GENET, V23, P4249, DOI 10.1093/hmg/ddu142; Boyer JG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-24; Bricceno KV, 2014, HUM MOL GENET, V23, P4745, DOI 10.1093/hmg/ddu189; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; d'Ydewalle C, 2015, NEUROTHERAPEUTICS, V12, P303, DOI 10.1007/s13311-015-0337-y; Dubowitz V, 2009, NEUROMUSCULAR DISORD, V19, P69, DOI 10.1016/j.nmd.2008.10.004; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Gilson H, 2009, AM J PHYSIOL-ENDOC M, V297, pE157, DOI 10.1152/ajpendo.00193.2009; Hayhurst M, 2012, DEV BIOL, V368, P323, DOI 10.1016/j.ydbio.2012.05.037; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jeanplong F, 2012, OPEN INT J MOL INTEG, V2012, P127, DOI [DOI 10.4236/ojmip.2012.24018, DOI 10.4236/OJMIP.2012.24018]; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Montes J, 2009, J CHILD NEUROL, V24, P968, DOI 10.1177/0883073809332702; Morine KJ, 2010, MUSCLE NERVE, V42, P722, DOI 10.1002/mus.21743; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Morrison BM, 2009, EXP NEUROL, V217, P258, DOI 10.1016/j.expneurol.2009.02.017; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Ngo ST, 2012, CLIN NEUROPHYSIOL, V123, P2080, DOI 10.1016/j.clinph.2012.01.028; Nicole S, 2002, MUSCLE NERVE, V26, P4, DOI 10.1002/mus.10110; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Ogino S, 2004, EUR J HUM GENET, V12, P1015, DOI 10.1038/sj.ejhg.5201288; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Osborne M, 2012, HUM MOL GENET, V21, P4431, DOI 10.1093/hmg/dds285; Qaisar R, 2012, FASEB J, V26, P1077, DOI 10.1096/fj.11-192195; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; Rindt H, 2012, NEUROMUSCULAR DISORD, V22, P277, DOI 10.1016/j.nmd.2011.10.012; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Sumner CJ, 2009, HUM MOL GENET, V18, P3145, DOI 10.1093/hmg/ddp253; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	52	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166803	10.1371/journal.pone.0166803	http://dx.doi.org/10.1371/journal.pone.0166803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870893	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400032
J	Zhou, XJ; Xia, YL; Liao, JH; Liu, KD; Li, Q; Dong, Y; Ren, XP; Chen, YN; Huang, L; Liao, BS; Lei, Y; Yan, LY; Jiang, HF				Zhou, Xiaojing; Xia, Youlin; Liao, Junhua; Liu, Kede; Li, Qiang; Dong, Yang; Ren, Xiaoping; Chen, Yuning; Huang, Li; Liao, Boshou; Lei, Yong; Yan, Liying; Jiang, Huifang			Quantitative Trait Locus Analysis of Late Leaf Spot Resistance and Plant-Type-Related Traits in Cultivated Peanut (Arachis hypogaea L.) under Multi-Environments	PLOS ONE			English	Article							SHEATH BLIGHT RESISTANCE; GENETIC-LINKAGE MAP; DISEASE RESISTANCE; YIELD COMPONENTS; GRAIN-YIELD; RUST RESISTANCE; PROTEIN-CONTENT; INBRED LINE; OIL CONTENT; MAJOR QTL	Late leaf spot (LLS) is one of the most serious foliar diseases affecting peanut worldwide leading to huge yield loss. To understand the genetic basis of LLS and assist breeding in the future, we conducted quantitative trait locus (QTL) analysis for LLS and three plant-type-related traits including height of main stem (HMS), length of the longest branch (LLB) and total number of branches (TNB). Significant negative correlations were observed between LLS and the plant-type-related traits in multi-environments of a RIL population from the cross Zhonghua 5 and ICGV 86699. A total of 20 QTLs were identified for LLS, of which two QTLs were identified in multi-environments and six QTLs with phenotypic variation explained (PVE) more than 10%. Ten, seven, fifteen QTLs were identified for HMS, LLB and TNB, respectively. Of these, one, one, two consensus QTLs and three, two, three major QTLs were detected for HMS, LLB and TNB, respectively. Of all 52 unconditional QTLs for LLS and plant-type-related traits, 10 QTLs were clustered in five genetic regions, of which three clusters including five robust major QTLs overlapped between LLS and one of the plant-type-related traits, providing evidence that the correlation could be genetically constrained. On the other hand, conditional mapping revealed different numbers and different extent of additive effects of QTLs for LLS conditioned on three plant-type-related traits (HMS, LLB and TNB), which improved our understanding of interrelationship between LLS and plant-type-related traits at the QTL level. Furthermore, two QTLs, qLLSB6-7 and qLLSB1 for LLS resistance, were identified residing in two clusters of NB-LRR D encoding genes. This study not only provided new favorable QTLs for fine-mapping, but also suggested that the relationship between LLS and plant-type-related traits of HMS, LLB and TNB should be considered while breeding for improved LLS resistance in peanut.	[Zhou, Xiaojing; Dong, Yang; Ren, Xiaoping; Chen, Yuning; Huang, Li; Liao, Boshou; Lei, Yong; Yan, Liying; Jiang, Huifang] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Xia, Youlin; Liao, Junhua] Nanchong Acad Agr Sci, Nanchong, Sichuan, Peoples R China; [Liu, Kede] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Li, Qiang] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; University of Saskatchewan	Jiang, HF (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	peanutlab@oilcrops.cn	Xia, Youlin/AAH-7297-2020		National Natural Science Foundation of China [31301362, 31471534, 31271764]; National Program for Crop Germplasm Protection of China [2005DKA21002-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Crop Germplasm Protection of China	This work was supported by the National Natural Science Foundation of China (grants no. 31301362, 31471534 and 31271764) and the National Program for Crop Germplasm Protection of China (grant no. 2005DKA21002-13).	Austin DF, 1998, CROP SCI, V38, P1296, DOI 10.2135/cropsci1998.0011183X003800050029x; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Burow MD, 2001, GENETICS, V159, P823; Burow MD, 1996, MOL BREEDING, V2, P369, DOI 10.1007/BF00437915; BUTLER DR, 1995, PLANT PATHOL, V44, P1, DOI 10.1111/j.1365-3059.1995.tb02710.x; BUTLER DR, 1995, PLANT PATHOL, V44, P662, DOI 10.1111/j.1365-3059.1995.tb01690.x; Chen GB, 2003, SOFTWARE CLASSICAL Q; Chen WG, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0337-x; Choi R, 1999, J NEMATOL, V31, P283; Dwivedi SL, 2002, EUPHYTICA, V125, P81, DOI 10.1023/A:1015707301659; Fonceka D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-26; Fonceka D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048642; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gowda M. V. C., 2002, International Arachis Newsletter, P29; GREEN CC, 1986, THEOR APPL GENET, V73, P228, DOI 10.1007/BF00289279; Hallauer AR, 1998, QUANTITATIVE GENETIC; Huang L, 2015, THEOR APPL GENET, V128, P1103, DOI 10.1007/s00122-015-2493-1; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; KOKALISBURELLE N, 1997, COMPENDIUM PEANUT DI, P94; Kolekar RM, 2016, EUPHYTICA, V209, P147, DOI 10.1007/s10681-016-1651-0; Kunihiro Yasufumi, 2002, Acta Genetica Sinica, V29, P50; LANDER ES, 1989, GENETICS, V121, P185; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Li YL, 2007, THEOR APPL GENET, V115, P129, DOI 10.1007/s00122-007-0549-6; LI ZK, 1995, THEOR APPL GENET, V91, P382, DOI 10.1007/BF00220903; Liu Y, 2014, THEOR APPL GENET, V127, P1019, DOI 10.1007/s00122-014-2276-0; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; McDonald D., 1985, INFORM B, V21; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Motagi, 2001, THESIS; Nagy ED, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-469; Nath B. C., 2013, Asian Journal of Bio Science, V8, P32; NEVILL DJ, 1982, OLEAGINEUX, V37, P355; Nigam S. N., 2012, Plant Breeding Reviews, V36, P293; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Reddy LJ, 1996, CROP SCI, V36, P821, DOI 10.2135/cropsci1996.0011183X003600030072x; Ruge-Wehling B, 2006, THEOR APPL GENET, V113, P867, DOI 10.1007/s00122-006-0345-8; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; SAS INSTITUTE, 2000, SAS STAT US GUID VER; Sato H, 2004, BREEDING SCI, V54, P265, DOI 10.1270/jsbbs.54.265; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scheurer KS, 2001, THEOR APPL GENET, V103, P1074, DOI 10.1007/s001220100632; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Shoha D, 2013, LEGUME RES, V36, P467; Simpson CE, 2001, CROP SCI, V41, P918, DOI 10.2135/cropsci2001.413918x; Su YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138073; Subbarao PV, 1990, 2 INT C FRENCH PHYT, P25; SUBRAHMANYAM P, 1984, ANN APPL BIOL, V104, P467, DOI 10.1111/j.1744-7348.1984.tb03029.x; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Waliyar F., 1991, P 2 ICRISAT REG GROU, P32; Wang H, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.05.0018; Wang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119454; Wang S., 2007, WINDOWS QTL CARTOGRA; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; [夏友霖 Xia Youlin], 2015, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V37, P134; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yi H, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-36; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089645; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5; Zhou XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-351; ZHU J, 1995, GENETICS, V141, P1633; Zhu J., 1992, J BIOMATH, V7, P1; Zou JH, 2000, THEOR APPL GENET, V101, P569, DOI 10.1007/s001220051517	68	19	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166873	10.1371/journal.pone.0166873	http://dx.doi.org/10.1371/journal.pone.0166873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870916	gold, Green Submitted, Green Published			2022-12-26	WOS:000388846400038
J	Salfati, EL; Herrington, DM; Assimes, TL				Salfati, Elias L.; Herrington, David M.; Assimes, Themistocles L.			Associations between a Genetic Risk Score for Clinical CAD and Early Stage Lesions in the Coronary Artery and the Aorta	PLOS ONE			English	Article							NATURAL-HISTORY; ATHEROSCLEROTIC LESIONS; VASCULAR-LESIONS; HEART-DISEASE; ARTERIOSCLEROSIS; SUSCEPTIBILITY; DEFINITION; COMMITTEE; COUNCIL	Objective The correlation between the extent of fatty streaks, more advanced atherosclerotic lesions, and community rates of coronary artery disease (CAD) is substantially higher for the coronary artery compared to the aorta. We sought to determine whether a genetic basis contributes to these differences. Approach and Results We conducted a cluster analysis of 6 subclinical atherosclerosis phenotypes documented in 564 white participants of the Pathobiological Determinants of Atherosclerosis in Youth study including the extent of fatty streaks and raised lesions in the coronary artery (CF and CR), thoracic aorta (TF and TR), and abdominal aorta (AF and AR) followed by a genetic association analysis of the same phenotypes. Our cluster analysis grouped all raised lesions and fatty streaks in the coronary into one cluster (CF, CR, TR, and AR) and the fatty streaks in the aorta into a second cluster (TF and AF). We found a genetic risk score of high- risk alleles at 57 susceptibility loci for CAD to be variably associated with the phenotypes in the first cluster (OR: 1.30 p = 0.009 for being in top quartile of degree of involvement of CF, 1.34 p = 0.005 for CR, 1.25: p = 0.11 for TR, and 1.19 p = 0.08 for AR) but not at all with the phenotypes in the second cluster (OR: 1.01, p = 0.95 for TF and 0.98, p = 0.82 for AF). Conclusions The genetic determinants of fatty streaks in the aorta do not appear to overlap substantially with the genetic determinants of fatty streaks in the coronary as well as raised lesions in both the coronary and the aorta. These findings may explain why a larger fraction of fatty streaks in the aorta are less likely to progress to raised lesions compared to the coronary artery.	[Salfati, Elias L.; Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Salfati, Elias L.; Assimes, Themistocles L.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Herrington, David M.] Wake Forest Univ, Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA	Stanford University; Stanford University; Wake Forest University; Wake Forest Baptist Medical Center	Assimes, TL (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.; Assimes, TL (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.	tassimes@stanford.edu	Assimes, Themistocles Leonard/D-9696-2015	Assimes, Themistocles Leonard/0000-0003-2349-0009	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Borenstein M., 2009, INTRO METAANALYSIS; CARDIoGRAMplusC4D Consortium, 2013, Nat Genet, V45, P25, DOI 10.1038/ng.2480; Dichgans M, 2014, STROKE, V45, P24, DOI 10.1161/STROKEAHA.113.002707; Dyer L, 2014, DEV BIOL, V395, P111, DOI 10.1016/j.ydbio.2014.08.024; Goldstein BA, 2015, GENET EPIDEMIOL, V39, P439, DOI 10.1002/gepi.21912; Goldstein BA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00254; Hansen J., 2014, NETTERS CLIN ANATOMY; Hidai H, 1998, MECH DEVELOP, V73, P33, DOI 10.1016/S0925-4773(98)00031-8; HOLMAN RL, 1958, AM J PATHOL, V34, P209; Kaufman L, 2008, CLUSTERING LARGE APP, P126; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; MCGILL HC, 1968, LAB INVEST, V18, P560; MONTENEGRO MR, 1968, LAB INVEST, V18, P586; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Ross M. H., 2003, HISTOLOGY TEXT ATLAS; Salfati E, 2015, CIRC-CARDIOVASC GENE, V8, P803, DOI 10.1161/CIRCGENETICS.114.001071; Schettler G, 1974, ATHEROSCLEROSIS, Vxxxv; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STARY HC, 1990, EUR HEART J, V11, P3, DOI 10.1093/eurheartj/11.suppl_E.3; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; STRONG JP, 1995, CLIN CHEM, V41, P134; STRONG JP, 1962, AM J PATHOL, V40, P37; Tomanek RJ, 2016, ANAT REC, V299, P25, DOI 10.1002/ar.23283	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166994	10.1371/journal.pone.0166994	http://dx.doi.org/10.1371/journal.pone.0166994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861582	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300141
J	Sunwoo, L; Yun, TJ; You, SH; Yoo, RE; Kang, KM; Choi, SH; Kim, JH; Sohn, CH; Park, SW; Jung, C; Park, CK				Sunwoo, Leonard; Yun, Tae Jin; You, Sung-Hye; Yoo, Roh-Eul; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho; Park, Sun-Won; Jung, Cheolkyu; Park, Chul-Kee			Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBRAL BLOOD-VOLUME; PERFUSION MRI; SOLITARY METASTASES; TUMORS; MULTIFORME; DIFFUSION; FLOW; ANGIOGENESIS	Purpose To evaluate the diagnostic performance of cerebral blood flow (CBF) by using arterial spin labeling (ASL) perfusion magnetic resonance (MR) imaging to differentiate glioblastoma (GBM) from brain metastasis. Materials and Methods The institutional review board of our hospital approved this retrospective study. The study population consisted of 128 consecutive patients who underwent surgical resection and were diagnosed as either GBM (n = 89) or brain metastasis (n = 39). All participants underwent preoperative MR imaging including ASL. For qualitative analysis, the tumors were visually graded into five categories based on ASL-CBF maps by two blinded reviewers. For quantitative analysis, the reviewers drew regions of interest (ROIs) on ASL-CBF maps upon the most hyperperfused portion within the tumor and upon peritumoral T2 hyperintensity area. Signal intensities of intratumoral and peritumoral ROIs for each subject were normalized by dividing the values by those of contralateral normal gray matter (nCBF(intratumoral) and nCBF(peritumoral), respectively). Visual grading scales and quantitative parameters between GBM and brain metastasis were compared. In addition, the area under the receiver-operating characteristic curve was used to evaluate the diagnostic performance of ASL-driven CBF to differentiate GBM from brain metastasis. Results For qualitative analysis, GBM group showed significantly higher grade compared to metastasis group (p = 0.001). For quantitative analysis, both nCB(Fintratumoral) and nCBF(peritumoral) in GBM were significantly higher than those in metastasis (both p < 0.001). The areas under the curve were 0.677, 0.714, and 0.835 for visual grading, nCBF(intratumoral), and nCBF(peritumoral), respectively (all p < 0.001). Conclusion ASL perfusion MR imaging can aid in the differentiation of GBM from brain metastasis.	[Sunwoo, Leonard; Yun, Tae Jin; Yoo, Roh-Eul; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho; Park, Sun-Won; Jung, Cheolkyu] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Sunwoo, Leonard; Jung, Cheolkyu] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea; [Yun, Tae Jin; You, Sung-Hye; Yoo, Roh-Eul; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Park, Sun-Won] Seoul Natl Univ, Dept Radiol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Park, Chul-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Yun, TJ (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Yun, TJ (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	radiologyyun@gmail.com	Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021; Park, Chul-Kee/J-5499-2012	Park, Chul-Kee/0000-0002-2350-9876; You, Sung-Hye/0000-0001-5005-9383; Yun, Tae Jin/0000-0001-8441-4574; Sunwoo, Leonard/0000-0003-0374-8658	National Research Foundation of Korea [NRF-2013R1A1A2008332]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF-2013R1A1A2008332; http://http://nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AH, 2015, NEURORADIOLOGY, V57, P697, DOI 10.1007/s00234-015-1524-6; Bertossi M, 1997, ULTRASTRUCT PATHOL, V21, P41, DOI 10.3109/01913129709023246; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484; Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Hirai T, 2011, AM J NEURORADIOL, V32, P2073, DOI 10.3174/ajnr.A2725; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; KELLY PJ, 1987, MAYO CLIN PROC, V62, P450, DOI 10.1016/S0025-6196(12)65470-6; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lehmann P, 2010, EUR NEUROL, V64, P21, DOI 10.1159/000311520; Ma JH, 2010, AM J NEURORADIOL, V31, P1699, DOI 10.3174/ajnr.A2161; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI 10.3174/ajnr.A0903; Server A, 2011, NEURORADIOLOGY, V53, P319, DOI 10.1007/s00234-010-0740-3; STRUGAR J, 1994, J NEUROSURG, V81, P560, DOI 10.3171/jns.1994.81.4.0560; Tsougos I, 2012, CANCER IMAGING, V12, P423, DOI 10.1102/1470-7330.2012.0038; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Weber MA, 2006, NEUROLOGY, V66, P1899, DOI 10.1212/01.wnl.0000219767.49705.9c; Weber MA, 2004, INVEST RADIOL, V39, P277, DOI 10.1097/01.rli.0000119195.50515.04; Wolf RL, 2005, J MAGN RESON IMAGING, V22, P475, DOI 10.1002/jmri.20415; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6; Yoo RE, 2016, J NEUROSURG, V125, P536, DOI 10.3171/2015.8.JNS151211; Yoo RE, 2013, J MAGN RESON IMAGING, V38, P852, DOI 10.1002/jmri.24026	26	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166662	10.1371/journal.pone.0166662	http://dx.doi.org/10.1371/journal.pone.0166662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861605	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300083
J	Dunnill, CJ; Ibraheem, K; Mohamed, A; Southgate, J; Georgopoulos, NT				Dunnill, C. J.; Ibraheem, K.; Mohamed, A.; Southgate, J.; Georgopoulos, N. T.			A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis	ONCOGENE			English	Article							HUMAN UROTHELIAL CELLS; IN-VITRO; C-JUN; ANTIOXIDANT PATHWAYS; EPITHELIAL-CELLS; CARCINOMA-CELLS; CD40 PATHWAY; CANCER-CELLS; JNK; ACTIVATION	CD40, a member of the tumour necrosis factor receptor (TNFR) superfamily, has the capacity to cause extensive apoptosis in carcinoma cells, while sparing normal epithelial cells. Yet, apoptosis is only achieved by membrane-presented CD40 ligand (mCD40L), as soluble receptor agonists are but weakly pro-apoptotic. Here, for the first time we have identified the precise signalling cascade underpinning mCD40L-mediated death as involving sequential TRAF3 stabilisation, ASK1 phosphorylation, MKK4 (but not MKK7) activation and JNK/AP-1 induction, leading to a Bak-and Bax-dependent mitochondrial apoptosis pathway. TRAF3 is central in the activation of the NADPH oxidase(Nox)-2 component p40phox and the elevation of reactive oxygen species (ROS) is essential in apoptosis. Strikingly, CD40 activation resulted in down-regulation of Thioredoxin (Trx)-1 to permit ASK1 activation and apoptosis. Although soluble receptor agonist alone could not induce death, combinatorial treatment incorporating soluble CD40 agonist and pharmacological inhibition of Trx-1 was functionally equivalent to the signal triggered by mCD40L. Finally, we demonstrate using normal, 'para-malignant' and tumour-derived cells that progression to malignant transformation is associated with increase in oxidative stress in epithelial cells, which coincides with increased susceptibility to CD40 killing, while in normal cells CD40 signalling is cytoprotective. Our studies have revealed the molecular nature of the tumour specificity of CD40 signalling and explained the differences in pro-apoptotic potential between soluble and membrane-bound CD40 agonists. Equally importantly, by exploiting a unique epithelial culture system that allowed us to monitor alterations in the redox-state of epithelial cells at different stages of malignant transformation, our study reveals how pro-apoptotic signals can elevate ROS past a previously hypothesised 'lethal pro-apoptotic threshold' to induce death; an observation that is both of fundamental importance and carries implications for cancer therapy.	[Dunnill, C. J.; Ibraheem, K.; Mohamed, A.; Georgopoulos, N. T.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Southgate, J.] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York, N Yorkshire, England	University of Huddersfield; University of York - UK	Georgopoulos, NT (corresponding author), Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England.	N.Georgopoulos@hud.ac.uk	Southgate, Jennifer/AAJ-9089-2021	Southgate, Jennifer/0000-0002-0135-480X	York Against Cancer	York Against Cancer	The authors are grateful to all clinical colleagues for the supply of normal urothelial tissue, and would like to thank Prof Alan Melcher and Dr Liz Illett (Targeted & Biological Therapies Group, Leeds Institute of Cancer and Pathology, University of Leeds, UK) for the provision of the G28-5 antibody and fruitful discussions. JS holds a research chair supported by York Against Cancer.	Al-Tameemi W, 2014, TOXICOL IN VITRO, V28, P1366, DOI 10.1016/j.tiv.2014.07.011; Albarbar B, 2015, CYTOKINE GROWTH F R, V26, P659, DOI 10.1016/j.cytogfr.2015.05.001; Altenburg A, 1999, J IMMUNOL, V162, P4140; Baker AF, 2006, J LAB CLIN MED, V147, P83, DOI 10.1016/j.lab.2005.09.001; Baxendale AJ, 2005, ONCOGENE, V24, P7913, DOI 10.1038/sj.onc.1208929; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bhogal RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030867; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Booth C, 1997, LAB INVEST, V76, P843; Bugajska U, 2002, J NATL CANCER I, V94, P1381; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Crallan RA, 2006, CARCINOGENESIS, V27, P374, DOI 10.1093/carcin/bgi266; Dadgostar H, 2000, J BIOL CHEM, V275, P2539, DOI 10.1074/jbc.275.4.2539; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Duffy CL, 2003, VIROLOGY, V314, P196, DOI 10.1016/S0042-6822(03)00390-8; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Eliopoulos AG, 2004, CURR OPIN PHARMACOL, V4, P360, DOI 10.1016/j.coph.2004.02.008; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; Elmetwali T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-52; Elmetwali T, 2010, J IMMUNOL, V184, P1111, DOI 10.4049/jimmunol.0900528; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Georgopoulos NT, 2007, INT J CANCER, V121, P1373, DOI 10.1002/ijc.22846; Georgopoulos NT, 2011, EUR UROL, V60, P141, DOI 10.1016/j.eururo.2011.02.022; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; Hill KS, 2008, J IMMUNOL, V181, P3108, DOI 10.4049/jimmunol.181.5.3108; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; JOHNSON PWM, 1993, BLOOD, V82, P1848, DOI 10.1182/blood.V82.6.1848.bloodjournal8261848; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Nishiyama A, 1999, IMMUNOL LETT, V68, P155, DOI 10.1016/S0165-2478(99)00045-0; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Pound JD, 1999, INT IMMUNOL, V11, P11, DOI 10.1093/intimm/11.1.11; Ramanathan RK, 2012, INVEST NEW DRUG, V30, P1591, DOI 10.1007/s10637-011-9739-9; Reznikoff CA, 1996, CANCER RES, V56, P2886; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Schattner E, 1996, IMMUNOL RES, V15, P246, DOI 10.1007/BF02918252; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shaw NJ, 2005, INT J CANCER, V116, P634, DOI 10.1002/ijc.21114; Simic T, 2009, NAT REV UROL, V6, P281, DOI 10.1038/nrurol.2009.49; Soga Mayumi, 2012, Int J Cell Biol, V2012, P439587, DOI 10.1155/2012/439587; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Southgate J, 2012, CULT EPITHEL CELLS, P381; Stewart R, 2007, J IMMUNOL, V179, P2705, DOI 10.4049/jimmunol.179.5.2705; T Georgopoulos N, 2006, CELL DEATH DIFFER, V13, P1789, DOI 10.1038/sj.cdd.4401859; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vardouli L, 2009, CANCER GENE THER, V16, P848, DOI 10.1038/cgt.2009.31; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang HCR, 2011, NAT REV UROL, V8, P608, DOI 10.1038/nrurol.2011.135; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yodoi J, 2001, BIOFACTORS, V15, P107, DOI 10.1002/biof.5520150212; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222	64	16	19	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2515	2528		10.1038/onc.2016.401	http://dx.doi.org/10.1038/onc.2016.401			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27869172	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000400597300003
J	Zhao, LM; Han, TT; Li, YS; Sun, JZ; Zhang, S; Liu, YX; Shan, BE; Zheng, DX; Shi, J				Zhao, Lianmei; Han, Taotao; Li, Yanshuang; Sun, Jiazeng; Zhang, Shang; Liu, Yanxin; Shan, Baoen; Zheng, Dexian; Shi, Juan			The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4	FASEB JOURNAL			English	Article						long noncoding RNA; ceRNA; GC	LONG NONCODING RNA; COMPETING ENDOGENOUS RNA; EXPRESSION; CARCINOMA; INVASION; GROWTH; CERNA; GENE; DIFFERENTIATION; PROGRESSION	Long noncoding RNAs (lncRNAs) are emerging as important regulators in cellular processes, including the development, proliferation, and migration of cancer cells. We have demonstrated in a prior study that small nucleolar RNA host gene 5 (SNHG5) is dysregulated in gastric cancer (GC). To further explore the underlying mechanisms of SNGH5 function in the development of GC, in this study, we screened the microRNAs interacting with SNHG5 and elucidated their roles in GC. We showed that SNHG5 contains a putative miR-32-binding site and that deletion of this site abolishes the responsiveness to miR-32. Suppression of SNHG5 expression by miR-32 was found to be Argonaute (Ago)2-dependent. Immunoprecipitation showed that SNHG5 could be pulled down from the Ago-2 complex with miR-32. Furthermore, it was reported that Kruppel-like factor 4 (KLF4) is a target gene of miR-32. In agreement with SNHG5 being a decoy for miR-32, we showed that KLF4 suppression by miR-32 could be partially rescued by SNHG5 overexpression, whereas miR-32 mimic rescued SNHG5 overexpression-mediated suppression of GC cell migration. In addition, we identified a negative correlation between the expression of SNHG5 and miR-32 in GC tissues. Furthermore, KLF4 expression was significantly downregulated in GC specimens, and a negative correlation between miR-32 and KLF4 expression and a positive correlation between KLF4 and SNHG5 expression levels were detected. Overall, this study demonstrated, for the first time, that the SNHG5/miR-32/KLF4 axis functions as an important player in GC cell migration and potentially contributes to the improvement of GC diagnosis and therapy.-Zhao, L., Han, T., Li, Y., Sun, J., Zhang, S., Liu, Y., Shan, B., Zheng D., Shi, J. The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4.	[Zhao, Lianmei; Han, Taotao; Li, Yanshuang; Sun, Jiazeng; Zhang, Shang; Liu, Yanxin; Zheng, Dexian; Shi, Juan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China; [Zhao, Lianmei; Han, Taotao; Li, Yanshuang; Sun, Jiazeng; Zhang, Shang; Liu, Yanxin; Zheng, Dexian; Shi, Juan] Peking Union Med Coll, Beijing, Peoples R China; [Zhao, Lianmei; Shan, Baoen] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hebei Medical University	Zheng, DX; Shi, J (corresponding author), Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	zhengdx@pumc.edu.cn; shijuantt@163.com		Zheng, Dexian/0000-0003-3966-1212	State Key Basic Research Program of China [2013CB530805]; Natural Science Foundation of China [81372200, 81572755, 81502032]; Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities [3332013055, 3332014007]	State Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by State Key Basic Research Program of China Grant 2013CB530805; Natural Science Foundation of China Grants 81372200, 81572755, and 81502032; and the Peking Union Medical College Youth Fund and Fundamental Research Funds for the Central Universities Grants 3332013055 and 3332014007. The authors declare no conflicts of interest.	Arita T, 2013, ANTICANCER RES, V33, P3185; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Boreiri M, 2013, ARCH IRAN MED, V16, P343, DOI 013166/AIM.007; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen LX, 2016, MOL CELLS, V39, P330, DOI 10.14348/molcells.2016.2308; Cho YG, 2007, APMIS, V115, P802, DOI 10.1111/j.1600-0463.2007.apm_643.x; Ergun S, 2015, TUMOR BIOL, V36, P3129, DOI 10.1007/s13277-015-3346-x; Guo XQ, 2014, TUMOR BIOL, V35, P10591, DOI 10.1007/s13277-014-2548-y; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Lu MH, 2016, ONCOGENE, V35, P3524, DOI 10.1038/onc.2015.413; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Pacilli A, 2013, INT J MOL SCI, V14, P14923, DOI 10.3390/ijms140714923; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Satolli MA, 2015, WORLD J GASTRO ONCOL, V7, P303, DOI 10.4251/wjgo.v7.i11.303; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wu WY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-30; Xu JQ, 2014, TUMOR BIOL, V35, P9847, DOI 10.1007/s13277-014-2229-x; Yan C, 2015, BIOCHEM BIOPH RES CO, V467, P913, DOI 10.1016/j.bbrc.2015.10.044; Yan SY, 2015, TUMOR BIOL, V36, P4747, DOI 10.1007/s13277-015-3124-9; Zhao L, 2016, ONCOGENE, V35, P5770, DOI 10.1038/onc.2016.110	27	156	166	0	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					893	903		10.1096/fj.201600994R	http://dx.doi.org/10.1096/fj.201600994R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27871067				2022-12-26	WOS:000395671200006
J	Chun, H; Sharma, AK; Lee, J; Chan, J; Jia, S; Kim, BE				Chun, Haarin; Sharma, Anuj Kumar; Lee, Jaekwon; Chan, Jefferson; Jia, Shang; Kim, Byung-Eun			The Intestinal Copper Exporter CUA-1 Is Required for Systemic Copper Homeostasis in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; TRANSCRIPTION FACTOR MTF-1; CELL-SPECIFIC EXPRESSION; C. ELEGANS; IRON-METABOLISM; SUPEROXIDE-DISMUTASE; FLUORESCENT-PROBES; DROSOPHILA MODEL; MENKES PROTEIN; ZINC	Copper plays key catalytic and regulatory roles in biochemical processes essential for normal growth, development, and health. Defects in copper metabolism cause Menkes and Wilson's disease, myeloneuropathy, and cardiovascular disease and are associated with other pathophysiological states. Consequently, it is critical to understand the mechanisms by which organisms control the acquisition, distribution, and utilization of copper. The intestinal enterocyte is a key regulatory point for copper absorption into the body; however, the mechanisms by which intestinal cells transport copper to maintain organismal copper homeostasis are poorly understood. Here, we identify a mechanism by which organismal copper homeostasis is maintained by intestinal copper exporter trafficking that is coordinated with extraintestinal copper levels in Caenorhabditis elegans. Specifically, we show that CUA-1, the C. elegans homolog of ATP7A/B, localizes to lysosome-like organelles (gut granules) in the intestine under copper overload conditions for copper detoxification, whereas copper deficiency results in a redistribution of CUA-1 to basolateral membranes for copper efflux to peripheral tissues. Worms defective in gut granule biogenesis exhibit defects in copper sequestration and increased susceptibility to toxic copper levels. Interestingly, however, a splice isoform CUA-1.2 that lacks a portion of the N-terminal domain is targeted constitutively to the basolateral membrane irrespective of dietary copper concentration. Our studies establish that CUA-1 is a key intestinal copper exporter and that its trafficking is regulated to maintain systemic copper homeostasis. C. elegans could therefore be exploited as a whole-animal model system to study regulation of intra-and intercellular copper trafficking pathways.	[Chun, Haarin; Sharma, Anuj Kumar; Kim, Byung-Eun] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Kim, Byung-Eun] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA; [Chan, Jefferson; Jia, Shang] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Berkeley	Kim, BE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Kim, BE (corresponding author), Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA.	bekim@umd.edu	Sharma, Anuj/G-3043-2011; 贾, 上/P-7344-2019	Sharma, Anuj/0000-0001-5061-9731; 贾, 上/0000-0001-6285-8959; Chun, Haarin/0000-0002-2668-6296	National Institutes of Health [DK074797]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Kim laboratory for helpful suggestions, technical assistance, and critical reading of this manuscript. We thank members of Dr. Iqbal Hamza's laboratory (University of Maryland, College Park) for technical assistance and expertise in C. elegans genetics and cell biology as well as for discussions regarding the work, and Dr. Tamara Korolnek for critical reading of this manuscript. We thank Dr. Stephen G. Kaler (National Institutes of Health, Bethesda) for the anti-ATP7A antibody, and Dr. Michael J. Petris (University of Missouri, Columbia) for ATP7A knock-out MEFs. We thank Dr. Christopher J. Chang (University of California, Berkeley) for discussion and help in providing and using the CF4 and Control-CF4 probes. The worm strain expressing MANS:: mCherry was generously provided by Dr. Christopher Rongo (Rutgers The State University of New Jersey). The COPAS Biosort instrument was purchased from funds supported by a supplement to National Institutes of Health Grant DK074797 (to I. H.).	Anderson CP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00113; Aron AT, 2015, ACCOUNTS CHEM RES, V48, P2434, DOI 10.1021/acs.accounts.5b00221; Bahadorani S, 2010, DIS MODEL MECH, V3, P84, DOI 10.1242/dmm.002642; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Cheli VT, 2010, TRAFFIC, V11, P579, DOI 10.1111/j.1600-0854.2010.01044.x; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Chen B, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/263685; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Chew YL, 2015, AGING CELL, V14, P148, DOI 10.1111/acel.12285; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Edgley Mark L, 2006, WormBook, P1; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kostich M, 2000, J CELL SCI, V113, P2595; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; Mak HY, 2012, J LIPID RES, V53, P28, DOI 10.1194/jlr.R021006; McGhee James D, 2007, WormBook, P1; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meredith D, 2000, CELL MOL LIFE SCI, V57, P754, DOI 10.1007/s000180050040; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Muckenthaler MU, 2008, CELL METAB, V8, P1, DOI 10.1016/j.cmet.2008.06.009; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Palgunow D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046198; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Roh HC, 2015, NUCLEIC ACIDS RES, V43, P803, DOI 10.1093/nar/gku1360; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Romney SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002394; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Sambongi Y, 1997, J BIOCHEM-TOKYO, V121, P1169, DOI 10.1093/oxfordjournals.jbchem.a021711; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; SIMON TC, 1995, CURR OPIN GENET DEV, V5, P577, DOI 10.1016/0959-437X(95)80026-3; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Wakabayashi T, 1998, FEBS LETT, V440, P141, DOI 10.1016/S0014-5793(98)01431-8; Wang YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043039; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	64	16	16	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					1	14		10.1074/jbc.M116.760876	http://dx.doi.org/10.1074/jbc.M116.760876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881675	Green Published, hybrid			2022-12-26	WOS:000391578000001
J	Basaran, M; Uzun, O; Cornelis, W; Gabriels, D; Erpul, G				Basaran, Mustafa; Uzun, Oguzhan; Cornelis, Wim; Gabriels, Donald; Erpul, Gunay			Potential Use of BEST (R) Sediment Trap in Splash - Saltation Transport Process by Simultaneous Wind and Rain Tests	PLOS ONE			English	Article							AEOLIAN SAND TRANSPORT; DRIVEN RAIN; FIELD CALIBRATION; NORTHERN ENGLAND; BLANKET PEAT; TUNNEL; EROSION; SOIL; DETACHMENT; EFFICIENCY	The research on wind-driven rain (WDR) transport process of the splash-saltation has increased over the last twenty years as wind tunnel experimental studies provide new insights into the mechanisms of simultaneous wind and rain (WDR) transport. The present study was conducted to investigate the efficiency of the BEST (R) sediment traps in catching the sand particles transported through the splash-saltation process under WDR conditions. Experiments were conducted in a wind tunnel rainfall simulator facility with water sprayed through sprinkler nozzles and free-flowing wind at different velocities to simulate the WDR conditions. Not only for vertical sediment distribution, but a series of experimental tests for horizontal distribution of sediments was also performed using BEST (R) collectors to obtain the actual total sediment mass flow by the splash-saltation in the center of the wind tunnel test section. Total mass transport (kg m(-2)) were estimated by analytically integrating the exponential functional relationship using the measured sediment amounts at the set trap heights for every run. Results revealed the integrated efficiency of the BEST (R) traps at 6, 9, 12 and 15 m s(-1) wind velocities under 55.8, 50.5, 55.0 and 50.5 mm h(-1) rain intensities were, respectively, 83, 106, 105, and 102%. Results as well showed that the efficiencies of BEST r did not change much as compared with those under rainless wind condition.	[Basaran, Mustafa; Uzun, Oguzhan] Erciyes Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Kayseri, Turkey; [Erpul, Gunay] Ankara Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Ankara, Turkey; [Cornelis, Wim; Gabriels, Donald] Univ Ghent, Dept Soil Management, ICE, Ghent, Belgium	Erciyes University; Ankara University; Ghent University	Basaran, M (corresponding author), Erciyes Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Kayseri, Turkey.	mbasaran@erciyes.edu.tr	uzun, oğuzhan/AAC-3311-2019; Basaran, Mustafa/AAQ-3724-2020	Basaran, Mustafa/0000-0001-5689-657X; Cornelis, Wim/0000-0002-6605-6723				ANDERSON RS, 1988, SCIENCE, V241, P820, DOI 10.1126/science.241.4867.820; Bagnold R., 1941, PHYS BLOWN SAND DESE; Basaran M, 2011, GEOMORPHOLOGY, V130, P343, DOI 10.1016/j.geomorph.2011.04.016; Bielders CL, 2002, GEODERMA, V109, P19, DOI 10.1016/S0016-7061(02)00138-6; Buschiazzo DE, 2007, J ARID ENVIRON, V69, P29, DOI 10.1016/j.jaridenv.2006.08.013; Cornelis WM, 2004, SOIL SCI SOC AM J, V68, P41, DOI 10.2136/sssaj2004.0041; Cornelis WM, 2004, SOIL SCI SOC AM J, V68, P32, DOI 10.2136/sssaj2004.0032; Cornelis WM, 2003, EARTH SURF PROC LAND, V28, P1033, DOI 10.1002/esp.1023; Cortes C, 2007, PROG ENERG COMBUST, V33, P409, DOI 10.1016/j.pecs.2007.02.001; DELIMA JLMP, 1990, J HYDROL, V115, P407, DOI 10.1016/0022-1694(90)90218-M; DEPLOEY J, 1980, ASSESSMENT EROSION, P143; Dong ZB, 2004, GEOMORPHOLOGY, V59, P119, DOI 10.1016/j.geomorph.2003.09.010; Erpul G, 2008, CATENA, V72, P413, DOI 10.1016/j.catena.2007.07.008; Erpul G, 2005, EARTH SURF PROC LAND, V30, P241, DOI 10.1002/esp.1178; Erpul G, 2004, GEOMORPHOLOGY, V59, P31, DOI 10.1016/j.geomorph.2003.09.003; Erpul G, 2004, EARTH SURF PROC LAND, V29, P955, DOI 10.1002/esp.1077; Erpul G, 2003, J HYDROL, V276, P184, DOI 10.1016/S0022-1694(03)00070-2; Erpul G, 2003, T ASAE, V46, P51, DOI 10.13031/2013.12548; Erpul G, 2002, CATENA, V47, P227, DOI 10.1016/S0341-8162(01)00182-5; Erpul G, 1998, SOIL TILL RES, V45, P455, DOI 10.1016/S0933-3630(97)00030-5; Erpul G, 2009, GEOMORPHOLOGY, V104, P191, DOI 10.1016/j.geomorph.2008.08.012; Erpul G, 2009, EARTH SURF PROC LAND, V34, P1270, DOI 10.1002/esp.1814; Erpul G., 2000, INT AGROPHYS, V14, P1; Erpul G., 1996, THESIS; Erpul G., 2001, THESIS; Evans M, 2005, EARTH SURF PROC LAND, V30, P557, DOI 10.1002/esp.1153; Finney R L., 1996, CALCULUS ANAL GEOMET; Foulds SA, 2007, EARTH SURF PROC LAND, V32, P481, DOI 10.1002/esp.1422; Foulds SA, 2007, GEOMORPHOLOGY, V83, P183, DOI 10.1016/j.geomorph.2006.07.001; FRYREAR DW, 1986, J SOIL WATER CONSERV, V41, P117; Gabriels D, 1997, SOIL TECHNOL, V10, P1, DOI 10.1016/S0933-3630(96)00012-8; GILLETTE DA, 1977, SOIL SCI, V123, P97, DOI 10.1097/00010694-197702000-00004; Goossens D, 2000, ATMOS ENVIRON, V34, P1043, DOI 10.1016/S1352-2310(99)00376-3; Goossens D, 2000, GEOMORPHOLOGY, V35, P233, DOI 10.1016/S0169-555X(00)00041-6; Gu ZM, 2007, PHYS LETT A, V368, P435, DOI 10.1016/j.physleta.2007.04.049; Hagen LJ, 2010, AEOLIAN RES, V1, P147, DOI 10.1016/j.aeolia.2009.08.002; Hoffmann C, 2008, CATENA, V75, P182, DOI 10.1016/j.catena.2008.06.003; LEATHERMAN SP, 1978, SEDIMENTOLOGY, V25, P303, DOI 10.1111/j.1365-3091.1978.tb00315.x; LEE JA, 1987, EARTH SURF PROCESSES, V12, P331, DOI 10.1002/esp.3290120311; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Li FR, 2003, CATENA, V53, P255, DOI 10.1016/S0341-8162(03)00039-0; Li ZS, 2003, GEOMORPHOLOGY, V52, P243, DOI 10.1016/S0169-555X(02)00259-3; NEUMAN CM, 1994, BOUND-LAY METEOROL, V68, P35, DOI 10.1007/BF00712663; PEDERSEN HS, 1995, CATENA, V24, P39, DOI 10.1016/0341-8162(94)00024-9; Pietravalle S, 2001, AGR FOREST METEOROL, V109, P171, DOI 10.1016/S0168-1923(01)00267-2; Poortinga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074007; Roney JA, 2006, ATMOS ENVIRON, V40, P7668, DOI 10.1016/j.atmosenv.2006.08.015; SHARON D, 1980, J HYDROL, V46, P165, DOI 10.1016/0022-1694(80)90041-4; Singh U., 1994, THESIS; SPAAN W P, 1991, Soil Technology, V4, P51, DOI 10.1016/0933-3630(91)90039-P; STERK G, 1993, 3 WAG AGR U DEP IRR; Stout JE, 1996, SOIL SCI, V161, P616, DOI 10.1097/00010694-199609000-00006; Temur C, 2012, J ENVIRON SCI HEAL B, V47, P842, DOI 10.1080/03601234.2012.693878; Visser, 2004, TROPICAL RESOURCE MA, P195; Wilson G R, 1994, THESIS; Wilson S. J., 1980, Soil erosion., P217; Youssef F, 2008, ENVIRON GEOL, V55, P741, DOI 10.1007/s00254-007-1027-9; Youssef F, 2012, GEOMORPHOLOGY, V159, P178, DOI 10.1016/j.geomorph.2012.03.023; Zobeck TM, 2006, J HAZARD MATER, V132, P26, DOI 10.1016/j.jhazmat.2005.11.090; [No title captured]	60	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166924	10.1371/journal.pone.0166924	http://dx.doi.org/10.1371/journal.pone.0166924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898716	Green Published, gold			2022-12-26	WOS:000389474000023
J	Park, S; Kim, M				Park, SangWook; Kim, Minhyuk			Numerical Exposure Assessment Method for Low Frequency Range and Application to Wireless Power Transfer	PLOS ONE			English	Article							BATTERY CHARGING PLATFORM; TRANSMISSION	In this paper, a numerical exposure assessment method is presented for a quasi-static analysis by the use of finite-difference time-domain (FDTD) algorithm. The proposed method is composed of scattered field FDTD method and quasi-static approximation for analyzing of the low frequency band electromagnetic problems. The proposed method provides an effective tool to compute induced electric fields in an anatomically realistic human voxel model exposed to an arbitrary non-uniform field source in the low frequency ranges. The method is verified, and excellent agreement with theoretical solutions is found for a dielectric sphere model exposed to a magnetic dipole source. The assessment method serves a practical example of the electric fields, current densities, and specific absorption rates induced in a human head and body in close proximity to a 150-kHz wireless power transfer system for cell phone charging. The results are compared to the limits recommended by the International Commission on Non-Ionizing Radiation Protection (ICNIRP) and the IEEE standard guidelines.	[Park, SangWook] Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea; [Kim, Minhyuk] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea	Seoul National University (SNU)	Park, S (corresponding author), Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea.	parksw@katech.re.kr			Ministry of Trade, Industry and Energy of Korea [10052912]	Ministry of Trade, Industry and Energy of Korea	This work was supported by a grant "Development of Induction/magnetic resonance type 6.6kW, 90% EV Wireless Charger (No. 10052912)" from the Ministry of Trade, Industry and Energy of Korea, http://english.motie.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant "Development of Induction/magnetic resonance type 6.6kW, 90% EV Wireless Charger (No. 10052912)" from the Ministry of Trade, Industry and Energy of Korea.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; [Anonymous], 2005, C951 IEEE, V1; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Choi B, 2004, IEEE T IND ELECTRON, V51, P140, DOI 10.1109/TIE.2003.822039; Christ A, 2013, IEEE T ELECTROMAGN C, V55, P265, DOI 10.1109/TEMC.2012.2219870; Dawson T. W., 1996, Applied Computational Electromagnetics Society Journal, V11, P63; Deford J, 1985, ELECTROMAGN COMPAT I; DeMoerloose J, 1997, RADIO SCI, V32, P329, DOI 10.1029/96RS03690; Dimbylow P, 1996, P INT WORK VOX PHANT; Elliott GAJ, 2006, IEEE T MAGN, V42, P3389, DOI 10.1109/TMAG.2006.879619; Gabriel C, 1996, ENV HEAL; Gandhi O, 1995, P INT WORK VOX PHANT; GREEN AW, 1994, IEE CONF PUBL, P694; Harrington RF, 1996, FIELD COMPUTATION MO; Hirata A, 2010, IEICE T ELECT C; Hui SYR, 2014, IEEE T POWER ELECTR, V29, P4500, DOI 10.1109/TPEL.2013.2249670; Hui SYR, 2005, IEEE T POWER ELECTR, V20, P620, DOI 10.1109/TPEL.2005.846550; HURLEY WG, 1979, IEEE T MAGN, V15, P1174, DOI 10.1109/TMAG.1979.1145874; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Jang YT, 2003, IEEE T IND ELECTRON, V50, P520, DOI 10.1109/TIE.2003.812472; Kissin MLG, 2009, IEEE T IND ELECTRON, V56, P2393, DOI 10.1109/TIE.2009.2020076; Kunz K. S., 1993, FINITE DIFFERENCE TI; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Laakso I, 2012, PHYS MED BIOL, V57, P4991, DOI 10.1088/0031-9155/57/15/4991; Lin JC, 2013, IEEE ANTENN PROPAG M, V55, P250, DOI 10.1109/MAP.2013.6529362; Liu X, 2007, IEEE T POWER ELECTR, V22, P2202, DOI 10.1109/TPEL.2007.909301; Mason PA, 2000, NATO ASI 3 HIGH TECH, V82, P141; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; Park SW, 2013, IEEE T MICROW THEORY, V61, P3461, DOI 10.1109/TMTT.2013.2274053; Park SW, 2015, J ELECTROMAGN ENG SC, V15, P129, DOI 10.5515/JKIEES.2015.15.3.129; Schuder J, 1961, I RADIO ENGRS INT CO; Shojafar M, 2015, IEEE INT CONF COMM, P1800, DOI 10.1109/ICCW.2015.7247442; Song H, 2014, IEEE T MAGN, V50, P3, DOI DOI 10.1109/; Stratton J. A., 2007, ELECTROMAGNETIC THEO; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; The Institute of Electrical and Electronics Engineers (IEEE), 2002, C956 IEEE	36	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166720	10.1371/journal.pone.0166720	http://dx.doi.org/10.1371/journal.pone.0166720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898688	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000016
J	Aspvik, NP; Viken, H; Zisko, N; Ingebrigtsen, JE; Wisloff, U; Stensvold, D				Aspvik, Nils Petter; Viken, Hallgeir; Zisko, Nina; Ingebrigtsen, Jan Erik; Wisloff, Ulrik; Stensvold, Dorthe			Are Older Adults Physically Active Enough - A Matter of Assessment Method? The Generation 100 Study	PLOS ONE			English	Article							RELATIVE INTENSITY; SEDENTARY BEHAVIOR; OXYGEN-UPTAKE; AGE; ACCELEROMETRY; LIFE; GUIDELINES; CAPACITY; DECLINE; FITNESS	Introduction Physical activity (PA) is beneficial for general health. As a result, adults around the world are recommended to undertake regular PA of either absolute or relative intensity. Traditionally, adherence to PA recommendation is assessed by accelerometers that record absolute intensity thresholds. Since ageing often results in a decrease in cardiorespiratory fitness (CRF), older adults (aged > 65 years) might be more susceptible to not meeting the PA recommendation when measured in absolute terms. The aim of the present study was to compare the adherence to the PA recommendation using both absolute and relative thresholds. Additionally, we aimed to report the reference values for overall PA in a large sample of Norwegian older adults. Methods PA was assessed for 7 days using the Actigraph GT3X+ accelerometer in 1219 older adults (624 females) aged 70-77 years. Overall PA was measured as counts per minute (CPM) and steps. Absolute and relative moderate-to-vigorous PA (MVPA) thresholds were applied to quantify adherence to PA recommendation. The relative MVPA thresholds were developed specifically for the Generation 100 population sample. CRF was directly measured as peak oxygen uptake (VO2peak). Results Proportions meeting PA recommendation were 29% and 71% when utilizing absolute and relative MVPA, respectively. More females met the relative PA recommendation compared to males. Overall PA was higher among the youngest age group. Older adults with medium- and high levels of CRF were more physically active, compared to those with the lowest levels of CRF. Conclusion This is the first study to compare adherence to PA recommendation, using absolute and relative intensity thresholds among older adults. The present study clearly illustrates the consequences of using different methodological approaches to surveillance of PA across age, gender and CRF in a population of older adults.	[Aspvik, Nils Petter; Ingebrigtsen, Jan Erik] Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, Fac Social Sci & Technol Management, Trondheim, Norway; [Viken, Hallgeir; Zisko, Nina; Wisloff, Ulrik; Stensvold, Dorthe] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Viken, Hallgeir; Stensvold, Dorthe] Liaison Comm Cent Norway Reg Hlth Author & Norweg, Trondheim, Norway; [Wisloff, Ulrik] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Queensland	Stensvold, D (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway.; Stensvold, D (corresponding author), Liaison Comm Cent Norway Reg Hlth Author & Norweg, Trondheim, Norway.	dorthe.stensvold@ntnu.no	Stensvold, Dorthe/HGE-7694-2022	stensvold, dorthe/0000-0002-8942-1316; Wisloff, Ulrik/0000-0002-7211-3587; Zisko, Nina/0000-0002-0044-7246	Liaison Committee; K.G. Jebsen Foundation; Research Council of Norway	Liaison Committee; K.G. Jebsen Foundation; Research Council of Norway(Research Council of Norway)	The Generation 100 study was funded by The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), The K.G. Jebsen Foundation, and The Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amara CE, 2000, EXP PHYSIOL, V85, P877, DOI 10.1017/S0958067000020662; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Bento T, 2012, REV SAUDE PUBL, V46, P561, DOI 10.1590/S0034-89102012005000022; Berkemeyer K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0316-z; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Hall KS, 2014, MED SCI SPORT EXER, V46, P2335, DOI 10.1249/MSS.0000000000000356; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2014, BRIT J SPORT MED, V48, P239, DOI 10.1136/bjsports-2013-092993; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Lohne-Seiler H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-284; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Orsini N, 2006, MED SCI SPORT EXER, V38, P240, DOI 10.1249/01.mss.0000185086.19220.b3; Ozemek C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-53; Pedisic Z, 2014, BR J SPORTS MED; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Stensvold D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007519; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Viken H, 2016, J AGING PHYS ACTIV, V24, P369, DOI 10.1123/japa.2015-0148; Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS79, DOI 10.1080/02701367.2000.11082790; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2011, NIH PUBL; Zisko N, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0093-1	38	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167012	10.1371/journal.pone.0167012	http://dx.doi.org/10.1371/journal.pone.0167012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893785	Green Published, gold			2022-12-26	WOS:000389472400069
J	Bhattacharjee, N; Khanra, R; Dua, TK; Das, S; De, B; Zia-Ul-Haq, M; De Feo, V; Dewanjee, S				Bhattacharjee, Niloy; Khanra, Ritu; Dua, Tarun K.; Das, Susmita; De, Bratati; Zia-Ul-Haq, M.; De Feo, Vincenzo; Dewanjee, Saikat			Sansevieria roxburghiana Schult. & Schult. F. (Family: Asparagaceae) Attenuates Type 2 Diabetes and Its Associated Cardiomyopathy	PLOS ONE			English	Article							HIGH-FAT DIET; OXIDATIVE STRESS; ANTIDIABETIC ACTIVITY; ENHYDRA-FLUCTUANS; CAFFEIC ACID; ANTIOXIDANT; RAT; INHIBITION; EXTRACT; MODEL	Background Sansevieria roxburghiana Schult. & Schult. F. (Family: Asparagaceae) rhizome has been claimed to possess antidiabetic activity in the ethno-medicinal literature in India. Therefore, present experiments were carried out to explore the protective role of edible (aqueous) extract of S. roxburghiana rhizome (SR) against experimentally induced type 2 diabetes mellitus (T2DM) and its associated cardiomyopathy in Wistar rats. Methods SR was chemically characterized by GC-MS analysis. Antidiabetic activity of SR (50 and 100 mg/kg, orally) was measured in high fat diets (ad libitum) + low-single dose of streptozotocin (35 mg/kg, intraperitoneal) induced type 2 diabetic (T2D) rat. Fasting blood glucose level was measured at specific intermissions. Serum biochemical and inflammatory markers were estimated after sacrificing the animals. Besides, myocardial redox status, expressions of signal proteins (NF-kappa B and PKCs), histological and ultrastructural studies of heart were performed in the controls and SR treated T2D rats. Results Phytochemical screening of the crude extract revealed the presence of phenolic compounds, sugar alcohols, sterols, amino acids, saturated fatty acids within SR. T2D rats exhibited significantly (p < 0.01) higher fasting blood glucose level with respect to control. Alteration in serum lipid profile (p < 0.01) and increased levels of lactate dehydrogenase (p < 0.01) and creatine kinase (p < 0.01) in the sera revealed the occurrence of hyperlipidemia and cell destruction in T2D rats. T2DM caused significant (p < 0.05-0.01) alteration in the biochemical markers in the sera. T2DM altered the redox status (p < 0.05-0.01), decreased (p < 0.01) the intracellular NAD and ATP concentrations in the myocardial tissues of experimental rats. While investigating the molecular mechanism, activation PKC isoforms was observed in the selected tissues. T2D rats also exhibited an up-regulation in nuclear NF-kappa B (p65) in the cardiac tissues. So, oral administration of SR (50 and 500 mg/kg) could reduce hyperglycemia, hyperlipidemia, membrane disintegration, oxidative stress, vascular inflammation and prevented the activation of oxidative stress induced signaling cascades leading to cell death. Histological and ultra-structural studies of cardiac tissues supported the protective characteristics of SR. Conclusions From the present findings it can be concluded that, SR could offer protection against T2DM and its associated cardio-toxicity via multiple mechanisms viz. hypoglycemic, antioxidant and anti-inflammatory actions.	[Bhattacharjee, Niloy; Khanra, Ritu; Dua, Tarun K.; Dewanjee, Saikat] Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata, India; [Das, Susmita; De, Bratati] Univ Calcutta, Dept Bot, Phytochem & Pharmacognosy Res Lab, Kolkata, India; [Zia-Ul-Haq, M.] Women Univ, Lahore Coll, Off Res Innovat & Commercializat, Lahore, Pakistan; [De Feo, Vincenzo] Univ Salerno, Dept Pharm, Salerno, Italy	Jadavpur University; University of Calcutta; University of Salerno	Dewanjee, S (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata, India.; De Feo, V (corresponding author), Univ Salerno, Dept Pharm, Salerno, Italy.	defeo@unisa.it; s.dewanjee@yahoo.com	De Feo, Vincenzo/AAF-2293-2019; KHANRA, RITU/AAV-4351-2021; Dua, Tarun Kumar/AAM-4891-2020; Dewanjee, Saikat/U-9778-2017	De Feo, Vincenzo/0000-0002-1070-3207; Dua, Tarun Kumar/0000-0001-5136-7564; DAS, SUSMITA/0000-0002-2782-8014; Dewanjee, Saikat/0000-0001-9085-4226	Department of Science and Technology (DST), New Delhi, India [1690-2012]	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India))	The financial support of the Department of Science and Technology (DST), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Niloy Bhattacharjee [Department of Science and Technology-Inspire fellowship Ref. No.: DST/INSPIRE Fellowship/2012 [1690-2012] dated 25th February, 2013].; The financial support of the Department of Science and Technology (DST), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Niloy Bhattacharjee [Department of Science and Technology-Inspire fellowship Ref. No.: DST/INSPIRE Fellowship/2012 [1690-2012] dated 25th February, 2013]. Authors are thankful to Jadavpur University, Kolkata, India for providing necessary facilities for this study. Finally, all authors would like to express their sincere gratitude to all the reviewers for their valuable comments to improve the quality of this manuscript.	Ahmad FK, 2005, CURR DRUG TARGETS, V6, P487, DOI 10.2174/1389450054021990; Ambika S., 2013, BIOMEDICINE AGING PA, V3, P253, DOI DOI 10.1016/j.biomag.2013.09.004; [Anonymous], 2009, INT J DIABETES METAB; Baghirova S, 2015, METHODSX, V2, P440, DOI 10.1016/j.mex.2015.11.001; Bastaki S., 2005, INT J DIABETES METAB, V13, P111; Bennett WL, 2011, COMP EFFECTIVENESS R; Bhandari U, 2013, FRONT LIFE SCI, V7, P186, DOI 10.1080/21553769.2014.881304; Bhattacharjee N, 2016, EUR J PHARMACOL, V791, P8, DOI 10.1016/j.ejphar.2016.08.022; Bhattacharya S, 2013, TOXICOL APPL PHARM, V267, P16, DOI 10.1016/j.taap.2012.12.005; Bolner A, 2011, CLIN LAB, V57, P859; Byeon SE, 2013, FREE RADICAL BIO MED, V57, P105, DOI 10.1016/j.freeradbiomed.2012.12.013; CARLSON EC, 1981, J ULTRA MOL STRUCT R, V77, P241, DOI 10.1016/S0022-5320(81)80022-6; Cheng Dong, 2005, Nutr Metab (Lond), V2, P29, DOI 10.1186/1743-7075-2-29; Choi J, 2004, PLANTA MED, V70, P1027, DOI 10.1055/s-2004-832642; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Das S, 2016, EUR FOOD RES TECHNOL, V242, P733, DOI 10.1007/s00217-015-2581-0; Dewanjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139831; Dewanjee S, 2009, FOOD CHEM TOXICOL, V47, P2679, DOI 10.1016/j.fct.2009.07.038; DHIMAN AK, 2006, AYURVEDIC DRUG PLANT; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dua TK, 2016, REDOX REP, V21, P147, DOI 10.1179/1351000215Y.0000000021; Dua TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148757; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0598-6; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0430-3; Eggli, 2007, ILLUSTRATED HDB SUCC, P158; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Haldar Pallab K., 2010, Diabetologia Croatica, V39, P115; Harini Ranganathan, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P79; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163; Kalofoutis Christos, 2007, Exp Clin Cardiol, V12, P17; Khanra R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0364-1; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; KIRTIKAR KR, 1935, INDIAN MED PLANTS, V4; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Li A, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/691594; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Lim EJ, 2008, BIOMOL THER, V16, P231, DOI 10.4062/biomolther.2008.16.3.231; Lin KT, 1997, BIOCHEM BIOPH RES CO, V230, P115, DOI 10.1006/bbrc.1996.5897; Makni M, 2011, EUR J PHARMACOL, V668, P133, DOI 10.1016/j.ejphar.2011.07.001; Manna P, 2012, BIOCHIMIE, V94, P786, DOI 10.1016/j.biochi.2011.11.010; Matsumura H., 1980, METHOD ENZYMOL, V69, P465, DOI DOI 10.1016/S0076-6879(80)69045-4; Mohammed A, 2016, J ETHNOPHARMACOL, V180, P131, DOI 10.1016/j.jep.2016.01.009; Mortan JF, 1981, ATLAS MED PLANTS MID; Nair Preetha, 1997, Indian Journal of Experimental Biology, V35, P451; Narasimhan A, 2015, APPL PHYSIOL NUTR ME, V40, P769, DOI 10.1139/apnm-2015-0002; NAYAK SS, 1981, CLIN CHIM ACTA, V109, P267; Nualkaew S., 2015, Journal of Medicinal Plants Research, V9, P629; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Patel BM, 2014, EUR J PHARMACOL, V728, P128, DOI 10.1016/j.ejphar.2014.01.063; Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743; Philip D., 2011, ASIAN J PHARM CLIN R, V4, P130; PHS (Public Health Service), 1986, PUBL HLTH SERV POL H; Pulliah T, 2019, ENCY WORLD MED PLANT, V2; Raghu KG, 2009, J TRACE ELEM MED BIO, V23, P61, DOI 10.1016/j.jtemb.2008.10.001; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Schulze C, 2014, MOL NUTR FOOD RES, V58, P1795, DOI 10.1002/mnfr.201400016; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Sulyman AO, 2016, J ETHNOPHARMACOL, V182, P122, DOI 10.1016/j.jep.2016.02.002; Szabo C, 2002, DRUG NEWS PERSPECT, V15, P197, DOI 10.1358/dnp.2002.15.4.840052; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Van de Laar FA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003639.pub2; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Venn-Watson SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132117; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; ZHANG YY, 1995, J NUTR, V125, P446; Zheng T, 2012, J ETHNOPHARMACOL, V139, P814, DOI 10.1016/j.jep.2011.12.025	72	11	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167131	10.1371/journal.pone.0167131	http://dx.doi.org/10.1371/journal.pone.0167131			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893829	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400090
J	Boeddha, NP; Driessen, GJ; Cnossen, MH; Hazelzet, JA; Emonts, M				Boeddha, Navin P.; Driessen, Gertjan J.; Cnossen, Marjon H.; Hazelzet, Jan A.; Emonts, Marieke			Circadian Variation of Plasminogen-Activator Inhibitor-1 Levels in Children with Meningococcal Sepsis	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; CASE-FATALITY; PROTEIN-C; MORTALITY; PAI-1; FIBRINOLYSIS; POLYMORPHISM; DISEASE; GENE	Objective To study whether the circadian variation of plasminogen-activator-inhibitor-1 (PAI-1) levels, with high morning levels, is associated with poor outcome of children with meningococcal sepsis presenting in the morning hours. Design Retrospective analysis of prospectively collected clinical and laboratory data. Setting Single center study at Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. Subjects 184 patients aged 3 weeks to 18 years with meningococcal sepsis. In 36 of these children, PAI-1 levels at admission to the PICU were measured in plasma by ELISA. Interventions None. Measurements and main results Circadian variation was studied by dividing one day in blocks of 6 hours. Patients admitted between 6:00 am and 12:00 am had increased illness severity scores and higher PAI-1 levels (n = 9, median 6912 ng/mL, IQR 5808-15600) compared to patients admitted at night (P = 0.019, n = 9, median 3546 ng/mL, IQR 1668-6118) or in the afternoon (P = 0.007, n = 7, median 4224 ng/mL, IQR 1804-5790). In 184 patients, analysis of circadian variation in relation to outcome showed more deaths, amputations and need for skin grafts in patients admitted to the PICU between 6:00 am and 12:00 am than patients admitted during the rest of the day (P = 0.009). Conclusions Circadian variation of PAI-1 levels is present in children with meningococcal sepsis and is associated with illness severity, with a peak level in the morning. Whether circadian variation is an independent risk factor for morbidity and mortality in meningococcal sepsis needs to be explored in future studies.	[Boeddha, Navin P.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands; [Boeddha, Navin P.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Boeddha, Navin P.; Driessen, Gertjan J.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Div Pediat Infect Dis & Immunol, Dept Pediat, Rotterdam, Netherlands; [Cnossen, Marjon H.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Div Pediat Hematol, Dept Pediat, Rotterdam, Netherlands; [Hazelzet, Jan A.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Emonts, Marieke] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Paediat Infect Dis & Immunol Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Emonts, Marieke] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Hazelzet, JA (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	j.a.hazelzet@erasmusmc.nl	Driessen, Gertjan/AAI-9711-2020; Hazelzet, Jan A/L-2888-2015	Cnossen, Marjon H./0000-0003-1557-2995	European Union's seventh Framework program under EC-GA [279185]; Baxter Bioscience, Vienna, Austria	European Union's seventh Framework program under EC-GA; Baxter Bioscience, Vienna, Austria	Research leading to these results has received funding from the European Union's seventh Framework program under EC-GA no. 279185 (EUCLIDS). Also, research has been supported, in part, by an unrestricted grant from Baxter Bioscience, Vienna, Austria, in 2000. We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2001, CRIT CARE MED, V29, P1164, DOI 10.1097/00003246-200106000-00015; BRANDTZAEG P, 1990, THROMB RES, V57, P271, DOI 10.1016/0049-3848(90)90326-8; Couto-Alves A, 2013, CRIT CARE, V17, DOI 10.1186/cc12609; de Kleijn ED, 2003, CRIT CARE MED, V31, P1839, DOI 10.1097/01.CCM.0000072121.61120.D8; GLADSON CL, 1989, BLOOD, V74, P173; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; HALSTENSEN A, 1987, SCAND J INFECT DIS, V19, P35, DOI 10.3109/00365548709032375; Henry M, 1998, ARTERIOSCL THROM VAS, V18, P84, DOI 10.1161/01.ATV.18.1.84; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Khemani R, 2009, INTENS CARE MED, V35, P327, DOI 10.1007/s00134-008-1280-8; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Lewis MR, 2001, THROMB HAEMOSTASIS, V86, P1495, DOI 10.1055/s-0037-1616754; Lorente L, 2014, THROMB RES, V134, P182, DOI 10.1016/j.thromres.2014.04.013; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Scheer FAJL, 2014, BLOOD, V123, P590, DOI 10.1182/blood-2013-07-517060; Smith I, 2006, EPIDEMIOL INFECT, V134, P103, DOI 10.1017/S0950268805004553; van der Bom JG, 2003, BLOOD, V101, P1841, DOI 10.1182/blood-2002-07-2181; Zeerleder S, 2005, CHEST, V128, P2864, DOI 10.1378/chest.128.4.2864	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167004	10.1371/journal.pone.0167004	http://dx.doi.org/10.1371/journal.pone.0167004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893784	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400067
J	Hagerman, GF; Noel, NCL; Cao, SY; Duval, MG; Oel, P; Allison, WT				Hagerman, Gordon F.; Noel, Nicole C. L.; Cao, Sylvia Y.; DuVal, Michele G.; Oel, Phillip; Allison, W. Ted			Rapid Recovery of Visual Function Associated with Blue Cone Ablation in Zebrafish	PLOS ONE			English	Article							TELEOST RETINA; PHOTORECEPTOR DEVELOPMENT; SENSITIVE CONES; CELL-DEATH; STEM-CELLS; REGENERATION; ROD; TRANSPLANTATION; DEGENERATION; RESTORATION	Hurdles in the treatment of retinal degeneration include managing the functional rewiring of surviving photoreceptors and integration of any newly added cells into the remaining second-order retinal neurons. Zebrafish are the premier genetic model for such questions, and we present two new transgenic lines allowing us to contrast vision loss and recovery following conditional ablation of specific cone types: UV or blue cones. The ablation of each cone type proved to be thorough (killing 80% of cells in each intended cone class), specific, and cell-autonomous. We assessed the loss and recovery of vision in larvae via the optomotor behavioural response (OMR). This visually mediated behaviour decreased to about 5% or 20% of control levels following ablation of UV or blue cones, respectively (P<0.05). We further assessed ocular photoreception by measuring the effects of UV light on body pigmentation, and observed that photoreceptor deficits and recovery occurred (p<0.01) with a timeline coincident to the OMR results. This corroborated and extended previous conclusions that UV cones are required photoreceptors for modulating body pigmentation, addressing assumptions that were unavoidable in previous experiments. Functional vision recovery following UV cone ablation was robust, as measured by both assays, returning to control levels within four days. In contrast, robust functional recovery following blue cone ablation was unexpectedly rapid, returning to normal levels within 24 hours after ablation. Ablation of cones led to increased proliferation in the retina, though the rapid recovery of vision following blue cone ablation was demonstrated to not be mediated by blue cone regeneration. Thus rapid visual recovery occurs following ablation of some, but not all, cone subtypes, suggesting an opportunity to contrast and dissect the sources and mechanisms of outer retinal recovery during cone photoreceptor death and regeneration.	[Hagerman, Gordon F.; Noel, Nicole C. L.; Cao, Sylvia Y.; DuVal, Michele G.; Oel, Phillip; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Allison, WT (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.; Allison, WT (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014	Allison, W. Ted/0000-0002-8461-4864; Noel, Nicole C. L./0000-0001-9094-6745; DuVal, Michele/0000-0001-6975-8117	University of Alberta Undergraduate Research Initiative; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; NSERC; Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates [201500066] Funding Source: researchfish	University of Alberta Undergraduate Research Initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	NCLN was supported by the University of Alberta Undergraduate Research Initiative (http://www.uri.ualberta.ca). MGD was supported by MD/PhD Studentships from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and from Alberta Innovates Health Solutions. SYC was funded by Studentships from Alberta Innovates Health Solutions (http://www.aihealthsolutions.ca) and NSERC. APO was supported by a CGSM Studentship from NSERC. Research was funded by Operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC http://www.nserc-crsng.gc.ca) to WTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2006, VISUAL NEUROSCI, V23, P25, DOI 10.1017/S0952523806231031; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Biehlmaier O, 2001, CELL TISSUE RES, V306, P199, DOI 10.1007/s004410100447; CAMERON DA, 1995, J NEUROSCI, V15, P2255, DOI 10.1523/JNEUROSCI.15-03-02255.1995; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; DuVal MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092991; DuVal MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089183; Duval MG, 2013, MOL VIS, V19, P1082; Easter SS, 2000, NEUROSCIENTIST, V6, P454, DOI 10.1177/107385840000600608; Engstrom K, 1960, ACTA ZOOLOGICA, V41, P227; ENGSTROM KJELL, 1963, ACTA ZOOL, V44, P179; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; Fleisch VC, 2013, NEUROBIOL DIS, V55, P11, DOI 10.1016/j.nbd.2013.03.007; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Kim JW, 2016, DEV CELL, V37, P520, DOI 10.1016/j.devcel.2016.05.023; Krauss A, 2003, VISION RES, V43, P1273, DOI 10.1016/S0042-6989(03)00090-7; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lakowski J, 2015, STEM CELLS, V33, P2469, DOI 10.1002/stem.2051; Lorach H, 2015, INVEST OPHTH VIS SCI, V56, P4644, DOI 10.1167/iovs.14-16011; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mensinger AF, 1999, VISUAL NEUROSCI, V16, P241, DOI 10.1017/S0952523899162059; Mensinger AF, 2007, VISUAL NEUROSCI, V24, P299, DOI 10.1017/S0952523807070265; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Mueller KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087372; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Ogawa Y, 2015, P BIOL SCI, V282; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; RAYMOND PA, 1988, J NEUROBIOL, V19, P431, DOI 10.1002/neu.480190504; Raymond PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085325; Risner ML, 2006, VISION RES, V46, P2625, DOI 10.1016/j.visres.2005.12.014; Sher A, 2013, J NEUROSCI, V33, P6800, DOI 10.1523/JNEUROSCI.1044-12.2013; Shiraki T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1498, DOI 10.1039/c0pp00199f; Snelson CD, 2008, DEV DYNAM, V237, P3538, DOI 10.1002/dvdy.21607; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Takechi M, 2008, J BIOL CHEM, V283, P31625, DOI 10.1074/jbc.M806226200; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123; White DT, 2013, METHODS, V62, P232, DOI 10.1016/j.ymeth.2013.03.017; Yoshimatsu T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4699	55	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166932	10.1371/journal.pone.0166932	http://dx.doi.org/10.1371/journal.pone.0166932			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893779	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400059
J	Karbiener, M; Jarvis, JC; Perkins, JD; Lanmuller, H; Schmoll, M; Rode, HS; Gerstenberger, C; Gugatschka, M				Karbiener, Michael; Jarvis, Jonathan C.; Perkins, Justin D.; Lanmueller, Hermann; Schmoll, Martin; Rode, Hanna S.; Gerstenberger, Claus; Gugatschka, Markus			Reversing Age Related Changes of the Laryngeal Muscles by Chronic Electrostimulation of the Recurrent Laryngeal Nerve	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; PARALYZED CANINE LARYNX; VOICE; MANAGEMENT; DYSPHONIA; ISOFORMS; YOUNG	Age related atrophy of the laryngeal muscles -mainly the thyroarytenoid muscle (TAM)leads to a glottal gap and consequently to a hoarse and dysphonic voice that significantly affects quality of life. The aim of our study was to reverse this atrophy by inducing muscular hypertrophy by unilateral functional electrical stimulation (FES) of the recurrent laryngeal nerve (RLN) in a large animal model using aged sheep (n = 5). Suitable stimulation parameters were determined by fatiguing experiments of the thyroarytenoid muscle in an acute trial. For the chronic trial an electrode was placed around the right RLN and stimulation was delivered once daily for 29 days. We chose a very conservative stimulation pattern, total stimulation time was two minutes per day, or 0.14% of total time. Overall, the mean muscle fiber diameter of the stimulated right TAM was significantly larger than the non-stimulated left TAM (30 mu m +/- 1.1 mu m vs. 28 mu m +/- 1.1 mu m, p<0.001). There was no significant shift in fiber type distribution as judged by immunohistochemistry. The changes of fiber diameter could not be observed in the posterior cricoarytenoid muscle (PCAM). FES is a possible new treatment option for reversing the effects of age related laryngeal muscle atrophy.	[Karbiener, Michael; Gerstenberger, Claus; Gugatschka, Markus] Med Univ Graz, ENT Univ Hosp, Dept Phoniatr, Graz, Austria; [Jarvis, Jonathan C.; Schmoll, Martin] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England; [Perkins, Justin D.; Rode, Hanna S.] Royal Vet Coll, Dept Vet Clin Sci, London, England; [Lanmueller, Hermann; Schmoll, Martin] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Medical University of Graz; Liverpool John Moores University; University of London; University of London Royal Veterinary College; Medical University of Vienna	Gugatschka, M (corresponding author), Med Univ Graz, ENT Univ Hosp, Dept Phoniatr, Graz, Austria.	markus.gugatschka@medunigraz.at		Schmoll, Martin/0000-0001-6354-3879; Gugatschka, Markus/0000-0001-8091-8812; Gerstenberger, Claus/0000-0002-6756-2986	Austrian Research Promotion Agency [848458]	Austrian Research Promotion Agency	This study was funded by the Austrian Research Promotion Agency (Grant Nr.: 848458; https://www.ffg.at/).	Andreasen CM, 2015, BONE, V75, P32, DOI 10.1016/j.bone.2015.02.014; Bloch I, 2001, LARYNGOSCOPE, V111, P2022, DOI 10.1097/00005537-200111000-00029; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Cheetham J, 2015, ARTIF ORGANS, V39, P876, DOI 10.1111/aor.12624; Chen PH, 2009, DYSPHAGIA, V24, P1, DOI 10.1007/s00455-008-9156-1; Chen RL, 2008, J GERONTOL A-BIOL, V63, P141, DOI 10.1093/gerona/63.2.141; Chen RL, 2010, J NEUROCHEM, V113, P1230, DOI 10.1111/j.1471-4159.2010.06689.x; Connor NP, 2002, ANN OTO RHINOL LARYN, V111, P579, DOI 10.1177/000348940211100703; Davids T, 2012, LARYNGOSCOPE, V122, P332, DOI 10.1002/lary.22397; Eurostat Statistics Explained, 2015, EUROSTAT STAT EXPLAI; Forster G, 2013, EUR ARCH OTO-RHINO-L, V270, P225, DOI 10.1007/s00405-012-2141-1; Martins RHG, 2015, LARYNGOSCOPE, V125, P2518, DOI 10.1002/lary.25398; Hagen P, 1996, SOUTHERN MED J, V89, P204, DOI 10.1097/00007611-199602000-00009; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Johns MM, 2011, OTOLARYNG HEAD NECK, V145, P1, DOI 10.1177/0194599811404640; Kletzien H, 2016, LARYNGOSCOPE, V126, P672, DOI 10.1002/lary.25520; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luschei ES, 1999, J NEUROPHYSIOL, V81, P2131, DOI 10.1152/jn.1999.81.5.2131; McMullen CA, 2011, J SPEECH LANG HEAR R, V54, P845, DOI 10.1044/1092-4388(2010/10-0127); Nomura K, 2010, LARYNGOSCOPE, V120, P2399, DOI 10.1002/lary.21065; Paniello RC, 2015, LARYNGOSCOPE, V125, pE67, DOI 10.1002/lary.24947; Paniello RC, 2000, ANN OTO RHINOL LARYN, V109, P447, DOI 10.1177/000348940010900502; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; RAMIG LA, 1983, J SPEECH HEAR RES, V26, P22, DOI 10.1044/jshr.2601.22; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; RODENO MT, 1993, ACTA OTO-LARYNGOL, V113, P445, DOI 10.3109/00016489309135842; Roy N, 2007, LARYNGOSCOPE, V117, P628, DOI 10.1097/MLG.0b013e3180306da1; Sauermann S, 2007, BIOMED TECH, V52, P267, DOI 10.1515/BMT.2007.046; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P962, DOI 10.1177/000348940211101102; Tulloch LK, 2011, EQUINE VET J, V43, P500, DOI 10.1111/j.2042-3306.2010.00329.x; Van Daele DJ, 2010, J COMMUN DISORD, V43, P327, DOI 10.1016/j.jcomdis.2010.04.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verdonck-de Leeuw Irma M, 2004, J Voice, V18, P193, DOI 10.1016/j.jvoice.2003.10.002; Wu YZ, 2000, ARCH OTOLARYNGOL, V126, P874, DOI 10.1001/archotol.126.7.874; Zealear DL, 2009, LARYNGOSCOPE, V119, P1737, DOI 10.1002/lary.20587; Ziegler A, 2014, LARYNGOSCOPE, V124, P1869, DOI 10.1002/lary.24548	39	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167367	10.1371/journal.pone.0167367	http://dx.doi.org/10.1371/journal.pone.0167367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893858	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400114
J	Zhang, W; Liu, C; Hai, B; Du, GH; Wang, H; Leng, HJ; Xu, YS; Song, CL				Zhang, Wen; Liu, Can; Hai, Bao; Du, Guohong; Wang, Hong; Leng, Huijie; Xu, Yingsheng; Song, Chunli			A Convenient In Vivo Model Using Small Interfering RNA Silencing to Rapidly Assess Skeletal Gene Function	PLOS ONE			English	Article							BONE-FORMATION; DELIVERY; MICE; INJECTION; INHIBITION; METABOLISM; PHYSIOLOGY; MINIPIGS; INSULIN; RODENTS	It is difficult to study bone in vitro because it contains various cell types that engage in crosstalk. Bone biologically links various organs, and it has thus become increasingly evident that skeletal physiology must be studied in an integrative manner in an intact animal. We developed a model using local intraosseous small interfering RNA (siRNA) injection to rapidly assess the effects of a target gene on the local skeletal environment. In this model, 160-g male Sprague-Dawley rats were treated for 1-2 weeks. The left tibia received intraosseous injection of a parathyroid hormone 1 receptor (Pth1r) or insulin-like growth factor 1 receptor (Igf-1r) siRNA transfection complex loaded in poloxamer 407 hydrogel, and the right tibia received the same volume of control siRNA. All the tibias received an intraosseous injection of recombinant human parathyroid hormone (1-34) (rhPTH (1-34)) or insulin-like growth factor-1 (IGF-1). Calcein green and alizarin red were injected 6 and 2 days before euthanasia, respectively. IGF-1R and PTH1R expression levels were detected via RT-PCR assays and immunohistochemistry. Bone mineral density (BMD), microstructure, mineral apposition rates (MARs), and strength were determined by dual-energy X-ray absorptiometry, micro-CT, histology and biomechanical tests. The RT-PCR and immunohistochemistry results revealed that IGF-1R and PTH1R expression levels were dramatically diminished in the siRNA-treated left tibias compared to the right tibias (both p<0.05). Using poloxamer 407 hydrogel as a controlled-release system prolonged the silencing effect of a single dose of siRNA; the mRNA expression levels of IGF-1R were lower at two weeks than at one week (p<0.01). The BMD, bone microstructure parameters, MAR and bone strength were significantly decreased in the left tibias compared to the right tibias (all p<0.05). This simple and convenient local intraosseous siRNA injection model achieved gene silencing with very small quantities of siRNA over a short treatment period(<= 7 days).	[Zhang, Wen; Liu, Can; Hai, Bao; Du, Guohong; Wang, Hong; Leng, Huijie; Song, Chunli] Peking Univ, Hosp 3, Dept Orthopaed, Beijing, Peoples R China; [Zhang, Wen; Liu, Can; Hai, Bao; Wang, Hong; Leng, Huijie; Song, Chunli] Beijing Key Lab Spinal Dis, Beijing, Peoples R China; [Xu, Yingsheng] Peking Univ, Hosp 3, Dept Neurol, Beijing, Peoples R China	Peking University; Peking University	Song, CL (corresponding author), Peking Univ, Hosp 3, Dept Orthopaed, Beijing, Peoples R China.; Song, CL (corresponding author), Beijing Key Lab Spinal Dis, Beijing, Peoples R China.	schl@bjmu.edu.cn	Leng, Huijie/AGQ-9574-2022	Leng, Huijie/0000-0002-4436-061X	National Natural Science Foundation of China [81641079, 81171693, 81672133]; National High Technology Research and Development Program of China (863 Program) [2015AA020304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Project Nos. 81641079, 81171693 and 81672133) and the National High Technology Research and Development Program of China (863 Program, Project No. 2015AA020304). Dr. CLS and Dr. YSX received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Manasi, 2010, Curr Osteoporos Rep, V8, P205, DOI 10.1007/s11914-010-0028-x; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hattori S, 2014, J NUTR SCI VITAMINOL, V60, P152, DOI 10.3177/jnsv.60.152; Hoskins SL, 2012, RESUSCITATION, V83, P107, DOI 10.1016/j.resuscitation.2011.07.041; Kaleagasioglu F, 2015, KNEE SURG SPORTS TRA; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; LI XJ, 1995, BONE, V17, pS243, DOI 10.1016/8756-3282(95)00298-R; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Maria CS, 2016, SEMIN CELL DEV BIOL, V49, P11, DOI 10.1016/j.semcdb.2015.12.004; Massarwi M, 2013, AM J EMERG MED, V31, P1255, DOI 10.1016/j.ajem.2013.05.020; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Murray DB, 2012, ANN EMERG MED, V60, P424, DOI 10.1016/j.annemergmed.2012.05.013; Pan M, 2015, BMB REP, V48, P147, DOI 10.5483/BMBRep.2015.48.3.089; Peer D, 2011, GENE THER, V18, P1127, DOI 10.1038/gt.2011.56; Pillai O, 2003, J CONTROL RELEASE, V89, P127, DOI 10.1016/S0168-3659(03)00094-4; Qing FZ, 2016, J ORTHOP RES, V34, P1147, DOI 10.1002/jor.23128; Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037; Rosen C, 2012, BONE, V50, P429, DOI 10.1016/j.bone.2011.10.006; Ruehe B, 2011, J ORAL IMPLANTOL, V37, P3, DOI 10.1563/AAID-JOI-D-09-00090; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tan J, 2016, OSTEOPOROSIS INT, V27, P757, DOI 10.1007/s00198-015-3230-y; Tan J, 2015, MED SCI MONITOR, V21, P1428, DOI 10.12659/MSM.892247; Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8; Ueda Y, 2016, IMMUNOBIOLOGY, V221, P1080, DOI 10.1016/j.imbio.2016.06.007; van't Hof RJ, 2000, P NATL ACAD SCI USA, V97, P7993, DOI 10.1073/pnas.130511497; Wang YC, 2013, INT J NANOMED, V8, P3805, DOI 10.2147/IJN.S48950; Wu SY, 2009, AAPS J, V11, P639, DOI 10.1208/s12248-009-9140-1; Yang N, 2014, J BONE MINER METAB, V32, P252, DOI 10.1007/s00774-013-0496-z	38	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167222	10.1371/journal.pone.0167222	http://dx.doi.org/10.1371/journal.pone.0167222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893850	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400104
J	Hart, J; Novak, V; Saunders, C; Gremaud, PA				Hart, Joseph; Novak, Vera; Saunders, Charles; Gremaud, Pierre A.			Transcranial Doppler-Based Surrogates for Cerebral Blood Flow: A Statistical Study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VELOCITY; MRI; QUANTIFICATION; VARIABILITY; HYPERINTENSITIES; REPRODUCIBILITY; VASOREACTIVITY; HYPERCAPNIA; VOLUNTEERS	It is commonly assumed that perfusion in a given cerebral territory can be inferred from Blood Flow Velocity (BFV) measurements in the corresponding stem artery. In order to test this hypothesis, we construct a cerebral blood flow (CBF) estimator based on transcranial Doppler (TCD) blood flow velocity and ten other easily available patient characteristics and clinical parameters. A total of 261 measurements were collected from 88 older patients. The estimator is based on local regression (Random Forest). Its performance is analyzed against baseline CBF from 3-D pseudocontinuous arterial spin labeling (pCASL) magnetic resonance imaging (MRI). Patient specific CBF predictions are of poor quality (r = 0.41 and p-value = 4.5 x 10(-12)); the hypothesis is thus not clearly supported by evidence.	[Hart, Joseph; Gremaud, Pierre A.] North Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA; [Novak, Vera] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Saunders, Charles] Univ Southampton, Engn & Environm, Southampton, Hants, England	University of North Carolina; North Carolina State University; Harvard University; Beth Israel Deaconess Medical Center; University of Southampton	Gremaud, PA (corresponding author), North Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.	gremaud@ncsu.edu		Hart, Joseph/0000-0001-6932-7894	National Science Foundation; National Institutes of Health [DMS-1557761, DMS-1522765]; Harvard Clinical and Translational Science Center [UL1 RR025758]; National Center for Research Resources [M01-RR-01032]; NIH-NINDS [R01-NS045745]; NIH-NIA [1R01-AG0287601A2]; American Diabetes Association [1-06CR-25]; National Science Foundation (NSF); National Institutes of Health (NIH) [DMS-1557761, DMS-1522765];  [1R01DK13902-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045745] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1522765] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1557761] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Diabetes Association(American Diabetes Association); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This material is based upon work supported by the National Science Foundation (http://www.nsf.gov) and the National Institutes of Health (http://www.nih.gov) under Awards No. DMS-1557761 and DMS-1522765 to P. Gremaud, by grant number UL1 RR025758 from the Harvard Clinical and Translational Science Center (http://www.catalyst.harvard.edu) and award No. M01-RR-01032 from the National Center for Research Resources (http://sdminutes.cit.nih.gov/about/almanac/organization/NCRR.htm). Support to Dr. Novak from NIH-NINDS R01-NS045745, NIH-NIA 1R01-AG0287601A2 and from the American Diabetes Association (http://diabetes.org) (1-06CR-25) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the m anuscript.; This material is based upon work supported by the National Science Foundation (NSF) and the National Institutes of Health (NIH) under Awards No. DMS-1557761 and DMS-1522765 to P. Gremaud, by grant number UL1 RR025758 from the Harvard Clinical and Translational Science Center and award No. M01-RR-01032 from the National Center for Research Resources. Support to Dr. Novak from NIH D NINDS R01-NS045745, NIH-NIA 1R01-AG0287601A2 and from the American Diabetes Association (1-06-CR-25) is acknowledged. Dr. Novak was also supported by 1R01DK13902-01A1 unrelated to this project. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institutes of Health or the National Science Foundation.	Ainslie PN, 2014, J APPL PHYSIOL, V117, P1081, DOI 10.1152/japplphysiol.00854.2014; Bathala L, 2013, ANN INDIAN ACAD NEUR, V16, P174, DOI 10.4103/0972-2327.112460; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 2014, PACKAGE RANDOMFOREST; Breiman L., 2017, CLASSIFICATION REGRE; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; D'Agostino E, 2004, LECT NOTES COMPUT SC, V3216, P745; Dai WY, 2012, MAGN RESON MED, V67, P1252, DOI 10.1002/mrm.23103; Dai WY, 2010, MAGN RESON MED, V64, P975, DOI 10.1002/mrm.22363; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Dolui S, 2016, J CEREBR BLOOD F MET, V36, P1244, DOI 10.1177/0271678X16646124; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Giller CA, 2003, J NEUROIMAGING, V13, P97, DOI 10.1177/1051228403251633; Hajjar I, 2010, HYPERTENSION, V56, P859, DOI 10.1161/HYPERTENSIONAHA.110.160002; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Henriksen OM, 2013, J CEREBR BLOOD F MET, V33, P787, DOI 10.1038/jcbfm.2013.17; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; Hermes M, 2007, MAGN RESON MATER PHY, V20, P103, DOI 10.1007/s10334-007-0073-3; Kamenskiy AV, 2011, J VASC SURG, V54, P1011, DOI 10.1016/j.jvs.2011.03.254; Knutsson L, 2007, J MAGN RESON IMAGING, V26, P913, DOI 10.1002/jmri.21093; Knutsson L, 2013, MAGN RESON IMAGING, V31, P651, DOI 10.1016/j.mri.2012.12.001; Knutsson L, 2010, MAGN RESON IMAGING, V28, P1, DOI 10.1016/j.mri.2009.06.006; Koziak AM, 2008, MAGN RESON IMAGING, V26, P543, DOI 10.1016/j.mri.2007.10.005; Maleki N, 2012, MAGN RESON MATER PHY, V25, P127, DOI 10.1007/s10334-011-0286-3; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Mette D, 2011, TRANSL STROKE RES, V2, P152, DOI 10.1007/s12975-010-0064-y; Novak V, 2003, CLIN AUTON RES, V13, P370; Novak V, 2006, DIABETES CARE, V29, P1529, DOI 10.2337/dc06-0261; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; Novak V, 2011, DIABETES CARE, V34, P2438, DOI 10.2337/dc11-0969; Qiu DQ, 2012, J MAGN RESON IMAGING, V36, P110, DOI 10.1002/jmri.23613; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Vakil P, 2013, RADIOLOGY, V266, P879, DOI 10.1148/radiol.12120756; Valdiviezo HC, 2015, INFORM SCIENCES, V311, P163, DOI 10.1016/j.ins.2015.03.018; van Golen LW, 2014, J MAGN RESON IMAGING, V40, P1300, DOI 10.1002/jmri.24484; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Yonan KA, 2014, ULTRASOUND MED BIOL, V40, P2692, DOI 10.1016/j.ultrasmedbio.2014.05.022; Zaharchuk G, 2010, MAGN RESON MED, V63, P1548, DOI 10.1002/mrm.22329; Zhang K, 2014, J CEREBR BLOOD F MET, V34, P1373, DOI 10.1038/jcbfm.2014.92; Zhao P, 2009, NEUROLOGY, V72, P643, DOI 10.1212/01.wnl.0000342473.65373.80	43	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165536	10.1371/journal.pone.0165536	http://dx.doi.org/10.1371/journal.pone.0165536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880813	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500011
J	Palmer, BA; Fanning, LJ				Palmer, Brendan A.; Fanning, Liam J.			Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness	PLOS ONE			English	Article							ORDERED RNA STRUCTURE; HYPERVARIABLE REGION-1; EVOLUTION; ARCHITECTURE; NETWORK; RATES; BIAS	Hepatitis C virus is a positive-sense single-stranded RNA virus. The gene junction partitioning the viral glycoproteins E1 and E2 displays concurrent sequence evolution with the 30end of E1 highly conserved and the 5'-end of E2 highly heterogeneous. This gene junction is also believed to contain structured RNA elements, with a growing body of evidence suggesting that such structures can act as an additional level of viral replication and transcriptional control. We have previously used ultradeep pyrosequencing to analyze an amplicon library spanning the E1/E2 gene junction from a treatment naive patient where samples were collected over 10 years of chronic HCV infection. During this timeframe maintenance of an inframe insertion, recombination and humoral immune targeting of discrete virus sub-populations was reported. In the current study, we present evidence of epistatic evolution across the E1/E2 gene junction and observe the development of co-varying networks of codons set against a background of a complex virome with periodic shifts in population dominance. Overtime, the number of codons actively mutating decreases for all virus groupings. We identify strong synonymous co-variation between codon sites in a group of sequences harbouring a 3 bp in-frame insertion and propose that synonymous mutation acts to stabilize the RNA structural backbone.	[Palmer, Brendan A.; Fanning, Liam J.] Univ Coll Cork, Dept Med, Mol Virol Diagnost & Res Lab, Cork, Ireland	University College Cork	Palmer, BA; Fanning, LJ (corresponding author), Univ Coll Cork, Dept Med, Mol Virol Diagnost & Res Lab, Cork, Ireland.	b.palmer@ucc.ie; l.fanning@ucc.ie	FANNING, LIAM J/F-5281-2015	FANNING, LIAM J/0000-0001-6629-8418; Palmer, Brendan/0000-0001-6637-0723				Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Champeimont R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26401; Cuevas JM, 2012, MOL BIOL EVOL, V29, P17, DOI 10.1093/molbev/msr179; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Davis M, 2008, J VIROL, V82, P11824, DOI 10.1128/JVI.01078-08; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Elena SF, 2010, CHAOS, V20, DOI 10.1063/1.3449300; Fricke M, 2016, BIOINFORMATICS, V32, P2928, DOI 10.1093/bioinformatics/btw323; Geller R, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.45, 10.1038/nmicrobiol.2016.45]; Hagen N, 2014, MOL CELL PROTEOMICS, V13, P1676, DOI 10.1074/mcp.M113.036301; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hillung J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0292; Hino K, 2002, J VIRAL HEPATITIS, V9, P194, DOI 10.1046/j.1365-2893.2002.00349.x; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Kawaguchi K, 2011, J VIROL, V85, P3408, DOI 10.1128/JVI.02554-10; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lauring AS, 2012, CELL HOST MICROBE, V12, P623, DOI 10.1016/j.chom.2012.10.008; Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112; Palmer BA, 2016, J VIROL, V90, P3318, DOI 10.1128/JVI.02995-15; Palmer BA, 2014, J VIROL, V88, P13709, DOI 10.1128/JVI.01732-14; Palmer BA, 2012, J GEN VIROL, V93, P2614, DOI 10.1099/vir.0.045344-0; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Shah P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001128; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Simon-Loriere E, 2010, J VIROL, V84, P12675, DOI 10.1128/JVI.01302-10; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Stewart H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22952; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Witteveldt J, 2014, NUCLEIC ACIDS RES, V42, P3314, DOI 10.1093/nar/gkt1291; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yi M, 2014, J VIROL, V88, P3678, DOI 10.1128/JVI.03540-13; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167089	10.1371/journal.pone.0167089	http://dx.doi.org/10.1371/journal.pone.0167089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880830	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500065
J	Bhattacharyya, R; Fenn, RH; Barren, C; Tanzi, RE; Kovacs, DM				Bhattacharyya, Raja; Fenn, Rebecca H.; Barren, Cory; Tanzi, Rudolph E.; Kovacs, Dora M.			Palmitoylated APP Forms Dimers, Cleaved by BACE1	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; HEPARIN-INDUCED DIMERIZATION; EXTRACELLULAR DOMAIN; BETA-SECRETASE; ALZHEIMERS; IDENTIFICATION; HOMODIMERIZATION; E1	A major rate-limiting step for A beta generation and deposition in Alzheimer's disease brains is BACE1-mediated cleavage (beta-cleavage) of the amyloid precursor protein (APP). We previously reported that APP undergoes palmitoylation at two cysteine residues (Cys(186) and Cys(187)) in the E1-ectodomain. 8-10% of total APP is palmitoylated in vitro and in vivo. Palmitoylated APP (palAPP) shows greater preference for beta-cleavage than total APP in detergent resistant lipid rafts. Protein palmitoylation is known to promote protein dimerization. Since dimerization of APP at its E1-ectodomain results in elevated BACE1-mediated cleavage of APP, we have now investigated whether palmitoylation of APP affects its dimerization and whether this leads to elevated beta-cleavage of the protein. Here we report that over 90% of palAPP is dimerized while only similar to 20% of total APP forms dimers. PalAPP-dimers are predominantly cis-oriented while total APP dimerizes in both cis- and trans-orientation. PalAPP forms dimers 4.5-times more efficiently than total APP. Overexpression of the palmitoylating enzymes DHHC7 and DHHC21 that increase palAPP levels and A beta release, also increased APP dimerization in cells. Conversely, inhibition of APP palmitoylation by pharmacological inhibitors reduced APP-dimerization in coimmunoprecipitation and FLIM/FRET assays. Finally, in vitro BACE1-activity assays demonstrate that palmitoylation-dependent dimerization of APP promotes beta-cleavage of APP in lipid-rich detergent resistant cell membranes (DRMs), when compared to total APP. Most importantly, generation of sAPP(beta)-sAPP(beta) dimers is dependent on APP-palmitoylation while total sAPP(beta) generation is not. Since BACE1 shows preference for palAPP dimers over total APP, palAPP dimers may serve as novel targets for effective beta-cleavage inhibitors of APP as opposed to BACE1 inhibitors.	[Bhattacharyya, Raja; Fenn, Rebecca H.; Barren, Cory; Tanzi, Rudolph E.; Kovacs, Dora M.] Harvard Med Sch, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis MIND, Genet & Aging Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Kovacs, DM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis MIND, Genet & Aging Res Unit, Charlestown, MA 02129 USA.	dora_kovacs@hms.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	Cure Alzheimer's Fund; NIH/NINDS [R01NS45860]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045860] Funding Source: NIH RePORTER	Cure Alzheimer's Fund; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Cure Alzheimer's Fund (grants to D.M.K. and R.E.T.) and the NIH/NINDS (R01NS45860 to D.M.K/R.E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our funding agencies the Cure Alzheimer's Fund (grants to D.M.K. and R.E.T.) and the NIH/NINDS (R01NS45860 to D.M.K/R.E.T.). We also thank Dr. Masaki Fukata (NIPS, Okazaki, Japan) for providing us with the DHHC-expression plasmids; Dr. Stephen Pasternak for providing us expression plasmid for HA-APP<INF>y</INF>; Dr. Stefan Kins for giving us the APP-dimerization deficient APP(H108/110A)-expression plasmid; Dr. Claus U. Pietrzik for the generous gifts of APP-split GFP plasmids; and Dr. Doo Yeon Kim (Massachusetts General Hospital, Charlestown, MA) for helpful advice on ReN cell maintenance and differentiation. We also thank Dr. Katarzyna Marta Zoltowska and Sarah Svirsky (Massachusetts General Hospital, Charlestown, MA) for FRET/FLIM analysis.	Asada-Utsugi M, 2011, J NEUROCHEM, V119, P354, DOI 10.1111/j.1471-4159.2011.07364.x; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Baumkotter F, 2014, J NEUROSCI, V34, P11159, DOI 10.1523/JNEUROSCI.0180-14.2014; Ben Khalifa N, 2010, CELL ADHES MIGR, V4, P268, DOI 10.4161/cam.4.2.11476; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Bettayeb K, 2016, P NATL ACAD SCI USA, V113, P5412, DOI 10.1073/pnas.1604156113; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; D'Avanzo C, 2015, BIOESSAYS, V37, P1139, DOI 10.1002/bies.201500063; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fogel H, 2014, CELL REP, V7, P1560, DOI 10.1016/j.celrep.2014.04.024; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; Hoefgen S, 2014, J STRUCT BIOL, V187, P30, DOI 10.1016/j.jsb.2014.05.006; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Huttunen HJ, 2009, FASEB J, V23, P3819, DOI 10.1096/fj.09-134999; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kuzuya A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0248-3; Meckler X, 2010, J NEUROSCI, V30, P16160, DOI 10.1523/JNEUROSCI.4436-10.2010; Morgan JE, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150091; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schmidt V, 2012, EMBO J, V31, P187, DOI 10.1038/emboj.2011.352; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang HB, 2013, TRENDS PHARMACOL SCI, V34, P215, DOI 10.1016/j.tips.2013.01.008	48	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166400	10.1371/journal.pone.0166400	http://dx.doi.org/10.1371/journal.pone.0166400			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875558	Green Submitted, Green Published, gold			2022-12-26	WOS:000388886000013
J	Schormann, N; Ayres, CA; Fry, A; Greene, TJ; Banerjee, S; Ulett, GC; Chattopadhyay, D				Schormann, Norbert; Ayres, Chapelle A.; Fry, Alexandra; Greene, Todd J.; Banerjee, Surajit; Ulett, Glen C.; Chattopadhyay, Debasish			Crystal Structures of Group B Streptococcus Glyceraldehyde-3-Phosphate Dehydrogenase: Apo-Form, Binary and Ternary Complexes	PLOS ONE			English	Article							X-RAY-DIFFRACTION; BACILLUS-STEAROTHERMOPHILUS; LEISHMANIA-MEXICANA; STRUCTURE VALIDATION; REFINEMENT; MOLPROBITY; AGALACTIAE; VIRULENCE; REVEALS; BINDING	Glyceraldehyde 3-phosphate dehydrogenase or GAPDH is an evolutionarily conserved glycolytic enzyme. It catalyzes the two step oxidative phosphorylation of D-glyceraldehyde 3 phosphate into 1,3-bisphosphoglycerate using inorganic phosphate and NAD+ as cofactor. GAPDH of Group B Streptococcus is a major virulence factor and a potential vaccine candidate. Moreover, since GAPDH activity is essential for bacterial growth it may serve as a possible drug target. Crystal structures of Group B Streptococcus GAPDH in the apo-form, two different binary complexes and the ternary complex are described here. The two binary complexes contained NAD+ bound to 2 (mixed-holo) or 4 (holo) subunits of the tetrameric protein. The structure of the mixed-holo complex reveals the effects of NAD+ binding on the conformation of the protein. In the ternary complex, the phosphate group of the substrate was bound to the new Pi site in all four subunits. Comparison with the structure of human GAPDH showed several differences near the adenosyl binding pocket in Group B Streptococcus GAPDH. The structures also reveal at least three surface-exposed areas that differ in amino acid sequence compared to the corresponding areas of human GAPDH.	[Schormann, Norbert; Ayres, Chapelle A.; Fry, Alexandra; Chattopadhyay, Debasish] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Greene, Todd J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Banerjee, Surajit] Cornell Univ, North Eastern Collaborat Access Team, Argonne, IL 60439 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Ulett, Glen C.; Chattopadhyay, Debasish] Griffith Univ, Sch Med Sci, Parklands 4222, Australia; [Ulett, Glen C.; Chattopadhyay, Debasish] Griffith Univ, Menzies Hlth Inst, Parklands 4222, Australia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; Cornell University; Griffith University; Griffith University; Menzies Health Institute Queensland	Chattopadhyay, D (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	dchattop@uabmc.edu		Ulett, Glen/0000-0002-9638-8091	National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; NIH-ORIP HEI [S10 RR029205]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-765F00515]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); U.S. DOE(United States Department of Energy (DOE)); NIH-ORIP HEI; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-765F00515.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alves J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144196; Ayres CA, 2014, ACTA CRYSTALLOGR F, V70, P1333, DOI 10.1107/S2053230X14019517; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cook WJ, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-9; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2002, PVMOL; Didierjean C, 2003, J BIOL CHEM, V278, P12968, DOI 10.1074/jbc.M211040200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim H, 1998, J MOL BIOL, V278, P5, DOI 10.1006/jmbi.1998.1661; KIM HD, 1995, BIOCHEMISTRY-US, V34, P14975, DOI 10.1021/bi00046a004; Madureira P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002363; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moniot S, 2008, J BIOL CHEM, V283, P21693, DOI 10.1074/jbc.M802286200; Mukherjee S, 2010, J MOL BIOL, V401, P949, DOI 10.1016/j.jmb.2010.07.002; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Robien MA, 2006, PROTEINS, V62, P570, DOI 10.1002/prot.20801; Roitel O, 2003, J MOL BIOL, V326, P1513, DOI 10.1016/S0022-2836(03)00049-4; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; Suresh S, 2001, J MOL BIOL, V309, P423, DOI 10.1006/jmbi.2001.4588; Ulett Glen C., 2006, Current Immunology Reviews, V2, P119, DOI 10.2174/157339506776843033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhou YGW, 2008, ASIAN J TRADIT MED, V3, P1, DOI DOI 10.1158/1541-7786.MCR-07-2170	36	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0165917	10.1371/journal.pone.0165917	http://dx.doi.org/10.1371/journal.pone.0165917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875551	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000007
J	Kamba, A; Daimon, M; Murakami, H; Otaka, H; Matsuki, K; Sato, E; Tanabe, J; Takayasu, S; Matsuhashi, Y; Yanagimachi, M; Terui, K; Kageyama, K; Tokuda, I; Takahashi, I; Nakaji, S				Kamba, Aya; Daimon, Makoto; Murakami, Hiroshi; Otaka, Hideyuki; Matsuki, Kota; Sato, Eri; Tanabe, Jutaro; Takayasu, Shinobu; Matsuhashi, Yuki; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori; Tokuda, Itoyo; Takahashi, Ippei; Nakaji, Shigeyuki			Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; RAT SKELETAL-MUSCLE; CUSHINGS-SYNDROME; CARDIOVASCULAR-DISEASE; RISK-FACTORS; RESISTANCE; GLUCOSE; HYPERTENSION; OBESITY; COMPLICATIONS	Glucocorticoids (GCs) are well known to induce insulin resistance. However, the effect of GCs on insulin secretion has not been well characterized under physiological conditions in human. We here evaluated the effect of GCs on insulin secretion/beta-cell function precisely in a physiological condition. A population-based study of 1,071 Japanese individuals enrolled in the 2014 Iwaki study (390 men, 681 women; aged 54.1 +/- 15.1 years), those excluded individuals taking medication for diabetes or steroid treatment, were enrolled in the present study. Association between serum cortisol levels and insulin resistance/ secretion assessed by homeostasis model assessment using fasting blood glucose and insulin levels (HOMA-R and HOMA-beta, respectively) were examined. Univariate linear regression analyses showed correlation of serum cortisol levels with HOMA-beta (beta = -0.134, p < 0.001) but not with HOMA-R (beta = 0.042, p = 0.172). Adjustments for age, gender, and the multiple clinical characteristics correlated with HOMA indices showed similar results (HOMA-beta : beta = -0.062, p = 0.025; HOMA-R: beta = -0.023, p = 0.394). The correlation between serum cortisol levels and HOMA beta remained significant after adjustment for HOMA-R (beta = -0.057, p = 0.034). When subjects were tertiled based on serum cortisol levels, the highest tertile was at greater risk of decreased insulin secretion (defined as lower one third of HOMA-beta (<= 70)) than the lowest tertile, after adjustment for multiple factors including HOMA-R (odds ratio 1.26, 95% confidence interval 1.03-1.54). In conclusion, higher serum cortisol levels are significantly associated with decreased insulin secretion in the physiological cortisol range in a Japanese population.	[Kamba, Aya; Daimon, Makoto; Murakami, Hiroshi; Otaka, Hideyuki; Matsuki, Kota; Sato, Eri; Tanabe, Jutaro; Takayasu, Shinobu; Matsuhashi, Yuki; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan; [Tokuda, Itoyo; Takahashi, Ippei; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Daimon, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan.	mdaimon@hirosaki-u.ac.jp	Takayasu, Shinobu/ABH-9199-2020; Kageyama, Ken/AAI-3549-2020; Daimon, Makoto/AAY-1289-2020	Kageyama, Ken/0000-0002-0787-9789; Daimon, Makoto/0000-0002-3775-1719	Center of Innovation Program from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [16K09092] Funding Source: KAKEN	Center of Innovation Program from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Center of Innovation Program from Japan Science and Technology Agency.; This work was supported by the Center of Innovation Program from Japan Science and Technology Agency. The authors have no conflict of interest	Ahren B, 2008, DIABETOLOGIA, V51, P1018, DOI 10.1007/s00125-008-0995-y; BEARD JC, 1984, AM J PHYSIOL, V247, pE592, DOI 10.1152/ajpendo.1984.247.5.E592; Bjorntorp P, 2000, INT J OBESITY, V24, pS80, DOI 10.1038/sj.ijo.0801285; Blondeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030210; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; Daimon M, 2015, J ATHEROSCLER THROMB, V22, P1030, DOI 10.5551/jat.29181; de Guia RM, 2014, HORM MOL BIOL CLIN I, V19, P117, DOI 10.1515/hmbci-2014-0021; DEFRONZO RA, 1989, METABOLISM, V38, P387, DOI 10.1016/0026-0495(89)90129-7; Delaunay F., 1997, CLIN MED RES, V100, P2094, DOI DOI 10.1172/JCI119743; Fujiwara T, 2004, ATHEROSCLEROSIS, V177, P83, DOI 10.1016/j.atherosclerosis.2004.05.028; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Isidori AM, 2015, J HYPERTENS, V33, P44, DOI 10.1097/HJH.0000000000000415; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; LONGANO CA, 1983, METABOLISM, V32, P603, DOI 10.1016/0026-0495(83)90031-8; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; MANTERO F, 1992, J STEROID BIOCHEM, V43, P409, DOI 10.1016/0960-0760(92)90077-V; Matsuhisa M, 2007, DIABETES RES CLIN PR, V77, P151, DOI 10.1016/j.diabres.2006.10.005; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazziotti G, 2011, TRENDS ENDOCRIN MET, V22, P499, DOI 10.1016/j.tem.2011.09.001; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV 2; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Pivonello R, 2016, LANCET DIABETES ENDO, V4, P611, DOI 10.1016/S2213-8587(16)00086-3; Rafacho A, 2014, J ENDOCRINOL, V223, pR49, DOI 10.1530/JOE-14-0373; Rosmond R, 1998, J HYPERTENS, V16, P1721, DOI 10.1097/00004872-199816120-00003; Schneiter P, 1998, AM J PHYSIOL-ENDOC M, V275, pE806, DOI 10.1152/ajpendo.1998.275.5.E806; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shimon I, 2015, PITUITARY, V18, P201, DOI 10.1007/s11102-015-0634-9; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Urushidate S, 2010, J TRACE ELEM MED BIO, V24, P236, DOI 10.1016/j.jtemb.2010.06.001; van Raalte DH, 2013, METABOLISM, V62, P568, DOI 10.1016/j.metabol.2012.10.007; Varughese AG, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0443-y; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Weinstein SP, 1998, METABOLISM, V47, P3, DOI 10.1016/S0026-0495(98)90184-6; WEINSTEIN SP, 1995, DIABETES, V44, P441, DOI 10.2337/diabetes.44.4.441	37	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166077	10.1371/journal.pone.0166077	http://dx.doi.org/10.1371/journal.pone.0166077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861636	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300026
J	Sahasranaman, A; Jensen, HJ				Sahasranaman, Anand; Jensen, Henrik Jeldtoft			Dynamics of Transformation from Segregation to Mixed Wealth Cities	PLOS ONE			English	Article							PERSONAL INCOME-DISTRIBUTION; RESIDENTIAL SEGREGATION; ECONOMIC SEGREGATION; NEIGHBORHOOD CHANGE; MODEL	We model the dynamics of a variation of the Schelling model for agents described simply by a continuously distributed variable-wealth. Agent movement is not dictated by agent choice as in the classic Schelling model, but by their wealth status. Agents move to neighborhoods where their wealth is not lesser than that of some proportion of their neighbors, the threshold level. As in the case of the classic Schelling model, we find here that wealth-based segregation occurs and persists. However, introducing uncertainty into the decision to move-that is, with some probability, if agents are allowed to move even though the threshold condition is contravened-we find that even for small proportions of such disallowed moves, the dynamics no longer yield segregation but instead sharply transition into a persistent mixed wealth distribution, consistent with empirical findings of Benenson, Hatna, and Or. We investigate the nature of this sharp transformation, and find that it is because of a non-linear relationship between allowed moves (moves where threshold condition is satisfied) and disallowed moves (moves where it is not). For small increases in disallowed moves, there is a rapid corresponding increase in allowed moves (before the rate of increase tapers off and tends to zero), and it is the effect of this non-linearity on the dynamics of the system that causes the rapid transition from a segregated to a mixed wealth state. The contravention of the tolerance condition, sanctioning disallowed moves, could be interpreted as public policy interventions to drive de-segregation. Our finding therefore suggests that it might require limited, but continually implemented, public intervention-just sufficient to enable a small, persistently sustained fraction of disallowed moves so as to trigger the dynamics that drive the transformation from a segregated to mixed equilibrium.	[Sahasranaman, Anand; Jensen, Henrik Jeldtoft] Imperial Coll London, Dept Math, London, England; [Sahasranaman, Anand; Jensen, Henrik Jeldtoft] Imperial Coll London, Ctr Complex Sci, 12th Floor EEE Bldg, London SW7 2AZ, England	Imperial College London; Imperial College London	Sahasranaman, A (corresponding author), Imperial Coll London, Dept Math, London, England.; Sahasranaman, A (corresponding author), Imperial Coll London, Ctr Complex Sci, 12th Floor EEE Bldg, London SW7 2AZ, England.	a.sahasranaman15@imperial.ac.uk			Schrodinger Scholarship from the Faculty of Natural Sciences, Imperial College London	Schrodinger Scholarship from the Faculty of Natural Sciences, Imperial College London	AS gratefully acknowledges the financial support received in the form of the Schrodinger Scholarship from the Faculty of Natural Sciences, Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AS gratefully acknowledges the financial support received in the form of the Schrodinger Scholarship from the Faculty of Natural Sciences, Imperial College London. The authors are also grateful for feedback from Tim Evans and Roozbeh Pazuki at Imperial College London.	Banerjee A, 2006, PHYSICA A, V370, P54, DOI 10.1016/j.physa.2006.04.023; Benard S, 2007, J MATH SOCIOL, V31, P149, DOI 10.1080/00222500601188486; Benenson I, 2009, SOCIOL METHOD RES, V37, P463, DOI 10.1177/0049124109334792; Bruch EE, 2006, AM J SOCIOL, V112, P667, DOI 10.1086/507856; Brzezinski M, 2014, PHYSICA A, V406, P155, DOI 10.1016/j.physa.2014.03.052; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290; Fossett M, 2006, J MATH SOCIOL, V30, P185, DOI 10.1080/00222500500544052; Fossett M, 2011, J MATH SOCIOL, V35, P114, DOI 10.1080/0022250X.2010.532367; Fossett M, 2009, ENVIRON PLANN B, V36, P149, DOI 10.1068/b33042; Gauvin L, 2009, EUR PHYS J B, V70, P293, DOI 10.1140/epjb/e2009-00234-0; Grauwin S, 2009, P NATL ACAD SCI USA, V106, P20622, DOI 10.1073/pnas.0906263106; Hazan A, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31142-1; Kawasaki K., 1972, PHASE TRANSITIONS CR; Laurie AJ, 2003, URBAN STUD, V40, P2687, DOI 10.1080/0042098032000146849; Oliver JE, 1999, AM J POLIT SCI, V43, P186, DOI 10.2307/2991790; Pancs R, 2007, J PUBLIC ECON, V91, P1, DOI 10.1016/j.jpubeco.2006.03.008; Quillian L, 2014, SOC PROBL, V61, P402, DOI 10.1525/sp.2014.12193; Rogers T., 2011, J STAT MECH, V2011; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Souma W, 2001, FRACTALS, V9, P463, DOI 10.1142/S0218348X01000816; Stauffer D, 2007, EUR PHYS J B, V57, P473, DOI 10.1140/epjb/e2007-00181-8; van de Rijt A, 2009, AM J SOCIOL, V114, P1166, DOI 10.1086/588795; Waitzman NJ, 1998, MILBANK Q, V76, P341, DOI 10.1111/1468-0009.00095; Zhang JF, 2004, J MATH SOCIOL, V28, P147, DOI 10.1080/00222500490480202	25	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166960	10.1371/journal.pone.0166960	http://dx.doi.org/10.1371/journal.pone.0166960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861578	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300137
J	Szentagotai-Tatar, A; Miu, AC				Szentagotai-Tatar, Aurora; Miu, Andrei C.			Individual Differences in Emotion Regulation, Childhood Trauma and Proneness to Shame and Guilt in Adolescence	PLOS ONE			English	Article							SELF-CONSCIOUS EMOTIONS; REGULATION STRATEGIES; DEPRESSION; STRESS; CHILDREN; ANXIETY; ANTECEDENTS; EVENTS; PRIDE	Dispositional shame and guilt have been associated with psychopathology and an increasing number of studies have traced this relation back to adolescence. This developmental period is thought to be characterized by maturational changes in emotion regulation, which also play an important role in vulnerability to psychopathology, but little is known about the links between emotion regulation and dispositional shame and guilt. The current study investigated the relations between individual differences in the habitual use of a wide range of emotion regulation strategies and proneness to shame and guilt in a large sample of adolescents (N = 706), aged 13 to 17 years. History of childhood trauma was also assessed. Our results showed that emotion regulation independently explained about 20% of the variance of shame-proneness and guilt-proneness. Higher use of maladaptive (e.g., Self-Blaming, Catastrophizing) and lower use of adaptive (e.g., Refocus on Planning, Positive Reappraisal) emotion regulation strategies were positively associated with shame-proneness. In contrast, lower use of maladaptive (e.g., Catastrophizing, Blaming Others) and higher use of adaptive (e.g., Refocus on Planning, Positive Reappraisal) emotion regulation strategies were associated with guilt-proneness, independent of the influence of childhood trauma, which also explained a relatively minor portion of guilt-proneness. Although there were age differences (i.e., rumination was used more by older adolescents, and the influence of emotion regulation on depression and anxiety symptoms increased with age) and sex differences (i.e., girls reported higher use of Putting into Perspective and Other Blaming compared to boys) in emotion regulation, age and sex were not significantly associated with proneness to shame and guilt. The positive relations with maladaptive emotion regulation underscores the dysfunctional nature of shame-proneness. Future studies could use longitudinal measures to establish that emotion regulation drives dispositional shame and guilt, and also investigate whether emotion regulation optimization is able to normalize proneness to shame and guilt and reduce risk for psychopathology.	[Szentagotai-Tatar, Aurora] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Cluj, Romania; [Miu, Andrei C.] Univ Babes Bolyai, Cognit Neurosci Lab, Dept Psychol, Cluj Napoca, Cluj, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Szentagotai-Tatar, A (corresponding author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Cluj, Romania.	auraszentagotai@psychology.ro	Miu, Andrei C./C-5184-2011	Miu, Andrei C./0000-0002-6459-5010	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by grants from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro/), grant number PNII-ID-PCCE-2011-2-0045. Although the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, provided funding for the collection of data and the manuscript preparation, they had no role in the study design, the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	Alessandri SM, 1996, CHILD DEV, V67, P1857, DOI 10.1111/j.1467-8624.1996.tb01832.x; Arndt JE, 2013, PERS INDIV DIFFER, V55, P147, DOI 10.1016/j.paid.2013.02.022; Bennett DS, 2010, CHILD MALTREATMENT, V15, P305, DOI 10.1177/1077559510379634; Berking M, 2008, J COUNS PSYCHOL, V55, P485, DOI 10.1037/a0013589; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Carnuta M, 2015, PSYCHONEUROENDOCRINO, V51, P176, DOI 10.1016/j.psyneuen.2014.09.026; Casey BJ, 2015, ANNU REV PSYCHOL, V66, P295, DOI 10.1146/annurev-psych-010814-015156; Claesson K, 2002, CLIN PSYCHOL PSYCHOT, V9, P277, DOI 10.1002/cpp.331; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen TR, 2011, J PERS SOC PSYCHOL, V100, P947, DOI 10.1037/a0022641; de Hooge IE, 2008, J PERS SOC PSYCHOL, V95, P933, DOI 10.1037/a0011991; Dickerson SS, 2004, PSYCHOSOM MED, V66, P124, DOI 10.1097/01.PSY.0000097338.75454.29; Donatelli J.L., 2007, J CHILD FAM STUD, V16, DOI [10.1007/s10826-006-9130-1, DOI 10.1007/S10826-006-9130-1]; Else-Quest NM, 2012, PSYCHOL BULL, V138, P947, DOI 10.1037/a0027930; Ferguson TJ, 2000, GENET SOC GEN PSYCH, V126, P319; Garnefski N, 2005, J ADOLESCENCE, V28, P619, DOI 10.1016/j.adolescence.2004.12.009; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Garnefski N, 2007, EUR CHILD ADOLES PSY, V16, P1, DOI 10.1007/s00787-006-0562-3; Gausel N, 2016, MOTIV EMOTION, V40, P118, DOI 10.1007/s11031-015-9513-y; Gavazzi IG, 2011, EUR J DEV PSYCHOL, V8, P311, DOI 10.1080/17405629.2010.491303; Heth JT, 2002, PERS INDIV DIFFER, V33, P883; Howell AJ, 2012, PERS INDIV DIFFER, V53, P917, DOI 10.1016/j.paid.2012.06.021; Hoyt WT, 2008, REHABIL PSYCHOL, V53, P321, DOI 10.1037/a0013021; Hughes EK, 2011, J PSYCHOPATHOL BEHAV, V33, P335, DOI 10.1007/s10862-011-9220-2; Lagattuta K. H., 2007, SELF CONSCIOUS EMOTI, P91; Lewis M., 2007, SELF CONSCIOUS EMOTI, P134; Lickel B, 2014, EMOTION, V14, P1049, DOI 10.1037/a0038235; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; MacDermott ST, 2010, J PSYCHOPATHOL BEHAV, V32, P301, DOI 10.1007/s10862-009-9154-0; Martin RC, 2005, PERS INDIV DIFFER, V39, P1249, DOI 10.1016/j.paid.2005.06.004; Mills RSL, 2005, DEV REV, V25, P26, DOI 10.1016/j.dr.2004.08.001; Muris P, 2014, CLIN CHILD FAM PSYCH, V17, P19, DOI 10.1007/s10567-013-0137-z; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olthof T, 2004, COGNITION EMOTION, V18, P383, DOI 10.1080/02699930341000077; Orth U, 2010, J PERS SOC PSYCHOL, V99, P1061, DOI 10.1037/a0021342; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Perte A, 2011, MANUAL PENTRU SCALEL; Perte A, 2011, COGNITION BRAIN BEHA, VXV, P111; Rahim M, 2015, PEERJ, V3, DOI 10.7717/peerj.737; Roos S, 2014, DEV PSYCHOL, V50, P941, DOI 10.1037/a0033904; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sheppes G, 2015, ANNU REV CLIN PSYCHO, V11, P379, DOI 10.1146/annurev-clinpsy-032814-112739; Stotz SJ, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.25863; Stuewig J, 2005, CHILD MALTREATMENT, V10, P324, DOI 10.1177/1077559505279308; Stuewig J, 2010, J RES PERS, V44, P91, DOI 10.1016/j.jrp.2009.12.005; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Szentagotai-Tatar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134716; Tangney J. P., 1991, TEST SELF CONSCIOUS; Tangney J. P., 2012, HDB SELF IDENTITY, P446, DOI DOI 10.4135/9781446263402; Tangney J.P., 2003, SHAME GUILT; Tangney JP, 1996, BEHAV RES THER, V34, P741, DOI 10.1016/0005-7967(96)00034-4; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Thabrew H, 2012, ADV PSYCHOSOM MED, V32, P35, DOI 10.1159/000330002; Tilghman-Osborne C, 2012, J ABNORM CHILD PSYCH, V40, P607, DOI 10.1007/s10802-011-9591-6; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Walter J. L., 2006, N AM J PSYCHOL, V8, P321, DOI DOI 10.1037/A0033904; Webb M, 2007, CHILD ABUSE NEGLECT, V31, P1143, DOI 10.1016/j.chiabu.2007.09.003	57	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167299	10.1371/journal.pone.0167299	http://dx.doi.org/10.1371/journal.pone.0167299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898709	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000049
J	Ardente, NC; Ferreguetti, AC; Gettinger, D; Leal, P; Mendes-Oliveira, AC; Martins-Hatano, F; Bergallo, HG				Ardente, Natalia Carneiro; Ferreguetti, Atilla Colombo; Gettinger, Donald; Leal, Pricila; Mendes-Oliveira, Ana Cristina; Martins-Hatano, Fernanda; Bergallo, Helena Godoy			Diversity and Impacts of Mining on the Non-Volant Small Mammal Communities of Two Vegetation Types in the Brazilian Amazon	PLOS ONE			English	Article							SPECIES-DIVERSITY; ATLANTIC FOREST; RODENT; POPULATIONS; RICHNESS; ECOLOGY; ISLAND	The Carajas National Forest contains some of the largest iron ore deposits in the world. The majority of the minerals are found below a plant community known as Savana Metalofila, or "Canga", which represents only 3% of the landscape within the Carajas National Forest (CNF). The aim of our study was to understand the diversity of community of non-volant small mammals in the two predominant vegetation types: Ombrophilous Forest and Canga, and to examine how mining impacts these communities. Sampling was conducted from January 2010 to August 2011 in 11 sampling sites divided by the total area of Canga and 12 sampling sites in the forest, totalizing 23 sites. Of these, 12 sites (Canga and Forest) were considered impacted areas located close to the mine (<< 900 meters) and 11 sites (Canga and Forest), serving as controls, which were at least 7,000 meters from the mine. We recorded 28 species, 11 from the Order Didelphimorphia and 17 from the Order Rodentia. The two forest types shared 68.42% of the species found in the CNF. A gradient analysis (Non-metric multidimensional scaling) revealed that the first axis clearly separated the non flying small mammal communities by vegetation type. Occupancy models showed that the detectability of species was affected by the distance from the mining activities. Of all the small mammals analyzed, 10 species were positively affected by the distance from mining in areas impacted (e.g. more likely to be detected farther from mining areas) and detectability was lower in impacted areas. However, three species were negatively affected by the distance from mining, with higher detectability in the impacted areas, and seven species showed no effect of their proximity to mining operations. To date, there are no studies in Brazil about the impact of mining on mammals or other vertebrates. This study reveals that the effect of mining may go beyond the forest destruction caused by the opening of the mining pits, but also may negatively affect sensitive wildlife species.	[Ardente, Natalia Carneiro; Ferreguetti, Atilla Colombo; Bergallo, Helena Godoy] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Ecol Mamiferos, Rio De Janeiro, Brazil; [Gettinger, Donald] Univ Nebraska, Harold W Manter Lab Parasitol, Lincoln, NE USA; [Leal, Pricila; Martins-Hatano, Fernanda] Univ Fed Rural Amazonia Biol, Dept Biol Anim, Belem, Para, Brazil; [Mendes-Oliveira, Ana Cristina] Fed Univ Para, Inst Ciencias Biol, Lab Ecol & Zool Vertebrados, Campus Basico,Rua Augusto Correa, Belem, Para, Brazil	Universidade do Estado do Rio de Janeiro; University of Nebraska System; University of Nebraska Lincoln; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Para	Ardente, NC (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Ecol Mamiferos, Rio De Janeiro, Brazil.	natalia_ardente@hotmail.com	Ardente, Natalia/AAF-4404-2020; Ferreguetti, Atilla/D-1163-2019; Bergallo, Helena Godoy/F-9257-2011; de Oliveira, Ana Cristina Mendes/I-2680-2012	Ferreguetti, Atilla/0000-0002-5139-8835; Bergallo, Helena Godoy/0000-0001-9771-965X; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	VALE; Universidade Federal Rural da Amazonia	VALE; Universidade Federal Rural da Amazonia	This work was supported by VALE - www.vale.com Universidade Federal Rural da Amazonia - https://portal.ufra.edu.br/. The funders had no role in study design, data collection and analysis.	Ab'Saber A, 1986, GEOMORFOLOGIA; Abu Baker M, 2011, J ARID ENVIRON, V75, P14, DOI 10.1016/j.jaridenv.2010.08.005; ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alencar A, 2004, DESMATAMENTO AMAZONI; Alho C.J.R., 1982, Pymatuning Laboratory of Ecology Special Publications, V6, P143; ALHO CJR, 1986, MAMMALIA, V50, P447, DOI 10.1515/mamm.1986.50.4.447; Ardente Natalia, 2013, Check List, V9, P1104; BERGALLO HD, 1994, STUD NEOTROP FAUNA E, V29, P197, DOI 10.1080/01650529409360932; Bernarde Paulo Sergio, 2003, Biociencias (Porto Alegre), V11, P183; Bramble W. C., 1949, Journal of Forestry, V47, P477; Brown JH, 2000, AM NAT, V156, P314, DOI 10.1086/303385; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chamblin H, 2002, SMALL MAMMAL COMMUNI; Chamblin HD, 2004, AM MIDL NAT, V151, P346, DOI 10.1674/0003-0031(2004)151[0346:AWNMUO]2.0.CO;2; Chiarello AG, 2000, CONSERV BIOL, V14, P1649, DOI 10.1046/j.1523-1739.2000.99071.x; Core R, 2012, R LANG ENV STAT COMP; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Da Silva MFF, 1996, ACTA AMAZONICA, V26, P16; DAFONSECA GAB, 1990, BIOL CONSERV, V53, P265, DOI 10.1016/0006-3207(90)90097-9; De Capita M.E, 1975, Ohio Journal of Science, V75, P305; Díaz M. Mónica, 2004, Mastozool. neotrop., V11, P185; EMMONS LH, 1984, BIOTROPICA, V16, P210, DOI 10.2307/2388054; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fearnside PM, 2010, GRUP EST ESTR AM GEE; Figueiredo MDL, 2004, J TROP ECOL, V20, P225, DOI 10.1017/S0266467403001093; Graipel Maurício E., 2006, Mastozool. neotrop., V13, P31; HINGTGEN TM, 1984, J RANGE MANAGE, V37, P438, DOI 10.2307/3899632; IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis, 2004, PLAN MAN US MULT FLO; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lacher TE, 2001, BIOTROPICA, V33, P171; Lambert TD, 2000, J MAMMAL, V81, P70, DOI 10.1644/1545-1542(2000)081&lt;0070:MUBATF&gt;2.0.CO;2; Lambert TD, 2006, J MAMMAL, V87, P766, DOI 10.1644/05-MAMM-A-261R1.1; Larkin JL, 2008, SOUTHEAST NAT, V7, P401, DOI 10.1656/1528-7092-7.3.401; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Magnus Luíza Z, 2012, Mastozool. neotrop., V19, P163; Malcolm J. R., 1991, THESIS U FLORIDA; Malcolm Jay R., 1997, P207; Malygin VM, 2005, ZOOL ZH, V84, P492; MARES M A, 1989, Annals of Carnegie Museum, V58, P1; Mazerolle MJ, 2003, BIOL CONSERV, V113, P215, DOI 10.1016/S0006-3207(02)00360-9; MMA-Ministe A rio do Meio Ambiente, 2000, SIST NAC UN CONS; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Ochoa J, 2000, BIOTROPICA, V32, P146, DOI 10.1646/0006-3606(2000)032[0146:EDLEND]2.0.CO;2; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paglia A.P., 2012, OCCAS PAP CONSERV BI; Reis EJ, 2001, PARCERIAS ESTRATEGIC, V12, P276; Ribeiro R, 2005, REV BRAS ZOOL, V22, P898, DOI 10.1590/S0101-81752005000400014; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ripley EA., 1996, ENV EFFECTS MINING; Santos-Filho M, 2012, BRAZ J BIOL, V72, P265; Silva MFF, 1991, ACTA BOTO BRAS, V6, P107; Steele B. B., 1982, Reclamation and Revegetation Research, V1, P367; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; YAHNER RH, 1988, CONSERV BIOL, V2, P333, DOI 10.1111/j.1523-1739.1988.tb00197.x	56	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167266	10.1371/journal.pone.0167266	http://dx.doi.org/10.1371/journal.pone.0167266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893798	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400107
J	Chen, CH; Hsu, CM; Lin, CL; Chou, AK; Jeng, LB				Chen, Chien-Hua; Hsu, Che-Ming; Lin, Cheng-Li; Chou, An-Kuo; Jeng, Long-Bin			The Development of Diabetes after Subtotal Gastrectomy with Billroth II Anastomosis for Peptic Ulcer Disease	PLOS ONE			English	Article							SLEEVE GASTRECTOMY; GASTRIC BYPASS; RISK; SURGERY; HYPERTENSION; ASSOCIATION; PREVALENCE; MELLITUS	Purpose A duodenal bypass after a Roux-en-Y gastric bypass operation for obesity can ameliorate the development of diabetes mellitus (DM). We attempted to determine the subsequent risk of developing DM after subtotal gastrectomy with Billroth II anastomosis (SGBIIA) for peptic ulcer disease (PUD). Methods We identified 662 patients undergoing SGBIIA for PUD between 2000 and 2011 from the Longitudinal Health Insurance Database as the study cohort, and we randomly selected 2647 controls from the peptic ulcer population not undergoing SGBIIA and were frequencymatched by age, sex, and index year for the control cohort. All patient cases in both cohorts were followed until the end of 2011 to measure the incidence of DM. We analyzed DM risk by using a Cox proportional hazards regression model. Results The patients who underwent SGBIIA demonstrated a lower cumulative incidence of DM compared with the control cohort (log-rank test, P<.001 and 6.73 vs 12.6 per 1000 persony). The difference in the DM risk between patients with and without SGBIIA increased gradually with the follow-up duration. Age and sex did not affect the subsequent risk of developing DM, according to the multivariable Cox regression model. Nevertheless, the SGBIIA cohort exhibited a lower DM risk after we adjusted for the comorbidities of hypertension, hyperlipidemia, and coronary artery disease (adjusted hazard ratio (aHR): 0.56, 95% confidence interval (CI): 0.40-0.78). The incidence rate ratio (IRR) of DM in the SGBIIA cohort was lower than that in the control cohort for all age groups (age <= 49 y, IRR: 0.40, 95% CI: 0.16-0.99; age 50-64 y, IRR: 0.54, 95% CI: 0.31-0.96; age. 65 y, IRR: 0.57, 95% CI: 0.36-0.91). Moreover, the IRR of DM was significantly lower in the SGBIIA cohort with comorbidities (IRR: 0.50, 95% CI: 0.31-0.78) compared with those without a comorbidity (IRR: 0.65, 95% CI: 0.40-1.04). Conclusion The findings of this population-based cohort study revealed that SGBIIA was associated with a reduced risk of DM development, and the inverse association was greater in the presence of a comorbidity.	[Chen, Chien-Hua; Hsu, Che-Ming] Show Chwan Mem Hosp, Ctr Digest Dis, Changhua, Taiwan; [Chen, Chien-Hua] Hungkuang Univ, Taichung, Taiwan; [Chen, Chien-Hua] Chung Chou Univ Sci & Technol, Yuanlin Township, Changhua County, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Chou, An-Kuo] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chou, An-Kuo] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan	Show Chwan Memorial Hospital; Hungkuang University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Jeng, LB (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Jeng, LB (corresponding author), China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan.	otc.Jeng@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST-105-2325B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST-105-2325B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.r This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Chen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003481; Chen YK, 2014, J GASTROENTEROL, V49, P923, DOI 10.1007/s00535-013-0846-6; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Chu X, 2013, DIABETES, V62, P561, DOI 10.2337/db12-0139; Chung WS, 2014, ANN RHEUM DIS, V73, P1774, DOI 10.1136/annrheumdis-2013-203380; Cohen Ricardo V, 2012, Surg Obes Relat Dis, V8, pe66, DOI 10.1016/j.soard.2011.07.007; Cummings S, 2008, J AM DIET ASSOC, V108, pS40, DOI 10.1016/j.jada.2008.01.017; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; FRANSSILAKALLUNKI A, 1992, AM J CLIN NUTR, V56, P247; Gill RS, 2010, SURG OBES RELAT DIS, V6, P707, DOI 10.1016/j.soard.2010.07.011; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gupta Sanjay, 2005, BMC Surg, V5, P15; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Knuth D. E, 1981, ART COMPUTER PROGRAM, V2; Lee CW, 2011, SURG CLIN N AM, V91, P1001, DOI 10.1016/j.suc.2011.06.008; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Liao CH, 2014, J PSYCHOSOM RES, V77, P541, DOI 10.1016/j.jpsychores.2014.08.005; Lockrey Gregory, 2011, Journal of Pharmacy Practice and Research, V41, P58; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; MCGEE GS, 1987, ARCH SURG-CHICAGO, V122, P555; Mugo MN, 2007, HYPERTENSION DIABETE; National Diabetes Clearinghouse, 2011, NAT DIAB STAT 2011; Ng EKW, 2000, ANN SURG, V231, P153, DOI 10.1097/00000658-200002000-00001; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Rutti S, 2009, ENDOCRINOLOGY, V150, P4521, DOI 10.1210/en.2009-0252; Schwesinger WH, 2001, J GASTROINTEST SURG, V5, P438, DOI 10.1016/S1091-255X(01)80074-3; Thorsen K, 2013, WORLD J GASTROENTERO, V19, P347, DOI 10.3748/wjg.v19.i3.347; Wang FW, 2011, WORLD J GASTROENTERO, V17, P1199, DOI 10.3748/wjg.v17.i9.1199; Wysocki A, 2011, WORLD J SURG, V35, P811, DOI 10.1007/s00268-010-0917-2; Yang SH, 2010, NEW ENGL J MED, V362, P2425	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167321	10.1371/journal.pone.0167321	http://dx.doi.org/10.1371/journal.pone.0167321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893867	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400112
J	Faivre, V; Lukaszewicz, AC; Payen, D				Faivre, Valerie; Lukaszewicz, Anne-Claire; Payen, Didier			Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LEUKOCYTE ANTIGEN-DR; EMERGENCY GRANULOPOIESIS; SECONDARY INFECTION; PERIPHERAL-BLOOD; SEPTIC PATIENTS; FLOW-CYTOMETRY; ORGAN FAILURE; SEPSIS; EXPRESSION	Background The downregulation of blood monocyte HLA-DR expression also occurs in tissue infiltrative cells in a context of acute clinical inflammation, especially sepsis. This context favors the development of secondary infections and results from various mechanisms. Little is known about HLA-DR expression on bone marrow (BM) cells of the monocyte lineage, the source of circulating monocytes. This study analyzed the BM HLA-DR expression in ICU patients compared to BM monocytes from non-ICU patients and to blood monocytes of control healthy donors. A potential dysfunction of myeloid differentiation was investigated in a subpopulation of these ICU patients to characterize the phenotype of the immature forms of monocytes and granulocytes in BM. Methods and Findings BM and blood were drawn from 33 ICU and 9 non-ICU patients having a BM analysis to precise the etiology of abnormal low count in blood cells. The data were compared with blood cells of 28 control donors. Flow cytometry was used for both HLA-DR expression and phenotyping of immature forms of monocytes and granulocytes. HLA-DR expression was down-regulated in both blood and BM monocyte in ICU patients compared to BM of non-ICU patients and blood of control donors. Amplitude of HLA-DR downregulation was comparable in septic and non-septic ICU patients. The phenotype of immature forms of monocytes and granulocytes in BM (n = 11) did not show abnormal myeloid (monocyte + granulocyte) differentiation. Conclusion The downregulation of HLA-DR in BM monocyte lineage is present in ICU patients without major changes in myeloid cells. It may result from a regulation mediated by soluble and/or neuro-endocrine factors present in BM cell microenvironment.	[Faivre, Valerie; Lukaszewicz, Anne-Claire; Payen, Didier] INSERM, U1160, Paris, France; [Faivre, Valerie; Lukaszewicz, Anne-Claire; Payen, Didier] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Payen, Didier] Hop Lariboisiere, AP HP, Dept Anesthesie Reanimat SMUR, Paris, France; [Lukaszewicz, Anne-Claire] Hop Pierre Wertheimer, Hosp Civils Lyon, Dept Anesthesie Reanimat, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon	Payen, D (corresponding author), INSERM, U1160, Paris, France.; Payen, D (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.; Payen, D (corresponding author), Hop Lariboisiere, AP HP, Dept Anesthesie Reanimat SMUR, Paris, France.	dpayen1234@orange.fr	Lukaszewicz, Anne-Claire/GXG-4590-2022		University Paris Diderot, Sorbonne Paris Cite grant from INSERM [U 1160]	University Paris Diderot, Sorbonne Paris Cite grant from INSERM	This work was supported by a grant from the University Paris Diderot, Sorbonne Paris Cite grant from INSERM U 1160 for material, products 2015-2017; and partially from an Eli Lilly Grant for RCT in sepsis Trial PROWESS Shock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Caren Brumpt for her help. This work was supported by a grant from the University Paris Diderot, Sorbonne Paris Cite. Grant from INSERM for material, products 2015-2017.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Arnoulet C, 2010, CYTOM PART B-CLIN CY, V78B, P3, DOI 10.1002/cyto.b.20484; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; BENDER JG, 1991, BLOOD, V77, P2591; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; BRACKMAN D, 1995, J LEUKOCYTE BIOL, V58, P547, DOI 10.1002/jlb.58.5.547; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Eighetany MT, 2004, J CLIN LAB ANAL, V18, P36, DOI 10.1002/jcla.20001; Fumeaux T, 2002, AM J RESP CRIT CARE, V166, P1475, DOI 10.1164/rccm.200203-217OC; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Harrington A, 2010, AM J CLIN PATHOL, V134, P749, DOI 10.1309/AJCPFNF5MN1GDWKU; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Howell K, 2012, J LEUKOCYTE BIOL, V91, P69, DOI 10.1189/jlb.0711338; Kamp VM, 2013, J LEUKOCYTE BIOL, V94, P513, DOI 10.1189/jlb.0213066; Kussick SJ, 2003, ARCH PATHOL LAB MED, V127, P1140; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Le Tulzo Y, 2004, AM J RESP CRIT CARE, V169, P1144, DOI 10.1164/rccm.200309-1329OC; Lukaszewicz AC, 2010, MINERVA ANESTESIOL, V76, P737; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; LUNDJOHANSEN F, 1993, J LEUKOCYTE BIOL, V54, P47, DOI 10.1002/jlb.54.1.47; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Matera G, 2013, CRIT CARE, V17, DOI 10.1186/cc12596; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Muthu K, 2008, J BURN CARE RES, V29, P12, DOI 10.1097/BCR.0b013e31815fa499; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nguyen HH, 2012, J IMMUNOL, V189, P3112, DOI 10.4049/jimmunol.1200360; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Prendergast AM, 2014, ANN NY ACAD SCI, V1310, P51, DOI 10.1111/nyas.12400; Reagan MR, 2016, NAT REV RHEUMATOL, V12, P154, DOI 10.1038/nrrheum.2015.160; Rossi L, 2012, BLOOD, V120, P2365, DOI 10.1182/blood-2012-04-422378; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Xu Y, 2005, AM J CLIN PATHOL, V124, P799, DOI 10.1309/HFJ1XKTD77J1UTFM; Zaretsky AG, 2014, J IMMUNOL, V192, P27, DOI 10.4049/jimmunol.1302061	43	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0164489	10.1371/journal.pone.0164489	http://dx.doi.org/10.1371/journal.pone.0164489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893741	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400003
J	Lopez-Gresa, MP; Lison, P; Yenush, L; Conejero, V; Rodrigo, I; Belles, JM				Lopez-Gresa, M. Pilar; Lison, Purificacion; Yenush, Lynne; Conejero, Vicente; Rodrigo, Ismael; Belles, Jose Maria			Salicylic Acid Is Involved in the Basal Resistance of Tomato Plants to Citrus Exocortis Viroid and Tomato Spotted Wilt Virus	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ACIBENZOLAR-S-METHYL; PATHOGEN PSEUDOMONAS-SYRINGAE; DISEASE RESISTANCE; GENTISIC ACID; DEFENSE RESPONSES; BACTERIAL SPOT; HYPERSENSITIVE RESPONSE; NICOTIANA-ATTENUATA; ETHYLENE PRODUCTION	Tomato plants expressing the NahG transgene, which prevents accumulation of endogenous salicylic acid (SA), were used to study the importance of the SA signalling pathway in basal defence against Citrus Exocortis Viroid (CEVd) or Tomato Spotted Wilt Virus (TSWV). The lack of SA accumulation in the CEVd- or TSWV-infected NahG tomato plants led to an early and dramatic disease phenotype, as compared to that observed in the corresponding parental Money Maker. Addition of acibenzolar-S-methyl, a benzothiadiazole (BTH), which activates the systemic acquired resistance pathway downstream of SA signalling, improves resistance of NahG tomato plants to CEVd and TSWV. CEVd and TSWV inoculation induced the accumulation of the hydroxycinnamic amides p-coumaroyltyramine, feruloyltyramine, caffeoylputrescine, and feruloylputrescine, and the defence related proteins PR1 and P23 in NahG plants earlier and with more intensity than in Money Maker plants, indicating that SA is not essential for the induction of these plant defence metabolites and proteins. In addition, NahG plants produced very high levels of ethylene upon CEVd or TSWV infection when compared with infected Money Maker plants, indicating that the absence of SA produced additional effects on other metabolic pathways. This is the first report to show that SA is an important component of basal resistance of tomato plants to both CEVd and TSWV, indicating that SA-dependent defence mechanisms play a key role in limiting the severity of symptoms in CEVd- and TSWV-infected NahG tomato plants.	[Lopez-Gresa, M. Pilar; Lison, Purificacion; Yenush, Lynne; Conejero, Vicente; Rodrigo, Ismael; Belles, Jose Maria] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Lison, P (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain.	plison@ibmcp.upv.es	Rodrigo, Ismael/H-4423-2015; Lisón, Purificación/H-7731-2015; Gresa, María Pilar López/N-8830-2013; Yenush, Lynne/J-8815-2014	Rodrigo, Ismael/0000-0002-8994-6112; Lisón, Purificación/0000-0002-1662-8084; Gresa, María Pilar López/0000-0001-9251-0160; Yenush, Lynne/0000-0001-8589-7002	Spanish Ministry of Economy and Competitiveness [BIO2012-33419]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grant BIO2012-33419 from the Spanish Ministry of Economy and Competitiveness received by JMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfoka GH, 2000, CROP PROT, DOI DOI 10.1094/MPMI.2001.14.6.785; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Baysal O, 2003, PLANT PATHOL, V52, P747, DOI 10.1111/j.1365-3059.2003.00936.x; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Belles JM, 2006, PLANTA, V223, P500, DOI 10.1007/s00425-005-0109-8; BELLES JM, 1989, J PHYTOPATHOL, V125, P198, DOI 10.1111/j.1439-0434.1989.tb01061.x; Belles JM, 1999, MOL PLANT MICROBE IN, V12, P227, DOI 10.1094/MPMI.1999.12.3.227; BELLES JM, 1989, J PHYTOPATHOL, V127, P81, DOI 10.1111/j.1439-0434.1989.tb04506.x; BELLES JM, 1991, J PHYTOPATHOL, V132, P245, DOI 10.1111/j.1439-0434.1991.tb00117.x; Benhamou N, 1998, PLANT PHYSIOL, V118, P1203, DOI 10.1104/pp.118.4.1203; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; Brading PA, 2000, PLANT J, V23, P305, DOI 10.1046/j.1365-313x.2000.00778.x; Branch C, 2004, MOL PLANT MICROBE IN, V17, P351, DOI 10.1094/MPMI.2004.17.4.351; Campos L, 2014, MOL PLANT MICROBE IN, V27, P1159, DOI 10.1094/MPMI-04-14-0104-R; Campos L, 2014, PLANT PHYSIOL BIOCH, V77, P35, DOI 10.1016/j.plaphy.2014.01.016; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Cavalcanti FR, 2006, PHYSIOL MOL PLANT P, V68, P198, DOI 10.1016/j.pmpp.2006.11.001; Conejero V., 1990, NATO ASI SERIES VOL, P233; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Dufour MC, 2013, PLANT PATHOL, V62, P370, DOI 10.1111/j.1365-3059.2012.02628.x; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Fayos J, 2006, PHYTOCHEMISTRY, V67, P142, DOI 10.1016/j.phytochem.2005.10.014; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez G, 2008, PLANT PHYSIOL, V148, P414, DOI 10.1104/pp.108.120808; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Hagel JM, 2005, PLANTA, V221, P904, DOI 10.1007/s00425-005-1484-x; Halim VA, 2007, MOL PLANT MICROBE IN, V20, P1346, DOI 10.1094/MPMI-20-11-1346; Huang CH, 2012, PLANT DIS, V96, P221, DOI 10.1094/PDIS-03-11-0183; Jang SM, 2004, PLANT PHYSIOL, V135, P346, DOI 10.1104/pp.103.038372; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kachroo P, 2000, PLANT CELL, V12, P677, DOI 10.1105/tpc.12.5.677; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Belles JM, 2008, PLANT SCI, V174, P524, DOI 10.1016/j.plantsci.2008.02.008; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; MARTINTANGUY J, 1985, PLANT GROWTH REGUL, V3, P381, DOI 10.1007/BF00117595; Nachappa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075909; Nakahara KS, 2014, CURR OPIN PLANT BIOL, V20, P88, DOI 10.1016/j.pbi.2014.05.004; Newman MA, 2001, MOL PLANT MICROBE IN, V14, P785, DOI 10.1094/MPMI.2001.14.6.785; Nombela G, 2005, J ECON ENTOMOL, V98, P2266, DOI 10.1603/0022-0493-98.6.2266; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; O'Donnell PJ, 2001, PLANT J, V25, P315, DOI 10.1046/j.1365-313x.2001.00968.x; Obradovic A, 2005, PLANT DIS, V89, P712, DOI 10.1094/PD-89-0712; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Rayapuram C, 2007, PLANT J, V52, P700, DOI 10.1111/j.1365-313X.2007.03267.x; Roberts PD, 2008, CROP PROT, V27, P1519, DOI 10.1016/j.cropro.2008.06.007; RODRIGO I, 1993, PLANT PHYSIOL, V102, P939, DOI 10.1104/pp.102.3.939; Rohilla R, 2002, PEST MANAG SCI, V58, P63, DOI 10.1002/ps.423; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Scarponi L, 2001, PEST MANAG SCI, V57, P262, DOI 10.1002/ps.285; SEMANCIK JS, 1988, J GEN VIROL, V69, P3059, DOI 10.1099/0022-1317-69-12-3059; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Sherwood J. L., 2001, ENCY PLANT PATHOLOGY, P1034; Soler S, 1999, CAN J PLANT PATHOL, V21, P317, DOI 10.1080/07060669909501167; Tebayashi SI, 2007, BIOSCI BIOTECH BIOCH, V71, P1521, DOI 10.1271/bbb.70033; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Trejo-Saavedra DL, 2013, BIOL RES, V46, P333, DOI 10.4067/S0716-97602013000400004; Uehara T, 2010, PLANT CELL PHYSIOL, V51, P1524, DOI 10.1093/pcp/pcq109; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; VERA P, 1988, PLANT SCI, V55, P223, DOI 10.1016/0168-9452(88)90065-9; Verberne MC, 2003, PLANT J, V35, P27, DOI 10.1046/j.1365-313X.2003.01778.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Zacares L, 2007, MOL PLANT MICROBE IN, V20, P1439, DOI 10.1094/MPMI-20-11-1439	71	37	42	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166938	10.1371/journal.pone.0166938	http://dx.doi.org/10.1371/journal.pone.0166938			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893781	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400061
J	Plestilova, L; Neidhart, M; Russo, G; Frank-Bertoncelj, M; Ospelt, C; Ciurea, A; Kolling, C; Gay, RE; Michel, BA; Vencovsky, J; Gay, S; Jungel, A				Plestilova, Lenka; Neidhart, Michel; Russo, Giancarlo; Frank-Bertoncelj, Mojca; Ospelt, Caroline; Ciurea, Adrian; Kolling, Christoph; Gay, Renate E.; Michel, Beat A.; Vencovsky, Jiri; Gay, Steffen; Juengel, Astrid			Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis	PLOS ONE			English	Article							SYNOVIAL FIBROBLASTS; DNA HYPOMETHYLATION; CANCER; TISSUE; PIRNAS; CELLS; GENE	Objective The PIWIL (P-element induced wimpy testis like protein) subfamily of argonaute proteins is essential for Piwi-interacting RNA (piRNA) biogenesis and their function to silence transposons during germ-line development. Here we explored their presence and regulation in rheumatoid arthritis (RA). Methods The expression of PIWIL genes in RA and osteoarthritis (OA) synovial tissues and synovial fibroblasts (SF) was analysed by Real-time PCR, immunofluorescence and Western blot. The expression of piRNAs was quantified by next generation small RNA sequencing (NGS). The regulation of PIWI/piRNAs, proliferation and methylation of LINE-1 after silencing of PIWIL genes were studied. Results PIWIL2 and 4 mRNA were similarly expressed in synovial tissues and SF from RA and OA patients. However, on the protein level only PIWIL4 was strongly expressed in SF. Using NGS up to 300 piRNAs were identified in all SF without significant differences in expression levels between RA and OASF. Of interest, the analysis of the co-expression of the detected piRNAs revealed a less tightly regulated pattern of piRNA-823, -4153 and -16659 expression in RASF. In RASF and OASF, stimulation with TNF alpha+IL1 beta/TLR-ligands further significantly increased the expression levels of PIWIL2 and 4 mRNA and piRNA-16659 was significantly (4-fold) induced upon Poly(I:C) stimulation. Silencing of PIWIL2/4 neither affect LINE-1 methylation/expression nor proliferation of RASF. Conclusion We detected a new class of small regulatory RNAs (piRNAs) and their specific binding partners (PIWIL2/4) in synovial fibroblasts. The differential regulation of co-expression of piRNAs in RASF and the induction of piRNA/Piwi-proteins by innate immune stimulators suggest a role in inflammatory processes.	[Plestilova, Lenka; Neidhart, Michel; Frank-Bertoncelj, Mojca; Ospelt, Caroline; Gay, Renate E.; Gay, Steffen; Juengel, Astrid] Univ Zurich Hosp, Ctr Expt Rheumatol, Zurich, Switzerland; [Russo, Giancarlo] Funct Genom Ctr Zurich, Zurich, Switzerland; [Ciurea, Adrian; Michel, Beat A.] Univ Zurich Hosp, Dept Rheumatol, Zurich, Switzerland; [Kolling, Christoph] Schulthess Clin, Zurich, Switzerland; [Vencovsky, Jiri] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Vencovsky, Jiri] Charles Univ Prague, Fac Med 1, Clin Rheumatol, Prague, Czech Republic	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Schulthess Clinic; Charles University Prague; Institute of Rheumatology; Charles University Prague	Jungel, A (corresponding author), Univ Zurich Hosp, Ctr Expt Rheumatol, Zurich, Switzerland.	astrid.juengel@usz.ch	Russo, Giancarlo/GQY-5601-2022; Vencovsky, Jiri/G-6094-2017; Bertoncelj, Mojca Frank/AAC-6042-2021; Frank-Bertoncelj, Mojca/G-6649-2017	Vencovsky, Jiri/0000-0002-0851-0713; Bertoncelj, Mojca Frank/0000-0002-7257-2468; Ciurea, Adrian/0000-0002-7870-7132; Kolling, Christoph/0000-0003-2802-7638; Ospelt, Caroline/0000-0002-9151-4650; Neidhart, Michel/0000-0002-9656-5967	FP7 OSTEOIMMUNE [289150]; OPO Stiftung; EU-funded IMI BTCure; Institute Arthritis Research (IAR); MHCR Project [023728]	FP7 OSTEOIMMUNE; OPO Stiftung; EU-funded IMI BTCure; Institute Arthritis Research (IAR); MHCR Project	This work was supported by: FP7 OSTEOIMMUNE 289150, http://www.osteoimune.eu/; OPO Stiftung, http://www.opostiftung.chi; EU-funded IMI BTCure, http://www.ropaeuicontentibtcure; Institute Arthritis Research (IAR), http://wwwiar-suissechi; EU-funded EuroTEAM, http://www.team-arthritis.Hi; and MHCR Project for conceptual development of research organization 023728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aradi B, 2015, ARTHRITIS RHEUMATOLO; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bamezai S, 2012, STEM CELLS, V30, P2603, DOI 10.1002/stem.1237; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; Cui L, 2011, CLIN BIOCHEM, V44, P1050, DOI 10.1016/j.clinbiochem.2011.06.004; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Greither T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-272; He XX, 2015, NUCLEIC ACIDS RES, V43, P3712, DOI 10.1093/nar/gkv214; Kang HJ, 2014, MOL BIOL REP, V41, P6729, DOI 10.1007/s11033-014-3558-y; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martinez VD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10423; Neidhart M, 2000, ARTHRITIS RHEUM-US, V43, P2634, DOI 10.1002/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1; Neidhart M, 2010, ARTHRITIS RHEUM-US, V62, P2673, DOI 10.1002/art.27567; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Ng KW, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0491-9; Pan Y, 2012, CELL TISSUE RES, V350, P177, DOI 10.1007/s00441-012-1447-z; Peng L, 2015, TUMOUR BIOL; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Su C, 2012, FEBS LETT, V586, P1356, DOI 10.1016/j.febslet.2012.03.053; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Varet H, SARTOOLS DESEQ2 EDGE; Zhong FD, 2015, NUCLEIC ACIDS RES, V43, P10474, DOI 10.1093/nar/gkv954	27	15	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166920	10.1371/journal.pone.0166920	http://dx.doi.org/10.1371/journal.pone.0166920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893851	Green Published, gold, Green Accepted			2022-12-26	WOS:000389472400057
J	Chiu, WC; Lee, YC; Su, YH; Wang, YY; Tsai, CH; Hou, YA; Wang, CH; Huang, YF; Huang, CJ; Chou, SH; Hsieh, W; Yuan, SSF				Chiu, Wen-Chin; Lee, Yi-Chen; Su, Yu-Han; Wang, Yen-Yun; Tsai, Chun-Hao; Hou, Yi-An; Wang, Chie-Hong; Huang, Ying-Fong; Huang, Chih-Jen; Chou, Shah-Hwa; Hsieh, Wen; Yuan, Shyng-Shiou F.			The Synthetic beta-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; NF-KAPPA-B; BREAST-CANCER; ONCOGENE ADDICTION; SIGNALING PATHWAY; MULTIPLE-MYELOMA; ACTIVATION; APOPTOSIS; AUTOPHAGY	The beta-nitrostyrene family have been implicated for anti-cancer property. However, the pharmacological role of beta-nitrostyrene in esophageal cancer remain unclear. Here, a beta-nitrostyrene derivative, CYT-Rx20, was synthesized and assessed for its anti-cancer activities and underlying mechanism in esophageal cancer. CYT-Rx20 induced cytotoxicity in esophageal cancer cells by promoting apoptosis through activation of caspase cascade and poly(ADPribose) polymerase (PARP) cleavage. Besides, CYT-Rx20 inhibited esophageal cancer cell migration and invasion by regulating the expression of epithelial to mesenchymal transition (EMT) markers. CYT-Rx20 decreased cell viability and migration through suppression of the PI3K/AKT and STAT3 pathways. Of note, the cytotoxicity and anti-migratory effect of CYT-Rx20 were enhanced by co-treatment with SC79 (AKT activator) or colivelin (STAT3 activator), suggesting the dependency of esophageal cancer cells on AKT and STAT3 for survival and migration, an oncogene addiction phenomenon. In xenograft tumor-bearing mice, CYT-Rx20 significantly reduced tumor growth of the implanted esophageal cancer cells accompanied by decreased Ki-67, phospho-AKT, and phospho-STAT3 expression. In orthotopic esophageal cancer mouse model, decreased tumor growth and lung metastasis with reduced Ki-67 and phospho-STAT3 expression were observed in mice treated with CYT-Rx20. Together, our results suggest that CYT-Rx20 is a potential beta-nitrostyrene-based anticancer compound against the tumor growth and metastasis of esophageal cancer.	[Chiu, Wen-Chin; Chou, Shah-Hwa] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Thorac Surg, Kaohsiung, Taiwan; [Lee, Yi-Chen] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Anat, Kaohsiung, Taiwan; [Su, Yu-Han; Wang, Chie-Hong; Yuan, Shyng-Shiou F.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung, Taiwan; [Wang, Yen-Yun; Yuan, Shyng-Shiou F.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Tsai, Chun-Hao; Yuan, Shyng-Shiou F.] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Hou, Yi-An] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Huang, Ying-Fong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Huang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Hsieh, Wen] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Hsieh, Wen] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Hsieh, Wen] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Yuan, Shyng-Shiou F.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yuan, SSF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung, Taiwan.; Yuan, SSF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.; Yuan, SSF (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Yuan, SSF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan.	yuanssf@kmu.edu.tw		yuan, shyng-shiou/0000-0002-4753-788X; Wang, Yen-Yun/0000-0003-4442-4801	Kaohsiung Medical University Hospital [KMUH103-3M19, KMUH104-4M22]; National Health Research Institutes (SSFY) of Taiwan [NHRI-EX104-10212131]	Kaohsiung Medical University Hospital; National Health Research Institutes (SSFY) of Taiwan	This study was supported by grants from the Kaohsiung Medical University Hospital (KMUH103-3M19, KMUH104-4M22) (SHC), and National Health Research Institutes (NHRI-EX104-10212131) (SSFY) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JT, 2014, CANCER TREAT REV, V40, P980, DOI 10.1016/j.ctrv.2014.06.006; Blagosklonny MV, 2011, ONCOTARGET, V2, P1352; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Buettner R, 2002, CLIN CANCER RES, V8, P945; Calgarotto AK, 2012, EUR J PHARMACOL, V678, P6, DOI 10.1016/j.ejphar.2011.12.031; Carter KC, 2002, IMMUNOPHARM IMMUNOT, V24, P187, DOI 10.1081/IPH-120003749; Chen IH, 2015, BIOCHIMIE, V110, P81, DOI 10.1016/j.biochi.2015.01.006; Chen YJ, 2013, GYNECOL ONCOL, V131, P734, DOI 10.1016/j.ygyno.2013.10.012; Cheng YJ, 2014, ONCOTARGET, V5, P11564, DOI 10.18632/oncotarget.2595; Davies E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17187; Demidenko ZN, 2005, CANCER BIOL THER, V4, P484, DOI 10.4161/cbt.4.4.1702; Engel K, 2016, EMBO MOL MED, V8, P851, DOI 10.15252/emmm.201506047; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; He Y, 2014, J BIOL CHEM, V289, P1142, DOI 10.1074/jbc.M113.515080; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Hsieh PW, 2010, BIOORGAN MED CHEM, V18, P7621, DOI 10.1016/j.bmc.2010.08.039; Hsu JH, 2004, ONCOGENE, V23, P3368, DOI 10.1038/sj.onc.1207459; Hung AC, 2016, CLIN CANCER RES, V22, P4478, DOI 10.1158/1078-0432.CCR-15-2704; Hung AC, 2016, CANCER LETT, V371, P251, DOI 10.1016/j.canlet.2015.11.035; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kaap S, 2003, BIOCHEM PHARMACOL, V65, P603, DOI 10.1016/S0006-2952(02)01618-0; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ku GY, 2010, CANCER TREAT REV, V36, P235, DOI 10.1016/j.ctrv.2009.12.009; Kuroda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114562; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Lennon FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091577; Li B, 2007, CARCINOGENESIS, V28, P2313, DOI 10.1093/carcin/bgm152; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Mancias JD, 2011, ONCOTARGET, V2, P1302; Masuda M, 2007, ORAL ONCOL, V43, P785, DOI 10.1016/j.oraloncology.2006.10.007; McNamara YM, 2011, BIOORGAN MED CHEM, V19, P1328, DOI 10.1016/j.bmc.2010.11.054; Milhazes N, 2006, BIOORGAN MED CHEM, V14, P4078, DOI 10.1016/j.bmc.2006.02.006; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Park GB, 2015, INVEST OPHTH VIS SCI, V56, P5162, DOI 10.1167/iovs.14-16058; Park J, 2004, BIOCHEMISTRY-US, V43, P15014, DOI 10.1021/bi0486233; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pettit RK, 2009, BIOORGAN MED CHEM, V17, P6606, DOI 10.1016/j.bmc.2009.07.076; Rahmani-Nezhad S, 2014, EUR J MED CHEM, V86, P562, DOI 10.1016/j.ejmech.2014.09.017; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Sakaeda T, 2009, ADV DRUG DELIVER REV, V61, P388, DOI 10.1016/j.addr.2008.10.005; Sawyers CL, 2009, NAT MED, V15, P1158, DOI 10.1038/nm1009-1158; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Stoyianni A, 2012, ANTICANCER RES, V32, P1273; Takahashi Y, 2013, BLOOD, V121, P1622, DOI 10.1182/blood-2012-10-459826; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Verma N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7064; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yang SX, 2016, CANCER TREAT REV, V45, P87, DOI 10.1016/j.ctrv.2016.03.004; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zeng ZP, 2015, CANCER RES, V75, P2049, DOI 10.1158/0008-5472.CAN-14-2435; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	59	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166453	10.1371/journal.pone.0166453	http://dx.doi.org/10.1371/journal.pone.0166453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875549	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000015
J	Moyer, K; Wang, HY; Salamon, D; Leber, A; Mejias, A				Moyer, Katherine; Wang, Huanyu; Salamon, Douglas; Leber, Amy; Mejias, Asuncion			Enterovirus D68 in Hospitalized Children: Sequence Variation, Viral Loads and Clinical Outcomes	PLOS ONE			English	Article								Background An outbreak of enterovirus D68 (EV-D68) caused severe respiratory illness in 2014. The disease spectrum of EV-D68 infections in children with underlying medical conditions other than asthma, the role of EV-D68 loads on clinical illness, and the variation of EV-D68 strains within the same institution over time have not been described. We sought to define the association between EV-D68 loads and sequence variation, and the clinical characteristic in hospitalized children at our institution from 2011 to 2014. Methods May through November 2014, and August to September 2011 to 2013, a convenience sample of nasopharyngeal specimens from children with rhinovirus (RV)/EV respiratory infections were tested for EV-D68 by RT-PCR. Clinical data were compared between children with RV/EV-non-EV-D68 and EV-D68 infections, and among children with EV-D68 infections categorized as healthy, asthmatics, and chronic medical conditions. EV-D68 loads were analyzed in relation to disease severity parameters and sequence variability characterized over time. Results In 2014, 44% (192/438) of samples tested positive for EV-D68 vs. 10% (13/130) in 2011-13 (p<0.0001). PICU admissions (p<0.0001) and non-invasive ventilation (p<0.0001) were more common in children with EV-D68 vs. RV/EV-non-EV-D68 infections. Asthmatic EVD68+ children, required supplemental oxygen administration (p = 0.03) and PICU admissions (p <0.001) more frequently than healthy children or those with chronic medical conditions; however oxygen duration (p<0.0001), and both PICU and total hospital stay (p<0.01) were greater in children with underlying medical conditions, irrespective of viral burden. By phylogenetic analysis, the 2014 EV-D68 strains clustered into a new sublineage within Glade B. Conclusions This is one of the largest pediatric cohorts described from the EV-D68 outbreak. Irrespective of viral loads, EV-D68 was associated with high morbidity in children with asthma and co morbidities. While EV-D68 circulated before 2014, the outbreak isolates clustered differently than those from prior years.	[Moyer, Katherine; Mejias, Asuncion] Nationwide Childrens Hosp, Div Infect Dis, Dept Pediat, Columbus, OH 43205 USA; [Wang, Huanyu; Salamon, Douglas; Leber, Amy] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA; [Mejias, Asuncion] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Mejias, A (corresponding author), Nationwide Childrens Hosp, Div Infect Dis, Dept Pediat, Columbus, OH 43205 USA.; Leber, A (corresponding author), Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA.; Mejias, A (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH 43210 USA.	Amy.Leber@nationwidechildrens.org; Asuncion.Mejias@nationwidechildrens.org	Wang, Huanyu/W-3145-2019; Mejias, Asuncion/AAC-5998-2019	Wang, Huanyu/0000-0002-5982-6371; Mejias, Asuncion/0000-0002-5983-8006	National Institutes of Health, National Center for Advancing Translational Sciences [UL1TR001070]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the National Institutes of Health, National Center for Advancing Translational Sciences (UL1TR001070). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01201-14; Drews SJ, 2015, J CLIN MICROBIOL, V53, P1042, DOI 10.1128/JCM.02982-14; Du J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144208; Foster CB, 2015, CLEV CLIN J MED, V82, P26, DOI 10.3949/ccjm.82a.14166; Huang WH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15223; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Mertz D, 2015, CAN MED ASSOC J, V187, P1279, DOI 10.1503/cmaj.150619; Midgley CM, 2015, LANCET RESP MED, V3, P879, DOI 10.1016/S2213-2600(15)00335-5; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Oermann CM, 2015, ANN AM THORAC SOC, V12, P775, DOI 10.1513/AnnalsATS.201412-592FR; Orvedahl A, 2016, PEDIATR INFECT DIS J, V35, P481, DOI 10.1097/INF.0000000000001060; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Schuster JE, 2015, J CLIN VIROL, V70, P77, DOI 10.1016/j.jcv.2015.07.298; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Todd AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-103; TOKARZ R, 2012, THE JOURNAL OF GENER, V93, P1952, DOI DOI 10.1099/VIR.0.043935-0	25	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167111	10.1371/journal.pone.0167111	http://dx.doi.org/10.1371/journal.pone.0167111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875593	Green Submitted, Green Published, gold			2022-12-26	WOS:000388886000050
J	Brown, EEA; Simmons, AM				Brown, Erika E. A.; Simmons, Andrea Megela			Variability of Rheotaxis Behaviors in Larval Bullfrogs Highlights Species Diversity in Lateral Line Function	PLOS ONE			English	Article							RHEOTACTIC BEHAVIOR; XENOPUS-LAEVIS; CLAWED FROG; TADPOLES; SYSTEM; NEUROMASTS; DAMAGE; FISH	The morphology and distribution of lateral line neuromasts vary between ecomorphological types of anuran tadpoles, but little is known about how this structural variability contributes to differences in lateral-line mediated behaviors. Previous research identified distinct differences in one such behavior, positive rheotaxis towards the source of a flow, in two tadpole species, the African clawed frog (Xenopus laevis; type 1) and the American bullfrog (Rana catesbeiana; type 4). Because these two species had been tested under different flow conditions, we re-evaluated these findings by quantifying flow-sensing behaviors of bullfrog tadpoles in the same flow field in which X. laevis tadpoles had been tested previously. Early larval bullfrog tadpoles were exposed to flow in the dark, in the presence of a discrete light cue, and after treatment with the ototoxin gentamicin. In response to flow, tadpoles moved downstream, closer to a side wall, and higher in the water column, but they did not station-hold. Tadpoles exhibited positive rheotaxis, but with long latencies, low to moderate accuracy, and considerable individual variability. This is in contrast to the robust, stereotyped station-holding and accurate rheotaxis of X. laevis tadpoles. The presence of a discrete visual cue and gentamicin treatment altered spatial positioning and disrupted rheotaxis in both tadpole species. Species differences in lateral-line mediated behaviors may reflect differences in neuromast number and distribution, life history, or perceptual salience of other environmental cues.	[Brown, Erika E. A.; Simmons, Andrea Megela] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Brown, Erika E. A.] Amer Phys Soc, College Pk, MD 20740 USA	Brown University	Simmons, AM (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	Andrea_Simmons@brown.edu		Simmons, Andrea/0000-0003-1353-8275	National Institute on Deafness and Other Communication Disorders [R01 DC05257]; National Science Foundation [1058262]; Rhode Island Space Grant Consortium	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); Rhode Island Space Grant Consortium	This work was supported by National Institute on Deafness and Other Communication Disorders, R01 DC05257, AMS; National Science Foundation Graduate Research Fellowship 1058262 to EEAB; and Rhode Island Space Grant Consortium awards to AMS and to EEAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak-Coleman J, 2014, J EXP BIOL, V217, P2338, DOI 10.1242/jeb.102574; Bak-Coleman J, 2013, J EXP BIOL, V216, P4011, DOI 10.1242/jeb.090480; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Batschelet E, 1981, CIRCULAR STAT BIOL; Brown AD, 2011, HEARING RES, V272, P1, DOI 10.1016/j.heares.2010.10.014; Buck LMJ, 2012, HEARING RES, V284, P67, DOI 10.1016/j.heares.2011.12.001; CLAAS B, 1993, J COMP PHYSIOL A, V172, P759; Drucker EG, 1999, J EXP BIOL, V202, P2393; ELEPFANDT A, 1996, BIOL XENOPUS, P97; Fritzsch B., 1989, EVOLUTIONARY BIOL HE, P351; Gosner K. L., 1960, Herpetologica, V16, P183; GREENWOOD JA, 1955, ANN MATH STAT, V26, P233, DOI 10.1214/aoms/1177728540; HATZE H, 1988, J BIOMECH, V21, P533, DOI 10.1016/0021-9290(88)90216-3; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Hoff KV, 1999, TADPOLES, P215; KATZ LC, 1981, ANIM BEHAV, V29, P20, DOI 10.1016/S0003-3472(81)80148-0; LANNOO MJ, 1987, J MORPHOL, V191, P115, DOI 10.1002/jmor.1051910203; LUM AM, 1982, PHARMACOL BIOCHEM BE, V17, P363, DOI 10.1016/0091-3057(82)90093-4; McDiarmid RW, 1999, TADPOLES, P7; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Montgomery J, 2014, SPRINGER HANDB AUDIT, V48, P121, DOI 10.1007/2506_2013_17; Olive R, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00014; Olszewski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036661; Quinzio S, 2014, ANAT REC, V297, P1508, DOI 10.1002/ar.22952; Roberts A, 2009, J EXP BIOL, V212, P914, DOI 10.1242/jeb.027250; Schmidt BP, 2011, J EXP BIOL, V214, P2297, DOI 10.1242/jeb.055392; SHELTON PMJ, 1971, J EXP ZOOL, V178, P211, DOI 10.1002/jez.1401780207; Simmons A, 2004, J COMP PHYSIOL A, V190, P747, DOI 10.1007/s00359-004-0534-3; Simmons A. M., 2014, DEV AUDITORY VESTIBU, P370; Simmons AM, 2015, J COMP PHYSIOL A, V201, P215, DOI 10.1007/s00359-014-0957-4; Song JK, 1995, HEARING RES, V91, P63, DOI 10.1016/0378-5955(95)00170-0; Suli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029727; Taylor ZJ, 2010, IEEE T INSTRUM MEAS, V59, P3262, DOI 10.1109/TIM.2010.2047149; Van Trump WJ, 2013, INTEGR COMP BIOL, V53, P799, DOI 10.1093/icb/ict064; Van Trump WJ, 2010, HEARING RES, V261, P42, DOI 10.1016/j.heares.2010.01.001; VANBERGEIJK WA, 1959, J ACOUST SOC AM, V31, P1340, DOI 10.1121/1.1907632; VOGEL S, 1978, BIOSCIENCE, V28, P638, DOI 10.2307/1307394; Webb JF., 2014, SPRINGER HDB AUDITOR, P17	38	1	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166989	10.1371/journal.pone.0166989	http://dx.doi.org/10.1371/journal.pone.0166989			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870909	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400052
J	Mandel, ER; Dunford, EC; Trifonova, A; Abdifarkosh, G; Teich, T; Riddell, MC; Haas, TL				Mandel, Erin R.; Dunford, Emily C.; Trifonova, Anastassia; Abdifarkosh, Ghoncheh; Teich, Trevor; Riddell, Michael C.; Haas, Tara L.			Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction	PLOS ONE			English	Article							SHEAR-STRESS; SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; NITRIC-OXIDE; BLOOD-FLOW; VEGF; GROWTH; ANGIOGENESIS; ANGIOPOIETIN-2; INVOLVEMENT	Glucocorticoids (GC) elicit skeletal muscle capillary rarefaction, which can subsequently impair blood distribution and muscle function; however, the mechanisms have not been established. We hypothesized that CORT would inhibit endothelial cell survival signals but that treatment with the alpha-1 adrenergic receptor inhibitor prazosin, which leads to angiogenesis in skeletal muscle of healthy rats, would reverse these effects and induce angiogenesis within the skeletal muscle of corticosterone (CORT)-treated rats. Male Sprague Dawley rats were implanted subcutaneously with CORT pellets (400 mg/rat), with or without concurrent prazosin treatment (50mg/L in drinking water), for 1 or 2 weeks. Skeletal muscle capillary rarefaction, as indicated by a significant reduction in capillary-to-fiber ratio (C:F), occurred after 2 weeks of CORT treatment. Concurrent prazosin administration prevented this capillary rarefaction in CORT-treated animals but did not induce angiogenesis or arterio-genesis as was observed with prazosin treatment in control rats. CORT treatment reduced the mRNA level of Angiopoietin-1 (Ang-1), which was partially offset in the muscles of rats that received 2 weeks of co-treatment with prazosin. In 2W CORT animals, prazosin treatment elicited a significant increase in vascular endothelial growth factor-A (VEGF-A) mRNA and protein. Conversely prazosin did not rescue CORT-induced reductions in transforming growth factor beta-1 (TGF beta 1 and matrix metalloproteinase-2 (MMP-2) mRNA. To determine if CORT impaired shear stress dependent signaling, cultured rat skeletal muscle endothelial cells were pre-treated with CORT (600nM) for 48 hours, then exposed to 15 dynes/cm(2) shear stress or maintained with no flow. CORT blunted the shear stress-induced increase in pSer473 Akt, while pThr308 Akt, ERK1/2 and p38 phosphorylation and nitric oxide (NO) production were unaffected. This study demonstrates that GC-mediated capillary rarefaction is associated with a reduction in Ang-1 mRNA within the skeletal muscle microenvironment and that concurrent prazosin treatment effectively increases VEGF-A levels and prevents capillary loss.	[Mandel, Erin R.; Dunford, Emily C.; Abdifarkosh, Ghoncheh; Teich, Trevor; Riddell, Michael C.; Haas, Tara L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Mandel, Erin R.; Dunford, Emily C.; Abdifarkosh, Ghoncheh; Teich, Trevor; Riddell, Michael C.; Haas, Tara L.] York Univ, Muscle Hlth Res Ctr, Toronto, ON, Canada; [Trifonova, Anastassia] York Univ, Dept Biol, Toronto, ON, Canada	York University - Canada; York University - Canada; York University - Canada	Haas, TL (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.; Haas, TL (corresponding author), York Univ, Muscle Hlth Res Ctr, Toronto, ON, Canada.	thaas@yorku.ca	Haas, Tara/F-6788-2013	Haas, Tara/0000-0001-8559-9574	Natural Science and Engineering Council of Canada Discovery Grants [RGPIN/222865, RGPIN/263877]; York University Faculty of Health Minor Research Grant	Natural Science and Engineering Council of Canada Discovery Grants; York University Faculty of Health Minor Research Grant	This study was funded by Natural Science and Engineering Council of Canada Discovery Grants to TLH (RGPIN/222865) and to MCR (RGPIN/263877) and a York University Faculty of Health Minor Research Grant to TLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom T, 2014, AJP ENDOCRINOL  1028; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Bongrazio M, 2008, INT J IMMUNOPATH PH, V19, P35; Bonner JS, 2013, DIABETES, V62, P572, DOI 10.2337/db12-0354; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Fleming I, 1999, J MOL CELL CARDIOL, V31, P5, DOI 10.1006/jmcc.1998.0839; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Haas TL, 2007, AM J PHYSIOL-HEART C, V293, pH2429, DOI 10.1152/ajpheart.00100.2007; Han XY, 2003, J BIOL CHEM, V278, P47785, DOI 10.1074/jbc.M309482200; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173; Hudlicka O, 2006, MICROCIRCULATION, V13, P249, DOI 10.1080/10739680600556951; Hudlicka O, 2009, J VASC RES, V46, P504, DOI 10.1159/000226127; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Kusters YHAM, 2016, AM J PHYSIOL-ENDOC M, V310, pE379, DOI 10.1152/ajpendo.00443.2015; Lansang MC, 2011, CLEV CLIN J MED, V78, P748, DOI 10.3949/ccjm.78a.10180; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Logie JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014476; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Messmer UK, 2000, BRIT J PHARMACOL, V129, P1673, DOI 10.1038/sj.bjp.0703255; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; Milkiewicz M, 2006, J CELL PHYSIOL, V208, P229, DOI 10.1002/jcp.20658; Nascimento AR, 2013, OBESITY, V21, P2046, DOI 10.1002/oby.20358; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Price RJ, 1998, MICROVASC RES, V55, P138, DOI 10.1006/mvre.1997.2062; Price RJ, 1996, AM J PHYSIOL-HEART C, V271, pH752, DOI 10.1152/ajpheart.1996.271.2.H752; PRICE RJ, 1994, CIRC RES, V75, P520, DOI 10.1161/01.RES.75.3.520; Prior SJ, 2015, DIABETES, V64, P3386, DOI 10.2337/db14-1771; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Shikatani EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046625; Shpilberg Y, 2012, DIS MODEL MECH, V5, P671, DOI 10.1242/dmm.008912; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Triantafyllou A, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0543-3; Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629; Uchida C, 2015, ACTA PHYSIOL, V214, P349, DOI 10.1111/apha.12463; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; Vogt CJ, 2001, MICROCIRCULATION, V8, P129, DOI 10.1080/713774024; Williams JL, 2006, MICROCIRCULATION, V13, P499, DOI 10.1080/10739680600785717; Williams JL, 2006, J PHYSIOL-LONDON, V570, P445, DOI 10.1113/jphysiol.2005.095596; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007; Zhou AL, 1998, CELL TISSUE RES, V293, P293, DOI 10.1007/s004410051121; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422; ZIADA A, 1989, PFLUG ARCH EUR J PHY, V415, P355, DOI 10.1007/BF00370888	59	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166899	10.1371/journal.pone.0166899	http://dx.doi.org/10.1371/journal.pone.0166899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861620	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300129
J	Endo, A; Ly, T; Pippa, R; Bensaddek, D; Nicolas, A; Lamond, AI				Endo, Akinori; Ly, Tony; Pippa, Raffaella; Bensaddek, Dalila; Nicolas, Armel; Lamond, Angus I.			The Chromatin Assembly Factor Complex 1 (CAF1) and 5-Azacytidine (5-AzaC) Affect Cell Motility in Src-transformed Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; BREAST-CANCER; FACTOR-I; MESENCHYMAL TRANSITION; ONCOGENE; LINK; FIBROBLASTS; INHERITANCE; METABOLISM; SENESCENCE	Tumor invasion into surrounding stromal tissue is a hallmark of high grade, metastatic cancers. Oncogenic transformation of human epithelial cells in culture can be triggered by activation of v-Src kinase, resulting in increased cell motility, invasiveness, and tumorigenicity and provides a valuable model for studying how changes in gene expression cause cancer phenotypes. Here, we show that epithelial cells transformed by activated Src show increased levels of DNA methylation and that the methylation inhibitor 5-azacytidine (5-AzaC) potently blocks the increased cell motility and invasiveness induced by Src activation. A proteomic screen for chromatin regulators acting downstream of activated Src identified the replication-dependent histone chaperone CAF1 as an important factor for Src-mediated increased cell motility and invasion. We show that Src causes a 5-AzaC-sensitive decrease in both mRNA and protein levels of the p150 (CHAF1A) and p60 (CHAF1B), subunits of CAF1. Depletion of CAF1 in untransformed epithelial cells using siRNA was sufficient to recapitulate the increased motility and invasive phenotypes characteristic of transformed cells without activation of Src. Maintaining high levels of CAF1 by exogenous expression suppressed the increased cell motility and invasiveness phenotypes when Src was activated. These data identify a critical role of CAF1 in the dysregulation of cell invasion and motility phenotypes seen in transformed cells and also highlight an important role for epigenetic remodeling through DNA methylation for Src-mediated induction of cancer phenotypes.	[Endo, Akinori; Ly, Tony; Pippa, Raffaella; Bensaddek, Dalila; Nicolas, Armel; Lamond, Angus I.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland.	a.i.lamond@dundee.ac.uk	Pippa, Raffaella/J-4566-2012; Pippa, Raffaella/AAH-8047-2020	Pippa, Raffaella/0000-0002-1028-6511; Pippa, Raffaella/0000-0002-1028-6511	Wellcome Trust [073980/Z/03/Z, 105024/Z/14/Z, 098503/E/12/Z, BB/K003801/1]; Seventh Framework Programme Grant [HEALTH-F4-2010-257082]; Gene Regulation and Expression Strategic Award [097945/B/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); Seventh Framework Programme Grant; Gene Regulation and Expression Strategic Award	This work was supported by Wellcome Trust Grants 073980/Z/03/Z, 105024/Z/14/Z, 098503/E/12/Z, and BB/K003801/1 (to A. I. L.), Seventh Framework Programme Grant HEALTH-F4-2010-257082 (to A. I. L.), and Gene Regulation and Expression Strategic Award 097945/B/11/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Cheloufi S, 2015, NATURE, V528, P218, DOI 10.1038/nature15749; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elsberger B, 2014, CRIT REV ONCOL HEMAT, V89, P343, DOI 10.1016/j.critrevonc.2013.12.009; Exner V, 2006, DEVELOPMENT, V133, P4163, DOI 10.1242/dev.02599; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hart PC, 2016, ONCOTARGET, V7, P308, DOI 10.18632/oncotarget.5687; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Hunter T, 2015, P NATL ACAD SCI USA, V112, P7877, DOI 10.1073/pnas.1508223112; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kustatscher G, 2014, NAT PROTOC, V9, P2090, DOI 10.1038/nprot.2014.142; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Petty RD, 2006, J CLIN ONCOL, V24, P1729, DOI 10.1200/JCO.2005.03.3399; Pippa R., 2016, ONCOTARGET, V5, DOI 10.18632/oncotarget.9840; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Polo SE, 2004, CANCER RES, V64, P2371, DOI 10.1158/0008-5472.CAN-03-2893; Ridgway P, 2000, J CELL SCI, V113, P2647; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Santini V, 2001, ANN INTERN MED, V134, P573, DOI 10.7326/0003-4819-134-7-200104030-00011; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SORM F, 1964, EXPERIENTIA, V20, P202, DOI 10.1007/BF02135399; SOULE HD, 1990, CANCER RES, V50, P6075; Staibano S, 2007, HISTOPATHOLOGY, V50, P911, DOI 10.1111/j.1365-2559.2007.02698.x; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; WANG E, 1976, P NATL ACAD SCI USA, V73, P4065, DOI 10.1073/pnas.73.11.4065; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	40	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					172	184		10.1074/jbc.M116.751024	http://dx.doi.org/10.1074/jbc.M116.751024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872192	Green Published, hybrid			2022-12-26	WOS:000391578000015
J	Pontrelli, P; Conserva, F; Papale, M; Oranger, A; Barozzino, M; Vocino, G; Rocchetti, MT; Gigante, M; Castellano, G; Rossini, M; Simone, S; Laviola, L; Giorgino, F; Grandaliano, G; Di Paolo, S; Gesualdo, L				Pontrelli, Paola; Conserva, Francesca; Papale, Massimo; Oranger, Annarita; Barozzino, Mariagrazia; Vocino, Grazia; Rocchetti, Maria Teresa; Gigante, Margherita; Castellano, Giuseppe; Rossini, Michele; Simone, Simona; Laviola, Luigi; Giorgino, Francesco; Grandaliano, Giuseppe; Di Paolo, Salvatore; Gesualdo, Loreto			Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic kidney; EMT; hyperglycemia; post-translational modifications	EPITHELIAL-MESENCHYMAL TRANSITION; HIGH GLUCOSE; CONJUGATING ENZYME; KIDNEY-DISEASE; THERAPEUTIC INTERVENTION; PROTEASOME SYSTEM; EXPRESSION; CELLS; MECHANISMS; PATHOGENESIS	The purpose of our study was to evaluate howhyperglycemia (HG) influences Lys63 protein ubiquitination and its involvement in tubular damage and fibrosis in diabetic nephropathy (DN). Gene and protein expression of UBE2v1, a ubiquitin-conjugating E2-enzyme variant that mediates Lys63-linked ubiquitination, and Lys63-ubiquitinated proteins increased in HK2 tubular cells under HG. Matrix-assisted laser desorption/ionization-time of flight/tandem mass spectrometry identified 30 Lys63-ubiquitinated proteins, mainly involved in cellular organization, such as beta-actin, whose Lys63 ubiquitination increased under HG, leading to cytoskeleton disorganization. This effect was reversed by the inhibitor of the Ubc13/UBE2v1 complexNSC697923. Western blot analysis confirmed that UBE2v1 silencing in HK2 under HG, restored Lys63-beta-actin ubiquitination levels to the basal condition. Immunohistochemistry on patients with type 2 diabetic (T2D) revealed an increase in UBE2v1- and Lys63-ubiquitinated proteins, particularly in kidneys of patients with DN compared with control kidneys and other nondiabetic renal diseases, such as membranous nephropathy. Increased Lys63 ubiquitination both in vivo in patients with DN and in vitro, correlated with alpha-SMA expression, whereas UBE2v1 silencing reduced HG-induced alpha-SMA protein levels, returning themto basal expression. In conclusion, UBE2v1- and Lys63-ubiquitinated proteins increase in vitro under HG, as well as in vivo in T2D, is augmented in patients with DN, and may affect cytoskeleton organization and influence epithelial-to-mesenchymal transition. This process may drive the progression of tubular damage and interstitial fibrosis in patients with DN.Pontrelli, P., Conserva, F., Papale, M., Oranger, A., Barozzino, M., Vocino, G., Rochetti, M. T., Gigante, M., Castellano, G., Rossini, M., Simone, S., Laviola, L., Giorgino, F., Grandaliano, G., DiPaolo, S., Gesualdo, L. Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy.	[Pontrelli, Paola; Conserva, Francesca; Oranger, Annarita; Barozzino, Mariagrazia; Rocchetti, Maria Teresa; Gigante, Margherita; Castellano, Giuseppe; Rossini, Michele; Simone, Simona; Gesualdo, Loreto] Univ Bari, Div Nephrol Dialysis & Transplantat, Dept Emergency & Organ Transplantat, Bari, Italy; [Laviola, Luigi; Giorgino, Francesco] Univ Bari, Div Endocrinol, Dept Emergency & Organ Transplantat, Bari, Italy; [Conserva, Francesca] Sci Clin Inst Maugeri, Dept Cardiol & Cardiac Rehabil, Bari, Italy; [Papale, Massimo; Vocino, Grazia; Grandaliano, Giuseppe] Univ Foggia, Div Nephrol, Dept Med & Surg Sci, Foggia, Italy; [Di Paolo, Salvatore] Dimiccoli Hosp, Nephrol Unit, Barletta, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Foggia	Pontrelli, P (corresponding author), Univ Bari, Dept Emergency & Transplantat, Div Nephrol Dialysis & Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	paola.pontrelli@uniba.it	Gesualdo, Loreto/K-7751-2016; Grandaliano, Giuseppe/J-7822-2016; Papale, Massimo/AAQ-2370-2020; Rocchetti, Maria Teresa/N-2212-2018; Laviola, Luigi/AAC-2237-2022; Rocchetti, Maria Teresa/AAA-6771-2019; Conserva, Francesca/D-3681-2013; Pontrelli, Paola/K-5881-2016; Rocchetti, Maria Teresa/AAQ-1881-2021; Rossini, Michele/AAC-6516-2022; Castellano, Giuseppe/H-1626-2012; Di+Paolo, Salvatore/AAX-5463-2021	Gesualdo, Loreto/0000-0002-4861-0911; Grandaliano, Giuseppe/0000-0003-1213-2177; Papale, Massimo/0000-0002-8278-5045; Rocchetti, Maria Teresa/0000-0002-2397-6474; Conserva, Francesca/0000-0003-2863-864X; Pontrelli, Paola/0000-0002-7654-8318; Rocchetti, Maria Teresa/0000-0002-2397-6474; Rossini, Michele/0000-0002-5801-4136; Castellano, Giuseppe/0000-0002-0153-3795; Barozzino, Mariagrazia/0000-0001-7697-7115; Oranger, Annarita/0000-0003-4402-244X	Ministero della Salute Ricerca Finalizzata [2009: 245/RF-2009-1470765]	Ministero della Salute Ricerca Finalizzata(Ministry of Health, Italy)	The authors thank Dr. Chiara Divella and Mr. Vincenzo Gesualdo for excellent technical assistance and Dr. Annamaria Di Palma (all from the University of Bari) for helpful discussions of the histologic findings. This study was supported by Ministero della Salute Ricerca Finalizzata 2009: 245/RF-2009-1470765. The authors declare no conflicts of interest.	Aghdam SY, 2013, BIOCHEM BIOPH RES CO, V432, P339, DOI 10.1016/j.bbrc.2013.01.101; Akimoto Yoshihiro, 2011, Clin Proteomics, V8, P15, DOI 10.1186/1559-0275-8-15; Bogachek MV, 2015, CANCER RES, V75, P11, DOI 10.1158/0008-5472.CAN-14-2824; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Clarkson MR, 2002, J BIOL CHEM, V277, P9707, DOI 10.1074/jbc.M109172200; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dihazi H, 2007, CLIN CHEM, V53, P1636, DOI 10.1373/clinchem.2007.088260; Dlugosz JA, 2002, AM J PHYSIOL-RENAL, V282, pF151, DOI 10.1152/ajprenal.0055.2001; Gao CL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160692; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Ha TS, 2006, NEPHROLOGY, V11, P435, DOI 10.1111/j.1440-1797.2006.00668.x; Hale PJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S16; Hu C, 2015, CURR MED CHEM, V22, P2858, DOI 10.2174/0929867322666150625095407; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kimura M, 2008, INTERNAL MED, V47, P1099, DOI 10.2169/internalmedicine.47.0352; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Loeffler I, 2015, CELLS-BASEL, V4, P631, DOI 10.3390/cells4040631; Luo ZF, 2011, LIFE SCI, V88, P512, DOI 10.1016/j.lfs.2010.12.023; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Neutzner M, 2012, ESSAYS BIOCHEM, V52, P37, DOI [10.1042/bse0520037, 10.1042/BSE0520037]; Papale M, 2010, DIABETES CARE, V33, P2409, DOI 10.2337/dc10-0345; Park SH, 2015, MOL CELLS, V38, P20, DOI 10.14348/molcells.2015.2120; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Ray DM, 2010, BIOCHEM CELL BIOL, V88, P947, DOI 10.1139/O10-148; Renal Pathology Society, 2010, J AM SOC NEPHROL, V21, P556; Rocchetti MT, 2013, CLIN J AM SOC NEPHRO, V8, P1115, DOI 10.2215/CJN.05950612; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; Soond SM, 2011, BIOESSAYS, V33, P749, DOI 10.1002/bies.201100057; Sun L, 2002, J BIOL CHEM, V277, P29953, DOI 10.1074/jbc.M204665200; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Voutsadakis IA, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-67; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Xu GQ, 2011, NAT BIOTECHNOL, V29, P1098, DOI 10.1038/nbt.2061; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P952; Yeo RWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044988; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhao L, 2016, PHYSIOL GENOMICS, V48, P580, DOI 10.1152/physiolgenomics.00058.2016	50	13	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					308	319		10.1096/fj.201600382RR	http://dx.doi.org/10.1096/fj.201600382RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27881486	Green Submitted			2022-12-26	WOS:000392177600029
J	Inzaule, SC; Hamers, RL; Kityo, C; De Wit, TFR; Roura, M				Inzaule, Seth C.; Hamers, Raph L.; Kityo, Cissy; Rinke de Wit, Tobias F.; Roura, Maria			Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study	PLOS ONE			English	Article								Background Long-term success of HIV antiretroviral therapy requires near-perfect adherence, maintained throughout one's lifetime. However, perceptions towards ART and patterns of adherence may change during the life course. We assessed challenges to long-term adherence in adolescents and adults in three regional HIV treatment centers in Uganda. Methods We conducted 24 in-depth interviews and 2 focus group discussions with a total of 33 health-care providers and expert clients (HIV patients on long-term ART who assist with adherence support of fellow patients). Interview topics included experiences with patients on long-term treatment with either declining adherence or persistent poor adherence. Transcribed texts were coded and analyzed based on the social-ecological framework highlighting differences and commonalities between adolescents and adults. Results The overarching themes in adolescents were unstructured treatment holidays, delays in disclosure of HIV status by caretakers, stigma, which was mainly experienced in boarding schools, and diminishing or lack of clinical support. In particular, there was minimal support for early and gradual disclosure for caretakers to the infected children, diminishing clinical support for young adults during transition to adult-based care and declining peer-to-peer support group activities. The predominating theme in adults was challenges with treatment access among temporary economic migrants. Common themes to adults and adolescents were challenges with disclosure in intimate relationships, treatment related factors including side effects, supply of single tablets in place of fixed-dose combined drugs, supply of drug brands with unfavorable taste and missed opportunities for counseling due to shortage of staff. Conclusion Adherence counseling and support should be adapted differently for adolescents and adults and to the emerging life course challenges in long-term treated patients. Programs should also address constraints experienced by temporary economic migrants to ensure continuity of treatment within the host country.	[Inzaule, Seth C.; Hamers, Raph L.; Rinke de Wit, Tobias F.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Inzaule, Seth C.; Hamers, Raph L.; Rinke de Wit, Tobias F.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hamers, Raph L.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, Amsterdam, Netherlands; [Kityo, Cissy] Joint Clin Res Ctr, Kampala, Uganda; [Roura, Maria] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Joint Clinic Research Center - United Arab Emirates; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Inzaule, SC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands.; Inzaule, SC (corresponding author), Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.	s.inzaule@aighd.org	Roura, Maria/K-6668-2014	Roura, Maria/0000-0001-9556-1940; Hamers, Raph/0000-0002-5007-7896	European Union through the Trans Global Health programme, part of the Erasmus Mundus Joint Doctorate Programme; Joint Clinical Research Centre (JCRC); RRC Mbale; RRC Fort Portal; Amsterdam Institute for Global Health and Development; Barcelona Centre for International Health Research (CRESIB) Hospital	European Union through the Trans Global Health programme, part of the Erasmus Mundus Joint Doctorate Programme; Joint Clinical Research Centre (JCRC); RRC Mbale; RRC Fort Portal; Amsterdam Institute for Global Health and Development; Barcelona Centre for International Health Research (CRESIB) Hospital	This work was supported by a grant from the European Union through the Trans Global Health programme, part of the Erasmus Mundus Joint Doctorate Programme.; The authors acknowledge the support of the study participants; The authors also acknowledge the support of the Joint Clinical Research Centre (JCRC), RRC Mbale, RRC Fort Portal, Amsterdam Institute for Global Health and Development, and Barcelona Centre for International Health Research (CRESIB) Hospital.	Adefolalu AO, 2013, DISEASES; Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; [Anonymous], 2014, HIV AIDS PREV CONTR; Bangsberg DR, 2013, ANTIVIRAL THERAPY; Bijker R, 2015, C RETR OPP INF CROI; Boender T. S., 2015, CLIN INFECT DIS; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bronfenbrenner U., 1977, AM PSYCHOL; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Cambiano V, 2010, AIDS; CHIVA, 2010, CHIVA GUID TRANS AD; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; DHHS, 2016, GUIDELINES USE ANTIR; Etard JF, 2007, TROP MED INT HLTH; Fair CD, 2012, AIDS PATIENT CARE ST; Feeney ER, 2011, OPEN CARDIOVASC MED; Fox MP, 2010, TROP MED INT HLTH; Funck-Brentano I, 2005, AIDS; Global Commission on HIV and the Law, 2012, RISKS RIGHTS HLTH; Gupta RK, 2009, LANCET INFECT DIS; Gusdal AK, 2011, AIDS CARE; Hardon AP, 2007, AIDS CARE; Havlir D V, 2004, CLIN INFECT DIS; Hazra R, 2010, ANN REV MED; Hudelson C, 2015, AIDS CARE; Kasedde S, 2013, CURR HIV AIDS REP; Kyakuwa M, 2012, MED ANTHR; Lima VD, 2009, J ACQUIR IMMUNE DEFI; Mbonye M, 2013, BMC PUBLIC HLTH; Mbonye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078243; Merten S, 2010, TROP MED INT HLTH; Mutumba M, 2015, J ASS NURSES AIDS CA; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; Nachega JB, 2009, J ACQUIR IMMUNE DEFI; Ortego C, 2011, AIDS BEHAV; Roura M, 2009, AIDS PATIENT CARE ST; Russell S, 2016, SOCIOL HLTH ILLN; Russell S, 2016, QUAL HLTH RES; Seeley J, 2009, CULT HLTH SEX; Taylor BS, 2011, MT SINAI J MED; Tesoriero J, 2003, J ACQUIR IMMUNE DEFI; UNAIDS, 2015, AIDS CHANG EV MDG6 1; UNICEF, 2014, LOST TRANS CURR ISS; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Williams PL, 2008, AM J EPIDEMIOL; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; World Health Organization, 2011, GUID HIV DISCL COUNS; Zelinsky W., 1971, GEOGR REV	49	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167492	10.1371/journal.pone.0167492	http://dx.doi.org/10.1371/journal.pone.0167492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898736	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000066
J	Saito, K; Ueta, M; Maekawa, K; Sotozono, C; Kinoshita, S; Saito, Y				Saito, Kosuke; Ueta, Mayumi; Maekawa, Keiko; Sotozono, Chie; Kinoshita, Shigeru; Saito, Yoshiro			Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens Johnson Syndrome/Toxic Epidermal Necrolysis	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; ERYTHEMA MULTIFORME; SHOTGUN LIPIDOMICS; IMMUNE-RESPONSE; BLOOD-PLASMA; INFLAMMATION; MANIFESTATIONS; SUSCEPTIBILITY; PHOSPHOLIPIDS	Stevens-Johnson syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), are drug-induced acute inflammatory vesiculobullous reactions of the skin and mucous membranes, including the ocular surface. Even after recovery from skin symptoms, some SJS/TEN patients continue to suffer with severe ocular complications (SOCs). Therefore, this study aims to understand the pathophysiology of chronic SOCs. Because plasma lipid profiling has emerged as a useful tool to understand pathophysiological alterations in the body, we performed plasma lipid profiling of 17 patients who suffered from SJS/TEN-associated chronic SOCs. A lipidomics approach yielded 386 lipid molecules and demonstrated that plasma levels of inflammatory oxylipins increased in patients with SJS/TEN-associated chronic SOCs. In addition, oxidized phosphatidylcholines and ether-type diacylglycerols increased in the patients with chronic SOCs, while phosphoglycerolipids decreased. When we compared these lipidomic profiles with those of patients with atopic dermatitis, we found that patients with chronic SOCs, specifically, had decreased levels of ether-type phosphatidylcholines (ePCs) containing arachidonic acid (AA), such as PC(18:0e/20:4) and PC (20:0e120:4). To confirm our finding, we recruited additional patients, who suffered from SOC associated with SJS/TEN (up to 51 patients), and validated the decreased plasma levels of AA-containing ePCs. Our study provides insight into the alterations of plasma lipidomic profiles in chronic SOCs and into the pathophysiology of SJS/TEN-associated chronic SOCs.	[Saito, Kosuke; Maekawa, Keiko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan; [Ueta, Mayumi; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kamigyo Ku, Kyoto, Japan; [Sotozono, Chie] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, Kyoto, Japan	National Institute of Health Sciences - Japan; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Saito, Y (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan.; Ueta, M (corresponding author), Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kamigyo Ku, Kyoto, Japan.	mueta@koto.kpu-m.ac.jp; yoshiro@nihs.go.jp	Saito, Kosuke/AAI-2878-2020		Japan Society for the Promotion of Science [26670758]; Japan Agency for Medical Research and development [16ak0101029j0003]; Grants-in-Aid for Scientific Research [26293122, 16H05488, 16K11327] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, MU SK, 26670758 "Core-to-Core Program, A. Advanced Research Networks", (www.jsps.go.jp) and Japan Agency for Medical Research and development, YS, 16ak0101029j0003, (www.amed.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkers CR, 2005, TRENDS PHARMACOL SCI, V26, P252, DOI 10.1016/j.tips.2005.03.005; BETZ M, 1991, J IMMUNOL, V146, P108; Caproni M, 2006, BRIT J DERMATOL, V155, P722, DOI 10.1111/j.1365-2133.2006.07398.x; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Lappas M, 2015, DIABETOLOGIA, V58, P1436, DOI 10.1007/s00125-015-3587-7; Li S, 2016, EXPERT REV PROTEOMIC, V13, P451, DOI 10.1080/14789450.2016.1177462; Mandal A, 1997, J BIOL CHEM, V272, P20306, DOI 10.1074/jbc.272.32.20306; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Mirzaian M, 2015, J LIPID RES, V56, P936, DOI 10.1194/jlr.M057232; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nagamachi M, 2007, J EXP MED, V204, P2865, DOI 10.1084/jem.20070773; Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Sales S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27710; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Sotozono C, 2015, AM J OPHTHALMOL, V160, P228, DOI 10.1016/j.ajo.2015.05.002; Surma MA, 2015, EUR J LIPID SCI TECH, V117, P1540, DOI 10.1002/ejlt.201500145; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Ueta M, 2015, J ALLERGY CLIN IMMUN, V135, P1538, DOI 10.1016/j.jaci.2014.12.1916; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04862; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Ueta M, 2012, PROG RETIN EYE RES, V31, P551, DOI 10.1016/j.preteyeres.2012.05.003; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Wei Y, 2012, INVEST OPHTH VIS SCI, V53, P2845, DOI 10.1167/iovs.11-8684; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; YETIV JZ, 1980, SOUTH MED J, V73, P599, DOI 10.1097/00007611-198005000-00015; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167402	10.1371/journal.pone.0167402	http://dx.doi.org/10.1371/journal.pone.0167402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898730	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474000060
J	Alvarado, E; Yousefelahiyeh, M; Alvarado, G; Shang, R; Whitman, T; Martinez, A; Yu, Y; Pham, A; Bhandari, A; Wang, BY; Nissen, RM				Alvarado, Estibaliz; Yousefelahiyeh, Mina; Alvarado, Greg; Shang, Robin; Whitman, Taryn; Martinez, Andrew; Yu, Yang; Pham, Annie; Bhandari, Anish; Wang, Bingyan; Nissen, Robert M.			Wdr68 Mediates Dorsal and Ventral Patterning Events for Craniofacial Development	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; BRANCHIAL ARCH; AURICULOCONDYLAR SYNDROME; ALAGILLE-SYNDROME; HUMAN JAGGED1; ZEBRAFISH; PROTEIN; ENDOTHELIN-1; EXPRESSION; GENE	Birth defects are among the leading causes of infant mortality and contribute substantially to illness and long-term disability. Defects in Bone Morphogenetic Protein (BMP) signaling are associated with cleft lip/palate. Many craniofacial syndromes are caused by defects in signaling pathways that pattern the cranial neural crest cells (CNCCs) along the dorsal-ventral axis. For example, auriculocondylar syndrome is caused by impaired Endothelin-1 (Edn1) signaling, and Alagille syndrome is caused by defects in Jagged-Notch signaling. The BMP, Edn1, and Jag1b pathways intersect because BMP signaling is required for ventral edn1 expression that, in turn, restricts jag1b to dorsal CNCC territory. In zebrafish, the scaffolding protein Wdr68 is required for edn1 expression and subsequent formation of the ventral Meckel's cartilage as well as the dorsal Palatoquadrate. Here we report that wdr68 activity is required between the 17-somites and prim-5 stages, that edn1 functions downstream of wdr68, and that wdr68 activity restricts jag1b, hey1, and grem2 expression from ventral CNCC territory. Expression of dlx1a and dlx2a was also severely reduced in anterior dorsal and ventral 1 st arch CNCC territory in wdr68 mutants. We also found that the BMP agonist isoliquiritigenin (ISL) can partially rescue lower jaw formation and edn1 expression in wdr68 mutants. However, we found no significant defects in BMP reporter induction or pSmad1/5 accumulation in wdr68 mutant cells or zebrafish. The Transforming Growth Factor Beta (TGF-beta) signaling pathway is also known to be important for craniofacial development and can interfere with BMP signaling. Here we further report that TGF-beta interference with BMP signaling was greater in wdr68 mutant cells relative to control cells. To determine whether interference might also act in vivo, we treated wdr68 mutant zebrafish embryos with the TGF-beta signaling inhibitor SB431542 and found partial rescue of edn1 expression and craniofacial development. While ISL treatment failed, SB431542 partially rescued dlx2a expression in wdr68 mutants. Together these findings reveal an indirect role for Wdr68 in the BMP-Edn1-Jag1b signaling hierarchy and dorso-anterior expression of dlx1a/2a.	[Alvarado, Estibaliz; Yousefelahiyeh, Mina; Alvarado, Greg; Shang, Robin; Whitman, Taryn; Martinez, Andrew; Yu, Yang; Pham, Annie; Bhandari, Anish; Wang, Bingyan; Nissen, Robert M.] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Nissen, RM (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	rnissen@calstatela.edu	Wang, Bingyan/AAB-3883-2019	Wang, Bingyan/0000-0002-3522-2848; Nissen, Robert/0000-0002-0591-1167	United States National Institute of Dental and Craniofacial Research [R15DE022902-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R15DE022902] Funding Source: NIH RePORTER	United States National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the United States National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/) grant R15DE022902-01A1 to Robert M Nissen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Angelo S, 2000, MECH DEVELOP, V95, P231, DOI 10.1016/S0925-4773(00)00334-8; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Askary A, 2015, DEV CELL, V35, P358, DOI 10.1016/j.devcel.2015.10.004; BINGHAM PM, 1986, EMBO J, V5, P3343, DOI 10.1002/j.1460-2075.1986.tb04649.x; Brown KA, 2008, J CELL BIOCHEM, V105, P596, DOI 10.1002/jcb.21860; Casari A, 2014, DEV BIOL, V396, P81, DOI 10.1016/j.ydbio.2014.09.025; Chablais F, 2012, DEVELOPMENT, V139, P1921, DOI 10.1242/dev.078543; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crump JG, 2004, DEVELOPMENT, V131, P5703, DOI 10.1242/dev.01444; David NB, 2002, DEVELOPMENT, V129, P4457; Degoutin JL, 2013, NAT CELL BIOL, DOI [10.1242/dev.049700, DOI 10.1242/DEV.049700]; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Di Vona C, 2015, MOL CELL, V57, P506, DOI 10.1016/j.molcel.2014.12.026; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Gordon CT, 2013, AM J HUM GENET, V93, P1118, DOI 10.1016/j.ajhg.2013.10.023; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Ho DM, 2006, DEV BIOL, V295, P730, DOI 10.1016/j.ydbio.2006.03.050; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Miller CT, 2000, DEVELOPMENT, V127, P3815; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; Monteiro R, 2008, DEV BIOL, V315, P55, DOI 10.1016/j.ydbio.2007.11.038; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; Nissen RM, 2003, DEVELOPMENT, V130, P2543, DOI 10.1242/dev.00455; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ozeki H, 2004, MECH DEVELOP, V121, P387, DOI 10.1016/j.mod.2004.02.002; Rashidian J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005735; Rieder MJ, 2012, AM J HUM GENET, V90, P907, DOI 10.1016/j.ajhg.2012.04.002; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; Tavares VLR, 2015, EUR J HUM GENET, V23, P481, DOI 10.1038/ejhg.2014.132; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Upton PD, 2013, AM J RESP CELL MOL, V49, P1135, DOI 10.1165/rcmb.2012-0470OC; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Wang B, 2013, SCI WORLD J, DOI 10.1155/2013/405645; WHO, 2002, STRATEGIES HEALTHCAR; Zecchin E, 2005, DEV DYNAM, V233, P638, DOI 10.1002/dvdy.20366; Zuniga E, 2011, DEVELOPMENT, V138, P5147, DOI 10.1242/dev.067785; Zuniga E, 2010, DEVELOPMENT, V137, P1843, DOI 10.1242/dev.049056	67	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166984	10.1371/journal.pone.0166984	http://dx.doi.org/10.1371/journal.pone.0166984			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880803	Green Submitted, Green Published, gold			2022-12-26	WOS:000388889500050
J	Su, YH				Su, Yi-Huang			Visual Enhancement of Illusory Phenomenal Accents in Non-Isochronous Auditory Rhythms	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; INVERSE EFFECTIVENESS; BEAT PERCEPTION; OSCILLATIONS; BRAIN; SYNCHRONIZATION; METRICALITY; HIERARCHY; DYNAMICS; FUTURE	Musical rhythms encompass temporal patterns that often yield regular metrical accents (e. g., a beat). There have been mixed results regarding perception as a function of metrical saliency, namely, whether sensitivity to a deviant was greater in metrically stronger or weaker positions. Besides, effects of metrical position have not been examined in non-iso-chronous rhythms, or with respect to multisensory influences. This study was concerned with two main issues: (1) In non-isochronous auditory rhythms with clear metrical accents, how would sensitivity to a deviant be modulated by metrical positions? (2) Would the effects be enhanced by multisensory information? Participants listened to strongly metrical rhythms with or without watching a point-light figure dance to the rhythm in the same meter, and detected a slight loudness increment. Both conditions were presented with or without an auditory interference that served to impair auditory metrical perception. Sensitivity to a deviant was found greater in weak beat than in strong beat positions, consistent with the Predictive Coding hypothesis and the idea of metrically induced illusory phenomenal accents. The visual rhythm of dance hindered auditory detection, but more so when the latter was itself less impaired. This pattern suggested that the visual and auditory rhythms were perceptually integrated to reinforce metrical accentuation, yielding more illusory phenomenal accents and thus lower sensitivity to deviants, in a manner consistent with the principle of inverse effectiveness. Results were discussed in the predictive framework for multisensory rhythms involving observed movements and possible mediation of the motor system.	[Su, Yi-Huang] Tech Univ Munich, Fac Sport & Hlth Sci, Dept Movement Sci, Munich, Germany	Technical University of Munich	Su, YH (corresponding author), Tech Univ Munich, Fac Sport & Hlth Sci, Dept Movement Sci, Munich, Germany.	yihuang.su@tum.de		Su, Yi-Huang/0000-0003-2660-9183	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SU 782/12]; German Research Foundation (DFG) [SU782/1-2]; Technical University of Munich (TUM)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work and the author were supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), grant number SU 782/12, to YHS. The publication of this work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work and the author were supported by a grant from the German Research Foundation (DFG), SU782/1-2. The publication of this work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The author thanks Theresa Neumayer for data collection.	Abecasis D, 2009, ANN NY ACAD SCI, V1169, P74, DOI 10.1111/j.1749-6632.2009.04766.x; Altieri N., 2014, FRONT PSYCHOL, V5, P1, DOI DOI 10.3389/FPSYG.2014.00257; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; Bouwer FL, 2015, FRONT PSYCHOL, V6, P74, DOI [10.1016/j.ijpsycho.2011.10.001, DOI 10.1016/J.IJPSYCHO.2011.10.001]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brochard R, 2003, PSYCHOL SCI, V14, P362, DOI 10.1111/1467-9280.24441; Brochard R, 2013, COGNITION, V127, P214, DOI 10.1016/j.cognition.2013.01.007; Burger B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00903; Case LK, 2015, NEUROPSYCHOLOGIA, V79, P233, DOI 10.1016/j.neuropsychologia.2015.04.005; Cevallos C, 2015, NEUROPSYCHOLOGIA, V79, P223, DOI 10.1016/j.neuropsychologia.2015.06.039; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Escoffier N, 2010, ACTA PSYCHOL, V135, P12, DOI 10.1016/j.actpsy.2010.04.005; Fitch WT, 2016, FRONT HUM NEUROSCI, V10, P119, DOI [10.1525/mp.2004.21.3.313, DOI 10.1525/MP.2004.21.3.313]; Fujioka T, 2015, J NEUROSCI, V35, P15187, DOI 10.1523/JNEUROSCI.2397-15.2015; Fujioka T, 2010, J NEUROSCI, V30, P3458, DOI 10.1523/JNEUROSCI.3086-09.2010; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Grube M, 2009, CORTEX, V45, P72, DOI 10.1016/j.cortex.2008.01.006; Holmes NP, 2007, NEUROPSYCHOLOGIA, V45, P3340, DOI 10.1016/j.neuropsychologia.2007.05.025; Holmes NP, 2009, BRAIN TOPOGR, V21, P168, DOI 10.1007/s10548-009-0097-2; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kirsch LP, 2015, CEREB CORTEX, V25, P4799, DOI 10.1093/cercor/bhv167; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lee KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134725; Lerdahl F, 1983, A GENERATIVE THEORY; London J., 2012, HEARING IN TIME PSYC; Martin XP, 2007, CLIN NEUROPHYSIOL, V118, P2709, DOI 10.1016/j.clinph.2007.08.019; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Morillon B, 2015, CURR OPIN NEUROBIOL, V31, P230, DOI 10.1016/j.conb.2014.12.005; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Repp BH, 2008, MUSIC PERCEPT, V26, P1, DOI 10.1525/MP.2008.26.1.1; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2010, ATTEN PERCEPT PSYCHO, V72, P1390, DOI 10.3758/APP.72.5.1390; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Su Y-H., 2016, FRONT HUM NEUROSCI, V10, P1, DOI [10.1525/mp.2011.29.1.65, DOI 10.1525/MP.2011.29.1.65]; Su YH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1678390; Su YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22774; Su YH, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00092; Su YH, 2014, BRAIN COGNITION, V90, P19, DOI 10.1016/j.bandc.2014.05.003; Su YH, 2014, ACTA PSYCHOL, V151, P40, DOI 10.1016/j.actpsy.2014.05.016; Talsma D., 2015, FRONT INTEGR NEUROSC, V09, P257, DOI [10.1016/j.nlm.2014.02.002, DOI 10.1016/J.NLM.2014.02.002]; van Wassenhove V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00388; Vuust P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01111	54	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166880	10.1371/journal.pone.0166880	http://dx.doi.org/10.1371/journal.pone.0166880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5KB	27880850	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500041
J	Batsching, S; Wolf, R; Heisenberg, M				Batsching, Sophie; Wolf, Reinhard; Heisenberg, Martin			Inescapable Stress Changes Walking Behavior in Flies - Learned Helplessness Revisited	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DEPRESSION; PARADIGM; ANXIETY; SHOCK	Like other animals flies develop a state of learned helplessness in response to unescapable aversive events. To show this, two flies, one 'master', one 'yoked', are each confined to a dark, small chamber and exposed to the same sequence of mild electric shocks. Both receive these shocks when the master fly stops walking for more than a second. Behavior in the two animals is differently affected by the shocks. Yoked flies are transiently impaired in place learning and take longer than master flies to exit from the chamber towards light. After the treatment they walk more slowly and take fewer and shorter walking bouts. The low activity is attributed to the fly's experience that its escape response, an innate behavior to terminate the electric shocks, does not help anymore. Earlier studies using heat pulses instead of electric shocks had shown similar effects. This parallel supports the interpretation that it is the uncontrollability that induces the state.	[Batsching, Sophie; Wolf, Reinhard; Heisenberg, Martin] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany	University of Wurzburg	Heisenberg, M (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany.	heisenberg@biozentrum.uni-wuerzburg.de			German Science Foundation [He 986/20-1]	German Science Foundation(German Research Foundation (DFG))	Funded by German Science Foundation He 986/20-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolucci F, 2008, OPERANT CLASSICAL LE, P1; Brown GE, 1996, PSYCHOL REP, V78, P962, DOI 10.2466/pr0.1996.78.3.962; Byrne JH, 2003, LEARNING MEMORY; DAQUILA PS, 1994, PHYSIOL BEHAV, V56, P861, DOI 10.1016/0031-9384(94)90316-6; Eisenstein EM, 1997, BEHAV BRAIN RES, V86, P149, DOI 10.1016/S0166-4328(96)02260-7; Galili DS, 2014, CURR BIOL, V24, P1712, DOI 10.1016/j.cub.2014.06.062; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Heisenberg M, 2015, LEARN MEMORY, V22, DOI 10.1101/lm.037481.114; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; Kapustjansky A., 2011, IN VIVO IMAGING OPTO, P1; Kercmar J, 2011, BEHAV BRAIN RES, V216, P647, DOI 10.1016/j.bbr.2010.09.007; Maier S.F. S MEP, 1969, APPLETON CENTURY CRO; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; Maier SF, 2016, PSYCHOL REV, V123, P349, DOI 10.1037/rev0000033; Michael A, 2000, HUM PSYCHOPHARM CLIN, V15, P337, DOI 10.1002/1099-1077(200007)15:5<337::AID-HUP207>3.0.CO;2-H; Mohammad F, 2016, CURR BIOL, V26, P981, DOI 10.1016/j.cub.2016.02.031; Panova A. A., 2013, Open Journal of Animal Sciences, V3, P31; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Ries A-S., 2015, NEURONALE GRUNDLAGEN; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Ueda A, 2002, PHYSIOLOGICAL ENTOMO, V27, P21; WILLNER P, 1986, PROG NEURO-PSYCHOPH, V10, P677, DOI 10.1016/0278-5846(86)90051-5; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Yang ZH, 2013, CURR BIOL, V23, P799, DOI 10.1016/j.cub.2013.03.054	25	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167066	10.1371/journal.pone.0167066	http://dx.doi.org/10.1371/journal.pone.0167066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5IV	27875580	Green Submitted, gold, Green Published			2022-12-26	WOS:000388886000046
J	Lee, KY; Chen, YH; Hsu, SC; Yu, MJ				Lee, Kuan-Ying; Chen, Yi-Hung; Hsu, Shih-Chin; Yu, Ming-Jiun			Phosphorylation of Serine 235 of the Hepatitis C Virus Non-Structural Protein NS5A by Multiple Kinases	PLOS ONE			English	Article							RNA REPLICATION; I-ALPHA; INHIBITORS; INFECTION; AFFINITY	Phosphorylation at serine 235 (S235) of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) plays a critical role in the viral life cycle. For medical and virological interests, we exploited the HEK293T kidney cells to test 3 candidate protein kinases on NS5A S235 phosphorylation. Inhibitors that inhibit casein kinase I alpha (CKI alpha), polo-like kinase I (PIKI) or calmodulin-dependent kinase II (CaMKII) all reduced NS5A S235 phosphorylation. CKIa was studied previously and PIKI had severe cytotoxicity, thus CaMKII was selected for validation in the Huh7.5.1 liver cells. In the HCV (J6/JFH1)-infected Huh7.5.1 cells, CaMKII inhibitor reduced NS5A S235 phosphorylation and HCV RNA levels without apparent cytotoxicity. RT-PCR analysis showed expression of CaMKII gamma and delta isoforms in the Huh7.5.1 cells. Both CaMKII gamma and delta directly phosphorylated NS5A S235 in vitro. CaMKII gamma or delta single knockdown did not affect NS5A S235 phosphorylation but elevated the HCV RNA levels in the infected cells. CKI alpha plus CaMKII (gamma or delta) double knockdown reduced NS5A S235 phosphorylation and reduced HCV RNA levels; however, the HCV RNA levels were higher than those in the infected cells with CKI alpha single knockdown. We conclude that CKI alpha-mediated NS5A S235 phosphorylation is critical for HCV replication. CaMKII gamma and delta may have negative roles in the HCV life cycle.	[Lee, Kuan-Ying; Chen, Yi-Hung; Hsu, Shih-Chin; Yu, Ming-Jiun] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan	National Taiwan University	Yu, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan.	mjyu@ntu.edu.tw	Chen, Yi-Chen/GVU-0551-2022	YU, MING-JIUN/0000-0003-0393-4696	National Health Research Institutes, Taiwan [NHRI-EX104-10213BI]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Health Research Institutes, Taiwan (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do; NHRI-EX104-10213BI to MJY).	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chen YC, 2010, J VIROL, V84, P7983, DOI 10.1128/JVI.00068-10; Chong WM, 2016, J BIOL CHEM, V291, P3918, DOI 10.1074/jbc.M115.675413; Fridell RA, 2013, J VIROL, V87, P2320, DOI 10.1128/JVI.02861-12; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Kalliampakou KI, 2005, J GEN VIROL, V86, P1015, DOI 10.1099/vir.0.80728-0; Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Pawlotsky JM, 2013, J HEPATOL, V59, P375, DOI 10.1016/j.jhep.2013.03.030; Qiu DK, 2011, J GEN VIROL, V92, P2502, DOI 10.1099/vir.0.034801-0; Quintavalle M, 2007, J BIOL CHEM, V282, P5536, DOI 10.1074/jbc.M610486200; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	28	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166763	10.1371/journal.pone.0166763	http://dx.doi.org/10.1371/journal.pone.0166763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875595	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000024
J	Paiva, JPLM; Paiva, HM; Esposito, E; Morais, MM				Lisboa Mohallem Paiva, Juliana Pereira; Paiva, Henrique Mohallem; Esposito, Elisa; Morais, Michelle Manfrini			On the Effects of Artificial Feeding on Bee Colony Dynamics: A Mathematical Model	PLOS ONE			English	Article							POLLEN SUBSTITUTE DIETS; POPULATION-DYNAMICS; HONEY-BEES; CONSUMPTION; SURVIVAL; FAILURE	This paper proposes a new mathematical model to evaluate the effects of artificial feeding on bee colony population dynamics. The proposed model is based on a classical framework and contains differential equations that describe the changes in the number of hive bees, forager bees, and brood cells, as a function of amounts of natural and artificial food. The model includes the following elements to characterize the artificial feeding scenario: a function to model the preference of the bees for natural food over artificial food; parameters to quantify the quality and palatability of artificial diets; a function to account for the efficiency of the foragers in gathering food under different environmental conditions; and a function to represent different approaches used by the beekeeper to feed the hive with artificial food. Simulated results are presented to illustrate the main characteristics of the model and its behavior under different scenarios. The model results are validated with experimental data from the literature involving four different artificial diets. A good match between simulated and experimental results was achieved.	[Lisboa Mohallem Paiva, Juliana Pereira; Esposito, Elisa] Univ Fed Sao Paulo, UNIFESP, Rua Talim 330, BR-12231280 Sao Jose Dos Campos, Brazil; [Paiva, Henrique Mohallem] Aeronaut Inst Technol, ITA, Praca Marechal Eduardo Gomes 50, BR-12228900 Sao Jose Dos Campos, Brazil; [Morais, Michelle Manfrini] Univ Fed Sao Paulo, UNIFESP, Rua Conceicao 329, BR-09920000 Diadema, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA); Universidade Federal de Sao Paulo (UNIFESP)	Paiva, HM (corresponding author), Aeronaut Inst Technol, ITA, Praca Marechal Eduardo Gomes 50, BR-12228900 Sao Jose Dos Campos, Brazil.	hmpaiva@pq.cnpq.br	Paiva, Henrique Mohallem/J-2491-2016; Morais, Michelle Manfrini/R-8711-2016	Paiva, Henrique Mohallem/0000-0001-7081-8383; Morais, Michelle Manfrini/0000-0001-6184-3202	CAPES Foundation; Ministry of Education, Brazil; Federal University of Sao Paulo (UNIFESP, Brazil)	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education, Brazil; Federal University of Sao Paulo (UNIFESP, Brazil)	Juliana P L M Paiva received a PhD grant from CAPES Foundation, Ministry of Education, Brazil (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the CAPES Foundation (PhD grant) and the Federal University of Sao Paulo (UNIFESP, Brazil).	Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Betti MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110237; DeGrandi-Hoffman G, 2004, INT J ACAROL, V30, P259, DOI 10.1080/01647950408684393; DeGrandi-Hoffman G, 2016, APIDOLOGIE, V47, P186, DOI 10.1007/s13592-015-0386-6; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; Dennis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150055; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; Eberl HJ, 2010, ELECTRON J DIFFER EQ, P85; Free J. B, 1971, J Apic Res, V10, P87; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Herbert E.W., 1992, HIVE HONEY BEE, P197; HERBERT EW, 1983, APIDOLOGIE, V14, P119, DOI 10.1051/apido:19830206; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Morais MM, 2013, GENET MOL RES, V12, P6915, DOI 10.4238/2013.December.19.10; Morais MM, 2013, J APICULT RES, V52, P119, DOI 10.3896/IBRA.1.52.3.01; OECD, 2014, OECD SER TEST ASS GU; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Saffari A, 2010, J APIC SCI, V54, P63; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Sihag Ram C., 2013, Journal of Entomology, V10, P120, DOI 10.3923/je.2013.120.135; Standifer L, 1980, AGR HDB, V335, P39; Standifer LN, 1978, AGR INFORM B USDA, V413, P1; STANGER W, 1974, American Bee Journal, V114, P138; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Winston M. L. L., 1991, BIOL HONEY BEE	28	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167054	10.1371/journal.pone.0167054	http://dx.doi.org/10.1371/journal.pone.0167054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875589	Green Published, gold, Green Submitted			2022-12-26	WOS:000388886000044
J	Tokuhara, D; Cho, Y; Shintaku, H				Tokuhara, Daisuke; Cho, Yuki; Shintaku, Haruo			Transient Elastography-Based Liver Stiffness Age-Dependently Increases in Children	PLOS ONE			English	Article							ATTENUATION PARAMETER CAP; NONINVASIVE METHOD; EFSUMB GUIDELINES; HEALTHY-CHILDREN; CLINICAL-USE; FIBROSIS; DIAGNOSIS; RECOMMENDATIONS; FEASIBILITY; STEATOSIS	Background and Aims Pediatric use of liver transient elastography (TE) is attractive for its non-invasiveness, but reference values have not been established. We aimed to determine reference values for TE in children. Methods In pediatric patients (1 to 18 years), TE (FibroScan (R)) with an M probe was used for both liver stiffness measurement (LSM) and measurement of hepatic fat deposition by using a controlled attenuation parameter (CAP). The patients were divided into three relevant age groups: preschoolers (1 to 5 years), elementary school children (6 to 11 years), and adolescents (12 to 18 years). Overweight or obese patients or those with known liver disease, elevated serum liver enzymes, or hepatic echogenic abnormality were excluded from the study. Results Among 139 children, 123 (88.5%; 62 male; median age, 11.7 years; age range, 1.3 to 17.2 years) were successfully subjected to M-probe TE without anesthesia. Median LSM increased with age: it was 3.4 kPa (2.3 to 4.6 kPa, 5th to 95th percentiles) at ages 1 to 5 years; 3.8 (2.5 to 6.1) kPa at ages 6 to 11; and 4.1 (3.3 to 7.9) kPa at ages 12 to 18 (P = 0.001). Median CAP was not age dependent: it was 183 (112 to 242) for ages 1 to 18 years. Conclusions M-probe TE is suitable in a wide age range of children from age 1 year up. In children without evidence of liver disease, LSM has an age-dependent increase, whereas CAP does not differ between ages 1 and 18.	[Tokuhara, Daisuke; Cho, Yuki; Shintaku, Haruo] Osaka City Univ, Dept Pediat, Grad Sch Med, Osaka, Japan	Osaka Metropolitan University	Tokuhara, D (corresponding author), Osaka City Univ, Dept Pediat, Grad Sch Med, Osaka, Japan.	m1155519@med.osaka-cu.ac.jp	Tokuhara, Daisuke/AAY-2554-2021; Shintaku, Haruo/AAP-1196-2020	Tokuhara, Daisuke/0000-0002-2441-5062				Alkhouri N, 2013, LIVER INT, V33, P79, DOI 10.1111/liv.12024; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; BURRITT MF, 1990, MAYO CLIN PROC, V65, P329, DOI 10.1016/S0025-6196(12)62533-6; Cho Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137239; Colli A, 2014, HEPATOLOGY, V60, P408, DOI 10.1002/hep.26948; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; de Ledinghen V, 2007, J PEDIATR GASTR NUTR, V45, P443, DOI 10.1097/MPG.0b013e31812e56ff; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Engelmann G, 2012, EUR J PEDIATR, V171, P353, DOI 10.1007/s00431-011-1558-7; Goldschmidt I, 2013, J PEDIATR GASTR NUTR, V57, P109, DOI 10.1097/MPG.0b013e31829206a0; Kawamoto M, 2006, WORLD J GASTROENTERO, V12, P4325, DOI 10.3748/wjg.v12.i27.4325; Kim S, 2014, J PEDIATR GASTR NUTR, V59, P624, DOI 10.1097/MPG.0000000000000489; Kwok R, 2015, GUT; Pang JX, 2014, FEASIBILITY RELIABIL, V28, P143; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Takeda T, 2006, WORLD J GASTROENTERO, V12, P7768, DOI 10.3748/wjg.v12.i48.7768; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312	19	41	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166683	10.1371/journal.pone.0166683	http://dx.doi.org/10.1371/journal.pone.0166683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861607	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300089
J	Miller, A; McLeod, L; Alhayyani, S; Szczepny, A; Watkins, DN; Chen, W; Enriori, P; Ferlin, W; Ruwanpura, S; Jenkins, BJ				Miller, A.; McLeod, L.; Alhayyani, S.; Szczepny, A.; Watkins, D. N.; Chen, W.; Enriori, P.; Ferlin, W.; Ruwanpura, S.; Jenkins, B. J.			Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma	ONCOGENE			English	Article							WEIGHT-LOSS; RECEPTOR ANTIBODY; CANCER; INTERLEUKIN-6; PROGRESSION; SURVIVAL; STAT3	Lung cancer is the leading cause of cancer death worldwide, and is frequently associated with the devastating paraneoplastic syndrome of cachexia. The potent immunomodulatory cytokine interleukin (IL)-6 has been linked with the development of lung cancer as well as cachexia; however, the mechanisms by which IL-6 promotes muscle wasting in lung cancer cachexia are ill-defined. In this study, we report that the gp130(F/F) knock-in mouse model displaying hyperactivation of the latent transcription factor STAT3 via the common IL-6 cytokine family signalling receptor, gp130, develops cachexia during Kras-driven lung carcinogenesis. Specifically, exacerbated weight loss, early mortality and reduced muscle and adipose tissue mass were features of the gp130(F/F): Kras(G12D) model, but not parental Kras(G12D) mice in which STAT3 was not hyperactivated. Gene expression profiling of muscle tissue in cachectic gp130(F/F): Kras(G12D) mice revealed the upregulation of IL-6 and STAT3-target genes compared with Kras(G12D) muscle tissue. These cachectic features of gp130(F/F): Kras(G12D) mice were abrogated upon the genetic normalization of STAT3 activation or ablation of IL-6 in gp130(F/F): Kras(G12D): Stat3(-/+) or gp130(F/F): Kras(G12D): Il6(-/-)mice, respectively. Furthermore, protein levels of the soluble IL-6 receptor (sIL-6R), which is the central facilitator of IL-6 trans-signalling, were elevated in cachectic muscle from gp130(F/F): Kras(G12D) mice, and the specific blockade of IL-6 trans-signalling, but not classical signalling, with an anti-IL-6R antibody ameliorated cachexia-related characteristics in gp130(F/F): Kras(G12D) mice. Collectively, these preclinical findings identify transsignalling via STAT3 as the signalling modality by which IL-6 promotes muscle wasting in lung cancer cachexia, and therefore support the clinical evaluation of the IL-6 trans-signalling/STAT3 axis as a therapeutic target in advanced lung cancer patients presenting with cachexia.	[Miller, A.; McLeod, L.; Alhayyani, S.; Szczepny, A.; Watkins, D. N.; Ruwanpura, S.; Jenkins, B. J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Miller, A.] Monash Hlth, Monash Med Ctr, Gen & Resp Med, Clayton, Vic, Australia; [McLeod, L.; Alhayyani, S.; Szczepny, A.; Ruwanpura, S.; Jenkins, B. J.] Monash Univ, Dept Mol Translat Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Alhayyani, S.] King Abdulaziz Univ, Dept Biol Sci, Rabigh Coll Sci & Art, Jeddah, Saudi Arabia; [Watkins, D. N.] Kinghorn Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Chen, W.; Enriori, P.] Monash Univ, Dept Physiol, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Ferlin, W.] NovImmune SA, Geneva, Switzerland	Hudson Institute of Medical Research; Monash University; Monash University; King Abdulaziz University; Garvan Institute of Medical Research; Monash University; NovImmune SA	Jenkins, BJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	brendan.jenkins@hudson.org.au	Alhayyani/AAR-7025-2020; Miller, Alistair/AAE-8766-2022	Miller, Alistair/0000-0002-0439-9747; Ruwanpura, saleela/0000-0002-4074-2012; Jenkins, Brendan/0000-0002-7552-4656	National Health and Medical Research Council (NHMRC) of Australia; Lung Cancer Research Foundation; NHMRC; Victorian Government of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lung Cancer Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government of Australia	This work was supported by grants awarded by the National Health and Medical Research Council (NHMRC) of Australia and the Lung Cancer Research Foundation, as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. SMR is supported by a NHMRC Post-doctoral Training Fellowship. BJJ is supported by a NHMRC Senior Medical Research Fellowship.	Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Ando K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102436; Ando K, 2013, J CLIN ONCOL, V31, pE69, DOI 10.1200/JCO.2012.44.2020; Angevin E, 2014, CLIN CANCER RES, V20, P2192, DOI 10.1158/1078-0432.CCR-13-2200; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bayliss TJ, 2011, EXPERT OPIN BIOL TH, V11, P1663, DOI 10.1517/14712598.2011.627850; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Brooks GD, 2016, CANCER RES, V76, P866, DOI 10.1158/0008-5472.CAN-15-2388; Del Ferraro C, 2012, J HOSP PALLIAT NURS, V14, P397, DOI 10.1097/NJH.0b013e31825f3470; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Gilabert M, 2014, J CELL PHYSIOL, V229, P1437, DOI 10.1002/jcp.24580; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kennedy CL, 2014, ONCOGENE, V33, P2540, DOI 10.1038/onc.2013.205; Lacroix M, 2015, J BIOL CHEM, V290, P26943, DOI 10.1074/jbc.M115.682138; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lissilaa R, 2010, J IMMUNOL, V185, P5512, DOI 10.4049/jimmunol.1002015; OHE Y, 1993, BRIT J CANCER, V67, P939, DOI 10.1038/bjc.1993.174; Puppa MJ, 2014, FASEB J, V28, P998, DOI 10.1096/fj.13-240580; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Ruwanpura SM, 2012, AM J PHYSIOL-LUNG C, V302, P1627, DOI 10.1152/ajplung.00285.2011; Ruwanpura SM, 2011, AM J RESP CELL MOL, V45, P720, DOI 10.1165/rcmb.2010-0462OC; Scott HR, 1996, BRIT J CANCER, V73, P1560, DOI 10.1038/bjc.1996.294; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Songur N, 2004, TUMORI J, V90, P196, DOI 10.1177/030089160409000207; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Tan BHL, 2011, J GENET, V90, P165, DOI 10.1007/s12041-011-0027-4; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	36	54	55	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					3059	3066		10.1038/onc.2016.437	http://dx.doi.org/10.1038/onc.2016.437			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27893707				2022-12-26	WOS:000402000400013
J	Lu, W; Liu, S; Li, B; Xie, Y; Izban, MG; Ballard, BR; Sathyanarayana, SA; Adunyah, SE; Matusik, RJ; Chen, Z				Lu, W.; Liu, S.; Li, B.; Xie, Y.; Izban, M. G.; Ballard, B. R.; Sathyanarayana, S. A.; Adunyah, S. E.; Matusik, R. J.; Chen, Z.			SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer	ONCOGENE			English	Article							ANDROGEN RECEPTOR; MEDIATED DEGRADATION; CELLULAR SENESCENCE; PROTEIN STABILITY; GENE-EXPRESSION; DOWN-REGULATION; LIGASE; POLYCOMB; COMPLEX; KINASE	EZH2 is crucial for the progression of prostate cancer (PCa) and castration-resistant prostate cancer (CRPC) through upregulation and activation of progenitor genes, as well as androgen receptor (AR)-target genes. However, the mechanisms by which EZH2 is regulated in PCa and CRPC remain elusive. Here we report that EZH2 is post-transcriptionally regulated by SKP2 in vitro in cultured cells and in vivo in mouse models. We observed aberrant upregulation of Skp2, Ezh2 and histone H3 lysine 27 trimethylation (H3K27me3) in both Pten null mouse embryonic fibroblasts (MEFs) and Pten null mouse prostate tissues. Loss of Skp2 resulted in a striking decrease of Ezh2 levels in Pten/Trp53 double-null MEFs and in prostate tumors of Pten/Trp53 double-null mutant mice. SKP2 knockdown decreased EZH2 levels in human PCa cells through upregulation of TRAF6-mediated and lysine(K) 63-linked ubiquitination of EZH2 for degradation. Ectopic expression of TRAF6 promoted the K63-linked ubiquitination of EZH2 to decrease EZH2 and H3K27me3 levels in PCa cells. In contrast, TRAF6 knockdown resulted in a reduced EZH2 ubiquitination with an increase of EZH2 and H3K27me3 levels in PCa cells. Furthermore, the catalytically dead mutant TRAF6 C70A abolished the TRAF6-mediated polyubiquitination of recombinant human EZH2 in vitro. Most importantly, a concurrent elevation of Skp2 and Ezh2 was found in CRPC tumors of Pten/Trp53 mutant mice, and expression levels of SKP2 and EZH2 were positively correlated in human PCa specimens. Taken together, our findings revealed a novel mechanism on EZH2 ubiquitination and an important signaling network of SKP2-TRAF6-EZH2/H3K27me3, and targeting SKP2-EZH2 pathway may be a promising therapeutic strategy for CRPC treatment.	[Lu, W.; Liu, S.; Li, B.; Adunyah, S. E.; Chen, Z.] Meharry Med Coll, Dept Biochem & Canc Biol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA; [Xie, Y.] Nazarbayev Univ, Sch Sci & Technol, Dept Biol, Astana, Kazakhstan; [Izban, M. G.; Ballard, B. R.] Meharry Med Coll, Dept Pathol Anat & Cell Biol, Nashville, TN 37208 USA; [Sathyanarayana, S. A.] Meharry Med Coll, Dept Surg, Nashville, TN 37208 USA; [Matusik, R. J.] Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA	Meharry Medical College; Nazarbayev University; Meharry Medical College; Meharry Medical College; Vanderbilt University	Chen, Z (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.	zchen@mmc.edu		Matusik, Robert/0000-0003-2057-9892	NIH [MD004038, DK055748, CA163069, MD007593, MD007586, DA036420, S10RR0254970, UL1TR000445-06]; National Institute on Minority Health and Health Disparities [U54MD007593, G12MD007586, R01MD004038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We would like to thank Dr Jae-Il Park for Flag-EZH2 plasmid, Dr Paul Bates and Dr Zhaocai (Joe) Zhou for Myc-TRAF6 and Myc-TRAF6-C70A plasmids, Dr Edward W. Harhaj for ubiquitin and ubiquitin mutant plasmids, and Dr Hui-Kuan Lin for GST, GST-TRAF6 and GST-TRAF6-C70A plasmids. HA-tagged EZH2 is a gift from Kristian Helin (Addgene plasmid # 24230).<SUP>54</SUP> This work was supported in part by NIH grants MD004038, DK055748, CA163069, MD007593 and UL1TR000445-06. Human tissue staining, microscopy experiments and data analysis were performed through the Human Tissue & Pathology Core and Morphology Core of Meharry Medical College, supported in part by NIH grants MD007593, MD007586, DA036420 and S10RR0254970.	Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Ellinger J, 2012, CANCER INVEST, V30, P92, DOI 10.3109/07357907.2011.636117; Ferreira JV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10210; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Huang FT, 2013, P NATL ACAD SCI USA, V110, P15722, DOI 10.1073/pnas.1308014110; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Li B, 2014, PROSTATE, V74, P421, DOI 10.1002/pros.22763; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lin TY, 2012, ONCOGENE, V31, P3287, DOI 10.1038/onc.2011.491; Lu WF, 2015, ONCOTARGET, V6, P771, DOI 10.18632/oncotarget.2718; Lu WF, 2013, MOL ENDOCRINOL, V27, P635, DOI 10.1210/me.2012-1294; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ngollo M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-994; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen Z, 2013, BBA-MOL CELL RES, V1833, P2190, DOI 10.1016/j.bbamcr.2013.05.014; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Valdes-Mora F, 2015, ONCOGENE, V34, P1609, DOI 10.1038/onc.2014.111; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang ZW, 2012, BBA-REV CANCER, V1825, P11, DOI 10.1016/j.bbcan.2011.09.002; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yang G, 2002, CLIN CANCER RES, V8, P3419; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	54	34	37	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1364	1373		10.1038/onc.2016.300	http://dx.doi.org/10.1038/onc.2016.300			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27869166	Green Accepted			2022-12-26	WOS:000395862500005
J	Hata, S; Kitamura, F; Yamaguchi, M; Shitara, H; Murakami, M; Sorimachi, H				Hata, Shoji; Kitamura, Fujiko; Yamaguchi, Midori; Shitara, Hiroshi; Murakami, Makoto; Sorimachi, Hiroyuki			A Gastrointestinal Calpain Complex, G-calpain, Is a Heterodimer of CAPN8 and CAPN9 Calpain Isoforms, Which Play Catalytic and Regulatory Roles, Respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; EFFICIENT GENE ACTIVATION; STOMACH-SPECIFIC CALPAIN; 5TH EF-HAND; CRYSTAL-STRUCTURE; EMBRYONIC-DEVELOPMENT; DIGESTIVE-TRACT; CRE RECOMBINASE; MU-CALPAIN; SUBUNIT	Calpains (CAPN) are a family of Ca2+-dependent cysteine proteases that regulate various cellular functions by cleaving diverse substrates. Of the 15 mammalian calpains, CAPN8 and CAPN9 are two that are expressed predominantly in the gastrointestinal tract, where they interact to form a protease complex, termed G-calpain. However, because native G-calpain exhibits a highly restricted expression pattern, it has never been purified, and the interactions between CAPN8 and CAPN9 have not been characterized. Here, we clarified the molecular nature of G-calpain by using recombinant proteins and transgenic mice expressing FLAG-tagged CAPN8 (CAPN8-FLAG). Recombinant mouse CAPN8 and CAPN9 co-expressed in eukaryotic expression systems exhibited the same mobility as native mouse G-calpain in Blue Native-PAGE gels, and CAPN8-FLAG immunoprecipitation from stomach homogenates of the transgenic mice showed that CAPN9 was the only protein that associated with CAPN8-FLAG. These results indicated that G-calpain is a heterodimer of CAPN8 and CAPN9. In addition, active recombinant G-calpain was expressed and purified using an in vitro translation system, and the purified protease exhibited enzymatic properties that were comparable with that of calpain-2. Wefound that an active-site mutant of CAPN8, but not CAPN9, compromised G-calpain's substrate cleavage activity, and that the N-terminal helix region of CAPN8 and the C-terminal EF-hands of CAPN8 and CAPN9 were involved in CAPN8/9 dimerization. Furthermore, CAPN8 protein in Capn9(-/-) mice was almost completely lost, whereas CAPN9 was only partially lost in Capn8(-/-) mice. Collectively, these results demonstrated that CAPN8 and CAPN9 function as catalytic and chaperone-like subunits, respectively, in G-calpain.	[Hata, Shoji; Kitamura, Fujiko; Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci IGAKUKEN, Dept Adv Sci Biomol, Calpain Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci IGAKUKEN, Dept Adv Sci Biomol, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Yamaguchi, Midori; Shitara, Hiroshi] Tokyo Metropolitan Inst Med Sci IGAKUKEN, Ctr Basic Technol Res, Lab Transgen Technol, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan		Hata, S (corresponding author), Tokyo Metropolitan Inst Med Sci IGAKUKEN, Dept Adv Sci Biomol, Calpain Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	hata-sj@igakuken.or.jp	Sorimachi, Hiroyuki/C-6448-2009	Sorimachi, Hiroyuki/0000-0001-9509-6727	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [JP26450172, JP23780152, JP15H02389, JP23247021]; Kato Memorial Bioscience Foundation; SUNTORY research grant; JSPS; Takeda Science Foundation; Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries; Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (NARO); Naito Foundation; Grants-in-Aid for Scientific Research [15H02389] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants; Kato Memorial Bioscience Foundation; SUNTORY research grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries; Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (NARO); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP26450172 and JP23780152 (to S. H.) and JP15H02389 and JP23247021 (to H. Sorimachi), a Kato Memorial Bioscience Foundation research grant (to S. H.), a SUNTORY research grant (to S. H.), Open Partnership Joint Projects of the JSPS Bilateral Joint Research Projects (to H. Sorimachi), a Takeda Science Foundation research grant (to H. Sorimachi), the Council for Science, Technology and Innovation (CSTI), the Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: the Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (NARO)) (to H. Sorimachi), and a research grant of The Naito Foundation (to H. Sorimachi). The authors declare that they have no conflicts of interest with the contents of this article.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Chou JS, 2011, BBA-PROTEINS PROTEOM, V1814, P864, DOI 10.1016/j.bbapap.2011.04.007; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Davis TL, 2007, J MOL BIOL, V366, P216, DOI 10.1016/j.jmb.2006.11.037; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hata S, 2006, J BIOL CHEM, V281, P11214, DOI 10.1074/jbc.M509244200; Hata S, 2001, FEBS LETT, V501, P111, DOI 10.1016/S0014-5793(01)02611-4; Hata S, 2007, J BIOL CHEM, V282, P27847, DOI 10.1074/jbc.M703168200; Hata S, 2012, J BIOCHEM, V151, P417, DOI 10.1093/jb/mvs002; Hata S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001040; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kitaura Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P12, DOI 10.1006/abbi.2001.2736; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; Lee HJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P22, DOI 10.1006/abbi.1998.1021; Liu KY, 2000, J BIOL CHEM, V275, P31093, DOI 10.1074/jbc.M005451200; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Nakagawa K, 2001, J BIOCHEM-TOKYO, V130, P605, DOI 10.1093/oxfordjournals.jbchem.a003025; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; Ravulapalli R, 2009, FEBS J, V276, P973, DOI 10.1111/j.1742-4658.2008.06833.x; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; Sorimachi H, 2011, J BIOCHEM, V150, P23, DOI 10.1093/jb/mvr070; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tonami K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003668; Tonami K, 2011, J CELL SCI, V124, P1214, DOI 10.1242/jcs.072561; Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2; Yamada M, 2009, NAT MED, V15, P1202, DOI 10.1038/nm.2023; Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459, DOI 10.1111/j.1349-7006.2000.tb00967.x	47	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27313	27322		10.1074/jbc.M116.763912	http://dx.doi.org/10.1074/jbc.M116.763912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27881674	hybrid, Green Published			2022-12-26	WOS:000391576300028
J	Palczewska, G; Maeda, A; Golczak, M; Arai, E; Dong, ZQ; Perusek, L; Kevany, B; Palczewski, K				Palczewska, Grazyna; Maeda, Akiko; Golczak, Marcin; Arai, Eisuke; Dong, Zhiqian; Perusek, Lindsay; Kevany, Brian; Palczewski, Krzysztof			Receptor MER Tyrosine Kinase Proto-oncogene (MERTK) Is Not Required for Transfer of Bis-retinoids to the Retinal Pigmented Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; ROD OUTER SEGMENTS; VISUAL CYCLE; RCS RAT; MOUSE MODEL; FUNDUS AUTOFLUORESCENCE; ADIPONECTIN RECEPTORS; MACULAR DEGENERATION; DYSTROPHY PHENOTYPE; BINDING PROTEIN	Accumulation of bis-retinoids in the retinal pigmented epithelium (RPE) is a hallmark of aging and retinal disorders such as Stargardt disease and age-related macular degeneration. These aberrant fluorescent condensation products, including di-retinoid-pyridinium-ethanolamine (A2E), are thought to be transferred to RPE cells primarily through phagocytosis of the photoreceptor outer segments. However, we observed by two-photon microscopy that mouse retinas incapable of phagocytosis due to a deficiency of the c-Mer proto-oncogene tyrosine kinase (Mertk) nonetheless contained fluorescent retinoid condensation material in their RPE. Primary RPE cells from Mertk(-/-) mice also accumulated fluorescent products in vitro. Finally, quantification of A2E demonstrated the acquisition of retinal condensation products in Mertk(-/-) mouse RPE prior to retinal degeneration. In these mice, we identified activated microglial cells that likely were recruited to transport A2E-like condensation products to the RPE and dispose of the dying photoreceptor cells. These observations demonstrate a novel transport mechanism between photoreceptor cells and RPE that does not involve canonical Mertk-dependent phagocytosis.	[Palczewska, Grazyna; Dong, Zhiqian] Polgenix Inc, Cleveland, OH USA; [Maeda, Akiko; Arai, Eisuke; Perusek, Lindsay] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Golczak, Marcin; Kevany, Brian; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Golczak, Marcin; Kevany, Brian; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Maeda, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.; Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu; kxp65@case.edu		DONG, ZHIQIAN/0000-0002-8748-4532	National Institutes of Health [EY022326, U01 EY025451, R24 EY024864, EY022658, EY023948]; VSRC CORE Grant [P30 EY011373]; Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY011373, R01EY022658, R01EY022326, R01EY023948, U01EY025451, R24EY024864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VSRC CORE Grant; Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY022326, U01 EY025451, and R24 EY024864 (to K. P.), EY022658 (to A. M.), and EY023948 (to M. G.), VSRC CORE Grant P30 EY011373, the Arnold and Mabel Beckman Foundation, and the Foundation Fighting Blindness. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; BOK D, 1993, J CELL SCI, P189; Bruban J, 2011, NEUROBIOL DIS, V42, P55, DOI 10.1016/j.nbd.2011.01.004; CHAITIN MH, 1983, INVEST OPHTH VIS SCI, V24, P812; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; Fujioka H, 2014, ULTRASTRUCT PATHOL, V38, P204, DOI 10.3109/01913123.2014.888114; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gliem M, 2016, JAMA OPHTHALMOL, V134, P817, DOI 10.1001/jamaophthalmol.2016.1475; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; LaVail MM, 2016, ADV EXP MED BIOL, V854, P487, DOI 10.1007/978-3-319-17121-0_65; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2014, P NATL ACAD SCI USA, V111, pE1428, DOI 10.1073/pnas.1317986111; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Molday RS, 2015, PROG MOL BIOL TRANSL, V134, P415, DOI 10.1016/bs.pmbts.2015.06.008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Palczewska G, 2014, NAT MED, V20, P785, DOI 10.1038/nm.3590; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Vollrath D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005723; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	57	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26937	26949		10.1074/jbc.M116.764563	http://dx.doi.org/10.1074/jbc.M116.764563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875314	Green Published, hybrid			2022-12-26	WOS:000391571400032
J	Garcia-Bardon, A; Thal, SC				Garcia-Bardon, Andreas; Thal, Serge C.			Normalization with Corresponding Naive Tissue Minimizes Bias Caused by Commercial Reverse Transcription Kits on Quantitative Real-Time PCR Results	PLoS One			English	Article							POLYMERASE-CHAIN-REACTION; MESSENGER-RNA; RT-PCR; QUANTIFICATION; EXPRESSION; GENES; BRAIN; SELECTION; ASSAYS; MICE	Real-time reverse transcription polymerase chain reaction (PCR) is the gold standard for expression analysis. Designed to improve reproducibility and sensitivity, commercial kits are commonly used for the critical step of cDNA synthesis. The present study was designed to determine the impact of these kits. mRNA from mouse brains were pooled to create serial dilutions ranging from 0.0625 mu g to 2 mu g, which were transcribed into cDNA using four different commercial reverse-transcription kits. Next, we transcribed mRNA from brain tissue after acute brain injury and naive mice into cDNA for qPCR. Depending on tested genes, some kits failed to show linear results in dilution series and revealed strong variations in cDNA yield. Absolute expression data in naive and trauma settings varied substantially between these kits. Normalization with a housekeeping gene failed to reduce kit-dependent variations, whereas normalization eliminated differences when naive samples from the same region were used. The study shows strong evidence that choice of commercial cDNA synthesis kit has a major impact on PCR results and, consequently, on comparability between studies. Additionally, it provides a solution to overcome this limitation by normalization with data from naive samples. This simple step helps to compare mRNA expression data between different studies and groups.	[Garcia-Bardon, Andreas; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany	Johannes Gutenberg University of Mainz	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Garcia-Bardon, Andreas/0000-0002-6229-1099	German Research Foundation [DFG TH1430/3-1]; Federal Ministry of Education and Research [BMBF 01EO1003]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was financially supported by a grant from the German Research Foundation (DFG TH1430/3-1) to SCT and by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dana Pieter for her excellent technical assistance. This work was financially supported by a grant from the German Research Foundation (DFG TH1430/3-1) to SCT and by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT. The authors would also like to thank Sandra Schmidt for her linguistic assistance.	Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Haberhausen G, 1998, J CLIN MICROBIOL, V36, P628, DOI 10.1128/JCM.36.3.628-633.1998; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Leite GM, 2012, J MICROBIOL METH, V88, P413, DOI 10.1016/j.mimet.2012.01.011; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Singh H B, 2006, J Commun Dis, V38, P274; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Thellin O, 1998, Dev Immunol, V6, P295, DOI 10.1155/1998/85209	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167209	10.1371/journal.pone.0167209	http://dx.doi.org/10.1371/journal.pone.0167209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898720	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474000038
J	Luo, KW; Gao, LD; Hu, SX; Zhang, H; Deng, ZH; Huang, W; Sun, QL; Zhang, F; Zhang, SY; Chen, Y				Luo, Kai-Wei; Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Deng, Zhi-Hong; Huang, Wei; Sun, Qian-Lai; Zhang, Fan; Zhang, Si-Yu; Chen, Yu			Hand, Foot, and Mouth Disease in Hunan Province, China, 2009-2014: Epidemiology and Death Risk Factors	PLOS ONE			English	Article							HUMAN ENTEROVIRUS 71; CLINICAL CHARACTERISTICS; OUTBREAK; SHENZHEN; THAILAND; CHILDREN; HENAN; JAPAN; A16	Hand, foot, and mouth disease (HFMD) is an arising public health problem in Asia, including China. Epidemiological data is necessary to enable judicious public health responses and interventions. We analyzed the epidemiological and laboratory data of 759,301 HFMD cases reported to the Hunan Provincial Center for Disease Control and Prevention from 1 January 2009 to 31 December 2014. Univariate and multivariable conditional logistic regression analyses were used to identify risk factors of fatality in HFMD. The incidence of HFMD was highest among children aged 1-3 years, compared with other age groups. Of the total HFMD cases, 7,222 (0.95%) were considered severe and 338 (0.04%) were fatal. Enterovirus-A71 was the major cause of severe and fatal cases (65.75% and 88.78%, respectively). For severe cases, the median time from symptom onset to diagnosis was 0.5 days (interquartile range [IQR] 0-1.5 days); the median time from diagnosis to severe illness was 2 days (IQR 1-3 days). For fatal cases, the median time from symptom onset to diagnosis was 0.5 days (IQR 0-1.5 days); the median time from diagnosis to death was 1.5 days (IQR 0.5-2.5 days). In multivariable analysis, the abuse of antibiotic, glucocorticoid and pyrazolone in village clinics at basic medical institutions were identified as independent risk factors for HFMD fatal cases. In conclusion, our results suggest that the future direction to control and respond to HFMD is intensive surveillance of enterovirus-A71 and improving the ability to diagnose disease and treat patients, especially in basic medical institutions.	[Luo, Kai-Wei; Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Deng, Zhi-Hong; Huang, Wei; Sun, Qian-Lai; Zhang, Fan; Zhang, Si-Yu; Chen, Yu] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China		Luo, KW (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	hncdclkw@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Chinese Preventive Medicine Association [20101801]; Health and Family Planning Commission of Hunan Province [C2015-62]	Chinese Preventive Medicine Association; Health and Family Planning Commission of Hunan Province	This work was supported by the Chinese Preventive Medicine Association (Grant number: 20101801,http://www.cpma.org.cn/) and the Health and Family Planning Commission of Hunan Province (Grant number: C2015-62,http://www.hunanwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; [Anonymous], [No title captured]; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen SY, 2011, J INF SCI ENG, V27, P715; Chen ZR, 2015, ARCH VIROL, V160, P315, DOI 10.1007/s00705-014-2294-x; CZERNIAWSKAMYSIK G, 1981, ALLERGY, V36, P381, DOI 10.1111/j.1398-9995.1981.tb01842.x; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980; Gao LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100003; He LY, 2014, EUR J CLIN MICROBIOL, V33, P1429, DOI 10.1007/s10096-014-2085-z; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Hubiche T, 2014, PEDIATR INFECT DIS J, V33, pE92, DOI 10.1097/INF.0000000000000120; Kadurugamuwa JL, 2011, AM J INFECT CONTROL, V39, P788, DOI 10.1016/j.ajic.2011.01.015; Li W, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-440; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Lu B, 2014, LANCET INFECT DIS, V14, P1041, DOI 10.1016/S1473-3099(14)70972-7; Lu J, 2014, CLIN MICROBIOL INFEC, V20, pO442, DOI 10.1111/1469-0691.12468; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Ma HL, 2010, PEDIATR INFECT DIS J, V29, P524, DOI 10.1097/INF.0b013e3181cdd178; Mauleekoonphairoj J, 2015, VIRUS GENES, V51, P290, DOI 10.1007/s11262-015-1239-0; Mou J, 2014, EPIDEMIOL INFECT, V142, P776, DOI 10.1017/S0950268813001453; Nadel S, 2013, CRIT CARE MED, V41, P1821, DOI 10.1097/CCM.0b013e318291cb2d; National Bureau of Statistics of China, NAT CENS CHIN 2014; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Pan Jiahua, 2012, Indian J Dermatol, V57, P316, DOI 10.4103/0019-5154.97683; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; The Ministry of Health of China, 2010, HAND FOOT MOUTH DIS; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu XN, 2014, JPN J INFECT DIS, V67, P95, DOI 10.7883/yoken.67.95; Xie Z., 2014, J EPIDEMIOL, V35, P1109; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yan Yan, 2013, Bing Du Xue Bao, V29, P176; Zha J, 2015, J MED VIROL, V87, P2000, DOI 10.1002/jmv.24272; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zheng S, 2014, EPIDEMIOL INFECT, V142, P1751, DOI 10.1017/S0950268813002586; Zhou H, 2012, CHINESE MED J-PEKING, V125, P1261, DOI 10.3760/cma.j.issn.0366-6999.2012.07.013	38	10	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167269	10.1371/journal.pone.0167269	http://dx.doi.org/10.1371/journal.pone.0167269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898715	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474000043
J	Smith, AD; Zhang, Y; Barber, RC; Minshall, CT; Huebinger, RM; Allen, MS				Smith, Ashley D.; Zhang, Yan; Barber, Robert C.; Minshall, Christian T.; Huebinger, Ryan M.; Allen, Michael S.			Common Lung Microbiome Identified among Mechanically Ventilated Surgical Patients	PLoS One			English	Article							PNEUMONIA; DIVERSITY; DIAGNOSIS; DISEASE	The examination of the pulmonary microbiome in patients with non-chronic disease states has not been extensively examined. Traditional culture based screening methods are often unable to identify bacteria from bronchoalveolar lavage samples. The advancement of next-generation sequencing technologies allows for a culture-independent molecular based analysis to determine the microbial composition in the lung of this patient population. For this study, the Ion Torrent PGM system was used to assess the microbial complexity of culture negative bronchoalveolar lavage samples. A group of samples were identified that all displayed high diversity and similar relative abundance of bacteria. This group consisted of Hydrogenophaga, unclassified Bacteroidetes, Pedobacter, Thauera, and Acinetobacter. These bacteria may be representative of a common non-pathogenic pulmonary microbiome associated within this population of patients.	[Smith, Ashley D.] Univ North Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX USA; [Smith, Ashley D.; Zhang, Yan; Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Ctr Biosafety & Biosecur, Ft Worth, TX 76107 USA; [Zhang, Yan; Barber, Robert C.; Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76107 USA; [Minshall, Christian T.; Huebinger, Ryan M.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Southwestern Medical Center Dallas	Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Ctr Biosafety & Biosecur, Ft Worth, TX 76107 USA.; Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76107 USA.; Huebinger, RM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	Ryan.Huebinger@UTSouthwestern.edu; Michael.Allen@unthsc.edu	Smith, Ashley/GZB-0298-2022; Zhang, Yan/L-1738-2015	Zhang, Yan/0000-0001-5784-4659; Allen, Michael/0000-0003-2293-8078	UNTHSC	UNTHSC	This work was supported in part by a grant from UNTHSC to MSA.; The authors thank personnel and staff at Parkland Memorial Hospital for samples. Work was supported in part by a grant from UNTHSC to MSA and ADS.	Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; Alex WI, 2012, AM THOR SOC INT C AM, pA4045; Cabello H, 1997, EUR RESPIR J, V10, P1137, DOI 10.1183/09031936.97.10051137; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Gholoobi A, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.8939; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Kelly BJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0151-8; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Nair GB, 2015, INTENS CARE MED, V41, P34, DOI 10.1007/s00134-014-3564-5; Nair GB, 2013, CRIT CARE CLIN, V29, P521, DOI 10.1016/j.ccc.2013.03.007; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Pascual A, 2010, INT J MICROBIOL, V2010; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Smith AD, 2013, BIO SYST, V2, P116; Smith AD, 2013, BIOL SYSTEMS, V2, P5; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401	32	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166313	10.1371/journal.pone.0166313	http://dx.doi.org/10.1371/journal.pone.0166313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898681	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000008
J	Yu, Y				Yu, Yan			Four Decades of Obesity Trends among Non-Hispanic Whites and Blacks in the United States: Analyzing the Influences of Educational Inequalities in Obesity and Population Improvements in Education	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ABDOMINAL OBESITY; PHYSICAL-ACTIVITY; US ADULTS; HEALTH; ASSOCIATION; AMERICANS; MORTALITY	Both obesity (body mass index >= 30) and educational attainment have increased dramatically in the United States since the 1970s. This study analyzed the influences of educational inequalities in obesity and population improvements in education on national obesity trends between 1970 and 2010. For non-Hispanic white and black males and females aged 25-74 years, educational differences in the probability of being obese were estimated from the 1971-2012 National Health and Nutrition Examination Surveys, and population distributions of age and educational groups, from the 1970 Census and 2010 American Community Survey. In the total population, obesity increased from 15.7% to 38.8%, and there were increases in the greater obese probabilities of non-college graduates relative to four-year college graduates. The increase in obesity would have been lower by 10% (2.2 percentage points) if educational inequalities in obesity had stayed at their 1970 values and lower by one third (7.9 points) if obesity inequalities had been eliminated. Obesity inequalities were larger for females than males and for whites than blacks, and obesity did not differ by education among black males. As a result, the impact of obesity inequalities on the obesity trend was largest among white females (a 47% reduction in the obesity increase if obesity inequalities had been eliminated), and virtually zero among black males. On the other hand, without educational improvements, the obesity increase would have been 9% more in the total population, 23% more among white females and not different in the other three subpopulations. Results indicate that obesity inequalities made sizable contributions to the obesity trends, and the obesity reductions associated with educational improvements were more limited.	[Yu, Yan] Univ Canberra, Hlth Res Inst, Bruce, ACT, Australia; [Yu, Yan] Australian Natl Univ, Sch Demog, Acton, ACT, Australia	University of Canberra; Australian National University	Yu, Y (corresponding author), Univ Canberra, Hlth Res Inst, Bruce, ACT, Australia.; Yu, Y (corresponding author), Australian Natl Univ, Sch Demog, Acton, ACT, Australia.	yan.yu@canberra.edu.au			Australian Research Council Centre of Excellence in Population Ageing Research [CE 1000 1029]	Australian Research Council Centre of Excellence in Population Ageing Research(Australian Research Council)	The work was supported by the Australian Research Council (http://www.arc.gov.au/) Centre of Excellence in Population Ageing Research (project number CE 1000 1029). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	An RP, 2015, ANN EPIDEMIOL, V25, P637, DOI 10.1016/j.annepidem.2015.06.004; [Anonymous], 2008, SOCIOECONOMIC STATUS; [Anonymous], 2006, AN REP GUID; [Anonymous], 2011, WORLD C SOC DET HLT; Cole SR, 2001, COMPUT METH PROG BIO, V64, P65, DOI 10.1016/S0169-2607(00)00088-2; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Goesling B, 2007, SOC FORCES, V85, P1621, DOI 10.1353/sof.2007.0068; Goldstein JR, 2001, AM SOCIOL REV, V66, P506, DOI 10.2307/3088920; Gottschalk P, 2005, REV INCOME WEALTH, P231; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Heckman JJ, 2001, AM ECON REV, V91, P145, DOI 10.1257/aer.91.2.145; Himes CL, 2005, GEND ISSUES, V22, P45, DOI 10.1007/s12147-005-0014-2; Hout M., 1993, PERSISTENT INEQUALIT; Krieger N, 2014, INT J EPIDEMIOL, V43, P1294, DOI 10.1093/ije/dyu047; Leon-Munoz LM, 2014, CLIN NUTR, V33, P836, DOI 10.1016/j.clnu.2013.10.013; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Martin SP, 2006, DEMOGR RES, V15, P537, DOI 10.4054/DemRes.2006.15.20; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; MURPHY KM, 1989, ED RES, V0018; National Center for Health Statistics, 1981, VITAL HLTH STAT SERI, V1; National Center for Health Statistics, 1973, VITAL HLTH STAT SERI, V1; National Center for Health Statistics, 1994, VITAL HLTH STAT SERI, V1; NCD Risk Factor Collaboration (NCD-RisC), 1975, LANCET, V2016, P1377; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ruggles S, 2010, INTEGRATED PUBLIC US; Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x; SEWELL WH, 1967, SOCIOL EDUC, V40, P1, DOI 10.2307/2112184; Smith JP, 2007, J HUM RESOUR, V42, P739; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; U.S. Department of Health and Human Services, 2014, SOCIAL DETERMINANTS; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; WHO, 2000, OB PREV MAN GLOB EP; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Xie B, 2003, PREV MED, V36, P30, DOI 10.1006/pmed.2002.1131; Yu Y, 2016, BIODEMOGR SOC BIOL, V62, P143, DOI 10.1080/19485565.2015.1108835; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.307; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167193	10.1371/journal.pone.0167193	http://dx.doi.org/10.1371/journal.pone.0167193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893853	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400098
J	Zhao, H; Ruberu, K; Li, HY; Garner, B				Zhao, Hua; Ruberu, Kalani; Li, Hongyun; Garner, Brett			Cell Type-Specific Modulation of Cobalamin Uptake by Bovine Serum	PLOS ONE			English	Article							TRANSCOBALAMIN-II; IMMUNOHISTOCHEMICAL QUANTIFICATION; CULTURED FIBROBLASTS; TRANSPORT PROTEIN; SURFACE RECEPTOR; BINDING PROTEIN; INBORN-ERRORS; IN-VITRO; VITAMIN-B12; EXPRESSION	Tracking cellular Co-57-labelled cobalamin (Co-57-Cbl) uptake is a well-established method for studying Cbl homeostasis. Previous studies established that bovine serum is not generally permissive for cellular Cbl uptake when used as a supplement in cell culture medium, whereas supplementation with human serum promotes cellular Cbl uptake. The underlying reasons for these differences are not fully defined. In the current study we address this question. We extend earlier observations by showing that fetal calf serum inhibits cellular Co-57-Cbl uptake by HT1080 cells (a fibrosarcoma-derived fibroblast cell line). Furthermore, we discovered that a simple heat-treatment protocol (95 degrees C for 10 min) ameliorates this inhibitory activity for HT1080 cell Co-57-Cbl uptake. We provide evidence that the very high level of haptocorrin in bovine serum (as compared to human serum) is responsible for this inhibitory activity. We suggest that bovine haptocorrin competes with cell-derived transcobalamin for Cbl binding, and that cellular Cbl uptake may be minimised in the presence of large amounts of bovine haptocorrin that are present under routine in vitro cell culture conditions. In experiments conducted with AG01518 cells (a neonatal foreskin-derived fibroblast cell line), overall cellular Co-57-Cbl uptake was 86% lower than for HT1080 cells, cellular TC production was below levels detectable by western blotting, and heat treatment of fetal calf serum resulted in only a modest increase in cellular Co-57-Cbl uptake. We recommend a careful assessment of cell culture protocols should be conducted in order to determine the potential benefits that heat-treated bovine serum may provide for in vitro studies of mammalian cell lines.	[Zhao, Hua; Ruberu, Kalani; Li, Hongyun; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Zhao, Hua; Ruberu, Kalani; Li, Hongyun; Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Zhao, Hua] Univ New South Wales, Prince Wales Clin Sch, Lowy Canc Ctr, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of New South Wales Sydney	Garner, B (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.; Garner, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	brettg@uow.edu.au	; Li, Hongyun/G-2301-2011	Ruberu, Kalani/0000-0003-2575-5242; Li, Hongyun/0000-0003-3332-3132	National Health and Medical Research Council (NHMRC) of Australia [1065982]; NHMRC Senior Research Fellowship [1109831]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council (NHMRC) of Australia (Grant ID #1065982). BG is supported by an NHMRC Senior Research Fellowship (Grant ID #1109831), NHMRC: http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Health and Medical Research Council (NHMRC) of Australia (Grant ID #1065982). BG is supported by an NHMRC Senior Research Fellowship (Grant ID # 1109831).	Abuyaman O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073110; Allen R H, 1975, Prog Hematol, V9, P57; ALLISON AC, 1961, BIOCHIM BIOPHYS ACTA, V49, P566, DOI 10.1016/0006-3002(61)90253-0; Alpers DH, 2016, BIOCHIMIE, V126, P52, DOI 10.1016/j.biochi.2015.11.006; AMAGASAKI T, 1990, BLOOD, V76, P1380; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; BERLINER N, 1981, METABOLISM, V30, P230, DOI 10.1016/0026-0495(81)90146-3; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Carmel R, 2009, BRIT J HAEMATOL, V147, P386, DOI 10.1111/j.1365-2141.2009.07855.x; Chlon TM, 2008, J NUTR, V138, P1323, DOI 10.1093/jn/138.7.1323; DIGIROLAMO PM, 1975, ARCH BIOCHEM BIOPHYS, V168, P386, DOI 10.1016/0003-9861(75)90267-2; EVANS VJ, 1956, CANCER RES, V16, P87; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; FRATERSCHRODER M, 1985, BIOCHIM BIOPHYS ACTA, V845, P421, DOI 10.1016/0167-4889(85)90207-1; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; LI N, 1994, BIOCHEM J, V301, P585, DOI 10.1042/bj3010585; Liu YW, 2002, WOUND REPAIR REGEN, V10, P336, DOI 10.1046/j.1524-475X.2002.10510.x; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; McLean GR, 1997, BLOOD, V89, P235, DOI 10.1182/blood.V89.1.235.235_235_242; MELLMAN I, 1978, J CLIN INVEST, V62, P952, DOI 10.1172/JCI109224; Moras E, 2007, MOL GENET METAB, V90, P140, DOI 10.1016/j.ymgme.2006.08.014; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Park Hyo Jin, 2009, Immune Netw, V9, P138, DOI 10.4110/in.2009.9.4.138; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; Quadros EV, 2013, BIOCHIMIE, V95, P1008, DOI 10.1016/j.biochi.2013.02.004; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; QUADROS EV, 1995, BBA-GEN SUBJECTS, V1244, P395, DOI 10.1016/0304-4165(95)00037-C; Quadros EV, 1999, AM J PHYSIOL-GASTR L, V277, pG161, DOI 10.1152/ajpgi.1999.277.1.G161; ROSENBERG LE, 1975, P NATL ACAD SCI USA, V72, P4617, DOI 10.1073/pnas.72.11.4617; Seetharam Bellur, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006422; SENNETT C, 1981, ANNU REV BIOCHEM, V50, P1053, DOI 10.1146/annurev.bi.50.070181.005201; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sysel AM, 2015, ONCOTARGET, V6, P2331, DOI 10.18632/oncotarget.3206; Sysel AM, 2013, ANTICANCER RES, V33, P4203; Arigony ALV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597282; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Watkins D, 2013, BIOCHIMIE, V95, P1019, DOI 10.1016/j.biochi.2013.01.013; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x; Zhao H, 2015, J ALZHEIMERS DIS, V43, P1017, DOI 10.3233/JAD-140681; Zhao H, 2014, BIOSCIENCE REP, V34, P43, DOI 10.1042/BSR20130130; Zhao H, 2013, J NEUROSCI METH, V217, P67, DOI 10.1016/j.jneumeth.2013.04.008; Zhao H, 2011, CELL MOL LIFE SCI, V68, P3963, DOI 10.1007/s00018-011-0861-9	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167044	10.1371/journal.pone.0167044	http://dx.doi.org/10.1371/journal.pone.0167044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893837	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400074
J	Mukherjee, SP; Lozano, N; Kucki, M; Del Rio-Castillo, AE; Newman, L; Vazquez, E; Kostarelos, K; Wick, P; Fadeel, B				Mukherjee, Sourav P.; Lozano, Neus; Kucki, Melanie; Del Rio-Castillo, Antonio E.; Newman, Leon; Vazquez, Ester; Kostarelos, Kostas; Wick, Peter; Fadeel, Bengt			Detection of Endotoxin Contamination of Graphene Based Materials Using the TNF-alpha Expression Test and Guidelines for Endotoxin-Free Graphene Oxide Production	PLOS ONE			English	Article							ENGINEERED NANOMATERIALS; NANOPARTICLES; MACROPHAGES; CELLS; CYTOTOXICITY; STABILITY; MONOCYTES; FILMS; LPS	Nanomaterials may be contaminated with bacterial endotoxin during production and handling, which may confound toxicological testing of these materials, not least when assessing for immunotoxicity. In the present study, we evaluated the conventional Limulus amebocyte lysate (LAL) assay for endotoxin detection in graphene based material (GBM) samples, including graphene oxide (GO) and few-layered graphene (FLG). Our results showed that some GO samples interfered with various formats of the LAL assay. To overcome this problem, we developed a TNF-alpha expression test (TET) using primary human monocyte-derived macrophages incubated in the presence or absence of the endotoxin inhibitor, polymyxin B sulfate, and found that this assay, performed with non-cytotoxic doses of the GBM samples, enabled unequivocal detection of endotoxin with a sensitivity that is comparable to the LAL assay. FLG also triggered TNF-a production in the presence of the LPS inhibitor, pointing to an intrinsic pro-inflammatory effect. Finally, we present guidelines for the preparation of endotoxin-free GO, validated by using the TET.	[Mukherjee, Sourav P.; Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, Nanosafety & Nanomed Lab, Stockholm, Sweden; [Lozano, Neus; Newman, Leon; Kostarelos, Kostas] Univ Manchester, Fac Med & Human Sci, Nanomed Lab, Manchester, Lancs, England; [Lozano, Neus; Newman, Leon; Kostarelos, Kostas] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Kucki, Melanie; Wick, Peter] Swiss Fed Labs Mat Sci & Technol, Particles Biol Interact Lab, St Gallen, Switzerland; [Del Rio-Castillo, Antonio E.; Vazquez, Ester] Univ Castilla La Mancha, Dept Organ Chem, Ciudad Real, Spain	Karolinska Institutet; University of Manchester; University of Manchester; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Universidad de Castilla-La Mancha	Fadeel, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Mol Toxicol, Nanosafety & Nanomed Lab, Stockholm, Sweden.	bengt.fadeel@ki.se	Lozano, Neus/ABA-3334-2021; Lozano, Neus/GOV-5046-2022; vazquez, ester/K-2244-2014; Del Rio Castillo, Antonio Esau/I-4811-2014; Kostarelos, Kostas/AAP-6879-2021	Lozano, Neus/0000-0002-9026-1743; vazquez, ester/0000-0003-3223-8024; Del Rio Castillo, Antonio Esau/0000-0001-9678-1187; Kostarelos, Kostas/0000-0002-2224-6672; Newman, Leon/0000-0003-2099-2660	European Commission [604391, 696656]; EPSRC [EP/K005014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1353926, EP/K005014/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the European Commission (GRAPHENE Flagship Project, grant agreement no. 604391 and 696656) to BF, KK, EV, and PW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Boucetta H, 2013, ADV HEALTHC MATER, V2, P433, DOI 10.1002/adhm.201200248; Bishop Russell E., 2005, V12, P1, DOI 10.1159/000081687; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Calil IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090013; CAVAILLON JM, 1986, MOL IMMUNOL, V23, P965, DOI 10.1016/0161-5890(86)90127-6; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Delogu LG, 2010, J NANOSCI NANOTECHNO, V10, P5293, DOI 10.1166/jnn.2010.3083; Dobrovolskaia MA, 2014, NANOMEDICINE-UK, V9, P1847, DOI [10.2217/NNM.13.157, 10.2217/nnm.13.157]; Dobrovolskaia MA, 2010, NANOMEDICINE-UK, V5, P555, DOI 10.2217/NNM.10.29; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Esch RK, 2010, NANOTOXICOLOGY, V4, P73, DOI 10.3109/17435390903428851; Feliu N, 2012, BIOMATERIALS, V33, P1970, DOI 10.1016/j.biomaterials.2011.11.054; Hidalgo RS, 2015, LANGMUIR, V31, P2697, DOI 10.1021/la5029178; Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010; HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268, DOI 10.1128/CMR.8.2.268; Juergen Hermanns CB, 2012, ALTEX P, P81; Konno S, 2005, J INTERF CYTOK RES, V25, P277, DOI 10.1089/jir.2005.25.277; Kostarelos K, 2014, SCIENCE, V344, P261, DOI 10.1126/science.1246736; Kucki M, 2012, NANOKON SOP 2 2 2 DE; Kucki M, 2014, INNATE IMMUN-LONDON, V20, P327, DOI 10.1177/1753425913492833; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Lopez-Diaz D, 2013, CHEMPHYSCHEM, V14, P4002, DOI 10.1002/cphc.201300620; Ma J, 2015, ACS NANO, V9, P10498, DOI 10.1021/acsnano.5b04751; Monteiro-Riviere NA, 2009, TOXICOL APPL PHARM, V234, P222, DOI 10.1016/j.taap.2008.09.030; Nel AE, 2013, J INTERN MED, V274, P561, DOI 10.1111/joim.12109; Qu GB, 2013, ACS NANO, V7, P5732, DOI 10.1021/nn402330b; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h; Smulders S, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-41; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; US-FDA, 2012, GUID IND PYR END TES; Vallhov H, 2006, NANO LETT, V6, P1682, DOI 10.1021/nl060860z; Vetten MA, 2014, NANOMED-NANOTECHNOL, V10, P1391, DOI 10.1016/j.nano.2014.03.017; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c	34	58	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166816	10.1371/journal.pone.0166816	http://dx.doi.org/10.1371/journal.pone.0166816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880838	Green Submitted, Green Published, gold			2022-12-26	WOS:000388889500035
J	Salamon, J; Bello, JP; Farnsworth, A; Robbins, M; Keen, S; Klinck, H; Kelling, S				Salamon, Justin; Bello, Juan Pablo; Farnsworth, Andrew; Robbins, Matt; Keen, Sara; Klinck, Holger; Kelling, Steve			Towards the Automatic Classification of Avian Flight Calls for Bioacoustic Monitoring	PLOS ONE			English	Article							FEATURE-EXTRACTION; BIRD SOUNDS; RECOGNITION; NETWORK; WEATHER; SCIENCE; EBIRD	Automatic classification of animal vocalizations has great potential to enhance the monitoring of species movements and behaviors. This is particularly true for monitoring nocturnal bird migration, where automated classification of migrants' flight calls could yield new biological insights and conservation applications for birds that vocalize during migration. In this paper we investigate the automatic classification of bird species from flight calls, and in particular the relationship between two different problem formulations commonly found in the literature: classifying a short clip containing one of a fixed set of known species (N-class problem) and the continuous monitoring problem, the latter of which is relevant to migration monitoring. We implemented a state-of-the-art audio classification model based on unsupervised feature learning and evaluated it on three novel datasets, one for studying the N-class problem including over 5000 flight calls from 43 different species, and two realistic datasets for studying the monitoring scenario comprising hundreds of thousands of audio clips that were compiled by means of remote acoustic sensors deployed in the field during two migration seasons. We show that the model achieves high accuracy when classifying a clip to one of N known species, even for a large number of species. In contrast, the model does not perform as well in the continuous monitoring case. Through a detailed error analysis (that included full expert review of false positives and negatives) we show the model is confounded by varying background noise conditions and previously unseen vocalizations. We also show that the model needs to be parameterized and benchmarked differently for the continuous monitoring scenario. Finally, we show that despite the reduced performance, given the right conditions the model can still characterize the migration pattern of a specific species. The paper concludes with directions for future research.	[Salamon, Justin; Bello, Juan Pablo] NYU, Mus & Audio Res Lab, New York, NY 10003 USA; [Salamon, Justin] NYU, Ctr Urban Sci & Progress, New York, NY 10003 USA; [Farnsworth, Andrew; Robbins, Matt; Keen, Sara; Klinck, Holger; Kelling, Steve] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA	New York University; New York University; Cornell University	Salamon, J (corresponding author), NYU, Mus & Audio Res Lab, New York, NY 10003 USA.; Salamon, J (corresponding author), NYU, Ctr Urban Sci & Progress, New York, NY 10003 USA.	justin.salamon@nyu.edu	Klinck, Holger/X-5214-2019	Klinck, Holger/0000-0003-1078-7268; Salamon, Justin/0000-0001-6345-4593; Keen, Sara/0000-0002-2988-8280; Farnsworth, Andrew/0000-0002-9854-4449	National Science Foundation [NSF IIS-1125098, NSF IIS-1633259]; Leon Levy Foundation; Ingalls Foundation; Center for Urban Science and Progress; Google Faculty Award	National Science Foundation(National Science Foundation (NSF)); Leon Levy Foundation; Ingalls Foundation; Center for Urban Science and Progress; Google Faculty Award(Google Incorporated)	This work was supported by National Science Foundation, NSF IIS-1125098, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1125098, S. Kelling; Leon Levy Foundation, AF; Ingalls Foundation, S. Kelling; Center for Urban Science and Progress, JS; National Science Foundation, NSF IIS-1633259, https://nsf.gov/awardsearch/showAward?AWD_ID=1633259, JPB; and Google Faculty Award, JPB, S. Kelling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864; Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Ba Jimmy, 2014, ADV NEURAL INFORM PR, P2654; Bardeli R, 2010, PATTERN RECOGN LETT, V31, P1524, DOI 10.1016/j.patrec.2009.09.014; Bas Y, 2008, BIODIVERS CONSERV, V17, P3403, DOI 10.1007/s10531-008-9420-6; Bastas S, 2012, IEEE INT SYMP CIRC S, P1676; Bello JP, 2005, IEEE T SPEECH AUDI P, V13, P1035, DOI 10.1109/TSA.2005.851998; Bengio Y, 2013, INT CONF ACOUST SPEE, P8624, DOI 10.1109/ICASSP.2013.6639349; Bogdanov D., 2013, 14 C INT SOC MUSIC I, P493; Bradski G, 2008, LEARNING OPENCV COMP; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Coates Adam, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P561, DOI 10.1007/978-3-642-35289-8_30; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dahl GE, 2013, INT CONF ACOUST SPEE, P8609, DOI 10.1109/ICASSP.2013.6639346; Damoulas T., 2010, 2010 Ninth International Conference on Machine Learning and Applications (ICMLA 2010), P424, DOI 10.1109/ICMLA.2010.69; Deng L, 2014, DEEP LEARNING METHOD, DOI [10.1561/2000000039, DOI 10.1561/2000000039]; Deng L, 2013, IEEE INT NEW CIRC; Dhillon IS, 2001, MACH LEARN, V42, P143, DOI 10.1023/A:1007612920971; Diefenbach DR, 2007, AUK, V124, P96, DOI 10.1642/0004-8038(2007)124[96:IAFDIE]2.0.CO;2; Dieleman S, 2013, 14 INT SOC MUS INF R; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Dufour O., 2013, P 1 WORKSHOP MACHINE, P89, DOI DOI 10.5772/56872; EMLEN JT, 1992, J FIELD ORNITHOL, V63, P26; Evans WR, 2000, ACOUSTIC MONITORING; Farnsworth A, 2015, ECOLOGICAL APPL; Farnsworth A, 2014, AI MAG, V35, P31, DOI 10.1609/aimag.v35i2.2527; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fink D, 2014, AI MAG, V35, P19, DOI 10.1609/aimag.v35i2.2533; Ganchev T., 2005, PROC SPECOM, V1, P191; Ganchev TD, 2015, EXPERT SYST APPL, V42, P6098, DOI 10.1016/j.eswa.2015.03.036; Glotin H, 2013, P 1 INT WORKSH MACH; GRABER R. R., 1960, WILSON BULL, V72, P253; GRABER RICHARD, 1959, WILSON BULL, V71, P220; Hernandez R. Murcia, 2013, 1 INT WORKSH MACH LE; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hoshen Y, 2015, INT CONF ACOUST SPEE, P4624, DOI 10.1109/ICASSP.2015.7178847; Hutto RL, 2009, J FIELD ORNITHOL, V80, P387, DOI 10.1111/j.1557-9263.2009.00245.x; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kelling S, 2015, AMBIO, V44, pS601, DOI 10.1007/s13280-015-0710-4; Kelling S, 2013, AI MAG, V34, P10; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Lanzone M, 2009, AUK, V126, P511, DOI 10.1525/auk.2009.08187; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Marcarini M, 2008, INT CONF ACOUST SPEE, P2029, DOI 10.1109/ICASSP.2008.4518038; Mazurek JA, 2005, P SOC PHOTO-OPT INS, V5778, P264, DOI 10.1117/12.607616; McFee B., 2015, ISMIR; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Platt JC, 2000, ADV NEUR IN, P61; Ptacek L, 2016, BIOACOUSTICS, V25, P55, DOI 10.1080/09524622.2015.1089524; Rosenstock SS, 2002, AUK, V119, P46, DOI 10.1642/0004-8038(2002)119[0046:LCTCPA]2.0.CO;2; Sainath TN, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P1; Salamon J, 2015, 2015 EUR SIGN PROC C; Salamon J, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P1041, DOI 10.1145/2647868.2655045; Salamon J, 2015, INT CONF ACOUST SPEE, P171, DOI 10.1109/ICASSP.2015.7177954; Schrama Thijs, 2007, P131; Stanley CQ, 2015, CONSERV BIOL, V29, P164, DOI 10.1111/cobi.12352; Stowell D, 2011, BIRDSONG C4DM SURVEY; Stowell D, 2014, PEERJ, V2, DOI 10.7717/peerj.488; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Tanttu JT, 2006, BIOACOUSTICS, V15, P251, DOI 10.1080/09524622.2006.9753553; Taylor A., 1995, J ACOUST SOC AM, V97, P3370, DOI [10.1121/1.412650, DOI 10.1121/1.412650]; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665	64	42	43	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166866	10.1371/journal.pone.0166866	http://dx.doi.org/10.1371/journal.pone.0166866			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880836	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500040
J	Chuvilin, AN; Smirnov, IP; Mosina, AG; Varizhuk, AM; Pozmogova, GE				Chuvilin, Andrey N.; Smirnov, Igor P.; Mosina, Alena G.; Varizhuk, Anna M.; Pozmogova, Galina E.			A Solution to the Common Problem of the Synthesis and Applications of Hexachlorofluorescein Labeled Oligonucleotides	PLOS ONE			English	Article							REAL-TIME PCR; DNA; CELLS; DELIVERY; HELICASE; BINDING; SITE	A common problem of the preparation of hexachlorofluorescein labeled oligonucleotides is the transformation of the fluorophore to an arylacridine derivative under standard ammonolysis conditions. We show here that the arylacridine byproduct with distinct optical characteristics cannot be efficiently separated from the major product by HPLC or electrophoretic methods, which hampers precise physicochemical experiments with the labeled oligonucleotides. Studies of the transformation mechanism allowed us to select optimal conditions for avoiding the side reaction. The novel method for the post-synthetic deblocking of hexachlorofluorescein- labeled oligodeoxyribonucleotides described in this paper prevents the formation of the arylacridine derivative, enhances the yield of target oligomers, and allows them to be proper real-time PCR probes.	[Chuvilin, Andrey N.; Smirnov, Igor P.; Mosina, Alena G.; Varizhuk, Anna M.; Pozmogova, Galina E.] Fed Res & Clin Ctr Phys Chem Med, Dept Mol Genesis, Moscow, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency	Chuvilin, AN; Pozmogova, GE (corresponding author), Fed Res & Clin Ctr Phys Chem Med, Dept Mol Genesis, Moscow, Russia.	achuvilin@yandex.ru; pozmge@gmail.com	Galina, Pozmogova/S-6204-2017; Varizhuk, Anna/Y-7558-2019	Galina, Pozmogova/0000-0001-9458-4972; Varizhuk, Anna/0000-0001-9359-8651	Russian Science Foundation [14-25-00013]; Russian Science Foundation [17-25-00005] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation http://rscf.ru/en/ [grant 14-25-00013 to GP]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu-Soler C, 2006, MOL VIS, V12, P1098; Chen LA, 2011, J CLIN MICROBIOL, V49, P579, DOI 10.1128/JCM.01588-10; Chuvilin AN, 2009, BIOCONJUGATE CHEM, V20, P1441, DOI 10.1021/bc900076e; Chuvilin AN, 2012, Patent, Patent No. [RF 2463347, 2463347]; Etzkorn C, 2004, BIOCHEMISTRY-US, V43, P13256, DOI 10.1021/bi0490082; Gebeyehu G, 2012, Patent, Patent No. [US 8093372 B2, 8093372]; Handy SM, 2006, LIMNOL OCEANOGR-METH, V4, P193, DOI 10.4319/lom.2006.4.193; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016033; Lamb HK, 2004, PROTEIN SCI, V13, P3127, DOI 10.1110/ps.04958904; Lee K, 2007, ADV FUNCT MATER, V17, P2580, DOI 10.1002/adfm.200700218; Lee Martin A., 2009, P23; Lu QY, 2014, ONCOL LETT, V8, P99, DOI 10.3892/ol.2014.2128; McClelland SE, 2005, J MOL BIOL, V348, P895, DOI 10.1016/j.jmb.2005.03.018; Normand N, 2005, MOL VIS, V11, P184; Pesquet E, 2004, PLANT J, V39, P947, DOI 10.1111/j.1365-313X.2004.02170.x; Porter DJT, 2000, BIOCHEMISTRY-US, V39, P5166, DOI 10.1021/bi992384f; Rudramurthy SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016086; Schudel BR, 2011, LAB CHIP, V11, P1916, DOI 10.1039/c0lc00342e; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Tatarinova ON, 2008, B EXP BIOL MED+, V145, P312, DOI 10.1007/s10517-008-0078-6; Templeton KE, 2003, J CLIN MICROBIOL, V41, P4016, DOI 10.1128/JCM.41.9.4016-4021.2003; Wilcox Denise M, 2006, J RNAi Gene Silencing, V3, P225; You Y, 2011, BIOPOLYMERS, V95, P472, DOI 10.1002/bip.21615; Zhang XD, 2005, ACTA BIOCH BIOPH SIN, V37, P593, DOI 10.1111/j.1745-7270.2005.00084.x; Zhou J, 2010, MOL BIOSYST, V6, P580, DOI 10.1039/b919600e	25	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166911	10.1371/journal.pone.0166911	http://dx.doi.org/10.1371/journal.pone.0166911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861573	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300132
J	Hogue, MR; Ishizuka, T; Inoue, K; Abe-Yoshizumi, R; Igarashi, H; Mishima, T; Kandori, H; Yawo, H				Hogue, Mohammad Razuanul; Ishizuka, Toru; Inoue, Keiichi; Abe-Yoshizumi, Rei; Igarashi, Hiroyuki; Mishima, Takaaki; Kandori, Hideki; Yawo, Hiromu			A Chimera Na+ -Pump Rhodopsin as an Effective Optogenetic Silencer	PLOS ONE			English	Article							OPTICAL CONTROL; CHLORIDE; CHANNELRHODOPSIN; GABA; EXPRESSION; NEURONS	With the progress of optogenetics, the activities of genetically identified neurons can be optically silenced to determine whether the neurons in question are necessary for the network performance of the behavioral expression. This logical induction is expected to be improved by the application of the Na+ pump rhodopsins (NaRs), which hyperpolarize the membrane potential with negligible influence on the ionic/pH balance. Here, we made several chimeric NaRs between two NaRs, KR2 and IaNaR from Krokinobacter eikastus and Indibacter alkaliphilus, respectively. We found that one of these chimeras, named I1K6NaR, exhibited some improvements in the membrane targeting and photocurrent properties over native NaRs. The I1K6NaR-expressing cortical neurons were stably silenced by green light irradiation for a certain long duration. With its rapid kinetics and voltage dependency, the photoactivation of I1K6NaR would specifically counteract the generation of action potentials with less hyperpolarization of the neuronal membrane potential than KR2.	[Hogue, Mohammad Razuanul; Ishizuka, Toru; Mishima, Takaaki; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan; [Inoue, Keiichi; Abe-Yoshizumi, Rei; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Inoue, Keiichi] Nagoya Inst Technol, Frontier Res Inst Mat Sci, Showa Ku, Nagoya, Aichi 4668555, Japan; [Igarashi, Hiroyuki; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Dept Physiol & Pharmacol, Sendai, Miyagi 9808577, Japan; [Igarashi, Hiroyuki] Tohoku Univ, Div Interdisciplinary Adv Res & Educ, Sendai, Miyagi 9808578, Japan	Tohoku University; Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); Nagoya Institute of Technology; Tohoku University; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan.; Yawo, H (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Neurosci, Dept Physiol & Pharmacol, Sendai, Miyagi 9808577, Japan.	hiromu.yavvo.c7@tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015; Inoue, Keiichi/AEO-3337-2022	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Inoue, Keiichi/0000-0002-6898-4347	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25250001, 25290002, 15H01413]; MEXT, Japan [15K15025]; JST, Strategic International Collaborative Research Program, SICORP; Grants-in-Aid for Scientific Research [15K15025, 15H01413, 14J40214] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, Strategic International Collaborative Research Program, SICORP; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in Aid for Scientific Research (No. 25250001 to HY and No. 25290002 to TI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan: http.//www.isps.gojp/englishie-grants/grants01.html, a Grant-in-Aid for Scientific Research on Innovative Areas "Adaptive Circuit Shift" (No. 15H01413 to HY) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan: http_//www.jsps.go.jp/enghsh/e-grants/grants01.html, a Grant-in-Aid for challenging Exploratory Research (No. 15K15025 to HY), MEXT, Japan: http://www.jsps.go.jp/english/egrants/grants01.html and JST, Strategic International Collaborative Research Program, SICORP.	Alfonsa H, 2015, J NEUROSCI, V35, P7715, DOI 10.1523/JNEUROSCI.4105-14.2015; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Bertsova YV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P449, DOI 10.1134/S0006297915040082; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Candan T., 2014, INT J DIFF EQS, V2014, P1, DOI DOI 10.1074/JBC.M114.550012; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deidda G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00119; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hososhima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119558; Inada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029019; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kaila K, 2014, CURR OPIN NEUROBIOL, V26, P34, DOI 10.1016/j.conb.2013.11.004; Kandori H, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00052; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kato Y, 2015, J PHYS CHEM LETT, V6, P5111, DOI 10.1021/acs.jpclett.5b02371; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Raimondo JV, 2012, NAT NEUROSCI, V15, P1102, DOI 10.1038/nn.3143; Schlebach JP, 2015, Q REV BIOPHYS, V48, P1, DOI 10.1017/S0033583514000110; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Ueno T, 2002, J BIOL CHEM, V277, P4945, DOI 10.1074/jbc.M109439200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Watanabe S, 2016, PHOTOCH PHOTOBIO SCI, V15, P365, DOI 10.1039/c5pp00290g; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yawo H, 2015, OPTOGENETICS LIGHT S, P111; Yawo H, 2013, DEV GROWTH DIFFER, V55, P474, DOI 10.1111/dgd.12053; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	48	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166820	10.1371/journal.pone.0166820	http://dx.doi.org/10.1371/journal.pone.0166820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861619	Green Submitted, gold, Green Published			2022-12-26	WOS:000388350300113
J	Liu, G; Zou, H; Luo, TW; Long, MF; Bian, JC; Liu, XZ; Gu, JH; Yuan, Y; Song, RL; Wang, Y; Zhu, JQ; Liu, ZP				Liu, Gang; Zou, Hui; Luo, Tongwang; Long, Mengfei; Bian, Jianchun; Liu, Xuezhong; Gu, Jianhong; Yuan, Yan; Song, Ruilong; Wang, Yi; Zhu, Jiaqiao; Liu, Zongping			Caspase-Dependent and Caspase-Independent Pathways Are Involved in Cadmium-Induced Apoptosis in Primary Rat Proximal Tubular Cell Culture	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; ENDONUCLEASE-G; NUCLEAR TRANSLOCATION; ENDOPLASMIC-RETICULUM; DNA FRAGMENTATION; CYTOCHROME-C; FACTOR AIF; BNIP3; ACTIVATION	We designed this study to investigate whether cadmium induces caspase-independent apoptosis and to investigate the relationship between the caspase-dependent and caspase-independent apoptotic pathways. Cadmium (1.25-2.5 mu M) induced oxidative stress in rat proximal tubular (rPT) cells, as seen in the reactive oxygen species levels; N-acetylcysteine prevented this. Cyclosporin A (CsA) prevented mitochondrial permeability transition pore opening and apoptosis; there was mitochondrial ultrastructural disruption, mitochondrial cytochrome c (cyt c) translocation to the cytoplasm, and subsequent caspase-9 and caspase-3 activation. Z-VAD-FMK prevented caspase-3 activation and apoptosis and decreased BNIP-3 (Bcl-2/adenovirus E1B 19-kDa interacting protein 3) expression levels and apoptosis-inducing factor/endonuclease G (AIF/Endo G) translocation. Simultaneously, cadmium induced prominent BNIP-3 expression in the mitochondria and cytoplasmic AIF/Endo G translocation to the nucleus. BNIP-3 silencing significantly prevented AIF and Endo G translocation and decreased the apoptosis rate, cyt c release, and caspase-9 and caspase-3 activation. These results suggest that BNIP-3 is involved in the caspase-independent apoptotic pathway and is located upstream of AIF/Endo G; both the caspase-dependent and caspase-independent pathways are involved in cadmium-induced rPT cell apoptosis and act synergistically.	[Zhu, Jiaqiao; Liu, Zongping] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; Jiangsu Key Lab Zoonosis, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Zhu, JQ; Liu, ZP (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.	jgzhu1998@163.com; liuzongping@yzu.edu.cn		YUAN, YAN/0000-0002-1658-5328	National Natural Science Foundation of China [31101866, 31372495, 31502128, 31302058]; Jiangsu Provincial Natural Science Foundation of China [BK20150447]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31101866, No. 31372495, No. 31502128 and No. 31302058), Jiangsu Provincial Natural Science Foundation of China (BK20150447) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). We state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Arnoult D, 2003, CELL DEATH DIFFER, V10, P845, DOI 10.1038/sj.cdd.4401240; Burton TR, 2009, J NEUROSCI, V29, P4189, DOI 10.1523/JNEUROSCI.5747-08.2009; Chaitanya GV, 2008, BRAIN RES, V1246, P178, DOI 10.1016/j.brainres.2008.09.075; Chen J, 2009, TOXICOL APPL PHARM, V241, P81, DOI 10.1016/j.taap.2009.07.038; Chen Q, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00271; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Choe JY, 2015, APOPTOSIS, V20, P38, DOI 10.1007/s10495-014-1057-1; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Dawson VL, 2004, J BIOENERG BIOMEMBR, V36, P287, DOI 10.1023/B:JOBB.0000041755.22613.8d; de Azevedo RA, 2015, PEPTIDES, V68, P113, DOI 10.1016/j.peptides.2014.09.024; Gerace E, 2014, NEUROBIOL DIS, V70, P43, DOI 10.1016/j.nbd.2014.05.023; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hashemi M, 2007, EUR J PHARMACOL, V557, P9, DOI 10.1016/j.ejphar.2006.11.010; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Jacotot E, 2006, BBA-BIOENERGETICS, V1757, P1312, DOI 10.1016/j.bbabio.2006.07.002; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Komoike Y, 2012, ARCH TOXICOL, V86, P37, DOI 10.1007/s00204-011-0742-x; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lee BI, 2005, NEUROSCI LETT, V386, P23, DOI 10.1016/j.neulet.2005.05.058; Lee WK, 2007, AM J PHYSIOL-CELL PH, V293, pC839, DOI 10.1152/ajpcell.00197.2007; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu G, 2016, ARCH TOXICOL, V90, P1193, DOI 10.1007/s00204-015-1547-0; Liu PL, 2005, AM J PHYSIOL-LUNG C, V289, pL739, DOI 10.1152/ajplung.00099.2005; Liu XY, 2010, TOXICOL LETT, V195, P90, DOI 10.1016/j.toxlet.2010.02.004; McManus MJ, 2014, MOL CELL NEUROSCI, V63, P13, DOI 10.1016/j.mcn.2014.09.002; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Pathak N, 2006, TOXICOLOGY, V220, P26, DOI 10.1016/j.tox.2005.11.027; Pathak N, 2006, TOXICOL LETT, V165, P121, DOI 10.1016/j.toxlet.2006.02.004; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Qi YM, 2012, J CELL BIOL, V198, P103, DOI 10.1083/jcb.201111063; Quinsay MN, 2010, J MOL CELL CARDIOL, V48, P1146, DOI 10.1016/j.yjmcc.2009.12.004; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Shih CM, 2004, J CELL BIOCHEM, V91, P384, DOI 10.1002/jcb.10761; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Thevenod F, 2013, METAL IONS LIFE SCI, V11, P415, DOI 10.1007/978-94-007-5179-8_14; Thijssen S, 2007, TOXICOLOGY, V236, P29, DOI 10.1016/j.tox.2007.03.022; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Wang L, 2011, ARCH ENVIRON CON TOX, V61, P500, DOI 10.1007/s00244-011-9644-4; Wang L, 2009, ARCH TOXICOL, V83, P417, DOI 10.1007/s00204-009-0425-z; Wang L, 2009, BIOL TRACE ELEM RES, V127, P53, DOI 10.1007/s12011-008-8223-7; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wang YZ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015001; Webster BR, 2014, BBA-MOL CELL BIOL L, V1841, P525, DOI 10.1016/j.bbalip.2014.02.001; Yu SW, 2009, ASN NEURO, V1, DOI 10.1042/AN20090046; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030; ZASSENHAUS HP, 1994, CURR GENET, V25, P142, DOI 10.1007/BF00309540; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017998; Zhang L, 2009, FASEB J, V23, P3405, DOI 10.1096/fj.08-124354; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhang Z. G., 2007, RES IRON STEEL, V03, P38, DOI DOI 10.1161/STR0KEAHA.106.475129	58	43	47	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166823	10.1371/journal.pone.0166823	http://dx.doi.org/10.1371/journal.pone.0166823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861627	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300115
J	Nunes, AMPB; Ribeiro, GS; Ferreira, IE; Moura, ARSS; Felzemburgh, RDM; de Lemos, APS; Reis, MG; de Moraes, JC; Campos, LC				Pithon Borges Nunes, Amelia Maria; Sousa Ribeiro, Guilherme; Eustaquio Ferreira, Italo; Silva Simoes Moura, Ana Rafaela; Martins Felzemburgh, Ridalva Dias; Silva de Lemos, Ana Paula; Galvao Reis, Mitermayer; Cassio de Moraes, Jose; Carvalho Campos, Leila			Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; DISEASE; EPIDEMIOLOGY; PREVALENCE; LESSONS	Neisseria meningitidis is a commensal bacterium of the human nasopharynx. In rare cases, it penetrates the mucosa, entering the blood stream and causing various forms of disease. Meningococcal conjugate vaccines can prevent invasive disease not only by direct effect in vaccinated individuals but also by herd protection, preventing acquisition of carriage, which interrupts transmission and leads to protection of unvaccinated persons. In 2010 in Salvador, Brazil, an outbreak of group C meningococcal disease led to a mass meningococcal serogroup C conjugate vaccination drive, targeting those <5 and 10-24 years of age. The present study aimed to estimate the prevalence of and identify factors associated with N. meningitidis carriage among adolescents from Salvador, Brazil, in the post-vaccination period. In spring 2014, we performed a cross-sectional study involving 1,200 public school students aged 11-19 years old. Oropharyngeal swabs were collected to identify N. meningitidis. Of the 59 colonized participants, 36 (61.0%) carried non-groupable N. meningitidis, while genogroup B (11.9%), Y (8.5%), E (6.8%), Z (5.1%), C (3.4%), and W(3.4%) were also detected. The overall prevalence of N. meningitidis carriage was 4.9% (95% confidence interval [CI], 3.6-6.1%); the prevalence of N. meningitidis genogroup C was 0.17% (95% CI, 0.0-0.40%). There was no difference by age. Factors associated with carriage were having only one, shared, bedroom in the household (PR, 2.02; 95% CI, 0.99-4.12, p = 0.05); the mother being the only smoker in the home (PR, 2.48; 95% CI, 1.16-5.29; p = 0.01); and going to pubs/parties more than 5 times/month (PR, 2.61; 95% CI, 1.38-4.92; p = 0.02). Our findings show that the N. meningitidis carriage rate in adolescents from Salvador, Bahia, is low and is potentially influenced by the low prevalence of N. meningitidis genogroup C. However, continued surveillance is important to identify changes in the dynamics of N. meningitidis, including the emergence of diseases due to a non-C serogroup.	[Pithon Borges Nunes, Amelia Maria; Sousa Ribeiro, Guilherme; Eustaquio Ferreira, Italo; Silva Simoes Moura, Ana Rafaela; Galvao Reis, Mitermayer; Carvalho Campos, Leila] FIOCRUZ BA, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil; [Sousa Ribeiro, Guilherme] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil; [Martins Felzemburgh, Ridalva Dias] Univ Fed Bahia, Escola Enfermagem, BR-40110040 Salvador, BA, Brazil; [Silva de Lemos, Ana Paula] Adolfo Lutz Inst, Ctr Bacteriol, BR-01246000 Sao Paulo, Brazil; [Cassio de Moraes, Jose] Fac Ciencias Med Santa Casa Sao Paulo, BR-01221020 Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia; Instituto Adolfo Lutz; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo	Campos, LC (corresponding author), FIOCRUZ BA, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.	Iccampos@bahia.fiocruz.br	MORAES, JOSE C/H-6788-2012; Campos, Leila/AAO-3207-2021; Lemos, Ana Paula/ABE-6240-2021; Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020	Campos, Leila/0000-0001-9150-464X; Ribeiro, Guilherme/0000-0002-6798-2059; Reis, Mitermayer/0000-0002-3051-9060; Kruemmel, Ana Rafaela/0000-0002-7406-1223	Ministerio da Saude, Brazil [TC335/2013]; Fundacao de Amparo a Pesquisa do Estado da Bahia [SUS007/2014]	Ministerio da Saude, Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia	This work was supported by the Ministerio da Saude, Brazil, #TC335/2013, http://portalsaudesaude.gov..br/ (LCC); Fundacao de Amparo a Pesquisa do Estado da Bahia, SUS007/2014, http://www.fapesb.ba.gov.br/ (LCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to all students and parents who participated in the survey reported in this article as well as the Secretaria Estadual de Educacao da Bahia, the Secretaria Municipal de Educacao de Salvador, and the school directors for their full support of this study. We also thank ARS Bispo, CMG Ribeiro, and VP Barsante for collecting information and samples. We are especially grateful to X Wang (Meningitis Laboratory, Centers for Disease Control and Prevention) for the identification of the serogroups E and Z using whole genome sequencing, and to HG Costa, MEN Gusmao, and ES Alves (Escola de Enfermagem, Universidade Federal da Bahia) as well as MAA Figueiredo (Secretaria de Sande do Estado da Bahia) for their support and guidance. The authors acknowledge RR da Anunciacao who helped with questionnaire development and provided technical assistance and IAD Paploski for his support in the statistical analysis. We would like to thank Editage (www.editage.com) for English language editing.	Abad R, 2014, EPIDEMIOL INFECT, V142, P2461, DOI 10.1017/S0950268814001149; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; BLACKWELL CC, 1990, LANCET, V336, P53, DOI 10.1016/0140-6736(90)91565-R; BLACKWELL CC, 1992, EPIDEMIOL INFECT, V108, P441, DOI 10.1017/S0950268800049943; Bratcher HB, 2012, FUTURE MICROBIOL, V7, P873, DOI [10.2217/fmb.12.62, 10.2217/FMB.12.62]; Cardoso CW, 2012, VACCINE, V30, P5541, DOI 10.1016/j.vaccine.2012.06.044; Cardoso CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123734; CAUGANT DA, 1992, EPIDEMIOL INFECT, V109, P241, DOI 10.1017/S0950268800050196; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; de Moraes JC, 2015, PEDIATR INFECT DIS J, V34, P1197, DOI 10.1097/INF.0000000000000853; Deasy AM, 2015, CLIN INFECT DIS, V60, P1512, DOI 10.1093/cid/civ098; Diaz J, 2016, J INFECT PUBLIC HEAL, V9, P506, DOI 10.1016/j.jiph.2015.12.011; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; Kretz CB, 2016, EMERG INFECT DIS, V22, P1762, DOI 10.3201/eid2210.160468; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Ministerio de Salud. Departamento de Epidemiologia, 2016, ENF MEN SIT EP; Ministry of Health, 2008, HLTH SURV; Moreno J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135497; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Orr HJ, 2003, EMERG INFECT DIS, V9, P1314, DOI 10.3201/eid0910.030344; Rodriguez P, 2014, VACCINE, V32, P5677, DOI 10.1016/j.vaccine.2014.08.015; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Safadi MAP, 2011, EXPERT REV VACCINES, V10, P1717, DOI [10.1586/erv.11.159, 10.1586/ERV.11.159]; Safadi MAP, 2015, VACCINE, V33, P6529, DOI 10.1016/j.vaccine.2015.10.055; STUART JM, 1989, LANCET, V2, P723, DOI 10.1016/S0140-6736(89)90781-2; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	40	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166475	10.1371/journal.pone.0166475	http://dx.doi.org/10.1371/journal.pone.0166475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861618	Green Published, gold			2022-12-26	WOS:000388350300062
J	Endo, H; Okami, J; Okuyama, H; Nishizawa, Y; Imamura, F; Inoue, M				Endo, H.; Okami, J.; Okuyama, H.; Nishizawa, Y.; Imamura, F.; Inoue, M.			The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations	ONCOGENE			English	Article							SIGNAL-REGULATED KINASE; GEFITINIB RESISTANCE; ACQUIRED-RESISTANCE; PROTEIN-SYNTHESIS; RECEPTOR; PATHWAY; QUIESCENCE; PROMOTES; SURVIVAL; MUTANT	The biologic activity of individual cancer cells is highly heterogeneous. Hypoxia, one of the prominent features of a tumor microenvironment, is thought to be causal in generating this cellular heterogeneity. In this study, we revealed that primary lung cancer cells harboring activating epidermal growth factor receptor (EGFR) mutations generally entered a dormant state when hypoxic. We found that heterodimer formation of the ERBB family receptor tyrosine kinases (RTKs), and their subsequent downstream signaling, was diminished under hypoxic conditions, although phosphorylation of the EGFR was retained. Dormant lung cancer cells were found to be resistant to EGFR tyrosine kinase inhibitor (TKI) treatment. In terms of mechanism, we found that a negative regulator of ERBB signaling, MIG6/ERRFI1/RALT/Gene33, was induced by hypoxia both in vitro and in vivo. MIG6 expression prevented heterodimer formation of ERBB family RTKs, and suppressed their downstream signaling. Knockdown of MIG6 enhanced tumor cell growth under hypoxic conditions, and promoted the phosphorylation of ERK and AKT via increased EGFR-HER3 binding. Critically, sensitivity to an EGFR-TKI, as well as to irradiation under hypoxic conditions, was increased in MIG6 knockdown cells. The expression of MIG6 was partly correlated with a pS6 negative zone in patient tumors. Analyses of tumor sections from 68 patients with activating EGFR mutations showed that patients with high MIG6 expression showed significantly shorter survival after EGFR-TKI treatment than other groups. Collectively, our data suggest that dormant cancer cells with a high MIG6 expression level might be one of the causes of EGFR-TKI resistance in EGFR mutant lung cancer cells.	[Endo, H.; Okuyama, H.; Inoue, M.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan; [Okami, J.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Osaka, Japan; [Nishizawa, Y.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Imamura, F.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	inoue-ma2@mc.pref.osaka.jp	Okami, Jiro/AAE-3837-2021		JSPS [26111005]; KAKENHI [25461937]; Grants-in-Aid for Scientific Research [26111005] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr T Tabuchi and Dr K Fukui for statistical counseling, N Kanto and T Yasuda for technical assistance, and M Izutsu for secretarial assistance. This work was supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas (26111005) (to MI) and KAKENHI (25461937) (to HE).	Abravanel DL, 2015, J CLIN INVEST, V125, P2484, DOI 10.1172/JCI74883; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Ameri K, 2015, CELL REP; Amin R, 2016, MOL ONCOL, V10, P575, DOI 10.1016/j.molonc.2015.11.009; Anastasi S, 2016, SEMIN CELL DEV BIOL, V50, P115, DOI 10.1016/j.semcdb.2015.10.001; Bui AT, 2015, CELL CYCLE, V14, P1218, DOI 10.1080/15384101.2015.1014145; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068966; Crea F, 2015, TRENDS MOL MED, V21, P206, DOI 10.1016/j.molmed.2015.02.005; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Endo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098858; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1786; Izumchenko E, 2014, CANCER RES, V74, P3995, DOI 10.1158/0008-5472.CAN-14-0110; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maity TK, 2015, CANCER DISCOV, V5, P534, DOI 10.1158/2159-8290.CD-14-0750; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Minakata K, 2012, CANCER SCI, V103, P1946, DOI 10.1111/j.1349-7006.2012.02408.x; Nakajima A, 2015, INT J CANCER, V136, P2949, DOI 10.1002/ijc.29349; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Okuyama H, 2010, CANCER RES, V70, P10213, DOI 10.1158/0008-5472.CAN-10-2720; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peart T, 2015, ONCOTARGET, V6, P22424, DOI 10.18632/oncotarget.4211; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sato Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24823; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sosa MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7170; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Tiram G, 2016, ACS NANO, V10, P2028, DOI 10.1021/acsnano.5b06189; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Wang N, 2015, FASEB J, V29, P3141, DOI 10.1096/fj.14-266379; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	53	22	22	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2824	2834		10.1038/onc.2016.431	http://dx.doi.org/10.1038/onc.2016.431			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27893711				2022-12-26	WOS:000401697800005
J	Bucay, N; Sekhon, K; Yang, T; Majid, S; Shahryari, V; Hsieh, C; Mitsui, Y; Deng, G; Tabatabai, ZL; Yamamura, S; Calin, GA; Dahiya, R; Tanaka, Y; Saini, S				Bucay, N.; Sekhon, K.; Yang, T.; Majid, S.; Shahryari, V.; Hsieh, C.; Mitsui, Y.; Deng, G.; Tabatabai, Z. L.; Yamamura, S.; Calin, G. A.; Dahiya, R.; Tanaka, Y.; Saini, S.			MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer	ONCOGENE			English	Article							TUMOR-INITIATING CELLS; STEM-CELLS; INTEGRATIVE ANALYSIS; DOWN-REGULATION; CYCLE ARREST; GLIOMA-CELLS; EXPRESSION; CARCINOMA; DELETIONS; PROGRESSION	A major genomic alteration in prostate cancer (PCa) is frequent loss of chromosome (chr) 8p with a common region of loss of heterozygosity (LOH) at chr8p22 locus. Genomic studies implicate this locus in the initiation of clinically significant PCa and with progression to metastatic disease. However, the genes within this region have not been fully characterized to date. Here we demonstrate for the first time that a microRNA component of this region-miR-383- is frequently downregulated in prostate cancer, has a critical role in determining tumor- initiating potential and is involved in prostate cancer metastasis via direct regulation of CD44, a ubiquitous marker of PCa tumor- initiating cells (TICs)/stem cells. Expression analyses of miR-383 in PCa clinical tissues established that low miR-383 expression is associated with poor prognosis. Functional data suggest that miR-383 regulates PCa tumor-initiating/stem-like cells via CD44 regulation. Ectopic expression of miR-383 inhibited tumor- initiating capacity of CD44+ PCa cells. Also, 'anti-metastatic' effects of ectopic miR-383 expression were observed in a PCa experimental metastasis model. In view of our results, we propose that frequent loss of miR-383 at chr8p22 region leads to tumor initiation and prostate cancer metastasis. Thus, we have identified a novel finding that associates a long observed genomic alteration to PCa stemness and metastasis. Our data suggest that restoration of miR-383 expression may be an effective therapeutic modality against PCa. Importantly, we identified miR-383 as a novel PCa tissue diagnostic biomarker with a potential that outperforms that of serum PSA.	[Bucay, N.; Sekhon, K.; Yang, T.; Majid, S.; Shahryari, V.; Hsieh, C.; Mitsui, Y.; Deng, G.; Tabatabai, Z. L.; Yamamura, S.; Dahiya, R.; Tanaka, Y.; Saini, S.] Vet Affairs Med Ctr, Dept Urol, 4150 Clement St, San Francisco, CA 94121 USA; [Bucay, N.; Sekhon, K.; Yang, T.; Majid, S.; Shahryari, V.; Hsieh, C.; Mitsui, Y.; Deng, G.; Tabatabai, Z. L.; Yamamura, S.; Dahiya, R.; Tanaka, Y.; Saini, S.] Univ Calif San Francisco, 4150 Clement St, San Francisco, CA 94121 USA; [Calin, G. A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Noncoding RNA Ctr, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center	Saini, S (corresponding author), Vet Affairs Med Ctr, Dept Urol, 4150 Clement St, San Francisco, CA 94121 USA.; Saini, S (corresponding author), Univ Calif San Francisco, 4150 Clement St, San Francisco, CA 94121 USA.; Saini, S (corresponding author), Univ Calif San Francisco, 4150 Clement St, San Francisco, CA 94121 USA.	Sharanjot.Saini@ucsf.edu	Calin, George/E-9390-2011	Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578	National Cancer Institute at the National Institutes of Health [RO1CA177984, RO1CA138642]; VA program project on PCa [BX001604]; NATIONAL CANCER INSTITUTE [R01CA182905, R01CA138642, R01CA177984] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002690, IP1BX001604] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); VA program project on PCa; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr Roger Erickson for his support and assistance with preparation of the manuscript. We acknowledge UCSF CTSI (Dr Iryna V. Lobach) for help with statistical analysis. This work was supported by the National Cancer Institute at the National Institutes of Health (Grant Number RO1CA177984, RO1CA138642), VA program project on PCa (BX001604).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BOVA GS, 1993, CANCER RES, V53, P3869; Brooks DD, 2010, J NATL MED ASSOC, V102, P423, DOI 10.1016/S0027-9684(15)30578-2; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; El Gammal AT, 2010, CLIN CANCER RES, V16, P56, DOI 10.1158/1078-0432.CCR-09-1423; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Han SL, 2015, CANCER LETT, V366, P61, DOI 10.1016/j.canlet.2015.06.004; He ZW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0557-0; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Huang HL, 2014, CELL SIGNAL, V26, P903, DOI 10.1016/j.cellsig.2014.01.016; KAGAN J, 1995, ONCOGENE, V11, P2121; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li HW, 2011, J SURG ONCOL, V103, P558, DOI 10.1002/jso.21806; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Liao XH, 2015, CELL SIGNAL, V27, P2285, DOI 10.1016/j.cellsig.2015.08.005; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lu W, 2006, GENE CHROMOSOME CANC, V45, P509, DOI 10.1002/gcc.20314; MACOSKA JA, 1995, CANCER RES, V55, P5390; Matsuyama H, 2003, AKTUEL UROL, V34, P247; Matsuyama H, 2003, PROSTATE, V54, P103, DOI 10.1002/pros.10173; Matsuyama H, 2007, CANCER GENET CYTOGEN, V174, P24, DOI 10.1016/j.cancergencyto.2006.11.008; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Piovani G, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-25; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Saini S, 2016, CELL ONCOL, V39, P97, DOI 10.1007/s13402-016-0268-6; Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wicha MS, 2011, NAT MED, V17, P162, DOI 10.1038/nm0211-162; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Xu DW, 2015, TUMOR BIOL, V36, P7743, DOI 10.1007/s13277-015-3378-2; Xu Z, 2014, BIOCHEM BIOPH RES CO, V453, P833, DOI 10.1016/j.bbrc.2014.10.047; Yang K, 2010, AM J TRANSL RES, V2, P88; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yin MM, 2014, J BIOL CHEM, V289, P18239, DOI 10.1074/jbc.M113.546044; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110472	52	23	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2667	2679		10.1038/onc.2016.419	http://dx.doi.org/10.1038/onc.2016.419			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27893706	Green Accepted, Green Submitted			2022-12-26	WOS:000401120900005
J	Schrock, MS; Batar, B; Lee, J; Druck, T; Ferguson, B; Cho, JH; Akakpo, K; Hagrass, H; Heerema, NA; Xia, F; Parvin, JD; Aldaz, CM; Huebner, K				Schrock, M. S.; Batar, B.; Lee, J.; Druck, T.; Ferguson, B.; Cho, J. H.; Akakpo, K.; Hagrass, H.; Heerema, N. A.; Xia, F.; Parvin, J. D.; Aldaz, C. M.; Huebner, K.			Wwox-Brca1 interaction: role in DNA repair pathway choice	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HOMOLOGOUS RECOMBINATION; WWOX; BRCA1; ASSOCIATION; INHIBITION; DAMAGE; ATM	In this study, loss of expression of the fragile site-encoded Wwox protein was found to contribute to radiation and cisplatin resistance of cells, responses that could be associated with cancer recurrence and poor outcome. WWOX gene deletions occur in a variety of human cancer types, and reduced Wwox protein expression can be detected early during cancer development. We found that Wwox loss is followed by mild chromosome instability in genomes of mouse embryo fibroblast cells from Wwox-knockout mice. Human and mouse cells deficient for Wwox also exhibit significantly enhanced survival of ionizing radiation and bleomycin treatment, agents that induce double-strand breaks (DSBs). Cancer cells that survive radiation recur more rapidly in a xenograft model of irradiated breast cancer cells; Wwox-deficient cells exhibited significantly shorter tumor latencies vs Wwox-expressing cells. This Wwox effect has important consequences in human disease: in a cohort of cancer patients treated with radiation, Wwox deficiency significantly correlated with shorter overall survival times. In examining mechanisms underlying Wwox-dependent survival differences, we found that Wwox-deficient cells exhibit enhanced homology directed repair (HDR) and decreased nonhomologous end-joining (NHEJ) repair, suggesting that Wwox contributes to DNA DSB repair pathway choice. Upon silencing of Rad51, a protein critical for HDR, Wwox-deficient cells were resensitized to radiation. We also demonstrated interaction of Wwox with Brca1, a driver of HDR, and show via immunofluorescent detection of repair proteins at ionizing radiation-induced DNA damage foci that Wwox expression suppresses DSB repair at the end-resection step of HDR. We propose a genome caretaker function for WWOX, in which Brca1-Wwox interaction supports NHEJ as the dominant DSB repair pathway in Wwox-sufficient cells. Taken together, the experimental results suggest that reduced Wwox expression, a common occurrence in cancers, dysregulates DSB repair, enhancing efficiency of likely mutagenic repair, and enabling radiation and cisplatin treatment resistance.	[Schrock, M. S.; Batar, B.; Druck, T.; Akakpo, K.; Hagrass, H.; Huebner, K.] Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Schrock, M. S.; Batar, B.; Druck, T.; Cho, J. H.; Akakpo, K.; Hagrass, H.; Heerema, N. A.; Xia, F.; Parvin, J. D.; Huebner, K.] Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lee, J.; Ferguson, B.; Aldaz, C. M.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Sci Pk,1808 Pk Rd 1C, Smithville, TX 78957 USA; [Cho, J. H.; Xia, F.] Ohio State Univ, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Heerema, N. A.] Ohio State Univ, Wexner Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Parvin, J. D.] Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, Div Computat Biol & Bioinformat, Columbus, OH 43210 USA; [Hagrass, H.] Zagazig Univ, Zagazig, Egypt; [Xia, F.] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Zagazig University; University of Arkansas System; University of Arkansas Medical Sciences	Aldaz, CM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Sci Pk,1808 Pk Rd 1C, Smithville, TX 78957 USA.; Huebner, K (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Ctr Comprehens Canc, Biomed Res Tower,Room 916,460 W 12th Ave, Columbus, OH 43210 USA.	maaldaz@mdanderson.org; kay.huebner@osumc.edu	Aldaz, C. Marcelo/E-7868-2011; Parvin, Jeffrey D/C-8955-2009; Batar, Bahadir/F-4724-2018	Aldaz, C. Marcelo/0000-0002-2453-2939; Akakpo, Kenneth/0000-0003-4720-7626	Pelotonia [9T32OD010429, CA154200, R01CA120516]; NIH/NCI [R01 CA102444, CA198228]; Scientific and Technological Research Council of Turkey (TUBITAK); Egyptian Cultural and Educational Bureau; breast cancer support foundations; Stefanie Spielman Fund of the OSUCCC; Anne M Wolfe Foundation; NATIONAL CANCER INSTITUTE [R01CA102444, P30CA016672, U01CA154200, R01CA120516, P30CA016058, R21CA198228] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010429] Funding Source: NIH RePORTER	Pelotonia; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau); breast cancer support foundations; Stefanie Spielman Fund of the OSUCCC; Anne M Wolfe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Pelotonia Graduate and Post-Doctoral Fellowships (to MS, BB), 9T32OD010429 (to MS), CA154200 (to KH), R01CA120516 (to KH), NIH/NCI R01 CA102444 (to CMA), CA198228 (to JP), a fellowship from the Scientific and Technological Research Council of Turkey (TUBITAK to BB) and a graduate research scholarship from the Egyptian Cultural and Educational Bureau (to HH). We thank the OSU CMIF shared Facility for confocal microscopy and the Genome Quebec company for assistance with CNA experiments. We also thank Matthew Guggenbiller (OSUMC) for help with the analysis of the brain cancer cohort and Megan Lowery and Richard D Wood (The University of Texas MD Anderson Cancer Center, Smithville, TX, USA) for providing the data in Figure 1d and Jenna Karras and T Banerjee for helpful discussions. We are especially appreciative of the additional funding by the breast cancer support foundations, the Stefanie Spielman Fund of the OSUCCC and the Anne M Wolfe Foundation (Anne's Army).	Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Abu-Odeh M, 2014, P NATL ACAD SCI USA, V111, pE4716, DOI 10.1073/pnas.1409252111; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2009, ENDOCRINOLOGY, V150, P1530, DOI 10.1210/en.2008-1087; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bednarek AK, 2000, CANCER RES, V60, P2140; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Choo A, 2015, GENE CHROMOSOME CANC, V54, P745, DOI 10.1002/gcc.22286; Christou Charita M, 2013, Biology (Basel), V2, P40, DOI 10.3390/biology2010040; Ferguson BW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-593; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Guler G, 2004, CANCER, V100, P1605, DOI 10.1002/cncr.20137; Hartmann C, 1999, INT J ONCOL, V15, P975; Hu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084638; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Iliopoulos D, 2007, CLIN CANCER RES, V13, P268, DOI 10.1158/1078-0432.CCR-06-2038; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Lim YC, 2014, MOL ONCOL, V8, P1603, DOI 10.1016/j.molonc.2014.06.012; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007775; Miuma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080730; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Salah Z, 2010, FUTURE ONCOL, V6, P249, DOI [10.2217/fon.09.152, 10.2217/FON.09.152]; Saldivar JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003077; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Scarpace L, 2015, CANC IMAG ARCH; Schrock MS, 2015, EXP BIOL MED, V240, P296, DOI 10.1177/1535370214561590; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108; You FL, 2004, ONCOGENE, V23, P5792, DOI 10.1038/sj.onc.1207739; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	41	30	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2215	2227		10.1038/onc.2016.389	http://dx.doi.org/10.1038/onc.2016.389			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27869163	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000399782700003
J	Juks, C; Lorents, A; Arukuusk, P; Langel, U; Pooga, M				Juks, Carmen; Lorents, Annely; Arukuusk, Piret; Langel, Ulo; Pooga, Margus			Cell-penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids	FASEB JOURNAL			English	Article						SR-A3; SR-A5; Ca2+ signaling; PI3K	PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; HAMSTER OVARY CELLS; PROTEIN CORONA; UP-REGULATION; IN-VIVO; OLIGONUCLEOTIDE DELIVERY; INTRACELLULAR CALCIUM; ENDOCYTIC PATHWAY; ENDOSOME FUSION; SURFACE	Scavenger receptors (SRs) are a large family of multifunctional receptors that are involved in a range of physiologic and pathologic processes. The ability of class A scavenger receptors (SR-As) to bind anionic ligands facilitates the internalization of negatively charged cell-penetrating peptide (CPP)-nucleic acid nanocomplexes and thus makes them attractive targets for delivery of various nucleic acids. Recently, we demonstrated that SR-A3 and SR-A5 are recruited from intracellular membranes to the plasma membrane after incubation with PepFect 14-splice-switching oligonucleotide complexes. Here, we examined the mechanisms responsible for translocation of SR-As to the cell surface. We demonstrate that, in addition to nanocomplexes, some amphipathic CPPs are able to induce externalization of SR-A3 and SR-A5, and this process requires the presence of calcium ions. Furthermore, translocation of SR-A3 and SR-A5 requires activity of phosphatidylinositol-3-kinase, intact actin cytoskeleton, and the presence of serum proteins in culture medium.	[Juks, Carmen; Lorents, Annely; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Arukuusk, Piret; Langel, Ulo] Univ Tartu, Inst Technol, Mol Biotechnol Lab, Tartu, Estonia; [Langel, Ulo] Stockholm Univ, Dept Neurochem, Stockholm, Sweden	University of Tartu; University of Tartu; Stockholm University	Pooga, M (corresponding author), Inst Mol & Cell Biol, 23 Riia Str, EE-51010 Tartu, Estonia.	mpooga@ut.ee	Pooga, Margus/A-8575-2011; Langel, Ulo/K-9773-2018	Pooga, Margus/0000-0003-4532-4087; Lorents, Annely/0000-0002-2823-5202; Langel, Ulo/0000-0001-6107-0844	Estonian Science Foundation [ESF 8705]; Estonian Ministry of Education and Research [0180019s11]; European Union Regional Development Fund through the Competence Centre on Reproductive Medicine and Biology [EU30020]; Estonian Research Council [IUT20-26]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union Regional Development Fund through the Competence Centre on Reproductive Medicine and Biology; Estonian Research Council	This study was supported by the Estonian Science Foundation (Grant ESF 8705), the Estonian Ministry of Education and Research (Grant 0180019s11), the European Union Regional Development Fund (Grant EU30020) through the Competence Centre on Reproductive Medicine and Biology, and the Estonian Research Council (IUT20-26). The authors declare no conflicts of interest.	Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arukuusk P, 2013, BIOCONJUGATE CHEM, V24, P1721, DOI 10.1021/bc4002757; Caracciolo G, 2013, ACS APPL MATER INTER, V5, P13171, DOI 10.1021/am404171h; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Choi CHJ, 2013, P NATL ACAD SCI USA, V110, P7625, DOI 10.1073/pnas.1305804110; Cholewa J, 2010, J LEUKOCYTE BIOL, V87, P443, DOI 10.1189/jlb.0509318; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Ezzat K, 2012, FASEB J, V26, P1172, DOI 10.1096/fj.11-191536; Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fleischer CC, 2014, ACCOUNTS CHEM RES, V47, P2651, DOI 10.1021/ar500190q; Fukuhara-Takaki K, 2005, J BIOL CHEM, V280, P3355, DOI 10.1074/jbc.M408715200; Jess TJ, 1996, CELL SIGNAL, V8, P297, DOI 10.1016/0898-6568(96)00054-X; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; Juks C, 2015, BBA-BIOMEMBRANES, V1848, P3205, DOI 10.1016/j.bbamem.2015.09.019; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Kelley JL, 2014, CRIT REV IMMUNOL, V34, P241, DOI 10.1615/CritRevImmunol.2014010267; Kjeken R, 2001, BIOCHEM J, V357, P497, DOI 10.1042/0264-6021:3570497; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Kundra A, 1998, J BIOL CHEM, V273, P3848, DOI 10.1074/jbc.273.7.3848; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Lindberg S, 2015, J CONTROL RELEASE, V206, P58, DOI 10.1016/j.jconrel.2015.03.009; Lindberg S, 2013, INT J PHARMACEUT, V441, P242, DOI 10.1016/j.ijpharm.2012.11.037; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu ZM, 2007, CELL MOL LIFE SCI, V64, P1428, DOI 10.1007/s00018-007-7107-x; Lorents A, 2012, J BIOL CHEM, V287, P16880, DOI 10.1074/jbc.M111.318063; Lu H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-80; Lundin P, 2008, BIOCONJUGATE CHEM, V19, P2535, DOI 10.1021/bc800212j; Margus H, 2016, MOL PHARMACEUT, V13, P172, DOI 10.1021/acs.molpharmaceut.5b00598; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Melikov K, 2015, BIOCHEM J, V471, P221, DOI 10.1042/BJ20150272; Mietus-Snyder M, 2000, J BIOL CHEM, V275, P17661, DOI 10.1074/jbc.275.23.17661; Morimoto K, 1999, BIOL PHARM BULL, V22, P1022; Mortimer GM, 2014, ACS NANO, V8, P3357, DOI 10.1021/nn405830g; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nellimarla S, 2015, J IMMUNOL, V195, P3858, DOI 10.4049/jimmunol.1501028; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Padari K, 2011, METHODS MOL BIOL, V683, P181, DOI 10.1007/978-1-60761-919-2_13; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; Pozzi D, 2015, NANOSCALE, V7, P13958, DOI 10.1039/c5nr03701h; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Rydstrom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025924; Saalik P, 2009, BIOCONJUGATE CHEM, V20, P877, DOI 10.1021/bc800416f; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Song Z., 2013, FASEB J, V27; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; van Asbeck AH, 2013, ACS NANO, V7, P3797, DOI 10.1021/nn305754c; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; Veiman KL, 2013, MOL PHARMACEUT, V10, P199, DOI 10.1021/mp3003557; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Yan Y, 2013, ACS NANO, V7, P10960, DOI 10.1021/nn404481f; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125	62	19	20	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					975	988		10.1096/fj.201600811R	http://dx.doi.org/10.1096/fj.201600811R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27881484				2022-12-26	WOS:000395671200014
J	Kang, I; Harten, IA; Chang, MY; Braun, KR; Sheih, A; Nivison, MP; Johnson, PY; Workman, G; Kaber, G; Evanko, SP; Chan, CK; Merrilees, MJ; Ziegler, SF; Kinsella, MG; Frevert, CW; Wight, TN				Kang, Inkyung; Harten, Ingrid A.; Chang, Mary Y.; Braun, Kathleen R.; Sheih, Alyssa; Nivison, Mary P.; Johnson, Pamela Y.; Workman, Gail; Kaber, Gernot; Evanko, Stephen P.; Chan, Christina K.; Merrilees, Mervyn J.; Ziegler, Steven F.; Kinsella, Michael G.; Frevert, Charles W.; Wight, Thomas N.			Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; NF-KAPPA-B; CHONDROITIN SULFATE PROTEOGLYCANS; DOUBLE-STRANDED-RNA; HYALURONAN SYNTHESIS; TOLL-LIKE; PATTERN-RECOGNITION; NLRP3 INFLAMMASOME; CELLS; ASTHMA	Viral infection is an exacerbating factor contributing to chronic airway diseases, such as asthma, via mechanisms that are still unclear. Polyinosine-polycytidylic acid (poly(I:C)), a Toll-like receptor 3 (TLR3) agonist used as a mimetic to study viral infection, has been shown to elicit inflammatory responses in lungs and to exacerbate pulmonary allergic reactions in animal models. Previously, we have shown that poly(I:C) stimulates lung fibroblasts to accumulate an extracellular matrix (ECM), enriched in hyaluronan (HA) and its binding partner versican, which promotes monocyte adhesion. In the current study, we aimed to determine the in vivo role of versican in mediating inflammatory responses in poly(I:C)-induced lung inflammation using a tamoxifen-inducible versican-deficient mouse model (Vcan(-/-) mice). In C57Bl/6 mice, poly(I:C) instillation significantly increased accumulation of versican and HA, especially in the perivascular and peribronchial regions, which were enriched in infiltrating leukocytes. In contrast, versican-deficient (Vcan(-/-)) lungs did not exhibit increases in versican or HA in these regions and had strikingly reduced numbers of leukocytes in the bronchoalveolar lavage fluid and lower expression of inflammatory chemokines and cytokines. Poly(I:C) stimulation of lung fibroblasts isolated from control mice generated HA-enriched cable structures in the ECM, providing a substrate for monocytic cells in vitro, whereas lung fibroblasts from Vcan(-/-) mice did not. Moreover, increases in proinflammatory cytokine expression were also greatly attenuated in the Vcan(-/-) lung fibroblasts. These findings provide strong evidence that versican is a critical inflammatory mediator during poly(I:C)induced acute lung injury and, in association with HA, generates an ECM that promotes leukocyte infiltration and adhesion.	[Kang, Inkyung; Harten, Ingrid A.; Braun, Kathleen R.; Nivison, Mary P.; Johnson, Pamela Y.; Workman, Gail; Kaber, Gernot; Evanko, Stephen P.; Chan, Christina K.; Kinsella, Michael G.; Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA; [Sheih, Alyssa; Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Chang, Mary Y.; Frevert, Charles W.; Wight, Thomas N.] Univ Washington, Dept Comparat Med, Seattle, WA 98109 USA; [Chang, Mary Y.; Frevert, Charles W.; Wight, Thomas N.] Univ Washington, Ctr Lung Biol, Seattle, WA 98109 USA; [Merrilees, Mervyn J.] Univ Auckland, Sch Med Sci, Dept Anat & Med Imaging, Auckland 1010, New Zealand; [Nivison, Mary P.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Kaber, Gernot] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Benaroya Research Institute; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Auckland; University of Washington; University of Washington Seattle; Stanford University	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org			National Institutes of Health [P30 DK17047]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR030249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068731, U19AI125378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Richard D. Palmiter (Howard Hughes Medical Institute and University of Washington) and Robert J. Hunter (University of Washington) for expert guidance in the development of Vcan e4<SUP>fl/fl</SUP> mice and Dr. Virginia M. Green for careful reading and editing of the manuscript. National Institutes of Health Grant P30 DK17047 (University of Washington Diabetes Research Center) provided Core support.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andersson-Sjoland A, 2015, GLYCOBIOLOGY, V25, P243, DOI 10.1093/glycob/cwu120; Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Ayars AG, 2013, INT ARCH ALLERGY IMM, V161, P65, DOI 10.1159/000343031; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; Bogels M, 2012, ONCOIMMUNOLOGY, V1, P798, DOI 10.4161/onci.20427; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Clarke DL, 2014, CLIN SCI, V126, P567, DOI 10.1042/CS20130149; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; Faggian J, 2007, AM J PHYSIOL-REG I, V293, pR784, DOI 10.1152/ajpregu.00801.2006; Fanhchaksai K, 2016, INT J CANCER, V138, P630, DOI 10.1002/ijc.29804; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Han Hongwei, 2013, Bio Protoc, V3; Hascall V. C., 2002, HYALURONAN CHEM BIOC, P381; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Hope C, 2014, BLOOD, V123, P3305, DOI 10.1182/blood-2014-02-554071; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Kang I, 2014, J BIOL CHEM, V289, P15393, DOI 10.1074/jbc.M113.544338; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kurai D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00293; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Li D, 2013, 2013 INTERNATIONAL CONFERENCE ON VIRTUAL REALITY AND VISUALIZATION (ICVRV 2013), P37, DOI 10.1109/ICVRV.2013.14; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Ludwig MS, 2004, CLIN EXP ALLERGY, V34, P926, DOI 10.1111/j.1365-2222.2004.01980.x; Malmstrom J, 2002, PROTEOMICS, V2, P394, DOI 10.1002/1615-9861(200204)2:4<394::AID-PROT394>3.0.CO;2-6; Masuda A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4251; Matsushita MD, 2005, J PATHOL, V207, P102, DOI 10.1002/path.1818; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Merrilees MJ, 2004, J PATHOL, V203, P653, DOI 10.1002/path.1577; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Morales MMB, 2011, CRIT CARE, V15, DOI 10.1186/cc9401; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Ohkawa T, 1999, BBA-MOL CELL RES, V1448, P416, DOI 10.1016/S0167-4889(98)00155-4; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Reeves SR, 2016, J HISTOCHEM CYTOCHEM, V64, P364, DOI 10.1369/0022155416642989; ROBERTS CR, 1995, CHEST, V107, pS111, DOI 10.1378/chest.107.3_Supplement.111S; Said N, 2012, ONCOIMMUNOLOGY, V1, P1175, DOI 10.4161/onci.20594; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Saraya T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00226; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Shannon JM, 2003, AM J PHYSIOL-LUNG C, V285, pL1323, DOI 10.1152/ajplung.00226.2003; Shibata T, 2014, J IMMUNOL, V192, P3569, DOI 10.4049/jimmunol.1302766; Shih SC, 2005, EXP MOL PATHOL, V79, P14, DOI 10.1016/j.yexmp.2005.03.004; Snyder JM, 2015, J HISTOCHEM CYTOCHEM, V63, P952, DOI 10.1369/0022155415610383; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Tan WC, 2005, CURR OPIN PULM MED, V11, P21; Tang M, 2015, CELL REP, V13, P2851, DOI 10.1016/j.celrep.2015.11.053; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang W, 2009, ARCH MED RES, V40, P321, DOI 10.1016/j.arcmed.2009.04.005; Weitoft M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-67; Westergren-Thorsson G, 2002, INT J BIOCHEM CELL B, V34, P1256, DOI 10.1016/S1357-2725(02)00058-4; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Zhang ZW, 2012, INT J MOL SCI, V13, P6873, DOI 10.3390/ijms13066873; Zhu Z, 2002, J IMMUNOL, V168, P2953, DOI 10.4049/jimmunol.168.6.2953	77	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					51	63		10.1074/jbc.M116.753186	http://dx.doi.org/10.1074/jbc.M116.753186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895126	Green Published, hybrid			2022-12-26	WOS:000391578000005
J	Chen, H; Dutta, T; Deutscher, MP				Chen, Hua; Dutta, Tanmay; Deutscher, Murray P.			Growth Phase-dependent Variation of RNase BN/Z Affects Small RNAs REGULATION OF 6S RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; 6S RNA; BACILLUS-SUBTILIS; BN/RNASE Z; PROCESSING ENZYME; MESSENGER-RNA; IN-VIVO; POLYMERASE; SEQUENCE; TRANSCRIPTION	RNase BN, the RNase Z family member in E. coli, can participate in the processing of tRNA precursors. However, this function only becomes apparent when other processing enzymes are absent, raising the question of its primary physiological role. Here, we show that RNase BN itself is subject to growth phase-dependent regulation, because both rbn mRNA and RNase BN protein are at their highest levels in early exponential phase, but then decrease dramatically and are essentially absent in stationary phase. As a consequence of this variation, certain small RNAs, such as 6S RNA, remain low in exponential phase cells, and increase greatly in stationary phase. RNase BN affects 6S RNA abundance by decreasing its stability in exponential phase. RNase BN levels increase rapidly as cells exit stationary phase and are primarily responsible for the decrease in 6S RNA that accompanies this process. Purified RNase BN directly cleaves 6S RNA as shown by in vitro assays, and the 6S RNA: pRNA duplex is an even more favorable substrate of RNase BN. The exoribonuclease activity of RNase BN is unnecessary because all its action on 6S RNA is due to endonucleolytic cleavages. These data indicate that RNase BN plays an important role in determining levels of the global transcription regulator, 6S RNA, throughout the growth cycle.	[Chen, Hua; Dutta, Tanmay; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu	Dutta, Tanmay/ABH-2431-2021		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM16317 (to M. P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Beckmann BM, 2012, EMBO J, V31, P1727, DOI 10.1038/emboj.2012.23; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cavanagh AT, 2014, ANNU REV MICROBIOL, V68, P45, DOI 10.1146/annurev-micro-092611-150135; Cavanagh AT, 2012, NUCLEIC ACIDS RES, V40, P2234, DOI 10.1093/nar/gkr1003; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Deutscher MP, 2015, FEMS MICROBIOL REV, V39, P350, DOI 10.1093/femsre/fuv012; Dutta T, 2013, J BIOL CHEM, V288, P30636, DOI 10.1074/jbc.M113.514570; Dutta T, 2012, J BIOL CHEM, V287, P35747, DOI 10.1074/jbc.M112.407403; Dutta T, 2010, J BIOL CHEM, V285, P22872, DOI 10.1074/jbc.M110.141101; Fadouloglou VE, 2015, FEBS J, V282, P4548, DOI 10.1111/febs.13516; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kim KS, 2004, NUCLEIC ACIDS RES, V32, P6057, DOI 10.1093/nar/gkh939; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lee JY, 2013, MOL CELLS, V36, P227, DOI 10.1007/s10059-013-0082-1; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Song LM, 2016, NUCLEIC ACIDS RES, V44, P1979, DOI 10.1093/nar/gkw053; Stead MB, 2011, NUCLEIC ACIDS RES, V39, P3188, DOI 10.1093/nar/gkq1242; Viegas SC, 2008, RNA BIOL, V5, P230, DOI 10.4161/rna.6915; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Zhou H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5884; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	34	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26435	26442		10.1074/jbc.M116.757450	http://dx.doi.org/10.1074/jbc.M116.757450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27875308	hybrid, Green Published			2022-12-26	WOS:000391568200017
J	Yamamoto, K; Iwase, T; Terasaki, H				Yamamoto, Kentaro; Iwase, Takeshi; Terasaki, Hiroko			Long-Term Changes in Intraocular Pressure after Vitrectomy for Rhegmatogenous Retinal Detachment, Epi-Retinal Membrane, or Macular Hole	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PROLIFERATIVE DIABETIC-RETINOPATHY; NUCLEAR CATARACT; RISK-FACTORS; LENS; COMPLICATIONS; MECHANISM; SURGERY	Purpose To determine the long-term changes in the intraocular pressure (IOP) following vitrectomy for rhegmatogenous retinal detachment (RRD), epiretinal membrane (ERM), and macular hole (MH), and to investigate the relationship between the retinal disease and the incidence of late-onset IOP elevation. Methods This was a retrospective, observational, comparative study. We reviewed the medical records of 54 eyes of 54 RRD patients, 117 eyes of 117 ERM patients, and 75 eyes of 75 MH patients who underwent 20-, 23- or 25-gauge vitrectomy. The IOPs before surgery and 1, 3, 6, and 12 months following vitrectomy, and also at the final visit (average, 23.95 months) were evaluated. We defined a significant increase in the IOP as an increase of >= 4 mmHg from the preoperative IOP, and this increase was taken to be a 'death' event for the Kaplan-Meier survival analyses. Results The mean follow-up period was not significantly different among the groups. The mean IOP at 3 (P = 0.001) and 12 (P = 0.011) months following the vitrectomy and at the final visit (P = 0.002) were significantly higher than that before the vitrectomy in the RRD group. The mean IOP in the RRD group was significant higher than that in the ERM group at 1 (P = 0.005), 3 (P = 0.009), and 12 (P = 0.013) months following vitrectomy, and at the final visit (P = 0.032). Kaplan-Meier survival analyses showed that the RRD group had a significantly higher risk of an IOP increase following vitrectomy than the other groups (P < 0.001 by log-rank test). Multivariate logistic regression analyses showed that a preoperative diagnosis of RRD was the only risk factor that was significantly associated with a postoperative IOP elevation after excluding eyes with a low preoperative IOP (odds ratio, 3.208; P = 0.003). Conclusions A late-onset IOP elevation following vitrectomy was observed only in eyes that underwent RRD surgery. The elevation was probably caused by the specific characteristics and surgical procedures of RRD. Clinicians should pay more attention to the IOP elevation for long times after vitrectomy especially in eyes with RRD.	[Yamamoto, Kentaro; Iwase, Takeshi; Terasaki, Hiroko] Nagoya Univ Hosp, Dept Ophthalmol, Nagoya, Aichi, Japan	Nagoya University	Iwase, T (corresponding author), Nagoya Univ Hosp, Dept Ophthalmol, Nagoya, Aichi, Japan.	TsuyoshiIwase@aol.com			Grants-in-Aid for Scientific Research [26462635] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barbazetto IA, 2004, EXP EYE RES, V78, P917, DOI 10.1016/j.exer.2004.01.003; Brazitikos P D, 2000, Semin Ophthalmol, V15, P65; Chang S, 2006, AM J OPHTHALMOL, V141, P1033, DOI 10.1016/j.ajo.2006.02.014; Chen CJ, 1998, OPHTHALMOLOGY, V105, P94, DOI 10.1016/S0161-6420(98)91470-1; Chen PP, 1997, OPHTHALMIC SURG LAS, V28, P37; Cheng MA, 2001, ANESTHESIOLOGY, V95, P1351, DOI 10.1097/00000542-200112000-00012; Fujikawa M, 2014, GRAEF ARCH CLIN EXP, V252, P389, DOI 10.1007/s00417-013-2475-4; HAN DP, 1989, OPHTHALMOLOGY, V96, P1357; Hasegawa Y, 2012, JPN J OPHTHALMOL, V56, P46, DOI 10.1007/s10384-011-0094-3; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; Hunt K, 2004, J NEUROSURG ANESTH, V16, P287, DOI 10.1097/00008506-200410000-00005; KALRA L, 1988, CHEST, V93, P739, DOI 10.1378/chest.93.4.739; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654, DOI 10.1001/archopht.1991.01080050068031; Ki-I Y, 2013, JPN J OPHTHALMOL, V57, P57, DOI 10.1007/s10384-012-0207-7; Koreen L, 2012, RETINA-J RET VIT DIS, V32, P160, DOI 10.1097/IAE.0b013e318217fffb; Lalezary M, 2011, RETINA-J RET VIT DIS, V31, P679, DOI 10.1097/IAE.0b013e3181ff0d5a; Luk FOJ, 2009, RETINA-J RET VIT DIS, V29, P218, DOI 10.1097/IAE.0b013e31818ba9ca; Mi CW, 2015, RETINA-J RET VIT DIS, V35, P2543, DOI 10.1097/IAE.0000000000000641; PALMQUIST BM, 1988, ACTA OPHTHALMOL, V66, P671; Sayed KM, 2011, J MED INVESTIG, V58, P29; SMIDDY WE, 1995, OPHTHALMOLOGY, V102, P1688; Toyokawa N, 2015, AM J OPHTHALMOL, V159, P727, DOI 10.1016/j.ajo.2015.01.010; Yu AL, 2010, GRAEF ARCH CLIN EXP, V248, P1407, DOI 10.1007/s00417-010-1409-7	24	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167303	10.1371/journal.pone.0167303	http://dx.doi.org/10.1371/journal.pone.0167303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898707	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000050
J	Kumar, AS; Sowpati, DT; Mishra, RK				Kumar, Amitha Sampath; Sowpati, Divya Tej; Mishra, Rakesh K.			Single Amino Acid Repeats in the Proteome World: Structural, Functional, and Evolutionary Insights	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; DYNAMIC MUTATIONS; PROTEINS; DISEASE; GLUTAMINE; REGIONS; TANDEM; RUNS	Microsatellites or simple sequence repeats (SSR) are abundant, highly diverse stretches of short DNA repeats present in all genomes. Tandem mono/tri/hexanucleotide repeats in the coding regions contribute to single amino acids repeats (SAARs) in the proteome. While SSRs in the coding region always result in amino acid repeats, a majority of SAARs arise due to a combination of various codons representing the same amino acid and not as a consequence of SSR events. Certain amino acids are abundant in repeat regions indicating a positive selection pressure behind the accumulation of SAARs. By analysing 22 proteomes including the human proteome, we explored the functional and structural relationship of amino acid repeats in an evolutionary context. Only similar to 15% of repeats are present in any known functional domain, while similar to 74% of repeats are present in the disordered regions, suggesting that SAARs add to the functionality of proteins by providing flexibility, stability and act as linker elements between domains. Comparison of SAAR containing proteins across species reveals that while shorter repeats are conserved among orthologs, proteins with longer repeats, >15 amino acids, are unique to the respective organism. Lysine repeats are well conserved among orthologs with respect to their length and number of occurrences in a protein. Other amino acids such as glutamic acid, proline, serine and alanine repeats are generally conserved among the orthologs with varying repeat lengths. These findings suggest that SAARs have accumulated in the proteome under positive selection pressure and that they provide flexibility for optimal folding of functional/structural domains of proteins. The insights gained from our observations can help in effective designing and engineering of proteins with novel features.	[Kumar, Amitha Sampath; Sowpati, Divya Tej; Mishra, Rakesh K.] CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Mishra, RK (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	mishra@ccmb.res.in	Mishra, Rakesh K/F-3496-2010	Mishra, Rakesh K/0000-0001-6636-7380	Department of Biotechnology (Government of India); Council of Scientific and Industrial Research (CSIR) [BSC0121, BSC0118]	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	We thank the Department of Biotechnology (Government of India) and Council of Scientific and Industrial Research (CSIR) for financial assistance through grants, Center of Excellence, Genesis (BSC0121) and EpiHeD (BSC0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GREEN H, 1994, P NATL ACAD SCI USA, V91, P4298, DOI 10.1073/pnas.91.10.4298; Hancock JM, 2005, GENE, V345, P113, DOI 10.1016/j.gene.2004.11.023; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Huntley MA, 2004, GENETICS, V166, P1141, DOI 10.1534/genetics.166.3.1141; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; King DG, 2012, ADV EXP MED BIOL, V769, P10; Kumar RP, 2010, BIOESSAYS, V32, P165, DOI 10.1002/bies.200900111; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Luo H, 2014, BRIEF BIOINFORM, V15, P582, DOI 10.1093/bib/bbt003; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Nithianantharajah J, 2007, BIOESSAYS, V29, P525, DOI 10.1002/bies.20589; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ramamoorthy S, 2014, GENE, V551, P167, DOI 10.1016/j.gene.2014.08.052; Richards RI, 2001, HUM MOL GENET, V10, P2187, DOI 10.1093/hmg/10.20.2187; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Sawaya SM, 2012, ADV EXP MED BIOL, V769, P41; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Veitia RA, 2004, GENOMICS, V83, P502, DOI 10.1016/j.ygeno.2003.09.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	42	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166854	10.1371/journal.pone.0166854	http://dx.doi.org/10.1371/journal.pone.0166854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893794	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400049
J	Novitsky, V; Moyo, S; Wang, R; Gaseitsiwe, S; Essex, M				Novitsky, Vlad; Moyo, Sikhulile; Wang, Rui; Gaseitsiwe, Simani; Essex, M.			Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD PHYLOGENIES; DUAL INFECTION; SEQUENCE ALIGNMENT; TYPE-1 SUPERINFECTION; VIRUS; LOAD; GAG; MEN; IDENTIFICATION; REPLICATION	Background A single viral variant is transmitted in the majority of HIV infections. However, about 20% of heterosexually transmitted HIV infections are caused by multiple viral variants. Detection of transmitted HIV variants is not trivial, as it involves analysis of multiple viral sequences representing intra-host HIV-1 quasispecies. Methodology We distinguish two types of multiple virus transmission in HIV infection: (1) HIV transmission from the same source, and (2) transmission from different sources. Viral sequences representing intra-host quasispecies in a longitudinally sampled cohort of 42 individuals with primary HIV-1C infection in Botswana were generated by single-genome amplification and sequencing and spanned the V1C5 region of HIV-1C env gp120. The Maximum Likelihood phylogeny and distribution of pairwise raw distances were assessed at each sampling time point (n = 217; 42 patients; median 5 (IQR: 4-6) time points per patient, range 2-12 time points per patient). Results Transmission of multiple viral variants from the same source (likely from the partner with established HIV infection) was found in 9 out of 42 individuals (21%; 95 CI 10-37%). HIV super-infection was identified in 2 patients (5%; 95% CI 1-17%) with an estimated rate of 3.9 per 100 person-years. Transmission of multiple viruses combined with HIV super-infection at a later time point was observed in one individual. Conclusions Multiple HIV lineages transmitted from the same source produce a monophyletic clade in the inferred phylogenetic tree. Such a clade has transiently distinct sub-clusters in the early stage of HIV infection, and follows a predictable evolutionary pathway. Over time, the gap between initially distinct viral lineages fills in and initially distinct sub-clusters converge. Identification of cases with transmission of multiple viral lineages from the same source needs to be taken into account in cross-sectional estimation of HIV recency in epidemiological and population studies.	[Novitsky, Vlad; Wang, Rui; Essex, M.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Novitsky, Vlad; Moyo, Sikhulile; Gaseitsiwe, Simani; Essex, M.] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Moyo, Sikhulile] Univ Stellenbosch, Div Med Virol, Tygerberg, South Africa; [Wang, Rui] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Stellenbosch University; Harvard University; Brigham & Women's Hospital	Essex, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA USA.; Essex, M (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.	messex@hsph.harvard.edu	Wang, Rui/X-1699-2019; Moyo, Sikhulile/E-1464-2015	Wang, Rui/0000-0001-5007-193X; Moyo, Sikhulile/0000-0003-3821-4592	NIH/NIAID [R01 A1057027, R37 AI051164]; Oak Foundation [OUSA-12-025]; NIH/FIC [D43 TW009610]; Stellenbosch University, Division of Medical Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051164] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oak Foundation; NIH/FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Stellenbosch University, Division of Medical Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary HIV-1C infection study in Botswana (Tshedimoso Study) was supported and funded by the NIH/NIAID (R01 A1057027). SM was supported by the Oak Foundation Fellowship (Grant # OUSA-12-025), by the NIH/FIC (D43 TW009610), and by Stellenbosch University, Division of Medical Virology. RW was supported by the NIH/NIAID (R37 AI051164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; [Anonymous], 2021, LANG ENV STAT COMP; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Castro E, 2014, AIDS, V28, P1840, DOI 10.1097/QAD.0000000000000342; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornelissen M, 2016, AIDS RES HUMAN RETRO; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Gottlieb GS, 2007, CLIN INFECT DIS, V45, P501, DOI 10.1086/520024; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Janes H, 2015, NAT MED, V21, P1139, DOI 10.1038/nm.3932; Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Kraft CS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-22; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Masharsky AE, 2010, J INFECT DIS, V201, P1697, DOI 10.1086/652702; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2013, INFECT GENET EVOL, V19, P361, DOI 10.1016/j.meegid.2013.02.023; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2007, CLIN INFECT DIS, V45, pE68, DOI 10.1086/520683; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ping LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071557; Redd AD, 2015, AIDS, V29, P1567, DOI 10.1097/QAD.0000000000000740; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Ronen K, 2014, AIDS, V28, P2281, DOI 10.1097/QAD.0000000000000422; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sheward DJ, 2015, J INFECT DIS, V212, P904, DOI 10.1093/infdis/jiv136; Sterrett S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu056; Tully DC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005619; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633	55	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166746	10.1371/journal.pone.0166746	http://dx.doi.org/10.1371/journal.pone.0166746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893822	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400042
J	Amaral, KB; Silva, TP; Malta, KK; Carmo, LAS; Dias, FF; Almeida, MR; Andrade, GFS; Martins, JS; Pinho, RR; Costa-Neto, SF; Gentile, R; Melo, RCN				Amaral, Katia B.; Silva, Thiago P.; Malta, Kassia K.; Carmo, Livia A. S.; Dias, Felipe F.; Almeida, Mariana R.; Andrade, Gustavo F. S.; Martins, Jefferson S.; Pinho, Roberto R.; Costa-Neto, Socrates F.; Gentile, Rosana; Melo, Rossana C. N.			Natural Schistosoma mansoni Infection in the Wild Reservoir Nectomys squamipes Leads to Excessive Lipid Droplet Accumulation in Hepatocytes in the Absence of Liver Functional Impairment	PLOS ONE			English	Article							ARACHIDONIC-ACID; MOLECULAR-MECHANISMS; MASS-SPECTROMETRY; IMMUNE-RESPONSE; FATTY-ACIDS; RAT-BRAIN; WATER-RAT; IN-VITRO; MICE; HAEMATOBIUM	Schistosomiasis is a neglected tropical disease of a significant public health impact. The water rat Nectomys squamipes is one of the most important non-human hosts in the schistosomiasis mansoni transmission in Brazil, being considered a wild reservoir. Cellular mechanisms that contribute to the physiological adaptation of this rodent to the Schistosoma mansoni parasite are poorly understood. Here we identified, for the first time, that a hepatic steatosis, a condition characterized by excessive lipid accumulation with formation of lipid droplets (LDs) within hepatocytes, occurs in response to the natural S. mansoni infection of N. squamipes, captured in an endemic region. Significant increases of LD area in the hepatic tissue and LD numbers/hepatocyte, detected by quantitative histopathological and ultrastructural analyses, were paralleled by increased serum profile (total cholesterol and triglycerides) in infected compared to uninfected animals. Raman spectroscopy showed high content of polyunsaturated fatty acids (PUFAs) in the liver of both groups. MALDI-TOFF mass spectroscopy revealed an amplified pool of omega-6 PUFA arachidonic acid in the liver of infected animals. Assessment of liver functional activity by the levels of hepatic transaminases (ALT and AST) did not detect any alteration during the natural infection. In summary, this work demonstrates that the natural infection of the wild reservoir N. squamipes with S. mansoni elicits hepatic steatosis in the absence of liver functional harm and that accumulation of lipids, markedly PUFAs, coexists with low occurrence of inflammatory granulomatous processes, suggesting that lipid stores may be acting as a protective mechanism for dealing with the infection.	[Amaral, Katia B.; Silva, Thiago P.; Malta, Kassia K.; Carmo, Livia A. S.; Dias, Felipe F.; Melo, Rossana C. N.] Fed Univ Juiz Fora UFJF, Dept Biol, Lab Cellular Biol, BR-36036 Juiz De Fora, MG, Brazil; [Almeida, Mariana R.; Andrade, Gustavo F. S.] Fed Univ Juiz Fora UFJF, Dept Chem, Mol Spect & Struct Grp, Lab Plasmon Nanostruct, BR-36036 Juiz De Fora, MG, Brazil; [Martins, Jefferson S.; Pinho, Roberto R.] Fed Univ Juiz Fora UFJF, Dept Phys, BR-36036 Juiz De Fora, MG, Brazil; [Costa-Neto, Socrates F.; Gentile, Rosana] Fundacao Oswaldo Cruz, Lab Biol & Parasitol Wild Reservoir Mammals, Rio De Janeiro, Brazil; [Almeida, Mariana R.] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Melo, RCN (corresponding author), Fed Univ Juiz Fora UFJF, Dept Biol, Lab Cellular Biol, BR-36036 Juiz De Fora, MG, Brazil.	rossana.melo@ufjf.edu.br	Malta, Kássia K./A-7938-2019; Carmo, Lívia A. S./O-1949-2018; Dias, Felipe F/P-1324-2016; Silva, Thiago/B-3293-2018; Almeida, Mariana R/F-2982-2018; Andrade, Gustavo/H-3045-2013; Melo, Rossana C. N./B-8248-2013; Martins, Jefferson Silva/B-5590-2017; Dias, Felipe Ferraz/K-4549-2019; Costa-Neto, Socrates/H-5169-2017; Gentile, Rosana/C-3101-2013	Malta, Kássia K./0000-0003-2203-2719; Carmo, Lívia A. S./0000-0002-2121-3107; Dias, Felipe F/0000-0002-3493-6929; Silva, Thiago/0000-0001-7122-3015; Almeida, Mariana R/0000-0002-2612-068X; Andrade, Gustavo/0000-0003-0718-9400; Melo, Rossana C. N./0000-0003-1736-0806; Martins, Jefferson Silva/0000-0003-4499-8549; Dias, Felipe Ferraz/0000-0002-3493-6929; Gentile, Rosana/0000-0001-9160-1204; Amaral, Katia/0000-0001-9812-8093	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil). Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil) and Fundacao Oswaldo Cruz (FIOCRUZ, Brazil).	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Couto JLA, 2008, REV SOC BRAS MED TRO, V41, P390, DOI 10.1590/S0037-86822008000400013; Barakat R, 2015, AM J TROP MED HYG, V92, P797, DOI 10.4269/ajtmh.14-0675; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Cheever AW, 2002, MEM I OSWALDO CRUZ, V97, P917, DOI 10.1590/S0074-02762002000700002; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Costa-Silva M, 2002, MEM I OSWALDO CRUZ, V97, P129, DOI 10.1590/S0074-02762002000900026; Costa-Silva M, 2012, EXP PARASITOL, V130, P394, DOI 10.1016/j.exppara.2012.02.002; Czamara K, 2015, J RAMAN SPECTROSC, V46, P4, DOI 10.1002/jrs.4607; D'Andrea PS, 2002, MEM I OSWALDO CRUZ, V97, P11, DOI 10.1590/S0074-02762002000900003; D'Andrea PS, 2000, PARASITOLOGY, V120, P573, DOI 10.1017/S0031182099005892; da Costa SF, 2013, REV BRAS PARASITOL V, V22, P519, DOI 10.1590/S1984-29612013000400011; Demir S, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5083746; DESOUZA VAM, 1992, MEM I OSWALDO CRUZ, V87, P277, DOI 10.1590/S0074-02761992000500052; Dias FF, 2014, MICROSC MICROANAL, V20, P869, DOI 10.1017/S143192761400066X; El Ridi R, 2012, INT J ANTIMICROB AG, V39, P232, DOI 10.1016/j.ijantimicag.2011.08.019; El Ridi R, 2010, ANTIMICROB AGENTS CH, V54, P3383, DOI 10.1128/AAC.00173-10; El Ridi RAF, 2013, J ADV RES, V4, P467, DOI 10.1016/j.jare.2012.05.002; Fabrino DL, 2011, J INNATE IMMUN, V3, P71, DOI 10.1159/000320641; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fournier I, 2003, NEUROENDOCRINOL LETT, V24, P9; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Fuchs B, 2010, PROG LIPID RES, V49, P450, DOI 10.1016/j.plipres.2010.07.001; Ge FX, 2010, EXP BIOL MED, V235, P1282, DOI 10.1258/ebm.2010.010095; Gentile R, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000900018; Grimes JET, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0766-9; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Hawk CT, 2005, MED ACOLA MED ECOLA; Hoffman WA, 1934, PUERTO RICO J PUB HL, V9, P283; Hoffmann E., 2007, MASS SPECTROSCOPY PR, DOI [10.1016/j.ijpddr.2016.01.003, DOI 10.1016/J.IJPDDR.2016.01.003]; Jackson SN, 2007, J MASS SPECTROM, V42, P1093, DOI 10.1002/jms.1245; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Lemos E.R.S., 2006, BIOSSEGURANCA INFORM, P273; Levene AP, 2012, HISTOPATHOLOGY, V60, P971, DOI 10.1111/j.1365-2559.2012.04193.x; LIAO PC, 1995, J MASS SPECTROM, V30, P408, DOI 10.1002/jms.1190300304; Maldonado Arnaldo Jr., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P193, DOI 10.1590/S0036-46651994000300001; Manoharan R, 1996, SPECTROCHIM ACTA A, V52, P215, DOI 10.1016/0584-8539(95)01573-6; Martinez EM, 2008, REV INST MED TROP SP, V50, P229, DOI 10.1590/S0036-46652008000400008; Martins JS, 2014, EUR POLYM J, V59, P1, DOI 10.1016/j.eurpo1ymj.2014.07.005; Melo RCN, 2016, EXP CELL RES, V340, P193, DOI 10.1016/j.yexcr.2015.10.028; Melo RCN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059578; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Melo RCN, 2011, METHODS MOL BIOL, V689, P149, DOI 10.1007/978-1-60761-950-5_9; Melo RCN, 2009, LAB INVEST, V89, P769, DOI 10.1038/labinvest.2009.40; Neves RH, 2006, MEM I OSWALDO CRUZ, V101, P253, DOI 10.1590/S0074-02762006000900039; Rey L., 1993, Research and Reviews in Parasitology, V53, P13; Ribeiro AC, 1998, MEM I OSWALDO CRUZ, V93, P295, DOI 10.1590/S0074-02761998000700058; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Selim S, 2014, AM J TROP MED HYG, V91, P973, DOI 10.4269/ajtmh.14-0328; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; SILVA RRE, 1992, MEM I OSWALDO CRUZ, V87, P271, DOI 10.1590/S0074-02761992000500051; SILVA TMC, 1989, MEM I OSWALDO CRUZ, V84, P227, DOI 10.1590/S0074-02761989000200011; SMITHERS SR, 1965, PARASITOLOGY, V55, P701, DOI 10.1017/S003118200008625X; Swartz JM, 2006, BLOOD, V108, P2420, DOI 10.1182/blood-2006-04-015933; Tallima H, 2005, J PARASITOL, V91, P1094, DOI 10.1645/GE-514R.1; Toledo DAM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00174; WHO, 2011, SCHIST WHO PROGR REP; Yaqoob P, 2003, CURR OPIN CLIN NUTR, V6, P133, DOI 10.1097/00075197-200303000-00002; Yu YR, 2016, INT J PARASITOL-DRUG, V6, P35, DOI 10.1016/j.ijpddr.2016.01.003; Zhou L, 2001, J LIPID RES, V42, P1521	62	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166979	10.1371/journal.pone.0166979	http://dx.doi.org/10.1371/journal.pone.0166979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880808	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500049
J	Milberg, A; Torres, S; Agard, P				Milberg, Anna; Torres, Sandra; Agard, Pernilla			Health Care Professionals' Understandings of Cross- Cultural Interaction in End- of- Life Care: A Focus Group Study	PLOS ONE			English	Article							PALLIATIVE CARE; OF-LIFE; ASIAN PEOPLE; NEW-ZEALAND; EXPERIENCES; IMMIGRANTS; ETHNICITY; CANCER; DEATH	Objective The academic debate on cross-cultural interaction within the context of end-of-life care takes for granted that this interaction is challenging. However, few empirical studies have actually focused on what health care professionals think about this interaction. This study aimed to explore health care professionals' understandings of cross-cultural interaction during end-of-life care. Methods Sixty end-of-life care professionals were recruited from eleven care units in Sweden to take part in focus group interviews. These interviews were analyzed using qualitative content analysis. Results The health care professionals interviewed talked about cross-cultural interaction in end-oflife care as interaction that brings about uncertainty, stress and frustration even though they had limited experience of this type of interaction. The focus group discussions brought attention to four specific challenges that they expected to meet when they care for patients with migrant backgrounds since they took for granted that they would have an ethno-cultural background that is different to their own. These challenges had to do with communication barriers, `unusual' emotional and pain expressions, the expectation that these patients' families would be `different' and the anticipation that these patients and their families lack knowledge. At the core of the challenges in question is the idea that cross-cultural interaction means meeting "the unknown". In addition, the end-of-life care professionals interviewed talked about patients whose backgrounds they did not share in homogenizing terms. It is against this backdrop that they worried about their ability to provide end-of-life care that is individualized enough to meet the needs of these patients. Conclusions The study suggests that end-of-life care professionals who regard cross-cultural interaction in this manner could face actual challenges when caring for patients whose backgrounds they regard as "the unknown" since they anticipate a variety of challenges and do not seem confident enough that they can provide good quality care when cross-cultural interaction is at stake.	[Milberg, Anna] Linkoping Univ, Palliat Educ & Res Ctr, Norrkoping, Sweden; [Milberg, Anna] Linkoping Univ, Dept Adv Home Care, Norrkoping, Sweden; [Milberg, Anna] Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden; [Torres, Sandra; Agard, Pernilla] Uppsala Univ, Dept Sociol, Uppsala, Sweden	Linkoping University; Linkoping University; Linkoping University; Uppsala University	Milberg, A (corresponding author), Linkoping Univ, Palliat Educ & Res Ctr, Norrkoping, Sweden.; Milberg, A (corresponding author), Linkoping Univ, Dept Adv Home Care, Norrkoping, Sweden.; Milberg, A (corresponding author), Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden.	anna.milberg@liu.se		Milberg, Anna/0000-0001-8828-0702	Medical Research Council of Southeast Sweden [FORSS-160161]; Uppsala university; Linkoping university	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Uppsala university; Linkoping university	The Medical Research Council of Southeast Sweden (http://www.fou.nu/is/forss) (FORSS-160161; AM), Uppsala university (SE) and Linkoping university (SE) contributed with funding of the Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhui K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-15; Born Wendi, 2004, J Palliat Med, V7, P247, DOI 10.1089/109662104773709369; Breen RL, 2006, J GEOGR HIGHER EDUC, V30, P463, DOI 10.1080/03098260600927575; Campbell SR, 2014, J PALLIAT MED, V17, P621, DOI 10.1089/jpm.2013.0443; Cang-Wong Celeste, 2009, Perm J, V13, P31; Cort Malcolm A, 2004, J Palliat Med, V7, P63, DOI 10.1089/109662104322737269; Crawley LM, 2005, J PALLIAT MED S1, V8, P58; Creswell J.W., 2018, QUAL INQ, V4; Evans N, 2012, J PAIN SYMPTOM MANAG, V43, P261, DOI 10.1016/j.jpainsymman.2011.04.012; Frey R, 2014, HEALTH SOC CARE COMM, V22, P290, DOI 10.1111/hsc.12081; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gunaratnam Y, 2001, SOCIOL HEALTH ILL, V23, P65, DOI 10.1111/1467-9566.00241; Gunaratnam Y, 2008, ETHNICITY INEQUALITI, V1, P9, DOI DOI 10.1108/17570980200800003; Gunaratnam Y, 2007, INT J PALLIAT NURS, V13, P470, DOI 10.12968/ijpn.2007.13.10.27477; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Hill S, 2010, CANCER-AM CANCER SOC, V116, P3205, DOI 10.1002/cncr.25127; Horvat L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009405.pub2; Horvath-Lindberg J, 1983, INVANDRARNAS MOTE ME; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jones K, 2005, J RES NURS, V10, P431, DOI 10.1177/174498710501000406; Kai J, 2007, PLOS MED, V4, P1766, DOI 10.1371/journal.pmed.0040323; Kvale S, 1996, INTERVIEWS INTRO QUA; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McNamara B, 2004, SOC SCI MED, V58, P929, DOI 10.1016/j.socscimed.2003.10.042; Milberg A, 2012, PSYCHO-ONCOLOGY, V21, P886, DOI 10.1002/pon.1982; Mindell JS, 2014, J EPIDEMIOL COMMUN H, V68, P1133, DOI 10.1136/jech-2014-203927; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Owens A, 2004, HEALTH SOC CARE COMM, V12, P414, DOI 10.1111/j.1365-2524.2004.00511.x; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Richardson A, 2006, EUR J ONCOL NURS, V10, P93, DOI 10.1016/j.ejon.2005.05.002; Shahid S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-26; Torres S., 2013, HLTH AGING SOCIOCULT; Torres S, 2006, J ETHN MIGR STUD, V32, P1341, DOI 10.1080/13691830600928730; Torres S, 2016, J INTERCULT STUD, V37, P103, DOI 10.1080/07256868.2016.1141756; Vaughn Sharon, 1996, FOCUS GROUP INTERVIE; Wang L, 2013, SOC SCI MED, V98, P8, DOI 10.1016/j.socscimed.2013.08.040; Wiking E, 2004, J EPIDEMIOL COMMUN H, V58, P574, DOI 10.1136/jech.2003.011387; World Health Organization, WHO DEF PALL CAR	38	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165452	10.1371/journal.pone.0165452	http://dx.doi.org/10.1371/journal.pone.0165452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5KB	27880814	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500008
J	Biermann, D; Eder, A; Arndt, F; Seoudy, H; Reichenspurner, H; Mir, T; Riso, A; Kozlik-Feldmann, R; Peldschus, K; Kaul, MG; Schuler, T; Krasemann, S; Hansen, A; Eschenhagen, T; Sachweh, JS				Biermann, Daniel; Eder, Alexandra; Arndt, Florian; Seoudy, Hatim; Reichenspurner, Hermann; Mir, Thomas; Riso, Arlindo; Kozlik-Feldmann, Rainer; Peldschus, Kersten; Kaul, Michael G.; Schuler, Tillman; Krasemann, Susanne; Hansen, Arne; Eschenhagen, Thomas; Sachweh, Joerg S.			Towards a Tissue-Engineered Contractile Fontan-Conduit: The Fate of Cardiac Myocytes in the Subpulmonary Circulation	PLOS ONE			English	Article							LONG-TERM SURVIVAL; TRICUSPID-ATRESIA; HEART-TISSUE; SURGERY; REPAIR	The long-term outcome of patients with single ventricles improved over time, but remains poor compared to other congenital heart lesions with biventricular circulation. Main cause for this unfavourable outcome is the unphysiological hemodynamic of the Fontan circulation, such as subnormal systemic cardiac output and increased systemic-venous pressure. To overcome this limitation, we are developing the concept of a contractile extracardiac Fontan-tunnel. In this study, we evaluated the survival and structural development of a tissue engineered conduit under in vivo conditions. Engineered heart tissue was generated from ventricular heart cells of neonatal Wistar rats, fibrinogen and thrombin. Engineered heart tissues started beating around day 8 in vitro and remained contractile in vivo throughout the experiment. After culture for 14 days constructs were implanted around the right superior vena cava of Wistar rats (n = 12). Animals were euthanized after 7, 14, 28 and 56 days postoperatively. Hematoxylin and eosin staining showed cardiomyocytes arranged in thick bundles within the engineered heart tissue-conduit. Immunostaining of sarcomeric actin, alpha actin and connexin 43 revealed a well-developed cardiac myocyte structure. Magnetic resonance imaging (d14, n = 3) revealed no constriction or stenosis of the superior vena cava by the constructs. Engineered heart tissues survive and contract for extended periods after implantation around the superior vena cava of rats. Generation of larger constructs is warranted to evaluate functional benefits of a contractile Fontan-conduit.	[Biermann, Daniel; Riso, Arlindo; Sachweh, Joerg S.] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr Hamburg, Cardiac Surg Congenital Heart Dis, Hamburg, Germany; [Arndt, Florian; Mir, Thomas; Kozlik-Feldmann, Rainer] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr Hamburg, Dept Paediat Cardiol, Hamburg, Germany; [Seoudy, Hatim; Reichenspurner, Hermann] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany; [Eder, Alexandra; Hansen, Arne; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Peldschus, Kersten; Kaul, Michael G.; Schuler, Tillman] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Krasemann, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Eder, Alexandra; Reichenspurner, Hermann; Hansen, Arne; Eschenhagen, Thomas] DZHK German Ctr Cardiovasc Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research	Biermann, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr Hamburg, Cardiac Surg Congenital Heart Dis, Hamburg, Germany.	d.biermann@uka.de			German Society for Paediatric Cardiology (DGPK); German Center of Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF)	German Society for Paediatric Cardiology (DGPK); German Center of Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by: D.B., F.A., T.M.: German Society for Paediatric Cardiology (DGPK), www.dgpk.org; A.E., A.H., T.E.: German Center of Cardiovascular Research (DZHK), www.dzhk.de; and A.E., A.H., T.E.: German Ministry of Education and Research (BMBF), www.bmbf.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beng ET, 2014, JACC-CARDIOVASC IMAG, V7, P215, DOI 10.1016/j.jcmg.2013.12.010; CHACHQUES JC, 1990, CIRCULATION, V82, P82; Corno AF, 2010, INTERACT CARDIOV TH, V10, P679, DOI 10.1510/icvts.2009.223024; d'Udekem Y, 2014, CIRCULATION, V130, pS32, DOI 10.1161/CIRCULATIONAHA.113.007764; de Leval MR, 2005, NAT CLIN PRACT CARD, V2, P202, DOI 10.1038/ncpcardio0157; DELEVAL MR, 1988, J THORAC CARDIOV SUR, V96, P682; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522; Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559; Khairy P, 2007, CIRCULATION, V115, P800, DOI 10.1161/CIRCULATIONAHA.105.592378; KREUTZER G, 1973, J THORAC CARDIOV SUR, V66, P613, DOI 10.1016/s0022-5223(19)40598-9; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; Ogle BM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad2304; Ohuchi H, 2013, EUR J CARDIO-THORAC, V43, pE49, DOI 10.1093/ejcts/ezs714; Rodefeld MD, 2003, ANN THORAC SURG, V76, P1911, DOI 10.1016/S0003-4975(03)01014-2; Rychik Jack, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P96, DOI 10.1053/j.pcsu.2010.02.006; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Wu FM, 2015, J HEART LUNG TRANSPL, V34, P883, DOI 10.1016/j.healun.2015.01.993; Ye L, 2013, CIRC RES, V113, P922, DOI 10.1161/CIRCRESAHA.113.300216; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6	22	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166963	10.1371/journal.pone.0166963	http://dx.doi.org/10.1371/journal.pone.0166963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875570	Green Submitted, gold, Green Published			2022-12-26	WOS:000388886000040
J	Baldivia, S; Levy, A; Hegde, S; Aper, SJA; Merkx, M; Grytz, R				Baldivia, Sarah; Levy, Alexander; Hegde, Shylaja; Aper, Stijn J. A.; Merkx, Maarten; Grytz, Rafael			A Novel Organ Culture Model to Quantify Collagen Remodeling in Tree Shrew Sclera	PLOS ONE			English	Article							MINUS-LENS COMPENSATION; MESSENGER-RNA LEVELS; FORM-DEPRIVATION MYOPIA; LASER-SCANNING MICROSCOPY; GENE-EXPRESSION; PATHOLOGICAL COMPLICATIONS; EXTRACELLULAR-MATRIX; PROTEIN EXPRESSION; TISSUE ADHESIVE; CELL-CULTURE	Increasing evidence suggests that unknown collagen remodeling mechanisms in the sclera underlie myopia development. We are proposing a novel organ culture system in combination with two-photon fluorescence imaging to quantify collagen remodeling at the tissue- and lamella-level. Tree shrew scleral shells were cultured up to 7 days in serum-free media and cellular viability was investigated under: (i) minimal tissue manipulations; (ii) removal of intraocular tissues; gluing the eye to a washer using (iii) 50 mu L and (iv) 200 mu L of cyanoacrylate adhesive; (v) supplementing media with Ham's F-12 Nutrient Mixture; and (vi) culturing eyes subjected to 15 mmHg intraocular pressure in our new bioreactor. Two scleral shells of normal juvenile tree shrews were fluorescently labeled using a collagen specific protein and cultured in our bioreactor. Using two-photon microscopy, grid patterns were photobleached into and across multiple scleral lamellae. These patterns were imaged daily for 3 days, and tissue-/lamella-level strains were calculated from the deformed patterns. No significant reduction in cell viability was observed under conditions (i) and (v). Compared to condition (i), cell viability was significantly reduced starting at day O (condition (ii)) and day 3 (conditions (iii, iv, vi)). Tissue-level strain and intralamellar shear angel increased significantly during the culture period. Some scleral lamellae elongated while others shortened. Findings suggest that tree shrew sclera can be cultured in serum-free media for 7 days with no significant reduction in cell viability. Scleral fibroblasts are sensitive to tissue manipulations and tissue gluing. However, Ham's F-12 Nutrient Mixture has a protective effect on cell viability and can offset the cytotoxic effect of cyanoacrylate adhesive. This is the first study to quantify collagen micro-deformations over a prolonged period in organ culture providing a new methodology to study scleral remodeling in myopia.	[Baldivia, Sarah; Levy, Alexander] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Hegde, Shylaja] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL USA; [Aper, Stijn J. A.; Merkx, Maarten] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Aper, Stijn J. A.; Merkx, Maarten] Eindhoven Univ Technol, ICMS, Eindhoven, Netherlands; [Grytz, Rafael] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Eindhoven University of Technology; Eindhoven University of Technology; University of Alabama System; University of Alabama Birmingham	Grytz, R (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA.	rafaelgrytz@uabmc.edu	Merkx, Maarten/E-7009-2011	Grytz, Rafael/0000-0001-9539-4070	National Institutes of Health (Bethesda, Maryland) [R01-EY026588, P30-EY003039]; Eye Sight Foundation of Alabama (Birmingham, Alabama); Research to Prevent Blindness (New York, New York); NATIONAL EYE INSTITUTE [R01EY026588, P30EY003039] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye Sight Foundation of Alabama (Birmingham, Alabama); Research to Prevent Blindness (New York, New York)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health Grants R01-EY026588 (RG) and P30-EY003039 (Bethesda, Maryland); Eye Sight Foundation of Alabama (Birmingham, Alabama); and Research to Prevent Blindness (New York, New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2001, INVEST OPHTH VIS SCI, V42, P2554; Aper SJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114983; Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Breurken M, 2011, BIOORGAN MED CHEM, V19, P1062, DOI 10.1016/j.bmc.2010.07.058; Bruehlmann SB, 2004, SPINE, V29, P2612, DOI 10.1097/01.brs.0000146465.05972.56; Bush PG, 2007, FRONT BIOSCI-LANDMRK, V12, P2646, DOI 10.2741/2261; Cao TV, 2013, J AM OSTEOPATH ASSOC, V113, P806, DOI 10.7556/jaoa.2013.056; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; Cheng VWT, 2007, J MATER SCI, V42, P8957, DOI 10.1007/s10853-007-1653-3; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Danciu TE, 2004, J DENT RES, V83, P596, DOI 10.1177/154405910408300803; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Diaspro A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-36; Downs JC, 2011, INVEST OPHTH VIS SCI, V52, P7365, DOI 10.1167/iovs.11-7955; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354; Gao H, 2011, MOL VIS, V17, P903; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Grytz R, 2015, INVEST OPHTH VIS SCI, V56, P2065, DOI 10.1167/iovs.14-15352; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; Guo L, 2013, INVESTIGATIVE OPHTHA; Guo L, 2014, MOL VIS, V20, P1643; He L, 2014, EXP EYE RES, V123, P56, DOI 10.1016/j.exer.2014.04.005; Heine, 1899, ARCH AUGENHEILKD, V38, P277; Jeong DW, 2014, INVEST OPHTH VIS SCI, V55, P2148, DOI 10.1167/iovs.13-13607; Jobling AI, 2004, J BIOL CHEM, V279, P18121, DOI 10.1074/jbc.M400381200; Kaplan M, 2005, HEART SURG FORUM, V8, pE169, DOI 10.1532/HSF98.20041126; Kim JW, 2001, INVEST OPHTH VIS SCI, V42, P1514; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Levin LA, 2011, ADLERS PHYSIOLOGY OF; Levy A, 2015, INVESTIGATIVE OPHTHA, V56; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Moring AG, 2007, INVEST OPHTH VIS SCI, V48, P2947, DOI 10.1167/iovs.06-0906; Norton TT, 2010, VISION RES, V50, P564, DOI 10.1016/j.visres.2009.12.014; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; Oglesby EN, 2016, MOL VIS, V22, P82; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1002/bjs.1800840206; Qiu M, 2013, INVEST OPHTH VIS SCI, V54, P830, DOI 10.1167/iovs.12-11158; Qu J, 2015, INVEST OPHTH VIS SCI, V56, P7821, DOI 10.1167/iovs.15-17848; Rada JA, 1997, INVEST OPHTH VIS SCI, V38, P1740; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Shepherd JH, 2014, J MECH BEHAV BIOMED, V38, P163, DOI 10.1016/j.jmbbm.2014.06.005; Siegwart JT, 2007, MOL VIS, V13, P1878; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Siegwart JT, 2005, INVEST OPHTH VIS SCI, V46, P3484, DOI 10.1167/iovs.05-0194; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Siegwart JT, 2001, INVEST OPHTH VIS SCI, V42, P1153; Szczesny SE, 2014, ACTA BIOMATER, V10, P2582, DOI 10.1016/j.actbio.2014.01.032; TORIUMI DM, 1990, ARCH OTOLARYNGOL, V116, P546; VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3; Verkicharla PK, 2015, OPHTHAL PHYSL OPT, V35, P465, DOI 10.1111/opo.12238; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	65	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166644	10.1371/journal.pone.0166644	http://dx.doi.org/10.1371/journal.pone.0166644			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870875	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400016
J	Mondal, A; Venkataramaiah, M; Rajamohan, G; Srinivasan, VB				Mondal, Amitabha; Venkataramaiah, Manjunath; Rajamohan, Govindan; Srinivasan, Vijaya Bharathi			Occurrence of Diverse Antimicrobial Resistance Determinants in Genetically Unrelated Biocide Tolerant Klebsiella pneumoniae	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; MULTIDRUG EFFLUX PUMP; ACINETOBACTER-BAUMANNII; ESCHERICHIA-COLI; CARBAPENEMASE; PLASMID; GENES; INDIA; HOSPITALS; INFECTION	Nosocomial infections due to Klebsiella pneumoniae is a significant problem in health care settings worldwide. In this study, we examined the antimicrobial susceptibility, genetic profiles and mechanisms of antibiotic resistance in K. pneumoniae isolates of Indian origin. To our knowledge this is the first report demonstrating the high prevalence of beta-lactamases, aminoglycoside modifying enzymes, quinolone resistance genes besides demonstrating the involvement of active efflux in K. pneumoniae Indian isolates. This study has enabled us to correlate the phenotypic and genotypic characteristics in K. pneumoniae, providing an important base for continued monitoring and epidemiological studies of this emerging nosocomial pathogen in Indian hospitals.	[Mondal, Amitabha; Venkataramaiah, Manjunath; Rajamohan, Govindan; Srinivasan, Vijaya Bharathi] Council Sci Ind Res Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, VB (corresponding author), Council Sci Ind Res Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	vijirmohan@gmail.com		Govindan, Rajamohan/0000-0002-0208-3546	Department of Scientific and Industrial Research, Ministry of Science and Technology (DST) [SERB/LS-908/2013]; DBT [BT/01/IYBA/2009, BT/HRD/NBA/34/01/2012]; Council of Scientific and Industrial Research (CSIR) [BSC0119H]; CSIR; DST	Department of Scientific and Industrial Research, Ministry of Science and Technology (DST); DBT(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was funded by the Department of Scientific and Industrial Research, Ministry of Science and Technology (DST) through grant SERB/LS-908/2013, DBT (BT/01/IYBA/2009, BT/HRD/NBA/34/01/2012) and by the Council of Scientific and Industrial Research (CSIR) through grant BSC0119H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors remain obliged to our Director, CSIR-Institute of Microbial Technology, Chandigarh, for giving excellent atmosphere for executing the study. AM, MV and VBS remains thankful to CSIR and DST for their fellowships.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bassetti M, 2015, LANGENBECK ARCH SURG, V400, P153, DOI 10.1007/s00423-015-1280-4; Broberg Christopher A, 2014, F1000Prime Rep, V6, P64, DOI 10.12703/P6-64; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Du DJ, 2015, TRENDS MICROBIOL, V23, P311, DOI 10.1016/j.tim.2015.01.010; Elemam A, 2009, CLIN INFECT DIS, V49, P271, DOI 10.1086/600042; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Fu YM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-8; Gupta Archana, 2003, J Perinatol, V23, P439, DOI 10.1038/sj.jp.7210973; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P4174, DOI 10.1128/AAC.49.10.4174-4179.2005; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108; Lalzampuia H, 2013, INDIAN J MICROBIOL, V53, P291, DOI 10.1007/s12088-013-0378-z; Lee YH, 2006, J ANTIMICROB CHEMOTH, V57, P1259, DOI 10.1093/jac/dkl115; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Mohamudha Parveen R, 2012, INDIAN J MICROBIOL, V52, P35, DOI DOI 10.1007/S12088-011-0140-3; Ogawa W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121619; Ogawa W, 2012, GENE, V498, P177, DOI 10.1016/j.gene.2012.02.008; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Ping Y, 2007, BIOL PHARM BULL, V30, P1962, DOI 10.1248/bpb.30.1962; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pournaras S, 2006, J ANTIMICROB CHEMOTH, V57, P557, DOI 10.1093/jac/dkl004; Povilonis J, 2013, J ANTIMICROB CHEMOTH, V68, P1000, DOI 10.1093/jac/dks499; Rafailidis PI, 2014, CURR OPIN INFECT DIS, V27, P479, DOI 10.1097/QCO.0000000000000109; Richter SN, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-7; Robilotti Elizabeth, 2014, F1000Prime Rep, V6, P80, DOI 10.12703/P6-80; Ryoo NH, 2005, J ANTIMICROB CHEMOTH, V56, P698, DOI 10.1093/jac/dki324; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shanmugam P, 2013, J CLIN DIAGN RES, V7, P2736, DOI 10.7860/JCDR/2013/7759.3747; Sidjabat H, 2011, CLIN INFECT DIS, V52, P481, DOI 10.1093/cid/ciq178; Srinivasan VB, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-21; Srinivasan VB, 2006, ANTIMICROB AGENTS CH, V50, P2428, DOI 10.1128/AAC.01561-05; Srinivasan VB, 2015, ANTIMICROB AGENTS CH, V59, P1236, DOI 10.1128/AAC.03626-14; Srinivasan VB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096288; Srinivasan VB, 2013, ANTIMICROB AGENTS CH, V57, P4449, DOI 10.1128/AAC.02284-12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi A, 2012, INDIAN J MICROBIOL, V52, P557, DOI 10.1007/s12088-012-0281-z; Tsai YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079640; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Wassef M., 2015, MICROB DRUG RESIST	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166730	10.1371/journal.pone.0166730	http://dx.doi.org/10.1371/journal.pone.0166730			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870879	Green Published, gold			2022-12-26	WOS:000388846400023
J	Sylla, S; Brevault, T; Diarra, K; Bearez, P; Desneux, N				Sylla, Serigne; Brevault, Thierry; Diarra, Karamoko; Bearez, Philippe; Desneux, Nicolas			Life-History Traits of Macrolophus pygmaeus with Different Prey Foods	PLOS ONE			English	Article							TUTA-ABSOLUTA; BIOLOGICAL-CONTROL; MYZUS-PERSICAE; NESIDIOCORIS-TENUIS; HEMIPTERA-MIRIDAE; APHIS-GLYCINES; BEMISIA-TABACI; PEST-CONTROL; PREDATOR; PLANTS	Macrolophus pygmaeus Rambur (Hemiptera: Miridae) is a generalist predatory mirid widely used in augmentative biological control of various insect pests in greenhouse tomato production in Europe, including the invasive tomato leafminer, Tuta absoluta (Meyrick) (Lepidoptera, Gelechiidae). However, its biocontrol efficacy often relies on the presence of alternative prey. The present study aimed at evaluating the effect of various prey foods (Ephestia kuehniella eggs, Bemisia tabaci nymphs, Tuta absoluta eggs and Macrosiphum euphorbiae nymphs) on some life history traits of M. pygmaeus. Both nymphal development and adult fertility of M. pygmaeus were significantly affected by prey food type, but not survival. Duration of nymphal stage was higher when M. pygmaeus fed on T. absoluta eggs compared to the other prey. Mean fertility of M. pygmaeus females was greatest when fed with B. tabaci nymphs, and was greater when offered M. euphorbiae aphids and E. kuehniella eggs than when offered T. absoluta eggs. Given the low quality of T. absoluta eggs, the efficacy of M. pygmaeus to control T. absoluta may be limited in the absence of other food sources. Experiments for assessing effectiveness of generalist predators should involve the possible impact of prey preference as well as a possible prey switching.	[Sylla, Serigne; Diarra, Karamoko] UCAD, Equipe Prod & Protect Integrees Agroecosyst Hort, Fac Sci & Tech, Dakar, Senegal; [Sylla, Serigne; Brevault, Thierry] ISRA UCAD IRD, BIOPASS, Dakar, Senegal; [Brevault, Thierry] CIRAD, UPR AIDA, F-34398 Montpellier, France; [Bearez, Philippe; Desneux, Nicolas] Univ Nice Sophia Antipolis, INRA French Natl Inst Agr Res, Inst Sophia Agrobiotech, CNRS,UMR 1355 7254, F-06903 Sophia Antipolis, France	University Cheikh Anta Diop Dakar; CIRAD; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Sylla, S (corresponding author), UCAD, Equipe Prod & Protect Integrees Agroecosyst Hort, Fac Sci & Tech, Dakar, Senegal.; Sylla, S (corresponding author), ISRA UCAD IRD, BIOPASS, Dakar, Senegal.	syllaserigne2@gmail.com	Desneux, Nicolas/J-6262-2013; Brévault, Thierry/AAV-5990-2021; Brevault, Thierry/R-9757-2019	Brévault, Thierry/0000-0003-0159-3509; Brevault, Thierry/0000-0003-0159-3509	IRD (AIRD) [PEERS-BIOBIO-2013]; CIRAD; IFS	IRD (AIRD); CIRAD; IFS(International Foundation for Science)	We express our sincere gratitude to IRD (AIRD) under Grant PEERS-BIO-BIO-2013, CIRAD (Action incitative 2014), and IFS for financial support.; We express our sincere gratitude to IRD (AIRD) under Grant PEERS-BIOBIO-2013, CIRAD (Action incitative 2014), and IFS for financial support. We thank Edwige Amiens-Desneux and Han Peng (INRA) for input and advice during the experiments.	Alomar O, 2002, AGR ECOSYST ENVIRON, V89, P105, DOI 10.1016/S0167-8809(01)00322-X; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bockmann E, 2015, J PEST SCI, V88, P439, DOI 10.1007/s10340-014-0601-7; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Campos MR, 2015, J PEST SCI, V88, P405, DOI 10.1007/s10340-014-0618-y; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Castane C, 2011, BIOL CONTROL, V59, P22, DOI 10.1016/j.biocontrol.2011.03.007; Chailleux A, 2014, J PEST SCI, V87, P441, DOI 10.1007/s10340-014-0557-7; Desneux N, 2008, B ENTOMOL RES, V98, P631, DOI 10.1017/S0007485308006238; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Diazl HLB, 2014, REV PROTECCION VEG, V29, P94; Guillemaud T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08371; Han P, 2015, J PEST SCI, V88, P685, DOI 10.1007/s10340-015-0662-2; Jaworski CC, 2015, J PEST SCI, V88, P793, DOI 10.1007/s10340-015-0698-3; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Jiao XG, 2014, J PEST SCI, V87, P629, DOI 10.1007/s10340-014-0594-2; LaRock DR, 1996, SOUTHWEST ENTOMOL, V21, P153; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Lykouressis D, 2008, BIOL CONTROL, V44, P142, DOI 10.1016/j.biocontrol.2007.11.003; Molla O, 2014, BIOCONTROL, V59, P175, DOI 10.1007/s10526-013-9553-8; Nogia VK, 2014, ENTOMOL GEN, V35, P11, DOI 10.1127/0171-8177/2014/0002; Perdikis D, 2014, BIOL CONTROL, V70, P35, DOI 10.1016/j.biocontrol.2013.12.003; Perdikis D, 2011, BIOL CONTROL, V59, P13, DOI 10.1016/j.biocontrol.2011.03.014; Perdikis DC, 2004, ENVIRON ENTOMOL, V33, P499, DOI 10.1603/0046-225X-33.3.499; Perdikis DC, 2002, ENTOMOL EXP APPL, V102, P261, DOI 10.1023/A:1019549720193; Perdikis DC, 1999, BIOCONTROL, V44, P281, DOI 10.1023/A:1009959325331; Perez-Hedo M, 2015, BIOL CONTROL, V86, P46, DOI 10.1016/j.biocontrol.2015.04.006; Perez-Hedo M, 2015, J PEST SCI, V88, P65, DOI 10.1007/s10340-014-0587-1; Put K, 2012, BIOL CONTROL, V63, P172, DOI 10.1016/j.biocontrol.2012.06.011; Roditakis E, 2015, J PEST SCI, V88, P9, DOI 10.1007/s10340-015-0643-5; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Urbaneja A, 2009, J APPL ENTOMOL, V133, P292, DOI 10.1111/j.1439-0418.2008.01319.x; Urbaneja A, 2013, CABI INVASIVE SER, P98, DOI 10.1079/9781845938291.0098; Van Damme V, 2015, J PEST SCI, V88, P533, DOI 10.1007/s10340-014-0636-9; van Lenteren JC, 2000, SUCCESS BIOL CONTROL; Vandekerkhove B, 2009, J APPL ENTOMOL, V133, P133, DOI 10.1111/j.1439-0418.2008.01332.x; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9	40	29	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166610	10.1371/journal.pone.0166610	http://dx.doi.org/10.1371/journal.pone.0166610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870857	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400015
J	Keshri, GK; Gupta, A; Yadav, A; Sharma, SK; Singh, SB				Keshri, Gaurav K.; Gupta, Asheesh; Yadav, Anju; Sharma, Sanjeev K.; Singh, Shashi Bala			Photobiomodulation with Pulsed and Continuous Wave Near-Infrared Laser (810 nm, Al-Ga-As) Augments Dermal Wound Healing in Immunosuppressed Rats	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; LIGHT THERAPY; IN-VITRO; SKIN; MODEL; HIF-1-ALPHA; MECHANISMS; NEURONS; ACID	Chronic non-healing cutaneous wounds are often vulnerable in one or more repair phases that prevent normal healing and pose challenges to the use of conventional wound care modalities. In immunosuppressed subject, the sequential stages of healing get hampered, which may be the consequences of dysregulated or stagnant wound inflammation. Photobiomodulation (PBM) or low-level laser (light) therapy (LLLT) emerges as a promising drug free, non-invasive biophysical approach for promoting wound healing, reduction of inflammation, pain and restoration of functions. The present study was therefore undertaken to evaluate the photobiomodulatory effects of 810 nm diode laser (40 mW/cm(2); 22.6 J/cm(2)) with pulsed (10 and 100 Hz, 50% duty cycle) and continuous wave on full-thickness excision -type dermal wound healing in hydrocortisone-induced immunosuppressed rats. Results clearly delineated that 810 nm PBM at 10 Hz was more effective over continuous and 100 Hz frequency in accelerating wound healing by attenuating the pro-inflammatory markers (NF-kB, TNF-alpha), augmenting wound contraction (alpha-SM actin), enhancing cellular proliferation, ECM deposition, neovascularization (HIF-1 alpha, VEGF), re-epithelialization along with up-regulated protein expression of FGFR-1, Fibronectin, HSP-90 and TGF-beta 2 as compared to the non-irradiated controls. Additionally, 810 nm laser irradiation significantly increased CCO activity and cellular ATP contents. Overall, the findings from this study might broaden the current biological mechanism that could be responsible for photobiomodulatory effect mediated through pulsed NIR 810 nm laser (10 Hz) for promoting dermal wound healing in immunosuppressed subjects.	[Keshri, Gaurav K.; Gupta, Asheesh; Yadav, Anju; Sharma, Sanjeev K.; Singh, Shashi Bala] DRDO, DIPAS, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Gupta, A (corresponding author), DRDO, DIPAS, Delhi, India.	asheeshgupta2001@gmail.com	Gupta, Asheesh/M-1076-2019; Singh, Shashi Bala/AAS-9889-2021	Sharma, Sanjeev/0000-0002-1883-3284; Sharma, Sanjeev Kumar/0000-0002-3273-0708	Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India DRDO [DIP-251]	Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India DRDO	The study was funded by the Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India DRDO, DIP-251.; The study was funded by the Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India. The authors are thankful to Dr. Kshipra Misra, Head of the Department for her constant support and constructive suggestions.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Assis L, PHOTONICS LASERS MED, DOI [10.1515/plm-2016-0005, DOI 10.1515/PLM-2016-0005]; Assis L, 2012, LASER SURG MED, V44, P726, DOI 10.1002/lsm.22077; Barretto SR, 2013, J PHOTOCH PHOTOBIO B, V129, P135, DOI 10.1016/j.jphotobiol.2013.10.002; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Capon A, 2003, AM J CLIN DERMATOL, V4, P1, DOI 10.2165/00128071-200304010-00001; Capon A, 2001, LASER SURG MED, V28, P168, DOI 10.1002/lsm.1035; Capon A, 2010, AESTHET PLAST SURG, V34, P438, DOI 10.1007/s00266-009-9469-y; Chen ACH, 2011, PHOTOMED LASER SURG, V29, P383, DOI 10.1089/pho.2010.2837; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Cury V, 2013, J PHOTOCH PHOTOBIO B, V125, P164, DOI 10.1016/j.jphotobiol.2013.06.004; Dancakova L, 2014, PHOTOMED LASER SURG, V32, P198, DOI 10.1089/pho.2013.3586; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Dickinson LE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00341; Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824; Farivar S, 2014, J LASERS MED SCI, V5, P58; Ferraresi C, 2015, J BIOPHOTONICS, V8, P740, DOI 10.1002/jbio.201400087; Gupta A, 2004, MOL CELL BIOCHEM, V259, P9, DOI 10.1023/B:MCBI.0000021339.34784.81; Gupta A, 1999, J PHARMACOL TOXICOL, V41, P183, DOI 10.1016/S1056-8719(99)00041-6; Gupta A, 2015, J BIOPHOTONICS, V8, P489, DOI 10.1002/jbio.201400058; Gupta A, 2014, LASER MED SCI, V29, P257, DOI 10.1007/s10103-013-1319-0; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Huang YY, 2014, J BIOPHOTONICS, V7, P656, DOI 10.1002/jbio.201300125; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Joensen J, 2012, PHOTOMED LASER SURG, V30, P688, DOI 10.1089/pho.2012.3306; Khoshvaghti A, 2011, PHOTOMED LASER SURG, V29, P597, DOI 10.1089/pho.2010.2783; Kim SJ, 2009, LASER SURG MED, V41, P524, DOI 10.1002/lsm.20792; Kymplova J, 2003, J CLIN LASER MED SUR, V21, P35, DOI 10.1089/10445470360516725; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Achar RAN, 2014, ACTA CIR BRAS, V29, P125, DOI 10.1590/S0102-86502014000200009; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Passarella S, 2014, J PHOTOCH PHOTOBIO B, V140, P344, DOI 10.1016/j.jphotobiol.2014.07.021; Rezende SB, 2007, J PHOTOCH PHOTOBIO B, V87, P145, DOI 10.1016/j.jphotobiol.2007.02.005; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Saracino S, 2009, LASER SURG MED, V41, P298, DOI 10.1002/lsm.20762; Sharif F, 2015, WOUND REPAIR REGEN, V23, P855, DOI 10.1111/wrr.12366; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tabakoglu HO, 2016, LASER SURG MED, V48, P409, DOI 10.1002/lsm.22462; Van U. P., 2008, BIOCHEM J, V412, P477, DOI DOI 10.1042/BJ20080476; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	45	40	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166705	10.1371/journal.pone.0166705	http://dx.doi.org/10.1371/journal.pone.0166705			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861614	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300091
J	Rajshankar, D; Wang, YQ; McCulloch, CA				Rajshankar, Dhaarmini; Wang, Yongqiang; McCulloch, Christopher A.			Osteogenesis requires FAK-dependent collagen synthesis by fibroblasts and osteoblasts	FASEB JOURNAL			English	Article						focal adhesions; periodontal ligament; picrosirius red stain; polarized light microscopy; quantitative RT-PCR	FOCAL ADHESION KINASE; MESENCHYMAL STEM-CELLS; PERIODONTAL-LIGAMENT; BONE-MARROW; ADHERENT CELLS; DIFFERENTIATION; EXPRESSION; PROTEIN; OSTEOPOROSIS; ACTIVATION	Focal adhesion kinase (FAK) is critical in adhesion-dependent signaling, but its role in osteogenesis in vivo is ill defined. We deleted Fak in fibroblasts and osteoblasts in Floxed-Fak mice bred with those expressing Cre-recombinase driven by 3.6-kb alpha 1(I)-collagen promoter. Compared with wild-type (WT), conditional FAK-knockout (CFKO) mice were shorter (2-fold; P < 0.0001) and had crooked, shorter tails (50%; P < 0.0001). Microcomputed tomography analysis showed reduced bone volume (4-fold in tails; P < 0.0001; 2-fold in mandibles; P < 0.0001), whereas bone surface area/bone volume increased (3-fold in tails; P < 0.0001; 2.5-fold in mandibles; P < 0.001). Collagen density and fiber alignment in periodontal ligament were reduced by 4-fold (P < 0.0001) and 30%(P < 0.05), respectively, in CFKO mice. In cultured CFKO osteoblasts, mineralization at d 7 and mineralizing colony-forming units atd21 were 30%(P< 0.0001) and >3-fold less than WT, respectively. Disruptions of FAK function in osteoblasts by conditional knockout, siRNA-knockdown, or FAK inhibitor reduced mRNA and protein expression of Runx2 (>30%), Osterix (>25%), and collagen-1 (2-fold). Collagen synthesis was abrogated in WT osteoblasts with Runx2 knockdown and in Fak-null fibroblasts transfected with an FAK kinase domain mutant or akinase-impaired mutant (Y397F). These data indicate that FAK regulates osteogenesis through transcription factors that regulate collagen synthesis.	[Rajshankar, Dhaarmini; Wang, Yongqiang; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto	Rajshankar, D (corresponding author), Univ Toronto, Room 243,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	dhaarmini.rajshankar@utoronto.ca			Canadian Institutes of Health Research operating Grant [MOP- 84254]; Canada Research Chair (Tier 1)	Canadian Institutes of Health Research operating Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1)(Canada Research Chairs)	The authors thank Dominic Fritz (University of Toronto) for assisting with troubleshooting the mice breeding strategy, and to Doug Holmyard (Mount Sinai Hospital, Toronto, ON, Canada) for assisting with TEM. This research was funded by a Canadian Institutes of Health Research operating Grant MOP-84254 (to C.A.M.). C.A.M. is also supported by a Canada Research Chair (Tier 1). The authors declare no conflicts of interest.	Ajami E, 2014, ACTA BIOMATER, V10, P394, DOI 10.1016/j.actbio.2013.09.020; [Anonymous], 2014, Osteoporos Int, V25 Suppl 6, P659, DOI 10.1007/s00198-014-2893-0; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Bernabei R, 2014, CLIN CASES MINER BON, V11, P201, DOI 10.11138/ccmbm/2014.11.3.201; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Castillo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043291; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen YJ, 2014, J BONE MINER METAB, V32, P671, DOI 10.1007/s00774-013-0549-3; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Everts V, 2012, METHODS MOL BIOL, V816, P351, DOI 10.1007/978-1-61779-415-5_23; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hu HM, 2013, INT J CLIN EXP PATHO, V6, P841; Hu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20875; HUNTER GK, 1993, J CELL SCI, V104, P1031; Ilic D, 1997, J CELL SCI, V110, P401; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kingsley LA, 2007, P NATL ACAD SCI USA, V104, P10753, DOI 10.1073/pnas.0704357104; Kling JM, 2014, J WOMENS HEALTH, V23, P563, DOI 10.1089/jwh.2013.4611; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Marcus R, 2001, RHEUM DIS CLIN N AM, V27, P131, DOI 10.1016/S0889-857X(05)70190-3; MCCULLOCH CAG, 1991, BLOOD, V77, P1906; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824; Mohammadi H, 2014, BIOMATERIALS, V35, P1138, DOI 10.1016/j.biomaterials.2013.10.059; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Perinpanayagam H, 2001, J ORTHOPAED RES, V19, P993, DOI 10.1016/S0736-0266(01)00045-6; Raisz LG, 2001, J BONE MINER RES, V16, P1948, DOI 10.1359/jbmr.2001.16.11.1948; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; SODEK J, 1977, ARCH ORAL BIOL, V22, P647, DOI 10.1016/0003-9969(77)90094-2; Sun CH, 2016, J BONE MINER RES, V31, P2227, DOI 10.1002/jbmr.2908; Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Viale-Bouroncle S, 2014, ARCH ORAL BIOL, V59, P1249, DOI 10.1016/j.archoralbio.2014.07.013; Ward Donald F. Jr., 2007, Molecular & Cellular Biomechanics, V4, P177; Yan SG, 2011, BIOMATERIALS, V32, P8676, DOI 10.1016/j.biomaterials.2011.07.072; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	63	20	20	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					937	953		10.1096/fj.201600645R	http://dx.doi.org/10.1096/fj.201600645R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27881487				2022-12-26	WOS:000395671200011
J	Zhao, JY; Chi, YL; Xu, YC; Jia, DY; Yao, K				Zhao, Jiayuan; Chi, Yuanlong; Xu, Yingchao; Jia, Dongying; Yao, Kai			Co-Metabolic Degradation of beta-Cypermethrin and 3-Phenoxybenzoic Acid by Co-Culture of Bacillus licheniformis B-1 and Aspergillus oryzae M-4	PLOS ONE			English	Article							MICROBIAL-DEGRADATION; PYRETHROID INSECTICIDES; GALLIC ACID; EXPOSURE; COMETABOLISM; PESTICIDES; BACTERIA	The degradation efficiency of organic contaminants and their associated metabolites by co-culture of microbes is mainly limited by toxic intermediates from co-metabolic degradation. In this study, we investigated the degradation of beta-cypermethrin (beta-CY) and 3-phenoxybenzoic acid (3-PBA) by co-culture of Bacillus licheniformis B-1 and Aspergillus oryzae M-4, as well as the influences of beta-CY and 3-PBA metabolites on their degradation and the growth of strains B-1 and M-4. Our results indicated that 100 mg/L beta-CY was degraded by 78.85%, and 3-PBA concentration was 0.05 mg/L after 72 h. Compared with using only strain B-1, the half-life (t(1/2)) of beta-CY by using the two strains together was shortened from 84.53 h to 38.54 h, and the yield coefficient of 3-PBA was decreased from 0.846 to 0.001. At 100 mg/L of 3-PBA and gallic acid, beta-CY and 3-PBA degradation were only 17.68% and 40.45%, respectively. As the toxic intermediate derived from co-metabolic degradation of beta-CY by strain B-1, 3-PBA was efficiently degraded by strain M-4, and gallic acid, as the toxic intermediate from co-metabolic degradation of 3-PBA by strain M-4, was efficiently degraded by strain B-1. These results provided a promising approach for efficient biodegradation of beta-CY and 3-PBA.	[Zhao, Jiayuan; Chi, Yuanlong; Xu, Yingchao; Jia, Dongying; Yao, Kai] Sichuan Univ, Coll Light Ind Text & Food Engn, Chengdu 610065, Sichuan, Peoples R China	Sichuan University	Yao, K (corresponding author), Sichuan Univ, Coll Light Ind Text & Food Engn, Chengdu 610065, Sichuan, Peoples R China.	yaokai555@126.com			National Natural Science Foundation of China [31371775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (31371775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08784; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050456; Deng Weiqin, 2015, Weishengwu Xuebao, V55, P1081; Deng WQ, 2015, APPL MICROBIOL BIOT, V99, P8187, DOI 10.1007/s00253-015-6690-2; Fenlon KA, 2007, J ENVIRON MONITOR, V9, P510, DOI 10.1039/b700668c; Halden RU, 1999, APPL ENVIRON MICROB, V65, P3354; Han Y, 2008, CHEMOSPHERE, V72, P785, DOI 10.1016/j.chemosphere.2008.03.058; Heudorf U, 2004, INT ARCH OCC ENV HEA, V77, P67, DOI 10.1007/s00420-003-0470-5; Hladik ML, 2012, J ENVIRON MONITOR, V14, P1838, DOI 10.1039/c2em10946h; Ji GX, 2011, REPROD TOXICOL, V31, P171, DOI 10.1016/j.reprotox.2010.10.005; Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7; Kolaczinski JH, 2004, FOOD CHEM TOXICOL, V42, P697, DOI 10.1016/j.fct.2003.12.008; Kong WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21558; KUMAR RA, 1992, J FERMENT BIOENG, V74, P159, DOI 10.1016/0922-338X(92)90076-7; Liu FF, 2014, J AGR FOOD CHEM, V62, P8256, DOI 10.1021/jf502835n; Liu SL, 2012, J CHROMATOGR SCI, V50, P469, DOI 10.1093/chromsci/bms030; Luo W, 2014, WATER SCI TECHNOL, V69, P1971, DOI 10.2166/wst.2014.108; McCoy MR, 2012, J AGR FOOD CHEM, V60, P5065, DOI 10.1021/jf2051653; NGOC H T, 2013, BIORESOURCE TECHNOLO, V146, P721; Ngoc Han T, 2010, J WATER ENV TECHNOL, V8, P125; Nzila A, 2013, ENVIRON POLLUT, V178, P474, DOI 10.1016/j.envpol.2013.03.042; Perry MJ, 2007, REPROD TOXICOL, V23, P113, DOI 10.1016/j.reprotox.2006.08.005; Sinha C, 2004, INT J DEV NEUROSCI, V22, P31, DOI 10.1016/j.ijdevneu.2003.10.005; Tang J, 2013, FRESEN ENVIRON BULL, V22, P1564; Van Eerd LL, 2003, WEED SCI, V51, P472, DOI 10.1614/0043-1745(2003)051[0472:PMIPAM]2.0.CO;2; Yang S, 2013, BIORESOURCE TECHNOL, V141, P97, DOI 10.1016/j.biortech.2013.01.173; Zhang YP, 2016, BIOMED CHROMATOGR, V30, P142, DOI 10.1002/bmc.3528; Zhao JY, 2015, J AGR FOOD CHEM, V63, P10729, DOI 10.1021/acs.jafc.5b04485	28	21	24	8	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166796	10.1371/journal.pone.0166796	http://dx.doi.org/10.1371/journal.pone.0166796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898684	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000018
J	Chung, J; Lee, WK; Cha, ES; Lee, JE; Kim, JH; Ryu, YH				Chung, Jin; Lee, Won Kyung; Cha, Eun-Suk; Lee, Jee Eun; Kim, Jeoung Hyun; Ryu, Young Hoon			Shear-Wave Elastography for the Differential Diagnosis of Breast Papillary Lesions	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; BI-RADS CLASSIFICATION; SONOGRAPHIC FEATURES; BENIGN PAPILLOMA; MASSES; ULTRASOUND; US; PERFORMANCE; MANAGEMENT; EXCISION	Objective To evaluate the diagnostic performance of shear-wave elastography (SWE) for the differential diagnosis of breast papillary lesions. Methods This study was an institutional review board-approved retrospective study, with a waiver of informed consent. A total of 79 breast papillary lesions in 71 consecutive women underwent ultrasound and SWE prior to biopsy. Ultrasound features and quantitative SWE parameters were recorded for each lesion. All lesions were surgically excised or excised using an ultra-sound-guided vacuum-assisted method. The diagnostic performances of the quantitative SWE parameters were compared using the area under the receiver operating characteristic curve (AUC). Results Of the 79 lesions, six (7.6%) were malignant and 12 (15.2%) were atypical. Orientation, margin, and the final BI-RADS ultrasound assessments were significantly different for the papillary lesions (p < 0.05). All qualitative SWE parameters were significantly different (p < 0.05). The AUC values for SWE parameters of benign and atypical or malignant papillary lesions ranged from 0.707 to 0.757 (sensitivity, 44.4-94.4%; specificity, 42.6-88.5%). The maximum elasticity and the mean elasticity showed the highest AUC (0.757) to differentiate papillary lesions. Conclusion SWE provides additional information for the differential diagnosis of breast papillary lesions. Quantitative SWE features were helpful to differentiate breast papillary lesions.	[Chung, Jin; Lee, Won Kyung; Cha, Eun-Suk; Lee, Jee Eun; Kim, Jeoung Hyun] Ewha Womans Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Chung, Jin] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ryu, Young Hoon] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, J (corresponding author), Ewha Womans Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Chung, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.	aqua0724@ewha.ac.kr						American College of Radiology ACR BI-RADS_Ultrasound, 2013, ACR BREAST IMAGING R; Au FWF, 2014, AM J ROENTGENOL, V203, pW328, DOI 10.2214/AJR.13.11693; Barr RG, 2012, J ULTRAS MED, V31, P773; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Chang JM, 2011, AM J ROENTGENOL, V196, P723, DOI 10.2214/AJR.10.4615; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Cho N, 2008, KOREAN J RADIOL, V9, P111, DOI 10.3348/kjr.2008.9.2.111; Choi JJ, 2012, JPN J RADIOL, V30, P422, DOI 10.1007/s11604-012-0070-y; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Hawley JR, 2015, CLIN IMAG, V39, P576, DOI 10.1016/j.clinimag.2015.01.017; Jagmohan P, 2013, DIAGN INTERV RADIOL, V19, P471, DOI 10.5152/dir.2013.13041; Kim MY, 2013, KOREAN J RADIOL, V14, P559, DOI 10.3348/kjr.2013.14.4.559; Kim TH, 2008, J ULTRAS MED, V27, P75, DOI 10.7863/jum.2008.27.1.75; Ko KH, 2012, ANN SURG ONCOL, V19, P908, DOI 10.1245/s10434-011-2050-3; Lam WWM, 2006, AM J ROENTGENOL, V186, P1322, DOI 10.2214/AJR.04.1908; Lee BE, 2015, EUR J RADIOL, V84, P1236, DOI 10.1016/j.ejrad.2015.04.005; Lee EJ, 2013, EUR RADIOL, V23, P1803, DOI 10.1007/s00330-013-2782-5; Lee SH, 2014, ULTRASONOGRAPHY, V33, P3, DOI 10.14366/usg.13012; Park HY, 2014, ULTRASOUND MED BIOL, V40, P1058, DOI 10.1016/j.ultrasmedbio.2013.12.021; Shin HJ, 2008, AM J ROENTGENOL, V190, P630, DOI 10.2214/AJR.07.2664; Skerl K, 2015, CLIN RADIOL, V70, P1421, DOI 10.1016/j.crad.2015.08.010; Sohn YM, 2013, J ULTRAS MED, V32, P303; Sohn YM, 2009, J ULTRAS MED, V28, P413, DOI 10.7863/jum.2009.28.4.413; Ueng SH, 2009, ARCH PATHOL LAB MED, V133, P893, DOI 10.1043/1543-2165-133.6.893; Vinnicombe SJ, 2014, EUR RADIOL, V24, P921, DOI 10.1007/s00330-013-3079-4; Yi A, 2012, EUR RADIOL, V22, P1033, DOI 10.1007/s00330-011-2341-x; Yoon J H, 2012, Ultraschall Med, V33, pE145, DOI 10.1055/s-0032-1313208; Yoon JH, 2013, EUR RADIOL, V23, P2432, DOI 10.1007/s00330-013-2854-6; Youk JH, 2013, EUR RADIOL, V23, P2695, DOI 10.1007/s00330-013-2873-3; Youk JH, 2012, ANN SURG ONCOL, V19, P922, DOI 10.1245/s10434-011-2033-4; Youk JH, 2011, RADIOLOGY, V258, P81, DOI 10.1148/radiol.10100728; Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167118	10.1371/journal.pone.0167118	http://dx.doi.org/10.1371/journal.pone.0167118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893857	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400089
J	Hennings, A; Hannemann, A; Rettig, R; Dorr, M; Nauck, M; Volzke, H; Lerch, MM; Lieb, W; Friedrich, N				Hennings, Anna; Hannemann, Anke; Rettig, Rainer; Doerr, Marcus; Nauck, Matthias; Voelzke, Henry; Lerch, Markus M.; Lieb, Wolfgang; Friedrich, Nele			Circulating Angiopoietin-2 and Its Soluble Receptor Tie-2 Concentrations Are Related to Renal Function in Two Population-Based Cohorts	PLOS ONE			English	Article							SERUM CYSTATIN-C; GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; ESSENTIAL-HYPERTENSION; LIGAND ANGIOPOIETIN-2; MARKER; CREATININE; ANGIOGENESIS; INFLAMMATION; ATHEROSCLEROSIS	Background An intact angiopoietin/Tie-2 ligand receptor system is indispensable for life. High circulating angiopoietin-2 (Ang-2) concentrations are strongly associated with kidney disease involving the progressive loss of glomerular filtration. The aim of our study was to investigate the associations between renal function and serum Ang-2 or serum Tie-2 concentrations in the general population. Methods Data of 3081 and 4088 subjects from two population-based studies, the Study of Health in Pomerania (SHIP-1) and SHIP-Trend, were used. Renal function was assessed by serum creatinine, cystatin C concentration, creatinine-based estimated glomerular filtration rate [eGFR(crea)], cystatin C-based eGFR [eGFR(cys)] and urinary albumin-to-creatinine ratio (uACR). Analyses of variance and linear regression models were calculated. Results In both cohorts, strong positive associations between serum cystatin C concentrations and serum Ang-2 or Tie-2 concentrations as well as inverse associations between eGFR(cys) and serum Ang-2 or Tie-2 concentrations were found. These relations were also present in a subpopulation without hypertension or diabetes mellitus type 2. Furthermore, we detected weak U-shaped associations between serum creatinine concentrations or eGFR(crea) and serum Ang-2 concentrations. With respect to uACR a strong positive association with serum Ang-2 concentrations was revealed. Conclusion Serum Ang-2 concentrations are strongly associated with sensitive parameters of renal impairment like serum cystatin C, uACR and eGFR(cys). These findings persisted even after exclusion of subjects with hypertension or diabetes mellitus type 2, conditions that predispose to chronic renal disease and are associated with increased Ang-2 concentrations. Interestingly, we did not detect the same strong relations between serum creatinine and eGFR(crea) with serum Ang-2 concentration. Additionally, significant association of serum Tie-2 concentrations with cystatin C and eGFR(cys) were detected.	[Hennings, Anna; Hannemann, Anke; Nauck, Matthias; Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Greifswald, Germany; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus; Nauck, Matthias; Voelzke, Henry] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Berlin, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Voelzke, Henry] DZD German Ctr Diabet Res, Partner Site Greifswald, Greifswald, Germany; [Lerch, Markus M.] Univ Med Greifswald, Dept Internal Med A, Greifswald, Germany; [Lieb, Wolfgang] Christian Albrechts Univ Kiel, Inst Epidemiol, Kiel, Germany; [Friedrich, Nele] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; University of Kiel	Friedrich, N (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.; Friedrich, N (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.	nele.friedrich@uni-greifswald.de	Lerch, Markus M./E-2206-2016; Lieb, Wolfgang/AAC-7650-2022; Dörr, Marcus/F-1919-2010	Lerch, Markus M./0000-0002-9643-8263; Dörr, Marcus/0000-0001-7471-475X	German Federal Ministry of Education and Research (BMBF) [01ZZ0403, 01ZZ0103, 01G10883]; Ministry for Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg West Pomerania [03I52061A]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg West Pomerania	This work was funded by grants from the German Federal Ministry of Education and Research (BMBF, Grants 01ZZ0403, 01ZZ0103, 01G10883), the Ministry for Education, Research and Cultural Affairs as well as the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg West Pomerania (03I52061A).; This work was funded by grants from the German Federal Ministry of Education and Research (BMBF, Grants 01ZZ0403, 01ZZ0103, 01GI0883), the Ministry for Education, Research and Cultural Affairs as well as the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg West Pomerania (03152061A).	Chang FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054668; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; David S, 2009, NEPHROLOGE, V4, P266; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; David S, 2009, J HYPERTENS, V27, P1641, DOI 10.1097/HJH.0b013e32832be575; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Dobrian AD, 2012, KIDNEY INT, V81, P722, DOI 10.1038/ki.2011.496; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jongman RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136205; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130; Kumpers P, 2009, NEPHROL DIAL TRANSPL, V24, P1845, DOI 10.1093/ndt/gfn755; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Gomez JML, 2011, NEFROLOGIA, V31, P560, DOI 10.3265/Nefrologia.pre2011.Jul.10834; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Murty M S N, 2013, Indian J Nephrol, V23, P180, DOI 10.4103/0971-4065.111840; Muslimovic Alma, 2015, Mater Sociomed, V27, P75, DOI 10.5455/msm.2015.27.75-78; Mussap M, 2002, KIDNEY INT, V61, P1453, DOI 10.1046/j.1523-1755.2002.00253.x; Okura T, 2010, CLIN EXP NEPHROL, V14, P584, DOI 10.1007/s10157-010-0334-8; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schmidt RJ, 2000, KIDNEY INT, V58, P1261, DOI 10.1046/j.1523-1755.2000.00281.x; Sporek M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5780903; STONE CJ, 1985, ADDITIVE SPLINES STA, P45; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tsai YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108862; Turner N, 2016, OXFORD TXB CLIN NEPH, Vxxix, P2932; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Watanabe S, 2003, HYPERTENS RES, V26, P895, DOI 10.1291/hypres.26.895; Whitcomb DC, 2010, AM J GASTROENTEROL, V105, P2287, DOI 10.1038/ajg.2010.183; YOU Ling, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P798; Yuan HT, 1999, J AM SOC NEPHROL, V10, P1722	40	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166492	10.1371/journal.pone.0166492	http://dx.doi.org/10.1371/journal.pone.0166492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893762	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400029
J	Nieto, RLM; Mehaffy, C; Creissen, E; Troudt, JL; Troy, A; Bielefeldt-Ohmann, H; Burgos, M; Izzo, A; Dobos, KM				Luisa Maria Nieto, R.; Mehaffy, Carolina; Creissen, Elizabeth; Troudt, JoLynn; Troy, Amber; Bielefeldt-Ohmann, Helle; Burgos, Marcos; Izzo, Angelo; Dobos, Karen M.			Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC	PLOS ONE			English	Article							CATALASE-PEROXIDASE GENE; DRUG-RESISTANCE; BEIJING GENOTYPE; EXPRESSION; MUTATIONS; STRAINS; CELLS; LUNG; DIFFERENTIATION; PERSISTENCE	In the last decade, there were 10 million new tuberculosis cases per year globally. Around 9.5% of these cases were caused by isoniazid resistant (INHr) Mycobacterium tuberculosis (Mtb) strains. Although isoniazid resistance in Mtb is multigenic, mutations in the catalase-peroxidase (katG) gene predominate among the INHr strains. The effect of these drug-resis-tance-conferring mutations on Mtb fitness and virulence is variable. Here, we assessed differences in bacterial growth, immune response and pathology induced by Mtb strains harboring mutations at the N-terminus of the katG gene. We studied one laboratory and one clinically isolated Mtb clonal pair from different genetic lineages. The INHr strain in each pair had one and two katG mutations with significantly reduced levels of the enzyme and peroxidase activity. Both strains share the V1A mutation, while the double mutant clinical INHr had also the novel E3V katG mutation. Four groups of C57BL/6 mice were infected with one of the Mtb strains previously described. We observed a strong reduction in virulence (reduced bacterial growth), lower induction of proinflammatory cytokines and significantly reduced pathology scores in mice infected with the clinical INHr strain compared to the infection caused by its INHs progenitor strain. On the other hand, there was a subtle reduction of bacteria growth without differences in the pathology scores in mice infected with the laboratory INHr strain. Our results also showed distinct alkyl-hydroperoxidase C (AhpC) levels in the katG mutant strains, which could explain the difference in the virulence profile observed. The difference in the AhpC levels between clonal strains was not related to a genetic defect in the gene or its promoter. Cumulatively, our results indicate that the virulence, pathology and fitness of INHr strains could be negatively affected by multiple mutations in katG, lack of the peroxidase activity and reduced AhpC levels.	[Luisa Maria Nieto, R.; Mehaffy, Carolina; Creissen, Elizabeth; Troudt, JoLynn; Troy, Amber; Izzo, Angelo; Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Burgos, Marcos] Univ New Mexico, Dept Med, Div Infect Dis, Albuquerque, NM 87131 USA	Colorado State University; University of Queensland; University of Queensland; University of New Mexico	Dobos, KM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Karen.Dobos@colostate.edu	Izzo, Angelo A/F-1229-2017; LM, Nieto/N-4646-2013; Dobos, Karen/D-1170-2017	Izzo, Angelo A/0000-0003-3208-2330; LM, Nieto/0000-0003-1566-5876; Dobos, Karen/0000-0001-7115-8524	ATCC [2010-0516-0005]; Colombian government scholarship "Francisco Jose de Caldas 512" scholarship for PhD students (Colciencias agency) [HHSN2722010000091, HHSN27200004]; NIH/NIAID IDIQ	ATCC; Colombian government scholarship "Francisco Jose de Caldas 512" scholarship for PhD students (Colciencias agency); NIH/NIAID IDIQ	This work was possible due to funding from the ATCC (fund number 2010-0516-0005) awarded to KMD, the Colombian government scholarship "Francisco Jose de Caldas 512" scholarship for PhD students (Colciencias agency) awarded to LMNR, and the NIH/NIAID IDIQ Contract No. HHSN2722010000091 Task Order HHSN27200004, Task A58, awarded to MI. Mouse studies performed at CSU were funded under this same NIH/NIAID IDIQ Contract entitled "Testing of mutant mycobacteria in established advanced small animal models" to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Almeida D, 2009, ANTIMICROB AGENTS CH, V53, P4178, DOI 10.1128/AAC.00830-09; Barry CE, 1998, DRUG RESIST UPDATE, V1, P128, DOI 10.1016/S1368-7646(98)80028-9; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Cade CE, 2010, PROTEIN SCI, V13, DOI 10.1146/annurev.immunol.19.1.93; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Caraway M., 2011, THESIS; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chindelevitch L, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004475; Datta G, 2016, TUBERCULOSIS, V98, P50, DOI 10.1016/j.tube.2016.02.004; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Jacobs Jr WR, 2014, MICROBIOLOGY SPECTRU, V2; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kruh-Garcia NA, 2014, J PROTEOMICS, V97, P141, DOI 10.1016/j.jprot.2013.07.005; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Njuma OJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P27, DOI 10.1016/j.abb.2013.11.007; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Peters JS, 2016, FRONTIERS MICROBIOLO, P7; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Sandy J, 2002, J MOL BIOL, V318, P1071, DOI 10.1016/S0022-2836(02)00141-9; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Taylor JL, 2012, IMMUNOL CELL BIOL, V90, P945, DOI 10.1038/icb.2012.34; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2014, GLOB TUB REP; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	47	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166807	10.1371/journal.pone.0166807	http://dx.doi.org/10.1371/journal.pone.0166807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893795	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400046
J	Smith, GC; Delahay, RJ; McDonald, RA; Budgey, R				Smith, Graham C.; Delahay, Richard J.; McDonald, Robbie A.; Budgey, Richard			Model of Selective and Non-Selective Management of Badgers (Meles meles) to Control Bovine Tuberculosis in Badgers and Cattle	PLOS ONE			English	Article							SEVERITY; PROGRESSION; IMPACT	Bovine tuberculosis (bTB) causes substantial economic losses to cattle farmers and taxpayers in the British Isles. Disease management in cattle is complicated by the role of the European badger (Meles meles) as a host of the infection. Proactive, non-selective culling of badgers can reduce the incidence of disease in cattle but may also have negative effects in the area surrounding culls that have been associated with social perturbation of badger populations. The selective removal of infected badgers would, in principle, reduce the number culled, but the effects of selective culling on social perturbation and disease outcomes are unclear. We used an established model to simulate non-selective badger culling, non-selective badger vaccination and a selective trap and vaccinate or remove (TVR) approach to badger management in two distinct areas: South West England and Northern Ireland. TVR was simulated with and without social perturbation in effect. The lower badger density in Northern Ireland caused no qualitative change in the effect of management strategies on badgers, although the absolute number of infected badgers was lower in all cases. However, probably due to differing herd density in Northern Ireland, the simulated badger management strategies caused greater variation in subsequent cattle bTB incidence. Selective culling in the model reduced the number of badgers killed by about 83% but this only led to an overall benefit for cattle TB incidence if there was no social perturbation of badgers. We conclude that the likely benefit of selective culling will be dependent on the social responses of badgers to intervention but that other population factors including badger and cattle density had little effect on the relative benefits of selective culling compared to other methods, and that this may also be the case for disease management in other wild host populations.	[Smith, Graham C.; Delahay, Richard J.; Budgey, Richard] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, Cornwall, England	Animal & Plant Health Agency UK; University of Exeter	Budgey, R (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	richard.budgey@apha.gsi.gov.uk	McDonald, Robbie A/A-2931-2012; Smith, Graham C/J-2593-2013; Budgey, Richard/A-4861-2016; McDonald, Robbie/AAK-2718-2020; Delahay, Richard/GSI-4663-2022	McDonald, Robbie A/0000-0002-6922-3195; Smith, Graham C/0000-0002-9897-6794; Budgey, Richard/0000-0002-9938-2584; McDonald, Robbie/0000-0002-6922-3195; 	Department for Food, Environment and Rural Affairs; Department of Agriculture and Rural Development Northern Ireland	Department for Food, Environment and Rural Affairs; Department of Agriculture and Rural Development Northern Ireland	Funding organisations were: 1. Department for Food, Environment and Rural Affairs, and 2. Department of Agriculture and Rural Development Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, VET REC, V176, P32, DOI 10.1136/vr.h24; [Anonymous], 2012, VET REC, V171, P361, DOI 10.1136/vr.e6782; [Anonymous], 2012, VET REC, V171, P285, DOI 10.1136/vr.e6219; [Anonymous], 2012, W MORNING NEWS; AUBERT M, 1994, VET REC, V134, P55, DOI 10.1136/vr.134.3.55; Bielby J, 2014, P NATL ACAD SCI USA, V111, P9193, DOI 10.1073/pnas.1401503111; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Carter Stephen P., 2009, P121, DOI 10.1007/978-4-431-77134-0_7; Central Science Laboratory, 2006, INT ACT PIL AR PAP A; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Corner LAL, 2008, RES VET SCI, V85, P238, DOI 10.1016/j.rvsc.2007.11.010; DARDNI, 2013, TEST VACC REM TVR WI; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Graham J, 2013, EPIDEMIOL INFECT, V141, P1429, DOI 10.1017/S0950268812003019; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Independent Scientific Group, 2007, BOVINE TB THE SCIENT; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Lachish S, 2010, CONSERV BIOL, V24, P841, DOI 10.1111/j.1523-1739.2009.01429.x; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; Smith GC, 1997, J APPL ECOL, V34, P1375, DOI 10.2307/2405255; Smith GC, 2001, J APPL ECOL, V38, P509, DOI 10.1046/j.1365-2664.2001.00609.x; Smith GC, 2001, J APPL ECOL, V38, P520, DOI 10.1046/j.1365-2664.2001.00610.x; Smith GC, 2013, SIMULATION MODEL TO; Smith GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039250; Tosa MI, 2016, J WILDLIFE MANAGEMEN; Welsh Assembly Government, 2009, BADG CONTR BACKGR 20; Wilkinson D, 2004, J APPL ECOL, V41, P492, DOI 10.1111/j.0021-8901.2004.00898.x; Wilkinson D, 2009, J WILDLIFE DIS, V45, P1062, DOI 10.7589/0090-3558-45.4.1062; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326	35	12	12	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167206	10.1371/journal.pone.0167206	http://dx.doi.org/10.1371/journal.pone.0167206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893809	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000389472400100
J	Janezic, S; Potocnik, M; Zidaric, V; Rupnik, M				Janezic, Sandra; Potocnik, Mojca; Zidaric, Valerija; Rupnik, Maja			Highly Divergent Clostridium difficile Strains Isolated from the Environment	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; PCR RIBOTYPES; PREVALENCE; DIVERSITY; EVOLUTION	Clostridium difficile is one of the most important human and animal pathogens. However, the bacterium is ubiquitous and can be isolated from various sources. Here we report the prevalence and characterization of C. difficile in less studied environmental samples, puddle water (n = 104) and soil (n = 79). C. difficile was detected in 14.4% of puddle water and in 36.7% of soil samples. Environmental strains displayed antimicrobial resistance patterns comparable to already published data of human and animal isolates. A total of 480 isolates were grouped into 34 different PCR ribotypes. More than half of these (52.9%; 18 of 34) were already described in humans or animals. However, 14 PCR ribotypes were new in our PCR ribotype library and all but one were non-toxigenic. The multilocus sequence analysis of these new PCR ribotypes revealed that non-toxigenic environmental isolates are phylogenetically distinct and belong to three highly divergent clades, two of which have not been described before. Our data suggest that environment is a potential reservoir of genetically diverse population of C. difficile.	[Janezic, Sandra; Potocnik, Mojca; Zidaric, Valerija; Rupnik, Maja] Natl Lab Hlth Environm & Food NLZOH, Maribor, Slovenia; [Janezic, Sandra; Rupnik, Maja] Univ Maribor, Fac Med, Maribor, Slovenia	University of Maribor	Janezic, S (corresponding author), Natl Lab Hlth Environm & Food NLZOH, Maribor, Slovenia.; Janezic, S (corresponding author), Univ Maribor, Fac Med, Maribor, Slovenia.	sandra.janezic@nlzoh.si			Slovenian Research Agency [J3-4298]; Wellcome Trust	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Wellcome Trust(Wellcome Trust)	This work was supported by Slovenian Research Agency grant J3-4298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors would like to thank Sara Beigot Glaser and Tanja Rikanovic for contributions in characterization of strains and Bozena Kotnik Kevorkijan for assistance with organization of sampling in the hospital area. This publication made use of the PubMLST website (http://pubmlst.org/) developed by Keith Jolley (Jolley & Maiden 2010, BMC Bioinformatics, 11:595) and sited at the University of Oxford. The development of that website was funded by the Wellcome Trust.	Alam MJ, 2014, ANAEROBE, V27, P31, DOI 10.1016/j.anaerobe.2014.03.002; AlSaif N, 1996, J MED MICROBIOL, V45, P133, DOI 10.1099/00222615-45-2-133; Baverud V, 2003, EQUINE VET J, V35, P465, DOI 10.2746/042516403775600505; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Bianciotto V, 1996, APPL ENVIRON MICROB, V62, P3005, DOI 10.1128/AEM.62.8.3005-3010.1996; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; CLSI, 2016, M100S CLSI; Dingle KE, 2014, GENOME BIOL EVOL, V6, P36, DOI 10.1093/gbe/evt204; Elliott B, 2009, ANAEROBE, V15, P249, DOI 10.1016/j.anaerobe.2009.08.006; European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Gamboa MDM, 2005, ANAEROBE, V11, P322, DOI 10.1016/j.anaerobe.2005.04.006; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hargreaves KR, 2013, APPL ENVIRON MICROB, V79, P6236, DOI 10.1128/AEM.01849-13; Janezic S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-48; Janezic S, 2015, J CLIN MICROBIOL, V53, P692, DOI 10.1128/JCM.02211-14; Janezic S, 2010, METHODS MOL BIOL, V646, P55, DOI 10.1007/978-1-60327-365-7_4; Keessen EC, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-14; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Knight DR, 2016, J ANTIMICROB CHEMOTH, V71, P2213, DOI 10.1093/jac/dkw124; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; Leffler DA, 2015, NEW ENGL J MED, V373, P287, DOI 10.1056/NEJMc1506004; Monot M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15023; Pasquale V, 2011, FOLIA MICROBIOL, V56, P431, DOI 10.1007/s12223-011-0068-3; Pirs T, 2013, J MED MICROBIOL, V62, P1478, DOI 10.1099/jmm.0.058875-0; Romano V, 2012, APPL ENVIRON MICROB, V78, P6643, DOI 10.1128/AEM.01379-12; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Rupnik M, 2016, J CLIN MICROBIOL, V54, P13, DOI 10.1128/JCM.02083-15; Rupnik M, 2010, METHODS MOL BIOL, V646, P67, DOI 10.1007/978-1-60327-365-7_5; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Simango C, 2006, T ROY SOC TROP MED H, V100, P1146, DOI 10.1016/j.trstmh.2006.01.009; Spigaglia P, 2016, THER ADV INFECT DIS, V3, P23, DOI 10.1177/2049936115622891; Steyer A, 2015, FOOD ENVIRON VIROL, V7, P164, DOI 10.1007/s12560-015-9183-7; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Weese JS, 2010, CLIN MICROBIOL INFEC, V16, P3, DOI 10.1111/j.1469-0691.2009.03108.x; Zidaric V, 2010, ANAEROBE, V16, P371, DOI 10.1016/j.anaerobe.2010.06.001	38	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167101	10.1371/journal.pone.0167101	http://dx.doi.org/10.1371/journal.pone.0167101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880843	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500067
J	Miller, JL; Spiro, SG; Dowall, SD; Taylor, I; Rule, A; Alonzi, DS; Sayce, AC; Wright, E; Bentley, EM; Thom, R; Hall, G; Dwek, RA; Hewson, R; Zitzmann, N				Miller, Joanna L.; Spiro, Simon G.; Dowall, Stuart D.; Taylor, Irene; Rule, Antony; Alonzi, Dominic S.; Sayce, Andrew C.; Wright, Edward; Bentley, Emma M.; Thom, Ruth; Hall, Graham; Dwek, Raymond A.; Hewson, Roger; Zitzmann, Nicole			Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model	PLOS ONE			English	Article							BUTYLDEOXYNOJIRIMYCIN-MEDIATED INHIBITION; N-BUTYL-DEOXYNOJIRIMYCIN; ER ALPHA-GLUCOSIDASES; VIRAL DIARRHEA VIRUS; HEPATITIS-C VIRUS; ANTIVIRAL ACTIVITY; DENGUE VIRUS; SUGAR-DERIVATIVES; ENTRY; HIV	The antiviral properties of iminosugars have been reported previously in vitro and in small animal models against Ebola virus (EBOV); however, their effects have not been tested in larger animal models such as guinea pigs. We tested the iminosugars N-butyl-deoxynojirimycin (NB-DNJ) and N-(9-methoxynonyl)-1deoxynojirimycin (MON-DNJ) for safety in uninfected animals, and for antiviral efficacy in animals infected with a lethal dose of guinea pig adapted EBOV. 1850 mg/kg/day NB-DNJ and 120 mg/kg/day MON-DNJ administered intra-venously, three times daily, caused no adverse effects and were well tolerated. A pilot study treating infected animals three times within an 8 hour period was promising with 1 of 4 infected NB-DNJ treated animals surviving and the remaining three showing improved clinical signs. MON-DNJ showed no protective effects when EBOV-infected guinea pigs were treated. On histopathological examination, animals treated with NB-DNJ had reduced lesion severity in liver and spleen. However, a second study, in which NB-DNJ was administered at equally-spaced 8 hour intervals, could not confirm drug-associated benefits. Neither was any antiviral effect of iminosugars detected in an EBOV glycoprotein pseudotyped virus assay. Overall, this study provides evidence that NB-DNJ and MON-DNJ do not protect guinea pigs from a lethal EBOV-infection at the dose levels and regimens tested. However, the one surviving animal and signs of improvements in three animals of the NB-DNJ treated cohort could indicate that NB-DNJ at these levels may have a marginal beneficial effect. Future work could be focused on the development of more potent iminosugars.	[Miller, Joanna L.; Spiro, Simon G.; Alonzi, Dominic S.; Sayce, Andrew C.; Dwek, Raymond A.; Zitzmann, Nicole] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Antiviral Res Unit, Oxford OX1 3QU, England; [Dowall, Stuart D.; Taylor, Irene; Rule, Antony; Thom, Ruth; Hall, Graham; Hewson, Roger] Publ Hlth England, Salisbury, Wilts, England; [Spiro, Simon G.] Royal Vet Coll, London, England; [Wright, Edward; Bentley, Emma M.] Univ Westminster, Fac Sci & Technol, Viral Pseudotype Unit, London, England	University of Oxford; Public Health England; University of London; University of London Royal Veterinary College; University of Westminster	Zitzmann, N (corresponding author), Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Antiviral Res Unit, S Parks Rd, Oxford OX1 3QU, England.	joanna.miller@bioch.ox.ac.uk; nicole.zitzmann@bioch.ox.ac.uk		Wright, Edward/0000-0001-7041-5138; Sayce, Andrew/0000-0003-1108-3895; Alonzi, Dominic/0000-0002-1330-9109; Spiro, Simon/0000-0002-9621-2192	Oxford Glycobiology Institute Endowment; Emergent BioSolutions, Inc.; Pembroke College, Oxford; Wellcome Trust [092872/Z/10/Z]	Oxford Glycobiology Institute Endowment; Emergent BioSolutions, Inc.; Pembroke College, Oxford; Wellcome Trust(Wellcome TrustEuropean Commission)	This work has been supported by Oxford Glycobiology Institute Endowment and a research grant from Emergent BioSolutions, Inc. (formerly Unither Virology LLC). ACS was funded by a Clarendon Fund Scholarship and a Santander Graduate Scholarship from Pembroke College, Oxford. SGS was funded by the Wellcome Trust, grant 092872/Z/10/Z. NZ is a Fellow of Merton College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Alonzi DS, 2008, BIOCHEM J, V409, P571, DOI 10.1042/BJ20070748; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; BLOCK TM, 1994, P NATL ACAD SCI USA, V91, P2235, DOI 10.1073/pnas.91.6.2235; Branza-Nichita N, 2001, J VIROL, V75, P3527, DOI 10.1128/JVI.75.8.3527-3536.2001; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011; Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023; Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08; CLAEYSSENS M, 1965, NATURWISSENSCHAFTEN, V52, P515, DOI 10.1007/BF00638350; Dowall S, 2013, ANTIVIR RES, V97, P108, DOI 10.1016/j.antiviral.2012.11.003; Dowall SD, 2015, J GEN VIROL, V96, P3484, DOI 10.1099/jgv.0.000309; Dowall SD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0540-x; Falzarano D, 2015, EMERG INFECT DIS, V21, P1065, DOI 10.3201/eid2106.150176; FISCHER P, 1995, J VIROL, V69, P5791, DOI 10.1128/JVI.69.9.5791-5797.1995; Fischer PB, 1996, J VIROL, V70, P7143, DOI 10.1128/JVI.70.10.7143-7152.1996; Fischer PB, 1996, J VIROL, V70, P7153, DOI 10.1128/JVI.70.10.7153-7160.1996; FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139; FLEET GWJ, 1988, FEBS LETT, V237, P128, DOI 10.1016/0014-5793(88)80185-6; GRUTERS RA, 1987, NATURE, V330, P74, DOI 10.1038/330074a0; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hussain S, 2015, J ANTIMICROB CHEMOTH, V70, P136, DOI 10.1093/jac/dku349; KARPAS A, 1988, P NATL ACAD SCI USA, V85, P9229, DOI 10.1073/pnas.85.23.9229; Kuhn JH, 2014, GENOME ANNOUNCE, V2, DOI [10.1128/genomeA.01178-14, DOI 10.1128/GENOMEA.01178-14]; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; Lennemann NJ, 2015, THE JOURNAL OF INFEC, DOI [10.1093/infdis/jiv201, DOI 10.1093/INFDIS/JIV201]; Long Jason, 2015, F1000Res, V4, P30, DOI 10.12688/f1000research.6085.1; Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579; Martinez-Romero C, 2015, VIRUS RES, V209, P4, DOI 10.1016/j.virusres.2015.05.025; Mehta Anand, 2002, Antivir Chem Chemother, V13, P299; Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12; NIWA T, 1970, AGR BIOL CHEM TOKYO, V34, P966, DOI 10.1080/00021369.1970.10859713; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; PAULSEN H, 1966, ANGEW CHEM INT EDIT, V5, P495, DOI 10.1002/anie.196604951; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524; Sayce AC, 2010, TRENDS MICROBIOL, V18, P323, DOI 10.1016/j.tim.2010.04.003; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; TIERNEY M, 1995, J ACQ IMMUN DEF SYND, V10, P549, DOI 10.1097/00042560-199510050-00008; TYMS AS, 1987, LANCET, V2, P1025; Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001; Warfield KL, 2015, VIRUSES-BASEL, V7, P2404, DOI 10.3390/v7052404; WARFIELD KL, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8030071; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Wong G, 2015, CLIN MICROBIOL REV, V28, P593, DOI 10.1128/CMR.00014-15; Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705; Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zitzmann N, 1999, P NATL ACAD SCI USA, V96, P11878, DOI 10.1073/pnas.96.21.11878	55	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167018	10.1371/journal.pone.0167018	http://dx.doi.org/10.1371/journal.pone.0167018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880800	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500054
J	Bose, ME; McCaul, KC; Mei, H; Sasman, A; He, J; Kramp, W; Shively, R; Yan, K; Henrickson, KJ				Bose, Michael E.; McCaul, Kate C.; Mei, Hong; Sasman, Amy; He, Jie; Kramp, William; Shively, Roxanne; Yan, Ke; Henrickson, Kelly J.			Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays	PLOS ONE			English	Article							NASAL SECRETIONS; IMMUNOGLOBULINS; ORIGIN; DNA	Many assays have been developed for the detection of influenza virus which is an important respiratory pathogen. Development of these assays commonly involves the use of human clinical samples for validation of their performance. However, clinical samples can be difficult to obtain, deteriorate over time, and be inconsistent in composition. The goal of this study was to develop a simulated respiratory secretion (SRS) that could act as a surrogate for clinical samples. To this end, we determined the effects major respiratory secretion components (Na+, K+, Ca2+, cells, albumin IgG, IgM, and mucin) have on the performance of influenza assays including both nucleic acid amplification and rapid antigen assays. Minimal effects on the molecular assays were observed for all of the components tested, except for serum derived human IgG, which suppressed the signal of the rapid antigen assays. Using dot blots we were able to show anti-influenza nucleoprotein IgG antibodies are common in human respiratory samples. We composed a SRS that contained mid-point levels of human respiratory sample components and studied its effect compared to phosphate buffered saline and virus negative clinical sample matrix on the Veritor, Sofia, CDC RT-PCR, Simplexa, cobas Liat, and Alere i influenza assays. Our results demonstrated that a SRS can interact with a variety of test methods in a similar manner to clinical samples with a similar impact on test performance.	[Bose, Michael E.; McCaul, Kate C.; Mei, Hong; Sasman, Amy; He, Jie; Henrickson, Kelly J.] Med Coll Wisconsin, Dept Pediat, Midwest Resp Virus Program, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kramp, William; Shively, Roxanne] US Dept HHS, Biomed Adv Res & Dev Author, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA; [Yan, Ke] Med Coll Wisconsin, Dept Pediat, Sect Quantitat Hlth Sci, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Henrickson, KJ (corresponding author), Med Coll Wisconsin, Dept Pediat, Midwest Resp Virus Program, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	khenrick@mcw.edu	Kramp, William J/E-5127-2011	Bose, Michael/0000-0001-9759-499X	Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services [HHSS01002010000101/HHS010033002T]	Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services	This project has been funded by the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services under contract number HHSS01002010000101/HHS010033002T (MEB, KCM, HM, AS, JH, YK, KJH). Members of the funding agency had a role in study design, data analysis, decision to publish, and preparation of the manuscript (WK and RS).	ASTM International, 2010, E272010 ASTM; BIEWENGA J, 1991, ANN CLIN BIOCHEM, V28, P260, DOI 10.1177/000456329102800311; Bose ME, 2014, INFLUENZA OTHER RESP, V8, P474, DOI 10.1111/irv.12246; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; DiMaio MA, 2012, J VIROL METHODS, V186, P137, DOI 10.1016/j.jviromet.2012.07.023; GALLAGHER ML, 1987, BIOCHEM BIOPH RES CO, V144, P271, DOI 10.1016/S0006-291X(87)80506-5; Global Influenza Programme, 2007, INFLUENZA OTHER RESP, V1, P131, DOI [10.1111/j.1750-2659.2007, DOI 10.1111/J.1750-2659.2007]; Inagaki K, 2016, J INFECT DIS, V213, P407, DOI 10.1093/infdis/jiv331; JOHANSSON SGO, 1976, INT ARCH ALLER A IMM, V52, P364, DOI 10.1159/000231703; Kishore R, 2006, J FORENSIC SCI, V51, P1055, DOI 10.1111/j.1556-4029.2006.00204.x; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LORIN MI, 1972, J LAB CLIN MED, V80, P275; MORGAN KL, 1980, IMMUNOLOGY, V41, P729; Mota-Ferreira DML, 2009, ACTA TROP, V109, P103, DOI 10.1016/j.actatropica.2008.09.023; Page J, 2007, 23 ANN CLIN VIR S; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sakakura Y, 1979, Auris Nasus Larynx, V6, P71; SCICCHITANO R, 1986, IMMUNOLOGY, V58, P315; U. S. Food and Drug Administration/Office of In Vitro Diagnostic Device Evaluation and Safety Division of Microbiology Devices, 2011, GUID IND FDA STAFF E; US FDA, 2010, GUID IND FDA STAFF I; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; WAGNER DK, 1987, J CLIN MICROBIOL, V25, P559, DOI 10.1128/JCM.25.3.559-562.1987; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YEAGER H, 1971, AM J MED, V50, P493, DOI 10.1016/0002-9343(71)90338-X	27	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166800	10.1371/journal.pone.0166800	http://dx.doi.org/10.1371/journal.pone.0166800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870895	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400031
J	Wallner, S; Grandl, M; Liebisch, G; Peer, M; Orso, E; Sigruner, A; Sobota, A; Schmitz, G				Wallner, Stefan; Grandl, Margot; Liebisch, Gerhard; Peer, Markus; Orso, Evelyn; Sigruener, Alexander; Sobota, Andrzej; Schmitz, Gerd			oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; OXIDIZED LDL; LIPID RAFTS; CHOLERA-TOXIN; INTRACELLULAR CHOLESTEROL; ACID SPHINGOMYELINASE; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; RICH DOMAINS	Background Extravasation of macrophages and formation of lipid-laden foam cells are key events in the development and progression of atherosclerosis. The degradation of atherogenic lipoproteins subsequently leads to alterations in cellular lipid metabolism that influence inflammatory signaling. Especially sphingolipids and ceramides are known to be involved in these processes. We therefore analyzed monocyte derived macrophages during differentiation and after loading with enzymatically (eLDL) and oxidatively (oxLDL) modified low-density lipoproteins (LDL). Methods Primary human monocytes were isolated from healthy, normolipidemic blood donors using leukapheresis and counterflow elutriation. On the fourth day of MCSF-induced differentiation eLDL (40 mu g/ml) or oxLDL (80 mu g/ml) were added for 48h. Lipid species were analyzed by quantitative tandem mass spectrometry. Taqman qPCR was performed to investigate transcriptional changes in enzymes involved in sphingolipid metabolism. Furthermore, membrane lipids were studied using flow cytometry and confocal microscopy. Results MCSF dependent phagocytic differentiation of blood monocytes had only minor effects on the sphingolipid composition. Levels of total sphingomyelin and total ceramide remained unchanged, while lactosylceramides, cholesterylesters and free cholesterol decreased. At the species level most ceramide species showed a reduction upon phagocytic differentiation. Loading with eLDL preferentially increased cellular cholesterol while loading with oxLDL increased cellular ceramide content. Activation of the salvage pathway with a higher mRNA expression of acid and neutral sphingomyelinase, neutral sphingomyelinase activation associated factor and glucosylceramidase as well as increased surface expression of SMPD1 were identified as potentially underlying mechanisms. Moreover, flow-cytometric analysis revealed a higher cell-surface-expression of ceramide, lactosylceramide (CDw17), globotriaosylceramide (CD77), dodecasaccharide-ceramide (CD65s) and GM1 ganglioside upon oxLDL loading. ApoE in contrast to apoA-I preferentially bound to the ceramide enriched surfaces of oxLDL loaded cells. Confocal microscopy showed a co-localization of acid sphingomyelinase with ceramide rich membrane microdomains. Conclusion eLDL leads to the formation of lipid droplets and preferentially induces cholesterol/sphingomyelin rich membrane microdomains while oxLDL promotes the development of cholesterol/ceramide rich microdomains via activation of the salvage pathway.	[Wallner, Stefan; Grandl, Margot; Liebisch, Gerhard; Peer, Markus; Orso, Evelyn; Sigruener, Alexander; Schmitz, Gerd] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany; [Sobota, Andrzej] Nencki Inst Expt Biol, Dept Cell Biol, Warsaw, Poland; [Grandl, Margot] Beckman Coulter GmbH, Berlin, Germany; [Peer, Markus] Bruker Daltonics Inc, Bremen, Germany	University of Regensburg; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Beckman Coulter Inc.; Bruker Corporation; Bruker Daltonik GmbH	Schmitz, G (corresponding author), Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany.	gerd.schmitz@klinik.uni-regensburg.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811	European Community [202272]; Deutsche Forschungsgemeinschaft [SFB Transregio 13]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet. Additional funding came from the Deutsche Forschungsgemeinschaft through the SFB Transregio 13 "Membrane Microdomains and Their Role in Human Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGSTROM J, 1994, P NATL ACAD SCI USA, V91, P11859, DOI 10.1073/pnas.91.25.11859; Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; BHADRA S, 1991, BIOCHEM BIOPH RES CO, V176, P431, DOI 10.1016/0006-291X(91)90942-Z; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Bournazos S, 2009, J IMMUNOL, V182, P8026, DOI 10.4049/jimmunol.0900107; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Buechler C, 2004, GENOMICS, V83, P1116, DOI 10.1016/j.ygeno.2003.12.011; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Dhaliwal BS, 2000, J LIPID RES, V41, P1658; Drobnik W, 2002, TRAFFIC, V3, P268, DOI 10.1034/j.1600-0854.2002.030404.x; Ecker J, 2007, BIOCHEM BIOPH RES CO, V352, P805, DOI 10.1016/j.bbrc.2006.11.087; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Fenger M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-44; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; FUKUTA S, 1988, INFECT IMMUN, V56, P1748, DOI 10.1128/IAI.56.7.1748-1753.1988; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Grandl M, 2006, CYTOM PART A, V69A, P189, DOI 10.1002/cyto.a.20232; Grandl M, 2010, CYTOM PART A, V77A, P231, DOI 10.1002/cyto.a.20828; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Herec M, 2008, BBA-BIOMEMBRANES, V1778, P872, DOI 10.1016/j.bbamem.2007.12.004; Jessup W, 2002, VASC PHARMACOL, V38, P239, DOI 10.1016/S1537-1891(02)00174-X; Kapinsky M, 2001, ARTERIOSCL THROM VAS, V21, P1004, DOI 10.1161/01.ATV.21.6.1004; Kinscherf R, 1997, FEBS LETT, V405, P55, DOI 10.1016/S0014-5793(97)00157-9; Kulma M, 2010, BBA-BIOMEMBRANES, V1798, P471, DOI 10.1016/j.bbamem.2009.12.004; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Li L, 2004, CIRC RES, V94, P892, DOI 10.1161/01.RES.0000124920.09738.26; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, JOURNAL OF LIPID RES; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Luan Y, 2006, ARCH BIOCHEM BIOPHYS, V450, P89, DOI 10.1016/j.abb.2006.03.016; MAOR I, 1995, ARTERIOSCL THROM VAS, V15, P1378, DOI 10.1161/01.ATV.15.9.1378; MASSERINI M, 1992, BIOCHEMISTRY-US, V31, P2422, DOI 10.1021/bi00123a030; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Miguet C, 2001, CELL DEATH DIFFER, V8, P83, DOI 10.1038/sj.cdd.4400792; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morita S, 2005, FEBS LETT, V579, P1759, DOI 10.1016/j.febslet.2005.02.018; Morita SY, 2004, J BIOL CHEM, V279, P24355, DOI 10.1074/jbc.M402035200; Myers SJ, 1999, ATHEROSCLEROSIS, V143, P389, DOI 10.1016/S0021-9150(98)00331-1; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Orso E, 2015, BBA-MOL CELL BIOL L, V1851, P299, DOI 10.1016/j.bbalip.2015.01.001; Orso E, 2011, CHEM PHYS LIPIDS, V164, P479, DOI 10.1016/j.chemphyslip.2011.06.001; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Scherer M, 2010, JOURNAL OF LIPID RES; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Schmitz G, 2007, ANTIOXID REDOX SIGN, V9, P1499, DOI 10.1089/ars.2007.1663; Schmitz G, 2009, ARTERIOSCL THROM VAS, V29, P1718, DOI 10.1161/ATVBAHA.108.179507; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stohr J, 1998, ARTERIOSCL THROM VAS, V18, P1424, DOI 10.1161/01.ATV.18.9.1424; Sviridov D, 2001, BIOCHEM J, V358, P79, DOI 10.1042/0264-6021:3580079; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Wallner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094102; WIELAND E, 1993, P NATL ACAD SCI USA, V90, P5929, DOI 10.1073/pnas.90.13.5929; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Wolf Z, 2007, CYTOM PART A, V71A, P486, DOI 10.1002/cyto.a.20403; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	81	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166798	10.1371/journal.pone.0166798	http://dx.doi.org/10.1371/journal.pone.0166798			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870891	Green Submitted, gold, Green Published			2022-12-26	WOS:000388846400030
J	Metkus, TS; Mullin, CJ; Grandin, EW; Rame, JE; Tampakakis, E; Hsu, S; Kolb, TM; Damico, R; Hassoun, PM; Kass, DA; Mathai, SC; Tedford, RJ				Metkus, Thomas S.; Mullin, Christopher J.; Grandin, E. Wilson; Rame, J. Eduardo; Tampakakis, Emmanouil; Hsu, Steven; Kolb, Todd M.; Damico, Rachel; Hassoun, Paul M.; Kass, David A.; Mathai, Stephen C.; Tedford, Ryan J.			Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; PRESSURE; DISTENSIBILITY; DYSFUNCTION; AFTERLOAD; IMPEDANCE; OUTCOMES; DECAY	Background The effect of heart rate (HR) and body surface area (BSA) on pulmonary RC time and right ventricular (RV) load is unknown. Methods To determine the association of HR and BSA with the pulmonary RC time and measures of RV load, we studied three large patient cohorts including subjects with 1) known or suspected pulmonary arterial hypertension (PAH) (n = 1008), 2) pulmonary hypertension due to left heart disease (n = 468), and 3) end-stage heart failure with reduced ejection fraction (n = 150). To corroborate these associations on an individual patient level, we performed an additional analysis using high-fidelity catheters in 22 patients with PAH undergoing right atrial pacing. Results A faster HR inversely correlated with RC time (p< 0.01 for all), suggesting augmented RV pulsatile loading. Lower BSA directly correlated with RC time (p< 0.05) although the magnitude of this effect was smaller than for HR. With incremental atrial pacing, cardiac output increased and total pulmonary resistance (TPR) fell. However, effective arterial elastance, its mean resistive component (TPR/heart period; 0.60 +/- 0.27 vs. 0.79 +/- 0.45; p = 0.048), and its pulsatile component (0.27 +/- 0.18 vs 0.39 +/- 0.28; p = 0.03) all increased at faster HR. Conclusion Heart rate and BSA are associated with pulmonary RC time. As heart rate increases, the pulsatile and total load on the RV also increase. This relationship supports a hemodynamic mechanism for adverse effects of tachycardia on the RV.	[Metkus, Thomas S.; Tampakakis, Emmanouil; Hsu, Steven; Kass, David A.; Tedford, Ryan J.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Mullin, Christopher J.; Kolb, Todd M.; Damico, Rachel; Hassoun, Paul M.; Mathai, Stephen C.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Grandin, E. Wilson; Rame, J. Eduardo] Univ Penn, Div Cardiovasc Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Tedford, RJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA.	Ryan.Tedford@jhmi.edu	Rame, J. Eduardo/ABF-2208-2021; Kolb, Todd/ABD-8204-2020	Rame, J. Eduardo/0000-0002-2936-1702; 	NIH-NHLBI [5-R01-HL114910, L30 HL110304, T32-HL007227-40]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [1UL1TR001079]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by the NIH-NHLBI (5-R01-HL114910 and L30 HL110304, T32-HL007227-40). We also acknowledge support for statistical review from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, grant #1UL1TR001079.; We acknowledge support for statistical review from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, grant #1UL1TR001079.	Bandyopadhyay D, 2015, EUR RESPIR J, V46, P750, DOI 10.1183/09031936.00215514; BOURGEOIS MJ, 1974, CIRC RES, V35, P56, DOI 10.1161/01.RES.35.1.56; Bristow MR, 2015, PULM CIRC, V5, P415, DOI 10.1086/682223; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; Chemla D, 2003, AM J PHYSIOL-HEART C, V285, pH614, DOI 10.1152/ajpheart.00823.2002; Chemla D, 2015, EUROPEAN RESP J, DOI [10.1183/13993003, DOI 10.1183/13993003]; Claessen G, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001602; COHENSOLAL A, 1994, J HYPERTENS, V12, P591; DOCK DS, 1961, J CLIN INVEST, V40, P317, DOI 10.1172/JCI104259; Dupont M, 2012, CIRC-HEART FAIL, V5, P778, DOI 10.1161/CIRCHEARTFAILURE.112.968511; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Grinnan D, 2014, AM J RESP CRIT CARE, V189, P1562, DOI 10.1164/rccm.201311-2025LE; Hadinnapola C, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12363; Henkens IR, 2009, AM J CARDIOL, V103, P1451, DOI 10.1016/j.amjcard.2009.01.359; Jardim C, 2007, EUR RESPIR J, V29, P476, DOI 10.1183/09031936.00016806; Kang KW, 2011, CIRC J, V75, P2244, DOI 10.1253/circj.CJ-10-1310; KUSSMAUL WG, 1992, CIRCULATION, V86, P1770, DOI 10.1161/01.CIR.86.6.1770; Lankhaar JW, 2006, AM J PHYSIOL-HEART C, V291, pH1731, DOI 10.1152/ajpheart.00336.2006; Ley S, 2007, EUR RADIOL, V17, P1892, DOI 10.1007/s00330-006-0559-9; Pagnamenta A, 2013, J APPL PHYSIOL, V114, P1586, DOI 10.1152/japplphysiol.00033.2013; Pellegrini P, 2014, CHEST, V145, P1064, DOI 10.1378/chest.13-1510; Perros F, 2015, J AM COLL CARDIOL, V65, P668, DOI 10.1016/j.jacc.2014.11.050; Ross RVM, 2013, AM J PHYSIOL-HEART C, V305, pH259, DOI 10.1152/ajpheart.00128.2013; Saouti N, 2010, EUR RESPIR REV, V19, P197, DOI 10.1183/09059180.00002210; Tampakakis E, 2015, JACC-HEART FAIL, V3, P9, DOI 10.1016/j.jchf.2014.07.010; Tedford RJ, 2014, PULM CIRC, V4, P211, DOI 10.1086/676020; Tedford RJ, 2013, CIRC-HEART FAIL, V6, P953, DOI 10.1161/CIRCHEARTFAILURE.112.000008; Tedford RJ, 2012, CIRCULATION, V125, P289, DOI 10.1161/CIRCULATIONAHA.111.051540; Thenappan T, 2014, CIRC-HEART FAIL, V7, P903, DOI 10.1161/CIRCHEARTFAILURE.114.001429; Vanderpool RR, 2015, HEART, V101, P37, DOI 10.1136/heartjnl-2014-306142; WESTERHOF N, 1991, AM J PHYSIOL, V261, pR126, DOI 10.1152/ajpregu.1991.261.1.R126; Wright SP, 2016, J PHYSIOL-LONDON, V594, P3307, DOI 10.1113/JP271788	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166463	10.1371/journal.pone.0166463	http://dx.doi.org/10.1371/journal.pone.0166463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861600	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300059
J	Ting, CK; Line, CS; Chan, MT; Chen, JW; Chuang, SY; Huang, YT				Ting, Chuan-Kang; Line, Choun-Sea; Chan, Ming-Tsai; Chen, Jian-Wei; Chuang, Sheng-Yu; Huang, Yao-Ting			A Genetic Algorithm for Diploid Genome Reconstruction Using Paired-End Sequencing	PLOS ONE			English	Article							SHORT-READ; STRUCTURAL VARIATION	The genome of many species in the biosphere is a diploid consisting of paternal and maternal haplotypes. The differences between these two haplotypes range from single nucleotide polymorphisms (SNPs) to large-scale structural variations (SVs). Existing genome assemblers for next-generation sequencing platforms attempt to reconstruct one consensus sequence, which is a mosaic of two parental haplotypes. Reconstructing paternal and maternal haplotypes is an important task in linkage analysis and association studies. This study designs and implemented HapSVAssembler on the basis of Genetic Algorithm (GA) and paired-end sequencing. The proposed method builds a consensus sequence, identifies various types of heterozygous variants, and reconstructs the paternal and maternal haplotypes by solving an optimization problem with a GA algorithm. Experimental results indicate that the HapSVAssembler has high accuracy and contiguity under various sequencing coverage, error rates, and insert sizes. The program is tested on pilot sequencing of a highly heterozygous genome, and 12,781 heterozygous SNPs and 602 hemizygous SVs are identified. We observe that, although the number of SVs is much less than that of SNPs, the genomic regions occupied by SVs are much larger, implying the heterozygosity computed using SNPs or k-mer spectrum may be under-estimated.	[Ting, Chuan-Kang; Chuang, Sheng-Yu; Huang, Yao-Ting] Natl Chung Cheng Univ, Dept Comp Sci & Informat Engn, Chiayi, Taiwan; [Line, Choun-Sea] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Chan, Ming-Tsai] Acad Sinica, Biotechnol Ctr Southern Taiwan, Tainan, Taiwan; [Chen, Jian-Wei] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan	National Chung Cheng University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University	Huang, YT (corresponding author), Natl Chung Cheng Univ, Dept Comp Sci & Informat Engn, Chiayi, Taiwan.	ythuang@cs.ccu.edu.tw	Chan, Ming-Tsair/L-2465-2015	Lin, Choun-Sea/0000-0001-9566-2952; Chen, Jeremy J.W./0000-0003-1049-3825; Huang, Yao-Ting/0000-0001-9253-2394	Ministry of Science and Technology (MOST) [103-2923-E-194-001-MY3, 104-2221-E-194-048-MY2]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	YTH was supported in part by the Ministry of Science and Technology (MOST) with grant numbers 103-2923-E-194-001-MY3 and 104-2221-E-194-048-MY2.; YTH was supported in part by the Ministry of Science and Technology (MOST) with grant numbers 103-2923-E-194-001-MY3 and 104-2221-E-194-048-MY2.	Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cilibrasi R, 2005, LECT NOTES COMPUT SC, V3692, P128; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; He D, 2010, BIOINFORMATICS, V26, pi183, DOI 10.1093/bioinformatics/btq215; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Lancia G., 2001, Algorithms - ESA 2001. 9th Annual European Symposium. Proceedings (Lecture Notes in Computer Science Vol.2161), P182; Lee S, 2009, NAT METHODS, V6, P473, DOI 10.1038/nmeth.f.256; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sindi S, 2009, BIOINFORMATICS, V25, pI222, DOI 10.1093/bioinformatics/btp208; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang RS, 2005, BIOINFORMATICS, V21, P2456, DOI 10.1093/bioinformatics/bti352; Wendl MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-359; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166721	10.1371/journal.pone.0166721	http://dx.doi.org/10.1371/journal.pone.0166721			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861560	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300096
J	Sen, CK; Khanna, S; Harris, H; Stewart, R; Balch, M; Heigel, M; Teplitsky, S; Gnyawali, S; Rink, C				Sen, Chandan K.; Khanna, Savita; Harris, Hallie; Stewart, Richard; Balch, Maria; Heigel, Mallory; Teplitsky, Seth; Gnyawali, Surya; Rink, Cameron			Robot-assisted mechanical therapy attenuates strokeinduced limb skeletal muscle injury	FASEB JOURNAL			English	Article						ischemia; rehabilitation; physical therapy; cerebrovascular accident	ACUTE ISCHEMIC-STROKE; MOTOR RECOVERY; BOBATH CONCEPT; BLOOD-FLOW; REHABILITATION; MASSAGE; BDNF; EXPRESSION; OUTCOMES; DIFFERENTIATION	The efficacy and optimization of poststroke physical therapy paradigms is challenged in part by a lack of objective tools available to researchers for systematic preclinical testing. This work represents a maiden effort to develop a robot-assisted mechanical therapy (RAMT) device to objectively address the significance of mechanical physiotherapy on poststroke outcomes. Wistar rats were subjected to right hemisphere middle-cerebral artery occlusion and reperfusion. After 24 h, rats were split into control (RAMT-) or RAMT+ groups (30 min daily RAMT over the stroke-affected gastrocnemius) and were followed up to poststroke d 14. RAMT+ increased perfusion 1.5-fold in stroke-affected gastrocnemius as compared to RAMT- controls. Furthermore, RAMT+ rats demonstrated improved poststroke track width (11% wider), stride length (21% longer), and travel distance (61% greater), as objectively measured using software-automated testing platforms. Stroke injury acutely increased myostatin (3-fold) and lowered brain-derived neurotrophic factor (BDNF) expression (0.6-fold) in the stroke-affected gastrocnemius, as compared to the contralateral one. RAMT attenuated the stroke-induced increase in myostatin and increased BDNF expression in skeletal muscle. Additional RAMT-sensitive myokine targets in skeletal muscle (IL-1ra and IP-10/CXCL10) were identified from a cytokine array. Taken together, outcomes suggest stroke acutely influences signal transduction in hindlimb skeletal muscle. Regimens based on mechanical therapy have the clear potential to protect hindlimb function from such adverse influence.Sen, C. K., Khanna, S., Harris, H., Stewart R., Balch, M., Heigel, M., Teplitsky, S., Gnyawali, S., Rink, C. Robot-assisted mechanical therapy attenuates stroke-induced limb skeletal muscle injury.	[Sen, Chandan K.; Khanna, Savita; Harris, Hallie; Stewart, Richard; Balch, Maria; Heigel, Mallory; Teplitsky, Seth; Gnyawali, Surya; Rink, Cameron] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Rink, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst 505, 473 West 12th Ave, Columbus, OH 43210 USA.	cameron.rink@osumc.edu	Rink, Cameron/AAA-4484-2021; Gnyawali, Surya/AAC-3082-2020; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Rink, Cameron/0000-0002-3149-3624; Balch, Maria/0000-0003-2011-6345; Gnyawali, Surya/0000-0002-4214-8068; Khanna, Savita/0000-0001-6661-9293; Teplitsky, Seth/0000-0001-9242-1360	U.S.National Institutes of Health,National Institute of Neurological Disorders and Stroke [NS42617, NS085272]; American Heart Association Scientific Development [12SDG11780023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042617, R01NS085272] Funding Source: NIH RePORTER	U.S.National Institutes of Health,National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association Scientific Development(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by U.S.National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS42617 (to C.K.S.) and NS085272 (to C.R.,S.K., and A.H.A.), and American Heart Association Scientific Development Grant 12SDG11780023 (to C. R.). The authors declare no conflicts of interest.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Beare JE, 2009, J NEUROTRAUM, V26, P2045, DOI 10.1089/neu.2009.0914; Canu MH, 1996, EUR J APPL PHYSIOL O, V74, P297, DOI 10.1007/s004210050078; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Choe MA, 2004, NURS RES, V53, P283, DOI 10.1097/00006199-200409000-00001; Clow C, 2010, MOL BIOL CELL, V21, P2182, DOI 10.1091/mbc.E10-02-0154; Coelho HJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3957958; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Crescioli C, 2012, EUR J CELL BIOL, V91, P139, DOI 10.1016/j.ejcb.2011.09.011; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Gao L, 2012, GROWTH FACTORS, V30, P167, DOI 10.3109/08977194.2012.678842; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOATS GC, 1994, BRIT J SPORT MED, V28, P153, DOI 10.1136/bjsm.28.3.153; Hafer-Macko CE, 2008, J REHABIL RES DEV, V45, P261, DOI 10.1682/JRRD.2007.02.0040; Herson PS, 2011, NEUROMETHODS, V50, P307, DOI 10.1007/978-1-60761-883-6_12; Hiraiwa Y, 2013, CRANIO, V31, P291, DOI 10.1179/crn.2013.31.4.007; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Junhua Z, 2009, STROKE, V40, P2797, DOI 10.1161/STROKEAHA.109.555227; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kwakkel G, 2002, PHYS THER, V82, P432, DOI 10.1093/ptj/82.5.432; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lennon S, 2001, DISABIL REHABIL, V23, P254; Li L, 2013, BRAIN INJURY, V27, P408, DOI 10.3109/02699052.2012.750750; Liu YH, 2016, INT J NEUROSCI, V126, P168, DOI 10.3109/00207454.2014.998759; Long RP, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8524560; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McIlwrath SL, 2005, NEUROSCIENCE, V131, P499, DOI 10.1016/j.neuroscience.2004.11.030; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Mori H, 2004, MED SCI MONITOR, V10, pCR173; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pomeroy VM, 2000, LANCET, V355, P836, DOI 10.1016/S0140-6736(99)08143-X; Rink C, 2011, J CEREBR BLOOD F MET, V31, P2218, DOI 10.1038/jcbfm.2011.85; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Ryan A. S., 2011, J AM HEART ASSOC, V42, P416; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; Sefton JM, 2010, J ALTERN COMPLEM MED, V16, P723, DOI 10.1089/acm.2009.0441; Shoemaker JK, 1997, MED SCI SPORT EXER, V29, P610, DOI 10.1097/00005768-199705000-00004; Stinear C, 2013, STROKE, V44, P2039, DOI 10.1161/STROKEAHA.113.000968; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Wu JJ, 2014, COMPLEMENT THER MED, V22, P456, DOI 10.1016/j.ctim.2014.04.001; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	50	11	11	1	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					927	936		10.1096/fj.201600437R	http://dx.doi.org/10.1096/fj.201600437R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895105	Green Published			2022-12-26	WOS:000395671200010
J	Zhang, C; Zhou, LW; Zhang, F; Lu, DY; Li, N; Zheng, L; Xu, YH; Li, Z; Sun, SJ; Long, M				Zhang, Chen; Zhou, Luwen; Zhang, Fan; Lu, Dongyuan; Li, Ning; Zheng, Lu; Xu, Yanhong; Li, Zhan; Sun, Shujin; Long, Mian			Mechanical remodeling of normally sized mammalian cells under a gravity vector	FASEB JOURNAL			English	Article						gravity-directed; mechanosensing; nucleus translocation; cytoskeletal remodeling; FAC reorganization	FOCAL ADHESION DYNAMICS; ROS 17/2.8 CELLS; NANOSCALE ARCHITECTURE; ACTIN; FORCE; MECHANOTRANSDUCTION; CYTOSKELETON; STRESS; TALIN; MICROTUBULES	Translocation of the dense nucleus along a gravity vector initiates mechanical remodeling of a cell, but the underlying mechanisms of cytoskeletal network and focal adhesion complex (FAC) reorganization in a mammalian cell remain unclear. We quantified the remodeling of an MC3T3-E1 cell placed in upward-, downward-, or edge-on-orientated substrate. Nucleus longitudinal translocation presents a high value in downward orientation at 24 h or in edge-on orientation at 72 h, which is consistent with orientation-dependent distribution of perinuclear actin stress fibers and vimentin cords. Redistribution of total FAC area and fractionized super mature adhesion number coordinates this dependence at short duration. This orientation-dependent remodeling is associated with nucleus flattering and lamin A/C phosphorylation. Actin depolymerization or Rho-associated protein kinase signaling inhibition abolishes the orientation dependence of nucleus translocation, whereas tubulin polymerization inhibition or vimentin disruption reserves the dependence. A biomechanical model is therefore proposed for integrating the mechanosensing of nucleus translocation with cytoskeletal remodeling and FAC reorganization induced by a gravity vector.	[Zhang, Chen; Zhou, Luwen; Zhang, Fan; Lu, Dongyuan; Li, Ning; Zheng, Lu; Xu, Yanhong; Li, Zhan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Key Lab Micrograv, Natl Micrograv Lab, Beijing, Peoples R China; [Zhang, Chen; Zhou, Luwen; Zhang, Fan; Lu, Dongyuan; Li, Ning; Zheng, Lu; Xu, Yanhong; Li, Zhan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Long, Mian] Chinese Acad Sci, Inst Mech, 15 North 4th Ring Rd, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Long, M (corresponding author), Chinese Acad Sci, Inst Mech, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn			National Key Basic Research Foundation of China [2011CB710904]; Strategic Priority Research Program [XDA04020219, XDA01030102]; National Natural Science Foundation of China [31110103918]; National High Technology Research and Development Program of China [2011AA020109]	National Key Basic Research Foundation of China(National Basic Research Program of China); Strategic Priority Research Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The authors thank Dr. Yan Zhang (Institute of Mechanics, Chinese Academy of Sciences), for technical assistance. This work was supported by National Key Basic Research Foundation of China Grant 2011CB710904, Strategic Priority Research Program Grants XDA04020219 and XDA01030102, National Natural Science Foundation of China Grant 31110103918, and National High Technology Research and Development Program of China Grant 2011AA020109.	Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Cassidy JW, 2014, ACTA BIOMATER, V10, P651, DOI 10.1016/j.actbio.2013.11.008; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Christophorou N, 2015, NAT CELL BIOL, V17, P1388, DOI 10.1038/ncb3249; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; George TF, 2011, COMPUTATIONAL STUDIE; Guignandon A, 1997, EXP CELL RES, V236, P66, DOI 10.1006/excr.1997.3703; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Helmstetter CE, 1997, P NATL ACAD SCI USA, V94, P10195, DOI 10.1073/pnas.94.19.10195; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ihalainen TO, 2015, NAT MATER, V14, P1252, DOI [10.1038/NMAT4389, 10.1038/nmat4389]; Kacena MA, 2002, CYTOTECHNOLOGY, V39, P147, DOI 10.1023/A:1023936503105; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Li H, 2010, SCI CHINA LIFE SCI, V53, P1085, DOI 10.1007/s11427-010-4057-6; Li Y, 2015, BIOPHYS J, V109, P670, DOI 10.1016/j.bpj.2015.07.006; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Maraldi M, 2014, BIOPHYS J, V106, P1890, DOI 10.1016/j.bpj.2014.03.027; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; MESLAND DAM, 1992, ADV SPACE RES-SERIES, V12, P15, DOI 10.1016/0273-1177(92)90259-Z; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Neelam S, 2015, P NATL ACAD SCI USA, V112, P5720, DOI 10.1073/pnas.1502111112; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Qi R, 2015, J CELL SCI, V128, P2830, DOI 10.1242/jcs.164566; ROBERTS WE, 1982, AM J ANAT, V165, P373, DOI 10.1002/aja.1001650403; Schaedel L, 2015, NAT MATER, V14, P1156, DOI [10.1038/NMAT4396, 10.1038/nmat4396]; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tamiello C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08752; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Van Loon JJWA, 2009, J MICROSC-OXFORD, V233, P234, DOI 10.1111/j.1365-2818.2009.03113.x; Vassy J., 2001, FASEB Journal, V15, P1104; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; WOROFKA R, 1978, BIOCHIM BIOPHYS ACTA, V518, P61, DOI 10.1016/0005-2787(78)90116-8; WYROBEK AJ, 1976, BIOPHYS J, V16, P811, DOI 10.1016/S0006-3495(76)85730-X	45	14	15	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					802	813		10.1096/fj.201600897RR	http://dx.doi.org/10.1096/fj.201600897RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871065	Green Submitted			2022-12-26	WOS:000394235400032
J	Nishina, T; Deguchi, Y; Miura, R; Yamazaki, S; Shinkai, Y; Kojima, Y; Okumura, K; Kumagai, Y; Nakano, H				Nishina, Takashi; Deguchi, Yutaka; Miura, Ryosuke; Yamazaki, Soh; Shinkai, Yasuhiro; Kojima, Yuko; Okumura, Ko; Kumagai, Yoshito; Nakano, Hiroyasu			Critical Contribution of Nuclear Factor Erythroid 2-related Factor 2 (NRF2) to Electrophile-induced Interleukin-11 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; SIGNAL TRANSDUCER; BINDING-SITES; PROTEIN; STRESS; ACTIVATION; RECEPTOR; CANCER; GENE; 1,2-NAPHTHOQUINONE	Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays a crucial role in protection of cells from electrophile-induced toxicity through up-regulating phase II detoxifying enzymes and phase III transporters. We previously reported that oxidative stress induces up-regulation of interleukin-11 (IL-11), a member of the IL-6 family that ameliorates acetaminophen-induced liver toxicity. However, a role for IL-11 in protection of cells from electrophile-induced toxicity remains unclear. Here we show that an environmental electrophile, 1,2-naphthoquinone (1,2-NQ), but not 15d-prostaglandin J(2) (PGJ(2)) or tert-butylhydroxyquinone (tBHQ), induced IL-11 production. Consistent with a crucial role for prolonged ERK activation in H2O2-induced IL-11 production, 1,2-NQ, but not 15d-PGJ(2) or tBHQ, elicited prolonged ERK activation. Conversely, inhibition of the ERK pathway by a MEK inhibitor completely blocked 1,2-NQ-induced IL-11 production at both protein and mRNA levels, further substantiating an intimate cross-talk between ERK activation and 1,2-NQ-induced IL-11 production. Promoter analysis of the Il11 gene revealed that two AP-1 sites were essential for 1,2-NQ-induced promoter activities. Among various members of the AP-1 family, Fra-1 was upregulated by 1,2-NQ, and its up-regulation was blocked by a MEK inhibitor. Although NRF2 was not required for H2O2-in-duced IL11 up-regulation, NRF2 was essential for 1,2-NQ-induced IL11 up-regulation by increasing Fra-1 proteins possibly through promoting mRNA translation of FOSL1. Finally, intraperitoneal administration of 1,2-NQ induced body weight loss in wild-type mice, which was further exacerbated in Il11ra1(-/-) mice compared with Il11ra1(+/-) mice. Together, both Fra-1 and NRF2 play crucial roles in IL-11 production that protects cells from 1,2-NQ intestinal toxicity.	[Nishina, Takashi; Deguchi, Yutaka; Miura, Ryosuke; Yamazaki, Soh; Nakano, Hiroyasu] Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan; [Miura, Ryosuke] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan; [Shinkai, Yasuhiro; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Tsukuba, Ibaraki 3058575, Japan; [Kojima, Yuko] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Morphol & Image Anal, Tokyo 1138421, Japan; [Okumura, Ko] Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Tokyo 1138421, Japan	Toho University; Tokyo University of Science; University of Tsukuba; Juntendo University; Juntendo University	Nakano, H (corresponding author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	hiroyasu.nakano@med.toho-u.ac.jp	Shinkai, Yasuhiro/F-9941-2013; Nishina, Takashi/AAQ-3942-2021	Nishina, Takashi/0000-0003-2301-9874; Nakano, Hiroyasu/0000-0003-4843-1427; Yamazaki, Soh/0000-0001-5038-1567; Miura, Ryosuke/0000-0003-1249-7803	Japan Society for the Promotion of Science (JSPS) [24390100, 26460397, 24790328, 25670167]; MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan [26110003]; Fund for the Advancement of Science in commemoration of Toho University's 60th anniversary; Project Research Grant of Toho University School of Medicine [28-3]; NOVARTIS Foundation for the Promotion of Science; Naito Science Foundation; Uehara Science Foundation; Takeda Science Foundation; JSPS Fellowship [13J10995]; Grants-in-Aid for Scientific Research [16K01378] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fund for the Advancement of Science in commemoration of Toho University's 60th anniversary; Project Research Grant of Toho University School of Medicine; NOVARTIS Foundation for the Promotion of Science; Naito Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) 24390100 (to H. N.) and Scientific Research (C) 26460397 (to T. N.) and Grant-in-Aid for Young Scientists (B) 24790328 (to T. N.), and Challenging Exploratory Research 25670167 (to H. N.) from the Japan Society for the Promotion of Science (JSPS). This work was also supported by Grant-in-Aid for Scientific Research on Innovative Areas 26110003 (to H. N.) from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan, the Fund for the Advancement of Science in commemoration of Toho University's 60th anniversary (to T. N.), and Project Research Grant of Toho University School of Medicine 28-3 (to T. N.). This work was also supported by research grants from the NOVARTIS Foundation for the Promotion of Science (to H. N.), the Naito Science Foundation (to H. N.), the Uehara Science Foundation (to H. N.), and the Takeda Science Foundation (to H. N.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by JSPS Fellowship 13J10995.	Beei C, 2013, J TOXICOL SCI, V38, P793; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; FRILING RS, 1992, P NATL ACAD SCI USA, V89, P668, DOI 10.1073/pnas.89.2.668; Fujii S, 2016, ARCH BIOCHEM BIOPHYS, V595, P140, DOI 10.1016/j.abb.2015.11.008; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Lorchner H, 2015, NAT MED, V21, P353, DOI 10.1038/nm.3816; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Miura T, 2011, CHEM RES TOXICOL, V24, P1836, DOI 10.1021/tx200025y; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Putoczki TL, 2015, IMMUNOTHERAPY-UK, V7, P441, DOI [10.2217/IMT.15.17, 10.2217/imt.15.17]; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Wages PA, 2015, CHEM RES TOXICOL, V28, P2411, DOI 10.1021/acs.chemrestox.5b00424	26	16	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					205	216		10.1074/jbc.M116.744755	http://dx.doi.org/10.1074/jbc.M116.744755			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872193	Green Published, hybrid			2022-12-26	WOS:000391578000018
J	Caetano-Anolles, K; Rhodes, JS; Garland, T; Perez, SD; Hernandez, AG; Southey, BR; Rodriguez-Zas, SL				Caetano-Anolles, Kelsey; Rhodes, Justin S.; Garland, Theodore, Jr.; Perez, Sam D.; Hernandez, Alvaro G.; Southey, Bruce R.; Rodriguez-Zas, Sandra L.			Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS NEURONS; GENE-EXPRESSION; HIPPOCAMPAL NEUROGENESIS; CONDITIONED PREFERENCE; DOPAMINE-RECEPTORS; FIRING PATTERNS; MESSENGER-RNA; BASAL GANGLIA; DENTATE GYRUS; TARGET GENES	The role of the cerebellum in motivation and addictive behaviors is less understood than that in control and coordination of movements. High running can be a self-rewarding behavior exhibiting addictive properties. Changes in the cerebellum transcriptional networks of mice from a line selectively bred for High voluntary running (H) were profiled relative to an unselected Control (C) line. The environmental modulation of these changes was assessed both in activity environments corresponding to 7 days of Free (F) access to running wheel and to Blocked (B) access on day 7. Overall, 457 genes exhibited a significant (FDR-adjusted P-value < 0.05) genotype-by-environment interaction effect, indicating that activity genotype differences in gene expression depend on environmental access to running. Among these genes, network analysis highlighted 6 genes (Nrgn, Drd2, Rxrg, Gda, Adora2a, and Rab40b) connected by their products that displayed opposite expression patterns in the activity genotype contrast within the B and F environments. The comparison of network expression topologies suggests that selection for high voluntary running is linked to a predominant dysregulation of hub genes in the F environment that enables running whereas a dysregulation of ancillary genes is favored in the B environment that blocks running. Genes associated with locomotor regulation, signaling pathways, reward-processing, goalfocused, and reward-dependent behaviors exhibited significant genotype-by-environment interaction (e.g. Pak6, Adora2a, Drd2, and Arhgap8). Neuropeptide genes including Adcyap1, Cck, Sst, Vgf, Npy, Nts, Penk, and Tac2 and related receptor genes also exhibited significant genotype-by-environment interaction. The majority of the 183 differentially expressed genes between activity genotypes (e.g. Drd1) were under-expressed in C relative to H genotypes and were also under-expressed in B relative to F environments. Our findings indicate that the high voluntary running mouse line studied is a helpful model for understanding the molecular mechanisms in the cerebellum that influence locomotor control and reward-dependent behaviors.	[Caetano-Anolles, Kelsey; Southey, Bruce R.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rhodes, Justin S.; Perez, Sam D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Rhodes, Justin S.] Univ Illinois, Ctr Nutr Learning & Memory, Urbana, IL 61801 USA; [Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Hernandez, Alvaro G.] Univ Illinois, Roy J Carver Biotechnol Ctr, High Throughput Sequencing & Genotyping Unit, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Riverside; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Stat, Urbana, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA.	rodrgzzs@illinois.edu		Rodriguez-Zas, Sandra/0000-0003-1122-4758; Southey, Bruce/0000-0002-8959-7709; Caetano-Anolles, Kelsey/0000-0001-6310-6679	NIH [R21 DA027548, P30 DA018310]; USDA NIFA [ILLU-538-632, ILLU-538-909]; NSF [IOS-1121273]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH R21 DA027548 to SRZ, NIH P30 DA018310 to BRS and SRZ, USDA NIFA ILLU-538-632 to KCA, USDA NIFA ILLU-538-909 to SRZ, and NSF IOS-1121273 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alliey-Rodriguez N, 2011, PSYCHIAT GENET, V21, P190, DOI 10.1097/YPG.0b013e3283457a31; American Psychiatric A, 2013, DIAGN STAT MAN MENT, VFifth; Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Aoyama S, 2000, J NEUROSCI, V20, P5848, DOI 10.1523/JNEUROSCI.20-15-05848.2000; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Belke TW, 2007, J EXP ANAL BEHAV, V88, P199, DOI 10.1901/jeab.2007.62-06; BENINGER RJ, 1989, NEUROSCI BIOBEHAV R, V13, P113, DOI 10.1016/S0149-7634(89)80019-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bough KJ, 2014, NEUROPSYCHOPHARMACOL, V39, P202, DOI 10.1038/npp.2013.210; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Brown JD, 2015, PSYCHOPHARMACOLOGY, V232, P673, DOI 10.1007/s00213-014-3698-8; Brown RM, 2008, J PHARM PHARMACOL, V60, P1409, DOI 10.1211/jpp/60.11.0001; BROWN RR, 1991, ADV EXP MED BIOL, V294, P425; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Carbo-Gas M, 2014, PHYSIOL BEHAV, V132, P24, DOI 10.1016/j.physbeh.2014.04.044; Carbo-Gas M, 2014, ADDICT BIOL, V19, P61, DOI 10.1111/adb.12042; CARELLI RM, 1993, BRAIN RES, V626, P14, DOI 10.1016/0006-8993(93)90557-4; Caston J, 1998, BRAIN RES, V808, P232, DOI 10.1016/S0006-8993(98)00847-6; CHANG JY, 1994, J NEUROSCI, V14, P1224, DOI 10.1523/JNEUROSCI.14-03-01224.1994; Chapter MC, 2010, PHARMACOL THERAPEUT, V125, P39, DOI 10.1016/j.pharmthera.2009.07.006; Chehadeh SEH, 2014, AM J PHYSIOL-ENDOC M, V307, pE1009, DOI 10.1152/ajpendo.00364.2014; Chen JL, 2014, INT J DEV NEUROSCI, V35, P35, DOI 10.1016/j.ijdevneu.2014.03.006; Claghorn GC, 2016, PHYSIOL BEHAV, V161, P145, DOI 10.1016/j.physbeh.2016.04.033; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; COUCEYRO P, 1994, MOL PHARMACOL, V46, P667; DAHHAOUI M, 1992, BEHAV NEURAL BIOL, V58, P180, DOI 10.1016/0163-1047(92)90440-F; Dale CS, 2005, MEM I OSWALDO CRUZ, V100, P105, DOI 10.1590/S0074-02762005000900017; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Delis F, 2008, CEREBELLUM, V7, P242, DOI 10.1007/s12311-008-0005-4; Dierssen M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00058; Fernandez-Castillo N, 2012, GENES BRAIN BEHAV, V11, P38, DOI 10.1111/j.1601-183X.2011.00735.x; FRANKLIN KBJ, 1983, PHARMACOL BIOCHEM BE, V18, P747, DOI 10.1016/0091-3057(83)90018-7; Gaiteri C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00095; Garcia-Fuster MJ, 2003, N-S ARCH PHARMACOL, V368, P421, DOI 10.1007/s00210-003-0801-9; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gelman JS, 2010, AAPS J, V12, P279, DOI 10.1208/s12248-010-9186-0; Gibbons TE, 2014, BEHAV BRAIN RES, V272, P131, DOI 10.1016/j.bbr.2014.05.049; Gong HL, 2013, J HISTOCHEM CYTOCHEM, V61, P857, DOI 10.1369/0022155413505601; Gonzalez-Pena D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157727; Gonzalez-Pena D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150858; HARBER VJ, 1984, SPORTS MED, V1, P154, DOI 10.2165/00007256-198401020-00004; Hart AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042646; Heck A, 2014, NEURON, V81, P1203, DOI 10.1016/j.neuron.2014.01.010; Hoffmann HM, 2012, ADDICT BIOL, V17, P565, DOI 10.1111/j.1369-1600.2011.00353.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito M, 2014, AIMS NEUROSCI, V1, P89, DOI 10.3934/Neuroscience.2014.1.89; Ivlieva N.Yu., 2011, NEUROSCI BEHAV PHYSI, V41, P715, DOI [10.1007/s11055-011-9477-7, DOI 10.1007/S11055-011-9477-7]; Joshi S, 2006, CELL MOL LIFE SCI, V63, P2859, DOI 10.1007/s00018-006-6333-y; Keeney BK, 2012, PHARMACOL BIOCHEM BE, V101, P528, DOI 10.1016/j.pbb.2012.02.017; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim EH, 2013, J ETHNOPHARMACOL, V148, P474, DOI 10.1016/j.jep.2013.04.041; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Kim YS, 2009, J NEUROSCI, V29, P8530, DOI 10.1523/JNEUROSCI.0468-09.2009; Kohman RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022654; Kolb EM, 2013, J EXP BIOL, V216, P515, DOI 10.1242/jeb.076000; Kolb EM, 2013, PHYSIOL BEHAV, V112, P49, DOI 10.1016/j.physbeh.2013.02.010; Konu O, 2004, MOL BRAIN RES, V121, P102, DOI 10.1016/j.molbrainres.2003.11.012; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KORNETSKY C, 1981, BRAIN RES, V209, P496, DOI 10.1016/0006-8993(81)90177-3; Kovacic P, 2005, MED HYPOTHESES, V64, P350, DOI 10.1016/j.mehy.2004.06.028; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Landoltl H, 2012, EDITOR GENETICS ADEN; Leuenberger A, 2006, IMPULSE PREMIER J UN; Levran O, 2015, CNS NEUROSCI THER, V21, P898, DOI 10.1111/cns.12450; Lim S, 2012, J GAMBL STUD, V28, P481, DOI 10.1007/s10899-011-9261-1; Liu J, 2015, DEVELOPMENT, V142, P1113, DOI 10.1242/dev.117424; Majdak P, 2014, BEHAV GENET, V44, P516, DOI 10.1007/s10519-014-9667-5; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MALDONADO R, 1993, PHARMACOL BIOCHEM BE, V45, P239, DOI 10.1016/0091-3057(93)90112-7; Malisch JL, 2009, BEHAV GENET, V39, P192, DOI 10.1007/s10519-008-9246-8; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mathes WF, 2010, BEHAV BRAIN RES, V210, P155, DOI 10.1016/j.bbr.2010.02.016; Miquel Marta, 2009, Curr Drug Abuse Rev, V2, P26; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; Negishi T, 2012, J NEUROPATH EXP NEUR, V71, P468, DOI 10.1097/NEN.0b013e3182561327; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Neveu I, 2002, NEUROSCIENCE, V113, P767, DOI 10.1016/S0306-4522(02)00256-7; Nixon SE, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500109; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Novak G, 2013, SYNAPSE, V67, P179, DOI 10.1002/syn.21628; PENNEY JB, 1983, ANNU REV NEUROSCI, V6, P73, DOI 10.1146/annurev.ne.06.030183.000445; Peoples LL, 1998, J NEUROSCI, V18, P7588; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V114, P477, DOI 10.1007/BF02249339; Podder A, 2014, J THEOR BIOL, V357, P169, DOI 10.1016/j.jtbi.2014.05.011; Poleszak E, 2002, POL J PHARMACOL, V54, P359; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Ruegsegger GN, 2016, NEUROSCI LETT, V618, P83, DOI 10.1016/j.neulet.2016.02.037; Salatino-Oliveira A, 2015, AM J MED GENET B, V168, P162, DOI 10.1002/ajmg.b.32293; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Scarr E, 2012, SCHIZOPHR RES, V138, P94, DOI 10.1016/j.schres.2012.02.011; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Short JL, 2006, NEUROPSYCHOPHARMACOL, V31, P525, DOI 10.1038/sj.npp.1300852; Singec I, 2003, J COMP NEUROL, V459, P278, DOI 10.1002/cne.10600; Sorensen G, 2013, PHARMACOL BIOCHEM BE, V105, P151, DOI 10.1016/j.pbb.2013.02.010; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussman S, 2011, EVAL HEALTH PROF, V34, P3, DOI 10.1177/0163278710380124; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Tang Liang, 2005, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V21, P137; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Thoma P, 2008, CEREBELLUM, V7, P433, DOI 10.1007/s12311-008-0046-8; Tobon KE, 2015, EUR J NEUROSCI, V42, P1849, DOI 10.1111/ejn.12933; Tomasi D, 2015, HUM BRAIN MAPP, V36, P120, DOI 10.1002/hbm.22617; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Valverde O, 2000, J NEUROSCI, V20, P9284; Vuckovic MG, 2010, MOVEMENT DISORD, V25, P2777, DOI 10.1002/mds.23407; Wang Ju, 2011, Front Psychiatry, V2, P5, DOI 10.3389/fpsyt.2011.00005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Waters RP, 2013, BRAIN RES, V1508, P9, DOI 10.1016/j.brainres.2013.01.033; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Yalachkov Y, 2010, BEHAV BRAIN RES, V207, P215, DOI 10.1016/j.bbr.2009.09.015; Zeyda T, 2001, BRAIN RES, V906, P107, DOI 10.1016/S0006-8993(01)02563-X; Zhang H, 2008, MOL PSYCHIATR, V13, P531, DOI 10.1038/sj.mp.4002035	131	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167095	10.1371/journal.pone.0167095	http://dx.doi.org/10.1371/journal.pone.0167095			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893846	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400084
J	Rojas, ER; Sueur, C; Henry, PY; Doligez, B; Wey, G; Dehorter, O; Massemin, S				Rojas, Emilio R.; Sueur, Cedric; Henry, Pierre-Yves; Doligez, Blandine; Wey, Gerard; Dehorter, Olivier; Massemin, Sylvie		Grp Cigognes France	Network Analysis Shows Asymmetrical Flows within a Bird Metapopulation	PLOS ONE			English	Article							STORK CICONIA-CICONIA; WHITE STORK; BREEDING SUCCESS; KIN COMPETITION; POPULATION-DYNAMICS; SURVIVAL RATES; SITE FIDELITY; GRAPH-THEORY; DISPERSAL; CONNECTIVITY	How the spatial expansion of a species changes at a human time scale is a process difficult to determine. We studied the dispersal pattern of the French white stork population, using a 21-year ringing/resighting dataset. We used the graph-theory to investigate the strength of links between 5 populations (North-East, North-West, Centre, West, and South) and to determine factors important for the birds' movements. Two clusters of populations were identified within the metapopulation, with most frequent movements of individuals between North-Eastern and Centre populations, and between North-Western and Western populations. Exchanges of individuals between populations were asymmetrical, where North-Eastern and North-Western populations provided more emigrants than they received immigrants. Neither the geographical distance between populations, nor the difference in densities influenced the number of individuals exchanging between populations. The graph-theory approach provides a dynamic view of individual movements within a metapopulation and might be useful for future population studies in the context of conservation.	[Rojas, Emilio R.; Sueur, Cedric; Massemin, Sylvie] CNRS, UNISTRA, IPHC, Strasbourg, France; [Henry, Pierre-Yves] Sorbonne Univ, CNRS, Mecanismes Adaptatifs & Evolut MECADEV UMR7179, MNHN, 1 Ave Petit Chateau, Brunoy, France; [Henry, Pierre-Yves; Dehorter, Olivier] UPMC, CNRS, Ctr Rech Biol Populat Oiseaux,MNHN, Ctr Ecol & Sci Conservat CESCO UMR7204,Sorbonne U, Paris, France; [Doligez, Blandine] UMR CNRS 5558 LBBE, Biometrie & Biol Evolut, Villeurbanne, France; [Wey, Gerard; Grp Cigognes France] Grp Cigognes France & APRECIAL, Colmar, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; VetAgro Sup	Massemin, S (corresponding author), CNRS, UNISTRA, IPHC, Strasbourg, France.	sylvie.massemin@iphc.cnrs.fr	Henry, Pierre-Yves/G-3139-2013; Sueur, Cédric/A-4020-2011; Doligez, Blandine/ABB-5977-2020; damien, chevallier/N-6532-2013	Henry, Pierre-Yves/0000-0003-2255-7347; Sueur, Cédric/0000-0001-8206-2739; Doligez, Blandine/0000-0003-3015-5022; damien, chevallier/0000-0002-2232-6787	Ministere francais de l'Enseignement et de la Recherche	Ministere francais de l'Enseignement et de la Recherche	ER was supported by the Ministere francais de l'Enseignement et de la Recherche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.; Croupe Cigognes France is the consortium of French ornithologists involved in Stork monitoring in France, led by G. Wey (collectifcigognesfrance@yahoo.fr), namely G. Balanca, J-P Baudet, J-Y Brie, V. Burot, P. Carruette, P. Chable, A. Chartier, D. Chevallier, T. Clauss, P. Delaporte, H. Dugue, J-Y. Fournier, C. Goulevant, S. Merle, F. Noel, J. Pitois, N. Pointecouteau, G. Ranvier, T. Roi, N. Vincent-Martin, B. Vollot. All ringing data used in this study have been collected by qualified, licensed volunteer bird ringers under the coordination of Centre de Recherches sur la Biologie des Populations d'Oiseaux (CRBPO), Museum National d'Histoire Naturelle. All stork ringers and observers are warmly thanked for their contribution to the long-term monitoring of this species. We also warmly thank J.-C. and C. Barbraud, A. Fleury, F. Ibanez, J. Pourreau, P. Provost, P. Dagnas, S. Samtmann, G. Paulus, G. Massez and A. Schierer for their data contribution. No individual affiliation available because all are affiliated to GCF (or CRBPO). E. Rojas was supported by the Ministere francais de l'Enseignement et de la Recherche. We also thank M. Enstipp and A. Nesterova for the help provided during the preparation of the manuscript.	Aguirre JI, 2007, EVOL ECOL RES, V9, P355; Bach LA, 2006, ECOL MODEL, V192, P658, DOI 10.1016/j.ecolmodel.2005.07.026; Bairlein F, 1991, BIRD POPULATION STUD, P207; Barbraud C, 1999, IBIS, V141, P469, DOI 10.1111/j.1474-919X.1999.tb04416.x; Barbraud J-C, 1987, TRAJHASSE, V16, P3; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Bret C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083015; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Chernetsov N, 2006, AUK, V123, P1103, DOI 10.1642/0004-8038(2006)123[1103:SNDOWS]2.0.CO;2; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Czajkowski M, 2014, TOURISM MANAGE, V40, P352, DOI 10.1016/j.tourman.2013.07.009; Dehorter O, 2013, BIRD RINGING MOVEMEN; Dubois PJ, 2001, INVENTAIRES OISEAUX; Duquet M., 1994, NOUVEL ATLAS OISEAUR, P108; Espinoza M, 2015, ECOL APPL, V25, P2101; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Gilroy JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038091; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HARRISON S, 1989, ECOLOGY, V70, P1236, DOI 10.2307/1938181; Itonaga N, 2011, IBIS, V153, P636, DOI 10.1111/j.1474-919X.2011.01131.x; Itonaga N, 2010, J ETHOL, V28, P393, DOI 10.1007/s10164-010-0204-6; Johst K, 2001, ECOL APPL, V11, P60, DOI 10.1890/1051-0761(2001)011[0060:FIAPAD]2.0.CO;2; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; KANYAMIBWA S, 1993, ORNIS SCAND, V24, P297, DOI 10.2307/3676791; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Leturque H, 2002, THEOR POPUL BIOL, V62, P169, DOI 10.1006/tpbi.2002.1600; MANTEL N, 1967, CANCER RES, V27, P209; Massemin-Challet S, 2006, IBIS, V148, P503, DOI 10.1111/j.1474-919X.2006.00550.x; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Moller AP, 2006, GLOBAL CHANGE BIOL, V12, P2005, DOI 10.1111/j.1365-2486.2006.01216.x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Muneepeerakul R, 2011, J THEOR BIOL, V269, P256, DOI 10.1016/j.jtbi.2010.11.003; Newman MEJ, 2004, PHYS REV E, P70; O'Brien D, 2006, BIOL CONSERV, V130, P70, DOI 10.1016/j.biocon.2005.12.014; Ortego J, 2011, ANIM BEHAV, V82, P131, DOI 10.1016/j.anbehav.2011.04.007; Pasquaretta C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07600; Rojas ER, 2015, THESIS; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Saether BE, 2006, J ANIM ECOL, V75, P80, DOI 10.1111/j.1365-2656.2005.01023.x; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; Schaub M, 2004, BIOL CONSERV, V119, P105, DOI 10.1016/j.biocon.2003.11.002; Schierer A., 1986, Ciconia (Eguelshardt), V10, P1; Schierer A., 1991, ATLAS OISEAUX FRANCE, P533; Schierer Alfred, 1992, P341; Schu E., 1979, INT COUNC BIRD PRESE, V13, P173; Shimada M, 2014, AM J PRIMATOL, V76, P1025, DOI 10.1002/ajp.22289; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Tobolka M, 2013, BIRD STUDY, V60, P399, DOI 10.1080/00063657.2013.818934; Tryjanowski P, 2005, WATERBIRDS, V28, P378, DOI 10.1675/1524-4695(2005)028[0378:EOWLAL]2.0.CO;2; Tryjanowski P, 2002, ARDEA, V90, P213; Vergara P, 2007, J AVIAN BIOL, V38, P573, DOI 10.1111/j.2007.0908-8857.03983.x; Vergara P, 2006, IBIS, V148, P672, DOI 10.1111/j.1474-919X.2006.00565.x; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166701	10.1371/journal.pone.0166701	http://dx.doi.org/10.1371/journal.pone.0166701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893770	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400039
J	O'Mara, MT; Bauer, K; Blank, D; Baldwin, JW; Dechmann, DKN				O'Mara, M. Teague; Bauer, Karla; Blank, Dominik; Baldwin, Justin W.; Dechmann, Dina K. N.			Common Noctule Bats Are Sexually Dimorphic in Migratory Behaviour and Body Size but Not Wing Shape	PLOS ONE			English	Article							NYCTALUS-NOCTULA; ELECTRICAL-CONDUCTIVITY; VESPERTILIONID BATS; POINTED WINGS; HABITAT USE; MORPHOLOGY; GROWTH; CONSERVATION; CHIROPTERA; ADAPTATION	Within the large order of bats, sexual size dimorphism measured by forearm length and body mass is often female-biased. Several studies have explained this through the effects on load carrying during pregnancy, intrasexual competition, as well as the fecundity and thermoregulation advantages of increased female body size. We hypothesized that wing shape should differ along with size and be under variable selection pressure in a species where there are large differences in flight behaviour. We tested whether load carrying, sex differential migration, or reproductive advantages of large females affect size and wing shape dimorphism in the common noctule (Nyctalus noctula), in which females are typically larger than males and only females migrate long distances each year. We tested for univariate and multivariate size and shape dimorphism using data sets derived from wing photos and biometric data collected during pre-migratory spring captures in Switzerland. Females had forearms that are on average 1% longer than males and are 1% heavier than males after emerging from hibernation, but we found no sex differences in other size, shape, or other functional characters in any wing parameters during this pre-migratory period. Female-biased size dimorphism without wing shape differences indicates that reproductive advantages of big mothers are most likely responsible for sexual dimorphism in this species, not load compensation or shape differences favouring aerodynamic efficiency during pregnancy or migration. Despite large behavioural and ecological sex differences, morphology associated with a specialized feeding niche may limit potential dimorphism in narrow-winged bats such as common noctules and the dramatic differences in migratory behaviour may then be accomplished through plasticity in wing kinematics.	[O'Mara, M. Teague; Bauer, Karla; Blank, Dominik; Baldwin, Justin W.; Dechmann, Dina K. N.] Max Planck Inst Ornithol, Dept Migrat & Immuno Ecol, Radolfzell am Bodensee, Germany; [O'Mara, M. Teague; Bauer, Karla; Blank, Dominik; Dechmann, Dina K. N.] Univ Konstanz, Dept Biol, Constance, Germany; [O'Mara, M. Teague; Dechmann, Dina K. N.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Max Planck Society; University of Konstanz; Smithsonian Institution; Smithsonian Tropical Research Institute	O'Mara, MT (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immuno Ecol, Radolfzell am Bodensee, Germany.; O'Mara, MT (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; O'Mara, MT (corresponding author), Smithsonian Trop Res Inst, Balboa, Ancon, Panama.	tomara@orn.mpg.de	O'Mara, M. Teague/J-6090-2012	O'Mara, M. Teague/0000-0002-6951-1648; Baldwin, Justin/0000-0001-9217-5366	Max Planck Poland Biodiversity Initiative; Max Planck Institute for Ornithology	Max Planck Poland Biodiversity Initiative; Max Planck Institute for Ornithology(Max Planck Society)	This work was funded by the Max Planck Poland Biodiversity Initiative and the Max Planck Institute for Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; de Camargo NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049734; Dechmann DKN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114810; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; FINDLEY JS, 1972, J MAMMAL, V53, P429, DOI 10.2307/1379035; Gordon AD, 2006, INT J PRIMATOL, V27, P27, DOI 10.1007/s10764-005-9003-2; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; Haussler T. F., 2003, GROSSER ABENDSEGLER, P591; Hayssen V, 1996, J MAMMAL, V77, P476, DOI 10.2307/1382823; Hubel TY, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0385; Hubel TY, 2012, J R SOC INTERFACE, V9, P1120, DOI 10.1098/rsif.2011.0838; HUGHES PM, 1991, J EXP BIOL, V161, P285; JONES C, 1967, J MAMMAL, V48, P1, DOI 10.2307/1378165; KLEIMAN DG, 1969, J ZOOL, V157, P187, DOI 10.1111/j.1469-7998.1969.tb01697.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lewton KL, 2015, ANAT REC, V298, P230, DOI 10.1002/ar.23070; Lison F, 2014, ACTA ZOOL-STOCKHOLM, V95, P137, DOI 10.1111/azo.12012; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; Mancina CA, 2012, J MAMMAL, V93, P1308, DOI 10.1644/11-MAMM-A-331.1; MCCRACKEN GF, 1981, BEHAV ECOL SOCIOBIOL, V8, P11, DOI 10.1007/BF00302840; MCNAB BK, 1970, J EXP BIOL, V53, P329; Melo D, 2015, P NATL ACAD SCI USA, V112, P470, DOI 10.1073/pnas.1322632112; Minias P, 2013, CONDOR, V115, P535, DOI 10.1525/cond.2013.120137; MONKKONEN M, 1995, EVOL ECOL, V9, P520, DOI 10.1007/BF01237833; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Norberg Ulla M., 1994, P205; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; O'Mara MT, 2012, AM J PHYS ANTHROPOL, V147, P11, DOI 10.1002/ajpa.21600; Pearce RD, 2008, ACTA CHIROPTEROL, V10, P153, DOI 10.3161/150811008X331171; Petit E, 2000, MOL ECOL, V9, P683, DOI 10.1046/j.1365-294x.2000.00896.x; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; R Core Team, R LANG ENV STAT COMP; Racey PA, 1987, S ZOOL SOC LOND, V57, P107; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; Reynolds DS, 2009, J WILDLIFE MANAGE, V73, P1197, DOI 10.2193/2008-151; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Safi K, 2005, P ROY SOC B-BIOL SCI, V272, P179, DOI 10.1098/rspb.2004.2924; Schmieder DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127043; SHINE R, 1988, AM NAT, V131, P124, DOI 10.1086/284778; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; Stockwell EF, 2001, J ZOOL, V254, P505, DOI 10.1017/S0952836901001005; O'Mara MT, 2012, ANIM BEHAV, V84, P1547, DOI 10.1016/j.anbehav.2012.09.032; van Toor ML, 2011, ANIM CONSERV, V14, P512, DOI 10.1111/j.1469-1795.2011.00454.x; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072	48	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167027	10.1371/journal.pone.0167027	http://dx.doi.org/10.1371/journal.pone.0167027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880791	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500056
J	Rubtsova, K; Rubtsov, AV; Halemano, K; Li, SX; Kappler, JW; Santiago, ML; Marrack, P				Rubtsova, Kira; Rubtsov, Anatoly V.; Halemano, Kalani; Li, Sam X.; Kappler, John W.; Santiago, Mario L.; Marrack, Philippa			T Cell Production of IFN gamma in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses	PLOS ONE			English	Article							ADAPTER MOLECULE MYD88; TOLL-LIKE RECEPTORS; EXPRESSION; BET; EXPANSION; ENHANCEMENT; SUPPRESSION; POPULATION; ACTIVATION; EFFECTOR	Knowledge of the processes that underlie IgG subclass switching could inform strategies designed to counteract infections and autoimmunity. Here we show that TLR7 ligands induce subsets of memory CD4 and CD8 T cells to secrete interferon gamma(IFN gamma) in the absence of antigen receptor stimulation. In turn, TLR ligation and IFN gamma cause B cells to express the transcription factor, T-bet, and to switch immunoglobulin production to IgG2a/c. Absence of TLR7 in T cells leads to the impaired T-bet expression in B cells and subsequent inefficient IgG2a isotype switching both in vitro and during the infection with Friend virus in vivo. Our results reveal a surprising mechanism of antiviral IgG subclass switching through T-cell intrinsic TLR7/IL-12 signaling.	[Rubtsova, Kira; Rubtsov, Anatoly V.; Kappler, John W.; Marrack, Philippa] Howard Hughes Med Inst, Denver, CO 80206 USA; [Rubtsova, Kira; Rubtsov, Anatoly V.; Kappler, John W.; Marrack, Philippa] Univ Colorado, Hlth Sci Ctr, Dept Biomed Sci, Natl Jewish Hlth, Denver, CO 80206 USA; [Rubtsova, Kira; Rubtsov, Anatoly V.; Kappler, John W.; Marrack, Philippa] Univ Colorado, Hlth Sci Ctr, Dept Immunol & Microbiol, Denver, CO 80206 USA; [Halemano, Kalani; Li, Sam X.; Santiago, Mario L.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Halemano, Kalani; Li, Sam X.; Santiago, Mario L.] Univ Colorado Denver, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Kappler, John W.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Marrack, Philippa] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rubtsova, K; Marrack, P (corresponding author), Howard Hughes Med Inst, Denver, CO 80206 USA.; Rubtsova, K; Marrack, P (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biomed Sci, Natl Jewish Hlth, Denver, CO 80206 USA.; Rubtsova, K; Marrack, P (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Immunol & Microbiol, Denver, CO 80206 USA.; Marrack, P (corresponding author), Univ Colorado, Sch Med, Aurora, CO 80045 USA.; Marrack, P (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	rubtsovak@njhealth.org; marrackp@njhealth.org	Marrack, Philippa/AHE-6316-2022	Santiago, Mario L./0000-0001-7792-2706; Marrack, Philippa/0000-0003-1883-3687	USPHS [AI-18785, AI-22295, T32 AI-074491, R21 AI-112418, T32 AI-052066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, R01AI018785, T32AI052066] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by USPHS grants AI-18785, AI-22295, T32 AI-074491 (KR), R21 AI-112418 (MLS), T32 AI-052066 (SXL), KH is a Robert D. Watkins fellow of the American Society for Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bartholdy C, 2009, J GEN VIROL, V90, P423, DOI 10.1099/vir.0.004960-0; Bendigs S, 1999, EUR J IMMUNOL, V29, P1209, DOI 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; COUTELIER JP, 1988, J EXP MED, V168, P2373, DOI 10.1084/jem.168.6.2373; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Gerth AJ, 2003, INT IMMUNOL, V15, P937, DOI 10.1093/intimm/dxg093; Halemano K, 2014, P NATL ACAD SCI USA, V111, P7759, DOI 10.1073/pnas.1403361111; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; LaRosa DF, 2008, P NATL ACAD SCI USA, V105, P3855, DOI 10.1073/pnas.0706663105; MAIZEL AL, 1981, J EXP MED, V153, P470, DOI 10.1084/jem.153.2.470; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peng SL, 2003, NAT IMMUNOL, V4, P1041, DOI 10.1038/ni1103-1041a; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; ROSENWASSER LJ, 1979, J EXP MED, V150, P709, DOI 10.1084/jem.150.3.709; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Rubtsova K, 2015, CELL IMMUNOL, V294, P80, DOI 10.1016/j.cellimm.2014.12.002; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Smith DS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002284; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhang YB, 2013, J IMMUNOL, V190, P4725, DOI 10.4049/jimmunol.1203024	34	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166322	10.1371/journal.pone.0166322	http://dx.doi.org/10.1371/journal.pone.0166322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880772	Green Submitted, gold, Green Published			2022-12-26	WOS:000388889500020
J	Aguiar, DD; Moscardini, MBM; Morais, ER; de Paula, RG; Ferreira, PM; Afonso, A; Belo, S; Ouchida, AT; Curti, C; Cunha, WR; Rodrigues, V; Magalhaes, LG				Aguiar, Daniela de Paula; Moreira Moscardini, Mayara Brunetto; Morais, Enyara Rezende; de Paula, Renato Graciano; Ferreira, Pedro Manuel; Afonso, Ana; Belo, Silvana; Ouchida, Amanda Tomie; Curti, Carlos; Cunha, Wilson Roberto; Rodrigues, Vanderlei; Magalhaes, Lizandra Guidi			Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms	PLOS ONE			English	Article							HUMAN BLOOD FLUKE; CELL-CYCLE ARREST; MEDIATED APOPTOSIS; IN-VITRO; CANCER CELLS; DEATH; EXPRESSION; PRAZIQUANTEL; VIVO; IDENTIFICATION	Inducing apoptosis is an interesting therapeutic approach to develop drugs that act against helminthic parasites. Researchers have investigated how curcumin (CUR), a biologically active compound extracted from rhizomes of Curcuma longa, affects Schistosoma mansoni and several cancer cell lines. This study evaluates how CUR influences the induction of apoptosis and oxidative stress in couples of adult S. mansoni worms. CUR decreased the viability of adult worms and killed them. The tegument of the parasite suffered morphological changes, the mitochondria underwent alterations, and chromatin condensed. Different apoptotic parameters were determined in an attempt to understand how CUR affected adult S. mansoni worms. CUR induced DNA damage and fragmentation and increased the expression of SmCASP3/7 transcripts and the activity of Caspase 3 in female and male worms. However, CUR did not intensify the activity of Caspase 8 in female or male worms. Evaluation of the superoxide anion and different antioxidant enzymes helped to explore the mechanism of parasite death further. The level of superoxide anion and the activity of Superoxide Dismutase (SOD) increased, whereas the activity of Glutathione-S-Transferase (GST), Glutathione reductase (GR), and Glutathione peroxidase (GPX) decreased, which culminated in the oxidation of proteins in adult female and male worms incubated with CUR. In conclusion, CUR generated oxidative stress followed by apoptotic-like-events in both adult female and male S. mansoni worms, ultimately killing them.	[Aguiar, Daniela de Paula; Moreira Moscardini, Mayara Brunetto; Cunha, Wilson Roberto; Magalhaes, Lizandra Guidi] Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, Franca, Brazil; [Morais, Enyara Rezende] Univ Fed Uberlandia, Inst Genet & Bioquim, Patos De Minas, Brazil; [de Paula, Renato Graciano; Rodrigues, Vanderlei] Univ Sao Paulo, Dept Bioquim & Imunol, Ribeirao Preto, Brazil; [Ferreira, Pedro Manuel; Afonso, Ana; Belo, Silvana] Univ Nova Lisboa, IHMT, GHTM, UEI Med Parasitol, Lisbon, Portugal; [Afonso, Ana] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Afonso, Ana] Univ Fed Sao Carlos, Dept Morfol & Patol, Sao Paulo, Brazil; [Ouchida, Amanda Tomie; Curti, Carlos] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Fis & Quim, Ribeirao Preto, SP, Brazil	Universidad de Franca; Universidade Federal de Uberlandia; Universidade de Sao Paulo; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade de Sao Paulo	Magalhaes, LG (corresponding author), Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, Franca, Brazil.	lizandra.magalhaes@unifran.edu.br	Belo, Silvana/J-8555-2012; Ferreira, Pedro/AAE-4684-2022; Cunha, Wilson R/G-4495-2012; Magalhães, Lizandra/B-9702-2014; De Paula, Renato Graciano/Q-2222-2016; DE PAULA, RENATO GRACIANO/T-8688-2019	Belo, Silvana/0000-0001-8701-8657; Ferreira, Pedro/0000-0003-3150-1791; Cunha, Wilson R/0000-0002-1952-1944; Magalhães, Lizandra/0000-0003-2959-6752; De Paula, Renato Graciano/0000-0002-6712-437X; DE PAULA, RENATO GRACIANO/0000-0002-6712-437X	Sao Paulo Research Foundation, Brazil-FAPESP [2013/11164-4, 2012/22041-8, 2014/26116-8]	Sao Paulo Research Foundation, Brazil-FAPESP	This work was supported by the Sao Paulo Research Foundation, Brazil-FAPESP (grants 2013/11164-4, 2012/22041-8 and 2014/26116-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Bazh EKA, 2013, PARASITOL RES, V112, P3679, DOI 10.1007/s00436-013-3541-x; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bhaumik S, 1999, FEBS LETT, V456, P311, DOI 10.1016/S0014-5793(99)00969-2; BROPHY PM, 1990, PARASITOLOGY, V100, P345, DOI 10.1017/S0031182000061369; Caffrey CR, 2015, FUTURE MED CHEM, V7, P675, DOI [10.4155/FMC.15.27, 10.4155/fmc.15.27]; CARLBERG I, 1981, ANAL BIOCHEM, V116, P531, DOI 10.1016/0003-2697(81)90398-5; Chan WH, 2003, J CELL BIOCHEM, V90, P327, DOI 10.1002/jcb.10638; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Cioli D, 2014, MOL BIOCHEM PARASIT, V195, P23, DOI 10.1016/j.molbiopara.2014.06.002; COMLEY JCW, 1989, INT J PARASITOL, V19, P77, DOI 10.1016/0020-7519(89)90024-6; Das Mohapatra A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001306; de Moraes J, 2015, FUTURE MED CHEM, V7, P801, DOI [10.4155/FMC.15.23, 10.4155/fmc.15.23]; de Paula R, 2015, PARASITOL RES, V114, P1747, DOI 10.1007/s00436-015-4360-z; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; El-Lakkany NM, 2013, PARASITOL RES, V112, P2005, DOI 10.1007/s00436-013-3358-7; FALLON PG, 1994, AM J TROP MED HYG, V51, P83, DOI 10.4269/ajtmh.1994.51.83; Fouladvand M, 2013, EUR REV MED PHARMACO, V17, P3306; Galanti SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001509; Goo YK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1268-5; Gunasekaran S, 2015, ENVIRON TOXICOL PHAR, V40, P966, DOI 10.1016/j.etap.2015.09.013; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; JAMES P, 1994, PROTEIN SCI, V3, P1347, DOI 10.1002/pro.5560030822; Jilkova A, 2011, J BIOL CHEM, V286, P35770, DOI 10.1074/jbc.M111.271304; Kang JH, 2005, BIOCHEM PHARMACOL, V69, P1205, DOI 10.1016/j.bcp.2005.01.014; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khar A, 2001, CELL STRESS CHAPERON, V6, P368, DOI 10.1379/1466-1268(2001)006<0368:IOSRRH>2.0.CO;2; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kumar S, 2013, BIOINFORMATION, V9, P456, DOI 10.6026/97320630009456; Lee EF, 2014, TRENDS PARASITOL, V30, P75, DOI 10.1016/j.pt.2013.12.005; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoVerde PT, 2002, J PARASITOL, V88, P3, DOI 10.1645/0022-3395(2002)088[0003:PASASA]2.0.CO;2; LoVerde PT, 1998, PARASITOL TODAY, V14, P284, DOI 10.1016/S0169-4758(98)01261-7; Luz PP, 2012, PARASITOL RES, V110, P593, DOI 10.1007/s00436-011-2527-9; Magalhaes LG, 2009, PARASITOL RES, V104, P1197, DOI 10.1007/s00436-008-1311-y; Mei HP, 1996, INFECT IMMUN, V64, P4299, DOI 10.1128/IAI.64.10.4299-4306.1996; Morais ER, 2013, MOL BIOCHEM PARASIT, V187, P91, DOI 10.1016/j.molbiopara.2012.11.006; Mourao MD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000502; Nayak A, 2012, PARASITOL RES, V111, P1173, DOI 10.1007/s00436-012-2948-0; Ndjonka D, 2013, INT J MOL SCI, V14, P3395, DOI 10.3390/ijms14023395; OLEARY KA, 1992, EXP PARASITOL, V75, P47, DOI 10.1016/0014-4894(92)90121-P; Oliveira AS, 2015, CURR MED CHEM, V22, P4196, DOI 10.2174/0929867322666151029104611; Oliveira KC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000556; Patel PB, 2015, J BREAST CANCER, V18, P225, DOI 10.4048/jbc.2015.18.3.225; Pica-Mattoccia L, 2004, INT J PARASITOL, V34, P527, DOI 10.1016/j.ijpara.2003.12.003; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Ramirez B, 2007, EXPERT OPIN DRUG DIS, V2, pS53, DOI 10.1517/17460441.2.S1.S53; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sakano K, 2002, ARCH BIOCHEM BIOPHYS, V405, P223, DOI 10.1016/S0003-9861(02)00302-8; Salganik RI, 2001, J AM COLL NUTR, V20, p464S, DOI 10.1080/07315724.2001.10719185; Sambrook J., 2001, MOL CLONING LAB MANU; Sayed AA, 2006, J BIOL CHEM, V281, P17001, DOI 10.1074/jbc.M512601200; Scott JC, 2000, PARASITOL INT, V49, P289, DOI 10.1016/S1383-5769(00)00058-1; Singhal SS, 1999, TOXICOL LETT, V109, P87, DOI 10.1016/S0378-4274(99)00124-1; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Song LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031456; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sueth SV, 2015, QUIM NOVA, V38, P538; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Wachter B, 2014, WIEN KLIN WOCHENSCHR, V126, pS32, DOI 10.1007/s00508-014-0522-8; Wang JB, 2009, J ZHEJIANG UNIV-SC B, V10, P93, DOI 10.1631/jzus.B0820238; Wang WH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/512907; Watson JL, 2010, CANCER LETT, V297, P1, DOI 10.1016/j.canlet.2010.04.018; Wilson RA, 2012, PROTOPLASMA, V249, P503, DOI 10.1007/s00709-011-0326-x; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yang ST, 2016, ENVIRON TOXICOL, V31, P1899, DOI 10.1002/tox.22191; Yepes E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109431; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang XH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1851-3; Zheng ZZ, 2016, ONCOL REP, V35, P1213, DOI 10.3892/or.2015.4443	79	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0167135	10.1371/journal.pone.0167135	http://dx.doi.org/10.1371/journal.pone.0167135			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875592	gold, Green Submitted, Green Published			2022-12-26	WOS:000388886000053
J	Arruda, AG; Friendship, R; Carpenter, J; Greer, A; Poljak, Z				Arruda, Andreia Gonsalves; Friendship, Robert; Carpenter, Jane; Greer, Amy; Poljak, Zvonimir			Evaluation of Control Strategies for Porcine Reproductive and Respiratory Syndrome (PRRS) in Swine Breeding Herds Using a Discrete Event Agent-Based Model	PLOS ONE			English	Article							SYNDROME VIRUS; FADE-OUT; TRANSMISSION; INFECTION; VACCINE; FIELD	The objective of this study was to develop a discrete event agent-based stochastic model to explore the likelihood of the occurrence of porcine reproductive and respiratory syndrome (PRRS) outbreaks in swine herds with different PRRS control measures in place. The control measures evaluated included vaccination with a modified-live attenuated vaccine and live-virus inoculation of gilts, and both were compared to a baseline scenario where no control measures were in place. A typical North American 1,000-sow farrow-to-wean swine herd was used as a model, with production and disease parameters estimated from the literature and expert opinion. The model constructed herein was not only able to capture individual animal heterogeneity in immunity to and shedding of the PRRS virus, but also the dynamic animal flow and contact structure typical in such herds under field conditions. The model outcomes included maximum number of females infected per simulation, and time at which that happened and the incidence of infected weaned piglets during the first year of challenge-virus introduction. Results showed that the baseline scenario produced a larger percentage of simulations resulting in outbreaks compared to the control scenarios, and interestingly some of the outbreaks occurred over long periods after virus introduction. The live-virus inoculation scenario showed promising results, with fewer simulations resulting in outbreaks than the other scenarios, but the negative impacts of maintaining a PRRS-positive population should be considered. Finally, under the assumptions of the current model, neither of the control strategies prevented the infection from spreading to the piglet population, which highlights the importance of maintaining internal biosecurity practices at the farrowing room level.	[Arruda, Andreia Gonsalves; Friendship, Robert; Greer, Amy; Poljak, Zvonimir] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph	Arruda, AG; Poljak, Z (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.	arrud002@umn.edu; zpoljak@uoguelph.ca		Arruda, Andreia/0000-0001-7040-9686	Ontario Ministry of Agriculture, Food and Rural Affairs; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; Ontario Ministry of Agriculture, Food and Rural Affairs grant [UofG2011-1031]	Ontario Ministry of Agriculture, Food and Rural Affairs; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Ministry of Agriculture, Food and Rural Affairs grant	Graduate student funding (A.G.A.) was provided by the Ontario Ministry of Agriculture, Food and Rural Affairs, the Natural Sciences and Engineering Research Council of Canada, and the Ontario Graduate Scholarship. This work was also supported by Ontario Ministry of Agriculture, Food and Rural Affairs grant number UofG2011-1031 to Zvonimir Poljak. These entities did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierk MD, 2001, CAN J VET RES, V65, P261; Carlsson U, 2009, TRANSBOUND EMERG DIS, V56, P121, DOI 10.1111/j.1865-1682.2008.01065.x; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dee SA, 1997, VET MICROBIOL, V55, P347, DOI 10.1016/S0378-1135(96)01319-3; Evans CM, 2010, PREV VET MED, V93, P248, DOI 10.1016/j.prevetmed.2009.11.001; Fangman TJ, 2007, J SWINE HEALTH PROD, V15, P219; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hermann JR, 2005, VET MICROBIOL, V110, P7, DOI 10.1016/j.vetmic.2005.06.012; Jeong J, 2014, AM J VET RES, V75, P260, DOI 10.2460/ajvr.75.3.260; Linhares DCL, 2014, PREV VET MED, V116, P111, DOI 10.1016/j.prevetmed.2014.05.010; Linhares DCL, 2012, VACCINE, V30, P407, DOI 10.1016/j.vaccine.2011.10.075; McCaw MB, 2000, SWINE HEALTH PROD, V8, P15; Mishra S, 2011, J EPIDEMIOL COMMUN H, V65, P87, DOI 10.1136/jech.2009.097113; Nodelijk G, 2000, EPIDEMIOL INFECT, V124, P173, DOI 10.1017/S0950268899003246; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Rose N, 2015, VACCINE, V33, P2493, DOI 10.1016/j.vaccine.2015.03.040; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Wills RW, 1997, SWINE HEALTH PROD, V5, P213	19	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166596	10.1371/journal.pone.0166596	http://dx.doi.org/10.1371/journal.pone.0166596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875546	Green Published, gold, Green Submitted			2022-12-26	WOS:000388886000018
J	Popova, D; Forsblad, A; Hashemian, S; Jacobsson, SOP				Popova, Dina; Forsblad, Andreas; Hashemian, Sanaz; Jacobsson, Stig O. P.			Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells	PLOS ONE			English	Article							RAT-BRAIN MITOCHONDRIA; MONOAMINE-OXIDASE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SEROTONIN TRANSPORTERS; BODY-TEMPERATURE; METHYLENEDIOXYMETHAMPHETAMINE MDMA; SUBSTANTIA-NIGRA; STEM-CELLS; MICE; GLUTAMATE	3,4-methylenedioxymethamphetamine (MDMA; ecstasy) is a commonly abused recreational drug that causes neurotoxic effects in both humans and animals. The mechanism behind MDMA-induced neurotoxicity is suggested to be species-dependent and needs to be further investigated on the cellular level. In this study, the effects of MDMA in neuronally differentiated P19 mouse embryonal carcinoma cells have been examined. MDMA produces a concentration-, time- and temperature-dependent toxicity in differentiated P19 neurons, as measured by intracellular MTT reduction and extracellular LDH activity assays. The P19 derived neurons express both the serotonin reuptake transporter (SERT), that is functionally active, and the serotonin metabolizing enzyme monoamine oxidase A (MAO-A). The involvement of these proteins in the MDMA-induced toxicity was investigated by a pharmacological approach. The MAO inhibitors clorgyline and deprenyl, and the SERT inhibitor fluoxetine, per se or in combination, were not able to mimic the toxic effects of MDMA in the P19-derived neurons or block the MDMA-induced cell toxicity. Oxidative stress has been implicated in MDMA-induced neurotoxicity, but pre-treatment with the antioxidants alpha-tocopherol or N-acetylcysteine did not reveal any protective effects in the P19 neurons. Involvement of mitochondria in the MDMA-induced cytotoxicity was also examined, but MDMA did not alter the mitochondrial membrane potential (Delta psi m) in the P19 neurons. We conclude that MDMA produce a concentration-, time- and temperature-dependent neurotoxicity and our results suggest that the mechanism behind MDMA-induced toxicity in mouse derived neurons do not involve the serotonergic system, oxidative stress or mitochondrial dysfunction.	[Popova, Dina; Forsblad, Andreas; Hashemian, Sanaz; Jacobsson, Stig O. P.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden	Umea University	Jacobsson, SOP (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	stig.jacobsson@umu.se		Jacobsson, Stig/0000-0001-9740-8499; Ronnberg, Dina/0000-0003-3640-9468	Research Funds of Umea University Medical Faculty	Research Funds of Umea University Medical Faculty	This work was supported by the Research Funds of Umea University Medical Faculty (to SOPJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2007, J NEUROSCI, V27, P10203, DOI 10.1523/JNEUROSCI.2645-07.2007; Alves E, 2009, ADDICT BIOL, V14, P185, DOI 10.1111/j.1369-1600.2008.00143.x; Anneken JH, 2013, J NEUROIMMUNE PHARM, V8, P58, DOI 10.1007/s11481-012-9420-x; Anneken JH, 2012, NEUROPHARMACOLOGY, V63, P1022, DOI 10.1016/j.neuropharm.2012.07.026; BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911; Biezonski DK, 2013, EUR J PHARMACOL, V701, P176, DOI 10.1016/j.ejphar.2012.12.024; Biezonski DK, 2010, J NEUROCHEM, V112, P951, DOI 10.1111/j.1471-4159.2009.06515.x; Capela JP, 2007, NEUROSCIENCE, V146, P1743, DOI 10.1016/j.neuroscience.2007.03.028; Capela JP, 2006, NEUROSCIENCE, V139, P1069, DOI 10.1016/j.neuroscience.2006.01.007; Capela JP, 2013, NEUROTOXICOLOGY, V34, P254, DOI 10.1016/j.neuro.2012.09.005; Cauley K, 1996, J NEUROBIOL, V30, P303, DOI 10.1002/(SICI)1097-4695(199606)30:2<303::AID-NEU11>3.0.CO;2-K; Colado MI, 1997, BRIT J PHARMACOL, V121, P889, DOI 10.1038/sj.bjp.0701213; Fantegrossi WE, 2003, PSYCHOPHARMACOLOGY, V166, P202, DOI 10.1007/s00213-002-1261-5; Ferreira PS, 2013, TOXICOL LETT, V216, P159, DOI 10.1016/j.toxlet.2012.11.015; Finley MFA, 1996, J NEUROSCI, V16, P1056; FITZGERALD JL, 1990, EUR J PHARMACOL, V191, P217, DOI 10.1016/0014-2999(90)94150-V; Fujishiro J, 2002, EUR J PHARMACOL, V454, P183, DOI 10.1016/S0014-2999(02)02557-8; Granado N, 2008, J NEUROCHEM, V107, P1102, DOI 10.1111/j.1471-4159.2008.05705.x; Green AR, 2005, BRIT J PHARMACOL, V146, P306, DOI 10.1038/sj.bjp.0706318; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Gudelsky GA, 1996, J NEURAL TRANSM, V103, P1397, DOI 10.1007/BF01271253; Gustafsson SB, 2013, ARCH TOXICOL, V87, P1939, DOI 10.1007/s00204-013-1051-3; Hagino Y, 2011, CURR NEUROPHARMACOL, V9, P91, DOI 10.2174/157015911795017254; Hall AP, 2006, BRIT J ANAESTH, V96, P678, DOI 10.1093/bja/ael078; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hewton R, 2007, CLIN EXP PHARMACOL P, V34, P1051, DOI 10.1111/j.1440-1681.2007.04734.x; JOHNSON MP, 1991, EUR J PHARMACOL, V200, P9, DOI 10.1016/0014-2999(91)90659-E; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kirilly Eszter, 2010, Neuropsychopharmacol Hung, V12, P413; LEONARDI ETK, 1994, NEUROPSYCHOPHARMACOL, V10, P231, DOI 10.1038/npp.1994.26; Li IH, 2010, NEUROIMAGE, V49, P1259, DOI 10.1016/j.neuroimage.2009.07.072; LOGAN BJ, 1988, EUR J PHARMACOL, V152, P227, DOI 10.1016/0014-2999(88)90717-0; MacPherson PA, 1997, NEUROSCIENCE, V80, P487, DOI 10.1016/S0306-4522(97)00102-4; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Malberg JE, 1996, J PHARMACOL EXP THER, V278, P258; Malberg JE, 1998, J NEUROSCI, V18, P5086; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; Meamar R, 2012, CELL J, V14, P185; Meamar R, 2010, TOXICOL IN VITRO, V24, P1133, DOI 10.1016/j.tiv.2010.03.005; Millan MJ, 2001, J PHARMACOL EXP THER, V298, P565; MORASSUTTI DJ, 1994, NEUROSCIENCE, V58, P753, DOI 10.1016/0306-4522(94)90452-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mounteney J, 2016, ADDICTION, V111, P34, DOI 10.1111/add.13056; Nagatsu T, 2004, NEUROTOXICOLOGY, V25, P11, DOI 10.1016/S0161-813X(03)00085-8; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; OHEARN E, 1988, J NEUROSCI, V8, P2788; Parnas D, 1995, INT J DEV NEUROSCI, V13, P767, DOI 10.1016/0736-5748(95)00052-6; Parnas D, 1997, DEV BRAIN RES, V101, P115, DOI 10.1016/S0165-3806(97)00057-6; Partilla JS, 2006, J PHARMACOL EXP THER, V319, P237, DOI 10.1124/jpet.106.103622; Popova D, 2014, TOXICOL IN VITRO, V28, P411, DOI 10.1016/j.tiv.2013.12.009; Puerta E, 2010, BRIT J PHARMACOL, V160, P233, DOI 10.1111/j.1476-5381.2010.00663.x; RAY WJ, 1993, BIOCHEM BIOPH RES CO, V197, P1475, DOI 10.1006/bbrc.1993.2643; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; ROBINSON JB, 1985, BIOCHEM PHARMACOL, V34, P4105, DOI 10.1016/0006-2952(85)90201-1; Rudd ML, 2005, J NEUROIMMUNOL, V159, P113, DOI 10.1016/j.jneuroim.2004.10.013; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Santana L, 2008, J MED CHEM, V51, P6740, DOI 10.1021/jm800656v; Shankaran M, 1999, EUR J PHARM, V385; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Sharma HS, 2008, ANN NY ACAD SCI, V1139, P242, DOI 10.1196/annals.1432.052; SHARMA S, 1988, DEV BIOL, V125, P246, DOI 10.1016/0012-1606(88)90208-4; Shioda K, 2008, NEUROTOXICOLOGY, V29, P1030, DOI 10.1016/j.neuro.2008.07.005; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; SPRAGUE JE, 1995, PSYCHOPHARMACOLOGY, V118, P357, DOI 10.1007/BF02245967; STEELE TD, 1987, BIOCHEM PHARMACOL, V36, P2297, DOI 10.1016/0006-2952(87)90594-6; STONE DM, 1987, NEUROPHARMACOLOGY, V26, P1657, DOI 10.1016/0028-3908(87)90017-7; Svensson AC, 2006, J NEUROSCI RES, V83, P1128, DOI 10.1002/jnr.20792; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Wallinga AE, 2011, BRAIN RES, V1398, P13, DOI 10.1016/j.brainres.2011.04.039; Wallinga AE, 2009, PHARMACOL BIOCHEM BE, V94, P227, DOI 10.1016/j.pbb.2009.08.009; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Zamani M, 2013, METAB BRAIN DIS, V28, P367, DOI 10.1007/s11011-013-9408-0; Zhang L, 2006, EUR J PHARMACOL, V544, P1, DOI 10.1016/j.ejphar.2006.05.047	76	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166750	10.1371/journal.pone.0166750	http://dx.doi.org/10.1371/journal.pone.0166750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861613	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300099
J	Yin, Y; Yong, W; Yu, JN; Zhang, X; Lin, HY; Zhu, YX; Han, X				Yin, Ye; Yong, Wei; Yu, Jiani; Zhang, Xu; Lin, Haiyan; Zhu, Yunxia; Han, Xiao			Pdcd2l Promotes Palmitate-Induced Pancreatic Beta-Cell Apoptosis as a FoxO1 Target Gene	PLOS ONE			English	Article							FORKHEAD PROTEIN FOXO1; SATURATED FATTY-ACIDS; INSULIN-RESISTANCE; TRANSCRIPTION FACTORS; FAILURE; PROLIFERATION; STRESS; DIFFERENTIATION; DIACYLGLYCEROL; IDENTIFICATION	Transcription factor FoxO1 is a key regulator of the insulin-signaling pathway, and is reported to play important roles in pancreatic beta cell differentiation, proliferation, apoptosis and stress resistance. The multifunctional nature of FoxO1 is due to its regulation of various downstream targets. Previous studies in our lab identified potential FoxO1 target genes using the ChIP-DSL technique and one of those genes, Pdcd2l, was selected for further study. We found that the expression of Pdcd2l was increased with palmitate treatment; the luciferase assay result revealed that enhanced Pdcd2l promoter activity was responsible for the elevation of Pdcd2l expression. ChIP-PCR was performed to confirm the combination of FoxO1 to Pdcd2l promoter, result showing that FoxO1 could bind to Pdcd2l promoter and this binding was further enhanced after palmitate treatment. Overexpression of FoxO1 significantly induced Pdcd2l promoter activity, leading to increased mRNA level; consistently, interference of FoxO1 abolished the increment of Pdcd2l gene expression triggered by palmitate treatment. In addition, overexpression of Pdcd2l could further increase the percentage of apoptotic cells induced by palmitate incubation, whilst interference of Pdcd2l partially reversed the palmitate-induced apoptosis together with activated Caspase-3, indicating that the latter may play a part in this process. Therefore, in this study, we confirmed the binding of FoxO1 to the Pdcd2l gene promoter and studied the role of Pdcd2l in beta cells for the first time. Our results suggested that FoxO1 may exert its activity partially through the regulation of Pdcd2l in palmitate-induced beta cell apoptosis and could help to clarify the molecular mechanisms of beta cell failure in type 2 diabetes.	[Yin, Ye; Yong, Wei; Yu, Jiani; Zhang, Xu; Lin, Haiyan; Zhu, Yunxia; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Han, Xiao] Nanjing Med Univ, Clin Diabet Ctr Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Lin, Haiyan] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Han, X (corresponding author), Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Han, X (corresponding author), Nanjing Med Univ, Clin Diabet Ctr Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	hanxiao@njmu.edu.cn	Zhu, Yunxia/G-6273-2014		National Natural Science Foundation of China [81300638]; Natural Science Foundation of Jiangsu Province [BK20130889, BK20131389]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from: (1) the National Natural Science Foundation of China (81300638) to Ye Yin; (2) the Natural Science Foundation of Jiangsu Province (BK20130889) to Ye Yin; and (3) the Natural Science Foundation of Jiangsu Province (BK20131389) to Haiyan Lin.; This work was supported by grants from: (1) the National Natural Science Foundation of China (81300638) to Ye Yin; (2) the Natural Science Foundation of Jiangsu Province (BK20130889) to Ye Yin; (3) the Natural Science Foundation of Jiangsu Province (BK20131389) to Haiyan Lin. Xiao Han is a fellow at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine.	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Barboza N, 2013, CANCER BIOL THER, V14, P546, DOI 10.4161/cbt.24484; Boden Guenther, 2005, Curr Diab Rep, V5, P167, DOI 10.1007/s11892-005-0004-5; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen Q, 2008, HUM IMMUNOL, V69, P259, DOI 10.1016/j.humimm.2008.01.020; Chen Q, 2008, CELL BIOCHEM FUNCT, V26, P141, DOI 10.1002/cbf.1410; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Janikiewicz J, 2015, BIOCHEM BIOPH RES CO, V460, P491, DOI 10.1016/j.bbrc.2015.03.153; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kramer J, 2013, STEM CELLS DEV, V22, P58, DOI 10.1089/scd.2012.0074; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lin HY, 2012, DIABETOLOGIA, V55, P2703, DOI 10.1007/s00125-012-2643-9; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; Meng ZX, 2009, DIABETOLOGIA, V52, P125, DOI 10.1007/s00125-008-1174-x; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Roep BO, 2007, NATURE, V450, P799, DOI 10.1038/450799a; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Zhang X, 2009, HEILONGJIANG TRADITI, V5, P5, DOI DOI 10.1210/EN.2009-0343; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	50	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166692	10.1371/journal.pone.0166692	http://dx.doi.org/10.1371/journal.pone.0166692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861641	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300090
J	Hiken, JF; McDonald, JI; Decker, KF; Sanchez, C; Hoog, J; VanderKraats, ND; Jung, KL; Akinhanmi, M; Rois, LE; Ellis, MJ; Edwards, JR				Hiken, J. F.; McDonald, J. I.; Decker, K. F.; Sanchez, C.; Hoog, J.; VanderKraats, N. D.; Jung, K. L.; Akinhanmi, M.; Rois, L. E.; Ellis, M. J.; Edwards, J. R.			Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITION; HUMAN ESTROGEN-RECEPTOR; DNA METHYLATION; GENE-EXPRESSION; PROTEIN-KINASE; SYNERGISTIC ACTIVATION; AROMATASE INHIBITORS; CELLS; ALPHA; PHOSPHORYLATION	Approximately 75% of breast cancers express estrogen receptor a (ER alpha) and depend on estrogen signals for continued growth. Aromatase inhibitors (AIs) prevent estrogen production and inhibit ER signaling, resulting in decreased cancer recurrence and mortality. Advanced tumors treated with AIs almost always develop resistance to these drugs via the upregulation of alternative growth signals. The mechanisms that drive this resistance-especially epigenetic events that alter gene expression-are, however, not well understood. Genome-wide DNA methylation and expression analysis of cell line models of acquired AI resistance indicated that prostaglandin E2 receptor 4 (PTGER4) is upregulated after demethylation in resistant cells. Knockdown and inhibitor studies demonstrate that PTGER4 is essential for estrogen-independent growth. Our exploratory analysis of downstream signaling indicates that PTGER4 likely promotes AI resistance via ligand-independent activation of the ER alpha-cofactor CARM1. We believe that we have discovered a novel epigenetic mechanism for altering cell signaling and acquiring endocrine therapy resistance. Our findings indicate that PTGER4 is a potential drug target in AI-resistant cancers. In addition, the epigenetic component of PTGER4 regulation suggests that further study of PTGER4 may yield valuable insights into how DNA methylation-targeted diagnoses and treatments can improve AI-resistant breast cancer treatment.	[Hiken, J. F.; McDonald, J. I.; Decker, K. F.; VanderKraats, N. D.; Jung, K. L.; Akinhanmi, M.; Rois, L. E.; Edwards, J. R.] Washington Univ, Sch Med, Ctr Pharmacogen, Dept Med, 660S Euclid Ave,Campus Box 8220, St Louis, MO 63110 USA; [Sanchez, C.] Pontificia Univ Catolica Chile, Haematol Oncol, Dept Canc Programme, Sch Med, Santiago, Chile; [Hoog, J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Ellis, M. J.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	Washington University (WUSTL); Pontificia Universidad Catolica de Chile; Washington University (WUSTL); Baylor College of Medicine	Edwards, JR (corresponding author), Washington Univ, Sch Med, Ctr Pharmacogen, Dept Med, 660S Euclid Ave,Campus Box 8220, St Louis, MO 63110 USA.	jedwards@dom.wustl.edu		Jung, Kyle/0000-0002-6694-4333	NIH [R00 CA127360, R21 LM011199, 2T32GM007067-37, P30 CA91842, UL1 TR000448]; Department of Defense [W81XWH-11-1-0401]; Siteman Cancer Center Breast Cancer Program career development award; NATIONAL CANCER INSTITUTE [R00CA127360, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108811] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM011199] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Siteman Cancer Center Breast Cancer Program career development award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank C de Guzman-Strong and S Matkovich for their comments on the manuscript. This work was supported by grants NIH R00 CA127360, NIH R21 LM011199, NIH 2T32GM007067-37, Department of Defense W81XWH-11-1-0401 and a Siteman Cancer Center Breast Cancer Program career development award to JRE. We also thank the Genome Technology Access Center at the Washington University School of Medicine for help with genomic analysis (partially supported by NIH P30 CA91842 and NIH UL1 TR000448).	Aguilar H, 2010, ONCOGENE, V29, P6071, DOI 10.1038/onc.2010.333; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Carascossa S, 2010, GENE DEV, V24, P708, DOI 10.1101/gad.568410; Chan CMW, 2002, J STEROID BIOCHEM, V81, P333, DOI 10.1016/S0960-0760(02)00074-2; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ellis MJ, 2011, J CLIN ONCOL, V29, P2342, DOI 10.1200/JCO.2010.31.6950; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FERGUSON AT, 1995, CANCER RES, V55, P2279; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Giacinti L, 2012, J CELL PHYSIOL, V227, P3426, DOI 10.1002/jcp.24043; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Keen JC, 2003, BREAST CANCER RES TR, V81, P177, DOI 10.1023/A:1026146524737; Kim JH, 2012, MOL CELLS, V33, P127, DOI 10.1007/s10059-012-2182-8; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lazennec G, 2001, J STEROID BIOCHEM, V77, P193, DOI 10.1016/S0960-0760(01)00060-7; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Ma CX, 2015, NAT REV CANCER, V15, P261, DOI 10.1038/nrc3920; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Miller TW, 2011, CLIN CANCER RES, V17, P2024, DOI 10.1158/1078-0432.CCR-10-2567; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nguyen VTM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10044; Olson JA, 2009, J AM COLL SURGEONS, V208, P906, DOI 10.1016/j.jamcollsurg.2009.01.035; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabnis GJ, 2011, CANCER RES, V71, P1893, DOI 10.1158/0008-5472.CAN-10-2458; Sanchez CG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2833; Stone A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8758; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Tharakan R, 2008, MOL CELL ENDOCRINOL, V295, P70, DOI 10.1016/j.mce.2008.07.018; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANAGTHOVEN T, 1994, MOL ENDOCRINOL, V8, P1474, DOI 10.1210/me.8.11.1474; VanderKraats ND, 2013, NUCLEIC ACIDS RES, V41, P6816, DOI 10.1093/nar/gkt482; Yang XW, 2001, CANCER RES, V61, P7025; Yang XW, 2000, CANCER RES, V60, P6890; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zhang QX, 1997, CANCER RES, V57, P1244; Zhou Q, 2009, BREAST CANCER RES TR, V117, P443, DOI 10.1007/s10549-008-0148-5; Zilli M, 2009, BBA-REV CANCER, V1795, P62, DOI 10.1016/j.bbcan.2008.08.003	55	16	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2319	2327		10.1038/onc.2016.397	http://dx.doi.org/10.1038/onc.2016.397			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27869171	Green Accepted, Green Submitted			2022-12-26	WOS:000399782700012
J	Huang, PH; Lu, PJ; Ding, LY; Chu, PC; Hsu, WY; Chen, CS; Tsao, CC; Chen, BH; Lee, CT; Shan, YS; Chen, CS				Huang, P-H; Lu, P-J; Ding, L-Y; Chu, P-C; Hsu, W-Y; Chen, C-S; Tsao, C-C; Chen, B-H; Lee, C-T; Shan, Y-S; Chen, C-S			TGF beta promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1	ONCOGENE			English	Article							NUCLEOTIDE EXCHANGE ACTIVITY; GROWTH-FACTOR-BETA; TUMOR-MICROENVIRONMENT; PROTOONCOGENE PRODUCT; PROSTATE-CANCER; LUNG-CANCER; EXPRESSION; METHYLATION; PROTEIN; ADENOCARCINOMA	The highly homeostasis-resistant nature of cancer cells leads to their escape from treatment and to liver metastasis, which in turn makes pancreatic ductal adenocarcinoma (PDAC) difficult to treat, especially the squamous/epithelial-to-mesenchymal transition (EMT)-like subtype. As the molecular mechanisms underlying tumour heterogeneity remain elusive, we investigated whether epigenetic regulation might explain inter-individual differences in the progression of specific subtypes. DNA methylation profiling performed on cancer tissues prior to chemo/radiotherapy identified one hypermethylated CpG site (CpG6882469) in the VAV1 gene body that was correlated with demethylation of two promoter CpGs (CpG6772370/CpG6772811) in both PDAC and peripheral blood. Transforming growth factor beta treatment induced gene-body hypermethylation, dissociation of DNMT1 from the promoter, and VAV1 expression via SMAD4 and mutant Kras(G12D). Pharmacological inhibition of TGF beta-VAV1 signalling decreased the squamous/EMT-like cancer cells, promoted nuclear VAV1 localization, and enhanced the efficacy of gemcitabine in prolonging the survival of (KPC)-C-fl/fl mice. Together, the three VAV1 CpGs serve as biomarkers for prognosis and early detection, and the TGF beta-VAV1 axis represents a therapeutic target.	[Huang, P-H; Ding, L-Y; Hsu, W-Y; Chen, C-S; Chen, B-H] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan, Taiwan; [Huang, P-H; Lu, P-J; Ding, L-Y; Chu, P-C; Chen, C-S; Shan, Y-S; Chen, C-S] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Lu, P-J; Tsao, C-C; Shan, Y-S] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, 1 Univ Rd, Tainan 701, Taiwan; [Chu, P-C; Chen, C-S] Acad Sinica, Inst Biol Chem, 128,Acad Rd Sect 2, Taipei 115, Taiwan; [Lee, C-T] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan; [Shan, Y-S] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan, Taiwan; [Chen, C-S] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; University System of Ohio; Ohio State University	Shan, YS (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.; Chen, CS (corresponding author), Acad Sinica, Inst Biol Chem, 128,Acad Rd Sect 2, Taipei 115, Taiwan.	ysshan@mail.ncku.edu.tw; chencs@gate.sinica.edu.tw			Bi-institutional Collaborative Pancreatic Cancer Research grant from the College of Medicine of National Cheng Kung University; Ministry of Science and Technology, Taiwan [MOST102-2320-B-006-050, MOST104-2320-B-006-028-]; Ministry of Health and Welfare, Taiwan [MOHW104-TDU-B-211-124-003]; Team of Excellent Research Program of the Ministry of Science and Technology, Taiwan [MOST 105-2321-B-001-064]	Bi-institutional Collaborative Pancreatic Cancer Research grant from the College of Medicine of National Cheng Kung University; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare, Taiwan; Team of Excellent Research Program of the Ministry of Science and Technology, Taiwan	The authors acknowledge the assistance of Yi-Chen Chen, Pei-Rong Gu, and Hui-Ling Tung, as well as assistance from the following core facilities: the Clinical Medicine Research Center of National Cheng Kung University Hospital, the Animal Center of National Cheng Kung University, and the National Center for Genome Medicine (technical/bioinformatics). The authors would like to thank Drs Yi-Chuang Liao and Po-Min Chiang for pathological consultations and Dr Cindy Lee for manuscript editing. This work is supported by the Bi-institutional Collaborative Pancreatic Cancer Research grant from the College of Medicine of National Cheng Kung University to PJL and CSC; and grants MOST102-2320-B-006-050 and MOST104-2320-B-006-028- from the Ministry of Science and Technology, Taiwan, to PHH; MOHW104-TDU-B-211-124-003 from the Ministry of Health and Welfare, Taiwan, to YSS; and MOST 105-2321-B-001-064 from the Team of Excellent Research Program of the Ministry of Science and Technology, Taiwan, to CSC.	Achyut BR, 2011, GASTROENTEROLOGY, V141, P1167, DOI 10.1053/j.gastro.2011.07.048; Bai LY, 2013, BIOCHEM PHARMACOL, V86, P1430, DOI 10.1016/j.bcp.2013.09.002; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bertagnolo V, 2005, EXP CELL RES, V306, P56, DOI 10.1016/j.yexcr.2004.12.001; Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Collazo J, 2014, CANCER RES, V74, P2362, DOI 10.1158/0008-5472.CAN-13-3058; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Ebert MPA, 2002, BRIT J CANCER, V86, P257, DOI 10.1038/sj/bjc/6600031; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Gore AJ, 2014, J CLIN INVEST, V124, P338, DOI 10.1172/JCI71526; Grassilli S, 2014, ONCOTARGET, V5, P4320, DOI 10.18632/oncotarget.2011; Grimmer MR, 2014, EPIGENOMICS-UK, V6, P493, DOI [10.2217/EPI.14.30, 10.2217/epi.14.30]; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Hou YC, 2014, CANCER-AM CANCER SOC, V120, P2766, DOI 10.1002/cncr.28774; Houlard M, 2005, ONCOGENE, V24, P28, DOI 10.1038/sj.onc.1208043; Houlard M, 2002, J EXP MED, V195, P1115, DOI 10.1084/jem.20011701; Huang PH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003816; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Katzav S, 2015, ONCOTARGET, V6, P28731, DOI 10.18632/oncotarget.5086; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Ksionda O, 2012, J CELL SCI, V125, P5302, DOI 10.1242/jcs.105148; Li RM, 2009, CANCER BIOL THER, V8, P1402, DOI 10.4161/cbt.8.14.8882; Lindsey JC, 2015, ONCOGENE, V34, P4746, DOI 10.1038/onc.2014.405; Garcia JL, 2012, J NEURO-ONCOL, V110, P69, DOI 10.1007/s11060-012-0936-y; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Miletic AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006599; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nolz JC, 2005, TRENDS CELL BIOL, V15, P514, DOI 10.1016/j.tcb.2005.08.003; Ostapoff KT, 2014, CANCER RES, V74, P4996, DOI 10.1158/0008-5472.CAN-13-1807; Qi Y, 2015, AM J CANCER RES, V5, P2491; Razanadrakoto L, 2015, ONCOTARGET, V6, P2524, DOI 10.18632/oncotarget.2629; Razidlo GL, 2015, CANCER RES, V75, P2907, DOI 10.1158/0008-5472.CAN-14-3103; Razidlo GL, 2013, DEV CELL, V24, P573, DOI 10.1016/j.devcel.2013.02.010; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Sebban S, 2014, ONCOTARGET, V5, P9214, DOI 10.18632/oncotarget.2400; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vidakovic AT, 2015, CELL REP, V13, P2480, DOI 10.1016/j.celrep.2015.11.040; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028	51	20	20	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2202	2214		10.1038/onc.2016.378	http://dx.doi.org/10.1038/onc.2016.378			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27893715				2022-12-26	WOS:000399782700002
J	Cil, O; Phuan, PW; Gillespie, AM; Lee, S; Tradtrantip, L; Yin, JY; Tse, M; Zachos, NC; Lin, RX; Donowitz, M; Verkman, AS				Cil, Onur; Phuan, Puay-Wah; Gillespie, Anne Marie; Lee, Sujin; Tradtrantip, Lukmanee; Yin, Jianyi; Tse, Ming; Zachos, Nicholas C.; Lin, Ruxian; Donowitz, Mark; Verkman, Alan S.			Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins	FASEB JOURNAL			English	Article						intestinal secretion; secretory diarrhea; cholera; traveler's diarrhea	TRANSMEMBRANE CONDUCTANCE REGULATOR; POLYCYSTIC KIDNEY-DISEASE; INTESTINAL FLUID SECRETION; DEPENDENT PROTEIN-KINASE; ANTIDIARRHEAL EFFICACY; ION-TRANSPORT; CL-SECRETION; CYST GROWTH; CHOLERA; CHANNEL	Secretory diarrheas caused by bacterial enterotoxins, including cholera and traveler's diarrhea, remain a major global health problem. Inappropriate activation of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel occurs in these diarrheas. We previously reported that the benzopyrimido-pyrrolo-oxazinedione (R)-BPO-27 inhibits CFTR chloride conductance with low-nanomolar potency. Here, we demonstrate using experimental mouse models and human enterocyte cultures the potential utility of (R)-BPO-27 for treatment of secretory diarrheas caused by cholera and Escherichia coli enterotoxins. (R)-BPO-27 fully blocked CFTR chloride conductance in epithelial cell cultures and intestine after cAMP agonists, cholera toxin, or heat-stable enterotoxin of E. coli (STa toxin), with IC50 down to similar to 5 nM. (R)-BPO-27 prevented cholera toxin and STa toxin-induced fluid accumulation in small intestinal loops, with IC50 down to 0.1 mg/kg. (R)-BPO-27 did not impair intestinal fluid absorption or inhibit other major intestinal transporters. Pharmacokinetics in mice showed >90% oral bioavailability with sustained therapeutic serum levels for >4 h without the significant toxicity seen with 7-d administration at 5 mg/kg/d. As evidence to support efficacy in human diarrheas, (R)-BPO-27 blocked fluid secretion in primary cultures of enteroids from human small intestine and anion current in enteroid monolayers. These studies support the potential utility of (R)-BPO-27 for therapy of CFTR-mediated secretory diarrheas.	[Cil, Onur; Phuan, Puay-Wah; Gillespie, Anne Marie; Lee, Sujin; Tradtrantip, Lukmanee; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cil, Onur; Phuan, Puay-Wah; Gillespie, Anne Marie; Lee, Sujin; Tradtrantip, Lukmanee; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Yin, Jianyi; Tse, Ming; Zachos, Nicholas C.; Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yin, Jianyi; Tse, Ming; Zachos, Nicholas C.; Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University	Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci East Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu	Cil, Onur/AAK-5166-2020; Zachos, Nicholas/GWC-7914-2022	Cil, Onur/0000-0001-5178-0199; Lee, Sujin/0000-0001-6701-1730	U.S. National Institute of Health [R24 DK099803, P30 DK72517, R01 DK101373, R01 DK35124, R37 EB00415, R01 EY13574, R01 DK26523, R01 DK61765, P30 DK089502, TR000552, TR000504]; Research Development Program grant from the Cystic Fibrosis Foundation; Catalyst grant [UL1 TR000004]; Gates Foundation Grand Challenges grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, U18TR000552, UH2TR000504, UH3TR000504] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101373, R01DK035124, R01DK061765, R24DK099803, R01DK026523, P30DK072517, P30DK089502] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Development Program grant from the Cystic Fibrosis Foundation; Catalyst grant; Gates Foundation Grand Challenges grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institute of Health (Grants R24 DK099803, P30 DK72517, R01 DK101373, R01 DK35124, R37 EB00415, R01 EY13574, R01 DK26523, R01 DK61765, P30 DK089502, TR000552, TR000504, and TR000504); a Research Development Program grant from the Cystic Fibrosis Foundation; a Catalyst grant from funds awarded to the University of California San Francisco Clinical and Translational Science Institute (UL1 TR000004); and a Gates Foundation Grand Challenges grant.	Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Cil O, 2016, CELL MOL GASTROENTER, V2, P317, DOI 10.1016/j.jcmgh.2015.12.010; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; de Hostos EL, 2011, FUTURE MED CHEM, V3, P1317, DOI [10.4155/FMC.11.87, 10.4155/fmc.11.87]; Felsenstein KM, 2016, ACS CHEM BIOL, V11, P139, DOI 10.1021/acschembio.5b00577; FIELD M, 1979, AM J CLIN NUTR, V32, P189, DOI 10.1093/ajcn/32.1.189; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Flores AM, 2016, FASEB J, V30, P1789, DOI 10.1096/fj.201500180; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Guarino A, 2012, EXPERT OPIN PHARMACO, V13, P17, DOI 10.1517/14656566.2011.634800; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Jin BJ, 2013, J GEN PHYSIOL, V141, P261, DOI 10.1085/jgp.201210885; Kim Y, 2015, MOL PHARMACOL, V88, P689, DOI 10.1124/mol.115.098368; Ko EA, 2014, GUT, V63, P1120, DOI 10.1136/gutjnl-2013-305663; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; KREJS GJ, 1987, AM J MED, V82, P37, DOI 10.1016/0002-9343(87)90425-6; Lee K, 2010, BIOORG MED CHEM LETT, V20, P1767, DOI 10.1016/j.bmcl.2010.01.036; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Lin C. M., 2016, VIRUS RES, V1702, P30225; Lin MI, 2015, EUR J MED CHEM, V102, P477, DOI 10.1016/j.ejmech.2015.08.016; Luan J, 2015, FITOTERAPIA, V100, P88, DOI 10.1016/j.fitote.2014.11.001; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Moon C, 2015, PHARMACOL RES, V102, P107, DOI 10.1016/j.phrs.2015.08.024; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Patanayindee J, 2012, INDIAN J PHARMACOL, V44, P619, DOI 10.4103/0253-7613.100392; Rufo PA, 2004, AM J PHYSIOL-CELL PH, V286, pC998, DOI 10.1152/ajpcell.00357.2003; Selvaraj NG, 2000, BBA-MOL CELL RES, V1498, P32, DOI 10.1016/S0167-4889(00)00075-6; Snyder DS, 2013, ACS MED CHEM LETT, V4, P456, DOI 10.1021/ml400069k; Snyder DS, 2011, J MED CHEM, V54, P5468, DOI 10.1021/jm200505e; Solomon GM, 2016, ANN AM THORAC SOC, V13, pS169, DOI 10.1513/AnnalsATS.201509-601KV; Solomon GM, 2015, PEDIATR PULM, V50, pS3, DOI 10.1002/ppul.23240; Sonawane ND, 2008, CHEM BIOL, V15, P718, DOI 10.1016/j.chembiol.2008.05.015; Sonawane ND, 2007, GASTROENTEROLOGY, V132, P1234, DOI 10.1053/j.gastro.2007.02.018; STEVEN K, 1981, GASTROENTEROLOGY, V80, P1562; Thiagarajah JR, 2015, NAT REV GASTRO HEPAT, V12, P446, DOI 10.1038/nrgastro.2015.111; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Tradtrantip L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002674; Tradtrantip L, 2010, MOL PHARMACOL, V77, P69, DOI 10.1124/mol.109.061051; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828	52	29	32	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					751	760		10.1096/fj.201600891R	http://dx.doi.org/10.1096/fj.201600891R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871064	Green Published			2022-12-26	WOS:000394235400027
J	Haggie, PM; Phuan, PW; Tan, JA; Xu, HJ; Avramescu, RG; Perdomo, D; Zlock, L; Nielson, DW; Finkbeiner, WE; Lukacs, GL; Verkman, AS				Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Xu, Haijin; Avramescu, Radu G.; Perdomo, Doranda; Zlock, Lorna; Nielson, Dennis W.; Finkbeiner, Walter E.; Lukacs, Gergely L.; Verkman, Alan S.			Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator ( CFTR) Translation Product*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; CONDUCTANCE REGULATOR; EPITHELIAL-CELLS; NONSENSE MUTATIONS; ROCK INHIBITOR; BIOAVAILABILITY; DOMAIN; TERMINATION; RESTORATION	W1282X is the fifth most common cystic fibrosis transmembrane regulator (CFTR) mutation that causes cystic fibrosis. Here, we investigated the utility of a small molecule corrector/potentiator strategy, as used for Delta F508-CFTR, to produce functional rescue of the truncated translation product of the W1282X mutation, CFTR1281, without the need for readthrough. In transfected cell systems, certain potentiators and correctors, including VX-809 and VX-770, increased CFTR1281 activity. To identify novel correctors and potentiators with potentially greater efficacy on CFTR1281, functional screens were done of similar to 30,000 synthetic small molecules and drugs/nutraceuticals in CFTR1281-transfected cells. Corrector scaffolds of 1-arylpyrazole-4-arylsulfonyl-piperazine and spiro-piperidine-quinazolinone classes were identified with up to similar to 5-fold greater efficacy than VX-809, some of which were selective for CFTR1281, whereas others also corrected Delta F508-CFTR. Several novel potentiator scaffolds were identified with efficacy comparable with VX-770; remarkably, a phenylsulfonamide-pyrrolopyridine acted synergistically with VX-770 to increaseCFTR(1281) function similar to 8-fold over that of VX-770 alone, normalizing CFTR1281 channel activity to that of wild type CFTR. Corrector and potentiator combinations were tested in primary cultures and conditionally reprogrammed cells generated from nasal brushings from one W1282X homozygous subject. Although robust chloride conductance was seen with correctors and potentiators in homozygous Delta F508 cells, increased chloride conductance was not found in W1282X cells despite the presence of adequate transcript levels. Notwithstanding the negative data inW1282Xcells from one human subject, we speculate that corrector and potentiator combinations may have therapeutic efficacy in cystic fibrosis caused by the W1282X mutation, although additional studies are needed on human cells from W1282X subjects.	[Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Zlock, Lorna; Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Nielson, Dennis W.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Xu, Haijin; Avramescu, Radu G.; Perdomo, Doranda; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McGill University	Haggie, PM; Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.; Lukacs, GL (corresponding author), McIntyre Med Sci Bldg,Rm 1006, Montreal, PQ H3G 1Y6, Canada.	peter.haggie@ucsf.edu; gergely.lukacs@mcgill.ca; alan.verkman@ucsf.edu		Lukacs, Gergely/0000-0003-0900-0675; Perdomo, Doranda/0000-0001-9949-751X	Cystic Fibrosis Foundation (The Cystic Fibrosis Foundation Therapeutics); National Institutes of Health [P30 CA082103]; NATIONAL CANCER INSTITUTE [P30CA082103, R44CA091661] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099803, R01DK075302, P30DK072517] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation (The Cystic Fibrosis Foundation Therapeutics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Robert Bridges, Rosalind Franklin University of Medicine and Science, for providing compounds through the CFTR Compound Program, CFFT. This compound repository is supported by the Cystic Fibrosis Foundation (The Cystic Fibrosis Foundation Therapeutics). The University of California at San Francisco Helen Diller Cancer Center Genome Analysis Core is supported by the National Institutes of Health Grant P30 CA082103.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bowden M., 2014, Patent, Patent No. [WO/2014/167530, 2014167530]; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Davies JC, 2015, CURR OPIN PULM MED, V21, P579, DOI 10.1097/MCP.0000000000000211; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Gentzsch M, 2002, BIOCHEM J, V366, P541, DOI 10.1042/BJ20020511; Gentzsch M, 2001, J BIOL CHEM, V276, P1291, DOI 10.1074/jbc.M003672200; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Gradolatto A, 2005, DRUG METAB DISPOS, V33, P49, DOI 10.1124/dmd.104.000893; Haggie PM, 2015, PEDIATR PULM, V50, P264; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Meyer H, 2006, ANN NUTR METAB, V50, P167, DOI 10.1159/000090736; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Phuan PW, 2015, MOL PHARMACOL, V88, P791, DOI 10.1124/mol.115.099689; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2007, AM J RESP CELL MOL, V37, P347, DOI 10.1165/rcmb.2006-0176OC; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sun DQ, 2008, BIOORG MED CHEM LETT, V18, P3513, DOI 10.1016/j.bmcl.2008.05.025; Sun HP, 2014, EUR J MED CHEM, V79, P399, DOI 10.1016/j.ejmech.2014.03.061; Tawada H, 1998, Preparation of 1-benzoyl-4-naphthalenesulfonylpiperazines and related compounds as inhibitors of activated coagulation factor X, Patent No. [WO 9854164A1, 9854164]; Valentine CD, 2012, J BIOL CHEM, V287, P43630, DOI 10.1074/jbc.M112.421172; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Wang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152232; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC	53	54	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					771	785		10.1074/jbc.M116.764720	http://dx.doi.org/10.1074/jbc.M116.764720			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27895116	hybrid, Green Published			2022-12-26	WOS:000392318700002
J	Shen, ZX; Chen, XQ; Sun, XN; Sun, JY; Zhang, WC; Zheng, XJ; Zhang, YY; Shi, HJ; Zhang, JW; Li, C; Wang, J; Liu, X; Duan, SZ				Shen, Zhu-Xia; Chen, Xiao-Qing; Sun, Xue-Nan; Sun, Jian-Yong; Zhang, Wu-Chang; Zheng, Xiao-Jun; Zhang, Yu-Yao; Shi, Huan-Jing; Zhang, Jia-Wei; Li, Chao; Wang, Jun; Liu, Xu; Duan, Sheng-Zhong			Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE ALDOSTERONE BLOCKER; ANGIOTENSIN-II; PPAR-ALPHA; KEY ROLE; EPLERENONE; DELETION; HEART; ACCUMULATION; INFLAMMATION; PHENOTYPE	Mineralocorticoid receptor (MR) has been considered as a potential target for treating atherosclerosis. However, the cellular and molecular mechanisms are not completely understood. We aim to explore the functions and mechanisms of macrophage MR in atherosclerosis. Atherosclerosis-susceptible LDLRKO chimeric mice with bone marrow cells from floxed control mice or from myeloid MR knock-out (MRKO) mice were generated and fed with high cholesterol diet. Oil red O staining showed that MRKO decreased atherosclerotic lesion area in LDLRKO mice. In another mouse model of atherosclerosis, MRKO/APOEKO mice and floxed control/APOEKO mice were generated and treated with angiotensin II. Similarly, MRKO inhibited the atherosclerotic lesion area in APOEKO mice. Histological analysis showed that MRKO increased collagen coverage and decreased necrosis and macrophage accumulation in the lesions. In vitro results demonstrated that MRKO suppressed macrophage foam cell formation and up-regulated the expression of genes involved in cholesterol efflux. Furthermore, MRKOdecreased accumulation of apoptotic cells and increased effective efferocytosis in atherosclerotic lesions. In vitro study further revealed that MRKO increased the phagocytic index of macrophages without affecting their apoptosis. In conclusion, MRKOreduces high cholesterol-or angiotensin II-induced atherosclerosis and favorably changes plaque composition, likely improving plaque stability. Mechanistically, MR deficiency suppresses macrophage foam cell formation and up-regulates expression of genes related to cholesterol efflux, as well as increases effective efferocytosis and phagocytic capacity of macrophages.	[Shen, Zhu-Xia; Sun, Xue-Nan; Zhang, Wu-Chang; Zheng, Xiao-Jun; Zhang, Yu-Yao; Li, Chao; Duan, Sheng-Zhong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Res Inst Stomatol,Sch Med, Shanghai Key Lab Stomatol,Sch Stomatol,Lab Oral M, Shanghai 200011, Peoples R China; [Shen, Zhu-Xia; Wang, Jun] Fudan Univ, Dept Cardiol, Jingan Dist Ctr Hosp Shanghai, Huashan Hosp,Jingan Branch, Shanghai 200040, Peoples R China; [Shen, Zhu-Xia; Sun, Xue-Nan; Sun, Jian-Yong; Zheng, Xiao-Jun; Zhang, Yu-Yao; Shi, Huan-Jing; Zhang, Jia-Wei; Li, Chao] Univ Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200031, Peoples R China; [Chen, Xiao-Qing; Liu, Xu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Duan, SZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	duansz@shsmu.edu.cn	chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; Zhang, Jiawei/AAY-4922-2020	Zhang, Jiawei/0000-0002-5782-5543	National Natural Science Foundation of China [31671181, 31400987, 91339110, 31371153]; Science and Technology Commission of Shanghai Municipality [15140904400]; Shanghai Summit & Plateau Discipline Developing Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Summit & Plateau Discipline Developing Projects	This work was supported by National Natural Science Foundation of China Grants 31671181, 31400987, 91339110, and 31371153; Science and Technology Commission of Shanghai Municipality Grant 15140904400; and the Shanghai Summit & Plateau Discipline Developing Projects. The authors declare that they have no conflicts of interest with the contents of this article.	Bienvenu LA, 2012, ENDOCRINOLOGY, V153, P3416, DOI 10.1210/en.2011-2098; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Duivenvoorden R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4065; Ferrario CM, 2015, CIRC RES, V116, P206, DOI 10.1161/CIRCRESAHA.116.302706; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Heo KS, 2014, CIRCULATION, V130, P180, DOI 10.1161/CIRCULATIONAHA.113.005991; Keidar S, 2005, CIRC RES, V97, P946, DOI 10.1161/01.RES.0000187500.24964.7A; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Keidar S, 2003, J CARDIOVASC PHARM, V41, P955, DOI 10.1097/00005344-200306000-00019; Kojima Y, 2014, J CLIN INVEST, V124, P1083, DOI 10.1172/JCI70391; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Lewis DR, 2015, P NATL ACAD SCI USA, V112, P2693, DOI 10.1073/pnas.1424594112; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110950; Libby P, 2016, CIRC RES, V118, P531, DOI 10.1161/CIRCRESAHA.116.308334; Lother A, 2015, ANNU REV PHARMACOL, V55, P289, DOI 10.1146/annurev-pharmtox-010814-124302; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moss ME, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00153; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rajagopalan S, 2002, CIRCULATION, V105, P2212, DOI 10.1161/01.CIR.0000015854.60710.10; Raz-Pasteur A, 2014, J RENIN-ANGIO-ALDO S, V15, P228, DOI 10.1177/1470320312467558; Rickard AJ, 2009, HYPERTENSION, V54, P537, DOI 10.1161/HYPERTENSIONAHA.109.131110; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Sun JY, 2016, ARTERIOSCL THROM VAS, V36, P874, DOI 10.1161/ATVBAHA.115.307031; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Takai S, 2005, HYPERTENSION, V46, P1135, DOI 10.1161/01.HYP.0000184640.81730.22; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	43	32	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					925	935		10.1074/jbc.M116.739243	http://dx.doi.org/10.1074/jbc.M116.739243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27881672	hybrid, Green Published			2022-12-26	WOS:000392318700014
J	Prantner, D; Perkins, DJ; Vogel, SN				Prantner, Daniel; Perkins, Darren J.; Vogel, Stefanie N.			AMP-activated Kinase (AMPK) Promotes Innate Immunity and Antiviral Defense through Modulation of Stimulator of Interferon Genes (STING) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC GMP-AMP; NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT PROTEIN-KINASE; I INTERFERON; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; AIRWAY INFLAMMATION; UPSTREAM KINASE	The host protein Stimulator of Interferon Genes (STING) has been shown to be essential for recognition of both viral and intracellular bacterial pathogens, but its regulation remains unclear. Previously, we reported that mitochondrial membrane potential regulates STING-dependent IFN-beta induction independently of ATP synthesis. Because mitochondrial membrane potential controls calcium homeostasis, and AMP-activated protein kinase (AMPK) is regulated, in part, by intracellular calcium, we postulated that AMPK participates in STING activation; however, its role has yet to be been defined. Addition of an intracellular calcium chelator or an AMPK inhibitor to either mouse macrophages or mouse embryonic fibroblasts (MEFs) suppressed IFN-beta and TNF-alpha induction following stimulation with the STING-dependent ligand 5,6-dimethyl xanthnone-4-acetic acid (DMXAA). These pharmacological findings were corroborated by showing that MEFs lacking AMPK activity also failed to up-regulate IFN-beta and TNF-alpha after treatment with DMXAA or the natural STING ligand cyclic GMP-AMP (cGAMP). As a result, AMPK-deficient MEFs exhibit impaired control of vesicular stomatitis virus (VSV), a virus sensed by STING that can cause an influenza-like illness in humans. This impairment could be overcome by pretreatment of AMPK-deficient MEFs with type I IFN, illustrating that de novo production of IFN-beta in response to VSV plays a key role in antiviral defense during infection. Loss of AMPK also led to dephosphorylation at Ser-555 of the known STING regulator, UNC-51-like kinase 1 (ULK1). However, ULK1-deficient cells responded normally to DMXAA, indicating that AMPK promotes STING-dependent signaling independent of ULK1 in mouse cells.	[Prantner, Daniel; Perkins, Darren J.; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Vogel, SN (corresponding author), 685 W Baltimore St,Rm 380, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu			National Institutes of Health [AI018797]; Ruth L. Kirschstein National Research Service Award [F32AI098167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123371, F32AI098167, R01AI018797, R56AI018797, R37AI018797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI018797 (to S. N. V.) and Ruth L. Kirschstein National Research Service Award F32AI098167 (to D. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Carroll KC, 2013, J LEUKOCYTE BIOL, V94, P1113, DOI 10.1189/jlb.0313157; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kim Young Sook, 2011, Evid Based Complement Alternat Med, V2011, P761859, DOI 10.1093/ecam/nep078; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Li L, 2014, FOOD CHEM TOXICOL, V63, P166, DOI 10.1016/j.fct.2013.08.036; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lo AKF, 2013, J PATHOL, V230, P336, DOI 10.1002/path.4201; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Nakashima K, 2011, MICROBIOL IMMUNOL, V55, P774, DOI 10.1111/j.1348-0421.2011.00382.x; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Park SJ, 2012, INFLAMM RES, V61, P1069, DOI 10.1007/s00011-012-0499-6; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; YEH LA, 1980, J BIOL CHEM, V255, P2308; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	78	49	50	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					292	304		10.1074/jbc.M116.763268	http://dx.doi.org/10.1074/jbc.M116.763268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879319	Green Published, hybrid			2022-12-26	WOS:000391578000025
J	Xing, LJ; An, Y; Shi, GS; Yan, J; Xie, PC; Qu, ZP; Zhang, ZH; Liu, ZW; Pan, DJ; Xu, Y				Xing, Lijuan; An, Yang; Shi, Guangsen; Yan, Jie; Xie, Pancheng; Qu, Zhipeng; Zhang, Zhihui; Liu, Zhiwei; Pan, Dejing; Xu, Ying			Correlated evolution between CK1 delta Protein and the Serine-rich Motif Contributes to Regulating the Mammalian Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN-KINASE-I; SLEEP PHASE SYNDROME; DROSOPHILA CLOCK; DOUBLE-TIME; CKI-EPSILON; PHOSPHORYLATION; PERIOD; MUTATION; BINDING; GENE	Understanding the mechanism underlying the physiological divergence of species is a long-standing issue in evolutionary biology. The circadian clock is a highly conserved system existing in almost all organisms that regulates a wide range of physiological and behavioral events to adapt to the day-night cycle. Here, the interactions between hCK1 epsilon/delta/DBT (Drosophila ortholog of CK1 delta/epsilon) and serine-rich (SR) motifs from hPER2 (ortholog of Drosophila per) were reconstructed in a Drosophila circadian system. The results indicated that in Drosophila, the SR mutant form hPER2(S662G) does not recapitulate the mouse or human mutant phenotype. However, introducing hCK1 delta (but not DBT) shortened the circadian period and restored the SR motif function. We found that hCK1 delta is catalytically more efficient than DBT in phosphorylating the SR motif, which demonstrates that the evolution of CK1 delta activity is required for SR motif modulation. Moreover, an abundance of phosphorylatable SR motifs and the striking emergence of putative SR motifs in vertebrate proteins were observed, which provides further evidence that the correlated evolution between kinase activity and its substrates set the stage for functional diversity in vertebrates. It is possible that such correlated evolution may serve as a biomarker associated with the adaptive benefits of diverse organisms. These results also provide a concrete example of how functional synthesis can be achieved through introducing evolutionary partners in vivo.	[Xing, Lijuan; Shi, Guangsen; Yan, Jie; Liu, Zhiwei; Pan, Dejing; Xu, Ying] Soochow Univ, Cambridge Suda Genom Resource Ctr, 199 Renai Rd, Suzhou 215123, Peoples R China; [An, Yang; Xie, Pancheng; Qu, Zhipeng; Zhang, Zhihui; Xu, Ying] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China	Soochow University - China; Nanjing University	Pan, DJ; Xu, Y (corresponding author), Soochow Univ, Cambridge Suda Genom Resource Ctr, 199 Renai Rd, Suzhou 215123, Peoples R China.; Xu, Y (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	pandejing@suda.edu.cn; yingxu@suda.edu.cn	Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; PAN, DEJING/0000-0002-4316-2849	National Science Foundation of China [31230049]; Royal Society-Newton Advanced Fellowship [NA150373]; Priority Academic Development Program of the Jiangsu Higher Education Institutions	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society-Newton Advanced Fellowship; Priority Academic Development Program of the Jiangsu Higher Education Institutions	This work was supported by grants from the National Science Foundation of China (31230049) (to Y. X), Royal Society-Newton Advanced Fellowship (NA150373) (to Y. X), and a project funded by the Priority Academic Development Program of the Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Coyle SM, 2013, CELL, V154, P875, DOI 10.1016/j.cell.2013.07.019; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Emery Patrick, 2007, Methods Mol Biol, V362, P375; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Li S., 2011, COMMUN INF SCI MANAG, V1, P1, DOI DOI 10.5812/K0WSAR.1735143X.771; Liu ZM, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/959386; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Pfeiffenberger C, 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.prot5519, DOI 10.1101/PDB.PROT5519]; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; Sekine T, 2008, J BIOL RHYTHM, V23, P3, DOI 10.1177/0748730407311652; Shi GS, 2016, CELL REP, V14, P823, DOI 10.1016/j.celrep.2015.12.076; Studer RA, 2009, TRENDS GENET, V25, P210, DOI 10.1016/j.tig.2009.03.004; Suri V, 2000, J NEUROSCI, V20, P7547; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	46	1	1	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					161	171		10.1074/jbc.M116.751214	http://dx.doi.org/10.1074/jbc.M116.751214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879317	Green Published, hybrid			2022-12-26	WOS:000391578000014
J	Zhang, Y; Agrebi, R; Bellows, LE; Collet, JF; Kaever, V; Grundling, A				Zhang, Yong; Agrebi, Rym; Bellows, Lauren E.; Collet, Jean-Francois; Kaever, Volkhard; Grundling, Angelika			Evolutionary Adaptation of the Essential tRNA Methyltransferase TrmD to the Signaling Molecule 3 ',5 '-cAMP in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADENOSINE-MONOPHOSPHATE; MULTIPLE SEQUENCE ALIGNMENTS; IV ADENYLYL-CYCLASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; THIAMINE TRIPHOSPHATASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; BINDING-SITE; ACTIVE-SITE	The nucleotide signaling molecule 3',5'-cyclic adenosine monophosphate (3',5'-cAMP) plays important physiological roles, ranging from carbon catabolite repression in bacteria to mediating the action of hormones in higher eukaryotes, including human. However, it remains unclear whether 3',5'-cAMP is universally present in the Firmicutes group of bacteria. We hypothesized that searching for proteins that bind 3',5'-cAMP might provide new insight into this question. Accordingly, we performed a genome-wide screen and identified the essential Staphylococcus aureus tRNA m(1)G37 methyltransferase enzyme TrmD, which is conserved in all three domains of life as a tight 3',5'-cAMP-binding protein. TrmD enzymes are known to use S-adenosyl-L-methionine (AdoMet) as substrate; we have shown that 3',5'-cAMP binds competitively with AdoMet to the S. aureus TrmD protein, indicating an overlapping binding site. However, the physiological relevance of this discovery remained unclear, as we were unable to identify a functional adenylate cyclase in S. aureus and only detected 2',3' -cAMP but not 3',5'-cAMP in cellular extracts. Interestingly, TrmD proteins from Escherichia coli and Mycobacterium tuberculosis, organisms known to synthesize 3',5'-cAMP, did not bind this signaling nucleotide. Comparative bioinformatics, mutagenesis, and biochemical analyses revealed that the highly conserved Tyr-86 residue in E. coli TrmD is essential to discriminate between 3',5'-cAMP and the native substrate AdoMet. Combined with a phylogenetic analysis, these results suggest that amino acids in the substrate binding pocket of TrmD underwent an adaptive evolution to accommodate the emergence of adenylate cyclases and thus the signaling molecule 3',5'-cAMP. Altogether this further indicates that S. aureus does not produce 3',5'-cAMP, which would otherwise competitively inhibit an essential enzyme.	[Zhang, Yong; Bellows, Lauren E.; Grundling, Angelika] Imperial Coll London, Sect Microbiol, London SW7 2AZ, England; [Zhang, Yong; Bellows, Lauren E.; Grundling, Angelika] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Agrebi, Rym; Collet, Jean-Francois] WELBIO, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Agrebi, Rym; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Zhang, Yong] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Imperial College London; Imperial College London; WELBIO; Universite Catholique Louvain; Hannover Medical School; University of Copenhagen	Grundling, A (corresponding author), Imperial Coll London, Sect Microbiol, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Kaever, Volkhard/G-3280-2013; ZHANG, YONG/J-3689-2019; ZHANG, YONG/H-1959-2011	ZHANG, YONG/0000-0003-2968-0081; ZHANG, YONG/0000-0003-2968-0081; Grundling, Angelika/0000-0002-6235-8687; Collet, Jean-Francois/0000-0001-8069-7036	Wellcome Trust [100289]; European Research Council [260371]; EMBO long-term fellowship [ALTF 721-2013]; MRC [MR/J006874/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 100289 and European Research Council Grant 260371 (to A. G.) and EMBO long-term fellowship ALTF 721-2013 (to Y. Z.). The authors declare that they have no conflict of interest with the contents of this article.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahre H, 2014, J CHROMATOGR B, V964, P208, DOI 10.1016/j.jchromb.2014.02.046; Bettendorff L, 2013, FEBS J, V280, P6443, DOI 10.1111/febs.12498; Bjork GR, 2003, J BACTERIOL, V185, P750, DOI 10.1128/JB.185.3.750-759.2003; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; BYSTROM AS, 1982, MOL GEN GENET, V188, P447, DOI 10.1007/BF00330047; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Cotta MA, 1998, FEMS MICROBIOL LETT, V164, P257, DOI 10.1111/j.1574-6968.1998.tb13095.x; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gonzalez-Pinzon R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001965; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; HARMAN JG, 1983, J BACTERIOL, V153, P191, DOI 10.1128/JB.153.1.191-199.1983; Hill PJ, 2013, J MED CHEM, V56, P7278, DOI 10.1021/jm400718n; Ito T, 2015, P NATL ACAD SCI USA, V112, pE4197, DOI 10.1073/pnas.1422981112; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF1160, DOI 10.1152/ajprenal.00450.2011; Jankovic I, 2007, J MOL MICROB BIOTECH, V12, P114, DOI 10.1159/000096466; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lahoud G, 2011, RNA, V17, P1236, DOI 10.1261/rna.2706011; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Linder JU, 2008, BIOCHEM J, V415, P449, DOI 10.1042/BJ20080350; MACH H, 1984, FEMS MICROBIOL LETT, V22, P27; MACH H, 1988, FEMS MICROBIOL LETT, V52, P189, DOI 10.1111/j.1574-6968.1988.tb02593.x; Makhlin J, 2007, J BACTERIOL, V189, P5976, DOI 10.1128/JB.00592-07; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Shih ACC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-63; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Taylor AB, 2008, NUCLEIC ACIDS RES, V36, P1542, DOI 10.1093/nar/gkm1172; Tellez-Sosa J, 2002, J BACTERIOL, V184, P3560, DOI 10.1128/JB.184.13.3560-3568.2002; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Van Damme T, 2014, PHYTOCHEMISTRY, V103, P59, DOI 10.1016/j.phytochem.2014.03.013; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White TA, 2004, COMP FUNCT GENOM, V5, P304, DOI 10.1002/cfg.411	54	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					313	327		10.1074/jbc.M116.758896	http://dx.doi.org/10.1074/jbc.M116.758896			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881678	hybrid, Green Published			2022-12-26	WOS:000391578000027
J	Zhang, Y; Xu, S; Liang, KY; Li, K; Zou, ZP; Yang, CL; Tan, K; Cao, X; Jiang, Y; Gao, TM; Bai, XC				Zhang, Yue; Xu, Song; Liang, Kang-yan; Li, Kai; Zou, Zhi-peng; Yang, Cui-lan; Tan, Kang; Cao, Xiong; Jiang, Yu; Gao, Tian-ming; Bai, Xiao-chun			Neuronal mTORC1 Is Required for Maintaining the Nonreactive State of Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; FIBROBLAST GROWTH FACTOR-2; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; BRAIN-INJURY; REACTIVE ASTROCYTES; SIGNALING PATHWAY; ACTIVATION; EPILEPSY; PROLIFERATION	Astrocytes respond to CNS insults through reactive astrogliosis, but the underlying mechanisms are unclear. In this study, we show that inactivation of mechanistic target of rapamycin complex (mTORC1) signaling in postnatal neurons induces reactive astrogliosis in mice. Ablation of Raptor (an mTORC1-specific component) in postmitotic neurons abolished mTORC1 activity and produced neurons with smaller soma and fewer dendrites, resulting in microcephaly and aberrant behavior in adult mice. Interestingly, extensive astrogliosis without significant astrocyte proliferation and glial scar formation was observed in these mice. The inhibition of neuronal mTORC1 may activate astrogliosis by reducing neuron-derived fibroblast growth factor 2 (FGF-2), which might trigger FGF receptor signaling in astrocytes to maintain their nonreactive state, and FGF-2 injection successfully prevented astrogliosis in Raptor knock-out mice. This study demonstrates that neuronal mTORC1 inhibits reactive astrogliosis and plays an important role in CNS pathologies.	[Zhang, Yue; Xu, Song; Bai, Xiao-chun] Southern Med Univ, Affiliated Hosp 3, Acad Orthoped, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Yue; Xu, Song; Liang, Kang-yan; Li, Kai; Zou, Zhi-peng; Yang, Cui-lan; Tan, Kang; Bai, Xiao-chun] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China; [Cao, Xiong; Gao, Tian-ming] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangzhou 510515, Guangdong, Peoples R China; [Cao, Xiong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bai, XC (corresponding author), Southern Med Univ, Affiliated Hosp 3, Acad Orthoped, Guangzhou 510515, Guangdong, Peoples R China.; Bai, XC (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China.	baixc15@smu.edu.cn		zhang, yue/0000-0002-6612-8002; Cao, Xiong/0000-0002-1889-4255	State Key Development Program for Basic Research of China [2013CB945203, 2015CB55360]; National Natural Sciences Foundation of China [U1301222, 81530070, 31600964, 81270080]; National Science Fund for Distinguished Young Scholars [81625015]; GDHVPS	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); GDHVPS	This work was supported by the State Key Development Program for Basic Research of China (Grants 2013CB945203 and 2015CB55360), National Natural Sciences Foundation of China (Grants U1301222, 81530070, 31600964, and 81270080), The National Science Fund for Distinguished Young Scholars (Grant 81625015), and GDHVPS (2011). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal A, 2014, NEURON, V83, P255, DOI 10.1016/j.neuron.2014.07.005; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chuang JH, 2013, STEM CELL RES, V11, P1117, DOI 10.1016/j.scr.2013.08.003; Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Goddard DR, 2002, J ANAT, V200, P57, DOI 10.1046/j.0021-8782.2001.00002.x; Habas A, 2013, P NATL ACAD SCI USA, V110, P18291, DOI 10.1073/pnas.1208764110; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Kang K, 2014, GLIA, V62, P1328, DOI 10.1002/glia.22684; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Kassai H, 2014, CELL REP, V7, P1626, DOI 10.1016/j.celrep.2014.04.048; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lee JH, 2015, NEURON, V85, P303, DOI 10.1016/j.neuron.2014.12.019; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; McLean JR, 2005, GLIA, V52, P59, DOI 10.1002/glia.20218; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neary Joseph T, 2006, Novartis Found Symp, V276, P131; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Nobuta H, 2012, ANN NEUROL, V72, P750, DOI 10.1002/ana.23670; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Russo E, 2012, MOL NEUROBIOL, V46, P662, DOI 10.1007/s12035-012-8314-5; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206; Zhang BL, 2006, J BIOL CHEM, V281, P905, DOI 10.1074/jbc.M503945200; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	47	14	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					100	111		10.1074/jbc.M116.744482	http://dx.doi.org/10.1074/jbc.M116.744482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895121	hybrid, Green Published			2022-12-26	WOS:000391578000009
J	Gomez-Gutierrez, P; Campos, PM; Vega, M; Perez, JJ				Gomez-Gutierrez, Patricia; Campos, Pedro M.; Vega, Miguel; Perez, Juan J.			Identification of a Novel Inhibitory Allosteric Site in p38 alpha	PLoS One			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASES; COMPLEX; SELECTIVITY; SUBSTRATE; DISEASE	In the present study, we report the discovery of a novel allosteric inhibitory site for p38 alpha, a subclass of the mitogen-activated protein kinases (MAPK) family. The putative site was discovered after inspection of the crystallographic structure of the p38 alpha-MK2 complex. MK2 (MAPK-activated protein kinase 2) is an interesting protein playing a dual role as modulator and substrate of p38 alpha. This intriguing behavior is due to the ability of the two proteins to form distinctive heterodimers when p38 alpha is phosphorylated or not. We hypothesized that the regulatory action of MK2 is due to its capability to keep p38 alpha in an inactive conformation and consequently, we investigated the atomic structure of the p38 alpha-MK2 complex to understand such regulatory behavior at the molecular level. After inspection of the complex structure, two peptides designed from the MK2 regulatory loop in contact with p38a with sequences Tyr(1)-Sere(2)-Asn(3)-His(4)-Gly(5)-Leu(6) (peptide-1) and [Phe(0)]-peptide-1 (peptide-2) in their zwitterionic form were investigated for their phosphorylation inhibitory capability in vitro. Since both peptides exhibited inhibitory capability of the p38 alpha kinase mediated phosphorylation of MEF2A, in a subsequent step we pursued the discovery of small molecule peptidomimetics. For this purpose we characterized in detail the peptide-p38 alpha interaction using molecular dynamics simulations, leading to the definition of a pharmacophore for the peptide-protein interaction. This hypothesis was used as query for a in silico screening, leading to the discovery of a fused ring compound with micromolar inhibitory activity. Site-directed mutagenesis studies support that the compound binds to the putative novel allosteric site in p38 alpha.	[Gomez-Gutierrez, Patricia; Campos, Pedro M.; Vega, Miguel] Allinky Biopharma, Madrid Sci Pk,7 Campus Cantoblanco, Madrid, Spain; [Gomez-Gutierrez, Patricia; Perez, Juan J.] Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Av Diagonal, Barcelona, Spain	Universitat Politecnica de Catalunya	Perez, JJ (corresponding author), Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Av Diagonal, Barcelona, Spain.	juan.jesus.perez@upc.edu	Campos, Pedro Manuel/AAD-3433-2020; Perez, Juan J/E-3710-2010	Campos, Pedro Manuel/0000-0002-4756-4087; Perez, Juan J/0000-0002-0748-8147				[Anonymous], MOE MOL OP ENV VERS; Bender A, 2009, J CHEM INF MODEL, V49, P108, DOI 10.1021/ci800249s; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Case DA, 2012, AMBER 12; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Gaestel M, 2009, PEPTIDES SIGNALING I; HALL HK, 1957, J AM CHEM SOC, V79, P5441, DOI 10.1021/ja01577a030; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krishna S, 2014, J CHEM INF MODEL, V54, P781, DOI 10.1021/ci5000032; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lipkus AH, 1999, J MATH CHEM, V26, P263, DOI 10.1023/A:1019154432472; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Perez JJ, 2005, CHEM SOC REV, V34, P143, DOI 10.1039/b209064n; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Tokunaga Y, 2014, NAT STRUCT MOL BIOL, V21, P704, DOI 10.1038/nsmb.2861; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Yang Y, 2011, J CHEM INF MODEL, V51, P3235, DOI 10.1021/ci200159g	30	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167379	10.1371/journal.pone.0167379	http://dx.doi.org/10.1371/journal.pone.0167379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898710	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000059
J	Subramanian, H; Doring, F; Kollert, S; Rukoyatkina, N; Sturm, J; Gambaryan, S; Stellzig-Eisenhauer, A; Meyer-Marcotty, P; Eigenthaler, M; Wischmeyer, E				Subramanian, Hariharan; Doering, Frank; Kollert, Sina; Rukoyatkina, Natalia; Sturm, Julia; Gambaryan, Stepan; Stellzig-Eisenhauer, Angelika; Meyer-Marcotty, Philipp; Eigenthaler, Martin; Wischmeyer, Erhard			PTH1R Mutants Found in Patients with Primary Failure of Tooth Eruption Disrupt G-Protein Signaling	PLOS ONE			English	Article							HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; MUTATIONS; CHONDRODYSPLASIA; RECEPTORS; CELLS	Aim Primary failure of tooth eruption (PFE) is causally linked to heterozygous mutations of the parathyroid hormone receptor (PTH1R) gene. The mutants described so far lead to exchange of amino acids or truncation of the protein that may result in structural changes of the expressed PTH1R. However, functional effects of these mutations have not been investigated yet. Materials and Methods In HEK293 cells, PTH1R wild type was co-transfected with selected PTH1R mutants identified in patients with PFE. The effects on activation of PTH-regulated intracellular signaling pathways were analyzed by ELISA and Western immunoblotting. Differential effects of wild type and mutated PTH1R on TRESK ion channel regulation were analyzed by electrophysiological recordings in Xenopus laevis oocytes. Results In HEK293 cells, activation of PTH1R wild type increases cAMP and in response activates cAMP-stimulated protein kinase as detected by phosphorylation of the vasodilator stimulated phosphoprotein (VASP). In contrast, the PTH1R mutants are functionally inactive and mutant PTH1R/Gly452Glu has a dominant negative effect on the signaling of PTH1R wild type. Confocal imaging revealed that wild type PTH1R is expressed on the cell surface, whereas PTH1R/Gly452Glu mutant is mostly retained inside the cell. Furthermore, in contrast to wild type PTH1R which substantially augmented K+ currents of TRESK channels, coupling of mutated PTH1R to TRESK channels was completely abolished. Conclusions PTH1R mutations affect intracellular PTH-regulated signaling in vitro. In patients with primary failure of tooth eruption defective signaling of PTH1R mutations is suggested to occur in dento-alveolar cells and thus may lead to impaired tooth movement.	[Subramanian, Hariharan; Rukoyatkina, Natalia; Eigenthaler, Martin] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Subramanian, Hariharan] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Doering, Frank; Kollert, Sina; Sturm, Julia; Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, AG Mol Electrophysiol, Wurzburg, Germany; [Rukoyatkina, Natalia; Gambaryan, Stepan] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Gambaryan, Stepan] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg, Russia; [Stellzig-Eisenhauer, Angelika; Meyer-Marcotty, Philipp; Eigenthaler, Martin] Univ Clin Wuerzburg, Dept Orthodont, Wurzburg, Germany; [Meyer-Marcotty, Philipp] Univ Clin Goettingen, Dept Orthodont, Gottingen, Germany	University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Saint Petersburg State University; University of Wurzburg; University of Gottingen	Eigenthaler, M (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany.; Eigenthaler, M (corresponding author), Univ Clin Wuerzburg, Dept Orthodont, Wurzburg, Germany.	M.Eigenthaler@medizin.uni-wuerzburg.de	Kollert, Sina/Q-8737-2017; Gambaryan, Stepan/I-3940-2016; meyer-marcotty, philipp/AAY-7610-2020; Rukoyatkina, Natalia/AAN-2227-2020	Gambaryan, Stepan/0000-0002-1470-0791; Doring, Frank/0000-0003-1017-1498; Rukoyatkina, Natalia/0000-0002-3920-206X	Interdisziplinares Zentrum fur Klinische Forschung des Universitatsklinikum Wurzburg [Z-4/113]; Open Access Publication Fund of the University of Wuerzburg	Interdisziplinares Zentrum fur Klinische Forschung des Universitatsklinikum Wurzburg; Open Access Publication Fund of the University of Wuerzburg	This work was supported by the Interdisziplinares Zentrum fur Klinische Forschung des Universitatsklinikum Wurzburg, grant Z-4/113. Publication was supported by the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Decker E, 2008, AM J HUM GENET, V83, P781, DOI 10.1016/j.ajhg.2008.11.006; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Doppler H, 2013, CELL ADHES MIGR, V7, P482, DOI 10.4161/cam.27351; Duchatelet S, 2005, HUM MOL GENET, V14, P1, DOI 10.1093/hmg/ddi001; Eigenthaler M, 1999, Rev Physiol Biochem Pharmacol, V135, P173, DOI 10.1007/BFb0033673; Frazier-Bowers SA, 2014, J DENT RES, V93, P134, DOI 10.1177/0022034513513588; Frazier-Bowers SA, 2009, ORTHOD CRANIOFAC RES, V12, P74, DOI 10.1111/j.1601-6343.2009.01440.x; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Hoogendam J, 2007, J CLIN ENDOCR METAB, V92, P1088, DOI 10.1210/jc.2006-0300; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; Kollert S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12548; Patterson EK, 2010, BONE, V46, P1180, DOI 10.1016/j.bone.2009.12.005; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Pilz P, 2014, J OROFAC ORTHOP, V75, P226, DOI 10.1007/s00056-014-0215-y; Prideaux M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125731; Roth H, 2014, CLIN ORAL INVEST, V18, P377, DOI 10.1007/s00784-013-1014-3; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shimomura-Kuroki J, 2016, ODONTOLOGY; Stellzig-Eisenhauer Angelika, 2013, Orthod Fr, V84, P241, DOI 10.1051/orthodfr/2013055; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Taylor CW, 2012, BIOCHEM SOC T, V40, P147, DOI 10.1042/BST20110615; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Yamaguchi T, 2011, J BONE MINER RES, V26, P1655, DOI 10.1002/jbmr.385	30	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167033	10.1371/journal.pone.0167033	http://dx.doi.org/10.1371/journal.pone.0167033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898723	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000030
J	Beauchene, C; Abaid, N; Moran, R; Diana, RA; Leonessa, A				Beauchene, Christine; Abaid, Nicole; Moran, Rosalyn; Diana, Rachel A.; Leonessa, Alexander			The Effect of Binaural Beats on Visuospatial Working Memory and Cortical Connectivity	PLOS ONE			English	Article							STEADY-STATE RESPONSES; PHASE SYNCHRONIZATION; THETA OSCILLATIONS; AUDITORY BEATS; EEG ACTIVITY; GAMMA; FREQUENCY; CORTEX; MECHANISMS; COMPONENT	Binaural beats utilize a phenomenon that occurs within the cortex when two different frequencies are presented separately to each ear. This procedure produces a third phantom binaural beat, whose frequency is equal to the difference of the two presented tones and which can be manipulated for non-invasive brain stimulation. The effects of binaural beats on working memory, the system in control of temporary retention and online organization of thoughts for successful goal directed behavior, have not been well studied. Furthermore, no studies have evaluated the effects of binaural beats on brain connectivity during working memory tasks. In this study, we determined the effects of different acoustic stimulation conditions on participant response accuracy and cortical network topology, as measured by EEG recordings, during a visuospatial working memory task. Three acoustic stimulation control conditions and three binaural beat stimulation conditions were used: None, Pure Tone, Classical Music, 5Hz binaural beats, 10Hz binaural beats, and 15Hz binaural beats. We found that listening to 15Hz binaural beats during a visuospatial working memory task not only increased the response accuracy, but also modified the strengths of the cortical networks during the task. The three auditory control conditions and the 5Hz and 10Hz binaural beats all decreased accuracy. Based on graphical network analyses, the cortical activity during 15Hz binaural beats produced networks characteristic of high information transfer with consistent connection strengths throughout the visuospatial working memory task.	[Beauchene, Christine; Leonessa, Alexander] Virginia Polytech Inst & State Univ, Dept Mech Engn, Ctr Dynam Syst Modeling & Control, Blacksburg, VA 24061 USA; [Abaid, Nicole] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Moran, Rosalyn] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Diana, Rachel A.] Virginia Polytech Inst & State Univ, Dept Psychol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Bristol; Virginia Polytechnic Institute & State University	Leonessa, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Mech Engn, Ctr Dynam Syst Modeling & Control, Blacksburg, VA 24061 USA.	aleoness@vt.edu	Diana, Rachel/B-7242-2009; Diana, Rachel/AAY-6520-2020	Diana, Rachel/0000-0002-9496-0971; Diana, Rachel/0000-0002-9496-0971; Moran, Rosalyn/0000-0002-2736-2621; Beauchene, Christine/0000-0003-0787-4520	General & Age Related Disabilities Engineering (GARDE) program through the National Science Foundation [1055315, 1604279]	General & Age Related Disabilities Engineering (GARDE) program through the National Science Foundation	The research leading to these results has received funding from the General & Age Related Disabilities Engineering (GARDE) program through the National Science Foundation (Award Numbers: 1055315 and 1604279). NSF had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based upon work performed while Alexander Leonessa was supported by (serving at) the National Science Foundation.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Babiloni C, 2004, BEHAV NEUROSCI, V118, P687, DOI 10.1037/0735-7044.118.4.687; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beauchene C., 2016, THE EFFECT OF BINAUR; Becher AK, 2015, EUR J NEUROSCI, V41, P254, DOI 10.1111/ejn.12760; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Borisyuk A, 2002, J NEUROPHYSIOL, V88, P2134, DOI 10.1152/jn.2002.88.4.2134; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Costa T, 2006, NEUROSCI LETT, V406, P159, DOI 10.1016/j.neulet.2006.06.039; Cotillon N, 2000, HEARING RES, V142, P113, DOI 10.1016/S0378-5955(00)00016-2; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Draganova R, 2008, CEREB CORTEX, V18, P1193, DOI 10.1093/cercor/bhm153; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2008, NEUROIMAGE, V43, P410, DOI 10.1016/j.neuroimage.2008.07.021; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fitzpatrick DC, 2009, JARO-J ASSOC RES OTO, V10, P579, DOI 10.1007/s10162-009-0177-8; Frederick JA., 1999, J NEUROTHERAPY, V3, P23, DOI [10.1300/J184v03n03_03, DOI 10.1300/J184V03N03_03]; Gao X, 2014, INT J PSYCHOPHYSIOL, V94, P399, DOI 10.1016/j.ijpsycho.2014.10.010; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Honey GD, 2002, NEUROIMAGE, V17, P573, DOI 10.1006/nimg.2002.1193; Ioannou CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129486; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Jutrast MJ, 2010, CURR OPIN NEUROBIOL, V20, P150, DOI 10.1016/j.conb.2010.02.006; Karino S, 2006, J NEUROPHYSIOL, V96, P1927, DOI 10.1152/jn.00859.2005; Kennerly R., 2004, J NEUROTHER, V8, P122; Kennerly RC, 1994, EMPIRICAL INVESTIGAT; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kuramoto Y., 1984, CHEM OSCILLATIONS WA, DOI [10.1007/978-3-642-69689-3, DOI 10.1007/978-3-642-69689-3]; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lane JD, 1998, PHYSIOL BEHAV, V63, P249, DOI 10.1016/S0031-9384(97)00436-8; Luan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073577; Lutzenberger W, 2002, J NEUROSCI, V22, P5630; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Moran RJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00200; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Ortiz T, 2008, ACTAS ESP PSIQUIATRI, V36, P307; OSTER G, 1973, SCI AM, V229, P94, DOI 10.1038/scientificamerican1073-94; Pastor MA, 2002, J NEUROSCIENCE, V22; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P1514, DOI 10.1016/j.clinph.2009.06.014; Ross B, 2014, J NEUROPHYSIOL, V112, P1871, DOI 10.1152/jn.00224.2014; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sato N, 2007, NEUROREPORT, V18, P419, DOI 10.1097/WNR.0b013e3280586760; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; Scott BH, 2009, J NEUROPHYSIOL, V101, P1781, DOI 10.1152/jn.00678.2007; Selesnick IW, 2002, IEEE T SIGNAL PROCES, V50, P1144, DOI 10.1109/78.995070; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spitzer MW, 1998, J NEUROPHYSIOL, V80, P3062, DOI 10.1152/jn.1998.80.6.3062; Sporns O., 2011, NETWORKS BRAIN; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Weiss S, 2000, COGNITIVE BRAIN RES, V9, P299, DOI 10.1016/S0926-6410(00)00011-2; Wu C, 2007, SYNCHRONIZATION COMP	69	37	39	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166630	10.1371/journal.pone.0166630	http://dx.doi.org/10.1371/journal.pone.0166630			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893766	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400036
J	Boeri, L; Ventimiglia, E; Capogrosso, P; Ippolito, S; Pecoraro, A; Paciotti, M; Scano, R; Galdini, A; Valsecchi, L; Papaleo, E; Montorsi, F; Salonia, A				Boeri, Luca; Ventimiglia, Eugenio; Capogrosso, Paolo; Ippolito, Silvia; Pecoraro, Angela; Paciotti, Marco; Scano, Roberta; Galdini, Alessandro; Valsecchi, Luca; Papaleo, Enrico; Montorsi, Francesco; Salonia, Andrea			Low Birth Weight Is Associated with a Decreased Overall Adult Health Status and Reproductive Capability - Results of a Cross-Sectional Study in Primary Infertile Patients	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ISCHEMIC-HEART-DISEASE; GIRLS BORN; INCREASED RISK; RETROSPECTIVE COHORT; BODY-COMPOSITION; GONADAL-FUNCTION; MEN; CANCER; APPROPRIATE	Individuals born with low birth weight (LBW) risk cardiometabolic complications later in life. However the impact of LBW on general health status and male reproductive function has been scantly analysed. We investigated the clinical and seminal impact of different birth weights (BW) in white-European men presenting for primary couple's infertility. Demographic, clinical, and laboratory data from 827 primary infertile men were compared with those of 373 consecutive fertile men. Patients with BW <= 2500, 2500-4200, and >= 4200gr were classified as having LBW, normal (NBW), and high BW (HBW), respectively. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Testicular volume was assessed with a Prader orchidometer. Semen analysis values were assessed based on 2010 WHO reference criteria. Descriptive statistics and regression models tested associations between semen parameters, clinical characteristics and BW categories. LBW, NBW and HBW were found in 71 (8.6%), 651 (78.7%) and 105 (12.7%) infertile men, respectively. LBW was more frequent in infertile patients than fertile men (p = 0.002). Infertile patients with LBW had a higher rate of comorbidities (p = 0.003), lower mean testicular volume (p = 0.007), higher FSH (p = 0.02) and lower tT levels (p = 0.04) compared to other BW groups. Higher rates of asthenozoospermia (p = 0.02) and teratozoospermia (p = 0.03) were also found in LBW men. At logistic regression models, LBW was univariably associated with pathologic progressive motility (p <= 0.02) and pathologic sperm morphology (p < 0.005). At multivariable logistic regression analysis, LBW achieved independent predictor status for both lower sperm motility and pathologic sperm morphology (all p <= 0.04). Only LBW independently predicted higher CCI values (p < 0.001). In conclusion, we found that LBW was more frequent in infertile than in fertile men. Infertile individuals with LBW showed a higher rate of comorbidities and significantly worse clinical, endocrine and semen parameters compared to other BW groups.	[Boeri, Luca; Ventimiglia, Eugenio; Capogrosso, Paolo; Ippolito, Silvia; Pecoraro, Angela; Paciotti, Marco; Scano, Roberta; Montorsi, Francesco; Salonia, Andrea] IRCCS Osped San Raffaele, URI, Div Expt Oncol, Unit Urol, Milan, Italy; [Ventimiglia, Eugenio; Capogrosso, Paolo; Montorsi, Francesco; Salonia, Andrea] Univ Vita Salute San Raffaele, Milan, Italy; [Galdini, Alessandro; Valsecchi, Luca; Papaleo, Enrico] IRCCS Osped San Raffaele, Dept Obstet & Gynaecol, Milan, Italy; [Papaleo, Enrico] IRCCS Osped San Raffaele, Infertil Unit, Unit Obstet Gynecol, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Salonia, A (corresponding author), IRCCS Osped San Raffaele, URI, Div Expt Oncol, Unit Urol, Milan, Italy.; Salonia, A (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	salonia.andrea@hsr.it	Salonia, Andrea/H-1025-2016; Boeri, Luca/AAC-4848-2022; Paciotti, Marco/AAX-4209-2021; Ippolito, Silvia/AAI-1361-2021; Pecoraro, Angela/V-4669-2019; Montorsi, Francesco/AAN-2473-2020; Ventimiglia, Eugenio/ABI-2333-2020; Papaleo, Enrico/AAN-9591-2021	Salonia, Andrea/0000-0002-0595-7165; Pecoraro, Angela/0000-0002-5184-2799; Papaleo, Enrico/0000-0003-0281-9143; Capogrosso, Paolo/0000-0003-2347-9504; Ventimiglia, Eugenio/0000-0003-3654-1629				[Anonymous], 2015, 2013 ACC AHA GUIDELI; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Chan KA, 2015, J ENDOCRINOL, V224, pR45, DOI 10.1530/JOE-14-0469; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cicognani A, 2002, J PEDIATR-US, V141, P376, DOI 10.1067/mpd.2002.126300; Eisenberg ML, 2015, FERTIL STERIL, V103, P66, DOI 10.1016/j.fertnstert.2014.10.017; Eisenberg ML, 2013, FERTIL STERIL, V100, P681, DOI 10.1016/j.fertnstert.2013.05.022; Faure C, 2015, FERTIL STERIL, V103, P6, DOI 10.1016/j.fertnstert.2014.11.027; Fisher JS, 1999, ENVIRON HEALTH PERSP, V107, P397, DOI 10.1289/ehp.99107397; Francois I, 1997, PEDIATR RES, V42, P899, DOI 10.1203/00006450-199712000-00029; Hernandez MI, 2006, J CLIN ENDOCR METAB, V91, P3377, DOI 10.1210/jc.2005-2368; Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P3391, DOI 10.1210/jc.87.7.3391; Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P1986, DOI 10.1210/jc.87.5.1986; Ibanez L, 2000, J CLIN ENDOCR METAB, V85, P2624, DOI 10.1210/jc.85.7.2624; Jensen RB, 2007, J CLIN ENDOCR METAB, V92, P1353, DOI 10.1210/jc.2006-2348; Kerkhof GF, 2009, J CLIN ENDOCR METAB, V94, P4243, DOI 10.1210/jc.2009-1036; Labayen I, 2008, OBESITY, V16, P1680, DOI 10.1038/oby.2008.258; Meas T, 2010, HUM REPROD, V25, P2354, DOI 10.1093/humrep/deq184; National Institute on Alcohol Abuse and Alcoholism, 1995, PHYS GUID HELP PAT A; Olsen J, 2000, INT J ANDROL, V23, P230, DOI 10.1046/j.1365-2605.2000.00239.x; Ozturk O, 2001, HUM REPROD, V16, P2238, DOI 10.1093/humrep/16.10.2238; Palatianou ME, 2014, HORM METAB RES, V46, P911, DOI 10.1055/s-0034-1395561; Ramlau-Hansen CH, 2010, FERTIL STERIL, V94, P610, DOI 10.1016/j.fertnstert.2009.01.142; Sadrzadeh S, 2003, HUM REPROD, V18, P2225, DOI 10.1093/humrep/deg409; Salonia A, 2009, EUR UROL, V56, P1025, DOI 10.1016/j.eururo.2009.03.001; Sharpe RM, 1998, BIOL REPROD, V59, P1084, DOI 10.1095/biolreprod59.5.1084; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; UNICEF, LOW BIRTH WEIGHT COU; Vanbillemont G, 2010, J CLIN ENDOCR METAB, V95, P1587, DOI 10.1210/jc.2009-2149; Ventimiglia E, 2015, FERTIL STERIL, V104, P48, DOI 10.1016/j.fertnstert.2015.04.020; Visentin S, 2014, ATHEROSCLEROSIS, V237, P391, DOI 10.1016/j.atherosclerosis.2014.09.027; Walsh TJ, 2010, CANCER-AM CANCER SOC, V116, P2140, DOI 10.1002/cncr.25075; Walsh TJ, 2009, ARCH INTERN MED, V169, P351, DOI 10.1001/archinternmed.2008.562; World Health Organization, 2010, LAB MAN EX PROC HUM; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166728	10.1371/journal.pone.0166728	http://dx.doi.org/10.1371/journal.pone.0166728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893825	Green Published, gold			2022-12-26	WOS:000389472400040
J	Liu, N; Wang, Z; Gan, WD; Xiong, L; Miao, BL; Chen, XC; Guo, HQ; Li, DM				Liu, Ning; Wang, Zhen; Gan, Weidong; Xiong, Lei; Miao, Baolei; Chen, Xiancheng; Guo, Hongqian; Li, Dongmei			Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E3; SOFT PART SARCOMA; BREAK-APART FISH; CLINICOPATHOLOGICAL FEATURES; TFE3; IMMUNOHISTOCHEMISTRY; EXPERIENCE; DIAGNOSIS; IMPACT; ADULTS	To investigate the clinical characteristics, treatments and prognosis of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions (Xp11.2 tRCC), the epidemiological features and treatment results of 34 cases of Xp11.2 tRCC, which were diagnosed by immunohistochemistry staining of TFE3 and fluorescence in situ hybridization at our center, were retrospectively reviewed. The 34 patients included 21 females and 13 males aged 3 to 64 years (median age: 27 years). Four patients were children or adolescents (<18 years of age), and 26 patients were young or middle-aged adults (18-45 years). Radical nephrectomy was performed on 25 patients. Laparoscopic nephron-sparing surgery was performed on 9 patients who presented with an isolated mass with a small diameter (<7 cm) and well-defined boundary on computed tomography imaging. Postoperative staging showed that 25 cases (73.53%) were at stage I/II, while 9 cases (26.47%) were at stage III/IV. All stage I/II patients received a favorable prognosis with a three-year overall survival rate of 100%, including the patients who underwent laparoscopic nephron-sparing surgery. With the exception of 2 children, the other 7 stage III/IV patients died or developed recurrence with a median follow-up of 29 months. On univariate analysis, maximum diameter, adjuvant treatment, TNM stage, lymph node metastasis, inferior vena cava tumor thrombosis and tumor boundary were identified as statistically significant factors impacting survival (P<0.05). Multivariate analysis indicated that TNM stage and inferior vena cava tumor thrombosis were independent prognostic factors (P<0.05). In conclusion, Xp11.2 tRCC is a rare subtype of renal cell carcinoma that mainly occurs in young females. Nephron-sparing surgery was confirmed effective preliminarily in the treatment of small Xp11.2 tRCCs with clear rims. Advanced TNM stage and inferior vena cava tumor thrombosis were associated with poor prognosis.	[Liu, Ning; Wang, Zhen; Gan, Weidong; Xiong, Lei; Miao, Baolei; Chen, Xiancheng; Guo, Hongqian] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Gan, WD (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	gwd@nju.edu.cn; lidm@nju.edu.cn	冬梅, 李/AHI-8180-2022	冬梅, 李/0000-0003-3819-355X; Liu, Ning/0000-0002-7283-7294	National Natural Science Foundation of China [81572512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (ID:81572512). The website of the program is http://www.nsfcngov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2005, AM J SURG PATHOL, V29, P230, DOI 10.1097/01.pas.0000146007.54092.37; Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Carini M, 2006, J UROLOGY, V175, P2022, DOI 10.1016/S0022-5347(06)00275-8; Chen Xiancheng, 2014, Zhonghua Yi Xue Za Zhi, V94, P3675; CHEN XZ, 2015, MEDICINE, V94, DOI DOI 10.1097/MD; Cheng XM, 2015, INT J CLIN EXP PATHO, V8, P5403; Choueiri TK, 2010, CANCER-AM CANCER SOC, V116, P5219, DOI 10.1002/cncr.25512; Chowdhury T, 2013, J PEDIAT HEMATOL ONC, V35, pE1, DOI 10.1097/MPH.0b013e318266bf34; Eble JN, 2004, PATHOLOGY GENETICS T; Ellis CL, 2014, MODERN PATHOL, V27, P875, DOI 10.1038/modpathol.2013.208; Gaillot-Durand L, 2013, PATHOL RES PRACT, V209, P83, DOI 10.1016/j.prp.2012.10.013; Geller JI, 2008, CANCER-AM CANCER SOC, V112, P1607, DOI 10.1002/cncr.23331; Geller JI, 2004, CANCER-AM CANCER SOC, V101, P1575, DOI 10.1002/cncr.20548; Gorin MA, 2015, CLIN GENITOURIN CANC, V13, pE199, DOI 10.1016/j.clgc.2014.12.008; Green WM, 2013, AM J SURG PATHOL, V37, P1150, DOI 10.1097/PAS.0b013e31828a69ae; He J, 2015, FUTURE ONCOL, V11, P3243, DOI 10.2217/fon.15.177; Hirobe M, 2016, INT J UROL, V23, P140, DOI 10.1111/iju.13007; Hodge JC, 2014, MODERN PATHOL, V27, P113, DOI 10.1038/modpathol.2013.83; Klatte T, 2012, AM J CLIN PATHOL, V137, P761, DOI 10.1309/AJCPQ6LLFMC4OXGC; Komai Y, 2009, CLIN CANCER RES, V15, P1170, DOI 10.1158/1078-0432.CCR-08-1183; Kuroda N, 2012, HISTOL HISTOPATHOL, V27, P133, DOI 10.14670/HH-27.133; Lim B, 2015, KOREAN J UROL, V56, P212, DOI 10.4111/kju.2015.56.3.212; Malouf GG, 2010, ANN ONCOL, V21, P1834, DOI 10.1093/annonc/mdq029; Malouf GG, 2011, J UROLOGY, V185, P24, DOI 10.1016/j.juro.2010.08.092; Minervini Andrea, 2009, Arch Ital Urol Androl, V81, P65; Nelius T, 2011, CASE REP MED, V2011, DOI 10.1155/2011/432917; Nesbitt JC, 1997, ANN THORAC SURG, V63, P1592, DOI 10.1016/S0003-4975(97)00329-9; Qu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21677; Ramphal R, 2006, AM J CLIN PATHOL, V126, P349, DOI 10.1309/98YE9E442ARLX2X; Rao Q, 2013, AM J SURG PATHOL, V37, P804, DOI 10.1097/PAS.0b013e31827e17cb; Rao Q, 2010, INT J SURG PATHOL, V18, P458, DOI 10.1177/1066896910375565; Reuter VE., 2016, WHO CLASSIFICATION T; Song HC, 2014, J PEDIATR SURG, V49, P539, DOI 10.1016/j.jpedsurg.2013.10.005; Sukov WR, 2012, AM J SURG PATHOL, V36, P663, DOI 10.1097/PAS.0b013e31824dd972	36	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166897	10.1371/journal.pone.0166897	http://dx.doi.org/10.1371/journal.pone.0166897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893792	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400053
J	Perwitasari, O; Johnson, S; Yan, XZ; Register, E; Crabtree, J; Gabbard, J; Howerth, E; Shacham, S; Carlson, R; Tamir, S; Tripp, RA				Perwitasari, Olivia; Johnson, Scott; Yan, Xiuzhen; Register, Emery; Crabtree, Jackelyn; Gabbard, Jon; Howerth, Elizabeth; Shacham, Sharon; Carlson, Robert; Tamir, Sharon; Tripp, Ralph A.			Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NUCLEAR EXPORT SIGNAL; CRM1; PROTEIN; INHIBITOR; MORTALITY; VITRO	Influenza A virus (IAV) causes seasonal epidemics of respiratory illness that can cause mild to severe illness and potentially death. Antiviral drugs are an important countermeasure against IAV; however, drug resistance has developed, thus new therapeutic approaches are being sought. Previously, we demonstrated the antiviral activity of a novel nuclear export inhibitor drug, verdinexor, to reduce influenza replication in vitro and pulmonary virus burden in mice. In this study, in vivo efficacy of verdinexor was further evaluated in two animal models or influenza virus infection, mice and ferrets. In mice, verdinexor was efficacious to limit virus shedding, reduce pulmonary pro-inflammatory cytokine expression, and moderate leukocyte infiltration into the bronchoalveolar space. Similarly, verdinexor-treated ferrets had reduced lung pathology, virus burden, and inflammatory cytokine expression in the nasal wash exudate. These findings support the anti-viral efficacy of verdinexor, and warrant its development as a novel antiviral therapeutic for influenza infection.	[Perwitasari, Olivia; Johnson, Scott; Yan, Xiuzhen; Register, Emery; Crabtree, Jackelyn; Gabbard, Jon; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Howerth, Elizabeth] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Shacham, Sharon; Carlson, Robert; Tamir, Sharon] Karyopharm Therapeut, Newton, MA USA; [Gabbard, Jon] Univ Louisville, Ctr Predict Med, Louisville, KY 40292 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Louisville	Tripp, RA (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA.	ratripp@uga.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700006C]; Georgia Research Alliance	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance	This study is supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (HHSN266200700006C), and funding from the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2012, GASTROENTEROLOGY; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Boltz DA, 2010, DRUGS, V70, P1349, DOI 10.2165/11537960-000000000-00000; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Freundt EC, 2009, J VIROL, V83, P6631, DOI 10.1128/JVI.00367-09; Kuruvilla J, 2013, 55 ANN M AM SOC HEM; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Loregian A, 2014, CELL MOL LIFE SCI, V71, P3659, DOI 10.1007/s00018-014-1615-2; Mau-Sorensen M, 2013, GASTR CANC S JAN 24; McKimm-Breschkin Jennifer L, 2005, Treat Respir Med, V4, P107, DOI 10.2165/00151829-200504020-00004; Monto AS, 2003, VACCINE, V21, P1796, DOI 10.1016/S0264-410X(03)00075-6; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanchez V, 2007, J VIROL, V81, P11730, DOI 10.1128/JVI.02760-06; Savona M, 2013, 55 ANN M AM SOC HEM; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Szretter KJ, 2005, CURRENT PROTOCOLS MI; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	29	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167221	10.1371/journal.pone.0167221	http://dx.doi.org/10.1371/journal.pone.0167221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893810	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400103
J	Nozaki, H; Ueki, N; Isaka, N; Saigo, T; Yamamoto, K; Matsuzaki, R; Takahashi, F; Wakabayashi, K; Kawachi, M				Nozaki, Hisayoshi; Ueki, Noriko; Isaka, Nanako; Saigo, Tokiko; Yamamoto, Kayoko; Matsuzaki, Ryo; Takahashi, Fumio; Wakabayashi, Ken-ichi; Kawachi, Masanobu			A New Morphological Type of Volvox from Japanese Large Lakes and Recent Divergence of this Type and V-ferrisii in Two Different Freshwater Habitats	PLOS ONE			English	Article							SEXUAL REPRODUCTION; VOLVOCALES; CHLOROPHYCEAE; RADIATION; EVOLUTION; ORIGIN	Volvox sect. Volvox is characterized by having unique morphological characteristics, such as thick cytoplasmic bridges between adult somatic cells in the spheroids and spiny zygote walls. Species of this section are found from various freshwater habitats. Recently, three species of Volvox sect. Volvox originating from rice paddies and a marsh were studied taxonomically based on molecular and morphological data of cultured materials. However, taxonomic studies have not been performed on cultured materials of this section originating from large lake water bodies. We studied a new morphological type of Volvox sect. Volvox ("Volvox sp. Sagami), using cultured materials originating from two large lakes and a pond in Japan. Volvox sp. Sagami produced monoecious sexual spheroids and may represent a new morphological species; it could be clearly distinguished from all previously described monoecious species of Volvox sect. Volvox by its small number of eggs or zygotes (5-25) in sexual spheroids, with short acute spines (up to 3 mu m long) on the zygote walls and elongated anterior somatic cells in asexual spheroids. Based on sequences of internal transcribed spacer (ITS) regions of nuclear ribosomal DNA (rDNA; ITS-1, 5.8S rDNA and ITS-2) and plastid genes, however, the Volvox sp. Sagami lineage and its sister lineage (the monoecious species V. ferrisii) showed very small genetic differences, which correspond to the variation within a single biological species in other volvocalean algae. Since V. ferrisii was different from Volvox sp. Sagami, by having approximately 100-200 zygotes in the sexual spheroids and long spines (6-8.5 mu m long) on the zygote walls, as well as growing in Japanese rice paddies, these two morphologically distinct lineages might have diverged rapidly in the two different freshwater habitats. In addition, the swimming velocity during phototaxis of Volvox sp. Sagami spheroids originating from large lakes was significantly higher than that of V. ferrisii originating from rice paddies, suggesting adaptation of Volvox sp. Sagami to large water bodies.	[Nozaki, Hisayoshi; Isaka, Nanako; Saigo, Tokiko; Yamamoto, Kayoko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ueki, Noriko; Wakabayashi, Ken-ichi] Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Yokohama, Kanagawa 2268503, Japan; [Matsuzaki, Ryo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga 5258577, Japan	University of Tokyo; Tokyo Institute of Technology; National Institute for Environmental Studies - Japan; Ritsumeikan University	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Wakabayashi, Ken-ichi/AAI-8617-2021; Wakabayashi, Ken-ichi/D-2440-2015	Wakabayashi, Ken-ichi/0000-0002-1025-9249; Nozaki, Hisayoshi/0000-0002-9308-4498; Matsuzaki, Ryo/0000-0002-8989-5933	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [25304012, 15K14580, 15H01314]; Grants-in-Aid for Scientific Research [25304012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HN and KW were supported by Grants-in-Aid for Scientific Research (grant numbers 25304012, 15K14580 and 15H01314) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annenkova NV, 2015, ISME J, V9, P1821, DOI 10.1038/ismej.2014.267; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Arii S, 2015, APPL ENVIRON MICROB, V81, P2667, DOI 10.1128/AEM.03729-14; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hamaji T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057177; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; Iyengar MOP, 1981, VOLVOCALES; Kato S, 2008, PHYCOLOGIA, V47, P191, DOI 10.2216/07-27.1; Kirk DL., 1998, VOLVOX MOL GENETIC O; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2002, MOL PHYLOGENET EVOL, V23, P326, DOI 10.1016/S1055-7903(02)00030-1; NOZAKI H, 1983, BOT MAG TOKYO, V96, P103, DOI 10.1007/BF02491095; NOZAKI H, 1988, PHYCOLOGIA, V27, P209, DOI 10.2216/i0031-8884-27-2-209.1; Nozaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142632; Nozaki H, 2015, PHYCOLOGIA, V54, P316, DOI 10.2216/15-14.1; Pringsheim E.G., 1946, PURE CULTURES ALGAE; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Solari CA, 2008, J PHYCOL, V44, P1395, DOI 10.1111/j.1529-8817.2008.00603.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wakabayashi K, 2011, P NATL ACAD SCI USA, V108, P11280, DOI 10.1073/pnas.1100592108	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							0167148	10.1371/journal.pone.0167148	http://dx.doi.org/10.1371/journal.pone.0167148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880842	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500072
J	Wang, Y; Tang, Q; Zhu, LW; Huang, RY; Huang, L; Koleini, M; Zou, DQ				Wang, Yan; Tang, Qiang; Zhu, Luwen; Huang, Ruyi; Huang, Lei; Koleini, Melanie; Zou, Dequan			Effects of Treatment of Treadmill Combined with Electro-Acupuncture on Tibia Bone Mass and Substance PExpression of Rabbits with Sciatic Nerve Injury	PLOS ONE			English	Article							IMMUNOREACTIVE NERVES; NEURAL INVOLVEMENT; SPINAL-CORD; EXERCISE; REGENERATION; STRENGTH; FRACTURE; REINNERVATION; RESISTANCE; REFLEX	The peripheral nervous system may play an important role in normal bone maintenance and remodeling. Substance P (SP) is a neuropeptide associated with bone loss and formation that may mediate the effects of the nervous system. The purpose of this study is to determine if treadmill running combined with electro-acupuncture at Jiaji acupoints (Jiaji-EA) affects tibial bone mass and SP expression in rabbits with sciatic nerve injury. Twenty-four juvenile male New Zealand white rabbits were randomly assigned to one of 4 groups: sham injury control (sham), sciatic never crush control (SNCr), treadmill running (treadmill), and Jiaji-EA combined with treadmill running (ET group). The SNCr, treadmill, and ET groups all had an induced sciatic never crush injury of approximately 2mm. Control groups received no intervention; the treadmill and ET groups were trained by treadmill; the ET group also received Jiaji-EA. After the 4 weeks of treatment, toe-spreading index (TSI), BMD, bone strength, and SP expression in the tibia were significantly lower in the nerve injury groups (SNCr, treadmill, and ET) compared to the sham groups (p < 0.05). Treatment (treadmill and ET groups) increased all measures compared to the SNCr group (p < 0.05). Further, TSI, BMD, bone strength, and SP expression in the ET group were higher than the treadmill group (p < 0.05). Our results indicate that treadmill therapy combined with electro-acupuncture at Jiaji acupoints prevents bone loss in rabbit tibias after sciatic nerve injury. This may occur in two ways: indirectly in association with axon regeneration and directly via loading on the bone mediated through increased SP expression. This study provides important evidence for the clinical treatment of bone loss after peripheral nerve injury.	[Wang, Yan; Tang, Qiang; Zhu, Luwen] Heilongjiang Univ Chinese Med, Affiliated Hosp 2, Harbin, Peoples R China; [Wang, Yan; Tang, Qiang; Zhu, Luwen; Huang, Ruyi; Huang, Lei] Heilongjiang Univ Chinese Med, Harbin, Peoples R China; [Koleini, Melanie] Washington Univ, Sch Med, HRPO, St Louis, MO USA; [Zou, Dequan] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA	Heilongjiang University of Chinese Medicine; Heilongjiang University of Chinese Medicine; Washington University (WUSTL); Washington University (WUSTL)	Wang, Y (corresponding author), Heilongjiang Univ Chinese Med, Affiliated Hosp 2, Harbin, Peoples R China.; Wang, Y (corresponding author), Heilongjiang Univ Chinese Med, Harbin, Peoples R China.	swallow-1113@163.com			Fund of Innovative Talents of the Heilongjiang University of Chinese Medicine [051290]; Administration Office of Heilongjiang Postdoctoral Program [LBH-Z13202]	Fund of Innovative Talents of the Heilongjiang University of Chinese Medicine; Administration Office of Heilongjiang Postdoctoral Program	This study was supported by the Fund of Innovative Talents of the Heilongjiang University of Chinese Medicine (grant number 051290). Additional funding for this study was provided by a postdoctoral research award from the Administration Office of Heilongjiang Postdoctoral Program (grant number LBH-Z13202).; This study was supported by the Fund of Innovative Talents of the Heilongjiang University of Chinese Medicine (grant number 051290). Additional funding for this study was provided by a postdoctoral research award from the Administration Office of Heilongjiang Postdoctoral Program (grant number LBH-Z13202). We also thank Dr. Zhongping Xu in surgical department of Washington University School of Medicine. The authors have approved the manuscript for publication and vouch for the completeness and accuracy of the data.	Apel PJ, 2009, J BONE JOINT SURG AM, V91A, P2886, DOI 10.2106/JBJS.H.01878; Asensio-Pinilla E, 2009, EXP NEUROL, V219, P258, DOI 10.1016/j.expneurol.2009.05.034; Bailey D. A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P335; BARENGOLTS EI, 1993, J BONE MINER RES, V8, P937; BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X; BOURRIN S, 1995, J BONE MINER RES, V10, P1745; de Bruin ED, 2005, SPINAL CORD, V43, P96, DOI 10.1038/sj.sc.3101685; DEMEDINACELI L, 1988, EXP NEUROL, V100, P166, DOI 10.1016/0014-4886(88)90209-9; Ding WG, 2010, REGUL PEPTIDES, V159, P28, DOI 10.1016/j.regpep.2009.11.004; Elziere L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097736; Forwood MR, 2008, J APPL PHYSIOL, V105, P334, DOI 10.1152/japplphysiol.00040.2008; Fuchs RK, 2007, BONE, V41, P290, DOI 10.1016/j.bone.2007.04.179; Goto T, 2007, NEUROPEPTIDES, V41, P25, DOI 10.1016/j.npep.2006.11.002; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Greenaway JB, 2001, J AM ANIM HOSP ASSOC, V37, P27, DOI 10.5326/15473317-37-1-27; Gunjigake KK, 2006, ACTA HISTOCHEM CYTOC, V39, P69, DOI 10.1267/ahc.05057; Gutmann E, 1942, J NEUROL PSYCHIATRY, V5, P81, DOI 10.1136/jnnp.5.3-4.81; He HT, 2010, J ORAL MAXIL SURG, V68, P2047, DOI 10.1016/j.joms.2010.02.016; Huang GF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/386012; Huang TH, 2003, J APPL PHYSIOL, V95, P300, DOI 10.1152/japplphysiol.01076.2002; Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7; HUKKANEN M, 1993, NEUROSCIENCE, V54, P969, DOI 10.1016/0306-4522(93)90588-7; HUKKANEN M, 1995, CLIN ORTHOP RELAT R, P247; HUKKANEN M, 1992, J RHEUMATOL, V19, P1252; Iwamoto J, 2005, EXP ANIM TOKYO, V54, P1, DOI 10.1538/expanim.54.1; Iwamoto J, 2004, J BONE MINER METAB, V22, P26, DOI 10.1007/s00774-003-0443-5; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Kerr D, 2001, J BONE MINER RES, V16, P175, DOI 10.1359/jbmr.2001.16.1.175; Kingery WS, 2003, BONE, V33, P927, DOI 10.1016/j.bone.2003.07.003; Lee H, 2007, NEUROL RES, V29, pS49, DOI 10.1179/016164107X172211; Li WJ, 2010, NEUROSCI RES, V67, P307, DOI 10.1016/j.neures.2010.04.012; Li XC, 2008, CAN ASSOC RADIOL J, V59, P123; Madsen JE, 1996, BONE, V18, P411, DOI 10.1016/8756-3282(96)00027-0; MCCARTHY RN, 1992, RES VET SCI, V52, P28, DOI 10.1016/0034-5288(92)90054-6; Nagata K, 2014, J CONTROL RELEASE, V183, P27, DOI 10.1016/j.jconrel.2014.03.021; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Niedermair T, 2014, MATRIX BIOL, V38, P22, DOI 10.1016/j.matbio.2014.06.007; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Notomi T, 2000, EUR J APPL PHYSIOL, V83, P469, DOI 10.1007/s004210000316; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Rude RK, 2006, OSTEOPOROSIS INT, V17, P1022, DOI 10.1007/s00198-006-0104-3; SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P579; Schaakxs D, 2017, J TISSUE ENG REGEN M, V11, P812, DOI 10.1002/term.1980; Schmitz HC, 2001, LAB ANIM-UK, V35, P340, DOI 10.1258/0023677011911930; Shih C, 1997, PEPTIDES, V18, P323, DOI 10.1016/S0196-9781(96)00280-X; Starnes JW, 2013, EXP GERONTOL, V48, P751, DOI 10.1016/j.exger.2013.04.007; Tos P, 2013, INT REV NEUROBIOL, V109, P165, DOI 10.1016/B978-0-12-420045-6.00008-0; Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480; Valero-Cabre A, 2001, BRAIN RES, V919, P302, DOI 10.1016/S0006-8993(01)03052-9; Varsegova TN, 2015, STRATEG TRAUMA LIMB, V10, P87, DOI 10.1007/s11751-015-0227-1; Wang Y, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0034-4; Welch JM, 2004, J APPL PHYSIOL, V97, P1859, DOI 10.1152/japplphysiol.00438.2004; Yamasaki T, 2015, MAGN RESON IMAGING, V33, P95, DOI 10.1016/j.mri.2014.09.005; Zhang DY, 2009, ARTIF CELL BLOOD SUB, V37, P85, DOI 10.1080/10731190902743149	55	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0164652	10.1371/journal.pone.0164652	http://dx.doi.org/10.1371/journal.pone.0164652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880769	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500005
J	He, ZW; Zhan, M; Liu, SA; Fang, ZB; Yao, CG				He, Zhiwei; Zhan, Meng; Liu, Shuai; Fang, Zebo; Yao, Chenggui			An Algorithm for Finding the Singleton Attractors and Pre-Images in Strong-Inhibition Boolean Networks	PLOS ONE			English	Article							P53 PATHWAY; MODEL; CYCLE; EXPRESSION; EVOLUTION; SIMULATION; STATES; GENES	The detection of the singleton attractors is of great significance for the systematic study of genetic regulatory network. In this paper, we design an algorithm to compute the singleton attractors and pre-images of the strong-inhibition Boolean networks which is a biophysically plausible gene model. Our algorithm can not only identify accurately the singleton attractors, but also find easily the pre-images of the network. Based on extensive computational experiments, we show that the computational time of the algorithm is proportional to the number of the singleton attractors, which indicates the algorithm has much advantage in finding the singleton attractors for the networks with high average degree and less inhibitory interactions. Our algorithm may shed light on understanding the function and structure of the strong-inhibition Boolean networks.	[He, Zhiwei; Yao, Chenggui] Shaoxing Univ, Dept Math, Shaoxing, Peoples R China; [Zhan, Meng] Huazhong Univ Sci & Technol, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China; [Liu, Shuai] Northwest A&F Univ, Coll Sci, Yangling, Peoples R China; [Fang, Zebo] Shaoxing Univ, Dept Phys, Shaoxing, Peoples R China	Shaoxing University; Huazhong University of Science & Technology; Northwest A&F University - China; Shaoxing University	Yao, CG (corresponding author), Shaoxing Univ, Dept Math, Shaoxing, Peoples R China.	yaochenggui@usx.edu.cn	Zhan, Meng/A-9926-2008; yao, chenggui/B-5379-2011	Zhan, Meng/0000-0002-2331-2002; Yao, Chenggui/0000-0002-0897-362X	Natural Science Foundation of Zhejiang Province [LY16A050001, LY15A04001]; National Natural Science Foundation of China [11675112, 11475253, 11605142, 51272159]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported partially by Natural Science Foundation of Zhejiang Province under Grant Nos. LY16A050001 (CY) and LY15A04001 (ZF), the National Natural Science Foundation of China under Grant Nos. 11675112 (CY), 11475253 (MZ), 11605142 (SL) and 51272159 (ZF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu, 1998, Genome Inform Ser Workshop Genome Inform, V9, P151; Akutsu Tatsuya, 2009, Information and Media Technologies, V4, P338; Akutsu T, 2011, J COMPUT BIOL, V18, P1275, DOI 10.1089/cmb.2010.0281; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U., 2006, INTRO SYSTEM BIOL DE; Ay F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007992; Bornholdt S, 2000, PHYS REV LETT, V84, P6114, DOI 10.1103/PhysRevLett.84.6114; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Cai XD, 2009, J COMPUT BIOL, V16, P917, DOI 10.1089/cmb.2008.0231; Chaos A, 2006, J PLANT GROWTH REGUL, V25, P278, DOI 10.1007/s00344-006-0068-8; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Devloo V, 2003, B MATH BIOL, V65, P1025, DOI 10.1016/S0092-8240(03)00061-2; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fortuna MA, 2007, J THEOR BIOL, V247, P331, DOI 10.1016/j.jtbi.2007.03.017; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goodwin B. C, 1963, TEMPORAL ORG CELLS D, DOI [10.5962/bhl.title.6268, DOI 10.5962/BHL.TITLE.6268]; Huang S, 1999, J MOL MED-JMM, V77, P469, DOI 10.1007/s001099900023; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Kauffman S.A., 1993, ORIGINS ORDER SELF O, DOI [10.1007/978-94-015-8054-0_8, DOI 10.1007/978-94-015-8054-0_8]; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klotz JG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S10-S4; Lane DP, 1999, BRIT J CANCER, V80, P1; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Melkman AA, 2013, J COMPUT BIOL, V20, P958, DOI 10.1089/cmb.2013.0060; Melkman AA, 2010, INFORM PROCESS LETT, V110, P565, DOI 10.1016/j.ipl.2010.05.001; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Michele L, 2006, J STAT MECH-THEORY E, V2006; Milano M, 2000, LECT NOTES ARTIF INT, V1792, P72; Nicolis G, 1977, SELF ORG NONEQUILIBR; Ning T, 2006, J THEOR BIOL, V240, P592, DOI 10.1016/j.jtbi.2005.10.019; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; RIGOUTSOS I, 2007, SYSTEMS BIOL, V2; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Tamura T, 2009, MATH COMPUT SCI, V2, P401, DOI 10.1007/s11786-008-0063-5; Tamyura T, 2007, INT S FUND COMP THEO, P494; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Wang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040330; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Wuensche A., 1994, ART LIF 3 P SANT FE; Wuensche A., 1992, GLOBAL DYNAMICS CELL; Xia QZ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083002; Yang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057009; Zhang SQ, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/20180; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009; Zheng D, 2013, GENET MOL RES, V12, P4656, DOI 10.4238/2013.October.18.4; Zheng DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060593; Zou YM, 2013, 2013 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING (CME), P670, DOI 10.1109/ICCME.2013.6548334	57	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166906	10.1371/journal.pone.0166906	http://dx.doi.org/10.1371/journal.pone.0166906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861624	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300131
J	Jonard, M; Ducloy-Bouthors, AS; Fourrieri, F				Jonard, Marie; Ducloy-Bouthors, Anne Sophie; Fourrieri, Francois			Comparison of Two Diagnostic Scores of Disseminated Intravascular Coagulation in Pregnant Women Admitted to the ICU	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; SCORING SYSTEM; POSTPARTUM HEMORRHAGE; HEMOSTASIS; THROMBOSIS	Objective To compare the validity of two previously published diagnostic scores of disseminated intravascular coagulation (DIC) in pregnant women admitted to ICU for an acute thrombotic or hemorrhagic complication of delivery and postpartum. Methods This was a population based retrospective study of 154 patients admitted to ICU for severe delivery and postpartum complications in a University Hospital. A recently published score (adapted to physiological changes of pregnancy and based on three components: platelet count, prothrombin time difference and fibrinogen) was compared to the International Society for Thrombosis and Hemostasis (ISTH) score (based on four components: platelet count, fibrinogen, prothrombin time, and fibrin related marker). Both scores were calculated at delivery, ICU admission (day 0), day 1 and day 2 during the postpartum ICU stay. The validity of both scores was assessed by comparison with the consensual and blinded analysis of two experts. The sensitivity, specificity, and area under the curve (AUC) of each score were calculated at each time and overall by generalized linear mixed model. The agreement between the two scores was evaluated by the Kappa coefficient. Results The new score had a sensitivity of 0.78, a specificity of 0.97 (p < 0.01) and a global AUC of 96% while the ISTH score had a sensitivity of 0.31, a specificity of 0.99 and an AUC of 94% (p < 0.01). The Kappa coefficient of correlation between both scores was 0.35. The lower sensitivity of the ISTH score was mainly explained by the lack of fibrinogen and fibrin-related peptides thresholds adapted to the physiological changes of coagulation induced by pregnancy. Conclusion The new DIC score seem highly discriminant in the subset of patients admitted to the ICU after delivery for an acute specific complication. The ISTH score is not recommended in pregnant women because of its poor sensitivity.	[Jonard, Marie] Ctr Hosp Reg Univ, Lens & Ctr Hosp Roger Salengro, Ctr Hosp Dr Schaffner, Dept Intens Care Unit, Lille, France; [Ducloy-Bouthors, Anne Sophie] Ctr Hosp Reg Univ, Dept Obstet Anesthesia, Lille, France; [Fourrieri, Francois] Ctr Hosp Reg Univ, Ctr Hosp Roger Salengro, Dept Intens Care Unit, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Jonard, M (corresponding author), Ctr Hosp Reg Univ, Lens & Ctr Hosp Roger Salengro, Ctr Hosp Dr Schaffner, Dept Intens Care Unit, Lille, France.	marie.jonard@wanadoo.fr	Ducloy-Bouthors, Anne-Sophie/N-4891-2016					Angstwurm MWA, 2006, CRIT CARE MED, V34, P314, DOI 10.1097/01.CCM.0000196832.27501.B2; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x; Collins PW, 2014, BLOOD, V124, P1727, DOI 10.1182/blood-2014-04-567891; Collis RE, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12913; Ducloy-Bouthors A-S, 2010, Ann Fr Anesth Reanim, V29, pe121, DOI 10.1016/j.annfar.2010.03.012; Erez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093240; Fourrier F, 2002, REANIMATION, V11, P341; Francalanci I, 1997, INT J CLIN LAB RES, V27, P65, DOI 10.1007/BF02827245; Levi M, 2011, BLOOD REV, V25, P33, DOI 10.1016/j.blre.2010.09.002; O'Riordan MN, 2003, BEST PRACT RES CL OB, V17, P385, DOI 10.1016/S1521-6934(03)00019-1; Rattray DD, 2012, J OBSTET GYNAECOL CA, V34, P341, DOI 10.1016/S1701-2163(16)35214-8; Szecsi PB, 2010, THROMB HAEMOSTASIS, V103, P718, DOI [10.1160/TH09-10-0704, DOI 10.1160/TH09-10-07074]; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Terao T, 1987, Asia Oceania J Obstet Gynaecol, V13, P1; Thachil J, 2009, BLOOD REV, V23, P167, DOI 10.1016/j.blre.2009.04.002; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; VANWERSCH JWJ, 1991, EUR J CLIN CHEM CLIN, V29, P45; Windsperger K, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.025	20	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166471	10.1371/journal.pone.0166471	http://dx.doi.org/10.1371/journal.pone.0166471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861597	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300061
J	Tabora, LC; Escalante, R				Tabara, Luis-Carlos; Escalante, Ricardo			VMP1 Establishes ER-Microdomains that Regulate Membrane Contact Sites and Autophagy	PLOS ONE			English	Article							MAMMALIAN ATG PROTEINS; ENDOPLASMIC-RETICULUM; DICTYOSTELIUM-DISCOIDEUM; LIPID DROPLETS; BIOGENESIS; MITOCHONDRIA; SECRETION; CELLS; VACUOLE-MEMBRANE-PROTEIN-1; ORGANIZATION	The endoplasmic reticulum (ER) regulates organelle dynamics through the formation of membrane contact sites (MCS). Here we describe that VMP1, a multispanning ER-resident protein involved in autophagy, is enriched in ER micro-domains that are in close proximity to diverse organelles in HeLa and Cos-7 cells. These VMP1 puncta are highly dynamic, moving in concert with lipid droplets, mitochondria and endosomes. Some of these micro-domains are associated with ER sliding events and also with fission events of mitochondria and endosomes. VMP1-depleted cells display increased ER-mitochondria MCS and altered mitochondria morphology demonstrating a role in the regulation of MCS. Additional defects in ER structure and lipid droplets size and distribution are consistent with a more general function of VMP1 in membrane remodeling and organelle function. We hypothesize that in autophagy VMP1 is required for the correct morphogenesis of the omegasome by regulating MCS at the site of autophagosome formation.	[Tabara, Luis-Carlos; Escalante, Ricardo] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Escalante, R (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain.	rescalante@iib.uam.es	Tabara, Luis Carlos/AAI-3989-2021; Escalante, Ricardo/G-8272-2015	Escalante, Ricardo/0000-0001-8547-531X; Tabara Rodriguez, Luis Carlos/0000-0001-7684-3811	MINECO/FEDER [BFU2012-32536, BFU2015-64440-P]; Spanish Ministerio de Educacion, Cultura y Deporte	MINECO/FEDER; Spanish Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This work was supported by MINECO/FEDER, grants BFU2012-32536, BFU2015-64440-P. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants BFU2012-32536, BFU2015-64440-P (MINECO/FEDER). L.C.T. was recipient of a FPU fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte. We thank the IIBM's microscopy facility and CBM's TEM facility for technical support. Tim23 Ab was kindly provided by Patricia Boya. We thank Rosa Calvo, Eunice Dominguez and Olivier Vincent for useful comments and corrections.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Biazik J, 2015, AUTOPHAGY, V11, P439, DOI 10.1080/15548627.2015.1017178; Calvo-Garrido J, 2008, MOL BIOL CELL, V19, P3442, DOI 10.1091/mbc.E08-01-0075; Calvo-Garrido J, 2008, AUTOPHAGY, V4, P835, DOI 10.4161/auto.6574; Calvo-Garrido J, 2014, TRAFFIC, V15, P1235, DOI 10.1111/tra.12210; Calvo-Garrido J, 2010, AUTOPHAGY, V6, P100, DOI 10.4161/auto.6.1.10697; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Eden ER, 2016, BBA-MOL CELL BIOL L, V1861, P874, DOI 10.1016/j.bbalip.2016.01.020; Ge L, 2014, AUTOPHAGY, V10, P170, DOI 10.4161/auto.26787; Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Grippa A, 2015, J CELL BIOL, V211, P829, DOI 10.1083/jcb.201502070; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi-Nishino M, 2010, AUTOPHAGY, V6, P301, DOI 10.4161/auto.6.2.11134; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Puri C, 2014, AUTOPHAGY, V10, P182, DOI 10.4161/auto.27174; Rabouille C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-213; Sanchez-Wandelmer J, 2015, J CELL SCI, V128, P185, DOI 10.1242/jcs.158758; Shpilka T, 2015, EMBO J, V34, P2117, DOI 10.15252/embj.201490315; Starkuviene V, 2004, GENOME RES, V14, P1948, DOI 10.1101/gr.2658304; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tenenboim H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-121; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Uemura T, 2014, MOL CELL BIOL, V34, P1695, DOI 10.1128/MCB.01327-13; van der Vaart A, 2010, AUTOPHAGY, V6, P800, DOI 10.1091/mbc.E09-04-0345; Velazquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Wang PW, 2011, PLANT J, V66, P613, DOI 10.1111/j.1365-313X.2011.04522.x; Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501; Wilson MI, 2014, BIOCHEM SOC T, V42, P1327, DOI 10.1042/BST20140177; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962	43	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166499	10.1371/journal.pone.0166499	http://dx.doi.org/10.1371/journal.pone.0166499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861594	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300065
J	Almquist, ZW; Bagozzi, BE				Almquist, Zack W.; Bagozzi, Benjamin E.			The Spatial Properties of Radical Environmental Organizations in the UK: Do or Die!	PLOS ONE			English	Article							NETWORKS; DIFFUSION; EMERGENCE; MODELS	Radical environmental groups and their members have a wide and varied agenda which often encompasses both local and global issues. In their efforts to call attention to environmental problems, communicate with like-minded groups, and mobilize support for their activities, radical environmental organizations also produce an enormous amount of text, which can be used to estimate the complex communications and task-based networks that underlie these organizations. Moreover, the tactics employed to garnish attention for these groups' agenda can range from peaceful activities such as information dissemination to violent activities such as fire-bombing buildings. To obtain these varied objectives, radical environmental organizations must harness their networks, which have an important spatial component that structures their ability to communicate, coordinate and act on any given agenda item. Here, we analyze a network built from communications and information provided by the semi-annual "Do or Die" (DoD) magazine published in the UK over a 10 year period in the late 1990s and early 2000s. We first employ structural topic model methods to discover violent and nonviolent actors within the larger environmental community. Using this designation, we then compare the spatial structure of these groups, finding that violent groups are especially likely to engage in coordination and/or communication if they are sufficiently close, but exhibit a quickly decreasing probability of interaction over even a few kilometers. Further, violent and nonviolent groups each have a higher probability of coordination with their own group than across groups over even short distances. In these respects, we see that violent groups are especially local in their organization and that their geographic reach is likely very limited. This suggests that nonviolent environmental groups seek each other out over both large and short distances for communication and coordination, but violent groups tend to be highly localized.	[Almquist, Zack W.] Univ Minnesota, Sch Stat, Dept Sociol, St Paul, MN USA; [Almquist, Zack W.] Univ Minnesota, MPC, St Paul, MN USA; [Bagozzi, Benjamin E.] Univ Delaware, Dept Polit Sci & Int Relat, Newark, DE USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Delaware	Almquist, ZW (corresponding author), Univ Minnesota, Sch Stat, Dept Sociol, St Paul, MN USA.; Almquist, ZW (corresponding author), Univ Minnesota, MPC, St Paul, MN USA.	almquist@umn.edu		Almquist, Zack/0000-0002-1967-123X	Army Research Office [W911NF-14-1-0577]	Army Research Office	This work was supported by Army Research Office, Young Investigator Program, Award #W911NF-14-1-0577 (http://www.arl.army. mil/www/default.ctm?page=29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman GA, 2003, TERROR POLIT VIOLENC, V15, P143, DOI 10.1080/09546550390449935; Almquist ZW, 2015, GEOGR ANAL, V47, P50, DOI 10.1111/gean.12045; Almquist ZW, 2012, SOC NETWORKS, V34, P493, DOI 10.1016/j.socnet.2012.03.002; Almquist ZW, 2012, DEMOGR RES, V26, P593, DOI 10.4054/DemRes.2012.26.22; Almquist ZW, 2015, WORKING PAPER; [Anonymous], 1999, STUDIES CONFLICT TER, DOI 10.1080/105761099265748; Ansell Ch, 2003, SOCIAL MOVEMENTS NET; Asal V, 2008, J POLIT, V70, P437, DOI 10.1017/S0022381608080419; Backstrom L., 2010, PROCEEDINGS OF THE 1, P61, DOI [10.1145/1772690.1772698, DOI 10.1145/1772690.1772698]; Beaumont J, 2007, ENVIRON PLANN A, V39, P29; BLAU PM, 1977, AM J SOCIOL, V83, P26, DOI 10.1086/226505; Boessen A, 2014, AM J COMMUN PSYCHOL, V53, P447, DOI 10.1007/s10464-014-9639-1; Bossard JHS, 1932, AM J SOCIOL, V38, P219, DOI 10.1086/216031; Burris V., 2000, SOCIOL FOCUS, V33, DOI https://doi.org/10.1080/00380237.2000.10571166; Butts C. T., 2002, THESIS; Butts C.T., 2011, SAGE HDB GIS SOC RES, P222, DOI DOI 10.4135/9781446201046.N12; Butts CT, 2012, SOC NETWORKS, V34, P82, DOI 10.1016/j.socnet.2011.08.003; Butts CT, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P313; Caspi D, 2010, THESIS; Chalecki EL, 2002, GLOBAL ENVIRON POLIT, V2, P103, DOI [DOI 10.1162/152638002317261463, 10.1162/152638002317261463]; Chermak S, 2013, STUD CONFL TERROR, V36, P193, DOI 10.1080/1057610X.2013.755912; Cunningham D, 2003, SOC SCI HIST, V27, P327, DOI 10.1215/01455532-27-3-327; Fafchamps M, 2010, J EUR ECON ASSOC, V8, P203, DOI 10.1162/jeea.2010.8.1.203; Festinger L., 1950, SOCIAL PRESSURES INF; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1988, J SOC BIOL STRUCT, V11, P415, DOI 10.1016/0140-1750(88)90080-2; Gerstenfeld P.B., 2003, ANAL SOCIAL ISSUES P, V3, DOI [DOI 10.1111/J.1530-2415.2003.00013.X, https://doi.org/10.1111/j.1530-2415.2003.00013.x]; GOULD RV, 1991, AM SOCIOL REV, V56, P716, DOI 10.2307/2096251; Hagerstrand T., 1966, PAP REG SCI ASS, V16, P27, DOI [10.1007/BF01888934, DOI 10.1007/BF01888934]; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Haynes KE, 1984, SCI GEOGRAPHY, V2; HEDSTROM P, 1994, AM J SOCIOL, V99, P1157, DOI 10.1086/230408; Henry AD, 2011, P NATL ACAD SCI USA, V108, P8605, DOI 10.1073/pnas.1014486108; Hipp JR, 2009, CITY COMMUNITY, V8, P5, DOI 10.1111/j.1540-6040.2009.01267.x; Ho P, 2001, DEV CHANGE, V32, P893, DOI 10.1111/1467-7660.00231; Horowitz MC, 2010, INT ORGAN, V64, P33, DOI 10.1017/S0020818309990233; Joosse P, 2007, TERROR POLIT VIOLENC, V19, P351, DOI 10.1080/09546550701424042; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kenney M., 2007, PABLO OSAMA TRAFFICK; Kousis M, 1999, ENV MOVEMENTLOCAL, P149; Krivitsky P. N., 2008, J STAT SOFTWARE, V24; LATANE B, 1994, BEHAV SCI, V39, P1, DOI 10.1002/bs.3830390102; Leader SH, 2003, TERROR POLIT VIOLENC, V15, P37, DOI 10.1080/09546550390449872; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Marx GT, 2003, J SOC ISSUES, V59, P369, DOI 10.1111/1540-4560.00069; MCADAM D, 1986, AM J SOCIOL, V92, P64, DOI 10.1086/228463; MCPHERSON JM, 1991, SOC FORCES, V70, P19, DOI 10.2307/2580060; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Medina R, 2008, STUD GLOB JUSTICE, V4, P151; Medina RM, 2011, T GIS, V15, P577, DOI 10.1111/j.1467-9671.2011.001281.x; Moon IC, 2007, IEEE INTELL SYST, V22, P40, DOI 10.1109/MIS.2007.4338493; Perry B, 2009, INF COMMUN TECHNOL L, V18, P185, DOI 10.1080/13600830902814984; Pianta M, 2001, PARALLEL SUMMITS GLO; Plows A, 2001, EARTH LIBERATION FRO; Plows A., 2004, SOC MOVEMENT STUD, V3, P199, DOI 10.1080/1474283042000266128; Posner RA, 2008, U CHICAGO LAW REV, V75, P245; Raab J, 2003, J PUBL ADM RES THEOR, V13, P413, DOI 10.1093/jopart/mug029; Ramana P., 2011, MEASURES DEAL LEFT W; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Rootes C, 1997, TECHNOLOGY ENV US, P30; Rydgren J, 2005, EUR J POLIT RES, V44, P413, DOI 10.1111/j.1475-6765.2005.00233.x; Sageman M, 2004, UNDERSTANDING TERROR NETWORKS, P1; Saunders Clare, 2007, GRADUATE J SOCIAL SC, V1, P109; Schlosberg David., 1999, ENVIRON POLIT, V6, P122, DOI [10.1080/09644019908414441, DOI 10.1080/09644019908414441]; Smith B.L., 2009, CRIMINOL PUBLIC POL, V8, P475, DOI 10.1111/j.1745-9133.2009.00571.x; Smith BL, GEOSPATIAL ANAL TERR; Smith E. J., 2014, J GERONTOL B-PSYCHOL, V70, P91, DOI DOI 10.1093/GER0NB/GBU142; Spiro ES., 2016, SOCIUS, V2, P1, DOI DOI 10.1177/2378023116634340; Wall D., 1999, ENVIRON POLIT, V8, P81, DOI DOI 10.1080/; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zanini M, 2001, NETWORKS NETWARDS FU	72	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166609	10.1371/journal.pone.0166609	http://dx.doi.org/10.1371/journal.pone.0166609			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898689	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000013
J	Arensman, E; Bennardi, M; Larkin, C; Wall, A; McAuliffe, C; McCarthy, J; Williamson, E; Perry, IJ				Arensman, Ella; Bennardi, Marco; Larkin, Celine; Wall, Amanda; McAuliffe, Carmel; McCarthy, Jacklyn; Williamson, Eileen; Perry, Ivan J.			Suicide among Young People and Adults in Ireland: Method Characteristics, Toxicological Analysis and Substance Abuse Histories Compared	PLOS ONE			English	Article							GENDER-DIFFERENCES; BINGE DRINKING; AGED 15-24; ALCOHOL; ACCESS; BEHAVIORS; MORTALITY; PATTERNS; ISSUES; CHOICE	Objective Information on factors associated with suicide among young individuals in Ireland is limited. The aim of this study was to identify socio-demographic characteristics and circumstances of death associated with age among individuals who died by suicide. Methods The study examined 121 consecutive suicides (2007-2012) occurring in the southern eastern part of Ireland (Cork city and county). Data were obtained from coroners, family informants, and health care professionals. A comparison was made between 15-24-year-old and 25-34-year-old individuals. Socio-demographic characteristics of the deceased, methods of suicide, history of alcohol and drug abuse, and findings from toxicological analysis of blood and urine samples taken at post mortem were included. Pearson's chi(2) tests and binary logistic regression analysis were performed. Results Alcohol and/or drugs were detected through toxicological analysis for the majority of the total sample (79.5%), which did not differentiate between 15-24-year-old and 25-34-year-old individuals (74.1% and 86.2% respectively). Compared to 25-34-year-old individuals, 15-24-year-old individuals were more likely to engage in suicide by hanging (88.5%). Younger individuals were less likely to die by intentional drug overdose and carbon monoxide poisoning compared to older individuals. Younger individuals who died between Saturday and Monday were more likely to have had alcohol before dying. Substance abuse histories were similar in the two age groups. Conclusion Based on this research it is recommended that strategies to reduce substance abuse be applied among 25-34-year-old individuals at risk of suicide. The wide use of hanging in young people should be taken into consideration for future means restriction strategies.	[Arensman, Ella; Bennardi, Marco; Larkin, Celine; Wall, Amanda; McCarthy, Jacklyn; Williamson, Eileen] Univ Coll Cork, Natl Suicide Res Fdn, Cork, Ireland; [Arensman, Ella; Perry, Ivan J.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [McAuliffe, Carmel] St Patricks Mental Hlth Serv, Cork, Ireland	University College Cork; University College Cork	Bennardi, M (corresponding author), Univ Coll Cork, Natl Suicide Res Fdn, Cork, Ireland.	marco.bennardi@gmail.com	Bennardi, Marco/ABC-4493-2020	Bennardi, Marco/0000-0001-8934-5416; Arensman, Ella/0000-0003-0376-1203; Larkin, Celine/0000-0003-2961-0585; Perry, Ivan/0000-0002-4965-9792	National Office for Suicide Prevention; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 [316795]; EU	National Office for Suicide Prevention; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7; EU(European Commission)	The first phase of the Suicide Support and Information System (September 2008 - March 2011) was funded by the National Office for Suicide Prevention. The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007 2013 under REA grant agreement no 316795.; We would like to thank Dr. Carla Sabariego and Prof. Alarcos Cieza for their helpful suggestions provided at the meeting 'Scientific Paper Reviews' that was offered in the scope of the EU-funded project MARATONE.	Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; [Anonymous], 2011, IBM SPSS STAT WINDOW; Arensman E., 2013, 2 REPORT SUICIDE SUP; Arensman E, 2012, 1 REPORT SUICIDE SUP; Arnett J. J, 2014, ADOLESCENCE EMERGING; Aseltine RH, 2009, J AM ACAD CHILD PSY, V48, P262, DOI 10.1097/CHI.0b013e318195bce8; Baca-Garcia E, 2001, J CLIN PSYCHIAT; Barnes LS, 2001, SUICIDE LIFE-THREAT, V32, P68, DOI 10.1521/suli.32.1.5.68.24217; Bedford D, 2006, Ir Med J, V99, P80; Biddle L, 2006, BRIT J GEN PRACT, V56, P924; Biddle L, 2012, J AFFECT DISORDERS, V136, P702, DOI 10.1016/j.jad.2011.10.004; Biddle L, 2010, BRIT J PSYCHIAT, V197, P320, DOI 10.1192/bjp.bp.109.076349; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bowers L, 2010, J NERV MENT DIS, V198, P315, DOI 10.1097/NMD.0b013e3181da47e2; Callanan VJ, 2012, SOC PSYCH PSYCH EPID, V47, P857, DOI 10.1007/s00127-011-0393-5; Cantor CH, 1998, AUST NZ J PSYCHIAT, V32, P8, DOI 10.3109/00048679809062700; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Cherpitel CJ, 2004, ALCOHOL CLIN EXP RES, V28, p18S, DOI 10.1097/01.ALC.0000127411.61634.14; Conner KR, 2011, SUICIDE LIFE-THREAT, V41, P594, DOI 10.1111/j.1943-278X.2011.00057.x; Conwell Y, 2002, AM J GERIAT PSYCHIAT, V10, P407, DOI 10.1176/appi.ajgp.10.4.407; Corcoran P, 2015, INT J EPIDEMIOL; Davoren MP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006045; Economic UNDo, 2007, WORLD YOUTH REP 2007; Elnour AA, 2008, INJURY PREV, V14, P39, DOI 10.1136/ip.2007.016246; FARMER R, 1980, ACTA PSYCHIAT SCAND, V62, P436, DOI 10.1111/j.1600-0447.1980.tb00632.x; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Health-Service-Executive N-S-R-G Department-of-Health-and-Children, 2005, REACH OUT IR NAT STR; Hingson R., 2004, SOCIAL HLTH EC CONSE; Houston K, 2001, J AFFECT DISORDERS, V63, P159, DOI 10.1016/S0165-0327(00)00175-0; Kanchan T, 2009, J FORENSIC SCI, V54, P938, DOI 10.1111/j.1556-4029.2009.01054.x; KAPLAN MS, 1994, GERONTOLOGIST, V34, P59, DOI 10.1093/geront/34.1.59; Kuntsche E, 2006, ADDICT BEHAV, V31, P1844, DOI 10.1016/j.addbeh.2005.12.028; Kuntsche E, 2012, DRUG ALCOHOL DEPEN, V124, P319, DOI 10.1016/j.drugalcdep.2012.02.001; Lin J-J, 2010, BMC PUBLIC HEALTH, V10, P1; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Long J., 2014, ALCOHOL CONSUMPTION; Mahay J, 2007, J FAM ISSUES, V28, P706, DOI 10.1177/0192513X06297272; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Owens C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5801; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Pirkis J, 2001, Crisis, V22, P155, DOI 10.1027//0227-5910.22.4.155; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; Pompili M, 2010, INT J ENV RES PUB HE, V7, P1392, DOI 10.3390/ijerph7041392; ROSENBERG ML, 1988, J FORENSIC SCI, V33, P1445; Samaritans T., 2002, MEDIA GUIDELINES POR; Schaffer M, 2008, ARCH SUICIDE RES, V12, P124, DOI 10.1080/13811110701857111; Skibin L, 2005, FORENSIC SCI INT, V147, pS49, DOI 10.1016/j.forsciint.2004.09.083; Snider JE, 2006, SUICIDE LIFE-THREAT, V36, P511, DOI 10.1521/suli.2006.36.5.511; SOUTH SJ, 1993, J MARRIAGE FAM, V55, P357, DOI 10.2307/352807; Stack Steven, 2005, Arch Suicide Res, V9, P57, DOI 10.1080/13811110590512949; Uzun Ibrahim, 2007, J Forensic Leg Med, V14, P406, DOI 10.1016/j.jflm.2007.01.002; Varnik A, 2009, J AFFECT DISORDERS, V113, P216, DOI 10.1016/j.jad.2008.06.004; Walsh B, 2011, ECON SOC REV, V42, P27; World Health Organization, 2008, PREV SUIC RES MED PR; World-Health-Organization, 2014, PREV SUIC GLOB IMP; Wulfert E, 2002, J PERS, V70, P533	57	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166881	10.1371/journal.pone.0166881	http://dx.doi.org/10.1371/journal.pone.0166881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898722	Green Published, gold			2022-12-26	WOS:000389474000020
J	Brandl, C; Breinlich, V; Stark, KJ; Enzinger, S; Assenmacher, M; Olden, M; Grassmann, F; Graw, J; Heier, M; Peters, A; Helbig, H; Kuchenhoff, H; Weber, BHF; Heid, IM				Brandl, Caroline; Breinlich, Valentin; Stark, Klaus J.; Enzinger, Sabrina; Assenmacher, Matthias; Olden, Matthias; Grassmann, Felix; Graw, Jochen; Heier, Margit; Peters, Annette; Helbig, Horst; Kuechenhoff, Helmut; Weber, Bernhard H. F.; Heid, Iris M.			Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LONG-TERM INCIDENCE; SEVERITY SCALE; EYE DISEASE; 10-YEAR INCIDENCE; CATARACT-SURGERY; POOLED FINDINGS; PREVALENCE; MACULOPATHY; CLASSIFICATION	Age-related macular degeneration (AMD) is a vision impairing disease of the central retina characterized by early and late forms in individuals older than 50 years of age. However, there is little knowledge to what extent also younger adults are affected. We have thus set out to estimate the prevalence of early AMD features and late AMD in a general adult population by acquiring color fundus images in 2,840 individuals aged 25 to 74 years of the Cooperative Health Research in the Region of Augsburg project (KORA) in South Germany. Among the 2,546 participants with gradable images for each eye, 10.9% (n = 277) had early AMD features (applying the 9-step Age-Related Eye Disease Study Severity Scale), 0.2% (n = 6) had late AMD. Prevalence increased with age, reaching 26.3% for early AMD features and 1.9% for late AMD at the age 70+. However, signs of early AMD were found in subjects as young as 25 years, with the risk for early AMD features increasing linearly by years of age in men, and, less consistent with a linear increase, in women. Risk for early AMD features increased linearly by pack years of smoking in men, not in women, nor was there any association with other lifestyle or metabolic factors. By providing much sought-after prevalence estimates for AMD from Central Europe, our data underscores a substantial proportion of the adult population with signs of early AMD, including individuals younger than 50 years. This supports the notion that early AMD features in the young might be under-acknowledged.	[Brandl, Caroline; Stark, Klaus J.; Olden, Matthias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Brandl, Caroline; Helbig, Horst] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Brandl, Caroline; Breinlich, Valentin; Grassmann, Felix; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Enzinger, Sabrina; Assenmacher, Matthias; Kuechenhoff, Helmut] Ludwig Maximilians Univ Munchen, Stat Consulting Unit, StaBLab, Dept Stat, Munich, Germany; [Graw, Jochen] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Heier, Margit; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Heid, Iris M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany.; Heid, IM (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany.	iris.heid@klinik.uni-regensburg.de	Heier, Margit/AAT-5280-2020; Stark, Klaus/L-7367-2013; Peters, Annette/A-6117-2011	Stark, Klaus/0000-0002-7832-1942; Peters, Annette/0000-0001-6645-0985; Graw, Jochen/0000-0003-0298-9660; Kuchenhoff, Helmut/0000-0002-6372-2487; Grassmann, Felix/0000-0003-1390-7528; Brandl, Caroline/0000-0001-8223-6137; Assenmacher, Matthias/0000-0003-2154-5774; Weber, Bernhard H.F./0000-0002-8808-7723	German Federal Ministry of Education and Research (BMBF) [01ER1206, 01ER1507]; Helmholtz Zentrum Munchen German Research Center for Environmental Health; State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	The analytical work in this study is supported in part by grants from the German Federal Ministry of Education and Research (BMBF 01ER1206 and 01ER1507) to I.M.H. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Akuffo KO, 2015, BRIT J OPHTHALMOL, V99, P1037, DOI 10.1136/bjophthalmol-2014-305768; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Buitendijk GHS, 2013, OPHTHALMOLOGY, V120, P2644, DOI 10.1016/j.ophtha.2013.07.053; BUTLER JS, 1987, REV ECON STAT, V69, P644, DOI 10.2307/1935959; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090973; Cugati S, 2006, OPHTHALMOLOGY, V113, P2020, DOI 10.1016/j.ophtha.2006.05.047; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Erke MG, 2014, ACTA OPHTHALMOL, V92, P662, DOI 10.1111/aos.12346; Erke MG, 2012, OPHTHALMOLOGY, V119, P1737, DOI 10.1016/j.ophtha.2012.03.016; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kaarniranta K, 2015, CURR EYE RES, V40, P226, DOI 10.3109/02713683.2014.925933; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Kim YJ, 2004, J R STAT SOC B, V66, P337, DOI 10.1046/j.1369-7412.2003.05316.x; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2014, OPHTHAL EPIDEMIOL, V21, P14, DOI 10.3109/09286586.2013.867512; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Korb CA, 2014, GRAEF ARCH CLIN EXP, V252, P1403, DOI 10.1007/s00417-014-2591-9; La TY, 2014, CURR EYE RES, V39, P1232, DOI 10.3109/02713683.2014.907431; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Meisinger C, 2005, DIABETOLOGIA, V48, P27, DOI 10.1007/s00125-004-1604-3; Neuner B, 2009, ADDICT BEHAV, V34, P938, DOI 10.1016/j.addbeh.2009.05.015; Risk factors associated with age-related macular degeneration, 2000, OPHTHALMOLOGY, P107; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2011, NEW ENGL J MED, V364, P1966, DOI 10.1056/NEJMe1103334; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Stratmann B, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-90; Tan JSL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1089, DOI 10.1001/archopht.125.8.1089; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; van Leeuwen R, 2003, EUR J EPIDEMIOL, V18, P845, DOI 10.1023/A:1025643303914; Velilla S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/895147; Vitale S, 2016, JAMA OPHTHALMOL, V134, P1041, DOI 10.1001/jamaophthalmol.2016.2383; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wang JJ, 2012, OPHTHALMOLOGY, V119, P2298, DOI 10.1016/j.ophtha.2012.07.003; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkler G, 1998, Z ERNAHRUNGSWISS, V37, P234, DOI 10.1007/s003940050022; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Wolfram C, 2012, WEISSBUCH SITUATION; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2006, AUST NZ J STAT, V48, P445, DOI 10.1111/j.1467-842X.2006.00450.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Ying GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1147, DOI 10.1001/archophthalmol.2009.189; YOUNG RW, 1988, SURV OPHTHALMOL, V32, P252, DOI 10.1016/0039-6257(88)90174-9; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645	61	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167181	10.1371/journal.pone.0167181	http://dx.doi.org/10.1371/journal.pone.0167181			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893849	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000389472400096
J	Horn, HG; Sander, N; Stuhr, A; Alguero-Muniz, M; Bach, LT; Loder, MGJ; Boersma, M; Riebesell, U; Aberle, N				Horn, Henriette G.; Sander, Nils; Stuhr, Annegret; Alguero-Muniz, Maria; Bach, Lennart T.; Loder, Martin G. J.; Boersma, Maarten; Riebesell, Ulf; Aberle, Nicole			Low CO2 Sensitivity of Microzooplankton Communities in the Gullmar Fjord, Skagerrak: Evidence from a Long-Term Mesocosm Study	PLOS ONE			English	Article							OCEAN ACIDIFICATION; GRAZING IMPACT; PHYTOPLANKTON GROWTH; ELEVATED CO2; HIGH PH; MARINE; PLANKTON; CARBON; TEMPERATURE; DYNAMICS	Ocean acidification is considered as a crucial stressor for marine communities. In this study, we tested the effects of the IPCC RPC6.0 end-of-century acidification scenario on a natural plankton community in the Gullmar Fjord, Sweden, during a long-term mesocosm experiment from a spring bloom to a mid-summer situation. The focus of this study was on microzooplankton and its interactions with phytoplankton and mesozooplankton. The microzooplankton community was dominated by ciliates, especially small Strombidium sp., with the exception of the last days when heterotrophic dinoflagellates increased in abundance. We did not observe any effects of high CO2 on the community composition and diversity of microzooplankton. While ciliate abundance, biomass and growth rate were not affected by elevated CO2, we observed a positive effect of elevated CO2 on dinoflagellate abundances. Additionally, growth rates of dinoflagellates were significantly higher in the high CO2 treatments. Given the higher Chlorophyll a content measured under high CO2, our results point at mainly indirect effects of CO2 on microzooplankton caused by changes in phytoplankton standing stocks, in this case most likely an increase in small-sized phytoplankton of <8 mu m. Overall, the results from the present study covering the most important part of the growing season indicate that coastal microzooplankton communities are rather robust towards realistic acidification scenarios.	[Horn, Henriette G.; Sander, Nils; Alguero-Muniz, Maria; Boersma, Maarten; Aberle, Nicole] Biolog Anstalt Helgoland, Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Helgoland, Germany; [Stuhr, Annegret; Bach, Lennart T.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Loder, Martin G. J.] Univ Bayreuth, Anim Ecol 1, Bayreuth, Germany; [Boersma, Maarten] Univ Bremen, Bremen, Germany; [Aberle, Nicole] NTNU Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bayreuth; University of Bremen; Norwegian University of Science & Technology (NTNU)	Horn, HG (corresponding author), Biolog Anstalt Helgoland, Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Helgoland, Germany.	henriette.horn@awi.de	Aberle, Nicole/C-7366-2014; Algueró-Muñiz, María/AAA-9748-2020; Löder, Martin G. J./HDM-8961-2022; Riebesell, Ulf/AAC-9717-2020; Boersma, Maarten/A-5475-2013; Horn, Henriette G./R-7667-2016	Aberle, Nicole/0000-0003-3254-5710; Algueró-Muñiz, María/0000-0001-8064-6212; Boersma, Maarten/0000-0003-1010-026X; Horn, Henriette G./0000-0002-4020-5559; Bach, Lennart/0000-0003-0202-3671; Riebesell, Ulf/0000-0002-9442-452X	German Federal Ministry of Education and Science (BMBF) [WP 1.6 (03F0655B)]; Swedish Academy of Sciences	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Swedish Academy of Sciences	This study is part of the German Federal Ministry of Education and Science (BMBF) funded "Verbundprojekt" BIOACID Phase II (Biological Impacts of Ocean ACIDification), consortium 1, WP 1.6 (03F0655B) and received funding from the Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is part of the German Federal Ministry of Science and Education (BMBF) funded "Verbundprojekt" BIOACID Phase II (Biological Impacts of Ocean ACIDification), consortium 1, WP 1.6 (03F0655B) and received funding from the Swedish Academy of Sciences. We gratefully acknowledge the Sven Loven Centre for Marine Sciences, University of Gothenburg, for accommodation and on-site logistic support. We also thank the captain and crew of R/V Alkor for assistance during transport, deployment and recovery of the mesocosms. The Kristineberg KOSMOS 2013 Consortium is acknowledged for the help with mesocosm maintenance and sampling. S. Peters, K. Carstens and S. Ohse are additionally acknowledged for their technical support and S. Frickenhaus for assistance with statistical analysis.	Aberle N, 2007, OECOLOGIA, V150, P668, DOI 10.1007/s00442-006-0540-y; Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; Aberle N, 2012, MAR BIOL, V159, P2441, DOI 10.1007/s00227-012-1947-0; Bach LT, PLOS ONE; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Calbet A, 2005, AQUAT MICROB ECOL, V38, P157, DOI 10.3354/ame038157; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Calbet A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094388; Calliari D, 2009, ESTUAR COAST SHELF S, V85, P107, DOI 10.1016/j.ecss.2009.06.016; Carey P.G, 1992, MARINE INTERSTITIAL; Caron DA, 2013, J PLANKTON RES, V35, P235, DOI 10.1093/plankt/fbs091; Ciais P, 2013, COMP GEOM-THEOR APPL; De Figueiredo GM, 2007, J MAR BIOL ASSOC UK, V87, P843, DOI 10.1017/S002531540705713X; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hansen PJ, 1999, J EUKARYOT MICROBIOL, V46, P382, DOI 10.1111/j.1550-7408.1999.tb04617.x; Havenhand JN, 2012, AMBIO, V41, P637, DOI 10.1007/s13280-012-0326-x; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HINGA KR, 1992, MAR ECOL PROG SER, V86, P181, DOI 10.3354/meps086181; Hoppenrath M., 2009, SCHWEIZERBART SCHE V; Horn HG, 2016, ICES J MAR SCI, V73, P772, DOI 10.1093/icesjms/fsv198; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jansen S, 2008, HELGOLAND MAR RES, V62, P251, DOI 10.1007/s10152-008-0113-z; JONSSON PR, 1986, MAR ECOL PROG SER, V33, P265, DOI 10.3354/meps033265; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kraberg A.C., 2010, COASTAL PHYTOPLANKTO; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; LANDRY MR, 1995, MAR ECOL PROG SER, V120, P53, DOI 10.3354/meps120053; Lauritano C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1574-5; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lischka S., 2015, BIOGEOSCIENCES DISCU, V12, P20025, DOI [10.5194/bgd-12-20025-2015, DOI 10.5194/BGD-12-20025-2015]; Loder MGJ, 2011, MAR BIOL, V158, P1551, DOI 10.1007/s00227-011-1670-2; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Low-Decarie E, 2014, TRENDS ECOL EVOL, V29, P223, DOI 10.1016/j.tree.2014.02.006; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Meunier CL, 2016, MAR FRESHW RES; Montagnes DJS, 1999, AQUAT MICROB ECOL, V20, P167, DOI 10.3354/ame020167; Montagnes DJS, 2001, THE PLANKTONIC CILIA; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Pedersen MF, 2003, MAR ECOL PROG SER, V260, P19; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P5619, DOI 10.5194/bg-10-5619-2013; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Salih FM., 2011, J ENV PROT SCI, V2, P648, DOI DOI 10.4236/jep.2011.25074; SCHNACK D, 1972, BER DEUT WISS KOMM, V22, P273; Shannon C. E., 1963, THE MATHEMATICAL THE; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; STOECKER DK, 1990, J PLANKTON RES, V12, P891, DOI 10.1093/plankt/12.5.891; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; Tignor M., 2013, CLIMATE CHANGE 2013; Tomas CR, 1997, IDENTIFYING MARINE P; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091	67	15	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0165800	10.1371/journal.pone.0165800	http://dx.doi.org/10.1371/journal.pone.0165800			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893740	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000389472400012
J	Qin, W; Zhang, XY; Yang, SN; Li, Y; Yuan, JL; Yang, L; Li, SJ; Hu, WL				Qin, Wei; Zhang, Xiaoyu; Yang, Shuna; Li, Yue; Yuan, Junliang; Yang, Lei; Li, Shujuan; Hu, Wenli			Risk Factors for Multiple Organ Dysfunction Syndrome in Severe Stroke Patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTENSIVE-CARE; MEDICAL COMPLICATIONS; PREDICTORS; INFARCTION; SURVIVAL; MORTALITY; FAILURE; PROJECT; SCORE	Background Severe stroke patients have poor clinical outcome which may be associated with development of multiple organ dysfunction syndrome (MODS). Therefore, the aim of our study was to investigate independent risk factors for development of MODS in severe stroke patients. Methods Ninety seven severe stroke patients were prospective recruited from Jan 2011 to Jun 2015. The development of MODS was identified by Sequential Organ Failure Assessment (SOFA) score (score >= 3, at least two organs), which was assessed on day 1, 4, 7, 10 and 14 after admission. Baseline characteristics, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Glasgow coma score (GCS) and cerebral imaging parameters were collected at admission. Cox regression was performed to determine predictors for the development of MODS. Medical complications after admission and in-hospital mortality were also investigated. Results 33 (34%) patients were in MODS group and 64 (66%) were in non-MODS group within 14 days after admission. Patients in MODS group had more smoker (51.5% vs 28.1%, p = 0.023), higher NIHSS score (23.48 +/- 6.12 vs 19.81 +/- 4.83, p = 0.004), higher APACHE II score (18.70 +/- 5.18 vs 15.64 +/- 4.36, p = 0.003) and lower GCS score (6.33 +/- 2.48 vs 8.14 +/- 2.73, p = 0.002). They also had higher rate of infarction in multi vascular territories (36.4% vs 10.9%, p = 0.003). The most common complication in all patients was pulmonary infection, while complication scores were comparable between two groups. Patients with MODS had higher in-hospital mortality (69.7% vs 9.4%, p = 0.000). In Cox regression, NIHSS score (RR = 1.084, 95% CI 1.019-1.153) and infarction in multi vascular territories (RR = 2.345 95% CI 1.105-4.978) were independent risk factors for development of MODS. Conclusions In acute phase of stroke, NIHSS score and infarction in multi vascular territories predicted MODS in severe stroke patients. Moreover, patients with MODS had higher in-hospital mortality, suggesting that early identification of MODS is critical important.	[Qin, Wei; Zhang, Xiaoyu; Yang, Shuna; Li, Yue; Yuan, Junliang; Yang, Lei; Li, Shujuan; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com	Zhang, xiaoyu/GXA-3206-2022					ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barber PA, 2003, CEREBROVASC DIS, V16, P230, DOI 10.1159/000071121; Bill O, 2013, J THROMB HAEMOST, V11, P92, DOI 10.1111/jth.12066; Chen YD, 2011, EUR NEUROL, V66, P204, DOI 10.1159/000330551; Fanshawe M, 2002, ANAESTH INTENS CARE, V30, P628, DOI 10.1177/0310057X0203000515; Gerriets T, 2004, CEREBROVASC DIS, V18, P90, DOI 10.1159/000078759; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Jeng JS, 2008, J NEUROL SCI, V270, P60, DOI 10.1016/j.jns.2008.01.015; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Kleiman DA, 2014, SURG INFECT, V15, P445, DOI 10.1089/sur.2012.071; Koh MG, 2000, STROKE, V31, P2062, DOI 10.1161/01.STR.31.9.2062; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Lam WWM, 2005, J NEUROL NEUROSUR PS, V76, P354, DOI 10.1136/jnnp.2003.035055; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Liu Hai-Bo, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P294; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; Ortega-Casarrubios M, 2007, NEUROLOGIA, V22, P426; Prosser J, 2007, STROKE, V38, P2295, DOI 10.1161/STROKEAHA.106.471813; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Ulvik A, 2007, CRIT CARE, V11, DOI 10.1186/cc6111; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Warlow CP, 2012, J NEUROL NEUROSUR PS, V83, P579, DOI 10.1136/jnnp-2011-301381; Yoo AJ, 2013, J STROKE CEREBROVASC, V22, P742, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.002	26	7	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167189	10.1371/journal.pone.0167189	http://dx.doi.org/10.1371/journal.pone.0167189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893797	Green Submitted, gold, Green Published			2022-12-26	WOS:000389472400097
J	de Carvalho, ALMB; Medeiros, PSC; Costa, FM; Ribeiro, VP; Sousa, JB; Diniz, C; Marques, MPM				Batista de Carvalho, Ana L. M.; Medeiros, Paula S. C.; Costa, Francisco M.; Ribeiro, Vanessa P.; Sousa, Joana B.; Diniz, Carmen; Marques, Maria P. M.			Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent	PLOS ONE			English	Article							CHICK CHORIOALLANTOIC MEMBRANE; NEGATIVE BREAST-CANCER; ANTICANCER DRUGS; POLYAMINE COMPLEXES; CYTOTOXIC ACTIVITY; PHASE-I; ANGIOGENESIS; COMBINATION; CISPLATIN; CELLS	The present work is aimed at evaluating the antitumour properties of a Pd(II) dinuclear complex with the biogenic polyamine spermine, by investigating: i) the anti-angiogenic and antimigration properties of a Pd(II) dinuclear complex with spermine (Pd(2)Spm); ii) the anti-proliferative activity of Pd(2)Spm against a triple negative human breast carcinoma (MDA-MB-231); and finally iii) the putative interaction mediated by combination of Pd(2)Spm with Docetaxel. Anti-invasive (anti-angiogenic and anti-migratory) as well as anti-proliferative capacities were assessed, for different combination schemes and drug exposure times, using the CAM assay and VEGFR2 activity measurement, the Matrigel (TM) method and the SRB proliferation test. The results thus obtained evidence the ability of Pd(2)Spm to restrict angiogenesis and cell migration: Pd(2)Spm induced a marked inhibition of migration (43.8 +/- 12.2%), and a higher inhibition of angiogenesis (81.8 +/- 4.4% for total length values, at 4 mu M) as compared to DTX at the clinical dosage 4x10(-2) mu M (26.4 +/- 14.4%; n = 4 to 11). Combination of Pd(2)Spm/DTX was more effective as anti-invasive and anti-proliferative than DTX or Pd(2)Spm in sole administration, which is compatible with the occurrence of synergism: for the anti-angiogenic effect, IC50(Pd(2)Spm/DTX) = 0.5/0.5x10(-2) mu M vs IC50(DTX) = 1.7x10(-2) mu M and IC50(Pd(2)Spm) = 1.6 mu M. In conclusion, the reported effects of Pd(2)Spm on angiogenesis, migration and proliferation showed that this compound is a promising therapeutic agent against this type of breast cancer. Moreover, combined administration of Pd(2)Spm and DTX was found to trigger a substantial synergetic effect regarding angiogenesis inhibition as well as anti-migratory and anti-proliferative activities reinforcing the putative use of Pd(II) complexes in chemotherapeutic regimens. This is a significant outcome, aiming at the application of these combined strategies towards metastatic breast cancer (or other type of resistant cancers), justifying further studies that include pre-clinical trials.	[Batista de Carvalho, Ana L. M.; Medeiros, Paula S. C.; Marques, Maria P. M.] Univ Coimbra, Dept Chem, Unidade I&D Quim Fis Mol, Coimbra, Portugal; [Costa, Francisco M.; Ribeiro, Vanessa P.; Sousa, Joana B.; Diniz, Carmen] Univ Porto, Dept Drug Sci, Pharmacol Lab, Fac Pharm, Porto, Portugal; [Sousa, Joana B.; Diniz, Carmen] Univ Porto, LAQV REQUIMTE, Porto, Portugal; [Marques, Maria P. M.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade de Coimbra	Diniz, C (corresponding author), Univ Porto, Dept Drug Sci, Pharmacol Lab, Fac Pharm, Porto, Portugal.	cdiniz@ff.up.pt	Sousa, Joana/N-4763-2019; , CDiniz/D-6293-2013; de Carvalho, Ana LM Batista/A-2929-2014; Marques, Maria Paula M./M-4130-2013	Sousa, Joana/0000-0002-1744-7840; , CDiniz/0000-0003-4668-9360; de Carvalho, Ana LM Batista/0000-0003-1280-3321; Marques, Maria Paula M./0000-0002-8391-0055	Portuguese Foundation for Science and Technology (FCT) [UID/MULTI/00070/2013, UID/QUI/50006/2013, SFRH/BD/72851/2010, PTDC/QEQ-MED/1890/2014]; European Community Fund FEDER) [3599-PPCDT]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Community Fund FEDER)	The authors acknowledge financial support from the Portuguese Foundation for Science and Technology (FCT): UID/MULTI/00070/2013, UID/QUI/50006/2013, PhD fellowship SFRH/BD/72851/2010 and PTDC/QEQ-MED/1890/2014 (within Project 3599 to Promote Scientific Production and Technological Development as well as the formation of thematic networks (3599-PPCDT) jointly financed by the European Community Fund FEDER).	Antunovic M, 2015, ANTI-CANCER DRUG, V26, P180, DOI 10.1097/CAD.0000000000000174; de Carvalho ALMB, 2016, FARADAY DISCUSS, V187, P273, DOI 10.1039/c5fd00148j; Bayless KJ, 2011, J VASC RES, V48, P369, DOI 10.1159/000324751; BERENBAUM MC, 1992, CANCER RES, V52, P4558; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carpentier G, 2012, USER AND DEVELOPER C; Codina G, 1999, HELV CHIM ACTA, V82, P1025, DOI 10.1002/(SICI)1522-2675(19990707)82:7<1025::AID-HLCA1025>3.0.CO;2-1; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; Fan Y, 2013, ANN ONCOL, V24, P1219, DOI 10.1093/annonc/mds603; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fiuza SM, 2006, LETT DRUG DES DISCOV, V3, P149, DOI 10.2174/157018006776286989; Fiuza SM, 2008, J PHYS CHEM A, V112, P3253, DOI 10.1021/jp710868p; Fiuza SM, 2015, NEW J CHEM, V39, P6274, DOI 10.1039/c5nj01088h; Fiuza SM, 2011, CHEM BIOL DRUG DES, V77, P477, DOI 10.1111/j.1747-0285.2011.01081.x; Fiuza SM, 2010, PHYS CHEM CHEM PHYS, V12, P14309, DOI 10.1039/c0cp00957a; Gacche RN, 2014, BBA-REV CANCER, V1846, P161, DOI 10.1016/j.bbcan.2014.05.002; Ghanbari P, 2014, APPL BIOCHEM BIOTECH, V174, P667, DOI 10.1007/s12010-014-1125-6; Gralla RJ, 1997, ONCOLOGY S7, V11, P27; Hoff PM, 2006, JPN J CLIN ONCOL, V36, P100, DOI 10.1093/jjco/hyi229; Hu G, 2003, CANC THER, V1, P31; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Kapdi AR, 2014, CHEM SOC REV, V43, P4751, DOI 10.1039/c4cs00063c; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Krawczyk N, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.352; Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Malina J, 2014, INORG CHEM, V53, P1662, DOI 10.1021/ic402796k; Marques M. P. M., 2013, ISRN Spectroscopy, DOI 10.1155/2013/287353; Marques MPM, 2015, PHYS CHEM CHEM PHYS, V17, P5155, DOI 10.1039/c4cp05183a; Nielsen DL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2642; O'Donnell A, 2005, BRIT J CANCER, V93, P876, DOI 10.1038/sj.bjc.6602797; Oliveira WXC, 2014, POLYHEDRON, V76, P16, DOI 10.1016/j.poly.2014.03.049; Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3; Reck M, 2015, LUNG CANCER, V90, P267, DOI 10.1016/j.lungcan.2015.08.003; Ribatti D, 2012, METHODS MOL BIOL, V843, P47, DOI 10.1007/978-1-61779-523-7_5; Richardson Mary, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P155, DOI 10.2174/1568006033481492; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Roth AD, 2000, ANN ONCOL, V11, P301, DOI 10.1023/A:1008342013224; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Tai CJ, 2012, ANTICANCER RES, V32, P5501; Tallarida RJ, 2012, J PHARMACOL EXP THER, V342, P2, DOI 10.1124/jpet.112.193474; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zec M, 2012, ANTI-CANCER AGENT ME, V12, P1071, DOI 10.2174/187152012803529682	47	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167218	10.1371/journal.pone.0167218	http://dx.doi.org/10.1371/journal.pone.0167218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880824	Green Published, gold, Green Submitted			2022-12-26	WOS:000388889500078
J	Kvie, KS; Heggenes, J; Anderson, DG; Kholodova, MV; Sipko, T; Mizin, I; Roed, KH				Kvie, Kjersti S.; Heggenes, Jan; Anderson, David G.; Kholodova, Marina V.; Sipko, Taras; Mizin, Ivan; Roed, Knut H.			Colonizing the High Arctic: Mitochondrial DNA Reveals Common Origin of Eurasian Archipelagic Reindeer (Rangifer tarandus)	PLOS ONE			English	Article							FRANZ JOSEF LAND; MUSEUM SPECIMENS; CONTROL REGION; POPULATION; PHYLOGEOGRAPHY; COLONIZATION; POLYMORPHISM; DYNAMICS; SVALBARD; REFUGIA	In light of current debates on global climate change it has become important to know more on how large, roaming species have responded to environmental change in the past. Using the highly variable mitochondrial control region, we revisit theories of Rangifer colonization and propose that the High Arctic archipelagos of Svalbard, Franz Josef Land, and Novaia Zemlia were colonized by reindeer from the Eurasian mainland after the last glacial maximum. Comparing mtDNA control region sequences from the three Arctic archipelagos showed a strong genetic connection between the populations, supporting a common origin in the past. A genetic connection between the three archipelagos and two Russian mainland populations was also found, suggesting colonization of the Eurasian high Arctic archipelagos from the Eurasian mainland. The age of the Franz Josef Land material (> 2000 years before present) implies that Arctic indigenous reindeer colonized the Eurasian Arctic archipelagos through natural dispersal, before humans approached this region.	[Kvie, Kjersti S.; Heggenes, Jan] Univ Coll Southeast Norway, Dept Environm Studies, Bo In Telemark, Norway; [Kvie, Kjersti S.; Roed, Knut H.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Anderson, David G.] Univ Aberdeen, Dept Anthropol, Aberdeen, Scotland; [Kholodova, Marina V.; Sipko, Taras] RAS, AN Severtsov Inst Ecol & Evolut, Moscow, Russia; [Mizin, Ivan] Russian Arctic Natl Pk, Arkhangelsk, Russia	University College of Southeast Norway; Norwegian University of Life Sciences; University of Aberdeen; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Kvie, KS (corresponding author), Univ Coll Southeast Norway, Dept Environm Studies, Bo In Telemark, Norway.; Kvie, KS (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	kjersti.kvie@nmbu.no	Anderson, David G/E-6125-2014; Kholodova, Marina/V-3628-2019	Anderson, David G/0000-0002-9624-5867; Mizin, Ivan/0000-0002-7094-7561	ERC Advanced Grant "Arctic Domus" ERC AdG at the University of Aberdeen [295458]; DGA; Economic and Social Research Council [ES/M011054/1] Funding Source: researchfish; ESRC [ES/M011054/1] Funding Source: UKRI	ERC Advanced Grant "Arctic Domus" ERC AdG at the University of Aberdeen; DGA; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was supported by the ERC Advanced Grant Arctic Domus ERC AdG 295458 based at the University of Aberdeen (http://www.arcticdomus.org/). Funding was recieved by DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balto AK, SAMER POLAREKSPEDISJ; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banfield A. W. F., 1961, REVISION REINDEER CA; Baranova AI, 2012, RUSS J GENET+, V48, P939, DOI 10.1134/S1022795412090025; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; BELIAEV D, 2004, VESTNIK EVRAZII, P3; Bjornstad G, 2010, ANIM GENET, V41, P281, DOI 10.1111/j.1365-2052.2009.01999.x; Bjornstad G, 2012, J ARCHAEOL SCI, V39, P102, DOI 10.1016/j.jas.2011.09.006; Bruce W, 1899, P ROY PHYS SOC EDINB, V16, P502; Chochorowski J., 1991, POLISH POLAR RES, V12, P391; Cote SD, 2002, MOL ECOL, V11, P1923, DOI 10.1046/j.1365-294X.2002.01582.x; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; DAVYDOV AN, 2006, MEZHETNICHESKIYE VZM; DAVYDOV AV, 2005, VESTNIK OKHOTOVEDENI, P2; Degerbol M., 1957, EXTINCT REINDEER E G; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fedorov VB, 2003, MOL ECOL, V12, P725, DOI 10.1046/j.1365-294X.2003.01776.x; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Flagstad O, 2003, EVOLUTION, V57, P658; FLEROV KK, 1952, FAUNA SSSR MLEKOPITA; Forman SL, 2000, HOLOCENE, V10, P763, DOI 10.1191/09596830095015; Forman SL, 2004, QUATERNARY SCI REV, V23, P1391, DOI 10.1016/j.quascirev.2003.12.007; FU YX, 1993, GENETICS, V133, P693; GEPTNER VG, 1961, MLEKOPITAIUSHCHIE SO; Gravlund P, 1998, MOL PHYLOGENET EVOL, V10, P151, DOI 10.1006/mpev.1998.0525; GRINEVETSKII LF, 1883, IZVESTIYA RUSSKOGO G; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Holtmeier FK, 2014, ANIMALS INFLUENCE LA; Hughes A.L.C., 2015, LAST EURASIAN ICE SH; Khakhin GB, 2001, KRASNAIA KNIGA ROSSI, P860; Kholodova MV, 2011, BIOL BULL+, V38, P42, DOI 10.1134/S1062359011010067; KHOLODOVA MV, IZVESTIYA RAN SERIIZ; KHOLODOVA MV, 2016, IZVESTIYA RAN SERIIZ; KOROLEV AN, 2016, ZOOLOGICHESKII ZH; Kvie KS, 2016, ECOL EVOL, V6, P4347, DOI 10.1002/ece3.2199; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lono O, 1959, NATUREN, V12, P40; LVOV V, 1912, NOVAYA ZEMLYA YEYE P; Mizin IA, 2013, VILLREINEN, V69-71; Nois DN, 1958, POLARBOKEN, V45-57; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A., 2014, TRACER V1 6; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; ROED K H, 1991, Rangifer, V11, P65; ROED KH, 1986, CAN J ZOOL, V64, P94, DOI 10.1139/z86-015; Roed KH, 2008, P ROY SOC B-BIOL SCI, V275, P1849, DOI 10.1098/rspb.2008.0332; Roed Knut H., 2005, Rangifer, V25, P19; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sahlman T, 2009, ECOGRAPHY, V32, P840, DOI 10.1111/j.1600-0587.2009.05774.x; Salonen JS, 2011, QUATERNARY RES, V75, P501, DOI 10.1016/j.yqres.2011.01.007; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Siegert MJ, 2004, QUATERNARY SCI REV, V23, P1273, DOI 10.1016/j.quascirev.2003.12.010; SLATKIN M, 1991, GENETICS, V129, P555; SOKOLOV II, 1959, FAUNA SSSR MLEKOPITA; Sommer RS, 2014, J BIOGEOGR, V41, P298, DOI 10.1111/jbi.12193; SOSIN VAF, 2010, RUSSKIY ORNITOLOGICH, P554; Stammler F., 2010, GOOD EAT GOOD LIVE N; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIULIN AN, 1938, T NAUCH ISSL TA PALY; Van der Knaap W., 1989, J BIOGEOGR, P379; Voronina E, 2001, J QUATERNARY SCI, V16, P717, DOI 10.1002/jqs.650; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Yannic G, 2014, NAT CLIM CHANGE, V4, P132, DOI 10.1038/NCLIMATE2074; ZHITKOV B, 1903, NOVAYA ZEMLYA; Zigouris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083837; ZUBKOV AI, 1935, T ARKTICHESKOGO I	78	11	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0165237	10.1371/journal.pone.0165237	http://dx.doi.org/10.1371/journal.pone.0165237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880778	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000388889500006
J	Reza-Paul, S; Lazarus, L; Doshi, M; Rahman, SHU; Ramaiah, M; Maiya, R; Venugopal, MS; Venukumar, KT; Sundararaman, S; Becker, M; Moses, S; Lorway, R				Reza-Paul, Sushena; Lazarus, Lisa; Doshi, Monika; Rahman, Syed Hafeez Ur; Ramaiah, Manjula; Maiya, Raviprakash; Venugopal, M. S.; Venukumar, K. T.; Sundararaman, Sundar; Becker, Marissa; Moses, Stephen; Lorway, Robert			Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South India	PLOS ONE			English	Article							HIV PREVENTION PROJECT; INJECTING DRUG-USERS; ANTIRETROVIRAL PROPHYLAXIS; MYSORE; INFECTION; INTERVENTION; POPULATIONS; ADHERENCE; BEHAVIOR; VIOLENCE	Background HIV prevalence among female sex workers (FSWs) in India remains well above the national average. Pre-exposure prophylaxis (PrEP), a new HIV prevention technology, may help to reduce HIV incidence, but there is a dearth of research that can inform the potential scaleup of PrEP in India. In partnership with Ashodaya Samithi, a local sex worker collective, we conducted a feasibility study to assess acceptance of a planned PrEP demonstration project, willingness to use PrEP, and recommendations for project roll-out among FSWs in southern Karnataka. Methods From January-April 2015, 6 focus group discussions, 47 in-depth interviews, and 427 interviewer-administered questionnaires were completed by female sex workers. All participants were 18 years of age or older and practiced sex work. Qualitative data were coded for key themes and emergent categories. Univariate descriptive analysis was employed to summarise the quantitative data. Results Qualitative. PrEP was described as an exciting new prevention technology that places control in the hands of FSWs and provides a "double safety" in combination with condom use. Participants expressed agreement that women who may experience more HIV risk in their occupational environments should be prioritized for enrollment into a demonstration project. Quantitative. 406 participants (95%) expressed interest in PrEP. Participants prioritized the inclusion of FSWs under the age of 25 (79%), those who do not use condoms when clients offer more money (58%), who do not consistently use condoms with regular partners (57%), who drink alcohol regularly (49%), and who do not use condoms consistently with clients (48%). Discussion This feasibility study indicated strong interest in PrEP and a desire to move forward with the demonstration project. Participants expressed their responses in terms of public health discourses surrounding risk, pointing to the importance of situating PrEP scale up within the trusted spaces of community-based organizations as a means of supporting PrEP uptake and adherence.	[Reza-Paul, Sushena; Lazarus, Lisa; Doshi, Monika; Becker, Marissa; Moses, Stephen; Lorway, Robert] Univ Manitoba, Ctr Global Publ Hlth, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Rahman, Syed Hafeez Ur; Ramaiah, Manjula; Maiya, Raviprakash; Venugopal, M. S.; Venukumar, K. T.] Ashodaya Samithi, Mysore, Karnataka, India	University of Manitoba	Reza-Paul, S (corresponding author), Univ Manitoba, Ctr Global Publ Hlth, Dept Community Hlth Sci, Winnipeg, MB, Canada.	sushenar@gmail.com		Becker, Marissa/0000-0002-9235-0547	World Health Organization [2014/470419-0]; Bill & Melinda Gates Foundation	World Health Organization(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the World Health Organization (grant number 2014/470419-0), and the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to sincerely thank the female sex worker and hijra/transgender communities in Mysore and Mandya, and to Ashodaya Samithi, for their support for this project. The study was funded by the World Health Organization and the Bill & Melinda Gates Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the World Health Organization or the Bill & Melinda Gates Foundation.	Amico KR, 2014, CLIN INFECT DIS, V59, pS55, DOI 10.1093/cid/ciu266; Amico KR, 2016, AIDS BEHAV, V17, P1; [Anonymous], 2015, NAT INT BIOL BEH SUR; [Anonymous], 2013, 20 C RETR OPP INF AT, DOI DOI 10.1056/NEJM0A1402269; Argento E, 2011, AIDS CARE, V23, P69, DOI 10.1080/09540121.2010.498868; Auerbach JD, 2011, GLOB PUBLIC HLTH S3, V6; Baeten J HRea, 2015, C RETR OPP INF SEATT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Caceres CF, 2015, J INT AIDS SOC, V18, P5, DOI [10.7448/IAS.18.4.19949, 10.7448/IAS.18.4.20527]; Caceres CF, 2015, PREP IMPLEMENTATION, V1; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Chevrier C, 2015, GLOB PUBLIC HEALTH, P1; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen S, 2014, C RETR OPP INF BOST; Cornish F, 2007, SOC SCI MED, V64, P496, DOI 10.1016/j.socscimed.2006.09.009; Coupland H, 2005, INT J DRUG POLICY, V16, P191, DOI 10.1016/j.drugpo.2004.12.002; Dixon V, 2012, GLOB PUBLIC HEALTH, V7, P779, DOI 10.1080/17441692.2012.668918; Grant RM, 2016, CURR OPIN HIV AIDS, V11, P3, DOI 10.1097/COH.0000000000000216; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2015, AIDS, V500; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lazarus L, 2012, J HIV-AIDS SOC SERV, V11, P152, DOI 10.1080/15381501.2012.678132; Lorway R, 2013, CRITICAL PUBLIC HLTH, V24, P37; Lorway R, 2014, SOC SCI MED, V112, P51, DOI 10.1016/j.socscimed.2014.04.034; Mack N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-231; Martin M, 2015, AIDS, V29, P819, DOI 10.1097/QAD.0000000000000613; McCormack S, 2015, LANCET; MORSE JM, 1991, NURS RES, V40, P120; Ndase P, 2014, JAIDS-J ACQ IMM DEF, V66, P206, DOI 10.1097/QAI.0000000000000141; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Schnarch B, 2004, J ABORIGINAL HLTH, V1, P80, DOI [DOI 10.3138/IJIH.V1I1.28934, DOI 10.1037/E509012013-037]; Syvertsen JL, 2014, AFR J REPROD HEALTH, V18, P74; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2014, THE GAP REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8; WHO, 2012, REC US CONT DEM PROJ; World Health Organization, 2015, PREEXP PROPH	44	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166889	10.1371/journal.pone.0166889	http://dx.doi.org/10.1371/journal.pone.0166889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5KB	27880833	Green Submitted, gold, Green Published			2022-12-26	WOS:000388889500043
J	Yang, BY; Shebl, FM; Sternberg, LR; Warner, AC; Kleiner, DE; Edelman, DC; Gomez, A; Dagnall, CL; Hicks, BD; Altekruse, SF; Hernandez, BY; Lynch, CF; Meltzer, PS; McGlynn, KA				Yang, Baiyu; Shebl, Fatma M.; Sternberg, Lawrence R.; Warner, Andrew C.; Kleiner, David E.; Edelman, Daniel C.; Gomez, Allison; Dagnall, Casey L.; Hicks, Belynda D.; Altekruse, Sean F.; Hernandez, Brenda Y.; Lynch, Charles F.; Meltzer, Paul S.; McGlynn, Katherine A.			Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; HEPATITIS-VIRUS; TRANSARTERIAL CHEMOEMBOLIZATION; QUANTITATIVE PCR; LONG TELOMERES; CANCER; HEPATOCARCINOGENESIS; TISSUES; REACTIVATION; MAINTENANCE	Background Telomere shortening is an important molecular event in hepatocellular carcinoma (HCC) initiation; however, its role in HCC progression and prognosis is less clear. Our study aimed to examine the association of telomere length with survival of patients with HCC. Methods We measured telomere length in tumor and adjacent non-tumor tissues from 126 persons with HCC in the United States (U.S.) who were followed for mortality outcomes. Relative telomere length (RTL) was measured by a monochrome multiplex quantitative polymerase chain reaction assay. Multivariable Cox proportional hazards modeling was used to calculate hazard ratios (HRs) and 95% CIs for the association between telomere length and allcause mortality. We also examined associations between telomere length and patient characteristics using multiple linear regression. Results During a mean follow-up of 6.0 years, 79 deaths occurred among 114 individuals for whom survival data were available. The ratio of RTL in tumor relative to non-tumor tissue was greater for individuals with regional or distant stage tumors (0.97) than localized stage tumors (0.77), and for individuals with grade III or IV tumors (0.95) than grade II (0.88) or grade I (0.67) tumors. An RTL ratio >= 1 was not associated with survival (HR 0.92, 95% CI 0.55, 1.55) compared to a ratio <1, after adjusting for age at diagnosis, sex, tumor stage and tumor size. Similarly, RTL in the tumor and non-tumor tissue, respectively, were not associated with survival. Conclusions This U.S. based study found that telomeres may be longer in more aggressive HCCs. There was no evidence, however, that telomere length was associated with survival of patients with HCC. Future investigations are warranted to clarify the role of telomere length in HCC prognosis.	[Yang, Baiyu; Dagnall, Casey L.; Hicks, Belynda D.; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Shebl, Fatma M.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Sternberg, Lawrence R.; Warner, Andrew C.] Frederick Natl Lab Canc Res, Pathol Histotechnol Lab, Frederick, MD 21701 USA; [Kleiner, David E.; Edelman, Daniel C.; Gomez, Allison; Meltzer, Paul S.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Dagnall, Casey L.; Hicks, Belynda D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Genom Res Lab, Frederick, MD 20892 USA; [Altekruse, Sean F.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Hernandez, Brenda Y.] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Lynch, Charles F.] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cancer Research Center of Hawaii; University of Hawaii System; University of Iowa	Yang, BY (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	baiyu.yang@nih.gov	Kleiner, David E/N-2770-2013	Kleiner, David E/0000-0003-3442-4453; Dagnall, Casey/0000-0001-7334-4718	Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010158, ZIABC011091, P30CA071789, P30CA086862] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Altekruse SF, 2012, HEPATOLOGY, V55, P476, DOI 10.1002/hep.24710; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; [Anonymous], 2013, GLOBOCAN 2012 V1 0; Arons E, 2015, LEUKEMIA RES, V39, P1360, DOI 10.1016/j.leukres.2015.09.015; Bao DK, 2016, CANCER CHEMOTH PHARM, V78, P791, DOI 10.1007/s00280-016-3128-1; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Farazi PA, 2003, CANCER RES, V63, P5021; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Huang GT, 1998, EUR J CANCER, V34, P1946, DOI 10.1016/S0959-8049(98)00237-8; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Ko E, 2016, HEPATOLOGY, V63, P341, DOI 10.1002/hep.27833; Ko E, 2014, BIOCHEM BIOPH RES CO, V447, P358, DOI 10.1016/j.bbrc.2014.04.022; Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303; Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045; Liu HQ, 2012, CARCINOGENESIS, V33, P1040, DOI 10.1093/carcin/bgs098; Mann CD, 2007, EUR J CANCER, V43, P979, DOI 10.1016/j.ejca.2007.01.004; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Oh BK, 2003, J HEPATOL, V39, P786, DOI 10.1016/S0168-8278(03)00395-7; Oh BK, 2008, LAB INVEST, V88, P144, DOI 10.1038/labinvest.3700710; Ohashi K, 1996, JPN J CANCER RES, V87, P419, DOI 10.1111/j.1349-7006.1996.tb00239.x; Ohashi K, 1996, CANCER, V77, P1747, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1747::AID-CNCR50>3.0.CO;2-W; Ohta K, 1997, J GASTROENTEROL, V32, P791, DOI 10.1007/BF02936956; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Saini N, 2009, LIVER INT, V29, P1162, DOI 10.1111/j.1478-3231.2009.02082.x; Satyanarayana A, 2004, HEPATOLOGY, V40, P276, DOI 10.1002/hep.20308; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Urabe Y, 1996, LIVER, V16, P293; Yokota T, 2003, CANCER-AM CANCER SOC, V98, P110, DOI 10.1002/cncr.11428; Zhang Y, 2007, CANCER INVEST, V25, P668, DOI 10.1080/07357900701561024	38	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166828	10.1371/journal.pone.0166828	http://dx.doi.org/10.1371/journal.pone.0166828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880792	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500036
J	Zou, J; Zhao, YS; Liu, PF; Shi, L; Wang, XH; Wang, M; Meng, JL; Reif, JC				Zou, Jun; Zhao, Yusheng; Liu, Peifa; Shi, Lei; Wang, Xiaohua; Wang, Meng; Meng, Jinling; Reif, Jochen Christoph			Seed Quality Traits Can Be Predicted with High Accuracy in Brassica napus Using Genomic Data	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MARKER-ASSISTED SELECTION; OIL CONTENT; GENETIC ARCHITECTURE; WIDE ASSOCIATION; GLUCOSINOLATE CONTENT; RAPESEED POPULATION; QUANTITATIVE TRAITS; HYBRID PERFORMANCE; MOLECULAR MARKERS	Improving seed oil yield and quality are central targets in rapeseed (Brassica napus) breeding. The primary goal of our study was to examine and compare the potential and the limits of marker-assisted selection and genome-wide prediction of six important seed quality traits of B. napus. Our study is based on a bi-parental population comprising 202 doubled haploid lines and a diverse validation set including 117 B. napus inbred lines derived from interspecific crosses between B. rapa and B. carinata. We used phenotypic data for seed oil, protein, erucic acid, linolenic acid, stearic acid, and glucosinolate content. All lines were genotyped with a 60k SNP array. We performed five-fold cross-validations in combination with linkage mapping and four genome-wide prediction approaches in the bi-parental population. Quantitative trait loci (QTL) with large effects were detected for erucic acid, stearic acid, and glucosinolate content, blazing the trail for marker-assisted selection. Despite substantial differences in the complexity of the genetic architecture of the six traits, genome-wide prediction models had only minor impacts on the prediction accuracies. We evaluated the effects of training population size, marker density and phenotyping intensity on the prediction accuracy. The prediction accuracy in the independent and genetically very distinct validation set still amounted to 0.14 for protein content and 0.17 for oil content reflecting the utility of the developed calibration models even in very diverse backgrounds.	[Zou, Jun; Liu, Peifa; Shi, Lei; Wang, Xiaohua; Wang, Meng; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhao, Yusheng; Reif, Jochen Christoph] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Huazhong Agricultural University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Zou, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.; Reif, JC (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	zoujun@mail.hzau.edu.cn; reif@ipk-gatersleben.de	Zhao, Yusheng/U-1883-2019; wang, xiao/HGB-7081-2022	Zhao, Yusheng/0000-0001-6783-5182; wang, xiao/0000-0002-4088-3341; Reif, Jochen/0000-0002-6742-265X; Zou, Jun/0000-0003-3271-895X	National Basic Research Program of China [2015CB150200]; National Key Research and Development Program of China [2016YFD0101300]; Natural Science Foundation of Hubei Province Key Program [2014CFA008]	National Basic Research Program of China(National Basic Research Program of China); National Key Research and Development Program of China; Natural Science Foundation of Hubei Province Key Program	This work was supported by the National Basic Research Program of China (Grant No. 2015CB150200), the National Key Research and Development Program of China (No.2016YFD0101300), and the Natural Science Foundation of Hubei Province Key Program 2014CFA008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadi A, 2011, EUR J LIPID SCI TECH, V113, P1198, DOI 10.1002/ejlt.201100063; Albrecht T, 2014, THEOR APPL GENET, V127, P1375, DOI 10.1007/s00122-014-2305-z; Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Bao Y, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0039; Barker GC, 2007, PLANT PHYSIOL, V144, P1827, DOI 10.1104/pp.107.096172; BELL JM, 1984, J ANIM SCI, V58, P996, DOI 10.2527/jas1984.584996x; Bernardo R, 2013, THEOR APPL GENET, V126, P999, DOI 10.1007/s00122-012-2032-2; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Bernardo R, 2014, CROP SCI, V54, P2586, DOI 10.2135/cropsci2014.01.0088; Burns MJ, 2003, HEREDITY, V90, P39, DOI 10.1038/sj.hdy.6800176; Butler D, 2009, REFERENCE MANUAL VER; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen YB, 2013, THEOR APPL GENET, V126, P2499, DOI 10.1007/s00122-013-2150-5; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; DOWNEY RK, 1964, J AM OIL CHEM SOC, V41, P475, DOI 10.1007/BF02670026; Falconer DS, 1996, INTRODUCTION TO QUAN; Feng J, 2012, NEW PHYTOL, V193, P96, DOI 10.1111/j.1469-8137.2011.03890.x; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Fu Y, 2015, THEOR APPL GENET, V128, P1029, DOI 10.1007/s00122-015-2487-z; Gajardo HA, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0340-3; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Gupta V, 2004, THEOR APPL GENET, V108, P743, DOI 10.1007/s00122-003-1481-z; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hayes BJ, 2013, PLANT BREEDING, V132, P133, DOI 10.1111/pbr.12037; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heslot N, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0171-z; Hickey JM, 2014, CROP SCI, V54, P1476, DOI 10.2135/cropsci2013.03.0195; Hofheinz N, 2012, THEOR APPL GENET, V125, P1639, DOI 10.1007/s00122-012-1940-5; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; Huang XQ, 2016, EUPHYTICA, V210, P1, DOI 10.1007/s10681-016-1675-5; Jan HU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147769; Jiang CC, 2014, THEOR APPL GENET, V127, P957, DOI 10.1007/s00122-014-2271-5; Jiang Y, 2015, GENETICS, V201, P759, DOI 10.1534/genetics.115.177907; Korber N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00386; LANDE R, 1990, GENETICS, V124, P743; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119425; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080990; Liu Z, 2012, PLANT MOL BIOL, V79, P179, DOI 10.1007/s11103-012-9905-2; Longin CFH, 2015, THEOR APPL GENET, V128, P1297, DOI 10.1007/s00122-015-2505-1; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Lu GY, 2014, DNA RES, V21, P613, DOI 10.1093/dnares/dsu024; Meuwissen THE, 2001, GENETICS, V157, P1819; Mollers C., 2004, RAPESEED AND CANOLA; PARK YC, 1977, THEOR APPL GENET, V50, P163, DOI 10.1007/BF00277737; Qian LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1170; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Raman H, 2016, PLANT CELL ENVIRON, V39, P1228, DOI 10.1111/pce.12644; Reif JC, 2013, PLANT BREEDING, V132, P107, DOI 10.1111/pbr.12007; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rutkoski JE, 2011, EUPHYTICA, V179, P161, DOI 10.1007/s10681-010-0301-1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shu YJ, 2013, GENET MOL RES, V12, P2178, DOI 10.4238/2013.July.3.2; Smooker AM, 2011, THEOR APPL GENET, V122, P1075, DOI 10.1007/s00122-010-1512-5; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Sun M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Utz HF, 2000, GENETICS, V154, P1839; Vageeshbabu HS, 1997, J PLANT BIOCHEM BIOT, V6, P53, DOI 10.1007/BF03263011; Velasco L, 1998, EUPHYTICA, V101, P221, DOI 10.1023/A:1018358707847; Wang XD, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0475-8; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Warnes GR, 2003, R NEWS; Wen J, 2016, J SCI FOOD AGR, V96, P465, DOI 10.1002/jsfa.7112; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wu G, 2008, THEOR APPL GENET, V116, P491, DOI 10.1007/s00122-007-0685-z; Wurschum T, 2014, PLANT BREEDING, V133, P45, DOI 10.1111/pbr.12137; Wurschum T, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-85; Xiao Y, 2010, THEOR APPL GENET, V121, P1141, DOI 10.1007/s00122-010-1378-6; Xu JF, 2015, EUR FOOD RES TECHNOL, V240, P147, DOI 10.1007/s00217-014-2316-7; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zhang X, 2015, HEREDITY, V114, P291, DOI 10.1038/hdy.2014.99; Zhang Y, 2016, CONSTRUCTION OF A HI; Zhao JY, 2008, MOL BREEDING, V21, P115, DOI 10.1007/s11032-007-9113-y; Zhao JY, 2012, THEOR APPL GENET, V124, P407, DOI 10.1007/s00122-011-1716-3; Zhao JY, 2005, CROP SCI, V45, P51; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zhao YS, 2015, P NATL ACAD SCI USA, V112, P15624, DOI 10.1073/pnas.1514547112; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259; Zhao YS, 2013, CROP SCI, V53, P802, DOI 10.2135/cropsci2012.08.0463; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075; Zou J, 2010, THEOR APPL GENET, V120, P283, DOI 10.1007/s00122-009-1201-4	85	22	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166624	10.1371/journal.pone.0166624	http://dx.doi.org/10.1371/journal.pone.0166624			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880793	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500028
J	Mace, OG; Steinauer, K; Jousset, A; Eisenhauer, N; Scheu, S				Mace, Odette Gonzalez; Steinauer, Katja; Jousset, Alexandre; Eisenhauer, Nico; Scheu, Stefan			Flood-Induced Changes in Soil Microbial Functions as Modified by Plant Diversity	PLOS ONE			English	Article							EXPERIMENTAL GRASSLAND; NITROGEN DEPOSITION; SPECIES RICHNESS; BIODIVERSITY; BIOMASS; COMMUNITY; PRODUCTIVITY; MICROCOMPARTMENTS; INCREASES; ENZYMES	Flooding frequency is predicted to increase during the next decades, calling for a better understanding of impacts on terrestrial ecosystems and for developing strategies to mitigate potential damage. Plant diversity is expected to buffer flooding effects by providing a broad range of species' responses. Here we report on the response of soil processes to a severe summer flood in 2013, which affected major parts of central Europe. We compared soil microbial respiration, biomass, nutrient limitation and enzyme activity in a grassland biodiversity experiment in Germany before flooding, one week and three months after the flood. Microbial biomass was reduced in the severely flooded plots at high, but not at low plant functional group richness. Flooding alleviated microbial nitrogen limitation, presumably due the input of nutrient-rich sediments. Further, the activity of soil enzymes including 1,4-beta-N-acetylglucosaminidase, phenol oxidase and peroxidase increased with flooding severity, suggesting increased chitin and lignin degradation as a consequence of the input of detritus in sediments. Flooding effects were enhanced at higher plant diversity, indicating that plant diversity temporarily reduces stability of soil processes during flooding. The long-term impacts, however, remain unknown and deserve further investigation.	[Mace, Odette Gonzalez; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Berliner Str 28, D-37073 Gottingen, Germany; [Steinauer, Katja; Eisenhauer, Nico] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Steinauer, Katja; Eisenhauer, Nico] Univ Leipzig, Inst Biol, Johannisallee 21, D-04103 Leipzig, Germany; [Jousset, Alexandre] Univ Utrecht, Inst Environm Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands	University of Gottingen; Leipzig University; Utrecht University	Mace, OG (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Berliner Str 28, D-37073 Gottingen, Germany.	ogonzal@gwdg.de	Eisenhauer, Nico/I-5932-2012; Eisenhauer, Nico/I-3191-2019; Jousset, Alexandre/C-7607-2011; Scheu, Stefan/H-7049-2015	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; 	German Science Foundation (DFG) [FOR 1451]; ETH Zurich	German Science Foundation (DFG)(German Research Foundation (DFG)); ETH Zurich(ETH Zurich)	The Jena Experiment is funded by the German Science Foundation (DFG; FOR 1451) with additional support from ETH Zurich (funds from N. Buchmann research group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; ANDERSON JPE, 1980, SOIL SCI, V130, P211, DOI 10.1097/00010694-198010000-00008; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; [Anonymous], 2014, R LANG ENV STAT COMP; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Burns A, 2001, FRESHWATER BIOL, V46, P1299, DOI 10.1046/j.1365-2427.2001.00750.x; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Creme A, 2016, PLANT SOIL, V402, P117, DOI 10.1007/s11104-015-2740-x; Dick R.P., 1997, METHODS ASSESSING SO, P247, DOI DOI 10.2136/SSSASPECPUB49.C15; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; FAO-Unesco, 1997, SOIL MAP WORLD REV L; Faraway J.J., 2014, LINEAR MODELS R 2 ED; Fox J., 2014, R COMPANION APPL REG; Habekost M, 2008, SOIL BIOL BIOCHEM, V40, P2588, DOI 10.1016/j.soilbio.2008.06.019; Hacker N, 2015, ECOL LETT, V18, P1356, DOI 10.1111/ele.12530; Hefting M, 2004, BIOGEOCHEMISTRY, V67, P113, DOI 10.1023/B:BIOG.0000015320.69868.33; Hoffmann K, 2014, KLIMAUNTERSUCHUNGEN; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Kreyling J, 2008, PLANT SOIL, V308, P175, DOI 10.1007/s11104-008-9617-1; Lange M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7707; Lockaby BG, 1996, SOIL SCI SOC AM J, V60, P1267, DOI 10.2136/sssaj1996.03615995006000040044x; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Mommer L, 2010, J ECOL, V98, P1117, DOI 10.1111/j.1365-2745.2010.01702.x; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Nilsson MC, 2008, OIKOS, V117, P439, DOI 10.1111/j.2007.0030-1299.16265.x; Oelmann Y, 2007, J ENVIRON QUAL, V36, P396, DOI 10.2134/jeq2006.0217; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Pankhurst CE, 1996, BIODIVERS CONSERV, V5, P197, DOI 10.1007/BF00055830; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sanaullah M, 2011, APPL SOIL ECOL, V48, P38, DOI 10.1016/j.apsoil.2011.02.004; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; SCHEU S, 1993, GEODERMA, V56, P575, DOI 10.1016/0016-7061(93)90136-9; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Steinauer K, 2015, ECOLOGY, V96, P99, DOI 10.1890/14-0088.1; Strecker T, 2016, OIKOS, V125, P1743, DOI 10.1111/oik.03181; Strecker T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125678; Unger IM, 2009, APPL SOIL ECOL, V42, P1, DOI 10.1016/j.apsoil.2009.01.007; Wagner D, 2015, SOIL BIOL BIOCHEM, V89, P135, DOI 10.1016/j.soilbio.2015.07.001; Walker LR, 2012, BIO HABIT, P1; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092; Wu HP, 2015, ECOL INDIC, V53, P129, DOI 10.1016/j.ecolind.2015.01.041; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	53	19	19	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166349	10.1371/journal.pone.0166349	http://dx.doi.org/10.1371/journal.pone.0166349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870864	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400009
J	Wang, B; Liu, MC; Li, XY; Liu, XH; Feng, QX; Lu, L; Zhu, Z; Liu, YS; Zhao, W; Gao, ZN				Wang, Bing; Liu, Ming-Chuan; Li, Xin-Yu; Liu, Xu-Han; Feng, Qiu-Xia; Lu, Lu; Zhu, Zhu; Liu, Ying-Shu; Zhao, Wei; Gao, Zheng-Nan			Cutoff Point of HbA1c for Diagnosis of Diabetes Mellitus in Chinese Individuals	PLOS ONE			English	Article								Background The purpose of the present study was to find the optimal threshold of glycated hemoglobin (HbA1c) for diagnosis of diabetes mellitus in Chinese individuals. Methods A total of 8 391 subjects (including 2 133 men and 6 258 women) aged 40-90 years with gradable retinal photographs were recruited. The relationship between HbA1c and diabetic retinopathy (DR) was examined. Receiver operating characteristic (ROC) curves were used to find the optimal threshold of HbA1c in screening DR and diagnosing diabetes. Results HbA1c values in patients with DR were significantly higher than in those with no DR. The ROC curve for HbA1c had an area under the curve of 0.881 (95% CI 0.857-0.905; P = 0.000). HbA1c at a cutoff of 6.5% had a high sensitivity (80.6%) and specificity (86.9%) for detecting DR. Conclusions HbA1c can be used to diagnose diabetes in a Chinese population, and the optimal HbA1c cutoff point for diagnosis is 6.5%.	[Wang, Bing; Li, Xin-Yu; Liu, Xu-Han; Feng, Qiu-Xia; Lu, Lu; Zhu, Zhu; Liu, Ying-Shu; Zhao, Wei; Gao, Zheng-Nan] Dalian Med Univ, Dept Endocrinol, Dalian Municipal Cent Hosp, Dalian, Peoples R China; [Liu, Ming-Chuan] Dalian Med Univ, Grad Sch, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Gao, ZN (corresponding author), Dalian Med Univ, Dept Endocrinol, Dalian Municipal Cent Hosp, Dalian, Peoples R China.	gao2008@163.com	Liu, Yingshu/AAD-1648-2019	Liu, Yingshu/0000-0002-4671-1145	China National Clinical Research Center for Metabolic Diseases [2013BA109B13]	China National Clinical Research Center for Metabolic Diseases	This study was supported by grant 2013BA109B13 from the China National Clinical Research Center for Metabolic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hong S, 2016, DIABETES METAB J, V40, P167, DOI 10.4093/dmj.2016.40.2.167; Incani M, 2015, J DIABETES INVEST, V6, P44, DOI 10.1111/jdi.12241; Kumar PR, 2010, J CLIN ENDOCR METAB, V95, P2832, DOI 10.1210/jc.2009-2433; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Rhee EJ, ENDOCRINOLOGY METABO, V30, P263; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Rosenstock J, 2009, DIABETOLOGIA, V52, P1778, DOI 10.1007/s00125-009-1415-7; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Tang ST, ZHONGHUA NEI KE ZA Z, V52, P21; Wiener K, 1998, DIABETIC MED, V15, P558, DOI 10.1002/(SICI)1096-9136(199807)15:7<558::AID-DIA669>3.3.CO;2-H; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wu SL, 2013, J DIABETES, V5, P282, DOI 10.1111/1753-0407.12035; Xin Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040610; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou XH, 2010, DIABETES CARE, V33, P545, DOI 10.2337/dc09-1410; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	25	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166597	10.1371/journal.pone.0166597	http://dx.doi.org/10.1371/journal.pone.0166597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861599	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300075
J	Shi, L; Wang, Y; Lu, Z; Zhang, H; Zhuang, N; Wang, B; Song, Z; Chen, G; Huang, C; Xu, D; Zhang, Y; Zhang, W; Gao, Y				Shi, L.; Wang, Y.; Lu, Z.; Zhang, H.; Zhuang, N.; Wang, B.; Song, Z.; Chen, G.; Huang, C.; Xu, D.; Zhang, Y.; Zhang, W.; Gao, Y.			miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop	ONCOGENE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; MOUSE MODEL; ACTIVATION; EXPRESSION; A20; RESISTANCE; GENE; HETEROGENEITY; MICRORNA-127	The coordination between cellular differentiation and the mesenchymal/stem transition is essential for both embryo development and neoplasia, suggesting a mechanistic link between these two major processes. In this work we show that miR-127, an embryoexpressing lung miRNA, was prominently induced in lung adenocarcinoma and correlated with poor prognosis. Elevated miR-127 level drove a pronounced shift from the epithelial to the mesenchymal phenotype in cancer cells, and this shift was associated with their acquisition of stem-like traits, increased resistance to the epidermal growth factor receptor inhibitor and tumor-propagating potential. In contrast, antagonizing miR-127 markedly reversed this malignant transition, compromised the stem-like properties and the in vivo tumorigenic capability of cancer cells. Importantly, a regulatory loop involving the inflammatory signals NF-.B, miR-127 and tumor necrosis factor alpha-induced protein 3 was uncovered as a self-reinforcing circuitry that ensured an aggressive transition in lung cancer. Thus, this work identifies a novel molecular mechanism linking stemness, malignancy and inflammation, opening a new avenue for cancer treatment.	[Shi, L.; Zhang, W.; Gao, Y.] Nanjing Univ Chinese Med, Sch Basic Med Sci, Dept Immunol, Nanjing, Jiangsu, Peoples R China; [Shi, L.; Wang, Y.; Lu, Z.; Zhang, H.; Zhuang, N.; Wang, B.; Xu, D.] Hangzhou Normal Univ, Sch Med, Dept Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Song, Z.; Zhang, Y.] Zhejiang Canc Hosp, Key Lab Diag & Treatment Technol Thorac Oncol, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Chen, G.; Huang, C.] Hangzhou Normal Univ, Affiliated Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Xu, D.] Monash Univ, Dept Mol & Translat Sci, Melbourne, Vic, Australia	Nanjing University of Chinese Medicine; Hangzhou Normal University; Zhejiang Cancer Hospital; Hangzhou Normal University; Monash University	Shi, L (corresponding author), Nanjing Univ Chinese Med, Sch Basic Med Sci, 138 Xianlin Rd, Nanjing 210046, Jiangsu, Peoples R China.	shi_liyun@msn.com		Shi, Liyun/0000-0003-3538-1571; Shi, Liyun/0000-0003-1767-0126	National Key Scientific Research Project [2012CB911200]; National Natural Scientific Funds of Science [81270066, 31200581, 81470210]	National Key Scientific Research Project; National Natural Scientific Funds of Science	We are grateful to Dr Weifeng Ni (the Animal Facility, Hangzhou Normal University) for his assistance in tumor xenograft experiments. This work was supported by the National Key Scientific Research Project (2012CB911200) and the National Natural Scientific Funds of Science (81270066, 31200581 and 81470210).	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chao CH, 2014, J CLIN INVEST, V124, P3093, DOI 10.1172/JCI73351; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; De S, 2014, P NATL ACAD SCI USA, V111, P11721, DOI 10.1073/pnas.1412390111; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Goswami RS, 2013, J CLIN ONCOL, V31, P2903, DOI 10.1200/JCO.2012.45.3050; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ito M, 2015, DEVELOPMENT, V142, P2425, DOI 10.1242/dev.121996; Jeon YJ, 2015, P NATL ACAD SCI USA, V112, pE3355, DOI 10.1073/pnas.1504630112; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Li L, 2014, CLIN CANCER RES, V20, P2714, DOI 10.1158/1078-0432.CCR-13-2613; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Nakagawa MM, 2015, J EXP MED, V212, P203, DOI 10.1084/jem.20132544; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Song LB, 2012, J CLIN INVEST, V122, P3563, DOI 10.1172/JCI62339; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang ZH, 2013, J BIOL CHEM, V288, P28893, DOI 10.1074/jbc.M113.502682; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yin C, 2013, HEPATOLOGY, V58, P1964, DOI 10.1002/hep.26573; Ying HJ, 2015, J IMMUNOL, V194, P1239, DOI 10.4049/jimmunol.1402088; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	50	54	60	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1631	1643		10.1038/onc.2016.332	http://dx.doi.org/10.1038/onc.2016.332			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27869168				2022-12-26	WOS:000397460600003
J	Ren, XM; Li, XZ; Jia, LN; Chen, DH; Hou, H; Rui, LY; Zhao, YJ; Chen, Z				Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Deheng; Hou, Hai; Rui, Liangyou; Zhao, Yujun; Chen, Zheng			A small-molecule inhibitor of NF-kappa B-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury	FASEB JOURNAL			English	Article						NIK; liver injury; inflammation; CCl4	REGULATES GLUCOSE-METABOLISM; CARBON-TETRACHLORIDE; HEPATIC-FIBROSIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; IKK-ALPHA; RAT-LIVER; ACTIVATION; MICE; EXPRESSION	Potent and selective chemical probes are valuable tools for discovery of novel treatments for human diseases. NF-B-inducing kinase (NIK) is a key trigger in the development of liver injury and fibrosis. Whether inhibition of NIK activity by chemical probes ameliorates liver inflammation and injury is largely unknown. In this study, a small-molecule inhibitor of NIK, B022, was found to be a potent and selective chemical probe for liver inflammation and injury. B022 inhibited the NIK signaling pathway, including NIK-induced p100-to-p52 processing and inflammatory gene expression, both in vitro and in vivo. Furthermore, in vivo administration of B022 protected against not only NIK but also CCl4-induced liver inflammation and injury. Our data suggest that inhibition of NIK is a novel strategy for treatment of liver inflammation, oxidative stress, and injury.-Ren, X., Li, X., Jia, L., Chen, D., Hou, H., Rui, L., Zhao, Y., Chen, Z. A small-molecule inhibitor of NF-kappa B-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury.	[Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Zheng] Northeast Normal Univ, Sch Life Sci, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Chen, Deheng; Zhao, Yujun] Chinese Acad Sci, Shanghai Inst Met Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Hou, Hai] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Bioscience & Biotechnol, Xian, Peoples R China; [Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Northeast Normal University - China; Chinese Academy of Sciences; Northwestern Polytechnical University; University of Michigan System; University of Michigan	Zhao, YJ (corresponding author), Chinese Acad Sci, Shanghai Inst Met Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.; Chen, Z (corresponding author), Northeast Normal Univ, Sch Life Sci, Changchun 130024, Jilin, Peoples R China.	yjzhao@simm.ac.cn	ZHAO, YUJUN/F-6552-2013; ZHAO, YUJUN/M-6027-2019	ZHAO, YUJUN/0000-0003-1035-2272; ZHAO, YUJUN/0000-0003-1035-2272	Changbai Mountain Scholars Program of The People's Government of Jilin Province Grant [2013046]; Jilin Science and Technology Development Program Grant [20160101204JC]; Jilin Talent Development Foundation Grant [111860000]; Fok Ying Tong Education Foundation Grant [151022]; National Natural Science Foundation of China Grants [31500957, 31671225]; startup funds from Northeast Normal University [120401204]; Shanghai Institute of Materia Medica startup grant; Young Overseas High-Level Talents Introduction Plan from the Chinese government	Changbai Mountain Scholars Program of The People's Government of Jilin Province Grant; Jilin Science and Technology Development Program Grant; Jilin Talent Development Foundation Grant; Fok Ying Tong Education Foundation Grant(Fok Ying Tung Education Foundation); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); startup funds from Northeast Normal University; Shanghai Institute of Materia Medica startup grant; Young Overseas High-Level Talents Introduction Plan from the Chinese government	The authors thank laboratory members Wangshu Qin, Sha Li, Xue Dong, Xiaoyue Chen, and Jiana Liu (Northeast Normal University), for helpful discussions and Shu-Sin Chng (National University of Singapore) for proofreading the manuscript. This study was supported by Changbai Mountain Scholars Program of The People's Government of Jilin Province Grant 2013046, Jilin Science and Technology Development Program Grant 20160101204JC, Jilin Talent Development Foundation Grant 111860000, Fok Ying Tong Education Foundation Grant 151022, National Natural Science Foundation of China Grants 31500957 and 31671225, and startup funds from Northeast Normal University 120401204 (all to Z.C.), and a Shanghai Institute of Materia Medica startup grant and Young Overseas High-Level Talents Introduction Plan from the Chinese government (to Y.Z.). The authors declare no conflicts of interest.	Armendariz-Borunda J, 2006, GUT, V55, P1663, DOI 10.1136/gut.2006.107136; BERGER ML, 1986, HEPATOLOGY, V6, P36, DOI 10.1002/hep.1840060108; Chen G., 2009, PCT Patent Publication, Patent No. [WO 2009159011, 2009159011]; Chen Z, 2015, MOL METAB, V4, P951, DOI 10.1016/j.molmet.2015.09.013; Chen Z, 2015, AM J PHYSIOL-ENDOC M, V308, pE460, DOI 10.1152/ajpendo.00470.2014; Chen Z, 2014, MOL ENDOCRINOL, V28, P696, DOI 10.1210/me.2013-1333; Chen Z, 2014, DIABETES, V63, P585, DOI 10.2337/db13-0666; Chen Z, 2012, DIABETES, V61, P566, DOI 10.2337/db11-0474; Cubero FJ, 2015, J HEPATOL, V62, P140, DOI 10.1016/j.jhep.2014.08.029; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; de Leon-Boenig G, 2012, STRUCTURE, V20, P1704, DOI 10.1016/j.str.2012.07.013; Demchenko YN, 2014, ONCOTARGET, V5, P4554, DOI 10.18632/oncotarget.2128; Fagone P, 2016, DRUG DISCOV TODAY, V21, P369, DOI 10.1016/j.drudis.2015.10.015; Jiang BJ, 2015, J BIOL CHEM, V290, P11704, DOI 10.1074/jbc.M114.635086; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Lee IC, 2014, FOOD CHEM TOXICOL, V63, P174, DOI 10.1016/j.fct.2013.11.006; Qin WS, 2016, NUCLEIC ACIDS RES, V44, P6423, DOI 10.1093/nar/gkw341; ROCKEY DC, 1994, J INVEST MED, V42, P660; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Shi JL, 1998, AM J PATHOL, V153, P515, DOI 10.1016/S0002-9440(10)65594-0; SLATER TF, 1966, NATURE, V209, P36, DOI 10.1038/209036a0; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	26	38	40	2	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					711	718		10.1096/fj.201600840R	http://dx.doi.org/10.1096/fj.201600840R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871061	Green Submitted			2022-12-26	WOS:000394235400023
J	O'Shea, C; Staby, L; Bendsen, SK; Tidemand, FG; Redsted, A; Willemoes, M; Kragelund, BB; Skriver, K				O'Shea, Charlotte; Staby, Lasse; Bendsen, Sidsel Krogh; Tidemand, Frederik Gronbaek; Redsted, Andreas; Willemoes, Martin; Kragelund, Birthe B.; Skriver, Karen			Structures and Short Linear Motif of Disordered Transcription Factor Regions Provide Clues to the Interactome of the Cellular Hub Protein Radical-induced Cell Death1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; STRUCTURE PREDICTION; SECONDARY STRUCTURE; INTRINSIC DISORDER; STRESS RESPONSES; OXIDATIVE STRESS; LEAF SENESCENCE; BINDING; RESOURCE; DOMAIN	Intrinsically disordered protein regions (IDRs) lack a well defined three-dimensional structure but often facilitate key protein functions. Some interactions between IDRs and folded protein domains rely on short linear motifs (SLiMs). These motifs are challenging to identify, but once found they can point to larger networks of interactions, such as with proteins that serve as hubs for essential cellular functions. The stress-associated plant protein radical-induced cell death1 (RCD1) is one such hub, interacting with many transcription factors via their flexible IDRs. To identify the SLiM bound by RCD1, we analyzed the IDRs in three protein partners, DREB2A (dehydration-responsive element-binding protein 2A), ANAC013, and ANAC046, considering parameters such as disorder, context, charges, and pI. Using a combined bioinformatics and experimental approach, we have identified the bipartite RCD1-binding SLiM as (DE) X(1,2)(YF) X(1,4)(DE)L, with essential contributions from conserved aromatic, acidic, and leucine residues. Detailed thermodynamic analysis revealed both favorable and unfavorable contributions from the IDRs surrounding the SLiM to the interactions with RCD1, and the SLiM affinities ranged from low nanomolar to 50 times higher K-d values. Specifically, although the SLiM was surrounded by IDRs, individual intrinsic alpha-helix propensities varied as shown by CD spectroscopy. NMR spectroscopy further demonstrated that DREB2A underwent coupled folding and binding with alpha-helix formation upon interaction with RCD1, whereas peptides from ANAC013 and ANAC046 formed different structures or were fuzzy in the complexes. These findings allow us to present a model of the stress-associated RCD1-transcription factor interactome and to contribute to the emerging understanding of the interactions between folded hubs and their intrinsically disordered partners.	[O'Shea, Charlotte; Staby, Lasse; Bendsen, Sidsel Krogh; Tidemand, Frederik Gronbaek; Redsted, Andreas; Willemoes, Martin; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci, 5 Ole Maaloes Vej, DK-2200 Copenhagen, Denmark	University of Copenhagen	Skriver, K (corresponding author), Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci, 5 Ole Maaloes Vej, DK-2200 Copenhagen, Denmark.	kskriver@bio.ku.dk	Skriver, Karen/K-9860-2014; Kragelund, Birthe/M-3927-2014; Willemoes, Martin/K-4359-2014; Tidemand, Frederik/N-2396-2016	Skriver, Karen/0000-0003-2225-4012; Kragelund, Birthe/0000-0002-7454-1761; Willemoes, Martin/0000-0003-1689-2712; Tidemand, Frederik/0000-0001-8914-9626; Staby, Lasse/0000-0002-5588-5163	Danish Research Councils [4181-00344]	Danish Research Councils(Det Frie Forskningsrad (DFF))	This work was supported by Danish Research Councils Grant 4181-00344 (to B. B. K. and K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098575; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balsa-Canto E, 2016, BIOINFORMATICS, V32, P3357, DOI 10.1093/bioinformatics/btw411; Bienkiewicz EA, 2002, BIOCHEMISTRY-US, V41, P752, DOI 10.1021/bi015763t; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cino EA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02305; Das RK, 2016, P NATL ACAD SCI USA, V113, P5616, DOI 10.1073/pnas.1516277113; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dunlap TB, 2013, PROTEINS, V81, P607, DOI 10.1002/prot.24215; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gibson TJ, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0121-y; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Heller GT, 2015, TRENDS BIOCHEM SCI, V40, P491, DOI 10.1016/j.tibs.2015.07.004; Hiltscher H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00475; Jaspers P, 2010, PLANT SIGNAL BEHAV, V5, P78, DOI 10.4161/psb.5.1.10293; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Kragelund BB, 2012, TRENDS PLANT SCI, V17, P625, DOI 10.1016/j.tplants.2012.06.010; Ladbury JE, 2010, BIOCHEM SOC T, V38, P888, DOI 10.1042/BST0380888; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Munoz V, 1996, FOLD DES, V1, P167, DOI 10.1016/S1359-0278(96)00029-6; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; O'Shea C, 2015, BIOCHEM J, V465, P281, DOI 10.1042/BJ20141045; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sakuraba Y, 2015, PLANT CELL, V27, P1771, DOI 10.1105/tpc.15.00222; Song JH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003239; SPERA S, 1991, Journal of Biomolecular NMR, V1, P155, DOI 10.1007/BF01877227; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stender EG, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1010967; Teotia S, 2009, PLANT PHYSIOL, V151, P180, DOI 10.1104/pp.109.142786; Tiwari SB, 2012, PLANT J, V70, P855, DOI 10.1111/j.1365-313X.2012.04935.x; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Vermeirssen V, 2014, PLANT CELL, V26, P4656, DOI 10.1105/tpc.114.131417; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wong ETC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003192; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	64	36	36	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					512	527		10.1074/jbc.M116.753426	http://dx.doi.org/10.1074/jbc.M116.753426			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27881680	Green Published, hybrid			2022-12-26	WOS:000392316100009
J	Primo, C; Ferri-Blazquez, A; Loewith, R; Yenush, L				Primo, Cecilia; Ferri-Blazquez, Alba; Loewith, Robbie; Yenush, Lynne			Reciprocal Regulation of Target of Rapamycin Complex 1 and Potassium Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP1 PERMEASE UBIQUITYLATION; PPZ PROTEIN PHOSPHATASES; CELL-GROWTH CONTROL; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; SIGNALING PATHWAY; UBIQUITIN LIGASE; SALT TOLERANCE; H+-ATPASE; NITROGEN-UPTAKE	The proper maintenance of potassium homeostasis is crucial for cell viability. Among the major determinants of potassium uptake in the model organism Saccharomyces cerevisiae are the Trk1 high affinity potassium transporter and the functionally redundant Hal4 (Sat4) and Hal5 protein kinases. These kinases are required for the plasma membrane accumulation of not only Trk1 but also several nutrient permeases. Here, we show that overexpression of the target of rapamycin complex 1 (TORC1) effector NPR1 improves hal4 hal5 growth defects by stabilizing nutrient permeases at the plasma membrane. We subsequently found that internal potassium levels and TORC1 activity are linked. Specifically, growth under limiting potassium alters the activities of Npr1 and another TORC1 effector kinase, Sch9; hal4 hal5 and trk1 trk2 mutants display hypersensitivity to rapamycin, and reciprocally, TORC1 inhibition reduces potassium accumulation. Our results demonstrate that in addition to carbon and nitrogen, TORC1 also responds to and regulates potassium fluxes.	[Primo, Cecilia; Ferri-Blazquez, Alba; Yenush, Lynne] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, Avd Naranjos S-N, E-46022 Valencia, Spain; [Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Loewith, Robbie] Univ Geneva, Inst Genet & Genom Geneva IGE3, Swiss Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Geneva; University of Geneva	Yenush, L (corresponding author), Inst Biol Mol & Celular Plantas, C Vera S-N, Valencia 46022, Spain.	lynne@ibmcp.upv.es	Primo, Cecilia/AAT-8561-2021; Primo Planta, Cecilia/AAU-1204-2021; Yenush, Lynne/J-8815-2014; Loewith, Robbie/S-6289-2016	Primo Planta, Cecilia/0000-0002-3305-5150; Yenush, Lynne/0000-0001-8589-7002; Loewith, Robbie/0000-0002-2482-603X; Ferri-Blazquez, Alba/0000-0002-4533-5117	Spanish Ministry of Science and Innovation (Madrid, Spain) [BFU2011-30197-C03-03]; Spanish Research Council (Consejo Superior de Investigaciones Cientificas); Swiss National Science Foundation; European Research Council; Canton of Geneva	Spanish Ministry of Science and Innovation (Madrid, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Research Council (Consejo Superior de Investigaciones Cientificas); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Canton of Geneva	This work was supported by Spanish Ministry of Science and Innovation (Madrid, Spain) Grant BFU2011-30197-C03-03 (to L. Y.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a pre-doctoral fellowship from the Spanish Research Council (Consejo Superior de Investigaciones Cientificas).; Supported by the Swiss National Science Foundation, the European Research Council, and the Canton of Geneva.	Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Bihler H, 2002, BBA-BIOMEMBRANES, V1558, P109, DOI 10.1016/S0005-2736(01)00414-X; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Brachmann CB, 1998, YEAST, V14, P115; Crapeau M, 2014, J BIOL CHEM, V289, P22103, DOI 10.1074/jbc.M114.582320; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; GRENSON M, 1982, EUR J BIOCHEM, V121, P643, DOI 10.1111/j.1432-1033.1982.tb05834.x; Hallett JEH, 2014, GENETICS, V198, P773, DOI 10.1534/genetics.114.168369; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hirasaki M, 2011, J BIOSCI BIOENG, V111, P249, DOI 10.1016/j.jbiosc.2010.11.013; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KO CH, 1993, MOL CELL BIOL, V13, P638, DOI 10.1128/MCB.13.1.638; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; LUBIN M, 1964, BIOCHIM BIOPHYS ACTA, V80, P614, DOI 10.1016/0926-6550(64)90306-8; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Navarrete C, 2010, FEMS YEAST RES, V10, P508, DOI 10.1111/j.1567-1364.2010.00630.x; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Omura F, 2004, FEMS MICROBIOL LETT, V230, P227, DOI 10.1016/S0378-1097(03)00918-2; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Perez-Valle J, 2010, EUKARYOT CELL, V9, P1881, DOI 10.1128/EC.00184-10; Petrezselyova S, 2010, FUNGAL BIOL-UK, V114, P144, DOI 10.1016/j.funbio.2009.11.002; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vargas RC, 2007, EUKARYOT CELL, V6, P134, DOI 10.1128/EC.00290-06; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wright MB, 1997, J BIOL CHEM, V272, P13647, DOI 10.1074/jbc.272.21.13647; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Zeng L, 2013, ELECTROPHORESIS, V34, P2234, DOI 10.1002/elps.201300140; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	57	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					563	574		10.1074/jbc.M116.746982	http://dx.doi.org/10.1074/jbc.M116.746982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27895122	Green Published, hybrid			2022-12-26	WOS:000392316100013
J	Mauricio, RPM; Jeffries, CM; Svergun, DI; Deane, JE				Mauricio, Rui P. M.; Jeffries, Cy M.; Svergun, Dmitri I.; Deane, Janet E.			The Shigella Virulence Factor IcsA Relieves N-WASP Autoinhibition by Displacing the Verprolin Homology/Cofilin/Acidic (VCA) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTILITY; WISKOTT-ALDRICH-SYNDROME; X-RAY-SCATTERING; SMALL-ANGLE SCATTERING; I-TASSER SERVER; ESCHERICHIA-COLI; SYNDROME PROTEIN; INTRACELLULAR MOTILITY; AUTOTRANSPORTER ICSA; LIGAND INTERACTIONS	Shigella flexneri is a bacterial pathogen that invades cells of the gastrointestinal tract, causing severe dysentery. Shigella mediates intracellular motility and spreading via actin comet tail formation. This process is dependent on the surface-exposed, membrane-embedded virulence factor IcsA, which recruits the host actin regulator N-WASP. Although it is clear that Shigella requires N-WASP for this process, the molecular details of this interaction and the mechanism of N-WASP activation remain poorly understood. Here, we show that co-expression of full-length IcsA and the Shigella membrane protease IcsP yields highly pure IcsA passenger domain (residues 53-758). We show that IcsA is monomeric and describe the solution structure of the passenger domain obtained by small-angle X-ray scattering (SAXS) analysis. The SAXS-derived models suggest that IcsA has an elongated shape but, unlike most other autotransporter proteins, possesses a central kink revealing a distinctly curved structure. Pull-down experiments show direct binding of the IcsA passenger domain to both the WASP homology 1 (WH1) domain and the GTPase binding domain (GBD) of N-WASP and no binding to the verprolin homology/cofilin/acidic (VCA) region. Using fluorescence polarization experiments, we demonstrate that IcsA binding to the GBD region displaces the VCA peptide and that this effect is synergistically enhanced upon IcsA binding to the WH1 region. Additionally, domain mapping of the IcsA interaction interface reveals that different regions of IcsA bind to the WH1 and GBD domains of N-WASP. Taken together, our data support a model where IcsA and N-WASP form a tight complex releasing the N-WASP VCA domain to recruit the host cell machinery for actin tail formation.	[Mauricio, Rui P. M.; Deane, Janet E.] Univ Cambridge, Dept Pathol, Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England; [Jeffries, Cy M.; Svergun, Dmitri I.] DESY, Hamburg Outstn, European Mol Biol Lab, D-22067 Hamburg, Germany	University of Cambridge; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Deane, JE (corresponding author), Univ Cambridge, Dept Pathol, Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.	jed55@cam.ac.uk		Svergun, Dmitri/0000-0003-0830-5696; Deane, Janet/0000-0002-4863-0330; /0000-0002-8718-7343	Wellcome Trust Strategic Award [100140]	Wellcome Trust Strategic Award(Wellcome Trust)	We thank Stephen Graham for helpful discussions and advice, Nele Dieckmann and Tom O'Loughlin for early contributions to this work, and Robin Antrobus for carrying out mass spectrometry experiments. The Cambridge Institute for Medical Research is supported by Wellcome Trust Strategic Award 100140.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Cheng HC, 2008, NATURE, V454, P1009, DOI 10.1038/nature07160; dHauteville H, 1996, INFECT IMMUN, V64, P511, DOI 10.1128/IAI.64.2.511-517.1996; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; FUKUDA I, 1995, J BACTERIOL, V177, P1719, DOI 10.1128/jb.177.7.1719-1726.1995; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Graewert MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10734; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KOCKS C, 1995, MOL MICROBIOL, V18, P413, DOI 10.1111/j.1365-2958.1995.mmi_18030413.x; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mounier J, 1999, J CELL SCI, V112, P2069; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Shibata T, 2002, CURR BIOL, V12, P341, DOI 10.1016/S0960-9822(02)00689-9; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Suzuki T, 1996, J BIOL CHEM, V271, P21878, DOI 10.1074/jbc.271.36.21878; Suzuki T, 1998, JPN J MED SCI BIOL, V51, pS63, DOI 10.7883/yoken1952.51.Supplement1_S63; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					134	145		10.1074/jbc.M116.758003	http://dx.doi.org/10.1074/jbc.M116.758003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881679	Green Published, hybrid			2022-12-26	WOS:000391578000012
J	Vella, S; Tavanti, E; Hattinger, CM; Fanelli, M; Versteeg, R; Koster, J; Picci, P; Serra, M				Vella, Serena; Tavanti, Elisa; Hattinger, Claudia Maria; Fanelli, Marilu; Versteeg, Rogier; Koster, Jan; Picci, Piero; Serra, Massimo			Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells	PLoS One			English	Article							CYCLIN-DEPENDENT KINASES; IN-VITRO; EMERGING DRUGS; R-ROSCOVITINE; CANCER CELLS; HIGH-GRADE; INHIBITOR; RESISTANCE; APOPTOSIS; LINES	Cyclin-dependent kinase 2 (CDK2) has been reported to be essential for cell proliferation in several human tumours and it has been suggested as an appropriate target to be considered in order to enhance the efficacy of treatment regimens based on the use of DNA damaging drugs. We evaluated the clinical impact of CDK2 overexpression on a series of 21 high-grade osteosarcoma (OS) samples profiled by using cDNA microarrays. We also assessed the in vitro efficacy of the CDKs inhibitor roscovitine in a panel of drug-sensitive and drug-resistant human OS cell lines. OS tumour samples showed an inherent overexpression of CDK2, and high expression levels at diagnosis of this kinase appeared to negatively impact on clinical outcome. CDK2 expression also proved to be relevant for in vitro OS cells growth. These findings indicated CDK2 as a promising candidate therapeutic marker for OS and therefore we assessed the efficacy of the CDKs-inhibitor roscovitine in both drug-sensitive and -resistant OS cell lines. All cell lines resulted to be responsive to roscovitine, which was also able to increase the activity of cisplatin and doxorubicin, the two most active DNA damaging drugs used in OS chemotherapy. Our results indicated that combined treatment with conventional OS chemotherapeutic drugs and roscovitine may represent a new candidate intervention approach, which may be considered to enhance tumour cell sensitivity to DNA damaging drugs.	[Vella, Serena; Tavanti, Elisa; Hattinger, Claudia Maria; Fanelli, Marilu; Picci, Piero; Serra, Massimo] Orthopaed Rizzoli Inst, Expt Oncol Lab, Bologna, Italy; [Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Serra, M (corresponding author), Orthopaed Rizzoli Inst, Expt Oncol Lab, Bologna, Italy.	massimo.serra@ior.it	Versteeg, Rogier/AAQ-1765-2020; Serra, Massimo/J-4878-2016; Koster, Jan/C-5934-2008; Hattinger, Claudia/Q-1212-2016	Serra, Massimo/0000-0003-0742-1177; Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Hattinger, Claudia/0000-0002-9316-5095	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) [IG2014 I.d.15851]; Istituto Ortopedico Rizzoli	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); Istituto Ortopedico Rizzoli	This study was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C. www.airc.it; grant to MS, IG2014 I.d.15851) and the Istituto Ortopedico Rizzoli (www.ior.it; 5 parts per thousand contributions to Rizzoli Institute). Dr. ET received a fellowship from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) to perform the research project "Pre-clinical validation of approaches targeting protein kinases in osteosarcoma". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza MSI, 2008, WORLD J GASTROENTERO, V14, P5162, DOI 10.3748/wjg.14.5162; Abbotts R, 2014, CANCER MANAG RES, V6, P77, DOI 10.2147/CMAR.S50497; Achille C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052356; Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Bruyere C, 2013, CURR OPIN CELL BIOL, V25, P772, DOI 10.1016/j.ceb.2013.08.004; Cicenas J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.61; Coley HM, 2007, GYNECOL ONCOL, V105, P462, DOI 10.1016/j.ygyno.2007.01.004; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ferrari S, 2015, EXPERT OPIN PHARMACO, V16, P2727, DOI 10.1517/14656566.2015.1102226; Fischer PM, 2003, EXPERT OPIN INV DRUG, V12, P955, DOI 10.1517/eoid.12.6.955.21792; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Han XF, 2014, CYTOTECHNOLOGY, V66, P567, DOI 10.1007/s10616-013-9604-0; Hattinger CM, 2015, EXPERT OPIN EMERG DR, V20, P495, DOI 10.1517/14728214.2015.1051965; Hattinger CM, 2015, HISTOPATHOLOGY, V67, P338, DOI 10.1111/his.12653; Hattinger CM, 2010, EXPERT OPIN EMERG DR, V15, P615, DOI 10.1517/14728214.2010.505603; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khalil HS, 2015, J BIOTECHNOL, V202, P40, DOI 10.1016/j.jbiotec.2015.02.032; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Le Tourneau C, 2010, EUR J CANCER, V46, P3243, DOI 10.1016/j.ejca.2010.08.001; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Messerschmitt PJ, 2008, CLIN ORTHOP RELAT R, V466, P2168, DOI 10.1007/s11999-008-0338-9; Mohapatra S, 2005, CANCER RES, V65, P7717, DOI 10.1158/0008-5472.CAN-05-0347; Mohapatra S, 2007, MOL CANCER RES, V5, P145, DOI 10.1158/1541-7786.MCR-06-0300; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pasello M, 2008, CANCER RES, V68, P6661, DOI 10.1158/0008-5472.CAN-07-5840; Pepper C, 2003, CELL CYCLE, V2, P53, DOI 10.4161/cc.2.1.249; Pitts TM, 2014, PHARMACOL THERAPEUT, V142, P258, DOI 10.1016/j.pharmthera.2013.12.010; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Senderowicz AM, 2003, CANCER BIOL THER, V2, pS84; Sero V, 2014, INVEST NEW DRUG, V32, P1167, DOI 10.1007/s10637-014-0158-6; SERRA M, 1993, ANTICANCER RES, V13, P323; Serra M, 2004, ANN ONCOL, V15, P151, DOI 10.1093/annonc/mdh004; Siemeister G, 2012, MOL CANCER THER, V11, P2265, DOI 10.1158/1535-7163.MCT-12-0286; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Tavanti E, 2013, BRIT J CANCER, V109, P2607, DOI 10.1038/bjc.2013.643; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wesierska-Gadek J, 2009, ANN NY ACAD SCI, V1171, P228, DOI 10.1111/j.1749-6632.2009.04726.x; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002	49	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166233	10.1371/journal.pone.0166233	http://dx.doi.org/10.1371/journal.pone.0166233			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898692	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474000006
J	Weston, C; Klobusicky, J; Weston, J; Connor, J; Toms, SA; Marko, NF				Weston, Cody; Klobusicky, Joe; Weston, Jennifer; Connor, James; Toms, Steven A.; Marko, Nicholas F.			Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas	PLOS ONE			English	Article							PROTEASE MATRIPTASE-2 TMPRSS6; HYDROGEN-PEROXIDE; CANCER GENOMICS; FENTON REACTION; STEAP PROTEINS; DNA DAMAGE; HFE; GLIOBLASTOMA; CELLS; PROLIFERATION	Iron is a tightly regulated micronutrient with no physiologic means of elimination and is necessary for cell division in normal tissue. Recent evidence suggests that dysregulation of iron regulatory proteins may play a role in cancer pathophysiology. We use public data from The Cancer Genome Atlas (TCGA) to study the association between survival and expression levels of 61 genes coding for iron regulatory proteins in patients with World Health Organization Grade II-III gliomas. Using a feature selection algorithm we identified a novel, optimized subset of eight iron regulatory genes (STEAP3, HFE, TMPRSS6, SFXN1, TFRC, UROS, SLC11A2, and STEAP4) whose differential expression defines two phenotypic groups with median survival differences of 52.3 months for patients with grade II gliomas (25.9 vs. 78.2 months, p< 10(-3)), 43.5 months for patients with grade III gliomas (43.9 vs. 87.4 months, p = 0.025), and 54.0 months when considering both grade II and III gliomas (79.9 vs. 25.9 months, p < 10(-5)).	[Weston, Cody; Connor, James] Penn State Milton S Hershey Med Ctr, Coll Med, Hershey, PA USA; [Klobusicky, Joe] Geisinger Med Ctr, Dept Data Sci, Danville, PA 17822 USA; [Weston, Jennifer] Penn State Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA USA; [Toms, Steven A.; Marko, Nicholas F.] Geisinger Med Ctr, Dept Neurosurg, Danville, PA 17822 USA; [Marko, Nicholas F.] Penn State Sch Med, Dept Surg, Danville, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Weston, C (corresponding author), Penn State Milton S Hershey Med Ctr, Coll Med, Hershey, PA USA.	cweston@hmc.psu.edu			Geisinger Health System; Penn State University	Geisinger Health System; Penn State University	This project was funded entirely through internal organizational funds provided through Geisinger Health System and Penn State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikyol B, 2013, NEUROSCIENCE, V235, P119, DOI 10.1016/j.neuroscience.2013.01.014; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; CAZZOLA M, 1990, BLOOD, V75, P1903; Ceci A, 2002, BRIT J HAEMATOL, V118, P330, DOI 10.1046/j.1365-2141.2002.03554.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chirasani SR, 2009, J MOL MED, V87, P153, DOI 10.1007/s00109-008-0414-3; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Dayani PN, 2004, J NEURO-ONCOL, V67, P367, DOI 10.1023/B:NEON.0000024238.21349.37; di Montemuros FM, 2001, NEUROLOGY, V57, P1342, DOI 10.1212/WNL.57.7.1342; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gomes IM, 2012, MOL CANCER RES, V10, P573, DOI 10.1158/1541-7786.MCR-11-0281; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Isobe T, 2011, EXP CELL RES, V317, P2582, DOI 10.1016/j.yexcr.2011.07.022; Jacobsen A., CGDSR R BAS API ACCE; Jiang XP, 2010, ANTICANCER RES, V30, P759; Jin Y, 2015, EMBO MOL MED, V7, P315, DOI 10.15252/emmm.201404181; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Kennedy AE, 2014, LEUKEMIA RES, V38, P1055, DOI 10.1016/j.leukres.2014.06.016; Kim H, 2013, INT J NANOMED, V8, P57, DOI 10.2147/IJN.S40733; LAHAV M, 1985, CANCER LETT, V25, P305, DOI 10.1016/S0304-3835(15)30010-0; Lee SY, 2015, J NEURO-ONCOL, V122, P97, DOI 10.1007/s11060-014-1681-1; Lee SY, 2011, INT J CANCER, V129, P2104, DOI 10.1002/ijc.25888; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x; Roy CN, 2001, HUM MOL GENET, V10, P2181, DOI 10.1093/hmg/10.20.2181; Sakurai K, 2014, HEPATO-GASTROENTEROL, V61, P426, DOI 10.5754/hge13969; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Simon N, 2011, J STAT SOFTW, V39, P1; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weston CL, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-14; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	40	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166593	10.1371/journal.pone.0166593	http://dx.doi.org/10.1371/journal.pone.0166593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898674	Green Published, gold			2022-12-26	WOS:000389474000012
J	Bian, QX; Wang, WH; Wang, NN; Peng, Y; Ma, W; Dai, RH				Bian, Qiaoxia; Wang, Weihui; Wang, Nannan; Peng, Yan; Ma, Wen; Dai, Ronghua			Quantification of Arachidonic Acid and Its Metabolites in Rat Tissues by UHPLC-MS/MS: Application for the Identification of Potential Biomarkers of Benign Prostatic Hyperplasia	PLOS ONE			English	Article							CHRONIC INFLAMMATION; BPH	To evaluate the potential relationship between benign prostatic hyperplasia (BPH) and the arachidonic acid (AA) metabolome, a UHPLC-MS/MS method has been developed and validated for simultaneous determination of AA and its cyclooxygenase(COX) and lipoxygenase( LOX) pathway metabolites (15-HETE, 12-HETE, TXA(2), 5-HETE, AA, PGI(2), PGF(2 alpha), 8-HETE, PGD(2), PGE(2) and LTB4) in rat tissues. The analytes were extracted from tissue samples with a protein precipitation procedure and then separated on a Shim-pack XR-ODSC18 column with 0.05% formic acid in water (pH adjusted with dilute ammonia) and methanol: acetonitrile (20: 80, v/v). Detection was performed on a UHPLC-MS/MS system with electrospray negative ionization (ESI) and a multiple reaction-monitoring mode. The lower limits of quantification (LLOQ) were 0.25-50 ng/mL for all of the analytes in the prostate, seminal, bladder, liver and kidney tissues. The absolute recoveries of the analytes from all of the tissues were more than 50%. By means of the method developed, the AA metabolites in tissue samples from Sham and BPH group rats were determined. The eleven bio-markers in the BPH group prostate, seminal, bladder, liver and kidney tissues were significantly higher than those of the sham group, indicating that BPH fortified the inducible expression of COX and LOX, as well as increased the production of AA and eicosanoids. The method described here offers a useful tool for the evaluation of complex regulatory eicosanoids responses in vivo.	[Bian, Qiaoxia; Wang, Weihui; Wang, Nannan; Peng, Yan; Ma, Wen; Dai, Ronghua] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China	Shenyang Pharmaceutical University	Dai, RH (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China.	ronghuadai@sina.com			Natural Science Foundation of Liaoning province, China [201602690]	Natural Science Foundation of Liaoning province, China(Natural Science Foundation of Liaoning Province)	This study was supported by the Natural Science Foundation of Liaoning province, China (No. 201602690). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Natural Science Foundation of Liaoning province, China (No. 201602690).	Altavilla D., 2013, J BR J PHARM, V157, P1410; [Anonymous], 2001, GUIDANCE IND BIOANAL; Bian QX, 2016, J PHARMACEUT BIOMED, V128, P149, DOI 10.1016/j.jpba.2016.05.027; Claus G., 2001, J UROLOGY, V58, P642; Donnell RF, 2011, CURR OPIN UROL, V21, P22, DOI 10.1097/MOU.0b013e32834100dd; Fibbi B, 2010, INT J ANDROL, V33, P475, DOI 10.1111/j.1365-2605.2009.00972.x; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Kessler OJ, 1998, J UROLOGY, V159, P1049, DOI 10.1016/S0022-5347(01)63834-5; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Larre S, 2008, PROSTAG OTH LIPID M, V87, P14, DOI 10.1016/j.prostaglandins.2008.05.001; Reem T, 2013, TOXICOL LETT, V219, P160; Roehrborn CG, 2011, MED CLIN N AM, V95, P87, DOI 10.1016/j.mcna.2010.08.013; Shinde DD, 2012, J CHROMATOGR B, V911, P113, DOI 10.1016/j.jchromb.2012.11.004; Warren JW, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.08.059; Xian Y, 2014, J ETHNOPHARMACOL, V157, P105, DOI [10.1016/j.jep.2014.09.025, DOI 10.1016/J.JEP.2014.09.025]; Yokomitso, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI [10.1006/abbi.2000.2168, DOI 10.1006/ABBI.2000.2168]	18	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166777	10.1371/journal.pone.0166777	http://dx.doi.org/10.1371/journal.pone.0166777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893755	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400043
J	Lieutaud, T; Gadegbeku, B; Ndiaye, A; Chiron, M; Viallon, V				Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian			The Decrease in Traumatic Brain Injury Epidemics Deriving from Road Traffic Collision Following Strengthened Legislative Measures in France	PLOS ONE			English	Article							GLASGOW COMA SCALE; PROGNOSTIC VALUE; HEAD-INJURY; MORTALITY; CASUALTIES; SEVERITY; MODERATE; CRASHES; OUTCOMES; ENGLAND	Background Since 2002, France has been strengthening legislation on road traffic. This study is intended to evaluate the changes in Traumatic Brain Injury (TBI) incidence and mortality resulting from Road Traffic Collision (RTC) in the two 6-year periods before and after 2002. Methods We used a Registry of all RTC casualties in the Rho A ne Department of France. Each casualty was coded according to the Abbreviated Injury Scale (AIS). The study describes changes in demographic variables, TBI (AIS >= 2) incidence and mortality, other body lesions (AIS >= 3) associated with TBI, road user types, seatbelt and helmet wearing. Findings RTC casualty occurrences decreased by 21% (from 64,312 to 50,746) during the period after 2002. TBI occurrence accounted for 8.6% and 6.7% of all RTC in both periods. This corresponds to a reduction of TBI casualty incidence (-42%), which was much more pronounced than RTC casualty incidence (-25%) (p < 0.0001). Severe and critical TBI (AIS-4 and -5) incidences were reduced by half as much (-21%), compared to TBI incidence. TBI mortality rate (among population) and lethality (among TBI related to RTC casualties) decreased 56% and 23%, respectively. This reduction particularly affected car occupants and victims who deceased. TBI incidence decreased 43% in all 10-year age classes until 60 on average, this decrease declining with age in the period after 2002. After adjustment for age, sex, road user types, and severity of lesions at the head and other body regions, logistic regression analysis displayed a protective effect of the period following 2002, on the risk of death after RTC-related TBI. Interpretation The greater reductions in the incidence, severity and mortality of TBI when compared with the reduction of casualty incidence have mainly affected car users. These results should be attributable to the improvements in standards of care, primary safety of the car fleet and general road architecture safety. However, the increased reduction in the TBI epidemics in France, when compared to those observed in other developed countries for the same periods, suggests that the effects should be strongly attributable to changes in road user behaviour induced by law enforcement. The at-risk groups for TBI after RTC are now two-wheel users ( motorized or not) and individuals over 60 years of age.	[Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian] IFSTTAR, UMRESTTE, UMR T 9405, Bron, France; [Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian] Univ Lyon, Lyon, France; [Lieutaud, Thomas] Univ Lyon, Univ Claude Bernard Lyon 1, Team TIGER, INSERM,U10128,CNRS,UMR5292,Lyon Neurosci Res Ctr, Lyon, France	Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lieutaud, T (corresponding author), IFSTTAR, UMRESTTE, UMR T 9405, Bron, France.; Lieutaud, T (corresponding author), Univ Lyon, Lyon, France.; Lieutaud, T (corresponding author), Univ Lyon, Univ Claude Bernard Lyon 1, Team TIGER, INSERM,U10128,CNRS,UMR5292,Lyon Neurosci Res Ctr, Lyon, France.	thomas.lieutaud@gmail.com	Gadegbeku, Blandine/AAE-3618-2019	Gadegbeku, Blandine/0000-0001-6720-206X	Institut National de Veille sanitaire Ministere de l'equipement	Institut National de Veille sanitaire Ministere de l'equipement	This work was funded by Institut National de Veille sanitaire Ministere de l'equipement.	Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blomberg RD, 2009, J SAFETY RES, V40, P285, DOI 10.1016/j.jsr.2009.07.002; Braver ER, 2003, ACCIDENT ANAL PREV, V35, P295, DOI 10.1016/S0001-4575(01)00106-3; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clark DE, 2003, ACCIDENT ANAL PREV, V35, P965, DOI 10.1016/S0001-4575(02)00104-5; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Edwards P, 2005, LANCET, V365, P1957; Eksler V, 2008, PUBLIC HEALTH, V122, P826, DOI 10.1016/j.puhe.2007.10.003; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Hetland A, 2014, ANN PHARMACOTHER, V48, P494, DOI 10.1177/1060028014520882; Heyes Gavin J, 2014, Ulster Med J, V83, P55; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Laumon B, 1997, 41 ANN P ASS ADV AUT, P127; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Licaj I, 2011, ACCIDENT ANAL PREV, V43, P1617, DOI 10.1016/j.aap.2011.02.003; Lieutaud T, 2012, J NEUROTRAUM, V29, P479, DOI 10.1089/neu.2011.1880; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nash S., 2014, Annals of Physical and Rehabilitation Medicine, V57, P600, DOI 10.1016/j.rehab.2014.08.010; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pilkington P, 2005, BMJ-BRIT MED J, V330, P331, DOI 10.1136/bmj.38324.646574.AE; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Viallon V, 2013, ACCIDENT ANAL PREV, V52, P250, DOI 10.1016/j.aap.2012.12.024; Yeguiayan JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11375	41	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167082	10.1371/journal.pone.0167082	http://dx.doi.org/10.1371/journal.pone.0167082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893865	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400080
J	Shen, P; Murphy, DV; George, SJ; Lapis-Gaza, H; Xu, MG; Gleeson, DB				Shen, Pu; Murphy, Daniel Vaughan; George, Suman J.; Lapis-Gaza, Hazel; Xu, Minggang; Gleeson, Deirdre Bridget			Increasing the Size of the Microbial Biomass Altered Bacterial Community Structure which Enhances Plant Phosphorus Uptake	PLOS ONE			English	Article							HIGHLY WEATHERED SOIL; MULTIVARIATE-ANALYSIS; AGRICULTURAL SOILS; ORGANIC-MATTER; FRACTIONS; AVAILABILITY; RHIZOSPHERE; DIVERSITY; CROP; GRASSLAND	Agricultural production can be limited by low phosphorus (P) availability, with soil P being constrained by sorption and precipitation reactions making it less available for plant uptake. There are strong links between carbon (C) and nitrogen (N) availability and P cycling within soil P pools, with microorganisms being an integral component of soil P cycling mediating the availability of P to plants. Here we tested a conceptual model that proposes (i) the addition of readily-available organic substrates would increase the size of the microbial biomass thus exhausting the pool of easily-available P and (ii) this would cause the microbial biomass to access P from more recalcitrant pools. In this model it is hypothesised that the size of the microbial population is regulating access to less available P rather than the diversity of organisms contained within this biomass. To test this hypothesis we added mixtures of simple organic compounds that reflect typical root exudates at different C:N ratios to a soil microcosm experiment and assessed changes in soil P pools, microbial biomass and bacterial diversity measures. We report that low C:N ratio (C:N = 12.5:1) artificial root exudates increased the size of the microbial biomass while high C: N ratio (C:N = 50:1) artificial root exudates did not result in a similar increase in microbial biomass. Interestingly, addition of the root exudates did not alter bacterial diversity (measured via univariate diversity indices) but did alter bacterial community structure. Where C, N and P supply was sufficient to support plant growth the increase observed in microbial biomass occurred with a concurrent increase in plant yield.	[Shen, Pu; Murphy, Daniel Vaughan; George, Suman J.; Lapis-Gaza, Hazel; Gleeson, Deirdre Bridget] Univ Western Australia, Sch Earth & Environm, Fac Sci, Soil Biol & Mol Ecol Grp, Perth, WA, Australia; [Shen, Pu; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Shanghai, Peoples R China	University of Western Australia; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Gleeson, DB (corresponding author), Univ Western Australia, Sch Earth & Environm, Fac Sci, Soil Biol & Mol Ecol Grp, Perth, WA, Australia.	deirdre.gleeson@uwa.edu.au	; gleeson, deirdre/F-9894-2011	Murphy, Daniel/0000-0002-4686-9276; gleeson, deirdre/0000-0002-9069-7723	Grains Research and Development Corporation [UWA00150]; Australian Research Council [FT110100246]; University of Western Australia; China Scholarship Council [2011325039]	Grains Research and Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); University of Western Australia; China Scholarship Council(China Scholarship Council)	This work was funded by the Grains Research and Development Corporation (UWA00150; www.grdc.com.au), the Australian Research Council Future Fellowship Scheme (FT110100246; www.arc.gov.au) awarded to D.V.M, The University of Western Australia and a China Scholarship Council (2011325039) award to P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; BROOKES PC, 1984, SOIL BIOL BIOCHEM, V16, P169, DOI 10.1016/0038-0717(84)90108-1; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Bunemann EK, 2004, SOIL SCI SOC AM J, V68, P1645, DOI 10.2136/sssaj2004.1645; Bunemann EK, 2004, SOIL BIOL BIOCHEM, V36, P889, DOI [10.1016/j.soilbio.2004.02.002, 10.1016/S0038-0717(04)00052-5]; Carson JK, 2007, FEMS MICROBIOL ECOL, V61, P414, DOI 10.1111/j.1574-6941.2007.00361.x; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Certini G, 2004, SOIL BIOL BIOCHEM, V36, P1119, DOI 10.1016/j.soilbio.2004.02.022; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cleveland CC, 2014, OECOLOGIA, V174, P283, DOI 10.1007/s00442-013-2758-9; COLWELL J. D., 1963, AUSTRALIAN JOUR EXPTL AGRIC AND ANIMAL HUSB, V3, P190, DOI 10.1071/EA9630190; Condron L. M., 2005, Organic phosphorus in the environment, P295, DOI 10.1079/9780851998220.0295; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; Damon PM, 2007, AUST J AGR RES, V58, P816, DOI 10.1071/AR06402; Damon PM, 2014, SOIL BIOL BIOCHEM, V74, P127, DOI 10.1016/j.soilbio.2014.03.003; DeAngelis KM, 2011, APPL ENVIRON MICROB, V77, P6313, DOI 10.1128/AEM.05262-11; Ehlers K, 2010, SOIL BIOL BIOCHEM, V42, P558, DOI 10.1016/j.soilbio.2009.11.025; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gleeson DB, 2016, SCI TOTAL E IN PRESS; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; GRISWOLD BL, 1951, ANAL CHEM, V23, P192, DOI 10.1021/ac60049a041; Guo FM, 1998, SOIL SCI, V163, P822, DOI 10.1097/00010694-199810000-00006; Guppy CN, 2009, CROP PASTURE SCI, V60, P116, DOI 10.1071/CP07157; Hamdali H, 2008, APPL SOIL ECOL, V38, P12, DOI 10.1016/j.apsoil.2007.08.007; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Iyamuremye F, 1996, SOIL SCI, V161, P436, DOI 10.1097/00010694-199607000-00003; KRAFFCZYK I, 1984, SOIL BIOL BIOCHEM, V16, P315, DOI 10.1016/0038-0717(84)90025-7; Kwabiah AB, 2003, AGR ECOSYST ENVIRON, V100, P53, DOI 10.1016/S0167-8809(03)00171-3; Lapis-Gaza HR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0334-z; Lehmann J, 2001, PLANT SOIL, V237, P309, DOI 10.1023/A:1013320721048; Mander C, 2012, SOIL BIOL BIOCHEM, V44, P93, DOI 10.1016/j.soilbio.2011.09.009; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Mori H, 2014, DNA RES, V21, P217, DOI 10.1093/dnares/dst052; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Oberson A., 2005, Organic phosphorus in the environment, P133, DOI 10.1079/9780851998220.0133; Oberson A, 1999, NUTR CYCL AGROECOSYS, V55, P77, DOI 10.1023/A:1009813008445; Oberson A, 2011, SOIL BIOL, V26, P431, DOI 10.1007/978-3-642-15271-9_17; Olander LP, 2004, ECOSYSTEMS, V7, P404, DOI 10.1007/s10021-004-0264-y; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Pearse SJ, 2006, PLANT SOIL, V288, P127, DOI 10.1007/s11104-006-9099-y; Pii Y, 2015, BIOL FERT SOILS, V51, P403, DOI 10.1007/s00374-015-0996-1; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Ragot S, 2013, GEODERMA, V202, P30, DOI 10.1016/j.geoderma.2013.03.006; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444; Ryan PR, 2014, PHYSIOL PLANTARUM, V151, P230, DOI 10.1111/ppl.12150; SEELING B, 1993, PLANT SOIL, V148, P277, DOI 10.1007/BF00012865; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; SMECK NE, 1985, GEODERMA, V36, P185, DOI 10.1016/0016-7061(85)90001-1; Terrazas RA, 2016, ADV APPL MICROBIOL, V95, P1, DOI 10.1016/bs.aambs.2016.03.001; TIAN G, 1995, APPL SOIL ECOL, V2, P25, DOI 10.1016/0929-1393(94)00033-4; Uroz S, 2012, GEOMICROBIOL J, V29, P88, DOI 10.1080/01490451.2010.523764; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vu DT, 2008, PLANT SOIL, V304, P21, DOI 10.1007/s11104-007-9516-x; Wang Y, 2013, PLANT SOIL, V362, P231, DOI 10.1007/s11104-012-1289-1; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zhang TQ, 2004, SOIL SCI SOC AM J, V68, P519, DOI 10.2136/sssaj2004.0519; Ziadi N, 2013, ADV AGRON, V122, P85, DOI 10.1016/B978-0-12-417187-9.00002-4	68	3	3	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166062	10.1371/journal.pone.0166062	http://dx.doi.org/10.1371/journal.pone.0166062			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893833	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400016
J	Ye, WQ; Ramos, EH; Wong, BC; Belsham, DD				Ye, Wenqing; Ramos, Ernesto H.; Wong, Brian C.; Belsham, Denise D.			Beneficial Effects of Metformin and/or Salicylate on Palmitate- or TNF alpha-Induced Neuroinflammatory Marker and Neuropeptide Gene Regulation in Immortalized NPY/AgRP Neurons	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; I-KAPPA-B; INDUCED INSULIN-RESISTANCE; FOOD-INTAKE; TARGETED DISRUPTION; SODIUM-SALICYLATE; HUMAN OBESITY; EXPRESSION	Neuropeptide Y (NPY)/Agouti-related peptide (AgRP)-expressing neurons in the hypothalamus induce feeding and decrease energy expenditure. With consumption of a diet high in fat, there is an increase in circulating saturated free fatty acids, including palmitate, leading to the development of neuroinflammation and secretion of cytokines, such as TNF alpha, and in turn activation of the canonical IKK beta/NFkB cascade. We describe a model of palmitate- and TNF alpha-induced neuroinflammation in a functionally characterized, immortalized NPY/AgRP-expressing cell model, mHypoE-46, to study whether the anti-diabetic metformin alone or in combination with the anti-inflammatory agent salicylate can ameliorate these detrimental effects. Treatment with palmitate increased mRNA expression of feeding peptides Npy and Agrp, and inflammatory cytokines Tnfa and Il-6, whereas treatment with TNFa increased mRNA expression of Npy, Nfkb, Ikba, Tnfa, and Il-6. The effects of metformin and/or sodium salicylate on these genes were assessed. Metformin increased phosphorylation of AMPK and S6K, while sodium salicylate increased phospho-AMPK and decreased phospho-S6K, but neither had any effect on -phospho-ERK,-JNK or -p38 in the mHypoE-46 NPY/AgRP neurons. Furthermore, we utilized a pre-treatment and/or co-treatment paradigm to model potential clinical regimens. We determined co-treatment with metformin or sodium salicylate alone was successful in alleviating changes observed in feeding peptide mRNA regulation, whereas a preventative pre-treatment with metformin and sodium salicylate together was able to alleviate palmitate- and TNF alpha-induced induction of NPY and/or AgRP mRNA levels. These results highlight important differences in reactive versus preventative treatments on palmitate- and TNF alpha-induced neuroinflammation in NPY/AgRP neurons.	[Ye, Wenqing; Ramos, Ernesto H.; Wong, Brian C.; Belsham, Denise D.] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Fac Med, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Belsham, DD (corresponding author), Univ Toronto, Dept Physiol, Fac Med, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Fac Med, Dept Obstet & Gynaecol, Toronto, ON, Canada.	d.belsham@utoronto.ca			Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation and Canada Research Chairs Program; Endocrine Society Summer Studentship; Banting and Best Diabetes Centre (BBDC) Summer Studentship; Banting and Best Diabetes Centre (BBDC) Graduate Studentship	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation and Canada Research Chairs Program; Endocrine Society Summer Studentship; Banting and Best Diabetes Centre (BBDC) Summer Studentship; Banting and Best Diabetes Centre (BBDC) Graduate Studentship	This work was supported by Canadian Institutes for Health Research (CIHR) and Canada Foundation for Innovation and Canada Research Chairs Program (DDB). WY was supported by an Endocrine Society Summer Studentship, EHR was supported by a Banting and Best Diabetes Centre (BBDC) Summer Studentship, and BCW was supported by a Banting and Best Diabetes Centre (BBDC) Graduate Studentship.	Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; [Anonymous], 2016, SATURATED FATTY ACID; Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bjorntorp P, 1999, DIABETIC MED, V16, P373, DOI 10.1046/j.1464-5491.1999.00067.x; Cakir I, 2013, J BIOL CHEM, V288, P17675, DOI 10.1074/jbc.M113.475343; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; CHEN M, 1978, DIABETES, V27, P750, DOI 10.2337/diabetes.27.7.750; Colwell John A, 2003, Diabetes Care, V26 Suppl 1, pS87; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dhillon SS, 2012, MOL CELL ENDOCRINOL, V358, P116, DOI 10.1016/j.mce.2012.03.012; Duan Y, 2013, NEURAL REGEN RES, V8, P2379, DOI 10.3969/j.issn.1673-5374.2013.25.009; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Guan XM, 1998, NEUROREPORT, V9, P3415, DOI 10.1097/00001756-199810260-00015; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; HORI T, 1991, BRAIN RES BULL, V27, P309, DOI 10.1016/0361-9230(91)90117-3; Hotamisligil G.S., 2008, INT J OBES S7, V32, pS52; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang Q, 2015, ANALYST, V140, P197, DOI 10.1039/c4an01443j; Kas MJH, 2005, J MOL ENDOCRINOL, V35, P159, DOI 10.1677/jme.1.01819; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim HJ, 2013, AM J PHYSIOL-REG I, V305, pR499, DOI 10.1152/ajpregu.00099.2013; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lv WS, 2012, BRAIN RES, V1444, P11, DOI 10.1016/j.brainres.2012.01.028; de Morentin PBM, 2010, BBA-MOL CELL BIOL L, V1801, P350, DOI 10.1016/j.bbalip.2009.09.016; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Mayer CM, 2009, MOL CELL ENDOCRINOL, V307, P99, DOI 10.1016/j.mce.2009.02.031; Michel C, 2003, PHYSIOL BEHAV, V78, P357, DOI 10.1016/S0031-9384(02)01002-8; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Morton GJ, 2001, INT J OBESITY, V25, pS56, DOI 10.1038/sj.ijo.0801915; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozes ON, 1999, NATURE, V401, P82; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vidarsdottir S, 2007, DIABETES, V56, P2547, DOI 10.2337/db07-0193; Wang XK, 2012, EXP DIABETES RES, DOI 10.1155/2012/847246; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166973	10.1371/journal.pone.0166973	http://dx.doi.org/10.1371/journal.pone.0166973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893782	Green Submitted, Green Published, gold			2022-12-26	WOS:000389472400065
J	Hamza, AA; Ahmed, MM; Elwey, HM; Amin, A				Hamza, Alaaeldin Ahmed; Ahmed, Mahguob Mohamed; Elwey, Hanan Mohamed; Amin, Amr			Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells	PLOS ONE			English	Article							BREAST-CANCER; OXIDATIVE STRESS; IN-VITRO; MAMMALIAN-CELLS; APOPTOSIS; ANTIOXIDANT; ASSAY; SUPPRESSION; PREVENTION; MECHANISM	Cardiotoxicity is a limiting factor of doxorubicin (DOX)-based anticancer therapy. Due to its beneficial effects, we investigated whether standardized extract of Melissa officinalis (MO) can attenuate doxorubicin-induced cardiotoxicity and can potentiate the efficacy of DOX against human breast cancer cells. MO was administered orally to male albino rats once daily for 10 consecutive days at doses of 250, 500 and 750 mg/kg b.wt. DOX (15 mg/kg b.wt. i.p.) was administered on the 8th day. MO protected against DOX-induced leakage of cardiac enzymes and histopathological changes. MO ameliorated DOX-induced oxidative stress as evidenced by decreasing lipid peroxidation, protein oxidation and total oxidant capacity depletion and by increasing antioxidant capacity. Additionally, MO pretreatment inhibited inflammatory responses to DOX by decreasing the expressions of nuclear factor kappa-B, tumor necrosis factor-alpha and cyclooxygenase-2 and the activity of myeloperoxidase. MO ameliorated DOX-induced apoptotic tissue damage in heart of rats. In vitro study showed that MO augmented the anticancer efficacy of DOX in human breast cancer cells (MCF-7) and potentiated oxidative damage and apoptosis. Thus, combination of DOX and MO may prove future cancer treatment protocols safer and more efficient.	[Hamza, Alaaeldin Ahmed] Natl Org Drug Control & Res NODCAR, Hormone Evaluat Dept, Giza, Egypt; [Ahmed, Mahguob Mohamed] NODCAR, Mol Drug Evaluat Dept, Giza, Egypt; [Elwey, Hanan Mohamed] NODCAR, Dept Analyt Chem, Giza, Egypt; [Amin, Amr] UAE Univ, Dept Biol, Al Ain, U Arab Emirates; [Amin, Amr] Cairo Univ, Dept Zool, Giza, Egypt	National Organization for Drug Control & Research (NODCAR); National Organization for Drug Control & Research (NODCAR); National Organization for Drug Control & Research (NODCAR); United Arab Emirates University; Egyptian Knowledge Bank (EKB); Cairo University	Amin, A (corresponding author), Natl Org Drug Control & Res NODCAR, Hormone Evaluat Dept, Giza, Egypt.	alaa17mm@gmail.com; a.amin@uaeu.ac.ae	Hamza, Alaaeldin Ahmed/O-9035-2017; Amin, Amr/I-2137-2019; Mustafa, Mahgoub/ABG-7779-2021	Hamza, Alaaeldin Ahmed/0000-0001-5450-1116; Amin, Amr/0000-0001-8888-1102; Mustafa, Mahgoub/0000-0001-8452-8651	Terry Fox Foundation [21S088]	Terry Fox Foundation	This work was supported by the Terry Fox Foundation, grant# 21S088. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmed AS, 2012, J ETHNOPHARMACOL, V143, P826, DOI 10.1016/j.jep.2012.08.004; Arceusz A, 2013, J PHARMACEUT BIOMED, V83, P215, DOI 10.1016/j.jpba.2013.05.020; Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003; Barros L, 2013, FOOD CHEM, V136, P1, DOI 10.1016/j.foodchem.2012.07.107; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bjelogrlic SK, 2005, ARCH BIOCHEM BIOPHYS, V97, P311; Block KI, 2015, SEMIN CANCER BIOL, V35, pS276, DOI 10.1016/j.semcancer.2015.09.007; Bolkent S, 2005, J ETHNOPHARMACOL, P99; Cummings J, 2004, BBA-REV CANCER, V1705, P53, DOI 10.1016/j.bbcan.2004.09.005; Dalloz F, 1999, FREE RADICAL BIO MED, V26, P785, DOI 10.1016/S0891-5849(98)00259-7; Dastmalchi K, 2008, LWT-FOOD SCI TECHNOL, V41, P391, DOI 10.1016/j.lwt.2007.03.007; de Sousa AC, 2004, J PHARM PHARMACOL, V56, P677, DOI 10.1211/0022357023321; De U, 2014, INT J ONCOL, V44, P167, DOI 10.3892/ijo.2013.2160; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gille L, 1997, FREE RADICAL BIO MED, V23, P775, DOI 10.1016/S0891-5849(97)00025-7; Hamza A, 2008, CELL BIOL TOXICOL, V24, P63, DOI 10.1007/s10565-007-9016-z; Hasinoff BB, 2003, FREE RADICAL BIO MED, V35, P1469, DOI 10.1016/j.freeradbiomed.2003.08.005; Herodez SS, 2003, FOOD CHEM, V80, P275, DOI 10.1016/S0308-8146(02)00382-5; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Khan HY, 2014, MOL NUTR FOOD RES, V58, P437, DOI 10.1002/mnfr.201300417; Khan N, 2008, BIOCHEM PHARMACOL, V76, P1333, DOI 10.1016/j.bcp.2008.07.015; Li W, 2009, BASIC CLIN PHARMACOL, V104, P192, DOI 10.1111/j.1742-7843.2008.00358.x; Lin JT, 2012, LWT-FOOD SCI TECHNOL, V49, P1, DOI 10.1016/j.lwt.2012.04.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majors BS, 2007, METAB ENG, V9, P317, DOI 10.1016/j.ymben.2007.05.003; Mantawy EM, 2014, EUR J PHARMACOL, V728, P107, DOI 10.1016/j.ejphar.2014.01.065; Mencherini T, 2007, J NAT PROD, V70, P1889, DOI 10.1021/np070351s; Michael J Morgan, 2011, Cell Research, V21, P103; Muanda F, 2009, ECAM ADV ACCESS, P1; Nagai K, 2015, FOOD CHEM TOXICOL, V78, P147, DOI 10.1016/j.fct.2015.02.009; NANDI A, 1988, J BIOSCIENCE, V13, P305, DOI 10.1007/BF02712155; Nichenametla SN, 2006, CRIT REV FOOD SCI, V46, P161, DOI 10.1080/10408390591000541; Park SJ, 2004, ANTICANCER RES, V24, P123; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Saeed NM, 2015, BIOCHEM PHARMACOL, V95, P145, DOI [10.1016/j.bcp.2015.02.006, 10.1016/j.bcp.2015.02.00]; Saraydin SU, 2012, ASIAN PAC J CANCER P, V13, P2765, DOI 10.7314/APJCP.2012.13.6.2765; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Tonomura Y, 2012, TOXICOLOGY, V302, P179, DOI 10.1016/j.tox.2012.07.012; Trivedi PP, 2011, CARDIOVASC TOXICOL, V11, P215, DOI 10.1007/s12012-011-9114-2; Weidner C, 2015, PHYTOMEDICINE, V22, P262, DOI 10.1016/j.phymed.2014.12.008; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Yagmurca M, 2003, PHARMACOL RES, V48, P377, DOI 10.1016/S1043-6618(03)00185-3; Yilmaz S, 2006, TOXICOLOGY, V218, P164, DOI 10.1016/j.tox.2005.10.015	49	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167049	10.1371/journal.pone.0167049	http://dx.doi.org/10.1371/journal.pone.0167049			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880817	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500060
J	Zhao, ZG; Reinstatler, L; Klaassen, Z; Xu, Y; Yang, XY; Madi, R; Terris, MK; Qian, SY; Kelavkar, U; Moses, KA				Zhao, Zhiguo; Reinstatler, Lael; Klaassen, Zachary; Xu, Yi; Yang, Xiaoyu; Madi, Rabii; Terris, Martha K.; Qian, Steven Y.; Kelavkar, Uddhav; Moses, Kelvin A.			The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy	PLOS ONE			English	Article							CANCER CELL-GROWTH; 12(S)-HYDROXYEICOSATETRAENOIC ACID; RISK; N-3; 15-LIPOXYGENASE-1; FISH; 12-LIPOXYGENASE; ADENOCARCINOMA; EPIDEMIOLOGY; RECURRENCE	Background Epidemiological data suggest that omega-6 (omega-6) fatty acids (FAs) may be associated with cancer incidence and/or cancer mortality, whereas omega-3 FAs are potentially protective. We examined the association of the ratio of omega-6 to omega-3 FA (omega-6:omega-3) and individual FA components with pathological results among men with prostate cancer (PCa) undergoing radical prostatectomy. Methods Sixty-nine men were included in the study. Components of omega-6 (linoleic acid (LA), arachidonic acid (AA), and dihomo-gamma- linolenic acid (DGLA)) and omega-3 (docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)) were analyzed by liquid chromatography/mass selective detector separation. Logistic regression analysis was performed to determine association of FA with pathological high grade (Gleason >= 4+3) disease. Results The were 35 men with low grade disease (Gleason <= 3+4) and 34 men with high grade disease. Men with low grade disease were significantly younger (58y vs 61y, p = 0.012) and had lower D'Amico clinical classification (p = 0.001) compared to men with high grade disease. There was no significant association of omega-6: omega-3 with high grade disease (OR 0.93, p = 0.78), however overall omega-6,omega-3, and individual components of omega-6 and omega-3 FAs except EPA were significantly associated with high grade disease (omega-6: OR 3.37, 95% CI: 1.27,8.98; LA: OR 3.33, 95% CI: 1.24,8.94; AA: OR 2.93, 95% CI: 1.24,6.94; DGLA: OR 3.21, 95% CI: 1.28,8.04;omega-3: OR 3.47, 95% CI: 1.22,9.83; DHA: OR 3.13, 95% CI: 1.26,7.74). omega-6 and omega-3 FA components were highly correlated (Spearman. = 0.77). Conclusion Higher levels of individual components of omega-6 and omega-3FAs may be associated with higher-grade PCa. Impact Studies into the causative factors/pathways regarding FAs and prostate carcinogenesis may prove a potential association with PCa aggressiveness.	[Zhao, Zhiguo] Vanderbilt Ingram Canc Ctr, Dept Biostat, Nashville, TN USA; [Reinstatler, Lael; Klaassen, Zachary; Madi, Rabii; Terris, Martha K.] Univ Gottingen, Coll Med, Dept Surg, Urol Sect, Augusta, GA USA; [Xu, Yi; Yang, Xiaoyu; Qian, Steven Y.] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND USA; [Kelavkar, Uddhav] Nutechbiomarkers LLC, Savannah, GA USA; [Moses, Kelvin A.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA	Vanderbilt University; North Dakota State University Fargo; Vanderbilt University	Moses, KA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA.	kelvin.a.moses@vanderbilt.edu			NCI NIH HHS [K12 CA090625] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K12CA090625] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abel S, 2014, P NUTR SOC, V73, P361, DOI 10.1017/S0029665114000585; Allison DB, 1999, J AM DIET ASSOC, V99, P166, DOI 10.1016/S0002-8223(99)00041-3; Allott EH, 2014, CANCER EPIDEM BIOMAR, V23, P2349, DOI 10.1158/1055-9965.EPI-14-0458; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Chavarro JE, 2008, AM J CLIN NUTR, V88, P1297, DOI 10.3945/ajcn.2008.26419; CHEN YQ, 1994, CANCER RES, V54, P1574; Connolly JM, 1997, NUTR CANCER, V29, P114, DOI 10.1080/01635589709514611; Dorin RP, 2012, UROLOGY, V79, P626, DOI 10.1016/j.urology.2011.09.051; DUNN JE, 1975, CANCER RES, V35, P3240; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Hall MN, 2008, CANCER EPIDEM BIOMAR, V17, P1136, DOI 10.1158/1055-9965.EPI-07-2803; HONN KV, 1994, CANCER RES, V54, P565; Kelavkar Uddhav, 2002, Curr Urol Rep, V3, P207, DOI 10.1007/s11934-002-0066-8; Kelavkar UP, 2006, NEOPLASIA, V8, P112, DOI 10.1593/neo.05637; Kelavkar UP, 2000, CARCINOGENESIS, V21, P1777; Kelavkar UP, 2004, NEOPLASIA, V6, P41, DOI 10.1016/S1476-5586(04)80052-6; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kuriki K, 2007, INT J CANCER, V121, P377, DOI 10.1002/ijc.22682; Kweldam CF, 2014, DIS SPECIFIC DEATH M; Lawrence GD, 2013, ADV NUTR, V4, P294, DOI 10.3945/an.113.003657; Leitzmann MF, 2004, AM J CLIN NUTR, V80, P204; LIU B, 1995, P NATL ACAD SCI USA, V92, P9323, DOI 10.1073/pnas.92.20.9323; Loeb S, 2010, UROLOGY, V76, P710, DOI 10.1016/j.urology.2009.09.014; Narayanan NK, 2005, INT J ONCOL, V26, P785; Nie D, 1998, CANCER RES, V58, P4047; Pham H, 2002, J STEROID BIOCHEM, V82, P393, DOI 10.1016/S0960-0760(02)00217-0; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Sasazuki S, 2011, INT J CANCER, V129, P1718, DOI 10.1002/ijc.25802; Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; TANG DG, 1994, ANN NY ACAD SCI, V744, P199, DOI 10.1111/j.1749-6632.1994.tb52738.x; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Yang M, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw141	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166594	10.1371/journal.pone.0166594	http://dx.doi.org/10.1371/journal.pone.0166594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880795	Green Submitted, Green Published, gold			2022-12-26	WOS:000388889500026
J	Casazza, G; Grassi, F; Zecca, G; Minuto, L				Casazza, Gabriele; Grassi, Fabrizio; Zecca, Giovanni; Minuto, Luigi			Phylogeographic Insights into a Peripheral Refugium: The Importance of Cumulative Effect of Glaciation on the Genetic Structure of Two Endemic Plants	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CHLOROPLAST DNA; ECOLOGICAL CHARACTERISTICS; ALPINE PLANT; MARITIME; ALPS; PATTERNS; MITOCHONDRIAL; AREAS; COLONIZATION	Quaternary glaciations and mostly last glacial maximum have shaped the contemporary distribution of many species in the Alps. However, in the Maritime and Ligurian Alps a more complex picture is suggested by the presence of many Tertiary paleoendemisms and by the divergence time between lineages in one endemic species predating the Late Pleistocene glaciation. The low number of endemic species studied limits the understanding of the processes that took place within this region. We used species distribution models and phylogeographical methods to infer glacial refugia and to reconstruct the phylogeographical pattern of Silene cordifolia All. and Viola argenteria Moraldo & Forneris. The predicted suitable area for last glacial maximum roughly fitted current known distribution. Our results suggest that separation of the major clades predates the last glacial maximum and the following repeated glacial and interglacial periods probably drove differentiations. The complex phylogeographical pattern observed in the study species suggests that both populations and genotypes extinction was minimal during the last glacial maximum, probably due to the low impact of glaciations and to topographic complexity in this area. This study underlines the importance of cumulative effect of previous glacial cycles in shaping the genetic structure of plant species in Maritime and Ligurian Alps, as expected for a Mediterranean mountain region more than for an Alpine region.	[Casazza, Gabriele; Minuto, Luigi] Univ Genoa, DISTAV, Genoa, Italy; [Grassi, Fabrizio] Univ Bari, Dipartimento Biol, Bari, Italy; [Zecca, Giovanni] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Genoa; Universita degli Studi di Bari Aldo Moro; University of Milan	Casazza, G (corresponding author), Univ Genoa, DISTAV, Genoa, Italy.	gabriele.casazza@unige.it	Casazza, Gabriele/O-5211-2017; MINUTO, LUIGI/E-6148-2018	Casazza, Gabriele/0000-0002-3334-8551; grassi, fabrizio/0000-0003-3606-6469; MINUTO, LUIGI/0000-0002-1582-3806; Zecca, Giovanni/0000-0003-2334-8897	Interreg Alcotra programme [192 BIODIVAM]	Interreg Alcotra programme	Interreg Alcotra programme 2007-2013, project n. 192 BIODIVAM.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Ballard HE, 2000, EVOLUTION, V54, P1521, DOI 10.1111/j.0014-3820.2000.tb00698.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Borer M, 2010, MOL PHYLOGENET EVOL, V57, P703, DOI 10.1016/j.ympev.2010.08.017; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 1984, CLASSIFICATION REGRE; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Casazza G, 2005, BIOL CONSERV, V123, P361, DOI 10.1016/j.biocon.2004.12.005; Casazza G, 2008, DIVERS DISTRIB, V14, P47, DOI 10.1111/j.1472-4642.2007.00412.x; Casazza G, 2013, BOT J LINN SOC, V173, P637, DOI 10.1111/boj.12110; Combourieu-Nebout N, 2015, REV PALAEOBOT PALYNO, V218, P127, DOI 10.1016/j.revpalbo.2015.03.001; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dehnert A, 2010, BOREAS, V39, P620, DOI 10.1111/j.1502-3885.2010.00146.x; Diadema K, 2005, TAXON, V54, P887, DOI 10.2307/25065475; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dullinger S, 2012, GLOBAL ECOL BIOGEOGR, V21, P829, DOI 10.1111/j.1466-8238.2011.00732.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehlers J, 2004, QUATERNARY GLACI A 1, V2a; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Federici PR, 2012, BOREAS, V41, P277, DOI 10.1111/j.1502-3885.2011.00233.x; Fernandez-Mazuecos M, 2013, NEW PHYTOL, V198, P1274, DOI 10.1111/nph.12220; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Grassi F, 2009, J PLANT RES, V122, P377, DOI 10.1007/s10265-009-0230-z; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt G.M., 2001, INTEGRATING ECOLOGY, P271; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hou Y, 2014, J HERED, V105, P101, DOI 10.1093/jhered/est072; Hughes PD, 2011, QUATERNARY SCI REV, V30, P3393, DOI 10.1016/j.quascirev.2011.08.016; Hughes PD, 2008, QUATERNARY RES, V69, P110, DOI 10.1016/j.yqres.2007.10.008; Ikeda H, 2007, J BIOGEOGR, V34, P169, DOI 10.1111/j.1365-2699.2006.01577.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Larena BG, 2002, MOL ECOL, V11, P1965, DOI 10.1046/j.1365-294X.2002.01594.x; Lomba A, 2010, BIOL CONSERV, V143, P2647, DOI 10.1016/j.biocon.2010.07.007; Mamayev, 1972, PINACEAE URALE TYPES; MANTEL N, 1967, CANCER RES, V27, P209; McCullagh P, 1989, GEN LINEAR MODELS; Medail F, 1997, BIOL CONSERV, V80, P269, DOI 10.1016/S0006-3207(96)00055-9; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Minuto L, 2006, PLANT BIOSYST, V140, P146, DOI 10.1080/11263500600756348; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Pajares AJ, 2013, METHODS ECOLOGY EVOL, V4, P1195; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patsiou TS, 2014, GLOBAL CHANGE BIOL, V20, P2286, DOI 10.1111/gcb.12515; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poelchau MF, 2013, J BIOGEOGR, V40, P618, DOI 10.1111/j.1365-2699.2011.02599.x; Pons O, 1996, GENETICS, V144, P1237; Pouget M, 2013, ANN BOT-LONDON, V112, P1409, DOI 10.1093/aob/mct183; R Development Core Team, 2005, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 5; Ramirez Villejas J., 2010, 1 INT CTR TROP AGR C; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saltonstall K, 2012, MOL ECOL RESOUR, V12, P581, DOI 10.1111/j.1755-0998.2012.03146.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schorr G, 2012, ECOL EVOL, V2, P1260, DOI 10.1002/ece3.100; Simmons MP, 2007, MOL PHYLOGENET EVOL, V44, P724, DOI 10.1016/j.ympev.2007.04.001; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Spina F, 2008, ATLANTE MIGRAZIONI U; Sun YX, 2014, J BIOGEOGR, V41, P1721, DOI 10.1111/jbi.12323; Szovenyi P, 2009, TAXON, V58, P532, DOI 10.1002/tax.582017; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Wang LY, 2009, J INTEGR PLANT BIOL, V51, P698, DOI 10.1111/j.1744-7909.2009.00818.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yockteng R, 2003, PLANT SYST EVOL, V241, P153, DOI 10.1007/s00606-003-0045-7	81	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166983	10.1371/journal.pone.0166983	http://dx.doi.org/10.1371/journal.pone.0166983			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870888	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400050
J	Huang, YP; Du, CF; Cheng, CK; Zhong, ZC; Chen, XW; Wu, G; Li, ZC; Ye, JD; Lin, JH; Wang, LZ				Huang, Yun-Peng; Du, Cheng-Fei; Cheng, Cheng-Kung; Zhong, Zheng-Cheng; Chen, Xuan-Wei; Wu, Gui; Li, Zhe-Cheng; Ye, Jin-Duo; Lin, Jian-Hua; Wang, Li Zhen			Preserving Posterior Complex Can Prevent Adjacent Segment Disease following Posterior Lumbar Interbody Fusion Surgeries: A Finite Element Analysis	PLOS ONE			English	Article							DEGENERATION; SPINE; LAMINECTOMY; INSTABILITY; PREVALENCE; FIXATION; MODEL; RISK; LOAD	Objective To investigate the biomechanical effects of the lumbar posterior complex on the adjacent segments after posterior lumbar interbody fusion (PLIF) surgeries. Methods A finite element model of the L1 S1 segment was modified to simulate PLIF with total laminectomy (PLIF-LAM) and PLIF with hemilaminectomy (PLIF-HEM I) procedures. The models were subjected to a 400N follower load with a 7.5-N.m moment of flexion, extension, torsion, and lateral bending. The range of motion (ROM), intradiscal pressure (IDP), and ligament force were compared. Results In Flexion, the ROM, IDP and ligament force of posterior longitudinal ligament, intertransverse ligament, and capsular ligament remarkably increased at the proximal adjacent segment in the PLIF-LAM model, and slightly increased in the PLIF-HEM I model. There was almost no difference for the ROM, IDP and ligament force at L5-S1 level between the two PLIF models although the ligament forces of ligamenta flava remarkably increased compared with the intact lumbar spine (INT) model. For the other loading conditions, these two models almost showed no difference in ROM, IDP and ligament force on the adjacent discs. Conclusions Preserved posterior complex acts as the posterior tension band during PLIF surgery and results in less ROM, IDP and ligament forces on the proximal adjacent segment in flexion. Preserving the posterior complex during decompression can be effective on preventing adjacent segment degeneration (ASD) following PLIF surgeries.	[Huang, Yun-Peng; Chen, Xuan-Wei; Wu, Gui; Li, Zhe-Cheng; Lin, Jian-Hua] Fujian Med Univ, Dept Orthopaed, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China; [Du, Cheng-Fei; Ye, Jin-Duo] Tianjin Univ Technol, Tianjin Key Lab Adv Mechatron Design & Intelligen, Tianjin 300384, Peoples R China; [Du, Cheng-Fei; Cheng, Cheng-Kung; Wang, Li Zhen] Beihang Univ, Key Lab Biomech & Mech, Int Res Ctr Implantable & Intervent Med Devices, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China; [Cheng, Cheng-Kung; Zhong, Zheng-Cheng] Natl Yang Ming Univ, Orthopaed Device Res Ctr, Taipei 11221, Peoples R China	Fujian Medical University; Tianjin University of Technology; Beihang University	Lin, JH (corresponding author), Fujian Med Univ, Dept Orthopaed, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China.; Wang, LZ (corresponding author), Beihang Univ, Key Lab Biomech & Mech, Int Res Ctr Implantable & Intervent Med Devices, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.	jianhua0918@126.com; lizhenwang@buaa.edu.cn	HUANG, YUNPENG/B-9168-2019	ZHONG, ZHENG-CHENG/0000-0001-6556-4470; HUANG, YUNPENG/0000-0001-8286-6964	Department of Public Health Bureau, Fujian, P. R.C [2013-ZQN-ZD-19]; key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.; National Natural Science Foundation of China (NSFC) [11372221, 11432016, 11602172]	Department of Public Health Bureau, Fujian, P. R.C; key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from the Department of Public Health Bureau, Fujian, P. R.C (No. 2013-ZQN-ZD-19); and by a grant from the key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. The study was also supported by the program from the National Natural Science Foundation of China (NSFC No. 11372221, No. 11432016 and No. 11602172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a grant from the Department of Public Health Bureau, Fujian, P. R.C (No. 2013-ZQN-ZD-19); and by a grant from the key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. The study was also supported by the program from the National Natural Science Foundation of China (NSFC No. 11372221, No. 11432016 and No. 11602172).	Abouhossein A, 2011, COMPUT METHOD BIOMEC, V14, P527, DOI 10.1080/10255842.2010.485568; Ahn YH, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044101; Chen CS, 2005, J SPINAL DISORD TECH, V18, P58, DOI 10.1097/01.bsd.0000123426.12852.e7; Du CF, 2014, INT J NUMER METH BIO, V30, P1121, DOI 10.1002/cnm.2647; Ekman P, 2009, EUR SPINE J, V18, P1175, DOI 10.1007/s00586-009-0947-3; GOEL VK, 1988, SPINE, V13, P1003, DOI 10.1097/00007632-198809000-00007; Goto Keisuke, 2003, J Orthop Sci, V8, P577, DOI 10.1007/s00776-003-0675-1; Imagama S, 2016, CLIN SPINE SURG; Kotani Y, 1998, SPINE, V23, P672, DOI 10.1097/00007632-199803150-00006; Lai PL, 2004, SPINE, V29, P2527, DOI 10.1097/01.brs.0000144408.02918.20; Lawrence BD, 2012, SPINE, V37, pS123, DOI 10.1097/BRS.0b013e31826d60d8; Lee JC, 2014, SPINE, V39, pE339, DOI 10.1097/BRS.0000000000000164; Levin DA, 2007, BULL HOSP JT DIS, V65, P29; Liu HC, 2013, J NEUROSURG-SPINE, V19, P201, DOI 10.3171/2013.5.SPINE12650; Ma JX, 2014, P I MECH ENG H, V228, P665, DOI 10.1177/0954411914541435; Moskowitz A, 2002, ORTHOP CLIN N AM, V33, P359, DOI 10.1016/S0030-5898(01)00008-6; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Panjabi MM, 2003, J ELECTROMYOGR KINES, V13, P371, DOI 10.1016/S1050-6411(03)00044-0; Renner SM, 2007, J BIOMECH, V40, P1326, DOI 10.1016/j.jbiomech.2006.05.019; Schmidt H, 2007, CLIN BIOMECH, V22, P377, DOI 10.1016/j.clinbiomech.2006.11.008; Sears WR, 2011, SPINE J, V11, P11, DOI 10.1016/j.spinee.2010.09.026; SHIRAZIADL A, 1986, SPINE, V11, P914, DOI 10.1097/00007632-198611000-00012; Sim HB, 2010, J NEUROSURG-SPINE, V12, P700, DOI 10.3171/2009.12.SPINE09123; Totoribe K, 1999, J Orthop Sci, V4, P115, DOI 10.1007/s007760050083; Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce; Wai EK, 2006, SPINE, V31, P1952, DOI 10.1097/01.brs.0000228849.37321.a8; Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea; Xiao ZT, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-31; Xu H, 2013, NEUROSURGERY; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020	30	28	38	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166452	10.1371/journal.pone.0166452	http://dx.doi.org/10.1371/journal.pone.0166452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870867	Green Submitted, Green Published, gold			2022-12-26	WOS:000388846400013
J	Igari, K; Kudo, T; Toyofuku, T; Inoue, Y				Igari, Kimihiro; Kudo, Toshifumi; Toyofuku, Takahiro; Inoue, Yoshinori			The Relationship between Endothelial Dysfunction and Endothelial Cell Markers in Peripheral Arterial Disease	PLOS ONE			English	Article							SOLUBLE THROMBOMODULIN; PROGNOSTIC VALUE; RISK; ATHEROSCLEROSIS; INFLAMMATION	Introduction The endothelial function plays key roles in both promoting and protecting against atherosclerotic disease. Several methods, including peripheral arterial tonometry (PAT), have been reported to be useful for investigating endothelial dysfunction. Furthermore, the level of thrombomodulin (TM) is assumed to reflect the endothelial dysfunction. In the present study, we investigated endothelial dysfunction in patients with peripheral arterial disease (PAD) by measuring their TM levels, and evaluated the correlation between TM and various parameters. Materials and Methods We measured the TM levels and performed PAT in 17 patients with PAD. We also recorded the patients' demographic information, including comorbidities, and investigated their hemo-dynamic status by measuring the ankle brachial pressure index (ABI). The PAT results were used to calculate the reactive hyperemia index (RHI), which reflected the patients' level of endothelial dysfunction. Results The RHI and ABI values and the serum level of creatinine were found to be significantly correlated with the TM level (P = 0.040, 0.041 and 0.005, respectively). After setting an RHI value of 1.67 as the cut-off, the patients with RHI values of <1.67 were found to have significantly higher TM levels (median, 20.3 U/mL) than the patients with RHI values of >= 1.67 (median, 13.7 U/mL) (P = 0.023). Conclusions The degree of endothelial dysfunction, as calculated by the TM level, might influence the prognostic value of the RHI, which is determined by PAT. The measurement of the TM level and PAT might both be useful methods of measuring endothelial dysfunction in patients with PAD.	[Igari, Kimihiro; Kudo, Toshifumi; Toyofuku, Takahiro; Inoue, Yoshinori] Tokyo Med & Dent Univ, Div Vasc & Endovasc Surg, Dept Surg, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Igari, K (corresponding author), Tokyo Med & Dent Univ, Div Vasc & Endovasc Surg, Dept Surg, Tokyo, Japan.	igari.srg1@tmd.ac.jp		Igari, Kimihiro/0000-0002-2273-4174				Babat S, 1996, VASA, V25, P233; Bao YS, 2014, BIOMARKERS, V19, P275, DOI 10.3109/1354750X.2014.904000; Blann AD, 1997, EUR J CLIN INVEST, V27, P916, DOI 10.1046/j.1365-2362.1997.2180766.x; Blann AD, 1997, THROMB HAEMOSTASIS, V77, P1077; Blann AD, 2000, THROMB RES, V97, P209, DOI 10.1016/S0049-3848(99)00156-5; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; Boos CJ, 2008, J THROMB HAEMOST, V6, P1841, DOI 10.1111/j.1538-7836.2008.03148.x; Brevetti G, 2003, J VASC SURG, V38, P374, DOI 10.1016/S0741-5214(03)00124-1; Celermajer DS, 2008, CIRCULATION, V117, P2428, DOI 10.1161/CIRCULATIONAHA.108.775155; Hagag AAE, 2014, J ONCOL PHARM PRACT, V20, P356, DOI 10.1177/1078155213508439; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Levi M, 2013, MINERVA ANESTESIOL, V79, P294; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; Matsuzawa Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002270; Matsuzawa Y, 2015, CIRC J, V79, P685, DOI 10.1253/circj.CJ-15-0068; Nasser M, 2006, THROMB RES, V117, P271, DOI 10.1016/j.thromres.2005.03.010; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Poredos P, 2013, J ATHEROSCLER THROMB, V20, P1; Salomaa V, 2001, ATHEROSCLEROSIS, V157, P309, DOI 10.1016/S0021-9150(00)00729-2; SEIGNEUR M, 1993, THROMB RES, V71, P423, DOI 10.1016/0049-3848(93)90116-6; SERNAU T, 1995, VASA-J VASCULAR DIS, V24, P347; Suessenbacher A, 2014, J ATHEROSCLER THROMB, V21, P230, DOI 10.5551/jat.18986; Syvanen K, 2011, VASC HEALTH RISK MAN, V7, P97, DOI 10.2147/VHRM.S17249; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Wang KC, 2015, ARTERIOSCL THROM VAS, V35, P2412, DOI 10.1161/ATVBAHA.115.305529; Wu KK, 2003, CIRCULATION, V107, P1729, DOI 10.1161/01.CIR.0000064894.97094.4F	27	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166840	10.1371/journal.pone.0166840	http://dx.doi.org/10.1371/journal.pone.0166840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861629	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300123
J	Pappalardo, M; Pappalardo, L; Brooks, P				Pappalardo, Matthew; Pappalardo, Linda; Brooks, Peter			Rapid and Reliable HPLC Method for the Simultaneous Determination of Dihydroxyacetone, Methylglyoxal and 5-Hydroxymethylfurfural in Leptospermum Honeys	PLOS ONE			English	Article							MANUKA HONEY; CONVERSION	A reliable determination of dihydroxyacetone, methylglyoxal and 5-hydroxymethylfurfural is essential to establishing the commercial value and antimicrobial potential of honeys derived from the Leptospermum species endemic to Australia and New Zealand. We report a robust method for quantitation of all three compounds in a single HPLC run. Honey samples (n = 6) that are derivatized with o-(2,3,4,5,6-Pentafluorobenzyl) hydroxylamine were quantitated against a stable anisole internal standard. Linear regression analysis was performed using calibration standards for each compound (n = 6) and results indicated a high degree of accuracy (R-2 = 0.999) for this method. The reliability of some commercial methylglyoxal solutions were found to be questionable. Effective quantitation of methylglyoxal content in honey is critical for researchers and industry, and the use of some commercial standards may bias data. Two accurate methylglyoxal standards are proposed, including a commercial standard and a derivative that can be prepared within the laboratory.	[Pappalardo, Matthew; Pappalardo, Linda; Brooks, Peter] Univ Sunshine Coast, Sch Sci & Engn, Maroochydore, Qld, Australia	University of the Sunshine Coast	Brooks, P (corresponding author), Univ Sunshine Coast, Sch Sci & Engn, Maroochydore, Qld, Australia.	pbrooks@usc.edu.au		Brooks, Peter/0000-0003-4915-4986				Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; Adams CJ, 2009, CARBOHYD RES, V344, P1; Atrott J, 2009, CZECH J FOOD SCI, V27, pS163, DOI 10.17221/911-CJFS; Atrott J, 2012, CARBOHYD RES, V361, P7, DOI 10.1016/j.carres.2012.07.025; Biondi PA, 2007, CHROMATOGRAPHIA, V65, P65, DOI 10.1365/s10337-006-0118-1; Grainger MNC, 2016, FOOD CHEM, V202, P484, DOI 10.1016/j.foodchem.2016.02.029; Grainger MNC, 2014, FOOD CHEM, V153, P134, DOI 10.1016/j.foodchem.2013.12.017; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Norton AM, 2015, J AGR FOOD CHEM, V63, P6513, DOI 10.1021/acs.jafc.5b01930; Rogers KM, 2014, J AGR FOOD CHEM, V62, P2615, DOI 10.1021/jf404767b; Windsor S., 2012, J PHARMACOGN PHYTHER, V4, P6, DOI DOI 10.5897/JPP11.025; Windsor S., 2013, J PHARMACOGN PHYTOTH, V5, P21	12	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0167006	10.1371/journal.pone.0167006	http://dx.doi.org/10.1371/journal.pone.0167006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861622	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300144
J	Rashid, S; Labani, S; Das, BC				Rashid, Shazia; Labani, Satyanarayana; Das, Bhudev C.			Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS HPV; YOUNG-WOMEN; TAMIL-NADU; PREVALENCE; ACCEPTANCE; DNA; ADOLESCENTS; POPULATION; CARCINOMAS; INFECTION	Background Infection of specific high risk Human papillomaviruses (HPVs) is known to cause cervical cancer and two prophylactic vaccines have been developed against two major high risk HPV types 16 and 18 for prevention of cervical cancer. Because of societal, religious and ethical issues associated with the vaccination of adolescent girls in India together with lack of awareness about HPV and HPV vaccines, no successful HPV immunization program has been employed in India. Objective To determine knowledge, awareness and attitude of college students on HPV, HPV vaccine and cervical cancer. Method A questionnaire-based survey was conducted in a total of 1580 undergraduate students between the age group 16-26 years comprising 684 girls and 876 boys. Results Out of a total of 1580 students, girls had more knowledge about cervical cancer (82.45%, p<0.001), HPV (45.61%, p<0.001) and HPV vaccines (44%, p<0.001) when compared to those in boys. However, knowledge about the types of HPV and vaccines was poor. Interestingly, students from biology-major had more knowledge and awareness about cervical cancer (81.89%, p<0.001) and HPV (46.58%, p<0.001) when compared to non-biology students. Girls from both biology and non-biology group had higher awareness compared to boys. Analysis of odds ratio (ORs) along with 95% CI showed older girls with 1.2 to 3 fold (p<0.05) higher knowledge than boys. All students agreed that girls should get vaccinated against HPV (p<0.001). Conclusion It is suggested that there is a need for educational intervention and awareness campaigns to augment HPV immunization program for control of cervical cancer in India.	[Rashid, Shazia] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Noida, India; [Labani, Satyanarayana] ICPO, Dept Epidemiol & Biostat, Noida, Uttar Pradesh, India; [Das, Bhudev C.] Amity Univ Uttar Pradesh, Stem Cell & Canc Res Lab, AIMMSCR, Noida, India	Amity University Noida; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Amity University Noida	Das, BC (corresponding author), Amity Univ Uttar Pradesh, Stem Cell & Canc Res Lab, AIMMSCR, Noida, India.	bcdas@amity.edu	Rashid, Shazia/ABI-2978-2020	Rashid, Shazia/0000-0002-8125-6790				Asthana S, 2013, GANGA RAM J, V3, P128; Bendik MK, 2011, J CANCER EDUC, V26, P459, DOI 10.1007/s13187-011-0200-8; Bhatla N, 2009, INDIAN J MED RES, V130, P334; Blodt S, 2012, EUR J PUBLIC HEALTH, V22, P808, DOI 10.1093/eurpub/ckr188; Choudhury P, 2010, INDIAN PEDIATR, V47, P724; DAS BC, 1992, LANCET, V340, P1417, DOI 10.1016/0140-6736(92)92612-J; DAS BC, 1992, J MED VIROL, V36, P239, DOI 10.1002/jmv.1890360402; Das BC, 2000, CURR SCI INDIA, V78, P52; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Duenas-Gonzalez A, 2014, INT J WOMENS HEALTH, V6, P1023, DOI 10.2147/IJWH.S49471; Ezem BU, 2007, ANN AFR MED, V6, P94, DOI 10.4103/1596-3519.55727; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hussain S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112861; Hussain S, 2012, J MED VIROL, V84, P298, DOI 10.1002/jmv.22261; Kerkar SC, 2011, SEX REPROD HEALTHC, V2, P7, DOI 10.1016/j.srhc.2010.11.001; Lambert EC, J AM BOARD FAMPRACT, V14, P178; Lee PWH, 2007, PREV MED, V45, P130, DOI 10.1016/j.ypmed.2007.07.013; Lenselink CH, 2008, PUBLIC HEALTH, V122, P1295, DOI 10.1016/j.puhe.2008.02.010; Lowy DR, 2012, CANCER PREV RES, V5, P18, DOI 10.1158/1940-6207.CAPR-11-0542; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Mehta Sumita, 2013, Indian J Community Med, V38, P92, DOI 10.4103/0970-0218.112438; Nnodu Obiageli, 2010, Afr J Reprod Health, V14, P95; Pandey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040619; Patel KR, 2014, J ORAL PATHOL MED, V43, P293, DOI 10.1111/jop.12147; Pillai RM, 2010, INT J GYNECOL CANCER, V20, P1046, DOI 10.1111/IGC.0b013e3181e02fe0; Pitts MK, 2010, SEX HEALTH, V7, P299, DOI 10.1071/SH09150; Prusty BK, 2005, INT J GYNECOL OBSTET, V90, P223, DOI 10.1016/j.ijgo.2005.06.004; Reagan-Steiner Sarah, 2015, CDC REPORT NATL REGI; Saha A, 2010, ASIAN PAC J CANCER P, V11, P1085; Sharma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125693; Simone B, 2012, INTRO HPV VACCINES E, DOI [10.2900/60814, DOI 10.2900/60814]; Sowjanya AP, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-116; Sureshkumar BT, 2015, INT J GYNECOL OBSTET, V129, P58, DOI 10.1016/j.ijgo.2014.10.025; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Vinodhini K, 2012, INT J GYNECOL OBSTET, V119, P253, DOI 10.1016/j.ijgo.2012.06.019; Woodhall SC, 2007, J ADOLESCENT HEALTH, V40, P466, DOI 10.1016/j.jadohealth.2007.01.005	38	49	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166713	10.1371/journal.pone.0166713	http://dx.doi.org/10.1371/journal.pone.0166713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861611	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300093
J	Deleuran, T; Vilstrup, H; Overgaard, S; Jepsen, P				Deleuran, Thomas; Vilstrup, Hendrik; Overgaard, Soren; Jepsen, Peter			No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study	PLoS One			English	Article							KNEE OSTEOARTHRITIS; SOCIOECONOMIC-STATUS; JOINT REGISTRY; HIP; REPLACEMENTS; MORTALITY; RELEVANCE; SURVIVAL; ENGLAND; WALES	Objective Chronic synovial inflammation causes primary osteoarthritis, but it is unknown whether chronic systemic inflammation does, too. Patients with cirrhosis have chronic systemic inflammation and therefore we examined the association between cirrhosis and primary osteoarthritis of the hip and knee. Methods In Danish healthcare databases we identified all residents over 60 years diagnosed with cirrhosis in 1994-2011, and for each of them we sampled five age- and gender-matched reference persons from the general population. We excluded everyone with risk factors for secondary osteoarthritis and computed incidence rates of primary osteoarthritis of the hip or knee. We used stratified Cox regression to estimate the hazard ratios of primary osteoarthritis for cirrhosis patients vs. reference persons in strata defined by gender, age, cirrhosis etiology, and ascites vs. no ascites. We also computed separate HRs for primary osteoarthritis of the hips or knees. Results We identified 10,049 cirrhosis patients. Their median age was 67 years, and 65% were men. Among the cirrhosis patients the crude incidence rate of primary osteoarthritis was 8.40 (95% CI: 7.30-9.63) per 1000 person-years. The rate was similar in the reference persons: 8.76 (95% CI: 8.43-9.12) per 1000 person-years. Accordingly, the hazard ratio for primary osteoarthritis for cirrhosis patients vs. reference persons was 0.99 (95% CI: 0.851.16), and we found the same null association in all patient strata and in both joints. Conclusion Cirrhosis, and thus chronic systemic inflammation, is not a risk factor for primary osteoarthritis.	[Deleuran, Thomas; Vilstrup, Hendrik; Jepsen, Peter] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark; [Deleuran, Thomas; Jepsen, Peter] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Overgaard, Soren] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Orthoped Surg & Traumatol, Odense, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital	Deleuran, T (corresponding author), Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark.; Deleuran, T (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	thomas.deleuran@clin.au.dk	Overgaard, Søren/AAX-9407-2020	Deleuran, Thomas/0000-0001-7319-975X; Jepsen, Peter/0000-0002-6641-1430; Overgaard, Soren/0000-0001-6829-4787	Aarhus University	Aarhus University	The study was supported by a PhD scolarship from Aarhus University.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Daghestani HN, 2015, ARTHRITIS RHEUMATOL, V67, P956, DOI 10.1002/art.39006; Deleuran T, 2014, ACTA ORTHOP, P1; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Hunt LP, 2014, LANCET, V384, P1429, DOI 10.1016/S0140-6736(14)60540-7; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Jepsen P, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-35; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Langholz B, 1996, STAT SCI, V11, P35; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pearce F, 2013, ARTHRIT CARE RES, V65, P1026, DOI 10.1002/acr.21954; Pedersen AB, 2004, ACTA ORTHOP SCAND, V75, P434, DOI 10.1080/00016470410001213-1; Pedersen AB, 2012, CLIN EPIDEMIOL, V4, P125, DOI DOI 10.2147/CLEP.S30050; Pedersen CB, 2006, DAN MED BULL, V53, P441; R. R Development Core Team, 2013, LANG ENV STAT COMP; Reyes C, 2015, OSTEOARTHR CARTILAGE, V23, P1323, DOI 10.1016/j.joca.2015.03.020; Stannus OP, 2013, ANN RHEUM DIS, V72, P535, DOI 10.1136/annrheumdis-2011-201047; Vestberg K, 1997, J Med Syst, V21, P11, DOI 10.1023/A:1022835207287	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167134	10.1371/journal.pone.0167134	http://dx.doi.org/10.1371/journal.pone.0167134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898694	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474000034
J	Umare, A; Seyoum, B; Gobena, T; Mariyam, TH				Umare, Abdi; Seyoum, Berhanu; Gobena, Tesfaye; Mariyam, Tamirat Haile			Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; SURFACE-ANTIGEN; ADDIS-ABABA; SEROPREVALENCE; EPIDEMIOLOGY; PREVALENCE; ANTIBODY	Background Hepatitis B virus (HBV) infection is a serious public health problem worldwide. Reports have shown that 68,600 people die of HBV infection and more than 300,000 deaths due to liver cancer secondary to hepatitis B every year globally. Women who are infected with HBV can vertically transmit the infection to their infants. This study aims to determine the prevalence of HBV infection and associated factors among pregnant women. Methods and Findings A hospital-based cross-sectional study was conducted among pregnant women who attended antenatal care clinic (ANC) for routine pregnancy check-up between 18 March 2015 and 15 May 2015. Data were collected by face to face interview using a pre-tested questionnaire. Serum was withdrawn for each study subject and used to test for Hepatitis B Surface Antigen (HBsAg) by an enzyme linked immunosorbent assay (ELISA) test kit. Binary logistic regression analysis was used to examine the association between explanatory variables and outcome variable. The prevalence of HBV infection was found to be 6.9%. Interestingly, the history of abortion (AOR 10.9; 95% CI: 2.2-53.9), nose piercing (AOR 9.1; 95% CI: 1.34-61.79), surgical procedure (AOR 12.8; 95% CI: 1.68-97.06) and history of multiple sexual partners (AOR 16.8; 95% CI: 3.18-89.06) were significant predictors of HBV infection. Conclusions This study determined that the prevalence of HBV infection among pregnant women was 6.9%, implying that it is high-intermediate endemic area, which is important public health issue needs to be addressed. History of abortion, nose piercing, surgical procedures and multiple sexual partners were significantly associated with this viral infection. Accordingly we advocate that health education programs on the mode of HBV transmission, high-risk behaviors and methods of preventions should be instituted at antenatal care clinics to raise the awareness of mothers and limit the spread of infection. It is also advisable to implement nosocomial infection prevention strategies to prevent the transmissions of HBV through health care related activities such as surgical procedures. Furthermore, all pregnant women should be screened for HBV, treated if necessary to reduce their viral loads and their children vaccinated at birth with the single-dose hepatitis B vaccine to break the cycle of mother-to-child transmission.	[Umare, Abdi] Deder Hosp, Dept Lab Med, Deder, Ethiopia; [Seyoum, Berhanu] Haramaya Univ, Dept Microbiol Sci, Coll Hlth & Med Sci, Harar, Ethiopia; [Gobena, Tesfaye] Haramaya Univ, Dept Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia; [Mariyam, Tamirat Haile] Ethiopian Red Cross Soc, Harar Branch, Blood Bank, Addis Ababa, Ethiopia	Haramaya University; Haramaya University	Umare, A (corresponding author), Deder Hosp, Dept Lab Med, Deder, Ethiopia.	umareabdi@gmail.com						Adibi P, 2012, INT J PREV MED, V3, P94; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; Desalegn Z, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0211-3; Duncan M. E., 1995, Ethiopian Journal of Health Development, V9, P31; Eke AC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-12; Elsheikh RM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-104; Federal Democratic Republic of Ethiopia, 2010, NAT EXP PROGR IMM CO; Gasim GI, 2013, J INFECT DEV COUNTR, V7, P566, DOI 10.3855/jidc.3243; GEBRESELASSIE L, 1983, ETHIOPIAN MED J, V21, P205; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; KEFENE H, 1988, J MED VIROL, V24, P75, DOI 10.1002/jmv.1890240110; Kolawole OM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-317; Mansour W, 2012, J MED VIROL, V84, P1186, DOI 10.1002/jmv.23336; Mohammed Awole, 2005, Ethiopian Journal of Health Development, V19, P45; Molla S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0437-7; Murad EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-127; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Negero A, 2011, BMC RES NOTES, V4, P3; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Rabiu KA, 2010, ACTA OBSTET GYN SCAN, V89, P1024, DOI 10.3109/00016349.2010.482580; Ramos JM, 2011, J CLIN VIROL, V51, P83, DOI 10.1016/j.jcv.2011.01.010; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seid MGB., 2014, ADV LIFE SCI HLTH, V1, P109; Stewart RD, 2013, HEPATITIS B VACCINAT, P167; Tegegne Dessie, 2014, BMC Res Notes, V7, P239, DOI 10.1186/1756-0500-7-239; Tiruneh Moges, 2008, Ethiop Med J, V46, P359; Verma R, 2011, HUM VACCINES, V7, P1387, DOI 10.4161/hv.7.12.17878; World Health O, 2009, WKLY EPIDEMIOL REC, V84, P405, DOI DOI 10.1016/J.VACCINE.2009.10.110; World Health Organization, 2015, WC536 WHO; World Health Organization, 1990, WHOEPIGEN906; Yakasai IA., 2012, J BASIC CLIN REPROD, V1, P49; Yohanes T., 2016, HEPAT RES TREAT, V2016, P9290163, DOI DOI 10.1155/2016/9290163; Zenebe Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-118	33	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166936	10.1371/journal.pone.0166936	http://dx.doi.org/10.1371/journal.pone.0166936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898721	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000025
J	Czupryna, AM; Brown, JS; Bigambo, MA; Whelan, CJ; Mehta, SD; Santymire, RM; Lankester, FJ; Faust, LJ				Czupryna, Anna M.; Brown, Joel S.; Bigambo, Machunde A.; Whelan, Christopher J.; Mehta, Supriya D.; Santymire, Rachel M.; Lankester, Felix J.; Faust, Lisa J.			Ecology and Demography of Free-Roaming Domestic Dogs in Rural Villages near Serengeti National Park in Tanzania	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; RABIES CONTROL; EPIDEMIOLOGIC PARAMETERS; VACCINATION COVERAGE; COQUIMBO REGION; URBAN AREAS; POPULATION; DISEASE; AFRICA; MANAGEMENT	Free-roaming dogs (Canis lupus familiaris) are of public health and conservation concern because of their potential to transmit diseases, such as rabies, to both people and wildlife. Understanding domestic dog population dynamics and how they could potentially be impacted by interventions, such as rabies vaccination, is vital for such disease control efforts. For four years, we measured demographic data on 2,649 free-roaming domestic dogs in four rural villages in Tanzania: two villages with and two without a rabies vaccination campaign. We examined the effects of body condition, sex, age and village on survivorship and reproduction. Furthermore, we compared sources of mortality among villages. We found that adult dogs (> 12mos) had higher survival than puppies in all villages. We observed a male-biased sex ratio across all age classes. Overall survival in one non-vaccination village was lower than in the other three villages, all of which had similar survival probabilities. In all villages, dogs in poor body condition had lower survival than dogs in ideal body condition. Sickness and spotted hyena (Crocuta crocuta) predation were the two main causes of dog death. Within vaccination villages, vaccinated dogs had higher survivorship than unvaccinated dogs. Dog population growth, however, was similar in all the villages suggesting village characteristics and ownership practices likely have a greater impact on overall dog population dynamics than vaccination. Free-roaming domestic dogs in rural communities exist in the context of their human owners as well as the surrounding wildlife. Our results did not reveal a clear effect of vaccination programs on domestic dog population dynamics. An investigation of the role of dogs and their care within these communities could provide additional insight for planning and implementing rabies control measures such as mass dog vaccination.	[Czupryna, Anna M.; Brown, Joel S.; Whelan, Christopher J.; Santymire, Rachel M.; Faust, Lisa J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Czupryna, Anna M.; Bigambo, Machunde A.; Santymire, Rachel M.; Lankester, Felix J.; Faust, Lisa J.] Lincoln Pk Zoo, Serengeti Hlth Initiat, Chicago, IL USA; [Mehta, Supriya D.] Univ Illinois, Dept Epidemiol & Biostat, Chicago, IL USA; [Lankester, Felix J.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington State University	Czupryna, AM (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.; Czupryna, AM (corresponding author), Lincoln Pk Zoo, Serengeti Hlth Initiat, Chicago, IL USA.	aczupr3@uic.edu	Whelan, Christopher J/H-4856-2019	Whelan, Christopher J/0000-0001-7511-2603; Lankester, Felix/0000-0002-0802-0693	University of Illinois at Chicago Bodmer International Travel Award; University of Illinois at Chicago Elmer Hadley Award for Graduate Research; American Society of Mammalogists; University of Illinois at Chicago Chancellor's Supplemental Research Fellowship; Explorer's Club Fund for Exploration; Idea Wild; University of Illinois at Chicago Institute for Environmental Science and Policy Fellowship; Portage Park Animal Hospital; HomeAgain/Schering-Plough; Lincoln Park Zoo	University of Illinois at Chicago Bodmer International Travel Award; University of Illinois at Chicago Elmer Hadley Award for Graduate Research; American Society of Mammalogists; University of Illinois at Chicago Chancellor's Supplemental Research Fellowship; Explorer's Club Fund for Exploration; Idea Wild; University of Illinois at Chicago Institute for Environmental Science and Policy Fellowship; Portage Park Animal Hospital; HomeAgain/Schering-Plough; Lincoln Park Zoo	Anna Czupryna received funding for this research from the following institutions and awards: University of Illinois at Chicago Bodmer International Travel Award, University of Illinois at Chicago Elmer Hadley Award for Graduate Research, American Society of Mammalogists Grant in Aid of Research, University of Illinois at Chicago Chancellor's Supplemental Research Fellowship, Explorer's Club Fund for Exploration, Idea Wild, University of Illinois at Chicago Institute for Environmental Science and Policy Fellowship, Portage Park Animal Hospital, HomeAgain/Schering-Plough, and the Lincoln Park Zoo. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta-Jamett G, 2015, EUR J WILDLIFE RES, V61, P329, DOI 10.1007/s10344-014-0886-0; Acosta-Jamett G, 2010, PREV VET MED, V94, P272, DOI 10.1016/j.prevetmed.2010.01.002; [Anonymous], 2010, MICR EXC AN TOOLP; [Anonymous], 2016, SENAPA GIS LAYERS; APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Belsare AV, 2015, ECOL MODEL, V296, P102, DOI 10.1016/j.ecolmodel.2014.10.031; Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003; BERAN GW, 1982, COMP IMMUNOL MICROB, V5, P265, DOI 10.1016/0147-9571(82)90047-9; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Butler JRA, 2000, VET REC, V147, P442, DOI 10.1136/vr.147.16.442; Butler JRA, 1998, ECOLOGY DOMESTIC DOG; Caughley G., 2004, ANAL VERTEBRATE POPU; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Cleaveland S, 2007, CONSERV BIOL, V21, P612, DOI 10.1111/j.1523-1739.2007.00701.x; Cleaveland S, 2006, VET MICROBIOL, V117, P43, DOI 10.1016/j.vetmic.2006.04.009; Cleves M., 2008, INTRO SURVIVAL ANAL; Coleman PG, 2004, EMERG INFECT DIS, V10, P140; Conan A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004177; Concannon PW, 2011, ANIM REPROD SCI, V124, P200, DOI 10.1016/j.anireprosci.2010.08.028; COX DR, 1972, J R STAT SOC B, V34, P187; Crawley MJ, 2005, STAT INTRO USING R; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; Deem SL, 2016, CANINE DISTEMPER TER, V31, P441; ESRI, 2015, ARC GIS DESKT REL 10; Feng N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27518; Flores-Ibarra M, 2004, PREV VET MED, V62, P79, DOI 10.1016/j.prevetmed.2003.10.002; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Gilbert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110811; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Gsell AS, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-236; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Herron ME, 2014, J VET BEHAV, V9, P13, DOI 10.1016/j.jveb.2013.09.003; Hossain M, 2013, PREV VET MED, V111, P134, DOI 10.1016/j.prevetmed.2013.03.008; Kaare M., 2007, RABIES CONTROL RURAL; Kat P. W., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P229, DOI 10.1098/rspb.1995.0200; Kitala P, 2001, ACTA TROP, V78, P217, DOI 10.1016/S0001-706X(01)00082-1; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Knobel DL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-5; Knobel DL, 2013, FREE RANGING DOGS WI; Kongkaew W, 2004, PREV VET MED, V65, P105, DOI 10.1016/j.prevetmed.2004.05.009; Laflamme D, 1997, VET CLIN N AM-SMALL, V27, P1561, DOI 10.1016/S0195-5616(97)50139-2; Lankester F, 2014, SCIENCE, V345, P1562, DOI 10.1126/science.1256306; Lembo T, 2007, P ROY SOC B-BIOL SCI, V274, P2123, DOI 10.1098/rspb.2007.0664; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; MACDONALD DW, 1993, ONDERSTEPOORT J VET, V60, P351; Macpherson CNL, 2013, DOGS, ZOONOSES AND PUBLIC HEALTH, 2ND EDITION, P1, DOI 10.1079/9781845938352.0000; Matter H. C., 2000, Dogs, zoonoses and public health, P17, DOI 10.1079/9780851994369.0017; Morters MK, 2014, J APPL ECOL, V51, P1096, DOI 10.1111/1365-2664.12279; Morters MK, 2013, J ANIM ECOL, V82, P6, DOI 10.1111/j.1365-2656.2012.02033.x; Nagao Y, 2012, J VET MED SCI, V74, P699, DOI 10.1292/jvms.11-0509; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; Ortega-Pacheeo A, 2007, THERIOGENOLOGY, V67, P382, DOI 10.1016/j.theriogenology.2006.07.020; Pal SK, 2003, ACTA THERIOL, V48, P271, DOI 10.1007/BF03194167; Piccione G, 2005, J VET MED A, V52, P377, DOI 10.1111/j.1439-0442.2005.00758.x; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; Pulczer AS, 2013, PREV VET MED, V108, P209, DOI 10.1016/j.prevetmed.2012.07.012; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; Rinzin K, 2016, PREV VET MED, V126, P39, DOI 10.1016/j.prevetmed.2016.01.030; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sambo M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002510; Sen Majumder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143501; Sepulveda MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086152; StataCorp, 2011, STAT STAT SOFTW REL; Suzuki K, 2008, ZOONOSES PUBLIC HLTH, V55, P177, DOI 10.1111/j.1863-2378.2008.01114.x; Totton SC, 2010, THERIOGENOLOGY, V74, P1115, DOI 10.1016/j.theriogenology.2010.05.008; Townsend SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002372; Whitman KL, 2006, MODELLING MONITORING; Wiggs RB., 1997, VET DENT PRINCIPLES, P165; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x; World Health Organization, 2013, WHO TECH REP SER; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	80	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167092	10.1371/journal.pone.0167092	http://dx.doi.org/10.1371/journal.pone.0167092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893866	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400083
J	Schmiedeberg, K; Krause, H; Rohl, FW; Hartig, R; Jorch, G; Brunner-Weinzierl, MC				Schmiedeberg, Kristin; Krause, Hardy; Roehl, Friedrich-Wilhelm; Hartig, Roland; Jorch, Gerhard; Brunner-Weinzierl, Monika C.			T Cells of Infants Are Mature, but Hyporeactive Due to Limited Ca2+ Influx	PLOS ONE			English	Article							CONSTITUTIVE NUCLEAR-LOCALIZATION; SUDDEN UNEXPECTED DEATH; ADULT-BLOOD LYMPHOCYTES; AGE-RELATED-CHANGES; NF-KAPPA-B; CALCINEURIN ACTIVITY; CYTOKINE PRODUCTION; EFFECTOR FUNCTIONS; HEALTHY-CHILDREN; CALCIUM FLUX	CD4 T cells in human infants and adults differ in the initiation and strength of their responses. The molecular basis for these differences is not yet understood. To address this the principle key molecular events of TCR-and CD28-induced signaling in naive CD4 T cells, such as Ca2+ influx, NFAT expression, phosphorylation and translocation into the nucleus, ERK activation and IL-2 response, were analyzed over at least the first 3 years of life. We report dramatically reduced IL-2 and TNFa responses in naive CD31(+) T cells during infancy. Looking at the obligatory Ca2+ influx required to induce T cell activation and proliferation, we demonstrate characteristic patterns of impairment for each stage of infancy that are partly due to the differential usage of Ca2+ stores. Consistent with those findings, translocation of NFATc2 is limited, but still dependent on Ca2+ influx as demonstrated by sensitivity to cyclosporin A (CsA) treatment. Thus weak Ca2+ influx functions as a catalyst for the implementation of restricted IL-2 response in T cells during infancy. Our studies also define limited mobilization of Ca2+ ions as a characteristic property of T cells during infancy. This work adds to our understanding of infants' poor T cell responsiveness against pathogens.	[Schmiedeberg, Kristin; Jorch, Gerhard; Brunner-Weinzierl, Monika C.] Otto von Guericke Univ, Univ Hosp, Dept Expt Pediat, Magdeburg, Germany; [Krause, Hardy] Otto von Guericke Univ, Clin Pediat Surg, Univ Hosp, Magdeburg, Germany; [Roehl, Friedrich-Wilhelm] Otto von Guericke Univ, Inst Biometry & Med Informat, Univ Hosp, Magdeburg, Germany; [Hartig, Roland] Otto von Guericke Univ, Inst Mol & Clin Immunol, Univ Hosp, Magdeburg, Germany	Otto von Guericke University; University Hospital Magdeburg; Otto von Guericke University; University Hospital Magdeburg; Otto von Guericke University; University Hospital Magdeburg; Otto von Guericke University; University Hospital Magdeburg	Brunner-Weinzierl, MC (corresponding author), Otto von Guericke Univ, Univ Hosp, Dept Expt Pediat, Magdeburg, Germany.	monika.brunner-weinzierl@med.ovgu.de	Brunner-Weinzierl, Monika/AAB-8813-2019	Brunner-Weinzierl, Monika/0000-0002-6838-3568; Hartig, Roland/0000-0002-3706-7458	DFG [SFB854 TP14, Br 1860/10]; Else Kroner Stiftung	DFG(German Research Foundation (DFG)); Else Kroner Stiftung	The study has been funded by the DFG, SFB854 TP14, DFG Br 1860/10, and by the Else Kroner Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Arrol HP, 2008, CLIN EXP IMMUNOL, V153, P86, DOI 10.1111/j.1365-2249.2008.03677.x; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bjorksten B, 2004, SPRINGER SEMIN IMMUN, V25, P257, DOI 10.1007/s00281-003-0142-2; Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x; BOHJANEN PR, 1992, J BIOL CHEM, V267, P6302; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Byrum JN, 2013, J IMMUNOL, V191, P3073, DOI 10.4049/jimmunol.1300485; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; Chalmers IMH, 1998, BLOOD, V92, P11, DOI 10.1182/blood.V92.1.11.413a39_11_18; Chang RKR, 2008, J PEDIATR-US, V153, P498, DOI 10.1016/j.jpeds.2008.04.022; Chipeta J, 1999, BLOOD, V93, P1120, DOI 10.1182/blood.V93.3.1120.403a38i_1120_1123; Christo SN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07760; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Gallegos AM, 2016, NAT IMMUNOL; Gasparoni A, 2003, BIOL NEONATE, V84, P297, DOI 10.1159/000073638; Gibbons D, 2014, NATURE MED, V6; Hartel C, 2005, CLIN EXP IMMUNOL, V142, P446, DOI 10.1111/j.1365-2249.2005.02928.x; Hebel K, 2014, J IMMUNOL, V192, P5160, DOI 10.4049/jimmunol.1302539; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Joseph N, 2014, BBA-BIOMEMBRANES, V1838, P557, DOI 10.1016/j.bbamem.2013.07.009; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Jutz S, 2016, J IMMUNOL METHODS, V430, P10, DOI 10.1016/j.jim.2016.01.007; Kadereit S, 2001, EXP HEMATOL, V29, P903, DOI 10.1016/S0301-472X(01)00662-2; Kadereit S, 1999, BLOOD, V94, P3101, DOI 10.1182/blood.V94.9.3101.421k04_3101_3107; Kaminski BA, 2003, BLOOD, V102, P4608, DOI 10.1182/blood-2003-05-1732; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kilpinen S, 1998, IMMUNOLOGY, V94, P167, DOI 10.1046/j.1365-2567.1998.00507.x; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kloosterboer FM, 2006, HUM IMMUNOL, V67, P874, DOI 10.1016/j.humimm.2006.02.040; Kormendy D, 2013, ARTHRITIS RHEUM-US, V65, P81, DOI 10.1002/art.37714; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; LEDBETTER JA, 1990, BLOOD, V75, P1531; Li QX, 2012, J IMMUNOL, V188, P4268, DOI 10.4049/jimmunol.1102376; LIN H, 1993, J IMMUNOL, V151, P4562; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mikami N, 2014, EUR J IMMUNOL, V44, P955, DOI 10.1002/eji.201444513; Mitchell EA, 2008, PEDIATRICS, V121, pR1478, DOI 10.1542/peds.2007-2749; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Morris JA, 2008, LANCET, V371, P1815, DOI 10.1016/S0140-6736(08)60774-6; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Palin AC, 2013, J IMMUNOL, V190, P2682, DOI 10.4049/jimmunol.1202534; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Rivet CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159248; Salerno F, 2016, J IMMUNOL, V196, P3695, DOI 10.4049/jimmunol.1501997; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samakai E, 2016, FASEB J; Scheel T, 2012, J IMMUNOL, V189, P4703, DOI 10.4049/jimmunol.1290068; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Schroeder HW, 2001, BLOOD, V98, P2745, DOI 10.1182/blood.V98.9.2745; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Stam J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025690; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; Thaker YR, 2015, IMMUNOL LETT, V163, P113, DOI 10.1016/j.imlet.2014.10.020; Thiel A, 1997, IMMUNOL LETT, V57, P189, DOI 10.1016/S0165-2478(97)00056-4; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; Toldi G, 2010, INT IMMUNOL, V22, P769, DOI 10.1093/intimm/dxq063; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; WEBB LMC, 1995, BLOOD, V86, P3479, DOI 10.1182/blood.V86.9.3479.bloodjournal8693479; Weber MA, 2008, LANCET, V371, P1848, DOI 10.1016/S0140-6736(08)60798-9; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Wiegering V, 2009, EUR CYTOKINE NETW, V20, P75, DOI 10.1684/ecn.2009.0149; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445	80	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166633	10.1371/journal.pone.0166633	http://dx.doi.org/10.1371/journal.pone.0166633			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893767	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400037
J	Barrowclough, GF; Cracraft, J; Klicka, J; Zink, RM				Barrowclough, George F.; Cracraft, Joel; Klicka, John; Zink, Robert M.			How Many Kinds of Birds Are There and Why Does It Matter?	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; MITOCHONDRIAL-DNA; CONSERVATION; TAXONOMY; BIOGEOGRAPHY; SYSTEMATICS; ENDEMISM; HISTORY	Estimates of global species diversity have varied widely, primarily based on variation in the numbers derived from different inventory methods of arthropods and other small invertebrates. Within vertebrates, current diversity metrics for fishes, amphibians, and reptiles are known to be poor estimators, whereas those for birds and mammals are often assumed to be relatively well established. We show that avian evolutionary diversity is significantly underestimated due to a taxonomic tradition not found in most other taxonomic groups. Using a sample of 200 species taken from a list of 9159 biological species determined primarily by morphological criteria, we applied a diagnostic, evolutionary species concept to a morphological and distributional data set that resulted in an estimate of 18,043 species of birds worldwide, with a 95% confidence interval of 15,845 to 20,470. In a second, independent analysis, we examined intraspecific genetic data from 437 traditional avian species, finding an average of 2.4 evolutionary units per species, which can be considered proxies for phylogenetic species. Comparing recent lists of species to that used in this study ( based primarily on morphology) revealed that taxonomic changes in the past 25 years have led to an increase of only 9%, well below what our results predict. Therefore, our molecular and morphological results suggest that the current taxonomy of birds understimates avian species diversity by at least a factor of two. We suggest that a revised taxonomy that better captures avian species diversity will enhance the quantification and analysis of global patterns of diversity and distribution, as well as provide a more appropriate framework for understanding the evolutionary history of birds.	[Barrowclough, George F.; Cracraft, Joel] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA; [Klicka, John] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Klicka, John] Univ Washington, Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Zink, Robert M.] Univ Nebraska, Sch Nat Resources, Nebraska State Museum, Lincoln, NE USA; [Zink, Robert M.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	American Museum of Natural History (AMNH); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Barrowclough, GF (corresponding author), Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA.	gfb@amnh.org		Barrowclough, George/0000-0001-7113-2076	U.S. National Science Foundation [1241066, 1146423, DEB 0815057]; Division Of Environmental Biology [1241066] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This paper received support from the U.S. National Science Foundation awards 1241066 and 1146423 (J.C.) and DEB 0815057 (J.K.); The authors thank D. S. Wood and T. Trombone for providing the digital lists of the biological species of birds of the world. We thank J. Bates, N. Caithness, C. Griffiths, S. Hackett, F. James, R. Prum, P. Sweet, and S. Weller for comments on the manuscript, helpful discussion, and other assistance. This paper received support from the U.S. National Science Foundation awards 1241066 and 1146423 (J. C.).	Amadon Dean, 1992, Bulletin of the British Ornithologists' Club, V112A, P11; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Barrowclough George F., 1996, P247; Blackburn TM, 1996, ECOGRAPHY, V19, P369, DOI 10.1111/j.1600-0587.1996.tb00247.x; Bock W.J., 1980, American Museum Novitates, P1; Christidis L, 2014, PASSERINE, V2; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Cracraft J., 1983, Current Ornithology, V1, P159; del Hoyo J, 2013, HDB BIRDS WORLD; Dickinson EC, 2013, HOWARD MOORE COMPLET, V1; Fjeldsa Jon, 2013, P77; Gill F., 2016, IOC WORLD BIRD LIST; Gill FB, 2014, AUK, V131, P150, DOI 10.1642/AUK-13-206.1; Groves C, 2014, EVOL ANTHROPOL, V23, P2, DOI 10.1002/evan.21395; Gutierrez EE, 2013, NATURE, V495, P314, DOI 10.1038/495314e; Harvey MG, 2015, MOL PHYLOGENET EVOL, V83, P305, DOI 10.1016/j.ympev.2014.10.023; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; *INT COUNC BIRD PR, 1992, PUTT BIOD MAP PRIOR; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Klicka J, 1999, P ROY SOC B-BIOL SCI, V266, P695, DOI 10.1098/rspb.1999.0691; Locey KJ, 2016, P NATL ACAD SCI USA, V113, P5970, DOI 10.1073/pnas.1521291113; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mayr Ernst, 1993, Proceedings of the California Academy of Sciences, V48, P131; McKay BD, 2013, MOL ECOL, V22, P4943, DOI 10.1111/mec.12446; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Mora C, 2013, SCIENCE, V341, DOI 10.1126/science.1237254; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Morony JJ, 1975, REFERENCE LIST BIRDS; Morrison WR, 2009, BIOL CONSERV, V142, P3201, DOI 10.1016/j.biocon.2009.07.019; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Oswald JA, 2016, AUK, V133, P593, DOI 10.1642/AUK-15-232.1; Paynter R. A., 1987, CHECK LIST BIRDS WOR, V16; Peters J.L., 1931, CHECK LIST BIRDS WOR, V1; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; Reddy S, 2008, MOL PHYLOGENET EVOL, V47, P54, DOI 10.1016/j.ympev.2008.01.014; Remsen JV, 2005, AUK, V122, P403, DOI 10.1642/0004-8038(2005)122[0403:PPARMC]2.0.CO;2; Riddle BR, 1999, GLOBAL ECOL BIOGEOGR, V8, P433, DOI 10.1046/j.1365-2699.1999.00170.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sangster G, 2014, BIOL REV, V89, P199, DOI 10.1111/brv.12051; Sangster G, 2009, P ROY SOC B-BIOL SCI, V276, P3185, DOI 10.1098/rspb.2009.0582; Sibley CG, 1990, DISTRIBUTION TAXONOM; Smith BT, 2014, NATURE, V515, P406, DOI 10.1038/nature13687; STIASSNY MLJ, 1992, SYSTEMATICS, ECOLOGY, AND THE BIODIVERSITY CRISIS, P109; Swenson JJ, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-1; USFWS NMFS, 1996, FED REGISTER, V61, P4722; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; WILSON E O, 1992; Wood D. S., 1986, REVISED WORLD INVENT; Zachos FE, 2013, NATURE, V494, P35, DOI 10.1038/494035c; Zachos FE, 2013, MAMM BIOL, V78, P1, DOI 10.1016/j.mambio.2012.07.083; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zink RM, 2015, CONDOR, V117, P76, DOI 10.1650/CONDOR-14-27.1; Zink RM, 2013, AUK, V130, P449, DOI 10.1525/auk.2013.12241	55	101	104	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166307	10.1371/journal.pone.0166307	http://dx.doi.org/10.1371/journal.pone.0166307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880775	Green Submitted, Green Published, gold			2022-12-26	WOS:000388889500019
J	Oka, S; Tomita, T; Miyamoto, K				Oka, Shin-ichiro; Tomita, Taketeru; Miyamoto, Kei			A Mighty Claw: Pinching Force of the Coconut Crab, the Largest Terrestrial Crustacean	PLOS ONE			English	Article							BIRGUS-LATRO; ANOMURA COENOBITIDAE; IDENTIFICATION; CARAPACE; DECAPODA; ANIMALS; ISLAND; OCEAN	Crustaceans can exert a greater force using their claws than many animals can with other appendages. Furthermore, in decapods, the chela is a notable organ with multifunctional roles. The coconut crab, Birgus latro, is the largest terrestrial crustacean and has a remarkable ability to lift weights up to approximately 30 kg. However, the pinching force of this crab's chelae has not been previously investigated. In the present study, we measured the pinching force of the chelae in 29 wild coconut crabs (33-2,120 g in body weight). The maximum force ranged from 29.4 to 1,765.2 N, and showed a strong positive correlation with body mass. Based on the correlation between pinching force and body weight, the force potentially exerted by the largest crab (4 kg weight) reported in a previous study would be 3300 N, which greatly exceeds the pinching force of other crustaceans as well as the bite force of most terrestrial predators. The mighty claw is a terrestrial adaptation that is not only a weapon, which can be used to prevent predator attack and inhibit competitors, but is also a tool to hunt other terrestrial organisms with rigid exteriors, aiding in these organisms to be omnivores.	[Oka, Shin-ichiro; Tomita, Taketeru; Miyamoto, Kei] Okinawa Churashima Fdn, 888 Ishikawa, Motobu, Okinawa 9050206, Japan		Oka, S (corresponding author), Okinawa Churashima Fdn, 888 Ishikawa, Motobu, Okinawa 9050206, Japan.	sh-oka@okichura.jp		Oka, Shin-ichiro/0000-0002-9554-6342				ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Altevogt R, 1975, Bulletin Dep mar Sci Univ Cochin, V7, P11; Anagnostou C, 2014, RAFFLES B ZOOL, P136; Bracken-Grissom HD, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-128; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Claussen DL, 2008, J COMP PHYSIOL B, V178, P333, DOI 10.1007/s00360-007-0226-8; Drew MM, 2010, ZOOL ANZ, V249, P45, DOI 10.1016/j.jcz.2010.03.001; Fujiwara S, 2016, J MORPHOL, V277, P1259, DOI 10.1002/jmor.20573; GOVIND CK, 1985, BIOL BULL, V168, P321, DOI 10.2307/1541244; Greenaway Peter, 2003, Memoirs of Museum Victoria, V60, P13; HELFMAN GS, 1977, Z TIERPSYCHOL, V43, P425; Hennicke Janos C., 2012, Australian Field Ornithology, V29, P196; Huber DR, 2005, J EXP BIOL, V208, P3553, DOI 10.1242/jeb.01816; Krieger J, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-06; Matsuzaki S., 2013, CRUSTAC RES, V42, P17, DOI 10.18353/crustacea.42.0_17; Oka S, 2015, ZOOL SCI, V32, P260, DOI 10.2108/zs150008; Oka Shin-ichiro, 2014, Biological Magazine Okinawa, V52, P11; REESE ES, 1968, SCIENCE, V161, P385, DOI 10.1126/science.161.3839.385; Taylor GM, 2000, P ROY SOC B-BIOL SCI, V267, P1475, DOI 10.1098/rspb.2000.1167	19	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166108	10.1371/journal.pone.0166108	http://dx.doi.org/10.1371/journal.pone.0166108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880779	Green Published, Green Submitted, gold			2022-12-26	WOS:000388889500017
J	Upson, R; Williams, JJ; Wilkinson, TP; Clubbe, CP; Maclean, IMD; McAdam, JH; Moat, JF				Upson, Rebecca; Williams, Jennifer J.; Wilkinson, Tim P.; Clubbe, Colin P.; Maclean, Ilya M. D.; McAdam, Jim H.; Moat, Justin F.			Potential Impacts of Climate Change on Native Plant Distributions in the Falkland Islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL RESPONSES; VASCULAR FLORA; PREDICTION; BIODIVERSITY; THRESHOLDS; PREVALENCE; ACCURACY; EVENTS; SHIFTS	The Falkland Islands are predicted to experience up to 2.2 degrees C rise in mean annual temperature over the coming century, greater than four times the rate over the last century. Our study investigates likely vulnerabilities of a suite of range-restricted species whose distributions are associated with archipelago-wide climatic variation. We used present day climate maps calibrated using local weather data, 2020-2080 climate predictions from regional climate models, non-climate variables derived from a digital terrain model and a comprehensive database on local plant distributions. Weighted mean ensemble models were produced to assess changes in range sizes and overlaps between the current range and protected areas network. Target species included three globally threatened Falkland endemics, Nassauvia falklandica, Nastanthus falklandicus and Plantago moorei; and two nationally threatened species, Acaena antarctica and Blechnum cordatum. Our research demonstrates that temperature increases predicted for the next century have the potential to significantly alter plant distributions across the Falklands. Upland species, in particular, were found to be highly vulnerable to climate change impacts. No known locations of target upland species or the southwestern species Plantago moorei are predicted to remain environmentally suitable in the face of predicted climate change. We identify potential refugia for these species and associated gaps in the current protected areas network. Species currently restricted to the milder western parts of the archipelago are broadly predicted to expand their ranges under warmer temperatures. Our results emphasise the importance of implementing suitable adaptation strategies to offset climate change impacts, particularly site management. There is an urgent need for long-term monitoring and artificial warming experiments; the results of this study will inform the selection of the most suitable locations for these. Results are also helping inform management recommendations for the Falkland Islands Government who seek to better conserve their biodiversity and meet commitments to multi-lateral environmental agreements.	[Upson, Rebecca; Williams, Jennifer J.; Wilkinson, Tim P.; Clubbe, Colin P.; Moat, Justin F.] Royal Bot Gardens, Richmond, Surrey, England; [Maclean, Ilya M. D.] Univ Exeter, Coll Life & Environm Sci, Environm & Sustainabil Inst, Penryn Campus, Penryn, England; [McAdam, Jim H.] UK Falkland Islands Trust, Westminster, London, England; [McAdam, Jim H.] Agri Food & Biosci Inst, New Forge Lane, Belfast, Antrim, North Ireland; [McAdam, Jim H.] Queens Univ Belfast, New Forge Lane, Belfast, Antrim, North Ireland; [Moat, Justin F.] Univ Nottingham, Sch Geog, Nottingham, England	Royal Botanic Gardens, Kew; University of Exeter; Agri-Food & Biosciences Institute; Queens University Belfast; University of Nottingham	Upson, R (corresponding author), Royal Bot Gardens, Richmond, Surrey, England.	R.Upson@kew.org		Moat, Justin/0000-0002-5513-3615; Maclean, Ilya/0000-0001-8030-9136; Clubbe, Colin/0000-0002-0532-1722; Wilkinson, Tim/0000-0003-1055-8318	EU-BEST initiative [BEST/2012/16]	EU-BEST initiative	The authors gratefully acknowledge funding from the EU-BEST initiative (http://ec.europa.eu/environment/nature/biodiversity/best/) for project TEFRA: Terrestrial Ecosystems of the Falklands Islands: a climate change risk assessment (BEST/2012/16). CPC RU BEST Initiative - Nature & Biodiversity - Environment ec.europa.eu. BEST voluntary scheme for Biodiversity and Ecosystem Services in Territories of European overseas aims to support the conservation of biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Andrew T, 2007, FIELD GUIDE ANIMALS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bokhorst Stef, 2007, BMC Ecology, V7, P15, DOI 10.1186/1472-6785-7-15; Bonta M, 2002, IDENTIFYING IMPORTAN; Bramwell D., 2011, The biology of island floras, P443; Broughton DA, 2005, J TORREY BOT SOC, V132, P115, DOI 10.3159/1095-5674(2005)132[115:ACOTNV]2.0.CO;2; Brusca RC, 2013, ECOL EVOL, V3, P3307, DOI 10.1002/ece3.720; Cabrelli AL, 2014, BIODIVERS CONSERV, V23, P3019, DOI 10.1007/s10531-014-0760-0; CBD, 2015, AICH BIOD TARG; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; ESRI, 2011, ARCGIS DESKT REL 10; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FIG, 2015, FALKL ISL BIOD STRAT; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Franklin J, 2009, MAPPING SPECIES DIST; Galbraith D., 2011, FIELD GUIDE FLORA S; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Hanberry B.B., 2013, WEB ECOL, V13, P19, DOI DOI 10.5194/we-13-13-2013; Harter DEV, 2015, PERSPECT PLANT ECOL, V17, P160, DOI 10.1016/j.ppees.2015.01.003; Hewitt N, 2011, BIOL CONSERV, V144, P2560, DOI 10.1016/j.biocon.2011.04.031; Hijmans R.J., 2011, PACKAGE DISMO; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jarvis A., 2008, HOLE FILLED SRTM GLO; Jones PD, 2013, CONSTRUCTION HIGH SP; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kullman L., 2006, Nordic Journal of Botany, V24, P445, DOI 10.1111/j.1756-1051.2004.tb02209.x; Lambdon P, 2008, BOT SURVEY ASCENSION; Lambdon P., 2012, FLOWERING PLANTS FER; Lassueur T, 2006, ECOL MODEL, V198, P139, DOI 10.1016/j.ecolmodel.2006.04.004; Lawson CR, 2014, METHODS ECOL EVOL, V5, P54, DOI 10.1111/2041-210X.12123; Le Roux PC, 2005, GLOBAL CHANGE BIOL, V11, P1628, DOI 10.1111/j.1365-2486.2005.001022.x; le Roux PC, 2008, GLOBAL CHANGE BIOL, V14, P2950, DOI 10.1111/j.1365-2486.2008.01687.x; Lister DH, 2015, INT J CLIMATOL, V35, P1224, DOI 10.1002/joc.4049; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lunt ID, 2013, BIOL CONSERV, V157, P172, DOI 10.1016/j.biocon.2012.08.034; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; McAdam JH, 1985, PROGR BIOMETEOROLOGY, V2, P753; McAdam Jim, 2011, Anales Instituto Patagonia (Chile), V39, P103, DOI 10.4067/S0718-686X2011000100009; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Nurse LA, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1613; Nyakatya M. J., 2006, THESIS; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peirce C S, 1884, Science, V4, P453, DOI 10.1126/science.ns-4.93.453-a; R Core Team, 2021, R LANGUAGE ENV STAT; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Solman SA, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/504357; Suggitt AJ, 2013, CLIMATE CHANGE REFUG; Suri M., 2004, T GIS, V8, P175, DOI [10.1111/j.1467-9671.2004.00174.x, DOI 10.1111/J.1467-9671.2004.00174.X]; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W., 2014, PACKAGE BIOMOD2 ENSE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Upson R, 2014, UPDATED ATLAS CHECKL; Upson R, 2012, IMPORTANT PLANT AREA; Upson R, 2013, KEW BULL, V68, P317, DOI 10.1007/S12225-013-9446-0; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Vitt P, 2009, TRENDS ECOL EVOL, V24, P473, DOI 10.1016/j.tree.2009.05.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weltzin JF, 2003, GLOBAL CHANGE BIOL, V9, P141, DOI 10.1046/j.1365-2486.2003.00571.x; Wigginton M. J., 1999, BRIT RED DATA BOOKS; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014	81	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167026	10.1371/journal.pone.0167026	http://dx.doi.org/10.1371/journal.pone.0167026			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880846	Green Submitted, gold, Green Published			2022-12-26	WOS:000388889500055
J	Meng, Q; Sayin, I; Canaday, DH; Mayanja-Kizza, H; Baseke, J; Toossi, Z				Meng, Qinglai; Sayin, Ismail; Canaday, David H.; Mayanja-Kizza, Harriet; Baseke, Joy; Toossi, Zahra			Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; VIRUS TYPE-1 INFECTION; PLASMA-LEVELS; VIRAL LOAD	Systemic immune activation is critical to the pathogenesis of HIV-1 disease, and is accentuated in HIV/TB co-infected patients. The contribution of immune activation at sites of HIV/TB co-infection to viral activity, CD4 T cell count, and productive HIV-1 infection remain unclear. In this study, we measured markers of immune activation both in pleural fluid and plasma, and in T cells in pleural fluid mononuclear cell (PFMC) and peripheral blood mononuclear cell (PBMC) in HIV/TB co-infected subjects. The relationship between soluble and T cell activation markers with viral load in pleural fluid and blood CD4 T cell count were assessed. The T cell phenotype and activation status of HIV-1 p24 + T cells in PFMC and PBMC from HIV/TB patients were determined. We found that T cell and macrophage-specific and nonspecific soluble markers of immune activation, sCD27, sCD163, IL1Ra, and sCD14, were higher in pleural fluid as compared to plasma from HIV/TB co-infected subjects, and higher as compared to pleural fluid from TB mono-infected subjects. Intestinal fatty acid-binding protein, a marker of intestinal tract damage, in plasma from HIV/TB co-infected patients was not different than that in HIV+ subjects. Expression of HLADR and CD38 double positive (HLADR/CD38) on CD4 T cells, and CD69+ on CD8 T cells correlated with pleural fluid viral load, and inversely with blood CD4 T cell count. Higher expression of HLADR/CD38 and CCR5 on CD4 T cells, and HLADR/CD38 and CD69 on CD8 T cells in PFMC were limited to effector memory populations. HIV-1 p24+ CD8 negative (includes CD4 + and double negative T cells) effector memory T cells in PFMC had higher expression of HLADR/CD38, Ki67, and CCR5 compared to HIV-1 p24- CD8 negative PFMC. Cumulatively, these data indicate that sites of HIV/TB co-infection are the source of intense immune activation.	[Meng, Qinglai; Sayin, Ismail; Canaday, David H.; Mayanja-Kizza, Harriet; Toossi, Zahra] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Canaday, David H.; Toossi, Zahra] Vet Affairs Med Ctr, Cleveland, OH USA; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda; [Baseke, Joy] Joint Clin Res Ctr, Kampala, Uganda	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Makerere University; Joint Clinic Research Center - United Arab Emirates	Toossi, Z (corresponding author), Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA.; Toossi, Z (corresponding author), Vet Affairs Med Ctr, Cleveland, OH USA.	zxt2@case.edu	Mayanja-Kizza, Harriet/AAM-5372-2020	Mayanja-Kizza, Harriet/0000-0002-9297-6208	National Institutes of Health: National Heart Lung Blood Institute [HL-051636]; National Institutes of Health: National Institute of Allergy and Infectious Disease [AI-1080313]; National Institutes of Health: Center for AIDS Research [AI-036219]; National Institutes of Health: Tuberculosis Research Unit grant [AI-70022]	National Institutes of Health: National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health: National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health: Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: Tuberculosis Research Unit grant	This work was supported by National Institutes of Health grants: National Heart Lung Blood Institute, HL-051636 to ZT; National Institute of Allergy and Infectious Disease, AI-1080313 to DHC; Center for AIDS Research, AI-036219; and the Tuberculosis Research Unit grant, AI-70022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Canary LA, 2013, J IMMUNOL, V190, P2959, DOI 10.4049/jimmunol.1202319; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; De Milito A, 2002, CLIN EXP IMMUNOL, V127, P486, DOI 10.1046/j.1365-2249.2002.01786.x; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hirsch CS, 2001, J INFECT DIS, V183, P779, DOI 10.1086/318817; Huang JP, 2013, J IMMUNOL, V190, P6250, DOI 10.4049/jimmunol.1300022; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaiser P, 2007, J VIROL, V81, P9693, DOI 10.1128/JVI.00492-07; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Meng QL, 2016, ARCH VIROL, V161, P181, DOI 10.1007/s00705-015-2640-7; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Perkins MR, 2015, J INFECT DIS, V212, P578, DOI 10.1093/infdis/jiv089; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Santos-Oliveira JR, 2013, J INFECT DIS, V208, P57, DOI 10.1093/infdis/jit135; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Toossi Z, CLIN EXPT IMMUNOLOGY, V163, P333, DOI [10.1111/j.1365-2249, DOI 10.1111/J.1365-2249]; Toossi Z, 2013, J INFECT DIS, V207, P1841, DOI 10.1093/infdis/jit092; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	30	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166954	10.1371/journal.pone.0166954	http://dx.doi.org/10.1371/journal.pone.0166954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870882	Green Submitted, Green Published, gold			2022-12-26	WOS:000388846400044
J	Martin, P; McGovern, A; Massey, J; Schoenfelder, S; Duffus, K; Yarwood, A; Barton, A; Worthington, J; Fraser, P; Eyre, S; Orozco, G				Martin, Paul; McGovern, Amanda; Massey, Jonathan; Schoenfelder, Stefan; Duffus, Kate; Yarwood, Annie; Barton, Anne; Worthington, Jane; Fraser, Peter; Eyre, Stephen; Orozco, Gisela			Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; TRANSCRIPTIONAL INTERACTOME; RHEUMATOID-ARTHRITIS; JOUBERT-SYNDROME; RISK ALLELES; AHI1 GENE; DISEASE; AUTOIMMUNE; VARIANTS; REVEALS	Background The chromosomal region 6q23 has been found to be associated with multiple sclerosis (MS) predisposition through genome wide association studies (GWAS). There are four independent single nucleotide polymorphisms (SNPs) associated with MS in this region, which spans around 2.5 Mb. Most GWAS variants associated with complex traits, including these four MS associated SNPs, are non-coding and their function is currently unknown. However, GWAS variants have been found to be enriched in enhancers and there is evidence that they may be involved in transcriptional regulation of their distant target genes through long range chromatin looping. Aim The aim of this work is to identify causal disease genes in the 6q23 locus by studying long range chromatin interactions, using the recently developed Capture Hi-C method in human T and B-cell lines. Interactions involving four independent associations unique to MS, tagged by rs11154801, rs17066096, rs7769192 and rs67297943 were analysed using Capture Hi-C Analysis of Genomic Organisation (CHiCAGO). Results We found that the pattern of chromatin looping interactions in the MS 6q23 associated region is complex. Interactions cluster in two regions, the first involving the rs11154801 region and a second containing the rs17066096, rs7769192 and rs67297943 SNPs. Firstly, SNPs located within the AHI1 gene, tagged by rs11154801, are correlated with expression of AHI1 and interact with its promoter. These SNPs also interact with other potential candidate genes such as SGK1 and BCLAF1. Secondly, the rs17066096, rs7769192 and rs67297943 SNPs interact with each other and with immune-related genes such as IL20RA, IL22RA2, IFNGR1 and TNFAIP3. Finally, the above-mentioned regions interact with each other and therefore, may co-regulate these target genes. Conclusion These results suggest that the four 6q23 variants, independently associated with MS, are involved in the regulation of several genes, including immune genes. These findings could help understand mechanisms of disease and suggest potential novel therapeutic targets.	[Martin, Paul; McGovern, Amanda; Massey, Jonathan; Duffus, Kate; Yarwood, Annie; Barton, Anne; Worthington, Jane; Eyre, Stephen; Orozco, Gisela] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester Acad Hlth Sci Ctr,Fac Biol Med & Hlth, Ctr Musculoskeletal Res,Div Musculoskeletal & Der, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Schoenfelder, Stefan; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England; [Barton, Anne; Worthington, Jane] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal BRU, Manchester, Lancs, England	University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Manchester	Orozco, G (corresponding author), Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester Acad Hlth Sci Ctr,Fac Biol Med & Hlth, Ctr Musculoskeletal Res,Div Musculoskeletal & Der, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	gisela.orozco@manchester.ac.uk	Orozco, Gisela/E-1856-2015; Barton, Anne/N-2053-2014; Yarwood, Annie/B-3882-2015	Orozco, Gisela/0000-0002-3479-0448; Martin, Paul/0000-0002-1016-6851; Massey, Jonathan/0000-0002-4576-1124; Barton, Anne/0000-0003-3316-2527; Fraser, Peter/0000-0002-0041-1227; Yarwood, Annie/0000-0001-5026-9815; Duffus, Kate/0000-0002-8925-1863	Wellcome Trust [095684, 097820/Z/11/B]; Arthritis Research UK [20385, 20571]; European Union [FP7-HEALTH-F2-2012-305549]; Innovative Medicines Initiative [115142]; Medical Research Council [MR/K015346/1]; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Biotechnology and Biological Sciences Research Council UK [BBS/E/B/000C0405]; BBSRC [BBS/E/B/000C0405] Funding Source: UKRI; MRC [MR/K015346/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0405] Funding Source: researchfish; Versus Arthritis [20571] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis); European Union(European Commission); Innovative Medicines Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	Wellcome Trust Research Career Development Fellowship (095684); Arthritis Research UK (grant numbers 20385, 20571); Wellcome Trust (097820/Z/11/B); European Union's FP7 Health Programme (FP7-HEALTH-F2-2012-305549, Euro-TEAM, FP7/2007-2013); Innovative Medicines Initiative (BeTheCure project 115142); Medical Research Council (MR/K015346/1); National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Biotechnology and Biological Sciences Research Council UK (BBS/E/B/000C0405).	Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bowes J, 2011, ANN RHEUM DIS, V70, P1641, DOI 10.1136/ard.2011.150102; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Dong XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-704; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gottlieb AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134703; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hemminki K, 2009, NEUROGENETICS, V10, P5, DOI 10.1007/s10048-008-0156-y; Homouz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054699; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Martin P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10069; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Pollard KM, 2013, DISCOV MED, V16, P123; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Senolt L, 2015, ARTHRITIS RHEUMATOL, V67, P1438, DOI 10.1002/art.39083; Sharief MK, 2003, J NEUROIMMUNOL, V134, P158, DOI 10.1016/S0165-5728(02)00400-9; Tipney H, 2015, NAT GENET NATURE RES, V47, P1, DOI [10.1038/ng.3314, DOI 10.1038/NG.3314]; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984	41	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166923	10.1371/journal.pone.0166923	http://dx.doi.org/10.1371/journal.pone.0166923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861577	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300133
J	Feng, J; Li, L; Zhang, N; Liu, J; Zhang, L; Gao, H; Wang, G; Li, Y; Zhang, Y; Li, X; Liu, D; Lu, J; Huang, B				Feng, J.; Li, L.; Zhang, N.; Liu, J.; Zhang, L.; Gao, H.; Wang, G.; Li, Y.; Zhang, Y.; Li, X.; Liu, D.; Lu, J.; Huang, B.			Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms	ONCOGENE			English	Article							TANDEM MASS-SPECTROMETRY; SEX STEROID-HORMONES; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; RECEPTOR EXPRESSION; CHROMATIN IMMUNOPRECIPITATION; TESTOSTERONE LEVELS; SERUM TESTOSTERONE; DEMETHYLASE LSD1; DUCTAL CARCINOMA	The role of androgen and androgen receptor (AR) in breast carcinogenesis has long been a disputed issue. This report provides a mechanistic insight into how androgen and AR contributes to invasion and metastasis of breast cancer. We find that dihydrotestosterone (DHT) is able to induce the epithelial-to-mesenchymal transition in breast cancer cells in an AR-dependent/ estrogen receptor-independent manner. This process is dependent on the demethylation activity of lysine-specific demethylase 1A (LSD1) by epigenetically regulating the target genes E-cadherin and vimentin. In vivo, DHT promotes metastasis in a nude mouse model, and AR and LSD1 are indispensable in this process. We establish that higher expression of nucleus AR to cytoplasm AR associated with worse prognostic outcomes in breast cancer patient samples. This study maps an 'androgen-AR/LSD1-target genes' pathway in breast carcinogenesis, implicating the importance of hormonal balance in women, and the potential clinical significance of serum androgen and AR in prediction of breast cancer and selection of breast cancer therapy.	[Feng, J.; Li, L.; Liu, J.; Zhang, Y.; Huang, B.] Northeast Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, 5268 Renmin St', Changchun 130024, Peoples R China; [Li, L.] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Dept Bone & Soft Tissue Tumors, Tianjin, Peoples R China; [Zhang, N.; Li, X.; Lu, J.] Northeast Normal Univ, Inst Genet & Cytol, 5268 Renmin St, Changchun 130024, Peoples R China; [Zhang, L.; Gao, H.] Jilin Univ, Dept Pathol, Hosp 2, Changchun, Peoples R China; [Wang, G.; Li, Y.] Northeast Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Liu, D.] Auckland Univ Technol, Sch Sci, Auckland, New Zealand	Northeast Normal University - China; Tianjin Medical University; Northeast Normal University - China; Jilin University; Northeast Normal University - China; Auckland University of Technology	Huang, B (corresponding author), Northeast Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, 5268 Renmin St', Changchun 130024, Peoples R China.; Lu, J (corresponding author), Northeast Normal Univ, Inst Genet & Cytol, 5268 Renmin St, Changchun 130024, Peoples R China.	luj809@nenu.edu.cn; huangbq705@nenu.edu.cn		Feng, Jing-Xin/0000-0003-0677-2792	National Natural Science Foundation of China [31570718, 31571478, 31571317, 31371294]; University S & T Innovation Platform of Jilin Province for Economic Fungi [2014B-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University S & T Innovation Platform of Jilin Province for Economic Fungi	We thank Dr Wei Huang from School of Mathematics and Statistics of Northeast Normal University for kindly providing statistical analysis guidance. This work was supported by the grants from the National Natural Science Foundation of China (Grant numbers 31570718, 31571478, 31571317 and 31371294), and a grant from The University S & T Innovation Platform of Jilin Province for Economic Fungi (#2014B-1).	Abdulla A, 2014, J BIOL CHEM, V289, P29937, DOI 10.1074/jbc.M114.573659; Agrawal AK, 2008, FOLIA HISTOCHEM CYTO, V46, P269, DOI 10.2478/v10042-008-0039-y; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Amente S, 2013, BBA-GENE REGUL MECH, V1829, P981, DOI 10.1016/j.bbagrm.2013.05.002; Amente S, 2010, CELL CYCLE, V9, P3002, DOI 10.4161/cc.9.15.12499; Berrino F, 2005, INT J CANCER, V113, P499, DOI 10.1002/ijc.20582; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bui HN, 2013, STEROIDS, V78, P96, DOI 10.1016/j.steroids.2012.10.010; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Castellano I, 2010, BREAST CANCER RES TR, V124, P607, DOI 10.1007/s10549-010-0761-y; Chen J, 2013, J STEROID BIOCHEM, V137, P316, DOI 10.1016/j.jsbmb.2013.01.012; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dorgan JF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2779; Feng JX, 2016, BREAST CANCER RES TR, V159, P443, DOI 10.1007/s10549-016-3959-9; Ferrari-Amorotti G, 2013, CANCER RES, V73, P235, DOI 10.1158/0008-5472.CAN-12-1739; Fourkala EO, 2012, ENDOCR-RELAT CANCER, V19, P137, DOI 10.1530/ERC-11-0310; Garay JP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3112; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gonzalez LO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-149; Gonzalez-Angulo AM, 2009, CLIN CANCER RES, V15, P2472, DOI 10.1158/1078-0432.CCR-08-1763; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanley K, 2008, HUM PATHOL, V39, P386, DOI 10.1016/j.humpath.2007.07.007; Harmeyer KM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1347; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; He JH, 2012, MED ONCOL, V29, P406, DOI 10.1007/s12032-011-9832-0; Hickey TE, 2015, ONCOTARGET, V6, P44728, DOI 10.18632/oncotarget.6296; Honma N, 2013, BREAST CANCER-TOKYO, V20, P323, DOI 10.1007/s12282-012-0337-2; Hu DG, 2014, HORM CANCER-US, V5, P61, DOI 10.1007/s12672-014-0171-4; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Kaaks R, 2005, JNCI-J NATL CANCER I, V97, P755, DOI 10.1093/jnci/dji132; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Kocaturk B, 2015, JOVE-J VIS EXP, DOI 10.3791/51967; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li YX, 2016, ONCOL REP, V35, P3586, DOI 10.3892/or.2016.4729; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Loibl S, 2011, BREAST CANCER RES TR, V130, P477, DOI 10.1007/s10549-011-1715-8; Luo HC, 2016, CELL REP, V15, P2665, DOI 10.1016/j.celrep.2016.05.050; Luo Xiang, 2010, Chin J Cancer, V29, P585; McNamara KM, 2013, J STEROID BIOCHEM, V133, P66, DOI 10.1016/j.jsbmb.2012.08.007; McNamara KM, 2010, J STEROID BIOCHEM, V121, P611, DOI 10.1016/j.jsbmb.2010.02.001; McNamara Keely M, 2013, Front Endocrinol (Lausanne), V4, P116, DOI 10.3389/fendo.2013.00116; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Micello D, 2010, VIRCHOWS ARCH, V457, P467, DOI 10.1007/s00428-010-0964-y; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Mrklic I, 2013, ACTA HISTOCHEM, V115, P344, DOI 10.1016/j.acthis.2012.09.006; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nam HJ, 2014, MOL CELL, V53, P791, DOI 10.1016/j.molcel.2014.01.028; Narayanan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103202; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ni L, 2013, MOL CELL BIOL, V33, P4766, DOI 10.1128/MCB.00647-13; Ni M, 2013, GENE DEV, V27, P734, DOI 10.1101/gad.209569.112; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Park S, 2011, ANN ONCOL, V22, P1755, DOI 10.1093/annonc/mdq678; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Peters KM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-132; Qu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082650; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; REMMELE W, 1986, VIRCHOWS ARCH A, V409, P127, DOI 10.1007/BF00708323; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Rothman MS, 2011, STEROIDS, V76, P177, DOI 10.1016/j.steroids.2010.10.010; Schippinger W, 2006, VIRCHOWS ARCH, V449, P24, DOI 10.1007/s00428-006-0213-6; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shufelt Chrisandra L, 2008, Menopause Int, V14, P117, DOI 10.1258/mi.2008.008015; Sieri S, 2009, CANCER EPIDEM BIOMAR, V18, P169, DOI 10.1158/1055-9965.EPI-08-0808; Spurdle AB, 1999, JNCI-J NATL CANCER I, V91, P961, DOI 10.1093/jnci/91.11.961; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tang DB, 2012, MED ONCOL, V29, P526, DOI 10.1007/s12032-011-9948-2; Tsutsumi Y, 2012, JPN J CLIN ONCOL, V42, P375, DOI 10.1093/jjco/hys034; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt319; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Wang B, 2009, INT J CANCER, V124, P1892, DOI 10.1002/ijc.24132; Wang Y, 2011, ONCOGENE, V30, P4327, DOI 10.1038/onc.2011.144; Wang Y, 2013, HUM MOL GENET, V22, P2263, DOI 10.1093/hmg/ddt077; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Witzel I, 2013, J CANCER RES CLIN, V139, P809, DOI 10.1007/s00432-013-1382-8; Yu H, 2003, INT J CANCER, V105, P92, DOI 10.1002/ijc.11034; Yu Q, 2011, ANN ONCOL, V22, P1288, DOI 10.1093/annonc/mdq586; Zeleniuch-Jacquotte A, 2004, BRIT J CANCER, V90, P153, DOI 10.1038/sj.bjc.6601517	86	56	58	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2775	2790		10.1038/onc.2016.432	http://dx.doi.org/10.1038/onc.2016.432			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27893717				2022-12-26	WOS:000401697800001
J	Hiraki, M; Maeda, T; Bouillez, A; Alam, M; Tagde, A; Hinohara, K; Suzuki, Y; Markert, T; Miyo, M; Komura, K; Ahmad, R; Rajabi, H; Kufe, D				Hiraki, M.; Maeda, T.; Bouillez, A.; Alam, M.; Tagde, A.; Hinohara, K.; Suzuki, Y.; Markert, T.; Miyo, M.; Komura, K.; Ahmad, R.; Rajabi, H.; Kufe, D.			MUC1-C activates BMI1 in human cancer cells	ONCOGENE			English	Article							POLYCOMB GROUP PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; DNA-DAMAGE RESPONSE; STEM-CELLS; SELF-RENEWAL; TRANSCRIPTION FACTOR; H2A UBIQUITYLATION; SENESCENT CELLS; BETA-CATENIN; HISTONE H2A	B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overexpressed in human carcinoma cells and has been linked to their self-renewal. There is no known relationship between MUC1-C and BMI1 in cancer. The present studies demonstrate that MUC1-C drives BMI1 transcription by a MYC-dependent mechanism in breast and other cancer cells. In addition, we show that MUC1-C blocks miR-200c-mediated downregulation of BMI1 expression. The functional significance of this MUC1-C -> BMI1 pathway is supported by the demonstration that targeting MUC1-C suppresses BMI1-induced ubiquitylation of H2A and thereby derepresses homeobox HOXC5 and HOXC13 gene expression. Notably, our results further show that MUC1-C binds directly to BMI1 and promotes occupancy of BMI1 on the CDKN2A promoter. In concert with BMI1-induced repression of the p16(INK4a) tumor suppressor, we found that targeting MUC1-C is associated with induction of p16(INK4a) expression. In support of these results, analysis of three gene expresssion data sets demonstrated highly significant correlations between MUC1-C and BMI1 in breast cancers. These findings uncover a previously unrecognized role for MUC1-C in driving BMI1 expression and in directly interacting with this stem cell factor, linking MUC1-C with function of the PRC1 in epigenetic gene silencing.	[Hiraki, M.; Maeda, T.; Bouillez, A.; Alam, M.; Tagde, A.; Hinohara, K.; Suzuki, Y.; Markert, T.; Miyo, M.; Komura, K.; Ahmad, R.; Rajabi, H.; Kufe, D.] Harvard Med Sch, Dana Farber Canc Inst, Med Oncol, Boston, MA USA; [Suzuki, Y.] Osaka Police Hosp, Dept Gastroenterol Surg, Kitayama Cho 10-31 Tennoji, Osaka, Osaka 5430035, Japan; [Ahmad, R.] King Saud Univ, Coll Med, Riyadh, Saudi Arabia	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Osaka Police Hospital; King Saud University	Kufe, D (corresponding author), Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu		Ahmad, Rehan/0000-0003-2612-2818	National Cancer Institute of the National Institutes of Health [CA97098, CA166480]; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA097098, R01CA166480] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants from the National Cancer Institute of the National Institutes of Health under award numbers CA97098 and CA166480 and by the Lung Cancer Research Foundation. The authors thank Dr Goberdhan P Dimri, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC for kindly providing the pGL-BMI1PrWT and pGL-BMI1PrMut reporter vectors.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Alam M, MOL CANC RES; Alam M, 2015, MOL CANCER RES, V13, P449, DOI 10.1158/1541-7786.MCR-14-0363; Alam M, 2014, ONCOTARGET, V5, P2622, DOI 10.18632/oncotarget.1848; Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Bouillez A, 2016, CANCER RES, V76, P1538, DOI 10.1158/0008-5472.CAN-15-1804; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dimri M, 2016, ONCOTARGET, V7, P36220, DOI 10.18632/oncotarget.8811; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Fleming A, 2004, CELL, V119, P449, DOI 10.1016/j.cell.2004.11.001; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Hasegawa M, 2016, ONCOTARGET, V7, P11756, DOI 10.18632/oncotarget.7598; Hasegawa M, 2015, CLIN CANCER RES, V21, P2338, DOI 10.1158/1078-0432.CCR-14-3000; Hiraki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26643; Hiraki M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.5; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kazanets A, 2016, BBA-REV CANCER, V1865, P275, DOI 10.1016/j.bbcan.2016.04.001; Kharbanda A, 2014, CLIN CANCER RES, V20, P5423, DOI 10.1158/1078-0432.CCR-13-3168; Kharbanda A, 2014, ONCOTARGET, V5, P8893, DOI 10.18632/oncotarget.2360; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; KUFE D, 2009, CANCER BIOL THER, V8, P1201; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lin XZ, 2015, BIOMOLECULES, V5, P3396, DOI 10.3390/biom5043396; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raina D, 2014, ONCOGENE, V33, P3422, DOI 10.1038/onc.2013.308; Raina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135156; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Rajabi H, 2016, ONCOGENE, V35, P6439, DOI 10.1038/onc.2016.180; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rizo A, 2009, BLOOD, V114, P1498, DOI 10.1182/blood-2009-03-209734; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Tagde A, 2016, ONCOTARGET, V7, P38974, DOI 10.18632/oncotarget.9777; Tagde A, 2016, BLOOD, V127, P2587, DOI 10.1182/blood-2015-07-659151; Takahashi H, 2015, ONCOGENE, V34, P5187, DOI 10.1038/onc.2014.442; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang YY, 2012, WORLD J SURG, V36, P1189, DOI 10.1007/s00268-012-1514-3; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	63	36	36	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2791	2801		10.1038/onc.2016.439	http://dx.doi.org/10.1038/onc.2016.439			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27893710	Green Accepted, Green Submitted			2022-12-26	WOS:000401697800002
J	Kumazoe, M; Takai, M; Bae, J; Hiroi, S; Huang, Y; Takamatsu, K; Won, Y; Yamashita, M; Hidaka, S; Yamashita, S; Yamada, S; Murata, M; Tsukamoto, S; Tachibana, H				Kumazoe, M.; Takai, M.; Bae, J.; Hiroi, S.; Huang, Y.; Takamatsu, K.; Won, Y.; Yamashita, M.; Hidaka, S.; Yamashita, S.; Yamada, S.; Murata, M.; Tsukamoto, S.; Tachibana, H.			FOXO3 is essential for CD44 expression in pancreatic cancer cells	ONCOGENE			English	Article							STEM-CELLS; GEMCITABINE; IDENTIFICATION; BAY-41-2272; METASTASIS; RESISTANCE; APOPTOSIS; BREAST; CGMP	Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal types of cancer and the 5-year survival rate is only 5%. Several studies have suggested that cancer stem cells (CSCs) are thought to be involved in recurrence and metastasis and so it is essential to establish an approach targeting CSCs. Here we have demonstrated that cyclic guanosine monophosphate (cGMP) suppressed CD44 expression and the properties of CSCs in PDAC. Microarray analysis suggested that cGMP inhibited Forkhead box O3 (FOXO3), which is known as a tumor suppressor. Surprisingly, our data demonstrated that FOXO3 is essential for CD44 expression and the properties of CSCs. Our data also indicated that patients with high FOXO3 activation signatures had poor prognoses. This evidence suggested that cGMP induction and FOXO3 inhibition could be ideal candidates for pancreatic CSC.	[Kumazoe, M.; Takai, M.; Bae, J.; Hiroi, S.; Huang, Y.; Takamatsu, K.; Won, Y.; Yamashita, M.; Hidaka, S.; Yamashita, S.; Yamada, S.; Murata, M.; Tsukamoto, S.; Tachibana, H.] Kyushu Univ, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fac Agr, Fukuoka, Japan	Kyushu University	Kumazoe, M (corresponding author), Kyushu Univ, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994	JSPS KAKENHI [22228002, 15H02448, 15K18821]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI grant 22228002 and 15H02448 to H Tachibana. This work was also supported in part by a Grant-in-Aid for JSPS Fellows to MK (PD) and JSPS KAKENHI grant 15K18821. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University, and the Center for Accelerator and Beam Applied Science, Kyushu University. We thank Takeshi Iwasaki (Kyushu University, Faculty of Medicine) for helpful advice on bioinformatics analysis. The authors would like to thank Enago (www.enago.jp) for the English language review.	Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Bera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106343; Bischoff E, 2004, CIRCULATION, V110, pE320, DOI 10.1161/01.CIR.0000142209.28862.12; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gao Y, 2015, ONCOTARGET, V6, P7828, DOI 10.18632/oncotarget.3488; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Ilmer Matthias, 2015, Genes Cancer, V6, P365; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li L, 2014, GASTROENTEROLOGY, V146, P1108, DOI 10.1053/j.gastro.2013.12.035; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Miranda-Lorenzo I, 2014, NAT METHODS, V11, P1161, DOI [10.1038/NMETH.3112, 10.1038/nmeth.3112]; Molejon MI, 2015, ONCOTARGET, V6, P7408, DOI 10.18632/oncotarget.3510; Nojiri T, 2012, J THORAC CARDIOV SUR, V143, P488, DOI 10.1016/j.jtcvs.2011.09.003; Ohara Y, 2013, CANCER SCI, V104, P1127, DOI 10.1111/cas.12198; Penchev VR, 2012, CLIN CANCER RES, V18, P4277, DOI 10.1158/1078-0432.CCR-11-3112; Quint K, 2012, INT J ONCOL, V41, P2093, DOI 10.3892/ijo.2012.1648; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sergeant G, 2009, NAT REV CLIN ONCOL, V6, P580, DOI 10.1038/nrclinonc.2009.127; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050867; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Teixeira CE, 2006, HYPERTENSION, V47, P596, DOI 10.1161/01.HYP.0000199914.36936.1b; Vaz AP, 2014, J CANC STEM CELL RES, V2, P1, DOI [10.14343/jcscr.2014.2e1004, DOI 10.14343/JCSCR.2014.2E1004]; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209	40	34	37	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2643	2654		10.1038/onc.2016.426	http://dx.doi.org/10.1038/onc.2016.426			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27893718				2022-12-26	WOS:000401120900003
J	Safferthal, C; Rohde, K; Fulda, S				Safferthal, C.; Rohde, K.; Fulda, S.			Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells	ONCOGENE			English	Article							ALPHA-DEPENDENT APOPTOSIS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TNF-ALPHA; PHASE-I; DEATH; CANCER; ACTIVATION; EXPRESSION; PATHWAYS	Resistance to apoptosis, for example due to overexpression of Inhibitor of Apoptosis (IAP) proteins, is associated with poor prognosis in acute myeloid leukemia (AML). Here, we identify that Smac mimetics such as BV6, which antagonizes IAP proteins, elicit necroptosis in AML cells, in which apoptosis is inhibited pharmacologically by caspase inhibitors or genetically by caspase-8 knockdown. Importantly, BV6 triggers necroptosis also in apoptosis-resistant patient-derived AML blasts, underlining the clinical relevance of our findings. Mechanistically, we show that BV6-induced cell death depends on key components of necroptosis signaling such as RIP1, RIP3 and MLKL, since pharmacological or genetic inhibition of these proteins significantly protects AML cells from BV6-mediated cell death, whereas PGAM5 is dispensable. Interestingly, we identify constitutive tumor necrosis factor-alpha (TNF alpha) secretion and an autocrine/paracrine TNF alpha loop as critical mediators of BV6-induced necroptosis in AML cell lines and patient-derived blasts, as the TNF alpha-blocking antibody Enbrel or tumor necrosis factor-alpha receptor 1 (TNFR1) knockdown significantly rescue cell death. Notably, AML cells exhibit high basal levels of TNF alpha compared to non-malignant CD34+ cells, which is further increased by BV6. In conclusion, this is the first report showing that Smac mimetics circumvent apoptosis resistance in AML cells by inducing necroptosis in a TNF alpha- dependent manner, which has important implications for the development of new strategies to overcome treatment resistance in AML.	[Safferthal, C.; Rohde, K.; Fulda, S.] Goethe Univ, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Hesse, Germany; [Fulda, S.] German Canc Consortium DKTK, Heidelberg, Germany; [Fulda, S.] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Fulda, S (corresponding author), Goethe Univ, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Hesse, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	BMBF (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)) [CI3 131A029B]; IUAP VII	BMBF (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)); IUAP VII	We thank X Wang (Beijing, China) for kindly providing PGAM5 antibody and C Hugenberg for expert secretarial assistance. This work has been partially supported by grants from the BMBF (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) and CI3 131A029B), IUAP VII (to SF).	Belz K, 2014, BLOOD, V124, P240, DOI 10.1182/blood-2013-05-500918; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bullinger L, 2007, BLOOD, V110, P1291, DOI 10.1182/blood-2006-10-049783; Carter BZ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt440; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chromik J, 2014, CANCER LETT, V344, P101, DOI 10.1016/j.canlet.2013.10.018; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; DiPersio JF, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.7029; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2012, LEUKEMIA, V26, P1155, DOI 10.1038/leu.2012.4; Fulda S, 2000, BLOOD, V95, P301, DOI 10.1182/blood.V95.1.301.001k24_301_308; Fulda S, 2015, CLIN CANCER RES, V21, P5030, DOI 10.1158/1078-0432.CCR-15-0365; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hess CJ, 2007, J CLIN ONCOL, V25, P1209, DOI 10.1200/JCO.2006.08.4061; Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Laukens B, 2011, NEOPLASIA, V13, P971, DOI 10.1593/neo.11610; Moriwaki K, 2016, J IMMUNOL, V196, P407, DOI 10.4049/jimmunol.1501662; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Schenk B, 2015, ONCOGENE, V34, P5796, DOI 10.1038/onc.2015.35; Servida F, 2011, INVEST NEW DRUG, V29, P1264, DOI 10.1007/s10637-010-9475-6; Steinhart L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.320; Steinwascher S, 2015, CANCER LETT, V366, P32, DOI 10.1016/j.canlet.2015.05.020; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weisberg E, 2010, LEUKEMIA, V24, P2100, DOI 10.1038/leu.2010.212; Weisberg E, 2007, MOL CANCER THER, V6, P1951, DOI 10.1158/1535-7163.MCT-06-0810; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	39	41	43	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1487	1502		10.1038/onc.2016.310	http://dx.doi.org/10.1038/onc.2016.310			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27869161				2022-12-26	WOS:000397458100004
J	Vijaykrishna, N; Melangath, G; Kumar, R; Khandelia, P; Bawa, P; Varadarajan, R; Vijayraghavan, U				Vijaykrishna, Nagampalli; Melangath, Geetha; Kumar, Rakesh; Khandelia, Piyush; Bawa, Pushpinder; Varadarajan, Raghavan; Vijayraghavan, Usha			The Fission Yeast Pre-mRNA-processing Factor 18 (prp18(+)) Has Intron-specific Splicing Functions with Links to G(1)-S Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; AMINO-ACID-SEQUENCE; SCHIZOSACCHAROMYCES-POMBE; 2ND STEP; SACCHAROMYCES-CEREVISIAE; U5 SNRNA; ALLELES MODULATE; CATALYTIC STEPS; BUDDING YEAST; PROTEIN	The fission yeast genome, which contains numerous short introns, is an apt model for studies on fungal splicing mechanisms and splicing by intron definition. Here we perform a domain analysis of the evolutionarily conserved Schizosaccharomyces pombe pre-mRNA-processing factor, SpPrp18. Our mutational and biophysical analyses of the C-terminal alpha-helical bundle reveal critical roles for the conserved region as well as helix five. We generate a novel conditional missense mutant, spprp18-5. To assess the role of SpPrp18, we performed global splicing analyses on cells depleted of prp18(+) and the conditional spprp18-5 mutant, which show widespread but intron-specific defects. In the absence of functional SpPrp18, primer extension analyses on a tfIId(+) intron 1-containing minitranscript show accumulated pre-mRNA, whereas the lariat intron-exon 2 splicing intermediate was undetectable. These phenotypes also occurred in cells lacking both SpPrp18 and SpDbr1 (lariat debranching enzyme), a genetic background suitable for detection of lariat RNAs. These data indicate a major precatalytic splicing arrest that is corroborated by the genetic interaction between spprp18-5 and spprp2-1, a mutant in the early acting U2AF59 protein. Interestingly, SpPrp18 depletion caused cell cycle arrest before S phase. The compromised splicing of transcripts coding for G(1)-S regulators, such as Res2, a transcription factor, and Skp1, a regulated proteolysis factor, are shown. The cumulative effects of SpPrp18-dependent intron splicing partly explain the G1 arrest upon the loss of SpPrp18. Our study using conditional depletion of spprp18(+) and the spprp18-5 mutant uncovers an intron-specific splicing function and early spliceosomal interactions and suggests links with cell cycle progression.	[Vijaykrishna, Nagampalli; Melangath, Geetha; Kumar, Rakesh; Khandelia, Piyush; Bawa, Pushpinder; Vijayraghavan, Usha] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vijaykrishna, Nagampalli] Cleveland Clin, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave,NC-22, Cleveland, OH 44195 USA; [Khandelia, Piyush] Singapore Inst Clin Sci, Brenner Ctr Mol Med, 30 Med Dr, Singapore 117609, Singapore	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Cleveland Clinic Foundation; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in	Bawa, Pushpinder Singh/AAV-4265-2021; NAGAMPALLI, VIJAY/J-8568-2019; Bawa, Pushpinder/AAH-2397-2021; Kumar, Rakesh/AAJ-3616-2020	Bawa, Pushpinder Singh/0000-0002-8370-3638; NAGAMPALLI, VIJAY/0000-0002-0917-3093; Kumar, Rakesh/0000-0001-6852-2655	Department of Biotechnology [BT/PR10725/AGR/36/574/2008]; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology Grant BT/PR10725/AGR/36/574/2008 (to U. V. R. and R. V.) and infrastructure support from the DBT-IISc Partnership Programme for Advanced Research in Biosciences and Bioengineering, Government of India, Department of Science and Technology-FIST, and University of Grants Commission-Centre for Advanced Studies. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a scholarship from the Council of Scientific and Industrial Research, Government of India.r Recipient of a Research Associate fellowship from the Department of Biotechnology, Government of India.	Alvarez CJ, 2001, RNA, V7, P342, DOI 10.1017/S1355838201002448; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aronova A, 2007, RNA, V13, P1437, DOI 10.1261/rna.572807; AYTE J, 1995, MOL CELL BIOL, V15, P2589; Bacikova D, 2005, MOL CELL BIOL, V25, P2107, DOI 10.1128/MCB.25.6.2107-2116.2005; Bacikova D, 2002, RNA, V8, P1280, DOI 10.1017/S1355838202023099; Banerjee S, 2013, MOL CELL BIOL, V33, P3125, DOI 10.1128/MCB.00007-13; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Burge CB, 1999, RNA WORLD, P525; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Chakshusmathi G, 2004, P NATL ACAD SCI USA, V101, P7925, DOI 10.1073/pnas.0402222101; Chawla G, 2003, NUCLEIC ACIDS RES, V31, P2333, DOI 10.1093/nar/gkg333; Chua K, 1999, GENE DEV, V13, P841, DOI 10.1101/gad.13.7.841; Crotti LB, 2007, GENE DEV, V21, P1204, DOI 10.1101/gad.1538207; Crotti LB, 2009, P NATL ACAD SCI USA, V106, P18954, DOI 10.1073/pnas.0907948106; Eckert D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005768; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; Horowitz DS, 1997, GENE DEV, V11, P139, DOI 10.1101/gad.11.1.139; HOROWITZ DS, 1993, MOL CELL BIOL, V13, P2959, DOI 10.1128/MCB.13.5.2959; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; Jiang JZ, 2000, P NATL ACAD SCI USA, V97, P3022, DOI 10.1073/pnas.97.7.3022; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kuhn AN, 2003, CURR GENET, V42, P241, DOI 10.1007/s00294-002-0355-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Livesay SB, 2013, EUKARYOT CELL, V12, P1472, DOI 10.1128/EC.00140-13; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2000, CURR OPIN MICROBIOL, V3, P631, DOI 10.1016/S1369-5274(00)00152-1; Munding EM, 2013, MOL CELL, V51, P338, DOI 10.1016/j.molcel.2013.06.012; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; Patrick KL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005074; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Query CC, 2012, RNA, V18, P1001, DOI 10.1261/rna.029421.111; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Romfo CM, 1997, NUCLEIC ACIDS RES, V25, P4658, DOI 10.1093/nar/25.22.4658; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Saha D, 2012, BIOCHEM BIOPH RES CO, V424, P579, DOI 10.1016/j.bbrc.2012.06.156; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sapra AK, 2004, J BIOL CHEM, V279, P52437, DOI 10.1074/jbc.M408815200; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; SHEA JE, 1994, NUCLEIC ACIDS RES, V22, P5555, DOI 10.1093/nar/22.25.5555; Sridharan V, 2011, MOL CELL BIOL, V31, P652, DOI 10.1128/MCB.01000-10; Toda T, 1999, PHILOS T ROY SOC B, V354, P1551, DOI 10.1098/rstb.1999.0498; Umen JG, 1995, RNA, V1, P869; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; VIJAYRAGHAVAN U, 1990, MOL CELL BIOL, V10, P324, DOI 10.1128/MCB.10.1.324; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Zhang XP, 1997, NUCLEIC ACIDS RES, V25, P2146, DOI 10.1093/nar/25.11.2146; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	65	7	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27387	27402		10.1074/jbc.M116.751289	http://dx.doi.org/10.1074/jbc.M116.751289			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875300	Green Published, hybrid			2022-12-26	WOS:000391576300035
J	Lin, ZJ; Zhang, YG; Xia, YL; Xu, XL; Jiao, XA; Sun, J				Lin, Zhijie; Zhang, Yong-Guo; Xia, Yinglin; Xu, Xiulong; Jiao, Xinan; Sun, Jun			Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ENTERICA SEROVAR ENTERITIDIS; EPITHELIAL BARRIER FUNCTION; INVASIVE SALMONELLA; UNITED-STATES; CELLS; INFLAMMATION; INFECTION; PROTEINS; RECEPTOR	Salmonella pathogenesis studies to date have focused on Salmonella typhimurium, and the pathogenesis of a second major serotype, Salmonella enteritidis, is poorly understood. Salmonella spp. possess effector proteins that display biochemical activities and modulate host functions. Here, we generated a deletion mutant of the effector AvrA, S.E-AvrA(-), and a plasmid-mediated complementary strain, S.E-AvrA(-)/pAvrA(+) (S.E-AvrA(+)), in S. Enteritidis. Using in vitro and in vivo infection models, we showed that AvrA stabilizes epithelial tight junction (TJ) proteins, such as ZO-1, in human intestinal epithelial cells. Transepithelial electrical resistance was significantly higher in cells infected with S.E-AvrA(+) than in cells infected with S.E-AvrA(-). Inhibition of the JNK pathway suppresses the disassembly of TJ proteins; we found that enteritidis AvrA inhibited JNK activity in cells infected with wild type or S.E-AvrA(+) strains. Therefore, Enteritidis AvrA-induced ZO-1 stability is achieved via suppression of the JNK pathway. Furthermore, the S.E-AvrA(-) strain led to enhanced bacterial invasion, both in vitro and in vivo. Taken together, our data reveal a novel role for AvrA in S. Enteritidis: Enteritidis AvrA stabilizes intestinal TJs and attenuates bacterial invasion. The manipulation of JNK activity and TJs in microbial-epithelial interactions may be a novel therapeutic approach for the treatment of infectious diseases.	[Lin, Zhijie; Xu, Xiulong; Jiao, Xinan; Sun, Jun] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Jiangsu Key Lab Zoonosis, Yangzhou 225009, Jiangsu, Peoples R China; [Xu, Xiulong] Yangzhou Univ, Coll Vet Med, Ctr Comparat Med, Anim Infect Dis Lab, Yangzhou 225009, Jiangsu, Peoples R China; [Lin, Zhijie; Zhang, Yong-Guo; Xia, Yinglin; Sun, Jun] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA; [Xu, Xiulong] Univ Illinois, Dept Anat & Cell Biol, Med Ctr, Chicago, IL 60612 USA	Yangzhou University; Yangzhou University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sun, J (corresponding author), Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, 840 S Wood St,Rm 704 CSB, Chicago, IL 60612 USA.	junsun7@uic.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	NIDDK; National Institutes of Health [1R01DK105118-01]; Swim Across America Cancer Research Award; University of Illinois at Chicago Cancer Center; Projects of International Cooperation and Exchanges National Natural Science Foundation of China [31320103907]; Graduate Research and Innovation Project of Jiangsu Province [KYZZ_0368]; International Program for Ph.D. students from Yangzhou University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105118] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swim Across America Cancer Research Award; University of Illinois at Chicago Cancer Center; Projects of International Cooperation and Exchanges National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Research and Innovation Project of Jiangsu Province; International Program for Ph.D. students from Yangzhou University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant 1R01DK105118-01, a Swim Across America Cancer Research Award, the University of Illinois at Chicago Cancer Center (to J. S.), and Projects of International Cooperation and Exchanges National Natural Science Foundation of China Grant 31320103907. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Graduate Research and Innovation Project of Jiangsu Province Grant KYZZ_0368 and the International Program for Ph.D. students from Yangzhou University.	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Ghosh TS, 2006, AM J INFECT CONTROL, V34, P348, DOI 10.1016/j.ajic.2005.09.010; Ghule VV, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-40; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Guppy D., 2007, Morbidity and Mortality Weekly Report, V56, P877; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hubert A, 2004, BIOCHIMIE, V86, P533, DOI 10.1016/j.biochi.2004.07.009; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Katsenos Chrisostomos, 2008, Cases J, V1, P5, DOI 10.1186/1757-1626-1-5; Kobayashi H, 2009, INT J INFECT DIS, V13, pE463, DOI 10.1016/j.ijid.2008.12.015; Kojima T, 2001, J HISTOCHEM CYTOCHEM, V49, P333, DOI 10.1177/002215540104900307; Kojima T, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24894; Kojima T, 2010, J CELL PHYSIOL, V225, P720, DOI 10.1002/jcp.22273; Konno T, 2015, HISTOCHEM CELL BIOL, V143, P471, DOI 10.1007/s00418-014-1300-4; Lane CR, 2014, EMERG INFECT DIS, V20, P1097, DOI 10.3201/eid2007.121850; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Liu Q, 2016, J BIOL CHEM, V291, P4779, DOI 10.1074/jbc.M115.683052; Liu XY, 2011, AM J PHYSIOL-GASTR L, V301, pG992, DOI 10.1152/ajpgi.00080.2011; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Muramatsu R, 2015, J BIOL CHEM, V290, P11515, DOI 10.1074/jbc.M114.587253; Mutlu H, 2009, J AM SOC ECHOCARDIOG, V22, DOI 10.1016/j.echo.2008.11.017; Naydenov NG, 2009, CELL CYCLE, V8, P2110, DOI 10.4161/cc.8.13.8928; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Ramos-Morales F., 2012, ISRN CELL BIOL, V2012, P1, DOI [10.5402/2012/787934, DOI 10.5402/2012/787934]; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Tena D, 2007, J INFECTION, V54, P245, DOI 10.1016/j.jinf.2006.05.007; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Uto T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11273; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Wu SP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12356; Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058606; Zhang YG, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688362.2014.972849	59	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26837	26849		10.1074/jbc.M116.757393	http://dx.doi.org/10.1074/jbc.M116.757393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875307	Green Published, hybrid			2022-12-26	WOS:000391571400021
J	De Mits, S; Lenaerts, J; Cruyssen, BV; Mielants, H; Westhovens, R; Durez, P; Elewaut, D				De Mits, Sophie; Lenaerts, Jan; Cruyssen, Bert Vander; Mielants, Herman; Westhovens, Rene; Durez, Patrick; Elewaut, Dirk		Be-Raise study grp	A Nationwide Survey on Patient's versus Physician's Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study	PLOS ONE			English	Article							SUBCUTANEOUSLY ADMINISTERED METHOTREXATE; DECISION-MAKING; PREFERENCES; SATISFACTION; CHOICE; AGENTS	Objectives Biological treatment of rheumatoid arthritis (RA) is one of the cornerstones of current treatment strategies for the disease. Surprisingly little information exists on whether the route of administration affects patients' treatment satisfaction. It is equally unclear whether rheumatologists are able to accurately perceive their patients' appreciation. Thus, the Belgian Beraise survey aimed to examine whether RA patient's experience of their current biological treatment coincided with the treating physician's perception. Methods A nationwide cross-sectional survey was conducted by 67 Belgian rheumatologists providing data obtained from 550 RA patients. Patients under stable dose of biologics for at least 6 months, were enrolled consecutively and all completed questionnaires. Separate questionnaires were completed by the treating rheumatologist which evaluated their patient's perception of the route of treatment administration. This study therefore evaluates whether a treating physician perceives the satisfaction with the route of administration to the same degree as the patient. Results Completed questionnaires were obtained from 293 and 257 patients who obtained treatment via the intravenous (IV) or subcutaneous (SC) route of administration, respectively. 58.4% of patients were in DAS28-CRP(3) remission. Patient satisfaction with disease control was higher (44% scored >= 9) than that of the treating physician (35%), regardless of the route of administration (p<0.01). No differences were seen for the patients treated with an IV as opposed to a SC route of administration. The physician's perception of patient's satisfaction with disease control was markedly lower for IV treated patients as opposed to SC treated patients (p<0.001). Conclusions Patients' satisfaction with biological treatment is high, but there is a considerable mismatch between patients' and rheumatologists' appreciation on the route of administration of biological therapy in RA. Physicians consistently consider IV biological therapy to be less satisfactory. Patient's appreciation is largely dependent on disease control, irrespective of the route of administration. Therefore, and encouraging shared decision making, we suggest that physicians and patients discuss the route of administration of biologicals in an open way.	[De Mits, Sophie; Mielants, Herman; Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium; [Lenaerts, Jan] Leuven Univ Hosp, Reuma Inst Hasselt, Dept Rheumatol, Leuven, Belgium; [Cruyssen, Bert Vander] OLV Hosp Aalst, Sint Jozef Hosp Bornem, Dept Rheumatol, Aalst, Belgium; [Westhovens, Rene] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Dept Dev & Regenerat, Leuven, Belgium; [Westhovens, Rene] Univ Hosp Leuven, Rheumatol, Leuven, Belgium; [Durez, Patrick] Catholic Univ Louvain, Dept Rheumatol, Louvain La Neuve, Belgium; [Elewaut, Dirk] Univ Ghent, VIB Inflammat Res Ctr, Lab Mol Immunol & Inflammat, Ghent, Belgium	Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Ghent University	Elewaut, D (corresponding author), Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium.; Elewaut, D (corresponding author), Univ Ghent, VIB Inflammat Res Ctr, Lab Mol Immunol & Inflammat, Ghent, Belgium.	Dirk.Elewaut@UGent.be		durez, patrick/0000-0002-7156-2356; Elewaut, Dirk/0000-0002-7468-974X	MSD	MSD	An unrestricted educational grant for logistics was provided by MSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustovski F, 2013, VALUE HEALTH, V16, P385, DOI 10.1016/j.jval.2012.11.007; Barton JL, 2009, PATIENT PREFER ADHER, V3, P335; Burmester GR, 2015, ANN RHEUM DIS; Chilton F, 2008, MUSCULOSKELET CARE, V6, P1, DOI 10.1002/msc.110; Curran D, 1998, STAT MED, V17, P739, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<739::AID-SIM818>3.0.CO;2-M; Demary W, 2014, PATIENT PREFER ADHER, V8, P1061, DOI 10.2147/PPA.S64111; Fraenkel L, 2004, ANN RHEUM DIS, V63, P1372, DOI 10.1136/ard.2003.019422; Garneau K, 2011, JCR-J CLIN RHEUMATOL, V17, P231, DOI 10.1097/RHU.0b013e318226a220; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P2854, DOI 10.1002/art.30463; Jeffery M, 2004, ANN RHEUM DIS, V63, P510; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Malaviya AP, 2012, PATIENT PREFER ADHER, V6, P589, DOI 10.2147/PPA.S23786; Martin RW, 2008, J RHEUMATOL, V35, P618; Rau R, 2004, SCAND J RHEUMATOL, V33, P145, DOI 10.1080/03009740410005467; Scarpato S, 2010, RHEUMATOLOGY, V49, P289, DOI 10.1093/rheumatology/kep354; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Striesow F, 2012, THER ADV MUSCULOSKEL, V4, P3, DOI 10.1177/1759720X11431004; Taylor PC, 2011, J RHEUMATOL, V38, P2572, DOI 10.3899/jrheum.110570; Huynh TK, 2014, PATIENT PREFER ADHER, V8, P93, DOI 10.2147/PPA.S55156; Willeke P, 2011, Z RHEUMATOL, V70, P232, DOI 10.1007/s00393-011-0752-3; Williams EL, 2006, RHEUMATOLOGY, V45, P1575, DOI 10.1093/rheumatology/kel369; Zhang Jie, 2013, Arthritis Care Res (Hoboken), V65, P1743	22	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166607	10.1371/journal.pone.0166607	http://dx.doi.org/10.1371/journal.pone.0166607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893771	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400034
J	Wang, HJ; Liu, SQ; Zhang, B; Wei, WQ				Wang, Hongju; Liu, Siqing; Zhang, Bo; Wei, Wenqiang			Analysis of Synonymous Codon Usage Bias of Zika Virus and Its Adaption to the Hosts	PLOS ONE			English	Article							SELECTION; ADAPTATION; MUTATION; BIOLOGY; GENES; RNA	Zika virus (ZIKV) is a mosquito-borne virus (arbovirus) in the family Flaviviridae, and the symptoms caused by ZIKV infection in humans include rash, fever, arthralgia, myalgia, asthenia and conjunctivitis. Codon usage bias analysis can reveal much about the molecular evolution and host adaption of ZIKV. To gain insight into the evolutionary characteristics of ZIKV, we performed a comprehensive analysis on the codon usage pattern in 46 ZIKV strains by calculating the effective number of codons (ENc), codon adaptation index (CAI), relative synonymous codon usage (RSCU), and other indicators. The results indicate that the codon usage bias of ZIKV is relatively low. Several lines of evidence support the hypothesis that translational selection plays a role in shaping the codon usage pattern of ZIKV. The results from a correspondence analysis (CA) indicate that other factors, such as base composition, aromaticity, and hydrophobicity may also be involved in shaping the codon usage pattern of ZIKV. Additionally, the results from a comparative analysis of RSCU between ZIKV and its hosts suggest that ZIKV tends to evolve codon usage patterns that are comparable to those of its hosts. Moreover, selection pressure from Homo sapiens on the ZIKV RSCU patterns was found to be dominant compared with that from Aedes aegypti and Aedes albopictus. Taken together, both natural translational selection and mutation pressure are important for shaping the codon usage pattern of ZIKV. Our findings contribute to understanding the evolution of ZIKV and its adaption to its hosts.	[Wang, Hongju; Wei, Wenqiang] Henan Univ, Sch Med, Kaifeng, Peoples R China; [Liu, Siqing; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China	Henan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wei, WQ (corresponding author), Henan Univ, Sch Med, Kaifeng, Peoples R China.	weiwq168@163.com			Plant Foundation for Young Scientists of Henan University [CX0000A40557]; National Natural Science Foundation of China [31501701]	Plant Foundation for Young Scientists of Henan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Plant Foundation for Young Scientists of Henan University (CX0000A40557) and the National Natural Science Foundation of China (31501701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Plant Foundation for Young Scientists of Henan University (CX0000A40557), and the National Natural Science Foundation of China (31501701). We thank Yihui Yuan (Wuhan Institute of Virology, Chinese Academy of Sciences) for helpful discussions and editing of this manuscript.	Auewarakul P, 2005, VIRUS RES, V109, P33, DOI 10.1016/j.virusres.2004.10.004; Babbitt GA, 2014, NUCLEIC ACIDS RES, V42, P10915, DOI 10.1093/nar/gku811; BULMER M, 1991, GENETICS, V129, P897; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Chen Youhua, 2014, VirusDisease, V25, P285, DOI 10.1007/s13337-014-0191-2; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022; Das S, 2006, VIRUS RES, V117, P227, DOI 10.1016/j.virusres.2005.10.007; Doran TM, 2011, THESIS; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Freire CCdM, 2015, SPREAD PANDEMIC ZIKA; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hemert FV, 2015, VIROL J, V13, P1; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jung SK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-340; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kumar N, 2016, PLOS ONE, V11; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lara-Ramirez EE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/851425; Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68; Ma YP, 2015, J FISH DIS, V38, P665, DOI 10.1111/jfd.12316; Ma YP, 2014, ARCH VIROL, V159, P1841, DOI 10.1007/s00705-014-2000-z; Ma YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111950; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4; Plotkin JB, 2006, J MOL EVOL, V63, P635, DOI 10.1007/s00239-005-0233-x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862; Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4; Vicario S, 2006, BMC EVOL BIOL, V7, P1; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zeng ZY, 2014, J VIROL METHODS, V208, P102, DOI 10.1016/j.jviromet.2014.08.001; Zhou JH, 2013, PLOS ONE, V8, P1175	56	19	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166260	10.1371/journal.pone.0166260	http://dx.doi.org/10.1371/journal.pone.0166260			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893824	gold, Green Published, Green Submitted			2022-12-26	WOS:000389472400020
J	Forgacs, D; Wallen, RL; Dobson, LK; Derr, JN				Forgacs, David; Wallen, Rick L.; Dobson, Lauren K.; Derr, James N.			Mitochondrial Genome Analysis Reveals Historical Lineages in Yellowstone Bison	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION SUBSTRUCTURE; CATTLE HYBRIDS; PLAINS BISON; FRAMEWORK; MARKERS; FORMAT; WOOD	Yellowstone National Park is home to one of the only plains bison populations that have continuously existed on their present landscape since prehistoric times without evidence of domestic cattle introgression. Previous studies characterized the relatively high levels of nuclear genetic diversity in these bison, but little is known about their mitochondrial haplotype diversity. This study assessed mitochondrial genomes from 25 randomly selected Yellowstone bison and found 10 different mitochondrial haplotypes with a haplotype diversity of 0.78 (+/- 0.06). Spatial analysis of these mitochondrial DNA (mtDNA) haplotypes did not detect geographic population subdivision (F-ST = -0.06, p = 0.76). However, we identified two independent and historically important lineages in Yellowstone bison by combining data from 65 bison (defined by 120 polymorphic sites) from across North America representing a total of 30 different mitochondrial DNA haplotypes. Mitochondrial DNA haplotypes from one of the Yellowstone lineages represent descendants of the 22 indigenous bison remaining in central Yellowstone in 1902. The other mitochondrial DNA lineage represents descendants of the 18 females introduced from northern Montana in 1902 to supplement the indigenous bison population and develop a new breeding herd in the northern region of the park. Comparing modern and historical mitochondrial DNA diversity in Yellowstone bison helps uncover a historical context of park restoration efforts during the early 1900s, provides evidence against a hypothesized mitochondrial disease in bison, and reveals the signature of recent hybridization between American plains bison (Bison bison bison) and Canadian wood bison (B.b. athabascae). Our study demonstrates how mitochondrial DNA can be applied to delineate the history of wildlife species and inform future conservation actions.	[Forgacs, David; Dobson, Lauren K.; Derr, James N.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Wallen, Rick L.] Natl Pk Serv, Yellowstone Natl Pk, Mammoth Hot Springs, WY USA	Texas A&M University System; Texas A&M University College Station; United States Department of the Interior	Derr, JN (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.	jderr@cvm.tamu.edu		Dobson, Lauren/0000-0001-8111-8542; Forgacs, David/0000-0002-3553-3320	Department of the Interior, National Park Service [P12AC71337]	Department of the Interior, National Park Service	The grant that enabled this study was P12AC71337 (formerly P12AT51121) awarded by the Department of the Interior, National Park Service [https://www.nps.gov/index.htm]. The funding agency had a role in the design and data collection of the study by picking and handling the animals, and also helped with the preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Aronesty E., 2011, EA UTILS COMMAND LIN; Blanton DW, 2015, YELLOWSTONE BISON CO, P1; Bolfikova B, 2012, HEREDITY, V108, P248, DOI 10.1038/hdy.2011.67; Botero-Castro F, 2013, MOL PHYLOGENET EVOL, V69, P728, DOI 10.1016/j.ympev.2013.07.003; Cahalane Victor H., 1944, TRANS NORTH AMER WILDLIFE CONF, V9, P135; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coder GD, 1975, THESIS; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobson LK, 2015, SEQUENCING GENOME N; Douglas KC, 2011, MITOCHONDRION, V11, P166, DOI 10.1016/j.mito.2010.09.005; Elshibli S, 2008, GENETICA, V134, P251, DOI 10.1007/s10709-007-9232-8; Emelianov I, 2004, P ROY SOC B-BIOL SCI, V271, P97, DOI 10.1098/rspb.2003.2574; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Furlan E, 2012, ECOL EVOL, V2, P844, DOI 10.1002/ece3.195; Gardipee FM, 2007, THESIS; Geremia C, 2014, ECOL APPL, V24, P346, DOI 10.1890/13-0137.1; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; Halbert ND, 2012, J HERED, V103, P360, DOI 10.1093/jhered/esr140; Hitchings SP, 1998, J EVOLUTION BIOL, V11, P269, DOI 10.1046/j.1420-9101.1998.11030269.x; Hobbs NT, 2015, ECOL MONOGR, V85, P525, DOI 10.1890/14-1413.1; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Isenberg Andrew C., 2014, OXFORD HDB ENV HIST, DOI DOI 10.1017/CBO9780511549861; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meagher, 1973, BISON YELLOWSTONE NA; Mendez-Harclerode FM, 2007, J MAMMAL, V88, P360, DOI 10.1644/05-MAMM-A-377R1.1; PEDEN DG, 1979, CAN J ZOOL, V57, P1778, DOI 10.1139/z79-231; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Pringle TH., 2011, NATURE PRECEDINGS; Pritchard JK, 2000, GENETICS, V155, P945; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; Ward TJ, 1999, ANIM CONSERV, V2, P51, DOI 10.1111/j.1469-1795.1999.tb00048.x; White PJ, 2012, J HERED, V103, P751, DOI 10.1093/jhered/ess050; Wilson GA, 1999, GENOME, V42, P483, DOI 10.1139/gen-42-3-483; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yuan ML, 2010, J ECON ENTOMOL, V103, P2204, DOI 10.1603/EC09392	46	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166081	10.1371/journal.pone.0166081	http://dx.doi.org/10.1371/journal.pone.0166081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880780	Green Published, gold			2022-12-26	WOS:000388889500015
J	Golabi, M; Padiolleau, L; Chen, X; Jafari, MJ; Sheikhzadeh, E; Turner, APF; Jager, EWH; Beni, V				Golabi, Mohsen; Padiolleau, Laurence; Chen, Xi; Jafari, Mohammad Javad; Sheikhzadeh, Elham; Turner, Anthony P. F.; Jager, Edwin W. H.; Beni, Valerio			Doping Polypyrrole Films with 4-N-Pentylphenylboronic Acid to Enhance Affinity towards Bacteria and Dopamine	PLOS ONE			English	Article							CONDUCTING POLYMERS; PHENYLBORONIC ACID; ELECTROCHEMICAL DETECTION; SELECTIVE DETECTION; BORONIC ACIDS; MODIFIED ELECTRODE; CARBON NANOTUBES; CHEMICAL SENSORS; ADHESION; RELEASE	Here we demonstrate the use of a functional dopant as a fast and simple way to tune the chemical affinity and selectivity of polypyrrole films. More specifically, a boronic-functionalised dopant, 4-N-Pentylphenylboronic Acid (PBA), was used to provide to polypyrrole films with enhanced affinity towards diols. In order to prove the proposed concept, two model systems were explored: (i) the capture and the electrochemical detection of dopamine and (ii) the adhesion of bacteria onto surfaces. The chemisensor, based on overoxidised polypyrrole boronic doped film, was shown to have the ability to capture and retain dopamine, thus improving its detection; furthermore the chemisensor showed better sensitivity in comparison with overoxidised perchlorate doped films. The adhesion of bacteria, Deinococcus proteolyticus, Escherichia coli, Streptococcus pneumoniae and Klebsiella pneumoniae, onto the boric doped polypyrrole film was also tested. The presence of the boronic group in the polypyrrole film was shown to favour the adhesion of sugar-rich bacterial cells when compared with a control film (Dodecyl benzenesulfonate (DBS) doped film) with similar morphological and physical properties. The presented single step synthesis approach is simple and fast, does not require the development and synthesis of functional monomers, and can be easily expanded to the electrochemical, and possibly chemical, fabrication of novel functional surfaces and interfaces with inherent pre-defined sensing and chemical properties.	[Golabi, Mohsen; Padiolleau, Laurence; Chen, Xi; Sheikhzadeh, Elham; Turner, Anthony P. F.; Jager, Edwin W. H.; Beni, Valerio] Linkoping Univ, Biosensors & Bioelect Ctr, Dept Phys Chem & Biol IFM, Linkoping, Sweden; [Padiolleau, Laurence] Cranfield Univ, Cranfield Hlth, Cranfield, Beds, England; [Chen, Xi] Univ Dundee, Sch Engn Phys & Math, Dundee, Scotland; [Jafari, Mohammad Javad] Linkoping Univ, Dept Phys Chem & Biol IFM, Linkoping, Sweden; [Sheikhzadeh, Elham] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Iran; [Beni, Valerio] Acreo Swedish ICT AB, Box 787, SE-60117 Norkoping, Sweden	Linkoping University; Cranfield University; University of Dundee; Linkoping University; Ferdowsi University Mashhad; Acreo AB	Jager, EWH; Beni, V (corresponding author), Linkoping Univ, Biosensors & Bioelect Ctr, Dept Phys Chem & Biol IFM, Linkoping, Sweden.	edwin.jager@liu.se; valbe1972@gmail.com	Jager, Edwin/F-1481-2013; Sheikhzadeh, Elham/AAU-5089-2021; Golabi, Mohsen/B-4041-2016; Jafari, Mohammad Javad/T-3371-2019	Jager, Edwin/0000-0002-2071-7768; Sheikhzadeh, Elham/0000-0002-1589-5316; Golabi, Mohsen/0000-0002-4332-1993; Jafari, Mohammad Javad/0000-0003-3899-4891; Beni, Valerio/0000-0001-6889-0351	Ministry of Science Research and Technology of Iran; Linkoping University; Swedish Research Council [VR-2014-3079]; Erasmus exchange program of the European Commission	Ministry of Science Research and Technology of Iran; Linkoping University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Erasmus exchange program of the European Commission	Mohsen Golabi and Elham Sheikhzadeh received financial support from the Ministry of Science Research and Technology of Iran (www.msrt.ir) for supporting their Ph.D. and research exchange, respectively. Anthony Turner, Valerio Beni and Edwin Jager are financially supported by Linkoping University. Edwin Jager is supported by the Swedish Research Council contract nr VR-2014-3079. Laurence Padiolleau, Xi Chen are supported by the Erasmus exchange program of the European Commission for their research exchange.; Mohsen Golabi and Elham Sheikhzadeh would like to thank the Ministry of Science Research and Technology of Iran (www.msrt.ir) for supporting their Ph.D. and research exchange, respectively. Anthony Turner, Valerio Beni and Edwin Jager would like to thank Linkoping University for the financial support; Edwin Jager would also thank the Swedish Research Council contract nr VR-2014-3079 for financial support of the project. Laurence Padiolleau, Xi Chen would like to thank the Erasmus exchange program of the European Commission to support their research exchange. Edwin Jager, Valerio Beni and Xi Chen would like to thank Prof Stephen Wilson, University of Dundee, UK for his support.	Ali SR, 2007, ANAL CHEM, V79, P2583, DOI 10.1021/ac062068o; Ates M, 2013, MAT SCI ENG C-MATER, V33, P1853, DOI 10.1016/j.msec.2013.01.035; Ates M, 2009, PROG ORG COAT, V66, P337, DOI 10.1016/j.porgcoat.2009.08.014; Aytac S, 2011, SENSOR ACTUAT B-CHEM, V160, P405, DOI 10.1016/j.snb.2011.07.069; Bayoudh S, 2006, MAT SCI ENG C-BIO S, V26, P300, DOI 10.1016/j.msec.2005.10.045; Brewer SH, 2004, LANGMUIR, V20, P5512, DOI 10.1021/la035037m; Collins GE, 1996, SYNTHETIC MET, V78, P93, DOI 10.1016/0379-6779(96)80108-1; Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3; Dechtrirat D, 2014, BIOSENS BIOELECTRON, V58, P1, DOI 10.1016/j.bios.2014.02.028; Deronzier A, 1996, COORDIN CHEM REV, V147, P339, DOI 10.1016/0010-8545(95)01130-7; Dhand C, 2011, BIOSENS BIOELECTRON, V26, P2811, DOI 10.1016/j.bios.2010.10.017; Dutta D, 2012, MOL VIS, V18, P14; Fabre B, 2003, CHEM COMMUN, P2982, DOI 10.1039/b311198a; FANIRAN JA, 1968, CAN J CHEMISTRY, V46, P2089, DOI 10.1139/v68-341; Fonner JM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034124; Fossey JS, 2012, CHEM REC, V12, P464, DOI 10.1002/tcr.201200006; Galvan A, 2008, CLIN NEUROPHYSIOL, V119, P1459, DOI 10.1016/j.clinph.2008.03.017; Gelmi A, 2014, J MATER CHEM B, V2, P3860, DOI 10.1039/c4tb00142g; Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Gholivand MB, 2012, J ELECTROANAL CHEM, V676, P53, DOI 10.1016/j.jelechem.2012.05.001; Golabi M, 2016, MACROMOL CHEM PHYS, V217, P1128, DOI 10.1002/macp.201500445; Golabi M, 2016, SENSOR ACTUAT B-CHEM, V222, P839, DOI 10.1016/j.snb.2015.09.033; Han DX, 2010, ELECTROANAL, V22, P2001, DOI 10.1002/elan.201000094; Harley CC, 2010, SENSOR ACTUAT B-CHEM, V150, P498, DOI 10.1016/j.snb.2010.09.012; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12; Huang Z.H., 2014, URBAN RAPID RAIL TRA, V08, P39, DOI DOI 10.1007/S11706-014-0238-8; Janata J, 2003, NAT MATER, V2, P19, DOI 10.1038/nmat768; Jiang L, 2005, SENSORS-BASEL, V5, P199, DOI 10.3390/s5040199; Kuralay F, 2012, J AM CHEM SOC, V134, P15217, DOI 10.1021/ja306080t; Lange U, 2008, ANAL CHIM ACTA, V614, P1, DOI 10.1016/j.aca.2008.02.068; Laskin A. I., 2011, ADV APPL MICROBIOLOG; Le HQA, 2010, ANAL CHIM ACTA, V674, P1, DOI 10.1016/j.aca.2010.06.008; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Li M, 2015, CHEM COMMUN, V51, P14562, DOI 10.1039/c5cc04976h; Liu L, 2013, INT J ELECTROCHEM SC, V8, P11161; Lundin V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018624; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mathiyarasu J, 2005, J APPL ELECTROCHEM, V35, P513, DOI 10.1007/s10800-005-0914-6; Melling D, 2015, RSC ADV, V5, P84153, DOI 10.1039/c5ra15587h; Mindroiu M, 2013, APPL SURF SCI, V276, P401, DOI 10.1016/j.apsusc.2013.03.107; Nambiar S, 2011, BIOSENS BIOELECTRON, V26, P1825, DOI 10.1016/j.bios.2010.09.046; Negrete-Raymond AC, 2003, APPL ENVIRON MICROB, V69, P4263, DOI 10.1128/AEM.69.7.4263-4267.2003; Nyberg T, 2007, J NEUROSCI METH, V160, P16, DOI 10.1016/j.jneumeth.2006.08.008; Perera-Costa D, 2014, LANGMUIR, V30, P4633, DOI 10.1021/la5001057; PERES RCD, 1989, SYNTHETIC MET, V28, pC59, DOI 10.1016/0379-6779(89)90499-2; Polsky R, 2008, ANGEW CHEM INT EDIT, V47, P2631, DOI 10.1002/anie.200704597; Rajkumar R, 2007, BIOSENS BIOELECTRON, V22, P3318, DOI 10.1016/j.bios.2007.03.001; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Sheikhzadeh E, 2016, BIOSENS BIOELECTRON, V80, P194, DOI 10.1016/j.bios.2016.01.057; Si P, 2011, ANALYST, V136, P5134, DOI 10.1039/c1an15772h; Springsteen G, 2001, CHEM COMMUN, P1608, DOI 10.1039/b104895n; Strawbridge SM, 2000, CHEM COMMUN, P2393, DOI 10.1039/b007187k; Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j; Svennersten K, 2009, BIOMATERIALS, V30, P6257, DOI 10.1016/j.biomaterials.2009.07.059; Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053; Tiwari JN, 2016, ACS NANO, V10, P46, DOI 10.1021/acsnano.5b05690; Tsai TC, 2012, SENSOR ACTUAT B-CHEM, V171, P93, DOI 10.1016/j.snb.2011.07.052; Uzun L, 2016, BIOSENS BIOELECTRON, V76, P131, DOI 10.1016/j.bios.2015.07.013; Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027; Wang J, 2000, LANGMUIR, V16, P2269, DOI 10.1021/la991122b; Wang XJ, 2013, INT J MOL SCI, V14, P20890, DOI 10.3390/ijms141020890; Wang ZH, 2011, ELECTROANAL, V23, P2463, DOI 10.1002/elan.201100256; WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201; Wu JC, 2004, ANAL CHIM ACTA, V520, P257, DOI 10.1016/j.aca.2004.05.019; Xu GY, 2015, MICROCHIM ACTA, V182, P679, DOI 10.1007/s00604-014-1373-8; Xu LB, 2005, ANGEW CHEM INT EDIT, V44, P6009, DOI 10.1002/anie.200500868; Yusoff N, 2015, MICROCHIM ACTA, V182, P2091, DOI 10.1007/s00604-015-1609-2; Zhong M, 2015, BIOSENS BIOELECTRON, V64, P212, DOI 10.1016/j.bios.2014.08.083; Zhong X, 2010, ADV FUNCT MATER, V20, P992, DOI 10.1002/adfm.200901915; Zhu LD, 2007, SENSOR ACTUAT B-CHEM, V125, P254, DOI 10.1016/j.snb.2007.02.012; ZINGER B, 1984, J AM CHEM SOC, V106, P6861, DOI 10.1021/ja00334a076	73	10	10	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166548	10.1371/journal.pone.0166548	http://dx.doi.org/10.1371/journal.pone.0166548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875555	gold, Green Submitted, Green Published			2022-12-26	WOS:000388886000017
J	Barbeiro, AR; Ureba, A; Baeza, JA; Linares, R; Perucha, M; Jimenez-Ortega, E; Velazquez, S; Mateos, JC; Leal, A				Barbeiro, A. R.; Ureba, A.; Baeza, J. A.; Linares, R.; Perucha, M.; Jimenez-Ortega, E.; Velazquez, S.; Mateos, J. C.; Leal, A.			3D VMAT Verification Based on Monte Carlo Log File Simulation with Experimental Feedback from Film Dosimetry	PLOS ONE			English	Article							VOLUMETRIC MODULATED ARC; QUALITY-ASSURANCE METHOD; PASSING RATES; THERAPY; QA; DELIVERY; SYSTEM; IMRT; RAPIDARC; PHANTOM	A model based on a specific phantom, called QuAArC, has been designed for the evaluation of planning and verification systems of complex radiotherapy treatments, such as volumetric modulated arc therapy (VMAT). This model uses the high accuracy provided by the Monte Carlo (MC) simulation of log files and allows the experimental feedback from the high spatial resolution of films hosted in QuAArC. This cylindrical phantom was specifically designed to host films rolled at different radial distances able to take into account the entrance fluence and the 3D dose distribution. Ionization chamber measurements are also included in the feedback process for absolute dose considerations. In this way, automated MC simulation of treatment log files is implemented to calculate the actual delivery geometries, while the monitor units are experimentally adjusted to reconstruct the dose-volume histogram (DVH) on the patient CT. Prostate and head and neck clinical cases, previously planned with Monaco and Pinnacle treatment planning systems and verified with two different commercial systems (Delta4 and COMPASS), were selected in order to test operational feasibility of the proposed model. The proper operation of the feedback procedure was proved through the achieved high agreement between reconstructed dose distributions and the film measurements (global gamma passing rates > 90% for the 2%/2 mm criteria). The necessary discretization level of the log file for dose calculation and the potential mismatching between calculated control points and detection grid in the verification process were discussed. Besides the effect of dose calculation accuracy of the analytic algorithm implemented in treatment planning systems for a dynamic technique, it was discussed the importance of the detection density level and its location in VMAT specific phantom to obtain a more reliable DVH in the patient CT. The proposed model also showed enough robustness and efficiency to be considered as a pre-treatment VMAT verification system.	[Barbeiro, A. R.; Ureba, A.; Baeza, J. A.; Jimenez-Ortega, E.; Mateos, J. C.; Leal, A.] Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain; [Linares, R.; Perucha, M.] Hosp Infanta Luisa, Serv Radiofis, Seville, Spain; [Velazquez, S.; Mateos, J. C.] Hosp Virgen del Rocio, Serv Radiofis, Seville, Spain; [Barbeiro, A. R.; Ureba, A.; Perucha, M.; Jimenez-Ortega, E.; Velazquez, S.; Leal, A.] Inst Biomed Sevilla, IBIS, Seville, Spain; [Ureba, A.] Stockholm Univ, Karolinska Inst, Med Radiat Phys, Stockholm, Sweden; [Baeza, J. A.] Maastricht Univ, Med Ctr, Dept Radiat Oncol, Maastricht, Netherlands	University of Sevilla; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Karolinska Institutet; Stockholm University; Maastricht University	Leal, A (corresponding author), Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain.; Leal, A (corresponding author), Inst Biomed Sevilla, IBIS, Seville, Spain.	alplaza@us.es	Ureba, Ana/B-2216-2018; IBIS, IMAGEN/J-7483-2017; Leal, Antonio/K-2180-2014; Jiménez-Ortega, Elisa/R-1360-2016; Barbeiro, Ana Rita/L-6194-2017	Ureba, Ana/0000-0002-1099-733X; Leal, Antonio/0000-0002-0687-5305; Jiménez-Ortega, Elisa/0000-0001-8369-2003; Baeza Ortega, Jose Antonio/0000-0001-9647-3889; Barbeiro, Ana Rita/0000-0002-9935-7178	Spanish Ministry of Science and Technology [SAF2011-27116, IPT-2011-1480-900000]; European Regional Development Fund	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This work was supported by the Spanish Ministry of Science and Technology (SAF2011-27116; IPT-2011-1480-900000) and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuni G, 2013, PHYS MED BIOL, V58, P3535, DOI 10.1088/0031-9155/58/11/3535; Bedford JL, 2009, INT J RADIAT ONCOL, V73, P537, DOI 10.1016/j.ijrobp.2008.08.055; Boggula R, 2010, PHYS MED BIOL, V55, P5619, DOI 10.1088/0031-9155/55/19/001; Bouchard H, 2009, MED PHYS, V36, P1931, DOI 10.1118/1.3121488; Boylan CJ, 2013, RADIOTHER ONCOL, V109, P377, DOI 10.1016/j.radonc.2013.08.046; Fakir H, 2012, MED PHYS, V39, P4203, DOI 10.1118/1.4728222; Hartford AC, 2012, AM J CLIN ONCOL-CANC, V35, P612, DOI 10.1097/COC.0b013e31826e0515; Hauri P1, 2014, J APPL CLIN MED PHYS, V15, P4647, DOI DOI 10.1120/JACMP.V15I2.4647; Hussein M, 2013, RADIOTHER ONCOL, V109, P370, DOI 10.1016/j.radonc.2013.08.048; Letourneau D, 2009, MED PHYS, V36, P1813, DOI 10.1118/1.3117563; Lin MH, 2013, J APPL CLIN MED PHYS, V14, P220, DOI 10.1120/jacmp.v14i2.3929; Ling CC, 2008, INT J RADIAT ONCOL, V72, P575, DOI 10.1016/j.ijrobp.2008.05.060; Lobo J, 2010, PHYS MED BIOL, V55, P4431, DOI 10.1088/0031-9155/55/16/S01; Manikandan A, 2012, BRIT J RADIOL, V85, P1002, DOI 10.1259/bjr/19152959; Micke A, 2011, MED PHYS, V38, P2523, DOI 10.1118/1.3576105; Montero JP, 2011, PHYS MED BIOL, V56, P2569, DOI 10.1088/0031-9155/56/8/015; Nelms BE, 2011, MED PHYS, V38, P1037, DOI 10.1118/1.3544657; Oldham M, 2012, INT J RADIAT ONCOL, V84, P540, DOI 10.1016/j.ijrobp.2011.12.015; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Park JY, 2011, MED PHYS, V38, P6688, DOI 10.1118/1.3659706; Richardson SL, 2003, MED PHYS, V30, P2553, DOI 10.1118/1.1603965; Rogers DW, 2011, 509 PIRS NRC; Schreibmann E, 2009, MED PHYS, V36, P4530, DOI 10.1118/1.3213085; Song JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119937; Teke T, 2010, MED PHYS, V37, P116, DOI 10.1118/1.3266821; Teoh M, 2011, BRIT J RADIOL, V84, P967, DOI 10.1259/bjr/22373346; Tyagi N, 2012, MED PHYS, V39, P7194, DOI 10.1118/1.4764482; Ureba A, 2014, MED PHYS, V41, P216, DOI 10.1118/1.4890602; Yu CX, 2011, PHYS MED BIOL, V56, pR31, DOI 10.1088/0031-9155/56/5/R01; Zhen HM, 2011, MED PHYS, V38, P5477, DOI 10.1118/1.3633904	30	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166767	10.1371/journal.pone.0166767	http://dx.doi.org/10.1371/journal.pone.0166767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870878	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400026
J	Li, JZ; Wang, GA; Zhang, RN; Lie, L				Li, Jiazhu; Wang, Guoan; Zhang, Runan; Lie, Li			A Negative Relationship between Foliar Carbon Isotope Composition and Mass-Based Nitrogen Concentration on the Eastern Slope of Mount Gongga, China	PLOS ONE			English	Article							LEAF NITROGEN; PHOSPHORUS STOICHIOMETRY; METROSIDEROS-POLYMORPHA; GLOBAL PATTERNS; DISCRIMINATION; DELTA-C-13; PLANTS; TRAITS; TEMPERATURE; LIMITATION	Plants adopt ecological strategy to resist environmental changes and increase their resource-use efficiency. The ecological strategy includes changes in physiological traits and leaf morphology, which may result in simultaneous variations in foliar N concentration and the ratio of intercellular CO2 concentration to ambient CO2 concentration (c(i)/c(a)). This in turn links to foliar carbon isotope discrimination, and thus, a relationship between foliar N concentration and foliar carbon isotope composition (delta C-13) is expected. To understand how plants integrate their structural and physiological resistance to environmental changes, the relationship between foliar N concentration and foliar delta C-13 has been assessed intensively, especially the correlation between area-based N concentration (N-area) and delta C-13. Less effort has been dedicated to the examination of the relationship between mass-based N concentration(N-mass) and delta C-13. Studies on the N-mass-delta(13) C relationship, especially those including a large amount of data and species, will enhance our understanding of leaf economics and benefit ecological modeling. The present study includes an intensive investigation into this relationship by measuring foliar N-mass and delta C-13 in a large number of plant species grown on the eastern slope of Mount Gongga, China. This study shows that foliar Nmass decreases with increasing delta C-13, which is independent of functional group, vegetation type, and altitude. This suggests that a negative correlation between N-mass and delta C-13 may be a general pattern for plants grown not only on Mount Gongga, but also in other areas.	[Li, Jiazhu] Chinese Acad Forestry, Inst Desertificat Studies, Beijing 100091, Peoples R China; [Wang, Guoan; Zhang, Runan; Lie, Li] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; China Agricultural University	Wang, GA (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	gawang@cau.edu.cn			Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QB048]; National Natural Science Foundation of China [41272193, 41403069]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Fundamental Research Funds for the Central Non-profit Research Institution of CAF (No. CAFYBB2014QB048) JL, the National Natural Science Foundation of China (No. 41272193) GW, the National Natural Science Foundation of China (No. 41403069) JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (No. CAFYBB2014QB048) and the National Natural Science Foundation of China (Nos. 41272193 and 41403069). We would like to thank Ma Yan for analyzing nitrogen isotopes at the Stable Isotope Laboratory of the College of Resources and Environment, China Agricultural University.	Aparicio N, 2000, DURUM WHEAT IMPROVEM, P181; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Brooks JR, 1997, OECOLOGIA, V110, P301, DOI 10.1007/s004420050163; Cordell S, 1999, FUNCT ECOL, V13, P811, DOI 10.1046/j.1365-2435.1999.00381.x; Damesin C, 1997, OECOLOGIA, V111, P26, DOI 10.1007/s004420050204; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Domingues TF, 2010, PLANT CELL ENVIRON, V33, P959, DOI 10.1111/j.1365-3040.2010.02119.x; Duursma RA, 2006, TREES-STRUCT FUNCT, V20, P496, DOI 10.1007/s00468-006-0065-3; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Field C. H., 1986, EC FORM FUNCTION, P25; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He MZ, 2015, ECOL EVOL, V5, P1494, DOI 10.1002/ece3.1441; Hikosaka K, 2004, J PLANT RES, V117, P481, DOI 10.1007/s10265-004-0174-2; Huang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18225; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Kloeppel BD, 1998, OECOLOGIA, V114, P153, DOI 10.1007/s004420050431; Korner C, 1987, FUNCT ECOL, V1, P179, DOI 10.2307/2389420; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Lloyd Jon, 2013, New Phytol, V199, P311, DOI 10.1111/nph.12281; Luo TX, 2009, ECOGRAPHY, V32, P526, DOI 10.1111/j.1600-0587.2008.05735.x; Patino S, 2012, BIOGEOSCIENCES, V9, P775, DOI 10.5194/bg-9-775-2012; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; REICH PB, 1994, OECOLOGIA, V97, P73, DOI 10.1007/BF00317910; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; Shi WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044628; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Tan WB, 2009, CHINESE SCI BULL, V54, P1759, DOI 10.1007/s11434-009-0046-1; VITOUSEK PM, 1990, OECOLOGIA, V84, P362, DOI 10.1007/BF00329760; Wang G, 2008, BIOGEOSCIENCES, V5, P1325, DOI 10.5194/bg-5-1325-2008; Watkins JE, 2007, OECOLOGIA, V153, P225, DOI 10.1007/s00442-007-0723-1; Westoby M, 2013, NEW PHYTOL, V199, P322, DOI 10.1111/nph.12345; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wu TG, 2012, FOREST ECOL MANAG, V284, P116, DOI 10.1016/j.foreco.2012.07.025; Zheng SX, 2007, PHOTOSYNTHETICA, V45, P110, DOI 10.1007/s11099-007-0017-1	39	4	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166958	10.1371/journal.pone.0166958	http://dx.doi.org/10.1371/journal.pone.0166958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870885	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400045
J	Maillard, A; Sorin, E; Etienne, P; Diquelou, S; Koprivova, A; Kopriva, S; Arkoun, M; Gallardo, K; Turner, M; Cruz, F; Yvin, JC; Ourry, A				Maillard, Anne; Sorin, Elise; Etienne, Philippe; Diquelou, Sylvain; Koprivova, Anna; Kopriva, Stanislav; Arkoun, Mustapha; Gallardo, Karine; Turner, Marie; Cruz, Florence; Yvin, Jean-Claude; Ourry, Alain			Non-Specific Root Transport of Nutrient Gives Access to an Early Nutritional Indicator: The Case of Sulfate and Molybdate	PLOS ONE			English	Article							SULFUR DEFICIENCY; SEED YIELD; NITROGEN; MOLYBDENUM; DEPRIVATION; QUALITY; L.; EXPRESSION; POTASSIUM; RESPONSES	Under sulfur (S) deficiency, crosstalk between nutrients induced accumulation of other nutrients, particularly molybdenum (Mo). This disturbed balanced between S and Mo could provide a way to detect S deficiency and therefore avoid losses in yield and seed quality in cultivated species. Under hydroponic conditions, S deprivation was applied to Brassica napus to determine the precise kinetics of S and Mo uptake and whether sulfate transporters were involved in Mo uptake. Leaf contents of S and Mo were also quantified in a field-grown S deficient oilseed rape crop with different S and N fertilization applications to evaluate the [Mo]:[S] ratio, as an indicator of S nutrition. To test genericity of this indicator, the [Mo]:[S] ratio was also assessed with other cultivated species under different controlled conditions. During S deprivation, Mo uptake was strongly increased in B. napus. This accumulation was not a result of the induction of the molybdate transporters, Mot1 and Asy, but could be a direct consequence of Sultr1.1 and Sultr1.2 inductions. However, analysis of single mutants of these transporters in Arabidopsis thaliana suggested that other sulfate deficiency responsive transporters may be involved. Under field conditions, Mo content was also increased in leaves by a reduction in S fertilization. The [Mo]:[S] ratio significantly discriminated between the plots with different rates of S fertilization. Threshold values were estimated for the hierarchical clustering of commercial crops according to S status. The use of the [Mo]:[S] ratio was also reliable to detect S deficiency for other cultivated species under controlled conditions. The analysis of the leaf [Mo]:[S] ratio seems to be a practical indicator to detect early S deficiency under field conditions and thus improve S fertilization management.	[Maillard, Anne; Sorin, Elise; Etienne, Philippe; Diquelou, Sylvain; Ourry, Alain] Normandie Univ, Caen, France; [Maillard, Anne; Sorin, Elise; Etienne, Philippe; Diquelou, Sylvain; Ourry, Alain] UNICAEN, UMR Ecophysiol Vegetale Agron & Nutr NCS 950, Esplanade Paix, Caen, France; [Maillard, Anne; Sorin, Elise; Etienne, Philippe; Diquelou, Sylvain; Ourry, Alain] INRA, UMR Ecophysiol Vegetale Agron & Nutr NCS 950, Esplanade Paix, Caen, France; [Sorin, Elise; Kopriva, Stanislav; Arkoun, Mustapha] Univ Cologne, Inst Bot, Cologne, Germany; [Sorin, Elise; Koprivova, Anna; Kopriva, Stanislav] Univ Cologne, Cluster Excellence Plant Sci CEPLAS, Cologne, Germany; [Arkoun, Mustapha; Cruz, Florence; Yvin, Jean-Claude] CMI, Grp Roullier, St Malo, France; [Gallardo, Karine] INRA, Agroecol UMR1347, Pole GEAPSI, Dijon, France; [Turner, Marie] VEGENOV BBV, St Pol De Leon, France	Universite de Caen Normandie; INRAE; University of Cologne; University of Cologne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Ourry, A (corresponding author), Normandie Univ, Caen, France.; Ourry, A (corresponding author), UNICAEN, UMR Ecophysiol Vegetale Agron & Nutr NCS 950, Esplanade Paix, Caen, France.; Ourry, A (corresponding author), INRA, UMR Ecophysiol Vegetale Agron & Nutr NCS 950, Esplanade Paix, Caen, France.	alain.ourry@unicaen.fr	Kopriva, Stanislav/C-7401-2013; ETIENNE, Philippe/AAS-2211-2021; OURRY, Alain/AFN-5444-2022	Kopriva, Stanislav/0000-0002-7416-6551; ETIENNE, Philippe/0000-0002-4531-3874; OURRY, Alain/0000-0002-3654-4195; Gallardo-Guerrero, Karine/0000-0002-2343-1941	Regional Council of Lower Normandy [12P03057]; Regional Council of Brittany [12008011]; European Regional Development Fund [33525]; Deutsche Forschungsgemeinschaft [EXC 1028]; Centre Mondial d'Innovation Groupe Roullier	Regional Council of Lower Normandy(Region Normandie); Regional Council of Brittany(Region Bretagne); European Regional Development Fund(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre Mondial d'Innovation Groupe Roullier	This work, conducted through the SERAPIS project, was supported by the Regional Council of Lower Normandy (grant number 12P03057), the Regional Council of Brittany (grant number 12008011) and the European Regional Development Fund (grant number 33525). SK's research is supported by the Deutsche Forschungsgemeinschaft (EXC 1028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Centre Mondial d'Innovation Groupe Roullier provided support in the form of salaries for authors MA, FC and JCY as well as the PhD grant of ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. VEGENOV-BBV provided support in the form of salary for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdallah M, 2010, J EXP BOT, V61, P2635, DOI 10.1093/jxb/erq096; Alhendawi RA, 2005, J PLANT NUTR, V28, P1347, DOI 10.1081/PLN-200067449; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Balik J, 2006, PLANT SOIL ENVIRON, V52, P301, DOI 10.17221/3445-PSE; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Bittner F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00028; Blake-Kalff MMA, 2001, ANN APPL BIOL, V138, P123, DOI 10.1111/j.1744-7348.2001.tb00093.x; Blake-Kalff MMA, 2000, PLANT SOIL, V225, P95, DOI 10.1023/A:1026503812267; Cao MJ, 2013, PLANT J, V73, P607, DOI 10.1111/tpj.12059; Casieri L, 2012, PLANTA, V235, P1431, DOI 10.1007/s00425-012-1645-7; D'Hooghe P, 2014, MOL CELL PROTEOMICS, V13, P1165, DOI 10.1074/mcp.M113.034215; Dudev T, 2004, J AM CHEM SOC, V126, P10296, DOI 10.1021/ja047951n; Fitzpatrick KL, 2008, FEBS LETT, V582, P1508, DOI 10.1016/j.febslet.2008.03.045; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Harris J, 2014, PLANTA, V239, P479, DOI 10.1007/s00425-013-1996-8; Hawkesford MJ, 2003, PHYSIOL PLANTARUM, V117, P155, DOI 10.1034/j.1399-3054.2003.00034.x; Hibara K. I., 2013, American Journal of Plant Sciences, V4, P1; Huang XY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006298; Hunashikatti M. G., 2000, Karnataka Journal of Agricultural Sciences, V13, P840; JANZEN HH, 1984, SOIL SCI SOC AM J, V48, P100, DOI 10.2136/sssaj1984.03615995004800010019x; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kopriva S, 2009, PLANT CELL REP, V28, P1769, DOI 10.1007/s00299-009-0793-0; Koprivova A, 2013, PLANT PHYSIOL, V163, P1133, DOI 10.1104/pp.113.225748; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llamas A, 2011, METALLOMICS, V3, P578, DOI 10.1039/c1mt00032b; Malhi SS, 2007, AGRON J, V99, P570, DOI 10.2134/agronj2006.0269; McGrath SP, 1996, J AGR SCI, V126, P53, DOI 10.1017/S0021859600088808; Mendel RR, 2005, DALTON T, P3404, DOI 10.1039/b505527j; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Parmar S, 2007, PLANT BIOLOGY, V9, P647, DOI 10.1055/s-2007-965428; Ranade-Malvi U., 2011, Karnataka Journal of Agricultural Sciences, V24, P106; Sarda X, 2014, J AGR SCI-CAMBRIDGE, V152, P616, DOI 10.1017/S0021859613000105; Schachtman D, 1999, TRENDS PLANT SCI, V4, P281, DOI 10.1016/S1360-1385(99)01428-4; Scherer HW, 2001, EUR J AGRON, V14, P81, DOI 10.1016/S1161-0301(00)00082-4; Schiavon M, 2012, ENVIRON EXP BOT, V75, P41, DOI 10.1016/j.envexpbot.2011.08.016; Shibagaki N, 2002, PLANT J, V29, P475, DOI 10.1046/j.0960-7412.2001.01232.x; Shinmachi F, 2010, PLANT PHYSIOL, V153, P327, DOI 10.1104/pp.110.153759; Sorin E, 2015, J EXP BOT, V66, P6175, DOI 10.1093/jxb/erv321; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Tejada-Jimenez M, 2007, P NATL ACAD SCI USA, V104, P20126, DOI 10.1073/pnas.0704646104; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Wang MY, 2009, PLANT SOIL ENVIRON, V55, P484, DOI 10.17221/70/2009-PSE; ZHAO FJ, 1993, J SCI FOOD AGR, V63, P29, DOI 10.1002/jsfa.2740630106	45	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166910	10.1371/journal.pone.0166910	http://dx.doi.org/10.1371/journal.pone.0166910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870884	Green Published, gold, Green Submitted			2022-12-26	WOS:000388846400042
J	Pan, C; Weng, JW; Wang, WN				Pan, Chao; Weng, Jingwei; Wang, Wenning			ATP Hydrolysis Induced Conformational Changes in the Vitamin B-12 Transporter BtuCD Revealed by MD Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BINDING CASSETTE TRANSPORTERS; BACTERIAL ABC TRANSPORTER; NUCLEOTIDE-BINDING; CONSTANT CONTACT; CATALYTIC CYCLE; FORCE-FIELD; NBD DIMER; MECHANISM; PROTEIN	ATP binding cassette (ABC) transporters utilize the energy of ATP hydrolysis to uni-directionally transport substrates across cell membrane. ATP hydrolysis occurs at the nucleo-tide-binding domain (NBD) dimer interface of ABC transporters, whereas substrate translocation takes place at the translocation pathway between the transmembrane domains (TMDs), which is more than 30 angstroms away from the NBD dimer interface. This raises the question of how the hydrolysis energy released at NBDs is "transmitted" to trigger the conformational changes at TMDs. Using molecular dynamics (MD) simulations, we studied the post-hydrolysis state of the vitamin B-12 importer BtuCD. Totally 3-mu s MD trajectories demonstrate a predominantly asymmetric arrangement of the NBD dimer interface, with the ADP-bound site disrupted and the ATP-bound site preserved in most of the trajectories. TMDs response to ATP hydrolysis by separation of the L-loops and opening of the cytoplasmic gate II, indicating that hydrolysis of one ATP could facilitate substrate translocation by opening the cytoplasmic end of translocation pathway. It was also found that motions of the L-loops and the cytoplasmic gate II are coupled with each other through a contiguous interaction network involving a conserved Asn83 on the extended stretch preceding TM3 helix plus the cytoplasmic end of TM2/6/7 helix bundle. These findings entail a TMD-NBD communication mechanism for type II ABC importers.	[Weng, Jingwei; Wang, Wenning] Fudan Univ, Shanghai Key Lab Mol Catalysis & Innovat Mat, Dept Chem, Shanghai, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China	Fudan University; Fudan University	Weng, JW; Wang, WN (corresponding author), Fudan Univ, Shanghai Key Lab Mol Catalysis & Innovat Mat, Dept Chem, Shanghai, Peoples R China.	jwweng@fudan.edu.cn; wnwang@fudan.edu.cn			National Major Basic Research Program of China [2016YFA0501702]; National Science Foundation of China [21473034, 21403036]; Specialized Research Fund for the Doctoral Program of Higher Education [20130071140004]	National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	WW is supported by National Major Basic Research Program of China (2016YFA0501702); National Science Foundation of China (21473034) and Specialized Research Fund for the Doctoral Program of Higher Education (20130071140004); JW is supported by National Science Foundation of China (21403036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Damas JM, 2011, PROTEIN SCI, V20, P1220, DOI 10.1002/pro.650; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; George AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059854; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Ivetac A, 2007, BIOCHEMISTRY-US, V46, P2767, DOI 10.1021/bi0622571; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph B, 2014, J BIOL CHEM, V289, P3176, DOI 10.1074/jbc.M113.512178; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kandt C, 2010, PROTEINS, V78, P738, DOI 10.1002/prot.22606; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Korkhov VM, 2012, FEBS LETT, V586, P972, DOI 10.1016/j.febslet.2012.02.042; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Livnat-Levanon N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21696; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oliveira ASF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002128; Oliveira ASF, 2010, J PHYS CHEM B, V114, P5486, DOI 10.1021/jp905735y; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Pan CW, 2016, CONFORMATIONAL DYNAM; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; Riedel C, 2015, NATURE, V517, P227, DOI 10.1038/nature14043; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Oliveira AS, 2011, PROTEINS, V79, P1977, DOI 10.1002/prot.23023; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; St-Pierre JF, 2012, J PHYS CHEM B, V116, P2934, DOI 10.1021/jp209126c; Stefkova J, 2004, PHYSIOL RES, V53, P235; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Sun TG, 2010, SCI CHINA LIFE SCI, V53, P620, DOI 10.1007/s11427-010-0103-7; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; Wen PC, 2008, BIOPHYS J, V95, P5100, DOI 10.1529/biophysj.108.139444	64	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166980	10.1371/journal.pone.0166980	http://dx.doi.org/10.1371/journal.pone.0166980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870912	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400049
J	Rozendaal, DMA; Kobe, RK				Rozendaal, Denae M. A.; Kobe, Richard K.			A Forest Tent Caterpillar Outbreak Increased Resource Levels and Seedling Growth in a Northern Hardwood Forest	PLOS ONE			English	Article							GYPSY-MOTH; ACER-SACCHARUM; SAPLING GROWTH; NITROGEN MINERALIZATION; MORPHOLOGICAL RESPONSES; CANOPY RECRUITMENT; CONIFER SEEDLINGS; TREE MORTALITY; SUGAR MAPLE; LIGHT	In closed-canopy forests, gap formation and closure are thought to be major drivers of forest dynamics. Crown defoliation by insects, however, may also influence understory resource levels and thus forest dynamics. We evaluate the effect of a forest tent caterpillar outbreak on understory light availability, soil nutrient levels and tree seedling height growth in six sites with contrasting levels of canopy defoliation in a hardwood forest in northern lower Michigan. We compared resource levels and seedling growth of six hardwood species before, during and in the three years after the outbreak (2008-2012). Canopy openness increased strongly during the forest tent caterpillar outbreak in the four moderately and severely defoliated sites, but not in lightly defoliated sites. Total inorganic soil nitrogen concentrations increased in response to the outbreak in moderately and severely defoliated sites. The increase in total inorganic soil nitrogen was driven by a strong increase in soil nitrate, and tended to become stronger with increasing site defoliation. Seedling height growth increased for all species in the moderately and severely defoliated sites, but not in lightly defoliated sites, either during the outbreak year or in the year after the outbreak. Growth increases did not become stronger with increasing site defoliation, but were strongest in a moderately defoliated site with high soil nutrient levels. Growth increases tended to be strongest for the shade intolerant species Fraxinus americana and Prunus serotina, and the shade tolerant species Ostrya virginiana. The strong growth response of F. americana and P. serotina suggests that recurring forest tent caterpillar outbreaks may facilitate the persistence of shade intolerant species in the understory in the absence of canopy gaps. Overall, our results suggest that recurrent canopy defoliation resulting from cyclical forest insect outbreaks may be an additional driver of dynamics in temperate closed-canopy forests.	[Rozendaal, Denae M. A.; Kobe, Richard K.] Michigan State Univ, Dept Forestry, Nat Resources Bldg,480 Wilson Rd,Room 126, E Lansing, MI 48824 USA; [Rozendaal, Denae M. A.] Univ Regina, Dept Biol, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada	Michigan State University; University of Regina	Rozendaal, DMA (corresponding author), Michigan State Univ, Dept Forestry, Nat Resources Bldg,480 Wilson Rd,Room 126, E Lansing, MI 48824 USA.; Rozendaal, DMA (corresponding author), Univ Regina, Dept Biol, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada.	danaerozendaal@gmail.com	Kobe, Richard K/M-1054-2014		US National Science Foundation [DEB 0958943]	US National Science Foundation(National Science Foundation (NSF))	This study was funded by the US National Science Foundation under DEB 0958943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Max Erickson, Michael Cook, Andrea Maguire, Beverly Bell, Megan Edwards and Amber Townes for help with field work. We thank Thomas Baribault and Ellen Holste for contributing soil nutrient data. We thank Benjamin Schram, Michelle Sandler and Ellen Holste for help with laboratory work. This study was funded by the National Science Foundation under DEB 0958943.	Baribault TW, 2010, FOREST ECOL MANAG, V260, P723, DOI 10.1016/j.foreco.2010.05.029; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Beaudet M, 1998, CAN J FOREST RES, V28, P1007, DOI 10.1139/cjfr-28-7-1007; Beaudet M, 2007, J ECOL, V95, P458, DOI 10.1111/j.1365-2745.2007.01219.x; Benes J, 2006, FOREST ECOL MANAG, V237, P353, DOI 10.1016/j.foreco.2006.09.058; Bigelow SW, 2002, J ECOL, V90, P188, DOI 10.1046/j.0022-0477.2001.00655.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; CAMPBELL RW, 1977, FOREST SCI, P1; CANHAM CD, 1990, B TORREY BOT CLUB, V117, P1, DOI 10.2307/2997123; CANHAM CD, 1985, B TORREY BOT CLUB, V112, P134, DOI 10.2307/2996410; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; Carter M.R., 2008, SOIL SAMPLING METHOD; Catovsky S, 2002, ECOL APPL, V12, P1611, DOI 10.2307/3099926; Christenson LM, 2002, OECOLOGIA, V131, P444, DOI 10.1007/s00442-002-0887-7; Clark JS, 2003, ECOLOGY; Claveau Y, 2002, CAN J FOREST RES, V32, P458, DOI 10.1139/X01-220; Claveau Y, 2006, CAN J FOREST RES, V36, P1891, DOI 10.1139/X06-049; COLLINS S, 1961, ECOLOGY, V42, P836, DOI 10.2307/1933521; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Davidson CB, 1999, FOREST SCI, V45, P74; Dekker M, 2009, EUR J FOREST RES, V128, P455, DOI 10.1007/s10342-009-0293-3; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Edwards A.W.F., 1992, LIKELIHOOD; Eisenbies MH, 2007, FOREST SCI, V53, P683; Eshleman KN, 1998, WATER RESOUR RES, V34, P2005, DOI 10.1029/98WR01198; Finzi AC, 2000, FOREST ECOL MANAG, V131, P153, DOI 10.1016/S0378-1127(99)00206-6; FITZGERALD TD, 1995, TENT CATERPILLARS; Frazer G.W., 2000, B ECOL SOC AM, V81, P191, DOI DOI 10.1890/0012-9623(2000)081[0190:TT]2.0.CO;2; Frost CJ, 2007, OECOLOGIA, V151, P42, DOI 10.1007/s00442-006-0579-9; Frost CJ, 2004, ECOLOGY, V85, P3335, DOI 10.1890/04-0003; George LO, 1999, ECOLOGY, V80, P846, DOI 10.1890/0012-9658(1999)080[0846:TFUAAE]2.0.CO;2; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; GRACE JR, 1986, FOREST SCI, V32, P855; Grubb PJ, 1996, J ECOL, V84, P827, DOI 10.2307/2960555; HIBBS DE, 1982, CAN J FOREST RES, V12, P522, DOI 10.1139/x82-081; HOST GE, 1992, CAN J FOREST RES, V22, P1547, DOI 10.1139/x92-205; Karolewski P, 2013, ACTA OECOL, V53, P19, DOI 10.1016/j.actao.2013.08.004; Kobe RK, 2007, CAN J FOREST RES, V37, P1203, DOI 10.1139/X06-320; Kobe RK, 2010, ECOLOGY, V91, P166, DOI 10.1890/09-0027.1; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Kobe RK, 2006, OECOLOGIA, V147, P119, DOI 10.1007/s00442-005-0252-8; Konvicka M, 2008, J INSECT CONSERV, V12, P549, DOI 10.1007/s10841-007-9087-4; Kosulic O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148585; KRAMER P J, 1979, P811; Landis RM, 2005, ECOLOGY, V86, P63, DOI 10.1890/03-0848; Lilles EB, 2012, CAN J FOREST RES, V42, P99, DOI [10.1139/X11-163, 10.1139/x11-163]; LOVETT GM, 1995, OECOLOGIA, V104, P133, DOI 10.1007/BF00328577; MARKS PL, 1975, B TORREY BOT CLUB, V102, P172, DOI 10.2307/2484938; Marks PL, 1998, J TORREY BOT SOC, V125, P287, DOI 10.2307/2997242; Murphy L, 2012, LIKELIHOOD METHODS M; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Peltzer DA, 2016, OIKOS, V125, P1121, DOI 10.1111/oik.02878; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Pugh SA, 2012, RESOURCE B USDA, V66; R Core Team, 2021, R LANGUAGE ENV STAT; Reinikainen M, 2012, FOREST ECOL MANAG, V266, P148, DOI 10.1016/j.foreco.2011.11.023; Rezac M, 2014, J INSECT CONSERV, V18, P523, DOI 10.1007/s10841-014-9668-y; Romberger JA., 1963, US FOREST SERVICE TE, V1293; Rozendaal DMA, 2014, FOREST ECOL MANAG, V327, P18, DOI 10.1016/j.foreco.2014.04.037; Runkle J. R., 1985, The ecology of natural disturbance and patch dynamics, P17; RUNKLE JR, 1981, ECOLOGY, V62, P1041, DOI 10.2307/1937003; Sinsabaugh RL, 2000, SOIL BIOL BIOCHEM, V32, P2095, DOI 10.1016/S0038-0717(00)00102-4; Spitzer L, 2008, BIOL CONSERV, V141, P827, DOI 10.1016/j.biocon.2008.01.005; STEPHENS GR, 1972, FOREST SCI, V18, P326; Townsend PA, 2004, ECOL APPL, V14, P504, DOI 10.1890/02-5356; Tripler CE, 2005, ECOSCIENCE, V12, P494, DOI 10.2980/i1195-6860-12-4-494.1; Valverde T, 1997, ECOLOGY, V78, P1555, DOI 10.1890/0012-9658(1997)078[1555:CCRAFS]2.0.CO;2; Walters MB, 1997, CAN J FOREST RES, V27, P237, DOI 10.1139/cjfr-27-2-237; Wargo PM, 1981, USDA TECHNICAL B, V1584; WARREN MS, 1987, J APPL ECOL, V24, P499, DOI 10.2307/2403889; Williams H, 1999, CAN J FOREST RES, V29, P222, DOI 10.1139/cjfr-29-2-222; ZAK DR, 1989, CAN J FOREST RES, V19, P1521, DOI 10.1139/x89-231	77	6	7	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0167139	10.1371/journal.pone.0167139	http://dx.doi.org/10.1371/journal.pone.0167139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870897	gold, Green Published, Green Submitted			2022-12-26	WOS:000388846400061
J	Bauer, JS; Hauck, N; Christof, L; Mehnaz, S; Gust, B; Gross, H				Bauer, Judith S.; Hauck, Nils; Christof, Lisa; Mehnaz, Samina; Gust, Bertolt; Gross, Harald			The Systematic Investigation of the Quorum Sensing System of the Biocontrol Strain Pseudomonas chlororaphis subsp aurantiaca PB-St2 Unveils aurI to Be a Biosynthetic Origin for 3-Oxo-Homoserine Lactones	PLOS ONE			English	Article							ACYL-HOMOSERINE-LACTONE; TO-CELL COMMUNICATION; CARBAPENEM ANTIBIOTIC PRODUCTION; N-ACYLHOMOSERINE LACTONES; ERWINIA-CAROTOVORA; MASS-SPECTROMETRY; BIOFILM FORMATION; VIBRIO-FISCHERI; TRANSCRIPTIONAL REGULATOR; BACTERIAL BIOLUMINESCENCE	The shoot endophytic biocontrol strain Pseudomonas chlororaphis subsp. aurantiaca PB-St2 produces a wide range of exoproducts, including enzymes and antibiotics. The production of exoproducts is commonly tightly regulated. In order to get a deeper insight into the regulatory network of PB-St2, the strain was systematically investigated regarding its quorum sensing systems, both on the genetic and metabolic level. The genome analysis of PB-St2 revealed the presence of four putative acyl homoserine lactone (AHL) biosynthesis genes: phzI, csaI, aurI, and hdtS. LC-MS/MS analyses of the crude supernatant extracts demonstrated that PB-St2 produces eight AHLs. In addition, the concentration of all AHL derivatives was quantified time-resolved in parallel over a period of 42 h during the growth of P. aurantiaca PB-St2, resulting in production curves, which showed differences regarding the maximum levels of the AHLs (14.6 nM-1.75 mu M) and the production period. Cloning and heterologous overexpression of all identified AHL synthase genes in Escherichia coli proved the functionality of the resulting synthases PhzI, CsaI, and AurI. A clear AHL production pattern was assigned to each of these three AHL synthases, while the HdtS synthase did not lead to any AHL production. Furthermore, the heterologous expression study demonstrated unequivocally and for the first time that AurI directs the synthesis of two 3-oxo-AHLs.	[Bauer, Judith S.; Hauck, Nils; Christof, Lisa; Gust, Bertolt; Gross, Harald] Univ Tubingen, Inst Pharmaceut, Dept Pharmaceut Biol, Tubingen, Germany; [Bauer, Judith S.; Hauck, Nils; Christof, Lisa; Gust, Bertolt; Gross, Harald] German Ctr Infect Res DZIF, Partner Site Tuebingen, Tubingen, Germany; [Mehnaz, Samina] Forman Christian Coll, Dept Biol Sci, Lahore, Pakistan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research	Gross, H (corresponding author), Univ Tubingen, Inst Pharmaceut, Dept Pharmaceut Biol, Tubingen, Germany.; Gross, H (corresponding author), German Ctr Infect Res DZIF, Partner Site Tuebingen, Tubingen, Germany.	harald.gross@uni-tuebingen.de	Mehnaz, Samina/I-1533-2015	Mehnaz, Samina/0000-0001-9828-255X	Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 766) to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036696; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bertani I, 2004, APPL ENVIRON MICROB, V70, P5493, DOI 10.1128/AEM.70.9.5493-5502.2004; Blosser-Middleton RS, 2001, J BACTERIOL, V183, P6771, DOI 10.1128/JB.183.23.6771-6777.2001; Burton EO, 2005, APPL ENVIRON MICROB, V71, P4906, DOI 10.1128/AEM.71.8.4906-4909.2005; Byers JT, 2002, J BACTERIOL, V184, P1163, DOI 10.1128/jb.184.4.1163-1171.2002; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P969, DOI 10.1094/MPMI.2001.14.8.969; Cude WN, 2015, APPL ENVIRON MICROB, V81, P1417, DOI 10.1128/AEM.02551-14; Cullinane M, 2005, MICROBIOL-SGM, V151, P3071, DOI 10.1099/mic.0.27958-0; De Maeyer K, 2011, MICROBIOL-SGM, V157, P459, DOI 10.1099/mic.0.043125-0; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Delalande L, 2005, FEMS MICROBIOL ECOL, V52, P13, DOI 10.1016/j.femsec.2004.10.005; Deveau A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01152-13; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Elasri M, 2001, APPL ENVIRON MICROB, V67, P1198, DOI 10.1128/AEM.67.3.1198-1209.2001; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fekete A, 2010, FEMS MICROBIOL ECOL, V72, P22, DOI 10.1111/j.1574-6941.2009.00828.x; Ghequire MGK, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00251-16; Gould TA, 2006, J BACTERIOL, V188, P773, DOI 10.1128/JB.188.2.773-783.2006; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Holden MTG, 1998, MICROBIOL-SGM, V144, P1495, DOI 10.1099/00221287-144-6-1495; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Khan SR, 2007, APPL ENVIRON MICROB, V73, P7443, DOI 10.1128/AEM.01354-07; Khan SR, 2005, J BACTERIOL, V187, P6517, DOI 10.1128/JB.187.18.6517-6527.2005; Kibria G., 2010, CLIMATE CHANGE CHEM; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Komarek M, 2010, ENVIRON INT, V36, P138, DOI 10.1016/j.envint.2009.10.005; Kookana RS, 1998, AUST J SOIL RES, V36, P715, DOI 10.1071/S97109; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Lee J, 2013, NAT CHEM BIOL, V9, P339, DOI [10.1038/NCHEMBIO.1225, 10.1038/nchembio.1225]; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Licciardello G, 2007, FEMS MICROBIOL ECOL, V61, P222, DOI 10.1111/j.1574-6941.2007.00338.x; Licciardello G, 2012, J BIOTECHNOL, V159, P274, DOI 10.1016/j.jbiotec.2011.07.036; Lithgow JK, 2000, MOL MICROBIOL, V37, P81, DOI 10.1046/j.1365-2958.2000.01960.x; Liu XG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-26; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Mattiuzzo M, 2011, ENVIRON MICROBIOL, V13, P145, DOI 10.1111/j.1462-2920.2010.02316.x; May AL, 2012, ANAL CHEM, V84, P1243, DOI 10.1021/ac202636d; Mazzola M, 2002, ANTON LEEUW INT J G, V81, P557, DOI 10.1023/A:1020557523557; MCGOWAN S, 1995, MICROBIOL-SGM, V141, P541, DOI 10.1099/13500872-141-3-541; Mehnaz S, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA, DOI 10.1128/GENOMEA.]; Mehnaz S, 2013, J BASIC MICROB, V53, P954, DOI 10.1002/jobm.201200299; Mehnaz S, 2013, J NAT PROD, V76, P135, DOI 10.1021/np3005166; Mehnaz S, 2010, J MICROBIOL BIOTECHN, V20, P1614, DOI 10.4014/jmb.1005.05014; Mehnaz S, 2009, J MICROBIOL BIOTECHN, V19, P1688, DOI 10.4014/jmb.0904.04022; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Morohoshi T, 2013, J BIOSCI BIOENG, V116, P580, DOI 10.1016/j.jbiosc.2013.04.022; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Olher VGA, 2016, J NAT PROD, V79, P1316, DOI 10.1021/acs.jnatprod.5b01075; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Quinones B, 2004, MOL PLANT MICROBE IN, V17, P521, DOI 10.1094/MPMI.2004.17.5.521; Rivas M, 2007, APPL ENVIRON MICROB, V73, P3225, DOI 10.1128/AEM.02948-06; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shepherd RW, 2009, APPL ENVIRON MICROB, V75, P45, DOI 10.1128/AEM.01723-08; Singh K, 2012, DIS SUGARCANE MAJOR; Steidle A, 2002, APPL ENVIRON MICROB, V68, P6371, DOI 10.1128/AEM.68.12.6371-6382.2002; Steindler L, 2009, APPL ENVIRON MICROB, V75, P5131, DOI 10.1128/AEM.02914-08; Stover C. K., 2000, NATURE, V406, P1, DOI DOI 10.1038/35023203; Tseng BS, 2016, J BACTERIOL; Van Der Voort M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00693; Wang MZ, 2012, BIORESOURCE TECHNOL, V125, P119, DOI 10.1016/j.biortech.2012.08.116; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wei HL, 2006, ANTON LEEUW INT J G, V89, P267, DOI 10.1007/s10482-005-9028-8; Wightwick AM, 2008, J AGR FOOD CHEM, V56, P2457, DOI 10.1021/jf0727950; Wilder CN, 2011, ISME J, V5, P1332, DOI 10.1038/ismej.2011.13; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zha DM, 2014, APPL ENVIRON MICROB, V80, P6627, DOI 10.1128/AEM.02184-14; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001	85	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0167002	10.1371/journal.pone.0167002	http://dx.doi.org/10.1371/journal.pone.0167002			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861617	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300143
J	Xu, HM; Cai, SY; Dai, HB				Xu, Huimin; Cai, Siyu; Dai, Haibin			Characteristics of Infective Endocarditis in a Tertiary Hospital in East China	PLOS ONE			English	Article							DEVELOPING-COUNTRY; DIAGNOSIS; EPIDEMIOLOGY; PREVENTION; MANAGEMENT; ADULTS; MULTICENTER; GUIDELINES; PREDICTORS; MORTALITY	The epidemiology, clinical presentation, and treatment of infective endocarditis (IE) has significantly changed over the past few years in developed countries. However, relevant data from developing countries are different and remain scarce. The objective of this study was to evaluate the clinical presentations, treatment and outcomes of IE patients in a tertiary hospital in East China over an 8-year period. This was a retrospective observational study of consecutive cases of definite or possible IE as per the modified Duke criteria between January 2008 and December 2015. A total of 135 definite and 39 probable IE cases were identified. The mean age was 47.8 +/- 15.7 years, with a male preponderance (1.9: 1). Degenerative valve disease accounted for 30.5% cases of IE, followed by congenital heart disease (29.9%) and rheumatic heart disease (14.9%). Native cardiac valves were present in 93.7% of the IE patients. Echocardiography and blood culture were performed in all patients, of whom 55.2% were found to have large vegetations (>= 10 mm) and the positive rate of blood culture was 60.3%. Streptococcus remained the chief causative agent that was identified in 61.9% of culture-positive patients. Glycopeptide antibacterials and cephalosporins were the most frequently used antimicrobial drugs for IE therapy. Seventy-six (43.7%) of the IE patients were surgically treated. The mortality rate during hospital stay was 10.9%. Our data reflected clinical and microbiological profile, and treatment of IE in a tertiary hospital located in the East China.	[Xu, Huimin; Dai, Haibin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pharm, Hangzhou, Zhejiang, Peoples R China; [Cai, Siyu] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Dai, HB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pharm, Hangzhou, Zhejiang, Peoples R China.	haibindai@zju.edu.cn		Dai, Haibin/0000-0002-5768-2714	Health Bureau of Zhejiang Provincial [2014KYB104, 2014RCA008, 2015KYB170]; Zhejiang Provincial Natural Science Foundation of China [LY15H310006, Y16H310002, LQ16H310001]	Health Bureau of Zhejiang Provincial; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by the research grants from the Health Bureau of Zhejiang Provincial (2014KYB104, 2014RCA008, 2015KYB170), and the foundation from the Zhejiang Provincial Natural Science Foundation of China (LY15H310006, Y16H310002, LQ16H310001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bin Abdulhak AA, 2014, GLOB HEART, V9, P131, DOI 10.1016/j.gheart.2014.01.002; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hase R, 2015, INT J INFECT DIS, V33, P62, DOI 10.1016/j.ijid.2015.01.003; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Leblebicioglu H, 2006, EUR J EPIDEMIOL, V21, P25, DOI 10.1007/s10654-005-4724-2; Letaief A, 2007, INT J INFECT DIS, V11, P430, DOI 10.1016/j.ijid.2006.10.006; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Li L, 2014, TEX HEART I J, V41, P491, DOI 10.14503/THIJ-13-3468; Math RS, 2011, AM HEART J, V162, P633, DOI 10.1016/j.ahj.2011.07.014; Mirabel M, 2015, INT J CARDIOL, V180, P270, DOI 10.1016/j.ijcard.2014.11.184; Munoz P, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001816; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nkomo VT, 2007, HEART, V93, P1510, DOI 10.1136/hrt.2007.118810; Pant S, 2015, J AM COLL CARDIOL, V65, P2070, DOI 10.1016/j.jacc.2015.03.518; Thuny F, 2014, CAN J CARDIOL, V30, P1046, DOI 10.1016/j.cjca.2014.03.042; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Wang WS, 2014, CARDIOLOGY, V128, P88, DOI 10.1159/000358040; Yang FF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.38; Zhu L, 2005, INT DENT J, V55, P231, DOI 10.1111/j.1875-595X.2005.tb00321.x	25	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166764	10.1371/journal.pone.0166764	http://dx.doi.org/10.1371/journal.pone.0166764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861628	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300104
J	Masuda, K; Kitakami, J; Kozasa, T; Kodama, T; Ihara, S; Hamakubo, T				Masuda, Kazuyuki; Kitakami, Jun-ichi; Kozasa, Tohru; Kodama, Tatsuhiko; Ihara, Sigeo; Hamakubo, Takao			Visualization of ligand-induced Gi-protein activation in chemotaxing cells	FASEB JOURNAL			English	Article						FRET; GPCR; heterotrimeric G protein; HL-60; RGS	COUPLED RECEPTOR ACTIVATION; RESONANCE ENERGY-TRANSFER; LEUKOTRIENE B-4 RECEPTOR; LIVING CELLS; LIVE CELLS; CHEMOATTRACTANT RECEPTOR; LIPID MEDIATORS; REGULATORS; MEMBRANE; ALPHA	Cell migration to chemoattractants is critically important in both normal physiology and the pathogenesis of many diseases. In GPCR-mediated chemotaxis, GPCRs transduce the gradient of an extracellular chemotactic ligand into intracellular responses via the activation of heterotrimeric G proteins. However, ligand-induced G protein activation has not been directly imaged as yet in mammalian chemotaxing cells. We developed a Forster resonance energy transfer (FRET) probe (R10-Gi) by linking the Gi protein ? subunit to the regulator of G protein signaling domain. The R10-Gi probe was coupled with a chemoattractant leukotriene B4 (LTB4) receptor 1 (BLT1) that induced the receptor to display a high-affinity ligand binding activity (Kd = 0.91 nM) in HEK293 cells. The R10-Gi probe exhibited an increased FRET signal in accord with the LTB4-dependent activation of Gi. Furthermore, neutrophil-like differentiated human leukemia cell line 60 that expressed the intrinsic BLT1 displayed temporal Gi protein activation in an area localized to the leading edge during chemotaxis in a shallow gradient of LTB4. These findings afford an opportunity to clarify the mechanisms underlying the subcellular regulation of Gi protein activity, as well as GPCR-mediated ligand sensing, during chemotaxis in mammalian cells.Masuda, K., Kitakami, J., Kozasa, T., Kodama, T., Ihara, S., Hamakubo, T. Visualization of ligand-induced Gi protein activation in chemotaxing cells.	[Masuda, Kazuyuki; Kozasa, Tohru; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Kitakami, Jun-ichi; Kodama, Tatsuhiko; Ihara, Sigeo] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Hamakubo, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	hamakubo@qbm.rcast.u-tokyo.ac.jp		Masuda, Kazuyuki/0000-0003-3813-8550	New Antibody Technologies of New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP);  [21790239];  [20221010]	New Antibody Technologies of New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP); ; 	The authors thank M. Matsuda (Kyoto University, Kyoto, Japan) for advice and technical training, and H. Tamaru (University of Tokyo), N. Mochizuki (National Cerebral and Cardiovascular Center, Osaka, Japan), and the members of our laboratories for helpful comments. The authors are grateful to K. Boru ( Pacific Edit, San Francisco, CA, USA) for review of the article. This work was supported, in part, by research grants from the New Antibody Technologies of New Energy and Industrial Technology Development Organization (NEDO) of Japan; the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP); JSPS Grant-in-Aid for Scientific Research 21790239; and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research 20221010.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Byrne MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085726; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Clister T, 2015, J BIOL CHEM, V290, P6681, DOI 10.1074/jbc.R114.616391; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Di Gennaro A, 2012, ADV IMMUNOL, V116, P51, DOI 10.1016/B978-0-12-394300-2.00002-8; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hwang IY, 2015, J IMMUNOL, V194, P2128, DOI 10.4049/jimmunol.1401952; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lambert NA, 2012, P NATL ACAD SCI USA, V109, P2175, DOI 10.1073/pnas.1200427109; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Smith B, 2009, CELL SIGNAL, V21, P1151, DOI 10.1016/j.cellsig.2009.03.004; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Terai K, 2006, EMBO J, V25, P3556, DOI 10.1038/sj.emboj.7601241; Tyson RA, 2010, MATH MODEL NAT PHENO, V5, P34, DOI 10.1051/mmnp/20105102; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078; Zabel BA, 2015, ANNU REV PATHOL-MECH, V10, P51, DOI 10.1146/annurev-pathol-012513-104640; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085; ZIGMOND SH, 1989, AM J RESP CELL MOL, V1, P451, DOI 10.1165/ajrcmb/1.6.451	45	2	2	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					910	+		10.1096/fj.201601102R	http://dx.doi.org/10.1096/fj.201601102R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27881485				2022-12-26	WOS:000395671200008
J	Yasuda, H; Oh, CD; Chen, D; de Crombrugghe, B; Kim, JH				Yasuda, Hideyo; Oh, Chun-do; Chen, Di; de Crombrugghe, Benoit; Kim, Jin-Hoi			A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; SOX9; CHONDROGENESIS; MUTATIONS; CARTILAGE; COL2A1; DIFFERENTIATION	Type II collagen alpha 1 is specific for cartilaginous tissues, and mutations in its gene are associated with skeletal diseases. Its expression has been shown to be dependent on SOX9, a master transcription factor required for chondrogenesis that binds to an enhancer region in intron 1. However, ChIP sequencing revealed that SOX9 does not strongly bind to intron 1, but rather it binds to intron 6 and a site 30 kb upstream of the transcription start site. Here, we aimed to determine the role of the novel SOX9-binding site in intron 6. We prepared reporter constructs that contain a Col2a1 promoter, intron 1 with or without intron 6, and the luciferase gene. Although the reporter constructs were not activated by SOX9 alone, the construct that contained both introns 1 and 6 was activated 5-10-fold by the SOX9/SOX5 or the SOX9/SOX6 combination in transient-transfection assays in 293T cells. This enhancement was also observed in rat chondrosarcoma cells that stably expressed the construct. CRISPR/Cas9-induced deletion of intron 6 in RCS cells revealed that a 10-bp region of intron 6 is necessary both for Col2a1 expression and SOX9 binding. Furthermore, SOX9, but not SOX5, binds to this region as demonstrated in an electrophoretic mobility shift assay, although both SOX9 and SOX5 bind to a larger 325-bp fragment of intron 6 containing this small sequence. These findings suggest a novel mechanism of action of SOX5/6; namely, the SOX9/5/6 combination enhances Col2a1 transcription through a novel enhancer in intron 6 together with the enhancer in intron 1.	[Yasuda, Hideyo; Kim, Jin-Hoi] Konkuk Univ, Dept Stem Cell & Regenerat Biol, Seoul 05029, South Korea; [Yasuda, Hideyo; Oh, Chun-do; de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Oh, Chun-do; Chen, Di] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA	Konkuk University; University of Texas System; UTMD Anderson Cancer Center; Rush University	Yasuda, H; Kim, JH (corresponding author), Konkuk Univ, Dept Stem Cell & Regenerat Biol, Seoul 05029, South Korea.; Yasuda, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	h-yasuda@yk9.so-net.ne.jp; jhkim541@konkuk.ac.kr	Chen, Di/AAJ-3665-2021	Oh, Chundo/0000-0002-5419-8011; kim, jin-hoi/0000-0003-1232-5307	Science Research Center from the National Research Foundation of Korea, Republic of Korea [2015R1A 5A1009701]	Science Research Center from the National Research Foundation of Korea, Republic of Korea	This work was supported by the Science Research Center (2015R1A 5A1009701) from the National Research Foundation of Korea, Republic of Korea. The authors declare that they have no conflict of interest with the contents of this article.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi Q, 2001, APPL BIOCHEM BIOTECH, V95, P23, DOI 10.1385/ABAB:95:1:23; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Coustry F, 2010, NUCLEIC ACIDS RES, V38, P6018, DOI 10.1093/nar/gkq417; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hattori T, 2013, J BIOL CHEM, V288, P35138, DOI 10.1074/jbc.M113.486795; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Oh CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143156; Oh CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107577; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richards AJ, 2000, BRIT J OPHTHALMOL, V84, P364, DOI 10.1136/bjo.84.4.364; Shinomura T, 2012, J BIOCHEM, V152, P565, DOI 10.1093/jb/mvs110; Su PQ, 2008, ARTHRITIS RHEUM-US, V58, P1701, DOI 10.1002/art.23491; Takigawa Y, 2010, J CELL SCI, V123, P3780, DOI 10.1242/jcs.071373; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Yasuda H, 2016, J GENET GENOMICS, V43, P705, DOI 10.1016/j.jgg.2016.10.006	33	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					528	538		10.1074/jbc.M116.758425	http://dx.doi.org/10.1074/jbc.M116.758425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27881681	hybrid, Green Published			2022-12-26	WOS:000392316100010
J	Klemens, CA; Edinger, RS; Kightlinger, L; Liu, XN; Butterworth, MB				Klemens, Christine A.; Edinger, Robert S.; Kightlinger, Lindsay; Liu, Xiaoning; Butterworth, Michael B.			Ankyrin G Expression Regulates Apical Delivery of the Epithelial Sodium Channel (ENaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL INITIAL SEGMENT; VOLTAGE-GATED SODIUM; COLLECTING DUCT; LATERAL MEMBRANE; NA+ CHANNEL; INTERCALATED DISC; PROTEIN-KINASE; ALPHA-SUBUNIT; BETA-SUBUNIT; E-CADHERIN	The epithelial sodium channel (ENaC) is the limiting entry point for Na+ reabsorption in the distal kidney nephron and is regulated by numerous hormones, including the mineralocorticoid hormone aldosterone. Previously we identified ankyrin G (AnkG), a cytoskeletal protein involved in vesicular transport, as a novel aldosterone-induced protein that can alter Na+ transport in mouse cortical collecting duct cells. However, the mechanisms underlying AnkG regulation of Na+ transport were unknown. Here we report that AnkG expression directly regulates Na+ transport by altering ENaC activity in the apical membrane. Increasing AnkG expression increased ENaC activity while depleting AnkG reduced ENaC-mediated Na+ transport. These changes were due to a change in ENaC directly rather than through alterations to the Na+ driving force created by Na+ /K+-ATPase. Using a constitutively open mutant of ENaC, we demonstrate that the augmentation of Na+ transport is caused predominantly by increasing the number of ENaCs at the surface. To determine the mechanism of AnkG action on ENaC surface number, changes in rates of internalization, recycling, and membrane delivery were investigated. AnkG did not alter ENaC delivery to the membrane from biosynthetic pathways or removal by endocytosis. However, AnkG did alter ENaC insertion from constitutive recycling pathways. These findings provide a mechanism to account for the role of AnkG in the regulation of Na+ transport in the distal kidney nephron.	[Klemens, Christine A.; Edinger, Robert S.; Kightlinger, Lindsay; Liu, Xiaoning; Butterworth, Michael B.] Univ Pittsburgh, Dept Cell Biol, Sch Med, S314 BST,200 Lothrop St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Butterworth, MB (corresponding author), Univ Pittsburgh, Dept Cell Biol, Sch Med, S314 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	michael7@pitt.edu	Klemens, Christine Anne/GXG-6739-2022; Klemens, Christine A./U-5520-2019	Klemens, Christine A./0000-0002-0812-824X	NIDDK, National Institutes of Health [DK102843]; American Heart Association [PRE25680068]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK102843] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant DK102843 (to M. B. B.) and Predoctoral Grant PRE25680068 from the American Heart Association (to C. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; Doctor RB, 1998, AM J PHYSIOL-RENAL, V274, pF129, DOI 10.1152/ajprenal.1998.274.1.F129; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Erlij D, 1999, PFLUG ARCH EUR J PHY, V438, P195, DOI 10.1007/s004240050898; GARVIN JL, 1985, J MEMBRANE BIOL, V87, P45, DOI 10.1007/BF01870698; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Liu X, 2008, J BIOL CHEM, V283, P11461, DOI 10.1074/jbc.M706942200; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; Lorenzo DN, 2014, J CELL BIOL, V207, P735, DOI 10.1083/jcb.201407063; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Luft Friedrich C, 2003, Clin Med Res, V1, P291; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Montersino A, 2014, J NEUROCHEM, V131, P33, DOI 10.1111/jnc.12785; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1417, DOI 10.1152/ajpcell.1995.269.6.C1417; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; ROTIN D, 1994, AM J PHYSIOL, V267, pL263, DOI 10.1152/ajplung.1994.267.3.L263; San-Cristobal P, 2014, KIDNEY INT, V85, P94, DOI 10.1038/ki.2013.280; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V344, P651, DOI 10.1016/j.bbrc.2006.03.160; Schafer JA, 2002, AM J PHYSIOL-RENAL, V283, pF221, DOI 10.1152/ajprenal.00068.2002; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; SHIBAYAMA T, 1993, CELL STRUCT FUNCT, V18, P79, DOI 10.1247/csf.18.79; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Stankewich MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142687; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Xu MX, 2015, J BIOL CHEM, V290, P16619, DOI 10.1074/jbc.M115.638932; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	64	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					375	385		10.1074/jbc.M116.753616	http://dx.doi.org/10.1074/jbc.M116.753616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895120	Green Published, hybrid			2022-12-26	WOS:000391578000032
J	Lin, SC; Lu, S; Mulaj, M; Fang, B; Keeley, T; Wan, LX; Hao, JH; Muschol, M; Sun, JW; Yang, SY				Lin, Shengchen; Lu, Shuang; Mulaj, Mentor; Fang, Bin; Keeley, Tyler; Wan, Lixin; Hao, Jihui; Muschol, Martin; Sun, Jianwei; Yang, Shengyu			Monoubiquitination Inhibits the Actin Bundling Activity of Fascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROGNOSTIC VALUE; BREAST-CANCER; CROSS-LINKER; FSCN2 GENE; PROTEIN; IMMUNOREACTIVITY; EXPRESSION; MECHANISM; INVASION; MOTILITY	Fascin is an actin bundling protein that cross-links individual actin filaments into straight, compact, and stiff bundles, which are crucial for the formation of filopodia, stereocillia, and other finger-like membrane protrusions. The dysregulation of fascin has been implicated in cancer metastasis, hearing loss, and blindness. Here we identified monoubiquitination as a novel mechanism that regulates fascin bundling activity and dynamics. The monoubiquitination sites were identified to be Lys247 and Lys250, two residues located in a positive charge patch at the actin binding site 2 of fascin. Using a chemical ubiquitination method, we synthesized chemically monoubiquitinated fascin and determined the effects of monoubiquitination on fascin bundling activity and dynamics. Our data demonstrated that monoubiquitination decreased the fascin bundling EC50, delayed the initiation of bundle assembly, and accelerated the disassembly of existing bundles. By analyzing the electrostatic properties on the solvent-accessible surface of fascin, we proposed that monoubiquitination introduced steric hindrance to interfere with the interaction between actin filaments and the positively charged patch at actin binding site 2. We also identified Smurf1 as a E3 ligase regulating the monoubiquitination of fascin. Our findings revealed a previously unidentified regulatory mechanism for fascin, which will have important implications for the understanding of actin bundle regulation under physiological and pathological conditions.	[Lin, Shengchen; Lu, Shuang; Keeley, Tyler; Sun, Jianwei; Yang, Shengyu] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Wan, Lixin] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Fang, Bin; Muschol, Martin] H Lee Moffitt Canc Ctr & Res Inst, Dept Prote, Tampa, FL 33612 USA; [Mulaj, Mentor] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Keeley, Tyler] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA; [Sun, Jianwei] South China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Hao, Jihui] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Pancreat Canc, Tianjin 300060, Peoples R China; [Lin, Shengchen; Yang, Shengyu] Penn State Coll Med, Dept Cellular & Mol Physiol, MC H166,500 Univ Dr, Hershey, PA 17033 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; South China Agricultural University; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yang, SY (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, MC H166,500 Univ Dr, Hershey, PA 17033 USA.; Sun, JW (corresponding author), 483 Wushan Rd, Guangzhou 510642, Guangdong, Peoples R China.	jwsun@scau.edu.cn; syang2@hmc.psu.edu	wan, li/GRY-7634-2022; Lin, Shengchen/T-3529-2018	Lin, Shengchen/0000-0003-1488-8680; Muschol, Martin/0000-0002-6488-0049	National Institutes of Health [R01CA175741]; National Natural Science Foundation of China [81572618, 31671448]; National Cancer Institute [P30 CA076292]; NATIONAL CANCER INSTITUTE [R01CA175741, P30CA076292, R00CA183914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health Grant R01CA175741 and National Natural Science Foundation of China Grants 81572618 and 31671448. The core facilities at the Moffitt Cancer Center are supported in part by the Cancer Center Support Grant P30 CA076292 from the National Cancer Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-241; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Hwang P, 2015, CELL REP, V13, P1287, DOI 10.1016/j.celrep.2015.10.003; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Kanda Y, 2014, PROTEOMICS, V14, P1031, DOI 10.1002/pmic.201300414; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Li A, 2014, GASTROENTEROLOGY, V146, P1386, DOI 10.1053/j.gastro.2014.01.046; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin-Jones J, 2007, INVEST OPHTH VIS SCI, V48, P1380, DOI 10.1167/iovs.06-0763; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mulaj M, 2014, J AM CHEM SOC, V136, P8947, DOI 10.1021/ja502529m; Ono S, 1997, J BIOL CHEM, V272, P2527; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Perrin BJ, 2013, J NEUROSCI, V33, P8114, DOI 10.1523/JNEUROSCI.0238-13.2013; Puppa G, 2007, BRIT J CANCER, V96, P1118, DOI 10.1038/sj.bjc.6603690; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Sun JW, 2013, J BIOL CHEM, V288, P36971, DOI 10.1074/jbc.M113.506535; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wada Y, 2003, ARCH OPHTHALMOL-CHIC, V121, P1613, DOI 10.1001/archopht.121.11.1613; Wada Y, 2001, INVEST OPHTH VIS SCI, V42, P2395; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Yokokura S, 2005, INVEST OPHTH VIS SCI, V46, P2905, DOI 10.1167/iovs.04-0856; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009	40	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27323	27333		10.1074/jbc.M116.767640	http://dx.doi.org/10.1074/jbc.M116.767640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27879315	hybrid, Green Published			2022-12-26	WOS:000391576300029
J	Baehr, CA; Huntoon, CJ; Hoang, SM; Jerde, CR; Karnitz, LM				Baehr, Carly A.; Huntoon, Catherine J.; Hoang, Song-My; Jerde, Calvin R.; Karnitz, Larry M.			Glycogen Synthase Kinase 3 (GSK-3)-mediated Phosphorylation of Uracil N-Glycosylase 2 (UNG2) Facilitates the Repair of Floxuridine-induced DNA Lesions and Promotes Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; REPLICATION; 5-FLUOROURACIL; CANCER; DEGRADATION; EXPRESSION; BETA; LOCALIZATION; ASSOCIATION; SEPARATION	Uracil N-glycosylase 2 (UNG2), the nuclear isoform of UNG, catalyzes the removal of uracil or 5-fluorouracil lesions that accumulate in DNA following treatment with the anticancer agents 5-fluorouracil and 5-fluorodeoxyuridine (floxuridine), a 5-fluorouracil metabolite. By repairing these DNA lesions before they can cause cell death, UNG2 promotes cancer cell survival and is therefore critically involved in tumor resistance to these agents. However, the mechanisms by which UNG2 is regulated remain unclear. Several phosphorylation sites within the N-terminal regulatory domain of UNG2 have been identified, although the effects of these modifications on UNG2 function have not been fully explored, nor have the identities of the kinases involved been determined. Here we show that glycogen synthase kinase 3 (GSK-3) interacts with and phosphorylates UNG2 at Thr(60) and that Thr(60) phosphorylation requires a Ser(64) priming phosphorylation event. We also show that mutating Thr(60) or Ser(64) to Ala increases the half-life of UNG2, reduces the rate of in vitro uracil excision, and slows UNG2 dissociation from chromatin after DNA replication. Using an UNG2-deficient ovarian cancer cell line that is hypersensitive to floxuridine, we show that GSK-3 phosphorylation facilitates UNG2-dependent repair of floxuridine-induced DNA lesions and promotes tumor cell survival following exposure to this agent. These data suggest that GSK-3 regulates UNG2 and promotes DNA damage repair.	[Baehr, Carly A.; Huntoon, Catherine J.; Hoang, Song-My; Jerde, Calvin R.; Karnitz, Larry M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Karnitz, Larry M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA; [Huntoon, Catherine J.; Karnitz, Larry M.] Mayo Clin, Div Oncol Res, Gonda 19-300,200 First St SW, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-300,200 First St SW, Rochester, MN 55905 USA.	karnitz.larry@mayo.edu	Jerde, Calvin/Q-6890-2017	Jerde, Calvin/0000-0003-3138-4759; Baehr, Carly/0000-0002-3395-6776	National Institutes of Health T32 Training Grant [GM72474]; Mayo Clinic Ovarian Cancer SPORE Grant [P50 CA136393]; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE [P50CA136393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Ovarian Cancer SPORE Grant; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health T32 Training Grant GM72474, Mayo Clinic Ovarian Cancer SPORE Grant P50 CA136393, and a grant from the Fred C. and Katherine B. Andersen Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Al-Zain A, 2015, MOL BIOL CELL, V26, P2609, DOI 10.1091/mbc.E14-07-1213; An Q, 2007, CANCER RES, V67, P940, DOI 10.1158/0008-5472.CAN-06-2960; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bulgar AD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.135; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dong QM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150234; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Fu YF, 2014, ONCOTARGETS THER, V7, P1159, DOI 10.2147/OTT.S62158; Geng LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028862; Grogan BC, 2011, BIOCHEMISTRY-US, V50, P618, DOI 10.1021/bi102046h; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Huehls AM, 2016, MOL PHARMACOL, V89, P53, DOI 10.1124/mol.115.100164; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Li DS, 2006, CELL RES, V16, P609, DOI 10.1038/sj.cr.7310082; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Luo Y, 2008, DNA REPAIR, V7, P162, DOI 10.1016/j.dnarep.2007.09.001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Nagaria P, 2013, MUTAT RES-FUND MOL M, V743, P26, DOI 10.1016/j.mrfmmm.2012.12.001; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Weeks LD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.477; Weeks LD, 2013, MOL CANCER THER, V12, P2248, DOI 10.1158/1535-7163.MCT-13-0172; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Welcker M, 2011, MOL CELL BIOL, V31, P1214, DOI 10.1128/MCB.01347-10; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	48	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26875	26885		10.1074/jbc.M116.746081	http://dx.doi.org/10.1074/jbc.M116.746081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875297	hybrid, Green Published			2022-12-26	WOS:000391571400024
J	Cui, ZH; Stevens, J; Truesdale, KP; Zeng, DL; French, S; Gordon-Larsen, P				Cui, Zhaohui; Stevens, June; Truesdale, Kimberly P.; Zeng, Donglin; French, Simone; Gordon-Larsen, Penny			Prediction of Body Mass Index Using Concurrently Self-Reported or Previously Measured Height and Weight	PLOS ONE			English	Article							ADOLESCENT OBESITY; VALIDITY; PREVALENCE; EQUATIONS; STATE	Objective To compare alternative models for the imputation of BMIM (measured weight in kilograms/measured height in meters squared) in a longitudinal study. Methods We used data from 11,008 adults examined at wave III (2001-2002) and wave IV (2007-2008) in the National Longitudinal Study of Adolescent to Adult Health. Participants were asked their height and weight before being measured. Equations to predict wave IV BMIM were developed in an 80% random subsample and evaluated in the remaining participants. The validity of models that included BMI constructed from previously measured height and weight (BMIPM) was compared to the validity of models that used BMI calculated from concurrently self-reported height and weight (BMISR). The usefulness of including demographics and perceived weight category in those models was also examined. Results The model that used BMISR, compared to BMIPM, as the only variable produced a larger R-2 (0.913 vs. 0.693), a smaller root mean square error (2.07 vs. 3.90 kg/m(2)) and a lower bias between normal-weight participants and those with obesity (0.98 vs. 4.24 kg/m(2)). The performance of the model containing BMISR alone was not substantially improved by the addition of demographics, perceived weight category or BMIPM. Conclusions Our work is the first to show that concurrent self-reports of height and weight may be more useful than previously measured height and weight for imputation of missing BMIM when the time interval between measures is relatively long. Other time frames and alternatives to inperson collection of self-reported data need to be examined.	[Cui, Zhaohui; Stevens, June; Truesdale, Kimberly P.; Gordon-Larsen, Penny] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA; [Stevens, June] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Zeng, Donglin] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [French, Simone] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Cui, ZH (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA.	cuiz@email.unc.edu		French, Simone/0000-0003-3413-5985	National Heart, Lung, And Blood Institute [1U01HL103561]; Eunice Kennedy Shriver National Institute of Child Health and Development [P01-HD31921]; Office of Behavioral and Social Sciences Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057194, P2CHD050924, P01HD031921] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Award Number 1U01HL103561 from the National Heart, Lung, And Blood Institute, the Eunice Kennedy Shriver National Institute of Child Health and Development and the Office of Behavioral and Social Sciences Research. The funder had no role in the design, analysis, or writing of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.; This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Burke G L, 1996, Ethn Health, V1, P327; Connor Gorber Sarah, 2008, Health Rep, V19, P71; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Harris KM, RES DESIGN; Hayes AJ, 2008, AUST NZ J PUBL HEAL, V32, P542, DOI 10.1111/j.1753-6405.2008.00306.x; Jain RB, 2010, INT J OBESITY, V34, P1655, DOI 10.1038/ijo.2010.80; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Paeratakul S, 2002, OBES RES, V10, P345, DOI 10.1038/oby.2002.48; Plankey MW, 1997, OBES RES, V5, P308, DOI 10.1002/j.1550-8528.1997.tb00556.x; Popkin BM, 1998, J NUTR, V128, P701, DOI 10.1093/jn/128.4.701; Pursey K, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2909; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schenker N, 2010, STAT MED, V29, P533, DOI 10.1002/sim.3809; Scribani M, 2014, JRSM OPEN, V5; Shields Margot, 2011, Health Rep, V22, P35; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Wen M, ETHN DIS, V22, P72; WHO Consultation on Obesity, 2000, OB PREV MAN GLOB EP, P9	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167288	10.1371/journal.pone.0167288	http://dx.doi.org/10.1371/journal.pone.0167288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898706	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474000047
J	Estensoro, I; Ballester-Lozano, G; Benedito-Palos, L; Grammes, F; Martos-Sitcha, JA; Mydland, LT; Calduch-Giner, JA; Fuentes, J; Karalazos, V; Ortiz, A; Overland, M; Sitja-Bobadilla, A; Perez-Sanchez, J				Estensoro, Itziar; Ballester-Lozano, Gabriel; Benedito-Palos, Laura; Grammes, Fabian; Martos-Sitcha, Juan Antonio; Mydland, Liv-Torunn; Calduch-Giner, Josep Alvar; Fuentes, Juan; Karalazos, Vasileios; Ortiz, Alvaro; Overland, Margareth; Sitja-Bobadilla, Ariadna; Perez-Sanchez, Jaume			Dietary Butyrate Helps to Restore the Intestinal Status of a Marine Teleost (Sparus aurata) Fed Extreme Diets Low in Fish Meal and Fish Oil	PLoS One			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; MEAGER ARGYROSOMUS-REGIUS; ATLANTIC SALMON; SOYBEAN-MEAL; GROWTH-PERFORMANCE; INDUCED ENTERITIS; ALKALINE-PHOSPHATASE; COMBINED REPLACEMENT; DIGESTIVE ENZYMES	There is a constant need to find feed additives that improve health and nutrition of farmed fish and lessen the intestinal inflammation induced by plant-based ingredients. The objective of this study was to evaluate the effects of adding an organic acid salt to alleviate some of the detrimental effects of extreme plant-ingredient substitution of fish meal (FM) and fish oil (FO) in gilthead sea bream diet. Three experiments were conducted. In a first trial (T1), the best dose (0.4%) of sodium butyrate (BP-70 (R) NOREL) was chosen after a short (9 weeks) feeding period. In a second longer trial (T2) (8 months), four diets were used: a control diet containing 25% FM (T2-D1) and three experimental diets containing 5% FM (T2-D2, T2-D3, T2-D4). FO was the only added oil in D1, while a blend of plant oils replaced 58% and 84% of FO in T2-D2, and T2-D3 and T2-D4, respectively. The latter was supplemented with 0.4% BP-70. In a third trial (T3), two groups of fish were fed for 12 and 38 months with D1, D3 and D4 diets of T2. The effects of dietary changes were studied using histochemical, immunohistochemical, molecular and electrophysiological tools. The extreme diet (T2-D3) modified significantly the transcriptomic profile, especially at the anterior intestine, up-regulating the expression of inflammatory markers, in coincidence with a higher presence of granulocytes and lymphocytes in the submucosa, and changing genes involved in antioxidant defences, epithelial permeability and mucus production. Trans-epithelial electrical resistance (Rt) was also decreased (T3-D3). Most of these modifications were returned to control values with the addition of BP-70. None of the experimental diets modified the staining pattern of PCNA, FABP2 or ALPI. These results further confirm the potential of this additive to improve or reverse the detrimental effects of extreme fish diet formulations.	[Estensoro, Itziar; Sitja-Bobadilla, Ariadna] CSIC, IATS, Fish Pathol Grp, Castellon de La Plana, Spain; [Ballester-Lozano, Gabriel; Benedito-Palos, Laura; Martos-Sitcha, Juan Antonio; Calduch-Giner, Josep Alvar; Perez-Sanchez, Jaume] CSIC, IATS, Nutrigen & Fish Endocrinol Grp, Castellon de La Plana, Spain; [Grammes, Fabian; Mydland, Liv-Torunn; Overland, Margareth] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ass, Norway; [Fuentes, Juan] Univ Algarve, CCMar, Comparat Endocrinol & Integrat Biol, Faro, Portugal; [Karalazos, Vasileios] BioMar R&D, Grangemouth, Scotland; [Ortiz, Alvaro] Norel SA, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Norwegian University of Life Sciences; Universidade do Algarve	Perez-Sanchez, J (corresponding author), CSIC, IATS, Nutrigen & Fish Endocrinol Grp, Castellon de La Plana, Spain.	jaime.perez.sanchez@csic.es	Karalazos, Vasileios/AAI-7953-2020; Karalazos, Vasileios/AGR-7881-2022; Fuentes, Juan/I-6663-2013; Mydland, Liv Torunn/AAO-2783-2020; Calduch-Giner, Josep/K-8253-2014; Calduch-Giner, Josep/AAY-1475-2021; Sitjà-Bobadilla, Ariadna/J-2715-2014; sanchez, jaume perez/K-3231-2014; estensoro, itziar/AAX-4469-2020; Sánchez, Jaume Pérez/AAJ-6628-2021; Martos-Sitcha, Juan Antonio/L-6140-2014	Karalazos, Vasileios/0000-0002-4490-5499; Fuentes, Juan/0000-0003-0430-8734; Calduch-Giner, Josep/0000-0003-3124-5986; Calduch-Giner, Josep/0000-0003-3124-5986; Sitjà-Bobadilla, Ariadna/0000-0002-7473-3413; sanchez, jaume perez/0000-0003-2506-1523; estensoro, itziar/0000-0002-6218-2191; Sánchez, Jaume Pérez/0000-0003-2506-1523; Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Benedito-Palos, Laura/0000-0003-4726-4196; Grammes, Fabian/0000-0002-9551-9280	European Commission of the European Union, specific RTD Framework Programme 7, (FP7) [KBBE-2011-288925, 262336, 0044/03/04/14a, 652831, 0004/01-INTEBREAM]; Portuguese Foundation for Science and Technology (FCT) [PTDC/MARBIO/3034/2014]; FCT [UID/Multi/04326/2013]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2013-48560-R]; Generalitat Valenciana [PROMETEOII/2014/085]	European Commission of the European Union, specific RTD Framework Programme 7, (FP7); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work has been carried out with financial support from the European Commission of the European Union, specific RTD Framework Programme 7, (FP7/2007-2013) under grant projects ARRAINA (KBBE-2011-288925) to JPS, AO and VK, AQUAEXCEL (262336) under TNA project 0044/03/04/14a to FG, and AQUAEXCEL2020 (652831) under TNA project 0004/01-INTEBREAM to JF. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. JF was also funded by the Portuguese Foundation for Science and Technology (FCT) through Project PTDC/MARBIO/3034/2014. CCMar was supported by national funds from FCT through institutional project UID/Multi/04326/2013. Additional funding has been received by Spanish Ministry of Economy and Competitiveness (MINECO) project no. AGL2013-48560-R to JPS and ASB, and Generalitat Valenciana (PROMETE011/2014/085) to ASB. JAMS received a Postdoctoral Research Fellow (Juan de la Cierva-Formacion, Reference FJCI-2014-20161) from MINECO.	Andre M, 2000, INT J DEV BIOL, V44, P249; Martos-Sitcha JA, 2013, GEN COMP ENDOCR, V193, P221, DOI 10.1016/j.ygcen.2013.07.017; Baeza-Arino R, 2016, AQUAC RES, V47, P460, DOI 10.1111/are.12507; Bakke-McKellep AM, 2000, J FISH DIS, V23, P115, DOI 10.1046/j.1365-2761.2000.00218.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Ballester-Lozano GF, 2014, AQUACULT NUTR, V20, P421, DOI 10.1111/anu.12095; Beauvieux Marie-Christine, 2008, BMC Physiology, V8, P19, DOI 10.1186/1472-6793-8-19; Benedito-Palos L, 2007, AQUACULTURE, V267, P199, DOI 10.1016/j.aquaculture.2007.01.011; Benedito-Palos L, 2016, AQUACULTURE, V454, P8, DOI 10.1016/j.aquaculture.2015.12.008; Benedito-Palos L, 2009, AQUACULTURE, V288, P98, DOI 10.1016/j.aquaculture.2008.11.010; Boltana S, 2011, DEV COMP IMMUNOL, V35, P1195, DOI 10.1016/j.dci.2011.02.010; Castro C, 2016, FISH PHYSIOL BIOCHEM, V42, P203, DOI 10.1007/s10695-015-0130-1; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Ducasse-Cabanot S, 2007, ANIMAL, V1, P1272, DOI 10.1017/S1751731107000596; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; Fang CL, 2014, J ANIM PHYSIOL AN N, V98, P680, DOI 10.1111/jpn.12122; Firdaus-Nawi M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-611; Forlenza M, 2008, MOL IMMUNOL, V45, P1531, DOI 10.1016/j.molimm.2007.10.010; Gao YL, 2011, AQUACULTURE, V311, P233, DOI 10.1016/j.aquaculture.2010.11.048; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geurden I, 2009, COMP BIOCHEM PHYS A, V152, P552, DOI 10.1016/j.cbpa.2008.12.016; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Jiang Y, 2015, CAN J ANIM SCI, V95, P389, DOI [10.4141/CJAS-2014-183, 10.4141/cjas-2014-183]; Karalazos V, 2007, AQUACULT NUTR, V13, P256, DOI 10.1111/j.1365-2095.2007.00471.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Knudsen D, 2008, BRIT J NUTR, V100, P120, DOI 10.1017/S0007114507886338; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Liu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074581; Liu WS, 2014, BRIT J NUTR, V112, P15, DOI 10.1017/S0007114514000610; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Posadas R, 2011, INFLAMM BOWEL DIS, V17, P543, DOI 10.1002/ibd.21381; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Medale F, 2013, INRA PROD ANIM, V26, P303; Nascimento DS, 2007, MOL IMMUNOL, V44, P2277, DOI 10.1016/j.molimm.2006.11.006; Nasopoulou C, 2012, LWT-FOOD SCI TECHNOL, V47, P217, DOI 10.1016/j.lwt.2012.01.018; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Perez-Sanchez J, 2015, FISH SHELLFISH IMMUN, V44, P117, DOI 10.1016/j.fsi.2015.01.039; Regost C, 2003, AQUACULTURE, V217, P465, DOI 10.1016/S0044-8486(02)00259-4; Ribeiro L, 2015, AQUACULTURE, V447, P116, DOI 10.1016/j.aquaculture.2014.12.017; RIMOLDI S, 2015, J NUTR SCI, V4; Robles R, 2013, FISH PHYSIOL BIOCHEM, V39, P1567, DOI 10.1007/s10695-013-9809-3; Romarheim OH, 2013, AQUACULTURE, V402, P13, DOI 10.1016/j.aquaculture.2013.03.011; Romarheim OH, 2013, BRIT J NUTR, V109, P1062, DOI 10.1017/S0007114512002899; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; de Rodriganez MAS, 2013, FISH PHYSIOL BIOCHEM, V39, P1365, DOI 10.1007/s10695-013-9790-x; Simo-Mirabet P, 2016, AQ EUR AE 2016 ED SC, P166; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Terova G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160332; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; Venold FF, 2013, COMP BIOCHEM PHYS A, V164, P229, DOI 10.1016/j.cbpa.2012.09.009; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang L, 2014, DEV COMP IMMUNOL, V43, P54, DOI 10.1016/j.dci.2013.10.006; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Welch A, 2010, REV FISH SCI, V18, P235, DOI 10.1080/10641262.2010.504865; Zheng RG, 2009, EFFECT SODIUM BUTYRA	63	76	79	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166564	10.1371/journal.pone.0166564	http://dx.doi.org/10.1371/journal.pone.0166564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898676	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000389474000011
J	Silva, D; Olsen, KW; Bednarz, MN; Droste, A; Lenkeit, CP; Chaharbakhshi, E; Temple-Wood, ER; Jemc, JC				Silva, Diane; Olsen, Kenneth W.; Bednarz, Magdalena N.; Droste, Andrew; Lenkeit, Christopher P.; Chaharbakhshi, Edwin; Temple-Wood, Emily R.; Jemc, Jennifer C.			Regulation of Gonad Morphogenesis in Drosophila melanogaster by BTB Family Transcription Factors	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; AXON GUIDANCE GENE; POZ-DOMAIN; BALANCER CHROMOSOMES; MOLECULAR-DYNAMICS; CELL-MIGRATION; SALIVARY-GLAND; LOLA ENCODES; EXPRESSION; RIBBON	During embryogenesis, primordial germ cells (PGCs) and somatic gonadal precursor cells (SGPs) migrate and coalesce to form the early gonad. A failure of the PGCs and SGPs to form a gonad with the proper architecture not only affects germ cell development, but can also lead to infertility. Therefore, it is critical to identify the molecular mechanisms that function within both the PGCs and SGPs to promote gonad morphogenesis. We have characterized the phenotypes of two genes, longitudinals lacking (lola) and ribbon (rib), that are required for the coalescence and compaction of the embryonic gonad in Drosophila melanogaster. rib and lola are expressed in the SGPs of the developing gonad, and genetic interaction analysis suggests these proteins cooperate to regulate gonad development. Both genes encode proteins with DNA binding motifs and a conserved protein-protein interaction domain, known as the Broad complex, Tramtrack, Bric-a-brac (BTB) domain. Through molecular modeling and yeast-two hybrid studies, we demonstrate that Rib and Lola homoand heterodimerize via their BTB domains. In addition, analysis of the colocalization of Rib and Lola with marks of transcriptional activation and repression on polytene chromosomes reveals that Rib and Lola colocalize with both repressive and activating marks and with each other. While previous studies have identified Rib and Lola targets in other tissues, we find that Rib and Lola are likely to function via different downstream targets in the gonad. These results suggest that Rib and Lola act as dual-function transcription factors to cooperatively regulate embryonic gonad morphogenesis.	[Silva, Diane; Bednarz, Magdalena N.; Droste, Andrew; Lenkeit, Christopher P.; Chaharbakhshi, Edwin; Temple-Wood, Emily R.; Jemc, Jennifer C.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Olsen, Kenneth W.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Silva, Diane] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Bednarz, Magdalena N.] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA; [Droste, Andrew] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Lenkeit, Christopher P.; Temple-Wood, Emily R.] Midwestern Univ, Chicago Coll Osteopath Med, Downers Grove, IL 60515 USA; [Chaharbakhshi, Edwin] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA	Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; Central Michigan University; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; Loyola University Chicago	Jemc, JC (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jmierisch@luc.edu			Loyola University Chicago	Loyola University Chicago	DS KWO MNB AD CPL EC ERTW and JCJ were recipients of funding from Loyola University Chicago to support this research. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bartoletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049958; Bass BP, 2007, DEV BIOL, V304, P771, DOI 10.1016/j.ydbio.2007.01.029; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; BOYLE M, 1995, DEVELOPMENT, V121, P1815; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Cavarec L, 1997, MOL CELL BIOL, V17, P482, DOI 10.1128/MCB.17.1.482; Cheshire AM, 2008, DEV DYNAM, V237, P2874, DOI 10.1002/dvdy.21709; Crowner D, 2002, DEVELOPMENT, V129, P1317; Davies EL, 2013, DEV BIOL, V373, P310, DOI 10.1016/j.ydbio.2012.11.004; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Enuameh MS, 2013, GENOME RES, V23, P928, DOI 10.1101/gr.151472.112; Gates MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-37; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GODT D, 1993, DEVELOPMENT, V119, P799; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Henderson KD, 2000, DEV BIOL, V217, P362, DOI 10.1006/dbio.1999.9560; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; Horowitz H, 1996, DEVELOPMENT, V122, P1859; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Jack J, 1997, GENETICS, V147, P243; Jemc JC, 2012, DEV BIOL, V367, P114, DOI 10.1016/j.ydbio.2012.04.027; Jemc JC, 2011, GENESIS, V49, P753, DOI 10.1002/dvg.20784; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kerman BE, 2008, DEV BIOL, V320, P278, DOI 10.1016/j.ydbio.2008.05.541; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Loganathan R, 2016, DEV BIOL, V409, P234, DOI 10.1016/j.ydbio.2015.10.016; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ohsako T, 2003, GENE, V311, P59, DOI 10.1016/S0378-1119(03)00554-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rosbrook GO, 2012, ACTA CRYSTALLOGR D, V68, P26, DOI 10.1107/S0907444911048335; Sano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052649; Shim K, 2001, DEVELOPMENT, V128, P4923; Siggs OM, 2012, CELL CYCLE, V11, P3358, DOI 10.4161/cc.21277; SIMON J, 1990, EMBO J, V9, P3945, DOI 10.1002/j.1460-2075.1990.tb07615.x; Southall TD, 2014, DEV CELL, V28, P685, DOI 10.1016/j.devcel.2014.01.030; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Trappe R, 2002, BIOCHEM BIOPH RES CO, V296, P319, DOI 10.1016/S0006-291X(02)00850-1; Tripathy R, 2014, DEV BIOL, V392, P193, DOI 10.1016/j.ydbio.2014.05.026; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Zhang WG, 2003, J BIOL CHEM, V278, P11696, DOI 10.1074/jbc.M213269200; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	67	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167283	10.1371/journal.pone.0167283	http://dx.doi.org/10.1371/journal.pone.0167283			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898696	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474000046
J	Anibaldi, A; Franciosi, CB; Massari, F; Tinti, F; Piccinetti, C; Riccioni, G				Anibaldi, Alessandra; Franciosi, Claudia Benassi; Massari, Francesco; Tinti, Fausto; Piccinetti, Corrado; Riccioni, Giulia			Morphology and Species Composition of Southern Adriatic Sea Leptocephali Evaluated Using DNA Barcoding	PLOS ONE			English	Article							WESTERN NORTH; OTOLITH MICROSTRUCTURE; MURAENID LEPTOCEPHALI; ECOLOGICAL ASPECTS; EUROPEAN CONGER; EEL CONGER; IDENTIFICATION; LARVAE; ATLANTIC; PACIFIC	Leptocephali are the characteristic larvae of the superorder Elopomorpha that are difficult to identify at the species level. In this study, we used DNA barcoding (i.e. short genetic sequences of DNA used as unique species tags) coupled with classical taxonomic methods to identify leptocephali in the southern Adriatic Sea. This information will provide an assessment of the biodiversity of the eel larvae in this region. A total of 2,785 leptocephali were collected, and using external morphology were assigned to seven morphotypes: Ariosoma balearicum, Conger conger, Gnathophis mystax, Facciolella sp., Nettastoma melanurum, Dalophis imberbis and Chlopsis bicolor. Collectively, these seven morphotypes are considered to be a good proxy for the Anguilliformes community (the main order of the Elopomorpha) in the southern Adriatic Sea (to date, seven families and sixteen species have been recorded in this region). Interestingly, the higher number of G. mystax larvae collected suggests an increased abundance of this genus. To validate the morphological identifications, we sequenced 61 leptocephali (at a 655 bp fragment from the cytochrome oxidase subunit 1 mitochondrial region) and developed barcode vouchers for the seven morphotypes. Using genetic information from reference databases, we validated three of these morphotypes. Where reference sequences were unavailable, we generated barcodes for both adult and juvenile forms to provide additional genetic information. Using this integrated approach allowed us to characterize a new species of Facciolella in the Adriatic Sea for the first time. Moreover, we also revealed a lack of differentiation, at the species level, between G. mistax and G. bathytopos, a western Atlantic Ocean species. Our morphological and barcode data have been published in the Barcoding of the Adriatic Leptocephali database. This work represents the first contribution to a wider project that aims to create a barcode database to support the assessment of leptocephali diversity in the Mediterranean Sea.	[Anibaldi, Alessandra; Franciosi, Claudia Benassi; Tinti, Fausto; Piccinetti, Corrado; Riccioni, Giulia] Univ Bologna, Lab Marine Biol & Fishery, Dept Biol Geol & Environm Sci, Fano, PU, Italy; [Tinti, Fausto] Univ Bologna, Lab Genet & Genom Marine Resources & Environm Gen, Dept Biol Geol & Environm Sci, Ravenna, Italy	University of Bologna; University of Bologna	Tinti, F (corresponding author), Univ Bologna, Lab Marine Biol & Fishery, Dept Biol Geol & Environm Sci, Fano, PU, Italy.; Tinti, F (corresponding author), Univ Bologna, Lab Genet & Genom Marine Resources & Environm Gen, Dept Biol Geol & Environm Sci, Ravenna, Italy.	fausto.tinti@unibo.it	Tinti, Fausto/D-4847-2012; Massari, Francesco/K-7239-2016	Tinti, Fausto/0000-0002-8649-5387; Massari, Francesco/0000-0001-6476-6871; Riccioni, Giulia/0000-0003-3934-8840				Aboussouan A, 1990, GUIDE POUR LIDENTIFI; Aoyama J, 1999, MAR ECOL PROG SER, V188, P193, DOI 10.3354/meps188193; Aoyama J, 2000, T AM FISH SOC, V129, P873, DOI 10.1577/1548-8659(2000)129&lt;0873:DOCEOG&gt;2.3.CO;2; Baldassi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092721; Baldwin CC, 2011, ZOOTAXA, P1; Bauchot M.-L., 1986, P567; Bellotti C, 1883, ATTI SOC ITAL SCI NA, V26, P165; Blache J, 1977, FAUNE TROP; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Bohlke EB, 1989, SEARS FOUND MAR RES, V2, P657; Bohlke EB, 1989, SEARS FDN MARINE R 9, V1, P1; CASTLE P H J, 1968, Zoologica Africana, V3, P139; CASTLE P. H. J., 1963, ZOOL PUBL VICTORIA UNIV WELLINGTON, V33, P1; CASTLE PHJ, 1965, T ROY SOC NZ ZOOL, V7, P57; CASTLE PHJ, 1965, T ROY SOC NZ ZOOL, V5, P131; CASTLE PHJ, 1966, ARCH FISCHEREIWISS, V17, P19; CASTLE PHJ, 1965, T ROY SOC NZ ZOOL, V7, P97; CASTLE PHJ, 1970, ARCH FISCHEREIWISS, V21, P1; Chen JN, 2014, MOL PHYLOGENET EVOL, V70, P152, DOI 10.1016/j.ympev.2013.09.002; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Correia AT, 2003, MAR BIOL, V142, P777, DOI 10.1007/s00227-002-0993-4; Correia AT, 2002, MAR BIOL, V141, P1141, DOI 10.1007/s00227-002-0908-4; Correia AT, 2002, MAR BIOL, V140, P165, DOI 10.1007/s002270100678; D'Ancona U, 1931, FAUNA E FLORA DEL GO; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Fahay M.P., 1983, Journal of Northwest Atlantic Fishery Science, V4, P1; Fahay MP, 2007, EARLY STAGES OF FISH; Figueroa DE, 2006, B MAR SCI, V78, P227; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Froese R., 2021, FISHBASE WORLD WIDE; Grassi GB, 1913, METAMORFOSI DEI MURE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Triana LM, 2015, ZOOTAXA, V3936, P93, DOI 10.11646/zootaxa.3936.1.5; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Hulet WH, 1978, PHILOS TRANS R SOC L, V282, P107; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLECKNER RC, 1985, DANA-J FISH MAR RES, V4, P67; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Kurogi H, 2016, ICHTHYOL RES, V63, P239, DOI 10.1007/s10228-015-0492-5; Kuroki M, 2008, MAR FRESHWATER RES, V59, P1035, DOI 10.1071/MF08041; Lea E, 1913, REP SCI RES MICHAEL; Ma T, 2008, COAST MAR SCI, V32, P48; Ma T, 2007, FISHERIES SCI, V73, P989, DOI 10.1111/j.1444-2906.2007.01427.x; Melo MRS, 2009, ZOOTAXA, P1; Miller MJ, 2015, ICES J MAR SCI, V72, P1359, DOI 10.1093/icesjms/fsv034; Miller Michael J., 2013, Marine Biodiversity Records, V6, pe82, DOI 10.1017/S1755267213000079; Miller Michael J., 2012, Coastal Marine Science, V35, P277; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Miller MJ, 2002, ENVIRON BIOL FISH, V63, P235, DOI 10.1023/A:1014311429809; Miller MJ, 2004, AN INTRODUCTION TO L; MOCHIOKA N, 1991, B MAR SCI, V48, P606; Nelson JS, 2006, FISHES WORLD; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Puncher GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130407; Relini Giulio, 2010, Biologia Marina Mediterranea, V17, P649; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SMITH DG, 1977, B MAR SCI, V27, P530; Smith DG, 1989, LEPTOCEPHALI SEARS F, V2, P933; Smith DG, 1989, LEPTOCEPHALI SEARS F, V2, P723; Smith DG, 1979, NOAA NATL OCEANIC AT; Smith DG, 1989, FISHES W N ATLANTI 9, V1, P460; Stramigioli P, 2002, BIOL MAR MED, P420; Strehlow B, 1998, HELGOLANDER MEERESUN, V52, P85, DOI 10.1007/BF02908739; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tawa A, 2013, B MAR SCI, V89, P461, DOI 10.5343/bms.2012.1010; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Uiblein F, 2014, MAR BIOL RES, V10, P655, DOI 10.1080/17451000.2013.850515; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; VANUTRECHT WL, 1983, BIJDR DIERKD, V53, P227, DOI 10.1163/26660644-05302004; Varezic DB, 2013, J APPL ICHTHYOL, V29, P663, DOI 10.1111/jai.12125; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073	78	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166137	10.1371/journal.pone.0166137	http://dx.doi.org/10.1371/journal.pone.0166137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893773	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400017
J	Bankoglu, EE; Tschopp, O; Schmitt, J; Burkard, P; Jahn, D; Geier, A; Stopper, H				Bankoglu, Ezgi Eyluel; Tschopp, Oliver; Schmitt, Johannes; Burkard, Philipp; Jahn, Daniel; Geier, Andreas; Stopper, Helga			Role of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEME OXYGENASE-1; SKELETAL-MUSCLE; KIDNEY-CELLS; LIFE-STYLE; OBESITY; GROWTH; CANCER	Type 2 diabetes (T2DM) and obesity are frequently associated with non-alcoholic fatty liver disease (NAFLD) and with an elevated cancer incidence. The molecular mechanisms of carcinogenesis in this context are only partially understood. High blood insulin levels are typical in early T2DM and excessive insulin can cause elevated reactive oxygen species (ROS) production and genomic instability. ROS are important for various cellular functions in signaling and host defense. However, elevated ROS formation is thought to be involved in cancer induction. In the molecular events from insulin receptor binding to genomic damage, some signaling steps have been identified, pointing at the PI3K/AKT pathway. For further elucidation Phosphatase and Tensin homolog (Pten), a tumour suppressor phosphatase that plays a role in insulin signaling by negative regulation of PI3K/AKT and its downstream targets, was investigated here. Dihydroethidium (DHE) staining was used to detect ROS formation in immortalized human hepatocytes. Comet assay and micronucleus test were performed to investigate genomic damage in vitro. In liver samples, DHE staining and western blot detection of HSP70 and HO-1 were performed to evaluate oxidative stress response. DNA double strand breaks (DSBs) were detected by immunohistostaining. Inhibition of PTEN with the pharmacologic inhibitor VO-OHpic resulted in increased ROS production and genomic damage in a liver cell line. Knockdown of Pten in a mouse model yielded increased oxidative stress levels, detected by ROS levels and expression of the two stress-proteins HSP70 and HO-1 and elevated genomic damage in the liver, which was significant in mice fed with a high fat diet. We conclude that PTEN is involved in oxidative stress and genomic damage induction in vitro and that this may also explain the in vivo observations. This further supports the hypothesis that the PI3K/AKT pathway is responsible for damaging effects of high levels of insulin.	[Bankoglu, Ezgi Eyluel; Burkard, Philipp; Stopper, Helga] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Tschopp, Oliver; Geier, Andreas] Univ Zurich Hosp, Clin Endocrinol & Diabetol, Zurich, Switzerland; [Schmitt, Johannes; Jahn, Daniel; Geier, Andreas] Univ Hosp Wuerzburg, Dept Med 2, Div Hepatol, Wurzburg, Germany	University of Wurzburg; University of Zurich; University Zurich Hospital; University of Wurzburg	Stopper, H (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany.	stopper@toxi.uni-wuerzburg.de	Tschopp, Oliver/H-7545-2018; Bankoglu, Ezgi Eyluel/ABA-2543-2021	Bankoglu, Ezgi Eyluel/0000-0001-7488-6228; Tschopp, Oliver/0000-0002-7733-7934; Burkard, Philipp/0000-0001-9748-7967	European Foundation for the Study of Diabetes in the frame of the "Research Program in Diabetes and Cancer"; Open Access Publication Fund of the University of Wuerzburg	European Foundation for the Study of Diabetes in the frame of the "Research Program in Diabetes and Cancer"; Open Access Publication Fund of the University of Wuerzburg	This work was supported by the European Foundation for the Study of Diabetes in the frame of the "Research Program in Diabetes and Cancer" to AG and OT. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Brunt KR, 2006, ARTERIOSCL THROM VAS, V26, P2027, DOI 10.1161/01.ATV.0000236204.37119.8d; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Dato S, 2013, INT J MOL SCI, V14, P16443, DOI 10.3390/ijms140816443; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Li YR, 2011, J PATHOL, V224, P90, DOI 10.1002/path.2855; MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50; Marti A, INT J OBES RELAT MET, V28, pS29; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Othman EM, 2014, FREE RADICAL BIO MED, V68, P247, DOI 10.1016/j.freeradbiomed.2013.12.010; Othman EM, 2013, MUTAT RES-FUND MOL M, V745, P34, DOI 10.1016/j.mrfmmm.2013.03.006; Othman EM, 2013, ENDOCRINOLOGY, V154, P1434, DOI 10.1210/en.2012-1768; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ramlo-Halsted BA, 1999, PRIMARY CARE, V26, P771, DOI 10.1016/S0095-4543(05)70130-5; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Schultze SM, 2015, LIVER INT, V35, P1354, DOI 10.1111/liv.12600; Soares JP, 2015, EXP GERONTOL, V62, P45, DOI 10.1016/j.exger.2015.01.001; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wang LL, 2012, J APPL PHYSIOL, V113, P1669, DOI 10.1152/japplphysiol.00658.2012; Weiss J, 2014, DTSCH ARZTEBL INT, V111, P447, DOI 10.3238/arztebl.2014.0447; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zou C, 2011, CARCINOGENESIS, V32, P1840, DOI 10.1093/carcin/bgr225	42	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166956	10.1371/journal.pone.0166956	http://dx.doi.org/10.1371/journal.pone.0166956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893783	Green Published, Green Accepted, gold			2022-12-26	WOS:000389472400062
J	Barth, SM; Schreitmuller, CM; Proehl, F; Oehl, K; Lumpp, LM; Kowalewski, DJ; Di Marco, M; Sturm, T; Backert, L; Schuster, H; Stevanovic, S; Rammensee, HG; Planz, O				Barth, Sharon M.; Schreitmueller, Christian M.; Proehl, Franziska; Oehl, Kathrin; Lumpp, Leonie M.; Kowalewski, Daniel J.; Di Marco, Moreno; Sturm, Theo; Backert, Linus; Schuster, Heiko; Stevanovic, Stefan; Rammensee, Hans-Georg; Planz, Oliver			Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy	PLOS ONE			English	Article							PET DOGS; NEURAL-NETWORKS; MATRIX PEPTIDE; VIRAL PEPTIDES; CANCER-THERAPY; DOMESTIC DOGS; ANIMAL-MODEL; ANTIGEN; MOLECULES; HLA-A2	There are limitations in pre-clinical settings using mice as a basis for clinical development in humans. In cancer, similarities exist between humans and dogs; thus, the dog patient can be a link in the transition from laboratory research on mouse models to clinical trials in humans. Knowledge of the peptides presented on MHC molecules is fundamental for the development of highly specific T cell-based immunotherapies. This information is available for human MHC molecules but is absent for the canine MHC. In the present study, we characterized the binding motif of dog leukocyte antigen (DLA) class I allele DLA-88*50101, using human C1R and K562 transfected cells expressing the DLA-88*50101 heavy chain. MHC class I immunoaffinity-purification revealed 3720 DLA-88*50101 derived peptides, which enabled the determination of major anchor positions. The characterized binding motif of DLA-88*50101 was similar to HLA-A*02:01. Peptide binding analyses on HLA-A*02:01 and DLA-88*50101 via flow cytometry showed weak binding of DLA-88*50101 derived peptides to HLA-A*02:01, and vice versa. Our results present for the first time a detailed peptide binding motif of the canine MHC class I allelic product DLA-88*50101. These data support the goal of establishing dogs as a suitable animal model for the evaluation and development of T cell-based cancer immunotherapies, benefiting both dog and human patients.	[Barth, Sharon M.; Schreitmueller, Christian M.; Proehl, Franziska; Oehl, Kathrin; Lumpp, Leonie M.; Kowalewski, Daniel J.; Di Marco, Moreno; Backert, Linus; Schuster, Heiko; Stevanovic, Stefan; Rammensee, Hans-Georg; Planz, Oliver] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany; [Oehl, Kathrin; Schuster, Heiko] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland; [Kowalewski, Daniel J.] Immat Biotechnol GmbH, Tubingen, Germany; [Sturm, Theo] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Sturm, Theo] Univ Utrecht, Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Sturm, Theo] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Backert, Linus] Univ Tubingen, Appl Bioinformat, Ctr Bioinformat, Tubingen, Germany; [Backert, Linus] Univ Tubingen, Dept Comp Sci, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Zurich; University Zurich Hospital; Immatics Biotechnologies GmbH; Swiss Federal Institutes of Technology Domain; ETH Zurich; Utrecht University; Utrecht University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Planz, O (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany.	oliver.planz@uni-tuebingen.de						Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; BAROUCH D, 1995, J EXP MED, V182, P1847, DOI 10.1084/jem.182.6.1847; Berlin C, 2016, LEUKEMIA, V30, P1003, DOI 10.1038/leu.2016.1; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bukowski JA, 1998, J TOXICOL ENV HEAL A, V54, P579, DOI 10.1080/009841098158719; Burnett RC, 1997, TISSUE ANTIGENS, V49, P484, DOI 10.1111/j.1399-0039.1997.tb02783.x; BURNETT RC, 1995, J IMMUNOL, V155, P4278; Du JM, 2009, J MOL RECOGNIT, V22, P465, DOI 10.1002/jmr.964; Dutra AS, 1996, CYTOGENET CELL GENET, V74, P113, DOI 10.1159/000134395; EDWARDS PAW, 1982, EUR J IMMUNOL, V12, P641, DOI 10.1002/eji.1830120804; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Graumann MB, 1998, TISSUE ANTIGENS, V51, P374, DOI 10.1111/j.1399-0039.1998.tb02976.x; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Hardt C, 2006, TISSUE ANTIGENS, V67, P163, DOI 10.1111/j.1399-0039.2006.00497.x; HAYES HM, 1981, AM J EPIDEMIOL, V114, P229, DOI 10.1093/oxfordjournals.aje.a113186; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kennedy LJ, 2001, TISSUE ANTIGENS, V58, P55, DOI 10.1034/j.1399-0039.2001.580111.x; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Kowalewski Daniel J, 2013, Methods Mol Biol, V960, P145, DOI 10.1007/978-1-62703-218-6_12; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; LOZZIO BB, 1981, P SOC EXP BIOL MED, V166, P546; Marchetti S, 2007, BRIT J CANCER, V97, P577, DOI 10.1038/sj.bjc.6603925; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; MATSUI M, 1993, P NATL ACAD SCI USA, V90, P674, DOI 10.1073/pnas.90.2.674; MATSUI M, 1994, HUM IMMUNOL, V41, P160, DOI 10.1016/0198-8859(94)90010-8; Momburg F, 1996, J IMMUNOL, V156, P1756; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; OBST R, 1995, EUR J IMMUNOL, V25, P2170, DOI 10.1002/eji.1830250808; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parmiani G, 2014, HUM VACC IMMUNOTHER, V10, P3175, DOI 10.4161/hv.29418; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Rammensee HG, 2013, EXPERT REV VACCINES, V12, P1211, DOI 10.1586/14760584.2013.836911; Reif JS, 1998, AM J EPIDEMIOL, V147, P488, DOI 10.1093/oxfordjournals.aje.a009475; Ross P, 2012, TISSUE ANTIGENS, V80, P175, DOI 10.1111/j.1399-0039.2012.01889.x; Ross P, 2012, VET IMMUNOL IMMUNOP, V150, P206, DOI 10.1016/j.vetimm.2012.08.012; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Sant A, 2003, CURR OPIN IMMUNOL, V15, P66, DOI 10.1016/S0952-7915(02)00020-1; Scheidt WM, 2003, EVOLUTION COGNITION, V9, P57; Singh-Jasuja H, 2004, CANCER IMMUNOL IMMUN, V53, P187, DOI 10.1007/s00262-003-0480-x; STEVANOVIC S, 1993, ANAL BIOCHEM, V212, P212, DOI 10.1006/abio.1993.1314; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; TENG JMC, 1994, MOL IMMUNOL, V31, P459, DOI 10.1016/0161-5890(94)90065-5; TERHORST C, 1976, P NATL ACAD SCI USA, V73, P910, DOI 10.1073/pnas.73.3.910; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; Tsai KL, 2013, IMMUNOGENETICS, V65, P501, DOI 10.1007/s00251-013-0704-y; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; Venkataraman GM, 2007, TISSUE ANTIGENS, V70, P53, DOI 10.1111/j.1399-0039.2007.00839.x; Wagner JL, 2000, TISSUE ANTIGENS, V55, P564, DOI 10.1034/j.1399-0039.2000.550607.x; Xiao J, 2016, J IMMUNOL, P50801; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167017	10.1371/journal.pone.0167017	http://dx.doi.org/10.1371/journal.pone.0167017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893789	Green Published, gold, Green Submitted			2022-12-26	WOS:000389472400070
J	Chen, SY; Kaeppler, SM; Vogel, KP; Casler, MD				Chen, Shiyu; Kaeppler, Shawn M.; Vogel, Kenneth P.; Casler, Michael D.			Selection Signatures in Four Lignin Genes from Switchgrass Populations Divergently Selected for In Vitro Dry Matter Digestibility	PLOS ONE			English	Article							LOLIUM-PERENNE L.; FESCUE FESTUCA-ARUNDINACEA; TRANSGENIC DOWN-REGULATION; TERM ARTIFICIAL SELECTION; FERMENTABLE SUGAR YIELDS; ACID-O-METHYLTRANSFERASE; HERBAGE QUALITY TRAITS; CELL-WALL COMPOSITION; PANICUM-VIRGATUM L.; COMPREHENSIVE ANALYSIS	Switchgrass is undergoing development as a dedicated cellulosic bioenergy crop. Fermentation of lignocellulosic biomass to ethanol in a bioenergy system or to volatile fatty acids in a livestock production system is strongly and negatively influenced by lignification of cell walls. This study detects specific loci that exhibit selection signatures across switchgrass breeding populations that differ in in vitro dry matter digestibility (IVDMD), ethanol yield, and lignin concentration. Allele frequency changes in candidate genes were used to detect loci under selection. Out of the 183 polymorphisms identified in the four candidate genes, twenty-five loci in the intron regions and four loci in coding regions were found to display a selection signature. All loci in the coding regions are synonymous substitutions. Selection in both directions were observed on polymorphisms that appeared to be under selection. Genetic diversity and linkage disequilibrium within the candidate genes were low. The recurrent divergent selection caused excessive moderate allele frequencies in the cycle 3 reduced lignin population as compared to the base population. This study provides valuable insight on genetic changes occurring in short-term selection in the polyploid populations, and discovered potential markers for breeding switchgrass with improved biomass quality.	[Chen, Shiyu; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Kaeppler, Shawn M.; Casler, Michael D.] Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53726 USA; [Vogel, Kenneth P.] USDA ARS, Grain Forage & Bioenergy Res Unit, Lincoln, NE USA; [Vogel, Kenneth P.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Casler, Michael D.] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Casler, MD (corresponding author), Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53726 USA.; Casler, MD (corresponding author), USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA.	mdcasler@wisc.edu		Chen, Shiyu/0000-0003-0102-8112	U.S. Department of Energy Great Lakes Bioenergy Research Center in Madison, WI; USDA-ARS in Madison, WI; University of Wisconsin, Department of Agricultural Research Stations; U.S. Department of Energy Great Lakes Bioenergy Research Center in East Lansing, MI; USDA-ARS in Lincoln, NE;  [DE-FC02-07ER64494]	U.S. Department of Energy Great Lakes Bioenergy Research Center in Madison, WI; USDA-ARS in Madison, WI; University of Wisconsin, Department of Agricultural Research Stations; U.S. Department of Energy Great Lakes Bioenergy Research Center in East Lansing, MI; USDA-ARS in Lincoln, NE; 	This research was funded principally by the U.S. Department of Energy Great Lakes Bioenergy Research Center located in Madison, WI and East Lansing, MI and supported by Grant DE-FC02-07ER64494. Secondary funding was provided by USDA-ARS in Madison, WI and Lincoln, NE, and by the University of Wisconsin, Department of Agricultural Research Stations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal DD, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0206-5; Alarcon-Zuniga B, 2009, MOLECULAR BREEDING OF FORAGE AND TURF, P151, DOI 10.1007/978-0-387-79144-9_14; Andersen J. R., 2007, Proceedings of the XXVIIth EUCARPIA Symposium on improvement of fodder crops and amenity grasses, Copenhagen, Denmark, 19th to 23rd August 2007, P145; Andersen JR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-2; Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188; Baxter HL, 2014, PLANT BIOTECHNOL J, V12, P914, DOI 10.1111/pbi.12195; Beissinger TM, 2014, GENETICS, V196, P829, DOI 10.1534/genetics.113.160655; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenner EA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-27; Brummer EC, 2009, MOLECULAR BREEDING OF FORAGE AND TURF, P193, DOI 10.1007/978-0-387-79144-9_18; Casler MD, 1999, CROP SCI, V39, P12, DOI 10.2135/cropsci1999.0011183X003900010003x; Casler MD, 2014, CROP SCI, V54, P626, DOI 10.2135/cropsci2013.04.0239; Casler MD, 2011, PLANT GENOME-US, V4, P273, DOI 10.3835/plantgenome2011.10.0026; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen L, 2004, FUNCT PLANT BIOL, V31, P235, DOI 10.1071/FP03254; Chen L, 2003, PLANT BIOTECHNOL J, V1, P437, DOI 10.1046/j.1467-7652.2003.00040.x; Chen YS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-12; Cogan N, 2005, THEOR APPL GENET, V110, P364, DOI 10.1007/s00122-004-1848-9; Cogan NOI, 2006, MOL GENET GENOMICS, V276, P101, DOI 10.1007/s00438-006-0126-8; Costich DE, 2010, PLANT GENOME-US, V3, P130, DOI 10.3835/plantgenome2010.04.0010; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; EIA, BIOFUELS PRODUCTION; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Ge Y, 2012, IN VITRO CELL DEV-PL, V48, P430; GODSHALK EB, 1986, CROP SCI, V26, P943, DOI 10.2135/cropsci1986.0011183X002600050021x; Guo DM, 2010, J MOL EVOL, V71, P202, DOI 10.1007/s00239-010-9378-3; Han KJ, 2013, GCB BIOENERGY, V5, P358, DOI 10.1111/j.1757-1707.2012.01203.x; Hirsch CN, 2014, GENETICS, V198, P409, DOI 10.1534/genetics.114.167155; HOPKINS AA, 1993, CROP SCI, V33, P253, DOI 10.2135/cropsci1993.0011183X003300020007x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HM, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-8; Liu LL, 2014, BIOENERG RES, V7, P253, DOI 10.1007/s12155-013-9367-7; Lorenzana RE, 2010, CROP SCI, V50, P541, DOI 10.2135/cropsci2009.04.0182; Masatoshi N., 1987, MOLECULAR EVOLUTIONA; Naaz H, 2013, BIOTECHNOL APPL BIOC, V60, P170, DOI 10.1002/bab.1075; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parvathi K, 2001, PLANT J, V25, P193, DOI 10.1046/j.1365-313x.2001.00956.x; Pembleton LW, 2013, CROP PASTURE SCI, V64, P244, DOI 10.1071/CP12392; Pettersson ME, 2013, G3-GENES GENOM GENET, V3, P2305, DOI 10.1534/g3.113.008375; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sarath G, 2008, APPL BIOCHEM BIOTECH, V150, P1, DOI 10.1007/s12010-008-8168-5; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Somleva MN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-79; Team RC, 2015, R A LANGUAGE AND ENV; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; Truntzler M, 2010, THEOR APPL GENET, V121, P1465, DOI 10.1007/s00122-010-1402-x; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Vogel KP, 2013, CROP SCI, V53, P853, DOI 10.2135/cropsci2012.09.0542; Vogel KP, 2002, CROP SCI, V42, P1857, DOI 10.2135/cropsci2002.1857; VOGEL KP, 1981, CROP SCI, V21, P39, DOI 10.2135/cropsci1981.0011183X002100010011x; Wang M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045905; Wang YH, 2013, GENOME, V56, P659, DOI 10.1139/gen-2013-0134; Wang ZY, 2012, ANN BOT-LONDON, V110, P1317, DOI 10.1093/aob/mcs027; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; Wisser RJ, 2008, GENETICS, V180, P583, DOI 10.1534/genetics.108.090118; Xing Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-43; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Zhang YW, 2011, GENETICA, V139, P933, DOI 10.1007/s10709-011-9597-6; Zhong RQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134611; Zhu QH, 2013, G3-GENES GENOM GENET, V3, P1031, DOI 10.1534/g3.112.005447	70	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167005	10.1371/journal.pone.0167005	http://dx.doi.org/10.1371/journal.pone.0167005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893787	Green Published, Green Submitted, gold			2022-12-26	WOS:000389472400068
J	Kobayashi, N; Okae, H; Hiura, H; Chiba, H; Shirakata, Y; Hara, K; Tanemura, K; Arima, T				Kobayashi, Norio; Okae, Hiroaki; Hiura, Hitoshi; Chiba, Hatsune; Shirakata, Yoshiki; Hara, Kenshiro; Tanemura, Kentaro; Arima, Takahiro			Genome-Scale Assessment of Age-Related DNA Methylation Changes in Mouse Spermatozoa	PLOS ONE			English	Article							SPERM; DIFFERENTIATION; TRANSCRIPTION; DYNAMICS; CELLS	DNA methylation plays important roles in the production and functioning of spermatozoa. Recent studies have suggested that DNA methylation patterns in spermatozoa can change with age, but the regions susceptible to age-related methylation changes remain to be fully elucidated. In this study, we conducted genome-scale DNA methylation profiling of spermatozoa obtained from C57BL/6N mice at 8 weeks (8w), 18 weeks (18w) and 17 months of age (17m). There was no substantial difference in the global DNA methylation patterns between 18w and 17m samples except for a slight increase of methylation levels in long interspersed nuclear elements in the 17m samples. We found that maternally methylated imprinting control regions (mICRs) and spermatogenesis-related gene promoters had 5-10% higher methylation levels in 8w samples than in 18w or 17m samples. Analysis of individual sequence reads suggested that these regions were fully methylated (80-100%) in a subset of 8w spermatozoa. These regions are also known to be highly methylated in a subset of postnatal spermatogonia, which might be the source of the increased DNA methylation in 8w spermatozoa. Another possible source was contamination by somatic cells. Although we carefully purified the spermatozoa, it was difficult to completely exclude the possibility of somatic cell contamination. Further studies are needed to clarify the source of the small increase in DNA methylation in the 8w samples. Overall, our findings suggest that DNA methylation patterns in mouse spermatozoa are relatively stable throughout reproductive life.	[Kobayashi, Norio; Okae, Hiroaki; Hiura, Hitoshi; Chiba, Hatsune; Arima, Takahiro] Tohoku Univ, Grad Sch Med, Dept Informat Genet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kobayashi, Norio; Shirakata, Yoshiki; Hara, Kenshiro; Tanemura, Kentaro] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod & Dev, Aoba Ku, Sendai, Miyagi 9818555, Japan	Tohoku University; Tohoku University	Arima, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Informat Genet, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	tarima@med.tohoku.ac.jp	Okae, Hiroaki/AAC-3705-2019	Okae, Hiroaki/0000-0002-1539-5063	KAKENHI [15K15592]; Health and Labour Sciences Research Grant [H25-Jisedai-Ippan-001]; Takeda Science Foundation; Tohoku University, Division for Interdisciplinary Advanced Research and Education; Core Research for Evolutional Science and Technology (CREST) from the Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [15K10657] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tohoku University, Division for Interdisciplinary Advanced Research and Education; Core Research for Evolutional Science and Technology (CREST) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aids for Scientific Research (KAKENHI) (15K15592), Health and Labour Sciences Research Grant (H25-Jisedai-Ippan-001) and the Takeda Science Foundation (TA) and by Grant-in-Aid of Tohoku University, Division for Interdisciplinary Advanced Research and Education (NK). The work was also supported by the Core Research for Evolutional Science and Technology (CREST) from the Japan Agency for Medical Research and Development (AMED) (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grants-in-Aids for Scientific Research (KAKENHI) (15K15592), Health and Labour Sciences Research Grant (H25-Jisedai-Ippan-001) and the Takeda Science Foundation (TA) and by Grant-in-Aid of Tohoku University, Division for Interdisciplinary Advanced Research and Education (NK). The work was also supported by the Core Research for Evolutional Science and Technology (CREST) from the Japan Agency for Medical Research and Development (AMED) ( TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHNAK BR, 1988, NUCLEIC ACIDS RES, V16, P1208, DOI 10.1093/nar/16.3.1208; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Denham J, 2015, EPIGENOMICS-UK, V7, P717, DOI 10.2217/epi.15.29; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FABRICANT JD, 1982, J REPROD FERTIL, V66, P485, DOI 10.1530/jrf.0.0660485; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; HACKERKLOM UB, 1995, Z NATURFORSCH C, V50, P303; Hammoud SS, 2015, GENE DEV, V29, P2312, DOI 10.1101/gad.261925.115; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Heyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047892; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jenkins TG, 2013, FERTIL STERIL, V100, P945, DOI 10.1016/j.fertnstert.2013.05.039; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kubo N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1833-5; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; McLean DJ, 2003, BIOL REPROD, V69, P2085, DOI 10.1095/biolreprod.103.017020; Milekic MH, 2015, MOL PSYCHIATR, V20, P995, DOI 10.1038/mp.2014.84; Nagamori I, 2015, CELL REP, V12, P1541, DOI 10.1016/j.celrep.2015.07.060; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Ohta H, 2009, HUM REPROD, V24, P775, DOI 10.1093/humrep/den456; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; QUINN P, 1985, FERTIL STERIL, V44, P493; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; REED JF, 1988, COMPUT METH PROG BIO, V26, P233, DOI 10.1016/0169-2607(88)90003-X; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sato A, 2011, FERTIL STERIL, V95, P129, DOI 10.1016/j.fertnstert.2010.06.076; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]	35	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0167127	10.1371/journal.pone.0167127	http://dx.doi.org/10.1371/journal.pone.0167127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27880848	gold, Green Published, Green Submitted			2022-12-26	WOS:000388889500070
J	Yu, XB; Luo, A; Sun, MX				Yu, Xiaobo; Luo, An; Sun, Meng-xiang			An Efficient Antipodal Cell Isolation Method for Screening of Cell Type-Specific Genes in Arabidopsis thaliana	PLOS ONE			English	Article							FEMALE GAMETOPHYTE; FERTILIZATION	In flowering plants, the mature embryo sac consists of seven cells, namely two synergid cells and an egg cell at the micropylar end, one central cell, and three antipodal cells at the chalazal end. Excluding the antipodal cell, as a model for the study of cell fate determination and cell type specification, the roles of these embryo sac component cells in fertilization and seed formation have been widely investigated. At this time, little is known regarding the function of antipodal cells and their cell type-specific gene expression patterns. One reason for this is difficulties related to the observation and isolation of cells for detailed functional analyses. Here, we report a method for antipodal cell isolation and transcriptome analysis. We identified antipodal cell-specific marker line K44-1, and based on this marker line, established a procedure allowing us to isolate antipodal cells with both high quality and quantity. PCR validation of antipodal-specific genes from antipodal cell cDNA showed that the isolated cells are qualified and can be used for transcriptome analysis and screening of cell type-specific marker genes. The isolated cells could keep viable for a week in culture condition. This method can be used to efficiently isolate antipodal cells of high quality and will promote the functional investigation of antipodal cells in Arabidopsis thaliana. This increases our understanding of the molecular regulatory mechanism of antipodal cell specification.	[Yu, Xiaobo; Luo, An; Sun, Meng-xiang] Wuhan Univ, Coll Life Sci, Dept Cell & Dev Biol, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Luo, An] Yangtze Univ, Coll Life Sci, Jingzhou 434023, Peoples R China	Wuhan University; Yangtze University	Sun, MX (corresponding author), Wuhan Univ, Coll Life Sci, Dept Cell & Dev Biol, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	mxsun@whu.edu.on			National Natural Science Foundation of China [31430007]; 973 Program [2013CB126900]; Chinese 111 Project Grant [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Chinese 111 Project Grant	The work was financially supported by the National Natural Science Foundation of China (31430007), http://www.nsfc.gov.cn/, "973 Program" (2013CB126900), http://www.973.gov.cn. This project is also partially supported by the Chinese 111 Project Grant (B06018).; The work was financially supported by the National Natural Science Foundation of China (31430007), http://www.nsfc.gov.c.n/, "973 Program" (2013CB126900), http://www.973.gov.cn. This project is also partially supported by the Chinese 111 Project Grant (B06018).	Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; David R, 1990, PLANT CELL; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Grossniklaus U, 2011, SEX PLANT REPROD, V24, P91, DOI 10.1007/s00497-011-0170-3; He YC, 2007, PLANT J, V49, P515, DOI 10.1111/j.1365-313X.2006.02970.x; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; KOVACS M, 1994, SEX PLANT REPROD, V7, P311, DOI 10.1007/BF00227715; KRANZ E, 1991, SEX PLANT REPROD, V4, P12; Krohn NG, 2012, DEV CELL, V23, P219, DOI 10.1016/j.devcel.2012.05.018; Kuang Q, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0092-4; Ma H, 2010, CURR TOP DEV BIOL, V91, P379, DOI 10.1016/S0070-2153(10)91013-2; MANSFIELD SG, 1991, CAN J BOT, V69, P447, DOI 10.1139/b91-062; Nonomura KI, 2003, PLANT CELL, V15, P1728, DOI 10.1105/tpc.012401; Song XY, 2014, PLANT REPROD, V27, P197, DOI 10.1007/s00497-014-0251-1; Sprunck S, 2011, SEX PLANT REPROD, V24, P123, DOI 10.1007/s00497-011-0161-4; Steffen JG, 2007, PLANT J, V51, P281, DOI 10.1111/j.1365-313X.2007.03137.x; Sun Meng-Xiang, 1995, Acta Botanica Sinica, V37, P1; Uchiumi T, 2006, SEX PLANT REPROD; Wu JJ, 2012, DEV CELL, V23, P1043, DOI 10.1016/j.devcel.2012.09.011; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203	21	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2016	11	11							e0166390	10.1371/journal.pone.0166390	http://dx.doi.org/10.1371/journal.pone.0166390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5IV	27875553	Green Published, Green Submitted, gold			2022-12-26	WOS:000388886000012
J	Youm, HW; Lee, J; Kim, EJ; Kong, HS; Lee, JR; Suh, CS; Kim, SH				Youm, Hye Won; Lee, Jaewang; Kim, Eun Jung; Kong, Hyun Sun; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun			Effects of Angiopoietin-2 on Transplanted Mouse Ovarian Tissue	PLOS ONE			English	Article							TIE2 RECEPTOR; CRYOPRESERVATION; ANGIOGENESIS; SURVIVAL; EXPRESSION; ISCHEMIA; LIGAND; CELLS; XENOTRANSPLANTATION; VASCULATURE	Transplantation of ovarian tissue (OT) is currently the only clinical option to restore fertility with cryopreserved OT. However, follicle loss caused by ischemia and slow revascularization occurs in transplanted OT. To shorten the ischemic period and promote angiogenesis, some angiogenic factors have been used. Angiopoietin-2 (Ang2) is one of the major angiogenic factors and has been reported to promote blood vessels and increase vascular permeability in ischemic and/or hypoxic environment. This study was performed to investigate the effects of Ang2 on follicle integrity and revascularization of transplanted mouse OT. Five-week- old B6D2F1 female mice were divided into a control group and two Ang2 groups, followed by ovary collection and vitrification. After warming, the ovaries were autotransplanted into kidney capsules with/without Ang2 injection (50 or 500 ng/kg), and then the mice were sacrificed at days 2, 7, 21, and 42 after transplantation. A total 2,437 follicles in OT grafts were assessed for follicular density, integrity, and classification by using hematoxylin and eosin staining. Apoptosis and revascularization were evaluated by using TUNEL assay and CD31 immunohistochemistry, respectively. Serum follicle-stimulating hormone (FSH) levels were measured by using enzyme-linked immunosorbent assay. Both Ang2 groups showed remarkable increase in morphologically intact follicle ratio across all grafting durations except D21. The numbers of CD31(+) vessels were significantly increased in both Ang2 groups compared with the control group at all durations, except in the 50 ng Ang2 group at D42. However, the mean numbers of follicles of the grafts, apoptosis ratios, and serum FSH levels showed no significant differences among the groups. Our results show that Ang2 treatment significantly increased the intact follicle ratios and the number of blood vessels of the mouse OT grafts. However, further studies performed with large animal or human OT are necessary before clinical application for fertility preservation in cancer patients, and the reliability of the systemic effects of Ang2 should be verified.	[Youm, Hye Won; Lee, Jaewang; Kim, Eun Jung; Kong, Hyun Sun; Lee, Jung Ryeol] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, 82 Gumi Ro 173 Beon Gil, Seongnam Si 463707, Gyeonggi Do, South Korea; [Kim, Eun Jung; Kong, Hyun Sun; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, 101 Daehak Ro, Seoul 110744, South Korea; [Lee, Jaewang] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Seoul National University (SNU); Seoul National University (SNU); Northwestern University; Feinberg School of Medicine	Lee, JR (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, 82 Gumi Ro 173 Beon Gil, Seongnam Si 463707, Gyeonggi Do, South Korea.; Lee, JR (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, 101 Daehak Ro, Seoul 110744, South Korea.	leejrmd@snu.ac.kr		Lee, Jaewang/0000-0001-6801-7149; Lee, Jung Ryeol/0000-0003-3743-2934	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant (No. HI12C0055) from the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea.	Abramovich D, 2009, REPRODUCTION, V137, P309, DOI 10.1530/REP-08-0130; Asahara T, 1998, CIRC RES, V96, P1378; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Chowdhury MWH, 2010, THERIOGENOLOGY, V73, P856, DOI 10.1016/j.theriogenology.2009.10.011; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; de Vries DK, 2013, TRANSPLANTATION, V96, P282, DOI 10.1097/TP.0b013e31829854d5; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Demeestere I, 2009, HUM REPROD UPDATE, V15, P649, DOI 10.1093/humupd/dmp021; DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146; Donnez J, 1998, HUM REPROD UPDATE, V4, P248, DOI 10.1093/humupd/4.3.248; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Donnez J, 2015, J ASSIST REPROD GEN, V32, P1167, DOI 10.1007/s10815-015-0544-9; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gandolfi F, 2006, FERTIL STERIL, V85, P1150, DOI 10.1016/j.fertnstert.2005.08.062; Hemadi M, 2009, EUR J PHARMACOL, V618, P84, DOI 10.1016/j.ejphar.2009.07.018; Jafarabadi M, 2015, J ASSIST REPROD GEN, V32, P195, DOI 10.1007/s10815-014-0382-1; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Joo HJ, 2011, BLOOD, V118, P2094, DOI 10.1182/blood-2010-12-323907; Liu J, 2002, HUM REPROD, V17, P605, DOI 10.1093/humrep/17.3.605; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; Mahmoodi M, 2014, REPRODUCTION, V147, P733, DOI 10.1530/REP-13-0379; Meirow D, 2007, LEUKEMIA LYMPHOMA, V48, P1569, DOI 10.1080/10428190701471957; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Syrjala SO, 2014, AM J TRANSPLANT, V14, P1096, DOI 10.1111/ajt.12672; Van den Broecke R, 2001, EUR J OBSTET GYN R B, V97, P193, DOI 10.1016/S0301-2115(00)00507-8; Wang L, 2013, J ASSIST REPROD GEN, V30, P1301, DOI 10.1007/s10815-013-0043-9; Wu DD, 2010, ANAT REC, V293, P2154, DOI 10.1002/ar.21228; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Youm HW, 2015, THERIOGENOLOGY, V83, P854, DOI 10.1016/j.theriogenology.2014.11.026; Youm HW, 2014, HUM REPROD, V29, P720, DOI 10.1093/humrep/det449	37	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166782	10.1371/journal.pone.0166782	http://dx.doi.org/10.1371/journal.pone.0166782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED4UE	27870915	Green Published, Green Submitted, gold			2022-12-26	WOS:000388846400028
J	Yasui, T; Masaki, T; Arita, Y; Ishibashi, T; Inagaki, T; Okazawa, M; Oka, T; Shioyama, W; Yamauchi-Takihara, K; Komuro, I; Sakata, Y; Nakaoka, Y				Yasui, Taku; Masaki, Takeshi; Arita, Yoh; Ishibashi, Tomohiko; Inagaki, Tadakatsu; Okazawa, Makoto; Oka, Toru; Shioyama, Wataru; Yamauchi-Takihara, Keiko; Komuro, Issei; Sakata, Yasushi; Nakaoka, Yoshikazu			Molecular Characterization of Striated Muscle-Specific Gab1 Isoform as a Critical Signal Transducer for Neuregulin-1/ErbB Signaling in Cardiomyocytes	PLOS ONE			English	Article							TYROSINE PHOSPHATASE SHP2; ADAPTER PROTEIN; GROWTH-FACTOR; DILATED CARDIOMYOPATHY; CARDIAC-FUNCTION; ERBB2; CYTOKINE; DELETION; RECEPTOR; HEART	Grb2-associated binder (Gab) docking proteins regulate signals downstream of a variety of growth factors and receptor tyrosine kinases. Neuregulin-1 (NRG-1), a member of epidermal growth factor family, plays a critical role for cardiomyocyte proliferation and prevention of heart failure via ErbB receptors. We previously reported that Gab1 and Gab2 in the myocardium are essential for maintenance of myocardial function in the postnatal heart via transmission of NRG-1/ErbB-signaling through analysis of Gab1/Gab2 cardiomyocyte-specific double knockout mice. In that study, we also found that there is an unknown high molecular weight (high-MW) Gab1 isoform (120 kDa) expressed exclusively in the heart, in addition to the ubiquitously expressed low-MW (100 kDa) Gab1. However, the high-MW Gab1 has been molecularly ill-defined to date. Here, we identified the high-MW Gab1 as a striated muscle-specific isoform. The high-MW Gab1 has an extra exon encoding 27 amino acid residues between the already-known 3rd and 4th exons of the ubiquitously expressed low-MW Gab1. Expression analysis by RT-PCR and immunostaining with the antibody specific for the high-MW Gab1 demonstrate that the high-MW Gab1 isoform is exclusively expressed in striated muscle including heart and skeletal muscle. The ratio of high-MW Gab1/total Gab1 mRNAs increased along with heart development. The high-MW Gab1 isoform in heart underwent tyrosine-phosphorylation exclusively after intravenous administration of NRG-1, among several growth factors. Adenovirus-mediated overexpression of the high-MW Gab1 induces more sustained activation of AKT after stimulation with NRG-1 in cardiomyocytes compared with that of P-galactosidase. On the contrary, siRNA-mediated knockdown of the high-MW Gab1 significantly attenuated AKT activation after stimulation with NRG-1 in cardiomyocytes. Taken together, these findings suggest that the striated muscle-specific high-MW isoform of Gab1 has a crucial role for NRG-1/ErbB signaling in cardiomyocytes.	[Yasui, Taku; Masaki, Takeshi; Ishibashi, Tomohiko; Inagaki, Tadakatsu; Okazawa, Makoto; Nakaoka, Yoshikazu] Natl Cerebral & Cardiovasc Ctr, Dept Vasc Physiol, Res Inst, Suita, Osaka, Japan; [Yasui, Taku; Masaki, Takeshi; Arita, Yoh; Yamauchi-Takihara, Keiko; Sakata, Yasushi; Nakaoka, Yoshikazu] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan; [Oka, Toru; Shioyama, Wataru] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Cardiol, Osaka, Japan; [Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Nakaoka, Yoshikazu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Tokyo; Japan Science & Technology Agency (JST)	Nakaoka, Y (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Vasc Physiol, Res Inst, Suita, Osaka, Japan.; Nakaoka, Y (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan.; Nakaoka, Y (corresponding author), Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan.	ynakaoka@ncvc.go.jp		Ishibashi, Tomohiko/0000-0003-1953-5016; Sakata, Yasushi/0000-0002-5618-4721	Ministry of Education, Science, Sports and Culture of Japan [KAKENHI-24659391]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants by KAKENHI-24659391 from the Ministry of Education, Science, Sports and Culture of Japan (to YN).	Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Furuta K, 2016, HEPATOLOGY, V63, P1340, DOI 10.1002/hep.28410; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Garratt AN, 2003, TRENDS CARDIOVAS MED, V13, P80, DOI 10.1016/S1050-1738(02)00231-1; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112; Higuchi K, 2012, CIRC J, V76, P2031, DOI 10.1253/circj.CJ-11-1507; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Kizu T, 2015, AM J PHYSIOL-GASTR L, V308, pG613, DOI 10.1152/ajpgi.00289.2014; Koyama T, 2008, J BIOL CHEM, V283, P24234, DOI 10.1074/jbc.M803907200; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmens K, 2006, J BIOL CHEM, V281, P19469, DOI 10.1074/jbc.M600399200; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nakaoka Y, 2003, CIRC RES, V93, P221, DOI 10.1161/01.RES.0000085562.48906.4A; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Nakaoka Y, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/141068; Nakaoka Y, 2010, J MOL CELL CARDIOL, V49, P157, DOI 10.1016/j.yjmcc.2010.03.001; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; PARDRIDGE WM, 1986, J CEREBR BLOOD F MET, V6, P203, DOI 10.1038/jcbfm.1986.33; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Shin YK, 2014, J NEUROSCI, V34, P7657, DOI 10.1523/JNEUROSCI.4947-13.2014; Shioyama W, 2011, CIRC RES, V108, P664, DOI 10.1161/CIRCRESAHA.110.232223; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sun LL, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0420-2; Suter TM, 2004, BREAST, V13, P173, DOI 10.1016/j.breast.2003.09.002; Weng TJ, 2010, J CELL SCI, V123, P682, DOI 10.1242/jcs.058396; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Zhao J, 2016, CELL DEATH DIFFER, V23, P695, DOI 10.1038/cdd.2015.143; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166710	10.1371/journal.pone.0166710	http://dx.doi.org/10.1371/journal.pone.0166710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861634	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300092
J	Tania, S; Behr, S; Thone, K; Bricout, H; Garbe, E				Schink, Tania; Behr, Sigrid; Thoene, Kathrin; Bricout, Helene; Garbe, Edeltraut			Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series Study	PLOS ONE			English	Article							ASSOCIATION; VACCINATION; HEMORRHAGE; DATABASE	Background Herpes zoster (HZ) is caused by reactivation of the latent varicella-zoster virus (VZV). A severe complication of HZ is VZV vasculopathy which can result in ischemic or hemorrhagic stroke. The aims of our study were to assess the risk of stroke after the onset of HZ and to investigate the roles of stroke subtype, HZ location and the time interval between HZ onset and stroke. Methods A self-controlled case-series study was performed on a cohort of patients with incident stroke recorded in the German Pharmacoepidemiological Research Database (GePaRD), which covers about 20 million persons throughout Germany. We estimated adjusted incidence rate ratios (IRR) by comparing the rate of stroke in risk periods (i.e., periods following HZ) with the rate of stroke in control periods (i.e., periods without HZ) in the same individuals, controlling for both time-invariant and major potentially time-variant confounders. Results The cohort included 124,462 stroke patients, of whom 6,035 (5%) had at least one HZ diagnosis identified in GePaRD either as main hospital discharge diagnosis or as HZ treated with antivirals. The risk of stroke was about 1.3 times higher in the risk periods 3 months after HZ onset, than in the control periods (IRR: 1.29; 95% confidence interval: 1.16-1.44). An elevated risk of similar magnitude was observed for ischemic and unspecified stroke, but a 1.5-fold higher risk was observed for hemorrhagic stroke. A slightly stronger effect on the risk of stroke was also observed during the 3 months after HZ ophthalmicus (HZO) onset (1.59; 1.10-2.32). The risk was highest 3 and 4 weeks after HZ onset and decreased thereafter. Conclusions Our study corroborates an increased risk of stroke after HZ, which is highest 3 to 4 weeks after HZ onset. The results suggest that the risk is more pronounced after HZO and is numerically higher for hemorrhagic than for ischemic stroke.	[Schink, Tania; Behr, Sigrid; Thoene, Kathrin; Garbe, Edeltraut] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Thoene, Kathrin] Univ Canc Ctr Hamburg, Univ Med Ctr Hamburg Eppendorf UKE, Hamburg, Germany; [Bricout, Helene] Sanofi Pasteur MSD, Dept Epidemiol, Lyon, France	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Hamburg; University Medical Center Hamburg-Eppendorf; Sanofi-Aventis; Sanofi France	Tania, S (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	schink@bips.uni-bremen.de	Marcus, Ulrich/AAF-3085-2020; Schink, Susanne Barbara/F-7758-2015; Schink, Tania/A-4585-2017; Schink, Susanne Barbara/A-2669-2017	Marcus, Ulrich/0000-0002-3143-2717; Schink, Tania/0000-0002-0224-1866; Schink, Susanne Barbara/0000-0001-7542-9416; Helene, BRICOUT/0000-0002-5439-8064	Sanofi Pasteur MSD; Sanofi Pasteur	Sanofi Pasteur MSD; Sanofi Pasteur	The study was funded by Sanofi Pasteur MSD and by BIPS own resources. In collaboration with Sanofi Pasteur MSD, TS, SB, and EG designed the study, analyzed and interpreted the data. SB and TS drafted the manuscript and KT, HB and EG critically reviewed the manuscript. All authors approved the final version for submission. All BIPS authors had full access to the data and final responsibility for the decision to submit for publication. HB is employed by Sanofi Pasteur. Sanofi Pasteur provided support in the form of salary for author HB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Breuer J, 2014, NEUROLOGY, V83, pE27, DOI 10.1212/WNL.0000000000000584; Garbe E, 2013, STROKE, V44, P2422, DOI 10.1161/STROKEAHA.111.000811; Garbe E, 2011, PHARMACOEPIDEM DR S, V20, P258, DOI 10.1002/pds.2038; Hillebrand K, 2015, J INFECTION, V70, P178, DOI 10.1016/j.jinf.2014.08.018; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Langan SM, 2014, CLIN INFECT DIS, V58, P1497, DOI 10.1093/cid/ciu098; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Minassian C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001919; Nagel MA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0534-4; Nagel MA, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0407-z; Ohlmeier C, 2014, BUNDESGESUNDHEITSBLA, V57, P464, DOI 10.1007/s00103-013-1912-1; Ohlmeier C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1943-7; Ohlmeier C, 2013, PHARMACOEPIDEM DR S, V22, P306; Pigeot I, 2008, PHARMACOEPIDEM DR S, V17, P215, DOI 10.1002/pds.1545; Powell DR, 2015, AM J MED SCI, V350, P243, DOI 10.1097/MAJ.0000000000000327; Schink T, 2014, VACCINE, V32, P645, DOI 10.1016/j.vaccine.2013.12.011; Schmedt N, 2016, INT CLIN PSYCHOPHARM, V31, P159, DOI 10.1097/YIC.0000000000000119; Schmedt N, 2013, J CLIN PSYCHOPHARM, V33, P753, DOI 10.1097/JCP.0b013e3182a412d5; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Sreenivasan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069156; Sundstrom K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1170-y; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Whitaker HJ, 2006, USING SAS SELF CONTR; Yawn BP, 2016, MAYO CLIN PROC, V91, P33, DOI 10.1016/j.mayocp.2015.09.015; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304	26	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166554	10.1371/journal.pone.0166554	http://dx.doi.org/10.1371/journal.pone.0166554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27486669	gold, Green Submitted, Green Published			2022-12-26	WOS:000388889500025
J	Hellenbrand, W; Claus, H; Schink, S; Marcus, U; Wichmann, O; Vogel, U				Hellenbrand, Wiebke; Claus, Heike; Schink, Susanne; Marcus, Ulrich; Wichmann, Ole; Vogel, Ulrich			Risk of Invasive Meningococcal Disease in Men Who Have Sex with Men: Lessons Learned from an Outbreak in Germany, 2012-2013	PLOS ONE			English	Article							NEW-YORK-CITY; NEISSERIA-MENINGITIDIS; HOMOSEXUAL MEN; SEROGROUP-B; VACCINATION; COMMUNITY; GONORRHEA; CHILDREN; USA	Background We undertook investigations in response to an invasive meningococcal disease (IMD) outbreak in men who have sex with men (MSM) in Berlin 2012-2013 to better understand meningococcal transmission and IMD risk in MSM. Methods We retrospectively searched for further IMD cases in MSM in Germany through local health departments and undertook exploratory interviews. We performed antigen sequence typing, characterized fHbp and aniA genes of strains with the outbreak finetype and reviewed epidemiologically or spatiotemporally linked cases from 2002-2014. Results Among the 148 IMD-cases notified from 01.01.2012-30.09.2013 in 18-59 year-old men we identified 13 MSM in 6 federal states: 11 serogroup C (MenC, all finetype C: P1.5-1,10-8: F3-6), 2 MenB. Interviews with 7 MSM revealed frequent meeting of multiple partners online or via mobile apps and illicit drug use as potential risk factors. MenC incidence was 13-fold higher in MSM than non-MSM. MenC isolates from 9/11 MSM had a novel fHbp allele 766. All C: P1.5-1,10-8: F3-6 strains from MSM versus 16/23 from non-MSM had intact aniA genes (p = 0.04). Although definitive evidence for transmission among MSM in epidemiological or spatiotemporal clusters in 2002-2014 was lacking, clusters were more frequent in men aged 20-49 years. Molecular analysis of C: P1.5-1,10-8: F3-6 strains revealed cases with intact aniA since 2007, mainly associated with fHbp361, fHbp766 and fHbp813, all involving one or more MSM. Conclusions MenC incidence was elevated in MSM during the study period. Multiple casual sexual contacts and illicit drug use were common in affected MSM. In all strains from MSM we detected an intact aniA gene coding for a nitrite reductase, which permits survival in microanaerobic environments and could play a role in meningococcal transmission in MSM through urogenital colonization. Furthermore, meningococcal transmission among MSM may be sustained over large areas and thus require modified spatiotemporal scanning algorithms for timely detection and control.	[Hellenbrand, Wiebke; Wichmann, Ole] Robert Koch Inst, Immunizat Unit, Seestr 10, D-13353 Berlin, Germany; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Reference Lab Meningococci & Haemophilus Influenz, Wurzburg, Germany; [Schink, Susanne; Marcus, Ulrich] Robert Koch Inst, Unit HIV AIDS STI & Blood Borne Infect, Seestr 10, D-13353 Berlin, Germany; [Schink, Susanne] Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany; [Schink, Susanne] ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Schink, Susanne] Charite, Augustenburger Pl 1, D-13353 Berlin, Germany	Robert Koch Institute; University of Wurzburg; Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hellenbrand, W (corresponding author), Robert Koch Inst, Immunizat Unit, Seestr 10, D-13353 Berlin, Germany.	hellenbrandw@rki.de	Marcus, Ulrich/AAF-3085-2020; Schink, Susanne Barbara/F-7758-2015; Schink, Tania/A-4585-2017; Schink, Susanne Barbara/A-2669-2017	Marcus, Ulrich/0000-0002-3143-2717; Schink, Tania/0000-0002-0224-1866; Schink, Susanne Barbara/0000-0001-7542-9416; Helene, BRICOUT/0000-0002-5439-8064	German Federal Ministry of Health [1369-237]	German Federal Ministry of Health	WH, SS, UM and OW received no specific funding for this work. The National Reference Laboratory for Meningococci and Haemophilus influenzae (HC and UV) received funding from the German Federal Ministry of Health (http://www.bmg.bund.de/ministerium.html), funding code 1369-237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert L, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.3.21016; Barth KR, 2009, MICROBIOL-SGM, V155, P4093, DOI 10.1099/mic.0.032961-0; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Bijlsma MW, 2014, J INFECTION, V68, P296, DOI 10.1016/j.jinf.2013.10.008; BISAILLON JG, 1984, SEX TRANSM DIS, V11, P296, DOI 10.1097/00007435-198410000-00006; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Elias J, 2006, EMERG INFECT DIS, V12, P1689, DOI 10.3201/eid1211.060682; FAUR YC, 1981, AM J PUBLIC HEALTH, V71, P53, DOI 10.2105/AJPH.71.1.53; Hellenbrand W, 2015, BUNDESGESUNDHEITSBLA, V58, P1314, DOI 10.1007/s00103-015-2253-z; Hellenbrand W, 2013, J INFECTION, V66, P48, DOI 10.1016/j.jinf.2012.09.008; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Kamiya H, 2015, MMWR-MORBID MORTAL W, V64, P1256, DOI 10.15585/mmwr.mm6444a6; Koch J, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.5.30122; Kratz MM, 2015, EMERG INFECT DIS, V21, P1379, DOI 10.3201/eid2108.141837; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marcus U., 2013, Eurosurveillance, V18, P20523, DOI 10.2807/1560-7917.ES2013.18.28.20523; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-180; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Moir JW, 2011, BIOCHEM SOC T, V39, P1890, DOI 10.1042/BST20110735; Ridpath A, 2015, EMERG INFECT DIS, V21, P1458, DOI 10.3201/eid2108.141932; Robert Koch Institute, 2012, EPIDEMIOLOGISCHES B, V39, P389; Robert Koch-Institut, 2012, MEN INV ERKR INF JB, P150; Robert Koch-Institut, HIV AIDS DEUTSCHL EC; Robert Koch-Institut, 2007, FALL R KOCH I UB ERK; Robert Koch-Institut, 2003, EPIDEMIOLOGISCHES B, V50, P415; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; Seib KL, 2015, EXPERT REV VACCINES, V14, P841, DOI 10.1586/14760584.2015.1016915; Senatsverwaltung fur Gesundheit und Soziales, 2014, AMTSBL BERL, V3, P60; Simmons RD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0538-6; Simon MS, 2013, ANN INTERN MED, V159, P300, DOI 10.7326/0003-4819-159-4-201308200-00674; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; Stefanelli P, 2008, IUBMB LIFE, V60, P629, DOI 10.1002/iub.95; STIKO, 2006, EPID B, V31, P255; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Tsang RSW, 2003, J CLIN MICROBIOL, V41, P4411, DOI 10.1128/JCM.41.9.4411-4414.2003; Vu DM, 2012, INFECT IMMUN, V80, P643, DOI 10.1128/IAI.05604-11; Weiss D, 2013, MMWR-MORBID MORTAL W, V61, P1048; Weiss D, 2009, CLIN INFECT DIS, V48, P894, DOI 10.1086/597257	39	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160126	10.1371/journal.pone.0160126	http://dx.doi.org/10.1371/journal.pone.0160126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486669	gold, Green Published, Green Submitted			2022-12-26	WOS:000381367800058
